data_2mkh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 218' ' ' MET . . . . . 0.429 ' H2 ' HG13 ' A' ' 413' ' ' VAL . 73.3 mtm . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 93.7 m -152.86 146.4 25.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.46 -169.27 3.25 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.659 1.118 . . . . 0.0 111.529 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.1 p -130.11 19.93 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.959 1.703 . . . . 0.0 109.786 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.48 12.23 65.69 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.14 1.352 . . . . 0.0 116.386 -168.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -51.85 156.0 1.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.48 139.46 20.65 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.346 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -44.21 109.63 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.512 3.475 . . . . 0.0 112.371 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.04 17.35 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.907 3.071 . . . . 0.0 111.138 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -133.63 19.51 3.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.539 0.336 . . . . 0.0 111.091 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -134.68 39.33 3.02 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 121.855 0.836 . . . . 0.0 110.845 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -76.13 161.7 28.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.165 0.986 . . . . 0.0 109.087 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -79.21 -10.18 59.75 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 42.7 62.34 8.38 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.894 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.33 -76.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.0 1.8 . . . . 0.0 112.224 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.9 pt -141.17 -178.83 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 124.909 1.284 . . . . 0.0 110.061 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -111.72 153.43 26.48 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.9 p -146.22 -9.95 0.5 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.617 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 16.8 t -143.85 171.14 14.63 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.033 0.533 . . . . 0.0 109.576 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.438 ' HG2' ' HG ' ' A' ' 236' ' ' CYS . 18.8 ptmt -53.66 174.13 0.05 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.824 1.649 . . . . 0.0 114.309 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.7 146.92 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.32 140.17 32.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.012 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' A' ' 328' ' ' VAL . 20.1 tp -141.47 143.2 33.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 111.123 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.5 156.55 28.57 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.537 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.95 14.28 1.47 Allowed Glycine 0 N--CA 1.475 1.235 0 O-C-N 122.005 -0.703 . . . . 0.0 112.616 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.96 72.98 18.04 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.342 -1.093 . . . . 0.0 110.905 -174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.8 7.72 2.27 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.532 2.154 . . . . 0.0 113.655 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 17.6 p-90 -141.42 -4.94 1.1 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.52 109.15 1.55 Allowed 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 124.69 1.196 . . . . 0.0 112.593 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -72.48 -30.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.351 -172.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.9 p -142.4 126.05 16.91 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 119.734 1.152 . . . . 0.0 112.977 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -71.0 -16.22 62.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.458 -172.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.12 -16.48 61.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 120.215 1.371 . . . . 0.0 108.472 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.33 99.23 Favored Glycine 0 N--CA 1.435 -1.424 0 O-C-N 120.88 -1.137 . . . . 0.0 112.704 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 48.6 mt -69.68 -31.84 70.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.504 1.122 . . . . 0.0 108.27 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.74 -36.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.608 -0.682 . . . . 0.0 110.179 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -80.29 -9.97 59.74 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.955 0.798 . . . . 0.0 111.179 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.0 m -96.49 -21.72 17.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -103.54 -24.32 13.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -74.3 -0.17 16.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.014 0.825 . . . . 0.0 111.81 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.23 -20.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.186 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -101.05 -7.09 23.56 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 156.23 -166.18 33.04 Favored Glycine 0 N--CA 1.432 -1.577 0 O-C-N 124.499 1.124 . . . . 0.0 114.684 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 58.5 m -51.02 124.11 10.69 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.456 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 152.95 42.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.497 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -146.99 168.84 20.52 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.598 1.559 . . . . 0.0 108.711 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.6 152.2 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 121.489 -0.757 . . . . 0.0 112.26 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.21 135.86 32.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 124.497 1.123 . . . . 0.0 110.792 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.486 ' CE2' ' HG2' ' A' ' 269' ' ' LYS . 20.0 p90 -148.11 154.07 42.33 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.93 136.33 24.85 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.162 1.908 . . . . 0.0 107.365 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.2 32.97 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.486 ' HG2' ' CE2' ' A' ' 266' ' ' TRP . 35.8 mtmt -64.28 -6.43 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.449 1.124 . . . . 0.0 111.387 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.67 5.43 43.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.919 1.288 . . . . 0.0 110.696 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -69.68 -160.75 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.435 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -77.43 -17.62 57.94 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 276' ' ' CYS . 3.7 p80 -166.04 154.43 9.96 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.81 -1.39 11.1 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.397 2.732 . . . . 0.0 114.124 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -90.77 31.11 1.09 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 110.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 17.2 t -125.61 40.16 0.52 Allowed Pre-proline 0 C--N 1.34 0.159 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 89.3 Cg_endo -75.07 170.37 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 107.117 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.96 161.56 6.28 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.07 1.846 . . . . 0.0 115.269 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -54.25 -14.82 1.27 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.501 1.12 . . . . 0.0 112.432 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -179.84 16.38 0.03 OUTLIER Glycine 0 CA--C 1.533 1.156 0 CA-C-N 120.488 1.494 . . . . 0.0 112.873 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -130.15 155.85 45.54 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.272 1.536 . . . . 0.0 112.732 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.14 158.43 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 124.176 0.99 . . . . 0.0 109.819 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -118.45 150.06 40.21 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.18 140.62 52.35 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.1 129.79 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -168.03 -167.21 0.8 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -44.6 122.54 3.17 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 124.499 1.124 . . . . 0.0 109.189 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.16 -18.39 35.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.105 2.562 . . . . 0.0 115.852 -166.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -140.32 -54.1 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 120.082 1.31 . . . . 0.0 113.675 -167.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -73.96 -45.34 50.78 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.102 -0.374 . . . . 0.0 110.909 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 71.1 m -70.13 -26.78 64.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.75 -53.58 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -67.6 -26.76 66.42 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.991 -0.443 . . . . 0.0 111.904 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.6 t -67.94 -46.25 72.01 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.207 0.317 . . . . 0.0 110.44 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.8 -42.25 97.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.03 0.377 . . . . 0.0 110.513 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.66 -25.94 61.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.424 0.69 . . . . 0.0 110.042 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -104.99 2.32 29.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.142 0.902 . . . . 0.0 110.077 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.1 -10.8 14.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.594 0.634 . . . . 0.0 110.03 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 16.6 p -107.25 -148.32 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.196 0.31 . . . . 0.0 110.743 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 67.0 m -106.78 145.27 32.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.236 0.541 . . . . 0.0 110.627 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -142.89 155.06 44.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.122 0.969 . . . . 0.0 108.849 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -145.92 137.58 13.07 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 304' ' ' LEU . 96.8 Cg_endo -71.72 -103.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 122.376 2.05 . . . . 0.0 109.338 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.415 ' H ' ' HG2' ' A' ' 303' ' ' PRO . 9.8 mp . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.374 1.07 . . . . 0.0 109.855 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 N--CA 1.465 0.292 0 N-CA-C 111.349 0.129 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 4.1 m -79.17 148.2 32.38 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.5 151.47 31.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.4 153.77 32.49 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 124.33 1.019 . . . . 0.0 109.978 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -147.62 152.66 38.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.915 -1.116 . . . . 0.0 110.017 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 5.4 t80 -153.28 178.05 10.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 30.0 ttmt -152.47 124.95 8.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -169.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 12.67 6.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.868 0.867 . . . . 0.0 110.046 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.6 p -87.48 159.74 18.54 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.416 1.086 . . . . 0.0 111.511 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.3 m -149.27 38.0 0.78 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.768 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 52.51 33.53 13.55 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 121.238 0.542 . . . . 0.0 111.725 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -80.5 -30.65 37.29 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.75 -41.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.093 0.86 . . . . 0.0 111.176 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -147.5 166.65 26.64 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.749 1.219 . . . . 0.0 109.632 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 90.7 m -140.54 123.44 16.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.927 1.346 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -159.0 152.56 22.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -89.88 156.5 18.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 110.679 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.38 152.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.244 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -117.83 131.69 56.53 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.764 0.711 . . . . 0.0 111.77 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 240' ' ' LEU . 2.6 t -115.15 143.35 25.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.302 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.99 98.08 4.45 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 124.19 0.931 . . . . 0.0 109.904 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -83.98 162.14 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.904 4.403 . . . . 0.0 111.99 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.617 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 1.8 t90 -88.34 123.65 33.13 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.777 0.799 . . . . 0.0 109.293 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.2 t -103.75 154.68 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.056 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.9 tt -54.26 -26.45 29.07 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.587 -0.696 . . . . 0.0 112.173 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.09 16.95 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.558 -0.714 . . . . 0.0 112.264 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.07 -5.3 18.15 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.782 0.833 . . . . 0.0 108.894 173.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 66.8 m -100.6 -34.82 9.73 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.016 -1.677 . . . . 0.0 113.906 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -167.18 171.93 10.41 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 124.196 0.935 . . . . 0.0 113.418 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -156.51 155.07 31.35 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.081 1.352 . . . . 0.0 108.294 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.67 148.17 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.481 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -88.83 -16.45 32.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 35.8 t -151.34 113.75 3.05 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.69 -15.03 30.36 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.598 2.865 . . . . 0.0 112.02 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.2 t -86.21 4.65 37.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.428 1.091 . . . . 0.0 112.402 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -114.37 -175.11 2.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.454 1.501 . . . . 0.0 110.936 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -141.7 -179.81 6.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 122.198 0.199 . . . . 0.0 110.892 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.484 HD13 ' HG1' ' A' ' 397' ' ' THR . 1.8 mm? -83.5 120.41 25.89 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -81.1 150.69 68.89 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 124.752 1.283 . . . . 0.0 111.121 -171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.63 108.69 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.648 3.565 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 86.2 p 52.79 23.51 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.52 73.98 0.99 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 119.453 1.024 . . . . 0.0 108.786 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 396' ' ' VAL . 8.2 t -155.75 144.14 20.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.38 159.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 118.294 0.497 . . . . 0.0 110.238 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -83.53 146.92 28.08 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.382 1.051 . . . . 0.0 113.561 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 67.5 t -131.07 136.09 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.962 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.48 -176.96 31.13 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 51.0 22.94 1.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.575 1.55 . . . . 0.0 113.365 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.644 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.65 171.94 14.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.686 0.794 . . . . 0.0 111.171 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -48.7 150.19 1.5 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.546 1.138 . . . . 0.0 109.28 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -66.39 10.6 0.64 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.945 1.259 . . . . 0.0 113.135 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.0 mmt -145.43 -53.21 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.191 0.596 . . . . 0.0 109.805 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 41.73 60.01 2.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.718 0.77 . . . . 0.0 109.639 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -72.43 173.92 8.11 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 121.986 -0.447 . . . . 0.0 111.835 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -57.12 -18.01 13.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -80.55 -35.51 34.29 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.547 -0.721 . . . . 0.0 110.807 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.64 -27.22 27.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 tt -78.68 -31.22 46.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.38 -28.59 56.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.91 -0.494 . . . . 0.0 111.993 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.9 -42.04 61.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 77.5 mt -79.09 -35.48 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 118.808 0.731 . . . . 0.0 109.067 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.31 -22.96 38.16 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.621 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.88 -23.61 21.59 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 120.561 1.528 . . . . 0.0 109.91 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.07 -36.48 58.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.527 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.86 -34.44 77.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.313 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 403' ' ' SER . 0.2 OUTLIER -158.67 -17.38 0.07 Allowed 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.21 -7.6 5.84 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 121.979 0.766 . . . . 0.0 113.679 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -94.05 78.94 0.98 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 122.045 -0.679 . . . . 0.0 113.135 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.42 159.44 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 118.654 1.227 . . . . 0.0 112.378 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.01 -33.06 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -158.28 147.04 18.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.81 146.35 23.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.51 38.16 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 123.058 1.366 . . . . 0.0 114.304 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.56 141.4 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 122.188 0.994 . . . . 0.0 109.2 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.41 148.73 26.44 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.557 -171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.4 p -131.39 159.6 37.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.87 -175.28 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.72 88.14 2.23 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 119.728 -1.858 . . . . 0.0 112.658 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 57.9 m170 70.49 38.58 1.32 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.18 -5.02 15.44 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.889 0.876 . . . . 0.0 110.384 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.1 p90 37.87 54.52 3.85 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 127.097 2.159 . . . . 0.0 114.364 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.18 -48.45 1.76 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.774 2.316 . . . . 0.0 111.169 -174.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.75 37.73 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 111.633 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.88 10.65 0.79 Allowed Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.5 p -155.17 126.66 7.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.265 0.555 . . . . 0.0 110.093 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -156.42 -164.94 13.95 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.468 1.038 . . . . 0.0 114.91 -171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -151.76 162.6 40.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.551 -0.824 . . . . 0.0 108.899 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.401 ' C ' ' HG1' ' A' ' 351' ' ' THR . 3.6 p -143.13 134.15 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.153 -0.967 . . . . 0.0 108.881 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.484 ' HG1' HD13 ' A' ' 346' ' ' LEU . 60.7 m -111.28 142.93 42.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.304 1.05 . . . . 0.0 109.549 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 73.8 m-85 -131.44 162.35 30.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.431 -0.793 . . . . 0.0 110.619 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.85 20.83 10.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.504 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -140.12 155.65 46.9 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.157 0.983 . . . . 0.0 109.183 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.08 -24.61 28.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.67 0.668 . . . . 0.0 110.196 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.608 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 3.8 mpt_? -52.89 -31.31 39.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.556 -0.715 . . . . 0.0 111.576 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 14.3 m -80.46 -29.21 37.48 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.577 0.751 . . . . 0.0 110.864 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.42 -54.37 10.91 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.942 0.337 . . . . 0.0 111.866 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -17.86 55.36 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.005 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -86.41 -31.63 21.33 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 120.45 1.477 . . . . 0.0 112.665 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -72.6 -33.32 66.63 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 120.875 -1.141 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.7 -30.7 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 14.0 t -78.41 -32.21 48.62 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.379 1.049 . . . . 0.0 110.498 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.47 -44.55 35.04 Favored 'General case' 0 C--O 1.227 -0.095 0 O-C-N 121.735 -0.603 . . . . 0.0 110.914 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.17 -17.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.124 2.569 . . . . 0.0 116.331 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.95 136.87 4.31 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.106 -1.621 . . . . 0.0 108.664 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.429 HG13 ' H2 ' ' A' ' 218' ' ' MET . 34.0 m -135.58 154.5 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.698 0.681 . . . . 0.0 110.728 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -112.8 141.48 46.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.559 0.743 . . . . 0.0 111.438 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.0 mt -100.54 122.72 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.44 52.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 418' ' ' THR . 0.3 OUTLIER -72.53 178.51 4.02 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.544 ' H ' HG23 ' A' ' 417' ' ' THR . 10.8 m -75.46 -27.36 58.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -144.32 16.32 1.68 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.963 0.887 . . . . 0.0 110.479 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.59 113.17 4.1 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.7 p -136.27 131.86 35.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.918 0.487 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -148.91 177.74 9.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -144.45 160.93 40.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.06 133.56 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -106.98 157.44 17.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.34 0.59 . . . . 0.0 111.413 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 24.8 mt -140.87 149.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.42 149.95 56.27 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 124.196 0.935 . . . . 0.0 109.387 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.5 161.61 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.413 3.409 . . . . 0.0 109.941 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 116.797 -1.573 . . . . 0.0 111.226 178.441 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.6 m -155.03 158.94 39.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.383 1.073 . . . . 0.0 111.009 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.76 -16.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.062 -0.971 . . . . 0.0 113.472 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.1 m 43.61 52.27 6.22 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.433 1.015 . . . . 0.0 112.383 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 224' ' ' LEU . . . -71.27 -22.32 78.54 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.555 -173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 59.67 27.33 16.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.727 0.811 . . . . 0.0 113.078 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.414 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.1 mm? -81.45 -22.55 0.34 Allowed Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 57.2 Cg_endo -67.76 121.43 8.48 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 CA-C-N 123.529 2.296 . . . . 0.0 111.619 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.14 166.98 4.57 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 125.232 3.955 . . . . 0.0 111.875 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -143.05 6.07 1.53 Allowed 'General case' 0 C--O 1.219 -0.541 0 O-C-N 122.003 -0.435 . . . . 0.0 112.128 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -115.88 30.15 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.976 1.71 . . . . 0.0 108.016 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -60.13 159.33 9.78 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -66.93 7.75 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -170.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 36.8 71.17 0.98 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.191 0.996 . . . . 0.0 112.183 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.31 -89.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.538 1 C-N-CA 126.072 4.515 . . . . 0.0 114.748 -173.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.6 mm -127.37 178.15 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.326 1.45 . . . . 0.0 107.465 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.39 157.45 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.369 -0.825 . . . . 0.0 110.108 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 77.9 p -155.39 13.24 0.36 Allowed 'General case' 0 C--N 1.341 0.208 0 CA-C-N 121.242 1.837 . . . . 0.0 115.741 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 9.1 t -151.96 -177.37 6.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.115 1.325 . . . . 0.0 108.67 172.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.89 -172.77 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.541 1.162 . . . . 0.0 113.327 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.74 144.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.185 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.48 150.86 22.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.483 0.658 . . . . 0.0 111.954 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -140.52 126.08 19.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.674 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.42 38.15 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.205 -0.934 . . . . 0.0 112.911 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.47 3.23 2.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -99.69 134.93 20.72 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.475 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.89 -3.19 12.64 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.332 2.688 . . . . 0.0 110.97 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -128.07 -177.11 4.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.88 1.324 . . . . 0.0 111.151 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -166.47 149.42 6.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.427 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -174.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 168.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.8 m -42.15 129.35 3.7 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.178 -0.951 . . . . 0.0 110.527 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.2 -25.03 65.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 121.694 -0.629 . . . . 0.0 112.242 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.93 64.25 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.397 0.999 . . . . 0.0 112.263 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.95 -30.47 67.89 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.582 1.657 . . . . 0.0 110.601 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.59 -36.17 60.4 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.731 -1.453 . . . . 0.0 108.829 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.48 -36.21 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 123.172 0.589 . . . . 0.0 110.066 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.4 -18.74 61.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.488 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 87.0 m -73.1 -33.63 65.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 118.722 0.692 . . . . 0.0 110.067 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -140.43 80.09 1.74 Allowed 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -133.59 1.35 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.257 0.623 . . . . 0.0 111.493 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.31 -1.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.136 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -100.43 -15.44 17.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.409 0.55 . . . . 0.0 110.416 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.37 170.94 23.63 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.0 t -64.08 131.18 46.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.1 165.35 35.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.709 0.766 . . . . 0.0 110.957 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -141.01 171.65 13.77 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.602 0.715 . . . . 0.0 110.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.84 147.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.564 0.746 . . . . 0.0 110.996 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -139.58 134.09 31.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.025 0.828 . . . . 0.0 109.936 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -155.23 151.0 21.79 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.011 1.324 . . . . 0.0 110.227 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.66 154.42 34.81 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.415 3.41 . . . . 0.0 111.126 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.49 11.22 75.37 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.181 -0.95 . . . . 0.0 112.783 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -79.44 9.26 4.99 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -118.56 148.2 42.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.202 1.401 . . . . 0.0 110.047 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.77 43.97 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.66 -0.65 . . . . 0.0 112.532 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -72.46 155.77 39.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 121.462 -1.022 . . . . 0.0 111.014 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 26.8 m170 46.37 61.04 13.67 Favored Pre-proline 0 N--CA 1.447 -0.613 0 O-C-N 124.537 1.148 . . . . 0.0 111.647 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.05 -20.05 57.26 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.599 2.199 . . . . 0.0 108.945 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -80.18 10.23 4.68 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.408 1.083 . . . . 0.0 113.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 44.4 t -133.84 110.41 12.11 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 120.591 -1.318 . . . . 0.0 111.592 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.62 157.95 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.548 2.165 . . . . 0.0 109.785 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.55 -11.81 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -143.15 -178.15 5.7 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 127.67 2.388 . . . . 0.0 110.286 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.88 4.02 59.02 Favored Glycine 0 CA--C 1.547 2.038 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.1 116.51 32.64 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.928 -1.51 . . . . 0.0 111.879 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.4 m -145.01 163.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.795 1.31 . . . . 0.0 108.59 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -87.85 157.22 19.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 18.5 mt -128.08 140.87 51.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.77 156.19 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.761 0.824 . . . . 0.0 109.94 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.513 ' CZ ' HG23 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -171.22 176.27 3.99 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -60.36 88.29 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.57 HD21 ' H ' ' A' ' 288' ' ' LEU . 1.9 pt? -56.56 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 129.411 3.084 . . . . 0.0 117.075 -167.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -131.67 -41.73 1.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.998 1.272 . . . . 0.0 111.372 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -95.18 -32.91 12.83 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.646 -0.659 . . . . 0.0 111.437 -173.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.8 t -83.51 -17.8 40.64 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.513 HG23 ' CZ ' ' A' ' 286' ' ' PHE . 1.8 t -82.41 -33.58 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 O-C-N 121.216 -0.927 . . . . 0.0 109.976 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -62.96 -47.44 83.17 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 123.97 0.794 . . . . 0.0 110.329 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 77.6 p -76.79 -31.52 57.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.23 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.32 -40.64 58.22 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.38 -16.8 60.34 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.122 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.08 1.64 31.14 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.007 1.442 . . . . 0.0 111.846 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -113.42 -25.08 8.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.148 0.885 . . . . 0.0 110.956 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.4 m -79.1 -157.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.5 m -116.67 161.27 19.47 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.346 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -141.68 151.4 42.97 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 304' ' ' LEU . 5.0 m-20 -140.85 118.8 8.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.49 33.04 0.44 Allowed 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 124.563 3.509 . . . . 0.0 109.931 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 302' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.828 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.342 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.393 0.616 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 16.2 m -143.01 157.08 44.88 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.544 -1.347 . . . . 0.0 112.16 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.7 149.7 51.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.185 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.19 148.68 23.34 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.768 1.227 . . . . 0.0 112.076 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -149.03 156.57 42.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.864 -0.522 . . . . 0.0 110.418 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -158.47 161.16 37.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 11.6 ptpt -120.23 135.54 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 9.17 4.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.7 t -105.96 145.67 31.02 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.4 p -147.85 -32.62 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -138.47 -0.93 1.93 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -105.09 -30.54 9.67 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.574 -0.704 . . . . 0.0 110.716 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.7 mmt -135.03 -163.1 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.643 1.577 . . . . 0.0 106.744 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -69.89 -95.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.674 0.75 . . . . 0.0 109.775 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 98.7 m -156.33 29.8 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.678 0.791 . . . . 0.0 110.768 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.96 121.31 17.12 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 119.942 1.246 . . . . 0.0 113.231 -169.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 0.1 OUTLIER -77.22 164.01 26.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.115 0.566 . . . . 0.0 111.722 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.34 164.03 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.458 0.703 . . . . 0.0 109.522 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -109.94 153.36 24.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.669 0.668 . . . . 0.0 110.55 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.36 149.09 18.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-O 122.493 1.14 . . . . 0.0 111.358 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 119.06 3.65 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.848 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -99.11 172.59 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 124.429 3.42 . . . . 0.0 113.828 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.524 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 7.9 t-105 -85.46 124.67 32.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.837 0.855 . . . . 0.0 110.596 170.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.63 151.78 3.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-O 121.021 0.438 . . . . 0.0 110.118 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.438 HD21 HD22 ' A' ' 337' ' ' ASN . 7.4 tt -61.04 -27.04 68.05 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.635 0.774 . . . . 0.0 110.156 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.2 -6.52 35.07 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 111.474 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.61 7.9 35.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.819 0.848 . . . . 0.0 109.101 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 62.6 m -111.44 -33.12 6.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.909 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . 0.438 HD22 HD21 ' A' ' 333' ' ' LEU . 1.7 p30 -155.26 158.29 38.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.233 0.924 . . . . 0.0 111.827 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -154.36 140.51 18.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.491 169.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.38 148.37 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.911 0.884 . . . . 0.0 113.121 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -111.63 -7.81 14.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.003 1.383 . . . . 0.0 108.807 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 31.1 t -123.82 132.63 24.3 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.49 -1.45 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.975 2.45 . . . . 0.0 112.072 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 43.2 t -87.3 -14.69 40.15 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.734 1.152 . . . . 0.0 114.035 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 52.02 48.95 21.71 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . 0.5 ' HG2' ' H ' ' A' ' 346' ' ' LEU . 40.1 ttt180 -98.25 -178.17 3.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.214 1.405 . . . . 0.0 111.379 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.5 ' H ' ' HG2' ' A' ' 345' ' ' ARG . 11.8 tp -149.16 163.84 36.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -119.23 164.67 20.15 Favored Pre-proline 0 C--N 1.351 0.666 0 CA-C-N 118.435 0.561 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.86 63.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 126.964 5.109 . . . . 0.0 115.362 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 18.8 m 59.21 21.25 9.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.32 58.09 4.32 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.545 1.164 . . . . 0.0 109.324 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.5 t -117.47 166.7 12.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.57 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.3 m -133.67 150.38 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 123.995 0.809 . . . . 0.0 110.507 171.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -78.3 142.54 37.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 124.254 0.971 . . . . 0.0 110.041 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.29 142.44 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 357' ' ' LEU . . . -164.74 -170.01 29.11 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 124.004 0.815 . . . . 0.0 112.704 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 61.18 -2.41 0.22 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.453 ' H ' ' CD2' ' A' ' 357' ' ' LEU . 2.3 pt? -69.46 159.15 33.81 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.205 0.602 . . . . 0.0 111.567 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -92.75 173.92 7.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.711 -0.618 . . . . 0.0 111.432 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -64.24 8.69 0.42 Allowed Glycine 0 CA--C 1.532 1.144 0 N-CA-C 118.232 2.053 . . . . 0.0 118.232 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 38.4 mtt -142.65 6.02 1.62 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.976 1.888 . . . . 0.0 111.319 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.7 68.13 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 124.008 1.861 . . . . 0.0 109.586 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -62.19 176.4 0.6 Allowed 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.417 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.23 62.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.04 -26.4 36.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -85.22 -32.83 22.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.232 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.89 -31.72 64.87 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.271 0.487 . . . . 0.0 110.817 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.36 42.69 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.064 1.302 . . . . 0.0 110.597 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.76 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 123.89 0.744 . . . . 0.0 110.263 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.41 -44.46 80.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 O-C-N 124.174 0.921 . . . . 0.0 109.571 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.39 -17.42 34.47 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 112.722 -168.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.03 -23.89 18.51 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.167 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -93.41 -23.73 18.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.43 0.559 . . . . 0.0 112.446 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.8 -11.51 16.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -115.12 -36.18 4.48 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 141.28 -45.76 0.94 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.899 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.95 150.92 10.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.521 -1.8 . . . . 0.0 111.187 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.53 170.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.326 1.851 . . . . 0.0 107.001 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.81 -29.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 118.101 0.41 . . . . 0.0 110.613 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.441 ' CD1' ' CD1' ' A' ' 346' ' ' LEU . 4.0 t80 -165.61 157.13 14.31 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.803 0.811 . . . . 0.0 111.464 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.55 150.61 35.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.954 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.89 29.94 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 121.248 -0.907 . . . . 0.0 113.071 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 20.7 mm -118.93 141.41 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.153 1.381 . . . . 0.0 107.349 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -90.81 139.97 30.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.4 p -132.78 168.44 18.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.197 0.999 . . . . 0.0 109.561 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -137.81 158.37 44.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.082 2.153 . . . . 0.0 105.528 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -58.66 112.81 1.75 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 18.7 m170 62.99 26.06 15.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.588 -1.32 . . . . 0.0 114.113 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -94.33 -24.48 17.39 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.9 t80 41.35 59.41 8.82 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 125.398 1.479 . . . . 0.0 111.237 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.21 -35.16 3.16 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.595 1.53 . . . . 0.0 110.992 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.524 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 6.5 tp 31.7 48.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 125.166 1.387 . . . . 0.0 110.839 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.14 12.89 0.45 Allowed Glycine 0 C--N 1.349 1.259 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.037 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.0 m -147.86 154.53 40.54 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 118.685 1.242 . . . . 0.0 110.318 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.41 -168.3 40.85 Favored Glycine 0 C--O 1.247 0.951 0 CA-C-N 119.531 1.06 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -152.22 161.23 42.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.02 145.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 123.13 0.269 . . . . 0.0 110.332 -173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.8 p -123.11 142.18 51.16 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.792 0.806 . . . . 0.0 110.563 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.44 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 26.0 m-85 -118.41 -24.81 6.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.153 -169.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.55 17.52 3.08 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.47 156.0 38.6 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.776 -0.577 . . . . 0.0 110.753 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -89.72 -18.33 26.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -55.77 -42.11 75.03 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.478 -1.389 . . . . 0.0 109.675 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.44 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 57.2 m -82.55 -13.37 56.71 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.455 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.36 -50.1 15.12 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 119.195 0.907 . . . . 0.0 110.93 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -29.43 51.99 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.386 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -70.39 -28.88 65.43 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.898 0.856 . . . . 0.0 111.296 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.23 19.74 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.276 -0.89 . . . . 0.0 113.291 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.56 -27.29 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.887 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 73.3 p -82.35 -26.28 33.1 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.22 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -81.58 -40.67 22.71 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.29 -12.54 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -168.71 143.64 3.31 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 123.815 0.846 . . . . 0.0 109.239 -174.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.21 162.44 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 O-C-N 123.688 0.618 . . . . 0.0 110.828 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -106.77 143.72 34.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 123.986 0.803 . . . . 0.0 111.888 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.8 mt -125.7 119.04 53.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 21.0 mtmt -143.59 130.71 20.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.9 p -136.55 -161.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.5 m -88.84 -2.37 58.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.997 0.519 . . . . 0.0 111.98 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -145.57 -4.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . 0.475 ' CZ ' ' HD3' ' A' ' 422' ' ' LYS . 51.2 t80 -138.39 141.07 39.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.341 -1.474 . . . . 0.0 111.1 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 45.4 m -147.2 102.01 3.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.198 0.999 . . . . 0.0 110.904 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.475 ' HD3' ' CZ ' ' A' ' 420' ' ' PHE . 0.6 OUTLIER -153.26 173.77 15.14 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.575 0.625 . . . . 0.0 110.502 178.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -131.43 163.15 28.57 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.39 133.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -100.5 149.91 23.21 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 72.0 mt -133.68 138.2 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.088 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -135.3 150.33 72.3 Favored Pre-proline 0 CA--C 1.53 0.18 0 O-C-N 123.977 0.798 . . . . 0.0 111.333 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.45 150.92 75.97 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.615 1.543 . . . . 0.0 111.344 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 124.852 1.261 . . . . 0.0 112.077 -177.39 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.1 m 60.03 159.68 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.879 2.072 . . . . 0.0 111.957 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.473 ' CZ3' ' CA ' ' A' ' 222' ' ' GLY . 87.8 t90 -161.51 158.6 26.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.931 0.493 . . . . 0.0 109.741 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 70.7 p -143.18 104.62 4.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.288 0.566 . . . . 0.0 110.735 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.473 ' CA ' ' CZ3' ' A' ' 220' ' ' TRP . . . -73.08 111.8 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.26 -17.38 13.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.027 -1.087 . . . . 0.0 110.165 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.551 ' H ' HD11 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -130.14 14.09 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 118.202 2.668 . . . . 0.0 118.202 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 72.6 Cg_exo -49.88 124.05 11.83 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 CA-C-N 120.989 1.389 . . . . 0.0 112.995 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.75 140.96 55.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.879 3.052 . . . . 0.0 110.992 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -142.78 -1.81 1.09 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -130.41 59.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.548 0.689 . . . . 0.0 112.829 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.32 163.75 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.445 1.098 . . . . 0.0 110.391 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -157.46 146.16 19.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.23 153.94 81.83 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -85.88 28.04 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.892 2.395 . . . . 0.0 113.397 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 74.6 mt -137.45 154.75 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 121.953 -0.467 . . . . 0.0 110.596 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.45 170.77 11.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.806 1.643 . . . . 0.0 108.484 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.413 ' HB2' ' H ' ' A' ' 236' ' ' CYS . 54.0 p -152.52 -155.44 0.61 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 122.81 0.444 . . . . 0.0 110.375 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.413 ' H ' ' HB2' ' A' ' 235' ' ' SER . 94.3 m -54.33 137.59 41.34 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.488 1.515 . . . . 0.0 114.416 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 56.26 143.85 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.18 149.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -107.73 156.33 19.21 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 117.885 0.312 . . . . 0.0 111.468 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.29 134.26 16.9 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 125.041 1.463 . . . . 0.0 107.261 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.82 155.92 23.89 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 120.658 -1.277 . . . . 0.0 112.391 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.97 7.35 1.57 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.729 -1.039 . . . . 0.0 112.99 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.96 70.47 10.14 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.697 1.599 . . . . 0.0 109.998 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.92 9.78 1.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 1 C-N-CA 125.726 4.284 . . . . 0.0 112.267 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.488 ' CE3' ' HE3' ' A' ' 321' ' ' MET . 12.5 p-90 -136.15 -8.94 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.94 116.98 8.38 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -174.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.467 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.59 -30.45 34.01 Favored 'Isoleucine or valine' 0 C--O 1.274 2.35 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 250' ' ' ALA . 17.4 m -146.85 127.1 13.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.861 -1.15 . . . . 0.0 112.197 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -56.82 -27.04 59.38 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 125.677 1.861 . . . . 0.0 113.202 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.511 ' H ' HG23 ' A' ' 248' ' ' THR . . . -61.4 -16.49 47.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.34 -57.07 3.04 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-O 121.65 0.583 . . . . 0.0 111.657 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.14 -48.99 68.99 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.46 -33.12 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.335 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -77.99 -8.75 58.56 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.369 0.531 . . . . 0.0 111.685 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.5 m -83.24 -22.96 32.93 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.309 -1.494 . . . . 0.0 112.329 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -141.56 29.85 1.74 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.391 1.451 . . . . 0.0 114.315 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -90.94 13.06 17.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.532 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.53 27.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -168.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.03 -1.32 8.3 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.002 -0.436 . . . . 0.0 111.156 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.34 1.28 88.22 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.006 -0.886 . . . . 0.0 113.869 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.8 m -126.55 30.08 5.61 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.409 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.2 OUTLIER -100.53 146.0 27.62 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -148.79 160.89 42.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 122.174 0.988 . . . . 0.0 109.551 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.8 148.07 22.18 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.76 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.32 149.77 44.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.547 0.612 . . . . 0.0 110.645 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -117.4 143.77 32.69 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.657 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.76 -25.69 7.56 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.826 2.351 . . . . 0.0 110.232 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 174.13 17.2 0.02 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-N 119.944 1.247 . . . . 0.0 114.858 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -112.96 22.03 14.83 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.968 1.884 . . . . 0.0 112.246 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.76 149.78 43.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.544 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -118.07 173.75 14.97 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-O 121.179 0.321 . . . . 0.0 112.32 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.418 ' HA ' ' CE ' ' A' ' 272' ' ' LYS . 3.1 mmpt? -92.06 5.78 48.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 275' ' ' ARG . 23.8 m170 -98.26 164.09 17.92 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.852 1.661 . . . . 0.0 111.346 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.69 5.06 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.757 2.972 . . . . 0.0 110.707 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 273' ' ' HIS . 7.3 ptm180 -140.57 147.54 39.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.871 1.269 . . . . 0.0 110.71 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.93 146.2 15.11 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -93.34 149.84 2.44 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 124.399 3.399 . . . . 0.0 110.447 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.81 163.79 28.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.32 2.68 . . . . 0.0 107.215 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -96.77 23.78 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.65 82.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -165.15 129.4 2.42 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.793 -0.828 . . . . 0.0 109.842 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 160.28 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.498 1.749 . . . . 0.0 108.719 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -92.25 159.18 15.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 43.3 mt -122.94 143.47 49.88 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 123.371 0.669 . . . . 0.0 109.834 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.53 132.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.409 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 30.0 p90 -171.05 -163.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.72 1.263 . . . . 0.0 108.16 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.9 107.81 0.2 Allowed 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -91.04 19.18 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -167.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.62 -72.23 0.64 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.052 -1.03 . . . . 0.0 109.918 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -25.68 29.96 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.26 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 48.9 m -83.83 -23.2 31.47 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.63 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -45.32 39.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.026 -1.046 . . . . 0.0 109.34 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -73.71 -17.2 61.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.896 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.8 t -75.3 -46.08 35.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.08 1.309 . . . . 0.0 108.572 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -61.07 -47.61 85.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.94 -24.61 67.57 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.158 -0.964 . . . . 0.0 110.12 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -101.66 -3.04 28.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.174 0.921 . . . . 0.0 113.088 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -107.24 -10.57 15.79 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.676 0.61 . . . . 0.0 110.489 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.2 m -105.79 -141.83 0.37 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.3 t -125.53 163.6 22.35 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.316 -0.865 . . . . 0.0 111.294 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -148.76 153.58 38.37 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.393 0.433 . . . . 0.0 110.036 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -135.17 122.78 15.24 Favored Pre-proline 0 N--CA 1.435 -1.182 0 O-C-N 125.761 1.913 . . . . 0.0 106.498 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.481 ' HG2' ' H ' ' A' ' 304' ' ' LEU . 69.8 Cg_endo -70.0 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.039 1.826 . . . . 0.0 113.461 -172.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.481 ' H ' ' HG2' ' A' ' 303' ' ' PRO . 8.1 mp . . . . . 0 C--O 1.223 -0.293 0 C-N-CA 123.856 0.862 . . . . 0.0 110.381 -170.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 12.3 m -109.62 144.77 37.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.092 0.245 . . . . 0.0 110.956 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -142.92 140.35 31.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 111.497 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.67 154.47 18.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.811 0.845 . . . . 0.0 110.026 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.38 158.17 44.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.042 -1.036 . . . . 0.0 112.387 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 2.0 t80 -148.37 177.89 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.153 0.501 . . . . 0.0 110.559 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.4 ' N ' ' CD1' ' A' ' 314' ' ' PHE . 23.5 ttmt -147.53 122.71 10.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.04 7.45 1.19 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.743 -167.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.0 p -70.68 157.99 37.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.628 1.171 . . . . 0.0 110.935 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 42.3 t -115.68 173.08 6.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -69.92 -15.87 63.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.646 1.178 . . . . 0.0 111.424 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -68.2 -20.95 64.88 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.488 ' HE3' ' CE3' ' A' ' 245' ' ' TRP . 22.7 ptm -160.95 -165.18 1.31 Allowed 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.724 1.21 . . . . 0.0 111.563 -172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 71.4 mtm-85 -55.76 157.64 4.1 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 110.151 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.3 m -140.48 145.01 36.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 125.068 1.48 . . . . 0.0 110.223 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.93 144.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.28 156.93 36.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.348 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.77 154.81 11.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.34 158.81 23.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 110.413 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.46 145.88 31.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.758 0.789 . . . . 0.0 109.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 60.4 mt -143.16 97.41 5.71 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.23 158.53 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.058 2.506 . . . . 0.0 112.368 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.45 122.27 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.558 HG11 ' H ' ' A' ' 334' ' ' ALA . 9.3 t -96.38 146.97 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.02 -24.42 58.22 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.827 1.251 . . . . 0.0 108.43 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.558 ' H ' HG11 ' A' ' 332' ' ' VAL . . . -63.49 -19.62 64.91 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.859 -1.151 . . . . 0.0 112.472 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -101.3 9.54 41.6 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.237 0.215 . . . . 0.0 111.252 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 74.0 m -102.78 -27.16 12.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.523 -1.361 . . . . 0.0 112.503 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.03 165.69 15.64 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.582 -0.699 . . . . 0.0 110.059 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -158.01 148.4 20.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.16 150.07 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.911 0.862 . . . . 0.0 108.855 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -94.46 -10.56 31.99 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.848 -0.533 . . . . 0.0 111.695 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 m -143.83 150.63 50.62 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.086 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.83 119.87 5.58 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.338 2.025 . . . . 0.0 110.239 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 23.3 t -145.84 161.61 39.6 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.596 0.236 . . . . 0.0 110.545 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -79.9 -27.34 39.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.274 0.63 . . . . 0.0 112.187 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -164.23 171.51 14.86 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.916 1.286 . . . . 0.0 108.905 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 60.5 mt -97.99 -178.31 4.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.958 1.303 . . . . 0.0 111.099 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -101.74 103.62 29.6 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.44 -6.09 12.68 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.253 1.968 . . . . 0.0 113.202 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 21.2 t -91.16 -22.32 20.73 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.621 -0.228 . . . . 0.0 111.072 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -131.82 103.87 6.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 t -154.31 156.56 37.17 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 120.966 -1.084 . . . . 0.0 110.531 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 154.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -86.83 144.36 27.05 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.279 0.987 . . . . 0.0 108.97 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.63 140.35 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.735 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -160.2 176.82 36.85 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 122.061 -0.4 . . . . 0.0 112.689 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.62 7.36 1.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.051 2.14 . . . . 0.0 114.843 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.593 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -78.02 -172.57 2.78 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 175.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -45.57 146.76 0.99 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.792 2.837 . . . . 0.0 115.182 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -71.75 -2.96 53.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.201 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.2 ptm -151.19 32.44 0.59 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.814 1.807 . . . . 0.0 111.022 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.77 140.63 1.82 Allowed 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -134.03 -177.85 4.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.822 0.82 . . . . 0.0 109.78 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.4 8.63 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.963 0.887 . . . . 0.0 111.489 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -44.19 -63.73 0.82 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.479 1.912 . . . . 0.0 110.906 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.3 -28.95 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.235 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.07 -35.34 80.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.231 0.923 . . . . 0.0 109.914 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.6 63.85 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.384 -0.927 . . . . 0.0 112.008 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.52 61.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.339 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.66 -42.51 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.47 -32.27 54.26 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.819 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.75 -16.91 46.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 118.17 -1.412 . . . . 0.0 111.294 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.11 -25.09 13.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.267 -0.896 . . . . 0.0 112.58 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 16.8 tp -92.42 -22.51 19.6 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 121.787 -0.571 . . . . 0.0 111.217 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.415 ' HB3' ' HG ' ' A' ' 403' ' ' SER . 7.4 m-85 -136.26 -47.01 0.63 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 111.281 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.29 -16.21 30.28 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.928 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . 0.451 ' HA3' HD22 ' A' ' 400' ' ' ASN . . . -99.37 22.26 41.57 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.334 1.067 . . . . 0.0 113.877 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.77 166.06 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 120.911 -1.347 . . . . 0.0 111.857 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.26 -30.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.505 ' CG ' ' N ' ' A' ' 380' ' ' ALA . 0.3 OUTLIER -156.02 162.85 40.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.15 0.886 . . . . 0.0 112.369 -174.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -153.63 146.38 24.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.67 150.19 22.39 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.57 1.077 . . . . 0.0 112.77 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 26.3 mm -85.92 136.89 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 125.641 1.576 . . . . 0.0 109.724 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.45 60.09 6.03 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.542 -0.724 . . . . 0.0 111.441 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.7 158.88 9.44 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.717 1.722 . . . . 0.0 112.683 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -140.12 157.78 45.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.968 1.707 . . . . 0.0 107.069 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -57.28 113.92 1.95 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.824 0.821 . . . . 0.0 110.494 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 28.6 m170 53.92 16.62 1.12 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -85.71 -9.67 56.82 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.356 0.98 . . . . 0.0 113.112 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 32.8 p90 39.93 54.13 5.81 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.845 1.658 . . . . 0.0 115.383 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.0 -48.86 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.868 2.379 . . . . 0.0 113.213 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.3 25.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.084 1.754 . . . . 0.0 114.243 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -145.35 19.58 1.89 Allowed Glycine 0 C--O 1.223 -0.567 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.2 p -151.34 159.77 44.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.969 0.885 . . . . 0.0 110.12 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.81 -157.31 20.76 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 115.924 1.13 . . . . 0.0 115.924 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -158.77 164.32 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.232 0.613 . . . . 0.0 109.477 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.13 143.03 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.2 p -112.05 148.77 33.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 403' ' ' SER . 71.2 m-85 -121.07 162.09 20.6 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.9 -171.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.13 0.95 15.11 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.005 0.816 . . . . 0.0 111.199 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.451 HD22 ' HA3' ' A' ' 376' ' ' GLY . 0.3 OUTLIER -150.39 164.74 35.09 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 173.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -80.67 -14.47 58.12 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 117.971 0.351 . . . . 0.0 111.103 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -58.98 -35.53 73.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.949 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 398' ' ' PHE . 8.8 m -78.36 -19.95 52.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.715 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.93 -64.29 0.91 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.444 0.64 . . . . 0.0 109.344 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -19.6 62.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.983 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -79.5 -25.49 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.053 0.221 . . . . 0.0 110.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 374' ' ' PHE . . . -78.81 -39.29 36.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.383 0.611 . . . . 0.0 111.425 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.2 m -78.54 -21.74 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.424 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 51.8 p -87.93 -26.7 22.57 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.59 56.26 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.95 -26.22 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.299 1.839 . . . . 0.0 115.242 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.26 148.67 22.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.019 1.281 . . . . 0.0 111.843 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.75 148.04 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -107.64 94.99 5.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.2 128.98 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 136.67 49.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.754 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.64 174.94 14.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.153 1.381 . . . . 0.0 108.378 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 75.6 m -75.08 -20.88 59.29 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.146 0.885 . . . . 0.0 111.533 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -139.71 24.29 2.43 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.946 -0.471 . . . . 0.0 111.963 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -156.25 118.69 4.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.878 0.871 . . . . 0.0 111.159 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.0 p -146.85 112.13 5.51 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.805 0.729 . . . . 0.0 112.109 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -165.05 173.58 11.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.779 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -100.59 168.13 9.91 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.5 0.667 . . . . 0.0 109.339 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 357' ' ' LEU . 90.3 t -151.05 136.1 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -117.71 153.09 33.96 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 119.119 0.872 . . . . 0.0 112.898 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 78.8 mt -125.84 135.78 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -131.37 139.83 36.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.936 -0.478 . . . . 0.0 109.863 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.31 150.8 31.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.652 2.902 . . . . 0.0 116.544 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.39 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.625 0.25 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m 50.92 119.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.971 1.709 . . . . 0.0 113.475 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.461 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -128.85 -13.01 4.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 111.065 178.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.3 m 43.63 61.5 2.23 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.35 -19.14 78.65 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.726 -0.609 . . . . 0.0 114.205 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.22 32.37 21.61 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.042 -1.858 . . . . 0.0 114.245 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 151.76 86.06 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.38 118.75 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.007 2.472 . . . . 0.0 110.364 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -97.83 5.22 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 126.117 4.545 . . . . 0.0 114.802 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -137.85 11.37 2.89 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.047 0.939 . . . . 0.0 113.104 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -82.86 39.09 0.61 Allowed 'General case' 0 C--N 1.348 0.522 0 O-C-N 121.03 -1.044 . . . . 0.0 111.883 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.0 153.86 35.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -88.59 -13.51 39.83 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.327 1.017 . . . . 0.0 111.79 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.409 ' HA ' HG11 ' A' ' 332' ' ' VAL . 2.5 t-20 50.27 43.53 1.71 Allowed Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.68 -43.49 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.838 1.692 . . . . 0.0 113.867 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 51.7 mt -152.45 157.15 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.94 1.696 . . . . 0.0 107.183 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.09 144.39 31.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.113 0.565 . . . . 0.0 109.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.1 m -128.43 3.07 5.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.726 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.2 t -153.05 179.53 8.62 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 283' ' ' TYR . 12.0 ptmm? -49.5 166.44 0.05 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.308 1.043 . . . . 0.0 109.819 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.86 149.24 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -93.84 132.08 38.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.99 119.94 18.57 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 125.198 1.562 . . . . 0.0 109.602 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.82 170.22 36.97 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 111.866 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.03 1.74 3.97 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.074 0.845 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.92 132.23 74.68 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 119.085 1.443 . . . . 0.0 108.556 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -88.86 -13.49 3.15 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 124.07 3.18 . . . . 0.0 110.921 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.463 ' CD2' ' HE1' ' A' ' 321' ' ' MET . 1.3 p-90 -105.65 -54.5 2.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.2 t0 57.48 151.41 0.01 OUTLIER 'General case' 0 C--N 1.374 1.655 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -170.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.26 -40.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.418 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.1 m -164.48 120.15 1.5 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -74.62 -23.08 58.64 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 120.926 1.694 . . . . 0.0 111.187 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -81.11 -12.58 59.23 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.003 0.921 . . . . 0.0 111.012 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.86 -41.01 29.37 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 124.94 1.4 . . . . 0.0 109.93 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.58 -42.57 78.08 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.447 1.118 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.15 -37.07 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -73.68 -15.49 61.23 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.613 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 62.2 m -80.34 -24.47 39.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.804 0.729 . . . . 0.0 109.545 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -139.9 32.04 2.0 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -103.37 12.77 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.503 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.46 23.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.7 -1.3 19.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.273 0.559 . . . . 0.0 111.651 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 110.82 -80.22 0.27 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 122.502 1.057 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.0 t -88.99 109.37 20.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.061 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 138.7 17.51 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.048 -1.032 . . . . 0.0 110.411 168.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.6 m -138.57 172.97 12.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.366 1.067 . . . . 0.0 109.311 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.95 147.61 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.876 -168.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -155.3 151.25 27.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.321 1.058 . . . . 0.0 110.726 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -160.28 138.57 7.45 Favored Pre-proline 0 C--N 1.352 0.691 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.52 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 85.1 Cg_endo -79.41 164.5 23.91 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.552 2.168 . . . . 0.0 110.772 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.61 -128.24 9.47 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -83.53 109.06 17.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.694 0.759 . . . . 0.0 109.485 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -125.75 141.22 52.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.278 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -175.85 -148.52 6.94 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 121.945 0.747 . . . . 0.0 112.325 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -80.97 1.78 29.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.242 1.417 . . . . 0.0 111.22 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -125.87 102.76 28.05 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.25 0.62 . . . . 0.0 110.264 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.8 28.29 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 125.273 3.982 . . . . 0.0 112.169 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -133.29 11.91 4.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 6.5 t -81.75 -33.41 0.65 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 116.884 -1.531 . . . . 0.0 112.203 -174.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 74.0 Cg_exo -55.72 122.5 11.86 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.293 2.662 . . . . 0.0 111.925 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.2 5.71 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.246 3.297 . . . . 0.0 112.177 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -121.95 6.16 9.84 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.87 36.73 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.944 -1.475 . . . . 0.0 113.659 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -112.6 146.87 37.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.178 1.489 . . . . 0.0 110.753 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.6 p -154.67 157.18 4.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.52 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 12.1 m-85 -109.0 154.84 21.62 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.07 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -116.02 134.37 55.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.428 1.108 . . . . 0.0 110.872 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.19 109.56 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -166.52 -166.58 0.88 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.55 -0.719 . . . . 0.0 111.261 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.63 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.235 1.814 . . . . 0.0 107.578 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.576 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 2.0 pt? -73.9 -3.61 29.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -167.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -111.13 -66.13 1.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -87.29 -31.72 20.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.504 -0.748 . . . . 0.0 109.602 -171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 67.4 m -83.24 -26.29 30.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 121.031 1.741 . . . . 0.0 110.381 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.25 -55.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -58.11 -31.53 67.24 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.999 -1.063 . . . . 0.0 112.194 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.3 m -68.2 -39.14 82.52 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.01 0.434 . . . . 0.0 112.144 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.03 -41.47 70.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.97 -19.75 61.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.361 -0.536 . . . . 0.0 112.339 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -98.06 -3.68 37.52 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.653 0.596 . . . . 0.0 110.187 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -101.66 -5.97 24.35 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 124.314 1.009 . . . . 0.0 110.277 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 300' ' ' SER . 33.9 m -90.59 -157.27 0.47 Allowed 'General case' 0 C--O 1.221 -0.418 0 O-C-N 125.846 1.967 . . . . 0.0 109.509 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.414 ' H ' ' HB3' ' A' ' 299' ' ' CYS . 63.8 m -136.95 -178.23 5.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -138.4 143.79 39.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.086 0.954 . . . . 0.0 111.788 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.83 127.49 26.22 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -83.43 37.19 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.125 4.55 . . . . 0.0 110.158 176.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 112.595 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.557 0.694 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.2 m -66.61 167.0 11.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.442 1.097 . . . . 0.0 108.858 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -138.58 154.05 48.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.249 0.931 . . . . 0.0 110.0 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -110.91 151.77 27.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 47.0 m-85 -147.4 159.75 43.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -162.99 151.58 14.34 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -114.57 131.48 56.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.11 0.868 . . . . 0.0 110.238 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.62 16.22 19.77 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.488 0.715 . . . . 0.0 110.376 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.438 ' HB2' ' H ' ' A' ' 322' ' ' ARG . 65.6 p -132.8 132.24 41.97 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.769 -0.582 . . . . 0.0 112.562 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 95.9 p -138.38 -18.53 1.12 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.225 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -137.2 -16.39 1.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -90.16 -25.38 20.7 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.411 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.463 ' HE1' ' CD2' ' A' ' 245' ' ' TRP . 96.9 mmm -148.38 -47.15 0.15 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.613 1.565 . . . . 0.0 109.676 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.438 ' H ' ' HB2' ' A' ' 317' ' ' SER . 21.8 ptt180 47.72 39.63 10.59 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.147 1.779 . . . . 0.0 114.7 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 21.8 m -132.35 -19.11 2.48 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.552 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -148.48 168.22 23.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 158.29 30.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.057 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.35 165.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.473 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 2.8 pp0? -118.2 166.89 12.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.99 140.91 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 111.644 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -143.1 98.09 5.63 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -83.49 155.54 14.1 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.094 1.863 . . . . 0.0 112.243 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -80.21 119.87 23.55 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.145 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.479 HG12 ' H ' ' A' ' 334' ' ' ALA . 18.0 t -97.25 157.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.109 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -54.34 -30.96 53.31 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.687 0.756 . . . . 0.0 110.549 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.479 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -74.93 6.76 3.75 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.491 1.116 . . . . 0.0 112.413 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -112.79 6.28 17.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 109.982 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 42.9 m -123.96 -29.14 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.21 165.76 35.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 110.387 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -152.45 136.65 16.56 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 125.631 1.572 . . . . 0.0 111.903 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.03 147.55 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 122.731 1.253 . . . . 0.0 110.844 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -113.34 3.95 16.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.489 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.7 m -133.58 150.33 74.59 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 125.439 1.496 . . . . 0.0 110.087 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -85.68 -7.29 8.61 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.524 3.483 . . . . 0.0 113.799 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.5 t -149.46 -16.01 0.28 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.666 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -97.89 166.46 11.44 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 109.994 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -151.25 -169.07 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.034 -0.416 . . . . 0.0 110.457 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.451 HD12 ' CZ ' ' A' ' 379' ' ' TYR . 9.4 mp -37.27 152.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.42 2.288 . . . . 0.0 114.183 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.99 134.9 25.75 Favored Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 126.331 1.852 . . . . 0.0 108.136 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -82.29 4.78 6.8 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.27 1.98 . . . . 0.0 113.811 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 6.2 t -139.24 -5.96 1.41 Allowed 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.117 1.326 . . . . 0.0 114.238 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -125.58 69.65 1.17 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.187 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -150.84 153.4 35.31 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.413 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.89 165.19 29.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 124.056 0.847 . . . . 0.0 111.131 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -83.32 151.4 25.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.331 0.586 . . . . 0.0 112.257 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.3 t -132.54 142.88 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.791 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.27 -163.8 18.08 Favored Glycine 0 C--O 1.246 0.863 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.174 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.72 37.37 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.001 1.721 . . . . 0.0 113.582 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.57 167.06 20.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -83.57 4.86 26.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.23 34.89 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.732 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 5.0 ptp -164.13 21.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.094 0.947 . . . . 0.0 110.289 174.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.81 140.45 58.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.896 1.225 . . . . 0.0 110.608 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.04 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.23 66.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -73.63 -31.92 63.78 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.819 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.62 60.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.838 -1.164 . . . . 0.0 108.551 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 382' ' ' ILE . 93.3 mt -60.95 -53.45 57.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.25 59.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.95 -41.65 42.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.913 0.863 . . . . 0.0 110.36 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.3 -26.99 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.197 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 51.7 mt -96.08 -20.74 18.43 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.274 -0.891 . . . . 0.0 112.882 -168.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 -7.53 18.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 116.211 -1.852 . . . . 0.0 110.543 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 -13.05 8.64 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.247 1.385 . . . . 0.0 114.684 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.12 -4.01 11.48 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.61 0.641 . . . . 0.0 111.313 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -133.08 -32.84 1.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.903 0.881 . . . . 0.0 111.857 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 79.29 -9.64 39.74 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.7 128.03 1.66 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 120.411 2.105 . . . . 0.0 110.661 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.41 171.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.04 -30.12 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.451 ' CZ ' HD12 ' A' ' 346' ' ' LEU . 1.1 t80 -171.11 159.67 6.06 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -148.99 145.6 27.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -151.78 -173.97 22.03 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 122.955 1.308 . . . . 0.0 114.865 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 366' ' ' LEU . 42.2 mm -116.47 144.37 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 112.093 -2.053 . . . . 0.0 109.834 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -76.3 44.81 0.35 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.799 0.439 . . . . 0.0 111.916 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.56 155.79 5.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.271 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -145.35 144.69 30.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -48.96 114.97 1.11 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 111.099 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 14.3 m170 57.99 28.53 16.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.045 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -105.65 -1.32 24.73 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.0 p90 33.21 59.44 1.63 Allowed Pre-proline 0 C--N 1.353 0.751 0 C-N-CA 126.497 1.919 . . . . 0.0 112.962 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.06 -49.02 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.3 tp 31.41 41.49 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.518 1.527 . . . . 0.0 112.473 -175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -141.3 11.72 2.77 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 117.975 -1.458 . . . . 0.0 112.155 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 45.6 m -151.95 153.44 34.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.068 0.934 . . . . 0.0 109.04 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.4 -166.5 32.5 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.707 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.08 167.68 29.55 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.34 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.89 135.47 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 119.303 0.956 . . . . 0.0 110.332 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 21.1 p -105.5 129.13 53.85 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 121.704 -0.623 . . . . 0.0 110.868 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.449 ' CD1' ' CB ' ' A' ' 403' ' ' SER . 95.0 m-85 -96.62 -45.14 6.83 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 53.9 t30 56.64 17.47 3.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.702 0.401 . . . . 0.0 111.01 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -141.66 155.78 45.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.664 1.986 . . . . 0.0 107.91 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -103.24 -37.47 7.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 117.718 -1.134 . . . . 0.0 112.499 -171.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.491 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -61.05 -22.92 65.04 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.518 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.449 ' CB ' ' CD1' ' A' ' 398' ' ' PHE . 7.3 m -74.02 -26.51 60.47 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.155 -0.966 . . . . 0.0 111.24 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -73.71 -56.03 5.51 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.234 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -78.16 -30.54 49.22 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.827 -0.546 . . . . 0.0 111.522 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.64 64.86 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.94 -30.82 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 123.392 0.432 . . . . 0.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 25.6 p -77.55 -14.52 59.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.81 1.319 . . . . 0.0 112.993 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -88.93 -46.31 9.0 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.681 0.613 . . . . 0.0 110.197 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.73 -16.6 0.01 OUTLIER 'General case' 0 C--O 1.242 0.692 0 C-N-CA 126.86 2.064 . . . . 0.0 115.099 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.562 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -163.88 145.87 9.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.4 160.81 41.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.51 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 33.5 mt-10 -118.76 128.14 54.21 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 125.354 1.659 . . . . 0.0 108.851 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.6 mt -99.29 125.25 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 40.09 3.46 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.092 0.87 . . . . 0.0 111.436 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.9 p -76.4 172.17 13.37 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.965 1.365 . . . . 0.0 110.162 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.9 t -73.62 -1.29 18.25 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 120.275 -1.516 . . . . 0.0 112.713 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -128.43 -9.69 5.17 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 422' ' ' LYS . 15.0 t80 -149.71 124.09 9.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.937 0.79 . . . . 0.0 109.175 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 14.1 p -131.43 72.14 1.49 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.668 0.787 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 420' ' ' PHE . 98.0 mttt -152.42 177.91 10.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.001 0.92 . . . . 0.0 111.156 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.51 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 93.7 mttt -122.28 -179.54 4.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.7 m -152.15 161.25 3.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.81 1.244 . . . . 0.0 107.824 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -116.26 155.08 28.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 123.413 1.578 . . . . 0.0 110.267 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.9 mt -143.37 138.35 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.341 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -139.04 153.64 71.78 Favored Pre-proline 0 C--O 1.246 0.915 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.72 149.99 88.86 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 123.468 2.779 . . . . 0.0 110.886 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.86 1.664 . . . . 0.0 111.646 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 60.0 m -162.2 152.97 17.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -18.96 1.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.96 1.709 . . . . 0.0 112.422 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m 43.65 56.43 4.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.905 0.86 . . . . 0.0 112.745 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.85 -17.71 80.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.784 -1.098 . . . . 0.0 114.964 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.426 ' HA ' ' CG2' ' A' ' 417' ' ' THR . 29.6 mt-30 46.91 44.56 14.68 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 1.3 pt? -137.0 6.28 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 116.068 -1.92 . . . . 0.0 115.302 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 84.3 Cg_endo -68.25 128.66 17.82 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 CA-C-N 123.091 2.14 . . . . 0.0 108.709 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.12 152.5 24.3 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.236 2.624 . . . . 0.0 111.829 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -140.44 3.52 1.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.5 1.52 . . . . 0.0 110.718 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -106.04 64.7 0.68 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -115.52 -99.01 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.344 1.458 . . . . 0.0 109.865 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.75 27.82 14.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.11 1.364 . . . . 0.0 112.277 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -91.09 -43.89 0.38 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.64 -170.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.483 2.122 . . . . 0.0 114.653 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -105.41 178.67 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.823 1.249 . . . . 0.0 108.228 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.34 151.33 19.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.34 -1.475 . . . . 0.0 108.91 -174.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -147.4 -2.11 0.6 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.029 0.442 . . . . 0.0 111.677 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 -169.58 2.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.344 -1.472 . . . . 0.0 113.092 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 170.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.677 0.751 . . . . 0.0 112.603 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.37 141.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.143 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -83.62 134.14 34.81 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.92 118.7 9.24 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 169.73 -162.25 35.68 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.03 7.18 3.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.115 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.34 131.59 41.9 Favored Pre-proline 0 C--O 1.216 -0.68 0 CA-C-N 117.798 0.799 . . . . 0.0 110.406 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -86.95 -4.3 7.99 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 124.341 3.361 . . . . 0.0 109.862 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.585 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 1.3 p-90 -118.62 -43.13 2.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.464 -1.398 . . . . 0.0 114.327 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER 54.04 154.87 0.0 OUTLIER 'General case' 0 C--O 1.271 2.221 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -171.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.72 178.32 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.058 175.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.0 m -44.02 123.14 3.18 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.37 -25.75 68.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.84 -14.53 62.44 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 118.218 0.463 . . . . 0.0 111.846 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.14 -44.22 36.49 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.866 0.703 . . . . 0.0 112.833 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.7 -35.83 57.61 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.433 1.111 . . . . 0.0 109.608 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.55 -35.84 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.881 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -80.9 -14.82 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 47.1 m -79.81 -28.75 40.17 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.947 -0.471 . . . . 0.0 112.002 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -130.87 26.81 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.419 ' HA ' HD12 ' A' ' 262' ' ' LEU . 10.9 ptm85 -101.8 1.85 37.67 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 113.275 169.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 99.1 t -76.22 -14.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 122.483 1.135 . . . . 0.0 111.708 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -87.61 -16.03 35.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.892 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 163.97 172.0 30.9 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.614 1.097 . . . . 0.0 112.569 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 52.8 m -58.13 130.89 48.72 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -160.25 173.92 14.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.492 167.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.41 ' HB2' HG21 ' A' ' 285' ' ' VAL . 50.2 m -138.96 174.84 10.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.531 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 146.65 25.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 125.235 1.414 . . . . 0.0 111.334 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -146.72 141.69 27.04 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.896 0.855 . . . . 0.0 112.928 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -151.08 140.1 13.46 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.475 1.11 . . . . 0.0 111.325 173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.08 10.27 3.02 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.691 3.594 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.32 -168.89 24.5 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -80.5 54.51 2.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.315 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.43 -15.93 63.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -78.63 -11.8 84.89 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 121.221 -0.925 . . . . 0.0 113.413 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.61 -45.98 4.28 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.267 1.534 . . . . 0.0 110.274 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.467 ' CG ' ' HE ' ' A' ' 275' ' ' ARG . 2.4 p80 -163.1 145.42 8.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 123.462 0.476 . . . . 0.0 109.837 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 41.11 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 126.586 4.857 . . . . 0.0 113.097 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.467 ' HE ' ' CG ' ' A' ' 273' ' ' HIS . 28.4 ptt180 -132.28 10.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.622 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.41 56.54 14.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.781 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.63 149.36 48.95 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 N-CA-C 108.429 -1.412 . . . . 0.0 108.429 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.55 -30.82 86.78 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.65 1.567 . . . . 0.0 113.415 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -146.84 176.13 10.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.85 0.86 . . . . 0.0 110.631 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -81.62 25.66 3.85 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.487 -1.383 . . . . 0.0 116.096 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.479 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 51.3 p90 -142.63 174.18 10.87 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.373 0.69 . . . . 0.0 109.534 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.45 157.1 4.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.85 140.03 30.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.779 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.3 mt -119.86 148.37 43.56 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.014 0.825 . . . . 0.0 109.676 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 263' ' ' SER . 2.8 m -131.8 98.48 3.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.529 ' C ' ' H ' ' A' ' 288' ' ' LEU . 67.2 m-85 -85.09 -171.58 3.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.176 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.96 43.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.796 1.284 . . . . 0.0 110.703 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 286' ' ' PHE . 4.1 mm? 54.12 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 131.107 3.763 . . . . 0.0 116.575 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.95 -42.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.118 0.872 . . . . 0.0 111.906 -170.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.1 -74.37 0.06 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-O 122.152 0.977 . . . . 0.0 113.026 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 37.9 m -70.33 -11.82 61.17 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.425 0.69 . . . . 0.0 109.537 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.83 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 O-C-N 119.837 -1.789 . . . . 0.0 111.452 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.11 -29.54 64.18 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.97 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.5 m -66.19 -36.68 83.69 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 121.794 -0.566 . . . . 0.0 111.368 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -52.38 21.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.723 -0.611 . . . . 0.0 111.449 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.07 -29.97 70.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.731 0.696 . . . . 0.0 111.707 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -80.74 -10.77 59.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.158 0.435 . . . . 0.0 110.969 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -109.99 -2.7 16.94 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.395 -0.816 . . . . 0.0 110.862 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 90.4 m -102.99 -156.11 0.55 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.895 1.278 . . . . 0.0 109.039 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 59.0 m -124.42 166.86 15.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.076 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -140.0 161.49 37.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.655 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -147.37 124.04 5.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -85.4 22.56 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.093 3.862 . . . . 0.0 112.593 173.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.343 0.315 0 C-N-CA 124.052 0.941 . . . . 0.0 113.506 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--O 1.218 -0.6 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 21.8 m -102.68 165.05 11.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.969 0.908 . . . . 0.0 110.1 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -142.51 154.98 44.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -111.56 154.5 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 110.996 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -144.96 149.26 34.88 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.455 -0.778 . . . . 0.0 112.059 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -161.84 160.6 28.32 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.129 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -124.69 147.38 48.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.23 -0.919 . . . . 0.0 110.68 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.84 9.39 3.58 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.179 -168.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 319' ' ' ARG . 66.9 p -121.75 -97.11 0.46 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.199 0.937 . . . . 0.0 109.724 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 6.2 m 65.67 -3.85 0.66 Allowed 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.232 1.013 . . . . 0.0 111.867 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 317' ' ' SER . 5.5 mpt_? -140.4 170.63 15.46 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.471 2.308 . . . . 0.0 106.624 170.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 321' ' ' MET . 17.5 ptt180 50.21 6.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.308 2.243 . . . . 0.0 115.115 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.585 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 11.7 mmt -156.68 -176.03 5.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.728 -0.607 . . . . 0.0 109.701 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -83.74 20.3 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.679 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 318' ' ' SER . 55.9 m 54.15 68.72 0.81 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.478 0.711 . . . . 0.0 112.554 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -124.55 108.11 11.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.26 169.01 2.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.039 1.336 . . . . 0.0 112.661 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.65 178.1 3.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.87 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 161.23 35.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.358 0.599 . . . . 0.0 109.851 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.33 135.69 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 24.1 mt -144.21 98.16 5.13 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 125.028 1.455 . . . . 0.0 109.837 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.75 160.47 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.13 1 C-N-CA 125.48 4.12 . . . . 0.0 112.969 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -89.19 125.16 34.95 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.133 0.895 . . . . 0.0 109.941 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.524 HG13 ' H ' ' A' ' 334' ' ' ALA . 63.4 t -109.86 147.85 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.94 -22.11 47.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 117.744 -1.582 . . . . 0.0 111.934 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.524 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -59.23 -14.34 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.706 1.139 . . . . 0.0 113.148 174.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -99.28 6.91 46.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.369 1.067 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.414 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.2 m -132.81 -33.73 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.518 0.727 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -146.76 152.83 39.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.988 0.899 . . . . 0.0 110.725 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -164.64 140.78 5.94 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.549 -1.66 . . . . 0.0 109.473 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 379' ' ' TYR . 5.5 m -118.85 150.6 21.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.668 -0.645 . . . . 0.0 112.112 -175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -125.1 28.52 6.36 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.655 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.4 t -148.23 143.0 16.98 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.756 0.823 . . . . 0.0 110.532 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.11 -10.69 26.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.717 2.944 . . . . 0.0 110.186 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.7 m -90.24 -9.48 47.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.355 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 43.11 17.3 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . 0.568 ' HA ' ' HE ' ' A' ' 345' ' ' ARG . 0.0 OUTLIER -117.6 174.34 6.22 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.421 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.7 mm? -86.57 169.67 12.57 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 125.019 1.45 . . . . 0.0 111.685 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -110.44 154.15 43.14 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.26 110.16 0.51 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.043 1.829 . . . . 0.0 112.003 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 35.8 m 50.82 35.65 12.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.121 0.968 . . . . 0.0 112.41 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -115.61 64.76 0.69 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.425 0.631 . . . . 0.0 112.251 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.1 t -148.61 159.26 44.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.653 0.381 . . . . 0.0 111.556 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 14.0 m -129.05 165.44 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.139 -0.976 . . . . 0.0 111.852 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -87.62 162.2 17.27 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.93 132.91 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.904 0.753 . . . . 0.0 109.345 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -136.4 -176.7 14.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 123.222 1.457 . . . . 0.0 111.414 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 63.0 -57.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.796 1.238 . . . . 0.0 113.056 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 47.8 -158.57 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.784 1.233 . . . . 0.0 111.74 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.88 163.71 35.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.517 1.927 . . . . 0.0 107.487 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -63.25 4.18 0.95 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 120.142 -0.255 . . . . 0.0 113.272 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.8 ptp -164.4 32.2 0.07 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.848 1.324 . . . . 0.0 108.756 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.4 111.89 2.21 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.537 0.735 . . . . 0.0 110.743 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.21 159.36 17.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -71.66 -20.32 61.97 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 121.479 -0.763 . . . . 0.0 112.497 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.09 -23.24 59.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -72.12 -35.25 69.08 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.223 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.14 -29.35 63.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.0 -1.08 . . . . 0.0 109.737 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -86.5 -15.87 38.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.172 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -85.93 -43.37 13.26 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 119.483 1.038 . . . . 0.0 110.958 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.73 -52.27 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.66 -38.86 70.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -21.2 60.45 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 118.35 -1.34 . . . . 0.0 110.376 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.6 -12.83 35.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.968 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.7 tp -75.53 -20.68 58.54 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 121.777 -0.577 . . . . 0.0 110.436 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.473 ' CD2' ' HB2' ' A' ' 403' ' ' SER . 27.7 p90 -156.34 -43.31 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 374' ' ' PHE . . . -177.37 -66.67 0.06 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 119.174 0.897 . . . . 0.0 114.182 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 176.46 149.95 7.91 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 119.087 1.444 . . . . 0.0 114.644 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 1.1 m -118.75 172.52 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.618 0.767 . . . . 0.0 110.914 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.8 -30.87 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.436 ' CD2' HG13 ' A' ' 339' ' ' VAL . 23.0 t80 -163.93 156.04 17.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.36 154.13 40.51 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.11 166.27 36.27 Favored Glycine 0 C--O 1.22 -0.739 0 CA-C-O 122.683 1.157 . . . . 0.0 114.951 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 336' ' ' SER . 11.4 mm -116.0 154.42 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.27 1.828 . . . . 0.0 107.071 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.64 134.09 42.05 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.375 -0.828 . . . . 0.0 110.758 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 4.3 p -135.2 154.05 51.73 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 125.26 1.6 . . . . 0.0 110.071 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.33 159.31 42.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 386' ' ' LYS . 1.7 tpmt? -46.82 103.18 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.315 0.646 . . . . 0.0 112.378 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.2 m170 45.07 45.77 9.15 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.886 2.475 . . . . 0.0 114.04 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -102.55 4.08 38.11 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.403 -0.81 . . . . 0.0 110.964 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.3 p90 42.26 54.0 8.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.276 1.43 . . . . 0.0 112.746 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.567 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 85.7 Cg_endo -70.08 -66.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.3 2.667 . . . . 0.0 112.426 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.567 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 4.0 tp 42.63 28.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 124.061 0.85 . . . . 0.0 111.854 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -123.11 10.69 8.76 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.904 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 69.1 p -158.08 158.81 35.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -168.96 -169.24 32.1 Favored Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.071 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 9.6 ptp85 -150.53 165.51 33.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 122.1 0.952 . . . . 0.0 109.051 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.49 136.14 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 120.755 -1.215 . . . . 0.0 108.719 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 43.8 m -115.74 142.83 46.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.524 -170.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.02 164.69 15.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.56 0.695 . . . . 0.0 112.007 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -116.37 7.21 13.84 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.107 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -129.1 164.86 22.4 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -107.54 -29.26 9.29 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.912 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.581 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -56.44 -28.79 60.52 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.753 1.16 . . . . 0.0 113.398 -173.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.473 ' HB2' ' CD2' ' A' ' 374' ' ' PHE . 32.6 t -78.38 -33.99 48.52 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.617 -1.302 . . . . 0.0 113.159 175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -51.87 -50.73 60.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 123.845 0.716 . . . . 0.0 111.494 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.407 HD11 ' H ' ' A' ' 405' ' ' LEU 0.282 0.0 OUTLIER -83.39 -26.55 30.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.618 176.9 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -74.3 -19.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.465 1.029 . . . . 0.0 110.86 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -89.34 -36.75 15.35 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.201 -0.937 . . . . 0.0 112.364 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.4 m -71.61 -22.16 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.841 1.2 . . . . 0.0 108.961 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.7 p -84.01 -29.66 26.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 124.499 1.124 . . . . 0.0 112.706 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.99 -41.33 64.43 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.493 0.717 . . . . 0.0 110.667 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.21 -9.78 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.93 148.51 10.33 Favored 'General case' 0 C--O 1.219 -0.522 0 O-C-N 120.766 -1.209 . . . . 0.0 110.7 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.38 163.51 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.233 0.469 . . . . 0.0 110.528 171.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.68 139.2 47.33 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.173 0.511 . . . . 0.0 110.782 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 421' ' ' THR . 29.6 mt -103.74 125.78 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 29.12 5.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.426 ' CG2' ' HA ' ' A' ' 223' ' ' GLN . 34.9 p -68.74 178.8 1.97 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.344 1.545 . . . . 0.0 111.638 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.3 p -73.94 -8.51 56.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -138.69 3.54 2.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.715 0.806 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.97 142.36 26.33 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.315 -1.491 . . . . 0.0 112.914 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 11.0 p -146.03 104.72 3.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.056 0.943 . . . . 0.0 110.091 175.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.545 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 41.4 tptt -165.87 176.55 7.79 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 56.2 mtpt -118.94 162.6 18.25 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.29 138.63 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -100.07 152.11 20.6 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 59.5 mt -135.38 135.11 52.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.89 150.94 29.02 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 119.395 0.998 . . . . 0.0 109.118 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.34 156.06 27.37 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.878 2.385 . . . . 0.0 111.464 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.642 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.9 m -58.61 153.74 15.76 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.826 0.85 . . . . 0.0 110.654 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -116.79 -59.18 1.99 Allowed 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.127 -0.983 . . . . 0.0 109.534 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.9 m 39.21 51.64 2.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.089 1.355 . . . . 0.0 111.917 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.04 -17.97 79.71 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.65 1.119 . . . . 0.0 111.643 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 63.53 32.4 14.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.21 93.18 17.47 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 125.15 1.38 . . . . 0.0 108.614 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.23 147.49 26.15 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 113.641 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.23 -149.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 125.054 3.836 . . . . 0.0 109.745 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 68.29 28.22 6.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.954 0.901 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -90.91 -4.96 56.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.47 147.77 52.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 112.792 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -153.5 33.65 0.46 Allowed 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.48 1.512 . . . . 0.0 109.378 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -129.42 80.08 72.76 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.95 105.83 2.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.467 2.111 . . . . 0.0 111.414 -172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.58 148.32 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.055 . . . . 0.0 107.1 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -125.94 157.46 37.7 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.197 -0.94 . . . . 0.0 113.072 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 99.2 p -152.4 -1.38 0.28 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 12.1 t -144.46 179.84 7.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.247 1.022 . . . . 0.0 110.837 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.82 161.43 0.76 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.76 150.45 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.205 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -94.01 140.37 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 109.691 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.77 108.93 4.43 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.68 163.9 34.89 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.668 1.122 . . . . 0.0 112.884 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.94 3.17 1.53 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.74 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 m -103.77 108.69 60.42 Favored Pre-proline 0 N--CA 1.435 -1.216 0 C-N-CA 122.514 0.326 . . . . 0.0 110.522 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.98 -20.99 11.23 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.081 1.854 . . . . 0.0 113.017 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.579 ' CE3' ' HE1' ' A' ' 321' ' ' MET . 35.7 p-90 -100.08 -26.33 14.0 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -43.56 104.34 0.04 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.106 1.362 . . . . 0.0 112.33 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.49 ' CD1' ' H ' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -74.92 -27.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.2 m -146.12 136.07 23.5 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.749 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -9.92 59.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.33 64.03 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.8 -58.07 10.84 Favored Glycine 0 C--N 1.359 1.859 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.75 -23.31 62.39 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 119.671 -2.076 . . . . 0.0 112.085 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.08 -27.21 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 122.993 0.517 . . . . 0.0 109.79 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.46 -13.85 24.24 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.555 0.342 . . . . 0.0 111.826 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.6 m -82.46 -26.82 32.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.35 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -131.96 64.49 1.59 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.109 -1.62 . . . . 0.0 113.221 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -140.12 2.23 1.89 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.794 0.838 . . . . 0.0 111.484 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.47 -10.43 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.408 0.683 . . . . 0.0 109.529 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.08 28.69 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.834 1.253 . . . . 0.0 111.275 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.26 8.25 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.813 -0.437 . . . . 0.0 114.157 -171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 38.8 m -156.3 51.65 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 125.127 1.134 . . . . 0.0 109.886 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.541 HD11 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -115.34 175.0 5.71 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.5 t -143.89 177.92 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.846 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.87 147.57 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -157.97 153.18 25.72 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 126.419 2.324 . . . . 0.0 110.101 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -155.89 149.7 19.24 Favored Pre-proline 0 N--CA 1.432 -1.374 0 O-C-N 124.21 0.944 . . . . 0.0 113.097 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.44 153.51 50.09 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.785 1.657 . . . . 0.0 107.929 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.32 21.4 45.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 119.275 -1.441 . . . . 0.0 110.474 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -61.29 -3.86 1.03 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 126.599 1.96 . . . . 0.0 114.65 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -118.77 131.2 56.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.953 1.301 . . . . 0.0 109.464 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.47 -165.52 38.92 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -94.47 149.66 21.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.856 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.465 ' N ' ' HD3' ' A' ' 274' ' ' PRO . 20.1 m80 42.7 49.96 5.03 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 113.015 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 273' ' ' HIS . 32.6 Cg_exo -61.55 124.59 14.94 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.823 1.682 . . . . 0.0 110.893 -171.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -155.86 -32.98 0.09 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.877 0.471 . . . . 0.0 110.435 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 37.9 t -155.22 141.17 12.85 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.664 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.413 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 88.9 Cg_endo -75.26 157.96 41.41 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.058 3.172 . . . . 0.0 115.096 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.29 155.37 35.53 Favored 'Trans proline' 0 C--O 1.223 -0.245 0 C-N-CA 125.278 3.985 . . . . 0.0 112.979 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.3 tttt 49.58 24.75 1.22 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.216 1.407 . . . . 0.0 112.59 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.08 2.04 0.5 Allowed Glycine 0 C--O 1.215 -1.092 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.29 126.71 30.35 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.979 1.39 . . . . 0.0 113.344 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.01 163.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -118.88 149.07 42.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.8 mt -114.97 137.52 51.9 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.017 1.448 . . . . 0.0 110.493 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.31 116.52 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.42 -166.17 2.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.88 0.848 . . . . 0.0 112.876 -168.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -48.61 139.29 9.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.461 HD23 ' HE2' ' A' ' 387' ' ' HIS . 24.4 mt -74.52 -39.06 62.62 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.745 0.702 . . . . 0.0 112.714 -171.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -121.89 -45.54 2.26 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.733 -1.229 . . . . 0.0 113.516 -170.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -69.96 -70.96 0.26 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.8 t -58.95 -29.47 67.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.145 0.498 . . . . 0.0 111.591 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -57.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.125 -174.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -66.82 -29.54 69.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.609 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.2 m -61.47 -59.96 4.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.896 1.372 . . . . 0.0 111.823 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.46 -26.74 41.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.84 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.17 -34.24 76.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.632 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.03 -2.78 57.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.814 0.696 . . . . 0.0 112.359 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.43 -15.84 20.46 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.7 m -85.09 -159.3 0.42 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.9 m -96.41 158.36 15.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.539 1.162 . . . . 0.0 109.804 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -158.04 153.41 25.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.6 147.08 34.68 Favored Pre-proline 0 C--N 1.349 0.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.95 5.0 4.21 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 123.06 2.507 . . . . 0.0 112.172 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.237 0.446 0 C-N-CA 129.352 3.061 . . . . 0.0 114.629 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.2 p -115.03 155.74 26.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -139.75 137.88 35.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 21.1 m-85 -116.87 144.83 44.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.075 0.95 . . . . 0.0 111.182 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -144.05 158.2 43.86 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -159.6 169.51 23.62 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 146.55 32.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.386 0.136 . . . . 0.0 110.925 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.6 162.95 36.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.527 1.531 . . . . 0.0 109.506 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -167.59 178.05 5.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.569 -0.707 . . . . 0.0 111.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.8 t -125.4 40.18 3.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.656 0.782 . . . . 0.0 109.779 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 57.42 24.29 10.01 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 111.939 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -140.98 -4.1 1.2 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 118.127 2.639 . . . . 0.0 118.127 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.579 ' HE1' ' CE3' ' A' ' 245' ' ' TRP . 1.1 pmm? -150.6 24.17 0.79 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.617 1.099 . . . . 0.0 113.877 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -48.61 110.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.747 0.419 . . . . 0.0 111.187 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 47.6 t -164.72 -49.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -110.68 132.61 54.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.844 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.91 156.18 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.256 1.422 . . . . 0.0 112.555 173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.76 168.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -127.03 150.42 49.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 3.1 t -130.98 143.31 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 124.708 1.255 . . . . 0.0 112.522 -173.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.4 mt -148.62 96.93 3.78 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.764 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -85.18 169.41 9.99 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 124.38 3.387 . . . . 0.0 113.286 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.426 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 2.0 t90 -91.51 121.04 32.85 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.249 1.42 . . . . 0.0 110.557 171.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.486 HG11 ' H ' ' A' ' 334' ' ' ALA . 83.3 t -101.82 145.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.54 -26.59 68.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.231 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.486 ' H ' HG11 ' A' ' 332' ' ' VAL . . . -63.31 -3.57 2.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.483 0.489 . . . . 0.0 112.306 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -103.7 -10.56 18.25 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 122.126 -0.359 . . . . 0.0 110.541 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.1 m -104.95 -24.16 12.88 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.483 0.713 . . . . 0.0 110.637 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.4 143.92 31.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -153.67 134.94 14.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 22.2 m -118.69 147.6 22.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.523 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -96.31 -14.42 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.3 t -146.48 125.66 6.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.674 1.99 . . . . 0.0 109.324 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.92 -8.8 15.62 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.36 2.706 . . . . 0.0 113.059 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -103.97 7.26 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.581 -170.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.4 166.07 14.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.857 0.753 . . . . 0.0 109.177 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -115.74 179.28 4.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.912 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 346' ' ' LEU . 2.4 mm? -72.89 155.68 39.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.466 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.06 118.61 64.6 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.25 -5.97 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.293 1.995 . . . . 0.0 113.02 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 42.1 m -123.78 -12.58 7.57 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.151 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -122.33 100.31 6.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.381 0.991 . . . . 0.0 112.358 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -150.75 161.42 42.67 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.26 150.33 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 121.964 0.888 . . . . 0.0 110.713 171.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -79.71 121.85 25.84 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.569 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.96 137.53 24.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 O-C-N 125.182 1.551 . . . . 0.0 110.121 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -126.23 64.95 0.57 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -114.2 123.08 48.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.875 0.87 . . . . 0.0 111.401 -172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -157.52 157.16 33.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 122.524 1.154 . . . . 0.0 113.325 -176.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.26 3.73 0.31 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.895 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.56 -29.49 3.8 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.546 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.5 ptp -160.19 43.86 0.21 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.873 0.836 . . . . 0.0 111.139 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 357' ' ' LEU . 2.9 tm? -63.6 133.4 53.66 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.754 -0.591 . . . . 0.0 109.748 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -130.88 -176.21 3.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.628 1.204 . . . . 0.0 111.541 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.5 -13.63 61.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.724 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.17 -20.6 40.89 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.869 -1.144 . . . . 0.0 109.419 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.76 -35.0 22.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 76.9 mt -73.6 -26.02 60.6 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.19 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -74.65 -40.72 61.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.644 0.378 . . . . 0.0 111.1 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.57 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.789 0.836 . . . . 0.0 110.261 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.03 -38.62 80.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.75 -27.88 19.74 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -15.18 58.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.812 0.733 . . . . 0.0 110.293 173.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.62 -19.03 19.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.93 0.787 . . . . 0.0 112.366 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.6 tp -96.64 -26.69 15.12 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 124.529 1.143 . . . . 0.0 114.004 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 -24.36 0.47 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.751 0.705 . . . . 0.0 112.367 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.47 -6.24 8.7 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.979 -0.9 . . . . 0.0 114.757 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -85.14 11.27 60.95 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.467 1.634 . . . . 0.0 113.907 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.418 ' H ' HG13 ' A' ' 377' ' ' VAL . 6.5 p -91.35 162.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 124.836 1.254 . . . . 0.0 111.569 -174.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.9 -27.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.847 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.9 OUTLIER -153.9 145.44 23.21 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -134.99 140.79 45.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.33 25.33 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.906 0.725 . . . . 0.0 112.428 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.58 138.0 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.08 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -81.63 135.86 35.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.8 p -125.27 162.24 25.16 Favored 'General case' 0 C--O 1.215 -0.732 0 O-C-N 121.499 -0.751 . . . . 0.0 112.184 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -127.88 157.61 40.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.281 1.433 . . . . 0.0 107.688 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.04 100.44 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.063 -1.023 . . . . 0.0 111.232 -169.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . 0.461 ' HE2' HD23 ' A' ' 288' ' ' LEU . 40.8 m170 53.47 39.4 29.93 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.022 1.329 . . . . 0.0 114.139 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -104.85 -4.26 22.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.408 -2.058 . . . . 0.0 114.493 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 49.7 51.76 11.37 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-N 119.557 1.071 . . . . 0.0 113.619 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.414 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 72.2 Cg_endo -63.55 -51.08 2.74 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.792 2.995 . . . . 0.0 110.252 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.426 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 9.0 tp 39.83 39.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.942 1.697 . . . . 0.0 110.181 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.07 29.8 1.37 Allowed Glycine 0 CA--C 1.508 -0.355 0 O-C-N 121.596 -0.69 . . . . 0.0 111.927 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 25.0 p -168.89 158.45 8.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.74 -170.62 32.76 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.65 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -150.0 157.88 43.6 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.35 130.79 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.6 p -96.57 138.52 34.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.104 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -113.44 155.44 25.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.044 0.84 . . . . 0.0 111.866 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -124.89 -10.34 7.2 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.042 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -119.5 150.65 39.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.158 0.983 . . . . 0.0 108.383 171.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.33 -16.45 61.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.003 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -65.83 -37.0 85.06 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.682 0.793 . . . . 0.0 111.144 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 43.7 m -71.5 -21.59 61.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.418 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.3 -63.47 1.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.038 0.923 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.405 ' CD1' ' H ' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -75.55 -20.87 58.37 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.832 -1.167 . . . . 0.0 112.116 -173.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -84.56 -21.94 30.26 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 120.154 -1.591 . . . . 0.0 110.603 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.39 -37.27 28.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.649 0.593 . . . . 0.0 111.095 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.18 -24.01 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.691 -0.631 . . . . 0.0 111.116 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.0 p -90.2 -16.02 30.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -90.61 -35.88 14.74 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 56.71 -41.24 0.03 OUTLIER 'General case' 0 C--N 1.344 0.36 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -157.3 124.75 5.26 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.191 -1.568 . . . . 0.0 107.963 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.46 157.2 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 423' ' ' LYS . 36.1 mt-10 -94.98 139.51 31.25 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 124.885 1.366 . . . . 0.0 110.104 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 15.3 mt -121.35 125.98 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 123.908 1.813 . . . . 0.0 112.541 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -124.59 52.28 1.54 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.944 -177.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -77.96 179.72 6.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 123.397 1.57 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 17.0 p -91.32 3.59 54.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.4 -29.83 7.64 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.52 164.27 27.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 59.1 m -123.37 113.3 18.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -162.07 178.88 8.42 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 111.786 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 414' ' ' GLU . 34.8 mtmm -124.04 166.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.25 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.28 152.73 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 O-C-N 124.747 1.279 . . . . 0.0 109.365 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -127.08 160.39 31.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.982 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 46.9 mt -139.12 141.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 O-C-N 125.573 1.796 . . . . 0.0 109.343 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -138.31 158.19 71.22 Favored Pre-proline 0 C--O 1.219 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.22 156.77 61.21 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 123.607 2.871 . . . . 0.0 111.259 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 8.5 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.144 -1.408 . . . . 0.0 112.348 -178.242 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.6 m -148.83 151.2 34.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.75 2.02 . . . . 0.0 109.382 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -3.47 1.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 m 38.02 60.05 1.27 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 123.903 0.881 . . . . 0.0 112.461 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.13 -28.84 74.03 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.555 -172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 53.54 46.43 26.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.146 0.473 . . . . 0.0 112.167 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.95 26.52 0.09 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.69 122.33 9.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 CA-C-N 123.316 2.22 . . . . 0.0 110.383 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 139.07 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.254 3.302 . . . . 0.0 111.951 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -153.31 170.4 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.286 1.034 . . . . 0.0 109.856 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.39 48.84 16.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 110.593 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.4 153.4 2.17 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.732 1.213 . . . . 0.0 111.111 -172.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.4 18.01 19.6 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.661 1.185 . . . . 0.0 111.602 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.72 48.13 2.94 Favored Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 123.874 0.87 . . . . 0.0 110.759 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.49 103.74 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.664 1.576 . . . . 0.0 114.487 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 mm -139.35 142.66 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -111.31 148.49 32.83 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -135.98 -8.24 2.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 84.5 m -135.85 -173.15 3.29 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.984 0.803 . . . . 0.0 110.038 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -65.83 161.59 20.68 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.906 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.43 148.98 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.536 -173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -93.23 137.21 32.77 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.151 0.58 . . . . 0.0 110.727 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.62 124.6 12.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.2 -170.27 36.97 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.939 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.76 12.63 1.31 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.9 m -61.19 124.28 79.67 Favored Pre-proline 0 C--O 1.217 -0.607 0 CA-C-N 120.016 1.908 . . . . 0.0 111.589 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -83.61 0.94 9.2 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.721 1.614 . . . . 0.0 115.072 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.51 -14.17 2.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.952 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 42.81 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.93 2.492 . . . . 0.0 115.142 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.671 HG13 ' H ' ' A' ' 248' ' ' THR . 5.9 pt -104.53 -96.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.879 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.671 ' H ' HG13 ' A' ' 247' ' ' ILE . 17.5 m -141.68 132.72 26.14 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 122.508 1.147 . . . . 0.0 108.838 173.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -59.61 -22.8 62.33 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.472 ' H ' HG21 ' A' ' 248' ' ' THR . . . -66.83 -39.86 87.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.356 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.68 -47.97 84.8 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 123.582 0.552 . . . . 0.0 112.374 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.11 -38.27 90.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.508 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.0 t -73.92 -41.57 53.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.409 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -78.57 -3.65 44.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.304 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.8 m -89.12 -34.86 16.58 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.857 171.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -136.08 75.82 1.57 Allowed 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 120.771 1.623 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -142.38 14.47 2.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.579 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.07 -9.75 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 122.969 0.507 . . . . 0.0 111.754 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.31 -4.39 58.4 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.422 -1.424 . . . . 0.0 109.078 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 62.18 5.13 7.26 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 125.75 1.906 . . . . 0.0 115.6 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 287' ' ' GLU . 55.2 p -103.39 7.15 38.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.57 163.56 25.74 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.357 0.98 . . . . 0.0 112.655 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.8 t -152.54 168.6 25.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.895 1.278 . . . . 0.0 108.419 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.7 p -118.22 144.58 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.134 1.773 . . . . 0.0 113.716 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -143.12 131.2 21.8 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -157.93 146.8 14.55 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.111 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -88.2 165.72 6.88 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 121.646 1.564 . . . . 0.0 111.141 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.72 14.67 82.16 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 118.796 -1.002 . . . . 0.0 110.943 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -69.76 17.74 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.771 1.628 . . . . 0.0 112.735 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -76.56 151.66 36.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.923 0.889 . . . . 0.0 111.224 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.54 167.85 12.73 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.221 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.66 8.28 5.58 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.42 1.488 . . . . 0.0 112.625 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' A' ' 275' ' ' ARG . 81.1 m-70 -135.74 152.14 75.49 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.12 9.41 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.625 2.216 . . . . 0.0 109.326 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' A' ' 273' ' ' HIS . 59.5 ttp85 -117.68 117.01 28.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.69 1.196 . . . . 0.0 109.239 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.658 ' H ' ' CD ' ' A' ' 277' ' ' PRO . 17.3 t -160.51 -30.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' A' ' 276' ' ' CYS . 86.3 Cg_endo -76.48 142.49 23.58 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.346 2.698 . . . . 0.0 111.829 -170.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.68 -4.36 15.12 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.386 3.39 . . . . 0.0 113.787 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.54 150.77 25.06 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.62 0.768 . . . . 0.0 109.087 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -99.79 21.72 43.65 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.985 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -154.87 166.06 34.69 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 119.959 1.88 . . . . 0.0 113.021 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.4 m -151.72 -170.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -126.12 148.94 49.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.635 1.207 . . . . 0.0 112.306 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.98 151.51 46.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.883 -1.136 . . . . 0.0 111.785 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.33 158.04 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.364 1.466 . . . . 0.0 110.11 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.548 ' C ' ' H ' ' A' ' 288' ' ' LEU . 62.7 m-85 -158.68 -178.22 7.1 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 123.626 1.679 . . . . 0.0 111.154 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 261' ' ' SER . 9.3 tp10 -75.43 19.44 0.18 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.803 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 286' ' ' PHE . 57.3 mt 55.51 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 128.877 2.871 . . . . 0.0 116.628 172.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.0 -51.75 3.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.872 0.869 . . . . 0.0 110.559 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.22 -74.2 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.685 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 38.7 t -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.263 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.47 -52.19 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 O-C-N 123.666 0.604 . . . . 0.0 112.618 -168.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -68.11 -26.16 65.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.495 0.497 . . . . 0.0 110.094 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.2 m -69.45 -44.32 71.47 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.992 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 291' ' ' SER . 10.2 mt -68.53 -52.89 27.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.916 1.234 . . . . 0.0 110.868 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 9.47 23.15 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -115.05 -7.33 12.51 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.124 0.964 . . . . 0.0 110.617 168.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.32 -25.1 18.71 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 13.8 t -101.78 -118.28 0.18 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.909 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.7 m -123.91 157.09 35.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.588 1.185 . . . . 0.0 113.194 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -154.07 161.27 42.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.716 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -148.25 133.86 9.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.38 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 125.514 4.142 . . . . 0.0 110.289 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.565 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.181 -174.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.2 m -60.85 170.33 1.56 Allowed 'General case' 0 C--N 1.344 0.338 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.532 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -129.08 134.8 48.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.351 0.596 . . . . 0.0 109.562 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -102.16 135.76 43.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.79 145.61 47.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -149.08 152.04 35.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.332 0.587 . . . . 0.0 111.003 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -123.77 116.33 22.82 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.966 1.365 . . . . 0.0 110.988 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.415 ' HE2' ' HB ' ' A' ' 326' ' ' VAL . 25.8 ptt? -133.19 1.34 3.49 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.748 -168.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 319' ' ' ARG . 58.8 p -119.97 2.43 10.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 21.4 t -62.67 -3.16 1.37 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.549 -1.344 . . . . 0.0 111.732 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 317' ' ' SER . 89.4 mtt-85 -88.26 -8.71 54.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.339 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -152.33 -9.65 0.19 Allowed 'General case' 0 C--N 1.347 0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 30.5 mmm -124.99 -178.4 4.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.937 2.095 . . . . 0.0 108.841 174.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -95.97 -37.03 10.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.703 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.8 t -176.52 146.6 0.61 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.953 0.901 . . . . 0.0 109.555 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -152.42 -56.0 0.13 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 62.79 100.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 124.144 0.903 . . . . 0.0 109.469 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.415 ' HB ' ' HE2' ' A' ' 316' ' ' MET . 4.6 p -84.44 155.7 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.597 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 147.77 24.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.036 0.922 . . . . 0.0 109.285 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 129.95 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.895 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.79 96.08 11.99 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.718 1.247 . . . . 0.0 108.37 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -88.29 160.22 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.392 1.395 . . . . 0.0 111.522 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.558 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 5.3 t-105 -74.7 124.31 26.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 334' ' ' ALA . 16.6 t -96.76 149.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.749 1.262 . . . . 0.0 110.382 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -59.41 -31.66 69.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.443 1.097 . . . . 0.0 108.602 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.425 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -73.62 -7.28 51.35 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.61 1.164 . . . . 0.0 113.741 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.28 0.02 33.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.842 0.857 . . . . 0.0 111.058 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 73.2 m -91.69 -54.78 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -157.33 154.71 29.44 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.864 0.865 . . . . 0.0 112.308 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -154.94 148.49 25.28 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 123.535 0.522 . . . . 0.0 111.021 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.52 155.3 29.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 122.796 0.438 . . . . 0.0 111.51 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -113.89 32.72 5.66 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 121.782 0.801 . . . . 0.0 109.157 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.0 t -152.17 141.36 14.19 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.143 0.977 . . . . 0.0 110.148 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.65 -6.57 17.03 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.22 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -115.77 149.22 38.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -99.2 138.87 35.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -158.53 152.56 23.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.79 0.805 . . . . 0.0 110.435 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.44 ' HA ' HG23 ' A' ' 397' ' ' THR . 3.4 mm? -128.78 174.74 9.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.068 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -141.4 110.45 6.34 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.04 0.79 4.61 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.766 2.977 . . . . 0.0 114.925 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 66.2 m -134.44 0.73 3.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 117.992 -1.004 . . . . 0.0 112.813 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -147.01 81.72 1.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.799 1.761 . . . . 0.0 109.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.1 p -136.9 173.33 11.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.7 143.4 37.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 O-C-N 121.506 -0.746 . . . . 0.0 109.398 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -77.83 145.47 36.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.668 1.223 . . . . 0.0 112.77 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.2 t -132.01 148.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -177.93 -161.99 27.1 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.671 -0.643 . . . . 0.0 112.853 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.5 0.54 Allowed 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 114.186 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.591 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -79.05 172.81 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.18 9.2 0.34 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -168.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.501 ' H ' HD23 ' A' ' 357' ' ' LEU . . . 100.91 15.17 29.42 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.8 mmt -147.11 -88.68 0.09 Allowed 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.933 1.366 . . . . 0.0 109.945 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 12.3 tp 44.39 70.78 0.3 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 111.299 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -55.58 170.25 0.27 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.104 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.35 68.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -80.56 -21.4 41.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.29 -26.15 42.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.813 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.61 -44.95 63.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.9 72.85 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.774 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.45 -53.55 50.36 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.957 -1.09 . . . . 0.0 110.728 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.37 -42.48 96.48 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -38.52 29.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.295 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -12.76 46.57 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 120.261 1.391 . . . . 0.0 112.726 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.7 -22.86 13.5 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.531 -0.73 . . . . 0.0 110.477 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 16.3 tp -98.73 -16.52 18.93 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -105.99 -81.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 164.13 -19.36 0.13 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 119.662 1.119 . . . . 0.0 111.925 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -174.86 142.52 6.35 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 118.727 1.263 . . . . 0.0 112.925 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.17 176.93 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.414 1.102 . . . . 0.0 109.824 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.83 -31.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.889 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -155.37 146.23 22.37 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -151.05 135.29 16.84 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 125.17 1.388 . . . . 0.0 108.086 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.65 173.45 38.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.1 mm -91.3 140.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.56 -1.32 . . . . 0.0 109.32 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.27 115.86 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.7 p -111.38 163.35 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.094 0.95 . . . . 0.0 111.773 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -133.41 159.91 38.94 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.98 103.1 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.337 -0.852 . . . . 0.0 112.056 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.26 46.66 20.8 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -108.95 -20.72 12.94 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.627 1.571 . . . . 0.0 115.021 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 46.36 57.89 16.53 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 124.834 1.334 . . . . 0.0 111.479 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.53 -41.02 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.245 1.297 . . . . 0.0 113.242 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 11.0 tp 31.82 38.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 127.846 2.458 . . . . 0.0 112.368 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -140.27 11.97 3.03 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 124.474 1.035 . . . . 0.0 110.749 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 93.0 p -151.15 158.33 43.84 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.896 0.409 . . . . 0.0 111.648 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 177.24 -178.45 48.26 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -150.85 166.91 29.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.31 140.36 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 346' ' ' LEU . 75.6 m -107.92 132.46 53.45 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.408 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -128.84 166.3 19.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.769 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.14 9.25 2.09 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.691 0.619 . . . . 0.0 110.656 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -124.15 144.39 49.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.28 -24.86 64.92 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -51.77 -38.8 57.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.036 0.835 . . . . 0.0 112.186 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.0 m -78.8 -19.26 52.57 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 112.367 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -74.47 -57.09 4.16 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 120.61 -1.306 . . . . 0.0 110.308 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -24.32 59.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.508 -1.277 . . . . 0.0 113.795 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.07 -27.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.804 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.34 -27.54 42.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.6 m -93.3 -24.48 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 O-C-N 121.378 -0.826 . . . . 0.0 112.02 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.4 p -86.18 -16.09 38.89 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.317 0.508 . . . . 0.0 112.02 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.25 -43.37 8.09 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.456 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.05 -10.93 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -170.66 152.44 3.81 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.985 -1.072 . . . . 0.0 110.764 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.54 162.16 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -100.84 123.74 45.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.63 0.729 . . . . 0.0 109.89 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.26 90.43 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -117.42 106.01 12.75 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.287 0.992 . . . . 0.0 110.344 -169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 73.0 p -138.55 -177.45 4.86 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.767 1.227 . . . . 0.0 110.583 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 24.1 m -79.93 -9.95 59.73 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.689 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.24 -19.48 13.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.833 1.253 . . . . 0.0 112.89 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -153.83 140.41 18.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.637 0.732 . . . . 0.0 109.244 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 89.5 m -144.09 89.03 2.0 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.318 0.647 . . . . 0.0 109.866 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -148.33 -171.37 3.83 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 122.671 1.224 . . . . 0.0 109.912 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -130.39 168.61 16.69 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.322 1.058 . . . . 0.0 110.179 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.58 138.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.258 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.65 154.85 25.44 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 124.806 1.316 . . . . 0.0 113.707 -168.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.72 134.47 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.448 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -137.56 156.72 74.7 Favored Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.884 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.33 163.51 37.65 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.856 3.037 . . . . 0.0 110.47 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 52.2 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.995 -176.178 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 59.8 mmm . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.517 0.198 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.7 m 36.21 59.3 0.94 Allowed 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 111.746 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -4.55 36.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.7 m 44.01 52.72 6.7 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.511 1.05 . . . . 0.0 111.959 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.76 72.81 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.354 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 57.01 32.48 21.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.45 146.02 95.96 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.214 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.09 124.57 9.17 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 124.731 3.621 . . . . 0.0 112.713 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.26 5.26 6.03 Favored 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 127.278 5.318 . . . . 0.0 114.325 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -127.93 26.22 5.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 118.916 0.78 . . . . 0.0 112.573 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.63 34.1 1.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.275 1.03 . . . . 0.0 108.67 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.58 176.3 9.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -169.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -67.14 150.58 48.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.223 1.809 . . . . 0.0 106.719 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -71.92 156.71 90.66 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 120.029 1.286 . . . . 0.0 112.264 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.49 140.16 21.86 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 124.232 3.288 . . . . 0.0 115.323 -170.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.3 mm -155.3 152.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.417 ' CD2' ' CG1' ' A' ' 292' ' ' VAL . 4.3 m-85 -125.18 149.83 47.54 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.604 1.093 . . . . 0.0 110.938 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.7 p -148.25 11.66 0.92 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -170.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.4 t -152.48 -167.33 2.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.636 1.107 . . . . 0.0 109.057 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.434 ' HE2' ' CD1' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -59.09 171.51 0.71 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 152.88 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.434 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 21.9 m-30 -90.25 145.11 25.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.777 -0.577 . . . . 0.0 109.794 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -149.13 126.51 11.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.21 165.93 30.85 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 119.276 0.944 . . . . 0.0 112.194 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.56 3.27 1.0 Allowed Glycine 0 CA--C 1.547 2.034 0 O-C-N 124.699 0.882 . . . . 0.0 112.27 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.9 m -107.87 121.79 42.88 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.417 0.609 . . . . 0.0 112.597 -170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.07 -13.93 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 123.281 2.654 . . . . 0.0 112.059 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.446 ' HE1' ' HB2' ' A' ' 324' ' ' LYS . 30.0 p-90 -124.03 -17.52 6.21 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -50.48 104.66 0.08 Allowed 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 118.928 0.786 . . . . 0.0 110.593 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -18.77 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 O-C-N 126.02 2.075 . . . . 0.0 115.781 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.0 m -152.48 126.91 9.31 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 124.486 1.116 . . . . 0.0 110.328 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.03 -34.16 68.59 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.77 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.21 66.04 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 120.051 1.296 . . . . 0.0 110.718 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.64 -55.9 27.96 Favored Glycine 0 C--N 1.368 2.32 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.92 -37.9 72.11 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.673 0.867 . . . . 0.0 111.124 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.44 -22.55 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 123.383 0.673 . . . . 0.0 110.284 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -94.34 -4.94 47.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.77 -0.581 . . . . 0.0 110.867 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -82.38 -24.43 34.47 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.548 -1.345 . . . . 0.0 111.046 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.35 26.58 1.62 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.404 ' HA ' HD12 ' A' ' 262' ' ' LEU . 53.6 ptt85 -94.46 -0.23 54.88 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.585 1.993 . . . . 0.0 113.466 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 -21.41 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.257 0.623 . . . . 0.0 111.243 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.09 -4.25 54.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.653 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.42 -125.61 0.77 Allowed Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.129 -0.982 . . . . 0.0 115.276 -170.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.5 t -153.69 110.83 3.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 124.562 0.801 . . . . 0.0 109.888 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -151.61 162.28 41.25 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 176.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 64.0 m -146.62 170.73 16.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.208 1.803 . . . . 0.0 109.763 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.78 143.06 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 123.878 0.871 . . . . 0.0 111.864 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -145.94 135.74 23.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.86 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 277' ' ' PRO . 21.9 p90 -161.23 149.03 12.34 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 125.69 1.596 . . . . 0.0 110.893 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.83 152.54 14.77 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 112.893 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.78 28.72 23.06 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.288 -0.729 . . . . 0.0 111.669 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -59.3 -36.28 75.31 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 120.127 1.964 . . . . 0.0 110.953 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 25.7 t0 33.41 89.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.471 2.308 . . . . 0.0 113.31 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.71 172.06 24.43 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 122.328 0.96 . . . . 0.0 111.604 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -60.62 -25.64 66.42 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.699 -0.883 . . . . 0.0 111.686 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -134.12 155.23 80.22 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.754 1.222 . . . . 0.0 108.016 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.57 107.1 2.38 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.676 1.584 . . . . 0.0 108.237 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -119.28 -166.61 1.28 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.328 0.651 . . . . 0.0 111.139 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.6 135.05 34.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.421 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 266' ' ' TRP . 44.3 Cg_endo -83.44 148.58 12.87 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 124.516 3.478 . . . . 0.0 112.024 170.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.27 -6.6 17.35 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.794 2.329 . . . . 0.0 111.367 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -95.77 -6.23 40.14 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.992 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.68 17.47 41.78 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-O 118.786 -1.008 . . . . 0.0 115.405 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -128.68 154.57 46.16 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 117.696 0.748 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.7 t -152.34 165.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -122.56 148.72 44.87 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.4 mt -108.23 143.86 36.48 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.49 1.138 . . . . 0.0 110.622 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.79 109.94 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -165.42 1.65 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.695 -171.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.31 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 288' ' ' LEU . 1.7 pt? -69.41 14.48 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.873 2.469 . . . . 0.0 114.802 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.74 -59.2 1.08 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.172 0.92 . . . . 0.0 111.242 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -90.31 -34.01 15.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 46.9 m -74.05 -17.1 61.01 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 119.391 0.996 . . . . 0.0 108.657 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 234' ' ' TYR . 46.6 t -76.14 -57.76 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.42 -32.57 73.43 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.741 -1.225 . . . . 0.0 112.818 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 25.0 m -68.37 -42.59 78.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.036 0.834 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.12 -39.45 49.37 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.76 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.7 mt -60.51 -25.6 66.22 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.555 1.071 . . . . 0.0 111.789 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.04 -6.82 23.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.99 22.21 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 123.796 0.685 . . . . 0.0 109.784 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.85 -153.86 0.44 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.4 t -117.09 174.88 5.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.628 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -149.84 150.7 32.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -135.15 124.87 16.66 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.308 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -81.03 37.53 0.69 Allowed 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 124.416 3.411 . . . . 0.0 108.262 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.886 0 CA-C-N 119.421 1.01 . . . . 0.0 111.941 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 121.356 0.598 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 58.8 m -132.56 151.69 51.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -144.65 139.02 27.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.419 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.87 144.67 42.02 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.161 0.984 . . . . 0.0 110.961 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 327' ' ' GLN . 59.8 m-85 -136.93 159.16 42.71 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.742 0.817 . . . . 0.0 110.524 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -156.86 170.68 21.93 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.2 0.938 . . . . 0.0 111.074 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.68 124.9 24.56 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -141.6 28.42 1.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.413 -168.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.1 p -43.99 138.56 2.79 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.801 1.182 . . . . 0.0 112.908 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 18.2 t -116.43 -51.15 2.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -73.56 -26.21 60.73 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 108.925 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 55.24 26.07 8.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.935 1.694 . . . . 0.0 113.4 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -78.37 -20.01 52.19 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -159.57 177.3 11.06 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.67 134.5 44.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.277 1.431 . . . . 0.0 108.624 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.446 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 59.2 tptt -136.76 -7.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.43 175.43 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.811 1.291 . . . . 0.0 113.75 -171.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -151.03 153.76 9.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.843 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 313' ' ' TYR . 3.0 pp0? -117.79 156.04 29.02 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.32 139.89 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.694 -175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.53 119.36 4.26 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 124.153 0.908 . . . . 0.0 109.819 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -95.82 161.74 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.365 4.043 . . . . 0.0 111.751 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.416 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 3.3 t-105 -70.38 118.58 13.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.56 149.65 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 110.497 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.06 -39.26 81.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.833 0.853 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.67 2.91 10.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 122.918 0.487 . . . . 0.0 112.235 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -93.27 -9.82 37.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.172 -0.955 . . . . 0.0 110.95 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 51.4 m -90.96 -58.44 2.47 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -160.9 173.49 15.24 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.892 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.65 161.52 41.54 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.783 0.833 . . . . 0.0 111.412 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.52 166.88 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 122.545 1.164 . . . . 0.0 110.837 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -126.33 27.51 6.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.694 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 342' ' ' PRO . 85.9 p -147.87 167.93 12.32 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 117.22 -1.371 . . . . 0.0 110.061 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 341' ' ' SER . 74.4 Cg_endo -69.71 56.91 1.41 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 124.821 3.681 . . . . 0.0 109.982 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.6 t 55.67 38.91 30.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.383 0.673 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -71.91 151.32 43.42 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -65.03 157.15 29.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.98 160.48 4.73 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.871 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.88 139.0 87.93 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.2 94.44 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.866 2.377 . . . . 0.0 111.891 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 63.4 m 62.83 49.83 3.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.761 -1.563 . . . . 0.0 114.334 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -140.99 43.3 1.81 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 109.332 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 t -117.38 159.06 23.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 159.08 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.16 147.67 36.37 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.008 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 83.3 t -130.75 136.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.395 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -172.44 -157.72 14.95 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.589 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.66 29.54 19.08 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.377 1.071 . . . . 0.0 111.981 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 24.6 mt -76.72 164.45 25.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.432 1.083 . . . . 0.0 110.293 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . 0.504 ' CE1' ' H ' ' A' ' 361' ' ' LEU . 8.7 p-80 -77.62 12.7 1.53 Allowed 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.468 -0.77 . . . . 0.0 112.573 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 97.0 2.49 59.37 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 119.028 -0.873 . . . . 0.0 112.362 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 mmt -145.23 -71.32 0.26 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.039 0.92 . . . . 0.0 111.643 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.504 ' H ' ' CE1' ' A' ' 358' ' ' HIS . 12.8 tp 38.0 69.36 0.25 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.789 0.804 . . . . 0.0 111.094 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -67.33 179.3 1.28 Allowed 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.158 -0.964 . . . . 0.0 113.041 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.21 -27.07 65.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -170.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.96 -15.2 57.76 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 119.34 0.973 . . . . 0.0 112.289 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -92.63 -27.1 17.53 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.389 0.43 . . . . 0.0 111.186 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.4 mt -76.22 -37.03 58.26 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 124.74 1.275 . . . . 0.0 110.426 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.0 56.14 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.33 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.23 -50.52 73.34 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.8 -32.07 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 123.914 0.759 . . . . 0.0 111.632 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.96 -28.96 18.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.608 -1.307 . . . . 0.0 113.774 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.63 -19.86 27.15 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.682 1.128 . . . . 0.0 113.742 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -113.86 -17.3 12.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 120.051 1.296 . . . . 0.0 111.083 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.3 tp -97.6 -3.99 38.49 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 118.873 0.76 . . . . 0.0 111.286 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -152.03 -48.05 0.11 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.47 -1.73 88.29 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.442 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.35 111.37 2.24 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.97 166.28 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 123.865 0.866 . . . . 0.0 110.396 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 -29.03 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.21 153.64 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 109.645 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -155.12 132.23 10.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.68 158.3 27.79 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 121.163 -0.96 . . . . 0.0 113.575 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.02 138.91 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.242 1.817 . . . . 0.0 108.037 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.89 153.5 23.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.081 0.467 . . . . 0.0 112.128 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 5.3 p -137.47 165.79 25.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.064 0.459 . . . . 0.0 110.233 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.21 -178.83 5.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.47 100.36 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.045 0.384 . . . . 0.0 111.107 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.2 m170 50.41 40.86 23.95 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.93 1.292 . . . . 0.0 110.848 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -88.72 -20.62 24.58 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.344 0.658 . . . . 0.0 109.72 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.0 p90 38.8 53.56 4.25 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 0.0 112.954 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.65 -48.24 0.42 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.716 3.61 . . . . 0.0 111.271 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.416 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 8.6 tp 41.05 41.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.277 1.431 . . . . 0.0 111.49 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -162.11 14.43 0.13 Allowed Glycine 0 C--N 1.349 1.299 0 C-N-CA 121.077 -0.582 . . . . 0.0 114.132 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.2 p -156.33 132.07 9.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.11 0.955 . . . . 0.0 110.796 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.08 -164.83 25.45 Favored Glycine 0 C--O 1.209 -1.415 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.349 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -142.09 166.82 23.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.505 -0.848 . . . . 0.0 110.624 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.23 146.42 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.627 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 26.2 p -125.99 122.61 36.4 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 122.252 1.025 . . . . 0.0 108.362 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.12 -28.45 25.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.721 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.4 t30 54.07 17.09 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.301 1.048 . . . . 0.0 112.585 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -141.4 164.23 30.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.234 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -99.68 -45.31 5.81 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.527 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.82 -25.64 66.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.617 1.098 . . . . 0.0 112.921 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.0 p -84.99 -18.48 34.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -72.92 -56.09 5.67 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.583 0.629 . . . . 0.0 109.964 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.27 63.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.753 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -77.08 -24.89 51.84 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.88 1.218 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.98 -29.43 35.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.565 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.1 m -78.92 -18.29 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 123.798 0.686 . . . . 0.0 112.203 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 91.3 p -88.9 -22.16 23.27 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -85.76 -44.56 12.4 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.299 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.48 -2.24 0.0 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 128.551 2.74 . . . . 0.0 116.627 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -158.4 141.15 14.58 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.73 163.36 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 119.103 0.865 . . . . 0.0 109.229 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 28.2 mt-10 -119.83 131.99 55.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.993 1.378 . . . . 0.0 112.552 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 422' ' ' LYS . 6.4 mm -93.95 117.09 36.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -117.61 25.71 10.22 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.909 0.777 . . . . 0.0 109.838 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.467 HG21 ' H ' ' A' ' 419' ' ' LYS . 86.2 m -63.74 158.12 22.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.021 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -86.17 -2.54 58.45 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 123.455 0.702 . . . . 0.0 112.149 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.467 ' H ' HG21 ' A' ' 417' ' ' THR . 39.4 pttt -128.22 -1.6 5.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.498 1.119 . . . . 0.0 111.523 174.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -150.26 127.52 11.34 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.6 m -142.08 109.1 5.47 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.195 -0.94 . . . . 0.0 111.105 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.647 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 33.6 tptt -167.22 -156.46 0.21 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 117.899 0.318 . . . . 0.0 111.416 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.647 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 98.7 mttt -141.11 176.21 9.01 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.601 0.76 . . . . 0.0 109.674 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.62 154.11 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.03 151.75 36.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.887 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.99 139.46 47.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -142.81 113.12 5.87 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.98 161.77 40.48 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.701 3.6 . . . . 0.0 112.33 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.606 -1.664 . . . . 0.0 111.51 178.291 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.035 0.445 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 221' ' ' SER . 9.7 m 45.45 55.97 6.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.409 1.099 . . . . 0.0 113.101 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.41 18.72 0.07 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.191 0.997 . . . . 0.0 113.245 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 219' ' ' THR . 66.4 m -37.21 121.02 0.8 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.04 1.336 . . . . 0.0 113.288 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.8 0.91 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-O 118.266 -1.296 . . . . 0.0 114.035 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -89.51 -29.75 18.74 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.387 1.593 . . . . 0.0 109.564 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.8 mt 61.7 148.42 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 115.064 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -63.01 131.14 31.49 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.641 2.227 . . . . 0.0 111.769 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.15 147.32 14.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.208 2.606 . . . . 0.0 109.209 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -144.88 22.42 1.59 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.34 30.68 3.74 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.555 0.742 . . . . 0.0 111.627 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -71.11 161.17 31.57 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 111.384 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -135.27 -143.34 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.357 1.063 . . . . 0.0 108.594 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.4 p30 36.17 51.51 1.68 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.536 1.534 . . . . 0.0 113.655 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.83 119.28 6.28 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.936 1.757 . . . . 0.0 112.131 -173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.1 mm -129.75 140.65 48.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.415 ' CD1' HG22 ' A' ' 292' ' ' VAL . 43.4 m-85 -104.27 155.02 19.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.987 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.3 t -137.58 -34.97 0.67 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 90.8 m -147.07 78.79 1.5 Allowed 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.67 0.748 . . . . 0.0 112.746 -168.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.476 ' HZ3' ' HB3' ' A' ' 389' ' ' TYR . 19.5 pttm 52.23 -169.07 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 172.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.64 145.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -87.77 149.58 24.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.489 1.116 . . . . 0.0 110.504 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 241' ' ' GLY . 0.6 OUTLIER -149.63 117.61 6.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.121 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . -179.89 -178.23 48.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 122.192 0.884 . . . . 0.0 112.722 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.02 15.93 1.46 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 124.31 0.957 . . . . 0.0 114.792 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.51 130.27 26.02 Favored Pre-proline 0 N--CA 1.473 0.719 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.484 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 13.3 Cg_endo -87.91 -8.69 5.77 Favored 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 124.156 3.237 . . . . 0.0 112.57 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.499 ' CE3' ' HE1' ' A' ' 321' ' ' MET . 11.5 p-90 -147.34 -7.8 0.45 Allowed 'General case' 0 C--O 1.251 1.172 0 CA-C-N 120.585 1.539 . . . . 0.0 114.876 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.33 110.55 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.486 -1.383 . . . . 0.0 108.931 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -20.25 25.68 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.152 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.3 p -153.31 154.49 34.68 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 119.416 -2.053 . . . . 0.0 111.451 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -16.89 39.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.56 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.44 -17.6 60.11 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.84 -62.28 2.86 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.75 -31.18 68.99 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 118.593 -1.243 . . . . 0.0 111.448 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.89 -50.91 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.657 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.51 -5.19 31.3 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.6 m -79.83 -21.58 44.02 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.899 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -131.59 -1.31 3.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 257' ' ' ARG . 26.4 ttt-85 -81.13 -21.39 39.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.304 1.442 . . . . 0.0 111.287 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.13 -16.86 15.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 O-C-N 125.262 1.601 . . . . 0.0 115.291 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -133.48 -5.76 2.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.783 1.233 . . . . 0.0 110.649 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -94.24 -166.42 36.8 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.478 ' H ' HD12 ' A' ' 295' ' ' LEU . 73.0 m -146.47 65.82 1.19 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 171.16 16.11 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.752 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 61.5 m -138.88 174.9 10.03 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -131.24 139.41 50.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 CA-C-O 122.62 1.2 . . . . 0.0 110.949 -174.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.23 142.02 24.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.237 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -163.81 142.04 5.98 Favored Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.95 -177.34 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.77 3.647 . . . . 0.0 111.787 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 67.74 -5.15 3.57 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -142.58 44.55 1.62 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 119.911 1.856 . . . . 0.0 110.619 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.12 153.03 40.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.469 0.652 . . . . 0.0 110.128 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.39 -6.27 38.93 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.015 0.817 . . . . 0.0 111.69 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -157.91 -27.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.427 1.113 . . . . 0.0 113.244 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.36 76.11 9.34 Favored Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.29 112.32 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.091 3.194 . . . . 0.0 111.203 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -170.86 -166.83 0.51 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.43 146.59 77.72 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.58 166.2 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.854 3.036 . . . . 0.0 109.18 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.74 4.16 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.632 2.888 . . . . 0.0 111.964 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -120.48 167.93 11.86 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.73 10.22 68.49 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.553 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 16.0 p90 -146.24 162.62 37.68 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.4 m -156.96 -166.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 129.069 2.948 . . . . 0.0 108.032 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -132.58 152.24 51.68 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.234 -0.916 . . . . 0.0 111.887 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.16 140.35 44.35 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.24 0.962 . . . . 0.0 109.979 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.0 -153.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.04 0.536 . . . . 0.0 110.45 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . 0.315 33.0 t80 78.62 -107.01 0.02 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.805 -173.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.02 128.54 34.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 120.574 1.534 . . . . 0.0 107.544 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.76 17.19 3.31 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.491 1.119 . . . . 0.0 112.651 -167.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.9 -71.12 0.71 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.577 1.151 . . . . 0.0 111.833 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -79.26 -19.3 50.92 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.669 -1.27 . . . . 0.0 112.585 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 24.5 m -101.26 -8.33 22.24 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.79 0.723 . . . . 0.0 111.556 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 234' ' ' TYR . 5.6 m -85.24 -40.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 168.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.0 -59.61 4.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.34 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.0 p -76.57 -39.58 52.31 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 120.069 1.304 . . . . 0.0 112.12 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.478 HD12 ' H ' ' A' ' 261' ' ' SER . 65.3 mt -68.57 -34.01 75.07 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -171.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -94.23 -12.89 27.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.317 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.05 0.87 54.53 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.652 0.66 . . . . 0.0 111.096 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.49 -24.63 14.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 96.7 m -78.86 -152.96 0.06 Allowed 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.767 170.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.4 m -118.81 166.89 12.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 120.675 -1.265 . . . . 0.0 111.997 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -144.99 151.74 39.06 Favored 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 122.414 0.286 . . . . 0.0 110.982 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.28 138.68 16.82 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -87.07 20.72 1.17 Allowed 'Trans proline' 0 N--CA 1.431 -2.197 0 C-N-CA 122.293 1.996 . . . . 0.0 111.478 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.9 m -67.91 168.85 10.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -139.18 154.51 48.07 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.09 156.66 18.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -152.69 155.69 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.354 0.409 . . . . 0.0 111.097 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -153.47 152.73 31.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -111.89 146.28 38.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.444 ' HE3' ' CG1' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -148.49 -1.98 0.51 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.903 1.377 . . . . 0.0 110.541 -169.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 69.8 m -71.68 145.84 48.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.638 0.586 . . . . 0.0 112.503 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.8 m -85.2 149.79 25.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 124.358 1.036 . . . . 0.0 110.747 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -62.21 -15.53 47.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.754 -170.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.79 -23.34 67.32 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.598 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.499 ' HE1' ' CE3' ' A' ' 245' ' ' TRP . 1.2 ptt? -159.65 15.04 0.15 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 173.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -44.21 142.59 1.43 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.043 0.925 . . . . 0.0 112.116 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 48.3 t -164.44 -35.64 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.031 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -137.1 163.81 29.92 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.575 0.75 . . . . 0.0 111.849 -173.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.57 167.05 10.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.443 2.697 . . . . 0.0 112.092 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.444 ' CG1' ' HE3' ' A' ' 316' ' ' MET . 12.5 m -104.15 160.42 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.88 0.848 . . . . 0.0 112.269 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 153.24 17.76 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.134 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 16.9 t -137.87 130.51 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.363 1.04 . . . . 0.0 109.946 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.5 mt -138.65 119.28 9.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.979 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.22 168.69 7.55 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.246 2.631 . . . . 0.0 110.221 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.483 ' CH2' ' HB ' ' A' ' 391' ' ' ILE . 2.9 t-105 -104.52 123.95 48.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.495 0.664 . . . . 0.0 111.68 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.21 143.67 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.558 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.53 -40.64 62.69 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 125.109 1.364 . . . . 0.0 109.851 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.59 57.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 122.277 -0.265 . . . . 0.0 110.847 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.88 -18.09 38.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.494 -1.378 . . . . 0.0 110.766 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 p -111.79 -25.97 9.2 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.844 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -141.1 142.34 34.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.883 0.765 . . . . 0.0 110.612 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -157.33 153.47 27.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.433 -1.417 . . . . 0.0 111.144 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.57 147.37 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.65 31.55 5.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.689 0.796 . . . . 0.0 109.636 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.8 t -145.72 145.94 27.33 Favored Pre-proline 0 CA--C 1.52 -0.208 0 C-N-CA 124.16 0.984 . . . . 0.0 108.396 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.21 -7.11 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.175 2.584 . . . . 0.0 111.45 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.9 p -135.1 164.58 27.33 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.693 0.797 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.93 132.97 34.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.411 0.624 . . . . 0.0 112.059 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -154.9 162.56 41.06 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.083 1.353 . . . . 0.0 110.411 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 17.8 tp -151.59 175.43 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.837 1.336 . . . . 0.0 107.76 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.423 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 9.0 t70 -145.95 129.07 8.21 Favored Pre-proline 0 N--CA 1.446 -0.674 0 O-C-N 120.931 -1.106 . . . . 0.0 109.679 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.18 0.87 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.962 1 C-N-CA 126.507 4.805 . . . . 0.0 114.996 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 14.6 t -131.67 -7.3 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.677 -0.677 . . . . 0.0 111.935 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -135.91 77.3 1.65 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.42 1.009 . . . . 0.0 110.112 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.1 p -135.54 84.67 2.11 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.328 1.643 . . . . 0.0 108.647 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.74 145.55 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.048 0.451 . . . . 0.0 111.239 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -73.08 150.39 42.33 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.122 0.963 . . . . 0.0 112.405 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.8 140.83 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.073 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.47 -166.56 23.59 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 122.25 0.917 . . . . 0.0 114.108 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.46 38.69 30.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.543 0.687 . . . . 0.0 110.248 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.26 -179.65 7.25 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.174 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -56.71 -11.87 1.58 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.231 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.59 88.15 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.192 0.906 . . . . 0.0 113.78 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.6 ptm -165.85 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.161 0.584 . . . . 0.0 110.814 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.68 144.06 52.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -94.88 159.3 15.1 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.75 60.29 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.144 -0.973 . . . . 0.0 112.524 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.66 -29.02 61.1 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.75 -26.23 24.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.22 0.95 . . . . 0.0 109.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 tt -72.42 -46.95 52.81 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -71.64 -24.28 61.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 110.224 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.04 -45.56 66.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.535 0.683 . . . . 0.0 109.799 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.39 -44.24 94.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.4 -15.04 51.29 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.829 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.95 -16.46 21.71 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 120.283 1.402 . . . . 0.0 112.169 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.48 -25.78 14.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.75 -24.81 61.01 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.203 0.94 . . . . 0.0 110.803 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 403' ' ' SER . 3.9 p90 -163.41 -24.71 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.459 0.572 . . . . 0.0 112.159 174.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 72.67 157.93 4.0 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.724 -0.61 . . . . 0.0 112.37 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 126.12 15.68 2.77 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 121.871 0.706 . . . . 0.0 111.58 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.81 173.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.053 -0.573 . . . . 0.0 112.132 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.97 -26.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.416 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -157.82 157.68 33.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.37 0.987 . . . . 0.0 110.079 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.04 141.48 28.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.79 133.64 4.76 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.512 1.062 . . . . 0.0 113.523 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.67 145.9 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.5 70.38 7.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.82 150.27 48.82 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.127 0.571 . . . . 0.0 112.097 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.83 164.19 29.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -56.68 103.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.307 0.643 . . . . 0.0 112.128 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 m170 53.05 26.65 4.99 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.788 1.635 . . . . 0.0 113.613 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -85.58 -8.39 58.31 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.157 -0.964 . . . . 0.0 111.672 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.476 ' HB3' ' HZ3' ' A' ' 237' ' ' LYS . 41.9 p90 54.3 45.57 2.38 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.875 1.67 . . . . 0.0 113.053 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.634 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 86.0 Cg_endo -73.97 -66.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.034 2.489 . . . . 0.0 110.738 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.634 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 8.9 tp 38.79 35.14 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.9 0.88 . . . . 0.0 113.338 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.66 15.12 0.45 Allowed Glycine 0 CA--C 1.524 0.649 0 O-C-N 121.321 -0.862 . . . . 0.0 113.53 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 62.7 p -151.68 154.29 36.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 166.77 -146.86 11.26 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.615 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -149.29 171.36 16.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.34 136.67 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 122.077 0.942 . . . . 0.0 110.332 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 346' ' ' LEU . 45.8 m -99.15 133.08 43.95 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.403 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -115.33 179.32 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -144.25 5.84 1.29 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.15 166.62 24.17 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -83.94 -29.65 26.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.114 0.566 . . . . 0.0 110.516 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.619 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -66.42 -27.72 68.05 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.143 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.433 ' HA ' ' CE1' ' A' ' 374' ' ' PHE . 51.0 m -73.12 -27.4 61.66 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.013 0.824 . . . . 0.0 110.536 174.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.78 -56.0 6.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.821 0.82 . . . . 0.0 110.201 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -8.83 56.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.884 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -100.77 -21.19 15.25 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.914 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.05 -34.16 44.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 43.2 t -83.58 -33.93 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 122.808 0.443 . . . . 0.0 110.769 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.0 t -70.44 -32.64 70.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 119.724 1.147 . . . . 0.0 109.051 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -73.04 -52.66 13.52 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.865 0.84 . . . . 0.0 110.175 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.24 -17.5 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 126.678 1.991 . . . . 0.0 115.672 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -157.91 142.78 16.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.34 0.518 . . . . 0.0 110.354 -178.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.94 154.26 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 122.254 -0.279 . . . . 0.0 110.537 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -101.54 140.66 35.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.06 126.88 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -131.1 121.79 25.58 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.3 m -150.64 162.75 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -172.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.7 t -65.67 -5.16 7.65 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -145.58 4.43 1.02 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.346 1.058 . . . . 0.0 113.368 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -150.63 129.45 12.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.784 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.8 p -147.9 102.17 3.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -147.88 173.31 12.97 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -118.87 179.08 4.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.3 145.88 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -122.12 144.65 48.81 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 122.931 0.144 . . . . 0.0 110.766 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.94 145.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -138.44 138.94 23.43 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.1 155.68 63.42 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.168 2.579 . . . . 0.0 110.15 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.066 -170.727 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' MET . . . . . 0.417 ' CG ' HG13 ' A' ' 413' ' ' VAL . 11.0 tpt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.8 m -153.11 159.22 42.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.241 1.417 . . . . 0.0 109.754 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 17.61 0.65 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.247 0.619 . . . . 0.0 112.479 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.6 m 61.06 26.65 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.078 1.751 . . . . 0.0 115.205 172.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 51.59 68.09 1.69 Allowed Glycine 0 CA--C 1.536 1.395 0 CA-C-O 121.117 0.287 . . . . 0.0 113.202 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.48 -17.19 63.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.375 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 151.82 39.92 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-O 121.365 0.602 . . . . 0.0 110.499 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.5 110.89 2.5 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.55 4.69 6.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.347 3.365 . . . . 0.0 111.989 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -143.46 -171.29 3.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.819 1.248 . . . . 0.0 109.195 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 25.8 m120 57.73 22.74 8.74 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.296 1.839 . . . . 0.0 114.078 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -62.55 -36.74 83.62 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.145 -0.347 . . . . 0.0 110.224 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 39.84 54.41 2.58 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.9 59.47 39.0 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.83 127.39 13.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.308 3.338 . . . . 0.0 114.43 -171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.8 mm -146.14 131.54 12.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 102.604 -3.109 . . . . 0.0 102.604 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -98.45 143.03 29.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.768 -1.173 . . . . 0.0 109.231 -169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.9 p -137.14 -1.24 2.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 14.7 t -158.97 -166.28 1.82 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.026 1.285 . . . . 0.0 108.317 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 176.91 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.535 1.134 . . . . 0.0 112.564 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.1 142.35 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.49 1.138 . . . . 0.0 109.01 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.25 130.12 38.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.512 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -137.07 113.57 10.14 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.94 173.98 38.35 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-O 121.418 0.454 . . . . 0.0 113.73 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 115.05 18.83 6.16 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.357 -1.421 . . . . 0.0 114.009 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.3 m -92.0 126.09 54.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.501 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -82.03 -17.03 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.991 3.128 . . . . 0.0 111.483 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.517 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 30.1 p-90 -130.54 -70.06 0.63 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.146 0.884 . . . . 0.0 109.709 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 245' ' ' TRP . 26.7 t70 10.97 90.72 0.01 OUTLIER 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.768 1.627 . . . . 0.0 113.225 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.412 ' CD1' ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -63.96 -22.0 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.7 m -150.33 143.15 24.7 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-N 121.029 1.74 . . . . 0.0 108.916 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.19 -24.93 64.11 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.197 0.999 . . . . 0.0 109.52 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.54 -13.94 62.59 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.54 1.136 . . . . 0.0 110.689 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.83 -58.16 5.94 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 54.8 mt -50.49 -47.21 57.32 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 122.199 0.999 . . . . 0.0 109.437 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.42 -45.59 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.916 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -73.92 -8.03 54.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.904 0.32 . . . . 0.0 110.853 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 84.6 m -90.49 -20.56 22.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.99 32.58 1.12 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.441 1.019 . . . . 0.0 112.468 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -88.25 14.98 8.25 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.14 12.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 O-C-N 120.541 -1.349 . . . . 0.0 112.37 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -93.36 -1.69 55.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.114 0.87 . . . . 0.0 111.56 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 70.12 -0.26 24.33 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.5 t -124.89 18.31 8.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.704 -0.88 . . . . 0.0 112.076 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.53 143.42 28.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.366 -0.533 . . . . 0.0 112.25 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.6 m -150.71 153.15 35.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 93.5 t -138.17 138.76 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 124.012 0.82 . . . . 0.0 111.29 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -143.45 156.19 44.58 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.488 1.118 . . . . 0.0 113.651 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -151.18 167.32 13.23 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.56 -19.28 22.8 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 124.087 3.191 . . . . 0.0 115.681 -168.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 170.46 157.53 12.77 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.085 1.311 . . . . 0.0 111.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -102.16 15.3 29.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.761 0.824 . . . . 0.0 112.766 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.86 144.41 47.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.639 1.176 . . . . 0.0 108.936 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.24 177.37 15.33 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.285 0.936 . . . . 0.0 110.775 -176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.74 173.36 8.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.553 -0.969 . . . . 0.0 108.494 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 60.66 142.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.539 1.135 . . . . 0.0 112.223 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.9 -11.87 11.1 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 123.852 3.034 . . . . 0.0 111.415 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -101.06 33.0 2.99 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.822 0.849 . . . . 0.0 111.991 -171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.582 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 48.9 t 64.98 144.58 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 124.685 1.194 . . . . 0.0 110.342 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.582 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 71.2 Cg_endo -66.55 166.08 23.09 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.068 1.846 . . . . 0.0 112.972 171.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.7 113.3 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 CA-C-O 122.643 1.018 . . . . 0.0 111.396 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -143.52 145.79 32.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.247 1.419 . . . . 0.0 109.977 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -92.8 4.11 75.07 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.236 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.93 165.79 35.57 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.62 161.66 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.863 1.265 . . . . 0.0 109.74 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -97.39 149.37 22.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.579 1.081 . . . . 0.0 109.752 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.79 137.09 52.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.16 107.52 11.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -153.51 -161.68 1.31 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 124.445 1.091 . . . . 0.0 111.058 -168.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.19 92.48 0.04 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.51 HD21 ' H ' ' A' ' 288' ' ' LEU . 1.8 pt? -67.03 17.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.792 2.437 . . . . 0.0 117.011 -168.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.86 -60.12 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.102 1.319 . . . . 0.0 109.98 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -86.19 -23.71 26.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.264 -0.897 . . . . 0.0 112.862 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 12.2 t -84.12 -22.73 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 286' ' ' PHE . 24.1 t -72.66 -48.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.561 0.696 . . . . 0.0 109.577 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.3 ptp180 -74.95 -25.67 59.04 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.551 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 48.0 m -78.18 -37.23 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 0.0 112.672 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.95 -35.96 67.08 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 7.0 mp -71.34 -24.21 62.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.087 0.858 . . . . 0.0 110.006 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -92.11 -2.35 56.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.76 -18.14 18.97 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.125 -1.609 . . . . 0.0 110.226 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.84 -151.32 0.44 Allowed 'General case' 0 C--O 1.24 0.554 0 O-C-N 125.925 2.016 . . . . 0.0 110.411 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -126.46 177.94 6.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.191 0.932 . . . . 0.0 113.125 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 310' ' ' SER . 83.3 t60 -145.8 162.03 38.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.45 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -144.12 131.78 10.66 Favored Pre-proline 0 C--N 1.351 0.648 0 O-C-N 124.026 0.829 . . . . 0.0 110.102 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -86.75 23.87 0.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 1 C-N-CA 125.807 4.338 . . . . 0.0 111.174 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 C-N-CA 123.517 0.727 . . . . 0.0 111.736 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 29.0 m -108.61 158.18 17.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.312 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -138.06 135.56 35.97 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.004 -171.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 296' ' ' LEU . 5.6 m-85 -85.2 148.88 25.87 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.24 149.42 51.98 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.177 -0.952 . . . . 0.0 111.141 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -151.88 168.03 26.44 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 123.313 1.53 . . . . 0.0 109.785 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.452 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 12.7 ptpt -130.46 116.74 18.64 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.921 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.5 OUTLIER -110.99 28.46 8.7 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -176.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 86.1 p -79.61 164.31 23.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.029 0.932 . . . . 0.0 111.401 -174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 66.6 m -117.05 176.13 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -79.1 23.71 0.35 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -128.79 15.16 6.42 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.63 0.772 . . . . 0.0 110.778 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.517 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 16.6 mmt -137.52 179.65 6.28 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -130.8 103.41 6.56 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.678 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.7 m 64.88 166.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 111.419 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -155.34 -64.6 0.12 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.749 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 44.05 69.61 0.4 Allowed 'General case' 0 C--N 1.343 0.318 0 O-C-N 123.84 0.713 . . . . 0.0 112.652 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.7 p -83.99 160.0 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 121.902 -0.499 . . . . 0.0 109.987 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -102.8 153.59 20.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.509 0.595 . . . . 0.0 110.114 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.3 139.15 49.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.83 88.1 3.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 122.854 1.311 . . . . 0.0 108.123 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.16 164.75 26.67 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.868 2.379 . . . . 0.0 113.062 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -78.28 122.49 25.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.104 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 334' ' ' ALA . 86.8 t -103.84 148.6 8.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 122.463 1.125 . . . . 0.0 110.161 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.44 -38.62 59.65 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.554 1.142 . . . . 0.0 110.775 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.547 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -64.32 -3.09 2.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.706 0.403 . . . . 0.0 111.892 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -102.96 7.24 39.2 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 120.823 -1.173 . . . . 0.0 111.202 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.9 m -119.85 -49.37 2.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -151.13 157.41 42.7 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 119.122 0.873 . . . . 0.0 111.609 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -156.08 143.33 19.15 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.901 1.375 . . . . 0.0 109.342 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.27 154.57 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.999 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -117.87 41.18 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.8 t -137.61 147.15 56.24 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.548 1.139 . . . . 0.0 110.074 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.66 -3.36 13.76 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.564 2.176 . . . . 0.0 111.022 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.8 m -130.19 -176.85 4.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -105.86 135.95 46.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.728 -1.233 . . . . 0.0 110.243 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -159.59 165.75 32.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.083 -1.011 . . . . 0.0 109.321 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.417 HD12 ' HG1' ' A' ' 397' ' ' THR . 12.6 tp -156.37 150.7 25.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.057 1.343 . . . . 0.0 110.04 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.1 110.78 8.51 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.13 -2.09 11.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.864 3.043 . . . . 0.0 111.348 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 67.8 m -84.45 -14.35 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -140.42 94.72 2.77 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 109.942 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.5 t -149.27 152.24 35.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.702 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.0 m -135.11 153.06 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 118.822 0.737 . . . . 0.0 109.375 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -75.04 145.71 42.17 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.923 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 66.9 t -132.0 140.75 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 125.089 1.493 . . . . 0.0 111.168 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -165.76 -162.15 16.39 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.523 -0.736 . . . . 0.0 111.945 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.66 31.9 18.25 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.15 0.975 . . . . 0.0 111.291 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.67 25.74 0.63 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . 0.295 0.0 OUTLIER 58.31 9.23 0.97 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.96 1.704 . . . . 0.0 114.739 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.16 63.98 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 167.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.5 ptm -165.48 21.7 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.19 1.495 . . . . 0.0 112.339 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.617 HD12 ' HZ2' ' A' ' 422' ' ' LYS . 18.4 tp -69.38 151.37 46.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.881 0.848 . . . . 0.0 111.496 -175.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -114.26 174.26 6.04 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.93 60.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -71.94 -25.26 61.81 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.031 -1.043 . . . . 0.0 109.247 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -90.24 -31.84 16.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.91 1.381 . . . . 0.0 110.74 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.545 0.612 . . . . 0.0 110.557 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.53 67.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.86 -45.09 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.701 -0.624 . . . . 0.0 110.745 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 81.4 mt -64.65 -43.45 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.701 0.8 . . . . 0.0 110.488 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 374' ' ' PHE . 3.7 mm? -81.0 -28.04 35.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.146 -0.971 . . . . 0.0 113.293 -173.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.24 -13.73 27.92 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -108.31 -22.04 12.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.743 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.23 -16.97 21.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.2 0.909 . . . . 0.0 111.535 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.443 ' CE2' HD11 ' A' ' 370' ' ' LEU . 16.2 m-30 -113.26 -12.29 13.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.763 1.165 . . . . 0.0 113.694 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 69.25 4.13 41.95 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.98 -0.45 . . . . 0.0 113.226 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -164.73 115.92 0.67 Allowed Glycine 0 C--N 1.357 1.717 0 CA-C-N 118.456 1.128 . . . . 0.0 115.177 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.44 179.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.237 0.615 . . . . 0.0 111.66 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.12 -39.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 O-C-N 122.028 -0.42 . . . . 0.0 110.936 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.77 152.75 30.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.653 0.66 . . . . 0.0 111.187 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.96 37.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.416 1.486 . . . . 0.0 109.036 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -168.41 169.56 41.64 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 120.83 -1.168 . . . . 0.0 115.371 175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.2 mm -90.16 150.4 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 125.994 1.718 . . . . 0.0 109.711 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.53 71.73 5.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 156.7 34.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.691 -0.63 . . . . 0.0 111.241 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.18 161.61 40.56 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.473 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 24.1 tptm -45.77 102.49 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.616 0.766 . . . . 0.0 112.201 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . 0.473 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 24.3 m170 48.39 42.12 17.73 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.692 1.997 . . . . 0.0 112.338 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -97.25 -11.42 24.18 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 124.312 1.007 . . . . 0.0 109.835 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 26.8 p90 44.58 45.49 2.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 90.0 Cg_endo -72.1 -58.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.88 3.72 . . . . 0.0 109.779 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.445 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 9.5 tp 42.72 32.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.421 0 C-N-CA 125.172 1.389 . . . . 0.0 113.838 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.6 16.81 0.97 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 54.0 m -152.37 157.74 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 117.833 0.816 . . . . 0.0 110.06 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 176.1 -163.84 33.49 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 123.66 0.6 . . . . 0.0 113.489 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -146.42 173.8 11.96 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.717 0.892 . . . . 0.0 111.213 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.17 144.03 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.417 ' HG1' HD12 ' A' ' 346' ' ' LEU . 34.9 p -119.1 152.27 36.8 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.623 1.201 . . . . 0.0 111.218 175.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.543 ' CE1' ' HB2' ' A' ' 403' ' ' SER . 35.0 m-85 -129.82 179.37 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 123.611 1.672 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -126.64 1.78 6.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.314 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.35 164.03 24.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.761 1.225 . . . . 0.0 109.593 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -96.91 -13.38 22.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.19 -38.12 87.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.795 1.18 . . . . 0.0 107.928 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.543 ' HB2' ' CE1' ' A' ' 398' ' ' PHE . 8.3 p -79.15 -17.99 53.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -72.75 -61.08 1.93 Allowed 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.798 -0.563 . . . . 0.0 111.944 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -25.58 61.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.206 -1.397 . . . . 0.0 113.028 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -77.92 -20.6 52.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.073 0.851 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.71 61.15 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.725 -0.609 . . . . 0.0 111.155 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.5 m -82.71 -11.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.648 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.8 p -106.89 -8.23 16.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.068 0.855 . . . . 0.0 112.507 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -93.44 -49.83 5.73 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.36 -15.26 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.56 138.77 12.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 218' ' ' MET . 10.6 m -143.94 158.98 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.972 0.351 . . . . 0.0 111.43 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.99 137.18 42.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.866 1.354 . . . . 0.0 109.713 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.21 128.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.61 50.16 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 28.4 m -73.9 166.5 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -71.6 -1.87 15.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -148.36 5.58 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.804 -1.185 . . . . 0.0 111.23 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -146.98 125.46 12.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.327 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 54.5 p -138.58 111.2 7.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 125.332 1.645 . . . . 0.0 112.822 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.617 ' HZ2' HD12 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -159.55 -176.68 5.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.466 -1.396 . . . . 0.0 112.323 177.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.61 163.42 24.25 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.762 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 25.9 m -143.98 156.88 15.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 123.68 0.613 . . . . 0.0 109.653 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -130.26 153.47 48.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.258 0.348 . . . . 0.0 111.216 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 79.2 mt -131.53 142.38 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.896 1.372 . . . . 0.0 108.115 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -139.23 155.97 72.2 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.558 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.9 158.08 35.37 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 C-N-CA 124.28 3.32 . . . . 0.0 115.22 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 75.8 t80 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.15 177.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -169.86 175.67 5.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.642 1.214 . . . . 0.0 111.199 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.406 ' HE3' ' H ' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -129.17 16.04 6.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 174.09 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.1 m 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.65 84.42 0.45 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.328 -1.483 . . . . 0.0 111.602 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -99.24 -5.33 30.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.19 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.65 125.07 20.32 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.405 1.082 . . . . 0.0 109.258 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.6 116.81 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 125.01 3.807 . . . . 0.0 111.169 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -81.8 -179.28 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.044 3.829 . . . . 0.0 111.86 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 37.93 66.21 0.5 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.923 1.689 . . . . 0.0 114.21 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -143.65 27.18 1.53 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.113 0.965 . . . . 0.0 110.186 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -66.23 0.93 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 112.561 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 55.97 45.88 22.99 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.877 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -117.61 -50.17 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.64 -170.78 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.419 3.413 . . . . 0.0 114.063 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.639 HD11 ' H ' ' A' ' 233' ' ' ILE . 0.2 OUTLIER -102.83 -171.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 125.388 1.475 . . . . 0.0 108.717 -178.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -106.37 148.74 27.72 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.7 m -141.99 11.56 2.0 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.6 t -158.48 -145.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.317 -1.49 . . . . 0.0 110.414 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 170.05 6.76 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.978 0.911 . . . . 0.0 110.616 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 m -144.53 155.12 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 122.32 1.057 . . . . 0.0 109.59 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.78 135.93 34.58 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.62 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.09 122.66 11.1 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.336 0.588 . . . . 0.0 111.088 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.27 -170.99 33.41 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.113 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.74 6.96 0.91 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 124.689 1.138 . . . . 0.0 112.109 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.57 145.8 30.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 122.707 1.241 . . . . 0.0 113.616 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.16 -13.02 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 125.0 3.8 . . . . 0.0 110.219 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -101.2 -104.09 0.25 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.631 1.105 . . . . 0.0 110.111 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.9 t70 46.38 59.5 3.81 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 124.278 1.031 . . . . 0.0 111.294 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.459 HG12 ' HG1' ' A' ' 248' ' ' THR . 0.2 OUTLIER -70.31 -17.24 20.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 O-C-N 121.069 -1.019 . . . . 0.0 110.903 -170.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.459 ' HG1' HG12 ' A' ' 247' ' ' ILE . 4.8 m -149.29 133.51 17.34 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 127.053 2.141 . . . . 0.0 105.357 172.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.19 -10.23 59.5 Favored 'General case' 0 CA--C 1.485 -1.554 0 O-C-N 117.508 -3.245 . . . . 0.0 115.66 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.12 -18.24 58.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.3 -43.83 30.35 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.52 -45.4 68.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.061 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.2 t -64.7 -39.06 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 123.761 0.663 . . . . 0.0 110.272 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.47 -16.79 64.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.651 -1.281 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 74.7 m -77.53 -33.55 54.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.727 -0.608 . . . . 0.0 111.513 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -142.53 80.6 1.7 Allowed 'General case' 0 C--O 1.218 -0.602 0 O-C-N 118.978 -2.326 . . . . 0.0 109.934 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.7 5.27 2.18 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.945 171.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.35 -4.91 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.452 1.024 . . . . 0.0 110.744 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -77.2 -12.27 59.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.21 3.26 6.33 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.6 m -114.06 16.41 18.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.165 1.482 . . . . 0.0 110.335 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.88 155.71 50.2 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -148.88 -172.49 4.12 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.383 2.273 . . . . 0.0 108.03 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.45 150.55 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -170.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 129.29 23.69 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.534 -0.729 . . . . 0.0 109.847 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -156.29 152.79 23.92 Favored Pre-proline 0 N--CA 1.439 -1.004 0 O-C-N 121.025 -1.047 . . . . 0.0 113.041 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.69 148.82 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.676 4.25 . . . . 0.0 105.969 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.86 -8.7 70.72 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.792 1.187 . . . . 0.0 110.307 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -66.67 -18.37 65.33 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.912 1.356 . . . . 0.0 110.419 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -81.35 -5.25 57.64 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 112.365 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -110.97 -176.85 20.52 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -74.92 163.56 27.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.315 0.646 . . . . 0.0 112.287 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.2 m80 64.43 145.54 0.09 OUTLIER Pre-proline 0 N--CA 1.444 -0.771 0 C-N-CA 125.426 1.491 . . . . 0.0 111.697 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.52 17.29 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.239 3.293 . . . . 0.0 111.712 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -145.16 140.27 27.84 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.619 1.168 . . . . 0.0 111.563 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.601 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 49.4 t -161.72 -43.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 45.1 Cg_endo -83.11 136.58 8.01 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.941 1.761 . . . . 0.0 111.748 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -93.71 6.71 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.236 2.624 . . . . 0.0 111.118 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -106.49 5.7 29.51 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.249 1.42 . . . . 0.0 111.294 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.45 29.98 0.15 Allowed Glycine 0 N--CA 1.467 0.704 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.7 121.54 40.37 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 118.858 1.329 . . . . 0.0 110.054 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.01 174.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 122.916 1.341 . . . . 0.0 112.034 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -98.54 169.0 9.83 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.937 -1.102 . . . . 0.0 112.019 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.0 mt -124.37 145.24 49.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.206 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.21 114.39 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.96 -161.82 0.58 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.266 1.032 . . . . 0.0 111.766 -172.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.412 ' HG2' ' HE3' ' A' ' 290' ' ' LYS . 10.8 tp10 -56.84 113.11 1.52 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.652 ' H ' HD21 ' A' ' 288' ' ' LEU . 0.9 OUTLIER -85.37 12.47 8.21 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -168.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -135.45 -67.13 0.55 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.172 1.806 . . . . 0.0 112.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . 0.412 ' HE3' ' HG2' ' A' ' 287' ' ' GLU . 0.0 OUTLIER -80.19 -31.34 38.76 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.908 -1.12 . . . . 0.0 112.184 -168.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.5 m -78.95 -30.85 44.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.195 0.907 . . . . 0.0 109.165 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.77 -56.49 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.57 -28.8 67.27 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.037 -1.04 . . . . 0.0 112.347 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.9 m -65.81 -32.67 74.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.36 -51.42 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.784 0.72 . . . . 0.0 109.817 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 3.7 pp -74.3 -4.82 38.51 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.38 -8.06 11.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.375 0.422 . . . . 0.0 110.994 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.03 65.68 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.292 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . 0.444 ' SG ' ' HE3' ' A' ' 315' ' ' LYS . 50.3 t -112.26 -91.76 0.48 Allowed 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 123.596 0.56 . . . . 0.0 111.734 -174.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 72.3 m -142.06 158.25 43.97 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -154.9 156.12 35.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.267 1.427 . . . . 0.0 108.704 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.64 104.75 4.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.404 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.57 12.55 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 125.604 4.203 . . . . 0.0 111.783 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 49.5 m -103.19 177.88 4.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.949 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -129.39 131.61 46.85 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.596 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -109.55 151.94 26.12 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -138.27 154.49 49.04 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 122.006 0.907 . . . . 0.0 112.105 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.45 178.81 7.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.408 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.444 ' HE3' ' SG ' ' A' ' 299' ' ' CYS . 9.1 ptpt -150.11 147.04 27.28 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.22 -14.92 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.583 -1.323 . . . . 0.0 110.557 -169.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.5 t -94.96 157.31 15.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.672 1.124 . . . . 0.0 112.528 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 43.4 p -131.58 -38.61 1.16 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -152.13 -13.3 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -99.15 -21.22 16.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 69.2 mmm -130.01 -179.36 5.17 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.625 0.77 . . . . 0.0 111.697 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -123.85 31.66 5.79 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 66.7 m -104.66 -45.46 4.6 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? 53.63 17.51 1.22 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -166.97 147.63 5.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.589 -1.319 . . . . 0.0 112.317 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.75 159.93 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 117.517 -1.23 . . . . 0.0 109.695 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -109.53 157.11 19.33 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 120.089 1.313 . . . . 0.0 113.198 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.81 141.93 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.937 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.9 pt -151.6 131.2 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -104.29 174.22 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.353 2.702 . . . . 0.0 114.344 -176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -82.4 125.0 30.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.544 HG13 ' H ' ' A' ' 334' ' ' ALA . 93.9 t -99.33 151.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.73 -26.37 68.02 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.543 -0.723 . . . . 0.0 111.523 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.544 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -71.16 -22.45 62.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.14 -10.3 59.63 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.341 0.401 . . . . 0.0 110.242 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 17.3 m -98.04 -31.79 11.96 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.1 162.06 40.3 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.728 -0.608 . . . . 0.0 111.462 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -147.55 127.67 13.76 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.59 140.43 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -103.86 -8.09 20.0 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -137.01 93.17 13.57 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.33 -9.98 27.1 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.301 2.667 . . . . 0.0 113.584 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 71.0 m -115.26 19.07 15.83 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.878 0.871 . . . . 0.0 112.845 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -140.65 172.43 12.71 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.056 1.343 . . . . 0.0 109.708 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -127.18 -83.8 0.61 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.643 -1.286 . . . . 0.0 111.083 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.483 ' CD1' ' HG1' ' A' ' 397' ' ' THR . 3.8 tp -151.35 173.24 14.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.957 0.785 . . . . 0.0 111.065 -170.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.434 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 1.4 m-20 -124.7 151.31 67.6 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 123.609 0.764 . . . . 0.0 110.187 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.57 -15.58 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.864 3.042 . . . . 0.0 113.611 -167.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 56.6 p -150.17 8.25 0.63 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -123.88 88.74 2.96 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 121.008 -1.058 . . . . 0.0 110.094 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.0 t -151.52 155.3 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.21 150.33 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.04 0.448 . . . . 0.0 110.961 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -90.58 141.35 28.86 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 122.265 1.031 . . . . 0.0 110.283 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 78.8 t -130.94 140.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.811 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.27 -164.19 21.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 56.64 29.2 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.0 mt -74.98 170.15 16.57 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.071 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -74.79 -27.94 60.53 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 147.48 -11.45 1.33 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.714 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 18.4 ptm -156.78 22.55 0.33 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.024 1.412 . . . . 0.0 112.109 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.03 129.29 3.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.442 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -104.44 164.26 11.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.954 0.901 . . . . 0.0 111.352 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.0 -12.16 60.55 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -81.2 -28.58 34.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.211 0.914 . . . . 0.0 109.053 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.07 77.44 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.05 -37.71 75.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.06 73.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.84 85.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.244 0.545 . . . . 0.0 110.285 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.6 mt -78.69 -33.31 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.145 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.08 1.05 47.24 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -171.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -22.56 5.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.662 0.665 . . . . 0.0 111.777 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.35 -8.93 13.43 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.08 -1.84 9.24 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 170.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.88 -24.59 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.968 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.59 34.62 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 124.032 0.825 . . . . 0.0 115.155 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.21 128.09 1.03 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.589 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 398' ' ' PHE . 33.4 m -138.02 174.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 O-C-N 121.632 -0.922 . . . . 0.0 111.533 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.17 -28.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 O-C-N 122.212 -0.305 . . . . 0.0 111.679 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.26 151.9 21.62 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.229 0.612 . . . . 0.0 110.584 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.82 149.81 34.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.362 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -176.99 175.76 47.8 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 120.58 -0.819 . . . . 0.0 115.036 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.07 147.26 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 109.082 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.46 130.04 34.64 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.262 -0.899 . . . . 0.0 111.913 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 2.5 p -111.2 169.92 8.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.861 0.838 . . . . 0.0 111.622 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.75 167.19 25.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.866 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.68 101.54 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.41 0.444 . . . . 0.0 112.099 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.0 m170 53.8 30.89 12.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -97.39 -4.25 38.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.415 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 55.6 t80 45.9 56.11 15.61 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 125.292 1.437 . . . . 0.0 113.396 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.35 -60.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.179 1.253 . . . . 0.0 109.362 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.251 9.7 tp 41.45 36.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.739 2.016 . . . . 0.0 113.85 175.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -153.71 5.92 0.36 Allowed Glycine 0 N--CA 1.474 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 115.122 -171.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 43.9 m -148.6 122.08 9.11 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 117.913 0.856 . . . . 0.0 110.296 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -158.89 -169.0 21.74 Favored Glycine 0 CA--C 1.542 1.757 0 O-C-N 120.705 -1.247 . . . . 0.0 111.848 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -152.45 171.31 18.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.034 0.534 . . . . 0.0 109.986 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.72 143.8 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.483 ' HG1' ' CD1' ' A' ' 346' ' ' LEU . 89.7 m -115.43 140.32 49.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 377' ' ' VAL . 8.3 p90 -163.25 158.15 21.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.194 1.397 . . . . 0.0 110.414 173.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -128.77 20.55 6.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.03 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -100.87 144.35 29.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.91 -27.06 21.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.594 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.07 64.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 119.593 1.088 . . . . 0.0 109.784 -174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 73.8 p -81.35 -21.6 39.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -69.73 -62.6 1.32 Allowed 'General case' 0 C--N 1.349 0.583 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -17.48 63.44 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -76.19 -34.88 59.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.983 0.81 . . . . 0.0 110.644 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.68 -26.35 37.62 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.227 -1.546 . . . . 0.0 111.192 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 37.6 t -79.77 -32.03 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.621 1.169 . . . . 0.0 108.635 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 29.0 t -75.09 -30.26 60.86 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 117.902 -1.046 . . . . 0.0 112.111 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.26 -48.74 6.53 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.572 1.078 . . . . 0.0 110.239 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 65.2 -14.04 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.999 2.12 . . . . 0.0 116.137 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 148.18 17.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.71 157.55 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.9 117.66 33.37 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 124.991 1.432 . . . . 0.0 110.489 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.25 127.99 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 416' ' ' LYS . 8.6 mmpt? -118.95 34.07 5.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.49 1.119 . . . . 0.0 111.16 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.4 m -59.83 154.83 17.52 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.233 0.924 . . . . 0.0 109.752 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 14.0 t -73.3 0.81 10.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -145.09 15.43 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 112.244 173.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -151.03 120.41 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.309 -1.495 . . . . 0.0 108.384 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 32.4 p -132.28 110.08 10.35 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.938 -0.476 . . . . 0.0 110.265 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 26.6 tptt -162.47 -175.91 4.76 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 124.118 0.886 . . . . 0.0 109.132 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.596 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.7 mttm -121.2 173.05 7.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.631 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.75 150.04 15.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -114.79 152.27 32.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.6 mt -130.79 142.49 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 125.299 1.624 . . . . 0.0 108.283 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -138.2 140.2 27.93 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 119.839 1.199 . . . . 0.0 112.731 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.77 153.85 41.02 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.692 2.261 . . . . 0.0 109.879 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.258 1.546 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.928 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.3 t -130.32 -178.36 4.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.497 1.142 . . . . 0.0 111.543 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 372' ' ' ASP . 0.0 OUTLIER -130.6 18.3 5.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.543 0.737 . . . . 0.0 111.654 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.4 m 56.31 29.04 14.31 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.762 1.625 . . . . 0.0 114.623 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.37 1.13 Allowed Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.535 -0.728 . . . . 0.0 112.191 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -80.83 -18.94 45.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.912 0.856 . . . . 0.0 112.765 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.8 127.63 25.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -84.67 132.08 4.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.003 3.135 . . . . 0.0 108.676 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.77 -5.53 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.1 1.867 . . . . 0.0 112.486 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.61 -168.6 1.62 Allowed 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 121.326 -0.859 . . . . 0.0 109.255 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.7 m120 58.4 27.97 16.17 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 122.066 -0.396 . . . . 0.0 111.128 -172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.07 145.65 0.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.25 0.62 . . . . 0.0 112.103 168.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -141.21 14.03 2.22 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.931 0.892 . . . . 0.0 111.713 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.546 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 8.0 p30 -141.76 28.21 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.322 0.51 . . . . 0.0 112.279 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 87.8 Cg_endo -66.53 116.99 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.529 1.486 . . . . 0.0 112.047 -169.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.3 mm -144.87 153.42 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -112.35 146.34 38.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -148.3 7.63 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 85.2 m -137.98 -74.2 0.4 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.838 0.745 . . . . 0.0 111.2 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' A' ' 389' ' ' TYR . 20.7 pttp -156.18 -169.73 3.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.302 0.641 . . . . 0.0 109.575 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.2 152.31 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 122.25 1.024 . . . . 0.0 108.685 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -98.95 146.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.857 1.263 . . . . 0.0 110.071 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.19 136.44 16.65 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.798 1.311 . . . . 0.0 108.102 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.87 -173.46 33.88 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 121.638 -0.664 . . . . 0.0 113.601 170.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.73 1.61 8.21 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.344 -1.253 . . . . 0.0 110.123 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -78.44 126.61 82.76 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 118.734 1.267 . . . . 0.0 110.521 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 66.1 Cg_endo -81.45 4.78 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.969 3.779 . . . . 0.0 114.07 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.48 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 2.8 p-90 -139.99 -48.72 0.46 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 23.7 t70 56.32 -41.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.194 2.598 . . . . 0.0 115.205 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . 0.337 2.8 pp 55.38 -50.69 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.9 m -150.19 135.64 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 122.113 2.233 . . . . 0.0 108.421 171.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -76.48 -22.08 54.99 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.51 -13.33 62.28 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.559 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.94 -74.73 0.68 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 120.956 -1.09 . . . . 0.0 113.021 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.57 -36.91 84.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.879 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.83 -50.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.533 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.438 ' HA ' ' HB3' ' A' ' 257' ' ' ARG . 19.8 m-20 -71.68 -8.77 56.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 94.8 m -76.82 -26.89 54.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 124.256 0.972 . . . . 0.0 111.617 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -129.03 16.74 6.2 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 124.002 0.814 . . . . 0.0 112.863 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 254' ' ' ASN . 35.3 ttt85 -97.59 -17.16 19.69 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.91 -10.79 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 121.654 0.74 . . . . 0.0 112.61 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -136.92 3.4 2.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.021 -1.05 . . . . 0.0 110.082 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.59 149.76 16.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 124.032 1.907 . . . . 0.0 111.54 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.3 m -105.17 83.4 1.97 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 112.063 -2.069 . . . . 0.0 107.235 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 171.29 16.92 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 113.596 -178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 t -144.71 165.82 26.98 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.84 150.8 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 121.298 -0.876 . . . . 0.0 113.207 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -141.23 142.92 33.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.014 1.387 . . . . 0.0 108.412 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.65 153.15 91.58 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.808 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.38 -17.41 16.63 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.7 2.267 . . . . 0.0 113.059 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -166.99 -5.36 0.03 OUTLIER Glycine 0 C--N 1.346 1.122 0 CA-C-O 117.346 -1.808 . . . . 0.0 116.429 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 60.0 tttm 58.95 86.28 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.216 2.008 . . . . 0.0 109.646 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.39 165.48 23.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.442 -0.786 . . . . 0.0 109.712 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -72.1 -55.12 7.33 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 123.101 0.382 . . . . 0.0 112.838 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -87.08 156.69 19.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.232 0.516 . . . . 0.0 111.289 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 275' ' ' ARG . 18.7 m170 44.31 61.74 10.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.63 2.04 0.17 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.62 3.546 . . . . 0.0 112.444 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 273' ' ' HIS . 18.2 ptt-85 -90.27 -9.55 47.53 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.604 1.093 . . . . 0.0 111.647 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 48.8 t -142.06 129.27 11.37 Favored Pre-proline 0 C--N 1.352 0.686 0 C-N-CA 125.685 1.594 . . . . 0.0 110.462 -172.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.76 156.15 67.12 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.783 3.655 . . . . 0.0 110.961 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.58 -3.5 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.549 3.499 . . . . 0.0 110.656 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 281' ' ' TYR . 5.5 ptpp? -149.84 179.34 8.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.552 1.141 . . . . 0.0 111.301 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.43 8.81 73.06 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.572 -1.127 . . . . 0.0 114.121 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.424 ' H ' ' HG3' ' A' ' 279' ' ' LYS . 1.8 m-85 -116.4 152.05 34.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.838 1.319 . . . . 0.0 113.565 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.69 167.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.22 1.808 . . . . 0.0 108.946 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -121.88 149.36 43.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.961 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.4 mp -121.45 148.47 44.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 286' ' ' PHE . 27.0 m -137.85 -154.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 O-C-N 125.223 1.577 . . . . 0.0 110.043 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 285' ' ' VAL 0.264 79.7 t80 77.55 -124.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 115.468 -2.206 . . . . 0.0 108.471 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.88 140.05 58.83 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 123.086 2.676 . . . . 0.0 108.993 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.34 8.44 3.4 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.247 1.419 . . . . 0.0 114.204 -170.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -128.9 -86.31 0.55 Allowed 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.545 1.153 . . . . 0.0 112.499 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -61.07 -30.33 70.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 52.6 m -100.2 -25.76 14.16 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.057 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.85 -28.62 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 121.684 2.038 . . . . 0.0 108.133 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -83.66 -32.02 25.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.115 0.884 . . . . 0.0 112.953 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.8 m -87.75 -35.93 17.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.283 0.99 . . . . 0.0 112.232 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 tt -68.85 -40.86 79.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.875 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 3.8 mp -67.2 -40.58 86.52 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.704 -1.247 . . . . 0.0 111.749 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -77.35 -7.48 56.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -87.44 -27.92 22.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.64 -174.15 4.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.041 -1.891 . . . . 0.0 106.379 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 151.48 28.54 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 124.029 1.871 . . . . 0.0 111.865 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -143.19 152.97 42.36 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.659 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -126.27 110.79 23.77 Favored Pre-proline 0 N--CA 1.434 -1.251 0 O-C-N 124.13 0.894 . . . . 0.0 109.433 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.85 46.04 2.07 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.781 2.988 . . . . 0.0 109.73 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.345 0.409 0 C-N-CA 123.725 0.81 . . . . 0.0 111.015 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 19.3 tp . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 121.549 0.69 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 43.0 m -106.98 178.8 4.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.613 1.196 . . . . 0.0 111.659 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -126.91 147.88 50.06 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.214 -0.929 . . . . 0.0 111.148 -171.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 296' ' ' LEU . 32.1 m-85 -117.23 156.6 27.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.682 1.229 . . . . 0.0 110.196 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -151.5 173.85 14.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.486 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -153.69 165.66 35.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.661 0.664 . . . . 0.0 110.717 170.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -128.59 57.33 1.6 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.1 0.56 . . . . 0.0 111.663 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -12.61 1.03 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.207 2.203 . . . . 0.0 113.899 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.8 p -89.18 138.64 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.156 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.3 t -160.11 -30.29 0.06 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-N 119.308 0.958 . . . . 0.0 112.606 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -143.64 -30.29 0.5 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.934 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -86.33 -34.52 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.481 1.037 . . . . 0.0 111.26 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 mmt -147.3 166.19 27.83 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -162.82 83.43 0.51 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 125.519 1.762 . . . . 0.0 109.047 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.9 m -133.87 -63.11 0.75 Allowed 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -149.16 139.84 22.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.082 0.944 . . . . 0.0 110.797 -174.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.87 162.6 21.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.263 1.425 . . . . 0.0 112.697 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.5 p -107.6 155.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.04 156.35 19.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.409 0.283 . . . . 0.0 111.575 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.71 134.0 24.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 122.897 0.479 . . . . 0.0 112.02 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.06 132.15 9.01 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.829 0.824 . . . . 0.0 109.917 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 165.39 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.367 2.044 . . . . 0.0 110.814 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -83.92 113.56 21.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 109.639 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.498 HG11 ' H ' ' A' ' 334' ' ' ALA . 4.2 t -83.1 150.21 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 123.058 1.408 . . . . 0.0 110.299 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.34 -20.89 65.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.429 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.498 ' H ' HG11 ' A' ' 332' ' ' VAL . . . -77.54 1.83 18.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.721 1.208 . . . . 0.0 113.612 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.64 -0.74 21.72 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.699 0.681 . . . . 0.0 110.954 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.0 m -103.79 -36.37 7.86 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.614 0.766 . . . . 0.0 112.25 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -162.45 153.43 17.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.884 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -146.7 148.81 32.39 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.506 -0.746 . . . . 0.0 111.704 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.86 144.3 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.159 0.98 . . . . 0.0 111.671 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.98 -24.42 30.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.297 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 74.8 m -146.44 137.89 13.06 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 123.546 0.738 . . . . 0.0 110.6 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -88.39 -2.7 6.82 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.705 2.27 . . . . 0.0 111.892 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.7 m -83.23 -1.47 53.18 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.673 0.789 . . . . 0.0 112.373 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -131.76 174.74 9.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.917 1.342 . . . . 0.0 111.216 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -128.57 166.19 19.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.837 0.855 . . . . 0.0 112.319 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.554 HD11 ' HG1' ' A' ' 397' ' ' THR . 1.7 mm? -70.65 157.75 37.42 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.904 1.282 . . . . 0.0 110.235 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -109.24 133.68 20.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.35 -7.7 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 124.227 3.284 . . . . 0.0 112.076 -174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.0 m -142.14 2.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 350' ' ' ARG . 34.5 mmt180 -126.67 71.75 1.31 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.902 0.881 . . . . 0.0 110.518 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.0 p -143.59 164.91 29.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 27.5 m -129.12 159.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.457 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -93.04 136.35 33.38 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.588 1.18 . . . . 0.0 111.681 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.93 144.91 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 121.531 0.681 . . . . 0.0 110.311 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -161.86 -160.62 11.1 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.44 34.0 15.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.999 0.92 . . . . 0.0 112.334 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 52.8 mt -89.51 169.14 11.61 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -95.0 14.9 20.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.11 66.23 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.688 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 6.8 ptp -161.14 15.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.702 1.751 . . . . 0.0 111.0 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.56 141.65 57.78 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.575 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.04 175.82 5.47 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 124.714 1.259 . . . . 0.0 111.242 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.86 -17.33 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -75.89 -30.17 58.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -76.43 -35.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.223 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.11 -41.75 76.99 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 122.692 1.234 . . . . 0.0 109.974 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.22 -0.925 . . . . 0.0 111.395 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.72 98.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 124.029 0.831 . . . . 0.0 110.241 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.98 -46.11 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.487 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.14 -29.73 21.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.533 -0.729 . . . . 0.0 112.939 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -12.03 36.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.747 -1.221 . . . . 0.0 112.088 -175.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 220' ' ' TRP . 25.1 t70 -109.93 -23.14 11.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.664 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.18 -19.25 32.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.037 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.482 ' CB ' ' HG ' ' A' ' 403' ' ' SER . 5.4 m-85 -118.61 -22.29 7.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.318 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 75.25 -23.75 1.43 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.57 47.99 1.14 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.251 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 32.6 t -131.56 142.28 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 120.301 2.05 . . . . 0.0 113.261 -173.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.62 -24.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.424 0.63 . . . . 0.0 112.601 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.408 ' CD2' HD13 ' A' ' 346' ' ' LEU . 1.0 OUTLIER -152.17 150.95 30.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.42 23.25 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.008 1.323 . . . . 0.0 109.481 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.8 156.42 27.94 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.99 144.22 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -92.4 148.66 21.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 118.537 0.608 . . . . 0.0 110.717 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 22.8 p -126.38 169.57 12.83 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.664 -0.647 . . . . 0.0 110.849 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.47 -178.43 5.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -72.81 90.29 1.42 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.248 1.023 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 20.5 m170 65.68 28.48 11.11 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 125.102 1.361 . . . . 0.0 111.783 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -89.55 4.08 50.42 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.494 ' HB3' ' HE2' ' A' ' 237' ' ' LYS . 8.0 p90 45.23 48.14 4.64 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.51 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 88.4 Cg_endo -69.14 -70.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.336 2.024 . . . . 0.0 112.304 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.51 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 7.2 tp 40.44 26.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 127.777 2.431 . . . . 0.0 112.285 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -135.11 4.37 4.18 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 120.533 -1.354 . . . . 0.0 112.504 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.5 p -148.77 130.56 15.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.273 0.558 . . . . 0.0 110.413 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.48 16.11 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.085 -1.009 . . . . 0.0 112.271 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 15.0 ptp180 -148.83 -178.12 6.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.165 0.986 . . . . 0.0 110.384 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.38 137.67 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.554 ' HG1' HD11 ' A' ' 346' ' ' LEU . 77.1 m -105.64 120.55 41.94 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -96.36 -33.6 11.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 60.5 t30 66.05 -2.76 0.88 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.71 179.65 8.22 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 120.962 -1.086 . . . . 0.0 110.106 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -92.28 -26.08 18.3 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.59 -41.13 80.54 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 120.252 -1.53 . . . . 0.0 112.441 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.482 ' HG ' ' CB ' ' A' ' 374' ' ' PHE . 53.7 m -80.15 -10.25 59.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -76.05 -55.37 5.66 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.799 0.727 . . . . 0.0 109.619 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -23.32 60.5 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 118.615 0.643 . . . . 0.0 111.022 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -79.14 -34.86 42.88 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.768 -0.583 . . . . 0.0 111.795 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.71 70.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 119.316 0.962 . . . . 0.0 110.583 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.85 -24.75 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 118.398 0.544 . . . . 0.0 111.661 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 t -74.83 -25.9 59.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.302 1.001 . . . . 0.0 108.691 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -84.87 -51.36 6.79 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 61.64 -23.33 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.321 2.248 . . . . 0.0 116.044 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.71 144.52 15.19 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 111.065 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.74 158.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-O 122.067 0.937 . . . . 0.0 111.289 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -112.59 131.81 55.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.75 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.76 124.29 39.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -121.3 31.9 6.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.015 -1.053 . . . . 0.0 110.228 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.7 m -62.26 154.83 26.48 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.4 p -61.38 -12.06 12.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.73 7.65 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -146.44 137.13 24.08 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.374 1.07 . . . . 0.0 109.054 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.43 125.55 13.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.527 0.731 . . . . 0.0 111.382 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 18.3 tptt -167.4 -170.74 1.52 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 81.2 mttt -131.02 165.27 23.57 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.225 1.01 . . . . 0.0 108.454 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.74 158.57 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 124.422 1.076 . . . . 0.0 108.599 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -126.87 148.29 50.0 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.193 0.933 . . . . 0.0 112.643 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.84 139.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.02 125.64 5.78 Favored Pre-proline 0 C--N 1.349 0.547 0 CA-C-O 121.742 0.782 . . . . 0.0 110.245 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.39 171.54 16.74 Favored 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 111.259 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.881 177.706 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 91.7 m -69.89 151.63 45.45 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -10.26 0.18 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m 46.89 52.33 11.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.589 1.185 . . . . 0.0 111.499 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.22 -24.24 70.39 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.002 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 54.59 33.5 19.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.172 0.986 . . . . 0.0 113.416 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.429 ' C ' ' HD3' ' A' ' 226' ' ' PRO . 4.6 mm? -63.68 157.25 67.68 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 123.002 0.521 . . . . 0.0 109.986 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.29 68.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 1 C-N-CA 125.997 4.464 . . . . 0.0 114.731 176.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 224' ' ' LEU . 71.6 Cg_exo -55.72 166.37 2.88 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.535 2.824 . . . . 0.0 110.814 169.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 60.08 23.63 12.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.631 1.572 . . . . 0.0 114.461 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -78.37 7.44 6.52 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.474 0.71 . . . . 0.0 111.399 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -73.4 155.93 38.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.227 1.011 . . . . 0.0 111.569 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -143.05 18.68 1.94 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.474 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -133.9 43.56 1.03 Allowed Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 123.947 0.899 . . . . 0.0 109.493 -170.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 93.8 Cg_endo -71.93 157.2 55.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.638 2.892 . . . . 0.0 113.094 -170.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.4 mm -147.5 153.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.02 150.53 31.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.649 1.113 . . . . 0.0 109.654 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 70.4 p -155.11 6.5 0.24 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.873 1.358 . . . . 0.0 114.612 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 4.9 t -154.7 -169.29 3.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.26 1.845 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -43.23 146.07 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 112.378 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 284' ' ' LEU . 3.5 p -122.47 139.56 49.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 125.529 1.768 . . . . 0.0 109.401 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.08 138.63 31.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.821 -1.174 . . . . 0.0 108.904 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.61 126.27 41.73 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 125.053 1.47 . . . . 0.0 108.453 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.72 154.94 21.04 Favored Glycine 0 N--CA 1.449 -0.49 0 O-C-N 120.583 -1.323 . . . . 0.0 111.234 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.73 10.28 0.92 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.2 m -120.49 73.25 21.76 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 118.446 1.123 . . . . 0.0 110.301 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.41 5.15 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 109.985 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.406 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 34.7 p-90 -116.54 -10.53 11.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.18 133.07 55.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.575 -1.328 . . . . 0.0 110.258 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.669 HD11 ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -109.14 -26.04 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 124.654 1.221 . . . . 0.0 112.822 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.565 ' HG1' HG12 ' A' ' 247' ' ' ILE . 16.8 m -138.54 118.84 13.65 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.026 0.53 . . . . 0.0 111.041 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.18 -24.05 67.27 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.378 0.608 . . . . 0.0 112.534 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.1 75.87 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.849 -1.782 . . . . 0.0 111.924 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.87 -63.42 4.43 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.249 0.343 . . . . 0.0 112.576 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -68.49 -21.68 64.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.662 -1.493 . . . . 0.0 113.555 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.54 -52.13 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -71.06 -12.73 61.68 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 125.435 1.709 . . . . 0.0 110.736 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m -79.6 -22.26 43.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.522 -1.361 . . . . 0.0 112.483 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.97 26.6 4.6 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -113.67 -27.32 7.87 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 123.383 0.427 . . . . 0.0 110.845 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.27 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.566 -0.709 . . . . 0.0 110.979 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.49 17.11 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.991 -1.068 . . . . 0.0 113.064 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.21 153.82 25.19 Favored Glycine 0 C--O 1.249 1.085 0 O-C-N 121.322 -0.861 . . . . 0.0 113.074 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.9 m -76.88 28.58 0.13 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 123.86 0.864 . . . . 0.0 113.3 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -109.35 164.38 12.54 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.147 -0.971 . . . . 0.0 112.092 -173.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 p -141.68 168.46 19.72 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.44 154.01 33.55 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.544 -168.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -130.6 129.34 42.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.429 ' C ' ' H ' ' A' ' 268' ' ' GLY . 1.0 OUTLIER -134.5 50.79 5.32 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 124.532 1.145 . . . . 0.0 113.979 -176.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.19 31.48 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 125.894 4.396 . . . . 0.0 111.827 -172.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 266' ' ' TRP . . . -92.29 -43.01 4.45 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -155.94 130.93 9.25 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.436 1.494 . . . . 0.0 111.346 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -125.54 154.8 41.61 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.75 -152.22 10.25 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.66 -16.41 58.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.343 -1.313 . . . . 0.0 109.283 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -152.55 135.11 9.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 118.798 0.726 . . . . 0.0 110.8 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.99 42.06 1.27 Allowed 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.396 4.064 . . . . 0.0 113.555 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.0 13.96 23.18 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.26 -0.9 . . . . 0.0 112.95 -171.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 63.7 m -141.31 36.51 0.24 Allowed Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.899 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.23 147.44 93.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 107.933 -1.603 . . . . 0.0 107.933 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.89 -15.12 13.43 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.138 3.226 . . . . 0.0 113.529 -175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 175.75 12.8 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.286 -0.884 . . . . 0.0 110.751 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -100.24 -9.58 47.54 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.373 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -73.3 121.84 21.04 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 118.598 1.199 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.34 -174.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 O-C-N 125.626 1.829 . . . . 0.0 109.008 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -132.21 165.73 23.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -169.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.503 ' HB2' ' CG1' ' A' ' 238' ' ' VAL . 55.0 mt -117.77 148.42 42.07 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.731 171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 143.37 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -171.64 178.2 3.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -168.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.4 136.04 56.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 166.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.35 -10.65 59.65 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.53 -43.59 0.68 Allowed 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -83.93 -49.57 8.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.207 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.9 t -71.13 -26.33 62.96 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.218 0.949 . . . . 0.0 111.583 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.57 -58.52 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 O-C-N 124.216 0.948 . . . . 0.0 111.047 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.45 -23.27 65.5 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.695 1.247 . . . . 0.0 110.571 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.6 t -71.27 -45.61 62.77 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.023 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.34 -57.54 9.07 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.297 2.1 pp -80.7 -2.01 44.99 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -170.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -100.43 -6.86 24.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 121.054 1.752 . . . . 0.0 108.202 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -94.97 -23.68 17.28 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.479 1.112 . . . . 0.0 110.585 170.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 -133.11 0.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 29.8 t -129.58 164.98 22.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.073 -2.267 . . . . 0.0 110.03 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -146.38 155.78 42.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.886 0.874 . . . . 0.0 110.206 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -136.43 126.19 15.96 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.68 47.36 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.635 3.557 . . . . 0.0 105.579 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.706 0 CA-C-O 115.911 -1.995 . . . . 0.0 113.339 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 122.015 0.912 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.7 m -152.73 145.39 24.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -143.73 143.96 31.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.725 0.774 . . . . 0.0 111.349 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.53 153.96 33.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.199 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.38 158.66 43.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.457 0.571 . . . . 0.0 111.331 -172.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -156.08 171.24 20.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -128.55 51.93 1.96 Allowed 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 122.884 1.326 . . . . 0.0 108.132 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -0.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.434 -1.712 . . . . 0.0 113.388 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 23.1 t -89.49 125.91 35.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 118.918 0.781 . . . . 0.0 110.245 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 13.5 t -145.98 142.44 28.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.145 0.498 . . . . 0.0 109.936 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 49.97 24.48 1.36 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.19 1.396 . . . . 0.0 113.447 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -147.51 -41.18 0.18 Allowed 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.121 -1.612 . . . . 0.0 111.852 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.406 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 23.5 mmm -119.83 -26.88 5.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.834 1.197 . . . . 0.0 111.224 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 57.7 2.1 0.15 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.032 1.733 . . . . 0.0 113.961 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.2 m -137.98 170.35 16.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 118.117 0.417 . . . . 0.0 112.022 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 63.15 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.961 2.104 . . . . 0.0 112.556 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -91.84 161.67 14.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.117 1.767 . . . . 0.0 111.095 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.28 143.47 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -90.27 154.71 19.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.273 -0.892 . . . . 0.0 111.861 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 45.9 t -138.75 139.84 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.369 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.0 pt -147.16 117.46 4.5 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.536 0.734 . . . . 0.0 110.515 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -85.7 162.37 10.71 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.035 2.49 . . . . 0.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -79.11 121.48 25.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.99 145.42 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.049 1.34 . . . . 0.0 110.222 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -55.83 -22.86 27.23 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.9 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.32 60.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.55 -23.95 25.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.345 0.658 . . . . 0.0 111.427 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 47.3 m -69.93 -39.7 75.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -163.32 154.84 17.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.592 1.187 . . . . 0.0 110.754 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -141.69 99.57 3.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.85 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -90.47 -17.82 26.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.589 -0.694 . . . . 0.0 112.808 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.9 m -142.18 136.32 14.85 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.711 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.03 3.82 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.172 1.915 . . . . 0.0 114.119 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.8 m -109.63 12.15 24.38 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -148.62 163.31 37.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.429 1.092 . . . . 0.0 113.4 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . 0.678 ' HG3' ' H ' ' A' ' 346' ' ' LEU . 10.6 tpp85 -125.99 -175.71 3.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.869 1.268 . . . . 0.0 109.504 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.678 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.1 tp -56.55 164.89 1.27 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.927 2.091 . . . . 0.0 113.521 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -135.89 145.52 53.05 Favored Pre-proline 0 CA--C 1.514 -0.412 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.48 123.54 7.11 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.434 2.09 . . . . 0.0 112.812 -172.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 36.6 m 59.9 26.19 15.39 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.288 1.435 . . . . 0.0 113.18 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -114.41 43.01 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.172 0.589 . . . . 0.0 109.98 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 p -135.78 163.84 29.28 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 122.476 1.131 . . . . 0.0 109.424 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.79 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.505 172.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -82.32 149.26 27.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.568 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.23 136.27 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -169.91 -170.44 34.34 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.547 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.72 18.08 0.95 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.335 1.454 . . . . 0.0 113.367 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.548 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.21 176.27 9.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.113 0.965 . . . . 0.0 110.267 172.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.7 32.44 0.16 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 76.1 18.23 79.52 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 120.564 -1.335 . . . . 0.0 112.596 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 17.2 mmt -140.3 -94.32 0.15 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.175 1.488 . . . . 0.0 111.718 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.7 tp 40.53 68.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.497 0.719 . . . . 0.0 110.863 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -55.62 168.16 0.44 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.726 0.239 . . . . 0.0 111.045 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -65.29 -16.64 63.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -170.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.66 -26.63 25.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.733 -1.229 . . . . 0.0 109.256 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.85 -26.91 40.24 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.542 -0.724 . . . . 0.0 110.317 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.7 -51.72 25.73 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.42 67.23 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.822 -0.549 . . . . 0.0 110.885 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.24 73.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.707 0.23 . . . . 0.0 111.298 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.8 mt -66.46 -42.6 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 119.03 -0.509 . . . . 0.0 109.836 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.24 -34.89 18.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -22.87 44.51 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.4 -1.438 . . . . 0.0 111.554 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -87.66 -27.34 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.614 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.15 -18.87 26.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.543 ' CZ ' ' HA3' ' A' ' 376' ' ' GLY . 4.1 t80 -136.16 -61.45 0.7 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.843 174.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 100.59 -16.07 58.05 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . 0.543 ' HA3' ' CZ ' ' A' ' 374' ' ' PHE . . . -85.38 59.52 4.82 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 118.089 0.944 . . . . 0.0 112.514 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.67 164.58 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 118.071 -1.452 . . . . 0.0 112.478 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.69 -40.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -150.79 148.0 27.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.163 0.506 . . . . 0.0 109.852 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.75 153.11 50.94 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.77 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.74 155.43 26.75 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 118.645 0.657 . . . . 0.0 112.501 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.11 147.19 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.5 126.48 29.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.584 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.6 p -138.99 157.49 45.9 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.962 0.789 . . . . 0.0 108.976 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -145.16 166.44 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.705 1.202 . . . . 0.0 108.755 173.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -53.05 102.32 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.443 -0.786 . . . . 0.0 111.784 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 65.8 m170 60.72 30.01 19.4 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -94.5 -8.2 39.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.577 -0.702 . . . . 0.0 110.759 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 15.6 p90 37.82 52.2 2.83 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 127.173 2.189 . . . . 0.0 113.213 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.77 -55.71 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.815 1.677 . . . . 0.0 112.585 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 10.2 tp 37.28 34.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 124.286 1.035 . . . . 0.0 112.504 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -136.5 5.32 3.79 Favored Glycine 0 N--CA 1.442 -0.958 0 O-C-N 124.104 0.878 . . . . 0.0 114.336 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.5 m -151.57 144.06 24.19 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.16 -172.87 36.32 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 170.34 22.44 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 124.233 0.608 . . . . 0.0 109.894 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.29 135.79 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 22.1 m -103.72 144.58 31.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.089 0.868 . . . . 0.0 111.37 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.43 179.55 6.14 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.342 1.057 . . . . 0.0 111.762 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.36 16.57 2.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.09 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -136.63 157.85 45.82 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -70.67 -26.42 63.43 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.001 0.92 . . . . 0.0 112.181 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . 79.8 mmt-85 -52.92 -31.7 41.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.35 1.06 . . . . 0.0 111.818 -171.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.4 p -80.88 -34.66 33.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.663 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -62.17 -52.29 64.39 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 117.919 0.327 . . . . 0.0 110.499 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . 0.299 0.0 OUTLIER -78.38 -19.19 53.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -85.67 -30.07 23.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 120.466 1.484 . . . . 0.0 110.69 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.3 -29.19 47.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.335 0.97 . . . . 0.0 109.423 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.17 -33.24 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 O-C-N 121.555 -0.716 . . . . 0.0 112.723 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.5 t -82.22 -11.92 58.39 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -83.79 -50.66 7.9 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.35 -50.5 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 16.4 t80 -154.61 132.8 11.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.41 160.2 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.548 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 20.3 mt-10 -111.5 99.42 8.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.74 140.67 17.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.825 0.821 . . . . 0.0 108.932 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -132.61 40.95 3.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.996 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.2 p -71.43 170.24 13.65 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.322 1.014 . . . . 0.0 108.908 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 t -79.24 -3.42 45.78 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.23 -0.919 . . . . 0.0 112.922 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 226' ' ' PRO . 67.5 mttm -93.51 -41.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.028 -0.42 . . . . 0.0 110.474 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -157.86 166.14 33.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.982 0.801 . . . . 0.0 111.071 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.5 p -127.53 104.34 7.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.296 1.838 . . . . 0.0 107.539 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -159.36 170.5 21.67 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.798 -0.564 . . . . 0.0 110.631 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.548 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 90.6 mttt -108.75 164.19 12.59 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.277 1.037 . . . . 0.0 112.139 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.46 153.9 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.347 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -119.7 156.45 30.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.135 0.897 . . . . 0.0 109.879 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.92 138.67 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 13.4 m-20 -135.75 156.1 77.63 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.165 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 37.3 Cg_exo -65.8 165.6 22.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.561 2.174 . . . . 0.0 113.922 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 116.029 -1.938 . . . . 0.0 110.896 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.6 m 49.05 42.62 21.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.193 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.47 -8.47 59.56 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.145 1.378 . . . . 0.0 112.544 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.6 t 42.6 74.41 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.355 1.862 . . . . 0.0 111.693 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.88 -23.18 78.36 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 122.03 -0.419 . . . . 0.0 112.496 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 54.99 24.74 6.19 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.469 ' O ' ' HD3' ' A' ' 226' ' ' PRO . 4.4 mm? -62.45 141.67 96.51 Favored Pre-proline 0 C--N 1.342 0.247 0 CA-C-N 119.181 0.9 . . . . 0.0 110.489 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.7 100.73 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.618 2.212 . . . . 0.0 110.129 171.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 224' ' ' LEU . 51.0 Cg_endo -80.77 14.61 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.682 3.588 . . . . 0.0 113.077 -175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -133.79 26.72 3.99 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 121.05 -1.031 . . . . 0.0 113.684 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -125.3 39.15 4.03 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.978 0.511 . . . . 0.0 110.663 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -72.05 154.9 40.85 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.641 0.734 . . . . 0.0 110.468 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -131.65 29.4 4.5 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.771 1.228 . . . . 0.0 112.56 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.95 47.44 0.58 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.203 0.601 . . . . 0.0 110.973 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.84 138.38 31.41 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.482 2.121 . . . . 0.0 112.759 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.4 mt -150.62 144.31 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 105.352 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -96.91 148.63 22.75 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 111.513 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.0 m -141.25 -16.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.609 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 63.9 m -143.67 -174.92 4.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.483 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.453 ' HE2' ' CD1' ' A' ' 283' ' ' TYR . 58.1 mtpt -43.22 153.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.336 1.065 . . . . 0.0 112.662 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.14 133.76 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.84 145.45 31.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.83 1.3 . . . . 0.0 110.727 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -135.23 116.7 14.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.218 -171.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 178.31 -179.6 48.53 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.17 22.19 0.92 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 28.1 m -91.09 128.55 47.15 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.801 0.841 . . . . 0.0 112.989 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.84 -15.56 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.944 2.429 . . . . 0.0 113.655 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.454 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 8.1 p-90 -140.58 0.24 1.62 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.98 1.263 . . . . 0.0 113.985 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.409 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 3.8 t0 -66.43 122.79 18.32 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.856 1.662 . . . . 0.0 115.426 -170.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.437 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -87.87 -0.86 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -173.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.7 p -158.68 167.71 28.82 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 122.455 1.121 . . . . 0.0 108.488 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -15.6 14.56 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.056 174.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -76.78 -31.38 56.98 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 121.088 0.471 . . . . 0.0 111.246 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.37 -52.6 45.53 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 120.658 -1.277 . . . . 0.0 113.787 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.544 HD21 ' H ' ' A' ' 252' ' ' LEU . 1.7 pt? -71.78 -32.49 67.71 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.514 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.48 -36.16 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.385 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -74.28 -17.77 60.81 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.809 0.693 . . . . 0.0 110.381 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.0 m -80.55 -26.99 37.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 111.807 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -129.34 19.07 5.85 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -101.73 -0.77 33.89 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.045 -1.034 . . . . 0.0 111.767 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.47 -21.14 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -127.61 3.24 6.15 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.27 1.028 . . . . 0.0 108.805 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -104.52 173.6 21.27 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 121.699 0.61 . . . . 0.0 112.836 -171.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' SER . . . . . 0.652 ' H ' ' CD1' ' A' ' 295' ' ' LEU . 61.2 m -135.54 77.0 1.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.56 167.96 22.44 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.702 1.201 . . . . 0.0 111.725 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -148.56 169.54 20.09 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.44 137.91 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -145.83 136.17 23.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -166.22 154.18 9.52 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.67 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.43 161.27 28.58 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.076 3.184 . . . . 0.0 110.987 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 83.03 3.66 90.33 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -75.84 -19.13 59.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.823 0.849 . . . . 0.0 110.572 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.24 142.24 58.49 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.14 -167.61 34.54 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.423 1.011 . . . . 0.0 111.738 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -80.07 170.34 16.59 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.198 0.599 . . . . 0.0 111.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 30.8 m80 53.03 99.35 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 125.364 1.466 . . . . 0.0 112.019 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -58.01 -3.53 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 1 C-N-CA 125.522 4.148 . . . . 0.0 115.816 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -99.36 9.99 42.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.223 1.809 . . . . 0.0 111.863 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 40.7 t -53.43 -45.26 98.59 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.53 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.38 148.85 49.55 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.911 1.741 . . . . 0.0 111.405 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.63 1.17 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.521 2.814 . . . . 0.0 111.501 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.41 143.97 36.31 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 118.933 0.788 . . . . 0.0 109.93 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.42 22.05 42.88 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.429 0.537 . . . . 0.0 113.014 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.424 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 37.5 p90 -152.95 164.58 37.68 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.71 -178.49 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 55.0 m-85 -110.91 157.27 20.05 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.208 0.913 . . . . 0.0 111.223 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 83.4 mt -126.13 136.0 52.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.671 1.188 . . . . 0.0 111.529 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.86 137.18 14.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.675 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 84.9 t80 -175.62 -76.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.614 0.366 . . . . 0.0 110.317 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -93.8 -36.8 12.09 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.675 ' CD2' ' H ' ' A' ' 286' ' ' PHE . 4.4 mm? 60.81 -3.39 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -136.12 -75.3 0.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 122.196 2.271 . . . . 0.0 112.643 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -84.28 -33.89 23.89 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' SER . . . . . 0.491 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 44.8 m -82.61 -45.34 14.68 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 116.509 -1.71 . . . . 0.0 108.527 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.16 -36.81 16.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-N 121.506 1.957 . . . . 0.0 107.878 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 30.3 ttt-85 -62.55 -45.48 92.75 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.875 0.845 . . . . 0.0 110.806 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -70.81 -35.3 72.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 118.15 -0.928 . . . . 0.0 113.148 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.652 ' CD1' ' H ' ' A' ' 261' ' ' SER . 55.6 mt -66.5 -47.09 74.08 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -7.0 59.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.523 -1.36 . . . . 0.0 111.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -97.47 -3.81 39.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.473 1.033 . . . . 0.0 111.709 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -105.49 -18.55 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.0 m -81.89 -158.3 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 61.4 m -84.44 146.05 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.013 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -137.34 149.53 47.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.052 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -137.93 127.3 14.92 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 122.049 -0.407 . . . . 0.0 110.703 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -82.87 35.55 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.754 4.303 . . . . 0.0 109.566 169.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 309' ' ' LEU . 1.4 pt? . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 171.59 10.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.851 0.86 . . . . 0.0 109.342 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.62 154.53 50.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -113.07 148.63 34.82 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.15 162.42 39.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -163.4 176.01 10.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.9 ptpt -135.4 132.47 37.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.49 9.47 3.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -165.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.0 t -66.13 150.98 47.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 11.0 m -85.36 15.36 4.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.556 0.743 . . . . 0.0 110.133 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.57 24.74 3.23 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.479 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -75.01 -23.44 58.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.848 0.749 . . . . 0.0 112.308 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.454 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 21.8 ptt? -148.76 -26.83 0.31 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 171.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -152.53 168.18 26.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.105 0.562 . . . . 0.0 110.642 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 74.1 m -118.22 134.63 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.818 1.247 . . . . 0.0 107.722 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 17.0 tppt? -152.93 129.68 10.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 122.542 1.163 . . . . 0.0 114.029 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.91 137.57 36.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.01 1.724 . . . . 0.0 111.972 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.89 157.58 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -107.46 154.72 20.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.117 0.261 . . . . 0.0 110.62 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.58 136.5 46.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.276 0.56 . . . . 0.0 111.788 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 73.0 mt -142.17 109.4 5.86 Favored Pre-proline 0 C--O 1.232 0.165 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 164.96 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.089 1 C-N-CA 125.337 4.025 . . . . 0.0 112.085 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.609 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 1.7 t90 -83.66 133.3 34.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 334' ' ' ALA . 3.3 t -110.46 152.33 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 123.605 0.762 . . . . 0.0 110.251 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.8 tt -54.46 -27.1 35.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.406 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -70.28 4.11 2.46 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.694 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.94 7.41 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.035 0.934 . . . . 0.0 109.567 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.3 m -129.24 -22.0 3.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 150.72 34.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.71 132.6 15.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.362 -1.745 . . . . 0.0 107.928 170.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 341' ' ' SER . 12.2 p -141.96 146.23 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.187 0.994 . . . . 0.0 111.816 177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -103.32 -15.72 15.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.575 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 339' ' ' VAL . 42.3 t -94.52 140.22 22.6 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.426 1.09 . . . . 0.0 110.444 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.4 16.2 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.204 3.269 . . . . 0.0 110.427 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 15.6 t -122.74 161.27 24.24 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.813 -1.179 . . . . 0.0 110.447 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . 0.41 ' CD ' ' H ' ' A' ' 344' ' ' GLN . 5.0 pm0 -79.8 22.47 0.48 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 122.33 1.062 . . . . 0.0 113.43 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -65.59 155.26 36.35 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.59 1.156 . . . . 0.0 109.342 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 22.4 tp -154.92 155.43 34.26 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.059 0.391 . . . . 0.0 111.222 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 397' ' ' THR . 42.4 t0 -136.58 73.35 55.37 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.016 0.926 . . . . 0.0 110.065 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.71 5.08 4.57 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.079 2.519 . . . . 0.0 111.946 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.5 t -78.29 -13.42 59.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.847 -1.158 . . . . 0.0 111.602 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -147.26 85.74 1.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.477 HG23 ' HG1' ' A' ' 397' ' ' THR . 17.8 p -133.8 154.0 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.049 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.02 158.76 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 119.086 0.857 . . . . 0.0 110.045 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -95.19 146.46 24.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 123.837 0.711 . . . . 0.0 111.352 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.22 140.4 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.12 -178.41 32.13 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.41 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.26 47.26 21.94 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 124.469 1.107 . . . . 0.0 110.595 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 36.5 mt -84.67 -174.83 5.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -25.35 67.52 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.764 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 78.22 5.54 87.39 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 120.364 -1.46 . . . . 0.0 109.939 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.5 ttt -152.93 29.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.11 95.43 0.73 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.849 1.309 . . . . 0.0 110.464 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -81.12 162.23 23.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.18 -7.75 50.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.134 -171.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -90.12 -26.59 20.13 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.97 -29.63 24.92 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.08 -49.1 63.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.201 0.6 . . . . 0.0 109.458 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.96 -31.38 71.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.264 -0.273 . . . . 0.0 111.538 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.4 87.1 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.2 mt -65.46 -45.02 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.2 mt -85.57 -29.76 23.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -21.56 30.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.778 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -107.71 -20.47 13.21 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.54 -14.96 23.19 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.399 -1.438 . . . . 0.0 110.521 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.05 -41.64 2.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 112.812 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 73.38 -1.6 42.18 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . 0.412 ' C ' HD22 ' A' ' 400' ' ' ASN . . . -143.65 117.61 1.1 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.107 0.953 . . . . 0.0 111.03 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 11.9 t -152.44 168.58 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.25 -29.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -159.75 158.56 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -165.94 146.66 6.68 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -159.46 151.97 22.86 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 121.42 0.456 . . . . 0.0 114.054 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.32 150.33 4.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -97.39 74.75 2.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.9 p -61.23 146.37 48.03 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.62 17.48 14.42 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.733 1.213 . . . . 0.0 111.705 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.0 tptm 51.53 124.31 0.0 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 128.022 2.529 . . . . 0.0 114.878 -170.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 58.2 m170 61.13 27.79 17.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -133.47 -0.91 3.19 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 6.1 p90 25.98 66.97 0.47 Allowed Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.033 1.333 . . . . 0.0 112.282 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.53 -49.84 0.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 124.262 3.308 . . . . 0.0 110.783 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.91 35.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 111.635 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.34 15.6 1.29 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.131 0.872 . . . . 0.0 114.659 -172.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 77.3 p -163.45 145.45 9.69 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.355 0.662 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.79 -161.95 28.71 Favored Glycine 0 N--CA 1.427 -1.907 0 O-C-N 120.685 -1.259 . . . . 0.0 112.725 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.54 166.88 25.15 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.719 -0.871 . . . . 0.0 111.946 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 144.07 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.662 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.477 ' HG1' HG23 ' A' ' 351' ' ' THR . 44.3 m -116.72 131.64 56.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 123.533 0.521 . . . . 0.0 110.693 -172.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -118.99 155.75 30.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.515 1.135 . . . . 0.0 111.909 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.11 7.01 10.77 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.412 HD22 ' C ' ' A' ' 376' ' ' GLY . 12.0 p30 -136.89 166.61 23.21 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.041 1.337 . . . . 0.0 109.648 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -98.08 -28.34 13.8 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -62.9 -26.1 68.64 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.878 0.763 . . . . 0.0 112.987 -175.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 71.7 p -73.45 -33.04 64.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -68.62 -55.13 12.56 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 119.237 0.926 . . . . 0.0 110.645 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -24.02 58.46 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.136 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -78.4 -23.2 46.87 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 118.238 -1.385 . . . . 0.0 111.221 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.91 -26.2 36.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.247 -0.908 . . . . 0.0 111.497 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.85 -27.95 5.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.059 0.457 . . . . 0.0 111.049 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.6 p -83.39 -18.86 37.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.744 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -90.69 -45.69 8.71 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.033 0.444 . . . . 0.0 110.456 171.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.91 -10.39 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.855 2.062 . . . . 0.0 114.31 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.536 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -161.07 144.65 13.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.32 156.31 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 O-C-N 120.868 -1.145 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 414' ' ' GLU . 17.1 mp0 -120.18 137.94 53.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.594 0.711 . . . . 0.0 112.396 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.45 124.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 46.91 1.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.247 1.022 . . . . 0.0 111.786 -175.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.9 p -66.47 169.7 7.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.67 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.8 t -69.78 1.53 4.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.305 0.642 . . . . 0.0 110.749 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.42 ' HZ1' ' HB3' ' A' ' 419' ' ' LYS . 0.7 OUTLIER -150.45 0.88 0.44 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -171.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -154.37 139.35 17.29 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.419 -0.801 . . . . 0.0 112.512 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 50.6 p -139.08 124.05 18.83 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.205 -0.934 . . . . 0.0 110.766 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.603 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 0.8 OUTLIER -168.82 -179.33 3.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.429 176.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.603 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 55.6 mtmt -140.99 172.15 13.08 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.18 152.32 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 124.346 1.028 . . . . 0.0 109.353 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -117.09 152.16 35.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 111.623 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.92 141.79 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.288 0.566 . . . . 0.0 111.61 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.92 124.85 8.64 Favored Pre-proline 0 C--O 1.246 0.874 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.85 158.47 18.53 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 124.082 3.188 . . . . 0.0 114.001 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 C--O 1.263 1.775 0 CA-C-O 117.285 -1.34 . . . . 0.0 111.115 171.329 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' MET . . . . . 0.485 ' HE3' ' HE3' ' A' ' 406' ' ' LYS . 11.0 tpt . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.355 0.598 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.2 t -167.06 173.28 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.37 7.37 7.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.8 m 46.56 37.75 4.81 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.356 -0.84 . . . . 0.0 112.464 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -168.96 77.92 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.244 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 164.92 25.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.939 0.435 . . . . 0.0 110.839 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.93 152.85 77.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.28 114.45 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.915 2.41 . . . . 0.0 112.314 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -82.12 -165.07 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.413 4.075 . . . . 0.0 111.43 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 58.51 32.67 22.38 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.797 0.439 . . . . 0.0 111.801 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -99.48 -1.06 39.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -74.12 153.55 39.52 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.854 0.861 . . . . 0.0 110.446 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -148.84 25.39 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.264 1.026 . . . . 0.0 110.809 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -131.99 62.2 62.43 Favored Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 120.632 -1.293 . . . . 0.0 112.084 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -68.91 117.46 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.328 3.352 . . . . 0.0 112.928 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.1 mm -140.82 151.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -109.38 141.25 42.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.925 1.239 . . . . 0.0 110.643 -173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.5 t -133.48 3.65 3.61 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.397 0.544 . . . . 0.0 112.449 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 3.6 t -153.21 177.6 10.66 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.053 0.541 . . . . 0.0 110.257 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.87 166.32 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.062 1.345 . . . . 0.0 113.924 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.01 138.14 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.89 133.01 33.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 23.0 tp -139.5 112.72 8.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.145 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.86 155.81 26.47 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.114 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.74 13.73 1.39 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 124.153 0.56 . . . . 0.0 113.081 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.17 117.14 58.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.674 -0.898 . . . . 0.0 111.826 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.7 -4.4 8.2 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.754 2.969 . . . . 0.0 113.368 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -105.71 -109.57 0.29 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.26 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 38.7 t70 43.87 74.8 0.11 Allowed 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 119.859 1.209 . . . . 0.0 111.372 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -10.37 11.73 Favored 'Isoleucine or valine' 0 C--O 1.273 2.291 0 CA-C-N 118.551 0.614 . . . . 0.0 110.692 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.4 p -146.18 129.03 16.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.3 -22.11 66.67 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.648 0.737 . . . . 0.0 109.917 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -74.14 -21.92 59.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.298 -1.501 . . . . 0.0 110.9 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.69 -57.3 5.48 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.47 -42.69 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.079 0.952 . . . . 0.0 112.52 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.1 t -73.51 -32.83 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.474 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.62 -20.16 57.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.693 0.679 . . . . 0.0 111.294 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -73.1 -30.03 63.36 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.905 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -129.88 16.87 5.73 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -89.63 -21.83 22.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 120.018 1.281 . . . . 0.0 112.181 171.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.18 24.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -143.29 7.88 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.782 0.719 . . . . 0.0 112.659 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -167.44 169.98 41.39 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-O 121.935 0.742 . . . . 0.0 113.04 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.9 t -82.31 77.92 9.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.385 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.502 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.05 166.85 24.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 52.7 m -147.88 -175.08 4.74 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.898 1.333 . . . . 0.0 110.836 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.67 154.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 123.813 0.845 . . . . 0.0 111.689 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -142.29 131.69 23.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 124.951 1.407 . . . . 0.0 110.929 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -93.07 133.67 28.42 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.578 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -76.71 -23.19 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 O-C-N 123.962 1.506 . . . . 0.0 112.189 172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.06 -66.99 1.57 Allowed Glycine 0 C--O 1.218 -0.866 0 C-N-CA 123.074 0.368 . . . . 0.0 112.379 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? 48.39 49.09 18.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.954 0.502 . . . . 0.0 110.253 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.87 35.31 3.95 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.259 1.824 . . . . 0.0 114.453 -170.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.88 163.06 35.1 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.521 0.512 . . . . 0.0 111.951 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -92.17 169.13 10.86 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 122.467 -0.431 . . . . 0.0 110.505 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.404 ' HB3' ' CD ' ' A' ' 274' ' ' PRO . 14.0 m80 60.67 173.33 0.06 OUTLIER Pre-proline 0 C--O 1.219 -0.525 0 C-N-CA 125.766 1.626 . . . . 0.0 112.846 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.404 ' CD ' ' HB3' ' A' ' 273' ' ' HIS . 32.4 Cg_exo -60.59 40.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 1 C-N-CA 126.723 4.948 . . . . 0.0 114.687 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -147.7 41.47 1.03 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.842 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.51 129.3 25.92 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.976 0.51 . . . . 0.0 109.671 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.42 134.04 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.456 1.438 . . . . 0.0 111.146 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.14 158.7 5.73 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 124.277 3.318 . . . . 0.0 109.545 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -100.95 12.87 36.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 0.0 108.858 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 112.95 -9.76 25.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -171.64 169.15 6.1 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.855 0.827 . . . . 0.0 110.606 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.79 -174.09 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.104 1.762 . . . . 0.0 108.978 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -123.08 153.39 39.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 111.466 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.76 139.06 42.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.728 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.9 131.25 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 35.6 p90 -167.35 -151.15 0.11 Allowed 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 123.509 0.505 . . . . 0.0 110.378 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.34 -8.53 0.78 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 90.8 mt 50.75 -163.58 0.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 111.461 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.9 -78.59 0.0 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.276 2.63 . . . . 0.0 114.952 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -84.18 -32.8 24.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.741 1.275 . . . . 0.0 111.213 -172.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 75.6 m -85.23 -15.69 42.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.643 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.32 -51.48 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -66.53 -26.4 67.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.2 t -65.19 -46.45 80.69 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 118.537 0.608 . . . . 0.0 110.786 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.39 -44.16 83.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 119.805 -1.809 . . . . 0.0 110.351 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.56 -26.96 67.37 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 124.341 1.025 . . . . 0.0 109.441 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -92.96 -10.0 37.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 120.14 1.336 . . . . 0.0 111.389 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -102.91 -19.78 14.51 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.08 178.39 7.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.013 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.2 t -77.91 163.81 25.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.369 1.668 . . . . 0.0 111.544 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -151.2 160.23 43.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.679 1.192 . . . . 0.0 111.079 -175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.18 124.76 7.67 Favored Pre-proline 0 CA--C 1.517 -0.312 0 O-C-N 121.473 -0.767 . . . . 0.0 110.02 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.43 51.29 3.24 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 124.556 3.504 . . . . 0.0 108.324 169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.441 ' H ' ' CD1' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 310' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 122.236 1.017 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.515 ' H ' HD11 ' A' ' 309' ' ' LEU . 32.3 m -143.35 149.36 37.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.747 1.619 . . . . 0.0 109.304 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -132.71 136.32 46.33 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 122.223 -0.298 . . . . 0.0 110.768 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -118.44 159.16 23.97 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -153.35 159.37 42.45 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 122.077 -0.389 . . . . 0.0 111.978 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -145.25 159.43 43.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.706 -0.621 . . . . 0.0 111.007 172.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -110.35 118.53 36.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.421 ' H ' ' HE1' ' A' ' 316' ' ' MET . 0.1 OUTLIER -90.25 21.23 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.63 0.195 . . . . 0.0 111.429 -169.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.5 t -137.11 162.67 32.76 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.185 -0.947 . . . . 0.0 111.122 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 32.4 p -145.3 -10.95 0.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.875 0.87 . . . . 0.0 111.112 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 4.59 0.13 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -107.81 -38.92 5.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.877 -1.139 . . . . 0.0 110.576 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 15.8 mmt -133.91 -31.96 1.13 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.513 0.725 . . . . 0.0 109.205 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 46.12 27.48 0.54 Allowed 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.541 0.686 . . . . 0.0 110.92 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.5 -173.68 4.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER 57.5 68.8 0.8 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.743 1.217 . . . . 0.0 114.001 176.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . 0.592 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 3.6 mp0 -46.7 156.73 0.18 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.327 173.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.4 142.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -86.53 137.46 32.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.829 0.74 . . . . 0.0 110.086 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.57 137.05 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 123.936 0.772 . . . . 0.0 111.924 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.8 pt -156.76 130.76 4.84 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.67 168.6 8.29 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.544 4.162 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -82.14 124.17 29.63 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 169.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 334' ' ' ALA . 21.3 t -100.76 137.31 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.85 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.69 -35.12 60.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.933 1.293 . . . . 0.0 110.994 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.46 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -79.82 11.44 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 118.392 -0.814 . . . . 0.0 112.807 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.11 6.28 10.79 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.671 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.1 p -139.45 -2.45 1.6 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -147.91 153.58 39.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -155.02 139.1 16.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.77 0.828 . . . . 0.0 111.82 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.93 155.5 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 118.867 0.758 . . . . 0.0 111.593 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -102.68 -6.86 22.24 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 108.789 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 342' ' ' PRO . 60.6 m -131.2 166.15 29.92 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 123.703 0.801 . . . . 0.0 112.818 -171.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 57.2 Cg_endo -66.15 -9.06 22.15 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.354 2.036 . . . . 0.0 112.169 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 58.4 p -85.14 168.94 14.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.897 0.879 . . . . 0.0 109.911 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -136.32 24.22 3.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.164 0.507 . . . . 0.0 110.938 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -112.57 164.45 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.016 0.927 . . . . 0.0 111.691 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.84 -171.58 1.87 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.426 1.49 . . . . 0.0 110.499 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.86 93.3 31.61 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.919 1.288 . . . . 0.0 107.923 171.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.71 -0.22 0.36 Allowed 'Trans proline' 0 C--O 1.24 0.579 1 C-N-CA 126.063 4.508 . . . . 0.0 115.933 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.7 m -117.66 3.93 12.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.18 0.592 . . . . 0.0 111.653 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -141.71 55.64 1.5 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.945 0.793 . . . . 0.0 109.981 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.5 t -143.34 154.02 43.32 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.88 159.89 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 124.18 0.925 . . . . 0.0 110.432 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -84.92 138.65 32.38 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.296 0.998 . . . . 0.0 113.306 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.48 149.04 24.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.095 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 178.15 -168.05 39.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.97 22.99 2.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.209 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.13 137.43 32.37 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.659 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 29.02 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.885 1.274 . . . . 0.0 112.98 169.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.64 -12.65 0.05 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-O 118.132 -1.371 . . . . 0.0 111.008 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.7 mmt -133.93 -52.41 0.85 Allowed 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 125.232 1.195 . . . . 0.0 108.389 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.0 tp 27.67 77.56 0.02 OUTLIER 'General case' 0 C--N 1.347 0.468 0 O-C-N 124.585 1.178 . . . . 0.0 111.992 -171.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -61.64 164.25 6.23 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 123.972 0.909 . . . . 0.0 111.761 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.74 -22.7 62.43 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -83.2 -32.54 26.5 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 119.508 1.049 . . . . 0.0 110.086 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -73.82 -40.78 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 122.117 -0.365 . . . . 0.0 110.135 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.09 -46.76 82.84 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.34 65.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.712 -1.242 . . . . 0.0 111.58 -173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.05 80.35 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.403 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 89.3 mt -71.66 -41.42 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 -16.31 49.71 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.35 -1.309 . . . . 0.0 114.2 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -16.55 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 120.316 1.417 . . . . 0.0 114.367 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.45 -20.62 13.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.105 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.77 -14.36 18.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.572 1.078 . . . . 0.0 111.091 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -117.3 -64.64 1.28 Allowed 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.206 -0.934 . . . . 0.0 110.766 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 161.73 -151.23 21.31 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.324 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -66.08 130.13 32.59 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 126.248 1.88 . . . . 0.0 110.376 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.23 164.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 126.177 1.791 . . . . 0.0 107.844 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.65 -28.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.444 0.565 . . . . 0.0 112.111 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.3 OUTLIER -157.32 156.78 32.96 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -149.67 143.03 25.22 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -154.24 171.85 32.81 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 122.09 0.828 . . . . 0.0 114.181 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.428 ' HA ' ' HA3' ' A' ' 394' ' ' GLY . 26.7 mt -127.39 144.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 128.635 2.774 . . . . 0.0 108.478 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.86 149.01 24.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.337 -0.852 . . . . 0.0 111.882 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.2 p -108.91 161.41 15.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.192 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -130.02 34.56 4.23 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.519 1.152 . . . . 0.0 111.973 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 tptm 61.99 95.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.454 1.902 . . . . 0.0 111.397 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 m170 48.48 28.04 1.6 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -104.12 11.73 34.79 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.522 1.056 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 52.4 p90 44.82 49.25 5.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 126.576 1.951 . . . . 0.0 114.144 173.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.62 -52.62 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 119.338 0.799 . . . . 0.0 112.082 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 10.6 tp 37.62 47.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 123.57 0.748 . . . . 0.0 109.826 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -158.86 6.71 0.15 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.9 p -153.8 138.61 17.09 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 382' ' ' ILE . . . -169.15 -149.17 6.1 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -154.94 172.85 17.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.974 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.2 132.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 52.2 m -101.59 110.68 22.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.848 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.1 157.17 16.01 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.708 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.76 -0.06 6.06 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.965 0.791 . . . . 0.0 109.604 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -120.82 135.86 55.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.058 1.343 . . . . 0.0 108.126 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.01 -25.69 67.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.662 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.94 -31.33 72.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.01 0.823 . . . . 0.0 110.965 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 m -80.43 -12.27 59.58 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.869 -1.144 . . . . 0.0 111.257 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.37 -60.72 2.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.536 -0.727 . . . . 0.0 109.174 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.65 63.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.495 -176.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . 0.485 ' HE3' ' HE3' ' A' ' 218' ' ' MET . 51.5 tptt -81.25 -26.32 35.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.965 0.802 . . . . 0.0 111.457 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.27 -31.03 60.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.373 -0.829 . . . . 0.0 111.036 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.31 -26.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.963 0.905 . . . . 0.0 111.223 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.2 p -84.27 -26.09 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.28 -40.82 10.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.517 0.327 . . . . 0.0 110.273 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.2 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.73 141.16 10.0 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 120.297 1.408 . . . . 0.0 108.89 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -141.38 159.3 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.548 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -113.64 110.15 19.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.172 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.1 mm -77.2 129.58 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 173.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 30.3 ttmt -153.99 98.12 2.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.302 0.572 . . . . 0.0 109.487 -170.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.9 m -143.79 179.65 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.0 m -78.52 2.11 20.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.9 -0.5 . . . . 0.0 110.781 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -129.98 -8.45 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.63 131.93 11.13 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.416 -0.802 . . . . 0.0 111.395 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 7.1 p -143.64 86.81 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.829 0.741 . . . . 0.0 110.871 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -150.55 172.32 15.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.95 0.9 . . . . 0.0 109.951 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -128.56 167.72 16.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.695 0.398 . . . . 0.0 111.17 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.93 145.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 CA-C-N 118.748 0.704 . . . . 0.0 109.296 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -122.69 150.2 43.04 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.026 0.917 . . . . 0.0 112.702 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.2 145.96 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.226 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -150.74 128.38 5.68 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -83.66 166.83 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 2.78 . . . . 0.0 111.538 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.359 1.064 . . . . 0.0 111.057 176.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 C--O 1.218 -0.603 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.9 m 57.65 164.77 0.03 OUTLIER 'General case' 0 C--O 1.246 0.888 0 CA-C-O 122.68 1.229 . . . . 0.0 110.407 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -157.59 -40.58 0.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.887 -1.133 . . . . 0.0 112.143 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.438 ' HA ' ' H ' ' A' ' 416' ' ' LYS . 13.5 m 47.81 22.89 0.39 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 170.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 57.41 69.25 1.33 Allowed Glycine 0 N--CA 1.447 -0.613 0 O-C-N 120.845 -1.159 . . . . 0.0 112.803 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -71.8 -21.58 61.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.794 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.48 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 1.0 OUTLIER -155.55 9.15 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -176.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.48 ' CD ' ' H ' ' A' ' 224' ' ' LEU . 42.6 Cg_endo -64.61 119.49 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 122.331 1.868 . . . . 0.0 111.605 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.2 142.28 41.35 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 124.4 3.4 . . . . 0.0 111.254 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -138.32 170.19 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.171 0.989 . . . . 0.0 110.772 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.35 38.11 29.44 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.816 0.817 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -54.58 30.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.989 1.316 . . . . 0.0 110.41 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 71.0 tttt 55.25 45.33 25.97 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -114.56 -46.91 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.11 -174.25 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.442 1 C-N-CA 125.304 4.002 . . . . 0.0 114.649 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.5 HG23 ' H ' ' A' ' 234' ' ' TYR . 4.2 mp -109.2 -179.09 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.5 ' H ' HG23 ' A' ' 233' ' ' ILE . 30.9 m-85 -93.74 158.25 15.76 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 51.0 m -145.08 -0.78 0.87 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.72 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.602 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 12.0 m -149.46 -164.55 2.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.875 1.216 . . . . 0.0 110.996 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 172.09 0.82 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.503 1.144 . . . . 0.0 111.542 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.29 138.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.413 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -81.64 143.4 31.95 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 122.162 0.982 . . . . 0.0 109.444 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.412 ' CD1' ' C ' ' A' ' 240' ' ' LEU . 1.0 OUTLIER -141.02 108.22 5.49 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.65 164.53 29.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.75 12.16 5.62 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.853 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.02 116.48 65.58 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 119.097 1.449 . . . . 0.0 111.431 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.24 1.83 5.23 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 124.644 3.562 . . . . 0.0 110.406 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.438 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 42.1 p-90 -141.49 175.82 9.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.3 1.04 . . . . 0.0 109.956 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.52 155.16 10.61 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.221 0.534 . . . . 0.0 110.584 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -44.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.281 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.014 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.475 HG23 ' H ' ' A' ' 250' ' ' ALA . 7.4 m -168.48 148.72 4.63 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.809 1.943 . . . . 0.0 108.18 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -70.08 -26.73 64.13 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 119.749 -1.845 . . . . 0.0 111.722 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.475 ' H ' HG23 ' A' ' 248' ' ' THR . . . -80.91 -19.35 44.49 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.464 0.706 . . . . 0.0 110.358 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.18 -58.04 6.42 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 8.0 tt -55.34 -40.06 70.76 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.178 0.575 . . . . 0.0 110.216 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 264' ' ' VAL . 54.6 t -70.39 -41.32 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 118.836 -2.415 . . . . 0.0 110.414 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.22 0.09 10.71 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.854 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 48.1 m -87.8 -28.04 21.92 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.036 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.417 ' CZ ' HD21 ' A' ' 252' ' ' LEU . 14.7 p90 -137.98 16.15 2.85 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.6 20.6 0.22 Allowed 'General case' 0 C--O 1.24 0.592 0 O-C-N 120.45 -1.406 . . . . 0.0 112.789 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.89 6.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 120.208 1.367 . . . . 0.0 110.611 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.98 -11.35 58.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.916 -1.115 . . . . 0.0 112.151 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.16 -4.08 59.76 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.828 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 10.7 t -127.3 22.6 6.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.26 1.03 . . . . 0.0 111.817 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.4 OUTLIER -92.76 144.26 25.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.928 -1.107 . . . . 0.0 109.988 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.3 m -152.68 172.05 17.26 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 125.788 1.93 . . . . 0.0 107.893 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 253' ' ' VAL . 61.3 t -148.29 144.0 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.293 -169.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -109.21 131.71 54.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.955 0.784 . . . . 0.0 109.939 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -145.28 81.99 10.04 Favored Pre-proline 0 C--O 1.242 0.691 0 CA-C-O 122.048 0.927 . . . . 0.0 110.979 -167.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 164.22 31.99 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 123.786 2.991 . . . . 0.0 109.747 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.01 -4.36 85.61 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -66.56 65.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.403 1.481 . . . . 0.0 111.308 174.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -142.95 2.25 1.33 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.512 0.725 . . . . 0.0 111.817 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.3 -154.08 8.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.264 0.935 . . . . 0.0 111.548 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.89 168.27 12.18 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 24.0 m170 67.47 150.84 0.12 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.066 2.147 . . . . 0.0 114.445 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.32 -4.27 14.55 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.823 2.349 . . . . 0.0 109.661 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -95.9 11.93 32.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.878 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 1.8 p 63.26 155.67 0.12 Allowed Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 129.012 2.925 . . . . 0.0 111.208 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.79 159.21 31.43 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.402 3.401 . . . . 0.0 111.814 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.94 136.36 18.46 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.037 3.158 . . . . 0.0 111.714 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -144.76 155.51 43.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -76.45 -21.08 76.0 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-O 117.998 -1.446 . . . . 0.0 113.334 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -166.56 168.66 14.43 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.8 m -156.84 -163.69 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.941 2.096 . . . . 0.0 108.71 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -148.09 150.7 34.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.532 1.06 . . . . 0.0 111.652 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.97 156.35 17.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.89 122.73 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 31.5 p90 -165.66 -157.54 0.32 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 117.499 -1.239 . . . . 0.0 109.915 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 93.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.689 HD21 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -69.78 14.0 0.12 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.65 2.38 . . . . 0.0 115.75 -167.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -136.09 -53.96 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.571 1.532 . . . . 0.0 111.111 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -88.05 -41.16 13.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.83 -170.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 73.9 m -74.77 -32.99 62.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.86 -47.81 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 122.105 -0.372 . . . . 0.0 110.896 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -73.3 -20.34 60.83 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.82 -0.55 . . . . 0.0 112.109 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.5 m -79.78 -35.53 38.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.606 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -46.34 87.05 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.713 172.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.07 -17.08 61.46 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.066 0.848 . . . . 0.0 110.467 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -87.97 -9.7 52.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 122.727 0.411 . . . . 0.0 111.743 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.04 -3.22 15.6 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.03 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . 0.482 ' SG ' ' CD1' ' A' ' 314' ' ' PHE . 71.4 m -109.68 -154.67 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.939 1.399 . . . . 0.0 110.858 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.6 m -136.06 160.49 38.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.028 1.394 . . . . 0.0 109.641 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 74.1 t60 -142.44 165.56 27.08 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.86 -1.775 . . . . 0.0 111.343 -173.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 13.3 m-20 -147.01 115.97 4.39 Favored Pre-proline 0 C--O 1.212 -0.913 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -85.39 25.75 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 126.178 4.586 . . . . 0.0 111.538 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.352 0.69 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.027 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.216 -0.685 0 CA-C-O 121.374 0.607 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.2 m -107.62 169.91 8.3 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.614 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -141.91 149.03 39.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 1.064 . . . . 0.0 109.154 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.47 149.09 44.35 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -138.61 153.62 48.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 122.808 1.289 . . . . 0.0 112.104 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.482 ' CD1' ' SG ' ' A' ' 299' ' ' CYS . 25.5 t80 -146.61 169.63 18.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.426 -0.797 . . . . 0.0 112.16 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -128.6 74.85 1.59 Allowed 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -76.72 1.37 17.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.373 177.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 67.9 m -57.66 137.27 56.61 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 25.1 t -108.77 175.2 5.55 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.816 -1.178 . . . . 0.0 109.257 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -60.65 0.5 0.2 Allowed 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 124.838 1.255 . . . . 0.0 113.822 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.7 ptm85 -105.12 8.21 34.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.35 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.438 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 74.1 mmm -128.78 169.91 13.97 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 46.4 mtt85 -119.49 0.06 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.342 0.657 . . . . 0.0 111.371 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 93.8 m -124.01 -174.94 3.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.677 0.791 . . . . 0.0 109.712 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -150.71 166.31 30.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 66.13 147.3 0.04 OUTLIER 'General case' 0 C--N 1.342 0.279 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.58 165.03 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.293 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 143.82 35.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.622 0.769 . . . . 0.0 110.249 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.903 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 34.9 mt -144.84 107.8 4.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.52 171.8 15.33 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.257 2.638 . . . . 0.0 111.892 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.602 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.2 t-105 -101.41 112.32 24.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 169.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.29 157.61 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.04 -0.412 . . . . 0.0 110.5 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.64 -28.0 63.32 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.355 1.062 . . . . 0.0 109.859 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.21 -4.98 8.75 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 124.687 1.242 . . . . 0.0 110.176 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.68 8.66 15.04 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.57 1.148 . . . . 0.0 110.274 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.8 m -115.5 -47.13 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.642 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -155.67 166.27 34.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.908 0.861 . . . . 0.0 110.125 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -153.86 144.53 22.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 110.451 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.22 145.06 18.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -106.66 -16.54 14.48 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.803 1.314 . . . . 0.0 111.427 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 60.1 m -96.73 147.36 32.82 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.294 -0.879 . . . . 0.0 111.351 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.09 -26.43 7.74 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.244 2.629 . . . . 0.0 112.707 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.1 m -143.51 2.92 1.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.2 154.26 22.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.912 1.339 . . . . 0.0 110.062 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.23 177.37 6.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.391 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 346' ' ' LEU . 1.3 mm? -58.33 151.64 19.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.234 -0.916 . . . . 0.0 111.303 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -89.88 137.49 28.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.08 -2.8 13.01 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.003 2.468 . . . . 0.0 115.869 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 41.5 p -142.26 -0.6 1.25 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.552 1.141 . . . . 0.0 112.98 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -123.24 60.66 1.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 397' ' ' THR . 18.6 p -138.27 147.72 43.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.68 169.72 14.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 122.508 -0.12 . . . . 0.0 110.921 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -97.91 125.45 42.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.68 131.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -120.44 97.28 0.64 Allowed Glycine 0 C--O 1.213 -1.181 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.72 132.89 20.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.498 0.666 . . . . 0.0 110.606 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.98 155.76 23.78 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.6 1.16 . . . . 0.0 113.32 -169.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 14.7 p80 -159.98 6.51 0.09 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 169.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 116.94 -17.97 12.74 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.315 1.912 . . . . 0.0 112.388 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.6 ptm -166.05 43.27 0.07 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.552 0.676 . . . . 0.0 109.783 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.79 132.23 52.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.37 166.0 12.83 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.758 -173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.36 -17.26 64.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 118.467 -0.778 . . . . 0.0 111.453 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -77.72 -30.4 51.72 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.919 0.781 . . . . 0.0 109.431 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.39 74.49 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.19 -43.92 55.38 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.665 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.68 69.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.41 70.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.577 1.173 . . . . 0.0 114.053 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.57 -32.29 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 O-C-N 123.612 0.57 . . . . 0.0 110.403 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.86 -30.89 18.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.14 -14.18 31.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.918 -0.563 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.36 -33.36 13.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.503 0.668 . . . . 0.0 111.593 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.41 -11.89 19.85 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.09 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 403' ' ' SER . 23.7 m-85 -128.19 -42.36 1.53 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 173.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.75 87.19 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.415 1.007 . . . . 0.0 113.451 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -134.03 103.04 0.48 Allowed Glycine 0 C--N 1.352 1.428 0 CA-C-N 119.007 1.403 . . . . 0.0 110.352 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.44 159.02 15.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 117.587 0.694 . . . . 0.0 111.056 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.49 -58.0 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 123.829 0.852 . . . . 0.0 111.257 174.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.414 ' CD1' HD12 ' A' ' 346' ' ' LEU . 1.9 t80 -147.2 152.38 38.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.742 1.258 . . . . 0.0 110.737 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.32 137.76 29.03 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -136.0 151.61 20.78 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 122.212 0.896 . . . . 0.0 112.19 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.41 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -98.46 123.87 42.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 56.1 p -126.92 158.97 35.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.765 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.12 159.77 40.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 113.03 -1.896 . . . . 0.0 107.358 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 23.1 tptm -50.2 102.21 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . 0.406 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 26.5 m80 54.99 22.31 4.29 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -12.45 59.99 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 111.731 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.8 p90 41.37 51.78 5.6 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.44 -30.31 8.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.112 2.541 . . . . 0.0 113.233 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.452 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 28.14 75.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 127.83 2.452 . . . . 0.0 114.143 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.53 -88.84 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 114.185 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.4 p -57.04 154.15 10.23 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.193 0.996 . . . . 0.0 108.809 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -162.77 -173.12 31.08 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.204 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -140.47 157.68 45.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.959 0.504 . . . . 0.0 110.234 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.16 151.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 351' ' ' THR . 9.9 t -129.59 146.22 51.42 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.518 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 61.4 m-85 -121.83 -30.09 4.19 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 123.947 0.779 . . . . 0.0 111.409 -172.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.93 16.48 5.79 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.472 0.483 . . . . 0.0 109.851 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -139.96 140.05 36.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.193 0.997 . . . . 0.0 109.735 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -80.53 -20.49 43.4 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.631 0.372 . . . . 0.0 111.692 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 402' ' ' ARG . 0.6 OUTLIER -58.6 -36.34 73.85 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.528 -177.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.518 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 12.1 m -82.71 -14.53 54.41 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.475 -0.766 . . . . 0.0 110.371 -172.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -76.91 -63.14 1.43 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.511 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.4 HD21 ' C ' ' A' ' 405' ' ' LEU 0.25 0.0 OUTLIER -71.09 -17.5 62.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 118.861 -1.136 . . . . 0.0 113.298 -176.246 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -84.45 -31.16 24.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.484 -0.76 . . . . 0.0 112.37 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.17 30.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.618 1.099 . . . . 0.0 108.197 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.51 -31.39 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.469 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.1 t -77.38 -27.36 52.5 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 124.868 1.355 . . . . 0.0 111.473 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.73 -53.69 3.62 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.133 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.96 -14.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 425' ' ' GLN . 1.9 m-85 -157.71 148.29 20.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.678 0.672 . . . . 0.0 110.352 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.19 149.87 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.875 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.38 151.05 20.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 110.78 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.8 mt -124.01 117.4 50.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.542 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.438 ' H ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -127.57 64.25 1.35 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.307 1.051 . . . . 0.0 109.044 -178.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -76.93 159.92 29.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.007 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -63.18 -23.09 67.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.723 0.692 . . . . 0.0 110.998 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -142.69 33.14 1.43 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -167.25 125.41 1.29 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.144 0.973 . . . . 0.0 109.0 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 15.2 p -136.4 121.88 19.47 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.784 -1.198 . . . . 0.0 112.017 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.54 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.8 tptp -164.77 176.52 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.604 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.54 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 47.7 tttt -124.66 156.75 37.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.41 148.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.366 0.984 . . . . 0.0 110.32 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . 0.466 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 40.3 tt0 -118.33 161.0 20.66 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 21.6 mt -142.29 137.63 29.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 124.46 1.1 . . . . 0.0 110.702 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.6 129.01 6.77 Favored Pre-proline 0 C--O 1.235 0.334 0 O-C-N 123.546 0.528 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -83.79 174.02 8.87 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.447 1.431 . . . . 0.0 113.846 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 116.458 -1.734 . . . . 0.0 112.651 171.97 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 122.538 1.161 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 40.8 m -143.92 75.79 1.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.78 1.276 . . . . 0.0 107.946 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.13 2.57 55.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.702 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 415' ' ' ILE . 94.6 p -38.99 141.86 0.26 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -169.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 164.86 -17.41 0.1 Allowed Glycine 0 CA--C 1.537 1.447 0 O-C-N 124.356 1.035 . . . . 0.0 111.966 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 57.7 128.6 0.0 OUTLIER 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.985 2.514 . . . . 0.0 111.664 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.8 mm? -107.04 -49.23 0.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 117.514 -1.232 . . . . 0.0 112.994 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 52.4 Cg_exo -60.55 161.31 21.22 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 125.337 4.024 . . . . 0.0 113.888 -174.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.94 160.46 45.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.796 2.997 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -151.63 32.0 0.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.648 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -99.32 -18.86 17.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.14 0.976 . . . . 0.0 112.763 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 42.4 -136.92 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 66.15 34.37 6.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.945 1.298 . . . . 0.0 111.997 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.504 ' H ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -136.4 -40.17 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 175.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.504 ' CD ' ' H ' ' A' ' 231' ' ' ASN . 7.6 Cg_exo -74.51 -176.88 2.98 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.362 2.041 . . . . 0.0 115.228 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.11 162.38 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 125.336 1.454 . . . . 0.0 108.868 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -109.75 138.78 45.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.962 1.705 . . . . 0.0 107.811 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.488 ' C ' ' HG ' ' A' ' 236' ' ' CYS . 13.9 t -152.04 2.34 0.36 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -171.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.627 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 71.2 m -148.63 63.58 1.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.48 -1.387 . . . . 0.0 114.44 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.23 162.3 0.2 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.356 0.662 . . . . 0.0 112.296 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.54 142.38 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -81.99 127.97 33.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.273 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.53 108.33 7.07 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -159.24 160.52 31.34 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-O 122.703 1.168 . . . . 0.0 110.252 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.48 -3.16 3.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.28 122.75 88.27 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 120.604 -1.527 . . . . 0.0 109.629 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -87.2 -4.67 7.72 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 124.232 3.288 . . . . 0.0 109.45 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -134.42 176.26 8.77 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.285 1.434 . . . . 0.0 110.415 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.99 145.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.582 0.753 . . . . 0.0 109.874 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 248' ' ' THR . 0.1 OUTLIER -144.14 -50.83 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.405 0 C-N-CA 122.601 0.36 . . . . 0.0 110.803 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.409 ' H ' HD12 ' A' ' 247' ' ' ILE . 2.8 m -164.78 130.43 2.76 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.721 2.008 . . . . 0.0 105.753 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -70.97 -13.33 61.97 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 120.421 1.464 . . . . 0.0 111.965 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.04 65.78 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 125.347 1.459 . . . . 0.0 109.278 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.99 -35.68 84.66 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.83 -45.73 41.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.685 1.231 . . . . 0.0 108.63 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.9 t -62.93 -53.61 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 120.509 -1.37 . . . . 0.0 110.485 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -79.89 -13.71 59.18 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.8 t -81.52 -26.22 35.3 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.525 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -126.44 32.11 5.25 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.276 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 28.6 tpt85 -96.09 -18.2 20.34 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.436 1.094 . . . . 0.0 109.822 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.7 t -70.35 20.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -128.12 0.4 5.84 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.466 -0.771 . . . . 0.0 112.888 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.56 -95.38 0.1 Allowed Glycine 0 N--CA 1.471 1.004 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.675 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.0 t -144.9 147.38 32.7 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.292 1.046 . . . . 0.0 109.408 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 151.67 24.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.0 m -149.71 175.72 11.32 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.34 150.25 18.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 121.072 -1.017 . . . . 0.0 113.468 -172.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.33 154.09 46.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.582 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.27 138.79 20.97 Favored Pre-proline 0 C--N 1.345 0.385 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.91 -170.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.98 -29.1 4.47 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 125.01 3.806 . . . . 0.0 109.769 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.56 -28.36 6.05 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.164 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 44.34 50.7 7.84 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.342 1.071 . . . . 0.0 110.371 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -118.89 -8.02 10.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.02 8.83 58.89 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.004 -0.887 . . . . 0.0 113.155 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.88 -36.33 76.68 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 118.642 1.221 . . . . 0.0 110.742 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -143.33 126.69 9.11 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.34 -12.41 12.8 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 125.06 3.84 . . . . 0.0 109.731 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -72.46 -72.28 0.25 Allowed 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 123.134 0.573 . . . . 0.0 111.014 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 42.5 t -158.24 143.7 12.22 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 124.592 1.183 . . . . 0.0 109.675 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 279' ' ' LYS . 65.7 Cg_endo -62.97 160.34 34.21 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.222 1.948 . . . . 0.0 111.16 175.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.37 27.19 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 125.234 3.956 . . . . 0.0 111.018 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 277' ' ' PRO . 74.5 mmtt -120.46 158.12 27.91 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -82.8 10.68 56.25 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.581 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.33 170.91 19.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.787 -177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 176.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 125.217 1.573 . . . . 0.0 107.197 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -118.17 155.19 30.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 119.763 1.165 . . . . 0.0 111.374 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.02 135.25 55.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.86 120.31 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 125.577 1.551 . . . . 0.0 107.419 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.426 ' C ' ' H ' ' A' ' 288' ' ' LEU . 0.0 OUTLIER -155.86 -156.3 0.63 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.232 -174.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.62 18.87 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.187 0.449 . . . . 0.0 110.714 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 286' ' ' PHE . 86.6 mt 48.99 -141.19 0.65 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 119.831 -1.793 . . . . 0.0 111.362 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 13.39 -74.42 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 127.593 2.357 . . . . 0.0 116.443 168.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -81.77 -29.12 32.92 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.813 0.845 . . . . 0.0 112.962 -170.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.7 m -78.56 -30.63 46.96 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.299 1.04 . . . . 0.0 108.705 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.19 -57.3 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -72.56 -20.4 61.32 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.8 t -71.77 -42.92 66.59 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.93 -0.482 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.86 -45.91 33.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.382 0.992 . . . . 0.0 111.497 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -16.32 61.84 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.468 1.031 . . . . 0.0 113.38 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -95.29 -17.03 21.99 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.69 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -78.16 -19.46 53.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 119.957 1.253 . . . . 0.0 112.307 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 5.1 t -115.26 -108.19 0.37 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.341 1.026 . . . . 0.0 113.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.2 t -142.64 163.56 32.48 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -168.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -146.94 156.23 42.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.314 1.846 . . . . 0.0 106.844 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -142.86 125.78 9.09 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.18 13.02 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 1 C-N-CA 127.521 5.481 . . . . 0.0 112.478 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 125.581 1.553 . . . . 0.0 112.766 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 309' ' ' LEU . 19.5 tp . . . . . 0 C--O 1.239 0.519 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 63.5 m -80.04 166.15 21.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.151 0.907 . . . . 0.0 109.702 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -136.18 142.15 44.12 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.44 145.04 35.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.78 151.18 40.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 123.211 1.481 . . . . 0.0 109.324 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -147.85 159.98 43.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.964 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 44.9 mtmt -132.53 131.27 41.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 -3.49 0.91 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 116.115 -1.898 . . . . 0.0 114.344 -167.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 m -144.63 33.71 1.16 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.563 1.529 . . . . 0.0 111.436 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.1 m -61.84 -9.7 7.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.239 1.816 . . . . 0.0 113.5 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -138.37 5.08 2.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.595 0.758 . . . . 0.0 110.221 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -113.51 -28.91 7.36 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.539 0.736 . . . . 0.0 111.464 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.624 ' C ' ' H ' ' A' ' 323' ' ' CYS . 85.7 mmm -131.28 7.52 4.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.383 -0.818 . . . . 0.0 113.167 -172.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 60.85 -16.13 0.03 OUTLIER 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.222 2.209 . . . . 0.0 110.567 -172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.624 ' H ' ' C ' ' A' ' 321' ' ' MET . 80.4 m -110.58 167.75 9.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.789 0.835 . . . . 0.0 110.346 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -159.25 -162.66 1.09 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 122.871 0.468 . . . . 0.0 111.519 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 62.69 137.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.696 1.599 . . . . 0.0 112.868 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 12.6 p -156.58 162.92 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -109.09 155.6 20.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.422 0.555 . . . . 0.0 111.989 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.84 137.72 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 8.5 pt -146.17 94.92 4.83 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.95 169.72 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.888 1 C-N-CA 125.781 4.321 . . . . 0.0 111.257 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.627 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.6 t-105 -86.53 115.35 23.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.254 175.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 18.0 t -99.48 145.09 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 123.298 1.523 . . . . 0.0 108.791 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.25 -31.97 69.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.039 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -84.58 -7.99 59.06 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.68 -1.77 57.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.721 0.692 . . . . 0.0 111.312 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 88.5 p -130.2 -2.11 4.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.725 -0.609 . . . . 0.0 112.37 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -149.58 140.24 22.61 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.202 0.314 . . . . 0.0 110.186 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -156.14 106.67 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.414 0.686 . . . . 0.0 109.331 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 341' ' ' SER . 12.2 p -89.2 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.157 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.24 28.64 8.59 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.455 1.121 . . . . 0.0 110.303 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' SER . . . . . 0.514 ' H ' HG23 ' A' ' 339' ' ' VAL . 26.5 t -141.63 149.11 52.68 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.06 -3.29 13.58 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.265 3.31 . . . . 0.0 110.592 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -137.85 165.72 25.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -115.14 127.64 55.7 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.756 0.788 . . . . 0.0 111.188 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -142.01 -41.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.127 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.64 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 O-C-N 124.722 1.264 . . . . 0.0 111.948 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.21 140.71 19.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.25 -5.06 14.95 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.718 1.612 . . . . 0.0 114.98 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.4 t -152.51 -169.66 3.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 48.47 99.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.889 2.075 . . . . 0.0 113.742 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.7 t -158.27 155.72 29.4 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 149.76 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 124.132 0.895 . . . . 0.0 110.326 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -85.47 152.91 22.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.796 -169.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 133.27 66.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -167.58 -168.07 29.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.476 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 58.07 19.57 6.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 19.2 mt -67.09 154.66 40.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.657 -1.277 . . . . 0.0 109.839 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . 0.456 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 3.6 p-80 -79.69 16.36 1.13 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 87.36 9.32 72.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.824 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.456 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 8.9 ptp -159.01 12.17 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 173.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 31.8 tp -64.62 140.06 58.83 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.154 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.4 161.05 15.38 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.682 0.793 . . . . 0.0 109.199 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -70.09 -8.63 51.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.16 -35.14 79.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.36 34.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.615 0.721 . . . . 0.0 110.567 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.9 -31.44 64.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.665 -0.647 . . . . 0.0 110.021 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.75 -50.17 70.13 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.14 76.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.879 -0.513 . . . . 0.0 111.576 -174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 90.2 mt -71.06 -41.8 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 122.034 -0.416 . . . . 0.0 110.109 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.22 -2.94 58.9 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -171.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . 0.474 ' C ' HD21 ' A' ' 371' ' ' ASN . 0.2 OUTLIER -127.99 1.41 5.93 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.571 -1.331 . . . . 0.0 112.528 175.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -119.78 -20.63 7.54 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.962 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.85 -22.76 24.26 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.21 -16.22 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.456 1.026 . . . . 0.0 111.994 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 55.32 84.15 0.04 OUTLIER Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -151.84 3.86 0.43 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 118.195 0.998 . . . . 0.0 113.136 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.8 m -96.0 166.67 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 122.402 1.096 . . . . 0.0 113.179 -173.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.08 -27.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.171 170.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.18 147.83 24.24 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.12 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 119.235 0.925 . . . . 0.0 108.608 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -153.37 168.58 32.08 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.322 0.889 . . . . 0.0 115.322 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.7 mt -116.65 140.44 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.49 146.96 24.9 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.663 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.3 p -140.52 171.62 13.87 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 124.734 1.272 . . . . 0.0 111.907 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -132.76 18.59 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.435 1.494 . . . . 0.0 108.494 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.54 ' HE2' ' CE1' ' A' ' 387' ' ' HIS 0.274 0.5 OUTLIER 51.83 3.68 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 130.53 3.532 . . . . 0.0 114.794 -176.674 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . 0.54 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 38.7 m170 -140.84 -9.8 1.03 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.681 1.192 . . . . 0.0 112.205 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -94.33 -11.09 30.75 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.86 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.0 p90 41.92 48.57 3.26 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.81 -52.01 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.389 2.726 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.286 6.9 tp 40.17 33.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 122.046 0.927 . . . . 0.0 110.674 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -160.49 16.13 0.19 Allowed Glycine 0 C--N 1.345 1.078 0 CA-C-O 118.593 -1.115 . . . . 0.0 112.496 -176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.5 p -145.44 112.12 5.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.81 0.805 . . . . 0.0 109.088 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -152.01 -175.76 24.01 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -147.28 167.04 25.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.87 142.08 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 27.8 m -99.93 105.49 17.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -85.75 162.35 18.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.231 0.613 . . . . 0.0 110.477 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -147.13 19.06 1.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.581 0.705 . . . . 0.0 111.346 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -144.39 165.37 28.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.44 1.096 . . . . 0.0 108.755 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -88.16 -36.28 16.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 120.943 1.702 . . . . 0.0 113.298 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -26.81 8.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -76.19 -30.26 57.97 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.51 -56.94 6.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.333 -1.479 . . . . 0.0 110.471 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -23.65 58.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.902 -1.124 . . . . 0.0 113.677 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -85.79 -22.91 27.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -87.58 -28.06 22.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.179 -0.325 . . . . 0.0 110.301 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.8 m -84.57 -25.0 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.2 p -85.55 -24.87 27.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.008 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -84.0 -44.59 14.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.5 -20.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.126 2.971 . . . . 0.0 115.096 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -149.99 145.88 26.69 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.23 156.14 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 O-C-N 121.41 -0.806 . . . . 0.0 110.221 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -109.38 139.54 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 124.277 0.985 . . . . 0.0 112.882 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.456 ' HA ' ' HB3' ' A' ' 221' ' ' SER . 37.5 mt -118.53 126.41 75.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.452 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -131.23 14.56 5.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.496 1.123 . . . . 0.0 110.598 -170.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -60.88 157.06 15.97 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.591 1.156 . . . . 0.0 109.735 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -62.68 -0.77 0.68 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -139.47 4.72 2.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -160.32 130.29 5.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.132 0.973 . . . . 0.0 112.516 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 416' ' ' LYS . 17.3 p -140.16 102.29 4.34 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 120.263 1.392 . . . . 0.0 110.95 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.59 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 32.4 tptt -166.39 -176.1 3.49 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.813 174.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.59 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 43.1 mtpt -128.04 172.23 11.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.617 0.767 . . . . 0.0 110.625 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.21 159.47 20.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.211 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -130.0 135.92 48.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.9 145.16 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.54 151.22 63.09 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 118.956 0.798 . . . . 0.0 110.614 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.01 166.41 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.242 2.628 . . . . 0.0 113.109 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 123.955 0.902 . . . . 0.0 110.045 -177.062 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 221' ' ' SER . 26.5 m 42.23 66.17 0.78 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.742 1.217 . . . . 0.0 112.729 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 19.35 0.11 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 219' ' ' THR . 18.7 m 57.16 35.1 25.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 169.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.07 86.23 0.05 OUTLIER Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -79.84 -14.78 58.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.821 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 43.75 113.34 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 128.29 2.636 . . . . 0.0 115.206 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.52 169.03 19.07 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.96 3.107 . . . . 0.0 110.039 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.11 156.55 12.79 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.072 2.515 . . . . 0.0 113.435 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -141.45 179.55 6.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.14 2.176 . . . . 0.0 108.199 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 50.48 40.79 24.06 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.674 0.79 . . . . 0.0 113.088 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.64 159.51 1.54 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.73 0.812 . . . . 0.0 111.006 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -101.26 2.41 39.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.524 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.9 OUTLIER -126.39 35.69 0.3 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -177.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 68.7 Cg_endo -75.15 155.89 42.29 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.892 2.394 . . . . 0.0 111.394 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.71 140.71 43.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.25 121.97 38.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 95.6 p -125.93 -6.87 6.68 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.777 -170.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.35 -173.96 3.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 123.948 0.899 . . . . 0.0 108.643 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -60.23 155.89 16.58 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.244 -170.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.57 135.52 31.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -100.67 122.55 43.51 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 108.704 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.2 tt -145.46 143.33 29.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.775 -0.578 . . . . 0.0 110.512 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.56 145.75 9.56 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 123.337 0.398 . . . . 0.0 112.147 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.5 17.43 0.02 OUTLIER Glycine 0 C--O 1.211 -1.329 0 CA-C-N 119.049 1.425 . . . . 0.0 113.818 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.05 95.4 39.45 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 118.147 0.973 . . . . 0.0 111.71 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.79 10.83 3.52 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 125.133 3.889 . . . . 0.0 112.533 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 246' ' ' ASP . 11.6 p-90 -128.14 -9.79 5.33 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.426 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 11.5 p-10 -60.28 116.26 4.12 Favored 'General case' 0 C--O 1.254 1.29 0 O-C-N 123.943 0.777 . . . . 0.0 113.087 -175.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -78.32 -15.81 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.4 p -153.6 148.17 26.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.249 1.023 . . . . 0.0 108.415 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -84.1 -22.56 31.09 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.772 -1.205 . . . . 0.0 108.727 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -78.31 -14.77 59.27 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.433 1.083 . . . . 0.0 113.319 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.82 -66.07 2.78 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.593 HD21 ' H ' ' A' ' 252' ' ' LEU . 2.5 pt? -66.08 -29.37 69.69 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.73 -35.87 76.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.786 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -77.11 -18.06 58.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.705 -1.872 . . . . 0.0 110.198 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.5 p -77.85 -25.68 48.88 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.359 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.33 20.03 4.81 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 121.832 2.106 . . . . 0.0 112.545 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.1 20.92 1.46 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 119.547 -1.971 . . . . 0.0 111.913 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.5 t -71.09 -9.91 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -166.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -91.88 -2.65 56.74 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.432 1.083 . . . . 0.0 111.085 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.81 -2.7 3.44 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-O 117.698 -1.612 . . . . 0.0 116.612 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.7 m -102.54 22.3 13.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 119.183 1.492 . . . . 0.0 112.337 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 262' ' ' LEU . 3.7 mm? -68.97 145.23 53.79 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 t -145.35 81.47 1.63 Allowed 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.1 p -75.7 141.25 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.068 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -150.94 157.82 43.38 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.368 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.453 ' HB3' HG21 ' A' ' 282' ' ' VAL . 42.4 p90 -151.66 146.67 19.02 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.05 91.91 1.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.635 2.223 . . . . 0.0 110.267 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -178.52 177.84 48.52 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -105.46 124.34 49.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.94 -0.741 . . . . 0.0 109.434 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -111.13 7.9 21.52 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.49 0.716 . . . . 0.0 110.097 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -67.05 -12.0 59.51 Favored Glycine 0 N--CA 1.47 0.951 0 CA-C-O 118.067 -1.407 . . . . 0.0 113.824 -172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -138.7 -35.5 0.58 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.561 1.681 . . . . 0.0 111.513 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -143.87 133.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.61 -13.96 6.83 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 125.059 3.839 . . . . 0.0 111.463 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -96.41 20.67 10.19 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.455 ' HB3' ' HD3' ' A' ' 277' ' ' PRO . 42.4 t -53.46 -41.27 85.94 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.892 -0.575 . . . . 0.0 112.03 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 276' ' ' CYS . 32.5 Cg_endo -98.29 95.72 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.41 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.83 4.85 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.585 4.19 . . . . 0.0 115.407 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -78.26 6.75 7.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 66.14 11.43 55.36 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.49 141.61 44.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.602 1.201 . . . . 0.0 112.739 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -150.03 170.76 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.983 0.897 . . . . 0.0 109.054 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -133.72 155.61 49.45 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.842 -1.161 . . . . 0.0 109.986 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 96.9 mt -131.16 145.76 52.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.19 0.596 . . . . 0.0 111.908 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.31 134.2 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 15.6 p90 -169.23 -163.26 0.4 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 125.007 1.442 . . . . 0.0 108.133 -174.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.16 110.21 0.46 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.582 1.153 . . . . 0.0 107.933 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 54.1 mt -89.83 -179.66 5.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.172 0.987 . . . . 0.0 110.396 -172.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 63.99 -67.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.367 1.867 . . . . 0.0 113.803 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -81.03 -43.35 19.69 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.433 -0.792 . . . . 0.0 111.261 -168.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 7.5 m -79.13 -31.4 44.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.84 -51.65 59.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -62.7 -32.22 73.27 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 70.4 m -57.23 -44.2 83.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.475 1.11 . . . . 0.0 111.884 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.7 -49.72 67.49 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.796 -1.19 . . . . 0.0 110.194 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -26.63 68.11 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 119.182 -0.437 . . . . 0.0 112.018 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -96.21 -4.25 42.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 123.855 0.722 . . . . 0.0 111.742 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.33 -12.57 19.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 314' ' ' PHE . 9.8 t -127.43 -124.05 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.0 t -116.49 163.65 15.75 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -155.8 159.6 39.55 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.724 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.19 137.73 31.47 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.26 75.52 5.02 Favored 'Trans proline' 0 C--N 1.35 0.612 1 C-N-CA 128.302 6.001 . . . . 0.0 112.867 -168.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 115.784 173.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.422 0.154 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 1.5 m -62.89 153.45 33.31 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.357 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -137.24 150.06 47.58 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 123.834 0.709 . . . . 0.0 110.744 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.44 146.86 44.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -140.02 155.13 47.22 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.654 -1.279 . . . . 0.0 112.17 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.489 ' HA ' ' SG ' ' A' ' 299' ' ' CYS . 32.4 t80 -145.22 174.29 11.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -125.4 132.41 52.77 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.21 0.914 . . . . 0.0 108.922 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.431 ' H ' ' HE3' ' A' ' 316' ' ' MET . 0.0 OUTLIER -123.3 14.3 9.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.295 1.038 . . . . 0.0 109.662 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.3 p -82.01 2.1 32.49 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.115 0.566 . . . . 0.0 111.312 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 45.7 t -61.31 150.87 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 109.968 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 56.1 8.49 0.39 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.861 0.864 . . . . 0.0 112.286 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -129.5 -62.97 0.95 Allowed 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.566 -0.709 . . . . 0.0 110.761 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.5 mmt -123.59 -13.68 7.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.435 1.094 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 44.74 23.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.8 2.04 . . . . 0.0 114.993 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 3.1 t -151.56 17.45 0.71 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 121.262 1.846 . . . . 0.0 114.172 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.525 ' HZ1' ' HB2' ' A' ' 324' ' ' LYS . 0.1 OUTLIER -122.56 115.55 22.35 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.989 0.9 . . . . 0.0 112.713 -174.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -74.95 162.34 28.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.016 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.88 150.02 32.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.159 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -83.32 136.71 34.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.292 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.36 133.36 57.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.013 0.824 . . . . 0.0 111.017 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 62.1 mt -149.64 114.98 3.52 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.5 154.44 6.47 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 125.024 3.816 . . . . 0.0 112.765 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.406 ' CZ3' ' HA ' ' A' ' 389' ' ' TYR . 5.3 t-105 -76.2 120.0 20.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 172.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.646 HG13 ' H ' ' A' ' 334' ' ' ALA . 44.4 t -90.06 142.67 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.377 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.01 -25.96 64.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.35 0.595 . . . . 0.0 112.195 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.646 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -76.9 1.95 16.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.045 -1.659 . . . . 0.0 114.047 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -94.82 -8.63 36.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.675 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.7 m -103.91 -27.98 11.85 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.337 1.426 . . . . 0.0 114.046 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -163.03 162.79 26.07 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.146 0.278 . . . . 0.0 110.794 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -160.67 147.51 15.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.299 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.3 141.65 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 O-C-N 123.67 0.607 . . . . 0.0 110.405 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.81 20.33 18.28 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.012 0.91 . . . . 0.0 109.007 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 18.3 t -143.54 145.98 33.72 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.68 1.592 . . . . 0.0 107.341 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.56 5.42 4.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 121.716 1.611 . . . . 0.0 112.865 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 63.9 m -106.11 158.42 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.485 0.714 . . . . 0.0 109.639 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -111.03 12.64 22.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.216 0.606 . . . . 0.0 112.559 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -70.6 162.99 27.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.718 1.247 . . . . 0.0 112.263 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 346' ' ' LEU . 11.1 tp -145.8 143.62 29.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . 0.513 ' H ' HG21 ' A' ' 397' ' ' THR . 12.1 m-20 -134.65 85.3 36.92 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 124.651 1.18 . . . . 0.0 110.535 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.89 -9.95 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 124.742 3.628 . . . . 0.0 114.196 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 87.9 p -72.61 -12.57 61.1 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.141 -0.974 . . . . 0.0 112.789 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -142.43 94.23 2.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.1 t -149.33 152.27 35.57 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.92 154.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.661 1.22 . . . . 0.0 108.942 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -90.34 161.96 15.37 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.328 -171.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 4.5 p -144.68 145.16 21.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 O-C-N 121.487 -0.758 . . . . 0.0 111.378 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.91 -174.88 36.55 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 47.47 34.57 3.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.699 0.4 . . . . 0.0 111.745 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.01 -176.52 3.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.867 1.267 . . . . 0.0 108.649 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' A' ' 360' ' ' MET . 22.6 t-160 -65.13 140.32 58.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.18 0.592 . . . . 0.0 111.075 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -67.85 5.61 3.39 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.162 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.443 ' HB2' ' CE1' ' A' ' 358' ' ' HIS . 40.7 mtp -138.71 28.08 2.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.857 1.329 . . . . 0.0 107.495 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.17 82.92 0.08 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.562 1.648 . . . . 0.0 108.473 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 360' ' ' MET . 5.4 p30 -64.69 156.78 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.107 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.92 -19.1 65.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 120.599 -1.313 . . . . 0.0 111.401 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -72.64 -27.77 62.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 120.943 -1.098 . . . . 0.0 109.001 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -87.49 -32.73 19.29 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.223 1.409 . . . . 0.0 111.017 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.91 -37.37 86.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -78.8 -28.99 44.63 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.835 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -67.82 -42.47 81.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.122 1.328 . . . . 0.0 108.558 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.0 -44.22 92.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.251 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 374' ' ' PHE . 45.4 mt -89.9 -7.86 53.21 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 117.784 -1.103 . . . . 0.0 112.724 -171.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.83 -28.43 15.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.742 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.7 -26.48 25.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.98 -13.02 20.1 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.46 ' CE2' HD23 ' A' ' 370' ' ' LEU . 22.1 m-30 -119.91 -23.07 6.52 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 120.25 1.387 . . . . 0.0 111.942 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 76.4 -0.68 63.37 Favored Glycine 0 CA--C 1.552 2.381 0 O-C-N 125.048 1.468 . . . . 0.0 113.867 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.46 120.08 0.71 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 121.36 2.58 . . . . 0.0 111.807 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.36 171.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 126.171 1.788 . . . . 0.0 107.834 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.85 -30.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.913 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -163.05 136.82 5.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.085 0.402 . . . . 0.0 110.656 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.15 129.66 13.04 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -140.73 159.67 26.46 Favored Glycine 0 C--O 1.22 -0.747 0 O-C-N 121.861 -0.525 . . . . 0.0 114.128 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 23.8 mm -80.88 149.2 5.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.5 47.8 0.5 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.909 0.755 . . . . 0.0 110.386 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.4 p -64.53 158.83 23.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 123.817 1.77 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -140.94 146.99 38.1 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.389 2.676 . . . . 0.0 104.4 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -61.01 122.5 15.09 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.695 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.4 m170 67.73 42.05 2.09 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.08 -10.86 8.11 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.406 ' HA ' ' CZ3' ' A' ' 331' ' ' TRP . 10.3 p90 38.18 50.71 2.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.15 -46.33 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.216 2.611 . . . . 0.0 113.995 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.8 tp 41.99 31.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 112.732 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -133.66 -6.37 2.63 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -172.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.0 p -156.91 160.69 39.36 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 118.626 1.213 . . . . 0.0 108.105 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -176.99 -165.26 32.11 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.182 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -156.82 161.24 39.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.554 0.741 . . . . 0.0 109.933 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.31 134.53 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 120.9 1.682 . . . . 0.0 108.477 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 347' ' ' ASP . 96.8 m -106.37 141.95 36.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 125.062 1.476 . . . . 0.0 108.323 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.58 161.44 16.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.592 1.557 . . . . 0.0 112.271 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -131.26 11.37 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -135.96 140.31 43.87 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -76.91 -29.56 55.77 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.578 0.549 . . . . 0.0 111.869 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . 0.538 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -64.44 -18.59 64.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.382 0.537 . . . . 0.0 110.739 -175.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.1 m -79.81 -19.74 47.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 118.485 0.584 . . . . 0.0 111.187 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -76.5 -51.14 12.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.107 0.867 . . . . 0.0 110.945 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -19.2 61.21 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 119.611 1.096 . . . . 0.0 111.646 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.81 -26.32 57.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.737 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.98 59.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.805 -0.559 . . . . 0.0 110.908 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.53 -9.07 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.567 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.2 p -105.25 -8.79 18.08 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.324 0.39 . . . . 0.0 110.26 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -100.9 -48.44 4.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.517 0.51 . . . . 0.0 110.335 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.01 -12.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 129.947 3.299 . . . . 0.0 118.858 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -162.72 138.5 7.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.255 -1.528 . . . . 0.0 107.262 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.83 157.0 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.375 -0.828 . . . . 0.0 111.031 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . 0.425 ' HA ' ' HG3' ' A' ' 423' ' ' LYS . 41.6 mt-10 -105.97 138.92 41.32 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.401 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 421' ' ' THR . 73.4 mt -103.41 116.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -134.45 110.19 9.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.632 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.0 p -132.39 -175.12 3.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.664 0.786 . . . . 0.0 110.249 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 88.9 m -83.19 4.49 26.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.64 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -143.27 -4.73 0.88 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.849 1.204 . . . . 0.0 113.73 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -144.65 145.53 31.8 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.681 0.613 . . . . 0.0 110.052 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 26.6 m -153.85 116.21 4.37 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.99 0.516 . . . . 0.0 109.955 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -162.16 157.12 22.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 123.804 0.69 . . . . 0.0 110.679 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 414' ' ' GLU . 0.1 OUTLIER -114.87 162.42 16.93 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.88 148.34 19.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.731 1.212 . . . . 0.0 108.316 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -132.19 129.36 39.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.937 1.351 . . . . 0.0 111.776 -170.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.13 143.83 16.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.047 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -136.64 148.5 63.86 Favored Pre-proline 0 N--CA 1.444 -0.745 0 O-C-N 123.676 0.61 . . . . 0.0 110.223 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.56 158.41 13.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.944 3.096 . . . . 0.0 112.468 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 117.448 -1.263 . . . . 0.0 109.028 178.497 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 221' ' ' SER . 2.3 m 43.99 45.7 6.67 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.339 1.056 . . . . 0.0 110.838 -170.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 15.02 0.04 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 219' ' ' THR . 78.5 p -46.52 143.05 2.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.571 1.548 . . . . 0.0 113.944 -168.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 134.96 -2.22 3.96 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.77 -1.104 . . . . 0.0 114.072 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -134.48 22.05 3.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.394 1.097 . . . . 0.0 111.326 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.71 -57.96 3.0 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-O 116.131 -1.89 . . . . 0.0 112.918 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.26 117.19 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.6 2.867 . . . . 0.0 108.88 -170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.57 -40.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.304 3.336 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 43.52 22.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -86.42 -7.7 58.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.755 1.222 . . . . 0.0 111.796 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.98 145.64 52.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 230' ' ' LYS . 25.8 mmmt -144.39 8.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.367 -0.833 . . . . 0.0 113.142 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 61.86 50.25 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.173 -172.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.04 129.61 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.859 2.373 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.5 mm -147.72 144.81 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -105.88 151.52 24.44 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.807 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -152.08 3.77 0.39 Allowed 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.455 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 4.0 t -146.99 -170.37 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.313 -0.867 . . . . 0.0 108.828 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 175.94 1.19 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.91 141.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.852 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -91.05 133.92 34.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.718 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.8 tt -143.11 124.36 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -156.62 152.11 23.5 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.04 14.55 0.1 Allowed Glycine 0 CA--C 1.537 1.42 0 O-C-N 124.646 0.85 . . . . 0.0 111.656 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.29 108.66 61.91 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 118.114 0.957 . . . . 0.0 110.982 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.3 0.26 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 124.847 3.698 . . . . 0.0 113.642 171.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.436 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 4.2 p-90 -135.9 -96.86 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 25.0 t0 42.53 65.02 0.99 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.577 . . . . 0.0 111.855 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.65 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.12 -30.49 36.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -171.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 250' ' ' ALA . 16.8 m -140.18 126.65 20.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.97 -7.41 58.78 Favored 'General case' 0 C--O 1.201 -1.499 0 O-C-N 123.554 0.534 . . . . 0.0 110.735 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.456 ' H ' HG23 ' A' ' 248' ' ' THR . . . -71.52 -21.71 61.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.062 -0.399 . . . . 0.0 111.462 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.76 -48.99 6.78 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.59 -41.2 98.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 114.823 -0.688 . . . . 0.0 109.638 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.57 -50.72 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.494 -1.379 . . . . 0.0 110.641 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -69.24 -9.06 51.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.4 m -80.94 -32.32 34.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.1 68.29 1.4 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.858 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 257' ' ' ARG . 13.6 ttt180 -123.74 7.18 8.78 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.439 1.096 . . . . 0.0 111.727 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.91 7.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 119.807 -1.808 . . . . 0.0 112.362 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.72 -10.32 23.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.34 -4.07 13.8 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.878 1.511 . . . . 0.0 116.878 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.7 p -112.32 44.76 1.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 120.599 -1.53 . . . . 0.0 111.704 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 163.57 32.47 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.6 m -149.99 175.69 11.46 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.483 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.98 157.08 41.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 O-C-N 121.525 -0.734 . . . . 0.0 111.013 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -138.11 135.6 35.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.392 1.091 . . . . 0.0 111.275 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.31 148.9 36.46 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.23 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.01 -21.37 15.9 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.239 3.293 . . . . 0.0 111.756 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 178.27 -6.5 0.03 OUTLIER Glycine 0 CA--C 1.547 2.078 0 CA-C-O 118.482 -1.176 . . . . 0.0 115.859 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -94.87 107.18 19.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.793 2.297 . . . . 0.0 109.872 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.69 145.02 29.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 167.88 -173.35 42.81 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -63.92 -40.52 96.66 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.82 1.648 . . . . 0.0 112.272 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -147.05 84.56 7.34 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.25 -48.65 1.16 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.528 2.152 . . . . 0.0 114.095 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 46.56 9.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.03 2.132 . . . . 0.0 114.922 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 41.9 t -164.52 111.33 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 119.255 0.934 . . . . 0.0 110.391 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.91 160.82 46.77 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.882 2.388 . . . . 0.0 110.076 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.28 -17.47 13.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.234 2.623 . . . . 0.0 112.01 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -146.9 167.35 24.17 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.146 1.379 . . . . 0.0 110.878 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.66 19.72 3.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.964 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -152.82 165.86 34.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.336 1.568 . . . . 0.0 112.631 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.6 m -154.76 -170.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 126.328 2.267 . . . . 0.0 109.391 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -118.3 153.87 33.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.418 1.087 . . . . 0.0 110.525 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.74 147.31 48.72 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.15 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.98 112.02 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 109.268 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -139.76 -179.73 6.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.53 -174.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.56 124.18 10.27 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.17 -13.38 26.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.67 -49.22 0.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 116.859 -1.937 . . . . 0.0 112.195 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -81.19 -36.68 29.82 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 72.7 m -76.22 -31.18 58.27 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 120.158 1.345 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.562 HG23 ' CE1' ' A' ' 286' ' ' PHE . 2.8 t -60.86 -52.33 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -74.54 -23.48 58.8 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 74.8 m -72.44 -36.42 68.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 109.924 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.9 mp -74.66 -54.14 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 4.16 36.76 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.573 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -111.19 -10.51 14.29 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 110.783 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.54 37.25 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.323 0.965 . . . . 0.0 110.773 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.41 -115.7 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.794 0.806 . . . . 0.0 112.634 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.4 m -126.01 155.97 40.62 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 111.688 -171.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -157.56 159.28 36.97 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.646 1.178 . . . . 0.0 109.049 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 304' ' ' LEU . 16.2 m-20 -146.65 89.12 5.85 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 109.684 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.02 22.52 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.998 1 C-N-CA 128.618 6.212 . . . . 0.0 110.194 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 302' ' ' ASP . 7.2 mp . . . . . 0 C--O 1.238 0.464 0 C-N-CA 124.492 1.117 . . . . 0.0 112.271 -166.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 3.2 p 171.08 176.97 0.06 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.418 1.487 . . . . 0.0 107.963 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.27 130.76 50.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -108.48 143.81 36.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -124.78 145.27 49.82 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.847 0.832 . . . . 0.0 110.725 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -151.71 155.98 39.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.315 -1.311 . . . . 0.0 107.77 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 11.0 ptpt -129.34 143.61 50.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.015 0.825 . . . . 0.0 110.177 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.49 -7.65 5.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.676 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.524 ' HG ' ' HB2' ' A' ' 321' ' ' MET . 47.7 t -140.34 133.34 29.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.653 1.115 . . . . 0.0 109.685 172.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 60.4 m -140.85 -13.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.1 -8.77 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.941 1.246 . . . . 0.0 110.849 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -86.24 -29.11 23.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.769 0.827 . . . . 0.0 111.479 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.524 ' HB2' ' HG ' ' A' ' 317' ' ' SER . 97.2 mmm -142.08 164.89 28.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.24 0.616 . . . . 0.0 109.748 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 322' ' ' ARG . 70.6 mtt-85 -92.07 45.94 1.24 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.147 1.379 . . . . 0.0 111.172 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.25 -166.13 1.53 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.798 0.839 . . . . 0.0 109.642 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -143.27 -173.2 3.87 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -54.36 158.65 2.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.571 1.548 . . . . 0.0 113.173 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -121.38 153.4 25.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -172.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.65 150.31 21.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 120.181 1.355 . . . . 0.0 110.253 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.86 145.65 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.865 0.466 . . . . 0.0 110.281 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -144.12 99.73 5.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 123.775 0.672 . . . . 0.0 111.803 172.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.22 168.11 15.28 Favored 'Trans proline' 0 N--CA 1.46 -0.454 1 C-N-CA 125.306 4.004 . . . . 0.0 110.849 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.455 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 2.8 t-105 -88.0 125.42 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.3 t -105.84 145.12 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.394 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 13.1 mt -55.79 -21.33 18.78 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.729 0.643 . . . . 0.0 111.071 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.6 -4.42 30.73 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.72 3.61 15.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.192 1.397 . . . . 0.0 111.073 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 46.6 m -107.13 -49.29 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 120.694 -1.254 . . . . 0.0 111.841 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -155.04 153.88 31.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.544 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -153.8 145.72 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.571 0.748 . . . . 0.0 109.446 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.86 138.52 41.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 18.17 4.12 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.0 t -150.6 141.44 14.72 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.29 1.836 . . . . 0.0 107.29 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -66.23 -15.99 50.25 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.901 3.067 . . . . 0.0 111.069 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 37.8 p -163.22 90.91 0.68 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.439 1.018 . . . . 0.0 111.758 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -154.29 168.59 26.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -131.95 -179.28 5.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.325 1.45 . . . . 0.0 110.235 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.63 171.76 13.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -116.36 155.27 48.64 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.681 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -68.72 104.1 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.701 2.267 . . . . 0.0 113.205 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 74.4 m 57.31 46.15 18.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.131 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 350' ' ' ARG . 4.6 tpm_? -138.03 87.99 2.28 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.102 -0.999 . . . . 0.0 112.439 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.0 p -144.08 166.95 23.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.72 163.32 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.009 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -86.78 160.83 18.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.726 0.694 . . . . 0.0 110.487 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.7 t -146.32 131.89 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.75 -175.85 37.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 49.39 29.14 2.67 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.423 1.089 . . . . 0.0 112.273 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.664 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -93.54 -175.73 3.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.668 -0.645 . . . . 0.0 110.175 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -59.13 154.03 16.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.155 0.582 . . . . 0.0 111.904 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.08 1.1 9.04 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.256 -0.746 . . . . 0.0 113.665 -172.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 13.3 ptp -158.18 30.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.466 2.133 . . . . 0.0 111.839 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.1 126.99 29.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.23 167.49 13.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.038 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.59 -25.54 61.37 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 121.469 -0.769 . . . . 0.0 112.167 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -82.99 -18.93 38.14 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 118.481 0.582 . . . . 0.0 111.994 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.88 -36.48 18.39 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.59 -46.59 89.2 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.23 68.08 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.613 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.97 84.52 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.916 0.78 . . . . 0.0 109.695 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 35.8 mt -71.12 -36.51 63.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 119.633 -0.222 . . . . 0.0 110.56 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.0 -0.9 55.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.79 -15.3 10.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 120.837 -1.165 . . . . 0.0 112.269 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.29 -26.83 13.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.852 0.751 . . . . 0.0 109.212 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 16.0 tp -80.87 -17.42 50.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 123.424 0.453 . . . . 0.0 110.428 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 403' ' ' SER . 29.0 p90 -166.74 -13.53 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 68.1 20.1 72.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -90.1 9.23 78.06 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 120.808 -1.407 . . . . 0.0 114.613 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.5 163.43 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.236 1.018 . . . . 0.0 113.516 -170.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.25 -33.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.232 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -159.46 147.55 17.48 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.43 149.04 29.5 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.457 0.646 . . . . 0.0 110.455 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.71 160.97 29.3 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.64 -0.662 . . . . 0.0 113.493 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.4 mm -96.37 144.28 10.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 124.383 0.696 . . . . 0.0 110.564 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -82.52 60.92 5.4 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 121.231 0.539 . . . . 0.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' THR . . . . . 0.412 ' HA ' ' HG2' ' A' ' 390' ' ' PRO . 2.9 p -61.15 154.53 22.96 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 124.068 1.89 . . . . 0.0 111.903 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.49 129.58 20.84 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.0 130.75 45.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.226 -170.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 8.4 m170 68.53 29.09 5.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.145 -2.298 . . . . 0.0 112.398 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.71 -0.53 13.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.2 t80 47.41 41.55 0.94 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.129 1.772 . . . . 0.0 113.645 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.541 ' C ' ' H ' ' A' ' 392' ' ' GLY . 36.1 Cg_endo -81.34 37.91 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.523 2.148 . . . . 0.0 109.025 -170.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.426 ' HB ' ' CH2' ' A' ' 331' ' ' TRP . 10.8 tp -69.83 25.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.984 0 C-N-CA 123.637 0.775 . . . . 0.0 111.448 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 390' ' ' PRO . . . -123.04 1.55 9.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 118.543 -1.143 . . . . 0.0 111.142 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.3 p -155.47 151.61 27.94 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.264 1.032 . . . . 0.0 110.794 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.81 -174.73 42.62 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.882 1.268 . . . . 0.0 113.958 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.07 166.8 20.93 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 121.324 -1.103 . . . . 0.0 111.227 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.18 144.12 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 23.1 m -103.76 119.15 38.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.6 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -106.39 156.3 18.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.656 0.782 . . . . 0.0 108.945 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -136.16 21.99 3.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -141.4 159.22 42.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -83.14 -47.24 11.83 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -21.86 62.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.409 ' HB3' ' CD1' ' A' ' 374' ' ' PHE . 34.2 p -72.51 -21.75 61.14 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.926 -1.109 . . . . 0.0 111.163 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.58 -62.73 1.48 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.28 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.455 ' H ' HD11 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -67.95 -17.08 64.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 119.317 0.962 . . . . 0.0 113.124 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.17 -29.34 28.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.586 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -18.25 58.0 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.31 -1.494 . . . . 0.0 110.411 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.14 -27.4 7.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.4 t -85.79 -9.56 56.87 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 0.0 111.299 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -112.22 -59.66 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.247 172.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.68 -16.33 0.03 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 127.921 2.488 . . . . 0.0 114.055 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -162.8 136.99 6.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.9 m -139.54 164.29 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -105.11 145.56 30.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.957 1.411 . . . . 0.0 110.824 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.9 mt -123.89 126.52 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.411 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 221' ' ' SER . 57.0 mmtt -137.65 114.37 10.5 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.704 1.253 . . . . 0.0 110.243 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 92.7 m -151.01 159.51 44.51 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -54.67 139.95 37.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.566 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? 59.32 13.43 3.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.12 1.368 . . . . 0.0 114.675 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.54 116.18 4.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.897 -1.127 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 17.2 p -145.84 112.43 5.91 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.681 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.2 tptm -166.64 -173.11 2.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.011 0.823 . . . . 0.0 110.022 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.681 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.5 mttp -125.66 172.18 9.99 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 123.604 0.762 . . . . 0.0 109.562 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -144.25 151.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.853 1.346 . . . . 0.0 109.881 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.0 158.57 36.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.235 -0.915 . . . . 0.0 110.274 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 23.8 mt -142.69 146.02 22.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -147.56 141.62 15.91 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.653 0.661 . . . . 0.0 110.669 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -82.76 174.62 9.43 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 124.243 3.295 . . . . 0.0 111.192 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.19 171.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.761 0.791 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 98.1 m -139.52 147.48 41.3 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 171.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.7 -25.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.1 m 50.39 119.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.426 2.29 . . . . 0.0 114.445 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.45 -3.92 0.05 OUTLIER Glycine 0 N--CA 1.469 0.84 0 O-C-N 120.394 -1.441 . . . . 0.0 115.598 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.06 -9.39 55.24 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.374 -1.663 . . . . 0.0 114.604 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.515 ' H ' ' CD2' ' A' ' 224' ' ' LEU . 3.8 mm? -16.5 88.05 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 128.954 2.902 . . . . 0.0 111.281 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.83 158.43 3.41 Favored 'Trans proline' 0 N--CA 1.449 -1.11 1 C-N-CA 127.581 5.521 . . . . 0.0 111.496 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 147.74 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.949 1.766 . . . . 0.0 110.484 172.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -139.83 18.33 2.49 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.867 0.73 . . . . 0.0 109.066 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -122.39 32.13 5.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.922 0.889 . . . . 0.0 112.647 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -64.33 162.26 15.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.196 1.398 . . . . 0.0 112.762 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -77.19 -19.37 56.84 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 58.74 73.35 0.72 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.96 -44.08 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.505 2.137 . . . . 0.0 115.419 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.9 mt -147.8 153.88 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.578 1.081 . . . . 0.0 108.274 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -112.53 150.9 30.65 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.6 t -150.06 17.75 0.86 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.387 0.994 . . . . 0.0 113.409 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' CYS . . . . . 0.476 ' HB3' ' CB ' ' A' ' 331' ' ' TRP . 0.9 OUTLIER -156.77 -175.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -61.54 171.25 1.55 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.469 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.25 150.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.456 -170.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -92.6 133.42 35.98 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.13 124.44 15.59 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.754 1.161 . . . . 0.0 110.564 -173.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 167.56 -172.5 42.46 Favored Glycine 0 N--CA 1.473 1.142 0 O-C-N 124.061 0.851 . . . . 0.0 112.635 172.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.47 7.12 3.2 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.273 0.94 . . . . 0.0 112.764 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.5 m -102.62 135.89 19.43 Favored Pre-proline 0 C--O 1.219 -0.51 0 C-N-CA 123.722 0.809 . . . . 0.0 111.203 -174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -70.23 -5.08 15.65 Favored 'Trans proline' 0 N--CA 1.439 -1.722 1 C-N-CA 126.33 4.687 . . . . 0.0 115.574 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 323' ' ' CYS . 22.3 p-90 -142.13 -60.9 0.46 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 120.216 1.371 . . . . 0.0 113.803 -174.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.48 -60.13 0.13 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.133 1.373 . . . . 0.0 112.996 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . 0.5 0.0 OUTLIER 63.34 -41.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.832 1.958 . . . . 0.0 115.232 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 25.9 p -157.86 134.95 10.08 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 124.901 1.281 . . . . 0.0 109.078 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.1 pm0 -89.51 -22.85 22.23 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 119.632 -1.918 . . . . 0.0 111.745 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.03 64.42 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.165 0.915 . . . . 0.0 111.32 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.19 15.69 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 255' ' ' THR . 46.6 mt -70.74 -36.97 73.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.66 -37.68 80.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.582 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.424 ' HA ' ' CD ' ' A' ' 257' ' ' ARG . 62.9 m-20 -64.14 -21.96 66.75 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.243 1.383 . . . . 0.0 109.735 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 252' ' ' LEU . 84.2 m -79.16 -27.62 42.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.784 0.72 . . . . 0.0 110.669 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -131.28 23.19 4.81 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.447 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 16.6 ptm180 -86.96 33.92 0.67 Allowed 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.052 0.941 . . . . 0.0 113.391 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.54 2.26 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.14 -2.27 15.02 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 64.01 3.56 8.87 Favored Glycine 0 C--O 1.214 -1.144 0 CA-C-O 118.113 -1.381 . . . . 0.0 113.189 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.52 2.39 28.4 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.891 0.995 . . . . 0.0 113.001 -167.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 257' ' ' ARG . 6.1 mt -68.52 141.72 55.46 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 122.931 1.348 . . . . 0.0 114.551 -167.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.5 t -152.23 96.12 2.14 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 124.677 2.179 . . . . 0.0 106.976 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.06 144.31 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 O-C-N 119.423 -2.048 . . . . 0.0 109.41 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.52 135.27 42.24 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 120.758 -1.214 . . . . 0.0 111.396 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 8.9 p90 -150.88 143.83 16.66 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 121.497 0.665 . . . . 0.0 112.018 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -86.0 169.37 8.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.492 3.461 . . . . 0.0 111.633 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.41 -8.06 7.58 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 126.465 1.983 . . . . 0.0 114.756 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.82 55.22 1.79 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.471 1.136 . . . . 0.0 111.869 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.14 5.45 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.832 0.453 . . . . 0.0 111.487 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.28 149.37 9.04 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 121.124 -0.985 . . . . 0.0 112.416 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 67.89 159.72 0.16 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.627 1.571 . . . . 0.0 110.696 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 16.9 m170 34.14 76.71 0.4 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.762 1.625 . . . . 0.0 115.138 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.35 111.9 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.588 2.192 . . . . 0.0 112.056 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -157.29 169.32 25.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.584 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 12.8 t -121.62 143.02 37.04 Favored Pre-proline 0 CA--C 1.513 -0.456 0 C-N-CA 124.436 1.095 . . . . 0.0 109.853 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' PRO . . . . . 0.584 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 84.3 Cg_endo -70.7 151.07 63.44 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.626 2.884 . . . . 0.0 109.631 -174.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.58 -6.19 16.01 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.612 2.875 . . . . 0.0 111.714 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -78.08 1.42 21.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.862 -0.59 . . . . 0.0 111.909 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.27 48.25 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 8.6 p90 -152.47 157.0 40.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.287 1.543 . . . . 0.0 112.034 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.3 m -152.48 -154.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 127.491 2.316 . . . . 0.0 108.827 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -114.98 164.28 14.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.646 0.779 . . . . 0.0 112.078 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.5 138.36 14.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.865 -0.522 . . . . 0.0 111.364 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.89 125.31 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 168.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' A' ' 292' ' ' VAL . 0.1 OUTLIER -146.71 92.27 2.13 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.973 -173.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 286' ' ' PHE . 11.5 tp10 37.88 61.69 1.02 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -48.64 9.87 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 128.306 2.642 . . . . 0.0 117.683 -167.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.02 -72.53 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.992 1.724 . . . . 0.0 111.166 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -78.39 -34.44 48.18 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 22.8 t -73.62 -32.58 64.14 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.497 HG23 ' CE1' ' A' ' 286' ' ' PHE . 89.0 t -63.87 -52.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -61.33 -34.92 76.06 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.668 0.605 . . . . 0.0 112.237 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.1 m -74.29 -34.15 63.44 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.773 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -45.8 65.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.469 0.652 . . . . 0.0 110.169 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -13.54 57.96 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.105 -0.997 . . . . 0.0 113.441 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.24 -4.58 35.0 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.288 -0.883 . . . . 0.0 111.54 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -104.58 -15.05 15.43 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.679 1.237 . . . . 0.0 108.841 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 60.6 m -107.68 -142.61 0.38 Allowed 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.744 -0.597 . . . . 0.0 109.829 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.2 m -110.54 172.51 6.83 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 120.474 -1.391 . . . . 0.0 113.388 -171.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.407 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 85.3 t60 -149.87 165.19 33.32 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.69 -0.631 . . . . 0.0 110.992 -172.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 33.3 t0 -134.45 112.2 11.83 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.92 51.65 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 1 C-N-CA 127.384 5.389 . . . . 0.0 110.187 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.25 5.8 mp . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.224 -0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 29.9 m -66.52 132.69 48.78 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.218 0.607 . . . . 0.0 110.5 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.53 144.26 49.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 119.253 0.933 . . . . 0.0 110.882 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -110.74 152.66 26.32 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.254 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 37.1 m-85 -140.36 148.33 41.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.743 1.258 . . . . 0.0 113.061 -170.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -158.89 163.73 36.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -135.31 133.05 38.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.698 0.761 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.2 OUTLIER -134.98 13.66 3.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.659 -171.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.7 p -58.5 153.73 15.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.8 m -111.88 163.05 14.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.219 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -70.84 -9.77 58.24 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ARG . . . . . 0.401 ' HG3' ' SD ' ' A' ' 321' ' ' MET . 17.1 ptp180 -82.36 -18.09 43.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.416 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.401 ' SD ' ' HG3' ' A' ' 320' ' ' ARG . 4.0 mpp? -135.93 -48.82 0.68 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 44.33 43.08 5.78 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' CYS . . . . . 0.475 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 71.1 m -93.23 -60.49 1.78 Allowed 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.326 -1.484 . . . . 0.0 113.842 -173.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -158.52 152.39 23.61 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 118.856 -1.138 . . . . 0.0 113.164 -170.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.51 173.42 4.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.842 2.057 . . . . 0.0 113.936 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 3.7 p -118.66 158.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.168 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 5.4 pp0? -115.69 163.28 16.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.198 0.908 . . . . 0.0 112.047 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.95 130.21 13.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.689 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 pt -136.68 88.59 19.08 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.16 0.584 . . . . 0.0 110.89 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -76.99 177.85 8.38 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.903 3.735 . . . . 0.0 116.604 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' TRP . . . . . 0.476 ' CB ' ' HB3' ' A' ' 236' ' ' CYS . 7.3 t-105 -82.24 140.89 33.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.915 0.886 . . . . 0.0 110.169 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.666 HG13 ' H ' ' A' ' 334' ' ' ALA . 9.5 t -115.0 151.66 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.558 1.171 . . . . 0.0 111.913 -176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.434 ' C ' HD21 ' A' ' 333' ' ' LEU . 6.6 tt -57.25 -36.96 71.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.269 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.666 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -70.44 -5.64 29.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.261 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -105.24 -7.01 19.24 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.701 -0.624 . . . . 0.0 111.667 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.8 m -83.83 -37.91 21.9 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -154.57 165.52 36.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.071 0.548 . . . . 0.0 111.872 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -146.03 133.9 21.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.8 m -120.39 148.3 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -5.07 24.89 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.869 -0.519 . . . . 0.0 110.254 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.9 m -131.11 148.46 70.32 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.07 108.4 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.669 1.579 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 8.3 t 54.58 38.57 30.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.248 1.419 . . . . 0.0 113.492 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -75.2 160.25 30.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.379 0.609 . . . . 0.0 111.061 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -92.92 179.33 5.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.13 167.06 13.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 123.966 0.791 . . . . 0.0 109.675 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.06 102.55 15.86 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.02 -1.45 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 114.568 -171.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 81.5 p -130.42 8.8 5.06 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.679 -1.263 . . . . 0.0 114.133 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -144.48 102.37 3.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.082 0.944 . . . . 0.0 108.753 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -160.46 149.5 17.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.27 0.628 . . . . 0.0 110.229 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.02 154.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -81.07 136.68 35.98 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.151 0.907 . . . . 0.0 109.753 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 84.7 t -128.61 133.13 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.761 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -175.8 -165.9 32.44 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 121.638 0.576 . . . . 0.0 114.104 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.07 28.71 5.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.562 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.6 -160.27 0.71 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.635 1.174 . . . . 0.0 111.86 -175.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -36.22 -24.64 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.949 2.1 . . . . 0.0 115.31 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.63 78.31 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 119.351 0.978 . . . . 0.0 113.644 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 28.0 ptm -156.76 30.29 0.31 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 113.115 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.7 tp -76.84 156.24 32.37 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 121.284 0.564 . . . . 0.0 110.973 -171.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.73 170.28 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.509 1.123 . . . . 0.0 110.48 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.1 -25.62 61.82 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -74.68 -26.27 59.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.818 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.55 -32.59 36.66 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.23 -34.46 68.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.855 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.07 80.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.131 0.972 . . . . 0.0 111.187 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.53 -34.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.48 -6.19 44.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.118 -173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -16.6 14.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.546 1.521 . . . . 0.0 111.338 172.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -97.3 -28.69 13.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.722 0.692 . . . . 0.0 110.744 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.0 tp -83.02 -26.71 30.95 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.26 -59.02 1.6 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.261 -0.899 . . . . 0.0 113.005 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 163.5 -139.66 6.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -70.33 148.16 45.23 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 123.555 1.642 . . . . 0.0 113.881 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.07 152.93 8.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 127.736 2.414 . . . . 0.0 109.893 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.58 -30.64 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.228 -0.892 . . . . 0.0 112.183 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.8 OUTLIER -150.46 147.91 28.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.177 0.899 . . . . 0.0 112.116 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -142.96 139.01 30.5 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -135.17 151.81 20.61 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.67 0.594 . . . . 0.0 114.095 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.85 148.46 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -103.5 147.78 26.74 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 125.281 1.613 . . . . 0.0 108.016 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 47.5 p -140.81 163.06 33.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.5 -0.75 . . . . 0.0 112.118 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.66 34.13 4.7 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.706 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.32 28.02 0.41 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.616 1.566 . . . . 0.0 113.498 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -136.04 23.77 3.29 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp 62.75 -15.66 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.43 ' N ' ' HD2' ' A' ' 390' ' ' PRO . 22.2 p90 -78.73 -22.0 0.37 Allowed Pre-proline 0 CA--C 1.515 -0.371 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -170.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 389' ' ' TYR . 18.5 Cg_endo -61.71 -67.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.419 HD11 ' CZ3' ' A' ' 331' ' ' TRP . 10.9 tp 32.44 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.811 1.644 . . . . 0.0 110.885 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 177.24 27.97 0.04 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.69 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 70.5 m -143.16 146.84 34.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 167.11 -159.08 32.35 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.618 -1.101 . . . . 0.0 112.095 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -154.37 166.82 32.02 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 125.299 1.234 . . . . 0.0 109.594 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.42 126.35 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 42.1 p -95.59 118.67 32.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 69.8 m-85 -90.15 162.63 15.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.145 0.974 . . . . 0.0 111.049 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -122.93 -0.51 8.99 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -124.88 153.04 43.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.628 0.371 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -80.76 -30.57 36.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.443 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -39.1 64.86 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.282 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' SER . . . . . 0.597 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 21.5 m -65.95 -25.59 67.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.536 0.607 . . . . 0.0 111.276 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.67 -57.15 3.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.338 0.589 . . . . 0.0 111.417 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' LEU . . . . . 0.414 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -74.26 -20.76 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.496 -0.752 . . . . 0.0 111.792 -177.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -81.13 -26.66 35.95 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.912 1.233 . . . . 0.0 109.626 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -71.02 -43.39 68.02 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.89 -21.84 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.233 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.4 p -81.18 -26.33 36.08 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 118.352 -0.833 . . . . 0.0 112.83 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.38 -33.15 14.68 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.232 0.469 . . . . 0.0 111.757 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 51.16 -22.54 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -163.69 130.53 3.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.891 -1.755 . . . . 0.0 107.506 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.57 174.69 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.884 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -116.46 153.85 31.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.516 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 28.6 mt -127.35 123.48 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.421 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -125.44 140.59 52.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.307 1.004 . . . . 0.0 108.815 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 m -148.8 167.76 24.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.4 t -60.95 -18.83 59.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . 0.557 ' HZ1' ' HB3' ' A' ' 419' ' ' LYS . 0.3 OUTLIER -151.0 15.94 0.75 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 176.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -139.42 128.88 24.29 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.634 -0.666 . . . . 0.0 110.622 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 52.5 p -146.86 124.18 11.59 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.063 -0.398 . . . . 0.0 110.148 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' LYS . . . . . 0.605 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 29.4 tptt -165.6 -161.33 0.51 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.631 0.582 . . . . 0.0 110.476 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . 0.605 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 92.8 mttt -141.45 168.48 19.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.39 139.21 29.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -122.3 160.76 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 60.2 mt -139.28 137.3 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.254 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -128.06 145.29 54.8 Favored Pre-proline 0 C--N 1.324 -0.543 0 O-C-N 123.911 0.757 . . . . 0.0 111.211 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 145.67 94.82 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.332 3.354 . . . . 0.0 111.644 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 79.0 t80 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.428 1.091 . . . . 0.0 112.967 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' MET . . . . . 0.429 ' H2 ' HG13 ' A' ' 413' ' ' VAL . 73.3 mtm . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 93.7 m -152.86 146.4 25.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.46 -169.27 3.25 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.659 1.118 . . . . 0.0 111.529 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.1 p -130.11 19.93 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.959 1.703 . . . . 0.0 109.786 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.48 12.23 65.69 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.14 1.352 . . . . 0.0 116.386 -168.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -51.85 156.0 1.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.48 139.46 20.65 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.346 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -44.21 109.63 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.512 3.475 . . . . 0.0 112.371 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.04 17.35 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.907 3.071 . . . . 0.0 111.138 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -133.63 19.51 3.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.539 0.336 . . . . 0.0 111.091 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -134.68 39.33 3.02 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 121.855 0.836 . . . . 0.0 110.845 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -76.13 161.7 28.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.165 0.986 . . . . 0.0 109.087 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -79.21 -10.18 59.75 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 42.7 62.34 8.38 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.894 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.33 -76.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.0 1.8 . . . . 0.0 112.224 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.9 pt -141.17 -178.83 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 124.909 1.284 . . . . 0.0 110.061 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -111.72 153.43 26.48 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.9 p -146.22 -9.95 0.5 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.617 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 16.8 t -143.85 171.14 14.63 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.033 0.533 . . . . 0.0 109.576 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.438 ' HG2' ' HG ' ' A' ' 236' ' ' CYS . 18.8 ptmt -53.66 174.13 0.05 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.824 1.649 . . . . 0.0 114.309 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.7 146.92 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.32 140.17 32.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.012 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.415 ' CD1' HG23 ' A' ' 328' ' ' VAL . 20.1 tp -141.47 143.2 33.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 111.123 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.5 156.55 28.57 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.537 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.95 14.28 1.47 Allowed Glycine 0 N--CA 1.475 1.235 0 O-C-N 122.005 -0.703 . . . . 0.0 112.616 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.96 72.98 18.04 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.342 -1.093 . . . . 0.0 110.905 -174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.8 7.72 2.27 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.532 2.154 . . . . 0.0 113.655 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 17.6 p-90 -141.42 -4.94 1.1 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.52 109.15 1.55 Allowed 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 124.69 1.196 . . . . 0.0 112.593 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -72.48 -30.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.351 -172.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.9 p -142.4 126.05 16.91 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 119.734 1.152 . . . . 0.0 112.977 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -71.0 -16.22 62.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.458 -172.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.12 -16.48 61.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 120.215 1.371 . . . . 0.0 108.472 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.33 99.23 Favored Glycine 0 N--CA 1.435 -1.424 0 O-C-N 120.88 -1.137 . . . . 0.0 112.704 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 48.6 mt -69.68 -31.84 70.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.504 1.122 . . . . 0.0 108.27 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.74 -36.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.608 -0.682 . . . . 0.0 110.179 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -80.29 -9.97 59.74 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.955 0.798 . . . . 0.0 111.179 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.0 m -96.49 -21.72 17.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -103.54 -24.32 13.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -74.3 -0.17 16.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.014 0.825 . . . . 0.0 111.81 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.23 -20.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.186 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -101.05 -7.09 23.56 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 156.23 -166.18 33.04 Favored Glycine 0 N--CA 1.432 -1.577 0 O-C-N 124.499 1.124 . . . . 0.0 114.684 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 58.5 m -51.02 124.11 10.69 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.456 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 152.95 42.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.497 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -146.99 168.84 20.52 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.598 1.559 . . . . 0.0 108.711 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.6 152.2 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 121.489 -0.757 . . . . 0.0 112.26 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.21 135.86 32.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 124.497 1.123 . . . . 0.0 110.792 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.486 ' CE2' ' HG2' ' A' ' 269' ' ' LYS . 20.0 p90 -148.11 154.07 42.33 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.93 136.33 24.85 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.162 1.908 . . . . 0.0 107.365 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.2 32.97 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.486 ' HG2' ' CE2' ' A' ' 266' ' ' TRP . 35.8 mtmt -64.28 -6.43 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.449 1.124 . . . . 0.0 111.387 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.67 5.43 43.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.919 1.288 . . . . 0.0 110.696 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -69.68 -160.75 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.435 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -77.43 -17.62 57.94 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 276' ' ' CYS . 3.7 p80 -166.04 154.43 9.96 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.81 -1.39 11.1 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.397 2.732 . . . . 0.0 114.124 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -90.77 31.11 1.09 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 110.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 17.2 t -125.61 40.16 0.52 Allowed Pre-proline 0 C--N 1.34 0.159 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 89.3 Cg_endo -75.07 170.37 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 107.117 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.96 161.56 6.28 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.07 1.846 . . . . 0.0 115.269 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -54.25 -14.82 1.27 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.501 1.12 . . . . 0.0 112.432 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -179.84 16.38 0.03 OUTLIER Glycine 0 CA--C 1.533 1.156 0 CA-C-N 120.488 1.494 . . . . 0.0 112.873 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -130.15 155.85 45.54 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.272 1.536 . . . . 0.0 112.732 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.14 158.43 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 124.176 0.99 . . . . 0.0 109.819 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -118.45 150.06 40.21 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.18 140.62 52.35 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.1 129.79 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -168.03 -167.21 0.8 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -44.6 122.54 3.17 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 124.499 1.124 . . . . 0.0 109.189 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.16 -18.39 35.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.105 2.562 . . . . 0.0 115.852 -166.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -140.32 -54.1 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 120.082 1.31 . . . . 0.0 113.675 -167.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -73.96 -45.34 50.78 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.102 -0.374 . . . . 0.0 110.909 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 71.1 m -70.13 -26.78 64.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.75 -53.58 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -67.6 -26.76 66.42 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.991 -0.443 . . . . 0.0 111.904 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.6 t -67.94 -46.25 72.01 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.207 0.317 . . . . 0.0 110.44 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.8 -42.25 97.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.03 0.377 . . . . 0.0 110.513 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.66 -25.94 61.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.424 0.69 . . . . 0.0 110.042 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -104.99 2.32 29.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.142 0.902 . . . . 0.0 110.077 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.1 -10.8 14.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.594 0.634 . . . . 0.0 110.03 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 16.6 p -107.25 -148.32 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.196 0.31 . . . . 0.0 110.743 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 67.0 m -106.78 145.27 32.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.236 0.541 . . . . 0.0 110.627 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -142.89 155.06 44.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.122 0.969 . . . . 0.0 108.849 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -145.92 137.58 13.07 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 304' ' ' LEU . 96.8 Cg_endo -71.72 -103.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 122.376 2.05 . . . . 0.0 109.338 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.415 ' H ' ' HG2' ' A' ' 303' ' ' PRO . 9.8 mp -115.47 15.02 16.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.374 1.07 . . . . 0.0 109.855 -170.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.537 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 70.4 m -66.67 -26.19 1.43 Allowed Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.799 1.64 . . . . 0.0 112.055 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 305' ' ' SER . 63.0 Cg_exo -61.67 -6.97 8.16 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.135 2.557 . . . . 0.0 111.842 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.87 34.46 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -172.17 -40.59 0.04 OUTLIER Glycine 0 C--O 1.243 0.662 0 O-C-N 120.949 -1.094 . . . . 0.0 113.974 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 26.9 tp -153.71 165.23 36.63 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.598 1.199 . . . . 0.0 111.349 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 4.1 m -79.17 148.2 32.38 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.5 151.47 31.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.4 153.77 32.49 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 124.33 1.019 . . . . 0.0 109.978 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -147.62 152.66 38.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.915 -1.116 . . . . 0.0 110.017 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 5.4 t80 -153.28 178.05 10.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 30.0 ttmt -152.47 124.95 8.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -169.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 12.67 6.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.868 0.867 . . . . 0.0 110.046 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.6 p -87.48 159.74 18.54 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.416 1.086 . . . . 0.0 111.511 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.3 m -149.27 38.0 0.78 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.768 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 52.51 33.53 13.55 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 121.238 0.542 . . . . 0.0 111.725 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -80.5 -30.65 37.29 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.75 -41.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.093 0.86 . . . . 0.0 111.176 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -147.5 166.65 26.64 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.749 1.219 . . . . 0.0 109.632 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 90.7 m -140.54 123.44 16.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.927 1.346 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -159.0 152.56 22.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -89.88 156.5 18.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 110.679 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.38 152.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.244 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -117.83 131.69 56.53 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.764 0.711 . . . . 0.0 111.77 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 240' ' ' LEU . 2.6 t -115.15 143.35 25.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.302 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.99 98.08 4.45 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 124.19 0.931 . . . . 0.0 109.904 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -83.98 162.14 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.904 4.403 . . . . 0.0 111.99 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.617 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 1.8 t90 -88.34 123.65 33.13 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.777 0.799 . . . . 0.0 109.293 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.2 t -103.75 154.68 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.056 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.9 tt -54.26 -26.45 29.07 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.587 -0.696 . . . . 0.0 112.173 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.09 16.95 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.558 -0.714 . . . . 0.0 112.264 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.07 -5.3 18.15 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.782 0.833 . . . . 0.0 108.894 173.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 66.8 m -100.6 -34.82 9.73 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.016 -1.677 . . . . 0.0 113.906 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -167.18 171.93 10.41 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 124.196 0.935 . . . . 0.0 113.418 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -156.51 155.07 31.35 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.081 1.352 . . . . 0.0 108.294 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.67 148.17 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.481 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -88.83 -16.45 32.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 35.8 t -151.34 113.75 3.05 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.69 -15.03 30.36 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.598 2.865 . . . . 0.0 112.02 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.2 t -86.21 4.65 37.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.428 1.091 . . . . 0.0 112.402 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -114.37 -175.11 2.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.454 1.501 . . . . 0.0 110.936 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -141.7 -179.81 6.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 122.198 0.199 . . . . 0.0 110.892 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.484 HD13 ' HG1' ' A' ' 397' ' ' THR . 1.8 mm? -83.5 120.41 25.89 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -81.1 150.69 68.89 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 124.752 1.283 . . . . 0.0 111.121 -171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.63 108.69 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.648 3.565 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 86.2 p 52.79 23.51 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.52 73.98 0.99 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 119.453 1.024 . . . . 0.0 108.786 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 396' ' ' VAL . 8.2 t -155.75 144.14 20.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.38 159.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 118.294 0.497 . . . . 0.0 110.238 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -83.53 146.92 28.08 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.382 1.051 . . . . 0.0 113.561 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 67.5 t -131.07 136.09 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.962 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.48 -176.96 31.13 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 51.0 22.94 1.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.575 1.55 . . . . 0.0 113.365 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.644 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.65 171.94 14.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.686 0.794 . . . . 0.0 111.171 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -48.7 150.19 1.5 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.546 1.138 . . . . 0.0 109.28 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -66.39 10.6 0.64 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.945 1.259 . . . . 0.0 113.135 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.0 mmt -145.43 -53.21 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.191 0.596 . . . . 0.0 109.805 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 41.73 60.01 2.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.718 0.77 . . . . 0.0 109.639 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -72.43 173.92 8.11 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 121.986 -0.447 . . . . 0.0 111.835 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -57.12 -18.01 13.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -80.55 -35.51 34.29 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.547 -0.721 . . . . 0.0 110.807 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.64 -27.22 27.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 tt -78.68 -31.22 46.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.38 -28.59 56.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.91 -0.494 . . . . 0.0 111.993 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.9 -42.04 61.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 77.5 mt -79.09 -35.48 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 118.808 0.731 . . . . 0.0 109.067 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.31 -22.96 38.16 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.621 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.88 -23.61 21.59 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 120.561 1.528 . . . . 0.0 109.91 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.07 -36.48 58.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.527 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 2.9 mp -66.86 -34.44 77.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.313 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 403' ' ' SER . 0.2 OUTLIER -158.67 -17.38 0.07 Allowed 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.21 -7.6 5.84 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 121.979 0.766 . . . . 0.0 113.679 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -94.05 78.94 0.98 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 122.045 -0.679 . . . . 0.0 113.135 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.42 159.44 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 118.654 1.227 . . . . 0.0 112.378 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.01 -33.06 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -158.28 147.04 18.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.81 146.35 23.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.51 38.16 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 123.058 1.366 . . . . 0.0 114.304 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.56 141.4 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 122.188 0.994 . . . . 0.0 109.2 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.41 148.73 26.44 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.557 -171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.4 p -131.39 159.6 37.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.87 -175.28 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.72 88.14 2.23 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 119.728 -1.858 . . . . 0.0 112.658 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 57.9 m170 70.49 38.58 1.32 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.18 -5.02 15.44 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.889 0.876 . . . . 0.0 110.384 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.1 p90 37.87 54.52 3.85 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 127.097 2.159 . . . . 0.0 114.364 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.18 -48.45 1.76 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.774 2.316 . . . . 0.0 111.169 -174.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.75 37.73 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 111.633 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.88 10.65 0.79 Allowed Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.5 p -155.17 126.66 7.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.265 0.555 . . . . 0.0 110.093 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -156.42 -164.94 13.95 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.468 1.038 . . . . 0.0 114.91 -171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -151.76 162.6 40.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.551 -0.824 . . . . 0.0 108.899 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.401 ' C ' ' HG1' ' A' ' 351' ' ' THR . 3.6 p -143.13 134.15 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.153 -0.967 . . . . 0.0 108.881 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.484 ' HG1' HD13 ' A' ' 346' ' ' LEU . 60.7 m -111.28 142.93 42.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.304 1.05 . . . . 0.0 109.549 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 73.8 m-85 -131.44 162.35 30.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.431 -0.793 . . . . 0.0 110.619 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.85 20.83 10.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.504 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -140.12 155.65 46.9 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.157 0.983 . . . . 0.0 109.183 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.08 -24.61 28.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.67 0.668 . . . . 0.0 110.196 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.608 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 3.8 mpt_? -52.89 -31.31 39.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.556 -0.715 . . . . 0.0 111.576 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 14.3 m -80.46 -29.21 37.48 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.577 0.751 . . . . 0.0 110.864 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.42 -54.37 10.91 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.942 0.337 . . . . 0.0 111.866 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.64 -17.86 55.36 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.005 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -86.41 -31.63 21.33 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 120.45 1.477 . . . . 0.0 112.665 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -72.6 -33.32 66.63 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 120.875 -1.141 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.7 -30.7 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 14.0 t -78.41 -32.21 48.62 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.379 1.049 . . . . 0.0 110.498 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.47 -44.55 35.04 Favored 'General case' 0 C--O 1.227 -0.095 0 O-C-N 121.735 -0.603 . . . . 0.0 110.914 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.17 -17.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.124 2.569 . . . . 0.0 116.331 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.95 136.87 4.31 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.106 -1.621 . . . . 0.0 108.664 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.429 HG13 ' H2 ' ' A' ' 218' ' ' MET . 34.0 m -135.58 154.5 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.698 0.681 . . . . 0.0 110.728 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -112.8 141.48 46.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.559 0.743 . . . . 0.0 111.438 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.0 mt -100.54 122.72 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.44 52.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 418' ' ' THR . 0.3 OUTLIER -72.53 178.51 4.02 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.544 ' H ' HG23 ' A' ' 417' ' ' THR . 10.8 m -75.46 -27.36 58.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -144.32 16.32 1.68 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.963 0.887 . . . . 0.0 110.479 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.59 113.17 4.1 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.7 p -136.27 131.86 35.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.918 0.487 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -148.91 177.74 9.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -144.45 160.93 40.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.06 133.56 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -106.98 157.44 17.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.34 0.59 . . . . 0.0 111.413 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 24.8 mt -140.87 149.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.42 149.95 56.27 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 124.196 0.935 . . . . 0.0 109.387 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.5 161.61 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.413 3.409 . . . . 0.0 109.941 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 116.797 -1.573 . . . . 0.0 111.226 178.441 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.6 m -155.03 158.94 39.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.383 1.073 . . . . 0.0 111.009 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.76 -16.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.062 -0.971 . . . . 0.0 113.472 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.1 m 43.61 52.27 6.22 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.433 1.015 . . . . 0.0 112.383 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 224' ' ' LEU . . . -71.27 -22.32 78.54 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.555 -173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 59.67 27.33 16.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.727 0.811 . . . . 0.0 113.078 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.414 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.1 mm? -81.45 -22.55 0.34 Allowed Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 57.2 Cg_endo -67.76 121.43 8.48 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 CA-C-N 123.529 2.296 . . . . 0.0 111.619 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.14 166.98 4.57 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 125.232 3.955 . . . . 0.0 111.875 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -143.05 6.07 1.53 Allowed 'General case' 0 C--O 1.219 -0.541 0 O-C-N 122.003 -0.435 . . . . 0.0 112.128 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -115.88 30.15 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.976 1.71 . . . . 0.0 108.016 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -60.13 159.33 9.78 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -66.93 7.75 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -170.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 36.8 71.17 0.98 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.191 0.996 . . . . 0.0 112.183 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.31 -89.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.538 1 C-N-CA 126.072 4.515 . . . . 0.0 114.748 -173.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 11.6 mm -127.37 178.15 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.326 1.45 . . . . 0.0 107.465 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.39 157.45 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.369 -0.825 . . . . 0.0 110.108 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 77.9 p -155.39 13.24 0.36 Allowed 'General case' 0 C--N 1.341 0.208 0 CA-C-N 121.242 1.837 . . . . 0.0 115.741 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 9.1 t -151.96 -177.37 6.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.115 1.325 . . . . 0.0 108.67 172.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.89 -172.77 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.541 1.162 . . . . 0.0 113.327 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.74 144.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.185 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.48 150.86 22.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.483 0.658 . . . . 0.0 111.954 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -140.52 126.08 19.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.674 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.42 38.15 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.205 -0.934 . . . . 0.0 112.911 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.47 3.23 2.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -99.69 134.93 20.72 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.475 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.89 -3.19 12.64 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.332 2.688 . . . . 0.0 110.97 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -128.07 -177.11 4.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.88 1.324 . . . . 0.0 111.151 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -166.47 149.42 6.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.427 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -174.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 168.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.8 m -42.15 129.35 3.7 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.178 -0.951 . . . . 0.0 110.527 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.2 -25.03 65.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 121.694 -0.629 . . . . 0.0 112.242 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.78 -22.93 64.25 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.397 0.999 . . . . 0.0 112.263 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.95 -30.47 67.89 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.582 1.657 . . . . 0.0 110.601 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.59 -36.17 60.4 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.731 -1.453 . . . . 0.0 108.829 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.48 -36.21 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 123.172 0.589 . . . . 0.0 110.066 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.4 -18.74 61.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.488 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 87.0 m -73.1 -33.63 65.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 118.722 0.692 . . . . 0.0 110.067 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -140.43 80.09 1.74 Allowed 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -133.59 1.35 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.257 0.623 . . . . 0.0 111.493 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.31 -1.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.136 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -100.43 -15.44 17.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.409 0.55 . . . . 0.0 110.416 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 158.37 170.94 23.63 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.0 t -64.08 131.18 46.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.1 165.35 35.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.709 0.766 . . . . 0.0 110.957 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -141.01 171.65 13.77 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.602 0.715 . . . . 0.0 110.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.84 147.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.564 0.746 . . . . 0.0 110.996 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -139.58 134.09 31.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.025 0.828 . . . . 0.0 109.936 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -155.23 151.0 21.79 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.011 1.324 . . . . 0.0 110.227 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.66 154.42 34.81 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.415 3.41 . . . . 0.0 111.126 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.49 11.22 75.37 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.181 -0.95 . . . . 0.0 112.783 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -79.44 9.26 4.99 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -118.56 148.2 42.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.202 1.401 . . . . 0.0 110.047 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.77 43.97 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.66 -0.65 . . . . 0.0 112.532 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -72.46 155.77 39.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 121.462 -1.022 . . . . 0.0 111.014 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 26.8 m170 46.37 61.04 13.67 Favored Pre-proline 0 N--CA 1.447 -0.613 0 O-C-N 124.537 1.148 . . . . 0.0 111.647 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.05 -20.05 57.26 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.599 2.199 . . . . 0.0 108.945 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -80.18 10.23 4.68 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.408 1.083 . . . . 0.0 113.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 44.4 t -133.84 110.41 12.11 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 120.591 -1.318 . . . . 0.0 111.592 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.62 157.95 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.548 2.165 . . . . 0.0 109.785 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.55 -11.81 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -143.15 -178.15 5.7 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 127.67 2.388 . . . . 0.0 110.286 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.88 4.02 59.02 Favored Glycine 0 CA--C 1.547 2.038 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.1 116.51 32.64 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.928 -1.51 . . . . 0.0 111.879 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.4 m -145.01 163.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.795 1.31 . . . . 0.0 108.59 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -87.85 157.22 19.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 18.5 mt -128.08 140.87 51.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.77 156.19 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.761 0.824 . . . . 0.0 109.94 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.513 ' CZ ' HG23 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -171.22 176.27 3.99 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -60.36 88.29 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.57 HD21 ' H ' ' A' ' 288' ' ' LEU . 1.9 pt? -56.56 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 129.411 3.084 . . . . 0.0 117.075 -167.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -131.67 -41.73 1.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.998 1.272 . . . . 0.0 111.372 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -95.18 -32.91 12.83 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.646 -0.659 . . . . 0.0 111.437 -173.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.8 t -83.51 -17.8 40.64 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.513 HG23 ' CZ ' ' A' ' 286' ' ' PHE . 1.8 t -82.41 -33.58 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 O-C-N 121.216 -0.927 . . . . 0.0 109.976 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -62.96 -47.44 83.17 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 123.97 0.794 . . . . 0.0 110.329 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 77.6 p -76.79 -31.52 57.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.23 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.32 -40.64 58.22 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.38 -16.8 60.34 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.122 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.08 1.64 31.14 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.007 1.442 . . . . 0.0 111.846 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -113.42 -25.08 8.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.148 0.885 . . . . 0.0 110.956 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.4 m -79.1 -157.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.5 m -116.67 161.27 19.47 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.346 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -141.68 151.4 42.97 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 304' ' ' LEU . 5.0 m-20 -140.85 118.8 8.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.49 33.04 0.44 Allowed 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 124.563 3.509 . . . . 0.0 109.931 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 302' ' ' ASP . 0.2 OUTLIER -53.05 -26.61 16.47 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.342 -177.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 7.6 t 41.96 70.91 1.5 Allowed Pre-proline 0 N--CA 1.469 0.479 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.93 -1.5 10.93 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 125.063 3.842 . . . . 0.0 110.978 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -160.33 28.59 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.505 1.048 . . . . 0.0 113.484 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.67 12.41 83.65 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 120.768 -1.208 . . . . 0.0 112.792 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.5 pp -131.16 -166.15 1.66 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.642 1.177 . . . . 0.0 109.531 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 16.2 m -143.01 157.08 44.88 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.544 -1.347 . . . . 0.0 112.16 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.7 149.7 51.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.185 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.19 148.68 23.34 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.768 1.227 . . . . 0.0 112.076 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -149.03 156.57 42.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.864 -0.522 . . . . 0.0 110.418 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -158.47 161.16 37.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.467 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 11.6 ptpt -120.23 135.54 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 9.17 4.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.7 t -105.96 145.67 31.02 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.4 p -147.85 -32.62 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -138.47 -0.93 1.93 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -105.09 -30.54 9.67 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.574 -0.704 . . . . 0.0 110.716 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.7 mmt -135.03 -163.1 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.643 1.577 . . . . 0.0 106.744 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -69.89 -95.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.674 0.75 . . . . 0.0 109.775 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 98.7 m -156.33 29.8 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.678 0.791 . . . . 0.0 110.768 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.96 121.31 17.12 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 119.942 1.246 . . . . 0.0 113.231 -169.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 0.1 OUTLIER -77.22 164.01 26.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.115 0.566 . . . . 0.0 111.722 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.34 164.03 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.458 0.703 . . . . 0.0 109.522 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -109.94 153.36 24.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.669 0.668 . . . . 0.0 110.55 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.36 149.09 18.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-O 122.493 1.14 . . . . 0.0 111.358 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 119.06 3.65 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.848 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -99.11 172.59 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 124.429 3.42 . . . . 0.0 113.828 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.524 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 7.9 t-105 -85.46 124.67 32.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.837 0.855 . . . . 0.0 110.596 170.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.63 151.78 3.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-O 121.021 0.438 . . . . 0.0 110.118 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.438 HD21 HD22 ' A' ' 337' ' ' ASN . 7.4 tt -61.04 -27.04 68.05 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.635 0.774 . . . . 0.0 110.156 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.2 -6.52 35.07 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 111.474 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.61 7.9 35.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.819 0.848 . . . . 0.0 109.101 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 62.6 m -111.44 -33.12 6.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.909 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . 0.438 HD22 HD21 ' A' ' 333' ' ' LEU . 1.7 p30 -155.26 158.29 38.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.233 0.924 . . . . 0.0 111.827 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -154.36 140.51 18.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.491 169.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.38 148.37 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.911 0.884 . . . . 0.0 113.121 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -111.63 -7.81 14.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.003 1.383 . . . . 0.0 108.807 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 31.1 t -123.82 132.63 24.3 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.49 -1.45 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.975 2.45 . . . . 0.0 112.072 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 43.2 t -87.3 -14.69 40.15 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.734 1.152 . . . . 0.0 114.035 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 52.02 48.95 21.71 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . 0.5 ' HG2' ' H ' ' A' ' 346' ' ' LEU . 40.1 ttt180 -98.25 -178.17 3.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.214 1.405 . . . . 0.0 111.379 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.5 ' H ' ' HG2' ' A' ' 345' ' ' ARG . 11.8 tp -149.16 163.84 36.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -119.23 164.67 20.15 Favored Pre-proline 0 C--N 1.351 0.666 0 CA-C-N 118.435 0.561 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.86 63.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 126.964 5.109 . . . . 0.0 115.362 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 18.8 m 59.21 21.25 9.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.32 58.09 4.32 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.545 1.164 . . . . 0.0 109.324 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.5 t -117.47 166.7 12.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.57 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.3 m -133.67 150.38 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 123.995 0.809 . . . . 0.0 110.507 171.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -78.3 142.54 37.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 124.254 0.971 . . . . 0.0 110.041 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.29 142.44 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 357' ' ' LEU . . . -164.74 -170.01 29.11 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 124.004 0.815 . . . . 0.0 112.704 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 61.18 -2.41 0.22 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.453 ' H ' ' CD2' ' A' ' 357' ' ' LEU . 2.3 pt? -69.46 159.15 33.81 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.205 0.602 . . . . 0.0 111.567 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -92.75 173.92 7.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.711 -0.618 . . . . 0.0 111.432 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -64.24 8.69 0.42 Allowed Glycine 0 CA--C 1.532 1.144 0 N-CA-C 118.232 2.053 . . . . 0.0 118.232 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 38.4 mtt -142.65 6.02 1.62 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.976 1.888 . . . . 0.0 111.319 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.7 68.13 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 124.008 1.861 . . . . 0.0 109.586 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -62.19 176.4 0.6 Allowed 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.417 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.23 62.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.04 -26.4 36.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -85.22 -32.83 22.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.232 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.89 -31.72 64.87 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.271 0.487 . . . . 0.0 110.817 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.36 42.69 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.064 1.302 . . . . 0.0 110.597 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.76 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 123.89 0.744 . . . . 0.0 110.263 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.41 -44.46 80.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 O-C-N 124.174 0.921 . . . . 0.0 109.571 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.39 -17.42 34.47 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 112.722 -168.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.03 -23.89 18.51 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.167 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -93.41 -23.73 18.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.43 0.559 . . . . 0.0 112.446 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.8 -11.51 16.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -115.12 -36.18 4.48 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 141.28 -45.76 0.94 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.899 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.95 150.92 10.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.521 -1.8 . . . . 0.0 111.187 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.53 170.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.326 1.851 . . . . 0.0 107.001 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.81 -29.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 118.101 0.41 . . . . 0.0 110.613 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.441 ' CD1' ' CD1' ' A' ' 346' ' ' LEU . 4.0 t80 -165.61 157.13 14.31 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.803 0.811 . . . . 0.0 111.464 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.55 150.61 35.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.954 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.89 29.94 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 121.248 -0.907 . . . . 0.0 113.071 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 20.7 mm -118.93 141.41 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.153 1.381 . . . . 0.0 107.349 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -90.81 139.97 30.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.4 p -132.78 168.44 18.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.197 0.999 . . . . 0.0 109.561 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -137.81 158.37 44.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.082 2.153 . . . . 0.0 105.528 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -58.66 112.81 1.75 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 18.7 m170 62.99 26.06 15.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.588 -1.32 . . . . 0.0 114.113 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -94.33 -24.48 17.39 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.9 t80 41.35 59.41 8.82 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 125.398 1.479 . . . . 0.0 111.237 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.21 -35.16 3.16 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.595 1.53 . . . . 0.0 110.992 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.524 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 6.5 tp 31.7 48.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 125.166 1.387 . . . . 0.0 110.839 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.14 12.89 0.45 Allowed Glycine 0 C--N 1.349 1.259 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.037 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.0 m -147.86 154.53 40.54 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 118.685 1.242 . . . . 0.0 110.318 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.41 -168.3 40.85 Favored Glycine 0 C--O 1.247 0.951 0 CA-C-N 119.531 1.06 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -152.22 161.23 42.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.02 145.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 123.13 0.269 . . . . 0.0 110.332 -173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.8 p -123.11 142.18 51.16 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.792 0.806 . . . . 0.0 110.563 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.44 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 26.0 m-85 -118.41 -24.81 6.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.153 -169.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.55 17.52 3.08 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.47 156.0 38.6 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.776 -0.577 . . . . 0.0 110.753 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -89.72 -18.33 26.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -55.77 -42.11 75.03 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.478 -1.389 . . . . 0.0 109.675 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.44 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 57.2 m -82.55 -13.37 56.71 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.455 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.36 -50.1 15.12 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 119.195 0.907 . . . . 0.0 110.93 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -29.43 51.99 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.386 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -70.39 -28.88 65.43 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.898 0.856 . . . . 0.0 111.296 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.23 19.74 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.276 -0.89 . . . . 0.0 113.291 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.56 -27.29 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.887 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 73.3 p -82.35 -26.28 33.1 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.22 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -81.58 -40.67 22.71 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.29 -12.54 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -168.71 143.64 3.31 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 123.815 0.846 . . . . 0.0 109.239 -174.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.21 162.44 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 O-C-N 123.688 0.618 . . . . 0.0 110.828 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -106.77 143.72 34.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 123.986 0.803 . . . . 0.0 111.888 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.8 mt -125.7 119.04 53.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 21.0 mtmt -143.59 130.71 20.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.9 p -136.55 -161.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.5 m -88.84 -2.37 58.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.997 0.519 . . . . 0.0 111.98 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -145.57 -4.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . 0.475 ' CZ ' ' HD3' ' A' ' 422' ' ' LYS . 51.2 t80 -138.39 141.07 39.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.341 -1.474 . . . . 0.0 111.1 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 45.4 m -147.2 102.01 3.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.198 0.999 . . . . 0.0 110.904 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.475 ' HD3' ' CZ ' ' A' ' 420' ' ' PHE . 0.6 OUTLIER -153.26 173.77 15.14 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.575 0.625 . . . . 0.0 110.502 178.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -131.43 163.15 28.57 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.39 133.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -100.5 149.91 23.21 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 72.0 mt -133.68 138.2 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.088 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -135.3 150.33 72.3 Favored Pre-proline 0 CA--C 1.53 0.18 0 O-C-N 123.977 0.798 . . . . 0.0 111.333 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.45 150.92 75.97 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.615 1.543 . . . . 0.0 111.344 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 124.852 1.261 . . . . 0.0 112.077 -177.39 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.1 m 60.03 159.68 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.879 2.072 . . . . 0.0 111.957 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.473 ' CZ3' ' CA ' ' A' ' 222' ' ' GLY . 87.8 t90 -161.51 158.6 26.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.931 0.493 . . . . 0.0 109.741 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 70.7 p -143.18 104.62 4.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.288 0.566 . . . . 0.0 110.735 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.473 ' CA ' ' CZ3' ' A' ' 220' ' ' TRP . . . -73.08 111.8 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.26 -17.38 13.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.027 -1.087 . . . . 0.0 110.165 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.551 ' H ' HD11 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -130.14 14.09 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 118.202 2.668 . . . . 0.0 118.202 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 72.6 Cg_exo -49.88 124.05 11.83 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 CA-C-N 120.989 1.389 . . . . 0.0 112.995 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.75 140.96 55.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.879 3.052 . . . . 0.0 110.992 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -142.78 -1.81 1.09 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -130.41 59.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.548 0.689 . . . . 0.0 112.829 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.32 163.75 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.445 1.098 . . . . 0.0 110.391 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -157.46 146.16 19.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.23 153.94 81.83 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -85.88 28.04 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.892 2.395 . . . . 0.0 113.397 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 74.6 mt -137.45 154.75 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 121.953 -0.467 . . . . 0.0 110.596 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.45 170.77 11.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.806 1.643 . . . . 0.0 108.484 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.413 ' HB2' ' H ' ' A' ' 236' ' ' CYS . 54.0 p -152.52 -155.44 0.61 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 122.81 0.444 . . . . 0.0 110.375 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.413 ' H ' ' HB2' ' A' ' 235' ' ' SER . 94.3 m -54.33 137.59 41.34 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.488 1.515 . . . . 0.0 114.416 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 56.26 143.85 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.18 149.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -107.73 156.33 19.21 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 117.885 0.312 . . . . 0.0 111.468 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.29 134.26 16.9 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 125.041 1.463 . . . . 0.0 107.261 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.82 155.92 23.89 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 120.658 -1.277 . . . . 0.0 112.391 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.97 7.35 1.57 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.729 -1.039 . . . . 0.0 112.99 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.96 70.47 10.14 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.697 1.599 . . . . 0.0 109.998 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.92 9.78 1.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 1 C-N-CA 125.726 4.284 . . . . 0.0 112.267 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.488 ' CE3' ' HE3' ' A' ' 321' ' ' MET . 12.5 p-90 -136.15 -8.94 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.94 116.98 8.38 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -174.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.467 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.59 -30.45 34.01 Favored 'Isoleucine or valine' 0 C--O 1.274 2.35 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.511 HG23 ' H ' ' A' ' 250' ' ' ALA . 17.4 m -146.85 127.1 13.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.861 -1.15 . . . . 0.0 112.197 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -56.82 -27.04 59.38 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 125.677 1.861 . . . . 0.0 113.202 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.511 ' H ' HG23 ' A' ' 248' ' ' THR . . . -61.4 -16.49 47.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.34 -57.07 3.04 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-O 121.65 0.583 . . . . 0.0 111.657 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.14 -48.99 68.99 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.46 -33.12 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.335 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -77.99 -8.75 58.56 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.369 0.531 . . . . 0.0 111.685 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.5 m -83.24 -22.96 32.93 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.309 -1.494 . . . . 0.0 112.329 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -141.56 29.85 1.74 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.391 1.451 . . . . 0.0 114.315 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -90.94 13.06 17.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.532 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.53 27.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -168.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.03 -1.32 8.3 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.002 -0.436 . . . . 0.0 111.156 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.34 1.28 88.22 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.006 -0.886 . . . . 0.0 113.869 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.8 m -126.55 30.08 5.61 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.409 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.2 OUTLIER -100.53 146.0 27.62 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -148.79 160.89 42.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 122.174 0.988 . . . . 0.0 109.551 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.8 148.07 22.18 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.76 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.32 149.77 44.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.547 0.612 . . . . 0.0 110.645 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -117.4 143.77 32.69 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.657 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.76 -25.69 7.56 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.826 2.351 . . . . 0.0 110.232 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 174.13 17.2 0.02 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-N 119.944 1.247 . . . . 0.0 114.858 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -112.96 22.03 14.83 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.968 1.884 . . . . 0.0 112.246 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.76 149.78 43.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.544 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -118.07 173.75 14.97 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-O 121.179 0.321 . . . . 0.0 112.32 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.418 ' HA ' ' CE ' ' A' ' 272' ' ' LYS . 3.1 mmpt? -92.06 5.78 48.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 275' ' ' ARG . 23.8 m170 -98.26 164.09 17.92 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.852 1.661 . . . . 0.0 111.346 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.69 5.06 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.757 2.972 . . . . 0.0 110.707 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 273' ' ' HIS . 7.3 ptm180 -140.57 147.54 39.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.871 1.269 . . . . 0.0 110.71 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.93 146.2 15.11 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -93.34 149.84 2.44 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 124.399 3.399 . . . . 0.0 110.447 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.81 163.79 28.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.32 2.68 . . . . 0.0 107.215 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -96.77 23.78 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.65 82.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -165.15 129.4 2.42 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.793 -0.828 . . . . 0.0 109.842 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 160.28 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.498 1.749 . . . . 0.0 108.719 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -92.25 159.18 15.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 43.3 mt -122.94 143.47 49.88 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 123.371 0.669 . . . . 0.0 109.834 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.53 132.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.409 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 30.0 p90 -171.05 -163.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.72 1.263 . . . . 0.0 108.16 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.9 107.81 0.2 Allowed 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -91.04 19.18 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -167.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.62 -72.23 0.64 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.052 -1.03 . . . . 0.0 109.918 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -25.68 29.96 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.26 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 48.9 m -83.83 -23.2 31.47 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.63 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -45.32 39.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.026 -1.046 . . . . 0.0 109.34 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -73.71 -17.2 61.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.896 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.8 t -75.3 -46.08 35.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.08 1.309 . . . . 0.0 108.572 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -61.07 -47.61 85.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.94 -24.61 67.57 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.158 -0.964 . . . . 0.0 110.12 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -101.66 -3.04 28.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.174 0.921 . . . . 0.0 113.088 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -107.24 -10.57 15.79 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.676 0.61 . . . . 0.0 110.489 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.2 m -105.79 -141.83 0.37 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.3 t -125.53 163.6 22.35 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.316 -0.865 . . . . 0.0 111.294 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -148.76 153.58 38.37 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.393 0.433 . . . . 0.0 110.036 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -135.17 122.78 15.24 Favored Pre-proline 0 N--CA 1.435 -1.182 0 O-C-N 125.761 1.913 . . . . 0.0 106.498 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.481 ' HG2' ' H ' ' A' ' 304' ' ' LEU . 69.8 Cg_endo -70.0 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.039 1.826 . . . . 0.0 113.461 -172.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.481 ' H ' ' HG2' ' A' ' 303' ' ' PRO . 8.1 mp -119.83 29.48 7.54 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.856 0.862 . . . . 0.0 110.381 -170.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.508 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 39.7 m -64.4 -31.04 5.31 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.471 1.508 . . . . 0.0 113.784 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 305' ' ' SER . 22.8 Cg_exo -69.4 -3.65 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.201 3.267 . . . . 0.0 111.748 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.4 t70 57.95 26.3 13.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.409 1.484 . . . . 0.0 112.641 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -176.17 -2.52 0.03 OUTLIER Glycine 0 CA--C 1.543 1.814 0 CA-C-N 118.518 0.599 . . . . 0.0 113.555 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 22.1 tp -157.03 172.58 18.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.442 1.621 . . . . 0.0 110.163 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 12.3 m -109.62 144.77 37.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.092 0.245 . . . . 0.0 110.956 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -142.92 140.35 31.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 111.497 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.67 154.47 18.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.811 0.845 . . . . 0.0 110.026 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.38 158.17 44.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.042 -1.036 . . . . 0.0 112.387 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 2.0 t80 -148.37 177.89 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.153 0.501 . . . . 0.0 110.559 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.4 ' N ' ' CD1' ' A' ' 314' ' ' PHE . 23.5 ttmt -147.53 122.71 10.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.04 7.45 1.19 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.743 -167.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.0 p -70.68 157.99 37.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.628 1.171 . . . . 0.0 110.935 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 42.3 t -115.68 173.08 6.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -69.92 -15.87 63.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.646 1.178 . . . . 0.0 111.424 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -68.2 -20.95 64.88 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.488 ' HE3' ' CE3' ' A' ' 245' ' ' TRP . 22.7 ptm -160.95 -165.18 1.31 Allowed 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.724 1.21 . . . . 0.0 111.563 -172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 71.4 mtm-85 -55.76 157.64 4.1 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 110.151 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.3 m -140.48 145.01 36.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 125.068 1.48 . . . . 0.0 110.223 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.93 144.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.28 156.93 36.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.348 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.77 154.81 11.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.34 158.81 23.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 110.413 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.46 145.88 31.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.758 0.789 . . . . 0.0 109.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 60.4 mt -143.16 97.41 5.71 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.23 158.53 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.058 2.506 . . . . 0.0 112.368 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.45 122.27 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.558 HG11 ' H ' ' A' ' 334' ' ' ALA . 9.3 t -96.38 146.97 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.02 -24.42 58.22 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.827 1.251 . . . . 0.0 108.43 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.558 ' H ' HG11 ' A' ' 332' ' ' VAL . . . -63.49 -19.62 64.91 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.859 -1.151 . . . . 0.0 112.472 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -101.3 9.54 41.6 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.237 0.215 . . . . 0.0 111.252 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 74.0 m -102.78 -27.16 12.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.523 -1.361 . . . . 0.0 112.503 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.03 165.69 15.64 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.582 -0.699 . . . . 0.0 110.059 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -158.01 148.4 20.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.16 150.07 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.911 0.862 . . . . 0.0 108.855 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -94.46 -10.56 31.99 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.848 -0.533 . . . . 0.0 111.695 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 m -143.83 150.63 50.62 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.086 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.83 119.87 5.58 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.338 2.025 . . . . 0.0 110.239 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 23.3 t -145.84 161.61 39.6 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.596 0.236 . . . . 0.0 110.545 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -79.9 -27.34 39.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.274 0.63 . . . . 0.0 112.187 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -164.23 171.51 14.86 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.916 1.286 . . . . 0.0 108.905 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 60.5 mt -97.99 -178.31 4.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.958 1.303 . . . . 0.0 111.099 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -101.74 103.62 29.6 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.44 -6.09 12.68 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.253 1.968 . . . . 0.0 113.202 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 21.2 t -91.16 -22.32 20.73 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.621 -0.228 . . . . 0.0 111.072 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -131.82 103.87 6.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 t -154.31 156.56 37.17 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 120.966 -1.084 . . . . 0.0 110.531 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 154.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -86.83 144.36 27.05 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.279 0.987 . . . . 0.0 108.97 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.63 140.35 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.735 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -160.2 176.82 36.85 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 122.061 -0.4 . . . . 0.0 112.689 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.62 7.36 1.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.051 2.14 . . . . 0.0 114.843 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.593 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -78.02 -172.57 2.78 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 175.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -45.57 146.76 0.99 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.792 2.837 . . . . 0.0 115.182 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -71.75 -2.96 53.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.201 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.2 ptm -151.19 32.44 0.59 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.814 1.807 . . . . 0.0 111.022 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -43.77 140.63 1.82 Allowed 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -134.03 -177.85 4.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.822 0.82 . . . . 0.0 109.78 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.4 8.63 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.963 0.887 . . . . 0.0 111.489 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -44.19 -63.73 0.82 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.479 1.912 . . . . 0.0 110.906 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.3 -28.95 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.235 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.07 -35.34 80.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.231 0.923 . . . . 0.0 109.914 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.6 63.85 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.384 -0.927 . . . . 0.0 112.008 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.52 61.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.339 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.66 -42.51 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.47 -32.27 54.26 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.819 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.75 -16.91 46.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 118.17 -1.412 . . . . 0.0 111.294 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.11 -25.09 13.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.267 -0.896 . . . . 0.0 112.58 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 16.8 tp -92.42 -22.51 19.6 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 121.787 -0.571 . . . . 0.0 111.217 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.415 ' HB3' ' HG ' ' A' ' 403' ' ' SER . 7.4 m-85 -136.26 -47.01 0.63 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 111.281 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.29 -16.21 30.28 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.928 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . 0.451 ' HA3' HD22 ' A' ' 400' ' ' ASN . . . -99.37 22.26 41.57 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.334 1.067 . . . . 0.0 113.877 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.77 166.06 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 120.911 -1.347 . . . . 0.0 111.857 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.26 -30.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.505 ' CG ' ' N ' ' A' ' 380' ' ' ALA . 0.3 OUTLIER -156.02 162.85 40.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.15 0.886 . . . . 0.0 112.369 -174.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -153.63 146.38 24.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.67 150.19 22.39 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.57 1.077 . . . . 0.0 112.77 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 26.3 mm -85.92 136.89 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 125.641 1.576 . . . . 0.0 109.724 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.45 60.09 6.03 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.542 -0.724 . . . . 0.0 111.441 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.7 158.88 9.44 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.717 1.722 . . . . 0.0 112.683 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -140.12 157.78 45.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.968 1.707 . . . . 0.0 107.069 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -57.28 113.92 1.95 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.824 0.821 . . . . 0.0 110.494 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 28.6 m170 53.92 16.62 1.12 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -85.71 -9.67 56.82 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.356 0.98 . . . . 0.0 113.112 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 32.8 p90 39.93 54.13 5.81 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.845 1.658 . . . . 0.0 115.383 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.0 -48.86 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.868 2.379 . . . . 0.0 113.213 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.3 25.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.084 1.754 . . . . 0.0 114.243 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -145.35 19.58 1.89 Allowed Glycine 0 C--O 1.223 -0.567 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.2 p -151.34 159.77 44.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.969 0.885 . . . . 0.0 110.12 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.81 -157.31 20.76 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 115.924 1.13 . . . . 0.0 115.924 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -158.77 164.32 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.232 0.613 . . . . 0.0 109.477 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.13 143.03 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.2 p -112.05 148.77 33.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 403' ' ' SER . 71.2 m-85 -121.07 162.09 20.6 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.9 -171.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.13 0.95 15.11 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.005 0.816 . . . . 0.0 111.199 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.451 HD22 ' HA3' ' A' ' 376' ' ' GLY . 0.3 OUTLIER -150.39 164.74 35.09 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 173.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -80.67 -14.47 58.12 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 117.971 0.351 . . . . 0.0 111.103 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -58.98 -35.53 73.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.949 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 398' ' ' PHE . 8.8 m -78.36 -19.95 52.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.715 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.93 -64.29 0.91 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.444 0.64 . . . . 0.0 109.344 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -19.6 62.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.983 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -79.5 -25.49 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.053 0.221 . . . . 0.0 110.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 374' ' ' PHE . . . -78.81 -39.29 36.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.383 0.611 . . . . 0.0 111.425 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.2 m -78.54 -21.74 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.424 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 51.8 p -87.93 -26.7 22.57 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.59 56.26 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.95 -26.22 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.299 1.839 . . . . 0.0 115.242 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.26 148.67 22.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.019 1.281 . . . . 0.0 111.843 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.75 148.04 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -107.64 94.99 5.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.2 128.98 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 136.67 49.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.754 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.64 174.94 14.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.153 1.381 . . . . 0.0 108.378 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 75.6 m -75.08 -20.88 59.29 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.146 0.885 . . . . 0.0 111.533 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -139.71 24.29 2.43 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.946 -0.471 . . . . 0.0 111.963 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -156.25 118.69 4.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.878 0.871 . . . . 0.0 111.159 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.0 p -146.85 112.13 5.51 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.805 0.729 . . . . 0.0 112.109 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -165.05 173.58 11.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.779 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -100.59 168.13 9.91 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.5 0.667 . . . . 0.0 109.339 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 357' ' ' LEU . 90.3 t -151.05 136.1 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -117.71 153.09 33.96 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 119.119 0.872 . . . . 0.0 112.898 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 78.8 mt -125.84 135.78 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -131.37 139.83 36.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.936 -0.478 . . . . 0.0 109.863 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.31 150.8 31.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.652 2.902 . . . . 0.0 116.544 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.39 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.625 0.25 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m 50.92 119.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.971 1.709 . . . . 0.0 113.475 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.461 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -128.85 -13.01 4.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 111.065 178.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.3 m 43.63 61.5 2.23 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.35 -19.14 78.65 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.726 -0.609 . . . . 0.0 114.205 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.22 32.37 21.61 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.042 -1.858 . . . . 0.0 114.245 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 151.76 86.06 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.38 118.75 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.007 2.472 . . . . 0.0 110.364 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -97.83 5.22 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 126.117 4.545 . . . . 0.0 114.802 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -137.85 11.37 2.89 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.047 0.939 . . . . 0.0 113.104 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -82.86 39.09 0.61 Allowed 'General case' 0 C--N 1.348 0.522 0 O-C-N 121.03 -1.044 . . . . 0.0 111.883 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.0 153.86 35.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -88.59 -13.51 39.83 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.327 1.017 . . . . 0.0 111.79 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.409 ' HA ' HG11 ' A' ' 332' ' ' VAL . 2.5 t-20 50.27 43.53 1.71 Allowed Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.68 -43.49 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.838 1.692 . . . . 0.0 113.867 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 51.7 mt -152.45 157.15 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.94 1.696 . . . . 0.0 107.183 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.09 144.39 31.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.113 0.565 . . . . 0.0 109.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.1 m -128.43 3.07 5.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.726 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.2 t -153.05 179.53 8.62 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 283' ' ' TYR . 12.0 ptmm? -49.5 166.44 0.05 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.308 1.043 . . . . 0.0 109.819 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.86 149.24 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -93.84 132.08 38.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.99 119.94 18.57 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 125.198 1.562 . . . . 0.0 109.602 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.82 170.22 36.97 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 111.866 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.03 1.74 3.97 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.074 0.845 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.92 132.23 74.68 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 119.085 1.443 . . . . 0.0 108.556 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -88.86 -13.49 3.15 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 124.07 3.18 . . . . 0.0 110.921 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.463 ' CD2' ' HE1' ' A' ' 321' ' ' MET . 1.3 p-90 -105.65 -54.5 2.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.2 t0 57.48 151.41 0.01 OUTLIER 'General case' 0 C--N 1.374 1.655 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -170.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.26 -40.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.418 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.1 m -164.48 120.15 1.5 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -74.62 -23.08 58.64 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 120.926 1.694 . . . . 0.0 111.187 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -81.11 -12.58 59.23 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.003 0.921 . . . . 0.0 111.012 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.86 -41.01 29.37 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 124.94 1.4 . . . . 0.0 109.93 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.58 -42.57 78.08 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.447 1.118 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.15 -37.07 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -73.68 -15.49 61.23 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.613 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 62.2 m -80.34 -24.47 39.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.804 0.729 . . . . 0.0 109.545 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -139.9 32.04 2.0 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -103.37 12.77 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.503 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.46 23.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.7 -1.3 19.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.273 0.559 . . . . 0.0 111.651 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 110.82 -80.22 0.27 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 122.502 1.057 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.0 t -88.99 109.37 20.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.061 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 138.7 17.51 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.048 -1.032 . . . . 0.0 110.411 168.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.6 m -138.57 172.97 12.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.366 1.067 . . . . 0.0 109.311 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.95 147.61 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.876 -168.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -155.3 151.25 27.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.321 1.058 . . . . 0.0 110.726 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -160.28 138.57 7.45 Favored Pre-proline 0 C--N 1.352 0.691 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.52 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 85.1 Cg_endo -79.41 164.5 23.91 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.552 2.168 . . . . 0.0 110.772 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.61 -128.24 9.47 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -83.53 109.06 17.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.694 0.759 . . . . 0.0 109.485 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -125.75 141.22 52.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.278 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -175.85 -148.52 6.94 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 121.945 0.747 . . . . 0.0 112.325 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -80.97 1.78 29.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.242 1.417 . . . . 0.0 111.22 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -125.87 102.76 28.05 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.25 0.62 . . . . 0.0 110.264 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.8 28.29 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 125.273 3.982 . . . . 0.0 112.169 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -133.29 11.91 4.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 6.5 t -81.75 -33.41 0.65 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 116.884 -1.531 . . . . 0.0 112.203 -174.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 74.0 Cg_exo -55.72 122.5 11.86 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.293 2.662 . . . . 0.0 111.925 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.2 5.71 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.246 3.297 . . . . 0.0 112.177 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -121.95 6.16 9.84 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.87 36.73 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.944 -1.475 . . . . 0.0 113.659 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -112.6 146.87 37.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.178 1.489 . . . . 0.0 110.753 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.6 p -154.67 157.18 4.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.52 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 12.1 m-85 -109.0 154.84 21.62 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.07 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -116.02 134.37 55.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.428 1.108 . . . . 0.0 110.872 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.19 109.56 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -166.52 -166.58 0.88 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.55 -0.719 . . . . 0.0 111.261 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.63 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.235 1.814 . . . . 0.0 107.578 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.576 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 2.0 pt? -73.9 -3.61 29.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -167.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -111.13 -66.13 1.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -87.29 -31.72 20.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.504 -0.748 . . . . 0.0 109.602 -171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 67.4 m -83.24 -26.29 30.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 121.031 1.741 . . . . 0.0 110.381 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.25 -55.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -58.11 -31.53 67.24 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.999 -1.063 . . . . 0.0 112.194 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.3 m -68.2 -39.14 82.52 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.01 0.434 . . . . 0.0 112.144 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.8 mp -71.03 -41.47 70.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.97 -19.75 61.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.361 -0.536 . . . . 0.0 112.339 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -98.06 -3.68 37.52 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.653 0.596 . . . . 0.0 110.187 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -101.66 -5.97 24.35 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 124.314 1.009 . . . . 0.0 110.277 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 300' ' ' SER . 33.9 m -90.59 -157.27 0.47 Allowed 'General case' 0 C--O 1.221 -0.418 0 O-C-N 125.846 1.967 . . . . 0.0 109.509 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.414 ' H ' ' HB3' ' A' ' 299' ' ' CYS . 63.8 m -136.95 -178.23 5.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -138.4 143.79 39.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.086 0.954 . . . . 0.0 111.788 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.83 127.49 26.22 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -83.43 37.19 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.125 4.55 . . . . 0.0 110.158 176.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -71.01 -20.23 62.43 Favored 'General case' 0 C--O 1.244 0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 112.595 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 47.5 t -162.92 74.92 1.99 Allowed Pre-proline 0 C--N 1.346 0.45 0 CA-C-O 122.427 1.108 . . . . 0.0 108.581 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.13 -5.88 10.32 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.024 2.483 . . . . 0.0 114.36 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.18 -13.55 61.97 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.183 -0.948 . . . . 0.0 111.004 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 154.44 -25.24 0.67 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.273 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.5 tp -96.11 38.3 1.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 111.898 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.2 m -66.61 167.0 11.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.442 1.097 . . . . 0.0 108.858 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -138.58 154.05 48.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.249 0.931 . . . . 0.0 110.0 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -110.91 151.77 27.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.54 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 47.0 m-85 -147.4 159.75 43.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -162.99 151.58 14.34 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -114.57 131.48 56.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.11 0.868 . . . . 0.0 110.238 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.62 16.22 19.77 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.488 0.715 . . . . 0.0 110.376 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.438 ' HB2' ' H ' ' A' ' 322' ' ' ARG . 65.6 p -132.8 132.24 41.97 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.769 -0.582 . . . . 0.0 112.562 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 95.9 p -138.38 -18.53 1.12 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.225 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -137.2 -16.39 1.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -90.16 -25.38 20.7 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.411 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.463 ' HE1' ' CD2' ' A' ' 245' ' ' TRP . 96.9 mmm -148.38 -47.15 0.15 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.613 1.565 . . . . 0.0 109.676 177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.438 ' H ' ' HB2' ' A' ' 317' ' ' SER . 21.8 ptt180 47.72 39.63 10.59 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.147 1.779 . . . . 0.0 114.7 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 21.8 m -132.35 -19.11 2.48 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.552 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -148.48 168.22 23.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 158.29 30.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.057 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.35 165.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.473 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.54 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 2.8 pp0? -118.2 166.89 12.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.99 140.91 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 111.644 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -143.1 98.09 5.63 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -83.49 155.54 14.1 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.094 1.863 . . . . 0.0 112.243 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -80.21 119.87 23.55 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.145 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.479 HG12 ' H ' ' A' ' 334' ' ' ALA . 18.0 t -97.25 157.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.109 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -54.34 -30.96 53.31 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.687 0.756 . . . . 0.0 110.549 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.479 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -74.93 6.76 3.75 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.491 1.116 . . . . 0.0 112.413 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -112.79 6.28 17.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 109.982 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 42.9 m -123.96 -29.14 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.21 165.76 35.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 110.387 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -152.45 136.65 16.56 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 125.631 1.572 . . . . 0.0 111.903 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.03 147.55 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 122.731 1.253 . . . . 0.0 110.844 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -113.34 3.95 16.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.489 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.7 m -133.58 150.33 74.59 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 125.439 1.496 . . . . 0.0 110.087 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -85.68 -7.29 8.61 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.524 3.483 . . . . 0.0 113.799 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.5 t -149.46 -16.01 0.28 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.666 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -97.89 166.46 11.44 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 109.994 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -151.25 -169.07 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.034 -0.416 . . . . 0.0 110.457 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.451 HD12 ' CZ ' ' A' ' 379' ' ' TYR . 9.4 mp -37.27 152.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.42 2.288 . . . . 0.0 114.183 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.99 134.9 25.75 Favored Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 126.331 1.852 . . . . 0.0 108.136 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -82.29 4.78 6.8 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.27 1.98 . . . . 0.0 113.811 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 6.2 t -139.24 -5.96 1.41 Allowed 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.117 1.326 . . . . 0.0 114.238 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -125.58 69.65 1.17 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.187 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -150.84 153.4 35.31 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.413 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.89 165.19 29.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 124.056 0.847 . . . . 0.0 111.131 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -83.32 151.4 25.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.331 0.586 . . . . 0.0 112.257 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.3 t -132.54 142.88 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.791 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.27 -163.8 18.08 Favored Glycine 0 C--O 1.246 0.863 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.174 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.72 37.37 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.001 1.721 . . . . 0.0 113.582 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.57 167.06 20.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -83.57 4.86 26.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.23 34.89 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.732 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 5.0 ptp -164.13 21.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.094 0.947 . . . . 0.0 110.289 174.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.81 140.45 58.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.896 1.225 . . . . 0.0 110.608 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.04 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.23 66.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -73.63 -31.92 63.78 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.819 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.62 60.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.838 -1.164 . . . . 0.0 108.551 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 382' ' ' ILE . 93.3 mt -60.95 -53.45 57.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.25 59.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.95 -41.65 42.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.913 0.863 . . . . 0.0 110.36 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.3 -26.99 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.197 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 51.7 mt -96.08 -20.74 18.43 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.274 -0.891 . . . . 0.0 112.882 -168.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 -7.53 18.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 116.211 -1.852 . . . . 0.0 110.543 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 -13.05 8.64 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.247 1.385 . . . . 0.0 114.684 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.12 -4.01 11.48 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.61 0.641 . . . . 0.0 111.313 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -133.08 -32.84 1.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.903 0.881 . . . . 0.0 111.857 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 79.29 -9.64 39.74 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.7 128.03 1.66 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 120.411 2.105 . . . . 0.0 110.661 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.41 171.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.04 -30.12 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.451 ' CZ ' HD12 ' A' ' 346' ' ' LEU . 1.1 t80 -171.11 159.67 6.06 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -148.99 145.6 27.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -151.78 -173.97 22.03 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 122.955 1.308 . . . . 0.0 114.865 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 366' ' ' LEU . 42.2 mm -116.47 144.37 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 112.093 -2.053 . . . . 0.0 109.834 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -76.3 44.81 0.35 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.799 0.439 . . . . 0.0 111.916 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.56 155.79 5.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.271 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -145.35 144.69 30.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -48.96 114.97 1.11 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 111.099 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 14.3 m170 57.99 28.53 16.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.045 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -105.65 -1.32 24.73 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.0 p90 33.21 59.44 1.63 Allowed Pre-proline 0 C--N 1.353 0.751 0 C-N-CA 126.497 1.919 . . . . 0.0 112.962 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.06 -49.02 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.3 tp 31.41 41.49 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.518 1.527 . . . . 0.0 112.473 -175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -141.3 11.72 2.77 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 117.975 -1.458 . . . . 0.0 112.155 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 45.6 m -151.95 153.44 34.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.068 0.934 . . . . 0.0 109.04 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.4 -166.5 32.5 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.707 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.08 167.68 29.55 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.34 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.89 135.47 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 119.303 0.956 . . . . 0.0 110.332 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 21.1 p -105.5 129.13 53.85 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 121.704 -0.623 . . . . 0.0 110.868 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.449 ' CD1' ' CB ' ' A' ' 403' ' ' SER . 95.0 m-85 -96.62 -45.14 6.83 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 53.9 t30 56.64 17.47 3.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.702 0.401 . . . . 0.0 111.01 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -141.66 155.78 45.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.664 1.986 . . . . 0.0 107.91 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -103.24 -37.47 7.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 117.718 -1.134 . . . . 0.0 112.499 -171.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.491 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -61.05 -22.92 65.04 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.518 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.449 ' CB ' ' CD1' ' A' ' 398' ' ' PHE . 7.3 m -74.02 -26.51 60.47 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.155 -0.966 . . . . 0.0 111.24 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -73.71 -56.03 5.51 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.234 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -78.16 -30.54 49.22 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.827 -0.546 . . . . 0.0 111.522 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.64 64.86 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.94 -30.82 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 123.392 0.432 . . . . 0.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 25.6 p -77.55 -14.52 59.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.81 1.319 . . . . 0.0 112.993 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -88.93 -46.31 9.0 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.681 0.613 . . . . 0.0 110.197 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.73 -16.6 0.01 OUTLIER 'General case' 0 C--O 1.242 0.692 0 C-N-CA 126.86 2.064 . . . . 0.0 115.099 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.562 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -163.88 145.87 9.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.4 160.81 41.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.51 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 33.5 mt-10 -118.76 128.14 54.21 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 125.354 1.659 . . . . 0.0 108.851 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.6 mt -99.29 125.25 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 40.09 3.46 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.092 0.87 . . . . 0.0 111.436 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.9 p -76.4 172.17 13.37 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.965 1.365 . . . . 0.0 110.162 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.9 t -73.62 -1.29 18.25 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 120.275 -1.516 . . . . 0.0 112.713 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -128.43 -9.69 5.17 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . 0.493 ' CE2' ' HB2' ' A' ' 422' ' ' LYS . 15.0 t80 -149.71 124.09 9.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.937 0.79 . . . . 0.0 109.175 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 14.1 p -131.43 72.14 1.49 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.668 0.787 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 420' ' ' PHE . 98.0 mttt -152.42 177.91 10.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.001 0.92 . . . . 0.0 111.156 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.51 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 93.7 mttt -122.28 -179.54 4.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.7 m -152.15 161.25 3.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.81 1.244 . . . . 0.0 107.824 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -116.26 155.08 28.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 123.413 1.578 . . . . 0.0 110.267 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.9 mt -143.37 138.35 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.341 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -139.04 153.64 71.78 Favored Pre-proline 0 C--O 1.246 0.915 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.72 149.99 88.86 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 123.468 2.779 . . . . 0.0 110.886 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.86 1.664 . . . . 0.0 111.646 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 60.0 m -162.2 152.97 17.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -18.96 1.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.96 1.709 . . . . 0.0 112.422 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m 43.65 56.43 4.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.905 0.86 . . . . 0.0 112.745 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.85 -17.71 80.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.784 -1.098 . . . . 0.0 114.964 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.426 ' HA ' ' CG2' ' A' ' 417' ' ' THR . 29.6 mt-30 46.91 44.56 14.68 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 1.3 pt? -137.0 6.28 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 116.068 -1.92 . . . . 0.0 115.302 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 84.3 Cg_endo -68.25 128.66 17.82 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 CA-C-N 123.091 2.14 . . . . 0.0 108.709 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.12 152.5 24.3 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.236 2.624 . . . . 0.0 111.829 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -140.44 3.52 1.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.5 1.52 . . . . 0.0 110.718 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -106.04 64.7 0.68 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -115.52 -99.01 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.344 1.458 . . . . 0.0 109.865 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.75 27.82 14.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.11 1.364 . . . . 0.0 112.277 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -91.09 -43.89 0.38 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.64 -170.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.483 2.122 . . . . 0.0 114.653 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -105.41 178.67 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.823 1.249 . . . . 0.0 108.228 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.34 151.33 19.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.34 -1.475 . . . . 0.0 108.91 -174.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -147.4 -2.11 0.6 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.029 0.442 . . . . 0.0 111.677 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 -169.58 2.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.344 -1.472 . . . . 0.0 113.092 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 170.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.677 0.751 . . . . 0.0 112.603 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.37 141.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.143 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -83.62 134.14 34.81 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.92 118.7 9.24 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 169.73 -162.25 35.68 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.03 7.18 3.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.115 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.34 131.59 41.9 Favored Pre-proline 0 C--O 1.216 -0.68 0 CA-C-N 117.798 0.799 . . . . 0.0 110.406 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -86.95 -4.3 7.99 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 124.341 3.361 . . . . 0.0 109.862 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.585 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 1.3 p-90 -118.62 -43.13 2.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.464 -1.398 . . . . 0.0 114.327 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER 54.04 154.87 0.0 OUTLIER 'General case' 0 C--O 1.271 2.221 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -171.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.72 178.32 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.058 175.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.0 m -44.02 123.14 3.18 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.37 -25.75 68.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.84 -14.53 62.44 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 118.218 0.463 . . . . 0.0 111.846 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.14 -44.22 36.49 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.866 0.703 . . . . 0.0 112.833 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.7 -35.83 57.61 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.433 1.111 . . . . 0.0 109.608 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.55 -35.84 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.881 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -80.9 -14.82 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 47.1 m -79.81 -28.75 40.17 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.947 -0.471 . . . . 0.0 112.002 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -130.87 26.81 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.419 ' HA ' HD12 ' A' ' 262' ' ' LEU . 10.9 ptm85 -101.8 1.85 37.67 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 113.275 169.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 99.1 t -76.22 -14.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 122.483 1.135 . . . . 0.0 111.708 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -87.61 -16.03 35.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.892 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 163.97 172.0 30.9 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.614 1.097 . . . . 0.0 112.569 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 52.8 m -58.13 130.89 48.72 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -160.25 173.92 14.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.492 167.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.41 ' HB2' HG21 ' A' ' 285' ' ' VAL . 50.2 m -138.96 174.84 10.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.531 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 146.65 25.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 125.235 1.414 . . . . 0.0 111.334 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -146.72 141.69 27.04 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.896 0.855 . . . . 0.0 112.928 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -151.08 140.1 13.46 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.475 1.11 . . . . 0.0 111.325 173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.08 10.27 3.02 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.691 3.594 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.32 -168.89 24.5 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -80.5 54.51 2.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.315 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.43 -15.93 63.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -78.63 -11.8 84.89 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 121.221 -0.925 . . . . 0.0 113.413 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.61 -45.98 4.28 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.267 1.534 . . . . 0.0 110.274 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.467 ' CG ' ' HE ' ' A' ' 275' ' ' ARG . 2.4 p80 -163.1 145.42 8.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 123.462 0.476 . . . . 0.0 109.837 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 41.11 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 126.586 4.857 . . . . 0.0 113.097 -177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.467 ' HE ' ' CG ' ' A' ' 273' ' ' HIS . 28.4 ptt180 -132.28 10.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.622 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.41 56.54 14.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.781 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.63 149.36 48.95 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 N-CA-C 108.429 -1.412 . . . . 0.0 108.429 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.55 -30.82 86.78 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.65 1.567 . . . . 0.0 113.415 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -146.84 176.13 10.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.85 0.86 . . . . 0.0 110.631 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -81.62 25.66 3.85 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.487 -1.383 . . . . 0.0 116.096 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.479 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 51.3 p90 -142.63 174.18 10.87 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.373 0.69 . . . . 0.0 109.534 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.45 157.1 4.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.85 140.03 30.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.779 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.3 mt -119.86 148.37 43.56 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.014 0.825 . . . . 0.0 109.676 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 263' ' ' SER . 2.8 m -131.8 98.48 3.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.529 ' C ' ' H ' ' A' ' 288' ' ' LEU . 67.2 m-85 -85.09 -171.58 3.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.176 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.96 43.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.796 1.284 . . . . 0.0 110.703 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 286' ' ' PHE . 4.1 mm? 54.12 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 131.107 3.763 . . . . 0.0 116.575 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.95 -42.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.118 0.872 . . . . 0.0 111.906 -170.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.1 -74.37 0.06 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-O 122.152 0.977 . . . . 0.0 113.026 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 37.9 m -70.33 -11.82 61.17 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.425 0.69 . . . . 0.0 109.537 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.83 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 O-C-N 119.837 -1.789 . . . . 0.0 111.452 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.11 -29.54 64.18 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.97 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.5 m -66.19 -36.68 83.69 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 121.794 -0.566 . . . . 0.0 111.368 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.59 -52.38 21.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.723 -0.611 . . . . 0.0 111.449 -175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.07 -29.97 70.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.731 0.696 . . . . 0.0 111.707 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -80.74 -10.77 59.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.158 0.435 . . . . 0.0 110.969 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -109.99 -2.7 16.94 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.395 -0.816 . . . . 0.0 110.862 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 90.4 m -102.99 -156.11 0.55 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.895 1.278 . . . . 0.0 109.039 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 59.0 m -124.42 166.86 15.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.076 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -140.0 161.49 37.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.655 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -147.37 124.04 5.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -85.4 22.56 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.093 3.862 . . . . 0.0 112.593 173.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.555 HD13 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -42.02 -36.41 1.11 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.052 0.941 . . . . 0.0 113.506 -177.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.555 ' H ' HD13 ' A' ' 304' ' ' LEU . 16.9 t 47.12 50.36 8.59 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.979 1.312 . . . . 0.0 114.382 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.58 -10.79 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -143.85 9.51 1.53 Allowed 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.035 0.834 . . . . 0.0 109.907 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 99.36 -0.02 56.98 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.537 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 77.9 mt -128.86 156.24 43.96 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 118.704 1.252 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 21.8 m -102.68 165.05 11.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.969 0.908 . . . . 0.0 110.1 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -142.51 154.98 44.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -111.56 154.5 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 110.996 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -144.96 149.26 34.88 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.455 -0.778 . . . . 0.0 112.059 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -161.84 160.6 28.32 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.129 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -124.69 147.38 48.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.23 -0.919 . . . . 0.0 110.68 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.84 9.39 3.58 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.179 -168.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 319' ' ' ARG . 66.9 p -121.75 -97.11 0.46 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.199 0.937 . . . . 0.0 109.724 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 6.2 m 65.67 -3.85 0.66 Allowed 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.232 1.013 . . . . 0.0 111.867 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 317' ' ' SER . 5.5 mpt_? -140.4 170.63 15.46 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.471 2.308 . . . . 0.0 106.624 170.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 321' ' ' MET . 17.5 ptt180 50.21 6.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.308 2.243 . . . . 0.0 115.115 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.585 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 11.7 mmt -156.68 -176.03 5.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.728 -0.607 . . . . 0.0 109.701 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -83.74 20.3 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.679 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 318' ' ' SER . 55.9 m 54.15 68.72 0.81 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.478 0.711 . . . . 0.0 112.554 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -124.55 108.11 11.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.26 169.01 2.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.039 1.336 . . . . 0.0 112.661 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.65 178.1 3.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.87 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 161.23 35.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.358 0.599 . . . . 0.0 109.851 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.33 135.69 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 24.1 mt -144.21 98.16 5.13 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 125.028 1.455 . . . . 0.0 109.837 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.75 160.47 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.13 1 C-N-CA 125.48 4.12 . . . . 0.0 112.969 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -89.19 125.16 34.95 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.133 0.895 . . . . 0.0 109.941 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.524 HG13 ' H ' ' A' ' 334' ' ' ALA . 63.4 t -109.86 147.85 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.94 -22.11 47.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 117.744 -1.582 . . . . 0.0 111.934 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.524 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -59.23 -14.34 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.706 1.139 . . . . 0.0 113.148 174.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -99.28 6.91 46.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.369 1.067 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.414 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.2 m -132.81 -33.73 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.518 0.727 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -146.76 152.83 39.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.988 0.899 . . . . 0.0 110.725 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -164.64 140.78 5.94 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.549 -1.66 . . . . 0.0 109.473 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 379' ' ' TYR . 5.5 m -118.85 150.6 21.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.668 -0.645 . . . . 0.0 112.112 -175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -125.1 28.52 6.36 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.655 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.4 t -148.23 143.0 16.98 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.756 0.823 . . . . 0.0 110.532 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.11 -10.69 26.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.717 2.944 . . . . 0.0 110.186 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.7 m -90.24 -9.48 47.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.355 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 43.11 17.3 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . 0.568 ' HA ' ' HE ' ' A' ' 345' ' ' ARG . 0.0 OUTLIER -117.6 174.34 6.22 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.421 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.7 mm? -86.57 169.67 12.57 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 125.019 1.45 . . . . 0.0 111.685 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -110.44 154.15 43.14 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.26 110.16 0.51 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.043 1.829 . . . . 0.0 112.003 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 35.8 m 50.82 35.65 12.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.121 0.968 . . . . 0.0 112.41 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -115.61 64.76 0.69 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.425 0.631 . . . . 0.0 112.251 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.1 t -148.61 159.26 44.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.653 0.381 . . . . 0.0 111.556 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 14.0 m -129.05 165.44 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.139 -0.976 . . . . 0.0 111.852 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -87.62 162.2 17.27 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.93 132.91 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.904 0.753 . . . . 0.0 109.345 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -136.4 -176.7 14.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 123.222 1.457 . . . . 0.0 111.414 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 63.0 -57.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.796 1.238 . . . . 0.0 113.056 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 47.8 -158.57 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.784 1.233 . . . . 0.0 111.74 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.88 163.71 35.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.517 1.927 . . . . 0.0 107.487 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -63.25 4.18 0.95 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 120.142 -0.255 . . . . 0.0 113.272 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.8 ptp -164.4 32.2 0.07 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.848 1.324 . . . . 0.0 108.756 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.4 111.89 2.21 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.537 0.735 . . . . 0.0 110.743 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.21 159.36 17.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -71.66 -20.32 61.97 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 121.479 -0.763 . . . . 0.0 112.497 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.09 -23.24 59.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -72.12 -35.25 69.08 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.223 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.14 -29.35 63.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.0 -1.08 . . . . 0.0 109.737 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -86.5 -15.87 38.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.172 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -85.93 -43.37 13.26 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 119.483 1.038 . . . . 0.0 110.958 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.73 -52.27 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.66 -38.86 70.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -21.2 60.45 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 118.35 -1.34 . . . . 0.0 110.376 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.6 -12.83 35.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.968 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.7 tp -75.53 -20.68 58.54 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 121.777 -0.577 . . . . 0.0 110.436 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.473 ' CD2' ' HB2' ' A' ' 403' ' ' SER . 27.7 p90 -156.34 -43.31 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 374' ' ' PHE . . . -177.37 -66.67 0.06 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 119.174 0.897 . . . . 0.0 114.182 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 176.46 149.95 7.91 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 119.087 1.444 . . . . 0.0 114.644 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 1.1 m -118.75 172.52 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.618 0.767 . . . . 0.0 110.914 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.8 -30.87 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.436 ' CD2' HG13 ' A' ' 339' ' ' VAL . 23.0 t80 -163.93 156.04 17.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.36 154.13 40.51 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.11 166.27 36.27 Favored Glycine 0 C--O 1.22 -0.739 0 CA-C-O 122.683 1.157 . . . . 0.0 114.951 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 336' ' ' SER . 11.4 mm -116.0 154.42 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.27 1.828 . . . . 0.0 107.071 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.64 134.09 42.05 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.375 -0.828 . . . . 0.0 110.758 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 4.3 p -135.2 154.05 51.73 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 125.26 1.6 . . . . 0.0 110.071 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.33 159.31 42.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 386' ' ' LYS . 1.7 tpmt? -46.82 103.18 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.315 0.646 . . . . 0.0 112.378 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.2 m170 45.07 45.77 9.15 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.886 2.475 . . . . 0.0 114.04 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -102.55 4.08 38.11 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.403 -0.81 . . . . 0.0 110.964 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.3 p90 42.26 54.0 8.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.276 1.43 . . . . 0.0 112.746 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.567 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 85.7 Cg_endo -70.08 -66.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.3 2.667 . . . . 0.0 112.426 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.567 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 4.0 tp 42.63 28.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 124.061 0.85 . . . . 0.0 111.854 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -123.11 10.69 8.76 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.904 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 69.1 p -158.08 158.81 35.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -168.96 -169.24 32.1 Favored Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.071 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 9.6 ptp85 -150.53 165.51 33.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 122.1 0.952 . . . . 0.0 109.051 174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.49 136.14 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 120.755 -1.215 . . . . 0.0 108.719 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 43.8 m -115.74 142.83 46.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.524 -170.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.02 164.69 15.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.56 0.695 . . . . 0.0 112.007 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -116.37 7.21 13.84 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.107 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -129.1 164.86 22.4 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -107.54 -29.26 9.29 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.912 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.581 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -56.44 -28.79 60.52 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.753 1.16 . . . . 0.0 113.398 -173.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.473 ' HB2' ' CD2' ' A' ' 374' ' ' PHE . 32.6 t -78.38 -33.99 48.52 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.617 -1.302 . . . . 0.0 113.159 175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -51.87 -50.73 60.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 123.845 0.716 . . . . 0.0 111.494 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.407 HD11 ' H ' ' A' ' 405' ' ' LEU 0.282 0.0 OUTLIER -83.39 -26.55 30.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.618 176.9 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -74.3 -19.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.465 1.029 . . . . 0.0 110.86 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -89.34 -36.75 15.35 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.201 -0.937 . . . . 0.0 112.364 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.4 m -71.61 -22.16 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.841 1.2 . . . . 0.0 108.961 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.7 p -84.01 -29.66 26.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 124.499 1.124 . . . . 0.0 112.706 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.99 -41.33 64.43 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.493 0.717 . . . . 0.0 110.667 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.21 -9.78 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.93 148.51 10.33 Favored 'General case' 0 C--O 1.219 -0.522 0 O-C-N 120.766 -1.209 . . . . 0.0 110.7 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.38 163.51 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.233 0.469 . . . . 0.0 110.528 171.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.68 139.2 47.33 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.173 0.511 . . . . 0.0 110.782 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 421' ' ' THR . 29.6 mt -103.74 125.78 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 29.12 5.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.426 ' CG2' ' HA ' ' A' ' 223' ' ' GLN . 34.9 p -68.74 178.8 1.97 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.344 1.545 . . . . 0.0 111.638 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.3 p -73.94 -8.51 56.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -138.69 3.54 2.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.715 0.806 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.97 142.36 26.33 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.315 -1.491 . . . . 0.0 112.914 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 11.0 p -146.03 104.72 3.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.056 0.943 . . . . 0.0 110.091 175.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.545 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 41.4 tptt -165.87 176.55 7.79 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 56.2 mtpt -118.94 162.6 18.25 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.29 138.63 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -100.07 152.11 20.6 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 59.5 mt -135.38 135.11 52.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.89 150.94 29.02 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 119.395 0.998 . . . . 0.0 109.118 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.34 156.06 27.37 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.878 2.385 . . . . 0.0 111.464 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.642 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.9 m -58.61 153.74 15.76 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.826 0.85 . . . . 0.0 110.654 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -116.79 -59.18 1.99 Allowed 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.127 -0.983 . . . . 0.0 109.534 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.9 m 39.21 51.64 2.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.089 1.355 . . . . 0.0 111.917 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.04 -17.97 79.71 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.65 1.119 . . . . 0.0 111.643 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 63.53 32.4 14.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.21 93.18 17.47 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 125.15 1.38 . . . . 0.0 108.614 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.23 147.49 26.15 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 113.641 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.23 -149.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 125.054 3.836 . . . . 0.0 109.745 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 68.29 28.22 6.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.954 0.901 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -90.91 -4.96 56.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.47 147.77 52.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 112.792 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -153.5 33.65 0.46 Allowed 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.48 1.512 . . . . 0.0 109.378 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -129.42 80.08 72.76 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.95 105.83 2.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.467 2.111 . . . . 0.0 111.414 -172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.58 148.32 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.055 . . . . 0.0 107.1 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -125.94 157.46 37.7 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.197 -0.94 . . . . 0.0 113.072 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 99.2 p -152.4 -1.38 0.28 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 12.1 t -144.46 179.84 7.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.247 1.022 . . . . 0.0 110.837 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.82 161.43 0.76 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.76 150.45 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.205 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -94.01 140.37 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 109.691 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.77 108.93 4.43 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.68 163.9 34.89 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.668 1.122 . . . . 0.0 112.884 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.94 3.17 1.53 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.74 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 m -103.77 108.69 60.42 Favored Pre-proline 0 N--CA 1.435 -1.216 0 C-N-CA 122.514 0.326 . . . . 0.0 110.522 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.98 -20.99 11.23 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.081 1.854 . . . . 0.0 113.017 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.579 ' CE3' ' HE1' ' A' ' 321' ' ' MET . 35.7 p-90 -100.08 -26.33 14.0 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -43.56 104.34 0.04 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.106 1.362 . . . . 0.0 112.33 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.49 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -74.92 -27.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.2 m -146.12 136.07 23.5 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.749 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -9.92 59.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.33 64.03 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.8 -58.07 10.84 Favored Glycine 0 C--N 1.359 1.859 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -70.75 -23.31 62.39 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 119.671 -2.076 . . . . 0.0 112.085 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.08 -27.21 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 122.993 0.517 . . . . 0.0 109.79 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.46 -13.85 24.24 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.555 0.342 . . . . 0.0 111.826 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.6 m -82.46 -26.82 32.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.35 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -131.96 64.49 1.59 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.109 -1.62 . . . . 0.0 113.221 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -140.12 2.23 1.89 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.794 0.838 . . . . 0.0 111.484 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.47 -10.43 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.408 0.683 . . . . 0.0 109.529 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.08 28.69 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.834 1.253 . . . . 0.0 111.275 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.26 8.25 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.813 -0.437 . . . . 0.0 114.157 -171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 38.8 m -156.3 51.65 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 125.127 1.134 . . . . 0.0 109.886 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.541 ' H ' HD11 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -115.34 175.0 5.71 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.5 t -143.89 177.92 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.846 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.87 147.57 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -157.97 153.18 25.72 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 126.419 2.324 . . . . 0.0 110.101 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -155.89 149.7 19.24 Favored Pre-proline 0 N--CA 1.432 -1.374 0 O-C-N 124.21 0.944 . . . . 0.0 113.097 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.44 153.51 50.09 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.785 1.657 . . . . 0.0 107.929 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.32 21.4 45.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 119.275 -1.441 . . . . 0.0 110.474 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -61.29 -3.86 1.03 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 126.599 1.96 . . . . 0.0 114.65 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -118.77 131.2 56.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.953 1.301 . . . . 0.0 109.464 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.47 -165.52 38.92 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -94.47 149.66 21.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.856 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.465 ' N ' ' HD3' ' A' ' 274' ' ' PRO . 20.1 m80 42.7 49.96 5.03 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 113.015 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 273' ' ' HIS . 32.6 Cg_exo -61.55 124.59 14.94 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.823 1.682 . . . . 0.0 110.893 -171.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -155.86 -32.98 0.09 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.877 0.471 . . . . 0.0 110.435 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.413 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 37.9 t -155.22 141.17 12.85 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.664 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.413 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 88.9 Cg_endo -75.26 157.96 41.41 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.058 3.172 . . . . 0.0 115.096 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -58.29 155.37 35.53 Favored 'Trans proline' 0 C--O 1.223 -0.245 0 C-N-CA 125.278 3.985 . . . . 0.0 112.979 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.3 tttt 49.58 24.75 1.22 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.216 1.407 . . . . 0.0 112.59 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.08 2.04 0.5 Allowed Glycine 0 C--O 1.215 -1.092 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.29 126.71 30.35 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.979 1.39 . . . . 0.0 113.344 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.01 163.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -118.88 149.07 42.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.8 mt -114.97 137.52 51.9 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.017 1.448 . . . . 0.0 110.493 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.31 116.52 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.42 -166.17 2.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.88 0.848 . . . . 0.0 112.876 -168.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -48.61 139.29 9.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.461 HD23 ' HE2' ' A' ' 387' ' ' HIS . 24.4 mt -74.52 -39.06 62.62 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.745 0.702 . . . . 0.0 112.714 -171.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -121.89 -45.54 2.26 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.733 -1.229 . . . . 0.0 113.516 -170.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -69.96 -70.96 0.26 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.8 t -58.95 -29.47 67.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.145 0.498 . . . . 0.0 111.591 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -57.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.125 -174.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -66.82 -29.54 69.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.609 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.2 m -61.47 -59.96 4.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.896 1.372 . . . . 0.0 111.823 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.46 -26.74 41.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.84 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.17 -34.24 76.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.632 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.03 -2.78 57.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.814 0.696 . . . . 0.0 112.359 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.43 -15.84 20.46 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.7 m -85.09 -159.3 0.42 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.9 m -96.41 158.36 15.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.539 1.162 . . . . 0.0 109.804 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -158.04 153.41 25.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.6 147.08 34.68 Favored Pre-proline 0 C--N 1.349 0.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.95 5.0 4.21 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 123.06 2.507 . . . . 0.0 112.172 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.434 ' C ' ' HD2' ' A' ' 306' ' ' PRO 0.276 0.0 OUTLIER 16.16 99.96 0.0 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.352 3.061 . . . . 0.0 114.629 -179.582 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 7.5 m -49.63 -29.55 2.21 Favored Pre-proline 0 C--O 1.235 0.291 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 305' ' ' SER . 31.9 Cg_exo -60.18 -22.17 69.06 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 123.95 3.1 . . . . 0.0 113.926 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -146.21 145.96 30.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -67.71 3.65 4.84 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.689 -1.257 . . . . 0.0 113.832 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -170.09 2.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.085 0.942 . . . . 0.0 112.309 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.2 p -115.03 155.74 26.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -139.75 137.88 35.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 21.1 m-85 -116.87 144.83 44.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.075 0.95 . . . . 0.0 111.182 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -144.05 158.2 43.86 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -159.6 169.51 23.62 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 146.55 32.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.386 0.136 . . . . 0.0 110.925 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.6 162.95 36.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.527 1.531 . . . . 0.0 109.506 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -167.59 178.05 5.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.569 -0.707 . . . . 0.0 111.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.8 t -125.4 40.18 3.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.656 0.782 . . . . 0.0 109.779 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 57.42 24.29 10.01 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 111.939 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -140.98 -4.1 1.2 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 118.127 2.639 . . . . 0.0 118.127 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.579 ' HE1' ' CE3' ' A' ' 245' ' ' TRP . 1.1 pmm? -150.6 24.17 0.79 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.617 1.099 . . . . 0.0 113.877 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -48.61 110.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.747 0.419 . . . . 0.0 111.187 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 47.6 t -164.72 -49.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -110.68 132.61 54.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.844 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.91 156.18 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.256 1.422 . . . . 0.0 112.555 173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.76 168.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -127.03 150.42 49.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 3.1 t -130.98 143.31 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 124.708 1.255 . . . . 0.0 112.522 -173.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.4 mt -148.62 96.93 3.78 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.764 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -85.18 169.41 9.99 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 124.38 3.387 . . . . 0.0 113.286 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.426 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 2.0 t90 -91.51 121.04 32.85 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.249 1.42 . . . . 0.0 110.557 171.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.486 HG11 ' H ' ' A' ' 334' ' ' ALA . 83.3 t -101.82 145.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.54 -26.59 68.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.231 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.486 ' H ' HG11 ' A' ' 332' ' ' VAL . . . -63.31 -3.57 2.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.483 0.489 . . . . 0.0 112.306 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -103.7 -10.56 18.25 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 122.126 -0.359 . . . . 0.0 110.541 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.1 m -104.95 -24.16 12.88 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.483 0.713 . . . . 0.0 110.637 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.4 143.92 31.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -153.67 134.94 14.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 22.2 m -118.69 147.6 22.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.523 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -96.31 -14.42 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.3 t -146.48 125.66 6.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.674 1.99 . . . . 0.0 109.324 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.92 -8.8 15.62 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.36 2.706 . . . . 0.0 113.059 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -103.97 7.26 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.581 -170.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.4 166.07 14.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.857 0.753 . . . . 0.0 109.177 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -115.74 179.28 4.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.912 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 346' ' ' LEU . 2.4 mm? -72.89 155.68 39.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.466 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.06 118.61 64.6 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.25 -5.97 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.293 1.995 . . . . 0.0 113.02 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 42.1 m -123.78 -12.58 7.57 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.151 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -122.33 100.31 6.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.381 0.991 . . . . 0.0 112.358 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -150.75 161.42 42.67 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.26 150.33 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 121.964 0.888 . . . . 0.0 110.713 171.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -79.71 121.85 25.84 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.569 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.96 137.53 24.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 O-C-N 125.182 1.551 . . . . 0.0 110.121 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -126.23 64.95 0.57 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -114.2 123.08 48.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.875 0.87 . . . . 0.0 111.401 -172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 361' ' ' LEU . 0.0 OUTLIER -157.52 157.16 33.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 122.524 1.154 . . . . 0.0 113.325 -176.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.26 3.73 0.31 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.895 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.56 -29.49 3.8 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.546 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.5 ptp -160.19 43.86 0.21 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.873 0.836 . . . . 0.0 111.139 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 357' ' ' LEU . 2.9 tm? -63.6 133.4 53.66 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.754 -0.591 . . . . 0.0 109.748 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -130.88 -176.21 3.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.628 1.204 . . . . 0.0 111.541 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.5 -13.63 61.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.724 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.17 -20.6 40.89 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.869 -1.144 . . . . 0.0 109.419 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.76 -35.0 22.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 76.9 mt -73.6 -26.02 60.6 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.19 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -74.65 -40.72 61.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.644 0.378 . . . . 0.0 111.1 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.57 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.789 0.836 . . . . 0.0 110.261 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.03 -38.62 80.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.75 -27.88 19.74 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -15.18 58.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.812 0.733 . . . . 0.0 110.293 173.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.62 -19.03 19.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.93 0.787 . . . . 0.0 112.366 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.6 tp -96.64 -26.69 15.12 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 124.529 1.143 . . . . 0.0 114.004 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 -24.36 0.47 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.751 0.705 . . . . 0.0 112.367 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.47 -6.24 8.7 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.979 -0.9 . . . . 0.0 114.757 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -85.14 11.27 60.95 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.467 1.634 . . . . 0.0 113.907 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.418 ' H ' HG13 ' A' ' 377' ' ' VAL . 6.5 p -91.35 162.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 124.836 1.254 . . . . 0.0 111.569 -174.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.9 -27.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.847 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.9 OUTLIER -153.9 145.44 23.21 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -134.99 140.79 45.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.33 25.33 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.906 0.725 . . . . 0.0 112.428 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.58 138.0 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.08 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -81.63 135.86 35.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.8 p -125.27 162.24 25.16 Favored 'General case' 0 C--O 1.215 -0.732 0 O-C-N 121.499 -0.751 . . . . 0.0 112.184 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -127.88 157.61 40.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.281 1.433 . . . . 0.0 107.688 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.04 100.44 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.063 -1.023 . . . . 0.0 111.232 -169.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . 0.461 ' HE2' HD23 ' A' ' 288' ' ' LEU . 40.8 m170 53.47 39.4 29.93 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.022 1.329 . . . . 0.0 114.139 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -104.85 -4.26 22.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.408 -2.058 . . . . 0.0 114.493 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 49.7 51.76 11.37 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-N 119.557 1.071 . . . . 0.0 113.619 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.414 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 72.2 Cg_endo -63.55 -51.08 2.74 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.792 2.995 . . . . 0.0 110.252 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.426 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 9.0 tp 39.83 39.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.942 1.697 . . . . 0.0 110.181 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.07 29.8 1.37 Allowed Glycine 0 CA--C 1.508 -0.355 0 O-C-N 121.596 -0.69 . . . . 0.0 111.927 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 25.0 p -168.89 158.45 8.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.74 -170.62 32.76 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.65 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -150.0 157.88 43.6 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.35 130.79 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.6 p -96.57 138.52 34.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.104 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -113.44 155.44 25.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.044 0.84 . . . . 0.0 111.866 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -124.89 -10.34 7.2 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.042 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -119.5 150.65 39.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.158 0.983 . . . . 0.0 108.383 171.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.33 -16.45 61.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.003 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -65.83 -37.0 85.06 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.682 0.793 . . . . 0.0 111.144 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 43.7 m -71.5 -21.59 61.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.418 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.3 -63.47 1.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.038 0.923 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.405 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -75.55 -20.87 58.37 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.832 -1.167 . . . . 0.0 112.116 -173.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -84.56 -21.94 30.26 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 120.154 -1.591 . . . . 0.0 110.603 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -81.39 -37.27 28.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.649 0.593 . . . . 0.0 111.095 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.18 -24.01 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.691 -0.631 . . . . 0.0 111.116 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.0 p -90.2 -16.02 30.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -90.61 -35.88 14.74 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 56.71 -41.24 0.03 OUTLIER 'General case' 0 C--N 1.344 0.36 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -157.3 124.75 5.26 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.191 -1.568 . . . . 0.0 107.963 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.46 157.2 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 423' ' ' LYS . 36.1 mt-10 -94.98 139.51 31.25 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 124.885 1.366 . . . . 0.0 110.104 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 15.3 mt -121.35 125.98 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 123.908 1.813 . . . . 0.0 112.541 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -124.59 52.28 1.54 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.944 -177.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -77.96 179.72 6.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 123.397 1.57 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 17.0 p -91.32 3.59 54.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.4 -29.83 7.64 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.52 164.27 27.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 59.1 m -123.37 113.3 18.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -162.07 178.88 8.42 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 111.786 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 414' ' ' GLU . 34.8 mtmm -124.04 166.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.25 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.28 152.73 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 O-C-N 124.747 1.279 . . . . 0.0 109.365 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -127.08 160.39 31.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.982 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 46.9 mt -139.12 141.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 O-C-N 125.573 1.796 . . . . 0.0 109.343 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -138.31 158.19 71.22 Favored Pre-proline 0 C--O 1.219 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.22 156.77 61.21 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 123.607 2.871 . . . . 0.0 111.259 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 8.5 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.144 -1.408 . . . . 0.0 112.348 -178.242 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.6 m -148.83 151.2 34.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.75 2.02 . . . . 0.0 109.382 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -3.47 1.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 m 38.02 60.05 1.27 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 123.903 0.881 . . . . 0.0 112.461 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.13 -28.84 74.03 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.555 -172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 53.54 46.43 26.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.146 0.473 . . . . 0.0 112.167 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.95 26.52 0.09 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.69 122.33 9.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 CA-C-N 123.316 2.22 . . . . 0.0 110.383 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 139.07 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.254 3.302 . . . . 0.0 111.951 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -153.31 170.4 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.286 1.034 . . . . 0.0 109.856 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.39 48.84 16.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 110.593 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.4 153.4 2.17 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.732 1.213 . . . . 0.0 111.111 -172.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.4 18.01 19.6 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.661 1.185 . . . . 0.0 111.602 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.72 48.13 2.94 Favored Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 123.874 0.87 . . . . 0.0 110.759 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.49 103.74 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.664 1.576 . . . . 0.0 114.487 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 mm -139.35 142.66 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -111.31 148.49 32.83 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -135.98 -8.24 2.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 84.5 m -135.85 -173.15 3.29 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.984 0.803 . . . . 0.0 110.038 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -65.83 161.59 20.68 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.906 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.43 148.98 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.536 -173.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -93.23 137.21 32.77 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.151 0.58 . . . . 0.0 110.727 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.62 124.6 12.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.2 -170.27 36.97 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.939 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.76 12.63 1.31 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.9 m -61.19 124.28 79.67 Favored Pre-proline 0 C--O 1.217 -0.607 0 CA-C-N 120.016 1.908 . . . . 0.0 111.589 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -83.61 0.94 9.2 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.721 1.614 . . . . 0.0 115.072 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.51 -14.17 2.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.952 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 42.81 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.93 2.492 . . . . 0.0 115.142 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.671 HG13 ' H ' ' A' ' 248' ' ' THR . 5.9 pt -104.53 -96.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.879 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.671 ' H ' HG13 ' A' ' 247' ' ' ILE . 17.5 m -141.68 132.72 26.14 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 122.508 1.147 . . . . 0.0 108.838 173.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -59.61 -22.8 62.33 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.472 ' H ' HG21 ' A' ' 248' ' ' THR . . . -66.83 -39.86 87.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.356 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.68 -47.97 84.8 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 123.582 0.552 . . . . 0.0 112.374 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.11 -38.27 90.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.508 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 16.0 t -73.92 -41.57 53.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.409 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -78.57 -3.65 44.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.304 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.8 m -89.12 -34.86 16.58 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.857 171.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -136.08 75.82 1.57 Allowed 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 120.771 1.623 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -142.38 14.47 2.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.579 175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.07 -9.75 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 122.969 0.507 . . . . 0.0 111.754 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.31 -4.39 58.4 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.422 -1.424 . . . . 0.0 109.078 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 62.18 5.13 7.26 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 125.75 1.906 . . . . 0.0 115.6 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 287' ' ' GLU . 55.2 p -103.39 7.15 38.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.57 163.56 25.74 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.357 0.98 . . . . 0.0 112.655 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.8 t -152.54 168.6 25.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.895 1.278 . . . . 0.0 108.419 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.7 p -118.22 144.58 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.134 1.773 . . . . 0.0 113.716 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -143.12 131.2 21.8 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -157.93 146.8 14.55 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.111 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -88.2 165.72 6.88 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 121.646 1.564 . . . . 0.0 111.141 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.72 14.67 82.16 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 118.796 -1.002 . . . . 0.0 110.943 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -69.76 17.74 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.771 1.628 . . . . 0.0 112.735 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -76.56 151.66 36.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.923 0.889 . . . . 0.0 111.224 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.54 167.85 12.73 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.221 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.66 8.28 5.58 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.42 1.488 . . . . 0.0 112.625 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' A' ' 275' ' ' ARG . 81.1 m-70 -135.74 152.14 75.49 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.12 9.41 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.625 2.216 . . . . 0.0 109.326 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' A' ' 273' ' ' HIS . 59.5 ttp85 -117.68 117.01 28.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.69 1.196 . . . . 0.0 109.239 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.658 ' H ' ' CD ' ' A' ' 277' ' ' PRO . 17.3 t -160.51 -30.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' A' ' 276' ' ' CYS . 86.3 Cg_endo -76.48 142.49 23.58 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.346 2.698 . . . . 0.0 111.829 -170.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.68 -4.36 15.12 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.386 3.39 . . . . 0.0 113.787 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.54 150.77 25.06 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.62 0.768 . . . . 0.0 109.087 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -99.79 21.72 43.65 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.985 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -154.87 166.06 34.69 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 119.959 1.88 . . . . 0.0 113.021 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.4 m -151.72 -170.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -126.12 148.94 49.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.635 1.207 . . . . 0.0 112.306 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.98 151.51 46.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.883 -1.136 . . . . 0.0 111.785 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.33 158.04 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.364 1.466 . . . . 0.0 110.11 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.548 ' C ' ' H ' ' A' ' 288' ' ' LEU . 62.7 m-85 -158.68 -178.22 7.1 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 123.626 1.679 . . . . 0.0 111.154 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 261' ' ' SER . 9.3 tp10 -75.43 19.44 0.18 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.803 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 286' ' ' PHE . 57.3 mt 55.51 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 128.877 2.871 . . . . 0.0 116.628 172.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.0 -51.75 3.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.872 0.869 . . . . 0.0 110.559 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.22 -74.2 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.685 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 38.7 t -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.263 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.47 -52.19 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 O-C-N 123.666 0.604 . . . . 0.0 112.618 -168.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -68.11 -26.16 65.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.495 0.497 . . . . 0.0 110.094 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.2 m -69.45 -44.32 71.47 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.992 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 291' ' ' SER . 10.2 mt -68.53 -52.89 27.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.916 1.234 . . . . 0.0 110.868 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 9.47 23.15 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -115.05 -7.33 12.51 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.124 0.964 . . . . 0.0 110.617 168.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.32 -25.1 18.71 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 13.8 t -101.78 -118.28 0.18 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.909 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.7 m -123.91 157.09 35.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.588 1.185 . . . . 0.0 113.194 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -154.07 161.27 42.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.716 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -148.25 133.86 9.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.38 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 125.514 4.142 . . . . 0.0 110.289 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -70.21 -14.12 62.48 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.181 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 16.5 m 37.16 78.98 0.33 Allowed Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.167 1.787 . . . . 0.0 113.829 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.42 -22.98 24.27 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.19 1.927 . . . . 0.0 111.63 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -144.86 3.08 1.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.671 0.748 . . . . 0.0 109.728 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.59 -11.69 15.94 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.81 108.13 19.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.2 m -60.85 170.33 1.56 Allowed 'General case' 0 C--N 1.344 0.338 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.532 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -129.08 134.8 48.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.351 0.596 . . . . 0.0 109.562 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -102.16 135.76 43.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.79 145.61 47.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -149.08 152.04 35.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.332 0.587 . . . . 0.0 111.003 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -123.77 116.33 22.82 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.966 1.365 . . . . 0.0 110.988 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.415 ' HE2' ' HB ' ' A' ' 326' ' ' VAL . 25.8 ptt? -133.19 1.34 3.49 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.748 -168.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 319' ' ' ARG . 58.8 p -119.97 2.43 10.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 21.4 t -62.67 -3.16 1.37 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.549 -1.344 . . . . 0.0 111.732 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 317' ' ' SER . 89.4 mtt-85 -88.26 -8.71 54.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.339 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -152.33 -9.65 0.19 Allowed 'General case' 0 C--N 1.347 0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 30.5 mmm -124.99 -178.4 4.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.937 2.095 . . . . 0.0 108.841 174.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -95.97 -37.03 10.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.703 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.8 t -176.52 146.6 0.61 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.953 0.901 . . . . 0.0 109.555 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -152.42 -56.0 0.13 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 62.79 100.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 124.144 0.903 . . . . 0.0 109.469 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.415 ' HB ' ' HE2' ' A' ' 316' ' ' MET . 4.6 p -84.44 155.7 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.597 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 147.77 24.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.036 0.922 . . . . 0.0 109.285 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 129.95 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.895 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.79 96.08 11.99 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.718 1.247 . . . . 0.0 108.37 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -88.29 160.22 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.392 1.395 . . . . 0.0 111.522 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.558 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 5.3 t-105 -74.7 124.31 26.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 334' ' ' ALA . 16.6 t -96.76 149.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.749 1.262 . . . . 0.0 110.382 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -59.41 -31.66 69.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.443 1.097 . . . . 0.0 108.602 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.425 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -73.62 -7.28 51.35 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.61 1.164 . . . . 0.0 113.741 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.28 0.02 33.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.842 0.857 . . . . 0.0 111.058 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 73.2 m -91.69 -54.78 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -157.33 154.71 29.44 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.864 0.865 . . . . 0.0 112.308 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -154.94 148.49 25.28 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 123.535 0.522 . . . . 0.0 111.021 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.52 155.3 29.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 122.796 0.438 . . . . 0.0 111.51 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -113.89 32.72 5.66 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 121.782 0.801 . . . . 0.0 109.157 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.0 t -152.17 141.36 14.19 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.143 0.977 . . . . 0.0 110.148 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.65 -6.57 17.03 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.22 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -115.77 149.22 38.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -99.2 138.87 35.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -158.53 152.56 23.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.79 0.805 . . . . 0.0 110.435 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.44 ' HA ' HG23 ' A' ' 397' ' ' THR . 3.4 mm? -128.78 174.74 9.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.068 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -141.4 110.45 6.34 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.04 0.79 4.61 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.766 2.977 . . . . 0.0 114.925 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 66.2 m -134.44 0.73 3.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 117.992 -1.004 . . . . 0.0 112.813 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -147.01 81.72 1.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.799 1.761 . . . . 0.0 109.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.1 p -136.9 173.33 11.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.7 143.4 37.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 O-C-N 121.506 -0.746 . . . . 0.0 109.398 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -77.83 145.47 36.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.668 1.223 . . . . 0.0 112.77 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.2 t -132.01 148.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -177.93 -161.99 27.1 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.671 -0.643 . . . . 0.0 112.853 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.5 0.54 Allowed 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 114.186 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.591 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -79.05 172.81 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.18 9.2 0.34 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -168.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.501 ' H ' HD23 ' A' ' 357' ' ' LEU . . . 100.91 15.17 29.42 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.8 mmt -147.11 -88.68 0.09 Allowed 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.933 1.366 . . . . 0.0 109.945 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 12.3 tp 44.39 70.78 0.3 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 111.299 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -55.58 170.25 0.27 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.104 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -64.28 -26.35 68.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -80.56 -21.4 41.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.29 -26.15 42.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.813 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.61 -44.95 63.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.9 72.85 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.774 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.45 -53.55 50.36 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.957 -1.09 . . . . 0.0 110.728 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.37 -42.48 96.48 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -38.52 29.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.295 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -12.76 46.57 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 120.261 1.391 . . . . 0.0 112.726 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.7 -22.86 13.5 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.531 -0.73 . . . . 0.0 110.477 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 16.3 tp -98.73 -16.52 18.93 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -105.99 -81.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 164.13 -19.36 0.13 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 119.662 1.119 . . . . 0.0 111.925 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -174.86 142.52 6.35 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 118.727 1.263 . . . . 0.0 112.925 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.17 176.93 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.414 1.102 . . . . 0.0 109.824 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.83 -31.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.889 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -155.37 146.23 22.37 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -151.05 135.29 16.84 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 125.17 1.388 . . . . 0.0 108.086 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.65 173.45 38.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.1 mm -91.3 140.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.56 -1.32 . . . . 0.0 109.32 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.27 115.86 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.7 p -111.38 163.35 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.094 0.95 . . . . 0.0 111.773 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -133.41 159.91 38.94 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.98 103.1 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.337 -0.852 . . . . 0.0 112.056 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.26 46.66 20.8 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -108.95 -20.72 12.94 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.627 1.571 . . . . 0.0 115.021 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 46.36 57.89 16.53 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 124.834 1.334 . . . . 0.0 111.479 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.53 -41.02 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.245 1.297 . . . . 0.0 113.242 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 11.0 tp 31.82 38.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 127.846 2.458 . . . . 0.0 112.368 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -140.27 11.97 3.03 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 124.474 1.035 . . . . 0.0 110.749 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 93.0 p -151.15 158.33 43.84 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.896 0.409 . . . . 0.0 111.648 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 177.24 -178.45 48.26 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -150.85 166.91 29.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.31 140.36 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 346' ' ' LEU . 75.6 m -107.92 132.46 53.45 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.408 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -128.84 166.3 19.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.769 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.14 9.25 2.09 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.691 0.619 . . . . 0.0 110.656 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -124.15 144.39 49.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.28 -24.86 64.92 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -51.77 -38.8 57.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.036 0.835 . . . . 0.0 112.186 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.0 m -78.8 -19.26 52.57 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 112.367 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -74.47 -57.09 4.16 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 120.61 -1.306 . . . . 0.0 110.308 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.92 -24.32 59.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.508 -1.277 . . . . 0.0 113.795 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.07 -27.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.804 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.34 -27.54 42.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.6 m -93.3 -24.48 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 O-C-N 121.378 -0.826 . . . . 0.0 112.02 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.4 p -86.18 -16.09 38.89 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.317 0.508 . . . . 0.0 112.02 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.25 -43.37 8.09 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.456 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.05 -10.93 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -170.66 152.44 3.81 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.985 -1.072 . . . . 0.0 110.764 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.54 162.16 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -100.84 123.74 45.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.63 0.729 . . . . 0.0 109.89 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.26 90.43 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -117.42 106.01 12.75 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.287 0.992 . . . . 0.0 110.344 -169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 73.0 p -138.55 -177.45 4.86 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.767 1.227 . . . . 0.0 110.583 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 24.1 m -79.93 -9.95 59.73 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.689 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.24 -19.48 13.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.833 1.253 . . . . 0.0 112.89 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -153.83 140.41 18.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.637 0.732 . . . . 0.0 109.244 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 89.5 m -144.09 89.03 2.0 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.318 0.647 . . . . 0.0 109.866 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -148.33 -171.37 3.83 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 122.671 1.224 . . . . 0.0 109.912 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -130.39 168.61 16.69 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.322 1.058 . . . . 0.0 110.179 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.58 138.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.258 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.65 154.85 25.44 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 124.806 1.316 . . . . 0.0 113.707 -168.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.72 134.47 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.448 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -137.56 156.72 74.7 Favored Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.884 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.33 163.51 37.65 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.856 3.037 . . . . 0.0 110.47 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 52.2 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.995 -176.178 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 59.8 mmm . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.517 0.198 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.7 m 36.21 59.3 0.94 Allowed 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 111.746 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -4.55 36.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.7 m 44.01 52.72 6.7 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.511 1.05 . . . . 0.0 111.959 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.76 72.81 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.354 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 57.01 32.48 21.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.45 146.02 95.96 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.214 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.09 124.57 9.17 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 124.731 3.621 . . . . 0.0 112.713 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.26 5.26 6.03 Favored 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 127.278 5.318 . . . . 0.0 114.325 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -127.93 26.22 5.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 118.916 0.78 . . . . 0.0 112.573 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.63 34.1 1.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.275 1.03 . . . . 0.0 108.67 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.58 176.3 9.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -169.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -67.14 150.58 48.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.223 1.809 . . . . 0.0 106.719 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -71.92 156.71 90.66 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 120.029 1.286 . . . . 0.0 112.264 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.49 140.16 21.86 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 124.232 3.288 . . . . 0.0 115.323 -170.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.3 mm -155.3 152.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.417 ' CD2' ' CG1' ' A' ' 292' ' ' VAL . 4.3 m-85 -125.18 149.83 47.54 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.604 1.093 . . . . 0.0 110.938 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.7 p -148.25 11.66 0.92 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -170.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.4 t -152.48 -167.33 2.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.636 1.107 . . . . 0.0 109.057 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.434 ' HE2' ' CD1' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -59.09 171.51 0.71 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 152.88 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.434 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 21.9 m-30 -90.25 145.11 25.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.777 -0.577 . . . . 0.0 109.794 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -149.13 126.51 11.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.21 165.93 30.85 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 119.276 0.944 . . . . 0.0 112.194 -176.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.56 3.27 1.0 Allowed Glycine 0 CA--C 1.547 2.034 0 O-C-N 124.699 0.882 . . . . 0.0 112.27 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.9 m -107.87 121.79 42.88 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.417 0.609 . . . . 0.0 112.597 -170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.07 -13.93 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 123.281 2.654 . . . . 0.0 112.059 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.446 ' HE1' ' HB2' ' A' ' 324' ' ' LYS . 30.0 p-90 -124.03 -17.52 6.21 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -50.48 104.66 0.08 Allowed 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 118.928 0.786 . . . . 0.0 110.593 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -18.77 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 O-C-N 126.02 2.075 . . . . 0.0 115.781 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.0 m -152.48 126.91 9.31 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 124.486 1.116 . . . . 0.0 110.328 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.03 -34.16 68.59 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.77 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.21 66.04 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 120.051 1.296 . . . . 0.0 110.718 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.64 -55.9 27.96 Favored Glycine 0 C--N 1.368 2.32 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.92 -37.9 72.11 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.673 0.867 . . . . 0.0 111.124 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.44 -22.55 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 123.383 0.673 . . . . 0.0 110.284 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -94.34 -4.94 47.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.77 -0.581 . . . . 0.0 110.867 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -82.38 -24.43 34.47 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.548 -1.345 . . . . 0.0 111.046 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.35 26.58 1.62 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.404 ' HA ' HD12 ' A' ' 262' ' ' LEU . 53.6 ptt85 -94.46 -0.23 54.88 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.585 1.993 . . . . 0.0 113.466 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 -21.41 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.257 0.623 . . . . 0.0 111.243 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.09 -4.25 54.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.653 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.42 -125.61 0.77 Allowed Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.129 -0.982 . . . . 0.0 115.276 -170.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.5 t -153.69 110.83 3.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 124.562 0.801 . . . . 0.0 109.888 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -151.61 162.28 41.25 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 176.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 64.0 m -146.62 170.73 16.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.208 1.803 . . . . 0.0 109.763 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.78 143.06 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 123.878 0.871 . . . . 0.0 111.864 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -145.94 135.74 23.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.86 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 277' ' ' PRO . 21.9 p90 -161.23 149.03 12.34 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 125.69 1.596 . . . . 0.0 110.893 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.83 152.54 14.77 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 112.893 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.78 28.72 23.06 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.288 -0.729 . . . . 0.0 111.669 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -59.3 -36.28 75.31 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 120.127 1.964 . . . . 0.0 110.953 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 25.7 t0 33.41 89.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.471 2.308 . . . . 0.0 113.31 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.71 172.06 24.43 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 122.328 0.96 . . . . 0.0 111.604 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -60.62 -25.64 66.42 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.699 -0.883 . . . . 0.0 111.686 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -134.12 155.23 80.22 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.754 1.222 . . . . 0.0 108.016 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.57 107.1 2.38 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.676 1.584 . . . . 0.0 108.237 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -119.28 -166.61 1.28 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.328 0.651 . . . . 0.0 111.139 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.6 135.05 34.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.421 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 266' ' ' TRP . 44.3 Cg_endo -83.44 148.58 12.87 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 124.516 3.478 . . . . 0.0 112.024 170.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.27 -6.6 17.35 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.794 2.329 . . . . 0.0 111.367 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -95.77 -6.23 40.14 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.992 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.68 17.47 41.78 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-O 118.786 -1.008 . . . . 0.0 115.405 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -128.68 154.57 46.16 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 117.696 0.748 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.7 t -152.34 165.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -122.56 148.72 44.87 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.4 mt -108.23 143.86 36.48 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.49 1.138 . . . . 0.0 110.622 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.79 109.94 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -165.42 1.65 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.695 -171.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.31 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 288' ' ' LEU . 1.7 pt? -69.41 14.48 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.873 2.469 . . . . 0.0 114.802 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.74 -59.2 1.08 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.172 0.92 . . . . 0.0 111.242 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -90.31 -34.01 15.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 46.9 m -74.05 -17.1 61.01 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 119.391 0.996 . . . . 0.0 108.657 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 234' ' ' TYR . 46.6 t -76.14 -57.76 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.42 -32.57 73.43 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.741 -1.225 . . . . 0.0 112.818 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 25.0 m -68.37 -42.59 78.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.036 0.834 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.12 -39.45 49.37 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.76 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.7 mt -60.51 -25.6 66.22 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.555 1.071 . . . . 0.0 111.789 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.04 -6.82 23.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.99 22.21 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 123.796 0.685 . . . . 0.0 109.784 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.85 -153.86 0.44 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.4 t -117.09 174.88 5.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.628 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -149.84 150.7 32.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -135.15 124.87 16.66 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.308 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -81.03 37.53 0.69 Allowed 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 124.416 3.411 . . . . 0.0 108.262 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -48.86 -36.57 17.29 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.421 1.01 . . . . 0.0 111.941 -177.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.469 ' H ' HD11 ' A' ' 304' ' ' LEU . 50.5 m 31.78 69.77 0.74 Allowed Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 126.6 1.96 . . . . 0.0 113.094 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.04 -7.99 18.57 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.666 2.244 . . . . 0.0 110.909 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.07 -5.99 0.06 Allowed 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 124.214 0.946 . . . . 0.0 111.062 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 130.71 -10.62 5.75 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.429 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.26 164.7 25.83 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 58.8 m -132.56 151.69 51.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -144.65 139.02 27.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.419 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.87 144.67 42.02 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.161 0.984 . . . . 0.0 110.961 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 327' ' ' GLN . 59.8 m-85 -136.93 159.16 42.71 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.742 0.817 . . . . 0.0 110.524 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -156.86 170.68 21.93 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.2 0.938 . . . . 0.0 111.074 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.68 124.9 24.56 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -141.6 28.42 1.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.413 -168.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.1 p -43.99 138.56 2.79 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.801 1.182 . . . . 0.0 112.908 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 18.2 t -116.43 -51.15 2.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -73.56 -26.21 60.73 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 108.925 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 55.24 26.07 8.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.935 1.694 . . . . 0.0 113.4 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -78.37 -20.01 52.19 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -159.57 177.3 11.06 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.67 134.5 44.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.277 1.431 . . . . 0.0 108.624 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.446 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 59.2 tptt -136.76 -7.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.43 175.43 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.811 1.291 . . . . 0.0 113.75 -171.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -151.03 153.76 9.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.843 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 313' ' ' TYR . 3.0 pp0? -117.79 156.04 29.02 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.32 139.89 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.694 -175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.53 119.36 4.26 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 124.153 0.908 . . . . 0.0 109.819 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -95.82 161.74 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.365 4.043 . . . . 0.0 111.751 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.416 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 3.3 t-105 -70.38 118.58 13.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.56 149.65 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 110.497 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.06 -39.26 81.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.833 0.853 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.67 2.91 10.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 122.918 0.487 . . . . 0.0 112.235 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -93.27 -9.82 37.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.172 -0.955 . . . . 0.0 110.95 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 51.4 m -90.96 -58.44 2.47 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -160.9 173.49 15.24 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.892 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.65 161.52 41.54 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.783 0.833 . . . . 0.0 111.412 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.52 166.88 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 122.545 1.164 . . . . 0.0 110.837 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -126.33 27.51 6.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.694 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 342' ' ' PRO . 85.9 p -147.87 167.93 12.32 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 117.22 -1.371 . . . . 0.0 110.061 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 341' ' ' SER . 74.4 Cg_endo -69.71 56.91 1.41 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 124.821 3.681 . . . . 0.0 109.982 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.6 t 55.67 38.91 30.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.383 0.673 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -71.91 151.32 43.42 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -65.03 157.15 29.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.98 160.48 4.73 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.871 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.88 139.0 87.93 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.2 94.44 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.866 2.377 . . . . 0.0 111.891 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 63.4 m 62.83 49.83 3.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.761 -1.563 . . . . 0.0 114.334 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -140.99 43.3 1.81 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 109.332 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 1.8 t -117.38 159.06 23.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 159.08 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.16 147.67 36.37 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.008 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 83.3 t -130.75 136.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.395 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -172.44 -157.72 14.95 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.589 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.66 29.54 19.08 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.377 1.071 . . . . 0.0 111.981 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 24.6 mt -76.72 164.45 25.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.432 1.083 . . . . 0.0 110.293 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . 0.504 ' CE1' ' H ' ' A' ' 361' ' ' LEU . 8.7 p-80 -77.62 12.7 1.53 Allowed 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.468 -0.77 . . . . 0.0 112.573 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 97.0 2.49 59.37 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 119.028 -0.873 . . . . 0.0 112.362 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 mmt -145.23 -71.32 0.26 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.039 0.92 . . . . 0.0 111.643 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.504 ' H ' ' CE1' ' A' ' 358' ' ' HIS . 12.8 tp 38.0 69.36 0.25 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.789 0.804 . . . . 0.0 111.094 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -67.33 179.3 1.28 Allowed 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.158 -0.964 . . . . 0.0 113.041 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.21 -27.07 65.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -170.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.96 -15.2 57.76 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 119.34 0.973 . . . . 0.0 112.289 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -92.63 -27.1 17.53 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.389 0.43 . . . . 0.0 111.186 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.4 mt -76.22 -37.03 58.26 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 124.74 1.275 . . . . 0.0 110.426 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.0 56.14 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.33 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.23 -50.52 73.34 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.8 -32.07 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 123.914 0.759 . . . . 0.0 111.632 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.96 -28.96 18.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.608 -1.307 . . . . 0.0 113.774 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.63 -19.86 27.15 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.682 1.128 . . . . 0.0 113.742 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -113.86 -17.3 12.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 120.051 1.296 . . . . 0.0 111.083 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.3 tp -97.6 -3.99 38.49 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 118.873 0.76 . . . . 0.0 111.286 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -152.03 -48.05 0.11 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.47 -1.73 88.29 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.442 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.35 111.37 2.24 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.97 166.28 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 123.865 0.866 . . . . 0.0 110.396 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 -29.03 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.21 153.64 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 109.645 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -155.12 132.23 10.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.68 158.3 27.79 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 121.163 -0.96 . . . . 0.0 113.575 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.02 138.91 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.242 1.817 . . . . 0.0 108.037 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.89 153.5 23.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.081 0.467 . . . . 0.0 112.128 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 5.3 p -137.47 165.79 25.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.064 0.459 . . . . 0.0 110.233 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.21 -178.83 5.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.47 100.36 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.045 0.384 . . . . 0.0 111.107 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.2 m170 50.41 40.86 23.95 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.93 1.292 . . . . 0.0 110.848 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -88.72 -20.62 24.58 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.344 0.658 . . . . 0.0 109.72 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.0 p90 38.8 53.56 4.25 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 0.0 112.954 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.65 -48.24 0.42 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.716 3.61 . . . . 0.0 111.271 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.416 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 8.6 tp 41.05 41.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.277 1.431 . . . . 0.0 111.49 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -162.11 14.43 0.13 Allowed Glycine 0 C--N 1.349 1.299 0 C-N-CA 121.077 -0.582 . . . . 0.0 114.132 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.2 p -156.33 132.07 9.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.11 0.955 . . . . 0.0 110.796 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.08 -164.83 25.45 Favored Glycine 0 C--O 1.209 -1.415 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.349 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -142.09 166.82 23.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.505 -0.848 . . . . 0.0 110.624 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.23 146.42 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.627 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 26.2 p -125.99 122.61 36.4 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 122.252 1.025 . . . . 0.0 108.362 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.12 -28.45 25.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.721 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.4 t30 54.07 17.09 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.301 1.048 . . . . 0.0 112.585 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -141.4 164.23 30.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.234 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -99.68 -45.31 5.81 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.527 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.82 -25.64 66.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.617 1.098 . . . . 0.0 112.921 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.0 p -84.99 -18.48 34.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -72.92 -56.09 5.67 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.583 0.629 . . . . 0.0 109.964 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.27 63.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.753 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -77.08 -24.89 51.84 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.88 1.218 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.98 -29.43 35.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.565 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.1 m -78.92 -18.29 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 123.798 0.686 . . . . 0.0 112.203 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 91.3 p -88.9 -22.16 23.27 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -85.76 -44.56 12.4 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.299 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.48 -2.24 0.0 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 128.551 2.74 . . . . 0.0 116.627 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -158.4 141.15 14.58 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.73 163.36 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 119.103 0.865 . . . . 0.0 109.229 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 28.2 mt-10 -119.83 131.99 55.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.993 1.378 . . . . 0.0 112.552 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.404 ' HB ' ' H ' ' A' ' 422' ' ' LYS . 6.4 mm -93.95 117.09 36.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -117.61 25.71 10.22 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.909 0.777 . . . . 0.0 109.838 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.467 HG21 ' H ' ' A' ' 419' ' ' LYS . 86.2 m -63.74 158.12 22.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.021 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -86.17 -2.54 58.45 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 123.455 0.702 . . . . 0.0 112.149 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.467 ' H ' HG21 ' A' ' 417' ' ' THR . 39.4 pttt -128.22 -1.6 5.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.498 1.119 . . . . 0.0 111.523 174.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -150.26 127.52 11.34 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.6 m -142.08 109.1 5.47 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.195 -0.94 . . . . 0.0 111.105 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.647 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 33.6 tptt -167.22 -156.46 0.21 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 117.899 0.318 . . . . 0.0 111.416 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.647 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 98.7 mttt -141.11 176.21 9.01 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.601 0.76 . . . . 0.0 109.674 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.62 154.11 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.03 151.75 36.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.887 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.99 139.46 47.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -142.81 113.12 5.87 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.98 161.77 40.48 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.701 3.6 . . . . 0.0 112.33 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.606 -1.664 . . . . 0.0 111.51 178.291 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.035 0.445 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 221' ' ' SER . 9.7 m 45.45 55.97 6.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.409 1.099 . . . . 0.0 113.101 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.41 18.72 0.07 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.191 0.997 . . . . 0.0 113.245 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 219' ' ' THR . 66.4 m -37.21 121.02 0.8 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.04 1.336 . . . . 0.0 113.288 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.8 0.91 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-O 118.266 -1.296 . . . . 0.0 114.035 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -89.51 -29.75 18.74 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.387 1.593 . . . . 0.0 109.564 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.8 mt 61.7 148.42 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 115.064 172.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -63.01 131.14 31.49 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.641 2.227 . . . . 0.0 111.769 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.15 147.32 14.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.208 2.606 . . . . 0.0 109.209 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -144.88 22.42 1.59 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.34 30.68 3.74 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.555 0.742 . . . . 0.0 111.627 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -71.11 161.17 31.57 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 111.384 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -135.27 -143.34 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.357 1.063 . . . . 0.0 108.594 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.4 p30 36.17 51.51 1.68 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.536 1.534 . . . . 0.0 113.655 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.83 119.28 6.28 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.936 1.757 . . . . 0.0 112.131 -173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.1 mm -129.75 140.65 48.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.415 ' CD1' HG22 ' A' ' 292' ' ' VAL . 43.4 m-85 -104.27 155.02 19.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.987 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.3 t -137.58 -34.97 0.67 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 90.8 m -147.07 78.79 1.5 Allowed 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.67 0.748 . . . . 0.0 112.746 -168.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.476 ' HZ3' ' HB3' ' A' ' 389' ' ' TYR . 19.5 pttm 52.23 -169.07 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 172.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.64 145.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -87.77 149.58 24.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.489 1.116 . . . . 0.0 110.504 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 241' ' ' GLY . 0.6 OUTLIER -149.63 117.61 6.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.121 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . -179.89 -178.23 48.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 122.192 0.884 . . . . 0.0 112.722 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.02 15.93 1.46 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 124.31 0.957 . . . . 0.0 114.792 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.51 130.27 26.02 Favored Pre-proline 0 N--CA 1.473 0.719 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.484 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 13.3 Cg_endo -87.91 -8.69 5.77 Favored 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 124.156 3.237 . . . . 0.0 112.57 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.499 ' CE3' ' HE1' ' A' ' 321' ' ' MET . 11.5 p-90 -147.34 -7.8 0.45 Allowed 'General case' 0 C--O 1.251 1.172 0 CA-C-N 120.585 1.539 . . . . 0.0 114.876 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.33 110.55 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.486 -1.383 . . . . 0.0 108.931 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -20.25 25.68 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.152 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.3 p -153.31 154.49 34.68 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 119.416 -2.053 . . . . 0.0 111.451 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -16.89 39.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.56 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.44 -17.6 60.11 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.84 -62.28 2.86 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.75 -31.18 68.99 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 118.593 -1.243 . . . . 0.0 111.448 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.89 -50.91 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.657 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.51 -5.19 31.3 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.6 m -79.83 -21.58 44.02 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.899 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -131.59 -1.31 3.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 257' ' ' ARG . 26.4 ttt-85 -81.13 -21.39 39.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.304 1.442 . . . . 0.0 111.287 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.13 -16.86 15.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 O-C-N 125.262 1.601 . . . . 0.0 115.291 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -133.48 -5.76 2.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.783 1.233 . . . . 0.0 110.649 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -94.24 -166.42 36.8 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.478 ' H ' HD12 ' A' ' 295' ' ' LEU . 73.0 m -146.47 65.82 1.19 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 171.16 16.11 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.752 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 61.5 m -138.88 174.9 10.03 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -131.24 139.41 50.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 CA-C-O 122.62 1.2 . . . . 0.0 110.949 -174.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.23 142.02 24.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.237 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -163.81 142.04 5.98 Favored Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.95 -177.34 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.77 3.647 . . . . 0.0 111.787 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 67.74 -5.15 3.57 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -142.58 44.55 1.62 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 119.911 1.856 . . . . 0.0 110.619 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.12 153.03 40.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.469 0.652 . . . . 0.0 110.128 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.39 -6.27 38.93 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.015 0.817 . . . . 0.0 111.69 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -157.91 -27.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.427 1.113 . . . . 0.0 113.244 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.36 76.11 9.34 Favored Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.29 112.32 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.091 3.194 . . . . 0.0 111.203 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -170.86 -166.83 0.51 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.43 146.59 77.72 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.58 166.2 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.854 3.036 . . . . 0.0 109.18 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.74 4.16 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.632 2.888 . . . . 0.0 111.964 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -120.48 167.93 11.86 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.73 10.22 68.49 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.553 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 16.0 p90 -146.24 162.62 37.68 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.4 m -156.96 -166.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 129.069 2.948 . . . . 0.0 108.032 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -132.58 152.24 51.68 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.234 -0.916 . . . . 0.0 111.887 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 77.5 mt -110.16 140.35 44.35 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.24 0.962 . . . . 0.0 109.979 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.0 -153.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.04 0.536 . . . . 0.0 110.45 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . 0.315 33.0 t80 78.62 -107.01 0.02 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.805 -173.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.02 128.54 34.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 120.574 1.534 . . . . 0.0 107.544 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.76 17.19 3.31 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.491 1.119 . . . . 0.0 112.651 -167.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.9 -71.12 0.71 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.577 1.151 . . . . 0.0 111.833 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -79.26 -19.3 50.92 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.669 -1.27 . . . . 0.0 112.585 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 24.5 m -101.26 -8.33 22.24 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.79 0.723 . . . . 0.0 111.556 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.415 HG22 ' CD1' ' A' ' 234' ' ' TYR . 5.6 m -85.24 -40.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 168.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.0 -59.61 4.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.34 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.0 p -76.57 -39.58 52.31 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 120.069 1.304 . . . . 0.0 112.12 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.478 HD12 ' H ' ' A' ' 261' ' ' SER . 65.3 mt -68.57 -34.01 75.07 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -171.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -94.23 -12.89 27.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.317 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.05 0.87 54.53 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.652 0.66 . . . . 0.0 111.096 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.49 -24.63 14.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 96.7 m -78.86 -152.96 0.06 Allowed 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.767 170.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.4 m -118.81 166.89 12.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 120.675 -1.265 . . . . 0.0 111.997 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -144.99 151.74 39.06 Favored 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 122.414 0.286 . . . . 0.0 110.982 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.28 138.68 16.82 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -87.07 20.72 1.17 Allowed 'Trans proline' 0 N--CA 1.431 -2.197 0 C-N-CA 122.293 1.996 . . . . 0.0 111.478 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.437 HD11 ' HD3' ' A' ' 306' ' ' PRO . 0.2 OUTLIER -60.16 -19.38 53.66 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t 38.24 60.61 4.79 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.789 2.036 . . . . 0.0 112.646 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.437 ' HD3' HD11 ' A' ' 304' ' ' LEU . 71.9 Cg_endo -76.18 1.07 8.68 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.678 2.919 . . . . 0.0 111.941 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.52 -7.26 0.88 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.565 -1.334 . . . . 0.0 112.922 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.42 -9.81 17.15 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 17.9 tp -132.89 143.2 49.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.14 1.776 . . . . 0.0 109.029 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.9 m -67.91 168.85 10.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -139.18 154.51 48.07 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.09 156.66 18.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -152.69 155.69 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.354 0.409 . . . . 0.0 111.097 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -153.47 152.73 31.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -111.89 146.28 38.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.444 ' HE3' ' CG1' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -148.49 -1.98 0.51 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.903 1.377 . . . . 0.0 110.541 -169.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 69.8 m -71.68 145.84 48.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.638 0.586 . . . . 0.0 112.503 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.8 m -85.2 149.79 25.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 124.358 1.036 . . . . 0.0 110.747 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -62.21 -15.53 47.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.754 -170.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.79 -23.34 67.32 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.598 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.499 ' HE1' ' CE3' ' A' ' 245' ' ' TRP . 1.2 ptt? -159.65 15.04 0.15 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 173.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -44.21 142.59 1.43 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.043 0.925 . . . . 0.0 112.116 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 48.3 t -164.44 -35.64 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.031 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -137.1 163.81 29.92 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.575 0.75 . . . . 0.0 111.849 -173.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.57 167.05 10.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.443 2.697 . . . . 0.0 112.092 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.444 ' CG1' ' HE3' ' A' ' 316' ' ' MET . 12.5 m -104.15 160.42 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.88 0.848 . . . . 0.0 112.269 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 153.24 17.76 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.134 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 16.9 t -137.87 130.51 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.363 1.04 . . . . 0.0 109.946 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.5 mt -138.65 119.28 9.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.979 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.22 168.69 7.55 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.246 2.631 . . . . 0.0 110.221 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.483 ' CH2' ' HB ' ' A' ' 391' ' ' ILE . 2.9 t-105 -104.52 123.95 48.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.495 0.664 . . . . 0.0 111.68 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.21 143.67 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.558 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.53 -40.64 62.69 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 125.109 1.364 . . . . 0.0 109.851 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.59 57.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 122.277 -0.265 . . . . 0.0 110.847 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.88 -18.09 38.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.494 -1.378 . . . . 0.0 110.766 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 p -111.79 -25.97 9.2 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.844 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -141.1 142.34 34.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.883 0.765 . . . . 0.0 110.612 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -157.33 153.47 27.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.433 -1.417 . . . . 0.0 111.144 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.57 147.37 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.65 31.55 5.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.689 0.796 . . . . 0.0 109.636 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.8 t -145.72 145.94 27.33 Favored Pre-proline 0 CA--C 1.52 -0.208 0 C-N-CA 124.16 0.984 . . . . 0.0 108.396 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.21 -7.11 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.175 2.584 . . . . 0.0 111.45 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.9 p -135.1 164.58 27.33 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.693 0.797 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.93 132.97 34.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.411 0.624 . . . . 0.0 112.059 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -154.9 162.56 41.06 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.083 1.353 . . . . 0.0 110.411 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 17.8 tp -151.59 175.43 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.837 1.336 . . . . 0.0 107.76 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.423 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 9.0 t70 -145.95 129.07 8.21 Favored Pre-proline 0 N--CA 1.446 -0.674 0 O-C-N 120.931 -1.106 . . . . 0.0 109.679 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.18 0.87 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.962 1 C-N-CA 126.507 4.805 . . . . 0.0 114.996 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 14.6 t -131.67 -7.3 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.677 -0.677 . . . . 0.0 111.935 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -135.91 77.3 1.65 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.42 1.009 . . . . 0.0 110.112 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.1 p -135.54 84.67 2.11 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.328 1.643 . . . . 0.0 108.647 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.74 145.55 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.048 0.451 . . . . 0.0 111.239 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -73.08 150.39 42.33 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.122 0.963 . . . . 0.0 112.405 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.8 140.83 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.073 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.47 -166.56 23.59 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 122.25 0.917 . . . . 0.0 114.108 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.46 38.69 30.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.543 0.687 . . . . 0.0 110.248 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.26 -179.65 7.25 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.174 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -56.71 -11.87 1.58 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.231 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.59 88.15 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.192 0.906 . . . . 0.0 113.78 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.6 ptm -165.85 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.161 0.584 . . . . 0.0 110.814 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.68 144.06 52.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -94.88 159.3 15.1 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.75 60.29 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.144 -0.973 . . . . 0.0 112.524 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.66 -29.02 61.1 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.75 -26.23 24.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.22 0.95 . . . . 0.0 109.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 tt -72.42 -46.95 52.81 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -71.64 -24.28 61.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 110.224 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.04 -45.56 66.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.535 0.683 . . . . 0.0 109.799 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.39 -44.24 94.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.4 -15.04 51.29 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.829 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.95 -16.46 21.71 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 120.283 1.402 . . . . 0.0 112.169 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.48 -25.78 14.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.75 -24.81 61.01 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.203 0.94 . . . . 0.0 110.803 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 403' ' ' SER . 3.9 p90 -163.41 -24.71 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.459 0.572 . . . . 0.0 112.159 174.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 72.67 157.93 4.0 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.724 -0.61 . . . . 0.0 112.37 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 126.12 15.68 2.77 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 121.871 0.706 . . . . 0.0 111.58 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.81 173.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.053 -0.573 . . . . 0.0 112.132 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.97 -26.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.416 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -157.82 157.68 33.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.37 0.987 . . . . 0.0 110.079 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.04 141.48 28.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.79 133.64 4.76 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.512 1.062 . . . . 0.0 113.523 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.67 145.9 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.5 70.38 7.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.82 150.27 48.82 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.127 0.571 . . . . 0.0 112.097 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.83 164.19 29.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -56.68 103.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.307 0.643 . . . . 0.0 112.128 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 m170 53.05 26.65 4.99 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.788 1.635 . . . . 0.0 113.613 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -85.58 -8.39 58.31 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.157 -0.964 . . . . 0.0 111.672 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.476 ' HB3' ' HZ3' ' A' ' 237' ' ' LYS . 41.9 p90 54.3 45.57 2.38 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.875 1.67 . . . . 0.0 113.053 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.634 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 86.0 Cg_endo -73.97 -66.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.034 2.489 . . . . 0.0 110.738 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.634 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 8.9 tp 38.79 35.14 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.9 0.88 . . . . 0.0 113.338 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.66 15.12 0.45 Allowed Glycine 0 CA--C 1.524 0.649 0 O-C-N 121.321 -0.862 . . . . 0.0 113.53 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 62.7 p -151.68 154.29 36.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 166.77 -146.86 11.26 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.615 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -149.29 171.36 16.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.34 136.67 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 122.077 0.942 . . . . 0.0 110.332 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 346' ' ' LEU . 45.8 m -99.15 133.08 43.95 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.403 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -115.33 179.32 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -144.25 5.84 1.29 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.15 166.62 24.17 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -83.94 -29.65 26.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.114 0.566 . . . . 0.0 110.516 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.619 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -66.42 -27.72 68.05 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.143 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.433 ' HA ' ' CE1' ' A' ' 374' ' ' PHE . 51.0 m -73.12 -27.4 61.66 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.013 0.824 . . . . 0.0 110.536 174.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.78 -56.0 6.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.821 0.82 . . . . 0.0 110.201 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -8.83 56.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.884 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -100.77 -21.19 15.25 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.914 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.05 -34.16 44.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 43.2 t -83.58 -33.93 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 122.808 0.443 . . . . 0.0 110.769 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.0 t -70.44 -32.64 70.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 119.724 1.147 . . . . 0.0 109.051 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -73.04 -52.66 13.52 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.865 0.84 . . . . 0.0 110.175 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.24 -17.5 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 126.678 1.991 . . . . 0.0 115.672 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -157.91 142.78 16.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.34 0.518 . . . . 0.0 110.354 -178.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.94 154.26 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 122.254 -0.279 . . . . 0.0 110.537 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -101.54 140.66 35.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.06 126.88 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -131.1 121.79 25.58 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.3 m -150.64 162.75 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -172.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.7 t -65.67 -5.16 7.65 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -145.58 4.43 1.02 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.346 1.058 . . . . 0.0 113.368 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -150.63 129.45 12.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.784 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.8 p -147.9 102.17 3.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -147.88 173.31 12.97 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -118.87 179.08 4.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.3 145.88 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -122.12 144.65 48.81 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 122.931 0.144 . . . . 0.0 110.766 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.94 145.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -138.44 138.94 23.43 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.1 155.68 63.42 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.168 2.579 . . . . 0.0 110.15 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.066 -170.727 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' MET . . . . . 0.417 ' CG ' HG13 ' A' ' 413' ' ' VAL . 11.0 tpt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.8 m -153.11 159.22 42.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.241 1.417 . . . . 0.0 109.754 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 17.61 0.65 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.247 0.619 . . . . 0.0 112.479 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.6 m 61.06 26.65 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.078 1.751 . . . . 0.0 115.205 172.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 51.59 68.09 1.69 Allowed Glycine 0 CA--C 1.536 1.395 0 CA-C-O 121.117 0.287 . . . . 0.0 113.202 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.48 -17.19 63.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.375 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.62 151.82 39.92 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-O 121.365 0.602 . . . . 0.0 110.499 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.5 110.89 2.5 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.55 4.69 6.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.347 3.365 . . . . 0.0 111.989 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -143.46 -171.29 3.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.819 1.248 . . . . 0.0 109.195 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 25.8 m120 57.73 22.74 8.74 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.296 1.839 . . . . 0.0 114.078 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -62.55 -36.74 83.62 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.145 -0.347 . . . . 0.0 110.224 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 39.84 54.41 2.58 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.9 59.47 39.0 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.83 127.39 13.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.308 3.338 . . . . 0.0 114.43 -171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.8 mm -146.14 131.54 12.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 102.604 -3.109 . . . . 0.0 102.604 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -98.45 143.03 29.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.768 -1.173 . . . . 0.0 109.231 -169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.9 p -137.14 -1.24 2.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 14.7 t -158.97 -166.28 1.82 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.026 1.285 . . . . 0.0 108.317 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 176.91 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.535 1.134 . . . . 0.0 112.564 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.1 142.35 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.49 1.138 . . . . 0.0 109.01 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.25 130.12 38.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.512 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -137.07 113.57 10.14 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.94 173.98 38.35 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-O 121.418 0.454 . . . . 0.0 113.73 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 115.05 18.83 6.16 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.357 -1.421 . . . . 0.0 114.009 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.3 m -92.0 126.09 54.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.501 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -82.03 -17.03 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.991 3.128 . . . . 0.0 111.483 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.517 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 30.1 p-90 -130.54 -70.06 0.63 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.146 0.884 . . . . 0.0 109.709 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 245' ' ' TRP . 26.7 t70 10.97 90.72 0.01 OUTLIER 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.768 1.627 . . . . 0.0 113.225 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.412 ' CD1' ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -63.96 -22.0 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.7 m -150.33 143.15 24.7 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-N 121.029 1.74 . . . . 0.0 108.916 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.19 -24.93 64.11 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.197 0.999 . . . . 0.0 109.52 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.54 -13.94 62.59 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.54 1.136 . . . . 0.0 110.689 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.83 -58.16 5.94 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 54.8 mt -50.49 -47.21 57.32 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 122.199 0.999 . . . . 0.0 109.437 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.42 -45.59 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.916 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -73.92 -8.03 54.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.904 0.32 . . . . 0.0 110.853 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 84.6 m -90.49 -20.56 22.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.99 32.58 1.12 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.441 1.019 . . . . 0.0 112.468 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -88.25 14.98 8.25 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.14 12.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 O-C-N 120.541 -1.349 . . . . 0.0 112.37 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -93.36 -1.69 55.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.114 0.87 . . . . 0.0 111.56 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 70.12 -0.26 24.33 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.5 t -124.89 18.31 8.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.704 -0.88 . . . . 0.0 112.076 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.53 143.42 28.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.366 -0.533 . . . . 0.0 112.25 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.6 m -150.71 153.15 35.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 93.5 t -138.17 138.76 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 124.012 0.82 . . . . 0.0 111.29 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -143.45 156.19 44.58 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.488 1.118 . . . . 0.0 113.651 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -151.18 167.32 13.23 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.56 -19.28 22.8 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 124.087 3.191 . . . . 0.0 115.681 -168.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 170.46 157.53 12.77 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.085 1.311 . . . . 0.0 111.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -102.16 15.3 29.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.761 0.824 . . . . 0.0 112.766 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.86 144.41 47.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.639 1.176 . . . . 0.0 108.936 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.24 177.37 15.33 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.285 0.936 . . . . 0.0 110.775 -176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.74 173.36 8.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.553 -0.969 . . . . 0.0 108.494 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 60.66 142.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.539 1.135 . . . . 0.0 112.223 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.9 -11.87 11.1 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 123.852 3.034 . . . . 0.0 111.415 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -101.06 33.0 2.99 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.822 0.849 . . . . 0.0 111.991 -171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.582 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 48.9 t 64.98 144.58 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 124.685 1.194 . . . . 0.0 110.342 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.582 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 71.2 Cg_endo -66.55 166.08 23.09 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.068 1.846 . . . . 0.0 112.972 171.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.7 113.3 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 CA-C-O 122.643 1.018 . . . . 0.0 111.396 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -143.52 145.79 32.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.247 1.419 . . . . 0.0 109.977 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -92.8 4.11 75.07 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.236 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.93 165.79 35.57 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.62 161.66 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.863 1.265 . . . . 0.0 109.74 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -97.39 149.37 22.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.579 1.081 . . . . 0.0 109.752 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -117.79 137.09 52.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.16 107.52 11.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -153.51 -161.68 1.31 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 124.445 1.091 . . . . 0.0 111.058 -168.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.19 92.48 0.04 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.51 HD21 ' H ' ' A' ' 288' ' ' LEU . 1.8 pt? -67.03 17.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.792 2.437 . . . . 0.0 117.011 -168.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.86 -60.12 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.102 1.319 . . . . 0.0 109.98 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -86.19 -23.71 26.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.264 -0.897 . . . . 0.0 112.862 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 12.2 t -84.12 -22.73 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 286' ' ' PHE . 24.1 t -72.66 -48.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.561 0.696 . . . . 0.0 109.577 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.3 ptp180 -74.95 -25.67 59.04 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.551 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 48.0 m -78.18 -37.23 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 0.0 112.672 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.95 -35.96 67.08 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 7.0 mp -71.34 -24.21 62.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.087 0.858 . . . . 0.0 110.006 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -92.11 -2.35 56.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.76 -18.14 18.97 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.125 -1.609 . . . . 0.0 110.226 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.84 -151.32 0.44 Allowed 'General case' 0 C--O 1.24 0.554 0 O-C-N 125.925 2.016 . . . . 0.0 110.411 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -126.46 177.94 6.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.191 0.932 . . . . 0.0 113.125 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.437 ' CE1' ' HB3' ' A' ' 310' ' ' SER . 83.3 t60 -145.8 162.03 38.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.45 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -144.12 131.78 10.66 Favored Pre-proline 0 C--N 1.351 0.648 0 O-C-N 124.026 0.829 . . . . 0.0 110.102 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -86.75 23.87 0.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 1 C-N-CA 125.807 4.338 . . . . 0.0 111.174 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.581 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -50.55 -40.53 52.27 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.517 0.727 . . . . 0.0 111.736 -172.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.581 ' H ' HD12 ' A' ' 304' ' ' LEU . 6.2 t 49.47 52.82 13.39 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -80.23 -9.66 13.87 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 122.242 1.961 . . . . 0.0 111.494 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 7.44 7.47 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.454 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 86.6 -0.17 86.6 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 119.072 -0.849 . . . . 0.0 111.965 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.29 158.53 27.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 29.0 m -108.61 158.18 17.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.312 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -138.06 135.56 35.97 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.004 -171.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 296' ' ' LEU . 5.6 m-85 -85.2 148.88 25.87 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.24 149.42 51.98 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.177 -0.952 . . . . 0.0 111.141 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -151.88 168.03 26.44 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 123.313 1.53 . . . . 0.0 109.785 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.452 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 12.7 ptpt -130.46 116.74 18.64 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.921 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.5 OUTLIER -110.99 28.46 8.7 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -176.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 86.1 p -79.61 164.31 23.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.029 0.932 . . . . 0.0 111.401 -174.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 66.6 m -117.05 176.13 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -79.1 23.71 0.35 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -128.79 15.16 6.42 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.63 0.772 . . . . 0.0 110.778 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.517 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 16.6 mmt -137.52 179.65 6.28 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -130.8 103.41 6.56 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.678 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.7 m 64.88 166.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 111.419 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -155.34 -64.6 0.12 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.749 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 44.05 69.61 0.4 Allowed 'General case' 0 C--N 1.343 0.318 0 O-C-N 123.84 0.713 . . . . 0.0 112.652 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.7 p -83.99 160.0 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 121.902 -0.499 . . . . 0.0 109.987 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -102.8 153.59 20.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.509 0.595 . . . . 0.0 110.114 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.3 139.15 49.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 19.7 tt -155.83 88.1 3.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 122.854 1.311 . . . . 0.0 108.123 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.16 164.75 26.67 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.868 2.379 . . . . 0.0 113.062 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -78.28 122.49 25.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.104 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.547 HG13 ' H ' ' A' ' 334' ' ' ALA . 86.8 t -103.84 148.6 8.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 122.463 1.125 . . . . 0.0 110.161 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.44 -38.62 59.65 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.554 1.142 . . . . 0.0 110.775 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.547 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -64.32 -3.09 2.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.706 0.403 . . . . 0.0 111.892 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -102.96 7.24 39.2 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 120.823 -1.173 . . . . 0.0 111.202 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.9 m -119.85 -49.37 2.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -151.13 157.41 42.7 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 119.122 0.873 . . . . 0.0 111.609 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -156.08 143.33 19.15 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.901 1.375 . . . . 0.0 109.342 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.27 154.57 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.999 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -117.87 41.18 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.8 t -137.61 147.15 56.24 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.548 1.139 . . . . 0.0 110.074 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.66 -3.36 13.76 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.564 2.176 . . . . 0.0 111.022 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.8 m -130.19 -176.85 4.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -105.86 135.95 46.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.728 -1.233 . . . . 0.0 110.243 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -159.59 165.75 32.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.083 -1.011 . . . . 0.0 109.321 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.417 HD12 ' HG1' ' A' ' 397' ' ' THR . 12.6 tp -156.37 150.7 25.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.057 1.343 . . . . 0.0 110.04 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.1 110.78 8.51 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.13 -2.09 11.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.864 3.043 . . . . 0.0 111.348 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 67.8 m -84.45 -14.35 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -140.42 94.72 2.77 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 109.942 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.5 t -149.27 152.24 35.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.702 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.0 m -135.11 153.06 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 118.822 0.737 . . . . 0.0 109.375 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -75.04 145.71 42.17 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.923 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 66.9 t -132.0 140.75 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 125.089 1.493 . . . . 0.0 111.168 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -165.76 -162.15 16.39 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.523 -0.736 . . . . 0.0 111.945 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.66 31.9 18.25 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.15 0.975 . . . . 0.0 111.291 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.67 25.74 0.63 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . 0.295 0.0 OUTLIER 58.31 9.23 0.97 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.96 1.704 . . . . 0.0 114.739 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.16 63.98 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 167.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.5 ptm -165.48 21.7 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.19 1.495 . . . . 0.0 112.339 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.617 HD12 ' HZ2' ' A' ' 422' ' ' LYS . 18.4 tp -69.38 151.37 46.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.881 0.848 . . . . 0.0 111.496 -175.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -114.26 174.26 6.04 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -75.53 -14.93 60.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -71.94 -25.26 61.81 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.031 -1.043 . . . . 0.0 109.247 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -90.24 -31.84 16.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.91 1.381 . . . . 0.0 110.74 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.545 0.612 . . . . 0.0 110.557 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.53 67.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.86 -45.09 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.701 -0.624 . . . . 0.0 110.745 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 81.4 mt -64.65 -43.45 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.701 0.8 . . . . 0.0 110.488 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 374' ' ' PHE . 3.7 mm? -81.0 -28.04 35.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.146 -0.971 . . . . 0.0 113.293 -173.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.24 -13.73 27.92 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -108.31 -22.04 12.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.743 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.23 -16.97 21.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.2 0.909 . . . . 0.0 111.535 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.443 ' CE2' HD11 ' A' ' 370' ' ' LEU . 16.2 m-30 -113.26 -12.29 13.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.763 1.165 . . . . 0.0 113.694 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 69.25 4.13 41.95 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.98 -0.45 . . . . 0.0 113.226 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -164.73 115.92 0.67 Allowed Glycine 0 C--N 1.357 1.717 0 CA-C-N 118.456 1.128 . . . . 0.0 115.177 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.44 179.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.237 0.615 . . . . 0.0 111.66 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.12 -39.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 O-C-N 122.028 -0.42 . . . . 0.0 110.936 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.77 152.75 30.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.653 0.66 . . . . 0.0 111.187 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.96 37.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.416 1.486 . . . . 0.0 109.036 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -168.41 169.56 41.64 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 120.83 -1.168 . . . . 0.0 115.371 175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.2 mm -90.16 150.4 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 125.994 1.718 . . . . 0.0 109.711 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.53 71.73 5.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 156.7 34.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.691 -0.63 . . . . 0.0 111.241 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.18 161.61 40.56 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.473 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 24.1 tptm -45.77 102.49 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.616 0.766 . . . . 0.0 112.201 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . 0.473 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 24.3 m170 48.39 42.12 17.73 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.692 1.997 . . . . 0.0 112.338 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -97.25 -11.42 24.18 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 124.312 1.007 . . . . 0.0 109.835 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 26.8 p90 44.58 45.49 2.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 90.0 Cg_endo -72.1 -58.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.88 3.72 . . . . 0.0 109.779 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.445 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 9.5 tp 42.72 32.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.421 0 C-N-CA 125.172 1.389 . . . . 0.0 113.838 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.6 16.81 0.97 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 54.0 m -152.37 157.74 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 117.833 0.816 . . . . 0.0 110.06 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 176.1 -163.84 33.49 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 123.66 0.6 . . . . 0.0 113.489 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -146.42 173.8 11.96 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.717 0.892 . . . . 0.0 111.213 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.17 144.03 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.417 ' HG1' HD12 ' A' ' 346' ' ' LEU . 34.9 p -119.1 152.27 36.8 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.623 1.201 . . . . 0.0 111.218 175.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.543 ' CE1' ' HB2' ' A' ' 403' ' ' SER . 35.0 m-85 -129.82 179.37 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 123.611 1.672 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -126.64 1.78 6.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.314 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.35 164.03 24.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.761 1.225 . . . . 0.0 109.593 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -96.91 -13.38 22.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.19 -38.12 87.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.795 1.18 . . . . 0.0 107.928 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.543 ' HB2' ' CE1' ' A' ' 398' ' ' PHE . 8.3 p -79.15 -17.99 53.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -72.75 -61.08 1.93 Allowed 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.798 -0.563 . . . . 0.0 111.944 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -25.58 61.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.206 -1.397 . . . . 0.0 113.028 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -77.92 -20.6 52.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.073 0.851 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.71 61.15 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.725 -0.609 . . . . 0.0 111.155 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.5 m -82.71 -11.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.648 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.8 p -106.89 -8.23 16.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.068 0.855 . . . . 0.0 112.507 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -93.44 -49.83 5.73 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.36 -15.26 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.56 138.77 12.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 218' ' ' MET . 10.6 m -143.94 158.98 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.972 0.351 . . . . 0.0 111.43 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.99 137.18 42.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.866 1.354 . . . . 0.0 109.713 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.21 128.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.61 50.16 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 28.4 m -73.9 166.5 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -71.6 -1.87 15.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -148.36 5.58 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.804 -1.185 . . . . 0.0 111.23 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -146.98 125.46 12.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.327 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 54.5 p -138.58 111.2 7.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 125.332 1.645 . . . . 0.0 112.822 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.617 ' HZ2' HD12 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -159.55 -176.68 5.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.466 -1.396 . . . . 0.0 112.323 177.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.61 163.42 24.25 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.762 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 25.9 m -143.98 156.88 15.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 123.68 0.613 . . . . 0.0 109.653 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -130.26 153.47 48.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.258 0.348 . . . . 0.0 111.216 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 79.2 mt -131.53 142.38 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.896 1.372 . . . . 0.0 108.115 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -139.23 155.97 72.2 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.558 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.9 158.08 35.37 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 C-N-CA 124.28 3.32 . . . . 0.0 115.22 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 75.8 t80 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.15 177.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -169.86 175.67 5.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.642 1.214 . . . . 0.0 111.199 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.406 ' HE3' ' H ' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -129.17 16.04 6.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 174.09 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.1 m 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.65 84.42 0.45 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.328 -1.483 . . . . 0.0 111.602 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -99.24 -5.33 30.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.19 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.65 125.07 20.32 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.405 1.082 . . . . 0.0 109.258 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.6 116.81 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 125.01 3.807 . . . . 0.0 111.169 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -81.8 -179.28 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.044 3.829 . . . . 0.0 111.86 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 37.93 66.21 0.5 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.923 1.689 . . . . 0.0 114.21 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -143.65 27.18 1.53 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.113 0.965 . . . . 0.0 110.186 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -66.23 0.93 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 112.561 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 55.97 45.88 22.99 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.877 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -117.61 -50.17 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.64 -170.78 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.419 3.413 . . . . 0.0 114.063 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.639 HD11 ' H ' ' A' ' 233' ' ' ILE . 0.2 OUTLIER -102.83 -171.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 125.388 1.475 . . . . 0.0 108.717 -178.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -106.37 148.74 27.72 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.7 m -141.99 11.56 2.0 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.6 t -158.48 -145.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.317 -1.49 . . . . 0.0 110.414 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 170.05 6.76 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.978 0.911 . . . . 0.0 110.616 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 m -144.53 155.12 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 122.32 1.057 . . . . 0.0 109.59 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.78 135.93 34.58 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.62 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -146.09 122.66 11.1 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.336 0.588 . . . . 0.0 111.088 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.27 -170.99 33.41 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.113 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.74 6.96 0.91 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 124.689 1.138 . . . . 0.0 112.109 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.57 145.8 30.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 122.707 1.241 . . . . 0.0 113.616 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.16 -13.02 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 125.0 3.8 . . . . 0.0 110.219 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -101.2 -104.09 0.25 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.631 1.105 . . . . 0.0 110.111 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.9 t70 46.38 59.5 3.81 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 124.278 1.031 . . . . 0.0 111.294 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.459 HG12 ' HG1' ' A' ' 248' ' ' THR . 0.2 OUTLIER -70.31 -17.24 20.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 O-C-N 121.069 -1.019 . . . . 0.0 110.903 -170.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.459 ' HG1' HG12 ' A' ' 247' ' ' ILE . 4.8 m -149.29 133.51 17.34 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 127.053 2.141 . . . . 0.0 105.357 172.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.19 -10.23 59.5 Favored 'General case' 0 CA--C 1.485 -1.554 0 O-C-N 117.508 -3.245 . . . . 0.0 115.66 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.12 -18.24 58.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.3 -43.83 30.35 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.52 -45.4 68.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.061 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.2 t -64.7 -39.06 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 123.761 0.663 . . . . 0.0 110.272 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.47 -16.79 64.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.651 -1.281 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 74.7 m -77.53 -33.55 54.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.727 -0.608 . . . . 0.0 111.513 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -142.53 80.6 1.7 Allowed 'General case' 0 C--O 1.218 -0.602 0 O-C-N 118.978 -2.326 . . . . 0.0 109.934 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.7 5.27 2.18 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.945 171.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.35 -4.91 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.452 1.024 . . . . 0.0 110.744 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -77.2 -12.27 59.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.21 3.26 6.33 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.6 m -114.06 16.41 18.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.165 1.482 . . . . 0.0 110.335 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.88 155.71 50.2 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -148.88 -172.49 4.12 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.383 2.273 . . . . 0.0 108.03 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.45 150.55 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -170.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 129.29 23.69 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.534 -0.729 . . . . 0.0 109.847 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -156.29 152.79 23.92 Favored Pre-proline 0 N--CA 1.439 -1.004 0 O-C-N 121.025 -1.047 . . . . 0.0 113.041 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.69 148.82 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.676 4.25 . . . . 0.0 105.969 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.86 -8.7 70.72 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.792 1.187 . . . . 0.0 110.307 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -66.67 -18.37 65.33 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.912 1.356 . . . . 0.0 110.419 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -81.35 -5.25 57.64 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 112.365 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -110.97 -176.85 20.52 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -74.92 163.56 27.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.315 0.646 . . . . 0.0 112.287 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.2 m80 64.43 145.54 0.09 OUTLIER Pre-proline 0 N--CA 1.444 -0.771 0 C-N-CA 125.426 1.491 . . . . 0.0 111.697 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.52 17.29 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.239 3.293 . . . . 0.0 111.712 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -145.16 140.27 27.84 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.619 1.168 . . . . 0.0 111.563 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.601 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 49.4 t -161.72 -43.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 45.1 Cg_endo -83.11 136.58 8.01 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.941 1.761 . . . . 0.0 111.748 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -93.71 6.71 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.236 2.624 . . . . 0.0 111.118 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -106.49 5.7 29.51 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.249 1.42 . . . . 0.0 111.294 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.45 29.98 0.15 Allowed Glycine 0 N--CA 1.467 0.704 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.7 121.54 40.37 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 118.858 1.329 . . . . 0.0 110.054 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.01 174.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 122.916 1.341 . . . . 0.0 112.034 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -98.54 169.0 9.83 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.937 -1.102 . . . . 0.0 112.019 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.0 mt -124.37 145.24 49.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.206 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.21 114.39 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.96 -161.82 0.58 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.266 1.032 . . . . 0.0 111.766 -172.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.412 ' HG2' ' HE3' ' A' ' 290' ' ' LYS . 10.8 tp10 -56.84 113.11 1.52 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.652 ' H ' HD21 ' A' ' 288' ' ' LEU . 0.9 OUTLIER -85.37 12.47 8.21 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -168.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -135.45 -67.13 0.55 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.172 1.806 . . . . 0.0 112.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . 0.412 ' HE3' ' HG2' ' A' ' 287' ' ' GLU . 0.0 OUTLIER -80.19 -31.34 38.76 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.908 -1.12 . . . . 0.0 112.184 -168.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.5 m -78.95 -30.85 44.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.195 0.907 . . . . 0.0 109.165 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.77 -56.49 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.57 -28.8 67.27 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.037 -1.04 . . . . 0.0 112.347 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.9 m -65.81 -32.67 74.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.36 -51.42 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.784 0.72 . . . . 0.0 109.817 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 3.7 pp -74.3 -4.82 38.51 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.38 -8.06 11.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.375 0.422 . . . . 0.0 110.994 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.03 65.68 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.292 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . 0.444 ' SG ' ' HE3' ' A' ' 315' ' ' LYS . 50.3 t -112.26 -91.76 0.48 Allowed 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 123.596 0.56 . . . . 0.0 111.734 -174.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 72.3 m -142.06 158.25 43.97 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -154.9 156.12 35.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.267 1.427 . . . . 0.0 108.704 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.64 104.75 4.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.404 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.57 12.55 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 125.604 4.203 . . . . 0.0 111.783 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.425 HD11 ' HD3' ' A' ' 306' ' ' PRO . 0.2 OUTLIER -58.92 -25.05 63.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.5 t 43.72 67.6 3.68 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.422 0.689 . . . . 0.0 111.912 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.425 ' HD3' HD11 ' A' ' 304' ' ' LEU . 27.1 Cg_endo -84.4 -4.26 10.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.275 3.316 . . . . 0.0 113.327 -173.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -142.29 -19.79 0.7 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.642 0.589 . . . . 0.0 112.494 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 150.56 -20.76 1.04 Allowed Glycine 0 C--N 1.34 0.758 0 O-C-N 120.616 -1.302 . . . . 0.0 113.669 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.48 165.61 19.52 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.6 0.76 . . . . 0.0 109.34 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 49.5 m -103.19 177.88 4.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.949 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -129.39 131.61 46.85 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.596 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -109.55 151.94 26.12 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -138.27 154.49 49.04 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 122.006 0.907 . . . . 0.0 112.105 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.45 178.81 7.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.408 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.444 ' HE3' ' SG ' ' A' ' 299' ' ' CYS . 9.1 ptpt -150.11 147.04 27.28 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.22 -14.92 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.583 -1.323 . . . . 0.0 110.557 -169.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.5 t -94.96 157.31 15.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.672 1.124 . . . . 0.0 112.528 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 43.4 p -131.58 -38.61 1.16 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -152.13 -13.3 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -99.15 -21.22 16.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 69.2 mmm -130.01 -179.36 5.17 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.625 0.77 . . . . 0.0 111.697 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -123.85 31.66 5.79 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 66.7 m -104.66 -45.46 4.6 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? 53.63 17.51 1.22 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -166.97 147.63 5.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.589 -1.319 . . . . 0.0 112.317 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.75 159.93 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 117.517 -1.23 . . . . 0.0 109.695 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -109.53 157.11 19.33 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 120.089 1.313 . . . . 0.0 113.198 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.81 141.93 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.937 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.9 pt -151.6 131.2 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -104.29 174.22 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.353 2.702 . . . . 0.0 114.344 -176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -82.4 125.0 30.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.544 HG13 ' H ' ' A' ' 334' ' ' ALA . 93.9 t -99.33 151.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.73 -26.37 68.02 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.543 -0.723 . . . . 0.0 111.523 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.544 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -71.16 -22.45 62.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.14 -10.3 59.63 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.341 0.401 . . . . 0.0 110.242 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 17.3 m -98.04 -31.79 11.96 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.1 162.06 40.3 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.728 -0.608 . . . . 0.0 111.462 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -147.55 127.67 13.76 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.59 140.43 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -103.86 -8.09 20.0 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -137.01 93.17 13.57 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.33 -9.98 27.1 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.301 2.667 . . . . 0.0 113.584 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 71.0 m -115.26 19.07 15.83 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.878 0.871 . . . . 0.0 112.845 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -140.65 172.43 12.71 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.056 1.343 . . . . 0.0 109.708 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -127.18 -83.8 0.61 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.643 -1.286 . . . . 0.0 111.083 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.483 ' CD1' ' HG1' ' A' ' 397' ' ' THR . 3.8 tp -151.35 173.24 14.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.957 0.785 . . . . 0.0 111.065 -170.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.434 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 1.4 m-20 -124.7 151.31 67.6 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 123.609 0.764 . . . . 0.0 110.187 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.57 -15.58 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.864 3.042 . . . . 0.0 113.611 -167.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 56.6 p -150.17 8.25 0.63 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -123.88 88.74 2.96 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 121.008 -1.058 . . . . 0.0 110.094 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.0 t -151.52 155.3 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.21 150.33 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.04 0.448 . . . . 0.0 110.961 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -90.58 141.35 28.86 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 122.265 1.031 . . . . 0.0 110.283 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 78.8 t -130.94 140.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.811 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.27 -164.19 21.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 56.64 29.2 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.0 mt -74.98 170.15 16.57 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.071 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -74.79 -27.94 60.53 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 147.48 -11.45 1.33 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.714 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 18.4 ptm -156.78 22.55 0.33 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.024 1.412 . . . . 0.0 112.109 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.03 129.29 3.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.442 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -104.44 164.26 11.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.954 0.901 . . . . 0.0 111.352 -175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.0 -12.16 60.55 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -81.2 -28.58 34.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.211 0.914 . . . . 0.0 109.053 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.07 77.44 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.05 -37.71 75.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.06 73.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.84 85.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.244 0.545 . . . . 0.0 110.285 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.6 mt -78.69 -33.31 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.145 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.08 1.05 47.24 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -171.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -22.56 5.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.662 0.665 . . . . 0.0 111.777 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.35 -8.93 13.43 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.08 -1.84 9.24 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 170.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.88 -24.59 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.968 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.59 34.62 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 124.032 0.825 . . . . 0.0 115.155 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.21 128.09 1.03 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.589 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 398' ' ' PHE . 33.4 m -138.02 174.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 O-C-N 121.632 -0.922 . . . . 0.0 111.533 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.17 -28.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 O-C-N 122.212 -0.305 . . . . 0.0 111.679 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.26 151.9 21.62 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.229 0.612 . . . . 0.0 110.584 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.82 149.81 34.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.362 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -176.99 175.76 47.8 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 120.58 -0.819 . . . . 0.0 115.036 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.07 147.26 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 109.082 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.46 130.04 34.64 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.262 -0.899 . . . . 0.0 111.913 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 2.5 p -111.2 169.92 8.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.861 0.838 . . . . 0.0 111.622 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.75 167.19 25.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.866 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.68 101.54 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.41 0.444 . . . . 0.0 112.099 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.0 m170 53.8 30.89 12.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -97.39 -4.25 38.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.415 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 55.6 t80 45.9 56.11 15.61 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 125.292 1.437 . . . . 0.0 113.396 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.35 -60.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.179 1.253 . . . . 0.0 109.362 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.251 9.7 tp 41.45 36.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.739 2.016 . . . . 0.0 113.85 175.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -153.71 5.92 0.36 Allowed Glycine 0 N--CA 1.474 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 115.122 -171.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 43.9 m -148.6 122.08 9.11 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 117.913 0.856 . . . . 0.0 110.296 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -158.89 -169.0 21.74 Favored Glycine 0 CA--C 1.542 1.757 0 O-C-N 120.705 -1.247 . . . . 0.0 111.848 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -152.45 171.31 18.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.034 0.534 . . . . 0.0 109.986 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.72 143.8 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.483 ' HG1' ' CD1' ' A' ' 346' ' ' LEU . 89.7 m -115.43 140.32 49.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 377' ' ' VAL . 8.3 p90 -163.25 158.15 21.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.194 1.397 . . . . 0.0 110.414 173.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -128.77 20.55 6.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.03 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -100.87 144.35 29.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.91 -27.06 21.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.594 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -25.07 64.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 119.593 1.088 . . . . 0.0 109.784 -174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 73.8 p -81.35 -21.6 39.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -69.73 -62.6 1.32 Allowed 'General case' 0 C--N 1.349 0.583 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -17.48 63.44 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -76.19 -34.88 59.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.983 0.81 . . . . 0.0 110.644 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.68 -26.35 37.62 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.227 -1.546 . . . . 0.0 111.192 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 37.6 t -79.77 -32.03 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.621 1.169 . . . . 0.0 108.635 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 29.0 t -75.09 -30.26 60.86 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 117.902 -1.046 . . . . 0.0 112.111 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.26 -48.74 6.53 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.572 1.078 . . . . 0.0 110.239 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 65.2 -14.04 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.999 2.12 . . . . 0.0 116.137 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 148.18 17.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.71 157.55 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.9 117.66 33.37 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 124.991 1.432 . . . . 0.0 110.489 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.25 127.99 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 416' ' ' LYS . 8.6 mmpt? -118.95 34.07 5.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.49 1.119 . . . . 0.0 111.16 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.4 m -59.83 154.83 17.52 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.233 0.924 . . . . 0.0 109.752 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 14.0 t -73.3 0.81 10.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -145.09 15.43 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 112.244 173.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -151.03 120.41 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.309 -1.495 . . . . 0.0 108.384 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 32.4 p -132.28 110.08 10.35 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.938 -0.476 . . . . 0.0 110.265 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.596 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 26.6 tptt -162.47 -175.91 4.76 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 124.118 0.886 . . . . 0.0 109.132 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.596 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.7 mttm -121.2 173.05 7.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.631 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.75 150.04 15.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -114.79 152.27 32.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.6 mt -130.79 142.49 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 125.299 1.624 . . . . 0.0 108.283 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -138.2 140.2 27.93 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 119.839 1.199 . . . . 0.0 112.731 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.77 153.85 41.02 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.692 2.261 . . . . 0.0 109.879 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.258 1.546 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.928 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 16.3 ptt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.3 t -130.32 -178.36 4.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.497 1.142 . . . . 0.0 111.543 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 372' ' ' ASP . 0.0 OUTLIER -130.6 18.3 5.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.543 0.737 . . . . 0.0 111.654 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.4 m 56.31 29.04 14.31 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.762 1.625 . . . . 0.0 114.623 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.37 1.13 Allowed Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.535 -0.728 . . . . 0.0 112.191 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -80.83 -18.94 45.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.912 0.856 . . . . 0.0 112.765 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.8 127.63 25.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -84.67 132.08 4.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.003 3.135 . . . . 0.0 108.676 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.77 -5.53 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.1 1.867 . . . . 0.0 112.486 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.61 -168.6 1.62 Allowed 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 121.326 -0.859 . . . . 0.0 109.255 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.7 m120 58.4 27.97 16.17 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 122.066 -0.396 . . . . 0.0 111.128 -172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.07 145.65 0.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.25 0.62 . . . . 0.0 112.103 168.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -141.21 14.03 2.22 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.931 0.892 . . . . 0.0 111.713 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.546 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 8.0 p30 -141.76 28.21 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.322 0.51 . . . . 0.0 112.279 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 87.8 Cg_endo -66.53 116.99 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.529 1.486 . . . . 0.0 112.047 -169.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.3 mm -144.87 153.42 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -112.35 146.34 38.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -148.3 7.63 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -170.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 85.2 m -137.98 -74.2 0.4 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.838 0.745 . . . . 0.0 111.2 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' A' ' 389' ' ' TYR . 20.7 pttp -156.18 -169.73 3.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.302 0.641 . . . . 0.0 109.575 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.2 152.31 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 122.25 1.024 . . . . 0.0 108.685 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -98.95 146.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.857 1.263 . . . . 0.0 110.071 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.19 136.44 16.65 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.798 1.311 . . . . 0.0 108.102 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.87 -173.46 33.88 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 121.638 -0.664 . . . . 0.0 113.601 170.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.73 1.61 8.21 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.344 -1.253 . . . . 0.0 110.123 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -78.44 126.61 82.76 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 118.734 1.267 . . . . 0.0 110.521 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 66.1 Cg_endo -81.45 4.78 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.969 3.779 . . . . 0.0 114.07 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.48 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 2.8 p-90 -139.99 -48.72 0.46 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 23.7 t70 56.32 -41.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.194 2.598 . . . . 0.0 115.205 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . 0.337 2.8 pp 55.38 -50.69 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -175.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 29.9 m -150.19 135.64 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 122.113 2.233 . . . . 0.0 108.421 171.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -76.48 -22.08 54.99 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.51 -13.33 62.28 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.559 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.94 -74.73 0.68 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 120.956 -1.09 . . . . 0.0 113.021 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.57 -36.91 84.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.879 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.83 -50.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.533 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.438 ' HA ' ' HB3' ' A' ' 257' ' ' ARG . 19.8 m-20 -71.68 -8.77 56.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 94.8 m -76.82 -26.89 54.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 124.256 0.972 . . . . 0.0 111.617 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -129.03 16.74 6.2 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 124.002 0.814 . . . . 0.0 112.863 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 254' ' ' ASN . 35.3 ttt85 -97.59 -17.16 19.69 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.3 m -69.91 -10.79 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 121.654 0.74 . . . . 0.0 112.61 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -136.92 3.4 2.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.021 -1.05 . . . . 0.0 110.082 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.59 149.76 16.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 124.032 1.907 . . . . 0.0 111.54 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.3 m -105.17 83.4 1.97 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 112.063 -2.069 . . . . 0.0 107.235 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 171.29 16.92 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 113.596 -178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 t -144.71 165.82 26.98 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.84 150.8 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 121.298 -0.876 . . . . 0.0 113.207 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -141.23 142.92 33.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.014 1.387 . . . . 0.0 108.412 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.65 153.15 91.58 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.808 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.38 -17.41 16.63 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.7 2.267 . . . . 0.0 113.059 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -166.99 -5.36 0.03 OUTLIER Glycine 0 C--N 1.346 1.122 0 CA-C-O 117.346 -1.808 . . . . 0.0 116.429 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 60.0 tttm 58.95 86.28 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.216 2.008 . . . . 0.0 109.646 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.39 165.48 23.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.442 -0.786 . . . . 0.0 109.712 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -72.1 -55.12 7.33 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 123.101 0.382 . . . . 0.0 112.838 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -87.08 156.69 19.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.232 0.516 . . . . 0.0 111.289 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 275' ' ' ARG . 18.7 m170 44.31 61.74 10.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.63 2.04 0.17 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.62 3.546 . . . . 0.0 112.444 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 273' ' ' HIS . 18.2 ptt-85 -90.27 -9.55 47.53 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.604 1.093 . . . . 0.0 111.647 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 48.8 t -142.06 129.27 11.37 Favored Pre-proline 0 C--N 1.352 0.686 0 C-N-CA 125.685 1.594 . . . . 0.0 110.462 -172.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.76 156.15 67.12 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.783 3.655 . . . . 0.0 110.961 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.58 -3.5 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.549 3.499 . . . . 0.0 110.656 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 281' ' ' TYR . 5.5 ptpp? -149.84 179.34 8.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.552 1.141 . . . . 0.0 111.301 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.43 8.81 73.06 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.572 -1.127 . . . . 0.0 114.121 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.424 ' H ' ' HG3' ' A' ' 279' ' ' LYS . 1.8 m-85 -116.4 152.05 34.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.838 1.319 . . . . 0.0 113.565 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.69 167.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.22 1.808 . . . . 0.0 108.946 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -121.88 149.36 43.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.961 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.4 mp -121.45 148.47 44.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 286' ' ' PHE . 27.0 m -137.85 -154.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 O-C-N 125.223 1.577 . . . . 0.0 110.043 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 285' ' ' VAL 0.264 79.7 t80 77.55 -124.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 115.468 -2.206 . . . . 0.0 108.471 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.88 140.05 58.83 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 123.086 2.676 . . . . 0.0 108.993 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.34 8.44 3.4 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.247 1.419 . . . . 0.0 114.204 -170.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -128.9 -86.31 0.55 Allowed 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.545 1.153 . . . . 0.0 112.499 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -61.07 -30.33 70.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 52.6 m -100.2 -25.76 14.16 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.057 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.85 -28.62 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 121.684 2.038 . . . . 0.0 108.133 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -83.66 -32.02 25.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.115 0.884 . . . . 0.0 112.953 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.8 m -87.75 -35.93 17.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.283 0.99 . . . . 0.0 112.232 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 tt -68.85 -40.86 79.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.875 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 3.8 mp -67.2 -40.58 86.52 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.704 -1.247 . . . . 0.0 111.749 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -77.35 -7.48 56.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -87.44 -27.92 22.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.64 -174.15 4.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.041 -1.891 . . . . 0.0 106.379 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 151.48 28.54 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 124.029 1.871 . . . . 0.0 111.865 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -143.19 152.97 42.36 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.659 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -126.27 110.79 23.77 Favored Pre-proline 0 N--CA 1.434 -1.251 0 O-C-N 124.13 0.894 . . . . 0.0 109.433 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.85 46.04 2.07 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.781 2.988 . . . . 0.0 109.73 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -70.63 -18.7 62.86 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 123.725 0.81 . . . . 0.0 111.015 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.418 ' H ' HD12 ' A' ' 304' ' ' LEU . 22.6 t -157.93 69.0 3.95 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.56 0.695 . . . . 0.0 109.82 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.14 -6.21 9.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.867 3.044 . . . . 0.0 115.577 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -120.71 0.53 10.41 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.279 -0.888 . . . . 0.0 108.786 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -128.15 25.9 4.81 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.035 1.302 . . . . 0.0 111.247 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 19.3 tp 65.33 134.02 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.467 1.107 . . . . 0.0 111.521 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 43.0 m -106.98 178.8 4.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.613 1.196 . . . . 0.0 111.659 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -126.91 147.88 50.06 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.214 -0.929 . . . . 0.0 111.148 -171.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 296' ' ' LEU . 32.1 m-85 -117.23 156.6 27.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.682 1.229 . . . . 0.0 110.196 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -151.5 173.85 14.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.486 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -153.69 165.66 35.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.661 0.664 . . . . 0.0 110.717 170.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -128.59 57.33 1.6 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.1 0.56 . . . . 0.0 111.663 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -12.61 1.03 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.207 2.203 . . . . 0.0 113.899 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.8 p -89.18 138.64 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.156 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.3 t -160.11 -30.29 0.06 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-N 119.308 0.958 . . . . 0.0 112.606 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -143.64 -30.29 0.5 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.934 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -86.33 -34.52 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.481 1.037 . . . . 0.0 111.26 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 mmt -147.3 166.19 27.83 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -162.82 83.43 0.51 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 125.519 1.762 . . . . 0.0 109.047 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.9 m -133.87 -63.11 0.75 Allowed 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -149.16 139.84 22.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.082 0.944 . . . . 0.0 110.797 -174.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.87 162.6 21.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.263 1.425 . . . . 0.0 112.697 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.5 p -107.6 155.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.04 156.35 19.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.409 0.283 . . . . 0.0 111.575 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.71 134.0 24.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 122.897 0.479 . . . . 0.0 112.02 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.06 132.15 9.01 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.829 0.824 . . . . 0.0 109.917 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -83.06 165.39 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.367 2.044 . . . . 0.0 110.814 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -83.92 113.56 21.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 109.639 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.498 HG11 ' H ' ' A' ' 334' ' ' ALA . 4.2 t -83.1 150.21 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 123.058 1.408 . . . . 0.0 110.299 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.34 -20.89 65.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.429 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.498 ' H ' HG11 ' A' ' 332' ' ' VAL . . . -77.54 1.83 18.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.721 1.208 . . . . 0.0 113.612 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.64 -0.74 21.72 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.699 0.681 . . . . 0.0 110.954 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.0 m -103.79 -36.37 7.86 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.614 0.766 . . . . 0.0 112.25 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -162.45 153.43 17.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.884 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -146.7 148.81 32.39 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.506 -0.746 . . . . 0.0 111.704 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.86 144.3 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.159 0.98 . . . . 0.0 111.671 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.98 -24.42 30.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.297 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 74.8 m -146.44 137.89 13.06 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 123.546 0.738 . . . . 0.0 110.6 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -88.39 -2.7 6.82 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.705 2.27 . . . . 0.0 111.892 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.7 m -83.23 -1.47 53.18 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.673 0.789 . . . . 0.0 112.373 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -131.76 174.74 9.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.917 1.342 . . . . 0.0 111.216 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -128.57 166.19 19.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.837 0.855 . . . . 0.0 112.319 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.554 HD11 ' HG1' ' A' ' 397' ' ' THR . 1.7 mm? -70.65 157.75 37.42 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.904 1.282 . . . . 0.0 110.235 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -109.24 133.68 20.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.35 -7.7 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 124.227 3.284 . . . . 0.0 112.076 -174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.0 m -142.14 2.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 350' ' ' ARG . 34.5 mmt180 -126.67 71.75 1.31 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.902 0.881 . . . . 0.0 110.518 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.0 p -143.59 164.91 29.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 27.5 m -129.12 159.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.457 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -93.04 136.35 33.38 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.588 1.18 . . . . 0.0 111.681 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.93 144.91 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 121.531 0.681 . . . . 0.0 110.311 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -161.86 -160.62 11.1 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.44 34.0 15.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.999 0.92 . . . . 0.0 112.334 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 52.8 mt -89.51 169.14 11.61 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -95.0 14.9 20.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.11 66.23 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.688 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 6.8 ptp -161.14 15.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.702 1.751 . . . . 0.0 111.0 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.56 141.65 57.78 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.575 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.04 175.82 5.47 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 124.714 1.259 . . . . 0.0 111.242 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.86 -17.33 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -75.89 -30.17 58.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -76.43 -35.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.223 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.11 -41.75 76.99 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 122.692 1.234 . . . . 0.0 109.974 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.22 -0.925 . . . . 0.0 111.395 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.72 98.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 124.029 0.831 . . . . 0.0 110.241 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.98 -46.11 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.487 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.14 -29.73 21.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.533 -0.729 . . . . 0.0 112.939 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -12.03 36.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.747 -1.221 . . . . 0.0 112.088 -175.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 220' ' ' TRP . 25.1 t70 -109.93 -23.14 11.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.664 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.18 -19.25 32.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.037 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.482 ' CB ' ' HG ' ' A' ' 403' ' ' SER . 5.4 m-85 -118.61 -22.29 7.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.318 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 75.25 -23.75 1.43 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.57 47.99 1.14 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.251 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 32.6 t -131.56 142.28 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 120.301 2.05 . . . . 0.0 113.261 -173.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.62 -24.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.424 0.63 . . . . 0.0 112.601 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.408 ' CD2' HD13 ' A' ' 346' ' ' LEU . 1.0 OUTLIER -152.17 150.95 30.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.42 23.25 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.008 1.323 . . . . 0.0 109.481 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.8 156.42 27.94 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.99 144.22 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -92.4 148.66 21.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 118.537 0.608 . . . . 0.0 110.717 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 22.8 p -126.38 169.57 12.83 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.664 -0.647 . . . . 0.0 110.849 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.47 -178.43 5.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -72.81 90.29 1.42 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.248 1.023 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 20.5 m170 65.68 28.48 11.11 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 125.102 1.361 . . . . 0.0 111.783 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -89.55 4.08 50.42 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.494 ' HB3' ' HE2' ' A' ' 237' ' ' LYS . 8.0 p90 45.23 48.14 4.64 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.51 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 88.4 Cg_endo -69.14 -70.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.336 2.024 . . . . 0.0 112.304 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.51 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 7.2 tp 40.44 26.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 127.777 2.431 . . . . 0.0 112.285 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -135.11 4.37 4.18 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 120.533 -1.354 . . . . 0.0 112.504 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.5 p -148.77 130.56 15.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.273 0.558 . . . . 0.0 110.413 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.48 16.11 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.085 -1.009 . . . . 0.0 112.271 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 15.0 ptp180 -148.83 -178.12 6.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.165 0.986 . . . . 0.0 110.384 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.38 137.67 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.554 ' HG1' HD11 ' A' ' 346' ' ' LEU . 77.1 m -105.64 120.55 41.94 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -96.36 -33.6 11.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 60.5 t30 66.05 -2.76 0.88 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.71 179.65 8.22 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 120.962 -1.086 . . . . 0.0 110.106 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -92.28 -26.08 18.3 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.59 -41.13 80.54 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 120.252 -1.53 . . . . 0.0 112.441 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.482 ' HG ' ' CB ' ' A' ' 374' ' ' PHE . 53.7 m -80.15 -10.25 59.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -76.05 -55.37 5.66 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.799 0.727 . . . . 0.0 109.619 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -23.32 60.5 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 118.615 0.643 . . . . 0.0 111.022 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -79.14 -34.86 42.88 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.768 -0.583 . . . . 0.0 111.795 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.71 70.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 119.316 0.962 . . . . 0.0 110.583 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.85 -24.75 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 118.398 0.544 . . . . 0.0 111.661 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 t -74.83 -25.9 59.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.302 1.001 . . . . 0.0 108.691 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -84.87 -51.36 6.79 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 61.64 -23.33 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.321 2.248 . . . . 0.0 116.044 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.71 144.52 15.19 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 111.065 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 22.0 m -142.74 158.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-O 122.067 0.937 . . . . 0.0 111.289 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -112.59 131.81 55.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.75 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.76 124.29 39.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -121.3 31.9 6.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.015 -1.053 . . . . 0.0 110.228 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.7 m -62.26 154.83 26.48 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.4 p -61.38 -12.06 12.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.73 7.65 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -146.44 137.13 24.08 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.374 1.07 . . . . 0.0 109.054 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.43 125.55 13.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.527 0.731 . . . . 0.0 111.382 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 18.3 tptt -167.4 -170.74 1.52 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 81.2 mttt -131.02 165.27 23.57 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.225 1.01 . . . . 0.0 108.454 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.74 158.57 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 124.422 1.076 . . . . 0.0 108.599 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -126.87 148.29 50.0 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.193 0.933 . . . . 0.0 112.643 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.84 139.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.02 125.64 5.78 Favored Pre-proline 0 C--N 1.349 0.547 0 CA-C-O 121.742 0.782 . . . . 0.0 110.245 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.39 171.54 16.74 Favored 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 111.259 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.881 177.706 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 91.7 m -69.89 151.63 45.45 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -10.26 0.18 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m 46.89 52.33 11.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.589 1.185 . . . . 0.0 111.499 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.22 -24.24 70.39 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.002 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 54.59 33.5 19.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.172 0.986 . . . . 0.0 113.416 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.429 ' C ' ' HD3' ' A' ' 226' ' ' PRO . 4.6 mm? -63.68 157.25 67.68 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 123.002 0.521 . . . . 0.0 109.986 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.29 68.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 1 C-N-CA 125.997 4.464 . . . . 0.0 114.731 176.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 224' ' ' LEU . 71.6 Cg_exo -55.72 166.37 2.88 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.535 2.824 . . . . 0.0 110.814 169.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 60.08 23.63 12.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.631 1.572 . . . . 0.0 114.461 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -78.37 7.44 6.52 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.474 0.71 . . . . 0.0 111.399 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -73.4 155.93 38.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.227 1.011 . . . . 0.0 111.569 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -143.05 18.68 1.94 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.474 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -133.9 43.56 1.03 Allowed Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 123.947 0.899 . . . . 0.0 109.493 -170.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 93.8 Cg_endo -71.93 157.2 55.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.638 2.892 . . . . 0.0 113.094 -170.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.4 mm -147.5 153.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.02 150.53 31.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.649 1.113 . . . . 0.0 109.654 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 70.4 p -155.11 6.5 0.24 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.873 1.358 . . . . 0.0 114.612 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 4.9 t -154.7 -169.29 3.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.26 1.845 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -43.23 146.07 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 112.378 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.503 ' CG1' ' HB2' ' A' ' 284' ' ' LEU . 3.5 p -122.47 139.56 49.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 125.529 1.768 . . . . 0.0 109.401 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.08 138.63 31.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.821 -1.174 . . . . 0.0 108.904 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.61 126.27 41.73 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 125.053 1.47 . . . . 0.0 108.453 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.72 154.94 21.04 Favored Glycine 0 N--CA 1.449 -0.49 0 O-C-N 120.583 -1.323 . . . . 0.0 111.234 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.73 10.28 0.92 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.2 m -120.49 73.25 21.76 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 118.446 1.123 . . . . 0.0 110.301 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.41 5.15 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 109.985 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.406 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 34.7 p-90 -116.54 -10.53 11.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.18 133.07 55.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.575 -1.328 . . . . 0.0 110.258 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.669 HD11 ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -109.14 -26.04 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 124.654 1.221 . . . . 0.0 112.822 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.565 ' HG1' HG12 ' A' ' 247' ' ' ILE . 16.8 m -138.54 118.84 13.65 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.026 0.53 . . . . 0.0 111.041 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.18 -24.05 67.27 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.378 0.608 . . . . 0.0 112.534 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.1 75.87 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.849 -1.782 . . . . 0.0 111.924 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.87 -63.42 4.43 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.249 0.343 . . . . 0.0 112.576 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -68.49 -21.68 64.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.662 -1.493 . . . . 0.0 113.555 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.54 -52.13 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -71.06 -12.73 61.68 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 125.435 1.709 . . . . 0.0 110.736 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m -79.6 -22.26 43.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.522 -1.361 . . . . 0.0 112.483 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.97 26.6 4.6 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -113.67 -27.32 7.87 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 123.383 0.427 . . . . 0.0 110.845 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.27 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.566 -0.709 . . . . 0.0 110.979 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.49 17.11 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.991 -1.068 . . . . 0.0 113.064 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.21 153.82 25.19 Favored Glycine 0 C--O 1.249 1.085 0 O-C-N 121.322 -0.861 . . . . 0.0 113.074 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.9 m -76.88 28.58 0.13 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 123.86 0.864 . . . . 0.0 113.3 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -109.35 164.38 12.54 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.147 -0.971 . . . . 0.0 112.092 -173.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 p -141.68 168.46 19.72 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.6 t -125.44 154.01 33.55 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.544 -168.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -130.6 129.34 42.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.429 ' C ' ' H ' ' A' ' 268' ' ' GLY . 1.0 OUTLIER -134.5 50.79 5.32 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 124.532 1.145 . . . . 0.0 113.979 -176.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.19 31.48 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 125.894 4.396 . . . . 0.0 111.827 -172.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 266' ' ' TRP . . . -92.29 -43.01 4.45 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -155.94 130.93 9.25 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.436 1.494 . . . . 0.0 111.346 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -125.54 154.8 41.61 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.75 -152.22 10.25 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.66 -16.41 58.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.343 -1.313 . . . . 0.0 109.283 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -152.55 135.11 9.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 118.798 0.726 . . . . 0.0 110.8 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.99 42.06 1.27 Allowed 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.396 4.064 . . . . 0.0 113.555 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.0 13.96 23.18 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.26 -0.9 . . . . 0.0 112.95 -171.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 63.7 m -141.31 36.51 0.24 Allowed Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.899 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.23 147.44 93.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 107.933 -1.603 . . . . 0.0 107.933 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.89 -15.12 13.43 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.138 3.226 . . . . 0.0 113.529 -175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 175.75 12.8 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.286 -0.884 . . . . 0.0 110.751 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -100.24 -9.58 47.54 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.373 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -73.3 121.84 21.04 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 118.598 1.199 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.34 -174.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 O-C-N 125.626 1.829 . . . . 0.0 109.008 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -132.21 165.73 23.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -169.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.503 ' HB2' ' CG1' ' A' ' 238' ' ' VAL . 55.0 mt -117.77 148.42 42.07 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.731 171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 143.37 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -171.64 178.2 3.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -168.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.4 136.04 56.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 166.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.35 -10.65 59.65 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.53 -43.59 0.68 Allowed 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -83.93 -49.57 8.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.207 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.9 t -71.13 -26.33 62.96 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.218 0.949 . . . . 0.0 111.583 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.57 -58.52 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 O-C-N 124.216 0.948 . . . . 0.0 111.047 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.45 -23.27 65.5 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.695 1.247 . . . . 0.0 110.571 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.6 t -71.27 -45.61 62.77 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.023 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.34 -57.54 9.07 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.297 2.1 pp -80.7 -2.01 44.99 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -170.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -100.43 -6.86 24.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 121.054 1.752 . . . . 0.0 108.202 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -94.97 -23.68 17.28 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.479 1.112 . . . . 0.0 110.585 170.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 -133.11 0.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 29.8 t -129.58 164.98 22.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.073 -2.267 . . . . 0.0 110.03 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -146.38 155.78 42.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.886 0.874 . . . . 0.0 110.206 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -136.43 126.19 15.96 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.68 47.36 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.635 3.557 . . . . 0.0 105.579 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 305' ' ' SER . 0.1 OUTLIER -67.22 -24.24 65.81 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 115.911 -1.995 . . . . 0.0 113.339 -174.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.409 ' H ' HD11 ' A' ' 304' ' ' LEU . 11.4 t -155.37 67.98 5.15 Favored Pre-proline 0 C--N 1.348 0.54 0 CA-C-N 120.873 1.67 . . . . 0.0 107.677 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.88 6.55 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 124.722 3.615 . . . . 0.0 114.441 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.2 0.71 20.85 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.919 0.866 . . . . 0.0 110.405 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 153.84 8.09 0.09 OUTLIER Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 44.0 tp -138.14 155.2 48.96 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 122.015 0.912 . . . . 0.0 109.699 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.7 m -152.73 145.39 24.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -143.73 143.96 31.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.725 0.774 . . . . 0.0 111.349 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.53 153.96 33.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.199 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.38 158.66 43.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.457 0.571 . . . . 0.0 111.331 -172.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -156.08 171.24 20.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -128.55 51.93 1.96 Allowed 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 122.884 1.326 . . . . 0.0 108.132 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -0.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.434 -1.712 . . . . 0.0 113.388 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 23.1 t -89.49 125.91 35.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 118.918 0.781 . . . . 0.0 110.245 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 13.5 t -145.98 142.44 28.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.145 0.498 . . . . 0.0 109.936 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 49.97 24.48 1.36 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.19 1.396 . . . . 0.0 113.447 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -147.51 -41.18 0.18 Allowed 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.121 -1.612 . . . . 0.0 111.852 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.406 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 23.5 mmm -119.83 -26.88 5.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.834 1.197 . . . . 0.0 111.224 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 57.7 2.1 0.15 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.032 1.733 . . . . 0.0 113.961 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.2 m -137.98 170.35 16.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 118.117 0.417 . . . . 0.0 112.022 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 63.15 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.961 2.104 . . . . 0.0 112.556 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -91.84 161.67 14.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.117 1.767 . . . . 0.0 111.095 170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.28 143.47 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -90.27 154.71 19.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.273 -0.892 . . . . 0.0 111.861 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 45.9 t -138.75 139.84 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.369 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.0 pt -147.16 117.46 4.5 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.536 0.734 . . . . 0.0 110.515 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -85.7 162.37 10.71 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.035 2.49 . . . . 0.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -79.11 121.48 25.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.99 145.42 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.049 1.34 . . . . 0.0 110.222 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -55.83 -22.86 27.23 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.9 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.32 60.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.55 -23.95 25.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.345 0.658 . . . . 0.0 111.427 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 47.3 m -69.93 -39.7 75.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -163.32 154.84 17.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.592 1.187 . . . . 0.0 110.754 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -141.69 99.57 3.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.85 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -90.47 -17.82 26.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.589 -0.694 . . . . 0.0 112.808 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.9 m -142.18 136.32 14.85 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.711 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.03 3.82 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.172 1.915 . . . . 0.0 114.119 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.8 m -109.63 12.15 24.38 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -148.62 163.31 37.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.429 1.092 . . . . 0.0 113.4 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . 0.678 ' HG3' ' H ' ' A' ' 346' ' ' LEU . 10.6 tpp85 -125.99 -175.71 3.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.869 1.268 . . . . 0.0 109.504 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.678 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.1 tp -56.55 164.89 1.27 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.927 2.091 . . . . 0.0 113.521 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -135.89 145.52 53.05 Favored Pre-proline 0 CA--C 1.514 -0.412 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.48 123.54 7.11 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.434 2.09 . . . . 0.0 112.812 -172.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 36.6 m 59.9 26.19 15.39 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.288 1.435 . . . . 0.0 113.18 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -114.41 43.01 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.172 0.589 . . . . 0.0 109.98 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 p -135.78 163.84 29.28 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 122.476 1.131 . . . . 0.0 109.424 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.79 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.505 172.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -82.32 149.26 27.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.568 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.23 136.27 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -169.91 -170.44 34.34 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.547 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.72 18.08 0.95 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.335 1.454 . . . . 0.0 113.367 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.548 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.21 176.27 9.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.113 0.965 . . . . 0.0 110.267 172.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.7 32.44 0.16 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 76.1 18.23 79.52 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 120.564 -1.335 . . . . 0.0 112.596 176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 17.2 mmt -140.3 -94.32 0.15 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.175 1.488 . . . . 0.0 111.718 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.7 tp 40.53 68.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.497 0.719 . . . . 0.0 110.863 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -55.62 168.16 0.44 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.726 0.239 . . . . 0.0 111.045 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -65.29 -16.64 63.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -170.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.66 -26.63 25.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.733 -1.229 . . . . 0.0 109.256 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.85 -26.91 40.24 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.542 -0.724 . . . . 0.0 110.317 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.7 -51.72 25.73 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.42 67.23 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.822 -0.549 . . . . 0.0 110.885 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.24 73.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.707 0.23 . . . . 0.0 111.298 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.8 mt -66.46 -42.6 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 119.03 -0.509 . . . . 0.0 109.836 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.24 -34.89 18.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -22.87 44.51 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.4 -1.438 . . . . 0.0 111.554 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -87.66 -27.34 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.614 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.15 -18.87 26.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.543 ' CZ ' ' HA3' ' A' ' 376' ' ' GLY . 4.1 t80 -136.16 -61.45 0.7 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.843 174.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 100.59 -16.07 58.05 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . 0.543 ' HA3' ' CZ ' ' A' ' 374' ' ' PHE . . . -85.38 59.52 4.82 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 118.089 0.944 . . . . 0.0 112.514 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.67 164.58 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 118.071 -1.452 . . . . 0.0 112.478 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.69 -40.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -150.79 148.0 27.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.163 0.506 . . . . 0.0 109.852 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.75 153.11 50.94 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.77 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.74 155.43 26.75 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 118.645 0.657 . . . . 0.0 112.501 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.11 147.19 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.5 126.48 29.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.584 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.6 p -138.99 157.49 45.9 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.962 0.789 . . . . 0.0 108.976 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -145.16 166.44 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.705 1.202 . . . . 0.0 108.755 173.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -53.05 102.32 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.443 -0.786 . . . . 0.0 111.784 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 65.8 m170 60.72 30.01 19.4 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -94.5 -8.2 39.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.577 -0.702 . . . . 0.0 110.759 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 15.6 p90 37.82 52.2 2.83 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 127.173 2.189 . . . . 0.0 113.213 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.77 -55.71 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.815 1.677 . . . . 0.0 112.585 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 10.2 tp 37.28 34.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 124.286 1.035 . . . . 0.0 112.504 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -136.5 5.32 3.79 Favored Glycine 0 N--CA 1.442 -0.958 0 O-C-N 124.104 0.878 . . . . 0.0 114.336 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.5 m -151.57 144.06 24.19 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.16 -172.87 36.32 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 170.34 22.44 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 124.233 0.608 . . . . 0.0 109.894 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.29 135.79 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 22.1 m -103.72 144.58 31.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.089 0.868 . . . . 0.0 111.37 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.43 179.55 6.14 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.342 1.057 . . . . 0.0 111.762 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.36 16.57 2.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.09 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -136.63 157.85 45.82 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -70.67 -26.42 63.43 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.001 0.92 . . . . 0.0 112.181 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . 79.8 mmt-85 -52.92 -31.7 41.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.35 1.06 . . . . 0.0 111.818 -171.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.4 p -80.88 -34.66 33.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.663 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -62.17 -52.29 64.39 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 117.919 0.327 . . . . 0.0 110.499 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . 0.299 0.0 OUTLIER -78.38 -19.19 53.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -85.67 -30.07 23.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 120.466 1.484 . . . . 0.0 110.69 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.3 -29.19 47.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.335 0.97 . . . . 0.0 109.423 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.17 -33.24 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 O-C-N 121.555 -0.716 . . . . 0.0 112.723 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.5 t -82.22 -11.92 58.39 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -83.79 -50.66 7.9 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.35 -50.5 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 16.4 t80 -154.61 132.8 11.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.41 160.2 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.548 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 20.3 mt-10 -111.5 99.42 8.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.74 140.67 17.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.825 0.821 . . . . 0.0 108.932 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -132.61 40.95 3.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.996 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.2 p -71.43 170.24 13.65 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.322 1.014 . . . . 0.0 108.908 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 t -79.24 -3.42 45.78 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.23 -0.919 . . . . 0.0 112.922 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 226' ' ' PRO . 67.5 mttm -93.51 -41.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.028 -0.42 . . . . 0.0 110.474 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -157.86 166.14 33.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.982 0.801 . . . . 0.0 111.071 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.5 p -127.53 104.34 7.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.296 1.838 . . . . 0.0 107.539 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -159.36 170.5 21.67 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.798 -0.564 . . . . 0.0 110.631 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.548 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 90.6 mttt -108.75 164.19 12.59 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.277 1.037 . . . . 0.0 112.139 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.46 153.9 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.347 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -119.7 156.45 30.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.135 0.897 . . . . 0.0 109.879 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.92 138.67 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 13.4 m-20 -135.75 156.1 77.63 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.165 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 37.3 Cg_exo -65.8 165.6 22.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.561 2.174 . . . . 0.0 113.922 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 116.029 -1.938 . . . . 0.0 110.896 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.6 m 49.05 42.62 21.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.193 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.47 -8.47 59.56 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.145 1.378 . . . . 0.0 112.544 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.6 t 42.6 74.41 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.355 1.862 . . . . 0.0 111.693 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.88 -23.18 78.36 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 122.03 -0.419 . . . . 0.0 112.496 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 54.99 24.74 6.19 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.469 ' O ' ' HD3' ' A' ' 226' ' ' PRO . 4.4 mm? -62.45 141.67 96.51 Favored Pre-proline 0 C--N 1.342 0.247 0 CA-C-N 119.181 0.9 . . . . 0.0 110.489 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.7 100.73 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.618 2.212 . . . . 0.0 110.129 171.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 224' ' ' LEU . 51.0 Cg_endo -80.77 14.61 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.682 3.588 . . . . 0.0 113.077 -175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -133.79 26.72 3.99 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 121.05 -1.031 . . . . 0.0 113.684 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -125.3 39.15 4.03 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.978 0.511 . . . . 0.0 110.663 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -72.05 154.9 40.85 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.641 0.734 . . . . 0.0 110.468 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -131.65 29.4 4.5 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.771 1.228 . . . . 0.0 112.56 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.95 47.44 0.58 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.203 0.601 . . . . 0.0 110.973 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.84 138.38 31.41 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.482 2.121 . . . . 0.0 112.759 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.4 mt -150.62 144.31 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 105.352 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -96.91 148.63 22.75 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 111.513 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.0 m -141.25 -16.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.609 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 63.9 m -143.67 -174.92 4.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.483 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.453 ' HE2' ' CD1' ' A' ' 283' ' ' TYR . 58.1 mtpt -43.22 153.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.336 1.065 . . . . 0.0 112.662 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.14 133.76 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.84 145.45 31.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.83 1.3 . . . . 0.0 110.727 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -135.23 116.7 14.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.218 -171.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 178.31 -179.6 48.53 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.17 22.19 0.92 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 28.1 m -91.09 128.55 47.15 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.801 0.841 . . . . 0.0 112.989 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.84 -15.56 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.944 2.429 . . . . 0.0 113.655 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.454 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 8.1 p-90 -140.58 0.24 1.62 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.98 1.263 . . . . 0.0 113.985 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.409 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 3.8 t0 -66.43 122.79 18.32 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.856 1.662 . . . . 0.0 115.426 -170.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.437 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -87.87 -0.86 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -173.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.7 p -158.68 167.71 28.82 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 122.455 1.121 . . . . 0.0 108.488 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -15.6 14.56 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.056 174.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -76.78 -31.38 56.98 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 121.088 0.471 . . . . 0.0 111.246 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.37 -52.6 45.53 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 120.658 -1.277 . . . . 0.0 113.787 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.544 HD21 ' H ' ' A' ' 252' ' ' LEU . 1.7 pt? -71.78 -32.49 67.71 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.514 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.48 -36.16 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.385 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -74.28 -17.77 60.81 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.809 0.693 . . . . 0.0 110.381 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.0 m -80.55 -26.99 37.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 111.807 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -129.34 19.07 5.85 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -101.73 -0.77 33.89 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.045 -1.034 . . . . 0.0 111.767 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.47 -21.14 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -127.61 3.24 6.15 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.27 1.028 . . . . 0.0 108.805 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -104.52 173.6 21.27 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 121.699 0.61 . . . . 0.0 112.836 -171.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.652 ' H ' ' CD1' ' A' ' 295' ' ' LEU . 61.2 m -135.54 77.0 1.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.56 167.96 22.44 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.702 1.201 . . . . 0.0 111.725 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -148.56 169.54 20.09 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.44 137.91 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -145.83 136.17 23.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -166.22 154.18 9.52 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.67 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.43 161.27 28.58 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.076 3.184 . . . . 0.0 110.987 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 83.03 3.66 90.33 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -75.84 -19.13 59.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.823 0.849 . . . . 0.0 110.572 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.24 142.24 58.49 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.14 -167.61 34.54 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.423 1.011 . . . . 0.0 111.738 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -80.07 170.34 16.59 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.198 0.599 . . . . 0.0 111.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 30.8 m80 53.03 99.35 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 125.364 1.466 . . . . 0.0 112.019 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -58.01 -3.53 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 1 C-N-CA 125.522 4.148 . . . . 0.0 115.816 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -99.36 9.99 42.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.223 1.809 . . . . 0.0 111.863 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 40.7 t -53.43 -45.26 98.59 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.53 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.38 148.85 49.55 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.911 1.741 . . . . 0.0 111.405 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.63 1.17 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.521 2.814 . . . . 0.0 111.501 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.41 143.97 36.31 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 118.933 0.788 . . . . 0.0 109.93 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.42 22.05 42.88 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.429 0.537 . . . . 0.0 113.014 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.424 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 37.5 p90 -152.95 164.58 37.68 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.71 -178.49 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.453 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 55.0 m-85 -110.91 157.27 20.05 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.208 0.913 . . . . 0.0 111.223 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 83.4 mt -126.13 136.0 52.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.671 1.188 . . . . 0.0 111.529 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.86 137.18 14.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.675 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 84.9 t80 -175.62 -76.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.614 0.366 . . . . 0.0 110.317 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -93.8 -36.8 12.09 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.675 ' CD2' ' H ' ' A' ' 286' ' ' PHE . 4.4 mm? 60.81 -3.39 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -136.12 -75.3 0.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 122.196 2.271 . . . . 0.0 112.643 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -84.28 -33.89 23.89 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' SER . . . . . 0.491 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 44.8 m -82.61 -45.34 14.68 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 116.509 -1.71 . . . . 0.0 108.527 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.16 -36.81 16.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-N 121.506 1.957 . . . . 0.0 107.878 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 30.3 ttt-85 -62.55 -45.48 92.75 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.875 0.845 . . . . 0.0 110.806 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -70.81 -35.3 72.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 118.15 -0.928 . . . . 0.0 113.148 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.652 ' CD1' ' H ' ' A' ' 261' ' ' SER . 55.6 mt -66.5 -47.09 74.08 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -7.0 59.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.523 -1.36 . . . . 0.0 111.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -97.47 -3.81 39.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.473 1.033 . . . . 0.0 111.709 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -105.49 -18.55 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.0 m -81.89 -158.3 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 61.4 m -84.44 146.05 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.013 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -137.34 149.53 47.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.052 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -137.93 127.3 14.92 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 122.049 -0.407 . . . . 0.0 110.703 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -82.87 35.55 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.754 4.303 . . . . 0.0 109.566 169.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -10.82 7.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -173.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 22.9 t 20.65 94.87 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 168.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -81.96 -10.1 11.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.652 2.901 . . . . 0.0 113.628 169.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.5 -24.58 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.668 0.787 . . . . 0.0 111.962 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 164.87 -26.89 0.19 Allowed Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.394 -1.226 . . . . 0.0 111.815 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 309' ' ' LEU . 1.4 pt? -89.74 169.94 10.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 171.59 10.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.851 0.86 . . . . 0.0 109.342 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.62 154.53 50.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -113.07 148.63 34.82 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.15 162.42 39.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -163.4 176.01 10.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.9 ptpt -135.4 132.47 37.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.49 9.47 3.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -165.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.0 t -66.13 150.98 47.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 11.0 m -85.36 15.36 4.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.556 0.743 . . . . 0.0 110.133 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.57 24.74 3.23 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.479 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -75.01 -23.44 58.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.848 0.749 . . . . 0.0 112.308 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.454 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 21.8 ptt? -148.76 -26.83 0.31 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 171.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -152.53 168.18 26.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.105 0.562 . . . . 0.0 110.642 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 74.1 m -118.22 134.63 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.818 1.247 . . . . 0.0 107.722 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 17.0 tppt? -152.93 129.68 10.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 122.542 1.163 . . . . 0.0 114.029 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.91 137.57 36.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.01 1.724 . . . . 0.0 111.972 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.89 157.58 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -107.46 154.72 20.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.117 0.261 . . . . 0.0 110.62 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.58 136.5 46.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.276 0.56 . . . . 0.0 111.788 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 73.0 mt -142.17 109.4 5.86 Favored Pre-proline 0 C--O 1.232 0.165 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 164.96 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.089 1 C-N-CA 125.337 4.025 . . . . 0.0 112.085 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.609 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 1.7 t90 -83.66 133.3 34.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 334' ' ' ALA . 3.3 t -110.46 152.33 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 123.605 0.762 . . . . 0.0 110.251 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.8 tt -54.46 -27.1 35.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.406 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -70.28 4.11 2.46 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.694 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.94 7.41 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.035 0.934 . . . . 0.0 109.567 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.3 m -129.24 -22.0 3.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 150.72 34.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.71 132.6 15.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.362 -1.745 . . . . 0.0 107.928 170.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 341' ' ' SER . 12.2 p -141.96 146.23 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.187 0.994 . . . . 0.0 111.816 177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -103.32 -15.72 15.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.575 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 339' ' ' VAL . 42.3 t -94.52 140.22 22.6 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.426 1.09 . . . . 0.0 110.444 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.4 16.2 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.204 3.269 . . . . 0.0 110.427 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 15.6 t -122.74 161.27 24.24 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.813 -1.179 . . . . 0.0 110.447 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . 0.41 ' CD ' ' H ' ' A' ' 344' ' ' GLN . 5.0 pm0 -79.8 22.47 0.48 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 122.33 1.062 . . . . 0.0 113.43 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -65.59 155.26 36.35 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.59 1.156 . . . . 0.0 109.342 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 22.4 tp -154.92 155.43 34.26 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.059 0.391 . . . . 0.0 111.222 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 397' ' ' THR . 42.4 t0 -136.58 73.35 55.37 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.016 0.926 . . . . 0.0 110.065 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.71 5.08 4.57 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.079 2.519 . . . . 0.0 111.946 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.5 t -78.29 -13.42 59.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.847 -1.158 . . . . 0.0 111.602 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -147.26 85.74 1.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.477 HG23 ' HG1' ' A' ' 397' ' ' THR . 17.8 p -133.8 154.0 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.049 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.02 158.76 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 119.086 0.857 . . . . 0.0 110.045 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -95.19 146.46 24.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 123.837 0.711 . . . . 0.0 111.352 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.22 140.4 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.12 -178.41 32.13 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.41 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.26 47.26 21.94 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 124.469 1.107 . . . . 0.0 110.595 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 36.5 mt -84.67 -174.83 5.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -25.35 67.52 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.764 176.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 78.22 5.54 87.39 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 120.364 -1.46 . . . . 0.0 109.939 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.5 ttt -152.93 29.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.11 95.43 0.73 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.849 1.309 . . . . 0.0 110.464 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -81.12 162.23 23.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.18 -7.75 50.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.134 -171.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -90.12 -26.59 20.13 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.97 -29.63 24.92 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.08 -49.1 63.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.201 0.6 . . . . 0.0 109.458 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.96 -31.38 71.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.264 -0.273 . . . . 0.0 111.538 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.4 87.1 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.2 mt -65.46 -45.02 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.2 mt -85.57 -29.76 23.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -21.56 30.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.778 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -107.71 -20.47 13.21 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.54 -14.96 23.19 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.399 -1.438 . . . . 0.0 110.521 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.05 -41.64 2.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 112.812 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 73.38 -1.6 42.18 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . 0.412 ' C ' HD22 ' A' ' 400' ' ' ASN . . . -143.65 117.61 1.1 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.107 0.953 . . . . 0.0 111.03 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 11.9 t -152.44 168.58 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.25 -29.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -159.75 158.56 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -165.94 146.66 6.68 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -159.46 151.97 22.86 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 121.42 0.456 . . . . 0.0 114.054 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.32 150.33 4.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -97.39 74.75 2.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.9 p -61.23 146.37 48.03 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.62 17.48 14.42 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.733 1.213 . . . . 0.0 111.705 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.0 tptm 51.53 124.31 0.0 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 128.022 2.529 . . . . 0.0 114.878 -170.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 58.2 m170 61.13 27.79 17.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -133.47 -0.91 3.19 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 6.1 p90 25.98 66.97 0.47 Allowed Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.033 1.333 . . . . 0.0 112.282 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.53 -49.84 0.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 124.262 3.308 . . . . 0.0 110.783 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.91 35.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 111.635 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.34 15.6 1.29 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.131 0.872 . . . . 0.0 114.659 -172.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 77.3 p -163.45 145.45 9.69 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.355 0.662 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.79 -161.95 28.71 Favored Glycine 0 N--CA 1.427 -1.907 0 O-C-N 120.685 -1.259 . . . . 0.0 112.725 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.54 166.88 25.15 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.719 -0.871 . . . . 0.0 111.946 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 144.07 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.662 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.477 ' HG1' HG23 ' A' ' 351' ' ' THR . 44.3 m -116.72 131.64 56.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 123.533 0.521 . . . . 0.0 110.693 -172.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -118.99 155.75 30.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.515 1.135 . . . . 0.0 111.909 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.11 7.01 10.77 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.412 HD22 ' C ' ' A' ' 376' ' ' GLY . 12.0 p30 -136.89 166.61 23.21 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.041 1.337 . . . . 0.0 109.648 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -98.08 -28.34 13.8 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -62.9 -26.1 68.64 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.878 0.763 . . . . 0.0 112.987 -175.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 71.7 p -73.45 -33.04 64.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -68.62 -55.13 12.56 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 119.237 0.926 . . . . 0.0 110.645 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -24.02 58.46 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.136 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -78.4 -23.2 46.87 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 118.238 -1.385 . . . . 0.0 111.221 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.91 -26.2 36.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.247 -0.908 . . . . 0.0 111.497 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.85 -27.95 5.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.059 0.457 . . . . 0.0 111.049 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.6 p -83.39 -18.86 37.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.744 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -90.69 -45.69 8.71 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.033 0.444 . . . . 0.0 110.456 171.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.91 -10.39 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.855 2.062 . . . . 0.0 114.31 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.536 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -161.07 144.65 13.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.32 156.31 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 O-C-N 120.868 -1.145 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 414' ' ' GLU . 17.1 mp0 -120.18 137.94 53.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.594 0.711 . . . . 0.0 112.396 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.45 124.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 46.91 1.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.247 1.022 . . . . 0.0 111.786 -175.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.9 p -66.47 169.7 7.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.67 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.8 t -69.78 1.53 4.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.305 0.642 . . . . 0.0 110.749 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.42 ' HZ1' ' HB3' ' A' ' 419' ' ' LYS . 0.7 OUTLIER -150.45 0.88 0.44 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -171.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -154.37 139.35 17.29 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.419 -0.801 . . . . 0.0 112.512 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 50.6 p -139.08 124.05 18.83 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.205 -0.934 . . . . 0.0 110.766 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.603 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 0.8 OUTLIER -168.82 -179.33 3.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.429 176.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.603 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 55.6 mtmt -140.99 172.15 13.08 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.18 152.32 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 124.346 1.028 . . . . 0.0 109.353 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -117.09 152.16 35.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 111.623 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.92 141.79 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.288 0.566 . . . . 0.0 111.61 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.92 124.85 8.64 Favored Pre-proline 0 C--O 1.246 0.874 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.85 158.47 18.53 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 124.082 3.188 . . . . 0.0 114.001 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 C--O 1.263 1.775 0 CA-C-O 117.285 -1.34 . . . . 0.0 111.115 171.329 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' MET . . . . . 0.485 ' HE3' ' HE3' ' A' ' 406' ' ' LYS . 11.0 tpt . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.355 0.598 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.2 t -167.06 173.28 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.37 7.37 7.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.8 m 46.56 37.75 4.81 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.356 -0.84 . . . . 0.0 112.464 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -168.96 77.92 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.244 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 164.92 25.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.939 0.435 . . . . 0.0 110.839 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.93 152.85 77.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.28 114.45 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.915 2.41 . . . . 0.0 112.314 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -82.12 -165.07 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.413 4.075 . . . . 0.0 111.43 175.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 58.51 32.67 22.38 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.797 0.439 . . . . 0.0 111.801 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -99.48 -1.06 39.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -74.12 153.55 39.52 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.854 0.861 . . . . 0.0 110.446 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -148.84 25.39 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.264 1.026 . . . . 0.0 110.809 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -131.99 62.2 62.43 Favored Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 120.632 -1.293 . . . . 0.0 112.084 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -68.91 117.46 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.328 3.352 . . . . 0.0 112.928 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.1 mm -140.82 151.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -109.38 141.25 42.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.925 1.239 . . . . 0.0 110.643 -173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.5 t -133.48 3.65 3.61 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.397 0.544 . . . . 0.0 112.449 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 3.6 t -153.21 177.6 10.66 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.053 0.541 . . . . 0.0 110.257 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.87 166.32 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.062 1.345 . . . . 0.0 113.924 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.01 138.14 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.89 133.01 33.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 23.0 tp -139.5 112.72 8.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.145 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.86 155.81 26.47 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.114 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.74 13.73 1.39 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 124.153 0.56 . . . . 0.0 113.081 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.17 117.14 58.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.674 -0.898 . . . . 0.0 111.826 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.7 -4.4 8.2 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.754 2.969 . . . . 0.0 113.368 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -105.71 -109.57 0.29 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.26 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 38.7 t70 43.87 74.8 0.11 Allowed 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 119.859 1.209 . . . . 0.0 111.372 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -10.37 11.73 Favored 'Isoleucine or valine' 0 C--O 1.273 2.291 0 CA-C-N 118.551 0.614 . . . . 0.0 110.692 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.4 p -146.18 129.03 16.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.3 -22.11 66.67 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.648 0.737 . . . . 0.0 109.917 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -74.14 -21.92 59.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.298 -1.501 . . . . 0.0 110.9 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.69 -57.3 5.48 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.47 -42.69 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.079 0.952 . . . . 0.0 112.52 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.1 t -73.51 -32.83 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.474 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.62 -20.16 57.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.693 0.679 . . . . 0.0 111.294 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -73.1 -30.03 63.36 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.905 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -129.88 16.87 5.73 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -89.63 -21.83 22.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 120.018 1.281 . . . . 0.0 112.181 171.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.18 24.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -143.29 7.88 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.782 0.719 . . . . 0.0 112.659 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -167.44 169.98 41.39 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-O 121.935 0.742 . . . . 0.0 113.04 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.9 t -82.31 77.92 9.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.385 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.502 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.05 166.85 24.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 52.7 m -147.88 -175.08 4.74 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.898 1.333 . . . . 0.0 110.836 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.67 154.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 123.813 0.845 . . . . 0.0 111.689 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -142.29 131.69 23.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 124.951 1.407 . . . . 0.0 110.929 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -93.07 133.67 28.42 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.578 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -76.71 -23.19 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 O-C-N 123.962 1.506 . . . . 0.0 112.189 172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.06 -66.99 1.57 Allowed Glycine 0 C--O 1.218 -0.866 0 C-N-CA 123.074 0.368 . . . . 0.0 112.379 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? 48.39 49.09 18.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.954 0.502 . . . . 0.0 110.253 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.87 35.31 3.95 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.259 1.824 . . . . 0.0 114.453 -170.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.88 163.06 35.1 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.521 0.512 . . . . 0.0 111.951 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -92.17 169.13 10.86 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 122.467 -0.431 . . . . 0.0 110.505 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.404 ' HB3' ' CD ' ' A' ' 274' ' ' PRO . 14.0 m80 60.67 173.33 0.06 OUTLIER Pre-proline 0 C--O 1.219 -0.525 0 C-N-CA 125.766 1.626 . . . . 0.0 112.846 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.404 ' CD ' ' HB3' ' A' ' 273' ' ' HIS . 32.4 Cg_exo -60.59 40.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 1 C-N-CA 126.723 4.948 . . . . 0.0 114.687 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -147.7 41.47 1.03 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.842 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.51 129.3 25.92 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.976 0.51 . . . . 0.0 109.671 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.42 134.04 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.456 1.438 . . . . 0.0 111.146 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.14 158.7 5.73 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 124.277 3.318 . . . . 0.0 109.545 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -100.95 12.87 36.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 0.0 108.858 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 112.95 -9.76 25.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -171.64 169.15 6.1 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.855 0.827 . . . . 0.0 110.606 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.79 -174.09 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.104 1.762 . . . . 0.0 108.978 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -123.08 153.39 39.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 111.466 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.76 139.06 42.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.728 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.9 131.25 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 35.6 p90 -167.35 -151.15 0.11 Allowed 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 123.509 0.505 . . . . 0.0 110.378 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.34 -8.53 0.78 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 90.8 mt 50.75 -163.58 0.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 111.461 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.9 -78.59 0.0 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.276 2.63 . . . . 0.0 114.952 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -84.18 -32.8 24.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.741 1.275 . . . . 0.0 111.213 -172.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 75.6 m -85.23 -15.69 42.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.643 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 79.0 t -68.32 -51.48 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -66.53 -26.4 67.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.2 t -65.19 -46.45 80.69 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 118.537 0.608 . . . . 0.0 110.786 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.39 -44.16 83.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 119.805 -1.809 . . . . 0.0 110.351 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.56 -26.96 67.37 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 124.341 1.025 . . . . 0.0 109.441 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -92.96 -10.0 37.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 120.14 1.336 . . . . 0.0 111.389 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -102.91 -19.78 14.51 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.08 178.39 7.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.013 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.2 t -77.91 163.81 25.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.369 1.668 . . . . 0.0 111.544 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -151.2 160.23 43.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.679 1.192 . . . . 0.0 111.079 -175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.18 124.76 7.67 Favored Pre-proline 0 CA--C 1.517 -0.312 0 O-C-N 121.473 -0.767 . . . . 0.0 110.02 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.412 ' C ' ' HD3' ' A' ' 306' ' ' PRO . 35.8 Cg_endo -84.43 51.29 3.24 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 124.556 3.504 . . . . 0.0 108.324 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.519 HD11 ' H ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -70.73 -27.57 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 -173.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.519 ' H ' HD11 ' A' ' 304' ' ' LEU . 23.2 t -159.78 57.51 1.01 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 111.236 177.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 303' ' ' PRO . 61.5 Cg_endo -67.94 6.62 0.76 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.695 2.93 . . . . 0.0 112.399 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.0 -18.35 64.69 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 124.203 0.939 . . . . 0.0 109.29 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -174.32 -1.98 0.03 OUTLIER Glycine 0 C--N 1.341 0.836 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.85 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -142.97 154.33 43.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.677 1.238 . . . . 0.0 109.857 -177.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.515 ' H ' HD11 ' A' ' 309' ' ' LEU . 32.3 m -143.35 149.36 37.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.747 1.619 . . . . 0.0 109.304 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -132.71 136.32 46.33 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 122.223 -0.298 . . . . 0.0 110.768 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -118.44 159.16 23.97 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -153.35 159.37 42.45 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 122.077 -0.389 . . . . 0.0 111.978 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -145.25 159.43 43.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.706 -0.621 . . . . 0.0 111.007 172.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -110.35 118.53 36.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.421 ' H ' ' HE1' ' A' ' 316' ' ' MET . 0.1 OUTLIER -90.25 21.23 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.63 0.195 . . . . 0.0 111.429 -169.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.5 t -137.11 162.67 32.76 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.185 -0.947 . . . . 0.0 111.122 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 32.4 p -145.3 -10.95 0.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.875 0.87 . . . . 0.0 111.112 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 4.59 0.13 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -107.81 -38.92 5.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.877 -1.139 . . . . 0.0 110.576 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 15.8 mmt -133.91 -31.96 1.13 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.513 0.725 . . . . 0.0 109.205 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 46.12 27.48 0.54 Allowed 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.541 0.686 . . . . 0.0 110.92 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.5 -173.68 4.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER 57.5 68.8 0.8 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.743 1.217 . . . . 0.0 114.001 176.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . 0.592 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 3.6 mp0 -46.7 156.73 0.18 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.327 173.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.4 142.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -86.53 137.46 32.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.829 0.74 . . . . 0.0 110.086 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.57 137.05 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 123.936 0.772 . . . . 0.0 111.924 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.8 pt -156.76 130.76 4.84 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.67 168.6 8.29 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.544 4.162 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -82.14 124.17 29.63 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 169.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 334' ' ' ALA . 21.3 t -100.76 137.31 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.85 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.69 -35.12 60.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.933 1.293 . . . . 0.0 110.994 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.46 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -79.82 11.44 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 118.392 -0.814 . . . . 0.0 112.807 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.11 6.28 10.79 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.671 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.1 p -139.45 -2.45 1.6 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -147.91 153.58 39.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -155.02 139.1 16.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.77 0.828 . . . . 0.0 111.82 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.93 155.5 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 118.867 0.758 . . . . 0.0 111.593 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -102.68 -6.86 22.24 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 108.789 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.422 ' HB3' ' HD2' ' A' ' 342' ' ' PRO . 60.6 m -131.2 166.15 29.92 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 123.703 0.801 . . . . 0.0 112.818 -171.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 57.2 Cg_endo -66.15 -9.06 22.15 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.354 2.036 . . . . 0.0 112.169 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 58.4 p -85.14 168.94 14.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.897 0.879 . . . . 0.0 109.911 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -136.32 24.22 3.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.164 0.507 . . . . 0.0 110.938 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -112.57 164.45 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.016 0.927 . . . . 0.0 111.691 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.84 -171.58 1.87 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.426 1.49 . . . . 0.0 110.499 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.86 93.3 31.61 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.919 1.288 . . . . 0.0 107.923 171.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.71 -0.22 0.36 Allowed 'Trans proline' 0 C--O 1.24 0.579 1 C-N-CA 126.063 4.508 . . . . 0.0 115.933 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.7 m -117.66 3.93 12.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.18 0.592 . . . . 0.0 111.653 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -141.71 55.64 1.5 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.945 0.793 . . . . 0.0 109.981 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.5 t -143.34 154.02 43.32 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.88 159.89 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 124.18 0.925 . . . . 0.0 110.432 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -84.92 138.65 32.38 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.296 0.998 . . . . 0.0 113.306 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.48 149.04 24.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.095 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 178.15 -168.05 39.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.97 22.99 2.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.209 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.13 137.43 32.37 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.659 -175.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 29.02 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.885 1.274 . . . . 0.0 112.98 169.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.64 -12.65 0.05 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-O 118.132 -1.371 . . . . 0.0 111.008 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.7 mmt -133.93 -52.41 0.85 Allowed 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 125.232 1.195 . . . . 0.0 108.389 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.0 tp 27.67 77.56 0.02 OUTLIER 'General case' 0 C--N 1.347 0.468 0 O-C-N 124.585 1.178 . . . . 0.0 111.992 -171.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -61.64 164.25 6.23 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 123.972 0.909 . . . . 0.0 111.761 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.74 -22.7 62.43 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -83.2 -32.54 26.5 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 119.508 1.049 . . . . 0.0 110.086 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -73.82 -40.78 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 122.117 -0.365 . . . . 0.0 110.135 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.09 -46.76 82.84 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.34 65.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.712 -1.242 . . . . 0.0 111.58 -173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.05 80.35 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.403 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 89.3 mt -71.66 -41.42 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 -16.31 49.71 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.35 -1.309 . . . . 0.0 114.2 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -16.55 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 120.316 1.417 . . . . 0.0 114.367 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.45 -20.62 13.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.105 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.77 -14.36 18.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.572 1.078 . . . . 0.0 111.091 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -117.3 -64.64 1.28 Allowed 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.206 -0.934 . . . . 0.0 110.766 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 161.73 -151.23 21.31 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.324 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -66.08 130.13 32.59 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 126.248 1.88 . . . . 0.0 110.376 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.23 164.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 126.177 1.791 . . . . 0.0 107.844 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.65 -28.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.444 0.565 . . . . 0.0 112.111 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.3 OUTLIER -157.32 156.78 32.96 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -149.67 143.03 25.22 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -154.24 171.85 32.81 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 122.09 0.828 . . . . 0.0 114.181 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.428 ' HA ' ' HA3' ' A' ' 394' ' ' GLY . 26.7 mt -127.39 144.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 128.635 2.774 . . . . 0.0 108.478 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.86 149.01 24.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.337 -0.852 . . . . 0.0 111.882 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.2 p -108.91 161.41 15.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.192 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -130.02 34.56 4.23 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.519 1.152 . . . . 0.0 111.973 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 tptm 61.99 95.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.454 1.902 . . . . 0.0 111.397 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 m170 48.48 28.04 1.6 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -104.12 11.73 34.79 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.522 1.056 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 52.4 p90 44.82 49.25 5.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 126.576 1.951 . . . . 0.0 114.144 173.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.62 -52.62 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 119.338 0.799 . . . . 0.0 112.082 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 10.6 tp 37.62 47.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 123.57 0.748 . . . . 0.0 109.826 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -158.86 6.71 0.15 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.9 p -153.8 138.61 17.09 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 382' ' ' ILE . . . -169.15 -149.17 6.1 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -154.94 172.85 17.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.974 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.2 132.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 52.2 m -101.59 110.68 22.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.848 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.1 157.17 16.01 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.708 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.76 -0.06 6.06 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.965 0.791 . . . . 0.0 109.604 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -120.82 135.86 55.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.058 1.343 . . . . 0.0 108.126 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.01 -25.69 67.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.662 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.94 -31.33 72.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.01 0.823 . . . . 0.0 110.965 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 m -80.43 -12.27 59.58 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.869 -1.144 . . . . 0.0 111.257 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.37 -60.72 2.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.536 -0.727 . . . . 0.0 109.174 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.65 63.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.495 -176.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . 0.485 ' HE3' ' HE3' ' A' ' 218' ' ' MET . 51.5 tptt -81.25 -26.32 35.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.965 0.802 . . . . 0.0 111.457 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.27 -31.03 60.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.373 -0.829 . . . . 0.0 111.036 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.31 -26.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.963 0.905 . . . . 0.0 111.223 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.2 p -84.27 -26.09 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.28 -40.82 10.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.517 0.327 . . . . 0.0 110.273 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.2 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.73 141.16 10.0 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 120.297 1.408 . . . . 0.0 108.89 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -141.38 159.3 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.548 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -113.64 110.15 19.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.172 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.1 mm -77.2 129.58 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 173.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 30.3 ttmt -153.99 98.12 2.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.302 0.572 . . . . 0.0 109.487 -170.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.9 m -143.79 179.65 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 2.0 m -78.52 2.11 20.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.9 -0.5 . . . . 0.0 110.781 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -129.98 -8.45 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.63 131.93 11.13 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.416 -0.802 . . . . 0.0 111.395 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 7.1 p -143.64 86.81 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.829 0.741 . . . . 0.0 110.871 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -150.55 172.32 15.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.95 0.9 . . . . 0.0 109.951 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -128.56 167.72 16.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.695 0.398 . . . . 0.0 111.17 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.93 145.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 CA-C-N 118.748 0.704 . . . . 0.0 109.296 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -122.69 150.2 43.04 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.026 0.917 . . . . 0.0 112.702 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.4 mp -133.2 145.96 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.226 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -150.74 128.38 5.68 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -83.66 166.83 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 2.78 . . . . 0.0 111.538 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.359 1.064 . . . . 0.0 111.057 176.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 C--O 1.218 -0.603 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.9 m 57.65 164.77 0.03 OUTLIER 'General case' 0 C--O 1.246 0.888 0 CA-C-O 122.68 1.229 . . . . 0.0 110.407 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -157.59 -40.58 0.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.887 -1.133 . . . . 0.0 112.143 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.438 ' HA ' ' H ' ' A' ' 416' ' ' LYS . 13.5 m 47.81 22.89 0.39 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 170.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 57.41 69.25 1.33 Allowed Glycine 0 N--CA 1.447 -0.613 0 O-C-N 120.845 -1.159 . . . . 0.0 112.803 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -71.8 -21.58 61.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.794 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.48 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 1.0 OUTLIER -155.55 9.15 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -176.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.48 ' CD ' ' H ' ' A' ' 224' ' ' LEU . 42.6 Cg_endo -64.61 119.49 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 122.331 1.868 . . . . 0.0 111.605 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.2 142.28 41.35 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 124.4 3.4 . . . . 0.0 111.254 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -138.32 170.19 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.171 0.989 . . . . 0.0 110.772 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.35 38.11 29.44 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.816 0.817 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -54.58 30.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.989 1.316 . . . . 0.0 110.41 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 71.0 tttt 55.25 45.33 25.97 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -114.56 -46.91 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.11 -174.25 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.442 1 C-N-CA 125.304 4.002 . . . . 0.0 114.649 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.5 HG23 ' H ' ' A' ' 234' ' ' TYR . 4.2 mp -109.2 -179.09 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.5 ' H ' HG23 ' A' ' 233' ' ' ILE . 30.9 m-85 -93.74 158.25 15.76 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 51.0 m -145.08 -0.78 0.87 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.72 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.602 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 12.0 m -149.46 -164.55 2.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.875 1.216 . . . . 0.0 110.996 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 172.09 0.82 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.503 1.144 . . . . 0.0 111.542 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.29 138.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.413 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -81.64 143.4 31.95 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 122.162 0.982 . . . . 0.0 109.444 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.412 ' CD1' ' C ' ' A' ' 240' ' ' LEU . 1.0 OUTLIER -141.02 108.22 5.49 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.65 164.53 29.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.75 12.16 5.62 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.853 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.02 116.48 65.58 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 119.097 1.449 . . . . 0.0 111.431 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.24 1.83 5.23 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 124.644 3.562 . . . . 0.0 110.406 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.438 ' CE3' ' HE2' ' A' ' 321' ' ' MET . 42.1 p-90 -141.49 175.82 9.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.3 1.04 . . . . 0.0 109.956 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.52 155.16 10.61 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.221 0.534 . . . . 0.0 110.584 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.67 -44.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.281 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.014 170.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.475 HG23 ' H ' ' A' ' 250' ' ' ALA . 7.4 m -168.48 148.72 4.63 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.809 1.943 . . . . 0.0 108.18 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -70.08 -26.73 64.13 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 119.749 -1.845 . . . . 0.0 111.722 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.475 ' H ' HG23 ' A' ' 248' ' ' THR . . . -80.91 -19.35 44.49 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.464 0.706 . . . . 0.0 110.358 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.18 -58.04 6.42 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 256' ' ' PHE . 8.0 tt -55.34 -40.06 70.76 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.178 0.575 . . . . 0.0 110.216 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 264' ' ' VAL . 54.6 t -70.39 -41.32 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 118.836 -2.415 . . . . 0.0 110.414 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.22 0.09 10.71 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.854 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 48.1 m -87.8 -28.04 21.92 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.036 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.417 ' CZ ' HD21 ' A' ' 252' ' ' LEU . 14.7 p90 -137.98 16.15 2.85 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.6 20.6 0.22 Allowed 'General case' 0 C--O 1.24 0.592 0 O-C-N 120.45 -1.406 . . . . 0.0 112.789 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.89 6.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 120.208 1.367 . . . . 0.0 110.611 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.98 -11.35 58.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.916 -1.115 . . . . 0.0 112.151 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.16 -4.08 59.76 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.828 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 10.7 t -127.3 22.6 6.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.26 1.03 . . . . 0.0 111.817 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.4 OUTLIER -92.76 144.26 25.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.928 -1.107 . . . . 0.0 109.988 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.3 m -152.68 172.05 17.26 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 125.788 1.93 . . . . 0.0 107.893 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 253' ' ' VAL . 61.3 t -148.29 144.0 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.293 -169.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -109.21 131.71 54.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.955 0.784 . . . . 0.0 109.939 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -145.28 81.99 10.04 Favored Pre-proline 0 C--O 1.242 0.691 0 CA-C-O 122.048 0.927 . . . . 0.0 110.979 -167.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 164.22 31.99 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 123.786 2.991 . . . . 0.0 109.747 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.01 -4.36 85.61 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -66.56 65.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.403 1.481 . . . . 0.0 111.308 174.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -142.95 2.25 1.33 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.512 0.725 . . . . 0.0 111.817 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.3 -154.08 8.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.264 0.935 . . . . 0.0 111.548 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.89 168.27 12.18 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 24.0 m170 67.47 150.84 0.12 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.066 2.147 . . . . 0.0 114.445 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.32 -4.27 14.55 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.823 2.349 . . . . 0.0 109.661 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -95.9 11.93 32.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.878 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 1.8 p 63.26 155.67 0.12 Allowed Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 129.012 2.925 . . . . 0.0 111.208 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.79 159.21 31.43 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.402 3.401 . . . . 0.0 111.814 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.94 136.36 18.46 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.037 3.158 . . . . 0.0 111.714 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -144.76 155.51 43.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -76.45 -21.08 76.0 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-O 117.998 -1.446 . . . . 0.0 113.334 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -166.56 168.66 14.43 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.8 m -156.84 -163.69 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.941 2.096 . . . . 0.0 108.71 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -148.09 150.7 34.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.532 1.06 . . . . 0.0 111.652 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.97 156.35 17.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.89 122.73 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 31.5 p90 -165.66 -157.54 0.32 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 117.499 -1.239 . . . . 0.0 109.915 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 93.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.689 HD21 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -69.78 14.0 0.12 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.65 2.38 . . . . 0.0 115.75 -167.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -136.09 -53.96 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.571 1.532 . . . . 0.0 111.111 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -88.05 -41.16 13.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.83 -170.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 73.9 m -74.77 -32.99 62.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.86 -47.81 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 122.105 -0.372 . . . . 0.0 110.896 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -73.3 -20.34 60.83 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.82 -0.55 . . . . 0.0 112.109 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.5 m -79.78 -35.53 38.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.606 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -46.34 87.05 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.713 172.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.07 -17.08 61.46 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.066 0.848 . . . . 0.0 110.467 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -87.97 -9.7 52.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 122.727 0.411 . . . . 0.0 111.743 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.04 -3.22 15.6 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.03 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . 0.482 ' SG ' ' CD1' ' A' ' 314' ' ' PHE . 71.4 m -109.68 -154.67 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.939 1.399 . . . . 0.0 110.858 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.6 m -136.06 160.49 38.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.028 1.394 . . . . 0.0 109.641 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 74.1 t60 -142.44 165.56 27.08 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.86 -1.775 . . . . 0.0 111.343 -173.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 13.3 m-20 -147.01 115.97 4.39 Favored Pre-proline 0 C--O 1.212 -0.913 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -85.39 25.75 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 126.178 4.586 . . . . 0.0 111.538 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -47.98 -36.23 12.26 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.027 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 7.5 t 39.35 47.97 1.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.173 1.789 . . . . 0.0 113.741 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.31 -19.68 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.279 3.319 . . . . 0.0 113.009 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -124.42 24.63 7.9 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.56 87.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.23 150.08 43.89 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.374 0.607 . . . . 0.0 110.24 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.2 m -107.62 169.91 8.3 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.614 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -141.91 149.03 39.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 1.064 . . . . 0.0 109.154 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -122.47 149.09 44.35 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -138.61 153.62 48.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 122.808 1.289 . . . . 0.0 112.104 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.482 ' CD1' ' SG ' ' A' ' 299' ' ' CYS . 25.5 t80 -146.61 169.63 18.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.426 -0.797 . . . . 0.0 112.16 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -128.6 74.85 1.59 Allowed 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -76.72 1.37 17.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.373 177.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 67.9 m -57.66 137.27 56.61 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 25.1 t -108.77 175.2 5.55 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.816 -1.178 . . . . 0.0 109.257 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -60.65 0.5 0.2 Allowed 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 124.838 1.255 . . . . 0.0 113.822 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 320' ' ' ARG . 11.7 ptm85 -105.12 8.21 34.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.35 -173.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.438 ' HE2' ' CE3' ' A' ' 245' ' ' TRP . 74.1 mmm -128.78 169.91 13.97 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 46.4 mtt85 -119.49 0.06 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.342 0.657 . . . . 0.0 111.371 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 93.8 m -124.01 -174.94 3.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.677 0.791 . . . . 0.0 109.712 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -150.71 166.31 30.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 66.13 147.3 0.04 OUTLIER 'General case' 0 C--N 1.342 0.279 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.58 165.03 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.293 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 143.82 35.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.622 0.769 . . . . 0.0 110.249 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.903 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 34.9 mt -144.84 107.8 4.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.52 171.8 15.33 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.257 2.638 . . . . 0.0 111.892 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.602 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.2 t-105 -101.41 112.32 24.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 169.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.29 157.61 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.04 -0.412 . . . . 0.0 110.5 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.64 -28.0 63.32 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.355 1.062 . . . . 0.0 109.859 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.21 -4.98 8.75 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 124.687 1.242 . . . . 0.0 110.176 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.68 8.66 15.04 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.57 1.148 . . . . 0.0 110.274 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.8 m -115.5 -47.13 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.642 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -155.67 166.27 34.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.908 0.861 . . . . 0.0 110.125 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -153.86 144.53 22.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 110.451 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.22 145.06 18.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -106.66 -16.54 14.48 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.803 1.314 . . . . 0.0 111.427 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 60.1 m -96.73 147.36 32.82 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.294 -0.879 . . . . 0.0 111.351 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.09 -26.43 7.74 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.244 2.629 . . . . 0.0 112.707 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.1 m -143.51 2.92 1.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.2 154.26 22.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.912 1.339 . . . . 0.0 110.062 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.23 177.37 6.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.391 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.648 ' H ' HD23 ' A' ' 346' ' ' LEU . 1.3 mm? -58.33 151.64 19.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.234 -0.916 . . . . 0.0 111.303 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -89.88 137.49 28.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.08 -2.8 13.01 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.003 2.468 . . . . 0.0 115.869 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 41.5 p -142.26 -0.6 1.25 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.552 1.141 . . . . 0.0 112.98 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -123.24 60.66 1.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 397' ' ' THR . 18.6 p -138.27 147.72 43.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.68 169.72 14.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 122.508 -0.12 . . . . 0.0 110.921 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -97.91 125.45 42.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.68 131.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -120.44 97.28 0.64 Allowed Glycine 0 C--O 1.213 -1.181 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -145.72 132.89 20.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.498 0.666 . . . . 0.0 110.606 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.98 155.76 23.78 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.6 1.16 . . . . 0.0 113.32 -169.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 14.7 p80 -159.98 6.51 0.09 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 169.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 116.94 -17.97 12.74 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.315 1.912 . . . . 0.0 112.388 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.6 ptm -166.05 43.27 0.07 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.552 0.676 . . . . 0.0 109.783 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.79 132.23 52.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.37 166.0 12.83 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.758 -173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.36 -17.26 64.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 118.467 -0.778 . . . . 0.0 111.453 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -77.72 -30.4 51.72 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.919 0.781 . . . . 0.0 109.431 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.39 74.49 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.19 -43.92 55.38 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.665 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.68 69.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.41 70.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.577 1.173 . . . . 0.0 114.053 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.57 -32.29 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 O-C-N 123.612 0.57 . . . . 0.0 110.403 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.86 -30.89 18.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.14 -14.18 31.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.918 -0.563 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.36 -33.36 13.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.503 0.668 . . . . 0.0 111.593 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.41 -11.89 19.85 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.09 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 403' ' ' SER . 23.7 m-85 -128.19 -42.36 1.53 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 173.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.75 87.19 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.415 1.007 . . . . 0.0 113.451 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -134.03 103.04 0.48 Allowed Glycine 0 C--N 1.352 1.428 0 CA-C-N 119.007 1.403 . . . . 0.0 110.352 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.44 159.02 15.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 117.587 0.694 . . . . 0.0 111.056 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.49 -58.0 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 123.829 0.852 . . . . 0.0 111.257 174.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.414 ' CD1' HD12 ' A' ' 346' ' ' LEU . 1.9 t80 -147.2 152.38 38.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.742 1.258 . . . . 0.0 110.737 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.32 137.76 29.03 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -136.0 151.61 20.78 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 122.212 0.896 . . . . 0.0 112.19 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.41 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -98.46 123.87 42.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 56.1 p -126.92 158.97 35.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.765 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.12 159.77 40.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 113.03 -1.896 . . . . 0.0 107.358 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.406 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 23.1 tptm -50.2 102.21 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . 0.406 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 26.5 m80 54.99 22.31 4.29 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -12.45 59.99 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 111.731 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.8 p90 41.37 51.78 5.6 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.44 -30.31 8.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.112 2.541 . . . . 0.0 113.233 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.452 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 28.14 75.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 127.83 2.452 . . . . 0.0 114.143 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.53 -88.84 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 114.185 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.4 p -57.04 154.15 10.23 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.193 0.996 . . . . 0.0 108.809 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -162.77 -173.12 31.08 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.204 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -140.47 157.68 45.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.959 0.504 . . . . 0.0 110.234 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.16 151.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 351' ' ' THR . 9.9 t -129.59 146.22 51.42 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.518 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 61.4 m-85 -121.83 -30.09 4.19 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 123.947 0.779 . . . . 0.0 111.409 -172.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.93 16.48 5.79 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.472 0.483 . . . . 0.0 109.851 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -139.96 140.05 36.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.193 0.997 . . . . 0.0 109.735 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -80.53 -20.49 43.4 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.631 0.372 . . . . 0.0 111.692 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 402' ' ' ARG . 0.6 OUTLIER -58.6 -36.34 73.85 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.528 -177.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.518 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 12.1 m -82.71 -14.53 54.41 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.475 -0.766 . . . . 0.0 110.371 -172.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -76.91 -63.14 1.43 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.511 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.4 HD21 ' C ' ' A' ' 405' ' ' LEU 0.25 0.0 OUTLIER -71.09 -17.5 62.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 118.861 -1.136 . . . . 0.0 113.298 -176.246 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -84.45 -31.16 24.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.484 -0.76 . . . . 0.0 112.37 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.17 30.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.618 1.099 . . . . 0.0 108.197 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.51 -31.39 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.469 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.1 t -77.38 -27.36 52.5 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 124.868 1.355 . . . . 0.0 111.473 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.73 -53.69 3.62 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.133 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.96 -14.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 425' ' ' GLN . 1.9 m-85 -157.71 148.29 20.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.678 0.672 . . . . 0.0 110.352 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.19 149.87 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.875 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.38 151.05 20.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 110.78 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.8 mt -124.01 117.4 50.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.542 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.438 ' H ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -127.57 64.25 1.35 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.307 1.051 . . . . 0.0 109.044 -178.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -76.93 159.92 29.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.007 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -63.18 -23.09 67.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.723 0.692 . . . . 0.0 110.998 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -142.69 33.14 1.43 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -167.25 125.41 1.29 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.144 0.973 . . . . 0.0 109.0 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 15.2 p -136.4 121.88 19.47 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.784 -1.198 . . . . 0.0 112.017 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.54 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.8 tptp -164.77 176.52 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.604 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.54 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 47.7 tttt -124.66 156.75 37.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.41 148.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.366 0.984 . . . . 0.0 110.32 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.466 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 40.3 tt0 -118.33 161.0 20.66 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 21.6 mt -142.29 137.63 29.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 124.46 1.1 . . . . 0.0 110.702 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.6 129.01 6.77 Favored Pre-proline 0 C--O 1.235 0.334 0 O-C-N 123.546 0.528 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -83.79 174.02 8.87 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.447 1.431 . . . . 0.0 113.846 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 116.458 -1.734 . . . . 0.0 112.651 171.97 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 122.538 1.161 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 40.8 m -143.92 75.79 1.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.78 1.276 . . . . 0.0 107.946 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.13 2.57 55.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.702 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 415' ' ' ILE . 94.6 p -38.99 141.86 0.26 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -169.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 164.86 -17.41 0.1 Allowed Glycine 0 CA--C 1.537 1.447 0 O-C-N 124.356 1.035 . . . . 0.0 111.966 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 57.7 128.6 0.0 OUTLIER 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.985 2.514 . . . . 0.0 111.664 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.401 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.8 mm? -107.04 -49.23 0.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 117.514 -1.232 . . . . 0.0 112.994 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 52.4 Cg_exo -60.55 161.31 21.22 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 125.337 4.024 . . . . 0.0 113.888 -174.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.94 160.46 45.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.796 2.997 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -151.63 32.0 0.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.648 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -99.32 -18.86 17.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.14 0.976 . . . . 0.0 112.763 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 42.4 -136.92 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 66.15 34.37 6.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.945 1.298 . . . . 0.0 111.997 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.504 ' H ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -136.4 -40.17 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 175.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.504 ' CD ' ' H ' ' A' ' 231' ' ' ASN . 7.6 Cg_exo -74.51 -176.88 2.98 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.362 2.041 . . . . 0.0 115.228 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.11 162.38 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 125.336 1.454 . . . . 0.0 108.868 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -109.75 138.78 45.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.962 1.705 . . . . 0.0 107.811 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.488 ' C ' ' HG ' ' A' ' 236' ' ' CYS . 13.9 t -152.04 2.34 0.36 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -171.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.627 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 71.2 m -148.63 63.58 1.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.48 -1.387 . . . . 0.0 114.44 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.23 162.3 0.2 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.356 0.662 . . . . 0.0 112.296 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.54 142.38 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -81.99 127.97 33.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.273 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.53 108.33 7.07 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -159.24 160.52 31.34 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-O 122.703 1.168 . . . . 0.0 110.252 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.48 -3.16 3.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.28 122.75 88.27 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 120.604 -1.527 . . . . 0.0 109.629 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -87.2 -4.67 7.72 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 124.232 3.288 . . . . 0.0 109.45 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -134.42 176.26 8.77 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.285 1.434 . . . . 0.0 110.415 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.99 145.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.582 0.753 . . . . 0.0 109.874 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 248' ' ' THR . 0.1 OUTLIER -144.14 -50.83 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.405 0 C-N-CA 122.601 0.36 . . . . 0.0 110.803 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.409 ' H ' HD12 ' A' ' 247' ' ' ILE . 2.8 m -164.78 130.43 2.76 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.721 2.008 . . . . 0.0 105.753 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -70.97 -13.33 61.97 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 120.421 1.464 . . . . 0.0 111.965 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.04 65.78 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 125.347 1.459 . . . . 0.0 109.278 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.99 -35.68 84.66 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.83 -45.73 41.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.685 1.231 . . . . 0.0 108.63 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.9 t -62.93 -53.61 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 120.509 -1.37 . . . . 0.0 110.485 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -79.89 -13.71 59.18 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.8 t -81.52 -26.22 35.3 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.525 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -126.44 32.11 5.25 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.276 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 28.6 tpt85 -96.09 -18.2 20.34 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.436 1.094 . . . . 0.0 109.822 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 4.7 t -70.35 20.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -128.12 0.4 5.84 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.466 -0.771 . . . . 0.0 112.888 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.56 -95.38 0.1 Allowed Glycine 0 N--CA 1.471 1.004 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.675 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.0 t -144.9 147.38 32.7 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.292 1.046 . . . . 0.0 109.408 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 151.67 24.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.0 m -149.71 175.72 11.32 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.34 150.25 18.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 121.072 -1.017 . . . . 0.0 113.468 -172.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.33 154.09 46.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.582 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.27 138.79 20.97 Favored Pre-proline 0 C--N 1.345 0.385 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.91 -170.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.98 -29.1 4.47 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 125.01 3.806 . . . . 0.0 109.769 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.56 -28.36 6.05 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.164 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 44.34 50.7 7.84 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.342 1.071 . . . . 0.0 110.371 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -118.89 -8.02 10.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.02 8.83 58.89 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.004 -0.887 . . . . 0.0 113.155 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.88 -36.33 76.68 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 118.642 1.221 . . . . 0.0 110.742 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -143.33 126.69 9.11 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.34 -12.41 12.8 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 125.06 3.84 . . . . 0.0 109.731 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -72.46 -72.28 0.25 Allowed 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 123.134 0.573 . . . . 0.0 111.014 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 42.5 t -158.24 143.7 12.22 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 124.592 1.183 . . . . 0.0 109.675 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 279' ' ' LYS . 65.7 Cg_endo -62.97 160.34 34.21 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.222 1.948 . . . . 0.0 111.16 175.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.37 27.19 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 125.234 3.956 . . . . 0.0 111.018 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.412 ' H ' ' C ' ' A' ' 277' ' ' PRO . 74.5 mmtt -120.46 158.12 27.91 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -82.8 10.68 56.25 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.581 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.33 170.91 19.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.787 -177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 176.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 125.217 1.573 . . . . 0.0 107.197 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -118.17 155.19 30.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 119.763 1.165 . . . . 0.0 111.374 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.02 135.25 55.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.86 120.31 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 125.577 1.551 . . . . 0.0 107.419 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.426 ' C ' ' H ' ' A' ' 288' ' ' LEU . 0.0 OUTLIER -155.86 -156.3 0.63 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.232 -174.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.62 18.87 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.187 0.449 . . . . 0.0 110.714 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 286' ' ' PHE . 86.6 mt 48.99 -141.19 0.65 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 119.831 -1.793 . . . . 0.0 111.362 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 13.39 -74.42 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 127.593 2.357 . . . . 0.0 116.443 168.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -81.77 -29.12 32.92 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.813 0.845 . . . . 0.0 112.962 -170.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.7 m -78.56 -30.63 46.96 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.299 1.04 . . . . 0.0 108.705 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 62.4 t -68.19 -57.3 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -72.56 -20.4 61.32 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.8 t -71.77 -42.92 66.59 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.93 -0.482 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.86 -45.91 33.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.382 0.992 . . . . 0.0 111.497 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -16.32 61.84 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.468 1.031 . . . . 0.0 113.38 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -95.29 -17.03 21.99 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.69 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -78.16 -19.46 53.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 119.957 1.253 . . . . 0.0 112.307 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 5.1 t -115.26 -108.19 0.37 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.341 1.026 . . . . 0.0 113.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.2 t -142.64 163.56 32.48 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -168.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -146.94 156.23 42.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.314 1.846 . . . . 0.0 106.844 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -142.86 125.78 9.09 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.18 13.02 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 1 C-N-CA 127.521 5.481 . . . . 0.0 112.478 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 305' ' ' SER . 0.3 OUTLIER -38.75 -45.34 1.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.581 1.553 . . . . 0.0 112.766 -177.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.657 ' H ' HD13 ' A' ' 304' ' ' LEU . 66.2 m 42.07 51.35 5.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.09 -10.78 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.927 1.751 . . . . 0.0 112.883 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -134.62 16.58 3.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.209 0.528 . . . . 0.0 110.267 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 88.62 5.98 74.01 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 309' ' ' LEU . 19.5 tp -128.68 142.09 51.13 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 121.949 -0.736 . . . . 0.0 112.395 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 63.5 m -80.04 166.15 21.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.151 0.907 . . . . 0.0 109.702 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -136.18 142.15 44.12 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.44 145.04 35.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.78 151.18 40.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 123.211 1.481 . . . . 0.0 109.324 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -147.85 159.98 43.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.964 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 44.9 mtmt -132.53 131.27 41.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 -3.49 0.91 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 116.115 -1.898 . . . . 0.0 114.344 -167.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 m -144.63 33.71 1.16 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.563 1.529 . . . . 0.0 111.436 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.1 m -61.84 -9.7 7.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.239 1.816 . . . . 0.0 113.5 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -138.37 5.08 2.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.595 0.758 . . . . 0.0 110.221 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -113.51 -28.91 7.36 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.539 0.736 . . . . 0.0 111.464 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.624 ' C ' ' H ' ' A' ' 323' ' ' CYS . 85.7 mmm -131.28 7.52 4.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.383 -0.818 . . . . 0.0 113.167 -172.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 60.85 -16.13 0.03 OUTLIER 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.222 2.209 . . . . 0.0 110.567 -172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.624 ' H ' ' C ' ' A' ' 321' ' ' MET . 80.4 m -110.58 167.75 9.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.789 0.835 . . . . 0.0 110.346 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -159.25 -162.66 1.09 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 122.871 0.468 . . . . 0.0 111.519 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 62.69 137.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.696 1.599 . . . . 0.0 112.868 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 12.6 p -156.58 162.92 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -109.09 155.6 20.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.422 0.555 . . . . 0.0 111.989 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.84 137.72 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 8.5 pt -146.17 94.92 4.83 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.95 169.72 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.888 1 C-N-CA 125.781 4.321 . . . . 0.0 111.257 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.627 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.6 t-105 -86.53 115.35 23.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.254 175.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 18.0 t -99.48 145.09 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 123.298 1.523 . . . . 0.0 108.791 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.25 -31.97 69.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.039 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -84.58 -7.99 59.06 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.68 -1.77 57.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.721 0.692 . . . . 0.0 111.312 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 88.5 p -130.2 -2.11 4.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.725 -0.609 . . . . 0.0 112.37 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -149.58 140.24 22.61 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.202 0.314 . . . . 0.0 110.186 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -156.14 106.67 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.414 0.686 . . . . 0.0 109.331 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 341' ' ' SER . 12.2 p -89.2 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.157 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.24 28.64 8.59 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.455 1.121 . . . . 0.0 110.303 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.514 ' H ' HG23 ' A' ' 339' ' ' VAL . 26.5 t -141.63 149.11 52.68 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.06 -3.29 13.58 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.265 3.31 . . . . 0.0 110.592 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -137.85 165.72 25.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -115.14 127.64 55.7 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.756 0.788 . . . . 0.0 111.188 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -142.01 -41.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.127 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.64 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 O-C-N 124.722 1.264 . . . . 0.0 111.948 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.21 140.71 19.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.25 -5.06 14.95 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.718 1.612 . . . . 0.0 114.98 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.4 t -152.51 -169.66 3.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 48.47 99.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.889 2.075 . . . . 0.0 113.742 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.7 t -158.27 155.72 29.4 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 149.76 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 124.132 0.895 . . . . 0.0 110.326 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -85.47 152.91 22.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.796 -169.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 133.27 66.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -167.58 -168.07 29.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.476 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 58.07 19.57 6.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 19.2 mt -67.09 154.66 40.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.657 -1.277 . . . . 0.0 109.839 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . 0.456 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 3.6 p-80 -79.69 16.36 1.13 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 87.36 9.32 72.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.824 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.456 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 8.9 ptp -159.01 12.17 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 173.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 31.8 tp -64.62 140.06 58.83 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.154 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.4 161.05 15.38 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.682 0.793 . . . . 0.0 109.199 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -70.09 -8.63 51.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -67.16 -35.14 79.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.36 34.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.615 0.721 . . . . 0.0 110.567 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.9 -31.44 64.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.665 -0.647 . . . . 0.0 110.021 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.75 -50.17 70.13 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -57.84 -39.14 76.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.879 -0.513 . . . . 0.0 111.576 -174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 90.2 mt -71.06 -41.8 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 122.034 -0.416 . . . . 0.0 110.109 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.22 -2.94 58.9 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -171.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . 0.474 ' C ' HD21 ' A' ' 371' ' ' ASN . 0.2 OUTLIER -127.99 1.41 5.93 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.571 -1.331 . . . . 0.0 112.528 175.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -119.78 -20.63 7.54 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.962 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.85 -22.76 24.26 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.21 -16.22 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.456 1.026 . . . . 0.0 111.994 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 55.32 84.15 0.04 OUTLIER Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -151.84 3.86 0.43 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 118.195 0.998 . . . . 0.0 113.136 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.8 m -96.0 166.67 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 122.402 1.096 . . . . 0.0 113.179 -173.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.08 -27.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.171 170.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -155.18 147.83 24.24 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.12 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 119.235 0.925 . . . . 0.0 108.608 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -153.37 168.58 32.08 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.322 0.889 . . . . 0.0 115.322 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.7 mt -116.65 140.44 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.49 146.96 24.9 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.663 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.3 p -140.52 171.62 13.87 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 124.734 1.272 . . . . 0.0 111.907 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -132.76 18.59 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.435 1.494 . . . . 0.0 108.494 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.54 ' HE2' ' CE1' ' A' ' 387' ' ' HIS 0.274 0.5 OUTLIER 51.83 3.68 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 130.53 3.532 . . . . 0.0 114.794 -176.674 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . 0.54 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 38.7 m170 -140.84 -9.8 1.03 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.681 1.192 . . . . 0.0 112.205 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -94.33 -11.09 30.75 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.86 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.0 p90 41.92 48.57 3.26 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.81 -52.01 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.389 2.726 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.286 6.9 tp 40.17 33.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 122.046 0.927 . . . . 0.0 110.674 -173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -160.49 16.13 0.19 Allowed Glycine 0 C--N 1.345 1.078 0 CA-C-O 118.593 -1.115 . . . . 0.0 112.496 -176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.5 p -145.44 112.12 5.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.81 0.805 . . . . 0.0 109.088 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -152.01 -175.76 24.01 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -147.28 167.04 25.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.87 142.08 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 27.8 m -99.93 105.49 17.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -85.75 162.35 18.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.231 0.613 . . . . 0.0 110.477 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -147.13 19.06 1.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.581 0.705 . . . . 0.0 111.346 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -144.39 165.37 28.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.44 1.096 . . . . 0.0 108.755 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -88.16 -36.28 16.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 120.943 1.702 . . . . 0.0 113.298 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -26.81 8.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -76.19 -30.26 57.97 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.51 -56.94 6.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.333 -1.479 . . . . 0.0 110.471 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -23.65 58.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.902 -1.124 . . . . 0.0 113.677 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -85.79 -22.91 27.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -87.58 -28.06 22.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.179 -0.325 . . . . 0.0 110.301 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.8 m -84.57 -25.0 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.2 p -85.55 -24.87 27.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.008 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -84.0 -44.59 14.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.5 -20.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.126 2.971 . . . . 0.0 115.096 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -149.99 145.88 26.69 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.23 156.14 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 O-C-N 121.41 -0.806 . . . . 0.0 110.221 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -109.38 139.54 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 124.277 0.985 . . . . 0.0 112.882 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.456 ' HA ' ' HB3' ' A' ' 221' ' ' SER . 37.5 mt -118.53 126.41 75.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.452 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -131.23 14.56 5.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.496 1.123 . . . . 0.0 110.598 -170.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -60.88 157.06 15.97 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.591 1.156 . . . . 0.0 109.735 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -62.68 -0.77 0.68 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -139.47 4.72 2.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -160.32 130.29 5.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.132 0.973 . . . . 0.0 112.516 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 416' ' ' LYS . 17.3 p -140.16 102.29 4.34 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 120.263 1.392 . . . . 0.0 110.95 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.59 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 32.4 tptt -166.39 -176.1 3.49 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.813 174.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.59 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 43.1 mtpt -128.04 172.23 11.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.617 0.767 . . . . 0.0 110.625 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.21 159.47 20.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.211 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -130.0 135.92 48.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.9 145.16 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.54 151.22 63.09 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 118.956 0.798 . . . . 0.0 110.614 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.01 166.41 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.242 2.628 . . . . 0.0 113.109 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 123.955 0.902 . . . . 0.0 110.045 -177.062 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 221' ' ' SER . 26.5 m 42.23 66.17 0.78 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.742 1.217 . . . . 0.0 112.729 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 19.35 0.11 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 219' ' ' THR . 18.7 m 57.16 35.1 25.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 169.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.07 86.23 0.05 OUTLIER Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -79.84 -14.78 58.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.821 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 43.75 113.34 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 128.29 2.636 . . . . 0.0 115.206 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.52 169.03 19.07 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.96 3.107 . . . . 0.0 110.039 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.11 156.55 12.79 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.072 2.515 . . . . 0.0 113.435 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -141.45 179.55 6.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.14 2.176 . . . . 0.0 108.199 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 50.48 40.79 24.06 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.674 0.79 . . . . 0.0 113.088 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.64 159.51 1.54 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.73 0.812 . . . . 0.0 111.006 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -101.26 2.41 39.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.524 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.9 OUTLIER -126.39 35.69 0.3 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -177.725 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 68.7 Cg_endo -75.15 155.89 42.29 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.892 2.394 . . . . 0.0 111.394 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.71 140.71 43.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.25 121.97 38.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 95.6 p -125.93 -6.87 6.68 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.777 -170.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.35 -173.96 3.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 123.948 0.899 . . . . 0.0 108.643 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -60.23 155.89 16.58 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.244 -170.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.57 135.52 31.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -100.67 122.55 43.51 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 108.704 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.2 tt -145.46 143.33 29.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.775 -0.578 . . . . 0.0 110.512 -169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.56 145.75 9.56 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 123.337 0.398 . . . . 0.0 112.147 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.5 17.43 0.02 OUTLIER Glycine 0 C--O 1.211 -1.329 0 CA-C-N 119.049 1.425 . . . . 0.0 113.818 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.05 95.4 39.45 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 118.147 0.973 . . . . 0.0 111.71 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.79 10.83 3.52 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 125.133 3.889 . . . . 0.0 112.533 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 246' ' ' ASP . 11.6 p-90 -128.14 -9.79 5.33 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.426 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 11.5 p-10 -60.28 116.26 4.12 Favored 'General case' 0 C--O 1.254 1.29 0 O-C-N 123.943 0.777 . . . . 0.0 113.087 -175.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -78.32 -15.81 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.4 p -153.6 148.17 26.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.249 1.023 . . . . 0.0 108.415 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -84.1 -22.56 31.09 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.772 -1.205 . . . . 0.0 108.727 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -78.31 -14.77 59.27 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.433 1.083 . . . . 0.0 113.319 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.82 -66.07 2.78 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.593 HD21 ' H ' ' A' ' 252' ' ' LEU . 2.5 pt? -66.08 -29.37 69.69 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.73 -35.87 76.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.786 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -77.11 -18.06 58.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.705 -1.872 . . . . 0.0 110.198 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.5 p -77.85 -25.68 48.88 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.359 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.33 20.03 4.81 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 121.832 2.106 . . . . 0.0 112.545 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.1 20.92 1.46 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 119.547 -1.971 . . . . 0.0 111.913 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.5 t -71.09 -9.91 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -166.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -91.88 -2.65 56.74 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.432 1.083 . . . . 0.0 111.085 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.81 -2.7 3.44 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-O 117.698 -1.612 . . . . 0.0 116.612 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.7 m -102.54 22.3 13.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 119.183 1.492 . . . . 0.0 112.337 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 262' ' ' LEU . 3.7 mm? -68.97 145.23 53.79 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 t -145.35 81.47 1.63 Allowed 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.1 p -75.7 141.25 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.068 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -150.94 157.82 43.38 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.368 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.453 ' HB3' HG21 ' A' ' 282' ' ' VAL . 42.4 p90 -151.66 146.67 19.02 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.05 91.91 1.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.635 2.223 . . . . 0.0 110.267 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -178.52 177.84 48.52 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -105.46 124.34 49.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.94 -0.741 . . . . 0.0 109.434 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -111.13 7.9 21.52 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.49 0.716 . . . . 0.0 110.097 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -67.05 -12.0 59.51 Favored Glycine 0 N--CA 1.47 0.951 0 CA-C-O 118.067 -1.407 . . . . 0.0 113.824 -172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -138.7 -35.5 0.58 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.561 1.681 . . . . 0.0 111.513 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -143.87 133.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.61 -13.96 6.83 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 125.059 3.839 . . . . 0.0 111.463 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -96.41 20.67 10.19 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.455 ' HB3' ' HD3' ' A' ' 277' ' ' PRO . 42.4 t -53.46 -41.27 85.94 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.892 -0.575 . . . . 0.0 112.03 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 276' ' ' CYS . 32.5 Cg_endo -98.29 95.72 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.41 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.83 4.85 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.585 4.19 . . . . 0.0 115.407 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -78.26 6.75 7.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 66.14 11.43 55.36 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.49 141.61 44.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.602 1.201 . . . . 0.0 112.739 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -150.03 170.76 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.983 0.897 . . . . 0.0 109.054 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -133.72 155.61 49.45 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.842 -1.161 . . . . 0.0 109.986 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 96.9 mt -131.16 145.76 52.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.19 0.596 . . . . 0.0 111.908 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.31 134.2 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 15.6 p90 -169.23 -163.26 0.4 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 125.007 1.442 . . . . 0.0 108.133 -174.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.16 110.21 0.46 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.582 1.153 . . . . 0.0 107.933 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 54.1 mt -89.83 -179.66 5.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.172 0.987 . . . . 0.0 110.396 -172.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 63.99 -67.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.367 1.867 . . . . 0.0 113.803 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -81.03 -43.35 19.69 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.433 -0.792 . . . . 0.0 111.261 -168.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 7.5 m -79.13 -31.4 44.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.84 -51.65 59.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -62.7 -32.22 73.27 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 70.4 m -57.23 -44.2 83.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.475 1.11 . . . . 0.0 111.884 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.7 -49.72 67.49 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.796 -1.19 . . . . 0.0 110.194 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -26.63 68.11 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 119.182 -0.437 . . . . 0.0 112.018 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -96.21 -4.25 42.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 123.855 0.722 . . . . 0.0 111.742 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.33 -12.57 19.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 314' ' ' PHE . 9.8 t -127.43 -124.05 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.0 t -116.49 163.65 15.75 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -155.8 159.6 39.55 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.724 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.19 137.73 31.47 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.26 75.52 5.02 Favored 'Trans proline' 0 C--N 1.35 0.612 1 C-N-CA 128.302 6.001 . . . . 0.0 112.867 -168.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 305' ' ' SER . 2.8 mp 64.58 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 115.784 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 304' ' ' LEU . 20.2 m 41.47 68.89 2.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -53.02 1.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 1 C-N-CA 127.224 5.283 . . . . 0.0 116.557 -166.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.88 16.2 24.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.701 1.601 . . . . 0.0 108.739 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -166.55 -113.66 0.28 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.802 1.668 . . . . 0.0 111.699 -175.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 16.3 tp -150.15 158.58 44.31 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.421 1.11 . . . . 0.0 111.007 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 1.5 m -62.89 153.45 33.31 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.357 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -137.24 150.06 47.58 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 123.834 0.709 . . . . 0.0 110.744 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.44 146.86 44.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -140.02 155.13 47.22 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.654 -1.279 . . . . 0.0 112.17 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.489 ' HA ' ' SG ' ' A' ' 299' ' ' CYS . 32.4 t80 -145.22 174.29 11.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -125.4 132.41 52.77 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.21 0.914 . . . . 0.0 108.922 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.431 ' H ' ' HE3' ' A' ' 316' ' ' MET . 0.0 OUTLIER -123.3 14.3 9.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.295 1.038 . . . . 0.0 109.662 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.3 p -82.01 2.1 32.49 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.115 0.566 . . . . 0.0 111.312 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 45.7 t -61.31 150.87 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 109.968 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 56.1 8.49 0.39 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.861 0.864 . . . . 0.0 112.286 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -129.5 -62.97 0.95 Allowed 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.566 -0.709 . . . . 0.0 110.761 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.5 mmt -123.59 -13.68 7.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.435 1.094 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 44.74 23.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.8 2.04 . . . . 0.0 114.993 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 3.1 t -151.56 17.45 0.71 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 121.262 1.846 . . . . 0.0 114.172 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.525 ' HZ1' ' HB2' ' A' ' 324' ' ' LYS . 0.1 OUTLIER -122.56 115.55 22.35 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.989 0.9 . . . . 0.0 112.713 -174.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -74.95 162.34 28.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.016 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.88 150.02 32.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.159 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -83.32 136.71 34.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.292 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.36 133.36 57.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.013 0.824 . . . . 0.0 111.017 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 62.1 mt -149.64 114.98 3.52 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.5 154.44 6.47 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 125.024 3.816 . . . . 0.0 112.765 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.406 ' CZ3' ' HA ' ' A' ' 389' ' ' TYR . 5.3 t-105 -76.2 120.0 20.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 172.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.646 HG13 ' H ' ' A' ' 334' ' ' ALA . 44.4 t -90.06 142.67 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.377 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.01 -25.96 64.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.35 0.595 . . . . 0.0 112.195 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.646 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -76.9 1.95 16.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.045 -1.659 . . . . 0.0 114.047 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -94.82 -8.63 36.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.675 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.7 m -103.91 -27.98 11.85 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.337 1.426 . . . . 0.0 114.046 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -163.03 162.79 26.07 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.146 0.278 . . . . 0.0 110.794 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -160.67 147.51 15.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.299 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.3 141.65 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 O-C-N 123.67 0.607 . . . . 0.0 110.405 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.81 20.33 18.28 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.012 0.91 . . . . 0.0 109.007 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 18.3 t -143.54 145.98 33.72 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.68 1.592 . . . . 0.0 107.341 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.56 5.42 4.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 121.716 1.611 . . . . 0.0 112.865 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 63.9 m -106.11 158.42 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.485 0.714 . . . . 0.0 109.639 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -111.03 12.64 22.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.216 0.606 . . . . 0.0 112.559 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -70.6 162.99 27.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.718 1.247 . . . . 0.0 112.263 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 346' ' ' LEU . 11.1 tp -145.8 143.62 29.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . 0.513 ' H ' HG21 ' A' ' 397' ' ' THR . 12.1 m-20 -134.65 85.3 36.92 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 124.651 1.18 . . . . 0.0 110.535 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.89 -9.95 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 124.742 3.628 . . . . 0.0 114.196 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 87.9 p -72.61 -12.57 61.1 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.141 -0.974 . . . . 0.0 112.789 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -142.43 94.23 2.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.1 t -149.33 152.27 35.57 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.92 154.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.661 1.22 . . . . 0.0 108.942 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -90.34 161.96 15.37 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.328 -171.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 4.5 p -144.68 145.16 21.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 O-C-N 121.487 -0.758 . . . . 0.0 111.378 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.91 -174.88 36.55 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 47.47 34.57 3.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.699 0.4 . . . . 0.0 111.745 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.01 -176.52 3.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.867 1.267 . . . . 0.0 108.649 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' A' ' 360' ' ' MET . 22.6 t-160 -65.13 140.32 58.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.18 0.592 . . . . 0.0 111.075 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -67.85 5.61 3.39 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.162 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.443 ' HB2' ' CE1' ' A' ' 358' ' ' HIS . 40.7 mtp -138.71 28.08 2.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.857 1.329 . . . . 0.0 107.495 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.17 82.92 0.08 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.562 1.648 . . . . 0.0 108.473 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 360' ' ' MET . 5.4 p30 -64.69 156.78 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.107 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.92 -19.1 65.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 120.599 -1.313 . . . . 0.0 111.401 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -72.64 -27.77 62.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 120.943 -1.098 . . . . 0.0 109.001 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -87.49 -32.73 19.29 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.223 1.409 . . . . 0.0 111.017 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.91 -37.37 86.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -78.8 -28.99 44.63 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.835 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -67.82 -42.47 81.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.122 1.328 . . . . 0.0 108.558 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.0 -44.22 92.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.251 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 374' ' ' PHE . 45.4 mt -89.9 -7.86 53.21 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 117.784 -1.103 . . . . 0.0 112.724 -171.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.83 -28.43 15.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.742 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.7 -26.48 25.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.98 -13.02 20.1 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.46 ' CE2' HD23 ' A' ' 370' ' ' LEU . 22.1 m-30 -119.91 -23.07 6.52 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 120.25 1.387 . . . . 0.0 111.942 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 76.4 -0.68 63.37 Favored Glycine 0 CA--C 1.552 2.381 0 O-C-N 125.048 1.468 . . . . 0.0 113.867 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.46 120.08 0.71 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 121.36 2.58 . . . . 0.0 111.807 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.36 171.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 126.171 1.788 . . . . 0.0 107.834 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.85 -30.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.913 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -163.05 136.82 5.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.085 0.402 . . . . 0.0 110.656 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.15 129.66 13.04 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -140.73 159.67 26.46 Favored Glycine 0 C--O 1.22 -0.747 0 O-C-N 121.861 -0.525 . . . . 0.0 114.128 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 23.8 mm -80.88 149.2 5.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.5 47.8 0.5 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.909 0.755 . . . . 0.0 110.386 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.4 p -64.53 158.83 23.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 123.817 1.77 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -140.94 146.99 38.1 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.389 2.676 . . . . 0.0 104.4 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -61.01 122.5 15.09 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.695 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.4 m170 67.73 42.05 2.09 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.08 -10.86 8.11 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.406 ' HA ' ' CZ3' ' A' ' 331' ' ' TRP . 10.3 p90 38.18 50.71 2.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.15 -46.33 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.216 2.611 . . . . 0.0 113.995 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.8 tp 41.99 31.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 112.732 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -133.66 -6.37 2.63 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -172.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.0 p -156.91 160.69 39.36 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 118.626 1.213 . . . . 0.0 108.105 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -176.99 -165.26 32.11 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.182 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -156.82 161.24 39.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.554 0.741 . . . . 0.0 109.933 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.31 134.53 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 120.9 1.682 . . . . 0.0 108.477 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' THR . . . . . 0.513 HG21 ' H ' ' A' ' 347' ' ' ASP . 96.8 m -106.37 141.95 36.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 125.062 1.476 . . . . 0.0 108.323 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.58 161.44 16.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.592 1.557 . . . . 0.0 112.271 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -131.26 11.37 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -135.96 140.31 43.87 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -76.91 -29.56 55.77 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.578 0.549 . . . . 0.0 111.869 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.538 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -64.44 -18.59 64.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.382 0.537 . . . . 0.0 110.739 -175.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.1 m -79.81 -19.74 47.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 118.485 0.584 . . . . 0.0 111.187 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -76.5 -51.14 12.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.107 0.867 . . . . 0.0 110.945 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -19.2 61.21 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 119.611 1.096 . . . . 0.0 111.646 177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.81 -26.32 57.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.737 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.98 59.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.805 -0.559 . . . . 0.0 110.908 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.53 -9.07 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.567 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.2 p -105.25 -8.79 18.08 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.324 0.39 . . . . 0.0 110.26 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -100.9 -48.44 4.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.517 0.51 . . . . 0.0 110.335 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.01 -12.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 129.947 3.299 . . . . 0.0 118.858 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -162.72 138.5 7.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.255 -1.528 . . . . 0.0 107.262 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.83 157.0 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.375 -0.828 . . . . 0.0 111.031 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.425 ' HA ' ' HG3' ' A' ' 423' ' ' LYS . 41.6 mt-10 -105.97 138.92 41.32 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.401 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 421' ' ' THR . 73.4 mt -103.41 116.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -134.45 110.19 9.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.632 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.0 p -132.39 -175.12 3.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.664 0.786 . . . . 0.0 110.249 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 88.9 m -83.19 4.49 26.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.64 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -143.27 -4.73 0.88 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.849 1.204 . . . . 0.0 113.73 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -144.65 145.53 31.8 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.681 0.613 . . . . 0.0 110.052 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 26.6 m -153.85 116.21 4.37 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.99 0.516 . . . . 0.0 109.955 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -162.16 157.12 22.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 123.804 0.69 . . . . 0.0 110.679 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 414' ' ' GLU . 0.1 OUTLIER -114.87 162.42 16.93 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.88 148.34 19.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.731 1.212 . . . . 0.0 108.316 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -132.19 129.36 39.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.937 1.351 . . . . 0.0 111.776 -170.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.13 143.83 16.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.047 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -136.64 148.5 63.86 Favored Pre-proline 0 N--CA 1.444 -0.745 0 O-C-N 123.676 0.61 . . . . 0.0 110.223 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.56 158.41 13.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.944 3.096 . . . . 0.0 112.468 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 117.448 -1.263 . . . . 0.0 109.028 178.497 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 221' ' ' SER . 2.3 m 43.99 45.7 6.67 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.339 1.056 . . . . 0.0 110.838 -170.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 15.02 0.04 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 219' ' ' THR . 78.5 p -46.52 143.05 2.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.571 1.548 . . . . 0.0 113.944 -168.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 134.96 -2.22 3.96 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.77 -1.104 . . . . 0.0 114.072 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -134.48 22.05 3.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.394 1.097 . . . . 0.0 111.326 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.71 -57.96 3.0 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-O 116.131 -1.89 . . . . 0.0 112.918 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.26 117.19 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.6 2.867 . . . . 0.0 108.88 -170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.57 -40.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.304 3.336 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 43.52 22.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -86.42 -7.7 58.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.755 1.222 . . . . 0.0 111.796 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.98 145.64 52.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 230' ' ' LYS . 25.8 mmmt -144.39 8.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.367 -0.833 . . . . 0.0 113.142 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 61.86 50.25 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.173 -172.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.04 129.61 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.859 2.373 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.5 mm -147.72 144.81 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -105.88 151.52 24.44 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.807 -172.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -152.08 3.77 0.39 Allowed 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.455 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 4.0 t -146.99 -170.37 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.313 -0.867 . . . . 0.0 108.828 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 175.94 1.19 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.91 141.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.852 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -91.05 133.92 34.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.718 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 8.8 tt -143.11 124.36 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -156.62 152.11 23.5 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.04 14.55 0.1 Allowed Glycine 0 CA--C 1.537 1.42 0 O-C-N 124.646 0.85 . . . . 0.0 111.656 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.29 108.66 61.91 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 118.114 0.957 . . . . 0.0 110.982 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.3 0.26 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 124.847 3.698 . . . . 0.0 113.642 171.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.436 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 4.2 p-90 -135.9 -96.86 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 25.0 t0 42.53 65.02 0.99 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.577 . . . . 0.0 111.855 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.65 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.12 -30.49 36.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -171.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 250' ' ' ALA . 16.8 m -140.18 126.65 20.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.97 -7.41 58.78 Favored 'General case' 0 C--O 1.201 -1.499 0 O-C-N 123.554 0.534 . . . . 0.0 110.735 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.456 ' H ' HG23 ' A' ' 248' ' ' THR . . . -71.52 -21.71 61.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.062 -0.399 . . . . 0.0 111.462 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.76 -48.99 6.78 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.59 -41.2 98.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 114.823 -0.688 . . . . 0.0 109.638 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.57 -50.72 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.494 -1.379 . . . . 0.0 110.641 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -69.24 -9.06 51.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.4 m -80.94 -32.32 34.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.1 68.29 1.4 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.858 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 257' ' ' ARG . 13.6 ttt180 -123.74 7.18 8.78 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.439 1.096 . . . . 0.0 111.727 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.91 7.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 119.807 -1.808 . . . . 0.0 112.362 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.72 -10.32 23.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.34 -4.07 13.8 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.878 1.511 . . . . 0.0 116.878 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.7 p -112.32 44.76 1.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 120.599 -1.53 . . . . 0.0 111.704 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 163.57 32.47 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.6 m -149.99 175.69 11.46 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.483 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.98 157.08 41.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 O-C-N 121.525 -0.734 . . . . 0.0 111.013 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -138.11 135.6 35.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.392 1.091 . . . . 0.0 111.275 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.31 148.9 36.46 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.23 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.01 -21.37 15.9 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.239 3.293 . . . . 0.0 111.756 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 178.27 -6.5 0.03 OUTLIER Glycine 0 CA--C 1.547 2.078 0 CA-C-O 118.482 -1.176 . . . . 0.0 115.859 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -94.87 107.18 19.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.793 2.297 . . . . 0.0 109.872 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.69 145.02 29.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 167.88 -173.35 42.81 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -63.92 -40.52 96.66 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.82 1.648 . . . . 0.0 112.272 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -147.05 84.56 7.34 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.25 -48.65 1.16 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.528 2.152 . . . . 0.0 114.095 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 46.56 9.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.03 2.132 . . . . 0.0 114.922 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 41.9 t -164.52 111.33 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 119.255 0.934 . . . . 0.0 110.391 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.91 160.82 46.77 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.882 2.388 . . . . 0.0 110.076 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.28 -17.47 13.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.234 2.623 . . . . 0.0 112.01 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -146.9 167.35 24.17 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.146 1.379 . . . . 0.0 110.878 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.66 19.72 3.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.964 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -152.82 165.86 34.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.336 1.568 . . . . 0.0 112.631 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.6 m -154.76 -170.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 126.328 2.267 . . . . 0.0 109.391 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -118.3 153.87 33.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.418 1.087 . . . . 0.0 110.525 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.74 147.31 48.72 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.15 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.98 112.02 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 109.268 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -139.76 -179.73 6.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.53 -174.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.56 124.18 10.27 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.17 -13.38 26.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.67 -49.22 0.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 116.859 -1.937 . . . . 0.0 112.195 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -81.19 -36.68 29.82 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 72.7 m -76.22 -31.18 58.27 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 120.158 1.345 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.562 HG23 ' CE1' ' A' ' 286' ' ' PHE . 2.8 t -60.86 -52.33 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -74.54 -23.48 58.8 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 74.8 m -72.44 -36.42 68.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 109.924 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.9 mp -74.66 -54.14 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 4.16 36.76 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.573 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -111.19 -10.51 14.29 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 110.783 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.54 37.25 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.323 0.965 . . . . 0.0 110.773 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.41 -115.7 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.794 0.806 . . . . 0.0 112.634 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.4 m -126.01 155.97 40.62 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 111.688 -171.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -157.56 159.28 36.97 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.646 1.178 . . . . 0.0 109.049 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 304' ' ' LEU . 16.2 m-20 -146.65 89.12 5.85 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 109.684 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.02 22.52 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.998 1 C-N-CA 128.618 6.212 . . . . 0.0 110.194 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 302' ' ' ASP . 7.2 mp -91.01 -2.36 57.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.492 1.117 . . . . 0.0 112.271 -166.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 19.9 t 44.91 44.54 1.7 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.26 -6.25 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.661 2.241 . . . . 0.0 113.096 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.99 -42.1 0.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -124.23 -118.76 2.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.84 -16.06 22.09 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.448 -1.031 . . . . 0.0 110.925 173.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 3.2 p 171.08 176.97 0.06 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.418 1.487 . . . . 0.0 107.963 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.27 130.76 50.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -108.48 143.81 36.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -124.78 145.27 49.82 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.847 0.832 . . . . 0.0 110.725 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -151.71 155.98 39.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.315 -1.311 . . . . 0.0 107.77 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 11.0 ptpt -129.34 143.61 50.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.015 0.825 . . . . 0.0 110.177 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.49 -7.65 5.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.676 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.524 ' HG ' ' HB2' ' A' ' 321' ' ' MET . 47.7 t -140.34 133.34 29.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.653 1.115 . . . . 0.0 109.685 172.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 60.4 m -140.85 -13.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.1 -8.77 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.941 1.246 . . . . 0.0 110.849 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -86.24 -29.11 23.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.769 0.827 . . . . 0.0 111.479 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.524 ' HB2' ' HG ' ' A' ' 317' ' ' SER . 97.2 mmm -142.08 164.89 28.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.24 0.616 . . . . 0.0 109.748 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 322' ' ' ARG . 70.6 mtt-85 -92.07 45.94 1.24 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.147 1.379 . . . . 0.0 111.172 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.25 -166.13 1.53 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.798 0.839 . . . . 0.0 109.642 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -143.27 -173.2 3.87 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -54.36 158.65 2.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.571 1.548 . . . . 0.0 113.173 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -121.38 153.4 25.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -172.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.65 150.31 21.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 120.181 1.355 . . . . 0.0 110.253 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.86 145.65 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.865 0.466 . . . . 0.0 110.281 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -144.12 99.73 5.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 123.775 0.672 . . . . 0.0 111.803 172.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.22 168.11 15.28 Favored 'Trans proline' 0 N--CA 1.46 -0.454 1 C-N-CA 125.306 4.004 . . . . 0.0 110.849 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.455 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 2.8 t-105 -88.0 125.42 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.3 t -105.84 145.12 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.394 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 13.1 mt -55.79 -21.33 18.78 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.729 0.643 . . . . 0.0 111.071 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.6 -4.42 30.73 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.72 3.61 15.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.192 1.397 . . . . 0.0 111.073 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 46.6 m -107.13 -49.29 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 120.694 -1.254 . . . . 0.0 111.841 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -155.04 153.88 31.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.544 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -153.8 145.72 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.571 0.748 . . . . 0.0 109.446 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.86 138.52 41.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 18.17 4.12 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.0 t -150.6 141.44 14.72 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.29 1.836 . . . . 0.0 107.29 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -66.23 -15.99 50.25 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.901 3.067 . . . . 0.0 111.069 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 37.8 p -163.22 90.91 0.68 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.439 1.018 . . . . 0.0 111.758 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -154.29 168.59 26.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -131.95 -179.28 5.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.325 1.45 . . . . 0.0 110.235 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.63 171.76 13.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -116.36 155.27 48.64 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.681 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -68.72 104.1 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.701 2.267 . . . . 0.0 113.205 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 74.4 m 57.31 46.15 18.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.131 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 350' ' ' ARG . 4.6 tpm_? -138.03 87.99 2.28 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.102 -0.999 . . . . 0.0 112.439 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.0 p -144.08 166.95 23.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.72 163.32 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.009 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -86.78 160.83 18.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.726 0.694 . . . . 0.0 110.487 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.7 t -146.32 131.89 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.75 -175.85 37.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 49.39 29.14 2.67 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.423 1.089 . . . . 0.0 112.273 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.664 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -93.54 -175.73 3.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.668 -0.645 . . . . 0.0 110.175 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -59.13 154.03 16.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.155 0.582 . . . . 0.0 111.904 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.08 1.1 9.04 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.256 -0.746 . . . . 0.0 113.665 -172.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 13.3 ptp -158.18 30.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.466 2.133 . . . . 0.0 111.839 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.1 126.99 29.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.23 167.49 13.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.038 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.59 -25.54 61.37 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 121.469 -0.769 . . . . 0.0 112.167 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -82.99 -18.93 38.14 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 118.481 0.582 . . . . 0.0 111.994 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.88 -36.48 18.39 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.59 -46.59 89.2 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.23 68.08 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.613 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.97 84.52 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.916 0.78 . . . . 0.0 109.695 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 35.8 mt -71.12 -36.51 63.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 119.633 -0.222 . . . . 0.0 110.56 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.0 -0.9 55.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.79 -15.3 10.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 120.837 -1.165 . . . . 0.0 112.269 174.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.29 -26.83 13.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.852 0.751 . . . . 0.0 109.212 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 16.0 tp -80.87 -17.42 50.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 123.424 0.453 . . . . 0.0 110.428 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 403' ' ' SER . 29.0 p90 -166.74 -13.53 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 68.1 20.1 72.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -90.1 9.23 78.06 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 120.808 -1.407 . . . . 0.0 114.613 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.5 163.43 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.236 1.018 . . . . 0.0 113.516 -170.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.25 -33.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.232 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -159.46 147.55 17.48 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.43 149.04 29.5 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.457 0.646 . . . . 0.0 110.455 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.71 160.97 29.3 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.64 -0.662 . . . . 0.0 113.493 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.4 mm -96.37 144.28 10.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 124.383 0.696 . . . . 0.0 110.564 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -82.52 60.92 5.4 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 121.231 0.539 . . . . 0.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.412 ' HA ' ' HG2' ' A' ' 390' ' ' PRO . 2.9 p -61.15 154.53 22.96 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 124.068 1.89 . . . . 0.0 111.903 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.49 129.58 20.84 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.0 130.75 45.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.226 -170.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 8.4 m170 68.53 29.09 5.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.145 -2.298 . . . . 0.0 112.398 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.71 -0.53 13.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.2 t80 47.41 41.55 0.94 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.129 1.772 . . . . 0.0 113.645 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.541 ' C ' ' H ' ' A' ' 392' ' ' GLY . 36.1 Cg_endo -81.34 37.91 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.523 2.148 . . . . 0.0 109.025 -170.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.426 ' HB ' ' CH2' ' A' ' 331' ' ' TRP . 10.8 tp -69.83 25.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.984 0 C-N-CA 123.637 0.775 . . . . 0.0 111.448 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 390' ' ' PRO . . . -123.04 1.55 9.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 118.543 -1.143 . . . . 0.0 111.142 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.3 p -155.47 151.61 27.94 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.264 1.032 . . . . 0.0 110.794 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.81 -174.73 42.62 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.882 1.268 . . . . 0.0 113.958 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.07 166.8 20.93 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 121.324 -1.103 . . . . 0.0 111.227 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.18 144.12 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 23.1 m -103.76 119.15 38.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.6 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -106.39 156.3 18.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.656 0.782 . . . . 0.0 108.945 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -136.16 21.99 3.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -141.4 159.22 42.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -83.14 -47.24 11.83 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -21.86 62.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.409 ' HB3' ' CD1' ' A' ' 374' ' ' PHE . 34.2 p -72.51 -21.75 61.14 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.926 -1.109 . . . . 0.0 111.163 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.58 -62.73 1.48 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.28 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.455 ' H ' HD11 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -67.95 -17.08 64.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 119.317 0.962 . . . . 0.0 113.124 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.17 -29.34 28.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.586 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -18.25 58.0 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.31 -1.494 . . . . 0.0 110.411 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.14 -27.4 7.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.4 t -85.79 -9.56 56.87 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 0.0 111.299 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -112.22 -59.66 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.247 172.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.68 -16.33 0.03 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 127.921 2.488 . . . . 0.0 114.055 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -162.8 136.99 6.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.9 m -139.54 164.29 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -105.11 145.56 30.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.957 1.411 . . . . 0.0 110.824 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.9 mt -123.89 126.52 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.411 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 221' ' ' SER . 57.0 mmtt -137.65 114.37 10.5 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.704 1.253 . . . . 0.0 110.243 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 92.7 m -151.01 159.51 44.51 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -54.67 139.95 37.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.566 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? 59.32 13.43 3.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.12 1.368 . . . . 0.0 114.675 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.54 116.18 4.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.897 -1.127 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 17.2 p -145.84 112.43 5.91 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.681 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.2 tptm -166.64 -173.11 2.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.011 0.823 . . . . 0.0 110.022 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.681 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.5 mttp -125.66 172.18 9.99 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 123.604 0.762 . . . . 0.0 109.562 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -144.25 151.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.853 1.346 . . . . 0.0 109.881 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.0 158.57 36.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.235 -0.915 . . . . 0.0 110.274 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 23.8 mt -142.69 146.02 22.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -147.56 141.62 15.91 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.653 0.661 . . . . 0.0 110.669 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -82.76 174.62 9.43 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 124.243 3.295 . . . . 0.0 111.192 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.19 171.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.761 0.791 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 98.1 m -139.52 147.48 41.3 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 171.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.7 -25.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.1 m 50.39 119.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.426 2.29 . . . . 0.0 114.445 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.45 -3.92 0.05 OUTLIER Glycine 0 N--CA 1.469 0.84 0 O-C-N 120.394 -1.441 . . . . 0.0 115.598 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.06 -9.39 55.24 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.374 -1.663 . . . . 0.0 114.604 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.515 ' H ' ' CD2' ' A' ' 224' ' ' LEU . 3.8 mm? -16.5 88.05 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 128.954 2.902 . . . . 0.0 111.281 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.83 158.43 3.41 Favored 'Trans proline' 0 N--CA 1.449 -1.11 1 C-N-CA 127.581 5.521 . . . . 0.0 111.496 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 147.74 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.949 1.766 . . . . 0.0 110.484 172.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -139.83 18.33 2.49 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.867 0.73 . . . . 0.0 109.066 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -122.39 32.13 5.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.922 0.889 . . . . 0.0 112.647 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -64.33 162.26 15.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.196 1.398 . . . . 0.0 112.762 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -77.19 -19.37 56.84 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 58.74 73.35 0.72 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.96 -44.08 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.505 2.137 . . . . 0.0 115.419 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.9 mt -147.8 153.88 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.578 1.081 . . . . 0.0 108.274 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -112.53 150.9 30.65 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.6 t -150.06 17.75 0.86 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.387 0.994 . . . . 0.0 113.409 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' CYS . . . . . 0.476 ' HB3' ' CB ' ' A' ' 331' ' ' TRP . 0.9 OUTLIER -156.77 -175.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -61.54 171.25 1.55 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.469 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.25 150.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.456 -170.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -92.6 133.42 35.98 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.13 124.44 15.59 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.754 1.161 . . . . 0.0 110.564 -173.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 167.56 -172.5 42.46 Favored Glycine 0 N--CA 1.473 1.142 0 O-C-N 124.061 0.851 . . . . 0.0 112.635 172.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.47 7.12 3.2 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.273 0.94 . . . . 0.0 112.764 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 6.5 m -102.62 135.89 19.43 Favored Pre-proline 0 C--O 1.219 -0.51 0 C-N-CA 123.722 0.809 . . . . 0.0 111.203 -174.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -70.23 -5.08 15.65 Favored 'Trans proline' 0 N--CA 1.439 -1.722 1 C-N-CA 126.33 4.687 . . . . 0.0 115.574 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 323' ' ' CYS . 22.3 p-90 -142.13 -60.9 0.46 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 120.216 1.371 . . . . 0.0 113.803 -174.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.48 -60.13 0.13 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.133 1.373 . . . . 0.0 112.996 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . 0.5 0.0 OUTLIER 63.34 -41.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.832 1.958 . . . . 0.0 115.232 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 25.9 p -157.86 134.95 10.08 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 124.901 1.281 . . . . 0.0 109.078 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.1 pm0 -89.51 -22.85 22.23 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 119.632 -1.918 . . . . 0.0 111.745 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.03 64.42 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.165 0.915 . . . . 0.0 111.32 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.19 15.69 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 255' ' ' THR . 46.6 mt -70.74 -36.97 73.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.66 -37.68 80.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.582 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.424 ' HA ' ' CD ' ' A' ' 257' ' ' ARG . 62.9 m-20 -64.14 -21.96 66.75 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.243 1.383 . . . . 0.0 109.735 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 252' ' ' LEU . 84.2 m -79.16 -27.62 42.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.784 0.72 . . . . 0.0 110.669 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -131.28 23.19 4.81 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.447 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 16.6 ptm180 -86.96 33.92 0.67 Allowed 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.052 0.941 . . . . 0.0 113.391 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.54 2.26 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.14 -2.27 15.02 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 64.01 3.56 8.87 Favored Glycine 0 C--O 1.214 -1.144 0 CA-C-O 118.113 -1.381 . . . . 0.0 113.189 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.52 2.39 28.4 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.891 0.995 . . . . 0.0 113.001 -167.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 257' ' ' ARG . 6.1 mt -68.52 141.72 55.46 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 122.931 1.348 . . . . 0.0 114.551 -167.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.5 t -152.23 96.12 2.14 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 124.677 2.179 . . . . 0.0 106.976 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.06 144.31 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 O-C-N 119.423 -2.048 . . . . 0.0 109.41 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.52 135.27 42.24 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 120.758 -1.214 . . . . 0.0 111.396 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 8.9 p90 -150.88 143.83 16.66 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 121.497 0.665 . . . . 0.0 112.018 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -86.0 169.37 8.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.492 3.461 . . . . 0.0 111.633 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.41 -8.06 7.58 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 126.465 1.983 . . . . 0.0 114.756 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.82 55.22 1.79 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.471 1.136 . . . . 0.0 111.869 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.14 5.45 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.832 0.453 . . . . 0.0 111.487 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.28 149.37 9.04 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 121.124 -0.985 . . . . 0.0 112.416 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 67.89 159.72 0.16 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.627 1.571 . . . . 0.0 110.696 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 16.9 m170 34.14 76.71 0.4 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.762 1.625 . . . . 0.0 115.138 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.35 111.9 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.588 2.192 . . . . 0.0 112.056 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -157.29 169.32 25.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.584 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 12.8 t -121.62 143.02 37.04 Favored Pre-proline 0 CA--C 1.513 -0.456 0 C-N-CA 124.436 1.095 . . . . 0.0 109.853 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' PRO . . . . . 0.584 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 84.3 Cg_endo -70.7 151.07 63.44 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.626 2.884 . . . . 0.0 109.631 -174.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.58 -6.19 16.01 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.612 2.875 . . . . 0.0 111.714 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -78.08 1.42 21.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.862 -0.59 . . . . 0.0 111.909 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.27 48.25 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 8.6 p90 -152.47 157.0 40.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.287 1.543 . . . . 0.0 112.034 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.3 m -152.48 -154.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 127.491 2.316 . . . . 0.0 108.827 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -114.98 164.28 14.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.646 0.779 . . . . 0.0 112.078 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.5 138.36 14.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.865 -0.522 . . . . 0.0 111.364 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.89 125.31 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 168.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' A' ' 292' ' ' VAL . 0.1 OUTLIER -146.71 92.27 2.13 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.973 -173.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 286' ' ' PHE . 11.5 tp10 37.88 61.69 1.02 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -48.64 9.87 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 128.306 2.642 . . . . 0.0 117.683 -167.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.02 -72.53 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.992 1.724 . . . . 0.0 111.166 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -78.39 -34.44 48.18 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 22.8 t -73.62 -32.58 64.14 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.497 HG23 ' CE1' ' A' ' 286' ' ' PHE . 89.0 t -63.87 -52.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -61.33 -34.92 76.06 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.668 0.605 . . . . 0.0 112.237 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.1 m -74.29 -34.15 63.44 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.773 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -45.8 65.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.469 0.652 . . . . 0.0 110.169 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -13.54 57.96 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.105 -0.997 . . . . 0.0 113.441 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.24 -4.58 35.0 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.288 -0.883 . . . . 0.0 111.54 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -104.58 -15.05 15.43 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.679 1.237 . . . . 0.0 108.841 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 60.6 m -107.68 -142.61 0.38 Allowed 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.744 -0.597 . . . . 0.0 109.829 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.2 m -110.54 172.51 6.83 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 120.474 -1.391 . . . . 0.0 113.388 -171.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.407 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 85.3 t60 -149.87 165.19 33.32 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.69 -0.631 . . . . 0.0 110.992 -172.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 33.3 t0 -134.45 112.2 11.83 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.92 51.65 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 1 C-N-CA 127.384 5.389 . . . . 0.0 110.187 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.25 5.8 mp 63.64 42.2 6.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . 0.491 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 47.5 m -64.78 -34.38 10.45 Favored Pre-proline 0 CA--C 1.552 1.043 0 O-C-N 121.366 -0.834 . . . . 0.0 110.639 168.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 305' ' ' SER . 24.1 Cg_exo -70.16 0.6 5.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.101 2.534 . . . . 0.0 114.383 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.9 t70 57.1 16.8 3.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.222 -0.924 . . . . 0.0 111.066 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -102.8 -129.17 6.58 Favored Glycine 0 CA--C 1.525 0.675 0 O-C-N 121.795 -0.566 . . . . 0.0 112.495 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.6 pp -101.97 173.5 6.36 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.413 1.085 . . . . 0.0 111.718 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 29.9 m -66.52 132.69 48.78 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.218 0.607 . . . . 0.0 110.5 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.53 144.26 49.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 119.253 0.933 . . . . 0.0 110.882 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -110.74 152.66 26.32 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.254 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 37.1 m-85 -140.36 148.33 41.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.743 1.258 . . . . 0.0 113.061 -170.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -158.89 163.73 36.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -135.31 133.05 38.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.698 0.761 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.2 OUTLIER -134.98 13.66 3.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.659 -171.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.7 p -58.5 153.73 15.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.8 m -111.88 163.05 14.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.219 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -70.84 -9.77 58.24 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . 0.401 ' HG3' ' SD ' ' A' ' 321' ' ' MET . 17.1 ptp180 -82.36 -18.09 43.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.416 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.401 ' SD ' ' HG3' ' A' ' 320' ' ' ARG . 4.0 mpp? -135.93 -48.82 0.68 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 44.33 43.08 5.78 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' CYS . . . . . 0.475 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 71.1 m -93.23 -60.49 1.78 Allowed 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.326 -1.484 . . . . 0.0 113.842 -173.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -158.52 152.39 23.61 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 118.856 -1.138 . . . . 0.0 113.164 -170.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.51 173.42 4.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.842 2.057 . . . . 0.0 113.936 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 3.7 p -118.66 158.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.168 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 5.4 pp0? -115.69 163.28 16.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.198 0.908 . . . . 0.0 112.047 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.95 130.21 13.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.689 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 pt -136.68 88.59 19.08 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.16 0.584 . . . . 0.0 110.89 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -76.99 177.85 8.38 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.903 3.735 . . . . 0.0 116.604 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' TRP . . . . . 0.476 ' CB ' ' HB3' ' A' ' 236' ' ' CYS . 7.3 t-105 -82.24 140.89 33.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.915 0.886 . . . . 0.0 110.169 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.666 HG13 ' H ' ' A' ' 334' ' ' ALA . 9.5 t -115.0 151.66 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.558 1.171 . . . . 0.0 111.913 -176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.434 ' C ' HD21 ' A' ' 333' ' ' LEU . 6.6 tt -57.25 -36.96 71.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.269 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.666 ' H ' HG13 ' A' ' 332' ' ' VAL . . . -70.44 -5.64 29.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.261 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -105.24 -7.01 19.24 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.701 -0.624 . . . . 0.0 111.667 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.8 m -83.83 -37.91 21.9 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -154.57 165.52 36.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.071 0.548 . . . . 0.0 111.872 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -146.03 133.9 21.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.8 m -120.39 148.3 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -5.07 24.89 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.869 -0.519 . . . . 0.0 110.254 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.9 m -131.11 148.46 70.32 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.07 108.4 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.669 1.579 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 8.3 t 54.58 38.57 30.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.248 1.419 . . . . 0.0 113.492 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -75.2 160.25 30.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.379 0.609 . . . . 0.0 111.061 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -92.92 179.33 5.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.13 167.06 13.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 123.966 0.791 . . . . 0.0 109.675 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.06 102.55 15.86 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.02 -1.45 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 114.568 -171.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 81.5 p -130.42 8.8 5.06 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.679 -1.263 . . . . 0.0 114.133 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -144.48 102.37 3.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.082 0.944 . . . . 0.0 108.753 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -160.46 149.5 17.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.27 0.628 . . . . 0.0 110.229 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.02 154.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -81.07 136.68 35.98 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.151 0.907 . . . . 0.0 109.753 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 84.7 t -128.61 133.13 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.761 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -175.8 -165.9 32.44 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 121.638 0.576 . . . . 0.0 114.104 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.07 28.71 5.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.562 HD11 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.6 -160.27 0.71 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.635 1.174 . . . . 0.0 111.86 -175.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -36.22 -24.64 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.949 2.1 . . . . 0.0 115.31 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.63 78.31 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 119.351 0.978 . . . . 0.0 113.644 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 28.0 ptm -156.76 30.29 0.31 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 113.115 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.7 tp -76.84 156.24 32.37 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 121.284 0.564 . . . . 0.0 110.973 -171.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.73 170.28 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.509 1.123 . . . . 0.0 110.48 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.1 -25.62 61.82 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -74.68 -26.27 59.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.818 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.55 -32.59 36.66 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.23 -34.46 68.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.855 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.07 80.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.131 0.972 . . . . 0.0 111.187 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.53 -34.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.48 -6.19 44.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.118 -173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -16.6 14.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.546 1.521 . . . . 0.0 111.338 172.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -97.3 -28.69 13.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.722 0.692 . . . . 0.0 110.744 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.0 tp -83.02 -26.71 30.95 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.26 -59.02 1.6 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.261 -0.899 . . . . 0.0 113.005 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 163.5 -139.66 6.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -70.33 148.16 45.23 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 123.555 1.642 . . . . 0.0 113.881 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.07 152.93 8.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 127.736 2.414 . . . . 0.0 109.893 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.58 -30.64 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.228 -0.892 . . . . 0.0 112.183 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.8 OUTLIER -150.46 147.91 28.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.177 0.899 . . . . 0.0 112.116 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -142.96 139.01 30.5 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -135.17 151.81 20.61 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.67 0.594 . . . . 0.0 114.095 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.85 148.46 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -103.5 147.78 26.74 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 125.281 1.613 . . . . 0.0 108.016 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 47.5 p -140.81 163.06 33.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.5 -0.75 . . . . 0.0 112.118 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.66 34.13 4.7 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.706 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.32 28.02 0.41 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.616 1.566 . . . . 0.0 113.498 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -136.04 23.77 3.29 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp 62.75 -15.66 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.43 ' N ' ' HD2' ' A' ' 390' ' ' PRO . 22.2 p90 -78.73 -22.0 0.37 Allowed Pre-proline 0 CA--C 1.515 -0.371 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -170.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 389' ' ' TYR . 18.5 Cg_endo -61.71 -67.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.419 HD11 ' CZ3' ' A' ' 331' ' ' TRP . 10.9 tp 32.44 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.811 1.644 . . . . 0.0 110.885 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 177.24 27.97 0.04 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.69 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 70.5 m -143.16 146.84 34.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 167.11 -159.08 32.35 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.618 -1.101 . . . . 0.0 112.095 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -154.37 166.82 32.02 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 125.299 1.234 . . . . 0.0 109.594 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.42 126.35 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 42.1 p -95.59 118.67 32.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 69.8 m-85 -90.15 162.63 15.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.145 0.974 . . . . 0.0 111.049 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -122.93 -0.51 8.99 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -124.88 153.04 43.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.628 0.371 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -80.76 -30.57 36.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.443 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -39.1 64.86 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.282 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' SER . . . . . 0.597 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 21.5 m -65.95 -25.59 67.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.536 0.607 . . . . 0.0 111.276 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.67 -57.15 3.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.338 0.589 . . . . 0.0 111.417 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' LEU . . . . . 0.414 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -74.26 -20.76 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.496 -0.752 . . . . 0.0 111.792 -177.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -81.13 -26.66 35.95 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.912 1.233 . . . . 0.0 109.626 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -71.02 -43.39 68.02 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.89 -21.84 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.233 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.4 p -81.18 -26.33 36.08 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 118.352 -0.833 . . . . 0.0 112.83 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.38 -33.15 14.68 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.232 0.469 . . . . 0.0 111.757 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 51.16 -22.54 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -163.69 130.53 3.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.891 -1.755 . . . . 0.0 107.506 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.57 174.69 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.884 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -116.46 153.85 31.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.516 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 28.6 mt -127.35 123.48 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.421 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -125.44 140.59 52.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.307 1.004 . . . . 0.0 108.815 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 m -148.8 167.76 24.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.4 t -60.95 -18.83 59.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.557 ' HZ1' ' HB3' ' A' ' 419' ' ' LYS . 0.3 OUTLIER -151.0 15.94 0.75 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 176.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -139.42 128.88 24.29 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.634 -0.666 . . . . 0.0 110.622 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 52.5 p -146.86 124.18 11.59 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.063 -0.398 . . . . 0.0 110.148 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' LYS . . . . . 0.605 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 29.4 tptt -165.6 -161.33 0.51 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.631 0.582 . . . . 0.0 110.476 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . 0.605 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 92.8 mttt -141.45 168.48 19.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.39 139.21 29.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -122.3 160.76 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 60.2 mt -139.28 137.3 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.254 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -128.06 145.29 54.8 Favored Pre-proline 0 C--N 1.324 -0.543 0 O-C-N 123.911 0.757 . . . . 0.0 111.211 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 145.67 94.82 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.332 3.354 . . . . 0.0 111.644 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 79.0 t80 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.428 1.091 . . . . 0.0 112.967 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 93.7 m -152.86 146.4 25.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.46 -169.27 3.25 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.659 1.118 . . . . 0.0 111.529 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.1 p -130.11 19.93 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.959 1.703 . . . . 0.0 109.786 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.48 12.23 65.69 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.14 1.352 . . . . 0.0 116.386 -168.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -51.85 156.0 1.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 224' ' ' LEU . 4.1 mm? -100.48 139.46 20.65 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.346 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -44.21 109.63 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.512 3.475 . . . . 0.0 112.371 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.04 17.35 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.907 3.071 . . . . 0.0 111.138 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -133.63 19.51 3.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.539 0.336 . . . . 0.0 111.091 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -134.68 39.33 3.02 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 121.855 0.836 . . . . 0.0 110.845 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -76.13 161.7 28.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.165 0.986 . . . . 0.0 109.087 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -79.21 -10.18 59.75 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.419 ' HA ' HG11 ' A' ' 332' ' ' VAL . 73.2 m-20 42.7 62.34 8.38 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 333' ' ' LEU . 37.7 Cg_endo -63.33 -76.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.0 1.8 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.9 pt -141.17 -178.83 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 124.909 1.284 . . . . 0.0 110.061 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -111.72 153.43 26.48 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.9 p -146.22 -9.95 0.5 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 16.8 t -143.85 171.14 14.63 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.033 0.533 . . . . 0.0 109.576 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -53.66 174.13 0.05 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.824 1.649 . . . . 0.0 114.309 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.7 146.92 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.32 140.17 32.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.012 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.407 ' CD1' HG22 ' A' ' 328' ' ' VAL . 20.1 tp -141.47 143.2 33.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 111.123 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.5 156.55 28.57 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.537 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.95 14.28 1.47 Allowed Glycine 0 N--CA 1.475 1.235 0 O-C-N 122.005 -0.703 . . . . 0.0 112.616 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.96 72.98 18.04 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.342 -1.093 . . . . 0.0 110.905 -174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.8 7.72 2.27 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.532 2.154 . . . . 0.0 113.655 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 17.6 p-90 -141.42 -4.94 1.1 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.52 109.15 1.55 Allowed 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 124.69 1.196 . . . . 0.0 112.593 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -72.48 -30.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.351 -172.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.9 p -142.4 126.05 16.91 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 119.734 1.152 . . . . 0.0 112.977 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -71.0 -16.22 62.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.458 -172.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.12 -16.48 61.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 120.215 1.371 . . . . 0.0 108.472 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.33 99.23 Favored Glycine 0 N--CA 1.435 -1.424 0 O-C-N 120.88 -1.137 . . . . 0.0 112.704 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 48.6 mt -69.68 -31.84 70.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.504 1.122 . . . . 0.0 108.27 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.74 -36.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.608 -0.682 . . . . 0.0 110.179 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -80.29 -9.97 59.74 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.955 0.798 . . . . 0.0 111.179 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.0 m -96.49 -21.72 17.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -103.54 -24.32 13.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -74.3 -0.17 16.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.014 0.825 . . . . 0.0 111.81 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.23 -20.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.186 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -101.05 -7.09 23.56 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 156.23 -166.18 33.04 Favored Glycine 0 N--CA 1.432 -1.577 0 O-C-N 124.499 1.124 . . . . 0.0 114.684 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 58.5 m -51.02 124.11 10.69 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.456 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 152.95 42.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.497 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -146.99 168.84 20.52 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.598 1.559 . . . . 0.0 108.711 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.6 152.2 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 121.489 -0.757 . . . . 0.0 112.26 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.21 135.86 32.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 124.497 1.123 . . . . 0.0 110.792 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.487 ' CE2' ' HG2' ' A' ' 269' ' ' LYS . 20.0 p90 -148.11 154.07 42.33 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.93 136.33 24.85 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.162 1.908 . . . . 0.0 107.365 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.2 32.97 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.487 ' HG2' ' CE2' ' A' ' 266' ' ' TRP . 35.8 mtmt -64.28 -6.43 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.449 1.124 . . . . 0.0 111.387 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.67 5.43 43.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.919 1.288 . . . . 0.0 110.696 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -69.68 -160.75 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.435 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -77.43 -17.62 57.94 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 276' ' ' CYS . 3.7 p80 -166.04 154.43 9.96 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.81 -1.39 11.1 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.397 2.732 . . . . 0.0 114.124 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -90.77 31.11 1.09 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 110.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 17.2 t -125.61 40.16 0.52 Allowed Pre-proline 0 C--N 1.34 0.159 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 89.3 Cg_endo -75.07 170.37 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 107.117 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.96 161.56 6.28 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.07 1.846 . . . . 0.0 115.269 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -54.25 -14.82 1.27 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.501 1.12 . . . . 0.0 112.432 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -179.84 16.38 0.03 OUTLIER Glycine 0 CA--C 1.533 1.156 0 CA-C-N 120.488 1.494 . . . . 0.0 112.873 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -130.15 155.85 45.54 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.272 1.536 . . . . 0.0 112.732 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.14 158.43 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 124.176 0.99 . . . . 0.0 109.819 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -118.45 150.06 40.21 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.18 140.62 52.35 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.1 129.79 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -168.03 -167.21 0.8 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -44.6 122.54 3.17 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 124.499 1.124 . . . . 0.0 109.189 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.16 -18.39 35.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.105 2.562 . . . . 0.0 115.852 -166.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -140.32 -54.1 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 120.082 1.31 . . . . 0.0 113.675 -167.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -73.96 -45.34 50.78 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.102 -0.374 . . . . 0.0 110.909 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 71.1 m -70.13 -26.78 64.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.75 -53.58 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -67.6 -26.76 66.42 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.991 -0.443 . . . . 0.0 111.904 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.6 t -67.94 -46.25 72.01 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.207 0.317 . . . . 0.0 110.44 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 291' ' ' SER . 5.4 mt -63.8 -42.25 97.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.03 0.377 . . . . 0.0 110.513 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.66 -25.94 61.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.424 0.69 . . . . 0.0 110.042 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -104.99 2.32 29.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.142 0.902 . . . . 0.0 110.077 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.1 -10.8 14.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.594 0.634 . . . . 0.0 110.03 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 16.6 p -107.25 -148.32 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.196 0.31 . . . . 0.0 110.743 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 67.0 m -106.78 145.27 32.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.236 0.541 . . . . 0.0 110.627 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -142.89 155.06 44.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.122 0.969 . . . . 0.0 108.849 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -145.92 137.58 13.07 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 304' ' ' LEU . 96.8 Cg_endo -71.72 -103.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 122.376 2.05 . . . . 0.0 109.338 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 303' ' ' PRO . 9.8 mp . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.374 1.07 . . . . 0.0 109.855 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 N--CA 1.465 0.292 0 N-CA-C 111.349 0.129 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 4.1 m -79.17 148.2 32.38 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.5 151.47 31.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.4 153.77 32.49 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 124.33 1.019 . . . . 0.0 109.978 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -147.62 152.66 38.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.915 -1.116 . . . . 0.0 110.017 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 5.4 t80 -153.28 178.05 10.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 30.0 ttmt -152.47 124.95 8.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -169.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 12.67 6.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.868 0.867 . . . . 0.0 110.046 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.6 p -87.48 159.74 18.54 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.416 1.086 . . . . 0.0 111.511 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.3 m -149.27 38.0 0.78 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.768 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 52.51 33.53 13.55 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 121.238 0.542 . . . . 0.0 111.725 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -80.5 -30.65 37.29 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.75 -41.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.093 0.86 . . . . 0.0 111.176 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -147.5 166.65 26.64 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.749 1.219 . . . . 0.0 109.632 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 90.7 m -140.54 123.44 16.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.927 1.346 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -159.0 152.56 22.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -89.88 156.5 18.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 110.679 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.38 152.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.244 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -117.83 131.69 56.53 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.764 0.711 . . . . 0.0 111.77 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 240' ' ' LEU . 2.6 t -115.15 143.35 25.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.302 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.99 98.08 4.45 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 124.19 0.931 . . . . 0.0 109.904 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -83.98 162.14 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.904 4.403 . . . . 0.0 111.99 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.614 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 1.8 t90 -88.34 123.65 33.13 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.777 0.799 . . . . 0.0 109.293 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 231' ' ' ASN . 17.2 t -103.75 154.68 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.056 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 333' ' ' LEU . 7.9 tt -54.26 -26.45 29.07 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.587 -0.696 . . . . 0.0 112.173 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.09 16.95 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.558 -0.714 . . . . 0.0 112.264 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.07 -5.3 18.15 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.782 0.833 . . . . 0.0 108.894 173.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 66.8 m -100.6 -34.82 9.73 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.016 -1.677 . . . . 0.0 113.906 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -167.18 171.93 10.41 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 124.196 0.935 . . . . 0.0 113.418 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -156.51 155.07 31.35 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.081 1.352 . . . . 0.0 108.294 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.67 148.17 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.481 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -88.83 -16.45 32.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 35.8 t -151.34 113.75 3.05 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.69 -15.03 30.36 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.598 2.865 . . . . 0.0 112.02 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.2 t -86.21 4.65 37.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.428 1.091 . . . . 0.0 112.402 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -114.37 -175.11 2.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.454 1.501 . . . . 0.0 110.936 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -141.7 -179.81 6.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 122.198 0.199 . . . . 0.0 110.892 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -83.5 120.41 25.89 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 10.3 m-20 -81.1 150.69 68.89 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 124.752 1.283 . . . . 0.0 111.121 -171.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 77.5 Cg_exo -54.63 108.69 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.648 3.565 . . . . 0.0 109.885 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 86.2 p 52.79 23.51 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.52 73.98 0.99 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 119.453 1.024 . . . . 0.0 108.786 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 t -155.75 144.14 20.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.38 159.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 118.294 0.497 . . . . 0.0 110.238 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -83.53 146.92 28.08 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.382 1.051 . . . . 0.0 113.561 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 67.5 t -131.07 136.09 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.962 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.48 -176.96 31.13 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 51.0 22.94 1.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.575 1.55 . . . . 0.0 113.365 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.986 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.65 171.94 14.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.686 0.794 . . . . 0.0 111.171 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -48.7 150.19 1.5 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.546 1.138 . . . . 0.0 109.28 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -66.39 10.6 0.64 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.945 1.259 . . . . 0.0 113.135 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.0 mmt -145.43 -53.21 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.191 0.596 . . . . 0.0 109.805 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 41.73 60.01 2.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.718 0.77 . . . . 0.0 109.639 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -72.43 173.92 8.11 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 121.986 -0.447 . . . . 0.0 111.835 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -57.12 -18.01 13.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -80.55 -35.51 34.29 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.547 -0.721 . . . . 0.0 110.807 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.64 -27.22 27.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 366' ' ' LEU . 2.3 tt -78.68 -31.22 46.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.38 -28.59 56.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.91 -0.494 . . . . 0.0 111.993 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.9 -42.04 61.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 77.5 mt -79.09 -35.48 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 118.808 0.731 . . . . 0.0 109.067 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.31 -22.96 38.16 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.621 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.88 -23.61 21.59 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 120.561 1.528 . . . . 0.0 109.91 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.07 -36.48 58.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.527 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.452 HD11 HG11 ' A' ' 413' ' ' VAL . 2.9 mp -66.86 -34.44 77.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.313 -177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 403' ' ' SER . 0.2 OUTLIER -158.67 -17.38 0.07 Allowed 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.21 -7.6 5.84 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 121.979 0.766 . . . . 0.0 113.679 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -94.05 78.94 0.98 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 122.045 -0.679 . . . . 0.0 113.135 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.42 159.44 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 118.654 1.227 . . . . 0.0 112.378 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.01 -33.06 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -158.28 147.04 18.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.81 146.35 23.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.51 38.16 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 123.058 1.366 . . . . 0.0 114.304 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.56 141.4 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 122.188 0.994 . . . . 0.0 109.2 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.41 148.73 26.44 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.557 -171.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.4 p -131.39 159.6 37.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.87 -175.28 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.72 88.14 2.23 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 119.728 -1.858 . . . . 0.0 112.658 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 57.9 m170 70.49 38.58 1.32 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.18 -5.02 15.44 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.889 0.876 . . . . 0.0 110.384 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.1 p90 37.87 54.52 3.85 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 127.097 2.159 . . . . 0.0 114.364 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.18 -48.45 1.76 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.774 2.316 . . . . 0.0 111.169 -174.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.75 37.73 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 111.633 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.88 10.65 0.79 Allowed Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.5 p -155.17 126.66 7.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.265 0.555 . . . . 0.0 110.093 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -156.42 -164.94 13.95 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.468 1.038 . . . . 0.0 114.91 -171.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -151.76 162.6 40.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.551 -0.824 . . . . 0.0 108.899 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.13 134.15 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.153 -0.967 . . . . 0.0 108.881 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 346' ' ' LEU . 60.7 m -111.28 142.93 42.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.304 1.05 . . . . 0.0 109.549 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 73.8 m-85 -131.44 162.35 30.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.431 -0.793 . . . . 0.0 110.619 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.85 20.83 10.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.504 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -140.12 155.65 46.9 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.157 0.983 . . . . 0.0 109.183 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.08 -24.61 28.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.67 0.668 . . . . 0.0 110.196 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.649 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 3.8 mpt_? -52.89 -31.31 39.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.556 -0.715 . . . . 0.0 111.576 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.501 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 14.3 m -80.46 -29.21 37.48 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.577 0.751 . . . . 0.0 110.864 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.42 -54.37 10.91 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.942 0.337 . . . . 0.0 111.866 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.64 -17.86 55.36 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.005 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -86.41 -31.63 21.33 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 120.45 1.477 . . . . 0.0 112.665 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -72.6 -33.32 66.63 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 120.875 -1.141 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.7 -30.7 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 14.0 t -78.41 -32.21 48.62 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.379 1.049 . . . . 0.0 110.498 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.47 -44.55 35.04 Favored 'General case' 0 C--O 1.227 -0.095 0 O-C-N 121.735 -0.603 . . . . 0.0 110.914 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.17 -17.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.124 2.569 . . . . 0.0 116.331 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 423' ' ' LYS . 0.1 OUTLIER -164.95 136.87 4.31 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.106 -1.621 . . . . 0.0 108.664 178.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.452 HG11 HD11 ' A' ' 373' ' ' LEU . 34.0 m -135.58 154.5 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.698 0.681 . . . . 0.0 110.728 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -112.8 141.48 46.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.559 0.743 . . . . 0.0 111.438 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.0 mt -100.54 122.72 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.44 52.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 418' ' ' THR . 0.3 OUTLIER -72.53 178.51 4.02 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.55 ' H ' HG22 ' A' ' 417' ' ' THR . 10.8 m -75.46 -27.36 58.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -144.32 16.32 1.68 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.963 0.887 . . . . 0.0 110.479 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.59 113.17 4.1 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.7 p -136.27 131.86 35.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.918 0.487 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -148.91 177.74 9.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 412' ' ' PHE . 32.3 mtmm -144.45 160.93 40.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.06 133.56 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -106.98 157.44 17.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.34 0.59 . . . . 0.0 111.413 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 24.8 mt -140.87 149.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.42 149.95 56.27 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 124.196 0.935 . . . . 0.0 109.387 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.5 161.61 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.413 3.409 . . . . 0.0 109.941 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 116.797 -1.573 . . . . 0.0 111.226 178.441 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.6 m -155.03 158.94 39.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.383 1.073 . . . . 0.0 111.009 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.76 -16.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.062 -0.971 . . . . 0.0 113.472 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.1 m 43.61 52.27 6.22 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.433 1.015 . . . . 0.0 112.383 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 224' ' ' LEU . . . -71.27 -22.32 78.54 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.555 -173.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 59.67 27.33 16.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.727 0.811 . . . . 0.0 113.078 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.414 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.1 mm? -81.45 -22.55 0.34 Allowed Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 57.2 Cg_endo -67.76 121.43 8.48 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 CA-C-N 123.529 2.296 . . . . 0.0 111.619 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.14 166.98 4.57 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 125.232 3.955 . . . . 0.0 111.875 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -143.05 6.07 1.53 Allowed 'General case' 0 C--O 1.219 -0.541 0 O-C-N 122.003 -0.435 . . . . 0.0 112.128 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -115.88 30.15 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.976 1.71 . . . . 0.0 108.016 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -60.13 159.33 9.78 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -66.93 7.75 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -170.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 36.8 71.17 0.98 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.191 0.996 . . . . 0.0 112.183 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.31 -89.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.538 1 C-N-CA 126.072 4.515 . . . . 0.0 114.748 -173.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 234' ' ' TYR . 11.6 mm -127.37 178.15 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.326 1.45 . . . . 0.0 107.465 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 233' ' ' ILE . 14.8 m-85 -118.39 157.45 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.369 -0.825 . . . . 0.0 110.108 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 77.9 p -155.39 13.24 0.36 Allowed 'General case' 0 C--N 1.341 0.208 0 CA-C-N 121.242 1.837 . . . . 0.0 115.741 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 9.1 t -151.96 -177.37 6.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.115 1.325 . . . . 0.0 108.67 172.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.89 -172.77 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.541 1.162 . . . . 0.0 113.327 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.74 144.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.185 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.48 150.86 22.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.483 0.658 . . . . 0.0 111.954 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.466 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.4 tm? -140.52 126.08 19.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.674 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.42 38.15 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.205 -0.934 . . . . 0.0 112.911 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.47 3.23 2.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -99.69 134.93 20.72 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.475 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.89 -3.19 12.64 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.332 2.688 . . . . 0.0 110.97 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -128.07 -177.11 4.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.88 1.324 . . . . 0.0 111.151 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -166.47 149.42 6.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.427 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -174.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 168.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 250' ' ' ALA . 18.8 m -42.15 129.35 3.7 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.178 -0.951 . . . . 0.0 110.527 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.2 -25.03 65.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 121.694 -0.629 . . . . 0.0 112.242 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.4 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.78 -22.93 64.25 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.397 0.999 . . . . 0.0 112.263 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.95 -30.47 67.89 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.582 1.657 . . . . 0.0 110.601 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.59 -36.17 60.4 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.731 -1.453 . . . . 0.0 108.829 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 262' ' ' LEU . 92.7 t -67.48 -36.21 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 123.172 0.589 . . . . 0.0 110.066 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.4 -18.74 61.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.488 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 87.0 m -73.1 -33.63 65.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 118.722 0.692 . . . . 0.0 110.067 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -140.43 80.09 1.74 Allowed 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.704 ' HA ' HD11 ' A' ' 262' ' ' LEU . 12.9 ptm180 -133.59 1.35 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.257 0.623 . . . . 0.0 111.493 171.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.31 -1.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.136 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -100.43 -15.44 17.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.409 0.55 . . . . 0.0 110.416 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 262' ' ' LEU . . . 158.37 170.94 23.63 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.0 t -64.08 131.18 46.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.704 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -152.1 165.35 35.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.709 0.766 . . . . 0.0 110.957 169.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -141.01 171.65 13.77 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.602 0.715 . . . . 0.0 110.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.84 147.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.564 0.746 . . . . 0.0 110.996 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -139.58 134.09 31.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.025 0.828 . . . . 0.0 109.936 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -155.23 151.0 21.79 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.011 1.324 . . . . 0.0 110.227 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.66 154.42 34.81 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.415 3.41 . . . . 0.0 111.126 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.49 11.22 75.37 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.181 -0.95 . . . . 0.0 112.783 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -79.44 9.26 4.99 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -118.56 148.2 42.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.202 1.401 . . . . 0.0 110.047 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.77 43.97 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.66 -0.65 . . . . 0.0 112.532 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -72.46 155.77 39.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 121.462 -1.022 . . . . 0.0 111.014 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 26.8 m170 46.37 61.04 13.67 Favored Pre-proline 0 N--CA 1.447 -0.613 0 O-C-N 124.537 1.148 . . . . 0.0 111.647 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.05 -20.05 57.26 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.599 2.199 . . . . 0.0 108.945 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 275' ' ' ARG . 5.7 ppt_? -80.18 10.23 4.68 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.408 1.083 . . . . 0.0 113.615 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 44.4 t -133.84 110.41 12.11 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 120.591 -1.318 . . . . 0.0 111.592 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.62 157.95 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.548 2.165 . . . . 0.0 109.785 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.55 -11.81 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -143.15 -178.15 5.7 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 127.67 2.388 . . . . 0.0 110.286 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.88 4.02 59.02 Favored Glycine 0 CA--C 1.547 2.038 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.1 116.51 32.64 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.928 -1.51 . . . . 0.0 111.879 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.4 m -145.01 163.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.795 1.31 . . . . 0.0 108.59 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -87.85 157.22 19.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 284' ' ' LEU . 18.5 mt -128.08 140.87 51.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.77 156.19 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.761 0.824 . . . . 0.0 109.94 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.575 ' CZ ' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -171.22 176.27 3.99 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -60.36 88.29 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.9 pt? -56.56 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 129.411 3.084 . . . . 0.0 117.075 -167.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -131.67 -41.73 1.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.998 1.272 . . . . 0.0 111.372 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -95.18 -32.91 12.83 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.646 -0.659 . . . . 0.0 111.437 -173.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.8 t -83.51 -17.8 40.64 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 1.8 t -82.41 -33.58 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 O-C-N 121.216 -0.927 . . . . 0.0 109.976 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -62.96 -47.44 83.17 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 123.97 0.794 . . . . 0.0 110.329 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 77.6 p -76.79 -31.52 57.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.23 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.32 -40.64 58.22 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.38 -16.8 60.34 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.122 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.08 1.64 31.14 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.007 1.442 . . . . 0.0 111.846 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -113.42 -25.08 8.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.148 0.885 . . . . 0.0 110.956 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 300' ' ' SER . 98.4 m -79.1 -157.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 299' ' ' CYS . 16.5 m -116.67 161.27 19.47 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.346 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -141.68 151.4 42.97 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -140.85 118.8 8.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.49 33.04 0.44 Allowed 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 124.563 3.509 . . . . 0.0 109.931 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.828 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.342 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 309' ' ' LEU . 1.5 pp . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.393 0.616 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 16.2 m -143.01 157.08 44.88 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.544 -1.347 . . . . 0.0 112.16 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.7 149.7 51.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.185 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.19 148.68 23.34 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.768 1.227 . . . . 0.0 112.076 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -149.03 156.57 42.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.864 -0.522 . . . . 0.0 110.418 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -158.47 161.16 37.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 11.6 ptpt -120.23 135.54 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 9.17 4.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.7 t -105.96 145.67 31.02 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.4 p -147.85 -32.62 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -138.47 -0.93 1.93 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -105.09 -30.54 9.67 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.574 -0.704 . . . . 0.0 110.716 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.7 mmt -135.03 -163.1 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.643 1.577 . . . . 0.0 106.744 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -69.89 -95.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.674 0.75 . . . . 0.0 109.775 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 98.7 m -156.33 29.8 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.678 0.791 . . . . 0.0 110.768 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.96 121.31 17.12 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 119.942 1.246 . . . . 0.0 113.231 -169.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 0.1 OUTLIER -77.22 164.01 26.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.115 0.566 . . . . 0.0 111.722 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.34 164.03 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.458 0.703 . . . . 0.0 109.522 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -109.94 153.36 24.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.669 0.668 . . . . 0.0 110.55 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.36 149.09 18.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-O 122.493 1.14 . . . . 0.0 111.358 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 119.06 3.65 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.848 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -99.11 172.59 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 124.429 3.42 . . . . 0.0 113.828 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.56 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 7.9 t-105 -85.46 124.67 32.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.837 0.855 . . . . 0.0 110.596 170.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.63 151.78 3.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-O 121.021 0.438 . . . . 0.0 110.118 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 333' ' ' LEU . 7.4 tt -61.04 -27.04 68.05 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.635 0.774 . . . . 0.0 110.156 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.2 -6.52 35.07 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 111.474 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.61 7.9 35.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.819 0.848 . . . . 0.0 109.101 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 62.6 m -111.44 -33.12 6.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.909 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.26 158.29 38.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.233 0.924 . . . . 0.0 111.827 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -154.36 140.51 18.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.491 169.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.38 148.37 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.911 0.884 . . . . 0.0 113.121 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -111.63 -7.81 14.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.003 1.383 . . . . 0.0 108.807 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 31.1 t -123.82 132.63 24.3 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.49 -1.45 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.975 2.45 . . . . 0.0 112.072 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 43.2 t -87.3 -14.69 40.15 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.734 1.152 . . . . 0.0 114.035 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 52.02 48.95 21.71 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' A' ' 346' ' ' LEU . 40.1 ttt180 -98.25 -178.17 3.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.214 1.405 . . . . 0.0 111.379 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.493 ' H ' ' HG2' ' A' ' 345' ' ' ARG . 11.8 tp -149.16 163.84 36.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -119.23 164.67 20.15 Favored Pre-proline 0 C--N 1.351 0.666 0 CA-C-N 118.435 0.561 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.86 63.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 126.964 5.109 . . . . 0.0 115.362 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 18.8 m 59.21 21.25 9.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.32 58.09 4.32 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.545 1.164 . . . . 0.0 109.324 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.5 t -117.47 166.7 12.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.57 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.3 m -133.67 150.38 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 123.995 0.809 . . . . 0.0 110.507 171.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -78.3 142.54 37.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 124.254 0.971 . . . . 0.0 110.041 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.29 142.44 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.01 29.11 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 124.004 0.815 . . . . 0.0 112.704 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 61.18 -2.41 0.22 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 357' ' ' LEU . 2.3 pt? -69.46 159.15 33.81 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.205 0.602 . . . . 0.0 111.567 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -92.75 173.92 7.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.711 -0.618 . . . . 0.0 111.432 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -64.24 8.69 0.42 Allowed Glycine 0 CA--C 1.532 1.144 0 N-CA-C 118.232 2.053 . . . . 0.0 118.232 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 38.4 mtt -142.65 6.02 1.62 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.976 1.888 . . . . 0.0 111.319 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.7 68.13 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 124.008 1.861 . . . . 0.0 109.586 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -62.19 176.4 0.6 Allowed 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.417 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.23 62.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.04 -26.4 36.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -85.22 -32.83 22.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.232 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.89 -31.72 64.87 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.271 0.487 . . . . 0.0 110.817 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.36 42.69 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.064 1.302 . . . . 0.0 110.597 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.76 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 123.89 0.744 . . . . 0.0 110.263 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.41 -44.46 80.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 O-C-N 124.174 0.921 . . . . 0.0 109.571 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.39 -17.42 34.47 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 112.722 -168.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.03 -23.89 18.51 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.167 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -93.41 -23.73 18.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.43 0.559 . . . . 0.0 112.446 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.8 -11.51 16.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -115.12 -36.18 4.48 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 141.28 -45.76 0.94 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.899 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.95 150.92 10.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.521 -1.8 . . . . 0.0 111.187 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.53 170.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.326 1.851 . . . . 0.0 107.001 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.81 -29.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 118.101 0.41 . . . . 0.0 110.613 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.441 ' CD1' ' CD1' ' A' ' 346' ' ' LEU . 4.0 t80 -165.61 157.13 14.31 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.803 0.811 . . . . 0.0 111.464 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.55 150.61 35.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.954 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.89 29.94 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 121.248 -0.907 . . . . 0.0 113.071 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 20.7 mm -118.93 141.41 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.153 1.381 . . . . 0.0 107.349 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -90.81 139.97 30.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.4 p -132.78 168.44 18.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.197 0.999 . . . . 0.0 109.561 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -137.81 158.37 44.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.082 2.153 . . . . 0.0 105.528 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -58.66 112.81 1.75 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 18.7 m170 62.99 26.06 15.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.588 -1.32 . . . . 0.0 114.113 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -94.33 -24.48 17.39 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.9 t80 41.35 59.41 8.82 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 125.398 1.479 . . . . 0.0 111.237 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.21 -35.16 3.16 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.595 1.53 . . . . 0.0 110.992 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.56 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 6.5 tp 31.7 48.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 125.166 1.387 . . . . 0.0 110.839 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.14 12.89 0.45 Allowed Glycine 0 C--N 1.349 1.259 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.037 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.0 m -147.86 154.53 40.54 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 118.685 1.242 . . . . 0.0 110.318 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.41 -168.3 40.85 Favored Glycine 0 C--O 1.247 0.951 0 CA-C-N 119.531 1.06 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -152.22 161.23 42.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.02 145.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 123.13 0.269 . . . . 0.0 110.332 -173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.8 p -123.11 142.18 51.16 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.792 0.806 . . . . 0.0 110.563 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.44 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 26.0 m-85 -118.41 -24.81 6.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.153 -169.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.55 17.52 3.08 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.47 156.0 38.6 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.776 -0.577 . . . . 0.0 110.753 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -89.72 -18.33 26.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -55.77 -42.11 75.03 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.478 -1.389 . . . . 0.0 109.675 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.44 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 57.2 m -82.55 -13.37 56.71 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.455 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.36 -50.1 15.12 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 119.195 0.907 . . . . 0.0 110.93 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.47 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.59 -29.43 51.99 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.386 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 405' ' ' LEU . 23.6 ttmm -70.39 -28.88 65.43 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.898 0.856 . . . . 0.0 111.296 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.23 19.74 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.276 -0.89 . . . . 0.0 113.291 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.56 -27.29 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.887 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 73.3 p -82.35 -26.28 33.1 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.22 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -81.58 -40.67 22.71 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.29 -12.54 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.71 143.64 3.31 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 123.815 0.846 . . . . 0.0 109.239 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.21 162.44 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 O-C-N 123.688 0.618 . . . . 0.0 110.828 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -106.77 143.72 34.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 123.986 0.803 . . . . 0.0 111.888 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.8 mt -125.7 119.04 53.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -143.59 130.71 20.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.9 p -136.55 -161.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.5 m -88.84 -2.37 58.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.997 0.519 . . . . 0.0 111.98 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -145.57 -4.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 422' ' ' LYS . 51.2 t80 -138.39 141.07 39.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.341 -1.474 . . . . 0.0 111.1 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 45.4 m -147.2 102.01 3.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.198 0.999 . . . . 0.0 110.904 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 420' ' ' PHE . 0.6 OUTLIER -153.26 173.77 15.14 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.575 0.625 . . . . 0.0 110.502 178.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -131.43 163.15 28.57 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.39 133.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -100.5 149.91 23.21 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 72.0 mt -133.68 138.2 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.088 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -135.3 150.33 72.3 Favored Pre-proline 0 CA--C 1.53 0.18 0 O-C-N 123.977 0.798 . . . . 0.0 111.333 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.45 150.92 75.97 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.615 1.543 . . . . 0.0 111.344 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 124.852 1.261 . . . . 0.0 112.077 -177.39 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.1 m 60.03 159.68 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.879 2.072 . . . . 0.0 111.957 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.473 ' CZ3' ' CA ' ' A' ' 222' ' ' GLY . 87.8 t90 -161.51 158.6 26.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.931 0.493 . . . . 0.0 109.741 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 70.7 p -143.18 104.62 4.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.288 0.566 . . . . 0.0 110.735 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.473 ' CA ' ' CZ3' ' A' ' 220' ' ' TRP . . . -73.08 111.8 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.26 -17.38 13.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.027 -1.087 . . . . 0.0 110.165 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -130.14 14.09 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 118.202 2.668 . . . . 0.0 118.202 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 72.6 Cg_exo -49.88 124.05 11.83 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 CA-C-N 120.989 1.389 . . . . 0.0 112.995 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.75 140.96 55.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.879 3.052 . . . . 0.0 110.992 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -142.78 -1.81 1.09 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -130.41 59.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.548 0.689 . . . . 0.0 112.829 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.32 163.75 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.445 1.098 . . . . 0.0 110.391 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -157.46 146.16 19.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -131.23 153.94 81.83 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -85.88 28.04 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.892 2.395 . . . . 0.0 113.397 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 74.6 mt -137.45 154.75 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 121.953 -0.467 . . . . 0.0 110.596 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.45 170.77 11.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.806 1.643 . . . . 0.0 108.484 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 54.0 p -152.52 -155.44 0.61 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 122.81 0.444 . . . . 0.0 110.375 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 94.3 m -54.33 137.59 41.34 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.488 1.515 . . . . 0.0 114.416 -168.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 56.26 143.85 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.18 149.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -107.73 156.33 19.21 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 117.885 0.312 . . . . 0.0 111.468 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.29 134.26 16.9 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 125.041 1.463 . . . . 0.0 107.261 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.82 155.92 23.89 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 120.658 -1.277 . . . . 0.0 112.391 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.97 7.35 1.57 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.729 -1.039 . . . . 0.0 112.99 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.96 70.47 10.14 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.697 1.599 . . . . 0.0 109.998 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.92 9.78 1.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 1 C-N-CA 125.726 4.284 . . . . 0.0 112.267 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.42 ' CE3' ' CE ' ' A' ' 321' ' ' MET . 12.5 p-90 -136.15 -8.94 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.94 116.98 8.38 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -174.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.533 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.59 -30.45 34.01 Favored 'Isoleucine or valine' 0 C--O 1.274 2.35 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.4 m -146.85 127.1 13.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.861 -1.15 . . . . 0.0 112.197 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -56.82 -27.04 59.38 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 125.677 1.861 . . . . 0.0 113.202 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.4 -16.49 47.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.34 -57.07 3.04 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-O 121.65 0.583 . . . . 0.0 111.657 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 252' ' ' LEU . 6.8 tt -66.14 -48.99 68.99 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.46 -33.12 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.335 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -77.99 -8.75 58.56 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.369 0.531 . . . . 0.0 111.685 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.5 m -83.24 -22.96 32.93 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.309 -1.494 . . . . 0.0 112.329 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -141.56 29.85 1.74 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.391 1.451 . . . . 0.0 114.315 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -90.94 13.06 17.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.532 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.53 27.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -168.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.03 -1.32 8.3 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.002 -0.436 . . . . 0.0 111.156 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.34 1.28 88.22 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.006 -0.886 . . . . 0.0 113.869 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.8 m -126.55 30.08 5.61 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.2 OUTLIER -100.53 146.0 27.62 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -148.79 160.89 42.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 122.174 0.988 . . . . 0.0 109.551 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.8 148.07 22.18 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.76 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.32 149.77 44.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.547 0.612 . . . . 0.0 110.645 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -117.4 143.77 32.69 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.657 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.76 -25.69 7.56 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.826 2.351 . . . . 0.0 110.232 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 174.13 17.2 0.02 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-N 119.944 1.247 . . . . 0.0 114.858 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -112.96 22.03 14.83 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.968 1.884 . . . . 0.0 112.246 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.76 149.78 43.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.544 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -118.07 173.75 14.97 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-O 121.179 0.321 . . . . 0.0 112.32 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -92.06 5.78 48.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 23.8 m170 -98.26 164.09 17.92 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.852 1.661 . . . . 0.0 111.346 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 273' ' ' HIS . 71.7 Cg_endo -69.69 5.06 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.757 2.972 . . . . 0.0 110.707 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 248' ' ' THR . 7.3 ptm180 -140.57 147.54 39.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.871 1.269 . . . . 0.0 110.71 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.93 146.2 15.11 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -93.34 149.84 2.44 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 124.399 3.399 . . . . 0.0 110.447 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.81 163.79 28.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.32 2.68 . . . . 0.0 107.215 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -96.77 23.78 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.65 82.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -165.15 129.4 2.42 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.793 -0.828 . . . . 0.0 109.842 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 160.28 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.498 1.749 . . . . 0.0 108.719 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -92.25 159.18 15.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 43.3 mt -122.94 143.47 49.88 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 123.371 0.669 . . . . 0.0 109.834 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.53 132.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 30.0 p90 -171.05 -163.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.72 1.263 . . . . 0.0 108.16 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.9 107.81 0.2 Allowed 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 288' ' ' LEU . 0.8 OUTLIER -91.04 19.18 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -167.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.62 -72.23 0.64 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.052 -1.03 . . . . 0.0 109.918 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -25.68 29.96 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.26 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 48.9 m -83.83 -23.2 31.47 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.63 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -45.32 39.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.026 -1.046 . . . . 0.0 109.34 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -73.71 -17.2 61.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.896 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.8 t -75.3 -46.08 35.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.08 1.309 . . . . 0.0 108.572 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -61.07 -47.61 85.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.94 -24.61 67.57 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.158 -0.964 . . . . 0.0 110.12 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -101.66 -3.04 28.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.174 0.921 . . . . 0.0 113.088 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -107.24 -10.57 15.79 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.676 0.61 . . . . 0.0 110.489 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.2 m -105.79 -141.83 0.37 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.3 t -125.53 163.6 22.35 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.316 -0.865 . . . . 0.0 111.294 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -148.76 153.58 38.37 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.393 0.433 . . . . 0.0 110.036 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -135.17 122.78 15.24 Favored Pre-proline 0 N--CA 1.435 -1.182 0 O-C-N 125.761 1.913 . . . . 0.0 106.498 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.0 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.039 1.826 . . . . 0.0 113.461 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.223 -0.293 0 C-N-CA 123.856 0.862 . . . . 0.0 110.381 -170.477 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 12.3 m -109.62 144.77 37.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.092 0.245 . . . . 0.0 110.956 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -142.92 140.35 31.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 111.497 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.67 154.47 18.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.811 0.845 . . . . 0.0 110.026 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.38 158.17 44.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.042 -1.036 . . . . 0.0 112.387 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 2.0 t80 -148.37 177.89 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.153 0.501 . . . . 0.0 110.559 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.4 ' N ' ' CD1' ' A' ' 314' ' ' PHE . 23.5 ttmt -147.53 122.71 10.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.04 7.45 1.19 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.743 -167.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.0 p -70.68 157.99 37.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.628 1.171 . . . . 0.0 110.935 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 42.3 t -115.68 173.08 6.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -69.92 -15.87 63.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.646 1.178 . . . . 0.0 111.424 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -68.2 -20.95 64.88 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.42 ' CE ' ' CE3' ' A' ' 245' ' ' TRP . 22.7 ptm -160.95 -165.18 1.31 Allowed 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.724 1.21 . . . . 0.0 111.563 -172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 71.4 mtm-85 -55.76 157.64 4.1 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 110.151 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.3 m -140.48 145.01 36.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 125.068 1.48 . . . . 0.0 110.223 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.93 144.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.28 156.93 36.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.348 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.77 154.81 11.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.34 158.81 23.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 110.413 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.46 145.88 31.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.758 0.789 . . . . 0.0 109.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 60.4 mt -143.16 97.41 5.71 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.23 158.53 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.058 2.506 . . . . 0.0 112.368 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.45 122.27 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.3 t -96.38 146.97 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.02 -24.42 58.22 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.827 1.251 . . . . 0.0 108.43 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.524 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.49 -19.62 64.91 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.859 -1.151 . . . . 0.0 112.472 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -101.3 9.54 41.6 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.237 0.215 . . . . 0.0 111.252 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 74.0 m -102.78 -27.16 12.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.523 -1.361 . . . . 0.0 112.503 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.03 165.69 15.64 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.582 -0.699 . . . . 0.0 110.059 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -158.01 148.4 20.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.16 150.07 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.911 0.862 . . . . 0.0 108.855 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -94.46 -10.56 31.99 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.848 -0.533 . . . . 0.0 111.695 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 m -143.83 150.63 50.62 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.086 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.83 119.87 5.58 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.338 2.025 . . . . 0.0 110.239 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 23.3 t -145.84 161.61 39.6 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.596 0.236 . . . . 0.0 110.545 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -79.9 -27.34 39.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.274 0.63 . . . . 0.0 112.187 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -164.23 171.51 14.86 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.916 1.286 . . . . 0.0 108.905 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 60.5 mt -97.99 -178.31 4.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.958 1.303 . . . . 0.0 111.099 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -101.74 103.62 29.6 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.44 -6.09 12.68 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.253 1.968 . . . . 0.0 113.202 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 21.2 t -91.16 -22.32 20.73 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.621 -0.228 . . . . 0.0 111.072 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -131.82 103.87 6.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 t -154.31 156.56 37.17 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 120.966 -1.084 . . . . 0.0 110.531 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 154.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -86.83 144.36 27.05 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.279 0.987 . . . . 0.0 108.97 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.63 140.35 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.735 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -160.2 176.82 36.85 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 122.061 -0.4 . . . . 0.0 112.689 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.62 7.36 1.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.051 2.14 . . . . 0.0 114.843 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.788 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -78.02 -172.57 2.78 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 175.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -45.57 146.76 0.99 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.792 2.837 . . . . 0.0 115.182 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -71.75 -2.96 53.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.201 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.2 ptm -151.19 32.44 0.59 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.814 1.807 . . . . 0.0 111.022 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.3 OUTLIER -43.77 140.63 1.82 Allowed 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 361' ' ' LEU . 34.3 m-80 -134.03 -177.85 4.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.822 0.82 . . . . 0.0 109.78 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.4 8.63 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.963 0.887 . . . . 0.0 111.489 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -44.19 -63.73 0.82 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.479 1.912 . . . . 0.0 110.906 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.3 -28.95 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.235 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.07 -35.34 80.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.231 0.923 . . . . 0.0 109.914 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.6 63.85 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.384 -0.927 . . . . 0.0 112.008 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.52 61.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.339 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.66 -42.51 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.47 -32.27 54.26 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.819 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.75 -16.91 46.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 118.17 -1.412 . . . . 0.0 111.294 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.11 -25.09 13.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.267 -0.896 . . . . 0.0 112.58 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.8 tp -92.42 -22.51 19.6 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 121.787 -0.571 . . . . 0.0 111.217 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 7.4 m-85 -136.26 -47.01 0.63 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 111.281 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.29 -16.21 30.28 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.928 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 400' ' ' ASN . . . -99.37 22.26 41.57 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.334 1.067 . . . . 0.0 113.877 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.77 166.06 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 120.911 -1.347 . . . . 0.0 111.857 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.26 -30.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.505 ' CG ' ' N ' ' A' ' 380' ' ' ALA . 0.3 OUTLIER -156.02 162.85 40.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.15 0.886 . . . . 0.0 112.369 -174.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -153.63 146.38 24.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.67 150.19 22.39 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.57 1.077 . . . . 0.0 112.77 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 26.3 mm -85.92 136.89 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 125.641 1.576 . . . . 0.0 109.724 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.45 60.09 6.03 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.542 -0.724 . . . . 0.0 111.441 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.7 158.88 9.44 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.717 1.722 . . . . 0.0 112.683 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -140.12 157.78 45.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.968 1.707 . . . . 0.0 107.069 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -57.28 113.92 1.95 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.824 0.821 . . . . 0.0 110.494 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 53.92 16.62 1.12 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -85.71 -9.67 56.82 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.356 0.98 . . . . 0.0 113.112 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 32.8 p90 39.93 54.13 5.81 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.845 1.658 . . . . 0.0 115.383 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.0 -48.86 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.868 2.379 . . . . 0.0 113.213 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.3 25.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.084 1.754 . . . . 0.0 114.243 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -145.35 19.58 1.89 Allowed Glycine 0 C--O 1.223 -0.567 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.2 p -151.34 159.77 44.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.969 0.885 . . . . 0.0 110.12 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.81 -157.31 20.76 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 115.924 1.13 . . . . 0.0 115.924 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -158.77 164.32 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.232 0.613 . . . . 0.0 109.477 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.13 143.03 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.2 p -112.05 148.77 33.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 403' ' ' SER . 71.2 m-85 -121.07 162.09 20.6 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.9 -171.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.13 0.95 15.11 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.005 0.816 . . . . 0.0 111.199 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.435 HD21 ' HA3' ' A' ' 376' ' ' GLY . 0.3 OUTLIER -150.39 164.74 35.09 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 173.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -80.67 -14.47 58.12 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 117.971 0.351 . . . . 0.0 111.103 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -58.98 -35.53 73.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.949 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 398' ' ' PHE . 8.8 m -78.36 -19.95 52.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.715 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.93 -64.29 0.91 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.444 0.64 . . . . 0.0 109.344 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.463 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.05 -19.6 62.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.983 -175.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -79.5 -25.49 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.053 0.221 . . . . 0.0 110.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -78.81 -39.29 36.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.383 0.611 . . . . 0.0 111.425 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.2 m -78.54 -21.74 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.424 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 51.8 p -87.93 -26.7 22.57 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.59 56.26 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.95 -26.22 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.299 1.839 . . . . 0.0 115.242 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.26 148.67 22.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.019 1.281 . . . . 0.0 111.843 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.75 148.04 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -107.64 94.99 5.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.2 128.98 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 136.67 49.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.754 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.64 174.94 14.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.153 1.381 . . . . 0.0 108.378 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 75.6 m -75.08 -20.88 59.29 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.146 0.885 . . . . 0.0 111.533 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -139.71 24.29 2.43 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.946 -0.471 . . . . 0.0 111.963 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -156.25 118.69 4.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.878 0.871 . . . . 0.0 111.159 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.0 p -146.85 112.13 5.51 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.805 0.729 . . . . 0.0 112.109 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -165.05 173.58 11.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.779 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -100.59 168.13 9.91 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.5 0.667 . . . . 0.0 109.339 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 357' ' ' LEU . 90.3 t -151.05 136.1 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -117.71 153.09 33.96 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 119.119 0.872 . . . . 0.0 112.898 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 78.8 mt -125.84 135.78 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -131.37 139.83 36.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.936 -0.478 . . . . 0.0 109.863 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.31 150.8 31.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.652 2.902 . . . . 0.0 116.544 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.39 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.625 0.25 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m 50.92 119.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.971 1.709 . . . . 0.0 113.475 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.493 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -128.85 -13.01 4.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 111.065 178.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.3 m 43.63 61.5 2.23 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.35 -19.14 78.65 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.726 -0.609 . . . . 0.0 114.205 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.22 32.37 21.61 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.042 -1.858 . . . . 0.0 114.245 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 151.76 86.06 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 86.5 Cg_endo -69.38 118.75 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.007 2.472 . . . . 0.0 110.364 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 8.1 Cg_endo -97.83 5.22 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 126.117 4.545 . . . . 0.0 114.802 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -137.85 11.37 2.89 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.047 0.939 . . . . 0.0 113.104 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -82.86 39.09 0.61 Allowed 'General case' 0 C--N 1.348 0.522 0 O-C-N 121.03 -1.044 . . . . 0.0 111.883 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.0 153.86 35.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -88.59 -13.51 39.83 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.327 1.017 . . . . 0.0 111.79 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.423 ' HA ' HG11 ' A' ' 332' ' ' VAL . 2.5 t-20 50.27 43.53 1.71 Allowed Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.68 -43.49 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.838 1.692 . . . . 0.0 113.867 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 51.7 mt -152.45 157.15 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.94 1.696 . . . . 0.0 107.183 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.09 144.39 31.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.113 0.565 . . . . 0.0 109.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.1 m -128.43 3.07 5.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.726 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.2 t -153.05 179.53 8.62 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 283' ' ' TYR . 12.0 ptmm? -49.5 166.44 0.05 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.308 1.043 . . . . 0.0 109.819 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.86 149.24 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -93.84 132.08 38.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.402 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.0 tm? -134.99 119.94 18.57 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 125.198 1.562 . . . . 0.0 109.602 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.82 170.22 36.97 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 111.866 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.03 1.74 3.97 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.074 0.845 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.92 132.23 74.68 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 119.085 1.443 . . . . 0.0 108.556 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -88.86 -13.49 3.15 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 124.07 3.18 . . . . 0.0 110.921 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -105.65 -54.5 2.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.2 t0 57.48 151.41 0.01 OUTLIER 'General case' 0 C--N 1.374 1.655 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -170.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.26 -40.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.418 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.1 m -164.48 120.15 1.5 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -74.62 -23.08 58.64 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 120.926 1.694 . . . . 0.0 111.187 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -81.11 -12.58 59.23 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.003 0.921 . . . . 0.0 111.012 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.86 -41.01 29.37 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 124.94 1.4 . . . . 0.0 109.93 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.58 -42.57 78.08 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.447 1.118 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.15 -37.07 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -73.68 -15.49 61.23 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.613 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 62.2 m -80.34 -24.47 39.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.804 0.729 . . . . 0.0 109.545 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -139.9 32.04 2.0 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -103.37 12.77 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.503 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.46 23.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.7 -1.3 19.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.273 0.559 . . . . 0.0 111.651 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 110.82 -80.22 0.27 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 122.502 1.057 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.0 t -88.99 109.37 20.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.061 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 138.7 17.51 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.048 -1.032 . . . . 0.0 110.411 168.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.6 m -138.57 172.97 12.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.366 1.067 . . . . 0.0 109.311 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.95 147.61 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.876 -168.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -155.3 151.25 27.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.321 1.058 . . . . 0.0 110.726 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -160.28 138.57 7.45 Favored Pre-proline 0 C--N 1.352 0.691 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.566 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 85.1 Cg_endo -79.41 164.5 23.91 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.552 2.168 . . . . 0.0 110.772 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.61 -128.24 9.47 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -83.53 109.06 17.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.694 0.759 . . . . 0.0 109.485 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -125.75 141.22 52.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.278 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -175.85 -148.52 6.94 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 121.945 0.747 . . . . 0.0 112.325 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -80.97 1.78 29.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.242 1.417 . . . . 0.0 111.22 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -125.87 102.76 28.05 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.25 0.62 . . . . 0.0 110.264 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.8 28.29 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 125.273 3.982 . . . . 0.0 112.169 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -133.29 11.91 4.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 6.5 t -81.75 -33.41 0.65 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 116.884 -1.531 . . . . 0.0 112.203 -174.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 74.0 Cg_exo -55.72 122.5 11.86 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.293 2.662 . . . . 0.0 111.925 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.2 5.71 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.246 3.297 . . . . 0.0 112.177 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -121.95 6.16 9.84 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.87 36.73 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.944 -1.475 . . . . 0.0 113.659 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -112.6 146.87 37.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.178 1.489 . . . . 0.0 110.753 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.6 p -154.67 157.18 4.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.566 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 12.1 m-85 -109.0 154.84 21.62 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.07 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -116.02 134.37 55.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.428 1.108 . . . . 0.0 110.872 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.19 109.56 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -166.52 -166.58 0.88 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.55 -0.719 . . . . 0.0 111.261 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.63 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.235 1.814 . . . . 0.0 107.578 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.784 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.0 pt? -73.9 -3.61 29.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -167.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -111.13 -66.13 1.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -87.29 -31.72 20.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.504 -0.748 . . . . 0.0 109.602 -171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 295' ' ' LEU . 67.4 m -83.24 -26.29 30.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 121.031 1.741 . . . . 0.0 110.381 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 288' ' ' LEU . 64.5 t -69.25 -55.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -58.11 -31.53 67.24 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.999 -1.063 . . . . 0.0 112.194 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.3 m -68.2 -39.14 82.52 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.01 0.434 . . . . 0.0 112.144 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 291' ' ' SER . 1.8 mp -71.03 -41.47 70.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.97 -19.75 61.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.361 -0.536 . . . . 0.0 112.339 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -98.06 -3.68 37.52 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.653 0.596 . . . . 0.0 110.187 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -101.66 -5.97 24.35 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 124.314 1.009 . . . . 0.0 110.277 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 33.9 m -90.59 -157.27 0.47 Allowed 'General case' 0 C--O 1.221 -0.418 0 O-C-N 125.846 1.967 . . . . 0.0 109.509 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 m -136.95 -178.23 5.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -138.4 143.79 39.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.086 0.954 . . . . 0.0 111.788 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.83 127.49 26.22 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -83.43 37.19 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.125 4.55 . . . . 0.0 110.158 176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.465 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 112.595 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.557 0.694 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.2 m -66.61 167.0 11.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.442 1.097 . . . . 0.0 108.858 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -138.58 154.05 48.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.249 0.931 . . . . 0.0 110.0 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -110.91 151.77 27.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 47.0 m-85 -147.4 159.75 43.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -162.99 151.58 14.34 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -114.57 131.48 56.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.11 0.868 . . . . 0.0 110.238 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.62 16.22 19.77 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.488 0.715 . . . . 0.0 110.376 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 322' ' ' ARG . 65.6 p -132.8 132.24 41.97 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.769 -0.582 . . . . 0.0 112.562 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 95.9 p -138.38 -18.53 1.12 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.225 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -137.2 -16.39 1.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -90.16 -25.38 20.7 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.411 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mmm -148.38 -47.15 0.15 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.613 1.565 . . . . 0.0 109.676 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.422 ' H ' ' HB2' ' A' ' 317' ' ' SER . 21.8 ptt180 47.72 39.63 10.59 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.147 1.779 . . . . 0.0 114.7 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 21.8 m -132.35 -19.11 2.48 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.552 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -148.48 168.22 23.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 158.29 30.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.057 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.35 165.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.473 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 2.8 pp0? -118.2 166.89 12.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.99 140.91 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 111.644 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -143.1 98.09 5.63 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -83.49 155.54 14.1 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.094 1.863 . . . . 0.0 112.243 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -80.21 119.87 23.55 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.145 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 334' ' ' ALA . 18.0 t -97.25 157.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.109 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -54.34 -30.96 53.31 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.687 0.756 . . . . 0.0 110.549 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.512 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -74.93 6.76 3.75 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.491 1.116 . . . . 0.0 112.413 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -112.79 6.28 17.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 109.982 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 42.9 m -123.96 -29.14 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.21 165.76 35.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 110.387 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -152.45 136.65 16.56 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 125.631 1.572 . . . . 0.0 111.903 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.03 147.55 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 122.731 1.253 . . . . 0.0 110.844 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -113.34 3.95 16.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.489 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.7 m -133.58 150.33 74.59 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 125.439 1.496 . . . . 0.0 110.087 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -85.68 -7.29 8.61 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.524 3.483 . . . . 0.0 113.799 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.5 t -149.46 -16.01 0.28 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.666 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -97.89 166.46 11.44 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 109.994 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -151.25 -169.07 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.034 -0.416 . . . . 0.0 110.457 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.533 ' H ' HD12 ' A' ' 346' ' ' LEU . 9.4 mp -37.27 152.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.42 2.288 . . . . 0.0 114.183 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 397' ' ' THR . 8.5 t70 -131.99 134.9 25.75 Favored Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 126.331 1.852 . . . . 0.0 108.136 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -82.29 4.78 6.8 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.27 1.98 . . . . 0.0 113.811 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 6.2 t -139.24 -5.96 1.41 Allowed 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.117 1.326 . . . . 0.0 114.238 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -125.58 69.65 1.17 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.187 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 397' ' ' THR . 8.8 t -150.84 153.4 35.31 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.413 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.89 165.19 29.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 124.056 0.847 . . . . 0.0 111.131 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -83.32 151.4 25.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.331 0.586 . . . . 0.0 112.257 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.3 t -132.54 142.88 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.791 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.27 -163.8 18.08 Favored Glycine 0 C--O 1.246 0.863 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.174 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.72 37.37 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.001 1.721 . . . . 0.0 113.582 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.57 167.06 20.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' HIS . . . . . 0.428 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 17.2 p-80 -83.57 4.86 26.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.23 34.89 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.732 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.428 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 5.0 ptp -164.13 21.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.094 0.947 . . . . 0.0 110.289 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.81 140.45 58.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.896 1.225 . . . . 0.0 110.608 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.04 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.23 66.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -73.63 -31.92 63.78 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.819 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.62 60.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.838 -1.164 . . . . 0.0 108.551 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' LEU . . . . . 0.488 HD11 HD11 ' A' ' 382' ' ' ILE . 93.3 mt -60.95 -53.45 57.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.25 59.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.95 -41.65 42.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.913 0.863 . . . . 0.0 110.36 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.3 -26.99 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.197 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 366' ' ' LEU . 51.7 mt -96.08 -20.74 18.43 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.274 -0.891 . . . . 0.0 112.882 -168.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 -7.53 18.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 116.211 -1.852 . . . . 0.0 110.543 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 -13.05 8.64 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.247 1.385 . . . . 0.0 114.684 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.412 HD21 ' CG ' ' A' ' 220' ' ' TRP . 60.5 mt -117.12 -4.01 11.48 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.61 0.641 . . . . 0.0 111.313 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 22.9 m-85 -133.08 -32.84 1.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.903 0.881 . . . . 0.0 111.857 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 79.29 -9.64 39.74 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.7 128.03 1.66 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 120.411 2.105 . . . . 0.0 110.661 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.41 171.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.04 -30.12 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.533 ' CE1' HD11 ' A' ' 346' ' ' LEU . 1.1 t80 -171.11 159.67 6.06 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -148.99 145.6 27.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -151.78 -173.97 22.03 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 122.955 1.308 . . . . 0.0 114.865 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 366' ' ' LEU . 42.2 mm -116.47 144.37 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 112.093 -2.053 . . . . 0.0 109.834 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -76.3 44.81 0.35 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.799 0.439 . . . . 0.0 111.916 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.56 155.79 5.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.271 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -145.35 144.69 30.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -48.96 114.97 1.11 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 111.099 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 14.3 m170 57.99 28.53 16.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.045 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -105.65 -1.32 24.73 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.0 p90 33.21 59.44 1.63 Allowed Pre-proline 0 C--N 1.353 0.751 0 C-N-CA 126.497 1.919 . . . . 0.0 112.962 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.06 -49.02 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 391' ' ' ILE . 8.3 tp 31.41 41.49 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.518 1.527 . . . . 0.0 112.473 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -141.3 11.72 2.77 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 117.975 -1.458 . . . . 0.0 112.155 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 45.6 m -151.95 153.44 34.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.068 0.934 . . . . 0.0 109.04 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.4 -166.5 32.5 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.707 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.08 167.68 29.55 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.34 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.89 135.47 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 119.303 0.956 . . . . 0.0 110.332 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.446 HG22 ' HB ' ' A' ' 351' ' ' THR . 21.1 p -105.5 129.13 53.85 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 121.704 -0.623 . . . . 0.0 110.868 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.449 ' CD1' ' CB ' ' A' ' 403' ' ' SER . 95.0 m-85 -96.62 -45.14 6.83 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 53.9 t30 56.64 17.47 3.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.702 0.401 . . . . 0.0 111.01 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -141.66 155.78 45.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.664 1.986 . . . . 0.0 107.91 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -103.24 -37.47 7.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 117.718 -1.134 . . . . 0.0 112.499 -171.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -61.05 -22.92 65.04 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.518 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.449 ' CB ' ' CD1' ' A' ' 398' ' ' PHE . 7.3 m -74.02 -26.51 60.47 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.155 -0.966 . . . . 0.0 111.24 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -73.71 -56.03 5.51 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.234 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -78.16 -30.54 49.22 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.827 -0.546 . . . . 0.0 111.522 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -73.08 -40.64 64.86 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.94 -30.82 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 123.392 0.432 . . . . 0.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 25.6 p -77.55 -14.52 59.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.81 1.319 . . . . 0.0 112.993 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -88.93 -46.31 9.0 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.681 0.613 . . . . 0.0 110.197 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.73 -16.6 0.01 OUTLIER 'General case' 0 C--O 1.242 0.692 0 C-N-CA 126.86 2.064 . . . . 0.0 115.099 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -163.88 145.87 9.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.4 160.81 41.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 33.5 mt-10 -118.76 128.14 54.21 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 125.354 1.659 . . . . 0.0 108.851 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.6 mt -99.29 125.25 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 40.09 3.46 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.092 0.87 . . . . 0.0 111.436 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.9 p -76.4 172.17 13.37 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.965 1.365 . . . . 0.0 110.162 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.9 t -73.62 -1.29 18.25 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 120.275 -1.516 . . . . 0.0 112.713 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -128.43 -9.69 5.17 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 422' ' ' LYS . 15.0 t80 -149.71 124.09 9.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.937 0.79 . . . . 0.0 109.175 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 14.1 p -131.43 72.14 1.49 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.668 0.787 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 420' ' ' PHE . 98.0 mttt -152.42 177.91 10.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.001 0.92 . . . . 0.0 111.156 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 93.7 mttt -122.28 -179.54 4.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.7 m -152.15 161.25 3.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.81 1.244 . . . . 0.0 107.824 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -116.26 155.08 28.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 123.413 1.578 . . . . 0.0 110.267 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.9 mt -143.37 138.35 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.341 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -139.04 153.64 71.78 Favored Pre-proline 0 C--O 1.246 0.915 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.72 149.99 88.86 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 123.468 2.779 . . . . 0.0 110.886 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.86 1.664 . . . . 0.0 111.646 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 60.0 m -162.2 152.97 17.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -18.96 1.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.96 1.709 . . . . 0.0 112.422 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m 43.65 56.43 4.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.905 0.86 . . . . 0.0 112.745 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.85 -17.71 80.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.784 -1.098 . . . . 0.0 114.964 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.534 ' HA ' HG22 ' A' ' 417' ' ' THR . 29.6 mt-30 46.91 44.56 14.68 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 1.3 pt? -137.0 6.28 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 116.068 -1.92 . . . . 0.0 115.302 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 84.3 Cg_endo -68.25 128.66 17.82 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 CA-C-N 123.091 2.14 . . . . 0.0 108.709 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.12 152.5 24.3 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.236 2.624 . . . . 0.0 111.829 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -140.44 3.52 1.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.5 1.52 . . . . 0.0 110.718 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -106.04 64.7 0.68 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -115.52 -99.01 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.344 1.458 . . . . 0.0 109.865 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.75 27.82 14.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.11 1.364 . . . . 0.0 112.277 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -91.09 -43.89 0.38 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.64 -170.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.483 2.122 . . . . 0.0 114.653 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -105.41 178.67 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.823 1.249 . . . . 0.0 108.228 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.34 151.33 19.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.34 -1.475 . . . . 0.0 108.91 -174.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -147.4 -2.11 0.6 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.029 0.442 . . . . 0.0 111.677 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 -169.58 2.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.344 -1.472 . . . . 0.0 113.092 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.41 170.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.677 0.751 . . . . 0.0 112.603 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.37 141.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.143 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -83.62 134.14 34.81 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.92 118.7 9.24 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 169.73 -162.25 35.68 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.03 7.18 3.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.115 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.34 131.59 41.9 Favored Pre-proline 0 C--O 1.216 -0.68 0 CA-C-N 117.798 0.799 . . . . 0.0 110.406 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -86.95 -4.3 7.99 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 124.341 3.361 . . . . 0.0 109.862 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 1.3 p-90 -118.62 -43.13 2.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.464 -1.398 . . . . 0.0 114.327 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER 54.04 154.87 0.0 OUTLIER 'General case' 0 C--O 1.271 2.221 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -171.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.0 OUTLIER -143.72 178.32 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.058 175.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 274' ' ' PRO . 18.0 m -44.02 123.14 3.18 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.37 -25.75 68.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.84 -14.53 62.44 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 118.218 0.463 . . . . 0.0 111.846 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.14 -44.22 36.49 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.866 0.703 . . . . 0.0 112.833 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.7 -35.83 57.61 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.433 1.111 . . . . 0.0 109.608 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.55 -35.84 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.881 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -80.9 -14.82 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 47.1 m -79.81 -28.75 40.17 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.947 -0.471 . . . . 0.0 112.002 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -130.87 26.81 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 262' ' ' LEU . 10.9 ptm85 -101.8 1.85 37.67 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 113.275 169.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 99.1 t -76.22 -14.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 122.483 1.135 . . . . 0.0 111.708 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -87.61 -16.03 35.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.892 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 163.97 172.0 30.9 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.614 1.097 . . . . 0.0 112.569 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 52.8 m -58.13 130.89 48.72 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -160.25 173.92 14.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.492 167.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.408 ' HB2' HG23 ' A' ' 285' ' ' VAL . 50.2 m -138.96 174.84 10.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.531 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 146.65 25.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 125.235 1.414 . . . . 0.0 111.334 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -146.72 141.69 27.04 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.896 0.855 . . . . 0.0 112.928 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.415 ' HB3' HG23 ' A' ' 282' ' ' VAL . 32.8 p90 -151.08 140.1 13.46 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.475 1.11 . . . . 0.0 111.325 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.08 10.27 3.02 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.691 3.594 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.32 -168.89 24.5 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -80.5 54.51 2.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.315 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.406 ' HB3' ' NE1' ' A' ' 266' ' ' TRP . 5.2 p-10 -69.43 -15.93 63.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -78.63 -11.8 84.89 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 121.221 -0.925 . . . . 0.0 113.413 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.61 -45.98 4.28 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.267 1.534 . . . . 0.0 110.274 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.47 ' CG ' ' HE ' ' A' ' 275' ' ' ARG . 2.4 p80 -163.1 145.42 8.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 123.462 0.476 . . . . 0.0 109.837 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.407 ' HG2' HG23 ' A' ' 248' ' ' THR . 35.5 Cg_endo -78.26 41.11 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 126.586 4.857 . . . . 0.0 113.097 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.47 ' HE ' ' CG ' ' A' ' 273' ' ' HIS . 28.4 ptt180 -132.28 10.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.622 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.41 56.54 14.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.781 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.63 149.36 48.95 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 N-CA-C 108.429 -1.412 . . . . 0.0 108.429 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.55 -30.82 86.78 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.65 1.567 . . . . 0.0 113.415 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -146.84 176.13 10.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.85 0.86 . . . . 0.0 110.631 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -81.62 25.66 3.85 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.487 -1.383 . . . . 0.0 116.096 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.485 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 51.3 p90 -142.63 174.18 10.87 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.373 0.69 . . . . 0.0 109.534 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 266' ' ' TRP . 9.1 p -155.45 157.1 4.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.85 140.03 30.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.779 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.3 mt -119.86 148.37 43.56 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.014 0.825 . . . . 0.0 109.676 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 263' ' ' SER . 2.8 m -131.8 98.48 3.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.469 ' C ' ' H ' ' A' ' 288' ' ' LEU . 67.2 m-85 -85.09 -171.58 3.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.176 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.96 43.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.796 1.284 . . . . 0.0 110.703 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 286' ' ' PHE . 4.1 mm? 54.12 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 131.107 3.763 . . . . 0.0 116.575 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.95 -42.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.118 0.872 . . . . 0.0 111.906 -170.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.1 -74.37 0.06 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-O 122.152 0.977 . . . . 0.0 113.026 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 37.9 m -70.33 -11.82 61.17 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.425 0.69 . . . . 0.0 109.537 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.83 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 O-C-N 119.837 -1.789 . . . . 0.0 111.452 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.11 -29.54 64.18 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.97 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.5 m -66.19 -36.68 83.69 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 121.794 -0.566 . . . . 0.0 111.368 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 295' ' ' LEU . 0.1 OUTLIER -70.59 -52.38 21.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.723 -0.611 . . . . 0.0 111.449 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.07 -29.97 70.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.731 0.696 . . . . 0.0 111.707 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -80.74 -10.77 59.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.158 0.435 . . . . 0.0 110.969 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -109.99 -2.7 16.94 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.395 -0.816 . . . . 0.0 110.862 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 90.4 m -102.99 -156.11 0.55 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.895 1.278 . . . . 0.0 109.039 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 59.0 m -124.42 166.86 15.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.076 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -140.0 161.49 37.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.655 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -147.37 124.04 5.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -85.4 22.56 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.093 3.862 . . . . 0.0 112.593 173.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.343 0.315 0 C-N-CA 124.052 0.941 . . . . 0.0 113.506 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--O 1.218 -0.6 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 21.8 m -102.68 165.05 11.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.969 0.908 . . . . 0.0 110.1 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -142.51 154.98 44.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -111.56 154.5 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 110.996 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -144.96 149.26 34.88 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.455 -0.778 . . . . 0.0 112.059 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -161.84 160.6 28.32 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.129 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -124.69 147.38 48.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.23 -0.919 . . . . 0.0 110.68 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.84 9.39 3.58 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.179 -168.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 319' ' ' ARG . 66.9 p -121.75 -97.11 0.46 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.199 0.937 . . . . 0.0 109.724 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' SER . . . . . 0.471 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 6.2 m 65.67 -3.85 0.66 Allowed 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.232 1.013 . . . . 0.0 111.867 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 317' ' ' SER . 5.5 mpt_? -140.4 170.63 15.46 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.471 2.308 . . . . 0.0 106.624 170.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 321' ' ' MET . 17.5 ptt180 50.21 6.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.308 2.243 . . . . 0.0 115.115 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 11.7 mmt -156.68 -176.03 5.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.728 -0.607 . . . . 0.0 109.701 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -83.74 20.3 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.679 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 318' ' ' SER . 55.9 m 54.15 68.72 0.81 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.478 0.711 . . . . 0.0 112.554 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -124.55 108.11 11.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.26 169.01 2.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.039 1.336 . . . . 0.0 112.661 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.65 178.1 3.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.87 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 161.23 35.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.358 0.599 . . . . 0.0 109.851 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.33 135.69 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 24.1 mt -144.21 98.16 5.13 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 125.028 1.455 . . . . 0.0 109.837 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.75 160.47 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.13 1 C-N-CA 125.48 4.12 . . . . 0.0 112.969 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -89.19 125.16 34.95 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.133 0.895 . . . . 0.0 109.941 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 334' ' ' ALA . 63.4 t -109.86 147.85 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.94 -22.11 47.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 117.744 -1.582 . . . . 0.0 111.934 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.544 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -59.23 -14.34 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.706 1.139 . . . . 0.0 113.148 174.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -99.28 6.91 46.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.369 1.067 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.2 m -132.81 -33.73 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.518 0.727 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -146.76 152.83 39.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.988 0.899 . . . . 0.0 110.725 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -164.64 140.78 5.94 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.549 -1.66 . . . . 0.0 109.473 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 379' ' ' TYR . 5.5 m -118.85 150.6 21.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.668 -0.645 . . . . 0.0 112.112 -175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -125.1 28.52 6.36 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.655 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.4 t -148.23 143.0 16.98 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.756 0.823 . . . . 0.0 110.532 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.11 -10.69 26.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.717 2.944 . . . . 0.0 110.186 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.7 m -90.24 -9.48 47.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.355 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 43.11 17.3 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.564 ' HE ' ' HA ' ' A' ' 345' ' ' ARG . 0.0 OUTLIER -117.6 174.34 6.22 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 379' ' ' TYR . 1.7 mm? -86.57 169.67 12.57 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 125.019 1.45 . . . . 0.0 111.685 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -110.44 154.15 43.14 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.26 110.16 0.51 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.043 1.829 . . . . 0.0 112.003 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 35.8 m 50.82 35.65 12.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.121 0.968 . . . . 0.0 112.41 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -115.61 64.76 0.69 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.425 0.631 . . . . 0.0 112.251 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.1 t -148.61 159.26 44.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.653 0.381 . . . . 0.0 111.556 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.05 165.44 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.139 -0.976 . . . . 0.0 111.852 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -87.62 162.2 17.27 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.93 132.91 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.904 0.753 . . . . 0.0 109.345 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -136.4 -176.7 14.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 123.222 1.457 . . . . 0.0 111.414 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 63.0 -57.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.796 1.238 . . . . 0.0 113.056 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 47.8 -158.57 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.784 1.233 . . . . 0.0 111.74 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.88 163.71 35.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.517 1.927 . . . . 0.0 107.487 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -63.25 4.18 0.95 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 120.142 -0.255 . . . . 0.0 113.272 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.8 ptp -164.4 32.2 0.07 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.848 1.324 . . . . 0.0 108.756 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.4 111.89 2.21 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.537 0.735 . . . . 0.0 110.743 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.21 159.36 17.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -71.66 -20.32 61.97 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 121.479 -0.763 . . . . 0.0 112.497 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.09 -23.24 59.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -72.12 -35.25 69.08 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.223 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.14 -29.35 63.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.0 -1.08 . . . . 0.0 109.737 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -86.5 -15.87 38.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.172 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -85.93 -43.37 13.26 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 119.483 1.038 . . . . 0.0 110.958 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.73 -52.27 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.66 -38.86 70.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.54 -21.2 60.45 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 118.35 -1.34 . . . . 0.0 110.376 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.6 -12.83 35.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.968 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.7 tp -75.53 -20.68 58.54 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 121.777 -0.577 . . . . 0.0 110.436 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 403' ' ' SER . 27.7 p90 -156.34 -43.31 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 374' ' ' PHE . . . -177.37 -66.67 0.06 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 119.174 0.897 . . . . 0.0 114.182 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 176.46 149.95 7.91 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 119.087 1.444 . . . . 0.0 114.644 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 1.1 m -118.75 172.52 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.618 0.767 . . . . 0.0 110.914 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.8 -30.87 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' A' ' 339' ' ' VAL . 23.0 t80 -163.93 156.04 17.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.36 154.13 40.51 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.11 166.27 36.27 Favored Glycine 0 C--O 1.22 -0.739 0 CA-C-O 122.683 1.157 . . . . 0.0 114.951 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 336' ' ' SER . 11.4 mm -116.0 154.42 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.27 1.828 . . . . 0.0 107.071 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.64 134.09 42.05 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.375 -0.828 . . . . 0.0 110.758 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 4.3 p -135.2 154.05 51.73 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 125.26 1.6 . . . . 0.0 110.071 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.33 159.31 42.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.572 ' HA ' ' HE3' ' A' ' 386' ' ' LYS . 1.7 tpmt? -46.82 103.18 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.315 0.646 . . . . 0.0 112.378 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.2 m170 45.07 45.77 9.15 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.886 2.475 . . . . 0.0 114.04 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -102.55 4.08 38.11 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.403 -0.81 . . . . 0.0 110.964 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.3 p90 42.26 54.0 8.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.276 1.43 . . . . 0.0 112.746 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 85.7 Cg_endo -70.08 -66.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.3 2.667 . . . . 0.0 112.426 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.47 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 4.0 tp 42.63 28.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 124.061 0.85 . . . . 0.0 111.854 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -123.11 10.69 8.76 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.904 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 69.1 p -158.08 158.81 35.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -168.96 -169.24 32.1 Favored Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.071 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -150.53 165.51 33.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 122.1 0.952 . . . . 0.0 109.051 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.49 136.14 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 120.755 -1.215 . . . . 0.0 108.719 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 43.8 m -115.74 142.83 46.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.524 -170.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.02 164.69 15.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.56 0.695 . . . . 0.0 112.007 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -116.37 7.21 13.84 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.107 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -129.1 164.86 22.4 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -107.54 -29.26 9.29 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.912 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -56.44 -28.79 60.52 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.753 1.16 . . . . 0.0 113.398 -173.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.481 ' HB2' ' CD2' ' A' ' 374' ' ' PHE . 32.6 t -78.38 -33.99 48.52 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.617 -1.302 . . . . 0.0 113.159 175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -51.87 -50.73 60.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 123.845 0.716 . . . . 0.0 111.494 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 405' ' ' LEU 0.282 0.0 OUTLIER -83.39 -26.55 30.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.618 176.9 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.407 ' N ' HD22 ' A' ' 405' ' ' LEU . 28.9 ttpp -74.3 -19.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.465 1.029 . . . . 0.0 110.86 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -89.34 -36.75 15.35 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.201 -0.937 . . . . 0.0 112.364 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.4 m -71.61 -22.16 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.841 1.2 . . . . 0.0 108.961 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.7 p -84.01 -29.66 26.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 124.499 1.124 . . . . 0.0 112.706 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.99 -41.33 64.43 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.493 0.717 . . . . 0.0 110.667 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.21 -9.78 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.93 148.51 10.33 Favored 'General case' 0 C--O 1.219 -0.522 0 O-C-N 120.766 -1.209 . . . . 0.0 110.7 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.38 163.51 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.233 0.469 . . . . 0.0 110.528 171.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.68 139.2 47.33 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.173 0.511 . . . . 0.0 110.782 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 29.6 mt -103.74 125.78 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 29.12 5.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 223' ' ' GLN . 34.9 p -68.74 178.8 1.97 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.344 1.545 . . . . 0.0 111.638 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.3 p -73.94 -8.51 56.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -138.69 3.54 2.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.715 0.806 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.97 142.36 26.33 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.315 -1.491 . . . . 0.0 112.914 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.0 p -146.03 104.72 3.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.056 0.943 . . . . 0.0 110.091 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 41.4 tptt -165.87 176.55 7.79 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.528 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 56.2 mtpt -118.94 162.6 18.25 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.29 138.63 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -100.07 152.11 20.6 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 59.5 mt -135.38 135.11 52.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.89 150.94 29.02 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 119.395 0.998 . . . . 0.0 109.118 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.34 156.06 27.37 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.878 2.385 . . . . 0.0 111.464 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.642 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.9 m -58.61 153.74 15.76 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.826 0.85 . . . . 0.0 110.654 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -116.79 -59.18 1.99 Allowed 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.127 -0.983 . . . . 0.0 109.534 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.9 m 39.21 51.64 2.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.089 1.355 . . . . 0.0 111.917 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.04 -17.97 79.71 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.65 1.119 . . . . 0.0 111.643 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 63.53 32.4 14.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.21 93.18 17.47 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 125.15 1.38 . . . . 0.0 108.614 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.23 147.49 26.15 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 113.641 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.23 -149.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 125.054 3.836 . . . . 0.0 109.745 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 68.29 28.22 6.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.954 0.901 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -90.91 -4.96 56.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.47 147.77 52.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 112.792 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -153.5 33.65 0.46 Allowed 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.48 1.512 . . . . 0.0 109.378 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' A' ' 334' ' ' ALA . 2.5 p30 -129.42 80.08 72.76 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.95 105.83 2.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.467 2.111 . . . . 0.0 111.414 -172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 333' ' ' LEU . 14.2 pt -149.58 148.32 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.055 . . . . 0.0 107.1 173.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -125.94 157.46 37.7 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.197 -0.94 . . . . 0.0 113.072 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 99.2 p -152.4 -1.38 0.28 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 12.1 t -144.46 179.84 7.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.247 1.022 . . . . 0.0 110.837 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.82 161.43 0.76 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.76 150.45 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.205 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -94.01 140.37 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 109.691 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.77 108.93 4.43 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.68 163.9 34.89 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.668 1.122 . . . . 0.0 112.884 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.94 3.17 1.53 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.74 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 m -103.77 108.69 60.42 Favored Pre-proline 0 N--CA 1.435 -1.216 0 C-N-CA 122.514 0.326 . . . . 0.0 110.522 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.98 -20.99 11.23 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.081 1.854 . . . . 0.0 113.017 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.403 ' CD2' ' HG3' ' A' ' 321' ' ' MET . 35.7 p-90 -100.08 -26.33 14.0 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -43.56 104.34 0.04 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.106 1.362 . . . . 0.0 112.33 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -74.92 -27.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.2 m -146.12 136.07 23.5 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.749 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -9.92 59.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.33 64.03 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.8 -58.07 10.84 Favored Glycine 0 C--N 1.359 1.859 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.2 pt? -70.75 -23.31 62.39 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 119.671 -2.076 . . . . 0.0 112.085 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.08 -27.21 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 122.993 0.517 . . . . 0.0 109.79 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.46 -13.85 24.24 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.555 0.342 . . . . 0.0 111.826 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.6 m -82.46 -26.82 32.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.35 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -131.96 64.49 1.59 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.109 -1.62 . . . . 0.0 113.221 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -140.12 2.23 1.89 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.794 0.838 . . . . 0.0 111.484 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.47 -10.43 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.408 0.683 . . . . 0.0 109.529 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.08 28.69 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.834 1.253 . . . . 0.0 111.275 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.26 8.25 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.813 -0.437 . . . . 0.0 114.157 -171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 38.8 m -156.3 51.65 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 125.127 1.134 . . . . 0.0 109.886 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.587 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -115.34 175.0 5.71 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.5 t -143.89 177.92 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.846 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.87 147.57 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -157.97 153.18 25.72 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 126.419 2.324 . . . . 0.0 110.101 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -155.89 149.7 19.24 Favored Pre-proline 0 N--CA 1.432 -1.374 0 O-C-N 124.21 0.944 . . . . 0.0 113.097 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.44 153.51 50.09 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.785 1.657 . . . . 0.0 107.929 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.32 21.4 45.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 119.275 -1.441 . . . . 0.0 110.474 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -61.29 -3.86 1.03 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 126.599 1.96 . . . . 0.0 114.65 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -118.77 131.2 56.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.953 1.301 . . . . 0.0 109.464 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.47 -165.52 38.92 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -94.47 149.66 21.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.856 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 274' ' ' PRO . 20.1 m80 42.7 49.96 5.03 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 113.015 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 273' ' ' HIS . 32.6 Cg_exo -61.55 124.59 14.94 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.823 1.682 . . . . 0.0 110.893 -171.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -155.86 -32.98 0.09 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.877 0.471 . . . . 0.0 110.435 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 37.9 t -155.22 141.17 12.85 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.664 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 88.9 Cg_endo -75.26 157.96 41.41 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.058 3.172 . . . . 0.0 115.096 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 277' ' ' PRO . 70.7 Cg_exo -58.29 155.37 35.53 Favored 'Trans proline' 0 C--O 1.223 -0.245 0 C-N-CA 125.278 3.985 . . . . 0.0 112.979 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.3 tttt 49.58 24.75 1.22 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.216 1.407 . . . . 0.0 112.59 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.08 2.04 0.5 Allowed Glycine 0 C--O 1.215 -1.092 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.29 126.71 30.35 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.979 1.39 . . . . 0.0 113.344 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.01 163.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -118.88 149.07 42.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.8 mt -114.97 137.52 51.9 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.017 1.448 . . . . 0.0 110.493 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.31 116.52 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.514 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.42 -166.17 2.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.88 0.848 . . . . 0.0 112.876 -168.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -48.61 139.29 9.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 24.4 mt -74.52 -39.06 62.62 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.745 0.702 . . . . 0.0 112.714 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -121.89 -45.54 2.26 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.733 -1.229 . . . . 0.0 113.516 -170.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -69.96 -70.96 0.26 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.8 t -58.95 -29.47 67.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.145 0.498 . . . . 0.0 111.591 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -57.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.125 -174.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -66.82 -29.54 69.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.609 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.2 m -61.47 -59.96 4.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.896 1.372 . . . . 0.0 111.823 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 298' ' ' ALA . 4.0 pp -79.46 -26.74 41.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.84 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.17 -34.24 76.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.632 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.03 -2.78 57.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.814 0.696 . . . . 0.0 112.359 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 295' ' ' LEU . . . -97.43 -15.84 20.46 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.7 m -85.09 -159.3 0.42 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.9 m -96.41 158.36 15.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.539 1.162 . . . . 0.0 109.804 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.421 ' HE1' ' HB2' ' A' ' 310' ' ' SER . 85.9 t60 -158.04 153.41 25.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.6 147.08 34.68 Favored Pre-proline 0 C--N 1.349 0.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.95 5.0 4.21 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 123.06 2.507 . . . . 0.0 112.172 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.237 0.446 0 C-N-CA 129.352 3.061 . . . . 0.0 114.629 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.421 ' HB2' ' HE1' ' A' ' 301' ' ' HIS . 30.2 p -115.03 155.74 26.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -139.75 137.88 35.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 21.1 m-85 -116.87 144.83 44.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.075 0.95 . . . . 0.0 111.182 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -144.05 158.2 43.86 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -159.6 169.51 23.62 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 146.55 32.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.386 0.136 . . . . 0.0 110.925 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.6 162.95 36.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.527 1.531 . . . . 0.0 109.506 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -167.59 178.05 5.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.569 -0.707 . . . . 0.0 111.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.8 t -125.4 40.18 3.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.656 0.782 . . . . 0.0 109.779 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 57.42 24.29 10.01 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 111.939 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HG3' ' HE3' ' A' ' 321' ' ' MET . 17.4 ptp180 -140.98 -4.1 1.2 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 118.127 2.639 . . . . 0.0 118.127 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.464 ' HE3' ' HG3' ' A' ' 320' ' ' ARG . 1.1 pmm? -150.6 24.17 0.79 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.617 1.099 . . . . 0.0 113.877 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -48.61 110.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.747 0.419 . . . . 0.0 111.187 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 47.6 t -164.72 -49.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -110.68 132.61 54.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.844 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.91 156.18 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.256 1.422 . . . . 0.0 112.555 173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.76 168.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -127.03 150.42 49.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 3.1 t -130.98 143.31 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 124.708 1.255 . . . . 0.0 112.522 -173.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.4 mt -148.62 96.93 3.78 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.764 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -85.18 169.41 9.99 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 124.38 3.387 . . . . 0.0 113.286 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 2.0 t90 -91.51 121.04 32.85 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.249 1.42 . . . . 0.0 110.557 171.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 334' ' ' ALA . 83.3 t -101.82 145.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 233' ' ' ILE . 6.8 mp -62.54 -26.59 68.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.231 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.533 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.31 -3.57 2.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.483 0.489 . . . . 0.0 112.306 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -103.7 -10.56 18.25 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 122.126 -0.359 . . . . 0.0 110.541 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.1 m -104.95 -24.16 12.88 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.483 0.713 . . . . 0.0 110.637 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.4 143.92 31.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -153.67 134.94 14.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 22.2 m -118.69 147.6 22.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.523 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -96.31 -14.42 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.3 t -146.48 125.66 6.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.674 1.99 . . . . 0.0 109.324 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.92 -8.8 15.62 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.36 2.706 . . . . 0.0 113.059 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -103.97 7.26 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.581 -170.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.4 166.07 14.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.857 0.753 . . . . 0.0 109.177 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -115.74 179.28 4.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.912 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.4 mm? -72.89 155.68 39.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.466 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.06 118.61 64.6 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.25 -5.97 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.293 1.995 . . . . 0.0 113.02 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 42.1 m -123.78 -12.58 7.57 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.151 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -122.33 100.31 6.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.381 0.991 . . . . 0.0 112.358 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -150.75 161.42 42.67 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.26 150.33 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 121.964 0.888 . . . . 0.0 110.713 171.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -79.71 121.85 25.84 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.569 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.96 137.53 24.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 O-C-N 125.182 1.551 . . . . 0.0 110.121 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -126.23 64.95 0.57 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.619 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -114.2 123.08 48.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.875 0.87 . . . . 0.0 111.401 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -157.52 157.16 33.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 122.524 1.154 . . . . 0.0 113.325 -176.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.26 3.73 0.31 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.895 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.56 -29.49 3.8 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.546 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.5 ptp -160.19 43.86 0.21 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.873 0.836 . . . . 0.0 111.139 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 357' ' ' LEU . 2.9 tm? -63.6 133.4 53.66 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.754 -0.591 . . . . 0.0 109.748 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -130.88 -176.21 3.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.628 1.204 . . . . 0.0 111.541 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.5 -13.63 61.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.724 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.17 -20.6 40.89 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.869 -1.144 . . . . 0.0 109.419 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.76 -35.0 22.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 76.9 mt -73.6 -26.02 60.6 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.19 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -74.65 -40.72 61.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.644 0.378 . . . . 0.0 111.1 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.57 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.789 0.836 . . . . 0.0 110.261 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.03 -38.62 80.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.75 -27.88 19.74 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -15.18 58.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.812 0.733 . . . . 0.0 110.293 173.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.62 -19.03 19.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.93 0.787 . . . . 0.0 112.366 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.6 tp -96.64 -26.69 15.12 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 124.529 1.143 . . . . 0.0 114.004 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 -24.36 0.47 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.751 0.705 . . . . 0.0 112.367 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.47 -6.24 8.7 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.979 -0.9 . . . . 0.0 114.757 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -85.14 11.27 60.95 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.467 1.634 . . . . 0.0 113.907 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.5 p -91.35 162.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 124.836 1.254 . . . . 0.0 111.569 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.9 -27.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.847 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.9 OUTLIER -153.9 145.44 23.21 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -134.99 140.79 45.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.33 25.33 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.906 0.725 . . . . 0.0 112.428 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.58 138.0 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.08 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -81.63 135.86 35.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.8 p -125.27 162.24 25.16 Favored 'General case' 0 C--O 1.215 -0.732 0 O-C-N 121.499 -0.751 . . . . 0.0 112.184 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -127.88 157.61 40.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.281 1.433 . . . . 0.0 107.688 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.04 100.44 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.063 -1.023 . . . . 0.0 111.232 -169.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.8 m170 53.47 39.4 29.93 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.022 1.329 . . . . 0.0 114.139 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -104.85 -4.26 22.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.408 -2.058 . . . . 0.0 114.493 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 49.7 51.76 11.37 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-N 119.557 1.071 . . . . 0.0 113.619 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -51.08 2.74 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.792 2.995 . . . . 0.0 110.252 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 9.0 tp 39.83 39.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.942 1.697 . . . . 0.0 110.181 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.07 29.8 1.37 Allowed Glycine 0 CA--C 1.508 -0.355 0 O-C-N 121.596 -0.69 . . . . 0.0 111.927 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 25.0 p -168.89 158.45 8.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.74 -170.62 32.76 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.65 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -150.0 157.88 43.6 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.35 130.79 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.6 p -96.57 138.52 34.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.104 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -113.44 155.44 25.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.044 0.84 . . . . 0.0 111.866 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -124.89 -10.34 7.2 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.042 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -119.5 150.65 39.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.158 0.983 . . . . 0.0 108.383 171.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.33 -16.45 61.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.003 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -65.83 -37.0 85.06 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.682 0.793 . . . . 0.0 111.144 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 43.7 m -71.5 -21.59 61.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.418 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.3 -63.47 1.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.038 0.923 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.521 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -75.55 -20.87 58.37 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.832 -1.167 . . . . 0.0 112.116 -173.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -84.56 -21.94 30.26 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 120.154 -1.591 . . . . 0.0 110.603 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' A' ' 426' ' ' ILE . . . -81.39 -37.27 28.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.649 0.593 . . . . 0.0 111.095 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.18 -24.01 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.691 -0.631 . . . . 0.0 111.116 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.0 p -90.2 -16.02 30.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -90.61 -35.88 14.74 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 56.71 -41.24 0.03 OUTLIER 'General case' 0 C--N 1.344 0.36 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -157.3 124.75 5.26 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.191 -1.568 . . . . 0.0 107.963 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.46 157.2 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 423' ' ' LYS . 36.1 mt-10 -94.98 139.51 31.25 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 124.885 1.366 . . . . 0.0 110.104 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 15.3 mt -121.35 125.98 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 123.908 1.813 . . . . 0.0 112.541 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -124.59 52.28 1.54 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.944 -177.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -77.96 179.72 6.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 123.397 1.57 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 17.0 p -91.32 3.59 54.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.4 -29.83 7.64 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.52 164.27 27.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 59.1 m -123.37 113.3 18.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -162.07 178.88 8.42 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 111.786 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 414' ' ' GLU . 34.8 mtmm -124.04 166.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.25 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.28 152.73 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 O-C-N 124.747 1.279 . . . . 0.0 109.365 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -127.08 160.39 31.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.982 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.476 HD13 ' HB1' ' A' ' 407' ' ' ALA . 46.9 mt -139.12 141.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 O-C-N 125.573 1.796 . . . . 0.0 109.343 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -138.31 158.19 71.22 Favored Pre-proline 0 C--O 1.219 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.22 156.77 61.21 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 123.607 2.871 . . . . 0.0 111.259 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 8.5 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.144 -1.408 . . . . 0.0 112.348 -178.242 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.6 m -148.83 151.2 34.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.75 2.02 . . . . 0.0 109.382 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -3.47 1.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 m 38.02 60.05 1.27 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 123.903 0.881 . . . . 0.0 112.461 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.13 -28.84 74.03 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.555 -172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 53.54 46.43 26.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.146 0.473 . . . . 0.0 112.167 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.95 26.52 0.09 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.69 122.33 9.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 CA-C-N 123.316 2.22 . . . . 0.0 110.383 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 139.07 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.254 3.302 . . . . 0.0 111.951 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -153.31 170.4 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.286 1.034 . . . . 0.0 109.856 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.39 48.84 16.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 110.593 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.4 153.4 2.17 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.732 1.213 . . . . 0.0 111.111 -172.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.4 18.01 19.6 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.661 1.185 . . . . 0.0 111.602 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.72 48.13 2.94 Favored Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 123.874 0.87 . . . . 0.0 110.759 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.49 103.74 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.664 1.576 . . . . 0.0 114.487 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 mm -139.35 142.66 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -111.31 148.49 32.83 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -135.98 -8.24 2.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 84.5 m -135.85 -173.15 3.29 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.984 0.803 . . . . 0.0 110.038 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 389' ' ' TYR . 60.0 pttt -65.83 161.59 20.68 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.906 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.43 148.98 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.536 -173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -93.23 137.21 32.77 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.151 0.58 . . . . 0.0 110.727 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.456 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.8 tm? -146.62 124.6 12.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.2 -170.27 36.97 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.939 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.76 12.63 1.31 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.9 m -61.19 124.28 79.67 Favored Pre-proline 0 C--O 1.217 -0.607 0 CA-C-N 120.016 1.908 . . . . 0.0 111.589 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -83.61 0.94 9.2 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.721 1.614 . . . . 0.0 115.072 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.51 -14.17 2.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.952 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 42.81 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.93 2.492 . . . . 0.0 115.142 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 248' ' ' THR . 5.9 pt -104.53 -96.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.879 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.5 m -141.68 132.72 26.14 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 122.508 1.147 . . . . 0.0 108.838 173.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -59.61 -22.8 62.33 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.596 ' H ' HG22 ' A' ' 248' ' ' THR . . . -66.83 -39.86 87.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.356 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.68 -47.97 84.8 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 123.582 0.552 . . . . 0.0 112.374 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 252' ' ' LEU . 6.4 mp -64.11 -38.27 90.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.508 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.458 HG12 ' HD3' ' A' ' 257' ' ' ARG . 16.0 t -73.92 -41.57 53.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.409 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -78.57 -3.65 44.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.304 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.8 m -89.12 -34.86 16.58 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.857 171.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -136.08 75.82 1.57 Allowed 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 120.771 1.623 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.48 ' HA ' HD21 ' A' ' 262' ' ' LEU . 39.0 ptt180 -142.38 14.47 2.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.579 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.07 -9.75 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 122.969 0.507 . . . . 0.0 111.754 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.31 -4.39 58.4 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.422 -1.424 . . . . 0.0 109.078 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 62.18 5.13 7.26 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 125.75 1.906 . . . . 0.0 115.6 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 287' ' ' GLU . 55.2 p -103.39 7.15 38.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -129.57 163.56 25.74 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.357 0.98 . . . . 0.0 112.655 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.8 t -152.54 168.6 25.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.895 1.278 . . . . 0.0 108.419 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.7 p -118.22 144.58 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.134 1.773 . . . . 0.0 113.716 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -143.12 131.2 21.8 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -157.93 146.8 14.55 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.111 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -88.2 165.72 6.88 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 121.646 1.564 . . . . 0.0 111.141 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.72 14.67 82.16 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 118.796 -1.002 . . . . 0.0 110.943 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -69.76 17.74 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.771 1.628 . . . . 0.0 112.735 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -76.56 151.66 36.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.923 0.889 . . . . 0.0 111.224 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.54 167.85 12.73 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.221 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.66 8.28 5.58 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.42 1.488 . . . . 0.0 112.625 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 275' ' ' ARG . 81.1 m-70 -135.74 152.14 75.49 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.12 9.41 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.625 2.216 . . . . 0.0 109.326 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' HIS . 59.5 ttp85 -117.68 117.01 28.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.69 1.196 . . . . 0.0 109.239 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.743 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 17.3 t -160.51 -30.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.743 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 86.3 Cg_endo -76.48 142.49 23.58 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.346 2.698 . . . . 0.0 111.829 -170.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.68 -4.36 15.12 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.386 3.39 . . . . 0.0 113.787 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.54 150.77 25.06 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.62 0.768 . . . . 0.0 109.087 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -99.79 21.72 43.65 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.985 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -154.87 166.06 34.69 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 119.959 1.88 . . . . 0.0 113.021 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.4 m -151.72 -170.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -126.12 148.94 49.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.635 1.207 . . . . 0.0 112.306 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.98 151.51 46.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.883 -1.136 . . . . 0.0 111.785 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.33 158.04 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.364 1.466 . . . . 0.0 110.11 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 288' ' ' LEU . 62.7 m-85 -158.68 -178.22 7.1 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 123.626 1.679 . . . . 0.0 111.154 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 261' ' ' SER . 9.3 tp10 -75.43 19.44 0.18 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.803 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 286' ' ' PHE . 57.3 mt 55.51 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 128.877 2.871 . . . . 0.0 116.628 172.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.0 -51.75 3.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.872 0.869 . . . . 0.0 110.559 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.22 -74.2 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.685 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 38.7 t -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.263 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.47 -52.19 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 O-C-N 123.666 0.604 . . . . 0.0 112.618 -168.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -68.11 -26.16 65.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.495 0.497 . . . . 0.0 110.094 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.2 m -69.45 -44.32 71.47 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.992 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 291' ' ' SER . 10.2 mt -68.53 -52.89 27.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.916 1.234 . . . . 0.0 110.868 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 9.47 23.15 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -115.05 -7.33 12.51 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.124 0.964 . . . . 0.0 110.617 168.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.32 -25.1 18.71 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 13.8 t -101.78 -118.28 0.18 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.909 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.7 m -123.91 157.09 35.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.588 1.185 . . . . 0.0 113.194 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -154.07 161.27 42.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.716 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -148.25 133.86 9.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.38 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 125.514 4.142 . . . . 0.0 110.289 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.476 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.565 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.181 -174.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.2 m -60.85 170.33 1.56 Allowed 'General case' 0 C--N 1.344 0.338 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.532 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -129.08 134.8 48.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.351 0.596 . . . . 0.0 109.562 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -102.16 135.76 43.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.79 145.61 47.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -149.08 152.04 35.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.332 0.587 . . . . 0.0 111.003 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -123.77 116.33 22.82 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.966 1.365 . . . . 0.0 110.988 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.402 ' HE2' ' HB ' ' A' ' 326' ' ' VAL . 25.8 ptt? -133.19 1.34 3.49 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.748 -168.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 58.8 p -119.97 2.43 10.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 21.4 t -62.67 -3.16 1.37 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.549 -1.344 . . . . 0.0 111.732 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -88.26 -8.71 54.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.339 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -152.33 -9.65 0.19 Allowed 'General case' 0 C--N 1.347 0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 30.5 mmm -124.99 -178.4 4.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.937 2.095 . . . . 0.0 108.841 174.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -95.97 -37.03 10.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.703 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.8 t -176.52 146.6 0.61 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.953 0.901 . . . . 0.0 109.555 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -152.42 -56.0 0.13 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 62.79 100.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 124.144 0.903 . . . . 0.0 109.469 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.402 ' HB ' ' HE2' ' A' ' 316' ' ' MET . 4.6 p -84.44 155.7 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.597 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 147.77 24.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.036 0.922 . . . . 0.0 109.285 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 129.95 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.895 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.79 96.08 11.99 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.718 1.247 . . . . 0.0 108.37 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -88.29 160.22 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.392 1.395 . . . . 0.0 111.522 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 5.3 t-105 -74.7 124.31 26.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 334' ' ' ALA . 16.6 t -96.76 149.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.749 1.262 . . . . 0.0 110.382 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -59.41 -31.66 69.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.443 1.097 . . . . 0.0 108.602 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.421 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -73.62 -7.28 51.35 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.61 1.164 . . . . 0.0 113.741 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.28 0.02 33.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.842 0.857 . . . . 0.0 111.058 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 73.2 m -91.69 -54.78 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -157.33 154.71 29.44 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.864 0.865 . . . . 0.0 112.308 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.454 ' CB ' ' HB1' ' A' ' 363' ' ' ALA . 60.7 t80 -154.94 148.49 25.28 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 123.535 0.522 . . . . 0.0 111.021 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.52 155.3 29.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 122.796 0.438 . . . . 0.0 111.51 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -113.89 32.72 5.66 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 121.782 0.801 . . . . 0.0 109.157 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.0 t -152.17 141.36 14.19 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.143 0.977 . . . . 0.0 110.148 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.65 -6.57 17.03 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.22 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -115.77 149.22 38.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -99.2 138.87 35.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -158.53 152.56 23.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.79 0.805 . . . . 0.0 110.435 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.439 ' HA ' HG21 ' A' ' 397' ' ' THR . 3.4 mm? -128.78 174.74 9.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.068 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -141.4 110.45 6.34 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.04 0.79 4.61 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.766 2.977 . . . . 0.0 114.925 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 66.2 m -134.44 0.73 3.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 117.992 -1.004 . . . . 0.0 112.813 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -147.01 81.72 1.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.799 1.761 . . . . 0.0 109.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.1 p -136.9 173.33 11.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.7 143.4 37.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 O-C-N 121.506 -0.746 . . . . 0.0 109.398 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -77.83 145.47 36.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.668 1.223 . . . . 0.0 112.77 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.2 t -132.01 148.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -177.93 -161.99 27.1 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.671 -0.643 . . . . 0.0 112.853 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.5 0.54 Allowed 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 114.186 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -79.05 172.81 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.18 9.2 0.34 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -168.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.698 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 100.91 15.17 29.42 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.8 mmt -147.11 -88.68 0.09 Allowed 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.933 1.366 . . . . 0.0 109.945 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 12.3 tp 44.39 70.78 0.3 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 111.299 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -55.58 170.25 0.27 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.104 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 338' ' ' PHE . . . -64.28 -26.35 68.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -80.56 -21.4 41.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.29 -26.15 42.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.813 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.61 -44.95 63.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.9 72.85 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.774 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.45 -53.55 50.36 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.957 -1.09 . . . . 0.0 110.728 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.37 -42.48 96.48 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 370' ' ' LEU . 4.4 mm? -80.61 -38.52 29.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.295 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -12.76 46.57 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 120.261 1.391 . . . . 0.0 112.726 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.7 -22.86 13.5 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.531 -0.73 . . . . 0.0 110.477 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.3 tp -98.73 -16.52 18.93 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -105.99 -81.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 164.13 -19.36 0.13 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 119.662 1.119 . . . . 0.0 111.925 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -174.86 142.52 6.35 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 118.727 1.263 . . . . 0.0 112.925 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.17 176.93 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.414 1.102 . . . . 0.0 109.824 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.83 -31.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.889 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -155.37 146.23 22.37 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -151.05 135.29 16.84 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 125.17 1.388 . . . . 0.0 108.086 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.65 173.45 38.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.1 mm -91.3 140.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.56 -1.32 . . . . 0.0 109.32 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.27 115.86 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.7 p -111.38 163.35 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.094 0.95 . . . . 0.0 111.773 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -133.41 159.91 38.94 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.98 103.1 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.337 -0.852 . . . . 0.0 112.056 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.26 46.66 20.8 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -108.95 -20.72 12.94 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.627 1.571 . . . . 0.0 115.021 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.414 ' HB2' ' HE2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER 46.36 57.89 16.53 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 124.834 1.334 . . . . 0.0 111.479 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.53 -41.02 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.245 1.297 . . . . 0.0 113.242 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 391' ' ' ILE . 11.0 tp 31.82 38.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 127.846 2.458 . . . . 0.0 112.368 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -140.27 11.97 3.03 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 124.474 1.035 . . . . 0.0 110.749 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 93.0 p -151.15 158.33 43.84 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.896 0.409 . . . . 0.0 111.648 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 177.24 -178.45 48.26 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -150.85 166.91 29.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.31 140.36 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 346' ' ' LEU . 75.6 m -107.92 132.46 53.45 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.408 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -128.84 166.3 19.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.769 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.14 9.25 2.09 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.691 0.619 . . . . 0.0 110.656 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -124.15 144.39 49.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.28 -24.86 64.92 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -51.77 -38.8 57.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.036 0.835 . . . . 0.0 112.186 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.0 m -78.8 -19.26 52.57 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 112.367 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -74.47 -57.09 4.16 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 120.61 -1.306 . . . . 0.0 110.308 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.92 -24.32 59.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.508 -1.277 . . . . 0.0 113.795 -175.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.07 -27.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.804 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.34 -27.54 42.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.6 m -93.3 -24.48 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 O-C-N 121.378 -0.826 . . . . 0.0 112.02 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.4 p -86.18 -16.09 38.89 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.317 0.508 . . . . 0.0 112.02 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.25 -43.37 8.09 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.456 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.05 -10.93 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -170.66 152.44 3.81 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.985 -1.072 . . . . 0.0 110.764 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.54 162.16 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -100.84 123.74 45.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.63 0.729 . . . . 0.0 109.89 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.26 90.43 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 32.3 ttmt -117.42 106.01 12.75 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.287 0.992 . . . . 0.0 110.344 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 73.0 p -138.55 -177.45 4.86 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.767 1.227 . . . . 0.0 110.583 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 24.1 m -79.93 -9.95 59.73 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.689 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.24 -19.48 13.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.833 1.253 . . . . 0.0 112.89 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -153.83 140.41 18.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.637 0.732 . . . . 0.0 109.244 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 89.5 m -144.09 89.03 2.0 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.318 0.647 . . . . 0.0 109.866 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -148.33 -171.37 3.83 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 122.671 1.224 . . . . 0.0 109.912 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 423' ' ' LYS . 42.0 mtmt -130.39 168.61 16.69 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.322 1.058 . . . . 0.0 110.179 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.58 138.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.258 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.65 154.85 25.44 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 124.806 1.316 . . . . 0.0 113.707 -168.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.72 134.47 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.448 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -137.56 156.72 74.7 Favored Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.884 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.33 163.51 37.65 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.856 3.037 . . . . 0.0 110.47 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 52.2 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.995 -176.178 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 59.8 mmm . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.517 0.198 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.7 m 36.21 59.3 0.94 Allowed 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 111.746 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -4.55 36.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.7 m 44.01 52.72 6.7 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.511 1.05 . . . . 0.0 111.959 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.76 72.81 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.354 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 57.01 32.48 21.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.45 146.02 95.96 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.214 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.09 124.57 9.17 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 124.731 3.621 . . . . 0.0 112.713 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.26 5.26 6.03 Favored 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 127.278 5.318 . . . . 0.0 114.325 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -127.93 26.22 5.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 118.916 0.78 . . . . 0.0 112.573 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.63 34.1 1.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.275 1.03 . . . . 0.0 108.67 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.58 176.3 9.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -169.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -67.14 150.58 48.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.223 1.809 . . . . 0.0 106.719 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -71.92 156.71 90.66 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 120.029 1.286 . . . . 0.0 112.264 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.49 140.16 21.86 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 124.232 3.288 . . . . 0.0 115.323 -170.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.3 mm -155.3 152.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.444 ' CG ' HG11 ' A' ' 292' ' ' VAL . 4.3 m-85 -125.18 149.83 47.54 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.604 1.093 . . . . 0.0 110.938 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.7 p -148.25 11.66 0.92 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -170.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.4 t -152.48 -167.33 2.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.636 1.107 . . . . 0.0 109.057 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -59.09 171.51 0.71 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 152.88 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 21.9 m-30 -90.25 145.11 25.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.777 -0.577 . . . . 0.0 109.794 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.48 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.5 tm? -149.13 126.51 11.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.436 ' N ' HD13 ' A' ' 240' ' ' LEU . . . 173.21 165.93 30.85 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 119.276 0.944 . . . . 0.0 112.194 -176.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.56 3.27 1.0 Allowed Glycine 0 CA--C 1.547 2.034 0 O-C-N 124.699 0.882 . . . . 0.0 112.27 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.9 m -107.87 121.79 42.88 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.417 0.609 . . . . 0.0 112.597 -170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.07 -13.93 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 123.281 2.654 . . . . 0.0 112.059 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.445 ' HE1' ' HB2' ' A' ' 324' ' ' LYS . 30.0 p-90 -124.03 -17.52 6.21 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -50.48 104.66 0.08 Allowed 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 118.928 0.786 . . . . 0.0 110.593 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -18.77 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 O-C-N 126.02 2.075 . . . . 0.0 115.781 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.0 m -152.48 126.91 9.31 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 124.486 1.116 . . . . 0.0 110.328 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.03 -34.16 68.59 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.77 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.21 66.04 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 120.051 1.296 . . . . 0.0 110.718 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.64 -55.9 27.96 Favored Glycine 0 C--N 1.368 2.32 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.92 -37.9 72.11 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.673 0.867 . . . . 0.0 111.124 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.44 -22.55 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 123.383 0.673 . . . . 0.0 110.284 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -94.34 -4.94 47.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.77 -0.581 . . . . 0.0 110.867 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -82.38 -24.43 34.47 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.548 -1.345 . . . . 0.0 111.046 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.35 26.58 1.62 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.641 ' HA ' HD11 ' A' ' 262' ' ' LEU . 53.6 ptt85 -94.46 -0.23 54.88 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.585 1.993 . . . . 0.0 113.466 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 -21.41 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.257 0.623 . . . . 0.0 111.243 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.09 -4.25 54.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.653 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.42 -125.61 0.77 Allowed Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.129 -0.982 . . . . 0.0 115.276 -170.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.5 t -153.69 110.83 3.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 124.562 0.801 . . . . 0.0 109.888 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.641 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -151.61 162.28 41.25 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 176.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 64.0 m -146.62 170.73 16.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.208 1.803 . . . . 0.0 109.763 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.78 143.06 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 123.878 0.871 . . . . 0.0 111.864 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -145.94 135.74 23.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.86 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 277' ' ' PRO . 21.9 p90 -161.23 149.03 12.34 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 125.69 1.596 . . . . 0.0 110.893 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.83 152.54 14.77 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 112.893 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.78 28.72 23.06 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.288 -0.729 . . . . 0.0 111.669 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -59.3 -36.28 75.31 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 120.127 1.964 . . . . 0.0 110.953 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 25.7 t0 33.41 89.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.471 2.308 . . . . 0.0 113.31 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.71 172.06 24.43 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 122.328 0.96 . . . . 0.0 111.604 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -60.62 -25.64 66.42 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.699 -0.883 . . . . 0.0 111.686 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -134.12 155.23 80.22 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.754 1.222 . . . . 0.0 108.016 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.57 107.1 2.38 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.676 1.584 . . . . 0.0 108.237 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -119.28 -166.61 1.28 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.328 0.651 . . . . 0.0 111.139 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.6 135.05 34.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.421 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 266' ' ' TRP . 44.3 Cg_endo -83.44 148.58 12.87 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 124.516 3.478 . . . . 0.0 112.024 170.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.27 -6.6 17.35 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.794 2.329 . . . . 0.0 111.367 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 279' ' ' LYS . 7.9 ptpp? -95.77 -6.23 40.14 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.992 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.68 17.47 41.78 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-O 118.786 -1.008 . . . . 0.0 115.405 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -128.68 154.57 46.16 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 117.696 0.748 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.7 t -152.34 165.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -122.56 148.72 44.87 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.4 mt -108.23 143.86 36.48 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.49 1.138 . . . . 0.0 110.622 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.79 109.94 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -158.72 -165.42 1.65 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.695 -171.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.31 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.749 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.7 pt? -69.41 14.48 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.873 2.469 . . . . 0.0 114.802 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.74 -59.2 1.08 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.172 0.92 . . . . 0.0 111.242 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -90.31 -34.01 15.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 46.9 m -74.05 -17.1 61.01 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 119.391 0.996 . . . . 0.0 108.657 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 234' ' ' TYR . 46.6 t -76.14 -57.76 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.42 -32.57 73.43 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.741 -1.225 . . . . 0.0 112.818 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 25.0 m -68.37 -42.59 78.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.036 0.834 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.12 -39.45 49.37 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.76 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.7 mt -60.51 -25.6 66.22 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.555 1.071 . . . . 0.0 111.789 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.04 -6.82 23.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.99 22.21 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 123.796 0.685 . . . . 0.0 109.784 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 314' ' ' PHE . 24.2 p -97.85 -153.86 0.44 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.4 t -117.09 174.88 5.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.628 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -149.84 150.7 32.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -135.15 124.87 16.66 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.308 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -81.03 37.53 0.69 Allowed 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 124.416 3.411 . . . . 0.0 108.262 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.886 0 CA-C-N 119.421 1.01 . . . . 0.0 111.941 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 121.356 0.598 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 58.8 m -132.56 151.69 51.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -144.65 139.02 27.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.419 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.87 144.67 42.02 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.161 0.984 . . . . 0.0 110.961 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 327' ' ' GLN . 59.8 m-85 -136.93 159.16 42.71 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.742 0.817 . . . . 0.0 110.524 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 299' ' ' CYS . 10.4 t80 -156.86 170.68 21.93 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.2 0.938 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.68 124.9 24.56 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -141.6 28.42 1.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.413 -168.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.1 p -43.99 138.56 2.79 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.801 1.182 . . . . 0.0 112.908 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 18.2 t -116.43 -51.15 2.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -73.56 -26.21 60.73 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 108.925 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 55.24 26.07 8.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.935 1.694 . . . . 0.0 113.4 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -78.37 -20.01 52.19 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -159.57 177.3 11.06 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.67 134.5 44.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.277 1.431 . . . . 0.0 108.624 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 59.2 tptt -136.76 -7.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.43 175.43 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.811 1.291 . . . . 0.0 113.75 -171.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -151.03 153.76 9.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.843 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.471 ' HB3' ' CE1' ' A' ' 313' ' ' TYR . 3.0 pp0? -117.79 156.04 29.02 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.32 139.89 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.694 -175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.53 119.36 4.26 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 124.153 0.908 . . . . 0.0 109.819 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -95.82 161.74 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.365 4.043 . . . . 0.0 111.751 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 3.3 t-105 -70.38 118.58 13.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.56 149.65 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 110.497 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.06 -39.26 81.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.833 0.853 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.67 2.91 10.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 122.918 0.487 . . . . 0.0 112.235 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -93.27 -9.82 37.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.172 -0.955 . . . . 0.0 110.95 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 51.4 m -90.96 -58.44 2.47 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -160.9 173.49 15.24 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.892 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.65 161.52 41.54 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.783 0.833 . . . . 0.0 111.412 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.52 166.88 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 122.545 1.164 . . . . 0.0 110.837 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -126.33 27.51 6.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.694 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 342' ' ' PRO . 85.9 p -147.87 167.93 12.32 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 117.22 -1.371 . . . . 0.0 110.061 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 341' ' ' SER . 74.4 Cg_endo -69.71 56.91 1.41 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 124.821 3.681 . . . . 0.0 109.982 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.6 t 55.67 38.91 30.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.383 0.673 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -71.91 151.32 43.42 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -65.03 157.15 29.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.98 160.48 4.73 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.871 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.88 139.0 87.93 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.2 94.44 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.866 2.377 . . . . 0.0 111.891 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 63.4 m 62.83 49.83 3.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.761 -1.563 . . . . 0.0 114.334 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -140.99 43.3 1.81 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 109.332 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.444 ' HB ' HG22 ' A' ' 397' ' ' THR . 1.8 t -117.38 159.06 23.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 159.08 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.16 147.67 36.37 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.008 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 83.3 t -130.75 136.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.395 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -172.44 -157.72 14.95 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.589 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 425' ' ' GLN . . . 60.66 29.54 19.08 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.377 1.071 . . . . 0.0 111.981 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.484 HD22 HD22 ' A' ' 361' ' ' LEU . 24.6 mt -76.72 164.45 25.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.432 1.083 . . . . 0.0 110.293 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -77.62 12.7 1.53 Allowed 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.468 -0.77 . . . . 0.0 112.573 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 97.0 2.49 59.37 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 119.028 -0.873 . . . . 0.0 112.362 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 mmt -145.23 -71.32 0.26 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.039 0.92 . . . . 0.0 111.643 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.484 HD22 HD22 ' A' ' 357' ' ' LEU . 12.8 tp 38.0 69.36 0.25 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.789 0.804 . . . . 0.0 111.094 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -67.33 179.3 1.28 Allowed 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.158 -0.964 . . . . 0.0 113.041 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.21 -27.07 65.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -170.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.96 -15.2 57.76 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 119.34 0.973 . . . . 0.0 112.289 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -92.63 -27.1 17.53 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.389 0.43 . . . . 0.0 111.186 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.4 mt -76.22 -37.03 58.26 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 124.74 1.275 . . . . 0.0 110.426 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.0 56.14 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.33 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.23 -50.52 73.34 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.8 -32.07 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 123.914 0.759 . . . . 0.0 111.632 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.96 -28.96 18.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.608 -1.307 . . . . 0.0 113.774 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.63 -19.86 27.15 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.682 1.128 . . . . 0.0 113.742 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -113.86 -17.3 12.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 120.051 1.296 . . . . 0.0 111.083 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 373' ' ' LEU . 10.3 tp -97.6 -3.99 38.49 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 118.873 0.76 . . . . 0.0 111.286 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -152.03 -48.05 0.11 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.47 -1.73 88.29 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.442 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.35 111.37 2.24 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.97 166.28 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 123.865 0.866 . . . . 0.0 110.396 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 -29.03 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.21 153.64 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 109.645 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -155.12 132.23 10.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.68 158.3 27.79 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 121.163 -0.96 . . . . 0.0 113.575 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.02 138.91 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.242 1.817 . . . . 0.0 108.037 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.89 153.5 23.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.081 0.467 . . . . 0.0 112.128 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 5.3 p -137.47 165.79 25.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.064 0.459 . . . . 0.0 110.233 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.21 -178.83 5.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.47 100.36 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.045 0.384 . . . . 0.0 111.107 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.2 m170 50.41 40.86 23.95 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.93 1.292 . . . . 0.0 110.848 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -88.72 -20.62 24.58 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.344 0.658 . . . . 0.0 109.72 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.0 p90 38.8 53.56 4.25 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 0.0 112.954 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.65 -48.24 0.42 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.716 3.61 . . . . 0.0 111.271 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 8.6 tp 41.05 41.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.277 1.431 . . . . 0.0 111.49 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -162.11 14.43 0.13 Allowed Glycine 0 C--N 1.349 1.299 0 C-N-CA 121.077 -0.582 . . . . 0.0 114.132 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.2 p -156.33 132.07 9.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.11 0.955 . . . . 0.0 110.796 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.08 -164.83 25.45 Favored Glycine 0 C--O 1.209 -1.415 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.349 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -142.09 166.82 23.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.505 -0.848 . . . . 0.0 110.624 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.23 146.42 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.627 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.444 HG22 ' HB ' ' A' ' 351' ' ' THR . 26.2 p -125.99 122.61 36.4 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 122.252 1.025 . . . . 0.0 108.362 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.12 -28.45 25.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.721 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.4 t30 54.07 17.09 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.301 1.048 . . . . 0.0 112.585 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -141.4 164.23 30.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.234 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -99.68 -45.31 5.81 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.56 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.82 -25.64 66.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.617 1.098 . . . . 0.0 112.921 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.0 p -84.99 -18.48 34.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -72.92 -56.09 5.67 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.583 0.629 . . . . 0.0 109.964 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.27 63.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.753 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -77.08 -24.89 51.84 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.88 1.218 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.98 -29.43 35.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.565 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.1 m -78.92 -18.29 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 123.798 0.686 . . . . 0.0 112.203 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 91.3 p -88.9 -22.16 23.27 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -85.76 -44.56 12.4 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.299 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.48 -2.24 0.0 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 128.551 2.74 . . . . 0.0 116.627 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.4 141.15 14.58 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.73 163.36 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 119.103 0.865 . . . . 0.0 109.229 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.459 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 28.2 mt-10 -119.83 131.99 55.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.993 1.378 . . . . 0.0 112.552 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.443 ' HB ' ' H ' ' A' ' 422' ' ' LYS . 6.4 mm -93.95 117.09 36.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -117.61 25.71 10.22 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.909 0.777 . . . . 0.0 109.838 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 419' ' ' LYS . 86.2 m -63.74 158.12 22.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.021 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -86.17 -2.54 58.45 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 123.455 0.702 . . . . 0.0 112.149 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 417' ' ' THR . 39.4 pttt -128.22 -1.6 5.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.498 1.119 . . . . 0.0 111.523 174.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -150.26 127.52 11.34 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.6 m -142.08 109.1 5.47 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.195 -0.94 . . . . 0.0 111.105 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 33.6 tptt -167.22 -156.46 0.21 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 117.899 0.318 . . . . 0.0 111.416 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.657 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 98.7 mttt -141.11 176.21 9.01 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.601 0.76 . . . . 0.0 109.674 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.62 154.11 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 356' ' ' ALA . 49.1 tt0 -117.03 151.75 36.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.887 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.99 139.46 47.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -142.81 113.12 5.87 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.98 161.77 40.48 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.701 3.6 . . . . 0.0 112.33 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.606 -1.664 . . . . 0.0 111.51 178.291 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.035 0.445 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 221' ' ' SER . 9.7 m 45.45 55.97 6.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.409 1.099 . . . . 0.0 113.101 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.41 18.72 0.07 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.191 0.997 . . . . 0.0 113.245 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 219' ' ' THR . 66.4 m -37.21 121.02 0.8 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.04 1.336 . . . . 0.0 113.288 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.8 0.91 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-O 118.266 -1.296 . . . . 0.0 114.035 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -89.51 -29.75 18.74 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.387 1.593 . . . . 0.0 109.564 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 10.8 mt 61.7 148.42 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 115.064 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 48.8 Cg_exo -63.01 131.14 31.49 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.641 2.227 . . . . 0.0 111.769 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 1.7 Cg_endo -82.15 147.32 14.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.208 2.606 . . . . 0.0 109.209 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -144.88 22.42 1.59 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.34 30.68 3.74 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.555 0.742 . . . . 0.0 111.627 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -71.11 161.17 31.57 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 111.384 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -135.27 -143.34 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.357 1.063 . . . . 0.0 108.594 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.4 p30 36.17 51.51 1.68 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.536 1.534 . . . . 0.0 113.655 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.83 119.28 6.28 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.936 1.757 . . . . 0.0 112.131 -173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.1 mm -129.75 140.65 48.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -104.27 155.02 19.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.987 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.3 t -137.58 -34.97 0.67 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 90.8 m -147.07 78.79 1.5 Allowed 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.67 0.748 . . . . 0.0 112.746 -168.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 19.5 pttm 52.23 -169.07 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.64 145.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -87.77 149.58 24.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.489 1.116 . . . . 0.0 110.504 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 241' ' ' GLY . 0.6 OUTLIER -149.63 117.61 6.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.121 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . -179.89 -178.23 48.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 122.192 0.884 . . . . 0.0 112.722 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.02 15.93 1.46 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 124.31 0.957 . . . . 0.0 114.792 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.51 130.27 26.02 Favored Pre-proline 0 N--CA 1.473 0.719 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 13.3 Cg_endo -87.91 -8.69 5.77 Favored 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 124.156 3.237 . . . . 0.0 112.57 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.478 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 11.5 p-90 -147.34 -7.8 0.45 Allowed 'General case' 0 C--O 1.251 1.172 0 CA-C-N 120.585 1.539 . . . . 0.0 114.876 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.33 110.55 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.486 -1.383 . . . . 0.0 108.931 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -20.25 25.68 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.152 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.3 p -153.31 154.49 34.68 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 119.416 -2.053 . . . . 0.0 111.451 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -16.89 39.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.56 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.44 -17.6 60.11 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.84 -62.28 2.86 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.75 -31.18 68.99 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 118.593 -1.243 . . . . 0.0 111.448 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.89 -50.91 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.657 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.51 -5.19 31.3 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.6 m -79.83 -21.58 44.02 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.899 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -131.59 -1.31 3.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 257' ' ' ARG . 26.4 ttt-85 -81.13 -21.39 39.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.304 1.442 . . . . 0.0 111.287 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 258' ' ' VAL . 1.2 m -61.13 -16.86 15.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 O-C-N 125.262 1.601 . . . . 0.0 115.291 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -133.48 -5.76 2.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.783 1.233 . . . . 0.0 110.649 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -94.24 -166.42 36.8 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.589 ' H ' HD11 ' A' ' 295' ' ' LEU . 73.0 m -146.47 65.82 1.19 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.492 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -147.75 171.16 16.11 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.752 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 61.5 m -138.88 174.9 10.03 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -131.24 139.41 50.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 CA-C-O 122.62 1.2 . . . . 0.0 110.949 -174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.23 142.02 24.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.237 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -163.81 142.04 5.98 Favored Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.95 -177.34 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.77 3.647 . . . . 0.0 111.787 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 67.74 -5.15 3.57 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -142.58 44.55 1.62 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 119.911 1.856 . . . . 0.0 110.619 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.12 153.03 40.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.469 0.652 . . . . 0.0 110.128 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.39 -6.27 38.93 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.015 0.817 . . . . 0.0 111.69 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -157.91 -27.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.427 1.113 . . . . 0.0 113.244 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.36 76.11 9.34 Favored Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.29 112.32 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.091 3.194 . . . . 0.0 111.203 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -170.86 -166.83 0.51 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.43 146.59 77.72 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.58 166.2 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.854 3.036 . . . . 0.0 109.18 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.74 4.16 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.632 2.888 . . . . 0.0 111.964 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -120.48 167.93 11.86 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.73 10.22 68.49 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.552 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 16.0 p90 -146.24 162.62 37.68 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.4 m -156.96 -166.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 129.069 2.948 . . . . 0.0 108.032 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -132.58 152.24 51.68 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.234 -0.916 . . . . 0.0 111.887 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.401 HD22 HD23 ' A' ' 262' ' ' LEU . 77.5 mt -110.16 140.35 44.35 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.24 0.962 . . . . 0.0 109.979 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.0 -153.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.04 0.536 . . . . 0.0 110.45 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . 0.315 33.0 t80 78.62 -107.01 0.02 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.805 -173.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.02 128.54 34.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 120.574 1.534 . . . . 0.0 107.544 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.76 17.19 3.31 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.491 1.119 . . . . 0.0 112.651 -167.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.9 -71.12 0.71 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.577 1.151 . . . . 0.0 111.833 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -79.26 -19.3 50.92 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.669 -1.27 . . . . 0.0 112.585 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 24.5 m -101.26 -8.33 22.24 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.79 0.723 . . . . 0.0 111.556 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 5.6 m -85.24 -40.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.0 -59.61 4.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.34 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.0 p -76.57 -39.58 52.31 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 120.069 1.304 . . . . 0.0 112.12 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.589 HD11 ' H ' ' A' ' 261' ' ' SER . 65.3 mt -68.57 -34.01 75.07 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -171.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -94.23 -12.89 27.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.317 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.05 0.87 54.53 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.652 0.66 . . . . 0.0 111.096 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.49 -24.63 14.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 96.7 m -78.86 -152.96 0.06 Allowed 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.767 170.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.4 m -118.81 166.89 12.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 120.675 -1.265 . . . . 0.0 111.997 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -144.99 151.74 39.06 Favored 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 122.414 0.286 . . . . 0.0 110.982 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.28 138.68 16.82 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -87.07 20.72 1.17 Allowed 'Trans proline' 0 N--CA 1.431 -2.197 0 C-N-CA 122.293 1.996 . . . . 0.0 111.478 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.9 m -67.91 168.85 10.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -139.18 154.51 48.07 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.09 156.66 18.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -152.69 155.69 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.354 0.409 . . . . 0.0 111.097 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -153.47 152.73 31.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.512 ' HD2' ' H ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -111.89 146.28 38.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.407 ' HE2' ' CG1' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -148.49 -1.98 0.51 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.903 1.377 . . . . 0.0 110.541 -169.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 69.8 m -71.68 145.84 48.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.638 0.586 . . . . 0.0 112.503 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.8 m -85.2 149.79 25.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 124.358 1.036 . . . . 0.0 110.747 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -62.21 -15.53 47.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.754 -170.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.79 -23.34 67.32 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.598 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -159.65 15.04 0.15 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -44.21 142.59 1.43 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.043 0.925 . . . . 0.0 112.116 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 48.3 t -164.44 -35.64 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.031 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -137.1 163.81 29.92 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.575 0.75 . . . . 0.0 111.849 -173.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.57 167.05 10.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.443 2.697 . . . . 0.0 112.092 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.407 ' CG1' ' HE2' ' A' ' 316' ' ' MET . 12.5 m -104.15 160.42 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.88 0.848 . . . . 0.0 112.269 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 153.24 17.76 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.134 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 16.9 t -137.87 130.51 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.363 1.04 . . . . 0.0 109.946 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.5 mt -138.65 119.28 9.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.979 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.22 168.69 7.55 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.246 2.631 . . . . 0.0 110.221 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.527 ' CH2' ' HB ' ' A' ' 391' ' ' ILE . 2.9 t-105 -104.52 123.95 48.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.495 0.664 . . . . 0.0 111.68 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.21 143.67 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.558 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 333' ' ' LEU . 4.3 tt -52.53 -40.64 62.69 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 125.109 1.364 . . . . 0.0 109.851 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.59 57.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 122.277 -0.265 . . . . 0.0 110.847 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.88 -18.09 38.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.494 -1.378 . . . . 0.0 110.766 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 p -111.79 -25.97 9.2 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.844 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -141.1 142.34 34.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.883 0.765 . . . . 0.0 110.612 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -157.33 153.47 27.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.433 -1.417 . . . . 0.0 111.144 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.57 147.37 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.65 31.55 5.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.689 0.796 . . . . 0.0 109.636 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.8 t -145.72 145.94 27.33 Favored Pre-proline 0 CA--C 1.52 -0.208 0 C-N-CA 124.16 0.984 . . . . 0.0 108.396 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.21 -7.11 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.175 2.584 . . . . 0.0 111.45 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.9 p -135.1 164.58 27.33 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.693 0.797 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.93 132.97 34.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.411 0.624 . . . . 0.0 112.059 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -154.9 162.56 41.06 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.083 1.353 . . . . 0.0 110.411 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 17.8 tp -151.59 175.43 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.837 1.336 . . . . 0.0 107.76 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.425 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 9.0 t70 -145.95 129.07 8.21 Favored Pre-proline 0 N--CA 1.446 -0.674 0 O-C-N 120.931 -1.106 . . . . 0.0 109.679 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.18 0.87 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.962 1 C-N-CA 126.507 4.805 . . . . 0.0 114.996 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 14.6 t -131.67 -7.3 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.677 -0.677 . . . . 0.0 111.935 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -135.91 77.3 1.65 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.42 1.009 . . . . 0.0 110.112 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.1 p -135.54 84.67 2.11 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.328 1.643 . . . . 0.0 108.647 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.74 145.55 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.048 0.451 . . . . 0.0 111.239 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -73.08 150.39 42.33 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.122 0.963 . . . . 0.0 112.405 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.8 140.83 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.073 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.47 -166.56 23.59 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 122.25 0.917 . . . . 0.0 114.108 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.46 38.69 30.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.543 0.687 . . . . 0.0 110.248 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.26 -179.65 7.25 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.174 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -56.71 -11.87 1.58 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.231 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.59 88.15 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.192 0.906 . . . . 0.0 113.78 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.6 ptm -165.85 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.161 0.584 . . . . 0.0 110.814 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.68 144.06 52.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -94.88 159.3 15.1 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.75 60.29 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.144 -0.973 . . . . 0.0 112.524 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.66 -29.02 61.1 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.75 -26.23 24.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.22 0.95 . . . . 0.0 109.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 tt -72.42 -46.95 52.81 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -71.64 -24.28 61.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 110.224 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.04 -45.56 66.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.535 0.683 . . . . 0.0 109.799 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.39 -44.24 94.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.4 -15.04 51.29 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.829 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.95 -16.46 21.71 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 120.283 1.402 . . . . 0.0 112.169 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.48 -25.78 14.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 373' ' ' LEU . 13.2 tp -72.75 -24.81 61.01 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.203 0.94 . . . . 0.0 110.803 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 403' ' ' SER . 3.9 p90 -163.41 -24.71 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.459 0.572 . . . . 0.0 112.159 174.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 72.67 157.93 4.0 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.724 -0.61 . . . . 0.0 112.37 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 126.12 15.68 2.77 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 121.871 0.706 . . . . 0.0 111.58 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.81 173.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.053 -0.573 . . . . 0.0 112.132 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.97 -26.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.416 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -157.82 157.68 33.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.37 0.987 . . . . 0.0 110.079 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.04 141.48 28.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.79 133.64 4.76 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.512 1.062 . . . . 0.0 113.523 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.67 145.9 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.5 70.38 7.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.82 150.27 48.82 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.127 0.571 . . . . 0.0 112.097 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.83 164.19 29.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -56.68 103.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.307 0.643 . . . . 0.0 112.128 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 m170 53.05 26.65 4.99 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.788 1.635 . . . . 0.0 113.613 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -85.58 -8.39 58.31 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.157 -0.964 . . . . 0.0 111.672 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.441 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 41.9 p90 54.3 45.57 2.38 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.875 1.67 . . . . 0.0 113.053 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 86.0 Cg_endo -73.97 -66.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.034 2.489 . . . . 0.0 110.738 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.54 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 8.9 tp 38.79 35.14 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.9 0.88 . . . . 0.0 113.338 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.66 15.12 0.45 Allowed Glycine 0 CA--C 1.524 0.649 0 O-C-N 121.321 -0.862 . . . . 0.0 113.53 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 62.7 p -151.68 154.29 36.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 166.77 -146.86 11.26 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.615 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -149.29 171.36 16.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.34 136.67 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 122.077 0.942 . . . . 0.0 110.332 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.8 m -99.15 133.08 43.95 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.403 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -115.33 179.32 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -144.25 5.84 1.29 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.15 166.62 24.17 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -83.94 -29.65 26.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.114 0.566 . . . . 0.0 110.516 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.662 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -66.42 -27.72 68.05 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.143 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.431 ' HA ' ' CE1' ' A' ' 374' ' ' PHE . 51.0 m -73.12 -27.4 61.66 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.013 0.824 . . . . 0.0 110.536 174.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.78 -56.0 6.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.821 0.82 . . . . 0.0 110.201 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -8.83 56.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.884 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -100.77 -21.19 15.25 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.914 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.05 -34.16 44.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 43.2 t -83.58 -33.93 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 122.808 0.443 . . . . 0.0 110.769 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.0 t -70.44 -32.64 70.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 119.724 1.147 . . . . 0.0 109.051 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.04 -52.66 13.52 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.865 0.84 . . . . 0.0 110.175 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.24 -17.5 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 126.678 1.991 . . . . 0.0 115.672 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.91 142.78 16.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.34 0.518 . . . . 0.0 110.354 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.94 154.26 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 122.254 -0.279 . . . . 0.0 110.537 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -101.54 140.66 35.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 415' ' ' ILE . 2.8 mp -105.06 126.88 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -131.1 121.79 25.58 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.3 m -150.64 162.75 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -172.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.7 t -65.67 -5.16 7.65 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -145.58 4.43 1.02 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.346 1.058 . . . . 0.0 113.368 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -150.63 129.45 12.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.784 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.8 p -147.9 102.17 3.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -147.88 173.31 12.97 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -118.87 179.08 4.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.3 145.88 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.12 144.65 48.81 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 122.931 0.144 . . . . 0.0 110.766 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.94 145.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -138.44 138.94 23.43 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.1 155.68 63.42 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.168 2.579 . . . . 0.0 110.15 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.066 -170.727 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 218' ' ' MET . . . . . 0.461 ' CG ' HG12 ' A' ' 413' ' ' VAL . 11.0 tpt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.8 m -153.11 159.22 42.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.241 1.417 . . . . 0.0 109.754 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 17.61 0.65 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.247 0.619 . . . . 0.0 112.479 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.6 m 61.06 26.65 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.078 1.751 . . . . 0.0 115.205 172.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 51.59 68.09 1.69 Allowed Glycine 0 CA--C 1.536 1.395 0 CA-C-O 121.117 0.287 . . . . 0.0 113.202 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.48 -17.19 63.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.375 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.7 mm? -105.62 151.82 39.92 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-O 121.365 0.602 . . . . 0.0 110.499 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.5 110.89 2.5 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.55 4.69 6.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.347 3.365 . . . . 0.0 111.989 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -143.46 -171.29 3.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.819 1.248 . . . . 0.0 109.195 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 25.8 m120 57.73 22.74 8.74 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.296 1.839 . . . . 0.0 114.078 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -62.55 -36.74 83.62 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.145 -0.347 . . . . 0.0 110.224 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 39.84 54.41 2.58 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.9 59.47 39.0 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 332' ' ' VAL . 83.5 Cg_endo -70.83 127.39 13.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.308 3.338 . . . . 0.0 114.43 -171.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.8 mm -146.14 131.54 12.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 102.604 -3.109 . . . . 0.0 102.604 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 292' ' ' VAL . 12.0 m-85 -98.45 143.03 29.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.768 -1.173 . . . . 0.0 109.231 -169.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.9 p -137.14 -1.24 2.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 14.7 t -158.97 -166.28 1.82 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.026 1.285 . . . . 0.0 108.317 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 176.91 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.535 1.134 . . . . 0.0 112.564 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.1 142.35 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.49 1.138 . . . . 0.0 109.01 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.25 130.12 38.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.512 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -137.07 113.57 10.14 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.94 173.98 38.35 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-O 121.418 0.454 . . . . 0.0 113.73 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 115.05 18.83 6.16 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.357 -1.421 . . . . 0.0 114.009 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.3 m -92.0 126.09 54.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.501 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -82.03 -17.03 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.991 3.128 . . . . 0.0 111.483 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.443 ' CH2' ' HG3' ' A' ' 321' ' ' MET . 30.1 p-90 -130.54 -70.06 0.63 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.146 0.884 . . . . 0.0 109.709 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 245' ' ' TRP . 26.7 t70 10.97 90.72 0.01 OUTLIER 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.768 1.627 . . . . 0.0 113.225 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.434 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -63.96 -22.0 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 250' ' ' ALA . 11.7 m -150.33 143.15 24.7 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-N 121.029 1.74 . . . . 0.0 108.916 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.19 -24.93 64.11 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.197 0.999 . . . . 0.0 109.52 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.54 -13.94 62.59 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.54 1.136 . . . . 0.0 110.689 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.83 -58.16 5.94 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 54.8 mt -50.49 -47.21 57.32 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 122.199 0.999 . . . . 0.0 109.437 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 264' ' ' VAL . 77.3 t -57.42 -45.59 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.916 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -73.92 -8.03 54.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.904 0.32 . . . . 0.0 110.853 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 84.6 m -90.49 -20.56 22.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.99 32.58 1.12 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.441 1.019 . . . . 0.0 112.468 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -88.25 14.98 8.25 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.14 12.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 O-C-N 120.541 -1.349 . . . . 0.0 112.37 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -93.36 -1.69 55.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.114 0.87 . . . . 0.0 111.56 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 70.12 -0.26 24.33 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.5 t -124.89 18.31 8.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.704 -0.88 . . . . 0.0 112.076 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.53 143.42 28.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.366 -0.533 . . . . 0.0 112.25 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.6 m -150.71 153.15 35.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 253' ' ' VAL . 93.5 t -138.17 138.76 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 124.012 0.82 . . . . 0.0 111.29 -169.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -143.45 156.19 44.58 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.488 1.118 . . . . 0.0 113.651 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -151.18 167.32 13.23 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.56 -19.28 22.8 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 124.087 3.191 . . . . 0.0 115.681 -168.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 170.46 157.53 12.77 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.085 1.311 . . . . 0.0 111.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -102.16 15.3 29.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.761 0.824 . . . . 0.0 112.766 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.86 144.41 47.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.639 1.176 . . . . 0.0 108.936 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.24 177.37 15.33 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.285 0.936 . . . . 0.0 110.775 -176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.74 173.36 8.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.553 -0.969 . . . . 0.0 108.494 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 60.66 142.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.539 1.135 . . . . 0.0 112.223 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.9 -11.87 11.1 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 123.852 3.034 . . . . 0.0 111.415 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -101.06 33.0 2.99 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.822 0.849 . . . . 0.0 111.991 -171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 48.9 t 64.98 144.58 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 124.685 1.194 . . . . 0.0 110.342 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.617 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 71.2 Cg_endo -66.55 166.08 23.09 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.068 1.846 . . . . 0.0 112.972 171.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.7 113.3 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 CA-C-O 122.643 1.018 . . . . 0.0 111.396 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -143.52 145.79 32.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.247 1.419 . . . . 0.0 109.977 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -92.8 4.11 75.07 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.236 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.93 165.79 35.57 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.62 161.66 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.863 1.265 . . . . 0.0 109.74 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -97.39 149.37 22.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.579 1.081 . . . . 0.0 109.752 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.509 HD23 HG22 ' A' ' 264' ' ' VAL . 81.6 mt -117.79 137.09 52.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.16 107.52 11.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -153.51 -161.68 1.31 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 124.445 1.091 . . . . 0.0 111.058 -168.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.19 92.48 0.04 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.8 pt? -67.03 17.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.792 2.437 . . . . 0.0 117.011 -168.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.86 -60.12 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.102 1.319 . . . . 0.0 109.98 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -86.19 -23.71 26.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.264 -0.897 . . . . 0.0 112.862 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 12.2 t -84.12 -22.73 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 286' ' ' PHE . 24.1 t -72.66 -48.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.561 0.696 . . . . 0.0 109.577 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.3 ptp180 -74.95 -25.67 59.04 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.551 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 48.0 m -78.18 -37.23 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 0.0 112.672 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.95 -35.96 67.08 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.34 -24.21 62.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.087 0.858 . . . . 0.0 110.006 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -92.11 -2.35 56.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.76 -18.14 18.97 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.125 -1.609 . . . . 0.0 110.226 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.84 -151.32 0.44 Allowed 'General case' 0 C--O 1.24 0.554 0 O-C-N 125.925 2.016 . . . . 0.0 110.411 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -126.46 177.94 6.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.191 0.932 . . . . 0.0 113.125 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 310' ' ' SER . 83.3 t60 -145.8 162.03 38.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.45 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -144.12 131.78 10.66 Favored Pre-proline 0 C--N 1.351 0.648 0 O-C-N 124.026 0.829 . . . . 0.0 110.102 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -86.75 23.87 0.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 1 C-N-CA 125.807 4.338 . . . . 0.0 111.174 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 C-N-CA 123.517 0.727 . . . . 0.0 111.736 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 29.0 m -108.61 158.18 17.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.312 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -138.06 135.56 35.97 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.004 -171.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.2 148.88 25.87 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.24 149.42 51.98 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.177 -0.952 . . . . 0.0 111.141 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -151.88 168.03 26.44 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 123.313 1.53 . . . . 0.0 109.785 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.7 ptpt -130.46 116.74 18.64 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.921 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.5 OUTLIER -110.99 28.46 8.7 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -176.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 86.1 p -79.61 164.31 23.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.029 0.932 . . . . 0.0 111.401 -174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 66.6 m -117.05 176.13 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 15.7 ptp180 -79.1 23.71 0.35 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -128.79 15.16 6.42 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.63 0.772 . . . . 0.0 110.778 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.443 ' HG3' ' CH2' ' A' ' 245' ' ' TRP . 16.6 mmt -137.52 179.65 6.28 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -130.8 103.41 6.56 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.678 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.7 m 64.88 166.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 111.419 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -155.34 -64.6 0.12 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.749 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 44.05 69.61 0.4 Allowed 'General case' 0 C--N 1.343 0.318 0 O-C-N 123.84 0.713 . . . . 0.0 112.652 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.7 p -83.99 160.0 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 121.902 -0.499 . . . . 0.0 109.987 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -102.8 153.59 20.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.509 0.595 . . . . 0.0 110.114 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.3 139.15 49.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 329' ' ' ILE . 19.7 tt -155.83 88.1 3.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 122.854 1.311 . . . . 0.0 108.123 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.16 164.75 26.67 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.868 2.379 . . . . 0.0 113.062 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -78.28 122.49 25.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.104 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 334' ' ' ALA . 86.8 t -103.84 148.6 8.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 122.463 1.125 . . . . 0.0 110.161 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.44 -38.62 59.65 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.554 1.142 . . . . 0.0 110.775 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -64.32 -3.09 2.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.706 0.403 . . . . 0.0 111.892 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -102.96 7.24 39.2 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 120.823 -1.173 . . . . 0.0 111.202 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.9 m -119.85 -49.37 2.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -151.13 157.41 42.7 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 119.122 0.873 . . . . 0.0 111.609 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.452 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 54.2 t80 -156.08 143.33 19.15 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.901 1.375 . . . . 0.0 109.342 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.27 154.57 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.999 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -117.87 41.18 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.8 t -137.61 147.15 56.24 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.548 1.139 . . . . 0.0 110.074 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.66 -3.36 13.76 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.564 2.176 . . . . 0.0 111.022 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.8 m -130.19 -176.85 4.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -105.86 135.95 46.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.728 -1.233 . . . . 0.0 110.243 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -159.59 165.75 32.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.083 -1.011 . . . . 0.0 109.321 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.37 150.7 25.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.057 1.343 . . . . 0.0 110.04 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.1 110.78 8.51 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.13 -2.09 11.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.864 3.043 . . . . 0.0 111.348 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 67.8 m -84.45 -14.35 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -140.42 94.72 2.77 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 109.942 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 396' ' ' VAL . 10.5 t -149.27 152.24 35.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.702 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.0 m -135.11 153.06 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 118.822 0.737 . . . . 0.0 109.375 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -75.04 145.71 42.17 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.923 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 66.9 t -132.0 140.75 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 125.089 1.493 . . . . 0.0 111.168 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -165.76 -162.15 16.39 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.523 -0.736 . . . . 0.0 111.945 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.66 31.9 18.25 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.15 0.975 . . . . 0.0 111.291 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.67 25.74 0.63 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . 0.295 0.0 OUTLIER 58.31 9.23 0.97 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.96 1.704 . . . . 0.0 114.739 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.16 63.98 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 167.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.5 ptm -165.48 21.7 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.19 1.495 . . . . 0.0 112.339 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.501 HD13 ' HZ2' ' A' ' 422' ' ' LYS . 18.4 tp -69.38 151.37 46.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.881 0.848 . . . . 0.0 111.496 -175.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -114.26 174.26 6.04 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -75.53 -14.93 60.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -71.94 -25.26 61.81 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.031 -1.043 . . . . 0.0 109.247 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -90.24 -31.84 16.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.91 1.381 . . . . 0.0 110.74 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.545 0.612 . . . . 0.0 110.557 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.53 67.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.86 -45.09 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.701 -0.624 . . . . 0.0 110.745 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 424' ' ' VAL . 81.4 mt -64.65 -43.45 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.701 0.8 . . . . 0.0 110.488 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.533 HD13 ' CE2' ' A' ' 374' ' ' PHE . 3.7 mm? -81.0 -28.04 35.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.146 -0.971 . . . . 0.0 113.293 -173.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.24 -13.73 27.92 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -108.31 -22.04 12.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.743 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.23 -16.97 21.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.2 0.909 . . . . 0.0 111.535 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 370' ' ' LEU . 16.2 m-30 -113.26 -12.29 13.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.763 1.165 . . . . 0.0 113.694 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 69.25 4.13 41.95 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.98 -0.45 . . . . 0.0 113.226 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -164.73 115.92 0.67 Allowed Glycine 0 C--N 1.357 1.717 0 CA-C-N 118.456 1.128 . . . . 0.0 115.177 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.44 179.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.237 0.615 . . . . 0.0 111.66 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.12 -39.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 O-C-N 122.028 -0.42 . . . . 0.0 110.936 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.77 152.75 30.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.653 0.66 . . . . 0.0 111.187 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.96 37.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.416 1.486 . . . . 0.0 109.036 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -168.41 169.56 41.64 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 120.83 -1.168 . . . . 0.0 115.371 175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.2 mm -90.16 150.4 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 125.994 1.718 . . . . 0.0 109.711 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.53 71.73 5.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 156.7 34.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.691 -0.63 . . . . 0.0 111.241 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.18 161.61 40.56 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.47 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 24.1 tptm -45.77 102.49 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.616 0.766 . . . . 0.0 112.201 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.47 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 24.3 m170 48.39 42.12 17.73 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.692 1.997 . . . . 0.0 112.338 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -97.25 -11.42 24.18 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 124.312 1.007 . . . . 0.0 109.835 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 26.8 p90 44.58 45.49 2.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.1 -58.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.88 3.72 . . . . 0.0 109.779 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.5 tp 42.72 32.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.421 0 C-N-CA 125.172 1.389 . . . . 0.0 113.838 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.6 16.81 0.97 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 54.0 m -152.37 157.74 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 117.833 0.816 . . . . 0.0 110.06 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 176.1 -163.84 33.49 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 123.66 0.6 . . . . 0.0 113.489 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -146.42 173.8 11.96 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.717 0.892 . . . . 0.0 111.213 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 351' ' ' THR . 2.5 p -139.17 144.03 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 34.9 p -119.1 152.27 36.8 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.623 1.201 . . . . 0.0 111.218 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 403' ' ' SER . 35.0 m-85 -129.82 179.37 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 123.611 1.672 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -126.64 1.78 6.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.314 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.35 164.03 24.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.761 1.225 . . . . 0.0 109.593 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -96.91 -13.38 22.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.19 -38.12 87.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.795 1.18 . . . . 0.0 107.928 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 398' ' ' PHE . 8.3 p -79.15 -17.99 53.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -72.75 -61.08 1.93 Allowed 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.798 -0.563 . . . . 0.0 111.944 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.523 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -72.11 -25.58 61.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.206 -1.397 . . . . 0.0 113.028 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -77.92 -20.6 52.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.073 0.851 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.71 61.15 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.725 -0.609 . . . . 0.0 111.155 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.5 m -82.71 -11.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.648 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.8 p -106.89 -8.23 16.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.068 0.855 . . . . 0.0 112.507 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -93.44 -49.83 5.73 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.36 -15.26 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.56 138.77 12.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.461 HG12 ' CG ' ' A' ' 218' ' ' MET . 10.6 m -143.94 158.98 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.972 0.351 . . . . 0.0 111.43 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.99 137.18 42.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.866 1.354 . . . . 0.0 109.713 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.21 128.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.61 50.16 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 418' ' ' THR . 28.4 m -73.9 166.5 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 417' ' ' THR . 6.7 t -71.6 -1.87 15.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -148.36 5.58 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.804 -1.185 . . . . 0.0 111.23 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -146.98 125.46 12.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.327 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 54.5 p -138.58 111.2 7.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 125.332 1.645 . . . . 0.0 112.822 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.501 ' HZ2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -159.55 -176.68 5.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.466 -1.396 . . . . 0.0 112.323 177.295 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.61 163.42 24.25 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.762 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 369' ' ' ILE . 25.9 m -143.98 156.88 15.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 123.68 0.613 . . . . 0.0 109.653 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -130.26 153.47 48.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.258 0.348 . . . . 0.0 111.216 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 79.2 mt -131.53 142.38 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.896 1.372 . . . . 0.0 108.115 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -139.23 155.97 72.2 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.558 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.9 158.08 35.37 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 C-N-CA 124.28 3.32 . . . . 0.0 115.22 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 75.8 t80 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.15 177.589 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -169.86 175.67 5.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.642 1.214 . . . . 0.0 111.199 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.486 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -129.17 16.04 6.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 174.09 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.1 m 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.65 84.42 0.45 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.328 -1.483 . . . . 0.0 111.602 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.47 ' C ' HD22 ' A' ' 224' ' ' LEU . 78.1 mm-40 -99.24 -5.33 30.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 223' ' ' GLN . 3.1 mm? -131.65 125.07 20.32 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.405 1.082 . . . . 0.0 109.258 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 3.4 Cg_exo -81.6 116.81 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 125.01 3.807 . . . . 0.0 111.169 172.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 225' ' ' PRO . 44.1 Cg_endo -81.8 -179.28 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.044 3.829 . . . . 0.0 111.86 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 37.93 66.21 0.5 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.923 1.689 . . . . 0.0 114.21 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -143.65 27.18 1.53 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.113 0.965 . . . . 0.0 110.186 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -66.23 0.93 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 112.561 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 55.97 45.88 22.99 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.877 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.413 ' H ' ' HD3' ' A' ' 232' ' ' PRO . 17.2 m-80 -117.61 -50.17 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 334' ' ' ALA . 24.2 Cg_exo -73.64 -170.78 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.419 3.413 . . . . 0.0 114.063 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.2 OUTLIER -102.83 -171.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 125.388 1.475 . . . . 0.0 108.717 -178.066 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -106.37 148.74 27.72 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.7 m -141.99 11.56 2.0 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.6 t -158.48 -145.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.317 -1.49 . . . . 0.0 110.414 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 170.05 6.76 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.978 0.911 . . . . 0.0 110.616 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 m -144.53 155.12 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 122.32 1.057 . . . . 0.0 109.59 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.78 135.93 34.58 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.62 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.5 tm? -146.09 122.66 11.1 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.336 0.588 . . . . 0.0 111.088 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.27 -170.99 33.41 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.113 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.74 6.96 0.91 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 124.689 1.138 . . . . 0.0 112.109 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.57 145.8 30.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 122.707 1.241 . . . . 0.0 113.616 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.16 -13.02 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 125.0 3.8 . . . . 0.0 110.219 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -101.2 -104.09 0.25 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.631 1.105 . . . . 0.0 110.111 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.9 t70 46.38 59.5 3.81 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 124.278 1.031 . . . . 0.0 111.294 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -70.31 -17.24 20.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 O-C-N 121.069 -1.019 . . . . 0.0 110.903 -170.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 4.8 m -149.29 133.51 17.34 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 127.053 2.141 . . . . 0.0 105.357 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.19 -10.23 59.5 Favored 'General case' 0 CA--C 1.485 -1.554 0 O-C-N 117.508 -3.245 . . . . 0.0 115.66 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.12 -18.24 58.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.3 -43.83 30.35 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.52 -45.4 68.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.061 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.2 t -64.7 -39.06 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 123.761 0.663 . . . . 0.0 110.272 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.47 -16.79 64.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.651 -1.281 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 74.7 m -77.53 -33.55 54.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.727 -0.608 . . . . 0.0 111.513 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -142.53 80.6 1.7 Allowed 'General case' 0 C--O 1.218 -0.602 0 O-C-N 118.978 -2.326 . . . . 0.0 109.934 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.424 ' HA ' HD11 ' A' ' 262' ' ' LEU . 8.6 ptm180 -139.7 5.27 2.18 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.945 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.35 -4.91 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.452 1.024 . . . . 0.0 110.744 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -77.2 -12.27 59.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.21 3.26 6.33 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.6 m -114.06 16.41 18.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.165 1.482 . . . . 0.0 110.335 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -134.88 155.71 50.2 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -148.88 -172.49 4.12 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.383 2.273 . . . . 0.0 108.03 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.45 150.55 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -170.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 129.29 23.69 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.534 -0.729 . . . . 0.0 109.847 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -156.29 152.79 23.92 Favored Pre-proline 0 N--CA 1.439 -1.004 0 O-C-N 121.025 -1.047 . . . . 0.0 113.041 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.69 148.82 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.676 4.25 . . . . 0.0 105.969 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.86 -8.7 70.72 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.792 1.187 . . . . 0.0 110.307 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -66.67 -18.37 65.33 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.912 1.356 . . . . 0.0 110.419 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -81.35 -5.25 57.64 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 112.365 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -110.97 -176.85 20.52 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -74.92 163.56 27.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.315 0.646 . . . . 0.0 112.287 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.2 m80 64.43 145.54 0.09 OUTLIER Pre-proline 0 N--CA 1.444 -0.771 0 C-N-CA 125.426 1.491 . . . . 0.0 111.697 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.52 17.29 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.239 3.293 . . . . 0.0 111.712 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -145.16 140.27 27.84 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.619 1.168 . . . . 0.0 111.563 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 49.4 t -161.72 -43.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.667 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 45.1 Cg_endo -83.11 136.58 8.01 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.941 1.761 . . . . 0.0 111.748 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -93.71 6.71 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.236 2.624 . . . . 0.0 111.118 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -106.49 5.7 29.51 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.249 1.42 . . . . 0.0 111.294 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.45 29.98 0.15 Allowed Glycine 0 N--CA 1.467 0.704 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.7 121.54 40.37 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 118.858 1.329 . . . . 0.0 110.054 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.01 174.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 122.916 1.341 . . . . 0.0 112.034 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -98.54 169.0 9.83 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.937 -1.102 . . . . 0.0 112.019 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.0 mt -124.37 145.24 49.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.206 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.21 114.39 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.96 -161.82 0.58 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.266 1.032 . . . . 0.0 111.766 -172.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.43 ' HG2' ' HE3' ' A' ' 290' ' ' LYS . 10.8 tp10 -56.84 113.11 1.52 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 288' ' ' LEU . 0.9 OUTLIER -85.37 12.47 8.21 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -168.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -135.45 -67.13 0.55 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.172 1.806 . . . . 0.0 112.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.43 ' HE3' ' HG2' ' A' ' 287' ' ' GLU . 0.0 OUTLIER -80.19 -31.34 38.76 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.908 -1.12 . . . . 0.0 112.184 -168.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.5 m -78.95 -30.85 44.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.195 0.907 . . . . 0.0 109.165 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.77 -56.49 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.57 -28.8 67.27 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.037 -1.04 . . . . 0.0 112.347 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.9 m -65.81 -32.67 74.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.36 -51.42 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.784 0.72 . . . . 0.0 109.817 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 296' ' ' LEU . 3.7 pp -74.3 -4.82 38.51 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.38 -8.06 11.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.375 0.422 . . . . 0.0 110.994 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.03 65.68 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.292 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' CYS . . . . . 0.454 ' SG ' ' HE3' ' A' ' 315' ' ' LYS . 50.3 t -112.26 -91.76 0.48 Allowed 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 123.596 0.56 . . . . 0.0 111.734 -174.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 72.3 m -142.06 158.25 43.97 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -154.9 156.12 35.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.267 1.427 . . . . 0.0 108.704 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.64 104.75 4.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.404 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.57 12.55 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 125.604 4.203 . . . . 0.0 111.783 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 49.5 m -103.19 177.88 4.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.949 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -129.39 131.61 46.85 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.596 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -109.55 151.94 26.12 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -138.27 154.49 49.04 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 122.006 0.907 . . . . 0.0 112.105 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.45 178.81 7.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.408 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.489 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 9.1 ptpt -150.11 147.04 27.28 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.22 -14.92 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.583 -1.323 . . . . 0.0 110.557 -169.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.5 t -94.96 157.31 15.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.672 1.124 . . . . 0.0 112.528 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 43.4 p -131.58 -38.61 1.16 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -152.13 -13.3 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -99.15 -21.22 16.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 69.2 mmm -130.01 -179.36 5.17 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.625 0.77 . . . . 0.0 111.697 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -123.85 31.66 5.79 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 66.7 m -104.66 -45.46 4.6 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -173.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? 53.63 17.51 1.22 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -166.97 147.63 5.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.589 -1.319 . . . . 0.0 112.317 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.75 159.93 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 117.517 -1.23 . . . . 0.0 109.695 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -109.53 157.11 19.33 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 120.089 1.313 . . . . 0.0 113.198 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.4 t -140.81 141.93 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.937 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 328' ' ' VAL . 3.9 pt -151.6 131.2 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 329' ' ' ILE . 1.5 Cg_endo -104.29 174.22 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.353 2.702 . . . . 0.0 114.344 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -82.4 125.0 30.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 334' ' ' ALA . 93.9 t -99.33 151.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.73 -26.37 68.02 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.543 -0.723 . . . . 0.0 111.523 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.553 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -71.16 -22.45 62.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.14 -10.3 59.63 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.341 0.401 . . . . 0.0 110.242 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 17.3 m -98.04 -31.79 11.96 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.1 162.06 40.3 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.728 -0.608 . . . . 0.0 111.462 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.631 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 30.2 t80 -147.55 127.67 13.76 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 341' ' ' SER . 55.2 t -104.59 140.43 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -103.86 -8.09 20.0 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.437 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 69.0 m -137.01 93.17 13.57 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.33 -9.98 27.1 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.301 2.667 . . . . 0.0 113.584 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 71.0 m -115.26 19.07 15.83 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.878 0.871 . . . . 0.0 112.845 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -140.65 172.43 12.71 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.056 1.343 . . . . 0.0 109.708 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -127.18 -83.8 0.61 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.643 -1.286 . . . . 0.0 111.083 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 3.8 tp -151.35 173.24 14.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.957 0.785 . . . . 0.0 111.065 -170.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 1.4 m-20 -124.7 151.31 67.6 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 123.609 0.764 . . . . 0.0 110.187 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.57 -15.58 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.864 3.042 . . . . 0.0 113.611 -167.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 56.6 p -150.17 8.25 0.63 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -123.88 88.74 2.96 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 121.008 -1.058 . . . . 0.0 110.094 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.0 t -151.52 155.3 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.21 150.33 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.04 0.448 . . . . 0.0 110.961 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -90.58 141.35 28.86 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 122.265 1.031 . . . . 0.0 110.283 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 78.8 t -130.94 140.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.811 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.27 -164.19 21.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 56.64 29.2 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.0 mt -74.98 170.15 16.57 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.071 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -74.79 -27.94 60.53 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 147.48 -11.45 1.33 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.714 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 18.4 ptm -156.78 22.55 0.33 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.024 1.412 . . . . 0.0 112.109 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.5 OUTLIER -42.03 129.29 3.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.442 -175.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.559 ' N ' HD13 ' A' ' 361' ' ' LEU . 10.0 p30 -104.44 164.26 11.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.954 0.901 . . . . 0.0 111.352 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -74.0 -12.16 60.55 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -168.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -81.2 -28.58 34.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.211 0.914 . . . . 0.0 109.053 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.07 77.44 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.05 -37.71 75.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.06 73.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.84 85.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.244 0.545 . . . . 0.0 110.285 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.6 mt -78.69 -33.31 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.145 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.08 1.05 47.24 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -171.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -22.56 5.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.662 0.665 . . . . 0.0 111.777 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.35 -8.93 13.43 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.08 -1.84 9.24 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 170.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.88 -24.59 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.968 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.59 34.62 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 124.032 0.825 . . . . 0.0 115.155 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.21 128.09 1.03 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.589 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 398' ' ' PHE . 33.4 m -138.02 174.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 O-C-N 121.632 -0.922 . . . . 0.0 111.533 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.17 -28.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 O-C-N 122.212 -0.305 . . . . 0.0 111.679 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.26 151.9 21.62 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.229 0.612 . . . . 0.0 110.584 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.82 149.81 34.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.362 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -176.99 175.76 47.8 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 120.58 -0.819 . . . . 0.0 115.036 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.07 147.26 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 109.082 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.46 130.04 34.64 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.262 -0.899 . . . . 0.0 111.913 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 2.5 p -111.2 169.92 8.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.861 0.838 . . . . 0.0 111.622 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.75 167.19 25.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.866 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.68 101.54 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.41 0.444 . . . . 0.0 112.099 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.0 m170 53.8 30.89 12.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -97.39 -4.25 38.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.415 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 55.6 t80 45.9 56.11 15.61 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 125.292 1.437 . . . . 0.0 113.396 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.35 -60.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.179 1.253 . . . . 0.0 109.362 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.251 9.7 tp 41.45 36.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.739 2.016 . . . . 0.0 113.85 175.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -153.71 5.92 0.36 Allowed Glycine 0 N--CA 1.474 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 115.122 -171.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 43.9 m -148.6 122.08 9.11 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 117.913 0.856 . . . . 0.0 110.296 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -158.89 -169.0 21.74 Favored Glycine 0 CA--C 1.542 1.757 0 O-C-N 120.705 -1.247 . . . . 0.0 111.848 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -152.45 171.31 18.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.034 0.534 . . . . 0.0 109.986 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.72 143.8 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 89.7 m -115.43 140.32 49.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 377' ' ' VAL . 8.3 p90 -163.25 158.15 21.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.194 1.397 . . . . 0.0 110.414 173.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -128.77 20.55 6.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.03 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -100.87 144.35 29.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.91 -27.06 21.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.594 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -68.45 -25.07 64.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 119.593 1.088 . . . . 0.0 109.784 -174.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 73.8 p -81.35 -21.6 39.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -69.73 -62.6 1.32 Allowed 'General case' 0 C--N 1.349 0.583 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.496 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -69.76 -17.48 63.44 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 178.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -76.19 -34.88 59.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.983 0.81 . . . . 0.0 110.644 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.68 -26.35 37.62 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.227 -1.546 . . . . 0.0 111.192 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 37.6 t -79.77 -32.03 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.621 1.169 . . . . 0.0 108.635 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 29.0 t -75.09 -30.26 60.86 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 117.902 -1.046 . . . . 0.0 112.111 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.26 -48.74 6.53 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.572 1.078 . . . . 0.0 110.239 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 65.2 -14.04 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.999 2.12 . . . . 0.0 116.137 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 148.18 17.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.71 157.55 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.9 117.66 33.37 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 124.991 1.432 . . . . 0.0 110.489 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.25 127.99 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 416' ' ' LYS . 8.6 mmpt? -118.95 34.07 5.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.49 1.119 . . . . 0.0 111.16 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.4 m -59.83 154.83 17.52 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.233 0.924 . . . . 0.0 109.752 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 14.0 t -73.3 0.81 10.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -145.09 15.43 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 112.244 173.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -151.03 120.41 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.309 -1.495 . . . . 0.0 108.384 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 32.4 p -132.28 110.08 10.35 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.938 -0.476 . . . . 0.0 110.265 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.545 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 26.6 tptt -162.47 -175.91 4.76 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 124.118 0.886 . . . . 0.0 109.132 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.7 mttm -121.2 173.05 7.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.631 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.75 150.04 15.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -114.79 152.27 32.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.6 mt -130.79 142.49 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 125.299 1.624 . . . . 0.0 108.283 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 24.9 t70 -138.2 140.2 27.93 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 119.839 1.199 . . . . 0.0 112.731 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 40.0 Cg_exo -57.77 153.85 41.02 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.692 2.261 . . . . 0.0 109.879 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.258 1.546 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.928 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 218' ' ' MET . . . . . 0.425 ' O ' HG12 ' A' ' 413' ' ' VAL . 16.3 ptt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.3 t -130.32 -178.36 4.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.497 1.142 . . . . 0.0 111.543 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.445 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -130.6 18.3 5.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.543 0.737 . . . . 0.0 111.654 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.4 m 56.31 29.04 14.31 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.762 1.625 . . . . 0.0 114.623 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.37 1.13 Allowed Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.535 -0.728 . . . . 0.0 112.191 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -80.83 -18.94 45.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.912 0.856 . . . . 0.0 112.765 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.8 127.63 25.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -84.67 132.08 4.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.003 3.135 . . . . 0.0 108.676 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.77 -5.53 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.1 1.867 . . . . 0.0 112.486 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.61 -168.6 1.62 Allowed 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 121.326 -0.859 . . . . 0.0 109.255 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.7 m120 58.4 27.97 16.17 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 122.066 -0.396 . . . . 0.0 111.128 -172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.07 145.65 0.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.25 0.62 . . . . 0.0 112.103 168.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -141.21 14.03 2.22 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.931 0.892 . . . . 0.0 111.713 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.546 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 8.0 p30 -141.76 28.21 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.322 0.51 . . . . 0.0 112.279 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 87.8 Cg_endo -66.53 116.99 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.529 1.486 . . . . 0.0 112.047 -169.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.3 mm -144.87 153.42 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.467 ' CE1' ' HG2' ' A' ' 330' ' ' PRO . 18.8 m-85 -112.35 146.34 38.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -171.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -148.3 7.63 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 85.2 m -137.98 -74.2 0.4 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.838 0.745 . . . . 0.0 111.2 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 389' ' ' TYR . 20.7 pttp -156.18 -169.73 3.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.302 0.641 . . . . 0.0 109.575 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.2 152.31 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 122.25 1.024 . . . . 0.0 108.685 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -98.95 146.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.857 1.263 . . . . 0.0 110.071 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.19 136.44 16.65 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.798 1.311 . . . . 0.0 108.102 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.87 -173.46 33.88 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 121.638 -0.664 . . . . 0.0 113.601 170.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.73 1.61 8.21 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.344 -1.253 . . . . 0.0 110.123 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -78.44 126.61 82.76 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 118.734 1.267 . . . . 0.0 110.521 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 66.1 Cg_endo -81.45 4.78 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.969 3.779 . . . . 0.0 114.07 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.469 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 2.8 p-90 -139.99 -48.72 0.46 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 23.7 t70 56.32 -41.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.194 2.598 . . . . 0.0 115.205 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 248' ' ' THR 0.337 2.8 pp 55.38 -50.69 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -175.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.418 ' H ' HD12 ' A' ' 247' ' ' ILE . 29.9 m -150.19 135.64 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 122.113 2.233 . . . . 0.0 108.421 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -76.48 -22.08 54.99 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.51 -13.33 62.28 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.559 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.94 -74.73 0.68 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 120.956 -1.09 . . . . 0.0 113.021 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.57 -36.91 84.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.879 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.83 -50.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.533 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 257' ' ' ARG . 19.8 m-20 -71.68 -8.77 56.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 94.8 m -76.82 -26.89 54.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 124.256 0.972 . . . . 0.0 111.617 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -129.03 16.74 6.2 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 124.002 0.814 . . . . 0.0 112.863 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 254' ' ' ASN . 35.3 ttt85 -97.59 -17.16 19.69 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 258' ' ' VAL . 2.3 m -69.91 -10.79 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 121.654 0.74 . . . . 0.0 112.61 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -136.92 3.4 2.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.021 -1.05 . . . . 0.0 110.082 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.59 149.76 16.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 124.032 1.907 . . . . 0.0 111.54 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.3 m -105.17 83.4 1.97 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 112.063 -2.069 . . . . 0.0 107.235 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.57 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -149.67 171.29 16.92 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 113.596 -178.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 t -144.71 165.82 26.98 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.84 150.8 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 121.298 -0.876 . . . . 0.0 113.207 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -141.23 142.92 33.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.014 1.387 . . . . 0.0 108.412 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.65 153.15 91.58 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.808 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.38 -17.41 16.63 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.7 2.267 . . . . 0.0 113.059 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -166.99 -5.36 0.03 OUTLIER Glycine 0 C--N 1.346 1.122 0 CA-C-O 117.346 -1.808 . . . . 0.0 116.429 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 60.0 tttm 58.95 86.28 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.216 2.008 . . . . 0.0 109.646 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.39 165.48 23.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.442 -0.786 . . . . 0.0 109.712 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -72.1 -55.12 7.33 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 123.101 0.382 . . . . 0.0 112.838 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -87.08 156.69 19.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.232 0.516 . . . . 0.0 111.289 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.7 m170 44.31 61.74 10.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.63 2.04 0.17 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.62 3.546 . . . . 0.0 112.444 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -90.27 -9.55 47.53 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.604 1.093 . . . . 0.0 111.647 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 48.8 t -142.06 129.27 11.37 Favored Pre-proline 0 C--N 1.352 0.686 0 C-N-CA 125.685 1.594 . . . . 0.0 110.462 -172.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.76 156.15 67.12 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.783 3.655 . . . . 0.0 110.961 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.58 -3.5 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.549 3.499 . . . . 0.0 110.656 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 281' ' ' TYR . 5.5 ptpp? -149.84 179.34 8.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.552 1.141 . . . . 0.0 111.301 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.43 8.81 73.06 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.572 -1.127 . . . . 0.0 114.121 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.429 ' H ' ' HG3' ' A' ' 279' ' ' LYS . 1.8 m-85 -116.4 152.05 34.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.838 1.319 . . . . 0.0 113.565 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.69 167.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.22 1.808 . . . . 0.0 108.946 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -121.88 149.36 43.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.961 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.4 mp -121.45 148.47 44.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 286' ' ' PHE . 27.0 m -137.85 -154.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 O-C-N 125.223 1.577 . . . . 0.0 110.043 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 285' ' ' VAL 0.264 79.7 t80 77.55 -124.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 115.468 -2.206 . . . . 0.0 108.471 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.88 140.05 58.83 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 123.086 2.676 . . . . 0.0 108.993 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.2 pt? -135.34 8.44 3.4 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.247 1.419 . . . . 0.0 114.204 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -128.9 -86.31 0.55 Allowed 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.545 1.153 . . . . 0.0 112.499 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -61.07 -30.33 70.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 52.6 m -100.2 -25.76 14.16 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.057 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.85 -28.62 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 121.684 2.038 . . . . 0.0 108.133 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -83.66 -32.02 25.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.115 0.884 . . . . 0.0 112.953 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 297' ' ' GLN . 27.8 m -87.75 -35.93 17.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.283 0.99 . . . . 0.0 112.232 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 tt -68.85 -40.86 79.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.875 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 3.8 mp -67.2 -40.58 86.52 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.704 -1.247 . . . . 0.0 111.749 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 294' ' ' SER . 17.8 pt20 -77.35 -7.48 56.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -87.44 -27.92 22.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.64 -174.15 4.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.041 -1.891 . . . . 0.0 106.379 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 151.48 28.54 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 124.029 1.871 . . . . 0.0 111.865 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -143.19 152.97 42.36 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.659 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -126.27 110.79 23.77 Favored Pre-proline 0 N--CA 1.434 -1.251 0 O-C-N 124.13 0.894 . . . . 0.0 109.433 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.85 46.04 2.07 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.781 2.988 . . . . 0.0 109.73 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.345 0.409 0 C-N-CA 123.725 0.81 . . . . 0.0 111.015 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 309' ' ' LEU . 19.3 tp . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 121.549 0.69 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 43.0 m -106.98 178.8 4.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.613 1.196 . . . . 0.0 111.659 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -126.91 147.88 50.06 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.214 -0.929 . . . . 0.0 111.148 -171.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 32.1 m-85 -117.23 156.6 27.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.682 1.229 . . . . 0.0 110.196 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -151.5 173.85 14.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.486 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -153.69 165.66 35.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.661 0.664 . . . . 0.0 110.717 170.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -128.59 57.33 1.6 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.1 0.56 . . . . 0.0 111.663 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -55.24 -12.61 1.03 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.207 2.203 . . . . 0.0 113.899 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.8 p -89.18 138.64 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.156 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.3 t -160.11 -30.29 0.06 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-N 119.308 0.958 . . . . 0.0 112.606 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -143.64 -30.29 0.5 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.934 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -86.33 -34.52 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.481 1.037 . . . . 0.0 111.26 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 mmt -147.3 166.19 27.83 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -162.82 83.43 0.51 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 125.519 1.762 . . . . 0.0 109.047 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.9 m -133.87 -63.11 0.75 Allowed 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -149.16 139.84 22.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.082 0.944 . . . . 0.0 110.797 -174.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.87 162.6 21.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.263 1.425 . . . . 0.0 112.697 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.5 p -107.6 155.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.04 156.35 19.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.409 0.283 . . . . 0.0 111.575 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 2.4 t -142.71 134.0 24.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 122.897 0.479 . . . . 0.0 112.02 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.06 132.15 9.01 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.829 0.824 . . . . 0.0 109.917 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.467 ' HG2' ' CE1' ' A' ' 234' ' ' TYR . 30.1 Cg_endo -83.06 165.39 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.367 2.044 . . . . 0.0 110.814 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.403 ' CH2' HD13 ' A' ' 391' ' ' ILE . 6.8 t-105 -83.92 113.56 21.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 109.639 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 334' ' ' ALA . 4.2 t -83.1 150.21 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 123.058 1.408 . . . . 0.0 110.299 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.34 -20.89 65.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.429 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.475 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -77.54 1.83 18.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.721 1.208 . . . . 0.0 113.612 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.64 -0.74 21.72 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.699 0.681 . . . . 0.0 110.954 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.0 m -103.79 -36.37 7.86 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.614 0.766 . . . . 0.0 112.25 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -162.45 153.43 17.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.884 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -146.7 148.81 32.39 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.506 -0.746 . . . . 0.0 111.704 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.86 144.3 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.159 0.98 . . . . 0.0 111.671 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.98 -24.42 30.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.297 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 74.8 m -146.44 137.89 13.06 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 123.546 0.738 . . . . 0.0 110.6 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -88.39 -2.7 6.82 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.705 2.27 . . . . 0.0 111.892 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.7 m -83.23 -1.47 53.18 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.673 0.789 . . . . 0.0 112.373 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -131.76 174.74 9.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.917 1.342 . . . . 0.0 111.216 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -128.57 166.19 19.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.837 0.855 . . . . 0.0 112.319 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.7 mm? -70.65 157.75 37.42 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.904 1.282 . . . . 0.0 110.235 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -109.24 133.68 20.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.35 -7.7 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 124.227 3.284 . . . . 0.0 112.076 -174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.0 m -142.14 2.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 350' ' ' ARG . 34.5 mmt180 -126.67 71.75 1.31 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.902 0.881 . . . . 0.0 110.518 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.0 p -143.59 164.91 29.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 27.5 m -129.12 159.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.457 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -93.04 136.35 33.38 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.588 1.18 . . . . 0.0 111.681 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.93 144.91 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 121.531 0.681 . . . . 0.0 110.311 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -161.86 -160.62 11.1 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.44 34.0 15.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.999 0.92 . . . . 0.0 112.334 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 52.8 mt -89.51 169.14 11.61 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -95.0 14.9 20.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.11 66.23 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.688 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 6.8 ptp -161.14 15.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.702 1.751 . . . . 0.0 111.0 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.56 141.65 57.78 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.575 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.04 175.82 5.47 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 124.714 1.259 . . . . 0.0 111.242 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.86 -17.33 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -75.89 -30.17 58.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -76.43 -35.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.223 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.11 -41.75 76.99 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 122.692 1.234 . . . . 0.0 109.974 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.22 -0.925 . . . . 0.0 111.395 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.72 98.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 124.029 0.831 . . . . 0.0 110.241 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.98 -46.11 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.487 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.14 -29.73 21.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.533 -0.729 . . . . 0.0 112.939 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -12.03 36.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.747 -1.221 . . . . 0.0 112.088 -175.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.438 ' HB3' ' HE1' ' A' ' 220' ' ' TRP . 25.1 t70 -109.93 -23.14 11.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.664 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.18 -19.25 32.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.037 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -118.61 -22.29 7.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.318 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 75.25 -23.75 1.43 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.57 47.99 1.14 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.251 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 32.6 t -131.56 142.28 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 120.301 2.05 . . . . 0.0 113.261 -173.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.62 -24.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.424 0.63 . . . . 0.0 112.601 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 346' ' ' LEU . 1.0 OUTLIER -152.17 150.95 30.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.42 23.25 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.008 1.323 . . . . 0.0 109.481 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.8 156.42 27.94 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.99 144.22 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -92.4 148.66 21.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 118.537 0.608 . . . . 0.0 110.717 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 22.8 p -126.38 169.57 12.83 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.664 -0.647 . . . . 0.0 110.849 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.47 -178.43 5.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -72.81 90.29 1.42 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.248 1.023 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 20.5 m170 65.68 28.48 11.11 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 125.102 1.361 . . . . 0.0 111.783 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -89.55 4.08 50.42 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.497 ' HB3' ' HE2' ' A' ' 237' ' ' LYS . 8.0 p90 45.23 48.14 4.64 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 88.4 Cg_endo -69.14 -70.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.336 2.024 . . . . 0.0 112.304 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.474 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 7.2 tp 40.44 26.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 127.777 2.431 . . . . 0.0 112.285 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -135.11 4.37 4.18 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 120.533 -1.354 . . . . 0.0 112.504 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.5 p -148.77 130.56 15.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.273 0.558 . . . . 0.0 110.413 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.48 16.11 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.085 -1.009 . . . . 0.0 112.271 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 15.0 ptp180 -148.83 -178.12 6.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.165 0.986 . . . . 0.0 110.384 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.38 137.67 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.1 m -105.64 120.55 41.94 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -96.36 -33.6 11.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 60.5 t30 66.05 -2.76 0.88 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.71 179.65 8.22 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 120.962 -1.086 . . . . 0.0 110.106 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -92.28 -26.08 18.3 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.59 -41.13 80.54 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 120.252 -1.53 . . . . 0.0 112.441 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 53.7 m -80.15 -10.25 59.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -76.05 -55.37 5.66 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.799 0.727 . . . . 0.0 109.619 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.473 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.1 -23.32 60.5 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 118.615 0.643 . . . . 0.0 111.022 -175.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -79.14 -34.86 42.88 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.768 -0.583 . . . . 0.0 111.795 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.71 70.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 119.316 0.962 . . . . 0.0 110.583 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.85 -24.75 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 118.398 0.544 . . . . 0.0 111.661 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 t -74.83 -25.9 59.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.302 1.001 . . . . 0.0 108.691 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -84.87 -51.36 6.79 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 61.64 -23.33 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.321 2.248 . . . . 0.0 116.044 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.71 144.52 15.19 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 111.065 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 218' ' ' MET . 22.0 m -142.74 158.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-O 122.067 0.937 . . . . 0.0 111.289 173.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -112.59 131.81 55.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.75 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.76 124.29 39.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -121.3 31.9 6.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.015 -1.053 . . . . 0.0 110.228 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.7 m -62.26 154.83 26.48 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.4 p -61.38 -12.06 12.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.73 7.65 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -146.44 137.13 24.08 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.374 1.07 . . . . 0.0 109.054 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.43 125.55 13.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.527 0.731 . . . . 0.0 111.382 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -167.4 -170.74 1.52 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.02 165.27 23.57 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.225 1.01 . . . . 0.0 108.454 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.74 158.57 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 124.422 1.076 . . . . 0.0 108.599 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -126.87 148.29 50.0 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.193 0.933 . . . . 0.0 112.643 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.84 139.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.02 125.64 5.78 Favored Pre-proline 0 C--N 1.349 0.547 0 CA-C-O 121.742 0.782 . . . . 0.0 110.245 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.39 171.54 16.74 Favored 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 111.259 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.881 177.706 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 91.7 m -69.89 151.63 45.45 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -10.26 0.18 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m 46.89 52.33 11.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.589 1.185 . . . . 0.0 111.499 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.22 -24.24 70.39 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.002 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 54.59 33.5 19.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.172 0.986 . . . . 0.0 113.416 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.473 ' C ' ' HD3' ' A' ' 226' ' ' PRO . 4.6 mm? -63.68 157.25 67.68 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 123.002 0.521 . . . . 0.0 109.986 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.29 68.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 1 C-N-CA 125.997 4.464 . . . . 0.0 114.731 176.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 224' ' ' LEU . 71.6 Cg_exo -55.72 166.37 2.88 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.535 2.824 . . . . 0.0 110.814 169.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 60.08 23.63 12.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.631 1.572 . . . . 0.0 114.461 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -78.37 7.44 6.52 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.474 0.71 . . . . 0.0 111.399 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -73.4 155.93 38.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.227 1.011 . . . . 0.0 111.569 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -143.05 18.68 1.94 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.474 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -133.9 43.56 1.03 Allowed Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 123.947 0.899 . . . . 0.0 109.493 -170.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 93.8 Cg_endo -71.93 157.2 55.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.638 2.892 . . . . 0.0 113.094 -170.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.4 mm -147.5 153.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.02 150.53 31.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.649 1.113 . . . . 0.0 109.654 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 70.4 p -155.11 6.5 0.24 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.873 1.358 . . . . 0.0 114.612 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 4.9 t -154.7 -169.29 3.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.26 1.845 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -43.23 146.07 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 112.378 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 284' ' ' LEU . 3.5 p -122.47 139.56 49.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 125.529 1.768 . . . . 0.0 109.401 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.08 138.63 31.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.821 -1.174 . . . . 0.0 108.904 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.61 126.27 41.73 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 125.053 1.47 . . . . 0.0 108.453 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.72 154.94 21.04 Favored Glycine 0 N--CA 1.449 -0.49 0 O-C-N 120.583 -1.323 . . . . 0.0 111.234 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.73 10.28 0.92 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.2 m -120.49 73.25 21.76 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 118.446 1.123 . . . . 0.0 110.301 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.41 5.15 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 109.985 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.435 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 34.7 p-90 -116.54 -10.53 11.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.18 133.07 55.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.575 -1.328 . . . . 0.0 110.258 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.835 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -109.14 -26.04 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 124.654 1.221 . . . . 0.0 112.822 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 m -138.54 118.84 13.65 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.026 0.53 . . . . 0.0 111.041 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.18 -24.05 67.27 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.378 0.608 . . . . 0.0 112.534 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.1 75.87 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.849 -1.782 . . . . 0.0 111.924 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.87 -63.42 4.43 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.249 0.343 . . . . 0.0 112.576 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -68.49 -21.68 64.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.662 -1.493 . . . . 0.0 113.555 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.4 HG22 HG21 ' A' ' 264' ' ' VAL . 3.3 t -71.54 -52.13 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -71.06 -12.73 61.68 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 125.435 1.709 . . . . 0.0 110.736 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m -79.6 -22.26 43.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.522 -1.361 . . . . 0.0 112.483 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.97 26.6 4.6 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -113.67 -27.32 7.87 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 123.383 0.427 . . . . 0.0 110.845 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.27 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.566 -0.709 . . . . 0.0 110.979 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.49 17.11 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.991 -1.068 . . . . 0.0 113.064 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.21 153.82 25.19 Favored Glycine 0 C--O 1.249 1.085 0 O-C-N 121.322 -0.861 . . . . 0.0 113.074 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.9 m -76.88 28.58 0.13 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 123.86 0.864 . . . . 0.0 113.3 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.691 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -109.35 164.38 12.54 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.147 -0.971 . . . . 0.0 112.092 -173.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 p -141.68 168.46 19.72 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 284' ' ' LEU . 6.6 t -125.44 154.01 33.55 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.544 -168.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -130.6 129.34 42.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.5 50.79 5.32 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 124.532 1.145 . . . . 0.0 113.979 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.19 31.48 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 125.894 4.396 . . . . 0.0 111.827 -172.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.29 -43.01 4.45 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -155.94 130.93 9.25 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.436 1.494 . . . . 0.0 111.346 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -125.54 154.8 41.61 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.75 -152.22 10.25 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.66 -16.41 58.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.343 -1.313 . . . . 0.0 109.283 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -152.55 135.11 9.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 118.798 0.726 . . . . 0.0 110.8 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.99 42.06 1.27 Allowed 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.396 4.064 . . . . 0.0 113.555 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.0 13.96 23.18 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.26 -0.9 . . . . 0.0 112.95 -171.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 63.7 m -141.31 36.51 0.24 Allowed Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.899 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.23 147.44 93.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 107.933 -1.603 . . . . 0.0 107.933 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.89 -15.12 13.43 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.138 3.226 . . . . 0.0 113.529 -175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 175.75 12.8 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.286 -0.884 . . . . 0.0 110.751 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -100.24 -9.58 47.54 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.373 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -73.3 121.84 21.04 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 118.598 1.199 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.34 -174.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 O-C-N 125.626 1.829 . . . . 0.0 109.008 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -132.21 165.73 23.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -169.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 238' ' ' VAL . 55.0 mt -117.77 148.42 42.07 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.731 171.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 143.37 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -171.64 178.2 3.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -168.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.4 136.04 56.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 166.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.35 -10.65 59.65 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.53 -43.59 0.68 Allowed 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -83.93 -49.57 8.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.207 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.9 t -71.13 -26.33 62.96 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.218 0.949 . . . . 0.0 111.583 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 3.3 t -67.57 -58.52 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 O-C-N 124.216 0.948 . . . . 0.0 111.047 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.45 -23.27 65.5 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.695 1.247 . . . . 0.0 110.571 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.6 t -71.27 -45.61 62.77 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.023 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.34 -57.54 9.07 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.297 2.1 pp -80.7 -2.01 44.99 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -170.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -100.43 -6.86 24.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 121.054 1.752 . . . . 0.0 108.202 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -94.97 -23.68 17.28 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.479 1.112 . . . . 0.0 110.585 170.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 -133.11 0.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 29.8 t -129.58 164.98 22.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.073 -2.267 . . . . 0.0 110.03 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -146.38 155.78 42.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.886 0.874 . . . . 0.0 110.206 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -136.43 126.19 15.96 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.68 47.36 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.635 3.557 . . . . 0.0 105.579 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.706 0 CA-C-O 115.911 -1.995 . . . . 0.0 113.339 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 122.015 0.912 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.7 m -152.73 145.39 24.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -143.73 143.96 31.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.725 0.774 . . . . 0.0 111.349 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.53 153.96 33.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.199 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.38 158.66 43.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.457 0.571 . . . . 0.0 111.331 -172.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 6.3 t80 -156.08 171.24 20.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 23.8 ttmt -128.55 51.93 1.96 Allowed 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 122.884 1.326 . . . . 0.0 108.132 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -0.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.434 -1.712 . . . . 0.0 113.388 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 23.1 t -89.49 125.91 35.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 118.918 0.781 . . . . 0.0 110.245 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 13.5 t -145.98 142.44 28.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.145 0.498 . . . . 0.0 109.936 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 49.97 24.48 1.36 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.19 1.396 . . . . 0.0 113.447 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.403 ' HG3' ' HG2' ' A' ' 321' ' ' MET . 16.3 ptp180 -147.51 -41.18 0.18 Allowed 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.121 -1.612 . . . . 0.0 111.852 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.435 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 23.5 mmm -119.83 -26.88 5.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.834 1.197 . . . . 0.0 111.224 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 57.7 2.1 0.15 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.032 1.733 . . . . 0.0 113.961 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.2 m -137.98 170.35 16.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 118.117 0.417 . . . . 0.0 112.022 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 63.15 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.961 2.104 . . . . 0.0 112.556 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 1.7 pm0 -91.84 161.67 14.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.117 1.767 . . . . 0.0 111.095 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.28 143.47 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -90.27 154.71 19.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.273 -0.892 . . . . 0.0 111.861 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 45.9 t -138.75 139.84 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.369 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.0 pt -147.16 117.46 4.5 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.536 0.734 . . . . 0.0 110.515 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -85.7 162.37 10.71 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.035 2.49 . . . . 0.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -79.11 121.48 25.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.99 145.42 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.049 1.34 . . . . 0.0 110.222 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -55.83 -22.86 27.23 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.9 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.32 60.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.55 -23.95 25.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.345 0.658 . . . . 0.0 111.427 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 47.3 m -69.93 -39.7 75.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -163.32 154.84 17.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.592 1.187 . . . . 0.0 110.754 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.479 ' HB3' ' HB1' ' A' ' 363' ' ' ALA . 70.8 t80 -141.69 99.57 3.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.85 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -90.47 -17.82 26.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.589 -0.694 . . . . 0.0 112.808 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.9 m -142.18 136.32 14.85 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.711 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.03 3.82 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.172 1.915 . . . . 0.0 114.119 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.8 m -109.63 12.15 24.38 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -148.62 163.31 37.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.429 1.092 . . . . 0.0 113.4 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.697 ' HG3' ' H ' ' A' ' 346' ' ' LEU . 10.6 tpp85 -125.99 -175.71 3.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.869 1.268 . . . . 0.0 109.504 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.697 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.1 tp -56.55 164.89 1.27 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.927 2.091 . . . . 0.0 113.521 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -135.89 145.52 53.05 Favored Pre-proline 0 CA--C 1.514 -0.412 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.48 123.54 7.11 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.434 2.09 . . . . 0.0 112.812 -172.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 36.6 m 59.9 26.19 15.39 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.288 1.435 . . . . 0.0 113.18 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -114.41 43.01 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.172 0.589 . . . . 0.0 109.98 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 p -135.78 163.84 29.28 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 122.476 1.131 . . . . 0.0 109.424 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.79 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.505 172.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -82.32 149.26 27.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.568 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.23 136.27 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -169.91 -170.44 34.34 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.547 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.72 18.08 0.95 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.335 1.454 . . . . 0.0 113.367 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.725 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.21 176.27 9.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.113 0.965 . . . . 0.0 110.267 172.442 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.7 32.44 0.16 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.537 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 76.1 18.23 79.52 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 120.564 -1.335 . . . . 0.0 112.596 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.404 ' HA ' HG13 ' A' ' 391' ' ' ILE . 17.2 mmt -140.3 -94.32 0.15 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.175 1.488 . . . . 0.0 111.718 171.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.7 tp 40.53 68.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.497 0.719 . . . . 0.0 110.863 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -55.62 168.16 0.44 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.726 0.239 . . . . 0.0 111.045 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 338' ' ' PHE . . . -65.29 -16.64 63.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.66 -26.63 25.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.733 -1.229 . . . . 0.0 109.256 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.85 -26.91 40.24 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.542 -0.724 . . . . 0.0 110.317 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.7 -51.72 25.73 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.42 67.23 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.822 -0.549 . . . . 0.0 110.885 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.24 73.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.707 0.23 . . . . 0.0 111.298 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.8 mt -66.46 -42.6 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 119.03 -0.509 . . . . 0.0 109.836 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.24 -34.89 18.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -22.87 44.51 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.4 -1.438 . . . . 0.0 111.554 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -87.66 -27.34 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.614 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.15 -18.87 26.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.553 ' CZ ' ' HA3' ' A' ' 376' ' ' GLY . 4.1 t80 -136.16 -61.45 0.7 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.843 174.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 100.59 -16.07 58.05 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 374' ' ' PHE . . . -85.38 59.52 4.82 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 118.089 0.944 . . . . 0.0 112.514 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.67 164.58 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 118.071 -1.452 . . . . 0.0 112.478 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.69 -40.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -150.79 148.0 27.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.163 0.506 . . . . 0.0 109.852 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.75 153.11 50.94 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.77 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.74 155.43 26.75 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 118.645 0.657 . . . . 0.0 112.501 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.11 147.19 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.5 126.48 29.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.584 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.6 p -138.99 157.49 45.9 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.962 0.789 . . . . 0.0 108.976 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -145.16 166.44 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.705 1.202 . . . . 0.0 108.755 173.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -53.05 102.32 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.443 -0.786 . . . . 0.0 111.784 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 65.8 m170 60.72 30.01 19.4 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -94.5 -8.2 39.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.577 -0.702 . . . . 0.0 110.759 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 15.6 p90 37.82 52.2 2.83 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 127.173 2.189 . . . . 0.0 113.213 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.77 -55.71 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.815 1.677 . . . . 0.0 112.585 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 360' ' ' MET . 10.2 tp 37.28 34.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 124.286 1.035 . . . . 0.0 112.504 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -136.5 5.32 3.79 Favored Glycine 0 N--CA 1.442 -0.958 0 O-C-N 124.104 0.878 . . . . 0.0 114.336 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.5 m -151.57 144.06 24.19 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.16 -172.87 36.32 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 170.34 22.44 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 124.233 0.608 . . . . 0.0 109.894 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.29 135.79 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 22.1 m -103.72 144.58 31.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.089 0.868 . . . . 0.0 111.37 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.43 179.55 6.14 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.342 1.057 . . . . 0.0 111.762 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.36 16.57 2.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.09 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -136.63 157.85 45.82 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -70.67 -26.42 63.43 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.001 0.92 . . . . 0.0 112.181 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . 79.8 mmt-85 -52.92 -31.7 41.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.35 1.06 . . . . 0.0 111.818 -171.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.4 p -80.88 -34.66 33.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.663 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -62.17 -52.29 64.39 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 117.919 0.327 . . . . 0.0 110.499 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 405' ' ' LEU 0.299 0.0 OUTLIER -78.38 -19.19 53.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.417 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -85.67 -30.07 23.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 120.466 1.484 . . . . 0.0 110.69 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.3 -29.19 47.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.335 0.97 . . . . 0.0 109.423 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.17 -33.24 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 O-C-N 121.555 -0.716 . . . . 0.0 112.723 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.5 t -82.22 -11.92 58.39 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -83.79 -50.66 7.9 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.35 -50.5 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 16.4 t80 -154.61 132.8 11.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.41 160.2 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.575 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 20.3 mt-10 -111.5 99.42 8.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.74 140.67 17.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.825 0.821 . . . . 0.0 108.932 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -132.61 40.95 3.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.996 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.2 p -71.43 170.24 13.65 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.322 1.014 . . . . 0.0 108.908 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 t -79.24 -3.42 45.78 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.23 -0.919 . . . . 0.0 112.922 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 226' ' ' PRO . 67.5 mttm -93.51 -41.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.028 -0.42 . . . . 0.0 110.474 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -157.86 166.14 33.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.982 0.801 . . . . 0.0 111.071 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.5 p -127.53 104.34 7.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.296 1.838 . . . . 0.0 107.539 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -159.36 170.5 21.67 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.798 -0.564 . . . . 0.0 110.631 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.575 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 90.6 mttt -108.75 164.19 12.59 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.277 1.037 . . . . 0.0 112.139 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.46 153.9 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.347 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -119.7 156.45 30.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.135 0.897 . . . . 0.0 109.879 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.92 138.67 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 13.4 m-20 -135.75 156.1 77.63 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.165 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 37.3 Cg_exo -65.8 165.6 22.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.561 2.174 . . . . 0.0 113.922 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 116.029 -1.938 . . . . 0.0 110.896 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.6 m 49.05 42.62 21.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.193 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.47 -8.47 59.56 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.145 1.378 . . . . 0.0 112.544 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.6 t 42.6 74.41 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.355 1.862 . . . . 0.0 111.693 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.88 -23.18 78.36 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 122.03 -0.419 . . . . 0.0 112.496 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 54.99 24.74 6.19 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' A' ' 226' ' ' PRO . 4.4 mm? -62.45 141.67 96.51 Favored Pre-proline 0 C--N 1.342 0.247 0 CA-C-N 119.181 0.9 . . . . 0.0 110.489 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.7 100.73 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.618 2.212 . . . . 0.0 110.129 171.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 224' ' ' LEU . 51.0 Cg_endo -80.77 14.61 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.682 3.588 . . . . 0.0 113.077 -175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -133.79 26.72 3.99 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 121.05 -1.031 . . . . 0.0 113.684 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -125.3 39.15 4.03 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.978 0.511 . . . . 0.0 110.663 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -72.05 154.9 40.85 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.641 0.734 . . . . 0.0 110.468 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -131.65 29.4 4.5 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.771 1.228 . . . . 0.0 112.56 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.95 47.44 0.58 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.203 0.601 . . . . 0.0 110.973 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.84 138.38 31.41 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.482 2.121 . . . . 0.0 112.759 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.4 mt -150.62 144.31 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 105.352 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -96.91 148.63 22.75 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 111.513 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.0 m -141.25 -16.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 63.9 m -143.67 -174.92 4.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.483 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.472 ' HE2' ' CD1' ' A' ' 283' ' ' TYR . 58.1 mtpt -43.22 153.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.336 1.065 . . . . 0.0 112.662 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.14 133.76 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.84 145.45 31.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.83 1.3 . . . . 0.0 110.727 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.4 tm? -135.23 116.7 14.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.218 -171.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 178.31 -179.6 48.53 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.17 22.19 0.92 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 28.1 m -91.09 128.55 47.15 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.801 0.841 . . . . 0.0 112.989 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.84 -15.56 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.944 2.429 . . . . 0.0 113.655 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -140.58 0.24 1.62 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.98 1.263 . . . . 0.0 113.985 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.43 122.79 18.32 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.856 1.662 . . . . 0.0 115.426 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -87.87 -0.86 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -173.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.7 p -158.68 167.71 28.82 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 122.455 1.121 . . . . 0.0 108.488 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.469 ' HA ' HD21 ' A' ' 252' ' ' LEU . 0.0 OUTLIER -107.53 -15.6 14.56 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.056 174.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -76.78 -31.38 56.98 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 121.088 0.471 . . . . 0.0 111.246 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.37 -52.6 45.53 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 120.658 -1.277 . . . . 0.0 113.787 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 252' ' ' LEU . 1.7 pt? -71.78 -32.49 67.71 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.514 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.48 -36.16 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.385 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -74.28 -17.77 60.81 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.809 0.693 . . . . 0.0 110.381 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.0 m -80.55 -26.99 37.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 111.807 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -129.34 19.07 5.85 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -101.73 -0.77 33.89 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.045 -1.034 . . . . 0.0 111.767 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.47 -21.14 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -127.61 3.24 6.15 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.27 1.028 . . . . 0.0 108.805 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -104.52 173.6 21.27 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 121.699 0.61 . . . . 0.0 112.836 -171.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' SER . . . . . 0.733 ' H ' HD11 ' A' ' 295' ' ' LEU . 61.2 m -135.54 77.0 1.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.56 167.96 22.44 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.702 1.201 . . . . 0.0 111.725 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 284' ' ' LEU . 22.7 t -148.56 169.54 20.09 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 170.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.44 137.91 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -145.83 136.17 23.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -166.22 154.18 9.52 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.67 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.43 161.27 28.58 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.076 3.184 . . . . 0.0 110.987 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 83.03 3.66 90.33 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -75.84 -19.13 59.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.823 0.849 . . . . 0.0 110.572 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.24 142.24 58.49 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.14 -167.61 34.54 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.423 1.011 . . . . 0.0 111.738 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -80.07 170.34 16.59 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.198 0.599 . . . . 0.0 111.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 30.8 m80 53.03 99.35 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 125.364 1.466 . . . . 0.0 112.019 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -58.01 -3.53 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 1 C-N-CA 125.522 4.148 . . . . 0.0 115.816 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -99.36 9.99 42.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.223 1.809 . . . . 0.0 111.863 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 277' ' ' PRO . 40.7 t -53.43 -45.26 98.59 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.53 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 276' ' ' CYS . 96.5 Cg_endo -72.38 148.85 49.55 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.911 1.741 . . . . 0.0 111.405 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.63 1.17 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.521 2.814 . . . . 0.0 111.501 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.41 143.97 36.31 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 118.933 0.788 . . . . 0.0 109.93 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.42 22.05 42.88 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.429 0.537 . . . . 0.0 113.014 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.418 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 37.5 p90 -152.95 164.58 37.68 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.71 -178.49 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.472 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 55.0 m-85 -110.91 157.27 20.05 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.208 0.913 . . . . 0.0 111.223 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 263' ' ' SER . 83.4 mt -126.13 136.0 52.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.671 1.188 . . . . 0.0 111.529 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.86 137.18 14.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.685 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 84.9 t80 -175.62 -76.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.614 0.366 . . . . 0.0 110.317 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -93.8 -36.8 12.09 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.685 ' CD2' ' H ' ' A' ' 286' ' ' PHE . 4.4 mm? 60.81 -3.39 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -136.12 -75.3 0.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 122.196 2.271 . . . . 0.0 112.643 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -84.28 -33.89 23.89 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' SER . . . . . 0.502 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 44.8 m -82.61 -45.34 14.68 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 116.509 -1.71 . . . . 0.0 108.527 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.16 -36.81 16.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-N 121.506 1.957 . . . . 0.0 107.878 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 30.3 ttt-85 -62.55 -45.48 92.75 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.875 0.845 . . . . 0.0 110.806 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -70.81 -35.3 72.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 118.15 -0.928 . . . . 0.0 113.148 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.733 HD11 ' H ' ' A' ' 261' ' ' SER . 55.6 mt -66.5 -47.09 74.08 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -7.0 59.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.523 -1.36 . . . . 0.0 111.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -97.47 -3.81 39.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.473 1.033 . . . . 0.0 111.709 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -105.49 -18.55 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.0 m -81.89 -158.3 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 61.4 m -84.44 146.05 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.013 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -137.34 149.53 47.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.052 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -137.93 127.3 14.92 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 122.049 -0.407 . . . . 0.0 110.703 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -82.87 35.55 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.754 4.303 . . . . 0.0 109.566 169.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.612 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -173.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 171.59 10.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.851 0.86 . . . . 0.0 109.342 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.62 154.53 50.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -113.07 148.63 34.82 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.15 162.42 39.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -163.4 176.01 10.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.9 ptpt -135.4 132.47 37.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.42 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 0.0 OUTLIER -135.49 9.47 3.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -165.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.0 t -66.13 150.98 47.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 11.0 m -85.36 15.36 4.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.556 0.743 . . . . 0.0 110.133 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.57 24.74 3.23 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.479 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -75.01 -23.44 58.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.848 0.749 . . . . 0.0 112.308 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -148.76 -26.83 0.31 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -152.53 168.18 26.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.105 0.562 . . . . 0.0 110.642 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 74.1 m -118.22 134.63 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.818 1.247 . . . . 0.0 107.722 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 17.0 tppt? -152.93 129.68 10.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 122.542 1.163 . . . . 0.0 114.029 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.91 137.57 36.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.01 1.724 . . . . 0.0 111.972 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 327' ' ' GLN . 9.1 p -123.89 157.58 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.416 ' N ' HG22 ' A' ' 326' ' ' VAL . 5.1 pp0? -107.46 154.72 20.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.117 0.261 . . . . 0.0 110.62 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.58 136.5 46.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.276 0.56 . . . . 0.0 111.788 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 73.0 mt -142.17 109.4 5.86 Favored Pre-proline 0 C--O 1.232 0.165 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 164.96 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.089 1 C-N-CA 125.337 4.025 . . . . 0.0 112.085 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.605 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 1.7 t90 -83.66 133.3 34.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.46 152.33 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 123.605 0.762 . . . . 0.0 110.251 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.8 tt -54.46 -27.1 35.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.28 4.11 2.46 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.694 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.94 7.41 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.035 0.934 . . . . 0.0 109.567 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.3 m -129.24 -22.0 3.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 150.72 34.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.71 132.6 15.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.362 -1.745 . . . . 0.0 107.928 170.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -141.96 146.23 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.187 0.994 . . . . 0.0 111.816 177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -103.32 -15.72 15.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.575 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 339' ' ' VAL . 42.3 t -94.52 140.22 22.6 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.426 1.09 . . . . 0.0 110.444 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.4 16.2 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.204 3.269 . . . . 0.0 110.427 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 15.6 t -122.74 161.27 24.24 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.813 -1.179 . . . . 0.0 110.447 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' A' ' 344' ' ' GLN . 5.0 pm0 -79.8 22.47 0.48 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 122.33 1.062 . . . . 0.0 113.43 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -65.59 155.26 36.35 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.59 1.156 . . . . 0.0 109.342 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 22.4 tp -154.92 155.43 34.26 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.059 0.391 . . . . 0.0 111.222 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.452 ' H ' HG21 ' A' ' 397' ' ' THR . 42.4 t0 -136.58 73.35 55.37 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.016 0.926 . . . . 0.0 110.065 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.71 5.08 4.57 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.079 2.519 . . . . 0.0 111.946 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.5 t -78.29 -13.42 59.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.847 -1.158 . . . . 0.0 111.602 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -147.26 85.74 1.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.8 p -133.8 154.0 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.049 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.02 158.76 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 119.086 0.857 . . . . 0.0 110.045 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -95.19 146.46 24.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 123.837 0.711 . . . . 0.0 111.352 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.22 140.4 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.12 -178.41 32.13 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.41 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.26 47.26 21.94 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 124.469 1.107 . . . . 0.0 110.595 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 36.5 mt -84.67 -174.83 5.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 360' ' ' MET . 0.2 OUTLIER -61.92 -25.35 67.52 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.764 176.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 78.22 5.54 87.39 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 120.364 -1.46 . . . . 0.0 109.939 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.413 ' HB3' ' CE1' ' A' ' 358' ' ' HIS . 16.5 ttt -152.93 29.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.11 95.43 0.73 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.849 1.309 . . . . 0.0 110.464 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -81.12 162.23 23.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.18 -7.75 50.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.134 -171.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -90.12 -26.59 20.13 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.97 -29.63 24.92 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.08 -49.1 63.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.201 0.6 . . . . 0.0 109.458 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.96 -31.38 71.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.264 -0.273 . . . . 0.0 111.538 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.4 87.1 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.2 mt -65.46 -45.02 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.2 mt -85.57 -29.76 23.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -21.56 30.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.778 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -107.71 -20.47 13.21 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.54 -14.96 23.19 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.399 -1.438 . . . . 0.0 110.521 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.05 -41.64 2.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 112.812 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 73.38 -1.6 42.18 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.65 117.61 1.1 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.107 0.953 . . . . 0.0 111.03 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 11.9 t -152.44 168.58 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.25 -29.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -159.75 158.56 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -165.94 146.66 6.68 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -159.46 151.97 22.86 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 121.42 0.456 . . . . 0.0 114.054 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.32 150.33 4.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -97.39 74.75 2.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.9 p -61.23 146.37 48.03 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.62 17.48 14.42 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.733 1.213 . . . . 0.0 111.705 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.0 tptm 51.53 124.31 0.0 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 128.022 2.529 . . . . 0.0 114.878 -170.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 58.2 m170 61.13 27.79 17.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -133.47 -0.91 3.19 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 6.1 p90 25.98 66.97 0.47 Allowed Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.033 1.333 . . . . 0.0 112.282 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.53 -49.84 0.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 124.262 3.308 . . . . 0.0 110.783 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.91 35.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 111.635 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.34 15.6 1.29 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.131 0.872 . . . . 0.0 114.659 -172.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 77.3 p -163.45 145.45 9.69 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.355 0.662 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.79 -161.95 28.71 Favored Glycine 0 N--CA 1.427 -1.907 0 O-C-N 120.685 -1.259 . . . . 0.0 112.725 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.54 166.88 25.15 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.719 -0.871 . . . . 0.0 111.946 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 144.07 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.662 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.452 HG21 ' H ' ' A' ' 347' ' ' ASP . 44.3 m -116.72 131.64 56.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 123.533 0.521 . . . . 0.0 110.693 -172.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -118.99 155.75 30.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.515 1.135 . . . . 0.0 111.909 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.11 7.01 10.77 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -136.89 166.61 23.21 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.041 1.337 . . . . 0.0 109.648 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -98.08 -28.34 13.8 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.575 ' HD3' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -62.9 -26.1 68.64 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.878 0.763 . . . . 0.0 112.987 -175.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 71.7 p -73.45 -33.04 64.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -68.62 -55.13 12.56 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 119.237 0.926 . . . . 0.0 110.645 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -24.02 58.46 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.136 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -78.4 -23.2 46.87 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 118.238 -1.385 . . . . 0.0 111.221 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.91 -26.2 36.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.247 -0.908 . . . . 0.0 111.497 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.85 -27.95 5.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.059 0.457 . . . . 0.0 111.049 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.6 p -83.39 -18.86 37.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.744 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -90.69 -45.69 8.71 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.033 0.444 . . . . 0.0 110.456 171.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.91 -10.39 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.855 2.062 . . . . 0.0 114.31 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -161.07 144.65 13.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.32 156.31 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 O-C-N 120.868 -1.145 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.434 ' CD ' ' N ' ' A' ' 414' ' ' GLU . 17.1 mp0 -120.18 137.94 53.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.594 0.711 . . . . 0.0 112.396 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.45 124.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 46.91 1.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.247 1.022 . . . . 0.0 111.786 -175.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.9 p -66.47 169.7 7.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.67 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.8 t -69.78 1.53 4.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.305 0.642 . . . . 0.0 110.749 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.45 0.88 0.44 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -171.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -154.37 139.35 17.29 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.419 -0.801 . . . . 0.0 112.512 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 50.6 p -139.08 124.05 18.83 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.205 -0.934 . . . . 0.0 110.766 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 0.8 OUTLIER -168.82 -179.33 3.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.429 176.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 55.6 mtmt -140.99 172.15 13.08 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.18 152.32 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 124.346 1.028 . . . . 0.0 109.353 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -117.09 152.16 35.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 111.623 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.92 141.79 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.288 0.566 . . . . 0.0 111.61 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.92 124.85 8.64 Favored Pre-proline 0 C--O 1.246 0.874 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.85 158.47 18.53 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 124.082 3.188 . . . . 0.0 114.001 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 C--O 1.263 1.775 0 CA-C-O 117.285 -1.34 . . . . 0.0 111.115 171.329 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.355 0.598 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.2 t -167.06 173.28 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TRP . . . . . 0.461 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -126.37 7.37 7.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.8 m 46.56 37.75 4.81 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.356 -0.84 . . . . 0.0 112.464 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -168.96 77.92 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.244 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 164.92 25.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.939 0.435 . . . . 0.0 110.839 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.3 mm? -78.93 152.85 77.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.28 114.45 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.915 2.41 . . . . 0.0 112.314 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 364' ' ' GLU . 34.8 Cg_endo -82.12 -165.07 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.413 4.075 . . . . 0.0 111.43 175.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 58.51 32.67 22.38 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.797 0.439 . . . . 0.0 111.801 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -99.48 -1.06 39.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -74.12 153.55 39.52 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.854 0.861 . . . . 0.0 110.446 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -148.84 25.39 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.264 1.026 . . . . 0.0 110.809 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -131.99 62.2 62.43 Favored Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 120.632 -1.293 . . . . 0.0 112.084 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -68.91 117.46 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.328 3.352 . . . . 0.0 112.928 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.1 mm -140.82 151.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -109.38 141.25 42.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.925 1.239 . . . . 0.0 110.643 -173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.5 t -133.48 3.65 3.61 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.397 0.544 . . . . 0.0 112.449 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 3.6 t -153.21 177.6 10.66 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.053 0.541 . . . . 0.0 110.257 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.87 166.32 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.062 1.345 . . . . 0.0 113.924 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.01 138.14 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.89 133.01 33.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.481 HD11 HG13 ' A' ' 326' ' ' VAL . 23.0 tp -139.5 112.72 8.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.145 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.86 155.81 26.47 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.114 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.74 13.73 1.39 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 124.153 0.56 . . . . 0.0 113.081 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.17 117.14 58.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.674 -0.898 . . . . 0.0 111.826 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.7 -4.4 8.2 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.754 2.969 . . . . 0.0 113.368 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -105.71 -109.57 0.29 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.26 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 38.7 t70 43.87 74.8 0.11 Allowed 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 119.859 1.209 . . . . 0.0 111.372 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.407 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -83.77 -10.37 11.73 Favored 'Isoleucine or valine' 0 C--O 1.273 2.291 0 CA-C-N 118.551 0.614 . . . . 0.0 110.692 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.4 p -146.18 129.03 16.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.3 -22.11 66.67 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.648 0.737 . . . . 0.0 109.917 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -74.14 -21.92 59.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.298 -1.501 . . . . 0.0 110.9 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.69 -57.3 5.48 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.47 -42.69 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.079 0.952 . . . . 0.0 112.52 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.1 t -73.51 -32.83 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.474 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.62 -20.16 57.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.693 0.679 . . . . 0.0 111.294 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -73.1 -30.03 63.36 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.905 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -129.88 16.87 5.73 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -89.63 -21.83 22.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 120.018 1.281 . . . . 0.0 112.181 171.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.18 24.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -143.29 7.88 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.782 0.719 . . . . 0.0 112.659 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -167.44 169.98 41.39 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-O 121.935 0.742 . . . . 0.0 113.04 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.9 t -82.31 77.92 9.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.385 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.05 166.85 24.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 52.7 m -147.88 -175.08 4.74 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.898 1.333 . . . . 0.0 110.836 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.67 154.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 123.813 0.845 . . . . 0.0 111.689 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -142.29 131.69 23.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 124.951 1.407 . . . . 0.0 110.929 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -93.07 133.67 28.42 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.578 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 282' ' ' VAL . 66.8 Cg_endo -76.71 -23.19 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 O-C-N 123.962 1.506 . . . . 0.0 112.189 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.06 -66.99 1.57 Allowed Glycine 0 C--O 1.218 -0.866 0 C-N-CA 123.074 0.368 . . . . 0.0 112.379 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? 48.39 49.09 18.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.954 0.502 . . . . 0.0 110.253 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.87 35.31 3.95 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.259 1.824 . . . . 0.0 114.453 -170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.88 163.06 35.1 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.521 0.512 . . . . 0.0 111.951 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -92.17 169.13 10.86 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 122.467 -0.431 . . . . 0.0 110.505 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB3' ' CD ' ' A' ' 274' ' ' PRO . 14.0 m80 60.67 173.33 0.06 OUTLIER Pre-proline 0 C--O 1.219 -0.525 0 C-N-CA 125.766 1.626 . . . . 0.0 112.846 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 273' ' ' HIS . 32.4 Cg_exo -60.59 40.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 1 C-N-CA 126.723 4.948 . . . . 0.0 114.687 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -147.7 41.47 1.03 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.842 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.51 129.3 25.92 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.976 0.51 . . . . 0.0 109.671 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.42 134.04 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.456 1.438 . . . . 0.0 111.146 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.14 158.7 5.73 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 124.277 3.318 . . . . 0.0 109.545 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -100.95 12.87 36.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 0.0 108.858 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 112.95 -9.76 25.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -171.64 169.15 6.1 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.855 0.827 . . . . 0.0 110.606 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 267' ' ' PRO . 32.7 m -148.79 -174.09 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.104 1.762 . . . . 0.0 108.978 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -123.08 153.39 39.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 111.466 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.76 139.06 42.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.728 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.9 131.25 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.498 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 35.6 p90 -167.35 -151.15 0.11 Allowed 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 123.509 0.505 . . . . 0.0 110.378 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.34 -8.53 0.78 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.453 ' HA ' HG23 ' A' ' 292' ' ' VAL . 90.8 mt 50.75 -163.58 0.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 111.461 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.9 -78.59 0.0 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.276 2.63 . . . . 0.0 114.952 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -84.18 -32.8 24.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.741 1.275 . . . . 0.0 111.213 -172.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 75.6 m -85.23 -15.69 42.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.643 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 288' ' ' LEU . 79.0 t -68.32 -51.48 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -66.53 -26.4 67.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.2 t -65.19 -46.45 80.69 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 118.537 0.608 . . . . 0.0 110.786 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.39 -44.16 83.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 119.805 -1.809 . . . . 0.0 110.351 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.56 -26.96 67.37 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 124.341 1.025 . . . . 0.0 109.441 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -92.96 -10.0 37.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 120.14 1.336 . . . . 0.0 111.389 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -102.91 -19.78 14.51 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.08 178.39 7.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.013 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.2 t -77.91 163.81 25.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.369 1.668 . . . . 0.0 111.544 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -151.2 160.23 43.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.679 1.192 . . . . 0.0 111.079 -175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.18 124.76 7.67 Favored Pre-proline 0 CA--C 1.517 -0.312 0 O-C-N 121.473 -0.767 . . . . 0.0 110.02 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.43 51.29 3.24 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 124.556 3.504 . . . . 0.0 108.324 169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.494 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 310' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 122.236 1.017 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.676 ' H ' HD13 ' A' ' 309' ' ' LEU . 32.3 m -143.35 149.36 37.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.747 1.619 . . . . 0.0 109.304 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -132.71 136.32 46.33 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 122.223 -0.298 . . . . 0.0 110.768 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 328' ' ' VAL . 64.9 m-85 -118.44 159.16 23.97 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -153.35 159.37 42.45 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 122.077 -0.389 . . . . 0.0 111.978 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -145.25 159.43 43.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.706 -0.621 . . . . 0.0 111.007 172.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -110.35 118.53 36.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.25 21.23 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.63 0.195 . . . . 0.0 111.429 -169.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.5 t -137.11 162.67 32.76 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.185 -0.947 . . . . 0.0 111.122 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 32.4 p -145.3 -10.95 0.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.875 0.87 . . . . 0.0 111.112 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 4.59 0.13 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -107.81 -38.92 5.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.877 -1.139 . . . . 0.0 110.576 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 15.8 mmt -133.91 -31.96 1.13 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.513 0.725 . . . . 0.0 109.205 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 46.12 27.48 0.54 Allowed 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.541 0.686 . . . . 0.0 110.92 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.5 -173.68 4.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER 57.5 68.8 0.8 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.743 1.217 . . . . 0.0 114.001 176.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 325' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 3.6 mp0 -46.7 156.73 0.18 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.327 173.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.481 HG13 HD11 ' A' ' 240' ' ' LEU . 7.6 p -119.4 142.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -86.53 137.46 32.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.829 0.74 . . . . 0.0 110.086 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.5 p -132.57 137.05 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 123.936 0.772 . . . . 0.0 111.924 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 328' ' ' VAL . 7.8 pt -156.76 130.76 4.84 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.67 168.6 8.29 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.544 4.162 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.409 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 1.7 t90 -82.14 124.17 29.63 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 169.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 334' ' ' ALA . 21.3 t -100.76 137.31 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.85 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.69 -35.12 60.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.933 1.293 . . . . 0.0 110.994 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.495 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -79.82 11.44 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 118.392 -0.814 . . . . 0.0 112.807 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.11 6.28 10.79 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.671 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.1 p -139.45 -2.45 1.6 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -147.91 153.58 39.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -155.02 139.1 16.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.77 0.828 . . . . 0.0 111.82 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.93 155.5 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 118.867 0.758 . . . . 0.0 111.593 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -102.68 -6.86 22.24 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 108.789 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 342' ' ' PRO . 60.6 m -131.2 166.15 29.92 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 123.703 0.801 . . . . 0.0 112.818 -171.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 57.2 Cg_endo -66.15 -9.06 22.15 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.354 2.036 . . . . 0.0 112.169 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 58.4 p -85.14 168.94 14.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.897 0.879 . . . . 0.0 109.911 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -136.32 24.22 3.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.164 0.507 . . . . 0.0 110.938 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -112.57 164.45 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.016 0.927 . . . . 0.0 111.691 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -111.84 -171.58 1.87 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.426 1.49 . . . . 0.0 110.499 -173.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.86 93.3 31.61 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.919 1.288 . . . . 0.0 107.923 171.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.71 -0.22 0.36 Allowed 'Trans proline' 0 C--O 1.24 0.579 1 C-N-CA 126.063 4.508 . . . . 0.0 115.933 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.7 m -117.66 3.93 12.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.18 0.592 . . . . 0.0 111.653 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -141.71 55.64 1.5 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.945 0.793 . . . . 0.0 109.981 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.5 t -143.34 154.02 43.32 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.88 159.89 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 124.18 0.925 . . . . 0.0 110.432 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -84.92 138.65 32.38 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.296 0.998 . . . . 0.0 113.306 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.48 149.04 24.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.095 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 178.15 -168.05 39.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.97 22.99 2.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.209 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 357' ' ' LEU . 0.6 OUTLIER -92.13 137.43 32.37 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.659 -175.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 358' ' ' HIS . . . . . 0.489 ' CD2' ' H ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER 29.02 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.885 1.274 . . . . 0.0 112.98 169.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.64 -12.65 0.05 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-O 118.132 -1.371 . . . . 0.0 111.008 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.7 mmt -133.93 -52.41 0.85 Allowed 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 125.232 1.195 . . . . 0.0 108.389 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 357' ' ' LEU . 16.0 tp 27.67 77.56 0.02 OUTLIER 'General case' 0 C--N 1.347 0.468 0 O-C-N 124.585 1.178 . . . . 0.0 111.992 -171.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -61.64 164.25 6.23 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 123.972 0.909 . . . . 0.0 111.761 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.74 -22.7 62.43 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 226' ' ' PRO . 71.1 mm-40 -83.2 -32.54 26.5 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 119.508 1.049 . . . . 0.0 110.086 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -73.82 -40.78 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 122.117 -0.365 . . . . 0.0 110.135 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.09 -46.76 82.84 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.34 65.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.712 -1.242 . . . . 0.0 111.58 -173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.05 80.35 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.403 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 89.3 mt -71.66 -41.42 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 -16.31 49.71 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.35 -1.309 . . . . 0.0 114.2 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -16.55 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 120.316 1.417 . . . . 0.0 114.367 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.45 -20.62 13.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.105 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.77 -14.36 18.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.572 1.078 . . . . 0.0 111.091 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -117.3 -64.64 1.28 Allowed 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.206 -0.934 . . . . 0.0 110.766 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 161.73 -151.23 21.31 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.324 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -66.08 130.13 32.59 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 126.248 1.88 . . . . 0.0 110.376 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.23 164.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 126.177 1.791 . . . . 0.0 107.844 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.65 -28.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.444 0.565 . . . . 0.0 112.111 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.3 OUTLIER -157.32 156.78 32.96 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -149.67 143.03 25.22 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -154.24 171.85 32.81 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 122.09 0.828 . . . . 0.0 114.181 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.487 ' HA ' ' HA3' ' A' ' 394' ' ' GLY . 26.7 mt -127.39 144.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 128.635 2.774 . . . . 0.0 108.478 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.86 149.01 24.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.337 -0.852 . . . . 0.0 111.882 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.2 p -108.91 161.41 15.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.192 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -130.02 34.56 4.23 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.519 1.152 . . . . 0.0 111.973 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 tptm 61.99 95.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.454 1.902 . . . . 0.0 111.397 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 m170 48.48 28.04 1.6 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -104.12 11.73 34.79 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.522 1.056 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 52.4 p90 44.82 49.25 5.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 126.576 1.951 . . . . 0.0 114.144 173.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.62 -52.62 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 119.338 0.799 . . . . 0.0 112.082 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.409 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 37.62 47.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 123.57 0.748 . . . . 0.0 109.826 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -158.86 6.71 0.15 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.9 p -153.8 138.61 17.09 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 382' ' ' ILE . . . -169.15 -149.17 6.1 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -154.94 172.85 17.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.974 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.2 132.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 52.2 m -101.59 110.68 22.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.848 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.1 157.17 16.01 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.708 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.76 -0.06 6.06 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.965 0.791 . . . . 0.0 109.604 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -120.82 135.86 55.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.058 1.343 . . . . 0.0 108.126 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.01 -25.69 67.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.662 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.94 -31.33 72.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.01 0.823 . . . . 0.0 110.965 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 m -80.43 -12.27 59.58 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.869 -1.144 . . . . 0.0 111.257 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.37 -60.72 2.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.536 -0.727 . . . . 0.0 109.174 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.65 63.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.495 -176.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.25 -26.32 35.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.965 0.802 . . . . 0.0 111.457 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 426' ' ' ILE . . . -75.27 -31.03 60.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.373 -0.829 . . . . 0.0 111.036 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.31 -26.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.963 0.905 . . . . 0.0 111.223 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.2 p -84.27 -26.09 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.28 -40.82 10.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.517 0.327 . . . . 0.0 110.273 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.2 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.73 141.16 10.0 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 120.297 1.408 . . . . 0.0 108.89 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -141.38 159.3 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.548 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -113.64 110.15 19.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.172 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.1 mm -77.2 129.58 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 173.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 30.3 ttmt -153.99 98.12 2.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.302 0.572 . . . . 0.0 109.487 -170.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 418' ' ' THR . 3.9 m -143.79 179.65 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 417' ' ' THR . 2.0 m -78.52 2.11 20.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.9 -0.5 . . . . 0.0 110.781 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -129.98 -8.45 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.63 131.93 11.13 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.416 -0.802 . . . . 0.0 111.395 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 7.1 p -143.64 86.81 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.829 0.741 . . . . 0.0 110.871 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -150.55 172.32 15.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.95 0.9 . . . . 0.0 109.951 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -128.56 167.72 16.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.695 0.398 . . . . 0.0 111.17 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.93 145.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 CA-C-N 118.748 0.704 . . . . 0.0 109.296 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -122.69 150.2 43.04 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.026 0.917 . . . . 0.0 112.702 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 407' ' ' ALA . 4.4 mp -133.2 145.96 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.226 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -150.74 128.38 5.68 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -83.66 166.83 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 2.78 . . . . 0.0 111.538 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.359 1.064 . . . . 0.0 111.057 176.886 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 C--O 1.218 -0.603 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.9 m 57.65 164.77 0.03 OUTLIER 'General case' 0 C--O 1.246 0.888 0 CA-C-O 122.68 1.229 . . . . 0.0 110.407 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -157.59 -40.58 0.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.887 -1.133 . . . . 0.0 112.143 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 m 47.81 22.89 0.39 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 57.41 69.25 1.33 Allowed Glycine 0 N--CA 1.447 -0.613 0 O-C-N 120.845 -1.159 . . . . 0.0 112.803 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -71.8 -21.58 61.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.794 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.513 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 1.0 OUTLIER -155.55 9.15 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -176.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 224' ' ' LEU . 42.6 Cg_endo -64.61 119.49 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 122.331 1.868 . . . . 0.0 111.605 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.2 142.28 41.35 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 124.4 3.4 . . . . 0.0 111.254 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -138.32 170.19 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.171 0.989 . . . . 0.0 110.772 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.35 38.11 29.44 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.816 0.817 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -54.58 30.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.989 1.316 . . . . 0.0 110.41 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 71.0 tttt 55.25 45.33 25.97 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -114.56 -46.91 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.11 -174.25 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.442 1 C-N-CA 125.304 4.002 . . . . 0.0 114.649 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 234' ' ' TYR . 4.2 mp -109.2 -179.09 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.709 ' H ' HG22 ' A' ' 233' ' ' ILE . 30.9 m-85 -93.74 158.25 15.76 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 51.0 m -145.08 -0.78 0.87 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.72 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.609 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 12.0 m -149.46 -164.55 2.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.875 1.216 . . . . 0.0 110.996 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 236' ' ' CYS . 0.1 OUTLIER -59.93 172.09 0.82 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.503 1.144 . . . . 0.0 111.542 -177.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.29 138.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.413 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -81.64 143.4 31.95 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 122.162 0.982 . . . . 0.0 109.444 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.479 ' C ' HD13 ' A' ' 240' ' ' LEU . 1.0 OUTLIER -141.02 108.22 5.49 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.65 164.53 29.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.75 12.16 5.62 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.853 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.02 116.48 65.58 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 119.097 1.449 . . . . 0.0 111.431 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.24 1.83 5.23 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 124.644 3.562 . . . . 0.0 110.406 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -141.49 175.82 9.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.3 1.04 . . . . 0.0 109.956 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.52 155.16 10.61 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.221 0.534 . . . . 0.0 110.584 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -133.67 -44.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.281 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.014 170.385 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 250' ' ' ALA . 7.4 m -168.48 148.72 4.63 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.809 1.943 . . . . 0.0 108.18 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -70.08 -26.73 64.13 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 119.749 -1.845 . . . . 0.0 111.722 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.454 ' H ' HG22 ' A' ' 248' ' ' THR . . . -80.91 -19.35 44.49 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.464 0.706 . . . . 0.0 110.358 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.18 -58.04 6.42 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.34 -40.06 70.76 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.178 0.575 . . . . 0.0 110.216 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.702 ' CG2' HG21 ' A' ' 264' ' ' VAL . 54.6 t -70.39 -41.32 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 118.836 -2.415 . . . . 0.0 110.414 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.22 0.09 10.71 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.854 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 48.1 m -87.8 -28.04 21.92 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.036 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -137.98 16.15 2.85 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.6 20.6 0.22 Allowed 'General case' 0 C--O 1.24 0.592 0 O-C-N 120.45 -1.406 . . . . 0.0 112.789 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.89 6.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 120.208 1.367 . . . . 0.0 110.611 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.98 -11.35 58.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.916 -1.115 . . . . 0.0 112.151 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.16 -4.08 59.76 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.828 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 10.7 t -127.3 22.6 6.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.26 1.03 . . . . 0.0 111.817 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.4 OUTLIER -92.76 144.26 25.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.928 -1.107 . . . . 0.0 109.988 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.3 m -152.68 172.05 17.26 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 125.788 1.93 . . . . 0.0 107.893 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.702 HG21 ' CG2' ' A' ' 253' ' ' VAL . 61.3 t -148.29 144.0 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.293 -169.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -109.21 131.71 54.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.955 0.784 . . . . 0.0 109.939 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.419 ' CE3' HG21 ' A' ' 282' ' ' VAL . 2.0 t-105 -145.28 81.99 10.04 Favored Pre-proline 0 C--O 1.242 0.691 0 CA-C-O 122.048 0.927 . . . . 0.0 110.979 -167.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 164.22 31.99 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 123.786 2.991 . . . . 0.0 109.747 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.01 -4.36 85.61 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -66.56 65.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.403 1.481 . . . . 0.0 111.308 174.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -142.95 2.25 1.33 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.512 0.725 . . . . 0.0 111.817 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.3 -154.08 8.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.264 0.935 . . . . 0.0 111.548 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.89 168.27 12.18 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 24.0 m170 67.47 150.84 0.12 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.066 2.147 . . . . 0.0 114.445 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.32 -4.27 14.55 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.823 2.349 . . . . 0.0 109.661 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -95.9 11.93 32.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.878 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 277' ' ' PRO . 1.8 p 63.26 155.67 0.12 Allowed Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 129.012 2.925 . . . . 0.0 111.208 -173.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 276' ' ' CYS . 84.7 Cg_endo -77.79 159.21 31.43 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.402 3.401 . . . . 0.0 111.814 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.94 136.36 18.46 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.037 3.158 . . . . 0.0 111.714 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -144.76 155.51 43.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -76.45 -21.08 76.0 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-O 117.998 -1.446 . . . . 0.0 113.334 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -166.56 168.66 14.43 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.419 HG21 ' CE3' ' A' ' 266' ' ' TRP . 21.8 m -156.84 -163.69 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.941 2.096 . . . . 0.0 108.71 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -148.09 150.7 34.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.532 1.06 . . . . 0.0 111.652 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 284' ' ' LEU . 5.3 mp -101.97 156.35 17.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.89 122.73 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 31.5 p90 -165.66 -157.54 0.32 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 117.499 -1.239 . . . . 0.0 109.915 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 93.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.81 ' H ' HD23 ' A' ' 288' ' ' LEU . 0.8 OUTLIER -69.78 14.0 0.12 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.65 2.38 . . . . 0.0 115.75 -167.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -136.09 -53.96 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.571 1.532 . . . . 0.0 111.111 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -88.05 -41.16 13.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.83 -170.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 73.9 m -74.77 -32.99 62.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.86 -47.81 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 122.105 -0.372 . . . . 0.0 110.896 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -73.3 -20.34 60.83 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.82 -0.55 . . . . 0.0 112.109 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.5 m -79.78 -35.53 38.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.606 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -46.34 87.05 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.713 172.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.07 -17.08 61.46 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.066 0.848 . . . . 0.0 110.467 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -87.97 -9.7 52.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 122.727 0.411 . . . . 0.0 111.743 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.04 -3.22 15.6 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.03 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.4 m -109.68 -154.67 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.939 1.399 . . . . 0.0 110.858 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.6 m -136.06 160.49 38.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.028 1.394 . . . . 0.0 109.641 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 74.1 t60 -142.44 165.56 27.08 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.86 -1.775 . . . . 0.0 111.343 -173.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 13.3 m-20 -147.01 115.97 4.39 Favored Pre-proline 0 C--O 1.212 -0.913 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -85.39 25.75 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 126.178 4.586 . . . . 0.0 111.538 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.352 0.69 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.027 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.216 -0.685 0 CA-C-O 121.374 0.607 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.2 m -107.62 169.91 8.3 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.614 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -141.91 149.03 39.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 1.064 . . . . 0.0 109.154 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' TYR . . . . . 0.404 ' HB2' HG23 ' A' ' 328' ' ' VAL . 5.9 m-85 -122.47 149.09 44.35 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -138.61 153.62 48.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 122.808 1.289 . . . . 0.0 112.104 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -146.61 169.63 18.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.426 -0.797 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -128.6 74.85 1.59 Allowed 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -76.72 1.37 17.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.373 177.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 67.9 m -57.66 137.27 56.61 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 25.1 t -108.77 175.2 5.55 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.816 -1.178 . . . . 0.0 109.257 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -60.65 0.5 0.2 Allowed 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 124.838 1.255 . . . . 0.0 113.822 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 ptm85 -105.12 8.21 34.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.35 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 74.1 mmm -128.78 169.91 13.97 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 46.4 mtt85 -119.49 0.06 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.342 0.657 . . . . 0.0 111.371 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 93.8 m -124.01 -174.94 3.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.677 0.791 . . . . 0.0 109.712 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -150.71 166.31 30.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 66.13 147.3 0.04 OUTLIER 'General case' 0 C--N 1.342 0.279 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.58 165.03 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.293 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 143.82 35.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.622 0.769 . . . . 0.0 110.249 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 312' ' ' TYR . 28.2 m -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.903 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 34.9 mt -144.84 107.8 4.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.52 171.8 15.33 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.257 2.638 . . . . 0.0 111.892 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.609 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.2 t-105 -101.41 112.32 24.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 169.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.29 157.61 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.04 -0.412 . . . . 0.0 110.5 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.64 -28.0 63.32 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.355 1.062 . . . . 0.0 109.859 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.21 -4.98 8.75 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 124.687 1.242 . . . . 0.0 110.176 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.68 8.66 15.04 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.57 1.148 . . . . 0.0 110.274 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.8 m -115.5 -47.13 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.642 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -155.67 166.27 34.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.908 0.861 . . . . 0.0 110.125 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -153.86 144.53 22.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 110.451 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.22 145.06 18.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -106.66 -16.54 14.48 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.803 1.314 . . . . 0.0 111.427 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 60.1 m -96.73 147.36 32.82 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.294 -0.879 . . . . 0.0 111.351 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.09 -26.43 7.74 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.244 2.629 . . . . 0.0 112.707 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.1 m -143.51 2.92 1.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.2 154.26 22.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.912 1.339 . . . . 0.0 110.062 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.23 177.37 6.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.391 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 346' ' ' LEU . 1.3 mm? -58.33 151.64 19.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.234 -0.916 . . . . 0.0 111.303 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -89.88 137.49 28.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.08 -2.8 13.01 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.003 2.468 . . . . 0.0 115.869 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 41.5 p -142.26 -0.6 1.25 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.552 1.141 . . . . 0.0 112.98 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -123.24 60.66 1.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 397' ' ' THR . 18.6 p -138.27 147.72 43.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 428' ' ' PRO . 22.3 m -123.68 169.72 14.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 122.508 -0.12 . . . . 0.0 110.921 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -97.91 125.45 42.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.68 131.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -120.44 97.28 0.64 Allowed Glycine 0 C--O 1.213 -1.181 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.599 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -145.72 132.89 20.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.498 0.666 . . . . 0.0 110.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -160.98 155.76 23.78 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.6 1.16 . . . . 0.0 113.32 -169.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 358' ' ' HIS . . . . . 0.468 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 40.2 p-80 -159.98 6.51 0.09 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 169.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 116.94 -17.97 12.74 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.315 1.912 . . . . 0.0 112.388 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.6 ptm -166.05 43.27 0.07 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.552 0.676 . . . . 0.0 109.783 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 361' ' ' LEU . 3.0 tm? -57.79 132.23 52.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.37 166.0 12.83 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.758 -173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.36 -17.26 64.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 118.467 -0.778 . . . . 0.0 111.453 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -77.72 -30.4 51.72 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.919 0.781 . . . . 0.0 109.431 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.39 74.49 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.19 -43.92 55.38 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.665 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.68 69.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.41 70.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.577 1.173 . . . . 0.0 114.053 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.57 -32.29 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 O-C-N 123.612 0.57 . . . . 0.0 110.403 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.86 -30.89 18.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.14 -14.18 31.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.918 -0.563 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.36 -33.36 13.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.503 0.668 . . . . 0.0 111.593 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.41 -11.89 19.85 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.09 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 403' ' ' SER . 23.7 m-85 -128.19 -42.36 1.53 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 173.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.75 87.19 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.415 1.007 . . . . 0.0 113.451 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -134.03 103.04 0.48 Allowed Glycine 0 C--N 1.352 1.428 0 CA-C-N 119.007 1.403 . . . . 0.0 110.352 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.44 159.02 15.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 117.587 0.694 . . . . 0.0 111.056 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.49 -58.0 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 123.829 0.852 . . . . 0.0 111.257 174.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' ' 346' ' ' LEU . 1.9 t80 -147.2 152.38 38.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.742 1.258 . . . . 0.0 110.737 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.32 137.76 29.03 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -136.0 151.61 20.78 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 122.212 0.896 . . . . 0.0 112.19 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.41 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -98.46 123.87 42.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 56.1 p -126.92 158.97 35.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.765 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.12 159.77 40.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 113.03 -1.896 . . . . 0.0 107.358 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.401 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 23.1 tptm -50.2 102.21 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.401 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 26.5 m80 54.99 22.31 4.29 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -12.45 59.99 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 111.731 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.8 p90 41.37 51.78 5.6 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.44 -30.31 8.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.112 2.541 . . . . 0.0 113.233 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.46 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 28.14 75.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 127.83 2.452 . . . . 0.0 114.143 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.53 -88.84 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 114.185 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.4 p -57.04 154.15 10.23 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.193 0.996 . . . . 0.0 108.809 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -162.77 -173.12 31.08 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.204 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -140.47 157.68 45.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.959 0.504 . . . . 0.0 110.234 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.16 151.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 351' ' ' THR . 9.9 t -129.59 146.22 51.42 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.518 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 61.4 m-85 -121.83 -30.09 4.19 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 123.947 0.779 . . . . 0.0 111.409 -172.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.93 16.48 5.79 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.472 0.483 . . . . 0.0 109.851 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -139.96 140.05 36.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.193 0.997 . . . . 0.0 109.735 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -80.53 -20.49 43.4 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.631 0.372 . . . . 0.0 111.692 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 402' ' ' ARG . 0.6 OUTLIER -58.6 -36.34 73.85 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.528 -177.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.518 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 12.1 m -82.71 -14.53 54.41 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.475 -0.766 . . . . 0.0 110.371 -172.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -76.91 -63.14 1.43 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.511 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.443 ' C ' HD22 ' A' ' 405' ' ' LEU 0.25 0.0 OUTLIER -71.09 -17.5 62.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 118.861 -1.136 . . . . 0.0 113.298 -176.246 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -84.45 -31.16 24.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.484 -0.76 . . . . 0.0 112.37 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.17 30.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.618 1.099 . . . . 0.0 108.197 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.51 -31.39 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.469 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.1 t -77.38 -27.36 52.5 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 124.868 1.355 . . . . 0.0 111.473 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.69 3.62 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.133 -176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.96 -14.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 425' ' ' GLN . 1.9 m-85 -157.71 148.29 20.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.678 0.672 . . . . 0.0 110.352 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.19 149.87 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.875 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.38 151.05 20.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 110.78 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.8 mt -124.01 117.4 50.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.542 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -127.57 64.25 1.35 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.307 1.051 . . . . 0.0 109.044 -178.125 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -76.93 159.92 29.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.007 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -63.18 -23.09 67.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.723 0.692 . . . . 0.0 110.998 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -142.69 33.14 1.43 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -167.25 125.41 1.29 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.144 0.973 . . . . 0.0 109.0 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 15.2 p -136.4 121.88 19.47 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.784 -1.198 . . . . 0.0 112.017 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.8 tptp -164.77 176.52 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.604 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 47.7 tttt -124.66 156.75 37.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.41 148.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.366 0.984 . . . . 0.0 110.32 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 40.3 tt0 -118.33 161.0 20.66 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 21.6 mt -142.29 137.63 29.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 124.46 1.1 . . . . 0.0 110.702 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.6 129.01 6.77 Favored Pre-proline 0 C--O 1.235 0.334 0 O-C-N 123.546 0.528 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' A' ' 352' ' ' VAL . 23.2 Cg_endo -83.79 174.02 8.87 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.447 1.431 . . . . 0.0 113.846 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 116.458 -1.734 . . . . 0.0 112.651 171.97 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 122.538 1.161 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 40.8 m -143.92 75.79 1.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.78 1.276 . . . . 0.0 107.946 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.13 2.57 55.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.702 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 415' ' ' ILE . 94.6 p -38.99 141.86 0.26 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -169.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 164.86 -17.41 0.1 Allowed Glycine 0 CA--C 1.537 1.447 0 O-C-N 124.356 1.035 . . . . 0.0 111.966 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 57.7 128.6 0.0 OUTLIER 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.985 2.514 . . . . 0.0 111.664 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.421 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 2.8 mm? -107.04 -49.23 0.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 117.514 -1.232 . . . . 0.0 112.994 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 368' ' ' ALA . 52.4 Cg_exo -60.55 161.31 21.22 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 125.337 4.024 . . . . 0.0 113.888 -174.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.94 160.46 45.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.796 2.997 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -151.63 32.0 0.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.648 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -99.32 -18.86 17.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.14 0.976 . . . . 0.0 112.763 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 42.4 -136.92 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 66.15 34.37 6.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.945 1.298 . . . . 0.0 111.997 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.565 ' H ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -136.4 -40.17 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 175.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 231' ' ' ASN . 7.6 Cg_exo -74.51 -176.88 2.98 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.362 2.041 . . . . 0.0 115.228 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.11 162.38 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 125.336 1.454 . . . . 0.0 108.868 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.454 ' CG ' HG11 ' A' ' 292' ' ' VAL . 14.1 m-85 -109.75 138.78 45.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.962 1.705 . . . . 0.0 107.811 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.9 t -152.04 2.34 0.36 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -171.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.632 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 71.2 m -148.63 63.58 1.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.48 -1.387 . . . . 0.0 114.44 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.23 162.3 0.2 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.356 0.662 . . . . 0.0 112.296 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.54 142.38 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -81.99 127.97 33.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.273 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.455 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.1 tm? -136.53 108.33 7.07 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -159.24 160.52 31.34 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-O 122.703 1.168 . . . . 0.0 110.252 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.48 -3.16 3.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.28 122.75 88.27 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 120.604 -1.527 . . . . 0.0 109.629 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -87.2 -4.67 7.72 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 124.232 3.288 . . . . 0.0 109.45 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -134.42 176.26 8.77 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.285 1.434 . . . . 0.0 110.415 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.99 145.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.582 0.753 . . . . 0.0 109.874 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.14 -50.83 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.405 0 C-N-CA 122.601 0.36 . . . . 0.0 110.803 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -164.78 130.43 2.76 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.721 2.008 . . . . 0.0 105.753 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -70.97 -13.33 61.97 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 120.421 1.464 . . . . 0.0 111.965 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.04 65.78 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 125.347 1.459 . . . . 0.0 109.278 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.99 -35.68 84.66 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.83 -45.73 41.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.685 1.231 . . . . 0.0 108.63 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.9 t -62.93 -53.61 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 120.509 -1.37 . . . . 0.0 110.485 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -79.89 -13.71 59.18 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.8 t -81.52 -26.22 35.3 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.525 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -126.44 32.11 5.25 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.276 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 28.6 tpt85 -96.09 -18.2 20.34 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.436 1.094 . . . . 0.0 109.822 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 258' ' ' VAL . 4.7 t -70.35 20.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -128.12 0.4 5.84 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.466 -0.771 . . . . 0.0 112.888 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.56 -95.38 0.1 Allowed Glycine 0 N--CA 1.471 1.004 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.675 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.0 t -144.9 147.38 32.7 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.292 1.046 . . . . 0.0 109.408 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 151.67 24.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.0 m -149.71 175.72 11.32 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.34 150.25 18.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 121.072 -1.017 . . . . 0.0 113.468 -172.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.33 154.09 46.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.582 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.27 138.79 20.97 Favored Pre-proline 0 C--N 1.345 0.385 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.91 -170.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.98 -29.1 4.47 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 125.01 3.806 . . . . 0.0 109.769 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.56 -28.36 6.05 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.164 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 44.34 50.7 7.84 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.342 1.071 . . . . 0.0 110.371 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -118.89 -8.02 10.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.02 8.83 58.89 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.004 -0.887 . . . . 0.0 113.155 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.88 -36.33 76.68 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 118.642 1.221 . . . . 0.0 110.742 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -143.33 126.69 9.11 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.34 -12.41 12.8 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 125.06 3.84 . . . . 0.0 109.731 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -72.46 -72.28 0.25 Allowed 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 123.134 0.573 . . . . 0.0 111.014 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -158.24 143.7 12.22 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 124.592 1.183 . . . . 0.0 109.675 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.97 160.34 34.21 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.222 1.948 . . . . 0.0 111.16 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.37 27.19 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 125.234 3.956 . . . . 0.0 111.018 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.46 158.12 27.91 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -82.8 10.68 56.25 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.581 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.33 170.91 19.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.787 -177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 283' ' ' TYR . 11.7 p -156.85 176.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 125.217 1.573 . . . . 0.0 107.197 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 282' ' ' VAL . 10.6 m-85 -118.17 155.19 30.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 119.763 1.165 . . . . 0.0 111.374 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.02 135.25 55.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.86 120.31 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 125.577 1.551 . . . . 0.0 107.419 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -156.3 0.63 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.232 -174.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.62 18.87 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.187 0.449 . . . . 0.0 110.714 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 86.6 mt 48.99 -141.19 0.65 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 119.831 -1.793 . . . . 0.0 111.362 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 13.39 -74.42 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 127.593 2.357 . . . . 0.0 116.443 168.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -81.77 -29.12 32.92 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.813 0.845 . . . . 0.0 112.962 -170.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.7 m -78.56 -30.63 46.96 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.299 1.04 . . . . 0.0 108.705 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.454 HG11 ' CG ' ' A' ' 234' ' ' TYR . 62.4 t -68.19 -57.3 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -72.56 -20.4 61.32 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.8 t -71.77 -42.92 66.59 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.93 -0.482 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.86 -45.91 33.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.382 0.992 . . . . 0.0 111.497 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -16.32 61.84 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.468 1.031 . . . . 0.0 113.38 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -95.29 -17.03 21.99 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.69 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -78.16 -19.46 53.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 119.957 1.253 . . . . 0.0 112.307 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 5.1 t -115.26 -108.19 0.37 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.341 1.026 . . . . 0.0 113.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.2 t -142.64 163.56 32.48 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -168.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -146.94 156.23 42.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.314 1.846 . . . . 0.0 106.844 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -142.86 125.78 9.09 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.18 13.02 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 1 C-N-CA 127.521 5.481 . . . . 0.0 112.478 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 125.581 1.553 . . . . 0.0 112.766 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--O 1.239 0.519 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 63.5 m -80.04 166.15 21.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.151 0.907 . . . . 0.0 109.702 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -136.18 142.15 44.12 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.44 145.04 35.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.78 151.18 40.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 123.211 1.481 . . . . 0.0 109.324 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -147.85 159.98 43.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.964 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 44.9 mtmt -132.53 131.27 41.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 -3.49 0.91 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 116.115 -1.898 . . . . 0.0 114.344 -167.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 m -144.63 33.71 1.16 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.563 1.529 . . . . 0.0 111.436 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.1 m -61.84 -9.7 7.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.239 1.816 . . . . 0.0 113.5 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -138.37 5.08 2.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.595 0.758 . . . . 0.0 110.221 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -113.51 -28.91 7.36 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.539 0.736 . . . . 0.0 111.464 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.578 ' C ' ' H ' ' A' ' 323' ' ' CYS . 85.7 mmm -131.28 7.52 4.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.383 -0.818 . . . . 0.0 113.167 -172.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 60.85 -16.13 0.03 OUTLIER 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.222 2.209 . . . . 0.0 110.567 -172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.578 ' H ' ' C ' ' A' ' 321' ' ' MET . 80.4 m -110.58 167.75 9.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.789 0.835 . . . . 0.0 110.346 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -159.25 -162.66 1.09 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 122.871 0.468 . . . . 0.0 111.519 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 62.69 137.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.696 1.599 . . . . 0.0 112.868 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 12.6 p -156.58 162.92 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -109.09 155.6 20.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.422 0.555 . . . . 0.0 111.989 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.84 137.72 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 8.5 pt -146.17 94.92 4.83 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.95 169.72 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.888 1 C-N-CA 125.781 4.321 . . . . 0.0 111.257 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.632 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.6 t-105 -86.53 115.35 23.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.254 175.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 18.0 t -99.48 145.09 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 123.298 1.523 . . . . 0.0 108.791 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.25 -31.97 69.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.039 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -84.58 -7.99 59.06 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.68 -1.77 57.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.721 0.692 . . . . 0.0 111.312 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 88.5 p -130.2 -2.11 4.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.725 -0.609 . . . . 0.0 112.37 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -149.58 140.24 22.61 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.202 0.314 . . . . 0.0 110.186 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -156.14 106.67 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.414 0.686 . . . . 0.0 109.331 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -89.2 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.157 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.24 28.64 8.59 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.455 1.121 . . . . 0.0 110.303 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' SER . . . . . 0.515 ' H ' HG22 ' A' ' 339' ' ' VAL . 26.5 t -141.63 149.11 52.68 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.06 -3.29 13.58 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.265 3.31 . . . . 0.0 110.592 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -137.85 165.72 25.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -115.14 127.64 55.7 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.756 0.788 . . . . 0.0 111.188 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -142.01 -41.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.127 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 379' ' ' TYR . 4.2 mm? 50.64 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 O-C-N 124.722 1.264 . . . . 0.0 111.948 -171.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.21 140.71 19.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.25 -5.06 14.95 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.718 1.612 . . . . 0.0 114.98 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.4 t -152.51 -169.66 3.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 48.47 99.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.889 2.075 . . . . 0.0 113.742 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.7 t -158.27 155.72 29.4 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 149.76 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 124.132 0.895 . . . . 0.0 110.326 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -85.47 152.91 22.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.796 -169.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 133.27 66.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -167.58 -168.07 29.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.476 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 58.07 19.57 6.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 19.2 mt -67.09 154.66 40.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.657 -1.277 . . . . 0.0 109.839 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.69 16.36 1.13 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 87.36 9.32 72.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.824 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 8.9 ptp -159.01 12.17 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 31.8 tp -64.62 140.06 58.83 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.154 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.4 161.05 15.38 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.682 0.793 . . . . 0.0 109.199 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -70.09 -8.63 51.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 364' ' ' GLU . 1.6 pp20? -67.16 -35.14 79.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.36 34.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.615 0.721 . . . . 0.0 110.567 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.9 -31.44 64.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.665 -0.647 . . . . 0.0 110.021 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.75 -50.17 70.13 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.427 ' HB2' ' CD ' ' A' ' 225' ' ' PRO . . . -57.84 -39.14 76.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.879 -0.513 . . . . 0.0 111.576 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 90.2 mt -71.06 -41.8 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 122.034 -0.416 . . . . 0.0 110.109 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.22 -2.94 58.9 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -171.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -127.99 1.41 5.93 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.571 -1.331 . . . . 0.0 112.528 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -119.78 -20.63 7.54 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.962 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.85 -22.76 24.26 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.21 -16.22 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.456 1.026 . . . . 0.0 111.994 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 55.32 84.15 0.04 OUTLIER Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -151.84 3.86 0.43 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 118.195 0.998 . . . . 0.0 113.136 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.8 m -96.0 166.67 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 122.402 1.096 . . . . 0.0 113.179 -173.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.08 -27.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.171 170.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.424 ' CD2' HD21 ' A' ' 346' ' ' LEU . 24.9 t80 -155.18 147.83 24.24 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.12 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 119.235 0.925 . . . . 0.0 108.608 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -153.37 168.58 32.08 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.322 0.889 . . . . 0.0 115.322 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.7 mt -116.65 140.44 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.49 146.96 24.9 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.663 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.3 p -140.52 171.62 13.87 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 124.734 1.272 . . . . 0.0 111.907 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -132.76 18.59 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.435 1.494 . . . . 0.0 108.494 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . 0.274 0.5 OUTLIER 51.83 3.68 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 130.53 3.532 . . . . 0.0 114.794 -176.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -140.84 -9.8 1.03 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.681 1.192 . . . . 0.0 112.205 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -94.33 -11.09 30.75 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.86 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.0 p90 41.92 48.57 3.26 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.81 -52.01 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.389 2.726 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 391' ' ' ILE 0.286 6.9 tp 40.17 33.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 122.046 0.927 . . . . 0.0 110.674 -173.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -160.49 16.13 0.19 Allowed Glycine 0 C--N 1.345 1.078 0 CA-C-O 118.593 -1.115 . . . . 0.0 112.496 -176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.5 p -145.44 112.12 5.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.81 0.805 . . . . 0.0 109.088 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -152.01 -175.76 24.01 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -147.28 167.04 25.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.87 142.08 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 27.8 m -99.93 105.49 17.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -85.75 162.35 18.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.231 0.613 . . . . 0.0 110.477 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -147.13 19.06 1.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.581 0.705 . . . . 0.0 111.346 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -144.39 165.37 28.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.44 1.096 . . . . 0.0 108.755 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -88.16 -36.28 16.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 120.943 1.702 . . . . 0.0 113.298 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -51.35 -26.81 8.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.449 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -76.19 -30.26 57.97 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.51 -56.94 6.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.333 -1.479 . . . . 0.0 110.471 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -23.65 58.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.902 -1.124 . . . . 0.0 113.677 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -85.79 -22.91 27.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -87.58 -28.06 22.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.179 -0.325 . . . . 0.0 110.301 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.8 m -84.57 -25.0 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.2 p -85.55 -24.87 27.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.008 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -84.0 -44.59 14.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.5 -20.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.126 2.971 . . . . 0.0 115.096 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -149.99 145.88 26.69 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.23 156.14 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 O-C-N 121.41 -0.806 . . . . 0.0 110.221 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -109.38 139.54 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 124.277 0.985 . . . . 0.0 112.882 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 221' ' ' SER . 37.5 mt -118.53 126.41 75.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.452 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -131.23 14.56 5.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.496 1.123 . . . . 0.0 110.598 -170.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -60.88 157.06 15.97 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.591 1.156 . . . . 0.0 109.735 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -62.68 -0.77 0.68 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -139.47 4.72 2.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -160.32 130.29 5.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.132 0.973 . . . . 0.0 112.516 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 416' ' ' LYS . 17.3 p -140.16 102.29 4.34 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 120.263 1.392 . . . . 0.0 110.95 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.571 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 32.4 tptt -166.39 -176.1 3.49 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.813 174.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 43.1 mtpt -128.04 172.23 11.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.617 0.767 . . . . 0.0 110.625 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.21 159.47 20.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.211 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -130.0 135.92 48.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 426' ' ' ILE . 3.7 mp -110.9 145.16 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.54 151.22 63.09 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 118.956 0.798 . . . . 0.0 110.614 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.01 166.41 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.242 2.628 . . . . 0.0 113.109 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 123.955 0.902 . . . . 0.0 110.045 -177.062 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 26.5 m 42.23 66.17 0.78 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.742 1.217 . . . . 0.0 112.729 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 19.35 0.11 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.7 m 57.16 35.1 25.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.07 86.23 0.05 OUTLIER Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -79.84 -14.78 58.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.821 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 43.75 113.34 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 128.29 2.636 . . . . 0.0 115.206 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.52 169.03 19.07 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.96 3.107 . . . . 0.0 110.039 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.11 156.55 12.79 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.072 2.515 . . . . 0.0 113.435 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -141.45 179.55 6.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.14 2.176 . . . . 0.0 108.199 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 50.48 40.79 24.06 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.674 0.79 . . . . 0.0 113.088 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.64 159.51 1.54 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.73 0.812 . . . . 0.0 111.006 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -101.26 2.41 39.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.524 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.9 OUTLIER -126.39 35.69 0.3 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -177.725 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 68.7 Cg_endo -75.15 155.89 42.29 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.892 2.394 . . . . 0.0 111.394 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.71 140.71 43.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.25 121.97 38.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 95.6 p -125.93 -6.87 6.68 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.777 -170.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.35 -173.96 3.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 123.948 0.899 . . . . 0.0 108.643 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -60.23 155.89 16.58 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.244 -170.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.57 135.52 31.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -100.67 122.55 43.51 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 108.704 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.2 tt -145.46 143.33 29.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.775 -0.578 . . . . 0.0 110.512 -169.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.56 145.75 9.56 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 123.337 0.398 . . . . 0.0 112.147 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.5 17.43 0.02 OUTLIER Glycine 0 C--O 1.211 -1.329 0 CA-C-N 119.049 1.425 . . . . 0.0 113.818 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.05 95.4 39.45 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 118.147 0.973 . . . . 0.0 111.71 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.79 10.83 3.52 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 125.133 3.889 . . . . 0.0 112.533 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 246' ' ' ASP . 11.6 p-90 -128.14 -9.79 5.33 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 11.5 p-10 -60.28 116.26 4.12 Favored 'General case' 0 C--O 1.254 1.29 0 O-C-N 123.943 0.777 . . . . 0.0 113.087 -175.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.52 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -78.32 -15.81 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.4 p -153.6 148.17 26.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.249 1.023 . . . . 0.0 108.415 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -84.1 -22.56 31.09 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.772 -1.205 . . . . 0.0 108.727 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -78.31 -14.77 59.27 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.433 1.083 . . . . 0.0 113.319 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.82 -66.07 2.78 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.5 pt? -66.08 -29.37 69.69 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.73 -35.87 76.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.786 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -77.11 -18.06 58.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.705 -1.872 . . . . 0.0 110.198 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.5 p -77.85 -25.68 48.88 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.359 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.33 20.03 4.81 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 121.832 2.106 . . . . 0.0 112.545 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.1 20.92 1.46 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 119.547 -1.971 . . . . 0.0 111.913 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.5 t -71.09 -9.91 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -166.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -91.88 -2.65 56.74 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.432 1.083 . . . . 0.0 111.085 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.81 -2.7 3.44 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-O 117.698 -1.612 . . . . 0.0 116.612 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.7 m -102.54 22.3 13.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 119.183 1.492 . . . . 0.0 112.337 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 3.7 mm? -68.97 145.23 53.79 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 t -145.35 81.47 1.63 Allowed 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.1 p -75.7 141.25 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.068 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -150.94 157.82 43.38 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.368 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.49 ' HB3' HG23 ' A' ' 282' ' ' VAL . 42.4 p90 -151.66 146.67 19.02 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.05 91.91 1.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.635 2.223 . . . . 0.0 110.267 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -178.52 177.84 48.52 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -105.46 124.34 49.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.94 -0.741 . . . . 0.0 109.434 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -111.13 7.9 21.52 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.49 0.716 . . . . 0.0 110.097 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -67.05 -12.0 59.51 Favored Glycine 0 N--CA 1.47 0.951 0 CA-C-O 118.067 -1.407 . . . . 0.0 113.824 -172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -138.7 -35.5 0.58 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.561 1.681 . . . . 0.0 111.513 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -143.87 133.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.61 -13.96 6.83 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 125.059 3.839 . . . . 0.0 111.463 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -96.41 20.67 10.19 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.452 ' HB3' ' HD3' ' A' ' 277' ' ' PRO . 42.4 t -53.46 -41.27 85.94 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.892 -0.575 . . . . 0.0 112.03 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 276' ' ' CYS . 32.5 Cg_endo -98.29 95.72 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.41 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.83 4.85 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.585 4.19 . . . . 0.0 115.407 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -78.26 6.75 7.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 66.14 11.43 55.36 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.49 141.61 44.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.602 1.201 . . . . 0.0 112.739 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -150.03 170.76 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.983 0.897 . . . . 0.0 109.054 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -133.72 155.61 49.45 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.842 -1.161 . . . . 0.0 109.986 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 96.9 mt -131.16 145.76 52.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.19 0.596 . . . . 0.0 111.908 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.31 134.2 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 15.6 p90 -169.23 -163.26 0.4 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 125.007 1.442 . . . . 0.0 108.133 -174.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.16 110.21 0.46 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.582 1.153 . . . . 0.0 107.933 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 54.1 mt -89.83 -179.66 5.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.172 0.987 . . . . 0.0 110.396 -172.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 63.99 -67.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.367 1.867 . . . . 0.0 113.803 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -81.03 -43.35 19.69 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.433 -0.792 . . . . 0.0 111.261 -168.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 7.5 m -79.13 -31.4 44.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.84 -51.65 59.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -62.7 -32.22 73.27 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 70.4 m -57.23 -44.2 83.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.475 1.11 . . . . 0.0 111.884 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.7 -49.72 67.49 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.796 -1.19 . . . . 0.0 110.194 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 296' ' ' LEU . 0.1 OUTLIER -65.35 -26.63 68.11 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 119.182 -0.437 . . . . 0.0 112.018 -177.258 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -96.21 -4.25 42.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 123.855 0.722 . . . . 0.0 111.742 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.33 -12.57 19.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 314' ' ' PHE . 9.8 t -127.43 -124.05 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.0 t -116.49 163.65 15.75 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -155.8 159.6 39.55 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.724 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.19 137.73 31.47 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.26 75.52 5.02 Favored 'Trans proline' 0 C--N 1.35 0.612 1 C-N-CA 128.302 6.001 . . . . 0.0 112.867 -168.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 304' ' ' LEU . 2.8 mp . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 115.784 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.422 0.154 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 1.5 m -62.89 153.45 33.31 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.357 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -137.24 150.06 47.58 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 123.834 0.709 . . . . 0.0 110.744 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.44 146.86 44.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -140.02 155.13 47.22 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.654 -1.279 . . . . 0.0 112.17 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.493 ' HA ' ' SG ' ' A' ' 299' ' ' CYS . 32.4 t80 -145.22 174.29 11.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -125.4 132.41 52.77 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.21 0.914 . . . . 0.0 108.922 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.602 ' HE3' ' H ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -123.3 14.3 9.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.295 1.038 . . . . 0.0 109.662 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.3 p -82.01 2.1 32.49 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.115 0.566 . . . . 0.0 111.312 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 45.7 t -61.31 150.87 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 109.968 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 56.1 8.49 0.39 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.861 0.864 . . . . 0.0 112.286 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -129.5 -62.97 0.95 Allowed 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.566 -0.709 . . . . 0.0 110.761 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.5 mmt -123.59 -13.68 7.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.435 1.094 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 44.74 23.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.8 2.04 . . . . 0.0 114.993 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 3.1 t -151.56 17.45 0.71 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 121.262 1.846 . . . . 0.0 114.172 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.56 115.55 22.35 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.989 0.9 . . . . 0.0 112.713 -174.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -74.95 162.34 28.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.016 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.88 150.02 32.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.159 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -83.32 136.71 34.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.292 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.36 133.36 57.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.013 0.824 . . . . 0.0 111.017 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 62.1 mt -149.64 114.98 3.52 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.5 154.44 6.47 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 125.024 3.816 . . . . 0.0 112.765 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -76.2 120.0 20.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 334' ' ' ALA . 44.4 t -90.06 142.67 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.377 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 333' ' ' LEU . 1.7 tt -59.01 -25.96 64.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.35 0.595 . . . . 0.0 112.195 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.653 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -76.9 1.95 16.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.045 -1.659 . . . . 0.0 114.047 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -94.82 -8.63 36.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.675 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.7 m -103.91 -27.98 11.85 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.337 1.426 . . . . 0.0 114.046 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -163.03 162.79 26.07 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.146 0.278 . . . . 0.0 110.794 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.603 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 79.0 t80 -160.67 147.51 15.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.299 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.3 141.65 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 O-C-N 123.67 0.607 . . . . 0.0 110.405 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.81 20.33 18.28 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.012 0.91 . . . . 0.0 109.007 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 18.3 t -143.54 145.98 33.72 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.68 1.592 . . . . 0.0 107.341 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.56 5.42 4.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 121.716 1.611 . . . . 0.0 112.865 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 63.9 m -106.11 158.42 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.485 0.714 . . . . 0.0 109.639 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -111.03 12.64 22.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.216 0.606 . . . . 0.0 112.559 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -70.6 162.99 27.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.718 1.247 . . . . 0.0 112.263 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 346' ' ' LEU . 11.1 tp -145.8 143.62 29.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ASP . . . . . 0.544 ' H ' HG21 ' A' ' 397' ' ' THR . 12.1 m-20 -134.65 85.3 36.92 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 124.651 1.18 . . . . 0.0 110.535 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.89 -9.95 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 124.742 3.628 . . . . 0.0 114.196 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 87.9 p -72.61 -12.57 61.1 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.141 -0.974 . . . . 0.0 112.789 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -142.43 94.23 2.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.1 t -149.33 152.27 35.57 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.92 154.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.661 1.22 . . . . 0.0 108.942 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -90.34 161.96 15.37 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.328 -171.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 4.5 p -144.68 145.16 21.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 O-C-N 121.487 -0.758 . . . . 0.0 111.378 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.91 -174.88 36.55 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 47.47 34.57 3.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.699 0.4 . . . . 0.0 111.745 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.01 -176.52 3.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.867 1.267 . . . . 0.0 108.649 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.13 140.32 58.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.18 0.592 . . . . 0.0 111.075 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -67.85 5.61 3.39 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.162 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.413 ' O ' ' N ' ' A' ' 362' ' ' ASN . 40.7 mtp -138.71 28.08 2.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.857 1.329 . . . . 0.0 107.495 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.17 82.92 0.08 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.562 1.648 . . . . 0.0 108.473 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 360' ' ' MET . 5.4 p30 -64.69 156.78 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.107 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -66.92 -19.1 65.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 120.599 -1.313 . . . . 0.0 111.401 -175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -72.64 -27.77 62.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 120.943 -1.098 . . . . 0.0 109.001 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -87.49 -32.73 19.29 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.223 1.409 . . . . 0.0 111.017 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.91 -37.37 86.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -78.8 -28.99 44.63 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.835 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -67.82 -42.47 81.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.122 1.328 . . . . 0.0 108.558 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.0 -44.22 92.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.251 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 374' ' ' PHE . 45.4 mt -89.9 -7.86 53.21 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 117.784 -1.103 . . . . 0.0 112.724 -171.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.83 -28.43 15.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.742 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.7 -26.48 25.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.98 -13.02 20.1 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 370' ' ' LEU . 22.1 m-30 -119.91 -23.07 6.52 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 120.25 1.387 . . . . 0.0 111.942 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 76.4 -0.68 63.37 Favored Glycine 0 CA--C 1.552 2.381 0 O-C-N 125.048 1.468 . . . . 0.0 113.867 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.46 120.08 0.71 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 121.36 2.58 . . . . 0.0 111.807 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.36 171.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 126.171 1.788 . . . . 0.0 107.834 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.85 -30.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.913 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -163.05 136.82 5.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.085 0.402 . . . . 0.0 110.656 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.15 129.66 13.04 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -140.73 159.67 26.46 Favored Glycine 0 C--O 1.22 -0.747 0 O-C-N 121.861 -0.525 . . . . 0.0 114.128 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 23.8 mm -80.88 149.2 5.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.5 47.8 0.5 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.909 0.755 . . . . 0.0 110.386 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.4 p -64.53 158.83 23.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 123.817 1.77 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -140.94 146.99 38.1 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.389 2.676 . . . . 0.0 104.4 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -61.01 122.5 15.09 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.695 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.4 m170 67.73 42.05 2.09 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.08 -10.86 8.11 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.3 p90 38.18 50.71 2.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.15 -46.33 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.216 2.611 . . . . 0.0 113.995 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.8 tp 41.99 31.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 112.732 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -133.66 -6.37 2.63 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -172.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.0 p -156.91 160.69 39.36 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 118.626 1.213 . . . . 0.0 108.105 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -176.99 -165.26 32.11 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.182 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -156.82 161.24 39.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.554 0.741 . . . . 0.0 109.933 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.31 134.53 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 120.9 1.682 . . . . 0.0 108.477 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' THR . . . . . 0.544 HG21 ' H ' ' A' ' 347' ' ' ASP . 96.8 m -106.37 141.95 36.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 125.062 1.476 . . . . 0.0 108.323 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.58 161.44 16.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.592 1.557 . . . . 0.0 112.271 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -131.26 11.37 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -135.96 140.31 43.87 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -76.91 -29.56 55.77 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.578 0.549 . . . . 0.0 111.869 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.567 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -64.44 -18.59 64.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.382 0.537 . . . . 0.0 110.739 -175.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.1 m -79.81 -19.74 47.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 118.485 0.584 . . . . 0.0 111.187 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -76.5 -51.14 12.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.107 0.867 . . . . 0.0 110.945 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.441 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.09 -19.2 61.21 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 119.611 1.096 . . . . 0.0 111.646 177.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.81 -26.32 57.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.737 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.98 59.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.805 -0.559 . . . . 0.0 110.908 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.53 -9.07 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.567 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.2 p -105.25 -8.79 18.08 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.324 0.39 . . . . 0.0 110.26 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -100.9 -48.44 4.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.517 0.51 . . . . 0.0 110.335 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.01 -12.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 129.947 3.299 . . . . 0.0 118.858 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -162.72 138.5 7.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.255 -1.528 . . . . 0.0 107.262 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.83 157.0 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.375 -0.828 . . . . 0.0 111.031 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 423' ' ' LYS . 41.6 mt-10 -105.97 138.92 41.32 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.401 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 421' ' ' THR . 73.4 mt -103.41 116.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -134.45 110.19 9.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.632 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.0 p -132.39 -175.12 3.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.664 0.786 . . . . 0.0 110.249 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 418' ' ' THR . 88.9 m -83.19 4.49 26.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.64 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -143.27 -4.73 0.88 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.849 1.204 . . . . 0.0 113.73 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -144.65 145.53 31.8 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.681 0.613 . . . . 0.0 110.052 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 26.6 m -153.85 116.21 4.37 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.99 0.516 . . . . 0.0 109.955 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -162.16 157.12 22.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 123.804 0.69 . . . . 0.0 110.679 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 414' ' ' GLU . 0.1 OUTLIER -114.87 162.42 16.93 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.88 148.34 19.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.731 1.212 . . . . 0.0 108.316 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -132.19 129.36 39.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.937 1.351 . . . . 0.0 111.776 -170.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.13 143.83 16.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.047 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -136.64 148.5 63.86 Favored Pre-proline 0 N--CA 1.444 -0.745 0 O-C-N 123.676 0.61 . . . . 0.0 110.223 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.56 158.41 13.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.944 3.096 . . . . 0.0 112.468 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 117.448 -1.263 . . . . 0.0 109.028 178.497 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 221' ' ' SER . 2.3 m 43.99 45.7 6.67 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.339 1.056 . . . . 0.0 110.838 -170.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 15.02 0.04 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.532 ' HB2' ' H ' ' A' ' 416' ' ' LYS . 78.5 p -46.52 143.05 2.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.571 1.548 . . . . 0.0 113.944 -168.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 134.96 -2.22 3.96 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.77 -1.104 . . . . 0.0 114.072 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -134.48 22.05 3.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.394 1.097 . . . . 0.0 111.326 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.71 -57.96 3.0 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-O 116.131 -1.89 . . . . 0.0 112.918 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.26 117.19 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.6 2.867 . . . . 0.0 108.88 -170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.57 -40.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.304 3.336 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 43.52 22.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -86.42 -7.7 58.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.755 1.222 . . . . 0.0 111.796 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.98 145.64 52.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 230' ' ' LYS . 25.8 mmmt -144.39 8.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.367 -0.833 . . . . 0.0 113.142 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 61.86 50.25 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.173 -172.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.04 129.61 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.859 2.373 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.5 mm -147.72 144.81 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.468 ' CG ' HG11 ' A' ' 292' ' ' VAL . 7.8 m-85 -105.88 151.52 24.44 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.807 -172.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -152.08 3.77 0.39 Allowed 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 4.0 t -146.99 -170.37 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.313 -0.867 . . . . 0.0 108.828 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 175.94 1.19 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.91 141.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.852 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -91.05 133.92 34.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.718 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.457 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.8 tt -143.11 124.36 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -156.62 152.11 23.5 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.04 14.55 0.1 Allowed Glycine 0 CA--C 1.537 1.42 0 O-C-N 124.646 0.85 . . . . 0.0 111.656 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.29 108.66 61.91 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 118.114 0.957 . . . . 0.0 110.982 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.3 0.26 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 124.847 3.698 . . . . 0.0 113.642 171.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.437 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 4.2 p-90 -135.9 -96.86 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 25.0 t0 42.53 65.02 0.99 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.577 . . . . 0.0 111.855 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.741 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.12 -30.49 36.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -171.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 250' ' ' ALA . 16.8 m -140.18 126.65 20.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.97 -7.41 58.78 Favored 'General case' 0 C--O 1.201 -1.499 0 O-C-N 123.554 0.534 . . . . 0.0 110.735 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.52 -21.71 61.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.062 -0.399 . . . . 0.0 111.462 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.76 -48.99 6.78 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.59 -41.2 98.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 114.823 -0.688 . . . . 0.0 109.638 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.57 -50.72 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.494 -1.379 . . . . 0.0 110.641 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -69.24 -9.06 51.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.4 m -80.94 -32.32 34.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.1 68.29 1.4 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.858 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 257' ' ' ARG . 13.6 ttt180 -123.74 7.18 8.78 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.439 1.096 . . . . 0.0 111.727 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.91 7.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 119.807 -1.808 . . . . 0.0 112.362 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.72 -10.32 23.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.34 -4.07 13.8 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.878 1.511 . . . . 0.0 116.878 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.7 p -112.32 44.76 1.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 120.599 -1.53 . . . . 0.0 111.704 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -142.47 163.57 32.47 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.65 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.6 m -149.99 175.69 11.46 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.483 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.98 157.08 41.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 O-C-N 121.525 -0.734 . . . . 0.0 111.013 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -138.11 135.6 35.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.392 1.091 . . . . 0.0 111.275 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.31 148.9 36.46 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.23 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.01 -21.37 15.9 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.239 3.293 . . . . 0.0 111.756 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 178.27 -6.5 0.03 OUTLIER Glycine 0 CA--C 1.547 2.078 0 CA-C-O 118.482 -1.176 . . . . 0.0 115.859 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 278' ' ' PRO . 18.5 tptp -94.87 107.18 19.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.793 2.297 . . . . 0.0 109.872 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.69 145.02 29.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 167.88 -173.35 42.81 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -63.92 -40.52 96.66 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.82 1.648 . . . . 0.0 112.272 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -147.05 84.56 7.34 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.25 -48.65 1.16 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.528 2.152 . . . . 0.0 114.095 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 46.56 9.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.03 2.132 . . . . 0.0 114.922 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 41.9 t -164.52 111.33 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 119.255 0.934 . . . . 0.0 110.391 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.91 160.82 46.77 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.882 2.388 . . . . 0.0 110.076 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 269' ' ' LYS . 87.0 Cg_endo -78.28 -17.47 13.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.234 2.623 . . . . 0.0 112.01 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -146.9 167.35 24.17 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.146 1.379 . . . . 0.0 110.878 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.66 19.72 3.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.964 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -152.82 165.86 34.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.336 1.568 . . . . 0.0 112.631 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.6 m -154.76 -170.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 126.328 2.267 . . . . 0.0 109.391 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -118.3 153.87 33.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.418 1.087 . . . . 0.0 110.525 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.74 147.31 48.72 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.15 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.98 112.02 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 109.268 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.629 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -139.76 -179.73 6.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.53 -174.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.56 124.18 10.27 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -62.17 -13.38 26.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.67 -49.22 0.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 116.859 -1.937 . . . . 0.0 112.195 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -81.19 -36.68 29.82 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 72.7 m -76.22 -31.18 58.27 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 120.158 1.345 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.629 HG22 ' CE1' ' A' ' 286' ' ' PHE . 2.8 t -60.86 -52.33 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -74.54 -23.48 58.8 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 74.8 m -72.44 -36.42 68.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 109.924 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.9 mp -74.66 -54.14 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 4.16 36.76 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.573 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -111.19 -10.51 14.29 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 110.783 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.54 37.25 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.323 0.965 . . . . 0.0 110.773 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.41 -115.7 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.794 0.806 . . . . 0.0 112.634 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.4 m -126.01 155.97 40.62 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 111.688 -171.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -157.56 159.28 36.97 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.646 1.178 . . . . 0.0 109.049 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 304' ' ' LEU . 16.2 m-20 -146.65 89.12 5.85 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 109.684 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' ASP . 65.0 Cg_endo -67.02 22.52 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.998 1 C-N-CA 128.618 6.212 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 302' ' ' ASP . 7.2 mp . . . . . 0 C--O 1.238 0.464 0 C-N-CA 124.492 1.117 . . . . 0.0 112.271 -166.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 310' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 309' ' ' LEU . 3.2 p 171.08 176.97 0.06 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.418 1.487 . . . . 0.0 107.963 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.27 130.76 50.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -108.48 143.81 36.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -124.78 145.27 49.82 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.847 0.832 . . . . 0.0 110.725 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -151.71 155.98 39.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.315 -1.311 . . . . 0.0 107.77 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 11.0 ptpt -129.34 143.61 50.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.015 0.825 . . . . 0.0 110.177 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.49 -7.65 5.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.676 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.7 t -140.34 133.34 29.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.653 1.115 . . . . 0.0 109.685 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 60.4 m -140.85 -13.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.1 -8.77 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.941 1.246 . . . . 0.0 110.849 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -86.24 -29.11 23.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.769 0.827 . . . . 0.0 111.479 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.437 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 97.2 mmm -142.08 164.89 28.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.24 0.616 . . . . 0.0 109.748 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 322' ' ' ARG . 70.6 mtt-85 -92.07 45.94 1.24 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.147 1.379 . . . . 0.0 111.172 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.25 -166.13 1.53 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.798 0.839 . . . . 0.0 109.642 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -143.27 -173.2 3.87 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -54.36 158.65 2.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.571 1.548 . . . . 0.0 113.173 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 240' ' ' LEU . 11.4 p -121.38 153.4 25.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -172.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.65 150.31 21.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 120.181 1.355 . . . . 0.0 110.253 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.86 145.65 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.865 0.466 . . . . 0.0 110.281 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -144.12 99.73 5.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 123.775 0.672 . . . . 0.0 111.803 172.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.22 168.11 15.28 Favored 'Trans proline' 0 N--CA 1.46 -0.454 1 C-N-CA 125.306 4.004 . . . . 0.0 110.849 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 2.8 t-105 -88.0 125.42 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.3 t -105.84 145.12 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.394 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 333' ' ' LEU . 13.1 mt -55.79 -21.33 18.78 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.729 0.643 . . . . 0.0 111.071 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.6 -4.42 30.73 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.72 3.61 15.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.192 1.397 . . . . 0.0 111.073 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 46.6 m -107.13 -49.29 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 120.694 -1.254 . . . . 0.0 111.841 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -155.04 153.88 31.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.544 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -153.8 145.72 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.571 0.748 . . . . 0.0 109.446 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.86 138.52 41.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 18.17 4.12 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.0 t -150.6 141.44 14.72 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.29 1.836 . . . . 0.0 107.29 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -66.23 -15.99 50.25 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.901 3.067 . . . . 0.0 111.069 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 37.8 p -163.22 90.91 0.68 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.439 1.018 . . . . 0.0 111.758 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -154.29 168.59 26.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -131.95 -179.28 5.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.325 1.45 . . . . 0.0 110.235 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 346' ' ' LEU . 3.8 mm? -74.63 171.76 13.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -175.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -116.36 155.27 48.64 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.681 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -68.72 104.1 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.701 2.267 . . . . 0.0 113.205 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 74.4 m 57.31 46.15 18.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.131 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 350' ' ' ARG . 4.6 tpm_? -138.03 87.99 2.28 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.102 -0.999 . . . . 0.0 112.439 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.0 p -144.08 166.95 23.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.72 163.32 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.009 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -86.78 160.83 18.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.726 0.694 . . . . 0.0 110.487 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.7 t -146.32 131.89 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.75 -175.85 37.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 49.39 29.14 2.67 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.423 1.089 . . . . 0.0 112.273 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.813 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -93.54 -175.73 3.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.668 -0.645 . . . . 0.0 110.175 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -59.13 154.03 16.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.155 0.582 . . . . 0.0 111.904 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.08 1.1 9.04 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.256 -0.746 . . . . 0.0 113.665 -172.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 13.3 ptp -158.18 30.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.466 2.133 . . . . 0.0 111.839 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.1 126.99 29.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.23 167.49 13.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.038 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.59 -25.54 61.37 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 121.469 -0.769 . . . . 0.0 112.167 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -82.99 -18.93 38.14 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 118.481 0.582 . . . . 0.0 111.994 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.88 -36.48 18.39 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.59 -46.59 89.2 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.23 68.08 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.613 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.97 84.52 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.916 0.78 . . . . 0.0 109.695 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 35.8 mt -71.12 -36.51 63.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 119.633 -0.222 . . . . 0.0 110.56 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.0 -0.9 55.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.404 ' HA ' ' HA2' ' A' ' 375' ' ' GLY . 0.5 OUTLIER -116.79 -15.3 10.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 120.837 -1.165 . . . . 0.0 112.269 174.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.29 -26.83 13.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.852 0.751 . . . . 0.0 109.212 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.0 tp -80.87 -17.42 50.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 123.424 0.453 . . . . 0.0 110.428 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 403' ' ' SER . 29.0 p90 -166.74 -13.53 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 371' ' ' ASN . . . 68.1 20.1 72.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 171.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -90.1 9.23 78.06 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 120.808 -1.407 . . . . 0.0 114.613 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.5 163.43 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.236 1.018 . . . . 0.0 113.516 -170.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.25 -33.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.232 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -159.46 147.55 17.48 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 396' ' ' VAL . . . -150.43 149.04 29.5 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.457 0.646 . . . . 0.0 110.455 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.71 160.97 29.3 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.64 -0.662 . . . . 0.0 113.493 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.4 mm -96.37 144.28 10.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 124.383 0.696 . . . . 0.0 110.564 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -82.52 60.92 5.4 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 121.231 0.539 . . . . 0.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' THR . . . . . 0.464 ' HA ' ' HG2' ' A' ' 390' ' ' PRO . 2.9 p -61.15 154.53 22.96 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 124.068 1.89 . . . . 0.0 111.903 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.49 129.58 20.84 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.0 130.75 45.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.226 -170.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 8.4 m170 68.53 29.09 5.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.145 -2.298 . . . . 0.0 112.398 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.71 -0.53 13.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.2 t80 47.41 41.55 0.94 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.129 1.772 . . . . 0.0 113.645 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 392' ' ' GLY . 36.1 Cg_endo -81.34 37.91 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.523 2.148 . . . . 0.0 109.025 -170.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.454 ' HB ' ' CH2' ' A' ' 331' ' ' TRP . 10.8 tp -69.83 25.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.984 0 C-N-CA 123.637 0.775 . . . . 0.0 111.448 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 390' ' ' PRO . . . -123.04 1.55 9.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 118.543 -1.143 . . . . 0.0 111.142 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.3 p -155.47 151.61 27.94 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.264 1.032 . . . . 0.0 110.794 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.81 -174.73 42.62 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.882 1.268 . . . . 0.0 113.958 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.07 166.8 20.93 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 121.324 -1.103 . . . . 0.0 111.227 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 380' ' ' ALA . 7.4 p -146.18 144.12 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 23.1 m -103.76 119.15 38.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.6 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -106.39 156.3 18.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.656 0.782 . . . . 0.0 108.945 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -136.16 21.99 3.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -141.4 159.22 42.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -83.14 -47.24 11.83 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ARG . . . . . 0.444 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.38 -21.86 62.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 374' ' ' PHE . 34.2 p -72.51 -21.75 61.14 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.926 -1.109 . . . . 0.0 111.163 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.58 -62.73 1.48 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.28 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.631 ' H ' HD13 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -67.95 -17.08 64.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 119.317 0.962 . . . . 0.0 113.124 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.17 -29.34 28.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.586 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -18.25 58.0 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.31 -1.494 . . . . 0.0 110.411 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.14 -27.4 7.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.4 t -85.79 -9.56 56.87 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 0.0 111.299 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -112.22 -59.66 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.247 172.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.68 -16.33 0.03 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 127.921 2.488 . . . . 0.0 114.055 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -162.8 136.99 6.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.9 m -139.54 164.29 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -105.11 145.56 30.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.957 1.411 . . . . 0.0 110.824 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.9 mt -123.89 126.52 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.411 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 221' ' ' SER . 57.0 mmtt -137.65 114.37 10.5 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.704 1.253 . . . . 0.0 110.243 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 92.7 m -151.01 159.51 44.51 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -54.67 139.95 37.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.566 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? 59.32 13.43 3.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.12 1.368 . . . . 0.0 114.675 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.54 116.18 4.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.897 -1.127 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 17.2 p -145.84 112.43 5.91 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.2 tptm -166.64 -173.11 2.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.011 0.823 . . . . 0.0 110.022 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.655 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.5 mttp -125.66 172.18 9.99 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 123.604 0.762 . . . . 0.0 109.562 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -144.25 151.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.853 1.346 . . . . 0.0 109.881 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.0 158.57 36.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.235 -0.915 . . . . 0.0 110.274 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 23.8 mt -142.69 146.02 22.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -147.56 141.62 15.91 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.653 0.661 . . . . 0.0 110.669 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -82.76 174.62 9.43 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 124.243 3.295 . . . . 0.0 111.192 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.19 171.883 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.761 0.791 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 98.1 m -139.52 147.48 41.3 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 171.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.7 -25.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.1 m 50.39 119.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.426 2.29 . . . . 0.0 114.445 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.45 -3.92 0.05 OUTLIER Glycine 0 N--CA 1.469 0.84 0 O-C-N 120.394 -1.441 . . . . 0.0 115.598 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.06 -9.39 55.24 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.374 -1.663 . . . . 0.0 114.604 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.617 ' H ' HD22 ' A' ' 224' ' ' LEU . 3.8 mm? -16.5 88.05 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 128.954 2.902 . . . . 0.0 111.281 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.83 158.43 3.41 Favored 'Trans proline' 0 N--CA 1.449 -1.11 1 C-N-CA 127.581 5.521 . . . . 0.0 111.496 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 147.74 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.949 1.766 . . . . 0.0 110.484 172.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -139.83 18.33 2.49 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.867 0.73 . . . . 0.0 109.066 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -122.39 32.13 5.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.922 0.889 . . . . 0.0 112.647 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -64.33 162.26 15.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.196 1.398 . . . . 0.0 112.762 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -77.19 -19.37 56.84 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 58.74 73.35 0.72 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.96 -44.08 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.505 2.137 . . . . 0.0 115.419 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.9 mt -147.8 153.88 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.578 1.081 . . . . 0.0 108.274 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -112.53 150.9 30.65 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.6 t -150.06 17.75 0.86 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.387 0.994 . . . . 0.0 113.409 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' CYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 331' ' ' TRP . 0.9 OUTLIER -156.77 -175.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -61.54 171.25 1.55 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.469 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 286' ' ' PHE . 2.7 p -136.25 150.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.456 -170.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -92.6 133.42 35.98 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.457 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.4 tm? -142.13 124.44 15.59 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.754 1.161 . . . . 0.0 110.564 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 167.56 -172.5 42.46 Favored Glycine 0 N--CA 1.473 1.142 0 O-C-N 124.061 0.851 . . . . 0.0 112.635 172.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.47 7.12 3.2 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.273 0.94 . . . . 0.0 112.764 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 6.5 m -102.62 135.89 19.43 Favored Pre-proline 0 C--O 1.219 -0.51 0 C-N-CA 123.722 0.809 . . . . 0.0 111.203 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 243' ' ' VAL . 33.4 Cg_exo -70.23 -5.08 15.65 Favored 'Trans proline' 0 N--CA 1.439 -1.722 1 C-N-CA 126.33 4.687 . . . . 0.0 115.574 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 245' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 323' ' ' CYS . 22.3 p-90 -142.13 -60.9 0.46 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 120.216 1.371 . . . . 0.0 113.803 -174.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.48 -60.13 0.13 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.133 1.373 . . . . 0.0 112.996 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 248' ' ' THR 0.5 0.0 OUTLIER 63.34 -41.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.832 1.958 . . . . 0.0 115.232 -179.461 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 247' ' ' ILE . 25.9 p -157.86 134.95 10.08 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 124.901 1.281 . . . . 0.0 109.078 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.1 pm0 -89.51 -22.85 22.23 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 119.632 -1.918 . . . . 0.0 111.745 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.03 64.42 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.165 0.915 . . . . 0.0 111.32 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.19 15.69 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 255' ' ' THR . 46.6 mt -70.74 -36.97 73.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.66 -37.68 80.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.582 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.431 ' HA ' ' CD ' ' A' ' 257' ' ' ARG . 62.9 m-20 -64.14 -21.96 66.75 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.243 1.383 . . . . 0.0 109.735 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 252' ' ' LEU . 84.2 m -79.16 -27.62 42.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.784 0.72 . . . . 0.0 110.669 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -131.28 23.19 4.81 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.442 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 16.6 ptm180 -86.96 33.92 0.67 Allowed 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.052 0.941 . . . . 0.0 113.391 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.54 2.26 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.14 -2.27 15.02 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 64.01 3.56 8.87 Favored Glycine 0 C--O 1.214 -1.144 0 CA-C-O 118.113 -1.381 . . . . 0.0 113.189 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.52 2.39 28.4 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.891 0.995 . . . . 0.0 113.001 -167.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 257' ' ' ARG . 6.1 mt -68.52 141.72 55.46 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 122.931 1.348 . . . . 0.0 114.551 -167.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.5 t -152.23 96.12 2.14 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 124.677 2.179 . . . . 0.0 106.976 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.06 144.31 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 O-C-N 119.423 -2.048 . . . . 0.0 109.41 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.52 135.27 42.24 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 120.758 -1.214 . . . . 0.0 111.396 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 8.9 p90 -150.88 143.83 16.66 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 121.497 0.665 . . . . 0.0 112.018 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -86.0 169.37 8.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.492 3.461 . . . . 0.0 111.633 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.41 -8.06 7.58 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 126.465 1.983 . . . . 0.0 114.756 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.82 55.22 1.79 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.471 1.136 . . . . 0.0 111.869 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.14 5.45 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.832 0.453 . . . . 0.0 111.487 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.28 149.37 9.04 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 121.124 -0.985 . . . . 0.0 112.416 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 67.89 159.72 0.16 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.627 1.571 . . . . 0.0 110.696 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 16.9 m170 34.14 76.71 0.4 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.762 1.625 . . . . 0.0 115.138 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.35 111.9 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.588 2.192 . . . . 0.0 112.056 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -157.29 169.32 25.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 12.8 t -121.62 143.02 37.04 Favored Pre-proline 0 CA--C 1.513 -0.456 0 C-N-CA 124.436 1.095 . . . . 0.0 109.853 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' PRO . . . . . 0.609 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 84.3 Cg_endo -70.7 151.07 63.44 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.626 2.884 . . . . 0.0 109.631 -174.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.58 -6.19 16.01 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.612 2.875 . . . . 0.0 111.714 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -78.08 1.42 21.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.862 -0.59 . . . . 0.0 111.909 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.27 48.25 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.462 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 8.6 p90 -152.47 157.0 40.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.287 1.543 . . . . 0.0 112.034 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.3 m -152.48 -154.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 127.491 2.316 . . . . 0.0 108.827 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -114.98 164.28 14.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.646 0.779 . . . . 0.0 112.078 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.5 138.36 14.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.865 -0.522 . . . . 0.0 111.364 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.89 125.31 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 168.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.535 ' CE1' HG11 ' A' ' 238' ' ' VAL . 0.1 OUTLIER -146.71 92.27 2.13 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.973 -173.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 286' ' ' PHE . 11.5 tp10 37.88 61.69 1.02 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -48.64 9.87 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 128.306 2.642 . . . . 0.0 117.683 -167.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.02 -72.53 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.992 1.724 . . . . 0.0 111.166 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -78.39 -34.44 48.18 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 22.8 t -73.62 -32.58 64.14 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 286' ' ' PHE . 89.0 t -63.87 -52.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -61.33 -34.92 76.06 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.668 0.605 . . . . 0.0 112.237 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.1 m -74.29 -34.15 63.44 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.773 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -45.8 65.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.469 0.652 . . . . 0.0 110.169 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -13.54 57.96 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.105 -0.997 . . . . 0.0 113.441 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.24 -4.58 35.0 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.288 -0.883 . . . . 0.0 111.54 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -104.58 -15.05 15.43 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.679 1.237 . . . . 0.0 108.841 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 60.6 m -107.68 -142.61 0.38 Allowed 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.744 -0.597 . . . . 0.0 109.829 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.2 m -110.54 172.51 6.83 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 120.474 -1.391 . . . . 0.0 113.388 -171.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.407 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 85.3 t60 -149.87 165.19 33.32 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.69 -0.631 . . . . 0.0 110.992 -172.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 33.3 t0 -134.45 112.2 11.83 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.92 51.65 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 1 C-N-CA 127.384 5.389 . . . . 0.0 110.187 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.25 5.8 mp . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.224 -0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 29.9 m -66.52 132.69 48.78 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.218 0.607 . . . . 0.0 110.5 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.53 144.26 49.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 119.253 0.933 . . . . 0.0 110.882 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -110.74 152.66 26.32 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.254 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 37.1 m-85 -140.36 148.33 41.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.743 1.258 . . . . 0.0 113.061 -170.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -158.89 163.73 36.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -135.31 133.05 38.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.698 0.761 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.2 OUTLIER -134.98 13.66 3.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.659 -171.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.7 p -58.5 153.73 15.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.8 m -111.88 163.05 14.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.219 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -70.84 -9.77 58.24 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 321' ' ' MET . 17.1 ptp180 -82.36 -18.09 43.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.416 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 320' ' ' ARG . 4.0 mpp? -135.93 -48.82 0.68 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 44.33 43.08 5.78 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' CYS . . . . . 0.475 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 71.1 m -93.23 -60.49 1.78 Allowed 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.326 -1.484 . . . . 0.0 113.842 -173.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -158.52 152.39 23.61 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 118.856 -1.138 . . . . 0.0 113.164 -170.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.51 173.42 4.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.842 2.057 . . . . 0.0 113.936 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 3.7 p -118.66 158.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.168 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 5.4 pp0? -115.69 163.28 16.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.198 0.908 . . . . 0.0 112.047 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.95 130.21 13.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.689 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 pt -136.68 88.59 19.08 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.16 0.584 . . . . 0.0 110.89 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -76.99 177.85 8.38 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.903 3.735 . . . . 0.0 116.604 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' TRP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 236' ' ' CYS . 7.3 t-105 -82.24 140.89 33.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.915 0.886 . . . . 0.0 110.169 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.5 t -115.0 151.66 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.558 1.171 . . . . 0.0 111.913 -176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 333' ' ' LEU . 6.6 tt -57.25 -36.96 71.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.269 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -70.44 -5.64 29.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.261 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -105.24 -7.01 19.24 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.701 -0.624 . . . . 0.0 111.667 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.8 m -83.83 -37.91 21.9 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -154.57 165.52 36.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.071 0.548 . . . . 0.0 111.872 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' PHE . . . . . 0.425 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 44.1 t80 -146.03 133.9 21.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.8 m -120.39 148.3 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -5.07 24.89 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.869 -0.519 . . . . 0.0 110.254 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.9 m -131.11 148.46 70.32 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.07 108.4 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.669 1.579 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 8.3 t 54.58 38.57 30.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.248 1.419 . . . . 0.0 113.492 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -75.2 160.25 30.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.379 0.609 . . . . 0.0 111.061 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -92.92 179.33 5.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.13 167.06 13.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 123.966 0.791 . . . . 0.0 109.675 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.06 102.55 15.86 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.02 -1.45 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 114.568 -171.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 81.5 p -130.42 8.8 5.06 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.679 -1.263 . . . . 0.0 114.133 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -144.48 102.37 3.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.082 0.944 . . . . 0.0 108.753 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -160.46 149.5 17.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.27 0.628 . . . . 0.0 110.229 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.02 154.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -81.07 136.68 35.98 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.151 0.907 . . . . 0.0 109.753 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 84.7 t -128.61 133.13 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.761 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -175.8 -165.9 32.44 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 121.638 0.576 . . . . 0.0 114.104 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.07 28.71 5.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.6 -160.27 0.71 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.635 1.174 . . . . 0.0 111.86 -175.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -36.22 -24.64 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.949 2.1 . . . . 0.0 115.31 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.63 78.31 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 119.351 0.978 . . . . 0.0 113.644 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.419 ' HA ' HG13 ' A' ' 391' ' ' ILE . 28.0 ptm -156.76 30.29 0.31 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 113.115 174.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 361' ' ' LEU . 13.7 tp -76.84 156.24 32.37 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 121.284 0.564 . . . . 0.0 110.973 -171.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.73 170.28 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.509 1.123 . . . . 0.0 110.48 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -72.1 -25.62 61.82 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -175.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -74.68 -26.27 59.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.818 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.55 -32.59 36.66 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.23 -34.46 68.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.855 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.07 80.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.131 0.972 . . . . 0.0 111.187 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.53 -34.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 370' ' ' LEU . 4.2 mm? -94.48 -6.19 44.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.118 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -16.6 14.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.546 1.521 . . . . 0.0 111.338 172.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -97.3 -28.69 13.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.722 0.692 . . . . 0.0 110.744 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.0 tp -83.02 -26.71 30.95 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.26 -59.02 1.6 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.261 -0.899 . . . . 0.0 113.005 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 163.5 -139.66 6.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -70.33 148.16 45.23 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 123.555 1.642 . . . . 0.0 113.881 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.07 152.93 8.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 127.736 2.414 . . . . 0.0 109.893 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.58 -30.64 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.228 -0.892 . . . . 0.0 112.183 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.8 OUTLIER -150.46 147.91 28.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.177 0.899 . . . . 0.0 112.116 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -142.96 139.01 30.5 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -135.17 151.81 20.61 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.67 0.594 . . . . 0.0 114.095 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.85 148.46 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -103.5 147.78 26.74 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 125.281 1.613 . . . . 0.0 108.016 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 47.5 p -140.81 163.06 33.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.5 -0.75 . . . . 0.0 112.118 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.66 34.13 4.7 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.706 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.32 28.02 0.41 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.616 1.566 . . . . 0.0 113.498 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -136.04 23.77 3.29 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp 62.75 -15.66 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.458 ' N ' ' HD2' ' A' ' 390' ' ' PRO . 22.2 p90 -78.73 -22.0 0.37 Allowed Pre-proline 0 CA--C 1.515 -0.371 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -170.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 389' ' ' TYR . 18.5 Cg_endo -61.71 -67.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.475 HD13 ' CZ3' ' A' ' 331' ' ' TRP . 10.9 tp 32.44 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.811 1.644 . . . . 0.0 110.885 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 177.24 27.97 0.04 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.69 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 70.5 m -143.16 146.84 34.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 167.11 -159.08 32.35 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.618 -1.101 . . . . 0.0 112.095 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -154.37 166.82 32.02 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 125.299 1.234 . . . . 0.0 109.594 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.42 126.35 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 42.1 p -95.59 118.67 32.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 69.8 m-85 -90.15 162.63 15.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.145 0.974 . . . . 0.0 111.049 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -122.93 -0.51 8.99 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -124.88 153.04 43.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.628 0.371 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -80.76 -30.57 36.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.443 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -39.1 64.86 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.282 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' SER . . . . . 0.633 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 21.5 m -65.95 -25.59 67.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.536 0.607 . . . . 0.0 111.276 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.67 -57.15 3.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.338 0.589 . . . . 0.0 111.417 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' LEU . . . . . 0.47 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -74.26 -20.76 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.496 -0.752 . . . . 0.0 111.792 -177.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -81.13 -26.66 35.95 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.912 1.233 . . . . 0.0 109.626 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -71.02 -43.39 68.02 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.89 -21.84 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.233 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.4 p -81.18 -26.33 36.08 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 118.352 -0.833 . . . . 0.0 112.83 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.38 -33.15 14.68 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.232 0.469 . . . . 0.0 111.757 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 51.16 -22.54 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 26.1 t80 -163.69 130.53 3.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.891 -1.755 . . . . 0.0 107.506 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.57 174.69 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.884 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -116.46 153.85 31.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.516 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 28.6 mt -127.35 123.48 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.421 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -125.44 140.59 52.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.307 1.004 . . . . 0.0 108.815 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 m -148.8 167.76 24.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.4 t -60.95 -18.83 59.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 15.94 0.75 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -139.42 128.88 24.29 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.634 -0.666 . . . . 0.0 110.622 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 52.5 p -146.86 124.18 11.59 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.063 -0.398 . . . . 0.0 110.148 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' LYS . . . . . 0.612 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 29.4 tptt -165.6 -161.33 0.51 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.631 0.582 . . . . 0.0 110.476 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.612 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 92.8 mttt -141.45 168.48 19.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.39 139.21 29.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -122.3 160.76 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 60.2 mt -139.28 137.3 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.254 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -128.06 145.29 54.8 Favored Pre-proline 0 C--N 1.324 -0.543 0 O-C-N 123.911 0.757 . . . . 0.0 111.211 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 145.67 94.82 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.332 3.354 . . . . 0.0 111.644 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 79.0 t80 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.428 1.091 . . . . 0.0 112.967 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 93.7 m -152.86 146.4 25.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.46 -169.27 3.25 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.659 1.118 . . . . 0.0 111.529 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.1 p -130.11 19.93 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.959 1.703 . . . . 0.0 109.786 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.48 12.23 65.69 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.14 1.352 . . . . 0.0 116.386 -168.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -51.85 156.0 1.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 224' ' ' LEU . 4.1 mm? -100.48 139.46 20.65 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.346 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -44.21 109.63 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.512 3.475 . . . . 0.0 112.371 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.04 17.35 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.907 3.071 . . . . 0.0 111.138 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -133.63 19.51 3.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.539 0.336 . . . . 0.0 111.091 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -134.68 39.33 3.02 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 121.855 0.836 . . . . 0.0 110.845 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -76.13 161.7 28.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.165 0.986 . . . . 0.0 109.087 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -79.21 -10.18 59.75 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.419 ' HA ' HG11 ' A' ' 332' ' ' VAL . 73.2 m-20 42.7 62.34 8.38 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 333' ' ' LEU . 37.7 Cg_endo -63.33 -76.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.0 1.8 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.9 pt -141.17 -178.83 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 124.909 1.284 . . . . 0.0 110.061 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -111.72 153.43 26.48 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.9 p -146.22 -9.95 0.5 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 16.8 t -143.85 171.14 14.63 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.033 0.533 . . . . 0.0 109.576 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -53.66 174.13 0.05 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.824 1.649 . . . . 0.0 114.309 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.7 146.92 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.32 140.17 32.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.012 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.407 ' CD1' HG22 ' A' ' 328' ' ' VAL . 20.1 tp -141.47 143.2 33.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 111.123 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.5 156.55 28.57 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.537 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.95 14.28 1.47 Allowed Glycine 0 N--CA 1.475 1.235 0 O-C-N 122.005 -0.703 . . . . 0.0 112.616 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.96 72.98 18.04 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.342 -1.093 . . . . 0.0 110.905 -174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.8 7.72 2.27 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.532 2.154 . . . . 0.0 113.655 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 17.6 p-90 -141.42 -4.94 1.1 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.52 109.15 1.55 Allowed 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 124.69 1.196 . . . . 0.0 112.593 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -72.48 -30.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.351 -172.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.9 p -142.4 126.05 16.91 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 119.734 1.152 . . . . 0.0 112.977 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -71.0 -16.22 62.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.458 -172.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.12 -16.48 61.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 120.215 1.371 . . . . 0.0 108.472 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.33 99.23 Favored Glycine 0 N--CA 1.435 -1.424 0 O-C-N 120.88 -1.137 . . . . 0.0 112.704 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 48.6 mt -69.68 -31.84 70.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.504 1.122 . . . . 0.0 108.27 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.74 -36.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.608 -0.682 . . . . 0.0 110.179 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -80.29 -9.97 59.74 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.955 0.798 . . . . 0.0 111.179 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.0 m -96.49 -21.72 17.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -103.54 -24.32 13.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -74.3 -0.17 16.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.014 0.825 . . . . 0.0 111.81 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.23 -20.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.186 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -101.05 -7.09 23.56 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 156.23 -166.18 33.04 Favored Glycine 0 N--CA 1.432 -1.577 0 O-C-N 124.499 1.124 . . . . 0.0 114.684 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 58.5 m -51.02 124.11 10.69 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.456 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 152.95 42.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.497 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -146.99 168.84 20.52 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.598 1.559 . . . . 0.0 108.711 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.6 152.2 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 121.489 -0.757 . . . . 0.0 112.26 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.21 135.86 32.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 124.497 1.123 . . . . 0.0 110.792 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.487 ' CE2' ' HG2' ' A' ' 269' ' ' LYS . 20.0 p90 -148.11 154.07 42.33 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.93 136.33 24.85 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.162 1.908 . . . . 0.0 107.365 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.2 32.97 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.487 ' HG2' ' CE2' ' A' ' 266' ' ' TRP . 35.8 mtmt -64.28 -6.43 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.449 1.124 . . . . 0.0 111.387 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.67 5.43 43.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.919 1.288 . . . . 0.0 110.696 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -69.68 -160.75 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.435 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -77.43 -17.62 57.94 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 276' ' ' CYS . 3.7 p80 -166.04 154.43 9.96 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.81 -1.39 11.1 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.397 2.732 . . . . 0.0 114.124 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -90.77 31.11 1.09 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 110.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 17.2 t -125.61 40.16 0.52 Allowed Pre-proline 0 C--N 1.34 0.159 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 89.3 Cg_endo -75.07 170.37 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 107.117 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.96 161.56 6.28 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.07 1.846 . . . . 0.0 115.269 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -54.25 -14.82 1.27 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.501 1.12 . . . . 0.0 112.432 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -179.84 16.38 0.03 OUTLIER Glycine 0 CA--C 1.533 1.156 0 CA-C-N 120.488 1.494 . . . . 0.0 112.873 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -130.15 155.85 45.54 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.272 1.536 . . . . 0.0 112.732 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.14 158.43 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 124.176 0.99 . . . . 0.0 109.819 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -118.45 150.06 40.21 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.18 140.62 52.35 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.1 129.79 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -168.03 -167.21 0.8 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -44.6 122.54 3.17 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 124.499 1.124 . . . . 0.0 109.189 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.16 -18.39 35.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.105 2.562 . . . . 0.0 115.852 -166.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -140.32 -54.1 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 120.082 1.31 . . . . 0.0 113.675 -167.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -73.96 -45.34 50.78 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.102 -0.374 . . . . 0.0 110.909 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 71.1 m -70.13 -26.78 64.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.75 -53.58 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -67.6 -26.76 66.42 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.991 -0.443 . . . . 0.0 111.904 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.6 t -67.94 -46.25 72.01 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.207 0.317 . . . . 0.0 110.44 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 291' ' ' SER . 5.4 mt -63.8 -42.25 97.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.03 0.377 . . . . 0.0 110.513 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.66 -25.94 61.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.424 0.69 . . . . 0.0 110.042 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -104.99 2.32 29.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.142 0.902 . . . . 0.0 110.077 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.1 -10.8 14.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.594 0.634 . . . . 0.0 110.03 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 16.6 p -107.25 -148.32 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.196 0.31 . . . . 0.0 110.743 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 67.0 m -106.78 145.27 32.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.236 0.541 . . . . 0.0 110.627 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -142.89 155.06 44.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.122 0.969 . . . . 0.0 108.849 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -145.92 137.58 13.07 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 304' ' ' LEU . 96.8 Cg_endo -71.72 -103.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 122.376 2.05 . . . . 0.0 109.338 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 303' ' ' PRO . 9.8 mp -115.47 15.02 16.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.374 1.07 . . . . 0.0 109.855 -170.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.537 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 70.4 m -66.67 -26.19 1.43 Allowed Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.799 1.64 . . . . 0.0 112.055 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 305' ' ' SER . 63.0 Cg_exo -61.67 -6.97 8.16 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.135 2.557 . . . . 0.0 111.842 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.87 34.46 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -172.17 -40.59 0.04 OUTLIER Glycine 0 C--O 1.243 0.662 0 O-C-N 120.949 -1.094 . . . . 0.0 113.974 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 26.9 tp -153.71 165.23 36.63 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.598 1.199 . . . . 0.0 111.349 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 4.1 m -79.17 148.2 32.38 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.5 151.47 31.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.4 153.77 32.49 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 124.33 1.019 . . . . 0.0 109.978 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -147.62 152.66 38.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.915 -1.116 . . . . 0.0 110.017 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 5.4 t80 -153.28 178.05 10.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 30.0 ttmt -152.47 124.95 8.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -169.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 12.67 6.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.868 0.867 . . . . 0.0 110.046 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.6 p -87.48 159.74 18.54 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.416 1.086 . . . . 0.0 111.511 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.3 m -149.27 38.0 0.78 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.768 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 52.51 33.53 13.55 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 121.238 0.542 . . . . 0.0 111.725 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -80.5 -30.65 37.29 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.75 -41.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.093 0.86 . . . . 0.0 111.176 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -147.5 166.65 26.64 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.749 1.219 . . . . 0.0 109.632 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 90.7 m -140.54 123.44 16.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.927 1.346 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -159.0 152.56 22.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -89.88 156.5 18.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 110.679 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.38 152.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.244 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -117.83 131.69 56.53 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.764 0.711 . . . . 0.0 111.77 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 240' ' ' LEU . 2.6 t -115.15 143.35 25.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.302 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.99 98.08 4.45 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 124.19 0.931 . . . . 0.0 109.904 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -83.98 162.14 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.904 4.403 . . . . 0.0 111.99 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.614 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 1.8 t90 -88.34 123.65 33.13 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.777 0.799 . . . . 0.0 109.293 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 231' ' ' ASN . 17.2 t -103.75 154.68 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.056 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 333' ' ' LEU . 7.9 tt -54.26 -26.45 29.07 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.587 -0.696 . . . . 0.0 112.173 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.09 16.95 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.558 -0.714 . . . . 0.0 112.264 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.07 -5.3 18.15 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.782 0.833 . . . . 0.0 108.894 173.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 66.8 m -100.6 -34.82 9.73 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.016 -1.677 . . . . 0.0 113.906 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -167.18 171.93 10.41 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 124.196 0.935 . . . . 0.0 113.418 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -156.51 155.07 31.35 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.081 1.352 . . . . 0.0 108.294 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.67 148.17 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.481 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -88.83 -16.45 32.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 35.8 t -151.34 113.75 3.05 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.69 -15.03 30.36 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.598 2.865 . . . . 0.0 112.02 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.2 t -86.21 4.65 37.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.428 1.091 . . . . 0.0 112.402 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -114.37 -175.11 2.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.454 1.501 . . . . 0.0 110.936 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -141.7 -179.81 6.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 122.198 0.199 . . . . 0.0 110.892 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -83.5 120.41 25.89 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 10.3 m-20 -81.1 150.69 68.89 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 124.752 1.283 . . . . 0.0 111.121 -171.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 77.5 Cg_exo -54.63 108.69 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.648 3.565 . . . . 0.0 109.885 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 86.2 p 52.79 23.51 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.52 73.98 0.99 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 119.453 1.024 . . . . 0.0 108.786 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 t -155.75 144.14 20.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.38 159.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 118.294 0.497 . . . . 0.0 110.238 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -83.53 146.92 28.08 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.382 1.051 . . . . 0.0 113.561 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 67.5 t -131.07 136.09 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.962 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.48 -176.96 31.13 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 51.0 22.94 1.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.575 1.55 . . . . 0.0 113.365 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.986 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.65 171.94 14.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.686 0.794 . . . . 0.0 111.171 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -48.7 150.19 1.5 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.546 1.138 . . . . 0.0 109.28 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -66.39 10.6 0.64 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.945 1.259 . . . . 0.0 113.135 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.0 mmt -145.43 -53.21 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.191 0.596 . . . . 0.0 109.805 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 41.73 60.01 2.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.718 0.77 . . . . 0.0 109.639 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -72.43 173.92 8.11 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 121.986 -0.447 . . . . 0.0 111.835 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -57.12 -18.01 13.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -80.55 -35.51 34.29 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.547 -0.721 . . . . 0.0 110.807 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.64 -27.22 27.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 366' ' ' LEU . 2.3 tt -78.68 -31.22 46.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.38 -28.59 56.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.91 -0.494 . . . . 0.0 111.993 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.9 -42.04 61.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 77.5 mt -79.09 -35.48 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 118.808 0.731 . . . . 0.0 109.067 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.31 -22.96 38.16 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.621 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.88 -23.61 21.59 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 120.561 1.528 . . . . 0.0 109.91 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.07 -36.48 58.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.527 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.452 HD11 HG11 ' A' ' 413' ' ' VAL . 2.9 mp -66.86 -34.44 77.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.313 -177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 403' ' ' SER . 0.2 OUTLIER -158.67 -17.38 0.07 Allowed 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.21 -7.6 5.84 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 121.979 0.766 . . . . 0.0 113.679 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -94.05 78.94 0.98 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 122.045 -0.679 . . . . 0.0 113.135 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.42 159.44 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 118.654 1.227 . . . . 0.0 112.378 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.01 -33.06 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -158.28 147.04 18.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.81 146.35 23.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.51 38.16 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 123.058 1.366 . . . . 0.0 114.304 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.56 141.4 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 122.188 0.994 . . . . 0.0 109.2 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.41 148.73 26.44 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.557 -171.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.4 p -131.39 159.6 37.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.87 -175.28 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.72 88.14 2.23 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 119.728 -1.858 . . . . 0.0 112.658 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 57.9 m170 70.49 38.58 1.32 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.18 -5.02 15.44 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.889 0.876 . . . . 0.0 110.384 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.1 p90 37.87 54.52 3.85 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 127.097 2.159 . . . . 0.0 114.364 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.18 -48.45 1.76 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.774 2.316 . . . . 0.0 111.169 -174.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.75 37.73 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 111.633 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.88 10.65 0.79 Allowed Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.5 p -155.17 126.66 7.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.265 0.555 . . . . 0.0 110.093 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -156.42 -164.94 13.95 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.468 1.038 . . . . 0.0 114.91 -171.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -151.76 162.6 40.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.551 -0.824 . . . . 0.0 108.899 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.13 134.15 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.153 -0.967 . . . . 0.0 108.881 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 346' ' ' LEU . 60.7 m -111.28 142.93 42.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.304 1.05 . . . . 0.0 109.549 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 73.8 m-85 -131.44 162.35 30.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.431 -0.793 . . . . 0.0 110.619 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.85 20.83 10.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.504 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -140.12 155.65 46.9 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.157 0.983 . . . . 0.0 109.183 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.08 -24.61 28.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.67 0.668 . . . . 0.0 110.196 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.649 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 3.8 mpt_? -52.89 -31.31 39.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.556 -0.715 . . . . 0.0 111.576 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.501 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 14.3 m -80.46 -29.21 37.48 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.577 0.751 . . . . 0.0 110.864 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.42 -54.37 10.91 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.942 0.337 . . . . 0.0 111.866 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.64 -17.86 55.36 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.005 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -86.41 -31.63 21.33 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 120.45 1.477 . . . . 0.0 112.665 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -72.6 -33.32 66.63 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 120.875 -1.141 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.7 -30.7 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 14.0 t -78.41 -32.21 48.62 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.379 1.049 . . . . 0.0 110.498 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.47 -44.55 35.04 Favored 'General case' 0 C--O 1.227 -0.095 0 O-C-N 121.735 -0.603 . . . . 0.0 110.914 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.17 -17.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.124 2.569 . . . . 0.0 116.331 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 423' ' ' LYS . 0.1 OUTLIER -164.95 136.87 4.31 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.106 -1.621 . . . . 0.0 108.664 178.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.452 HG11 HD11 ' A' ' 373' ' ' LEU . 34.0 m -135.58 154.5 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.698 0.681 . . . . 0.0 110.728 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -112.8 141.48 46.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.559 0.743 . . . . 0.0 111.438 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.0 mt -100.54 122.72 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.44 52.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 418' ' ' THR . 0.3 OUTLIER -72.53 178.51 4.02 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.55 ' H ' HG22 ' A' ' 417' ' ' THR . 10.8 m -75.46 -27.36 58.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -144.32 16.32 1.68 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.963 0.887 . . . . 0.0 110.479 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.59 113.17 4.1 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.7 p -136.27 131.86 35.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.918 0.487 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -148.91 177.74 9.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 412' ' ' PHE . 32.3 mtmm -144.45 160.93 40.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.06 133.56 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -106.98 157.44 17.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.34 0.59 . . . . 0.0 111.413 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 24.8 mt -140.87 149.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.42 149.95 56.27 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 124.196 0.935 . . . . 0.0 109.387 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.5 161.61 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.413 3.409 . . . . 0.0 109.941 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 116.797 -1.573 . . . . 0.0 111.226 178.441 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.6 m -155.03 158.94 39.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.383 1.073 . . . . 0.0 111.009 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.76 -16.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.062 -0.971 . . . . 0.0 113.472 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.1 m 43.61 52.27 6.22 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.433 1.015 . . . . 0.0 112.383 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 224' ' ' LEU . . . -71.27 -22.32 78.54 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.555 -173.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 59.67 27.33 16.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.727 0.811 . . . . 0.0 113.078 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.414 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.1 mm? -81.45 -22.55 0.34 Allowed Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 57.2 Cg_endo -67.76 121.43 8.48 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 CA-C-N 123.529 2.296 . . . . 0.0 111.619 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.14 166.98 4.57 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 125.232 3.955 . . . . 0.0 111.875 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -143.05 6.07 1.53 Allowed 'General case' 0 C--O 1.219 -0.541 0 O-C-N 122.003 -0.435 . . . . 0.0 112.128 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -115.88 30.15 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.976 1.71 . . . . 0.0 108.016 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -60.13 159.33 9.78 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -66.93 7.75 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -170.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 36.8 71.17 0.98 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.191 0.996 . . . . 0.0 112.183 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.31 -89.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.538 1 C-N-CA 126.072 4.515 . . . . 0.0 114.748 -173.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 234' ' ' TYR . 11.6 mm -127.37 178.15 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.326 1.45 . . . . 0.0 107.465 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 233' ' ' ILE . 14.8 m-85 -118.39 157.45 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.369 -0.825 . . . . 0.0 110.108 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 77.9 p -155.39 13.24 0.36 Allowed 'General case' 0 C--N 1.341 0.208 0 CA-C-N 121.242 1.837 . . . . 0.0 115.741 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 9.1 t -151.96 -177.37 6.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.115 1.325 . . . . 0.0 108.67 172.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.89 -172.77 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.541 1.162 . . . . 0.0 113.327 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.74 144.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.185 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.48 150.86 22.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.483 0.658 . . . . 0.0 111.954 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.466 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.4 tm? -140.52 126.08 19.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.674 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.42 38.15 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.205 -0.934 . . . . 0.0 112.911 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.47 3.23 2.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -99.69 134.93 20.72 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.475 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.89 -3.19 12.64 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.332 2.688 . . . . 0.0 110.97 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -128.07 -177.11 4.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.88 1.324 . . . . 0.0 111.151 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -166.47 149.42 6.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.427 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -174.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 168.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 250' ' ' ALA . 18.8 m -42.15 129.35 3.7 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.178 -0.951 . . . . 0.0 110.527 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.2 -25.03 65.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 121.694 -0.629 . . . . 0.0 112.242 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.4 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.78 -22.93 64.25 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.397 0.999 . . . . 0.0 112.263 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.95 -30.47 67.89 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.582 1.657 . . . . 0.0 110.601 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.59 -36.17 60.4 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.731 -1.453 . . . . 0.0 108.829 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 262' ' ' LEU . 92.7 t -67.48 -36.21 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 123.172 0.589 . . . . 0.0 110.066 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.4 -18.74 61.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.488 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 87.0 m -73.1 -33.63 65.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 118.722 0.692 . . . . 0.0 110.067 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -140.43 80.09 1.74 Allowed 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.704 ' HA ' HD11 ' A' ' 262' ' ' LEU . 12.9 ptm180 -133.59 1.35 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.257 0.623 . . . . 0.0 111.493 171.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.31 -1.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.136 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -100.43 -15.44 17.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.409 0.55 . . . . 0.0 110.416 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 262' ' ' LEU . . . 158.37 170.94 23.63 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.0 t -64.08 131.18 46.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.704 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -152.1 165.35 35.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.709 0.766 . . . . 0.0 110.957 169.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -141.01 171.65 13.77 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.602 0.715 . . . . 0.0 110.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.84 147.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.564 0.746 . . . . 0.0 110.996 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -139.58 134.09 31.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.025 0.828 . . . . 0.0 109.936 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -155.23 151.0 21.79 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.011 1.324 . . . . 0.0 110.227 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.66 154.42 34.81 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.415 3.41 . . . . 0.0 111.126 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.49 11.22 75.37 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.181 -0.95 . . . . 0.0 112.783 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -79.44 9.26 4.99 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -118.56 148.2 42.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.202 1.401 . . . . 0.0 110.047 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.77 43.97 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.66 -0.65 . . . . 0.0 112.532 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -72.46 155.77 39.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 121.462 -1.022 . . . . 0.0 111.014 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 26.8 m170 46.37 61.04 13.67 Favored Pre-proline 0 N--CA 1.447 -0.613 0 O-C-N 124.537 1.148 . . . . 0.0 111.647 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.05 -20.05 57.26 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.599 2.199 . . . . 0.0 108.945 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 275' ' ' ARG . 5.7 ppt_? -80.18 10.23 4.68 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.408 1.083 . . . . 0.0 113.615 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 44.4 t -133.84 110.41 12.11 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 120.591 -1.318 . . . . 0.0 111.592 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.62 157.95 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.548 2.165 . . . . 0.0 109.785 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.55 -11.81 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -143.15 -178.15 5.7 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 127.67 2.388 . . . . 0.0 110.286 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.88 4.02 59.02 Favored Glycine 0 CA--C 1.547 2.038 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.1 116.51 32.64 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.928 -1.51 . . . . 0.0 111.879 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.4 m -145.01 163.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.795 1.31 . . . . 0.0 108.59 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -87.85 157.22 19.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 284' ' ' LEU . 18.5 mt -128.08 140.87 51.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.77 156.19 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.761 0.824 . . . . 0.0 109.94 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.575 ' CZ ' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -171.22 176.27 3.99 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -60.36 88.29 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.9 pt? -56.56 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 129.411 3.084 . . . . 0.0 117.075 -167.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -131.67 -41.73 1.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.998 1.272 . . . . 0.0 111.372 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -95.18 -32.91 12.83 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.646 -0.659 . . . . 0.0 111.437 -173.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.8 t -83.51 -17.8 40.64 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 1.8 t -82.41 -33.58 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 O-C-N 121.216 -0.927 . . . . 0.0 109.976 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -62.96 -47.44 83.17 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 123.97 0.794 . . . . 0.0 110.329 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 77.6 p -76.79 -31.52 57.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.23 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.32 -40.64 58.22 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.38 -16.8 60.34 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.122 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.08 1.64 31.14 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.007 1.442 . . . . 0.0 111.846 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -113.42 -25.08 8.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.148 0.885 . . . . 0.0 110.956 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 300' ' ' SER . 98.4 m -79.1 -157.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 299' ' ' CYS . 16.5 m -116.67 161.27 19.47 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.346 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -141.68 151.4 42.97 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -140.85 118.8 8.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.49 33.04 0.44 Allowed 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 124.563 3.509 . . . . 0.0 109.931 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -26.61 16.47 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.342 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 7.6 t 41.96 70.91 1.5 Allowed Pre-proline 0 N--CA 1.469 0.479 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.93 -1.5 10.93 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 125.063 3.842 . . . . 0.0 110.978 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -160.33 28.59 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.505 1.048 . . . . 0.0 113.484 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.67 12.41 83.65 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 120.768 -1.208 . . . . 0.0 112.792 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 309' ' ' LEU . 1.5 pp -131.16 -166.15 1.66 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.642 1.177 . . . . 0.0 109.531 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 16.2 m -143.01 157.08 44.88 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.544 -1.347 . . . . 0.0 112.16 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.7 149.7 51.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.185 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.19 148.68 23.34 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.768 1.227 . . . . 0.0 112.076 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -149.03 156.57 42.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.864 -0.522 . . . . 0.0 110.418 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -158.47 161.16 37.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 11.6 ptpt -120.23 135.54 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 9.17 4.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.7 t -105.96 145.67 31.02 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.4 p -147.85 -32.62 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -138.47 -0.93 1.93 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -105.09 -30.54 9.67 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.574 -0.704 . . . . 0.0 110.716 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.7 mmt -135.03 -163.1 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.643 1.577 . . . . 0.0 106.744 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -69.89 -95.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.674 0.75 . . . . 0.0 109.775 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 98.7 m -156.33 29.8 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.678 0.791 . . . . 0.0 110.768 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.96 121.31 17.12 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 119.942 1.246 . . . . 0.0 113.231 -169.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 0.1 OUTLIER -77.22 164.01 26.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.115 0.566 . . . . 0.0 111.722 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.34 164.03 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.458 0.703 . . . . 0.0 109.522 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -109.94 153.36 24.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.669 0.668 . . . . 0.0 110.55 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.36 149.09 18.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-O 122.493 1.14 . . . . 0.0 111.358 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 119.06 3.65 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.848 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -99.11 172.59 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 124.429 3.42 . . . . 0.0 113.828 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.56 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 7.9 t-105 -85.46 124.67 32.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.837 0.855 . . . . 0.0 110.596 170.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.63 151.78 3.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-O 121.021 0.438 . . . . 0.0 110.118 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 333' ' ' LEU . 7.4 tt -61.04 -27.04 68.05 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.635 0.774 . . . . 0.0 110.156 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.2 -6.52 35.07 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 111.474 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.61 7.9 35.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.819 0.848 . . . . 0.0 109.101 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 62.6 m -111.44 -33.12 6.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.909 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -155.26 158.29 38.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.233 0.924 . . . . 0.0 111.827 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -154.36 140.51 18.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.491 169.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.38 148.37 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.911 0.884 . . . . 0.0 113.121 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -111.63 -7.81 14.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.003 1.383 . . . . 0.0 108.807 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 31.1 t -123.82 132.63 24.3 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.49 -1.45 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.975 2.45 . . . . 0.0 112.072 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 43.2 t -87.3 -14.69 40.15 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.734 1.152 . . . . 0.0 114.035 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 52.02 48.95 21.71 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' A' ' 346' ' ' LEU . 40.1 ttt180 -98.25 -178.17 3.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.214 1.405 . . . . 0.0 111.379 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.493 ' H ' ' HG2' ' A' ' 345' ' ' ARG . 11.8 tp -149.16 163.84 36.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -119.23 164.67 20.15 Favored Pre-proline 0 C--N 1.351 0.666 0 CA-C-N 118.435 0.561 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.86 63.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 126.964 5.109 . . . . 0.0 115.362 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 18.8 m 59.21 21.25 9.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.32 58.09 4.32 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.545 1.164 . . . . 0.0 109.324 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.5 t -117.47 166.7 12.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.57 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.3 m -133.67 150.38 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 123.995 0.809 . . . . 0.0 110.507 171.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -78.3 142.54 37.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 124.254 0.971 . . . . 0.0 110.041 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.29 142.44 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.01 29.11 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 124.004 0.815 . . . . 0.0 112.704 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 61.18 -2.41 0.22 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 357' ' ' LEU . 2.3 pt? -69.46 159.15 33.81 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.205 0.602 . . . . 0.0 111.567 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -92.75 173.92 7.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.711 -0.618 . . . . 0.0 111.432 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -64.24 8.69 0.42 Allowed Glycine 0 CA--C 1.532 1.144 0 N-CA-C 118.232 2.053 . . . . 0.0 118.232 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 38.4 mtt -142.65 6.02 1.62 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.976 1.888 . . . . 0.0 111.319 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.7 68.13 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 124.008 1.861 . . . . 0.0 109.586 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -62.19 176.4 0.6 Allowed 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.417 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.23 62.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.04 -26.4 36.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -85.22 -32.83 22.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.232 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.89 -31.72 64.87 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.271 0.487 . . . . 0.0 110.817 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.36 42.69 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.064 1.302 . . . . 0.0 110.597 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.76 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 123.89 0.744 . . . . 0.0 110.263 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.41 -44.46 80.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 O-C-N 124.174 0.921 . . . . 0.0 109.571 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.39 -17.42 34.47 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 112.722 -168.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.03 -23.89 18.51 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.167 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -93.41 -23.73 18.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.43 0.559 . . . . 0.0 112.446 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.8 -11.51 16.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -115.12 -36.18 4.48 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 141.28 -45.76 0.94 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.899 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.95 150.92 10.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.521 -1.8 . . . . 0.0 111.187 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.53 170.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.326 1.851 . . . . 0.0 107.001 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.81 -29.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 118.101 0.41 . . . . 0.0 110.613 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.441 ' CD1' ' CD1' ' A' ' 346' ' ' LEU . 4.0 t80 -165.61 157.13 14.31 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.803 0.811 . . . . 0.0 111.464 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.55 150.61 35.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.954 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.89 29.94 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 121.248 -0.907 . . . . 0.0 113.071 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 20.7 mm -118.93 141.41 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.153 1.381 . . . . 0.0 107.349 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -90.81 139.97 30.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.4 p -132.78 168.44 18.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.197 0.999 . . . . 0.0 109.561 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -137.81 158.37 44.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.082 2.153 . . . . 0.0 105.528 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -58.66 112.81 1.75 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 18.7 m170 62.99 26.06 15.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.588 -1.32 . . . . 0.0 114.113 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -94.33 -24.48 17.39 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.9 t80 41.35 59.41 8.82 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 125.398 1.479 . . . . 0.0 111.237 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.21 -35.16 3.16 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.595 1.53 . . . . 0.0 110.992 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.56 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 6.5 tp 31.7 48.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 125.166 1.387 . . . . 0.0 110.839 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.14 12.89 0.45 Allowed Glycine 0 C--N 1.349 1.259 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.037 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.0 m -147.86 154.53 40.54 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 118.685 1.242 . . . . 0.0 110.318 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.41 -168.3 40.85 Favored Glycine 0 C--O 1.247 0.951 0 CA-C-N 119.531 1.06 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -152.22 161.23 42.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.02 145.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 123.13 0.269 . . . . 0.0 110.332 -173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.8 p -123.11 142.18 51.16 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.792 0.806 . . . . 0.0 110.563 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.44 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 26.0 m-85 -118.41 -24.81 6.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.153 -169.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.55 17.52 3.08 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.47 156.0 38.6 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.776 -0.577 . . . . 0.0 110.753 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -89.72 -18.33 26.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -55.77 -42.11 75.03 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.478 -1.389 . . . . 0.0 109.675 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.44 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 57.2 m -82.55 -13.37 56.71 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.455 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.36 -50.1 15.12 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 119.195 0.907 . . . . 0.0 110.93 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.47 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.59 -29.43 51.99 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.386 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 405' ' ' LEU . 23.6 ttmm -70.39 -28.88 65.43 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.898 0.856 . . . . 0.0 111.296 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.23 19.74 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.276 -0.89 . . . . 0.0 113.291 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.56 -27.29 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.887 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 73.3 p -82.35 -26.28 33.1 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.22 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -81.58 -40.67 22.71 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.29 -12.54 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.71 143.64 3.31 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 123.815 0.846 . . . . 0.0 109.239 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.21 162.44 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 O-C-N 123.688 0.618 . . . . 0.0 110.828 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -106.77 143.72 34.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 123.986 0.803 . . . . 0.0 111.888 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.8 mt -125.7 119.04 53.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -143.59 130.71 20.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.9 p -136.55 -161.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.5 m -88.84 -2.37 58.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.997 0.519 . . . . 0.0 111.98 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -145.57 -4.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 422' ' ' LYS . 51.2 t80 -138.39 141.07 39.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.341 -1.474 . . . . 0.0 111.1 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 45.4 m -147.2 102.01 3.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.198 0.999 . . . . 0.0 110.904 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 420' ' ' PHE . 0.6 OUTLIER -153.26 173.77 15.14 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.575 0.625 . . . . 0.0 110.502 178.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -131.43 163.15 28.57 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.39 133.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -100.5 149.91 23.21 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 72.0 mt -133.68 138.2 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.088 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -135.3 150.33 72.3 Favored Pre-proline 0 CA--C 1.53 0.18 0 O-C-N 123.977 0.798 . . . . 0.0 111.333 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.45 150.92 75.97 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.615 1.543 . . . . 0.0 111.344 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 124.852 1.261 . . . . 0.0 112.077 -177.39 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.1 m 60.03 159.68 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.879 2.072 . . . . 0.0 111.957 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.473 ' CZ3' ' CA ' ' A' ' 222' ' ' GLY . 87.8 t90 -161.51 158.6 26.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.931 0.493 . . . . 0.0 109.741 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 70.7 p -143.18 104.62 4.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.288 0.566 . . . . 0.0 110.735 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.473 ' CA ' ' CZ3' ' A' ' 220' ' ' TRP . . . -73.08 111.8 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.26 -17.38 13.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.027 -1.087 . . . . 0.0 110.165 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -130.14 14.09 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 118.202 2.668 . . . . 0.0 118.202 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 72.6 Cg_exo -49.88 124.05 11.83 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 CA-C-N 120.989 1.389 . . . . 0.0 112.995 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.75 140.96 55.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.879 3.052 . . . . 0.0 110.992 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -142.78 -1.81 1.09 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -130.41 59.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.548 0.689 . . . . 0.0 112.829 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.32 163.75 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.445 1.098 . . . . 0.0 110.391 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -157.46 146.16 19.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -131.23 153.94 81.83 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -85.88 28.04 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.892 2.395 . . . . 0.0 113.397 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 74.6 mt -137.45 154.75 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 121.953 -0.467 . . . . 0.0 110.596 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.45 170.77 11.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.806 1.643 . . . . 0.0 108.484 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 54.0 p -152.52 -155.44 0.61 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 122.81 0.444 . . . . 0.0 110.375 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 94.3 m -54.33 137.59 41.34 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.488 1.515 . . . . 0.0 114.416 -168.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 56.26 143.85 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.18 149.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -107.73 156.33 19.21 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 117.885 0.312 . . . . 0.0 111.468 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.29 134.26 16.9 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 125.041 1.463 . . . . 0.0 107.261 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.82 155.92 23.89 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 120.658 -1.277 . . . . 0.0 112.391 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.97 7.35 1.57 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.729 -1.039 . . . . 0.0 112.99 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.96 70.47 10.14 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.697 1.599 . . . . 0.0 109.998 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.92 9.78 1.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 1 C-N-CA 125.726 4.284 . . . . 0.0 112.267 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.42 ' CE3' ' CE ' ' A' ' 321' ' ' MET . 12.5 p-90 -136.15 -8.94 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.94 116.98 8.38 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -174.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.533 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.59 -30.45 34.01 Favored 'Isoleucine or valine' 0 C--O 1.274 2.35 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.4 m -146.85 127.1 13.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.861 -1.15 . . . . 0.0 112.197 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -56.82 -27.04 59.38 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 125.677 1.861 . . . . 0.0 113.202 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.4 -16.49 47.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.34 -57.07 3.04 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-O 121.65 0.583 . . . . 0.0 111.657 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.406 HD23 ' C ' ' A' ' 252' ' ' LEU . 6.8 tt -66.14 -48.99 68.99 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.46 -33.12 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.335 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -77.99 -8.75 58.56 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.369 0.531 . . . . 0.0 111.685 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.5 m -83.24 -22.96 32.93 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.309 -1.494 . . . . 0.0 112.329 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -141.56 29.85 1.74 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.391 1.451 . . . . 0.0 114.315 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -90.94 13.06 17.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.532 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.53 27.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -168.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.03 -1.32 8.3 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.002 -0.436 . . . . 0.0 111.156 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.34 1.28 88.22 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.006 -0.886 . . . . 0.0 113.869 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.8 m -126.55 30.08 5.61 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.2 OUTLIER -100.53 146.0 27.62 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -148.79 160.89 42.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 122.174 0.988 . . . . 0.0 109.551 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.8 148.07 22.18 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.76 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.32 149.77 44.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.547 0.612 . . . . 0.0 110.645 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -117.4 143.77 32.69 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.657 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.76 -25.69 7.56 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.826 2.351 . . . . 0.0 110.232 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 174.13 17.2 0.02 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-N 119.944 1.247 . . . . 0.0 114.858 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -112.96 22.03 14.83 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.968 1.884 . . . . 0.0 112.246 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.76 149.78 43.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.544 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -118.07 173.75 14.97 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-O 121.179 0.321 . . . . 0.0 112.32 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -92.06 5.78 48.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 23.8 m170 -98.26 164.09 17.92 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.852 1.661 . . . . 0.0 111.346 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 273' ' ' HIS . 71.7 Cg_endo -69.69 5.06 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.757 2.972 . . . . 0.0 110.707 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 248' ' ' THR . 7.3 ptm180 -140.57 147.54 39.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.871 1.269 . . . . 0.0 110.71 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.93 146.2 15.11 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -93.34 149.84 2.44 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 124.399 3.399 . . . . 0.0 110.447 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.81 163.79 28.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.32 2.68 . . . . 0.0 107.215 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -96.77 23.78 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.65 82.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -165.15 129.4 2.42 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.793 -0.828 . . . . 0.0 109.842 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 160.28 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.498 1.749 . . . . 0.0 108.719 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -92.25 159.18 15.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 43.3 mt -122.94 143.47 49.88 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 123.371 0.669 . . . . 0.0 109.834 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.53 132.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 30.0 p90 -171.05 -163.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.72 1.263 . . . . 0.0 108.16 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.9 107.81 0.2 Allowed 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 288' ' ' LEU . 0.8 OUTLIER -91.04 19.18 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -167.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.62 -72.23 0.64 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.052 -1.03 . . . . 0.0 109.918 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -25.68 29.96 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.26 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 48.9 m -83.83 -23.2 31.47 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.63 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -45.32 39.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.026 -1.046 . . . . 0.0 109.34 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -73.71 -17.2 61.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.896 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.8 t -75.3 -46.08 35.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.08 1.309 . . . . 0.0 108.572 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -61.07 -47.61 85.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.94 -24.61 67.57 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.158 -0.964 . . . . 0.0 110.12 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -101.66 -3.04 28.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.174 0.921 . . . . 0.0 113.088 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -107.24 -10.57 15.79 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.676 0.61 . . . . 0.0 110.489 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.2 m -105.79 -141.83 0.37 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.3 t -125.53 163.6 22.35 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.316 -0.865 . . . . 0.0 111.294 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -148.76 153.58 38.37 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.393 0.433 . . . . 0.0 110.036 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -135.17 122.78 15.24 Favored Pre-proline 0 N--CA 1.435 -1.182 0 O-C-N 125.761 1.913 . . . . 0.0 106.498 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.0 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.039 1.826 . . . . 0.0 113.461 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.83 29.48 7.54 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.856 0.862 . . . . 0.0 110.381 -170.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.508 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 39.7 m -64.4 -31.04 5.31 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.471 1.508 . . . . 0.0 113.784 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 305' ' ' SER . 22.8 Cg_exo -69.4 -3.65 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.201 3.267 . . . . 0.0 111.748 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.4 t70 57.95 26.3 13.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.409 1.484 . . . . 0.0 112.641 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -176.17 -2.52 0.03 OUTLIER Glycine 0 CA--C 1.543 1.814 0 CA-C-N 118.518 0.599 . . . . 0.0 113.555 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 22.1 tp -157.03 172.58 18.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.442 1.621 . . . . 0.0 110.163 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 12.3 m -109.62 144.77 37.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.092 0.245 . . . . 0.0 110.956 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -142.92 140.35 31.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 111.497 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.67 154.47 18.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.811 0.845 . . . . 0.0 110.026 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.38 158.17 44.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.042 -1.036 . . . . 0.0 112.387 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 2.0 t80 -148.37 177.89 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.153 0.501 . . . . 0.0 110.559 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.4 ' N ' ' CD1' ' A' ' 314' ' ' PHE . 23.5 ttmt -147.53 122.71 10.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.04 7.45 1.19 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.743 -167.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.0 p -70.68 157.99 37.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.628 1.171 . . . . 0.0 110.935 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 42.3 t -115.68 173.08 6.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -69.92 -15.87 63.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.646 1.178 . . . . 0.0 111.424 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -68.2 -20.95 64.88 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.42 ' CE ' ' CE3' ' A' ' 245' ' ' TRP . 22.7 ptm -160.95 -165.18 1.31 Allowed 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.724 1.21 . . . . 0.0 111.563 -172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 71.4 mtm-85 -55.76 157.64 4.1 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 110.151 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.3 m -140.48 145.01 36.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 125.068 1.48 . . . . 0.0 110.223 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.93 144.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.28 156.93 36.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.348 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.77 154.81 11.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.34 158.81 23.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 110.413 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.46 145.88 31.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.758 0.789 . . . . 0.0 109.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 60.4 mt -143.16 97.41 5.71 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.23 158.53 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.058 2.506 . . . . 0.0 112.368 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.45 122.27 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.3 t -96.38 146.97 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.02 -24.42 58.22 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.827 1.251 . . . . 0.0 108.43 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.524 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.49 -19.62 64.91 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.859 -1.151 . . . . 0.0 112.472 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -101.3 9.54 41.6 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.237 0.215 . . . . 0.0 111.252 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 74.0 m -102.78 -27.16 12.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.523 -1.361 . . . . 0.0 112.503 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.03 165.69 15.64 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.582 -0.699 . . . . 0.0 110.059 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -158.01 148.4 20.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.16 150.07 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.911 0.862 . . . . 0.0 108.855 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -94.46 -10.56 31.99 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.848 -0.533 . . . . 0.0 111.695 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 m -143.83 150.63 50.62 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.086 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.83 119.87 5.58 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.338 2.025 . . . . 0.0 110.239 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 23.3 t -145.84 161.61 39.6 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.596 0.236 . . . . 0.0 110.545 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -79.9 -27.34 39.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.274 0.63 . . . . 0.0 112.187 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -164.23 171.51 14.86 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.916 1.286 . . . . 0.0 108.905 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 60.5 mt -97.99 -178.31 4.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.958 1.303 . . . . 0.0 111.099 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -101.74 103.62 29.6 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.44 -6.09 12.68 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.253 1.968 . . . . 0.0 113.202 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 21.2 t -91.16 -22.32 20.73 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.621 -0.228 . . . . 0.0 111.072 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -131.82 103.87 6.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 t -154.31 156.56 37.17 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 120.966 -1.084 . . . . 0.0 110.531 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 154.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -86.83 144.36 27.05 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.279 0.987 . . . . 0.0 108.97 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.63 140.35 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.735 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -160.2 176.82 36.85 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 122.061 -0.4 . . . . 0.0 112.689 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.62 7.36 1.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.051 2.14 . . . . 0.0 114.843 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.788 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -78.02 -172.57 2.78 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 175.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -45.57 146.76 0.99 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.792 2.837 . . . . 0.0 115.182 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -71.75 -2.96 53.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.201 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.2 ptm -151.19 32.44 0.59 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.814 1.807 . . . . 0.0 111.022 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.3 OUTLIER -43.77 140.63 1.82 Allowed 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 361' ' ' LEU . 34.3 m-80 -134.03 -177.85 4.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.822 0.82 . . . . 0.0 109.78 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.4 8.63 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.963 0.887 . . . . 0.0 111.489 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -44.19 -63.73 0.82 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.479 1.912 . . . . 0.0 110.906 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.3 -28.95 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.235 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.07 -35.34 80.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.231 0.923 . . . . 0.0 109.914 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.6 63.85 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.384 -0.927 . . . . 0.0 112.008 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.52 61.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.339 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.66 -42.51 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.47 -32.27 54.26 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.819 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.75 -16.91 46.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 118.17 -1.412 . . . . 0.0 111.294 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.11 -25.09 13.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.267 -0.896 . . . . 0.0 112.58 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.8 tp -92.42 -22.51 19.6 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 121.787 -0.571 . . . . 0.0 111.217 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 7.4 m-85 -136.26 -47.01 0.63 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 111.281 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.29 -16.21 30.28 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.928 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 400' ' ' ASN . . . -99.37 22.26 41.57 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.334 1.067 . . . . 0.0 113.877 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.77 166.06 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 120.911 -1.347 . . . . 0.0 111.857 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.26 -30.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.505 ' CG ' ' N ' ' A' ' 380' ' ' ALA . 0.3 OUTLIER -156.02 162.85 40.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.15 0.886 . . . . 0.0 112.369 -174.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -153.63 146.38 24.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.67 150.19 22.39 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.57 1.077 . . . . 0.0 112.77 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 26.3 mm -85.92 136.89 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 125.641 1.576 . . . . 0.0 109.724 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.45 60.09 6.03 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.542 -0.724 . . . . 0.0 111.441 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.7 158.88 9.44 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.717 1.722 . . . . 0.0 112.683 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -140.12 157.78 45.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.968 1.707 . . . . 0.0 107.069 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -57.28 113.92 1.95 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.824 0.821 . . . . 0.0 110.494 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 53.92 16.62 1.12 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -85.71 -9.67 56.82 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.356 0.98 . . . . 0.0 113.112 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 32.8 p90 39.93 54.13 5.81 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.845 1.658 . . . . 0.0 115.383 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.0 -48.86 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.868 2.379 . . . . 0.0 113.213 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.3 25.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.084 1.754 . . . . 0.0 114.243 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -145.35 19.58 1.89 Allowed Glycine 0 C--O 1.223 -0.567 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.2 p -151.34 159.77 44.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.969 0.885 . . . . 0.0 110.12 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.81 -157.31 20.76 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 115.924 1.13 . . . . 0.0 115.924 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -158.77 164.32 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.232 0.613 . . . . 0.0 109.477 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.13 143.03 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.2 p -112.05 148.77 33.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 403' ' ' SER . 71.2 m-85 -121.07 162.09 20.6 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.9 -171.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.13 0.95 15.11 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.005 0.816 . . . . 0.0 111.199 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.435 HD21 ' HA3' ' A' ' 376' ' ' GLY . 0.3 OUTLIER -150.39 164.74 35.09 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 173.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -80.67 -14.47 58.12 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 117.971 0.351 . . . . 0.0 111.103 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -58.98 -35.53 73.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.949 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 398' ' ' PHE . 8.8 m -78.36 -19.95 52.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.715 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.93 -64.29 0.91 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.444 0.64 . . . . 0.0 109.344 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.463 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.05 -19.6 62.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.983 -175.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -79.5 -25.49 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.053 0.221 . . . . 0.0 110.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -78.81 -39.29 36.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.383 0.611 . . . . 0.0 111.425 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.2 m -78.54 -21.74 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.424 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 51.8 p -87.93 -26.7 22.57 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.59 56.26 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.95 -26.22 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.299 1.839 . . . . 0.0 115.242 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.26 148.67 22.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.019 1.281 . . . . 0.0 111.843 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.75 148.04 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -107.64 94.99 5.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.2 128.98 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 136.67 49.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.754 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.64 174.94 14.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.153 1.381 . . . . 0.0 108.378 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 75.6 m -75.08 -20.88 59.29 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.146 0.885 . . . . 0.0 111.533 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -139.71 24.29 2.43 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.946 -0.471 . . . . 0.0 111.963 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -156.25 118.69 4.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.878 0.871 . . . . 0.0 111.159 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.0 p -146.85 112.13 5.51 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.805 0.729 . . . . 0.0 112.109 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -165.05 173.58 11.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.779 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -100.59 168.13 9.91 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.5 0.667 . . . . 0.0 109.339 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 357' ' ' LEU . 90.3 t -151.05 136.1 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -117.71 153.09 33.96 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 119.119 0.872 . . . . 0.0 112.898 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 78.8 mt -125.84 135.78 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -131.37 139.83 36.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.936 -0.478 . . . . 0.0 109.863 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.31 150.8 31.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.652 2.902 . . . . 0.0 116.544 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.39 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.625 0.25 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m 50.92 119.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.971 1.709 . . . . 0.0 113.475 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.493 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -128.85 -13.01 4.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 111.065 178.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.3 m 43.63 61.5 2.23 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.35 -19.14 78.65 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.726 -0.609 . . . . 0.0 114.205 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.22 32.37 21.61 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.042 -1.858 . . . . 0.0 114.245 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 151.76 86.06 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 86.5 Cg_endo -69.38 118.75 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.007 2.472 . . . . 0.0 110.364 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 8.1 Cg_endo -97.83 5.22 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 126.117 4.545 . . . . 0.0 114.802 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -137.85 11.37 2.89 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.047 0.939 . . . . 0.0 113.104 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -82.86 39.09 0.61 Allowed 'General case' 0 C--N 1.348 0.522 0 O-C-N 121.03 -1.044 . . . . 0.0 111.883 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.0 153.86 35.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -88.59 -13.51 39.83 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.327 1.017 . . . . 0.0 111.79 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.423 ' HA ' HG11 ' A' ' 332' ' ' VAL . 2.5 t-20 50.27 43.53 1.71 Allowed Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.68 -43.49 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.838 1.692 . . . . 0.0 113.867 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 51.7 mt -152.45 157.15 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.94 1.696 . . . . 0.0 107.183 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.09 144.39 31.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.113 0.565 . . . . 0.0 109.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.1 m -128.43 3.07 5.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.726 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.2 t -153.05 179.53 8.62 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 283' ' ' TYR . 12.0 ptmm? -49.5 166.44 0.05 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.308 1.043 . . . . 0.0 109.819 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.86 149.24 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -93.84 132.08 38.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.402 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.0 tm? -134.99 119.94 18.57 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 125.198 1.562 . . . . 0.0 109.602 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.82 170.22 36.97 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 111.866 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.03 1.74 3.97 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.074 0.845 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.92 132.23 74.68 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 119.085 1.443 . . . . 0.0 108.556 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -88.86 -13.49 3.15 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 124.07 3.18 . . . . 0.0 110.921 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -105.65 -54.5 2.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.2 t0 57.48 151.41 0.01 OUTLIER 'General case' 0 C--N 1.374 1.655 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -170.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.26 -40.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.418 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.1 m -164.48 120.15 1.5 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -74.62 -23.08 58.64 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 120.926 1.694 . . . . 0.0 111.187 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -81.11 -12.58 59.23 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.003 0.921 . . . . 0.0 111.012 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.86 -41.01 29.37 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 124.94 1.4 . . . . 0.0 109.93 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.58 -42.57 78.08 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.447 1.118 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.15 -37.07 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -73.68 -15.49 61.23 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.613 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 62.2 m -80.34 -24.47 39.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.804 0.729 . . . . 0.0 109.545 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -139.9 32.04 2.0 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -103.37 12.77 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.503 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.46 23.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.7 -1.3 19.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.273 0.559 . . . . 0.0 111.651 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 110.82 -80.22 0.27 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 122.502 1.057 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.0 t -88.99 109.37 20.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.061 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 138.7 17.51 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.048 -1.032 . . . . 0.0 110.411 168.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.6 m -138.57 172.97 12.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.366 1.067 . . . . 0.0 109.311 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.95 147.61 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.876 -168.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -155.3 151.25 27.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.321 1.058 . . . . 0.0 110.726 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -160.28 138.57 7.45 Favored Pre-proline 0 C--N 1.352 0.691 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.566 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 85.1 Cg_endo -79.41 164.5 23.91 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.552 2.168 . . . . 0.0 110.772 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.61 -128.24 9.47 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -83.53 109.06 17.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.694 0.759 . . . . 0.0 109.485 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -125.75 141.22 52.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.278 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -175.85 -148.52 6.94 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 121.945 0.747 . . . . 0.0 112.325 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -80.97 1.78 29.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.242 1.417 . . . . 0.0 111.22 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -125.87 102.76 28.05 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.25 0.62 . . . . 0.0 110.264 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.8 28.29 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 125.273 3.982 . . . . 0.0 112.169 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -133.29 11.91 4.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 6.5 t -81.75 -33.41 0.65 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 116.884 -1.531 . . . . 0.0 112.203 -174.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 74.0 Cg_exo -55.72 122.5 11.86 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.293 2.662 . . . . 0.0 111.925 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.2 5.71 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.246 3.297 . . . . 0.0 112.177 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -121.95 6.16 9.84 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.87 36.73 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.944 -1.475 . . . . 0.0 113.659 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -112.6 146.87 37.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.178 1.489 . . . . 0.0 110.753 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.6 p -154.67 157.18 4.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.566 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 12.1 m-85 -109.0 154.84 21.62 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.07 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -116.02 134.37 55.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.428 1.108 . . . . 0.0 110.872 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.19 109.56 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -166.52 -166.58 0.88 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.55 -0.719 . . . . 0.0 111.261 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.63 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.235 1.814 . . . . 0.0 107.578 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.784 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.0 pt? -73.9 -3.61 29.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -167.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -111.13 -66.13 1.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -87.29 -31.72 20.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.504 -0.748 . . . . 0.0 109.602 -171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 295' ' ' LEU . 67.4 m -83.24 -26.29 30.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 121.031 1.741 . . . . 0.0 110.381 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 288' ' ' LEU . 64.5 t -69.25 -55.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -58.11 -31.53 67.24 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.999 -1.063 . . . . 0.0 112.194 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.3 m -68.2 -39.14 82.52 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.01 0.434 . . . . 0.0 112.144 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 291' ' ' SER . 1.8 mp -71.03 -41.47 70.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.97 -19.75 61.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.361 -0.536 . . . . 0.0 112.339 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -98.06 -3.68 37.52 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.653 0.596 . . . . 0.0 110.187 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -101.66 -5.97 24.35 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 124.314 1.009 . . . . 0.0 110.277 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 33.9 m -90.59 -157.27 0.47 Allowed 'General case' 0 C--O 1.221 -0.418 0 O-C-N 125.846 1.967 . . . . 0.0 109.509 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 m -136.95 -178.23 5.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -138.4 143.79 39.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.086 0.954 . . . . 0.0 111.788 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.83 127.49 26.22 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -83.43 37.19 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.125 4.55 . . . . 0.0 110.158 176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.465 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -71.01 -20.23 62.43 Favored 'General case' 0 C--O 1.244 0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 112.595 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.441 ' H ' HD13 ' A' ' 304' ' ' LEU . 47.5 t -162.92 74.92 1.99 Allowed Pre-proline 0 C--N 1.346 0.45 0 CA-C-O 122.427 1.108 . . . . 0.0 108.581 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.13 -5.88 10.32 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.024 2.483 . . . . 0.0 114.36 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.18 -13.55 61.97 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.183 -0.948 . . . . 0.0 111.004 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 154.44 -25.24 0.67 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.273 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.5 tp -96.11 38.3 1.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 111.898 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.2 m -66.61 167.0 11.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.442 1.097 . . . . 0.0 108.858 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -138.58 154.05 48.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.249 0.931 . . . . 0.0 110.0 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -110.91 151.77 27.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 47.0 m-85 -147.4 159.75 43.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -162.99 151.58 14.34 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -114.57 131.48 56.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.11 0.868 . . . . 0.0 110.238 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.62 16.22 19.77 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.488 0.715 . . . . 0.0 110.376 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 322' ' ' ARG . 65.6 p -132.8 132.24 41.97 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.769 -0.582 . . . . 0.0 112.562 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 95.9 p -138.38 -18.53 1.12 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.225 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -137.2 -16.39 1.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -90.16 -25.38 20.7 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.411 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mmm -148.38 -47.15 0.15 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.613 1.565 . . . . 0.0 109.676 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.422 ' H ' ' HB2' ' A' ' 317' ' ' SER . 21.8 ptt180 47.72 39.63 10.59 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.147 1.779 . . . . 0.0 114.7 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 21.8 m -132.35 -19.11 2.48 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.552 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -148.48 168.22 23.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 158.29 30.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.057 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.35 165.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.473 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 2.8 pp0? -118.2 166.89 12.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.99 140.91 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 111.644 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -143.1 98.09 5.63 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -83.49 155.54 14.1 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.094 1.863 . . . . 0.0 112.243 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -80.21 119.87 23.55 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.145 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 334' ' ' ALA . 18.0 t -97.25 157.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.109 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -54.34 -30.96 53.31 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.687 0.756 . . . . 0.0 110.549 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.512 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -74.93 6.76 3.75 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.491 1.116 . . . . 0.0 112.413 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -112.79 6.28 17.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 109.982 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 42.9 m -123.96 -29.14 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.21 165.76 35.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 110.387 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -152.45 136.65 16.56 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 125.631 1.572 . . . . 0.0 111.903 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.03 147.55 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 122.731 1.253 . . . . 0.0 110.844 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -113.34 3.95 16.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.489 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.7 m -133.58 150.33 74.59 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 125.439 1.496 . . . . 0.0 110.087 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -85.68 -7.29 8.61 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.524 3.483 . . . . 0.0 113.799 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.5 t -149.46 -16.01 0.28 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.666 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -97.89 166.46 11.44 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 109.994 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -151.25 -169.07 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.034 -0.416 . . . . 0.0 110.457 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.533 ' H ' HD12 ' A' ' 346' ' ' LEU . 9.4 mp -37.27 152.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.42 2.288 . . . . 0.0 114.183 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 397' ' ' THR . 8.5 t70 -131.99 134.9 25.75 Favored Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 126.331 1.852 . . . . 0.0 108.136 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -82.29 4.78 6.8 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.27 1.98 . . . . 0.0 113.811 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 6.2 t -139.24 -5.96 1.41 Allowed 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.117 1.326 . . . . 0.0 114.238 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -125.58 69.65 1.17 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.187 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 397' ' ' THR . 8.8 t -150.84 153.4 35.31 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.413 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.89 165.19 29.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 124.056 0.847 . . . . 0.0 111.131 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -83.32 151.4 25.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.331 0.586 . . . . 0.0 112.257 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.3 t -132.54 142.88 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.791 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.27 -163.8 18.08 Favored Glycine 0 C--O 1.246 0.863 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.174 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.72 37.37 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.001 1.721 . . . . 0.0 113.582 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.57 167.06 20.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' HIS . . . . . 0.428 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 17.2 p-80 -83.57 4.86 26.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.23 34.89 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.732 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.428 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 5.0 ptp -164.13 21.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.094 0.947 . . . . 0.0 110.289 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.81 140.45 58.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.896 1.225 . . . . 0.0 110.608 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.04 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.23 66.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -73.63 -31.92 63.78 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.819 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.62 60.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.838 -1.164 . . . . 0.0 108.551 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.488 HD11 HD11 ' A' ' 382' ' ' ILE . 93.3 mt -60.95 -53.45 57.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.25 59.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.95 -41.65 42.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.913 0.863 . . . . 0.0 110.36 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.3 -26.99 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.197 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 366' ' ' LEU . 51.7 mt -96.08 -20.74 18.43 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.274 -0.891 . . . . 0.0 112.882 -168.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 -7.53 18.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 116.211 -1.852 . . . . 0.0 110.543 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 -13.05 8.64 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.247 1.385 . . . . 0.0 114.684 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.412 HD21 ' CG ' ' A' ' 220' ' ' TRP . 60.5 mt -117.12 -4.01 11.48 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.61 0.641 . . . . 0.0 111.313 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 22.9 m-85 -133.08 -32.84 1.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.903 0.881 . . . . 0.0 111.857 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 79.29 -9.64 39.74 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.7 128.03 1.66 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 120.411 2.105 . . . . 0.0 110.661 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.41 171.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.04 -30.12 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.533 ' CE1' HD11 ' A' ' 346' ' ' LEU . 1.1 t80 -171.11 159.67 6.06 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -148.99 145.6 27.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -151.78 -173.97 22.03 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 122.955 1.308 . . . . 0.0 114.865 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 366' ' ' LEU . 42.2 mm -116.47 144.37 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 112.093 -2.053 . . . . 0.0 109.834 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -76.3 44.81 0.35 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.799 0.439 . . . . 0.0 111.916 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.56 155.79 5.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.271 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -145.35 144.69 30.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -48.96 114.97 1.11 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 111.099 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 14.3 m170 57.99 28.53 16.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.045 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -105.65 -1.32 24.73 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.0 p90 33.21 59.44 1.63 Allowed Pre-proline 0 C--N 1.353 0.751 0 C-N-CA 126.497 1.919 . . . . 0.0 112.962 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.06 -49.02 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 391' ' ' ILE . 8.3 tp 31.41 41.49 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.518 1.527 . . . . 0.0 112.473 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -141.3 11.72 2.77 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 117.975 -1.458 . . . . 0.0 112.155 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 45.6 m -151.95 153.44 34.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.068 0.934 . . . . 0.0 109.04 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.4 -166.5 32.5 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.707 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.08 167.68 29.55 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.34 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.89 135.47 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 119.303 0.956 . . . . 0.0 110.332 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.446 HG22 ' HB ' ' A' ' 351' ' ' THR . 21.1 p -105.5 129.13 53.85 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 121.704 -0.623 . . . . 0.0 110.868 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.449 ' CD1' ' CB ' ' A' ' 403' ' ' SER . 95.0 m-85 -96.62 -45.14 6.83 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 53.9 t30 56.64 17.47 3.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.702 0.401 . . . . 0.0 111.01 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -141.66 155.78 45.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.664 1.986 . . . . 0.0 107.91 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -103.24 -37.47 7.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 117.718 -1.134 . . . . 0.0 112.499 -171.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -61.05 -22.92 65.04 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.518 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.449 ' CB ' ' CD1' ' A' ' 398' ' ' PHE . 7.3 m -74.02 -26.51 60.47 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.155 -0.966 . . . . 0.0 111.24 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -73.71 -56.03 5.51 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.234 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -78.16 -30.54 49.22 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.827 -0.546 . . . . 0.0 111.522 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -73.08 -40.64 64.86 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.94 -30.82 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 123.392 0.432 . . . . 0.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 25.6 p -77.55 -14.52 59.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.81 1.319 . . . . 0.0 112.993 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -88.93 -46.31 9.0 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.681 0.613 . . . . 0.0 110.197 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.73 -16.6 0.01 OUTLIER 'General case' 0 C--O 1.242 0.692 0 C-N-CA 126.86 2.064 . . . . 0.0 115.099 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -163.88 145.87 9.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.4 160.81 41.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 33.5 mt-10 -118.76 128.14 54.21 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 125.354 1.659 . . . . 0.0 108.851 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.6 mt -99.29 125.25 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 40.09 3.46 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.092 0.87 . . . . 0.0 111.436 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.9 p -76.4 172.17 13.37 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.965 1.365 . . . . 0.0 110.162 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.9 t -73.62 -1.29 18.25 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 120.275 -1.516 . . . . 0.0 112.713 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -128.43 -9.69 5.17 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 422' ' ' LYS . 15.0 t80 -149.71 124.09 9.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.937 0.79 . . . . 0.0 109.175 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 14.1 p -131.43 72.14 1.49 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.668 0.787 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 420' ' ' PHE . 98.0 mttt -152.42 177.91 10.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.001 0.92 . . . . 0.0 111.156 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 93.7 mttt -122.28 -179.54 4.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.7 m -152.15 161.25 3.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.81 1.244 . . . . 0.0 107.824 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -116.26 155.08 28.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 123.413 1.578 . . . . 0.0 110.267 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.9 mt -143.37 138.35 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.341 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -139.04 153.64 71.78 Favored Pre-proline 0 C--O 1.246 0.915 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.72 149.99 88.86 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 123.468 2.779 . . . . 0.0 110.886 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.86 1.664 . . . . 0.0 111.646 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 60.0 m -162.2 152.97 17.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -18.96 1.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.96 1.709 . . . . 0.0 112.422 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m 43.65 56.43 4.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.905 0.86 . . . . 0.0 112.745 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.85 -17.71 80.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.784 -1.098 . . . . 0.0 114.964 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.534 ' HA ' HG22 ' A' ' 417' ' ' THR . 29.6 mt-30 46.91 44.56 14.68 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 1.3 pt? -137.0 6.28 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 116.068 -1.92 . . . . 0.0 115.302 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 84.3 Cg_endo -68.25 128.66 17.82 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 CA-C-N 123.091 2.14 . . . . 0.0 108.709 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.12 152.5 24.3 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.236 2.624 . . . . 0.0 111.829 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -140.44 3.52 1.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.5 1.52 . . . . 0.0 110.718 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -106.04 64.7 0.68 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -115.52 -99.01 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.344 1.458 . . . . 0.0 109.865 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.75 27.82 14.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.11 1.364 . . . . 0.0 112.277 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -91.09 -43.89 0.38 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.64 -170.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.483 2.122 . . . . 0.0 114.653 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -105.41 178.67 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.823 1.249 . . . . 0.0 108.228 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.34 151.33 19.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.34 -1.475 . . . . 0.0 108.91 -174.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -147.4 -2.11 0.6 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.029 0.442 . . . . 0.0 111.677 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 -169.58 2.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.344 -1.472 . . . . 0.0 113.092 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.41 170.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.677 0.751 . . . . 0.0 112.603 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.37 141.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.143 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -83.62 134.14 34.81 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.92 118.7 9.24 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 169.73 -162.25 35.68 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.03 7.18 3.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.115 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.34 131.59 41.9 Favored Pre-proline 0 C--O 1.216 -0.68 0 CA-C-N 117.798 0.799 . . . . 0.0 110.406 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -86.95 -4.3 7.99 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 124.341 3.361 . . . . 0.0 109.862 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 1.3 p-90 -118.62 -43.13 2.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.464 -1.398 . . . . 0.0 114.327 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER 54.04 154.87 0.0 OUTLIER 'General case' 0 C--O 1.271 2.221 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -171.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.0 OUTLIER -143.72 178.32 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.058 175.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 274' ' ' PRO . 18.0 m -44.02 123.14 3.18 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.37 -25.75 68.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.84 -14.53 62.44 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 118.218 0.463 . . . . 0.0 111.846 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.14 -44.22 36.49 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.866 0.703 . . . . 0.0 112.833 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.7 -35.83 57.61 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.433 1.111 . . . . 0.0 109.608 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.55 -35.84 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.881 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -80.9 -14.82 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 47.1 m -79.81 -28.75 40.17 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.947 -0.471 . . . . 0.0 112.002 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -130.87 26.81 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 262' ' ' LEU . 10.9 ptm85 -101.8 1.85 37.67 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 113.275 169.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 99.1 t -76.22 -14.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 122.483 1.135 . . . . 0.0 111.708 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -87.61 -16.03 35.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.892 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 163.97 172.0 30.9 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.614 1.097 . . . . 0.0 112.569 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 52.8 m -58.13 130.89 48.72 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -160.25 173.92 14.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.492 167.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.408 ' HB2' HG23 ' A' ' 285' ' ' VAL . 50.2 m -138.96 174.84 10.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.531 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 146.65 25.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 125.235 1.414 . . . . 0.0 111.334 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -146.72 141.69 27.04 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.896 0.855 . . . . 0.0 112.928 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.415 ' HB3' HG23 ' A' ' 282' ' ' VAL . 32.8 p90 -151.08 140.1 13.46 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.475 1.11 . . . . 0.0 111.325 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.08 10.27 3.02 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.691 3.594 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.32 -168.89 24.5 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -80.5 54.51 2.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.315 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.406 ' HB3' ' NE1' ' A' ' 266' ' ' TRP . 5.2 p-10 -69.43 -15.93 63.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -78.63 -11.8 84.89 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 121.221 -0.925 . . . . 0.0 113.413 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.61 -45.98 4.28 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.267 1.534 . . . . 0.0 110.274 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.47 ' CG ' ' HE ' ' A' ' 275' ' ' ARG . 2.4 p80 -163.1 145.42 8.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 123.462 0.476 . . . . 0.0 109.837 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.407 ' HG2' HG23 ' A' ' 248' ' ' THR . 35.5 Cg_endo -78.26 41.11 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 126.586 4.857 . . . . 0.0 113.097 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.47 ' HE ' ' CG ' ' A' ' 273' ' ' HIS . 28.4 ptt180 -132.28 10.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.622 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.41 56.54 14.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.781 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.63 149.36 48.95 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 N-CA-C 108.429 -1.412 . . . . 0.0 108.429 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.55 -30.82 86.78 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.65 1.567 . . . . 0.0 113.415 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -146.84 176.13 10.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.85 0.86 . . . . 0.0 110.631 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -81.62 25.66 3.85 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.487 -1.383 . . . . 0.0 116.096 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.485 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 51.3 p90 -142.63 174.18 10.87 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.373 0.69 . . . . 0.0 109.534 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 266' ' ' TRP . 9.1 p -155.45 157.1 4.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.85 140.03 30.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.779 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.3 mt -119.86 148.37 43.56 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.014 0.825 . . . . 0.0 109.676 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 263' ' ' SER . 2.8 m -131.8 98.48 3.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.469 ' C ' ' H ' ' A' ' 288' ' ' LEU . 67.2 m-85 -85.09 -171.58 3.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.176 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.96 43.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.796 1.284 . . . . 0.0 110.703 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 286' ' ' PHE . 4.1 mm? 54.12 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 131.107 3.763 . . . . 0.0 116.575 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.95 -42.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.118 0.872 . . . . 0.0 111.906 -170.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.1 -74.37 0.06 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-O 122.152 0.977 . . . . 0.0 113.026 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 37.9 m -70.33 -11.82 61.17 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.425 0.69 . . . . 0.0 109.537 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.83 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 O-C-N 119.837 -1.789 . . . . 0.0 111.452 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.11 -29.54 64.18 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.97 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.5 m -66.19 -36.68 83.69 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 121.794 -0.566 . . . . 0.0 111.368 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 295' ' ' LEU . 0.1 OUTLIER -70.59 -52.38 21.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.723 -0.611 . . . . 0.0 111.449 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.07 -29.97 70.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.731 0.696 . . . . 0.0 111.707 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -80.74 -10.77 59.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.158 0.435 . . . . 0.0 110.969 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -109.99 -2.7 16.94 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.395 -0.816 . . . . 0.0 110.862 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 90.4 m -102.99 -156.11 0.55 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.895 1.278 . . . . 0.0 109.039 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 59.0 m -124.42 166.86 15.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.076 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -140.0 161.49 37.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.655 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -147.37 124.04 5.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -85.4 22.56 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.093 3.862 . . . . 0.0 112.593 173.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.59 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -42.02 -36.41 1.11 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.052 0.941 . . . . 0.0 113.506 -177.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.59 ' H ' HD12 ' A' ' 304' ' ' LEU . 16.9 t 47.12 50.36 8.59 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.979 1.312 . . . . 0.0 114.382 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.428 ' HD3' HD13 ' A' ' 304' ' ' LEU . 90.0 Cg_endo -71.58 -10.79 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -143.85 9.51 1.53 Allowed 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.035 0.834 . . . . 0.0 109.907 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 99.36 -0.02 56.98 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.537 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 77.9 mt -128.86 156.24 43.96 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 118.704 1.252 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 21.8 m -102.68 165.05 11.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.969 0.908 . . . . 0.0 110.1 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -142.51 154.98 44.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -111.56 154.5 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 110.996 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -144.96 149.26 34.88 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.455 -0.778 . . . . 0.0 112.059 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -161.84 160.6 28.32 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.129 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -124.69 147.38 48.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.23 -0.919 . . . . 0.0 110.68 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.84 9.39 3.58 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.179 -168.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 319' ' ' ARG . 66.9 p -121.75 -97.11 0.46 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.199 0.937 . . . . 0.0 109.724 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.471 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 6.2 m 65.67 -3.85 0.66 Allowed 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.232 1.013 . . . . 0.0 111.867 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 317' ' ' SER . 5.5 mpt_? -140.4 170.63 15.46 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.471 2.308 . . . . 0.0 106.624 170.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 321' ' ' MET . 17.5 ptt180 50.21 6.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.308 2.243 . . . . 0.0 115.115 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 11.7 mmt -156.68 -176.03 5.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.728 -0.607 . . . . 0.0 109.701 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -83.74 20.3 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.679 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 318' ' ' SER . 55.9 m 54.15 68.72 0.81 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.478 0.711 . . . . 0.0 112.554 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -124.55 108.11 11.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.26 169.01 2.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.039 1.336 . . . . 0.0 112.661 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.65 178.1 3.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.87 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 161.23 35.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.358 0.599 . . . . 0.0 109.851 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.33 135.69 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 24.1 mt -144.21 98.16 5.13 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 125.028 1.455 . . . . 0.0 109.837 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.75 160.47 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.13 1 C-N-CA 125.48 4.12 . . . . 0.0 112.969 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -89.19 125.16 34.95 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.133 0.895 . . . . 0.0 109.941 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 334' ' ' ALA . 63.4 t -109.86 147.85 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.94 -22.11 47.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 117.744 -1.582 . . . . 0.0 111.934 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.544 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -59.23 -14.34 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.706 1.139 . . . . 0.0 113.148 174.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -99.28 6.91 46.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.369 1.067 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.2 m -132.81 -33.73 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.518 0.727 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -146.76 152.83 39.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.988 0.899 . . . . 0.0 110.725 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -164.64 140.78 5.94 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.549 -1.66 . . . . 0.0 109.473 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 379' ' ' TYR . 5.5 m -118.85 150.6 21.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.668 -0.645 . . . . 0.0 112.112 -175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -125.1 28.52 6.36 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.655 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.4 t -148.23 143.0 16.98 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.756 0.823 . . . . 0.0 110.532 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.11 -10.69 26.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.717 2.944 . . . . 0.0 110.186 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.7 m -90.24 -9.48 47.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.355 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 43.11 17.3 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.564 ' HE ' ' HA ' ' A' ' 345' ' ' ARG . 0.0 OUTLIER -117.6 174.34 6.22 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 379' ' ' TYR . 1.7 mm? -86.57 169.67 12.57 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 125.019 1.45 . . . . 0.0 111.685 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -110.44 154.15 43.14 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.26 110.16 0.51 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.043 1.829 . . . . 0.0 112.003 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 35.8 m 50.82 35.65 12.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.121 0.968 . . . . 0.0 112.41 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -115.61 64.76 0.69 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.425 0.631 . . . . 0.0 112.251 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.1 t -148.61 159.26 44.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.653 0.381 . . . . 0.0 111.556 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.05 165.44 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.139 -0.976 . . . . 0.0 111.852 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -87.62 162.2 17.27 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.93 132.91 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.904 0.753 . . . . 0.0 109.345 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -136.4 -176.7 14.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 123.222 1.457 . . . . 0.0 111.414 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 63.0 -57.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.796 1.238 . . . . 0.0 113.056 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 47.8 -158.57 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.784 1.233 . . . . 0.0 111.74 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.88 163.71 35.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.517 1.927 . . . . 0.0 107.487 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -63.25 4.18 0.95 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 120.142 -0.255 . . . . 0.0 113.272 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.8 ptp -164.4 32.2 0.07 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.848 1.324 . . . . 0.0 108.756 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.4 111.89 2.21 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.537 0.735 . . . . 0.0 110.743 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.21 159.36 17.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -71.66 -20.32 61.97 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 121.479 -0.763 . . . . 0.0 112.497 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.09 -23.24 59.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -72.12 -35.25 69.08 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.223 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.14 -29.35 63.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.0 -1.08 . . . . 0.0 109.737 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -86.5 -15.87 38.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.172 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -85.93 -43.37 13.26 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 119.483 1.038 . . . . 0.0 110.958 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.73 -52.27 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.66 -38.86 70.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.54 -21.2 60.45 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 118.35 -1.34 . . . . 0.0 110.376 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.6 -12.83 35.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.968 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.7 tp -75.53 -20.68 58.54 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 121.777 -0.577 . . . . 0.0 110.436 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 403' ' ' SER . 27.7 p90 -156.34 -43.31 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 374' ' ' PHE . . . -177.37 -66.67 0.06 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 119.174 0.897 . . . . 0.0 114.182 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 176.46 149.95 7.91 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 119.087 1.444 . . . . 0.0 114.644 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 1.1 m -118.75 172.52 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.618 0.767 . . . . 0.0 110.914 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.8 -30.87 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' A' ' 339' ' ' VAL . 23.0 t80 -163.93 156.04 17.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.36 154.13 40.51 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.11 166.27 36.27 Favored Glycine 0 C--O 1.22 -0.739 0 CA-C-O 122.683 1.157 . . . . 0.0 114.951 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 336' ' ' SER . 11.4 mm -116.0 154.42 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.27 1.828 . . . . 0.0 107.071 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.64 134.09 42.05 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.375 -0.828 . . . . 0.0 110.758 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 4.3 p -135.2 154.05 51.73 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 125.26 1.6 . . . . 0.0 110.071 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.33 159.31 42.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.572 ' HA ' ' HE3' ' A' ' 386' ' ' LYS . 1.7 tpmt? -46.82 103.18 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.315 0.646 . . . . 0.0 112.378 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.2 m170 45.07 45.77 9.15 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.886 2.475 . . . . 0.0 114.04 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -102.55 4.08 38.11 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.403 -0.81 . . . . 0.0 110.964 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.3 p90 42.26 54.0 8.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.276 1.43 . . . . 0.0 112.746 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 85.7 Cg_endo -70.08 -66.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.3 2.667 . . . . 0.0 112.426 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.47 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 4.0 tp 42.63 28.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 124.061 0.85 . . . . 0.0 111.854 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -123.11 10.69 8.76 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.904 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 69.1 p -158.08 158.81 35.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -168.96 -169.24 32.1 Favored Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.071 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -150.53 165.51 33.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 122.1 0.952 . . . . 0.0 109.051 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.49 136.14 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 120.755 -1.215 . . . . 0.0 108.719 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 43.8 m -115.74 142.83 46.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.524 -170.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.02 164.69 15.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.56 0.695 . . . . 0.0 112.007 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -116.37 7.21 13.84 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.107 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -129.1 164.86 22.4 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -107.54 -29.26 9.29 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.912 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -56.44 -28.79 60.52 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.753 1.16 . . . . 0.0 113.398 -173.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.481 ' HB2' ' CD2' ' A' ' 374' ' ' PHE . 32.6 t -78.38 -33.99 48.52 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.617 -1.302 . . . . 0.0 113.159 175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -51.87 -50.73 60.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 123.845 0.716 . . . . 0.0 111.494 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 405' ' ' LEU 0.282 0.0 OUTLIER -83.39 -26.55 30.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.618 176.9 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.407 ' N ' HD22 ' A' ' 405' ' ' LEU . 28.9 ttpp -74.3 -19.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.465 1.029 . . . . 0.0 110.86 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -89.34 -36.75 15.35 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.201 -0.937 . . . . 0.0 112.364 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.4 m -71.61 -22.16 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.841 1.2 . . . . 0.0 108.961 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.7 p -84.01 -29.66 26.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 124.499 1.124 . . . . 0.0 112.706 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.99 -41.33 64.43 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.493 0.717 . . . . 0.0 110.667 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.21 -9.78 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.93 148.51 10.33 Favored 'General case' 0 C--O 1.219 -0.522 0 O-C-N 120.766 -1.209 . . . . 0.0 110.7 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.38 163.51 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.233 0.469 . . . . 0.0 110.528 171.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.68 139.2 47.33 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.173 0.511 . . . . 0.0 110.782 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 29.6 mt -103.74 125.78 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 29.12 5.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 223' ' ' GLN . 34.9 p -68.74 178.8 1.97 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.344 1.545 . . . . 0.0 111.638 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.3 p -73.94 -8.51 56.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -138.69 3.54 2.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.715 0.806 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.97 142.36 26.33 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.315 -1.491 . . . . 0.0 112.914 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.0 p -146.03 104.72 3.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.056 0.943 . . . . 0.0 110.091 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 41.4 tptt -165.87 176.55 7.79 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.528 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 56.2 mtpt -118.94 162.6 18.25 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.29 138.63 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -100.07 152.11 20.6 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 59.5 mt -135.38 135.11 52.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.89 150.94 29.02 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 119.395 0.998 . . . . 0.0 109.118 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.34 156.06 27.37 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.878 2.385 . . . . 0.0 111.464 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.642 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.9 m -58.61 153.74 15.76 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.826 0.85 . . . . 0.0 110.654 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -116.79 -59.18 1.99 Allowed 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.127 -0.983 . . . . 0.0 109.534 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.9 m 39.21 51.64 2.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.089 1.355 . . . . 0.0 111.917 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.04 -17.97 79.71 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.65 1.119 . . . . 0.0 111.643 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 63.53 32.4 14.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.21 93.18 17.47 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 125.15 1.38 . . . . 0.0 108.614 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.23 147.49 26.15 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 113.641 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.23 -149.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 125.054 3.836 . . . . 0.0 109.745 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 68.29 28.22 6.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.954 0.901 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -90.91 -4.96 56.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.47 147.77 52.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 112.792 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -153.5 33.65 0.46 Allowed 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.48 1.512 . . . . 0.0 109.378 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' A' ' 334' ' ' ALA . 2.5 p30 -129.42 80.08 72.76 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.95 105.83 2.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.467 2.111 . . . . 0.0 111.414 -172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 333' ' ' LEU . 14.2 pt -149.58 148.32 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.055 . . . . 0.0 107.1 173.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -125.94 157.46 37.7 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.197 -0.94 . . . . 0.0 113.072 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 99.2 p -152.4 -1.38 0.28 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 12.1 t -144.46 179.84 7.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.247 1.022 . . . . 0.0 110.837 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.82 161.43 0.76 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.76 150.45 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.205 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -94.01 140.37 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 109.691 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.77 108.93 4.43 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.68 163.9 34.89 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.668 1.122 . . . . 0.0 112.884 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.94 3.17 1.53 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.74 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 m -103.77 108.69 60.42 Favored Pre-proline 0 N--CA 1.435 -1.216 0 C-N-CA 122.514 0.326 . . . . 0.0 110.522 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.98 -20.99 11.23 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.081 1.854 . . . . 0.0 113.017 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.403 ' CD2' ' HG3' ' A' ' 321' ' ' MET . 35.7 p-90 -100.08 -26.33 14.0 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -43.56 104.34 0.04 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.106 1.362 . . . . 0.0 112.33 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -74.92 -27.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.2 m -146.12 136.07 23.5 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.749 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -9.92 59.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.33 64.03 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.8 -58.07 10.84 Favored Glycine 0 C--N 1.359 1.859 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.2 pt? -70.75 -23.31 62.39 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 119.671 -2.076 . . . . 0.0 112.085 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.08 -27.21 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 122.993 0.517 . . . . 0.0 109.79 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.46 -13.85 24.24 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.555 0.342 . . . . 0.0 111.826 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.6 m -82.46 -26.82 32.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.35 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -131.96 64.49 1.59 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.109 -1.62 . . . . 0.0 113.221 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -140.12 2.23 1.89 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.794 0.838 . . . . 0.0 111.484 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.47 -10.43 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.408 0.683 . . . . 0.0 109.529 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.08 28.69 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.834 1.253 . . . . 0.0 111.275 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.26 8.25 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.813 -0.437 . . . . 0.0 114.157 -171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 38.8 m -156.3 51.65 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 125.127 1.134 . . . . 0.0 109.886 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.587 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -115.34 175.0 5.71 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.5 t -143.89 177.92 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.846 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.87 147.57 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -157.97 153.18 25.72 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 126.419 2.324 . . . . 0.0 110.101 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -155.89 149.7 19.24 Favored Pre-proline 0 N--CA 1.432 -1.374 0 O-C-N 124.21 0.944 . . . . 0.0 113.097 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.44 153.51 50.09 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.785 1.657 . . . . 0.0 107.929 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.32 21.4 45.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 119.275 -1.441 . . . . 0.0 110.474 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -61.29 -3.86 1.03 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 126.599 1.96 . . . . 0.0 114.65 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -118.77 131.2 56.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.953 1.301 . . . . 0.0 109.464 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.47 -165.52 38.92 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -94.47 149.66 21.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.856 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 274' ' ' PRO . 20.1 m80 42.7 49.96 5.03 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 113.015 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 273' ' ' HIS . 32.6 Cg_exo -61.55 124.59 14.94 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.823 1.682 . . . . 0.0 110.893 -171.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -155.86 -32.98 0.09 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.877 0.471 . . . . 0.0 110.435 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 37.9 t -155.22 141.17 12.85 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.664 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 88.9 Cg_endo -75.26 157.96 41.41 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.058 3.172 . . . . 0.0 115.096 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 277' ' ' PRO . 70.7 Cg_exo -58.29 155.37 35.53 Favored 'Trans proline' 0 C--O 1.223 -0.245 0 C-N-CA 125.278 3.985 . . . . 0.0 112.979 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.3 tttt 49.58 24.75 1.22 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.216 1.407 . . . . 0.0 112.59 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.08 2.04 0.5 Allowed Glycine 0 C--O 1.215 -1.092 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.29 126.71 30.35 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.979 1.39 . . . . 0.0 113.344 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.01 163.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -118.88 149.07 42.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.8 mt -114.97 137.52 51.9 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.017 1.448 . . . . 0.0 110.493 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.31 116.52 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.514 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.42 -166.17 2.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.88 0.848 . . . . 0.0 112.876 -168.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -48.61 139.29 9.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 24.4 mt -74.52 -39.06 62.62 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.745 0.702 . . . . 0.0 112.714 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -121.89 -45.54 2.26 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.733 -1.229 . . . . 0.0 113.516 -170.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -69.96 -70.96 0.26 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.8 t -58.95 -29.47 67.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.145 0.498 . . . . 0.0 111.591 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -57.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.125 -174.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -66.82 -29.54 69.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.609 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.2 m -61.47 -59.96 4.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.896 1.372 . . . . 0.0 111.823 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 298' ' ' ALA . 4.0 pp -79.46 -26.74 41.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.84 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.17 -34.24 76.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.632 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.03 -2.78 57.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.814 0.696 . . . . 0.0 112.359 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 295' ' ' LEU . . . -97.43 -15.84 20.46 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.7 m -85.09 -159.3 0.42 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.9 m -96.41 158.36 15.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.539 1.162 . . . . 0.0 109.804 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.421 ' HE1' ' HB2' ' A' ' 310' ' ' SER . 85.9 t60 -158.04 153.41 25.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.6 147.08 34.68 Favored Pre-proline 0 C--N 1.349 0.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.95 5.0 4.21 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 123.06 2.507 . . . . 0.0 112.172 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.466 ' C ' ' HD2' ' A' ' 306' ' ' PRO 0.276 0.0 OUTLIER 16.16 99.96 0.0 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.352 3.061 . . . . 0.0 114.629 -179.582 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 7.5 m -49.63 -29.55 2.21 Favored Pre-proline 0 C--O 1.235 0.291 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.466 ' HD2' ' C ' ' A' ' 304' ' ' LEU . 31.9 Cg_exo -60.18 -22.17 69.06 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 123.95 3.1 . . . . 0.0 113.926 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -146.21 145.96 30.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -67.71 3.65 4.84 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.689 -1.257 . . . . 0.0 113.832 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -170.09 2.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.085 0.942 . . . . 0.0 112.309 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.421 ' HB2' ' HE1' ' A' ' 301' ' ' HIS . 30.2 p -115.03 155.74 26.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -139.75 137.88 35.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 21.1 m-85 -116.87 144.83 44.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.075 0.95 . . . . 0.0 111.182 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -144.05 158.2 43.86 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -159.6 169.51 23.62 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 146.55 32.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.386 0.136 . . . . 0.0 110.925 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.6 162.95 36.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.527 1.531 . . . . 0.0 109.506 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -167.59 178.05 5.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.569 -0.707 . . . . 0.0 111.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.8 t -125.4 40.18 3.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.656 0.782 . . . . 0.0 109.779 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 57.42 24.29 10.01 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 111.939 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HG3' ' HE3' ' A' ' 321' ' ' MET . 17.4 ptp180 -140.98 -4.1 1.2 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 118.127 2.639 . . . . 0.0 118.127 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.464 ' HE3' ' HG3' ' A' ' 320' ' ' ARG . 1.1 pmm? -150.6 24.17 0.79 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.617 1.099 . . . . 0.0 113.877 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -48.61 110.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.747 0.419 . . . . 0.0 111.187 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 47.6 t -164.72 -49.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -110.68 132.61 54.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.844 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.91 156.18 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.256 1.422 . . . . 0.0 112.555 173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.76 168.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -127.03 150.42 49.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 3.1 t -130.98 143.31 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 124.708 1.255 . . . . 0.0 112.522 -173.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.4 mt -148.62 96.93 3.78 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.764 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -85.18 169.41 9.99 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 124.38 3.387 . . . . 0.0 113.286 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 2.0 t90 -91.51 121.04 32.85 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.249 1.42 . . . . 0.0 110.557 171.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 334' ' ' ALA . 83.3 t -101.82 145.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 233' ' ' ILE . 6.8 mp -62.54 -26.59 68.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.231 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.533 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.31 -3.57 2.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.483 0.489 . . . . 0.0 112.306 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -103.7 -10.56 18.25 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 122.126 -0.359 . . . . 0.0 110.541 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.1 m -104.95 -24.16 12.88 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.483 0.713 . . . . 0.0 110.637 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.4 143.92 31.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -153.67 134.94 14.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 22.2 m -118.69 147.6 22.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.523 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -96.31 -14.42 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.3 t -146.48 125.66 6.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.674 1.99 . . . . 0.0 109.324 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.92 -8.8 15.62 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.36 2.706 . . . . 0.0 113.059 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -103.97 7.26 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.581 -170.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.4 166.07 14.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.857 0.753 . . . . 0.0 109.177 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -115.74 179.28 4.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.912 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.4 mm? -72.89 155.68 39.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.466 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.06 118.61 64.6 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.25 -5.97 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.293 1.995 . . . . 0.0 113.02 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 42.1 m -123.78 -12.58 7.57 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.151 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -122.33 100.31 6.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.381 0.991 . . . . 0.0 112.358 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -150.75 161.42 42.67 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.26 150.33 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 121.964 0.888 . . . . 0.0 110.713 171.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -79.71 121.85 25.84 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.569 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.96 137.53 24.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 O-C-N 125.182 1.551 . . . . 0.0 110.121 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -126.23 64.95 0.57 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.619 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -114.2 123.08 48.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.875 0.87 . . . . 0.0 111.401 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -157.52 157.16 33.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 122.524 1.154 . . . . 0.0 113.325 -176.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.26 3.73 0.31 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.895 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.56 -29.49 3.8 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.546 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.5 ptp -160.19 43.86 0.21 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.873 0.836 . . . . 0.0 111.139 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 357' ' ' LEU . 2.9 tm? -63.6 133.4 53.66 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.754 -0.591 . . . . 0.0 109.748 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -130.88 -176.21 3.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.628 1.204 . . . . 0.0 111.541 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.5 -13.63 61.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.724 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.17 -20.6 40.89 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.869 -1.144 . . . . 0.0 109.419 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.76 -35.0 22.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 76.9 mt -73.6 -26.02 60.6 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.19 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -74.65 -40.72 61.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.644 0.378 . . . . 0.0 111.1 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.57 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.789 0.836 . . . . 0.0 110.261 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.03 -38.62 80.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.75 -27.88 19.74 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -15.18 58.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.812 0.733 . . . . 0.0 110.293 173.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.62 -19.03 19.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.93 0.787 . . . . 0.0 112.366 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.6 tp -96.64 -26.69 15.12 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 124.529 1.143 . . . . 0.0 114.004 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 -24.36 0.47 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.751 0.705 . . . . 0.0 112.367 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.47 -6.24 8.7 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.979 -0.9 . . . . 0.0 114.757 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -85.14 11.27 60.95 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.467 1.634 . . . . 0.0 113.907 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.5 p -91.35 162.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 124.836 1.254 . . . . 0.0 111.569 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.9 -27.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.847 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.9 OUTLIER -153.9 145.44 23.21 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -134.99 140.79 45.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.33 25.33 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.906 0.725 . . . . 0.0 112.428 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.58 138.0 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.08 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -81.63 135.86 35.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.8 p -125.27 162.24 25.16 Favored 'General case' 0 C--O 1.215 -0.732 0 O-C-N 121.499 -0.751 . . . . 0.0 112.184 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -127.88 157.61 40.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.281 1.433 . . . . 0.0 107.688 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.04 100.44 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.063 -1.023 . . . . 0.0 111.232 -169.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.8 m170 53.47 39.4 29.93 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.022 1.329 . . . . 0.0 114.139 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -104.85 -4.26 22.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.408 -2.058 . . . . 0.0 114.493 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 49.7 51.76 11.37 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-N 119.557 1.071 . . . . 0.0 113.619 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -51.08 2.74 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.792 2.995 . . . . 0.0 110.252 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 9.0 tp 39.83 39.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.942 1.697 . . . . 0.0 110.181 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.07 29.8 1.37 Allowed Glycine 0 CA--C 1.508 -0.355 0 O-C-N 121.596 -0.69 . . . . 0.0 111.927 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 25.0 p -168.89 158.45 8.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.74 -170.62 32.76 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.65 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -150.0 157.88 43.6 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.35 130.79 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.6 p -96.57 138.52 34.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.104 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -113.44 155.44 25.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.044 0.84 . . . . 0.0 111.866 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -124.89 -10.34 7.2 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.042 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -119.5 150.65 39.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.158 0.983 . . . . 0.0 108.383 171.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.33 -16.45 61.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.003 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -65.83 -37.0 85.06 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.682 0.793 . . . . 0.0 111.144 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 43.7 m -71.5 -21.59 61.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.418 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.3 -63.47 1.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.038 0.923 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.521 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -75.55 -20.87 58.37 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.832 -1.167 . . . . 0.0 112.116 -173.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -84.56 -21.94 30.26 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 120.154 -1.591 . . . . 0.0 110.603 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' A' ' 426' ' ' ILE . . . -81.39 -37.27 28.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.649 0.593 . . . . 0.0 111.095 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.18 -24.01 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.691 -0.631 . . . . 0.0 111.116 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.0 p -90.2 -16.02 30.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -90.61 -35.88 14.74 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 56.71 -41.24 0.03 OUTLIER 'General case' 0 C--N 1.344 0.36 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -157.3 124.75 5.26 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.191 -1.568 . . . . 0.0 107.963 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.46 157.2 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 423' ' ' LYS . 36.1 mt-10 -94.98 139.51 31.25 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 124.885 1.366 . . . . 0.0 110.104 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 15.3 mt -121.35 125.98 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 123.908 1.813 . . . . 0.0 112.541 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -124.59 52.28 1.54 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.944 -177.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -77.96 179.72 6.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 123.397 1.57 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 17.0 p -91.32 3.59 54.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.4 -29.83 7.64 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.52 164.27 27.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 59.1 m -123.37 113.3 18.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -162.07 178.88 8.42 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 111.786 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 414' ' ' GLU . 34.8 mtmm -124.04 166.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.25 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.28 152.73 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 O-C-N 124.747 1.279 . . . . 0.0 109.365 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -127.08 160.39 31.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.982 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.476 HD13 ' HB1' ' A' ' 407' ' ' ALA . 46.9 mt -139.12 141.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 O-C-N 125.573 1.796 . . . . 0.0 109.343 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -138.31 158.19 71.22 Favored Pre-proline 0 C--O 1.219 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.22 156.77 61.21 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 123.607 2.871 . . . . 0.0 111.259 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 8.5 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.144 -1.408 . . . . 0.0 112.348 -178.242 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.6 m -148.83 151.2 34.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.75 2.02 . . . . 0.0 109.382 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -3.47 1.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 m 38.02 60.05 1.27 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 123.903 0.881 . . . . 0.0 112.461 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.13 -28.84 74.03 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.555 -172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 53.54 46.43 26.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.146 0.473 . . . . 0.0 112.167 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.95 26.52 0.09 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.69 122.33 9.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 CA-C-N 123.316 2.22 . . . . 0.0 110.383 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 139.07 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.254 3.302 . . . . 0.0 111.951 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -153.31 170.4 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.286 1.034 . . . . 0.0 109.856 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.39 48.84 16.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 110.593 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.4 153.4 2.17 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.732 1.213 . . . . 0.0 111.111 -172.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.4 18.01 19.6 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.661 1.185 . . . . 0.0 111.602 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.72 48.13 2.94 Favored Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 123.874 0.87 . . . . 0.0 110.759 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.49 103.74 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.664 1.576 . . . . 0.0 114.487 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 mm -139.35 142.66 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -111.31 148.49 32.83 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -135.98 -8.24 2.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 84.5 m -135.85 -173.15 3.29 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.984 0.803 . . . . 0.0 110.038 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 389' ' ' TYR . 60.0 pttt -65.83 161.59 20.68 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.906 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.43 148.98 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.536 -173.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -93.23 137.21 32.77 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.151 0.58 . . . . 0.0 110.727 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.456 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.8 tm? -146.62 124.6 12.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.2 -170.27 36.97 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.939 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.76 12.63 1.31 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.9 m -61.19 124.28 79.67 Favored Pre-proline 0 C--O 1.217 -0.607 0 CA-C-N 120.016 1.908 . . . . 0.0 111.589 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -83.61 0.94 9.2 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.721 1.614 . . . . 0.0 115.072 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.51 -14.17 2.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.952 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 42.81 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.93 2.492 . . . . 0.0 115.142 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 248' ' ' THR . 5.9 pt -104.53 -96.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.879 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.5 m -141.68 132.72 26.14 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 122.508 1.147 . . . . 0.0 108.838 173.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -59.61 -22.8 62.33 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.596 ' H ' HG22 ' A' ' 248' ' ' THR . . . -66.83 -39.86 87.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.356 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.68 -47.97 84.8 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 123.582 0.552 . . . . 0.0 112.374 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 252' ' ' LEU . 6.4 mp -64.11 -38.27 90.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.508 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.458 HG12 ' HD3' ' A' ' 257' ' ' ARG . 16.0 t -73.92 -41.57 53.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.409 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -78.57 -3.65 44.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.304 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.8 m -89.12 -34.86 16.58 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.857 171.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -136.08 75.82 1.57 Allowed 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 120.771 1.623 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.48 ' HA ' HD21 ' A' ' 262' ' ' LEU . 39.0 ptt180 -142.38 14.47 2.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.579 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.07 -9.75 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 122.969 0.507 . . . . 0.0 111.754 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.31 -4.39 58.4 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.422 -1.424 . . . . 0.0 109.078 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 62.18 5.13 7.26 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 125.75 1.906 . . . . 0.0 115.6 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 287' ' ' GLU . 55.2 p -103.39 7.15 38.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -129.57 163.56 25.74 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.357 0.98 . . . . 0.0 112.655 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.8 t -152.54 168.6 25.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.895 1.278 . . . . 0.0 108.419 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.7 p -118.22 144.58 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.134 1.773 . . . . 0.0 113.716 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -143.12 131.2 21.8 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -157.93 146.8 14.55 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.111 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -88.2 165.72 6.88 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 121.646 1.564 . . . . 0.0 111.141 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.72 14.67 82.16 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 118.796 -1.002 . . . . 0.0 110.943 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -69.76 17.74 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.771 1.628 . . . . 0.0 112.735 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -76.56 151.66 36.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.923 0.889 . . . . 0.0 111.224 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.54 167.85 12.73 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.221 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.66 8.28 5.58 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.42 1.488 . . . . 0.0 112.625 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 275' ' ' ARG . 81.1 m-70 -135.74 152.14 75.49 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.12 9.41 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.625 2.216 . . . . 0.0 109.326 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' HIS . 59.5 ttp85 -117.68 117.01 28.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.69 1.196 . . . . 0.0 109.239 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.743 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 17.3 t -160.51 -30.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.743 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 86.3 Cg_endo -76.48 142.49 23.58 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.346 2.698 . . . . 0.0 111.829 -170.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.68 -4.36 15.12 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.386 3.39 . . . . 0.0 113.787 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.54 150.77 25.06 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.62 0.768 . . . . 0.0 109.087 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -99.79 21.72 43.65 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.985 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -154.87 166.06 34.69 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 119.959 1.88 . . . . 0.0 113.021 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.4 m -151.72 -170.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -126.12 148.94 49.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.635 1.207 . . . . 0.0 112.306 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.98 151.51 46.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.883 -1.136 . . . . 0.0 111.785 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.33 158.04 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.364 1.466 . . . . 0.0 110.11 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 288' ' ' LEU . 62.7 m-85 -158.68 -178.22 7.1 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 123.626 1.679 . . . . 0.0 111.154 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 261' ' ' SER . 9.3 tp10 -75.43 19.44 0.18 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.803 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 286' ' ' PHE . 57.3 mt 55.51 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 128.877 2.871 . . . . 0.0 116.628 172.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.0 -51.75 3.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.872 0.869 . . . . 0.0 110.559 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.22 -74.2 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.685 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 38.7 t -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.263 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.47 -52.19 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 O-C-N 123.666 0.604 . . . . 0.0 112.618 -168.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -68.11 -26.16 65.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.495 0.497 . . . . 0.0 110.094 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.2 m -69.45 -44.32 71.47 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.992 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 291' ' ' SER . 10.2 mt -68.53 -52.89 27.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.916 1.234 . . . . 0.0 110.868 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 9.47 23.15 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -115.05 -7.33 12.51 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.124 0.964 . . . . 0.0 110.617 168.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.32 -25.1 18.71 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 13.8 t -101.78 -118.28 0.18 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.909 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.7 m -123.91 157.09 35.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.588 1.185 . . . . 0.0 113.194 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -154.07 161.27 42.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.716 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -148.25 133.86 9.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.38 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 125.514 4.142 . . . . 0.0 110.289 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.476 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -70.21 -14.12 62.48 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.181 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 16.5 m 37.16 78.98 0.33 Allowed Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.167 1.787 . . . . 0.0 113.829 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.42 -22.98 24.27 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.19 1.927 . . . . 0.0 111.63 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -144.86 3.08 1.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.671 0.748 . . . . 0.0 109.728 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.59 -11.69 15.94 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.81 108.13 19.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.2 m -60.85 170.33 1.56 Allowed 'General case' 0 C--N 1.344 0.338 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.532 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -129.08 134.8 48.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.351 0.596 . . . . 0.0 109.562 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -102.16 135.76 43.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.79 145.61 47.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -149.08 152.04 35.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.332 0.587 . . . . 0.0 111.003 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -123.77 116.33 22.82 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.966 1.365 . . . . 0.0 110.988 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.402 ' HE2' ' HB ' ' A' ' 326' ' ' VAL . 25.8 ptt? -133.19 1.34 3.49 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.748 -168.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 58.8 p -119.97 2.43 10.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 21.4 t -62.67 -3.16 1.37 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.549 -1.344 . . . . 0.0 111.732 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -88.26 -8.71 54.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.339 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -152.33 -9.65 0.19 Allowed 'General case' 0 C--N 1.347 0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 30.5 mmm -124.99 -178.4 4.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.937 2.095 . . . . 0.0 108.841 174.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -95.97 -37.03 10.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.703 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.8 t -176.52 146.6 0.61 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.953 0.901 . . . . 0.0 109.555 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -152.42 -56.0 0.13 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 62.79 100.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 124.144 0.903 . . . . 0.0 109.469 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.402 ' HB ' ' HE2' ' A' ' 316' ' ' MET . 4.6 p -84.44 155.7 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.597 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 147.77 24.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.036 0.922 . . . . 0.0 109.285 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 129.95 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.895 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.79 96.08 11.99 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.718 1.247 . . . . 0.0 108.37 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -88.29 160.22 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.392 1.395 . . . . 0.0 111.522 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 5.3 t-105 -74.7 124.31 26.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 334' ' ' ALA . 16.6 t -96.76 149.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.749 1.262 . . . . 0.0 110.382 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -59.41 -31.66 69.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.443 1.097 . . . . 0.0 108.602 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.421 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -73.62 -7.28 51.35 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.61 1.164 . . . . 0.0 113.741 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.28 0.02 33.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.842 0.857 . . . . 0.0 111.058 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 73.2 m -91.69 -54.78 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -157.33 154.71 29.44 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.864 0.865 . . . . 0.0 112.308 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.454 ' CB ' ' HB1' ' A' ' 363' ' ' ALA . 60.7 t80 -154.94 148.49 25.28 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 123.535 0.522 . . . . 0.0 111.021 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.52 155.3 29.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 122.796 0.438 . . . . 0.0 111.51 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -113.89 32.72 5.66 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 121.782 0.801 . . . . 0.0 109.157 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.0 t -152.17 141.36 14.19 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.143 0.977 . . . . 0.0 110.148 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.65 -6.57 17.03 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.22 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -115.77 149.22 38.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -99.2 138.87 35.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -158.53 152.56 23.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.79 0.805 . . . . 0.0 110.435 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.439 ' HA ' HG21 ' A' ' 397' ' ' THR . 3.4 mm? -128.78 174.74 9.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.068 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -141.4 110.45 6.34 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.04 0.79 4.61 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.766 2.977 . . . . 0.0 114.925 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 66.2 m -134.44 0.73 3.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 117.992 -1.004 . . . . 0.0 112.813 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -147.01 81.72 1.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.799 1.761 . . . . 0.0 109.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.1 p -136.9 173.33 11.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.7 143.4 37.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 O-C-N 121.506 -0.746 . . . . 0.0 109.398 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -77.83 145.47 36.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.668 1.223 . . . . 0.0 112.77 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.2 t -132.01 148.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -177.93 -161.99 27.1 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.671 -0.643 . . . . 0.0 112.853 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.5 0.54 Allowed 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 114.186 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -79.05 172.81 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.18 9.2 0.34 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -168.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.698 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 100.91 15.17 29.42 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.8 mmt -147.11 -88.68 0.09 Allowed 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.933 1.366 . . . . 0.0 109.945 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 12.3 tp 44.39 70.78 0.3 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 111.299 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -55.58 170.25 0.27 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.104 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 338' ' ' PHE . . . -64.28 -26.35 68.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -80.56 -21.4 41.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.29 -26.15 42.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.813 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.61 -44.95 63.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.9 72.85 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.774 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.45 -53.55 50.36 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.957 -1.09 . . . . 0.0 110.728 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.37 -42.48 96.48 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 370' ' ' LEU . 4.4 mm? -80.61 -38.52 29.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.295 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -12.76 46.57 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 120.261 1.391 . . . . 0.0 112.726 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.7 -22.86 13.5 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.531 -0.73 . . . . 0.0 110.477 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.3 tp -98.73 -16.52 18.93 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -105.99 -81.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 164.13 -19.36 0.13 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 119.662 1.119 . . . . 0.0 111.925 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -174.86 142.52 6.35 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 118.727 1.263 . . . . 0.0 112.925 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.17 176.93 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.414 1.102 . . . . 0.0 109.824 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.83 -31.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.889 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -155.37 146.23 22.37 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -151.05 135.29 16.84 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 125.17 1.388 . . . . 0.0 108.086 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.65 173.45 38.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.1 mm -91.3 140.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.56 -1.32 . . . . 0.0 109.32 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.27 115.86 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.7 p -111.38 163.35 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.094 0.95 . . . . 0.0 111.773 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -133.41 159.91 38.94 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.98 103.1 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.337 -0.852 . . . . 0.0 112.056 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.26 46.66 20.8 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -108.95 -20.72 12.94 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.627 1.571 . . . . 0.0 115.021 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.414 ' HB2' ' HE2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER 46.36 57.89 16.53 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 124.834 1.334 . . . . 0.0 111.479 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.53 -41.02 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.245 1.297 . . . . 0.0 113.242 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 391' ' ' ILE . 11.0 tp 31.82 38.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 127.846 2.458 . . . . 0.0 112.368 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -140.27 11.97 3.03 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 124.474 1.035 . . . . 0.0 110.749 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 93.0 p -151.15 158.33 43.84 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.896 0.409 . . . . 0.0 111.648 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 177.24 -178.45 48.26 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -150.85 166.91 29.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.31 140.36 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 346' ' ' LEU . 75.6 m -107.92 132.46 53.45 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.408 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -128.84 166.3 19.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.769 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.14 9.25 2.09 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.691 0.619 . . . . 0.0 110.656 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -124.15 144.39 49.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.28 -24.86 64.92 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -51.77 -38.8 57.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.036 0.835 . . . . 0.0 112.186 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.0 m -78.8 -19.26 52.57 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 112.367 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -74.47 -57.09 4.16 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 120.61 -1.306 . . . . 0.0 110.308 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.92 -24.32 59.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.508 -1.277 . . . . 0.0 113.795 -175.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.07 -27.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.804 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.34 -27.54 42.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.6 m -93.3 -24.48 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 O-C-N 121.378 -0.826 . . . . 0.0 112.02 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.4 p -86.18 -16.09 38.89 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.317 0.508 . . . . 0.0 112.02 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.25 -43.37 8.09 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.456 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.05 -10.93 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -170.66 152.44 3.81 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.985 -1.072 . . . . 0.0 110.764 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.54 162.16 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -100.84 123.74 45.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.63 0.729 . . . . 0.0 109.89 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.26 90.43 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 32.3 ttmt -117.42 106.01 12.75 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.287 0.992 . . . . 0.0 110.344 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 73.0 p -138.55 -177.45 4.86 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.767 1.227 . . . . 0.0 110.583 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 24.1 m -79.93 -9.95 59.73 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.689 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.24 -19.48 13.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.833 1.253 . . . . 0.0 112.89 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -153.83 140.41 18.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.637 0.732 . . . . 0.0 109.244 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 89.5 m -144.09 89.03 2.0 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.318 0.647 . . . . 0.0 109.866 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -148.33 -171.37 3.83 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 122.671 1.224 . . . . 0.0 109.912 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 423' ' ' LYS . 42.0 mtmt -130.39 168.61 16.69 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.322 1.058 . . . . 0.0 110.179 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.58 138.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.258 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.65 154.85 25.44 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 124.806 1.316 . . . . 0.0 113.707 -168.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.72 134.47 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.448 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -137.56 156.72 74.7 Favored Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.884 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.33 163.51 37.65 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.856 3.037 . . . . 0.0 110.47 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 52.2 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.995 -176.178 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 59.8 mmm . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.517 0.198 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.7 m 36.21 59.3 0.94 Allowed 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 111.746 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -4.55 36.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.7 m 44.01 52.72 6.7 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.511 1.05 . . . . 0.0 111.959 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.76 72.81 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.354 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 57.01 32.48 21.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.45 146.02 95.96 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.214 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.09 124.57 9.17 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 124.731 3.621 . . . . 0.0 112.713 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.26 5.26 6.03 Favored 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 127.278 5.318 . . . . 0.0 114.325 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -127.93 26.22 5.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 118.916 0.78 . . . . 0.0 112.573 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.63 34.1 1.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.275 1.03 . . . . 0.0 108.67 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.58 176.3 9.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -169.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -67.14 150.58 48.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.223 1.809 . . . . 0.0 106.719 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -71.92 156.71 90.66 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 120.029 1.286 . . . . 0.0 112.264 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.49 140.16 21.86 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 124.232 3.288 . . . . 0.0 115.323 -170.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.3 mm -155.3 152.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.444 ' CG ' HG11 ' A' ' 292' ' ' VAL . 4.3 m-85 -125.18 149.83 47.54 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.604 1.093 . . . . 0.0 110.938 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.7 p -148.25 11.66 0.92 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -170.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.4 t -152.48 -167.33 2.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.636 1.107 . . . . 0.0 109.057 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -59.09 171.51 0.71 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 152.88 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 21.9 m-30 -90.25 145.11 25.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.777 -0.577 . . . . 0.0 109.794 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.48 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.5 tm? -149.13 126.51 11.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.436 ' N ' HD13 ' A' ' 240' ' ' LEU . . . 173.21 165.93 30.85 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 119.276 0.944 . . . . 0.0 112.194 -176.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.56 3.27 1.0 Allowed Glycine 0 CA--C 1.547 2.034 0 O-C-N 124.699 0.882 . . . . 0.0 112.27 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.9 m -107.87 121.79 42.88 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.417 0.609 . . . . 0.0 112.597 -170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.07 -13.93 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 123.281 2.654 . . . . 0.0 112.059 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.445 ' HE1' ' HB2' ' A' ' 324' ' ' LYS . 30.0 p-90 -124.03 -17.52 6.21 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -50.48 104.66 0.08 Allowed 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 118.928 0.786 . . . . 0.0 110.593 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -18.77 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 O-C-N 126.02 2.075 . . . . 0.0 115.781 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.0 m -152.48 126.91 9.31 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 124.486 1.116 . . . . 0.0 110.328 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.03 -34.16 68.59 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.77 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.21 66.04 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 120.051 1.296 . . . . 0.0 110.718 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.64 -55.9 27.96 Favored Glycine 0 C--N 1.368 2.32 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.92 -37.9 72.11 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.673 0.867 . . . . 0.0 111.124 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.44 -22.55 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 123.383 0.673 . . . . 0.0 110.284 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -94.34 -4.94 47.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.77 -0.581 . . . . 0.0 110.867 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -82.38 -24.43 34.47 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.548 -1.345 . . . . 0.0 111.046 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.35 26.58 1.62 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.641 ' HA ' HD11 ' A' ' 262' ' ' LEU . 53.6 ptt85 -94.46 -0.23 54.88 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.585 1.993 . . . . 0.0 113.466 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 -21.41 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.257 0.623 . . . . 0.0 111.243 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.09 -4.25 54.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.653 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.42 -125.61 0.77 Allowed Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.129 -0.982 . . . . 0.0 115.276 -170.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.5 t -153.69 110.83 3.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 124.562 0.801 . . . . 0.0 109.888 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.641 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -151.61 162.28 41.25 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 176.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 64.0 m -146.62 170.73 16.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.208 1.803 . . . . 0.0 109.763 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.78 143.06 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 123.878 0.871 . . . . 0.0 111.864 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -145.94 135.74 23.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.86 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 277' ' ' PRO . 21.9 p90 -161.23 149.03 12.34 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 125.69 1.596 . . . . 0.0 110.893 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.83 152.54 14.77 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 112.893 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.78 28.72 23.06 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.288 -0.729 . . . . 0.0 111.669 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -59.3 -36.28 75.31 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 120.127 1.964 . . . . 0.0 110.953 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 25.7 t0 33.41 89.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.471 2.308 . . . . 0.0 113.31 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.71 172.06 24.43 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 122.328 0.96 . . . . 0.0 111.604 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -60.62 -25.64 66.42 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.699 -0.883 . . . . 0.0 111.686 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -134.12 155.23 80.22 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.754 1.222 . . . . 0.0 108.016 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.57 107.1 2.38 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.676 1.584 . . . . 0.0 108.237 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -119.28 -166.61 1.28 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.328 0.651 . . . . 0.0 111.139 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.6 135.05 34.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.421 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 266' ' ' TRP . 44.3 Cg_endo -83.44 148.58 12.87 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 124.516 3.478 . . . . 0.0 112.024 170.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.27 -6.6 17.35 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.794 2.329 . . . . 0.0 111.367 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 279' ' ' LYS . 7.9 ptpp? -95.77 -6.23 40.14 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.992 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.68 17.47 41.78 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-O 118.786 -1.008 . . . . 0.0 115.405 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -128.68 154.57 46.16 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 117.696 0.748 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.7 t -152.34 165.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -122.56 148.72 44.87 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.4 mt -108.23 143.86 36.48 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.49 1.138 . . . . 0.0 110.622 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.79 109.94 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -158.72 -165.42 1.65 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.695 -171.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.31 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.749 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.7 pt? -69.41 14.48 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.873 2.469 . . . . 0.0 114.802 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.74 -59.2 1.08 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.172 0.92 . . . . 0.0 111.242 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -90.31 -34.01 15.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 46.9 m -74.05 -17.1 61.01 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 119.391 0.996 . . . . 0.0 108.657 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 234' ' ' TYR . 46.6 t -76.14 -57.76 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.42 -32.57 73.43 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.741 -1.225 . . . . 0.0 112.818 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 25.0 m -68.37 -42.59 78.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.036 0.834 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.12 -39.45 49.37 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.76 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.7 mt -60.51 -25.6 66.22 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.555 1.071 . . . . 0.0 111.789 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.04 -6.82 23.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.99 22.21 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 123.796 0.685 . . . . 0.0 109.784 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 314' ' ' PHE . 24.2 p -97.85 -153.86 0.44 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.4 t -117.09 174.88 5.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.628 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -149.84 150.7 32.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -135.15 124.87 16.66 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.308 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -81.03 37.53 0.69 Allowed 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 124.416 3.411 . . . . 0.0 108.262 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -48.86 -36.57 17.29 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.421 1.01 . . . . 0.0 111.941 -177.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.606 ' H ' HD12 ' A' ' 304' ' ' LEU . 50.5 m 31.78 69.77 0.74 Allowed Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 126.6 1.96 . . . . 0.0 113.094 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.04 -7.99 18.57 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.666 2.244 . . . . 0.0 110.909 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.07 -5.99 0.06 Allowed 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 124.214 0.946 . . . . 0.0 111.062 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 130.71 -10.62 5.75 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.429 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.26 164.7 25.83 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 58.8 m -132.56 151.69 51.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -144.65 139.02 27.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.419 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.87 144.67 42.02 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.161 0.984 . . . . 0.0 110.961 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 327' ' ' GLN . 59.8 m-85 -136.93 159.16 42.71 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.742 0.817 . . . . 0.0 110.524 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 299' ' ' CYS . 10.4 t80 -156.86 170.68 21.93 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.2 0.938 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.68 124.9 24.56 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -141.6 28.42 1.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.413 -168.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.1 p -43.99 138.56 2.79 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.801 1.182 . . . . 0.0 112.908 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 18.2 t -116.43 -51.15 2.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -73.56 -26.21 60.73 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 108.925 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 55.24 26.07 8.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.935 1.694 . . . . 0.0 113.4 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -78.37 -20.01 52.19 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -159.57 177.3 11.06 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.67 134.5 44.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.277 1.431 . . . . 0.0 108.624 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 59.2 tptt -136.76 -7.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.43 175.43 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.811 1.291 . . . . 0.0 113.75 -171.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -151.03 153.76 9.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.843 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.471 ' HB3' ' CE1' ' A' ' 313' ' ' TYR . 3.0 pp0? -117.79 156.04 29.02 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.32 139.89 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.694 -175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.53 119.36 4.26 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 124.153 0.908 . . . . 0.0 109.819 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -95.82 161.74 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.365 4.043 . . . . 0.0 111.751 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 3.3 t-105 -70.38 118.58 13.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.56 149.65 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 110.497 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.06 -39.26 81.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.833 0.853 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.67 2.91 10.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 122.918 0.487 . . . . 0.0 112.235 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -93.27 -9.82 37.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.172 -0.955 . . . . 0.0 110.95 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 51.4 m -90.96 -58.44 2.47 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -160.9 173.49 15.24 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.892 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.65 161.52 41.54 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.783 0.833 . . . . 0.0 111.412 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.52 166.88 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 122.545 1.164 . . . . 0.0 110.837 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -126.33 27.51 6.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.694 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 342' ' ' PRO . 85.9 p -147.87 167.93 12.32 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 117.22 -1.371 . . . . 0.0 110.061 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 341' ' ' SER . 74.4 Cg_endo -69.71 56.91 1.41 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 124.821 3.681 . . . . 0.0 109.982 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.6 t 55.67 38.91 30.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.383 0.673 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -71.91 151.32 43.42 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -65.03 157.15 29.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.98 160.48 4.73 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.871 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.88 139.0 87.93 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.2 94.44 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.866 2.377 . . . . 0.0 111.891 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 63.4 m 62.83 49.83 3.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.761 -1.563 . . . . 0.0 114.334 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -140.99 43.3 1.81 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 109.332 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.444 ' HB ' HG22 ' A' ' 397' ' ' THR . 1.8 t -117.38 159.06 23.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 159.08 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.16 147.67 36.37 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.008 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 83.3 t -130.75 136.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.395 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -172.44 -157.72 14.95 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.589 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 425' ' ' GLN . . . 60.66 29.54 19.08 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.377 1.071 . . . . 0.0 111.981 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.484 HD22 HD22 ' A' ' 361' ' ' LEU . 24.6 mt -76.72 164.45 25.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.432 1.083 . . . . 0.0 110.293 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -77.62 12.7 1.53 Allowed 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.468 -0.77 . . . . 0.0 112.573 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 97.0 2.49 59.37 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 119.028 -0.873 . . . . 0.0 112.362 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 mmt -145.23 -71.32 0.26 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.039 0.92 . . . . 0.0 111.643 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.484 HD22 HD22 ' A' ' 357' ' ' LEU . 12.8 tp 38.0 69.36 0.25 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.789 0.804 . . . . 0.0 111.094 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -67.33 179.3 1.28 Allowed 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.158 -0.964 . . . . 0.0 113.041 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.21 -27.07 65.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -170.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.96 -15.2 57.76 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 119.34 0.973 . . . . 0.0 112.289 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -92.63 -27.1 17.53 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.389 0.43 . . . . 0.0 111.186 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.4 mt -76.22 -37.03 58.26 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 124.74 1.275 . . . . 0.0 110.426 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.0 56.14 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.33 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.23 -50.52 73.34 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.8 -32.07 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 123.914 0.759 . . . . 0.0 111.632 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.96 -28.96 18.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.608 -1.307 . . . . 0.0 113.774 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.63 -19.86 27.15 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.682 1.128 . . . . 0.0 113.742 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -113.86 -17.3 12.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 120.051 1.296 . . . . 0.0 111.083 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 373' ' ' LEU . 10.3 tp -97.6 -3.99 38.49 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 118.873 0.76 . . . . 0.0 111.286 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -152.03 -48.05 0.11 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.47 -1.73 88.29 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.442 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.35 111.37 2.24 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.97 166.28 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 123.865 0.866 . . . . 0.0 110.396 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 -29.03 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.21 153.64 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 109.645 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -155.12 132.23 10.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.68 158.3 27.79 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 121.163 -0.96 . . . . 0.0 113.575 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.02 138.91 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.242 1.817 . . . . 0.0 108.037 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.89 153.5 23.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.081 0.467 . . . . 0.0 112.128 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 5.3 p -137.47 165.79 25.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.064 0.459 . . . . 0.0 110.233 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.21 -178.83 5.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.47 100.36 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.045 0.384 . . . . 0.0 111.107 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.2 m170 50.41 40.86 23.95 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.93 1.292 . . . . 0.0 110.848 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -88.72 -20.62 24.58 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.344 0.658 . . . . 0.0 109.72 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.0 p90 38.8 53.56 4.25 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 0.0 112.954 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.65 -48.24 0.42 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.716 3.61 . . . . 0.0 111.271 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 8.6 tp 41.05 41.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.277 1.431 . . . . 0.0 111.49 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -162.11 14.43 0.13 Allowed Glycine 0 C--N 1.349 1.299 0 C-N-CA 121.077 -0.582 . . . . 0.0 114.132 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.2 p -156.33 132.07 9.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.11 0.955 . . . . 0.0 110.796 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.08 -164.83 25.45 Favored Glycine 0 C--O 1.209 -1.415 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.349 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -142.09 166.82 23.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.505 -0.848 . . . . 0.0 110.624 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.23 146.42 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.627 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.444 HG22 ' HB ' ' A' ' 351' ' ' THR . 26.2 p -125.99 122.61 36.4 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 122.252 1.025 . . . . 0.0 108.362 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.12 -28.45 25.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.721 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.4 t30 54.07 17.09 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.301 1.048 . . . . 0.0 112.585 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -141.4 164.23 30.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.234 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -99.68 -45.31 5.81 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.56 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.82 -25.64 66.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.617 1.098 . . . . 0.0 112.921 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.0 p -84.99 -18.48 34.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -72.92 -56.09 5.67 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.583 0.629 . . . . 0.0 109.964 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.27 63.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.753 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -77.08 -24.89 51.84 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.88 1.218 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.98 -29.43 35.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.565 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.1 m -78.92 -18.29 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 123.798 0.686 . . . . 0.0 112.203 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 91.3 p -88.9 -22.16 23.27 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -85.76 -44.56 12.4 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.299 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.48 -2.24 0.0 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 128.551 2.74 . . . . 0.0 116.627 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.4 141.15 14.58 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.73 163.36 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 119.103 0.865 . . . . 0.0 109.229 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.459 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 28.2 mt-10 -119.83 131.99 55.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.993 1.378 . . . . 0.0 112.552 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.443 ' HB ' ' H ' ' A' ' 422' ' ' LYS . 6.4 mm -93.95 117.09 36.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -117.61 25.71 10.22 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.909 0.777 . . . . 0.0 109.838 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 419' ' ' LYS . 86.2 m -63.74 158.12 22.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.021 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -86.17 -2.54 58.45 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 123.455 0.702 . . . . 0.0 112.149 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 417' ' ' THR . 39.4 pttt -128.22 -1.6 5.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.498 1.119 . . . . 0.0 111.523 174.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -150.26 127.52 11.34 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.6 m -142.08 109.1 5.47 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.195 -0.94 . . . . 0.0 111.105 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 33.6 tptt -167.22 -156.46 0.21 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 117.899 0.318 . . . . 0.0 111.416 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.657 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 98.7 mttt -141.11 176.21 9.01 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.601 0.76 . . . . 0.0 109.674 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.62 154.11 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 356' ' ' ALA . 49.1 tt0 -117.03 151.75 36.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.887 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.99 139.46 47.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -142.81 113.12 5.87 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.98 161.77 40.48 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.701 3.6 . . . . 0.0 112.33 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.606 -1.664 . . . . 0.0 111.51 178.291 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.035 0.445 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 221' ' ' SER . 9.7 m 45.45 55.97 6.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.409 1.099 . . . . 0.0 113.101 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.41 18.72 0.07 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.191 0.997 . . . . 0.0 113.245 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 219' ' ' THR . 66.4 m -37.21 121.02 0.8 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.04 1.336 . . . . 0.0 113.288 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.8 0.91 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-O 118.266 -1.296 . . . . 0.0 114.035 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -89.51 -29.75 18.74 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.387 1.593 . . . . 0.0 109.564 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 10.8 mt 61.7 148.42 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 115.064 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 48.8 Cg_exo -63.01 131.14 31.49 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.641 2.227 . . . . 0.0 111.769 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 1.7 Cg_endo -82.15 147.32 14.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.208 2.606 . . . . 0.0 109.209 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -144.88 22.42 1.59 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.34 30.68 3.74 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.555 0.742 . . . . 0.0 111.627 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -71.11 161.17 31.57 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 111.384 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -135.27 -143.34 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.357 1.063 . . . . 0.0 108.594 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.4 p30 36.17 51.51 1.68 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.536 1.534 . . . . 0.0 113.655 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.83 119.28 6.28 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.936 1.757 . . . . 0.0 112.131 -173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.1 mm -129.75 140.65 48.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -104.27 155.02 19.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.987 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.3 t -137.58 -34.97 0.67 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 90.8 m -147.07 78.79 1.5 Allowed 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.67 0.748 . . . . 0.0 112.746 -168.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 19.5 pttm 52.23 -169.07 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.64 145.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -87.77 149.58 24.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.489 1.116 . . . . 0.0 110.504 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 241' ' ' GLY . 0.6 OUTLIER -149.63 117.61 6.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.121 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . -179.89 -178.23 48.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 122.192 0.884 . . . . 0.0 112.722 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.02 15.93 1.46 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 124.31 0.957 . . . . 0.0 114.792 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.51 130.27 26.02 Favored Pre-proline 0 N--CA 1.473 0.719 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 13.3 Cg_endo -87.91 -8.69 5.77 Favored 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 124.156 3.237 . . . . 0.0 112.57 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.478 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 11.5 p-90 -147.34 -7.8 0.45 Allowed 'General case' 0 C--O 1.251 1.172 0 CA-C-N 120.585 1.539 . . . . 0.0 114.876 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.33 110.55 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.486 -1.383 . . . . 0.0 108.931 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -20.25 25.68 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.152 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.3 p -153.31 154.49 34.68 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 119.416 -2.053 . . . . 0.0 111.451 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -16.89 39.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.56 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.44 -17.6 60.11 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.84 -62.28 2.86 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.75 -31.18 68.99 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 118.593 -1.243 . . . . 0.0 111.448 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.89 -50.91 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.657 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.51 -5.19 31.3 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.6 m -79.83 -21.58 44.02 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.899 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -131.59 -1.31 3.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 257' ' ' ARG . 26.4 ttt-85 -81.13 -21.39 39.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.304 1.442 . . . . 0.0 111.287 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 258' ' ' VAL . 1.2 m -61.13 -16.86 15.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 O-C-N 125.262 1.601 . . . . 0.0 115.291 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -133.48 -5.76 2.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.783 1.233 . . . . 0.0 110.649 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -94.24 -166.42 36.8 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.589 ' H ' HD11 ' A' ' 295' ' ' LEU . 73.0 m -146.47 65.82 1.19 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.492 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -147.75 171.16 16.11 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.752 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 61.5 m -138.88 174.9 10.03 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -131.24 139.41 50.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 CA-C-O 122.62 1.2 . . . . 0.0 110.949 -174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.23 142.02 24.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.237 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -163.81 142.04 5.98 Favored Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.95 -177.34 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.77 3.647 . . . . 0.0 111.787 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 67.74 -5.15 3.57 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -142.58 44.55 1.62 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 119.911 1.856 . . . . 0.0 110.619 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.12 153.03 40.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.469 0.652 . . . . 0.0 110.128 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.39 -6.27 38.93 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.015 0.817 . . . . 0.0 111.69 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -157.91 -27.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.427 1.113 . . . . 0.0 113.244 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.36 76.11 9.34 Favored Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.29 112.32 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.091 3.194 . . . . 0.0 111.203 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -170.86 -166.83 0.51 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.43 146.59 77.72 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.58 166.2 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.854 3.036 . . . . 0.0 109.18 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.74 4.16 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.632 2.888 . . . . 0.0 111.964 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -120.48 167.93 11.86 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.73 10.22 68.49 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.552 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 16.0 p90 -146.24 162.62 37.68 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.4 m -156.96 -166.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 129.069 2.948 . . . . 0.0 108.032 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -132.58 152.24 51.68 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.234 -0.916 . . . . 0.0 111.887 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.401 HD22 HD23 ' A' ' 262' ' ' LEU . 77.5 mt -110.16 140.35 44.35 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.24 0.962 . . . . 0.0 109.979 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.0 -153.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.04 0.536 . . . . 0.0 110.45 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . 0.315 33.0 t80 78.62 -107.01 0.02 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.805 -173.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.02 128.54 34.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 120.574 1.534 . . . . 0.0 107.544 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.76 17.19 3.31 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.491 1.119 . . . . 0.0 112.651 -167.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.9 -71.12 0.71 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.577 1.151 . . . . 0.0 111.833 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -79.26 -19.3 50.92 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.669 -1.27 . . . . 0.0 112.585 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 24.5 m -101.26 -8.33 22.24 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.79 0.723 . . . . 0.0 111.556 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 5.6 m -85.24 -40.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.0 -59.61 4.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.34 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.0 p -76.57 -39.58 52.31 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 120.069 1.304 . . . . 0.0 112.12 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.589 HD11 ' H ' ' A' ' 261' ' ' SER . 65.3 mt -68.57 -34.01 75.07 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -171.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -94.23 -12.89 27.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.317 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.05 0.87 54.53 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.652 0.66 . . . . 0.0 111.096 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.49 -24.63 14.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 96.7 m -78.86 -152.96 0.06 Allowed 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.767 170.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.4 m -118.81 166.89 12.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 120.675 -1.265 . . . . 0.0 111.997 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -144.99 151.74 39.06 Favored 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 122.414 0.286 . . . . 0.0 110.982 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.28 138.68 16.82 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -87.07 20.72 1.17 Allowed 'Trans proline' 0 N--CA 1.431 -2.197 0 C-N-CA 122.293 1.996 . . . . 0.0 111.478 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.502 HD13 ' HD3' ' A' ' 306' ' ' PRO . 0.2 OUTLIER -60.16 -19.38 53.66 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t 38.24 60.61 4.79 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.789 2.036 . . . . 0.0 112.646 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.502 ' HD3' HD13 ' A' ' 304' ' ' LEU . 71.9 Cg_endo -76.18 1.07 8.68 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.678 2.919 . . . . 0.0 111.941 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.52 -7.26 0.88 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.565 -1.334 . . . . 0.0 112.922 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.42 -9.81 17.15 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 17.9 tp -132.89 143.2 49.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.14 1.776 . . . . 0.0 109.029 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.9 m -67.91 168.85 10.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -139.18 154.51 48.07 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.09 156.66 18.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -152.69 155.69 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.354 0.409 . . . . 0.0 111.097 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -153.47 152.73 31.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.512 ' HD2' ' H ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -111.89 146.28 38.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.407 ' HE2' ' CG1' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -148.49 -1.98 0.51 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.903 1.377 . . . . 0.0 110.541 -169.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 69.8 m -71.68 145.84 48.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.638 0.586 . . . . 0.0 112.503 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.8 m -85.2 149.79 25.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 124.358 1.036 . . . . 0.0 110.747 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -62.21 -15.53 47.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.754 -170.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.79 -23.34 67.32 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.598 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -159.65 15.04 0.15 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -44.21 142.59 1.43 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.043 0.925 . . . . 0.0 112.116 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 48.3 t -164.44 -35.64 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.031 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -137.1 163.81 29.92 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.575 0.75 . . . . 0.0 111.849 -173.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.57 167.05 10.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.443 2.697 . . . . 0.0 112.092 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.407 ' CG1' ' HE2' ' A' ' 316' ' ' MET . 12.5 m -104.15 160.42 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.88 0.848 . . . . 0.0 112.269 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 153.24 17.76 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.134 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 16.9 t -137.87 130.51 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.363 1.04 . . . . 0.0 109.946 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.5 mt -138.65 119.28 9.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.979 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.22 168.69 7.55 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.246 2.631 . . . . 0.0 110.221 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.527 ' CH2' ' HB ' ' A' ' 391' ' ' ILE . 2.9 t-105 -104.52 123.95 48.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.495 0.664 . . . . 0.0 111.68 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.21 143.67 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.558 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.458 HD23 ' C ' ' A' ' 333' ' ' LEU . 4.3 tt -52.53 -40.64 62.69 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 125.109 1.364 . . . . 0.0 109.851 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.59 57.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 122.277 -0.265 . . . . 0.0 110.847 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.88 -18.09 38.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.494 -1.378 . . . . 0.0 110.766 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 p -111.79 -25.97 9.2 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.844 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -141.1 142.34 34.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.883 0.765 . . . . 0.0 110.612 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -157.33 153.47 27.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.433 -1.417 . . . . 0.0 111.144 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.57 147.37 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.65 31.55 5.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.689 0.796 . . . . 0.0 109.636 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.8 t -145.72 145.94 27.33 Favored Pre-proline 0 CA--C 1.52 -0.208 0 C-N-CA 124.16 0.984 . . . . 0.0 108.396 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.21 -7.11 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.175 2.584 . . . . 0.0 111.45 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.9 p -135.1 164.58 27.33 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.693 0.797 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.93 132.97 34.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.411 0.624 . . . . 0.0 112.059 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -154.9 162.56 41.06 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.083 1.353 . . . . 0.0 110.411 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 17.8 tp -151.59 175.43 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.837 1.336 . . . . 0.0 107.76 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.425 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 9.0 t70 -145.95 129.07 8.21 Favored Pre-proline 0 N--CA 1.446 -0.674 0 O-C-N 120.931 -1.106 . . . . 0.0 109.679 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.18 0.87 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.962 1 C-N-CA 126.507 4.805 . . . . 0.0 114.996 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 14.6 t -131.67 -7.3 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.677 -0.677 . . . . 0.0 111.935 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -135.91 77.3 1.65 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.42 1.009 . . . . 0.0 110.112 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.1 p -135.54 84.67 2.11 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.328 1.643 . . . . 0.0 108.647 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.74 145.55 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.048 0.451 . . . . 0.0 111.239 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -73.08 150.39 42.33 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.122 0.963 . . . . 0.0 112.405 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.8 140.83 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.073 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.47 -166.56 23.59 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 122.25 0.917 . . . . 0.0 114.108 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.46 38.69 30.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.543 0.687 . . . . 0.0 110.248 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.26 -179.65 7.25 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.174 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -56.71 -11.87 1.58 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.231 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.59 88.15 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.192 0.906 . . . . 0.0 113.78 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.6 ptm -165.85 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.161 0.584 . . . . 0.0 110.814 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.68 144.06 52.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -94.88 159.3 15.1 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.75 60.29 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.144 -0.973 . . . . 0.0 112.524 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.66 -29.02 61.1 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.75 -26.23 24.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.22 0.95 . . . . 0.0 109.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 tt -72.42 -46.95 52.81 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -71.64 -24.28 61.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 110.224 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.04 -45.56 66.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.535 0.683 . . . . 0.0 109.799 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.39 -44.24 94.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.4 -15.04 51.29 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.829 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.95 -16.46 21.71 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 120.283 1.402 . . . . 0.0 112.169 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.48 -25.78 14.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 373' ' ' LEU . 13.2 tp -72.75 -24.81 61.01 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.203 0.94 . . . . 0.0 110.803 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 403' ' ' SER . 3.9 p90 -163.41 -24.71 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.459 0.572 . . . . 0.0 112.159 174.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 72.67 157.93 4.0 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.724 -0.61 . . . . 0.0 112.37 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 126.12 15.68 2.77 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 121.871 0.706 . . . . 0.0 111.58 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.81 173.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.053 -0.573 . . . . 0.0 112.132 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.97 -26.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.416 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -157.82 157.68 33.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.37 0.987 . . . . 0.0 110.079 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.04 141.48 28.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.79 133.64 4.76 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.512 1.062 . . . . 0.0 113.523 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.67 145.9 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.5 70.38 7.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.82 150.27 48.82 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.127 0.571 . . . . 0.0 112.097 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.83 164.19 29.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -56.68 103.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.307 0.643 . . . . 0.0 112.128 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 m170 53.05 26.65 4.99 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.788 1.635 . . . . 0.0 113.613 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -85.58 -8.39 58.31 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.157 -0.964 . . . . 0.0 111.672 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.441 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 41.9 p90 54.3 45.57 2.38 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.875 1.67 . . . . 0.0 113.053 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 86.0 Cg_endo -73.97 -66.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.034 2.489 . . . . 0.0 110.738 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.54 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 8.9 tp 38.79 35.14 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.9 0.88 . . . . 0.0 113.338 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.66 15.12 0.45 Allowed Glycine 0 CA--C 1.524 0.649 0 O-C-N 121.321 -0.862 . . . . 0.0 113.53 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 62.7 p -151.68 154.29 36.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 166.77 -146.86 11.26 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.615 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -149.29 171.36 16.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.34 136.67 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 122.077 0.942 . . . . 0.0 110.332 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.8 m -99.15 133.08 43.95 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.403 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -115.33 179.32 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -144.25 5.84 1.29 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.15 166.62 24.17 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -83.94 -29.65 26.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.114 0.566 . . . . 0.0 110.516 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.662 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -66.42 -27.72 68.05 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.143 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.431 ' HA ' ' CE1' ' A' ' 374' ' ' PHE . 51.0 m -73.12 -27.4 61.66 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.013 0.824 . . . . 0.0 110.536 174.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.78 -56.0 6.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.821 0.82 . . . . 0.0 110.201 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -8.83 56.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.884 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -100.77 -21.19 15.25 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.914 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.05 -34.16 44.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 43.2 t -83.58 -33.93 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 122.808 0.443 . . . . 0.0 110.769 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.0 t -70.44 -32.64 70.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 119.724 1.147 . . . . 0.0 109.051 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.04 -52.66 13.52 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.865 0.84 . . . . 0.0 110.175 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.24 -17.5 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 126.678 1.991 . . . . 0.0 115.672 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.91 142.78 16.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.34 0.518 . . . . 0.0 110.354 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.94 154.26 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 122.254 -0.279 . . . . 0.0 110.537 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -101.54 140.66 35.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 415' ' ' ILE . 2.8 mp -105.06 126.88 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -131.1 121.79 25.58 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.3 m -150.64 162.75 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -172.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.7 t -65.67 -5.16 7.65 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -145.58 4.43 1.02 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.346 1.058 . . . . 0.0 113.368 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -150.63 129.45 12.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.784 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.8 p -147.9 102.17 3.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -147.88 173.31 12.97 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -118.87 179.08 4.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.3 145.88 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.12 144.65 48.81 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 122.931 0.144 . . . . 0.0 110.766 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.94 145.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -138.44 138.94 23.43 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.1 155.68 63.42 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.168 2.579 . . . . 0.0 110.15 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.066 -170.727 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 218' ' ' MET . . . . . 0.461 ' CG ' HG12 ' A' ' 413' ' ' VAL . 11.0 tpt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.8 m -153.11 159.22 42.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.241 1.417 . . . . 0.0 109.754 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 17.61 0.65 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.247 0.619 . . . . 0.0 112.479 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.6 m 61.06 26.65 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.078 1.751 . . . . 0.0 115.205 172.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 51.59 68.09 1.69 Allowed Glycine 0 CA--C 1.536 1.395 0 CA-C-O 121.117 0.287 . . . . 0.0 113.202 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.48 -17.19 63.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.375 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.7 mm? -105.62 151.82 39.92 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-O 121.365 0.602 . . . . 0.0 110.499 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.5 110.89 2.5 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.55 4.69 6.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.347 3.365 . . . . 0.0 111.989 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -143.46 -171.29 3.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.819 1.248 . . . . 0.0 109.195 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 25.8 m120 57.73 22.74 8.74 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.296 1.839 . . . . 0.0 114.078 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -62.55 -36.74 83.62 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.145 -0.347 . . . . 0.0 110.224 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 39.84 54.41 2.58 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.9 59.47 39.0 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 332' ' ' VAL . 83.5 Cg_endo -70.83 127.39 13.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.308 3.338 . . . . 0.0 114.43 -171.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.8 mm -146.14 131.54 12.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 102.604 -3.109 . . . . 0.0 102.604 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 292' ' ' VAL . 12.0 m-85 -98.45 143.03 29.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.768 -1.173 . . . . 0.0 109.231 -169.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.9 p -137.14 -1.24 2.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 14.7 t -158.97 -166.28 1.82 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.026 1.285 . . . . 0.0 108.317 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 176.91 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.535 1.134 . . . . 0.0 112.564 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.1 142.35 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.49 1.138 . . . . 0.0 109.01 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.25 130.12 38.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.512 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -137.07 113.57 10.14 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.94 173.98 38.35 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-O 121.418 0.454 . . . . 0.0 113.73 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 115.05 18.83 6.16 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.357 -1.421 . . . . 0.0 114.009 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.3 m -92.0 126.09 54.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.501 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -82.03 -17.03 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.991 3.128 . . . . 0.0 111.483 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.443 ' CH2' ' HG3' ' A' ' 321' ' ' MET . 30.1 p-90 -130.54 -70.06 0.63 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.146 0.884 . . . . 0.0 109.709 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 245' ' ' TRP . 26.7 t70 10.97 90.72 0.01 OUTLIER 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.768 1.627 . . . . 0.0 113.225 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.434 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -63.96 -22.0 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 250' ' ' ALA . 11.7 m -150.33 143.15 24.7 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-N 121.029 1.74 . . . . 0.0 108.916 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.19 -24.93 64.11 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.197 0.999 . . . . 0.0 109.52 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.54 -13.94 62.59 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.54 1.136 . . . . 0.0 110.689 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.83 -58.16 5.94 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 54.8 mt -50.49 -47.21 57.32 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 122.199 0.999 . . . . 0.0 109.437 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 264' ' ' VAL . 77.3 t -57.42 -45.59 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.916 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -73.92 -8.03 54.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.904 0.32 . . . . 0.0 110.853 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 84.6 m -90.49 -20.56 22.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.99 32.58 1.12 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.441 1.019 . . . . 0.0 112.468 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -88.25 14.98 8.25 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.14 12.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 O-C-N 120.541 -1.349 . . . . 0.0 112.37 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -93.36 -1.69 55.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.114 0.87 . . . . 0.0 111.56 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 70.12 -0.26 24.33 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.5 t -124.89 18.31 8.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.704 -0.88 . . . . 0.0 112.076 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.53 143.42 28.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.366 -0.533 . . . . 0.0 112.25 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.6 m -150.71 153.15 35.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 253' ' ' VAL . 93.5 t -138.17 138.76 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 124.012 0.82 . . . . 0.0 111.29 -169.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -143.45 156.19 44.58 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.488 1.118 . . . . 0.0 113.651 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -151.18 167.32 13.23 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.56 -19.28 22.8 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 124.087 3.191 . . . . 0.0 115.681 -168.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 170.46 157.53 12.77 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.085 1.311 . . . . 0.0 111.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -102.16 15.3 29.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.761 0.824 . . . . 0.0 112.766 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.86 144.41 47.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.639 1.176 . . . . 0.0 108.936 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.24 177.37 15.33 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.285 0.936 . . . . 0.0 110.775 -176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.74 173.36 8.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.553 -0.969 . . . . 0.0 108.494 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 60.66 142.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.539 1.135 . . . . 0.0 112.223 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.9 -11.87 11.1 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 123.852 3.034 . . . . 0.0 111.415 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -101.06 33.0 2.99 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.822 0.849 . . . . 0.0 111.991 -171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 48.9 t 64.98 144.58 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 124.685 1.194 . . . . 0.0 110.342 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.617 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 71.2 Cg_endo -66.55 166.08 23.09 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.068 1.846 . . . . 0.0 112.972 171.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.7 113.3 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 CA-C-O 122.643 1.018 . . . . 0.0 111.396 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -143.52 145.79 32.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.247 1.419 . . . . 0.0 109.977 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -92.8 4.11 75.07 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.236 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.93 165.79 35.57 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.62 161.66 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.863 1.265 . . . . 0.0 109.74 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -97.39 149.37 22.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.579 1.081 . . . . 0.0 109.752 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.509 HD23 HG22 ' A' ' 264' ' ' VAL . 81.6 mt -117.79 137.09 52.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.16 107.52 11.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -153.51 -161.68 1.31 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 124.445 1.091 . . . . 0.0 111.058 -168.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.19 92.48 0.04 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.8 pt? -67.03 17.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.792 2.437 . . . . 0.0 117.011 -168.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.86 -60.12 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.102 1.319 . . . . 0.0 109.98 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -86.19 -23.71 26.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.264 -0.897 . . . . 0.0 112.862 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 12.2 t -84.12 -22.73 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 286' ' ' PHE . 24.1 t -72.66 -48.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.561 0.696 . . . . 0.0 109.577 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.3 ptp180 -74.95 -25.67 59.04 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.551 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 48.0 m -78.18 -37.23 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 0.0 112.672 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.95 -35.96 67.08 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.34 -24.21 62.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.087 0.858 . . . . 0.0 110.006 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -92.11 -2.35 56.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.76 -18.14 18.97 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.125 -1.609 . . . . 0.0 110.226 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.84 -151.32 0.44 Allowed 'General case' 0 C--O 1.24 0.554 0 O-C-N 125.925 2.016 . . . . 0.0 110.411 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -126.46 177.94 6.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.191 0.932 . . . . 0.0 113.125 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 310' ' ' SER . 83.3 t60 -145.8 162.03 38.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.45 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -144.12 131.78 10.66 Favored Pre-proline 0 C--N 1.351 0.648 0 O-C-N 124.026 0.829 . . . . 0.0 110.102 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -86.75 23.87 0.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 1 C-N-CA 125.807 4.338 . . . . 0.0 111.174 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.655 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -50.55 -40.53 52.27 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.517 0.727 . . . . 0.0 111.736 -172.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.655 ' H ' HD12 ' A' ' 304' ' ' LEU . 6.2 t 49.47 52.82 13.39 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -80.23 -9.66 13.87 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 122.242 1.961 . . . . 0.0 111.494 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 7.44 7.47 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.454 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 86.6 -0.17 86.6 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 119.072 -0.849 . . . . 0.0 111.965 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.29 158.53 27.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 29.0 m -108.61 158.18 17.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.312 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -138.06 135.56 35.97 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.004 -171.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.2 148.88 25.87 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.24 149.42 51.98 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.177 -0.952 . . . . 0.0 111.141 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -151.88 168.03 26.44 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 123.313 1.53 . . . . 0.0 109.785 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.7 ptpt -130.46 116.74 18.64 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.921 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.5 OUTLIER -110.99 28.46 8.7 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -176.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 86.1 p -79.61 164.31 23.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.029 0.932 . . . . 0.0 111.401 -174.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 66.6 m -117.05 176.13 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 15.7 ptp180 -79.1 23.71 0.35 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -128.79 15.16 6.42 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.63 0.772 . . . . 0.0 110.778 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.443 ' HG3' ' CH2' ' A' ' 245' ' ' TRP . 16.6 mmt -137.52 179.65 6.28 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -130.8 103.41 6.56 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.678 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.7 m 64.88 166.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 111.419 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -155.34 -64.6 0.12 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.749 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 44.05 69.61 0.4 Allowed 'General case' 0 C--N 1.343 0.318 0 O-C-N 123.84 0.713 . . . . 0.0 112.652 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.7 p -83.99 160.0 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 121.902 -0.499 . . . . 0.0 109.987 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -102.8 153.59 20.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.509 0.595 . . . . 0.0 110.114 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.3 139.15 49.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 329' ' ' ILE . 19.7 tt -155.83 88.1 3.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 122.854 1.311 . . . . 0.0 108.123 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.16 164.75 26.67 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.868 2.379 . . . . 0.0 113.062 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -78.28 122.49 25.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.104 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 334' ' ' ALA . 86.8 t -103.84 148.6 8.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 122.463 1.125 . . . . 0.0 110.161 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.44 -38.62 59.65 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.554 1.142 . . . . 0.0 110.775 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -64.32 -3.09 2.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.706 0.403 . . . . 0.0 111.892 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -102.96 7.24 39.2 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 120.823 -1.173 . . . . 0.0 111.202 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.9 m -119.85 -49.37 2.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -151.13 157.41 42.7 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 119.122 0.873 . . . . 0.0 111.609 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.452 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 54.2 t80 -156.08 143.33 19.15 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.901 1.375 . . . . 0.0 109.342 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.27 154.57 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.999 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -117.87 41.18 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.8 t -137.61 147.15 56.24 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.548 1.139 . . . . 0.0 110.074 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.66 -3.36 13.76 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.564 2.176 . . . . 0.0 111.022 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.8 m -130.19 -176.85 4.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -105.86 135.95 46.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.728 -1.233 . . . . 0.0 110.243 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -159.59 165.75 32.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.083 -1.011 . . . . 0.0 109.321 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.37 150.7 25.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.057 1.343 . . . . 0.0 110.04 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.1 110.78 8.51 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.13 -2.09 11.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.864 3.043 . . . . 0.0 111.348 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 67.8 m -84.45 -14.35 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -140.42 94.72 2.77 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 109.942 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 396' ' ' VAL . 10.5 t -149.27 152.24 35.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.702 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.0 m -135.11 153.06 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 118.822 0.737 . . . . 0.0 109.375 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -75.04 145.71 42.17 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.923 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 66.9 t -132.0 140.75 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 125.089 1.493 . . . . 0.0 111.168 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -165.76 -162.15 16.39 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.523 -0.736 . . . . 0.0 111.945 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.66 31.9 18.25 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.15 0.975 . . . . 0.0 111.291 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.67 25.74 0.63 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . 0.295 0.0 OUTLIER 58.31 9.23 0.97 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.96 1.704 . . . . 0.0 114.739 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.16 63.98 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 167.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.5 ptm -165.48 21.7 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.19 1.495 . . . . 0.0 112.339 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.501 HD13 ' HZ2' ' A' ' 422' ' ' LYS . 18.4 tp -69.38 151.37 46.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.881 0.848 . . . . 0.0 111.496 -175.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -114.26 174.26 6.04 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -75.53 -14.93 60.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -71.94 -25.26 61.81 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.031 -1.043 . . . . 0.0 109.247 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -90.24 -31.84 16.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.91 1.381 . . . . 0.0 110.74 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.545 0.612 . . . . 0.0 110.557 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.53 67.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.86 -45.09 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.701 -0.624 . . . . 0.0 110.745 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 424' ' ' VAL . 81.4 mt -64.65 -43.45 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.701 0.8 . . . . 0.0 110.488 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.533 HD13 ' CE2' ' A' ' 374' ' ' PHE . 3.7 mm? -81.0 -28.04 35.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.146 -0.971 . . . . 0.0 113.293 -173.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.24 -13.73 27.92 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -108.31 -22.04 12.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.743 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.23 -16.97 21.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.2 0.909 . . . . 0.0 111.535 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 370' ' ' LEU . 16.2 m-30 -113.26 -12.29 13.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.763 1.165 . . . . 0.0 113.694 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 69.25 4.13 41.95 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.98 -0.45 . . . . 0.0 113.226 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -164.73 115.92 0.67 Allowed Glycine 0 C--N 1.357 1.717 0 CA-C-N 118.456 1.128 . . . . 0.0 115.177 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.44 179.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.237 0.615 . . . . 0.0 111.66 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.12 -39.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 O-C-N 122.028 -0.42 . . . . 0.0 110.936 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.77 152.75 30.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.653 0.66 . . . . 0.0 111.187 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.96 37.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.416 1.486 . . . . 0.0 109.036 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -168.41 169.56 41.64 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 120.83 -1.168 . . . . 0.0 115.371 175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.2 mm -90.16 150.4 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 125.994 1.718 . . . . 0.0 109.711 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.53 71.73 5.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 156.7 34.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.691 -0.63 . . . . 0.0 111.241 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.18 161.61 40.56 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.47 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 24.1 tptm -45.77 102.49 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.616 0.766 . . . . 0.0 112.201 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.47 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 24.3 m170 48.39 42.12 17.73 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.692 1.997 . . . . 0.0 112.338 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -97.25 -11.42 24.18 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 124.312 1.007 . . . . 0.0 109.835 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 26.8 p90 44.58 45.49 2.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.1 -58.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.88 3.72 . . . . 0.0 109.779 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.5 tp 42.72 32.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.421 0 C-N-CA 125.172 1.389 . . . . 0.0 113.838 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.6 16.81 0.97 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 54.0 m -152.37 157.74 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 117.833 0.816 . . . . 0.0 110.06 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 176.1 -163.84 33.49 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 123.66 0.6 . . . . 0.0 113.489 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -146.42 173.8 11.96 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.717 0.892 . . . . 0.0 111.213 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 351' ' ' THR . 2.5 p -139.17 144.03 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 34.9 p -119.1 152.27 36.8 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.623 1.201 . . . . 0.0 111.218 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 403' ' ' SER . 35.0 m-85 -129.82 179.37 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 123.611 1.672 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -126.64 1.78 6.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.314 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.35 164.03 24.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.761 1.225 . . . . 0.0 109.593 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -96.91 -13.38 22.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.19 -38.12 87.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.795 1.18 . . . . 0.0 107.928 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 398' ' ' PHE . 8.3 p -79.15 -17.99 53.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -72.75 -61.08 1.93 Allowed 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.798 -0.563 . . . . 0.0 111.944 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.523 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -72.11 -25.58 61.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.206 -1.397 . . . . 0.0 113.028 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -77.92 -20.6 52.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.073 0.851 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.71 61.15 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.725 -0.609 . . . . 0.0 111.155 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.5 m -82.71 -11.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.648 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.8 p -106.89 -8.23 16.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.068 0.855 . . . . 0.0 112.507 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -93.44 -49.83 5.73 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.36 -15.26 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.56 138.77 12.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.461 HG12 ' CG ' ' A' ' 218' ' ' MET . 10.6 m -143.94 158.98 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.972 0.351 . . . . 0.0 111.43 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.99 137.18 42.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.866 1.354 . . . . 0.0 109.713 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.21 128.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.61 50.16 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 418' ' ' THR . 28.4 m -73.9 166.5 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 417' ' ' THR . 6.7 t -71.6 -1.87 15.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -148.36 5.58 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.804 -1.185 . . . . 0.0 111.23 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -146.98 125.46 12.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.327 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 54.5 p -138.58 111.2 7.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 125.332 1.645 . . . . 0.0 112.822 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.501 ' HZ2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -159.55 -176.68 5.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.466 -1.396 . . . . 0.0 112.323 177.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.61 163.42 24.25 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.762 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 369' ' ' ILE . 25.9 m -143.98 156.88 15.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 123.68 0.613 . . . . 0.0 109.653 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -130.26 153.47 48.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.258 0.348 . . . . 0.0 111.216 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 79.2 mt -131.53 142.38 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.896 1.372 . . . . 0.0 108.115 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -139.23 155.97 72.2 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.558 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.9 158.08 35.37 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 C-N-CA 124.28 3.32 . . . . 0.0 115.22 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 75.8 t80 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.15 177.589 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -169.86 175.67 5.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.642 1.214 . . . . 0.0 111.199 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.486 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -129.17 16.04 6.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 174.09 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.1 m 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.65 84.42 0.45 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.328 -1.483 . . . . 0.0 111.602 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.47 ' C ' HD22 ' A' ' 224' ' ' LEU . 78.1 mm-40 -99.24 -5.33 30.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 223' ' ' GLN . 3.1 mm? -131.65 125.07 20.32 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.405 1.082 . . . . 0.0 109.258 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 3.4 Cg_exo -81.6 116.81 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 125.01 3.807 . . . . 0.0 111.169 172.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 225' ' ' PRO . 44.1 Cg_endo -81.8 -179.28 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.044 3.829 . . . . 0.0 111.86 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 37.93 66.21 0.5 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.923 1.689 . . . . 0.0 114.21 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -143.65 27.18 1.53 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.113 0.965 . . . . 0.0 110.186 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -66.23 0.93 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 112.561 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 55.97 45.88 22.99 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.877 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.413 ' H ' ' HD3' ' A' ' 232' ' ' PRO . 17.2 m-80 -117.61 -50.17 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 334' ' ' ALA . 24.2 Cg_exo -73.64 -170.78 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.419 3.413 . . . . 0.0 114.063 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.2 OUTLIER -102.83 -171.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 125.388 1.475 . . . . 0.0 108.717 -178.066 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -106.37 148.74 27.72 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.7 m -141.99 11.56 2.0 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.6 t -158.48 -145.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.317 -1.49 . . . . 0.0 110.414 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 170.05 6.76 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.978 0.911 . . . . 0.0 110.616 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 m -144.53 155.12 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 122.32 1.057 . . . . 0.0 109.59 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.78 135.93 34.58 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.62 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.5 tm? -146.09 122.66 11.1 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.336 0.588 . . . . 0.0 111.088 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.27 -170.99 33.41 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.113 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.74 6.96 0.91 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 124.689 1.138 . . . . 0.0 112.109 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.57 145.8 30.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 122.707 1.241 . . . . 0.0 113.616 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.16 -13.02 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 125.0 3.8 . . . . 0.0 110.219 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -101.2 -104.09 0.25 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.631 1.105 . . . . 0.0 110.111 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.9 t70 46.38 59.5 3.81 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 124.278 1.031 . . . . 0.0 111.294 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -70.31 -17.24 20.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 O-C-N 121.069 -1.019 . . . . 0.0 110.903 -170.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 4.8 m -149.29 133.51 17.34 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 127.053 2.141 . . . . 0.0 105.357 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.19 -10.23 59.5 Favored 'General case' 0 CA--C 1.485 -1.554 0 O-C-N 117.508 -3.245 . . . . 0.0 115.66 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.12 -18.24 58.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.3 -43.83 30.35 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.52 -45.4 68.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.061 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.2 t -64.7 -39.06 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 123.761 0.663 . . . . 0.0 110.272 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.47 -16.79 64.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.651 -1.281 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 74.7 m -77.53 -33.55 54.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.727 -0.608 . . . . 0.0 111.513 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -142.53 80.6 1.7 Allowed 'General case' 0 C--O 1.218 -0.602 0 O-C-N 118.978 -2.326 . . . . 0.0 109.934 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.424 ' HA ' HD11 ' A' ' 262' ' ' LEU . 8.6 ptm180 -139.7 5.27 2.18 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.945 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.35 -4.91 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.452 1.024 . . . . 0.0 110.744 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -77.2 -12.27 59.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.21 3.26 6.33 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.6 m -114.06 16.41 18.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.165 1.482 . . . . 0.0 110.335 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -134.88 155.71 50.2 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -148.88 -172.49 4.12 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.383 2.273 . . . . 0.0 108.03 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.45 150.55 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -170.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 129.29 23.69 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.534 -0.729 . . . . 0.0 109.847 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -156.29 152.79 23.92 Favored Pre-proline 0 N--CA 1.439 -1.004 0 O-C-N 121.025 -1.047 . . . . 0.0 113.041 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.69 148.82 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.676 4.25 . . . . 0.0 105.969 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.86 -8.7 70.72 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.792 1.187 . . . . 0.0 110.307 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -66.67 -18.37 65.33 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.912 1.356 . . . . 0.0 110.419 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -81.35 -5.25 57.64 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 112.365 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -110.97 -176.85 20.52 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -74.92 163.56 27.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.315 0.646 . . . . 0.0 112.287 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.2 m80 64.43 145.54 0.09 OUTLIER Pre-proline 0 N--CA 1.444 -0.771 0 C-N-CA 125.426 1.491 . . . . 0.0 111.697 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.52 17.29 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.239 3.293 . . . . 0.0 111.712 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -145.16 140.27 27.84 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.619 1.168 . . . . 0.0 111.563 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 49.4 t -161.72 -43.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.667 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 45.1 Cg_endo -83.11 136.58 8.01 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.941 1.761 . . . . 0.0 111.748 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -93.71 6.71 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.236 2.624 . . . . 0.0 111.118 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -106.49 5.7 29.51 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.249 1.42 . . . . 0.0 111.294 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.45 29.98 0.15 Allowed Glycine 0 N--CA 1.467 0.704 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.7 121.54 40.37 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 118.858 1.329 . . . . 0.0 110.054 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.01 174.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 122.916 1.341 . . . . 0.0 112.034 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -98.54 169.0 9.83 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.937 -1.102 . . . . 0.0 112.019 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.0 mt -124.37 145.24 49.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.206 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.21 114.39 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.96 -161.82 0.58 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.266 1.032 . . . . 0.0 111.766 -172.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.43 ' HG2' ' HE3' ' A' ' 290' ' ' LYS . 10.8 tp10 -56.84 113.11 1.52 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 288' ' ' LEU . 0.9 OUTLIER -85.37 12.47 8.21 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -168.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -135.45 -67.13 0.55 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.172 1.806 . . . . 0.0 112.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.43 ' HE3' ' HG2' ' A' ' 287' ' ' GLU . 0.0 OUTLIER -80.19 -31.34 38.76 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.908 -1.12 . . . . 0.0 112.184 -168.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.5 m -78.95 -30.85 44.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.195 0.907 . . . . 0.0 109.165 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.77 -56.49 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.57 -28.8 67.27 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.037 -1.04 . . . . 0.0 112.347 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.9 m -65.81 -32.67 74.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.36 -51.42 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.784 0.72 . . . . 0.0 109.817 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.456 ' C ' HD12 ' A' ' 296' ' ' LEU . 3.7 pp -74.3 -4.82 38.51 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.38 -8.06 11.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.375 0.422 . . . . 0.0 110.994 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.03 65.68 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.292 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' CYS . . . . . 0.454 ' SG ' ' HE3' ' A' ' 315' ' ' LYS . 50.3 t -112.26 -91.76 0.48 Allowed 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 123.596 0.56 . . . . 0.0 111.734 -174.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 72.3 m -142.06 158.25 43.97 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -154.9 156.12 35.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.267 1.427 . . . . 0.0 108.704 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.64 104.75 4.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.404 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.57 12.55 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 125.604 4.203 . . . . 0.0 111.783 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.523 HD13 ' HD3' ' A' ' 306' ' ' PRO . 0.2 OUTLIER -58.92 -25.05 63.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.5 t 43.72 67.6 3.68 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.422 0.689 . . . . 0.0 111.912 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.523 ' HD3' HD13 ' A' ' 304' ' ' LEU . 27.1 Cg_endo -84.4 -4.26 10.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.275 3.316 . . . . 0.0 113.327 -173.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -142.29 -19.79 0.7 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.642 0.589 . . . . 0.0 112.494 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 150.56 -20.76 1.04 Allowed Glycine 0 C--N 1.34 0.758 0 O-C-N 120.616 -1.302 . . . . 0.0 113.669 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.48 165.61 19.52 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.6 0.76 . . . . 0.0 109.34 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 49.5 m -103.19 177.88 4.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.949 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -129.39 131.61 46.85 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.596 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -109.55 151.94 26.12 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -138.27 154.49 49.04 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 122.006 0.907 . . . . 0.0 112.105 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.45 178.81 7.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.408 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.489 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 9.1 ptpt -150.11 147.04 27.28 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.22 -14.92 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.583 -1.323 . . . . 0.0 110.557 -169.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.5 t -94.96 157.31 15.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.672 1.124 . . . . 0.0 112.528 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 43.4 p -131.58 -38.61 1.16 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -152.13 -13.3 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -99.15 -21.22 16.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 69.2 mmm -130.01 -179.36 5.17 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.625 0.77 . . . . 0.0 111.697 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -123.85 31.66 5.79 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 66.7 m -104.66 -45.46 4.6 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -173.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? 53.63 17.51 1.22 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -166.97 147.63 5.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.589 -1.319 . . . . 0.0 112.317 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.75 159.93 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 117.517 -1.23 . . . . 0.0 109.695 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -109.53 157.11 19.33 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 120.089 1.313 . . . . 0.0 113.198 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.4 t -140.81 141.93 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.937 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 328' ' ' VAL . 3.9 pt -151.6 131.2 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 329' ' ' ILE . 1.5 Cg_endo -104.29 174.22 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.353 2.702 . . . . 0.0 114.344 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -82.4 125.0 30.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 334' ' ' ALA . 93.9 t -99.33 151.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.73 -26.37 68.02 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.543 -0.723 . . . . 0.0 111.523 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.553 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -71.16 -22.45 62.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.14 -10.3 59.63 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.341 0.401 . . . . 0.0 110.242 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 17.3 m -98.04 -31.79 11.96 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.1 162.06 40.3 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.728 -0.608 . . . . 0.0 111.462 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.631 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 30.2 t80 -147.55 127.67 13.76 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 341' ' ' SER . 55.2 t -104.59 140.43 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -103.86 -8.09 20.0 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.437 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 69.0 m -137.01 93.17 13.57 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.33 -9.98 27.1 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.301 2.667 . . . . 0.0 113.584 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 71.0 m -115.26 19.07 15.83 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.878 0.871 . . . . 0.0 112.845 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -140.65 172.43 12.71 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.056 1.343 . . . . 0.0 109.708 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -127.18 -83.8 0.61 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.643 -1.286 . . . . 0.0 111.083 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 3.8 tp -151.35 173.24 14.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.957 0.785 . . . . 0.0 111.065 -170.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 1.4 m-20 -124.7 151.31 67.6 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 123.609 0.764 . . . . 0.0 110.187 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.57 -15.58 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.864 3.042 . . . . 0.0 113.611 -167.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 56.6 p -150.17 8.25 0.63 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -123.88 88.74 2.96 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 121.008 -1.058 . . . . 0.0 110.094 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.0 t -151.52 155.3 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.21 150.33 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.04 0.448 . . . . 0.0 110.961 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -90.58 141.35 28.86 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 122.265 1.031 . . . . 0.0 110.283 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 78.8 t -130.94 140.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.811 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.27 -164.19 21.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 56.64 29.2 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.0 mt -74.98 170.15 16.57 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.071 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -74.79 -27.94 60.53 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 147.48 -11.45 1.33 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.714 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 18.4 ptm -156.78 22.55 0.33 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.024 1.412 . . . . 0.0 112.109 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.5 OUTLIER -42.03 129.29 3.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.442 -175.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.559 ' N ' HD13 ' A' ' 361' ' ' LEU . 10.0 p30 -104.44 164.26 11.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.954 0.901 . . . . 0.0 111.352 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -74.0 -12.16 60.55 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -168.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -81.2 -28.58 34.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.211 0.914 . . . . 0.0 109.053 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.07 77.44 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.05 -37.71 75.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.06 73.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.84 85.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.244 0.545 . . . . 0.0 110.285 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.6 mt -78.69 -33.31 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.145 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.08 1.05 47.24 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -171.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -22.56 5.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.662 0.665 . . . . 0.0 111.777 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.35 -8.93 13.43 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.08 -1.84 9.24 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 170.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.88 -24.59 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.968 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.59 34.62 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 124.032 0.825 . . . . 0.0 115.155 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.21 128.09 1.03 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.589 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 398' ' ' PHE . 33.4 m -138.02 174.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 O-C-N 121.632 -0.922 . . . . 0.0 111.533 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.17 -28.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 O-C-N 122.212 -0.305 . . . . 0.0 111.679 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.26 151.9 21.62 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.229 0.612 . . . . 0.0 110.584 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.82 149.81 34.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.362 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -176.99 175.76 47.8 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 120.58 -0.819 . . . . 0.0 115.036 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.07 147.26 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 109.082 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.46 130.04 34.64 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.262 -0.899 . . . . 0.0 111.913 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 2.5 p -111.2 169.92 8.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.861 0.838 . . . . 0.0 111.622 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.75 167.19 25.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.866 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.68 101.54 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.41 0.444 . . . . 0.0 112.099 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.0 m170 53.8 30.89 12.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -97.39 -4.25 38.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.415 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 55.6 t80 45.9 56.11 15.61 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 125.292 1.437 . . . . 0.0 113.396 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.35 -60.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.179 1.253 . . . . 0.0 109.362 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.251 9.7 tp 41.45 36.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.739 2.016 . . . . 0.0 113.85 175.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -153.71 5.92 0.36 Allowed Glycine 0 N--CA 1.474 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 115.122 -171.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 43.9 m -148.6 122.08 9.11 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 117.913 0.856 . . . . 0.0 110.296 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -158.89 -169.0 21.74 Favored Glycine 0 CA--C 1.542 1.757 0 O-C-N 120.705 -1.247 . . . . 0.0 111.848 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -152.45 171.31 18.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.034 0.534 . . . . 0.0 109.986 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.72 143.8 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 89.7 m -115.43 140.32 49.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 377' ' ' VAL . 8.3 p90 -163.25 158.15 21.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.194 1.397 . . . . 0.0 110.414 173.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -128.77 20.55 6.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.03 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -100.87 144.35 29.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.91 -27.06 21.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.594 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -68.45 -25.07 64.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 119.593 1.088 . . . . 0.0 109.784 -174.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 73.8 p -81.35 -21.6 39.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -69.73 -62.6 1.32 Allowed 'General case' 0 C--N 1.349 0.583 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.496 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -69.76 -17.48 63.44 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 178.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -76.19 -34.88 59.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.983 0.81 . . . . 0.0 110.644 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.68 -26.35 37.62 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.227 -1.546 . . . . 0.0 111.192 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 37.6 t -79.77 -32.03 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.621 1.169 . . . . 0.0 108.635 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 29.0 t -75.09 -30.26 60.86 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 117.902 -1.046 . . . . 0.0 112.111 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.26 -48.74 6.53 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.572 1.078 . . . . 0.0 110.239 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 65.2 -14.04 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.999 2.12 . . . . 0.0 116.137 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 148.18 17.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.71 157.55 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.9 117.66 33.37 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 124.991 1.432 . . . . 0.0 110.489 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.25 127.99 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 416' ' ' LYS . 8.6 mmpt? -118.95 34.07 5.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.49 1.119 . . . . 0.0 111.16 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.4 m -59.83 154.83 17.52 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.233 0.924 . . . . 0.0 109.752 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 14.0 t -73.3 0.81 10.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -145.09 15.43 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 112.244 173.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -151.03 120.41 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.309 -1.495 . . . . 0.0 108.384 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 32.4 p -132.28 110.08 10.35 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.938 -0.476 . . . . 0.0 110.265 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.545 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 26.6 tptt -162.47 -175.91 4.76 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 124.118 0.886 . . . . 0.0 109.132 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.7 mttm -121.2 173.05 7.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.631 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.75 150.04 15.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -114.79 152.27 32.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.6 mt -130.79 142.49 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 125.299 1.624 . . . . 0.0 108.283 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 24.9 t70 -138.2 140.2 27.93 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 119.839 1.199 . . . . 0.0 112.731 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 40.0 Cg_exo -57.77 153.85 41.02 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.692 2.261 . . . . 0.0 109.879 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.258 1.546 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.928 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 218' ' ' MET . . . . . 0.425 ' O ' HG12 ' A' ' 413' ' ' VAL . 16.3 ptt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.3 t -130.32 -178.36 4.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.497 1.142 . . . . 0.0 111.543 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.445 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -130.6 18.3 5.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.543 0.737 . . . . 0.0 111.654 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.4 m 56.31 29.04 14.31 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.762 1.625 . . . . 0.0 114.623 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.37 1.13 Allowed Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.535 -0.728 . . . . 0.0 112.191 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -80.83 -18.94 45.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.912 0.856 . . . . 0.0 112.765 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.8 127.63 25.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -84.67 132.08 4.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.003 3.135 . . . . 0.0 108.676 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.77 -5.53 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.1 1.867 . . . . 0.0 112.486 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.61 -168.6 1.62 Allowed 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 121.326 -0.859 . . . . 0.0 109.255 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.7 m120 58.4 27.97 16.17 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 122.066 -0.396 . . . . 0.0 111.128 -172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.07 145.65 0.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.25 0.62 . . . . 0.0 112.103 168.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -141.21 14.03 2.22 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.931 0.892 . . . . 0.0 111.713 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.546 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 8.0 p30 -141.76 28.21 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.322 0.51 . . . . 0.0 112.279 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 87.8 Cg_endo -66.53 116.99 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.529 1.486 . . . . 0.0 112.047 -169.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.3 mm -144.87 153.42 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.467 ' CE1' ' HG2' ' A' ' 330' ' ' PRO . 18.8 m-85 -112.35 146.34 38.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -171.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -148.3 7.63 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -170.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 85.2 m -137.98 -74.2 0.4 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.838 0.745 . . . . 0.0 111.2 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 389' ' ' TYR . 20.7 pttp -156.18 -169.73 3.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.302 0.641 . . . . 0.0 109.575 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.2 152.31 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 122.25 1.024 . . . . 0.0 108.685 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -98.95 146.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.857 1.263 . . . . 0.0 110.071 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.19 136.44 16.65 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.798 1.311 . . . . 0.0 108.102 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.87 -173.46 33.88 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 121.638 -0.664 . . . . 0.0 113.601 170.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.73 1.61 8.21 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.344 -1.253 . . . . 0.0 110.123 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -78.44 126.61 82.76 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 118.734 1.267 . . . . 0.0 110.521 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 66.1 Cg_endo -81.45 4.78 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.969 3.779 . . . . 0.0 114.07 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.469 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 2.8 p-90 -139.99 -48.72 0.46 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 23.7 t70 56.32 -41.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.194 2.598 . . . . 0.0 115.205 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 248' ' ' THR 0.337 2.8 pp 55.38 -50.69 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -175.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.418 ' H ' HD12 ' A' ' 247' ' ' ILE . 29.9 m -150.19 135.64 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 122.113 2.233 . . . . 0.0 108.421 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -76.48 -22.08 54.99 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.51 -13.33 62.28 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.559 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.94 -74.73 0.68 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 120.956 -1.09 . . . . 0.0 113.021 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.57 -36.91 84.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.879 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.83 -50.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.533 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 257' ' ' ARG . 19.8 m-20 -71.68 -8.77 56.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 94.8 m -76.82 -26.89 54.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 124.256 0.972 . . . . 0.0 111.617 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -129.03 16.74 6.2 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 124.002 0.814 . . . . 0.0 112.863 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 254' ' ' ASN . 35.3 ttt85 -97.59 -17.16 19.69 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 258' ' ' VAL . 2.3 m -69.91 -10.79 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 121.654 0.74 . . . . 0.0 112.61 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -136.92 3.4 2.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.021 -1.05 . . . . 0.0 110.082 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.59 149.76 16.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 124.032 1.907 . . . . 0.0 111.54 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.3 m -105.17 83.4 1.97 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 112.063 -2.069 . . . . 0.0 107.235 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.57 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -149.67 171.29 16.92 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 113.596 -178.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 t -144.71 165.82 26.98 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.84 150.8 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 121.298 -0.876 . . . . 0.0 113.207 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -141.23 142.92 33.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.014 1.387 . . . . 0.0 108.412 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.65 153.15 91.58 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.808 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.38 -17.41 16.63 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.7 2.267 . . . . 0.0 113.059 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -166.99 -5.36 0.03 OUTLIER Glycine 0 C--N 1.346 1.122 0 CA-C-O 117.346 -1.808 . . . . 0.0 116.429 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 60.0 tttm 58.95 86.28 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.216 2.008 . . . . 0.0 109.646 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.39 165.48 23.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.442 -0.786 . . . . 0.0 109.712 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -72.1 -55.12 7.33 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 123.101 0.382 . . . . 0.0 112.838 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -87.08 156.69 19.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.232 0.516 . . . . 0.0 111.289 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.7 m170 44.31 61.74 10.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.63 2.04 0.17 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.62 3.546 . . . . 0.0 112.444 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -90.27 -9.55 47.53 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.604 1.093 . . . . 0.0 111.647 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 48.8 t -142.06 129.27 11.37 Favored Pre-proline 0 C--N 1.352 0.686 0 C-N-CA 125.685 1.594 . . . . 0.0 110.462 -172.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.76 156.15 67.12 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.783 3.655 . . . . 0.0 110.961 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.58 -3.5 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.549 3.499 . . . . 0.0 110.656 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 281' ' ' TYR . 5.5 ptpp? -149.84 179.34 8.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.552 1.141 . . . . 0.0 111.301 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.43 8.81 73.06 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.572 -1.127 . . . . 0.0 114.121 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.429 ' H ' ' HG3' ' A' ' 279' ' ' LYS . 1.8 m-85 -116.4 152.05 34.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.838 1.319 . . . . 0.0 113.565 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.69 167.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.22 1.808 . . . . 0.0 108.946 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -121.88 149.36 43.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.961 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.4 mp -121.45 148.47 44.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 286' ' ' PHE . 27.0 m -137.85 -154.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 O-C-N 125.223 1.577 . . . . 0.0 110.043 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 285' ' ' VAL 0.264 79.7 t80 77.55 -124.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 115.468 -2.206 . . . . 0.0 108.471 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.88 140.05 58.83 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 123.086 2.676 . . . . 0.0 108.993 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.2 pt? -135.34 8.44 3.4 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.247 1.419 . . . . 0.0 114.204 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -128.9 -86.31 0.55 Allowed 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.545 1.153 . . . . 0.0 112.499 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -61.07 -30.33 70.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 52.6 m -100.2 -25.76 14.16 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.057 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.85 -28.62 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 121.684 2.038 . . . . 0.0 108.133 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -83.66 -32.02 25.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.115 0.884 . . . . 0.0 112.953 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 297' ' ' GLN . 27.8 m -87.75 -35.93 17.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.283 0.99 . . . . 0.0 112.232 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 tt -68.85 -40.86 79.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.875 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 3.8 mp -67.2 -40.58 86.52 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.704 -1.247 . . . . 0.0 111.749 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 294' ' ' SER . 17.8 pt20 -77.35 -7.48 56.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -87.44 -27.92 22.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.64 -174.15 4.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.041 -1.891 . . . . 0.0 106.379 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 151.48 28.54 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 124.029 1.871 . . . . 0.0 111.865 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -143.19 152.97 42.36 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.659 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -126.27 110.79 23.77 Favored Pre-proline 0 N--CA 1.434 -1.251 0 O-C-N 124.13 0.894 . . . . 0.0 109.433 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.85 46.04 2.07 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.781 2.988 . . . . 0.0 109.73 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.459 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -70.63 -18.7 62.86 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 123.725 0.81 . . . . 0.0 111.015 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.459 ' H ' HD12 ' A' ' 304' ' ' LEU . 22.6 t -157.93 69.0 3.95 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.56 0.695 . . . . 0.0 109.82 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 305' ' ' SER . 23.8 Cg_exo -63.14 -6.21 9.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.867 3.044 . . . . 0.0 115.577 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -120.71 0.53 10.41 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.279 -0.888 . . . . 0.0 108.786 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -128.15 25.9 4.81 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.035 1.302 . . . . 0.0 111.247 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 309' ' ' LEU . 19.3 tp 65.33 134.02 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.467 1.107 . . . . 0.0 111.521 -170.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 43.0 m -106.98 178.8 4.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.613 1.196 . . . . 0.0 111.659 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -126.91 147.88 50.06 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.214 -0.929 . . . . 0.0 111.148 -171.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 32.1 m-85 -117.23 156.6 27.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.682 1.229 . . . . 0.0 110.196 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -151.5 173.85 14.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.486 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -153.69 165.66 35.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.661 0.664 . . . . 0.0 110.717 170.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -128.59 57.33 1.6 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.1 0.56 . . . . 0.0 111.663 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -55.24 -12.61 1.03 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.207 2.203 . . . . 0.0 113.899 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.8 p -89.18 138.64 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.156 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.3 t -160.11 -30.29 0.06 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-N 119.308 0.958 . . . . 0.0 112.606 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -143.64 -30.29 0.5 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.934 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -86.33 -34.52 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.481 1.037 . . . . 0.0 111.26 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 mmt -147.3 166.19 27.83 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -162.82 83.43 0.51 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 125.519 1.762 . . . . 0.0 109.047 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.9 m -133.87 -63.11 0.75 Allowed 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -149.16 139.84 22.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.082 0.944 . . . . 0.0 110.797 -174.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.87 162.6 21.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.263 1.425 . . . . 0.0 112.697 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.5 p -107.6 155.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.04 156.35 19.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.409 0.283 . . . . 0.0 111.575 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 2.4 t -142.71 134.0 24.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 122.897 0.479 . . . . 0.0 112.02 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.06 132.15 9.01 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.829 0.824 . . . . 0.0 109.917 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.467 ' HG2' ' CE1' ' A' ' 234' ' ' TYR . 30.1 Cg_endo -83.06 165.39 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.367 2.044 . . . . 0.0 110.814 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.403 ' CH2' HD13 ' A' ' 391' ' ' ILE . 6.8 t-105 -83.92 113.56 21.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 109.639 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 334' ' ' ALA . 4.2 t -83.1 150.21 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 123.058 1.408 . . . . 0.0 110.299 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.34 -20.89 65.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.429 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.475 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -77.54 1.83 18.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.721 1.208 . . . . 0.0 113.612 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.64 -0.74 21.72 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.699 0.681 . . . . 0.0 110.954 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.0 m -103.79 -36.37 7.86 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.614 0.766 . . . . 0.0 112.25 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -162.45 153.43 17.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.884 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -146.7 148.81 32.39 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.506 -0.746 . . . . 0.0 111.704 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.86 144.3 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.159 0.98 . . . . 0.0 111.671 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.98 -24.42 30.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.297 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 74.8 m -146.44 137.89 13.06 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 123.546 0.738 . . . . 0.0 110.6 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -88.39 -2.7 6.82 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.705 2.27 . . . . 0.0 111.892 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.7 m -83.23 -1.47 53.18 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.673 0.789 . . . . 0.0 112.373 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -131.76 174.74 9.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.917 1.342 . . . . 0.0 111.216 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -128.57 166.19 19.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.837 0.855 . . . . 0.0 112.319 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.7 mm? -70.65 157.75 37.42 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.904 1.282 . . . . 0.0 110.235 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -109.24 133.68 20.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.35 -7.7 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 124.227 3.284 . . . . 0.0 112.076 -174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.0 m -142.14 2.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 350' ' ' ARG . 34.5 mmt180 -126.67 71.75 1.31 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.902 0.881 . . . . 0.0 110.518 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.0 p -143.59 164.91 29.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 27.5 m -129.12 159.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.457 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -93.04 136.35 33.38 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.588 1.18 . . . . 0.0 111.681 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.93 144.91 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 121.531 0.681 . . . . 0.0 110.311 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -161.86 -160.62 11.1 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.44 34.0 15.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.999 0.92 . . . . 0.0 112.334 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 52.8 mt -89.51 169.14 11.61 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -95.0 14.9 20.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.11 66.23 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.688 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 6.8 ptp -161.14 15.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.702 1.751 . . . . 0.0 111.0 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.56 141.65 57.78 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.575 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.04 175.82 5.47 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 124.714 1.259 . . . . 0.0 111.242 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.86 -17.33 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -75.89 -30.17 58.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -76.43 -35.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.223 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.11 -41.75 76.99 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 122.692 1.234 . . . . 0.0 109.974 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.22 -0.925 . . . . 0.0 111.395 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.72 98.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 124.029 0.831 . . . . 0.0 110.241 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.98 -46.11 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.487 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.14 -29.73 21.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.533 -0.729 . . . . 0.0 112.939 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -12.03 36.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.747 -1.221 . . . . 0.0 112.088 -175.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.438 ' HB3' ' HE1' ' A' ' 220' ' ' TRP . 25.1 t70 -109.93 -23.14 11.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.664 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.18 -19.25 32.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.037 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -118.61 -22.29 7.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.318 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 75.25 -23.75 1.43 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.57 47.99 1.14 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.251 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 32.6 t -131.56 142.28 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 120.301 2.05 . . . . 0.0 113.261 -173.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.62 -24.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.424 0.63 . . . . 0.0 112.601 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 346' ' ' LEU . 1.0 OUTLIER -152.17 150.95 30.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.42 23.25 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.008 1.323 . . . . 0.0 109.481 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.8 156.42 27.94 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.99 144.22 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -92.4 148.66 21.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 118.537 0.608 . . . . 0.0 110.717 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 22.8 p -126.38 169.57 12.83 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.664 -0.647 . . . . 0.0 110.849 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.47 -178.43 5.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -72.81 90.29 1.42 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.248 1.023 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 20.5 m170 65.68 28.48 11.11 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 125.102 1.361 . . . . 0.0 111.783 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -89.55 4.08 50.42 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.497 ' HB3' ' HE2' ' A' ' 237' ' ' LYS . 8.0 p90 45.23 48.14 4.64 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 88.4 Cg_endo -69.14 -70.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.336 2.024 . . . . 0.0 112.304 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.474 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 7.2 tp 40.44 26.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 127.777 2.431 . . . . 0.0 112.285 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -135.11 4.37 4.18 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 120.533 -1.354 . . . . 0.0 112.504 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.5 p -148.77 130.56 15.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.273 0.558 . . . . 0.0 110.413 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.48 16.11 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.085 -1.009 . . . . 0.0 112.271 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 15.0 ptp180 -148.83 -178.12 6.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.165 0.986 . . . . 0.0 110.384 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.38 137.67 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.1 m -105.64 120.55 41.94 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -96.36 -33.6 11.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 60.5 t30 66.05 -2.76 0.88 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.71 179.65 8.22 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 120.962 -1.086 . . . . 0.0 110.106 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -92.28 -26.08 18.3 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.59 -41.13 80.54 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 120.252 -1.53 . . . . 0.0 112.441 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 53.7 m -80.15 -10.25 59.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -76.05 -55.37 5.66 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.799 0.727 . . . . 0.0 109.619 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.473 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.1 -23.32 60.5 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 118.615 0.643 . . . . 0.0 111.022 -175.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -79.14 -34.86 42.88 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.768 -0.583 . . . . 0.0 111.795 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.71 70.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 119.316 0.962 . . . . 0.0 110.583 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.85 -24.75 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 118.398 0.544 . . . . 0.0 111.661 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 t -74.83 -25.9 59.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.302 1.001 . . . . 0.0 108.691 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -84.87 -51.36 6.79 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 61.64 -23.33 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.321 2.248 . . . . 0.0 116.044 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.71 144.52 15.19 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 111.065 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 218' ' ' MET . 22.0 m -142.74 158.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-O 122.067 0.937 . . . . 0.0 111.289 173.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -112.59 131.81 55.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.75 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.76 124.29 39.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -121.3 31.9 6.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.015 -1.053 . . . . 0.0 110.228 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.7 m -62.26 154.83 26.48 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.4 p -61.38 -12.06 12.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.73 7.65 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -146.44 137.13 24.08 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.374 1.07 . . . . 0.0 109.054 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.43 125.55 13.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.527 0.731 . . . . 0.0 111.382 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -167.4 -170.74 1.52 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.02 165.27 23.57 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.225 1.01 . . . . 0.0 108.454 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.74 158.57 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 124.422 1.076 . . . . 0.0 108.599 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -126.87 148.29 50.0 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.193 0.933 . . . . 0.0 112.643 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.84 139.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.02 125.64 5.78 Favored Pre-proline 0 C--N 1.349 0.547 0 CA-C-O 121.742 0.782 . . . . 0.0 110.245 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.39 171.54 16.74 Favored 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 111.259 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.881 177.706 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 91.7 m -69.89 151.63 45.45 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -10.26 0.18 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m 46.89 52.33 11.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.589 1.185 . . . . 0.0 111.499 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.22 -24.24 70.39 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.002 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 54.59 33.5 19.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.172 0.986 . . . . 0.0 113.416 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.473 ' C ' ' HD3' ' A' ' 226' ' ' PRO . 4.6 mm? -63.68 157.25 67.68 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 123.002 0.521 . . . . 0.0 109.986 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.29 68.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 1 C-N-CA 125.997 4.464 . . . . 0.0 114.731 176.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 224' ' ' LEU . 71.6 Cg_exo -55.72 166.37 2.88 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.535 2.824 . . . . 0.0 110.814 169.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 60.08 23.63 12.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.631 1.572 . . . . 0.0 114.461 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -78.37 7.44 6.52 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.474 0.71 . . . . 0.0 111.399 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -73.4 155.93 38.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.227 1.011 . . . . 0.0 111.569 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -143.05 18.68 1.94 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.474 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -133.9 43.56 1.03 Allowed Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 123.947 0.899 . . . . 0.0 109.493 -170.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 93.8 Cg_endo -71.93 157.2 55.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.638 2.892 . . . . 0.0 113.094 -170.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.4 mm -147.5 153.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.02 150.53 31.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.649 1.113 . . . . 0.0 109.654 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 70.4 p -155.11 6.5 0.24 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.873 1.358 . . . . 0.0 114.612 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 4.9 t -154.7 -169.29 3.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.26 1.845 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -43.23 146.07 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 112.378 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 284' ' ' LEU . 3.5 p -122.47 139.56 49.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 125.529 1.768 . . . . 0.0 109.401 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.08 138.63 31.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.821 -1.174 . . . . 0.0 108.904 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.61 126.27 41.73 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 125.053 1.47 . . . . 0.0 108.453 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.72 154.94 21.04 Favored Glycine 0 N--CA 1.449 -0.49 0 O-C-N 120.583 -1.323 . . . . 0.0 111.234 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.73 10.28 0.92 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.2 m -120.49 73.25 21.76 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 118.446 1.123 . . . . 0.0 110.301 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.41 5.15 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 109.985 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.435 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 34.7 p-90 -116.54 -10.53 11.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.18 133.07 55.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.575 -1.328 . . . . 0.0 110.258 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.835 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -109.14 -26.04 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 124.654 1.221 . . . . 0.0 112.822 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 m -138.54 118.84 13.65 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.026 0.53 . . . . 0.0 111.041 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.18 -24.05 67.27 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.378 0.608 . . . . 0.0 112.534 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.1 75.87 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.849 -1.782 . . . . 0.0 111.924 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.87 -63.42 4.43 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.249 0.343 . . . . 0.0 112.576 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -68.49 -21.68 64.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.662 -1.493 . . . . 0.0 113.555 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.4 HG22 HG21 ' A' ' 264' ' ' VAL . 3.3 t -71.54 -52.13 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -71.06 -12.73 61.68 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 125.435 1.709 . . . . 0.0 110.736 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m -79.6 -22.26 43.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.522 -1.361 . . . . 0.0 112.483 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.97 26.6 4.6 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -113.67 -27.32 7.87 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 123.383 0.427 . . . . 0.0 110.845 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.27 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.566 -0.709 . . . . 0.0 110.979 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.49 17.11 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.991 -1.068 . . . . 0.0 113.064 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.21 153.82 25.19 Favored Glycine 0 C--O 1.249 1.085 0 O-C-N 121.322 -0.861 . . . . 0.0 113.074 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.9 m -76.88 28.58 0.13 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 123.86 0.864 . . . . 0.0 113.3 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.691 ' H ' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -109.35 164.38 12.54 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.147 -0.971 . . . . 0.0 112.092 -173.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 p -141.68 168.46 19.72 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 284' ' ' LEU . 6.6 t -125.44 154.01 33.55 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.544 -168.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -130.6 129.34 42.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.5 50.79 5.32 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 124.532 1.145 . . . . 0.0 113.979 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.19 31.48 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 125.894 4.396 . . . . 0.0 111.827 -172.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.29 -43.01 4.45 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -155.94 130.93 9.25 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.436 1.494 . . . . 0.0 111.346 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -125.54 154.8 41.61 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.75 -152.22 10.25 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.66 -16.41 58.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.343 -1.313 . . . . 0.0 109.283 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -152.55 135.11 9.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 118.798 0.726 . . . . 0.0 110.8 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.99 42.06 1.27 Allowed 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.396 4.064 . . . . 0.0 113.555 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.0 13.96 23.18 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.26 -0.9 . . . . 0.0 112.95 -171.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 63.7 m -141.31 36.51 0.24 Allowed Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.899 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.23 147.44 93.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 107.933 -1.603 . . . . 0.0 107.933 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.89 -15.12 13.43 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.138 3.226 . . . . 0.0 113.529 -175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 175.75 12.8 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.286 -0.884 . . . . 0.0 110.751 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -100.24 -9.58 47.54 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.373 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -73.3 121.84 21.04 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 118.598 1.199 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.34 -174.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 O-C-N 125.626 1.829 . . . . 0.0 109.008 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -132.21 165.73 23.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -169.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 238' ' ' VAL . 55.0 mt -117.77 148.42 42.07 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.731 171.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 143.37 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -171.64 178.2 3.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -168.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.4 136.04 56.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 166.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.35 -10.65 59.65 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.53 -43.59 0.68 Allowed 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -83.93 -49.57 8.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.207 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.9 t -71.13 -26.33 62.96 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.218 0.949 . . . . 0.0 111.583 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 3.3 t -67.57 -58.52 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 O-C-N 124.216 0.948 . . . . 0.0 111.047 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.45 -23.27 65.5 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.695 1.247 . . . . 0.0 110.571 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.6 t -71.27 -45.61 62.77 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.023 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.34 -57.54 9.07 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.297 2.1 pp -80.7 -2.01 44.99 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -170.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -100.43 -6.86 24.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 121.054 1.752 . . . . 0.0 108.202 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -94.97 -23.68 17.28 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.479 1.112 . . . . 0.0 110.585 170.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 -133.11 0.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 29.8 t -129.58 164.98 22.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.073 -2.267 . . . . 0.0 110.03 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -146.38 155.78 42.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.886 0.874 . . . . 0.0 110.206 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -136.43 126.19 15.96 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.68 47.36 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.635 3.557 . . . . 0.0 105.579 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER -67.22 -24.24 65.81 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 115.911 -1.995 . . . . 0.0 113.339 -174.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.42 ' H ' HD12 ' A' ' 304' ' ' LEU . 11.4 t -155.37 67.98 5.15 Favored Pre-proline 0 C--N 1.348 0.54 0 CA-C-N 120.873 1.67 . . . . 0.0 107.677 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.88 6.55 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 124.722 3.615 . . . . 0.0 114.441 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.2 0.71 20.85 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.919 0.866 . . . . 0.0 110.405 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 153.84 8.09 0.09 OUTLIER Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 44.0 tp -138.14 155.2 48.96 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 122.015 0.912 . . . . 0.0 109.699 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.7 m -152.73 145.39 24.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -143.73 143.96 31.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.725 0.774 . . . . 0.0 111.349 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.53 153.96 33.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.199 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.38 158.66 43.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.457 0.571 . . . . 0.0 111.331 -172.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 6.3 t80 -156.08 171.24 20.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 23.8 ttmt -128.55 51.93 1.96 Allowed 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 122.884 1.326 . . . . 0.0 108.132 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -0.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.434 -1.712 . . . . 0.0 113.388 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 23.1 t -89.49 125.91 35.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 118.918 0.781 . . . . 0.0 110.245 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 13.5 t -145.98 142.44 28.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.145 0.498 . . . . 0.0 109.936 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 49.97 24.48 1.36 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.19 1.396 . . . . 0.0 113.447 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.403 ' HG3' ' HG2' ' A' ' 321' ' ' MET . 16.3 ptp180 -147.51 -41.18 0.18 Allowed 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.121 -1.612 . . . . 0.0 111.852 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.435 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 23.5 mmm -119.83 -26.88 5.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.834 1.197 . . . . 0.0 111.224 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 57.7 2.1 0.15 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.032 1.733 . . . . 0.0 113.961 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.2 m -137.98 170.35 16.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 118.117 0.417 . . . . 0.0 112.022 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 63.15 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.961 2.104 . . . . 0.0 112.556 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 1.7 pm0 -91.84 161.67 14.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.117 1.767 . . . . 0.0 111.095 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.28 143.47 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -90.27 154.71 19.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.273 -0.892 . . . . 0.0 111.861 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 45.9 t -138.75 139.84 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.369 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.0 pt -147.16 117.46 4.5 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.536 0.734 . . . . 0.0 110.515 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -85.7 162.37 10.71 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.035 2.49 . . . . 0.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -79.11 121.48 25.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.99 145.42 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.049 1.34 . . . . 0.0 110.222 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -55.83 -22.86 27.23 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.9 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.32 60.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.55 -23.95 25.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.345 0.658 . . . . 0.0 111.427 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 47.3 m -69.93 -39.7 75.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -163.32 154.84 17.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.592 1.187 . . . . 0.0 110.754 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.479 ' HB3' ' HB1' ' A' ' 363' ' ' ALA . 70.8 t80 -141.69 99.57 3.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.85 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -90.47 -17.82 26.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.589 -0.694 . . . . 0.0 112.808 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.9 m -142.18 136.32 14.85 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.711 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.03 3.82 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.172 1.915 . . . . 0.0 114.119 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.8 m -109.63 12.15 24.38 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -148.62 163.31 37.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.429 1.092 . . . . 0.0 113.4 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.697 ' HG3' ' H ' ' A' ' 346' ' ' LEU . 10.6 tpp85 -125.99 -175.71 3.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.869 1.268 . . . . 0.0 109.504 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.697 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.1 tp -56.55 164.89 1.27 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.927 2.091 . . . . 0.0 113.521 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -135.89 145.52 53.05 Favored Pre-proline 0 CA--C 1.514 -0.412 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.48 123.54 7.11 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.434 2.09 . . . . 0.0 112.812 -172.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 36.6 m 59.9 26.19 15.39 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.288 1.435 . . . . 0.0 113.18 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -114.41 43.01 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.172 0.589 . . . . 0.0 109.98 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 p -135.78 163.84 29.28 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 122.476 1.131 . . . . 0.0 109.424 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.79 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.505 172.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -82.32 149.26 27.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.568 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.23 136.27 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -169.91 -170.44 34.34 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.547 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.72 18.08 0.95 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.335 1.454 . . . . 0.0 113.367 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.725 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.21 176.27 9.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.113 0.965 . . . . 0.0 110.267 172.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.7 32.44 0.16 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.537 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 76.1 18.23 79.52 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 120.564 -1.335 . . . . 0.0 112.596 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.404 ' HA ' HG13 ' A' ' 391' ' ' ILE . 17.2 mmt -140.3 -94.32 0.15 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.175 1.488 . . . . 0.0 111.718 171.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.7 tp 40.53 68.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.497 0.719 . . . . 0.0 110.863 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -55.62 168.16 0.44 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.726 0.239 . . . . 0.0 111.045 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 338' ' ' PHE . . . -65.29 -16.64 63.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.66 -26.63 25.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.733 -1.229 . . . . 0.0 109.256 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.85 -26.91 40.24 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.542 -0.724 . . . . 0.0 110.317 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.7 -51.72 25.73 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.42 67.23 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.822 -0.549 . . . . 0.0 110.885 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.24 73.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.707 0.23 . . . . 0.0 111.298 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.8 mt -66.46 -42.6 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 119.03 -0.509 . . . . 0.0 109.836 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.24 -34.89 18.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -22.87 44.51 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.4 -1.438 . . . . 0.0 111.554 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -87.66 -27.34 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.614 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.15 -18.87 26.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.553 ' CZ ' ' HA3' ' A' ' 376' ' ' GLY . 4.1 t80 -136.16 -61.45 0.7 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.843 174.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 100.59 -16.07 58.05 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 374' ' ' PHE . . . -85.38 59.52 4.82 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 118.089 0.944 . . . . 0.0 112.514 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.67 164.58 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 118.071 -1.452 . . . . 0.0 112.478 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.69 -40.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -150.79 148.0 27.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.163 0.506 . . . . 0.0 109.852 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.75 153.11 50.94 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.77 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.74 155.43 26.75 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 118.645 0.657 . . . . 0.0 112.501 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.11 147.19 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.5 126.48 29.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.584 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.6 p -138.99 157.49 45.9 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.962 0.789 . . . . 0.0 108.976 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -145.16 166.44 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.705 1.202 . . . . 0.0 108.755 173.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -53.05 102.32 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.443 -0.786 . . . . 0.0 111.784 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 65.8 m170 60.72 30.01 19.4 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -94.5 -8.2 39.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.577 -0.702 . . . . 0.0 110.759 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 15.6 p90 37.82 52.2 2.83 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 127.173 2.189 . . . . 0.0 113.213 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.77 -55.71 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.815 1.677 . . . . 0.0 112.585 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 360' ' ' MET . 10.2 tp 37.28 34.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 124.286 1.035 . . . . 0.0 112.504 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -136.5 5.32 3.79 Favored Glycine 0 N--CA 1.442 -0.958 0 O-C-N 124.104 0.878 . . . . 0.0 114.336 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.5 m -151.57 144.06 24.19 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.16 -172.87 36.32 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 170.34 22.44 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 124.233 0.608 . . . . 0.0 109.894 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.29 135.79 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 22.1 m -103.72 144.58 31.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.089 0.868 . . . . 0.0 111.37 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.43 179.55 6.14 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.342 1.057 . . . . 0.0 111.762 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.36 16.57 2.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.09 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -136.63 157.85 45.82 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -70.67 -26.42 63.43 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.001 0.92 . . . . 0.0 112.181 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . 79.8 mmt-85 -52.92 -31.7 41.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.35 1.06 . . . . 0.0 111.818 -171.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.4 p -80.88 -34.66 33.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.663 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -62.17 -52.29 64.39 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 117.919 0.327 . . . . 0.0 110.499 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 405' ' ' LEU 0.299 0.0 OUTLIER -78.38 -19.19 53.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.417 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -85.67 -30.07 23.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 120.466 1.484 . . . . 0.0 110.69 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.3 -29.19 47.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.335 0.97 . . . . 0.0 109.423 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.17 -33.24 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 O-C-N 121.555 -0.716 . . . . 0.0 112.723 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.5 t -82.22 -11.92 58.39 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -83.79 -50.66 7.9 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.35 -50.5 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 16.4 t80 -154.61 132.8 11.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.41 160.2 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.575 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 20.3 mt-10 -111.5 99.42 8.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.74 140.67 17.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.825 0.821 . . . . 0.0 108.932 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -132.61 40.95 3.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.996 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.2 p -71.43 170.24 13.65 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.322 1.014 . . . . 0.0 108.908 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 t -79.24 -3.42 45.78 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.23 -0.919 . . . . 0.0 112.922 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 226' ' ' PRO . 67.5 mttm -93.51 -41.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.028 -0.42 . . . . 0.0 110.474 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -157.86 166.14 33.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.982 0.801 . . . . 0.0 111.071 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.5 p -127.53 104.34 7.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.296 1.838 . . . . 0.0 107.539 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -159.36 170.5 21.67 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.798 -0.564 . . . . 0.0 110.631 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.575 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 90.6 mttt -108.75 164.19 12.59 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.277 1.037 . . . . 0.0 112.139 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.46 153.9 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.347 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -119.7 156.45 30.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.135 0.897 . . . . 0.0 109.879 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.92 138.67 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 13.4 m-20 -135.75 156.1 77.63 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.165 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 37.3 Cg_exo -65.8 165.6 22.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.561 2.174 . . . . 0.0 113.922 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 116.029 -1.938 . . . . 0.0 110.896 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.6 m 49.05 42.62 21.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.193 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.47 -8.47 59.56 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.145 1.378 . . . . 0.0 112.544 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.6 t 42.6 74.41 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.355 1.862 . . . . 0.0 111.693 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.88 -23.18 78.36 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 122.03 -0.419 . . . . 0.0 112.496 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 54.99 24.74 6.19 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' A' ' 226' ' ' PRO . 4.4 mm? -62.45 141.67 96.51 Favored Pre-proline 0 C--N 1.342 0.247 0 CA-C-N 119.181 0.9 . . . . 0.0 110.489 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.7 100.73 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.618 2.212 . . . . 0.0 110.129 171.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 224' ' ' LEU . 51.0 Cg_endo -80.77 14.61 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.682 3.588 . . . . 0.0 113.077 -175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -133.79 26.72 3.99 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 121.05 -1.031 . . . . 0.0 113.684 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -125.3 39.15 4.03 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.978 0.511 . . . . 0.0 110.663 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -72.05 154.9 40.85 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.641 0.734 . . . . 0.0 110.468 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -131.65 29.4 4.5 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.771 1.228 . . . . 0.0 112.56 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.95 47.44 0.58 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.203 0.601 . . . . 0.0 110.973 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.84 138.38 31.41 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.482 2.121 . . . . 0.0 112.759 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.4 mt -150.62 144.31 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 105.352 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -96.91 148.63 22.75 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 111.513 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.0 m -141.25 -16.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 63.9 m -143.67 -174.92 4.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.483 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.472 ' HE2' ' CD1' ' A' ' 283' ' ' TYR . 58.1 mtpt -43.22 153.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.336 1.065 . . . . 0.0 112.662 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.14 133.76 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.84 145.45 31.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.83 1.3 . . . . 0.0 110.727 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.4 tm? -135.23 116.7 14.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.218 -171.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 178.31 -179.6 48.53 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.17 22.19 0.92 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 28.1 m -91.09 128.55 47.15 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.801 0.841 . . . . 0.0 112.989 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.84 -15.56 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.944 2.429 . . . . 0.0 113.655 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -140.58 0.24 1.62 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.98 1.263 . . . . 0.0 113.985 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.43 122.79 18.32 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.856 1.662 . . . . 0.0 115.426 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -87.87 -0.86 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -173.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.7 p -158.68 167.71 28.82 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 122.455 1.121 . . . . 0.0 108.488 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.469 ' HA ' HD21 ' A' ' 252' ' ' LEU . 0.0 OUTLIER -107.53 -15.6 14.56 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.056 174.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -76.78 -31.38 56.98 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 121.088 0.471 . . . . 0.0 111.246 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.37 -52.6 45.53 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 120.658 -1.277 . . . . 0.0 113.787 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 252' ' ' LEU . 1.7 pt? -71.78 -32.49 67.71 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.514 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.48 -36.16 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.385 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -74.28 -17.77 60.81 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.809 0.693 . . . . 0.0 110.381 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.0 m -80.55 -26.99 37.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 111.807 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -129.34 19.07 5.85 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -101.73 -0.77 33.89 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.045 -1.034 . . . . 0.0 111.767 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.47 -21.14 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -127.61 3.24 6.15 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.27 1.028 . . . . 0.0 108.805 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -104.52 173.6 21.27 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 121.699 0.61 . . . . 0.0 112.836 -171.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.733 ' H ' HD11 ' A' ' 295' ' ' LEU . 61.2 m -135.54 77.0 1.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.56 167.96 22.44 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.702 1.201 . . . . 0.0 111.725 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 284' ' ' LEU . 22.7 t -148.56 169.54 20.09 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 170.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.44 137.91 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -145.83 136.17 23.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -166.22 154.18 9.52 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.67 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.43 161.27 28.58 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.076 3.184 . . . . 0.0 110.987 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 83.03 3.66 90.33 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -75.84 -19.13 59.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.823 0.849 . . . . 0.0 110.572 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.24 142.24 58.49 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.14 -167.61 34.54 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.423 1.011 . . . . 0.0 111.738 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -80.07 170.34 16.59 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.198 0.599 . . . . 0.0 111.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 30.8 m80 53.03 99.35 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 125.364 1.466 . . . . 0.0 112.019 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -58.01 -3.53 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 1 C-N-CA 125.522 4.148 . . . . 0.0 115.816 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -99.36 9.99 42.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.223 1.809 . . . . 0.0 111.863 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 277' ' ' PRO . 40.7 t -53.43 -45.26 98.59 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.53 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 276' ' ' CYS . 96.5 Cg_endo -72.38 148.85 49.55 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.911 1.741 . . . . 0.0 111.405 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.63 1.17 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.521 2.814 . . . . 0.0 111.501 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.41 143.97 36.31 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 118.933 0.788 . . . . 0.0 109.93 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.42 22.05 42.88 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.429 0.537 . . . . 0.0 113.014 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.418 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 37.5 p90 -152.95 164.58 37.68 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.71 -178.49 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.472 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 55.0 m-85 -110.91 157.27 20.05 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.208 0.913 . . . . 0.0 111.223 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 263' ' ' SER . 83.4 mt -126.13 136.0 52.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.671 1.188 . . . . 0.0 111.529 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.86 137.18 14.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.685 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 84.9 t80 -175.62 -76.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.614 0.366 . . . . 0.0 110.317 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -93.8 -36.8 12.09 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.685 ' CD2' ' H ' ' A' ' 286' ' ' PHE . 4.4 mm? 60.81 -3.39 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -136.12 -75.3 0.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 122.196 2.271 . . . . 0.0 112.643 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -84.28 -33.89 23.89 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' SER . . . . . 0.502 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 44.8 m -82.61 -45.34 14.68 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 116.509 -1.71 . . . . 0.0 108.527 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.16 -36.81 16.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-N 121.506 1.957 . . . . 0.0 107.878 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 30.3 ttt-85 -62.55 -45.48 92.75 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.875 0.845 . . . . 0.0 110.806 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -70.81 -35.3 72.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 118.15 -0.928 . . . . 0.0 113.148 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.733 HD11 ' H ' ' A' ' 261' ' ' SER . 55.6 mt -66.5 -47.09 74.08 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -7.0 59.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.523 -1.36 . . . . 0.0 111.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -97.47 -3.81 39.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.473 1.033 . . . . 0.0 111.709 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -105.49 -18.55 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.0 m -81.89 -158.3 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 61.4 m -84.44 146.05 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.013 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -137.34 149.53 47.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.052 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -137.93 127.3 14.92 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 122.049 -0.407 . . . . 0.0 110.703 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -82.87 35.55 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.754 4.303 . . . . 0.0 109.566 169.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.612 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -61.26 -10.82 7.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -173.139 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.427 ' N ' HD22 ' A' ' 304' ' ' LEU . 22.9 t 20.65 94.87 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 168.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -81.96 -10.1 11.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.652 2.901 . . . . 0.0 113.628 169.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.5 -24.58 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.668 0.787 . . . . 0.0 111.962 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 164.87 -26.89 0.19 Allowed Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.394 -1.226 . . . . 0.0 111.815 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 309' ' ' LEU . 1.4 pt? -89.74 169.94 10.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 171.59 10.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.851 0.86 . . . . 0.0 109.342 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.62 154.53 50.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -113.07 148.63 34.82 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.15 162.42 39.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -163.4 176.01 10.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.9 ptpt -135.4 132.47 37.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.42 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 0.0 OUTLIER -135.49 9.47 3.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -165.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.0 t -66.13 150.98 47.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 11.0 m -85.36 15.36 4.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.556 0.743 . . . . 0.0 110.133 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.57 24.74 3.23 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.479 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -75.01 -23.44 58.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.848 0.749 . . . . 0.0 112.308 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -148.76 -26.83 0.31 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -152.53 168.18 26.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.105 0.562 . . . . 0.0 110.642 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 74.1 m -118.22 134.63 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.818 1.247 . . . . 0.0 107.722 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 17.0 tppt? -152.93 129.68 10.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 122.542 1.163 . . . . 0.0 114.029 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.91 137.57 36.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.01 1.724 . . . . 0.0 111.972 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 327' ' ' GLN . 9.1 p -123.89 157.58 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.416 ' N ' HG22 ' A' ' 326' ' ' VAL . 5.1 pp0? -107.46 154.72 20.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.117 0.261 . . . . 0.0 110.62 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.58 136.5 46.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.276 0.56 . . . . 0.0 111.788 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 73.0 mt -142.17 109.4 5.86 Favored Pre-proline 0 C--O 1.232 0.165 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 164.96 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.089 1 C-N-CA 125.337 4.025 . . . . 0.0 112.085 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.605 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 1.7 t90 -83.66 133.3 34.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.46 152.33 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 123.605 0.762 . . . . 0.0 110.251 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.8 tt -54.46 -27.1 35.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.28 4.11 2.46 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.694 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.94 7.41 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.035 0.934 . . . . 0.0 109.567 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.3 m -129.24 -22.0 3.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 150.72 34.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.71 132.6 15.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.362 -1.745 . . . . 0.0 107.928 170.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -141.96 146.23 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.187 0.994 . . . . 0.0 111.816 177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -103.32 -15.72 15.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.575 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 339' ' ' VAL . 42.3 t -94.52 140.22 22.6 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.426 1.09 . . . . 0.0 110.444 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.4 16.2 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.204 3.269 . . . . 0.0 110.427 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 15.6 t -122.74 161.27 24.24 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.813 -1.179 . . . . 0.0 110.447 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' A' ' 344' ' ' GLN . 5.0 pm0 -79.8 22.47 0.48 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 122.33 1.062 . . . . 0.0 113.43 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -65.59 155.26 36.35 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.59 1.156 . . . . 0.0 109.342 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 22.4 tp -154.92 155.43 34.26 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.059 0.391 . . . . 0.0 111.222 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.452 ' H ' HG21 ' A' ' 397' ' ' THR . 42.4 t0 -136.58 73.35 55.37 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.016 0.926 . . . . 0.0 110.065 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.71 5.08 4.57 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.079 2.519 . . . . 0.0 111.946 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.5 t -78.29 -13.42 59.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.847 -1.158 . . . . 0.0 111.602 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -147.26 85.74 1.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.8 p -133.8 154.0 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.049 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.02 158.76 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 119.086 0.857 . . . . 0.0 110.045 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -95.19 146.46 24.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 123.837 0.711 . . . . 0.0 111.352 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.22 140.4 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.12 -178.41 32.13 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.41 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.26 47.26 21.94 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 124.469 1.107 . . . . 0.0 110.595 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 36.5 mt -84.67 -174.83 5.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 360' ' ' MET . 0.2 OUTLIER -61.92 -25.35 67.52 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.764 176.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 78.22 5.54 87.39 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 120.364 -1.46 . . . . 0.0 109.939 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.413 ' HB3' ' CE1' ' A' ' 358' ' ' HIS . 16.5 ttt -152.93 29.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.11 95.43 0.73 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.849 1.309 . . . . 0.0 110.464 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -81.12 162.23 23.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.18 -7.75 50.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.134 -171.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -90.12 -26.59 20.13 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.97 -29.63 24.92 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.08 -49.1 63.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.201 0.6 . . . . 0.0 109.458 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.96 -31.38 71.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.264 -0.273 . . . . 0.0 111.538 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.4 87.1 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.2 mt -65.46 -45.02 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.2 mt -85.57 -29.76 23.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -21.56 30.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.778 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -107.71 -20.47 13.21 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.54 -14.96 23.19 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.399 -1.438 . . . . 0.0 110.521 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.05 -41.64 2.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 112.812 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 73.38 -1.6 42.18 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.65 117.61 1.1 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.107 0.953 . . . . 0.0 111.03 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 11.9 t -152.44 168.58 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.25 -29.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -159.75 158.56 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -165.94 146.66 6.68 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -159.46 151.97 22.86 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 121.42 0.456 . . . . 0.0 114.054 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.32 150.33 4.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -97.39 74.75 2.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.9 p -61.23 146.37 48.03 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.62 17.48 14.42 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.733 1.213 . . . . 0.0 111.705 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.0 tptm 51.53 124.31 0.0 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 128.022 2.529 . . . . 0.0 114.878 -170.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 58.2 m170 61.13 27.79 17.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -133.47 -0.91 3.19 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 6.1 p90 25.98 66.97 0.47 Allowed Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.033 1.333 . . . . 0.0 112.282 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.53 -49.84 0.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 124.262 3.308 . . . . 0.0 110.783 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.91 35.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 111.635 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.34 15.6 1.29 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.131 0.872 . . . . 0.0 114.659 -172.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 77.3 p -163.45 145.45 9.69 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.355 0.662 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.79 -161.95 28.71 Favored Glycine 0 N--CA 1.427 -1.907 0 O-C-N 120.685 -1.259 . . . . 0.0 112.725 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.54 166.88 25.15 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.719 -0.871 . . . . 0.0 111.946 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 144.07 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.662 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.452 HG21 ' H ' ' A' ' 347' ' ' ASP . 44.3 m -116.72 131.64 56.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 123.533 0.521 . . . . 0.0 110.693 -172.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -118.99 155.75 30.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.515 1.135 . . . . 0.0 111.909 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.11 7.01 10.77 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -136.89 166.61 23.21 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.041 1.337 . . . . 0.0 109.648 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -98.08 -28.34 13.8 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.575 ' HD3' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -62.9 -26.1 68.64 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.878 0.763 . . . . 0.0 112.987 -175.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 71.7 p -73.45 -33.04 64.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -68.62 -55.13 12.56 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 119.237 0.926 . . . . 0.0 110.645 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -24.02 58.46 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.136 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -78.4 -23.2 46.87 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 118.238 -1.385 . . . . 0.0 111.221 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.91 -26.2 36.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.247 -0.908 . . . . 0.0 111.497 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.85 -27.95 5.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.059 0.457 . . . . 0.0 111.049 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.6 p -83.39 -18.86 37.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.744 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -90.69 -45.69 8.71 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.033 0.444 . . . . 0.0 110.456 171.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.91 -10.39 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.855 2.062 . . . . 0.0 114.31 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -161.07 144.65 13.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.32 156.31 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 O-C-N 120.868 -1.145 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.434 ' CD ' ' N ' ' A' ' 414' ' ' GLU . 17.1 mp0 -120.18 137.94 53.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.594 0.711 . . . . 0.0 112.396 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.45 124.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 46.91 1.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.247 1.022 . . . . 0.0 111.786 -175.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.9 p -66.47 169.7 7.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.67 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.8 t -69.78 1.53 4.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.305 0.642 . . . . 0.0 110.749 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.45 0.88 0.44 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -171.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -154.37 139.35 17.29 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.419 -0.801 . . . . 0.0 112.512 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 50.6 p -139.08 124.05 18.83 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.205 -0.934 . . . . 0.0 110.766 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 0.8 OUTLIER -168.82 -179.33 3.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.429 176.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 55.6 mtmt -140.99 172.15 13.08 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.18 152.32 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 124.346 1.028 . . . . 0.0 109.353 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -117.09 152.16 35.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 111.623 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.92 141.79 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.288 0.566 . . . . 0.0 111.61 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.92 124.85 8.64 Favored Pre-proline 0 C--O 1.246 0.874 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.85 158.47 18.53 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 124.082 3.188 . . . . 0.0 114.001 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 C--O 1.263 1.775 0 CA-C-O 117.285 -1.34 . . . . 0.0 111.115 171.329 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.355 0.598 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.2 t -167.06 173.28 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TRP . . . . . 0.461 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -126.37 7.37 7.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.8 m 46.56 37.75 4.81 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.356 -0.84 . . . . 0.0 112.464 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -168.96 77.92 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.244 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 164.92 25.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.939 0.435 . . . . 0.0 110.839 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.3 mm? -78.93 152.85 77.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.28 114.45 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.915 2.41 . . . . 0.0 112.314 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 364' ' ' GLU . 34.8 Cg_endo -82.12 -165.07 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.413 4.075 . . . . 0.0 111.43 175.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 58.51 32.67 22.38 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.797 0.439 . . . . 0.0 111.801 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -99.48 -1.06 39.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -74.12 153.55 39.52 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.854 0.861 . . . . 0.0 110.446 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -148.84 25.39 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.264 1.026 . . . . 0.0 110.809 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -131.99 62.2 62.43 Favored Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 120.632 -1.293 . . . . 0.0 112.084 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -68.91 117.46 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.328 3.352 . . . . 0.0 112.928 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.1 mm -140.82 151.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -109.38 141.25 42.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.925 1.239 . . . . 0.0 110.643 -173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.5 t -133.48 3.65 3.61 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.397 0.544 . . . . 0.0 112.449 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 3.6 t -153.21 177.6 10.66 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.053 0.541 . . . . 0.0 110.257 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.87 166.32 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.062 1.345 . . . . 0.0 113.924 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.01 138.14 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.89 133.01 33.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.481 HD11 HG13 ' A' ' 326' ' ' VAL . 23.0 tp -139.5 112.72 8.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.145 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.86 155.81 26.47 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.114 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.74 13.73 1.39 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 124.153 0.56 . . . . 0.0 113.081 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.17 117.14 58.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.674 -0.898 . . . . 0.0 111.826 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.7 -4.4 8.2 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.754 2.969 . . . . 0.0 113.368 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -105.71 -109.57 0.29 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.26 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 38.7 t70 43.87 74.8 0.11 Allowed 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 119.859 1.209 . . . . 0.0 111.372 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.407 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -83.77 -10.37 11.73 Favored 'Isoleucine or valine' 0 C--O 1.273 2.291 0 CA-C-N 118.551 0.614 . . . . 0.0 110.692 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.4 p -146.18 129.03 16.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.3 -22.11 66.67 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.648 0.737 . . . . 0.0 109.917 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -74.14 -21.92 59.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.298 -1.501 . . . . 0.0 110.9 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.69 -57.3 5.48 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.47 -42.69 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.079 0.952 . . . . 0.0 112.52 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.1 t -73.51 -32.83 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.474 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.62 -20.16 57.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.693 0.679 . . . . 0.0 111.294 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -73.1 -30.03 63.36 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.905 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -129.88 16.87 5.73 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -89.63 -21.83 22.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 120.018 1.281 . . . . 0.0 112.181 171.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.18 24.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -143.29 7.88 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.782 0.719 . . . . 0.0 112.659 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -167.44 169.98 41.39 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-O 121.935 0.742 . . . . 0.0 113.04 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.9 t -82.31 77.92 9.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.385 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.05 166.85 24.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 52.7 m -147.88 -175.08 4.74 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.898 1.333 . . . . 0.0 110.836 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.67 154.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 123.813 0.845 . . . . 0.0 111.689 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -142.29 131.69 23.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 124.951 1.407 . . . . 0.0 110.929 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -93.07 133.67 28.42 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.578 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 282' ' ' VAL . 66.8 Cg_endo -76.71 -23.19 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 O-C-N 123.962 1.506 . . . . 0.0 112.189 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.06 -66.99 1.57 Allowed Glycine 0 C--O 1.218 -0.866 0 C-N-CA 123.074 0.368 . . . . 0.0 112.379 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? 48.39 49.09 18.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.954 0.502 . . . . 0.0 110.253 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.87 35.31 3.95 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.259 1.824 . . . . 0.0 114.453 -170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.88 163.06 35.1 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.521 0.512 . . . . 0.0 111.951 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -92.17 169.13 10.86 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 122.467 -0.431 . . . . 0.0 110.505 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB3' ' CD ' ' A' ' 274' ' ' PRO . 14.0 m80 60.67 173.33 0.06 OUTLIER Pre-proline 0 C--O 1.219 -0.525 0 C-N-CA 125.766 1.626 . . . . 0.0 112.846 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 273' ' ' HIS . 32.4 Cg_exo -60.59 40.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 1 C-N-CA 126.723 4.948 . . . . 0.0 114.687 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -147.7 41.47 1.03 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.842 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.51 129.3 25.92 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.976 0.51 . . . . 0.0 109.671 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.42 134.04 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.456 1.438 . . . . 0.0 111.146 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.14 158.7 5.73 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 124.277 3.318 . . . . 0.0 109.545 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -100.95 12.87 36.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 0.0 108.858 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 112.95 -9.76 25.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -171.64 169.15 6.1 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.855 0.827 . . . . 0.0 110.606 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 267' ' ' PRO . 32.7 m -148.79 -174.09 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.104 1.762 . . . . 0.0 108.978 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -123.08 153.39 39.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 111.466 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.76 139.06 42.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.728 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.9 131.25 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.498 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 35.6 p90 -167.35 -151.15 0.11 Allowed 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 123.509 0.505 . . . . 0.0 110.378 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.34 -8.53 0.78 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.453 ' HA ' HG23 ' A' ' 292' ' ' VAL . 90.8 mt 50.75 -163.58 0.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 111.461 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.9 -78.59 0.0 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.276 2.63 . . . . 0.0 114.952 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -84.18 -32.8 24.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.741 1.275 . . . . 0.0 111.213 -172.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 75.6 m -85.23 -15.69 42.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.643 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 288' ' ' LEU . 79.0 t -68.32 -51.48 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -66.53 -26.4 67.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.2 t -65.19 -46.45 80.69 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 118.537 0.608 . . . . 0.0 110.786 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.39 -44.16 83.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 119.805 -1.809 . . . . 0.0 110.351 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.56 -26.96 67.37 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 124.341 1.025 . . . . 0.0 109.441 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -92.96 -10.0 37.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 120.14 1.336 . . . . 0.0 111.389 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -102.91 -19.78 14.51 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.08 178.39 7.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.013 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.2 t -77.91 163.81 25.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.369 1.668 . . . . 0.0 111.544 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -151.2 160.23 43.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.679 1.192 . . . . 0.0 111.079 -175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.18 124.76 7.67 Favored Pre-proline 0 CA--C 1.517 -0.312 0 O-C-N 121.473 -0.767 . . . . 0.0 110.02 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.426 ' C ' ' HD3' ' A' ' 306' ' ' PRO . 35.8 Cg_endo -84.43 51.29 3.24 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 124.556 3.504 . . . . 0.0 108.324 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.5 HD13 ' H ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -70.73 -27.57 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 -173.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.5 ' H ' HD13 ' A' ' 304' ' ' LEU . 23.2 t -159.78 57.51 1.01 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 111.236 177.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 303' ' ' PRO . 61.5 Cg_endo -67.94 6.62 0.76 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.695 2.93 . . . . 0.0 112.399 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.0 -18.35 64.69 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 124.203 0.939 . . . . 0.0 109.29 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -174.32 -1.98 0.03 OUTLIER Glycine 0 C--N 1.341 0.836 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.85 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -142.97 154.33 43.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.677 1.238 . . . . 0.0 109.857 -177.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.676 ' H ' HD13 ' A' ' 309' ' ' LEU . 32.3 m -143.35 149.36 37.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.747 1.619 . . . . 0.0 109.304 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -132.71 136.32 46.33 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 122.223 -0.298 . . . . 0.0 110.768 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 328' ' ' VAL . 64.9 m-85 -118.44 159.16 23.97 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -153.35 159.37 42.45 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 122.077 -0.389 . . . . 0.0 111.978 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -145.25 159.43 43.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.706 -0.621 . . . . 0.0 111.007 172.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -110.35 118.53 36.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.25 21.23 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.63 0.195 . . . . 0.0 111.429 -169.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.5 t -137.11 162.67 32.76 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.185 -0.947 . . . . 0.0 111.122 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 32.4 p -145.3 -10.95 0.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.875 0.87 . . . . 0.0 111.112 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 4.59 0.13 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -107.81 -38.92 5.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.877 -1.139 . . . . 0.0 110.576 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 15.8 mmt -133.91 -31.96 1.13 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.513 0.725 . . . . 0.0 109.205 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 46.12 27.48 0.54 Allowed 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.541 0.686 . . . . 0.0 110.92 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.5 -173.68 4.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 324' ' ' LYS . 0.4 OUTLIER 57.5 68.8 0.8 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.743 1.217 . . . . 0.0 114.001 176.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 325' ' ' GLU . 3.6 mp0 -46.7 156.73 0.18 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.327 173.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.481 HG13 HD11 ' A' ' 240' ' ' LEU . 7.6 p -119.4 142.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -86.53 137.46 32.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.829 0.74 . . . . 0.0 110.086 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.5 p -132.57 137.05 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 123.936 0.772 . . . . 0.0 111.924 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 328' ' ' VAL . 7.8 pt -156.76 130.76 4.84 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.67 168.6 8.29 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.544 4.162 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.409 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 1.7 t90 -82.14 124.17 29.63 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 169.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 334' ' ' ALA . 21.3 t -100.76 137.31 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.85 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.69 -35.12 60.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.933 1.293 . . . . 0.0 110.994 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.495 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -79.82 11.44 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 118.392 -0.814 . . . . 0.0 112.807 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.11 6.28 10.79 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.671 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.1 p -139.45 -2.45 1.6 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -147.91 153.58 39.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -155.02 139.1 16.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.77 0.828 . . . . 0.0 111.82 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.93 155.5 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 118.867 0.758 . . . . 0.0 111.593 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -102.68 -6.86 22.24 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 108.789 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 342' ' ' PRO . 60.6 m -131.2 166.15 29.92 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 123.703 0.801 . . . . 0.0 112.818 -171.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 57.2 Cg_endo -66.15 -9.06 22.15 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.354 2.036 . . . . 0.0 112.169 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 58.4 p -85.14 168.94 14.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.897 0.879 . . . . 0.0 109.911 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -136.32 24.22 3.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.164 0.507 . . . . 0.0 110.938 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -112.57 164.45 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.016 0.927 . . . . 0.0 111.691 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -111.84 -171.58 1.87 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.426 1.49 . . . . 0.0 110.499 -173.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.86 93.3 31.61 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.919 1.288 . . . . 0.0 107.923 171.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.71 -0.22 0.36 Allowed 'Trans proline' 0 C--O 1.24 0.579 1 C-N-CA 126.063 4.508 . . . . 0.0 115.933 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.7 m -117.66 3.93 12.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.18 0.592 . . . . 0.0 111.653 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -141.71 55.64 1.5 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.945 0.793 . . . . 0.0 109.981 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.5 t -143.34 154.02 43.32 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.88 159.89 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 124.18 0.925 . . . . 0.0 110.432 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -84.92 138.65 32.38 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.296 0.998 . . . . 0.0 113.306 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.48 149.04 24.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.095 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 178.15 -168.05 39.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.97 22.99 2.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.209 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 357' ' ' LEU . 0.6 OUTLIER -92.13 137.43 32.37 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.659 -175.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 358' ' ' HIS . . . . . 0.489 ' CD2' ' H ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER 29.02 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.885 1.274 . . . . 0.0 112.98 169.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.64 -12.65 0.05 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-O 118.132 -1.371 . . . . 0.0 111.008 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.7 mmt -133.93 -52.41 0.85 Allowed 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 125.232 1.195 . . . . 0.0 108.389 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 357' ' ' LEU . 16.0 tp 27.67 77.56 0.02 OUTLIER 'General case' 0 C--N 1.347 0.468 0 O-C-N 124.585 1.178 . . . . 0.0 111.992 -171.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -61.64 164.25 6.23 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 123.972 0.909 . . . . 0.0 111.761 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.74 -22.7 62.43 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 226' ' ' PRO . 71.1 mm-40 -83.2 -32.54 26.5 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 119.508 1.049 . . . . 0.0 110.086 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -73.82 -40.78 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 122.117 -0.365 . . . . 0.0 110.135 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.09 -46.76 82.84 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.34 65.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.712 -1.242 . . . . 0.0 111.58 -173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.05 80.35 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.403 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 89.3 mt -71.66 -41.42 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 -16.31 49.71 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.35 -1.309 . . . . 0.0 114.2 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -16.55 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 120.316 1.417 . . . . 0.0 114.367 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.45 -20.62 13.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.105 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.77 -14.36 18.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.572 1.078 . . . . 0.0 111.091 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -117.3 -64.64 1.28 Allowed 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.206 -0.934 . . . . 0.0 110.766 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 161.73 -151.23 21.31 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.324 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -66.08 130.13 32.59 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 126.248 1.88 . . . . 0.0 110.376 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.23 164.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 126.177 1.791 . . . . 0.0 107.844 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.65 -28.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.444 0.565 . . . . 0.0 112.111 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.3 OUTLIER -157.32 156.78 32.96 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -149.67 143.03 25.22 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -154.24 171.85 32.81 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 122.09 0.828 . . . . 0.0 114.181 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.487 ' HA ' ' HA3' ' A' ' 394' ' ' GLY . 26.7 mt -127.39 144.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 128.635 2.774 . . . . 0.0 108.478 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.86 149.01 24.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.337 -0.852 . . . . 0.0 111.882 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.2 p -108.91 161.41 15.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.192 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -130.02 34.56 4.23 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.519 1.152 . . . . 0.0 111.973 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 tptm 61.99 95.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.454 1.902 . . . . 0.0 111.397 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 m170 48.48 28.04 1.6 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -104.12 11.73 34.79 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.522 1.056 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 52.4 p90 44.82 49.25 5.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 126.576 1.951 . . . . 0.0 114.144 173.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.62 -52.62 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 119.338 0.799 . . . . 0.0 112.082 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.409 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 37.62 47.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 123.57 0.748 . . . . 0.0 109.826 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -158.86 6.71 0.15 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.9 p -153.8 138.61 17.09 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 382' ' ' ILE . . . -169.15 -149.17 6.1 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -154.94 172.85 17.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.974 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.2 132.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 52.2 m -101.59 110.68 22.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.848 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.1 157.17 16.01 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.708 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.76 -0.06 6.06 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.965 0.791 . . . . 0.0 109.604 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -120.82 135.86 55.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.058 1.343 . . . . 0.0 108.126 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.01 -25.69 67.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.662 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.94 -31.33 72.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.01 0.823 . . . . 0.0 110.965 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 m -80.43 -12.27 59.58 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.869 -1.144 . . . . 0.0 111.257 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.37 -60.72 2.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.536 -0.727 . . . . 0.0 109.174 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.65 63.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.495 -176.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.25 -26.32 35.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.965 0.802 . . . . 0.0 111.457 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 426' ' ' ILE . . . -75.27 -31.03 60.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.373 -0.829 . . . . 0.0 111.036 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.31 -26.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.963 0.905 . . . . 0.0 111.223 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.2 p -84.27 -26.09 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.28 -40.82 10.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.517 0.327 . . . . 0.0 110.273 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.2 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.73 141.16 10.0 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 120.297 1.408 . . . . 0.0 108.89 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -141.38 159.3 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.548 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -113.64 110.15 19.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.172 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.1 mm -77.2 129.58 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 173.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 30.3 ttmt -153.99 98.12 2.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.302 0.572 . . . . 0.0 109.487 -170.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 418' ' ' THR . 3.9 m -143.79 179.65 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 417' ' ' THR . 2.0 m -78.52 2.11 20.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.9 -0.5 . . . . 0.0 110.781 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -129.98 -8.45 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.63 131.93 11.13 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.416 -0.802 . . . . 0.0 111.395 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 7.1 p -143.64 86.81 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.829 0.741 . . . . 0.0 110.871 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -150.55 172.32 15.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.95 0.9 . . . . 0.0 109.951 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -128.56 167.72 16.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.695 0.398 . . . . 0.0 111.17 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.93 145.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 CA-C-N 118.748 0.704 . . . . 0.0 109.296 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -122.69 150.2 43.04 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.026 0.917 . . . . 0.0 112.702 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 407' ' ' ALA . 4.4 mp -133.2 145.96 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.226 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -150.74 128.38 5.68 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -83.66 166.83 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 2.78 . . . . 0.0 111.538 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.359 1.064 . . . . 0.0 111.057 176.886 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 C--O 1.218 -0.603 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.9 m 57.65 164.77 0.03 OUTLIER 'General case' 0 C--O 1.246 0.888 0 CA-C-O 122.68 1.229 . . . . 0.0 110.407 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -157.59 -40.58 0.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.887 -1.133 . . . . 0.0 112.143 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 m 47.81 22.89 0.39 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 57.41 69.25 1.33 Allowed Glycine 0 N--CA 1.447 -0.613 0 O-C-N 120.845 -1.159 . . . . 0.0 112.803 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -71.8 -21.58 61.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.794 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.513 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 1.0 OUTLIER -155.55 9.15 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -176.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 224' ' ' LEU . 42.6 Cg_endo -64.61 119.49 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 122.331 1.868 . . . . 0.0 111.605 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.2 142.28 41.35 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 124.4 3.4 . . . . 0.0 111.254 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -138.32 170.19 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.171 0.989 . . . . 0.0 110.772 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.35 38.11 29.44 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.816 0.817 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -54.58 30.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.989 1.316 . . . . 0.0 110.41 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 71.0 tttt 55.25 45.33 25.97 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -114.56 -46.91 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.11 -174.25 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.442 1 C-N-CA 125.304 4.002 . . . . 0.0 114.649 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 234' ' ' TYR . 4.2 mp -109.2 -179.09 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.709 ' H ' HG22 ' A' ' 233' ' ' ILE . 30.9 m-85 -93.74 158.25 15.76 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 51.0 m -145.08 -0.78 0.87 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.72 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.609 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 12.0 m -149.46 -164.55 2.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.875 1.216 . . . . 0.0 110.996 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 236' ' ' CYS . 0.1 OUTLIER -59.93 172.09 0.82 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.503 1.144 . . . . 0.0 111.542 -177.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.29 138.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.413 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -81.64 143.4 31.95 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 122.162 0.982 . . . . 0.0 109.444 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.479 ' C ' HD13 ' A' ' 240' ' ' LEU . 1.0 OUTLIER -141.02 108.22 5.49 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.65 164.53 29.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.75 12.16 5.62 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.853 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.02 116.48 65.58 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 119.097 1.449 . . . . 0.0 111.431 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.24 1.83 5.23 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 124.644 3.562 . . . . 0.0 110.406 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -141.49 175.82 9.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.3 1.04 . . . . 0.0 109.956 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.52 155.16 10.61 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.221 0.534 . . . . 0.0 110.584 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -133.67 -44.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.281 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.014 170.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 250' ' ' ALA . 7.4 m -168.48 148.72 4.63 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.809 1.943 . . . . 0.0 108.18 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -70.08 -26.73 64.13 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 119.749 -1.845 . . . . 0.0 111.722 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.454 ' H ' HG22 ' A' ' 248' ' ' THR . . . -80.91 -19.35 44.49 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.464 0.706 . . . . 0.0 110.358 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.18 -58.04 6.42 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.34 -40.06 70.76 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.178 0.575 . . . . 0.0 110.216 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.702 ' CG2' HG21 ' A' ' 264' ' ' VAL . 54.6 t -70.39 -41.32 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 118.836 -2.415 . . . . 0.0 110.414 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.22 0.09 10.71 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.854 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 48.1 m -87.8 -28.04 21.92 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.036 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -137.98 16.15 2.85 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.6 20.6 0.22 Allowed 'General case' 0 C--O 1.24 0.592 0 O-C-N 120.45 -1.406 . . . . 0.0 112.789 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.89 6.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 120.208 1.367 . . . . 0.0 110.611 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.98 -11.35 58.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.916 -1.115 . . . . 0.0 112.151 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.16 -4.08 59.76 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.828 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 10.7 t -127.3 22.6 6.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.26 1.03 . . . . 0.0 111.817 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.4 OUTLIER -92.76 144.26 25.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.928 -1.107 . . . . 0.0 109.988 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.3 m -152.68 172.05 17.26 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 125.788 1.93 . . . . 0.0 107.893 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.702 HG21 ' CG2' ' A' ' 253' ' ' VAL . 61.3 t -148.29 144.0 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.293 -169.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -109.21 131.71 54.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.955 0.784 . . . . 0.0 109.939 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.419 ' CE3' HG21 ' A' ' 282' ' ' VAL . 2.0 t-105 -145.28 81.99 10.04 Favored Pre-proline 0 C--O 1.242 0.691 0 CA-C-O 122.048 0.927 . . . . 0.0 110.979 -167.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 164.22 31.99 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 123.786 2.991 . . . . 0.0 109.747 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.01 -4.36 85.61 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -66.56 65.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.403 1.481 . . . . 0.0 111.308 174.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -142.95 2.25 1.33 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.512 0.725 . . . . 0.0 111.817 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.3 -154.08 8.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.264 0.935 . . . . 0.0 111.548 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.89 168.27 12.18 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 24.0 m170 67.47 150.84 0.12 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.066 2.147 . . . . 0.0 114.445 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.32 -4.27 14.55 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.823 2.349 . . . . 0.0 109.661 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -95.9 11.93 32.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.878 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 277' ' ' PRO . 1.8 p 63.26 155.67 0.12 Allowed Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 129.012 2.925 . . . . 0.0 111.208 -173.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 276' ' ' CYS . 84.7 Cg_endo -77.79 159.21 31.43 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.402 3.401 . . . . 0.0 111.814 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.94 136.36 18.46 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.037 3.158 . . . . 0.0 111.714 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -144.76 155.51 43.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -76.45 -21.08 76.0 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-O 117.998 -1.446 . . . . 0.0 113.334 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -166.56 168.66 14.43 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.419 HG21 ' CE3' ' A' ' 266' ' ' TRP . 21.8 m -156.84 -163.69 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.941 2.096 . . . . 0.0 108.71 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -148.09 150.7 34.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.532 1.06 . . . . 0.0 111.652 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 284' ' ' LEU . 5.3 mp -101.97 156.35 17.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.89 122.73 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 31.5 p90 -165.66 -157.54 0.32 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 117.499 -1.239 . . . . 0.0 109.915 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 93.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.81 ' H ' HD23 ' A' ' 288' ' ' LEU . 0.8 OUTLIER -69.78 14.0 0.12 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.65 2.38 . . . . 0.0 115.75 -167.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -136.09 -53.96 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.571 1.532 . . . . 0.0 111.111 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -88.05 -41.16 13.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.83 -170.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 73.9 m -74.77 -32.99 62.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.86 -47.81 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 122.105 -0.372 . . . . 0.0 110.896 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -73.3 -20.34 60.83 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.82 -0.55 . . . . 0.0 112.109 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.5 m -79.78 -35.53 38.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.606 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -46.34 87.05 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.713 172.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.07 -17.08 61.46 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.066 0.848 . . . . 0.0 110.467 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -87.97 -9.7 52.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 122.727 0.411 . . . . 0.0 111.743 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.04 -3.22 15.6 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.03 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.4 m -109.68 -154.67 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.939 1.399 . . . . 0.0 110.858 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.6 m -136.06 160.49 38.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.028 1.394 . . . . 0.0 109.641 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 74.1 t60 -142.44 165.56 27.08 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.86 -1.775 . . . . 0.0 111.343 -173.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 13.3 m-20 -147.01 115.97 4.39 Favored Pre-proline 0 C--O 1.212 -0.913 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -85.39 25.75 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 126.178 4.586 . . . . 0.0 111.538 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -47.98 -36.23 12.26 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.027 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.419 ' H ' HD12 ' A' ' 304' ' ' LEU . 7.5 t 39.35 47.97 1.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.173 1.789 . . . . 0.0 113.741 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.31 -19.68 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.279 3.319 . . . . 0.0 113.009 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -124.42 24.63 7.9 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.56 87.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.23 150.08 43.89 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.374 0.607 . . . . 0.0 110.24 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.2 m -107.62 169.91 8.3 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.614 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -141.91 149.03 39.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 1.064 . . . . 0.0 109.154 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' TYR . . . . . 0.404 ' HB2' HG23 ' A' ' 328' ' ' VAL . 5.9 m-85 -122.47 149.09 44.35 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -138.61 153.62 48.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 122.808 1.289 . . . . 0.0 112.104 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -146.61 169.63 18.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.426 -0.797 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -128.6 74.85 1.59 Allowed 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -76.72 1.37 17.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.373 177.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 67.9 m -57.66 137.27 56.61 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 25.1 t -108.77 175.2 5.55 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.816 -1.178 . . . . 0.0 109.257 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -60.65 0.5 0.2 Allowed 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 124.838 1.255 . . . . 0.0 113.822 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 ptm85 -105.12 8.21 34.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.35 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 74.1 mmm -128.78 169.91 13.97 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 46.4 mtt85 -119.49 0.06 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.342 0.657 . . . . 0.0 111.371 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 93.8 m -124.01 -174.94 3.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.677 0.791 . . . . 0.0 109.712 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -150.71 166.31 30.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 66.13 147.3 0.04 OUTLIER 'General case' 0 C--N 1.342 0.279 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.58 165.03 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.293 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 143.82 35.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.622 0.769 . . . . 0.0 110.249 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 312' ' ' TYR . 28.2 m -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.903 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 34.9 mt -144.84 107.8 4.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.52 171.8 15.33 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.257 2.638 . . . . 0.0 111.892 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.609 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.2 t-105 -101.41 112.32 24.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 169.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.29 157.61 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.04 -0.412 . . . . 0.0 110.5 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.64 -28.0 63.32 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.355 1.062 . . . . 0.0 109.859 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.21 -4.98 8.75 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 124.687 1.242 . . . . 0.0 110.176 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.68 8.66 15.04 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.57 1.148 . . . . 0.0 110.274 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.8 m -115.5 -47.13 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.642 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -155.67 166.27 34.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.908 0.861 . . . . 0.0 110.125 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -153.86 144.53 22.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 110.451 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.22 145.06 18.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -106.66 -16.54 14.48 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.803 1.314 . . . . 0.0 111.427 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 60.1 m -96.73 147.36 32.82 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.294 -0.879 . . . . 0.0 111.351 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.09 -26.43 7.74 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.244 2.629 . . . . 0.0 112.707 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.1 m -143.51 2.92 1.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.2 154.26 22.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.912 1.339 . . . . 0.0 110.062 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.23 177.37 6.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.391 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 346' ' ' LEU . 1.3 mm? -58.33 151.64 19.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.234 -0.916 . . . . 0.0 111.303 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -89.88 137.49 28.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.08 -2.8 13.01 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.003 2.468 . . . . 0.0 115.869 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 41.5 p -142.26 -0.6 1.25 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.552 1.141 . . . . 0.0 112.98 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -123.24 60.66 1.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 397' ' ' THR . 18.6 p -138.27 147.72 43.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 428' ' ' PRO . 22.3 m -123.68 169.72 14.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 122.508 -0.12 . . . . 0.0 110.921 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -97.91 125.45 42.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.68 131.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -120.44 97.28 0.64 Allowed Glycine 0 C--O 1.213 -1.181 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.599 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -145.72 132.89 20.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.498 0.666 . . . . 0.0 110.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -160.98 155.76 23.78 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.6 1.16 . . . . 0.0 113.32 -169.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 358' ' ' HIS . . . . . 0.468 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 40.2 p-80 -159.98 6.51 0.09 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 169.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 116.94 -17.97 12.74 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.315 1.912 . . . . 0.0 112.388 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.6 ptm -166.05 43.27 0.07 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.552 0.676 . . . . 0.0 109.783 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.495 ' C ' HD13 ' A' ' 361' ' ' LEU . 3.0 tm? -57.79 132.23 52.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.37 166.0 12.83 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.758 -173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.36 -17.26 64.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 118.467 -0.778 . . . . 0.0 111.453 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -77.72 -30.4 51.72 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.919 0.781 . . . . 0.0 109.431 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.39 74.49 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.19 -43.92 55.38 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.665 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.68 69.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.41 70.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.577 1.173 . . . . 0.0 114.053 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.57 -32.29 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 O-C-N 123.612 0.57 . . . . 0.0 110.403 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.86 -30.89 18.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.14 -14.18 31.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.918 -0.563 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.36 -33.36 13.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.503 0.668 . . . . 0.0 111.593 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.41 -11.89 19.85 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.09 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 403' ' ' SER . 23.7 m-85 -128.19 -42.36 1.53 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 173.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.75 87.19 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.415 1.007 . . . . 0.0 113.451 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -134.03 103.04 0.48 Allowed Glycine 0 C--N 1.352 1.428 0 CA-C-N 119.007 1.403 . . . . 0.0 110.352 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.44 159.02 15.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 117.587 0.694 . . . . 0.0 111.056 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.49 -58.0 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 123.829 0.852 . . . . 0.0 111.257 174.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' ' 346' ' ' LEU . 1.9 t80 -147.2 152.38 38.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.742 1.258 . . . . 0.0 110.737 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.32 137.76 29.03 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -136.0 151.61 20.78 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 122.212 0.896 . . . . 0.0 112.19 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.41 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -98.46 123.87 42.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 56.1 p -126.92 158.97 35.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.765 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.12 159.77 40.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 113.03 -1.896 . . . . 0.0 107.358 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.401 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 23.1 tptm -50.2 102.21 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.401 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 26.5 m80 54.99 22.31 4.29 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -12.45 59.99 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 111.731 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.8 p90 41.37 51.78 5.6 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.44 -30.31 8.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.112 2.541 . . . . 0.0 113.233 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.46 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 28.14 75.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 127.83 2.452 . . . . 0.0 114.143 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.53 -88.84 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 114.185 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.4 p -57.04 154.15 10.23 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.193 0.996 . . . . 0.0 108.809 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -162.77 -173.12 31.08 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.204 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -140.47 157.68 45.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.959 0.504 . . . . 0.0 110.234 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.16 151.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 351' ' ' THR . 9.9 t -129.59 146.22 51.42 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.518 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 61.4 m-85 -121.83 -30.09 4.19 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 123.947 0.779 . . . . 0.0 111.409 -172.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.93 16.48 5.79 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.472 0.483 . . . . 0.0 109.851 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -139.96 140.05 36.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.193 0.997 . . . . 0.0 109.735 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -80.53 -20.49 43.4 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.631 0.372 . . . . 0.0 111.692 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 402' ' ' ARG . 0.6 OUTLIER -58.6 -36.34 73.85 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.528 -177.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.518 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 12.1 m -82.71 -14.53 54.41 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.475 -0.766 . . . . 0.0 110.371 -172.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -76.91 -63.14 1.43 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.511 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.443 ' C ' HD22 ' A' ' 405' ' ' LEU 0.25 0.0 OUTLIER -71.09 -17.5 62.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 118.861 -1.136 . . . . 0.0 113.298 -176.246 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -84.45 -31.16 24.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.484 -0.76 . . . . 0.0 112.37 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.17 30.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.618 1.099 . . . . 0.0 108.197 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.51 -31.39 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.469 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.1 t -77.38 -27.36 52.5 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 124.868 1.355 . . . . 0.0 111.473 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.69 3.62 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.133 -176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.96 -14.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 425' ' ' GLN . 1.9 m-85 -157.71 148.29 20.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.678 0.672 . . . . 0.0 110.352 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.19 149.87 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.875 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.38 151.05 20.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 110.78 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.8 mt -124.01 117.4 50.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.542 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -127.57 64.25 1.35 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.307 1.051 . . . . 0.0 109.044 -178.125 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -76.93 159.92 29.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.007 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -63.18 -23.09 67.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.723 0.692 . . . . 0.0 110.998 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -142.69 33.14 1.43 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -167.25 125.41 1.29 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.144 0.973 . . . . 0.0 109.0 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 15.2 p -136.4 121.88 19.47 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.784 -1.198 . . . . 0.0 112.017 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.8 tptp -164.77 176.52 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.604 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 47.7 tttt -124.66 156.75 37.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.41 148.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.366 0.984 . . . . 0.0 110.32 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 40.3 tt0 -118.33 161.0 20.66 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 21.6 mt -142.29 137.63 29.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 124.46 1.1 . . . . 0.0 110.702 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.6 129.01 6.77 Favored Pre-proline 0 C--O 1.235 0.334 0 O-C-N 123.546 0.528 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' A' ' 352' ' ' VAL . 23.2 Cg_endo -83.79 174.02 8.87 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.447 1.431 . . . . 0.0 113.846 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 116.458 -1.734 . . . . 0.0 112.651 171.97 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 122.538 1.161 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 40.8 m -143.92 75.79 1.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.78 1.276 . . . . 0.0 107.946 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.13 2.57 55.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.702 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 415' ' ' ILE . 94.6 p -38.99 141.86 0.26 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -169.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 164.86 -17.41 0.1 Allowed Glycine 0 CA--C 1.537 1.447 0 O-C-N 124.356 1.035 . . . . 0.0 111.966 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 57.7 128.6 0.0 OUTLIER 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.985 2.514 . . . . 0.0 111.664 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.421 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 2.8 mm? -107.04 -49.23 0.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 117.514 -1.232 . . . . 0.0 112.994 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 368' ' ' ALA . 52.4 Cg_exo -60.55 161.31 21.22 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 125.337 4.024 . . . . 0.0 113.888 -174.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.94 160.46 45.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.796 2.997 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -151.63 32.0 0.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.648 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -99.32 -18.86 17.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.14 0.976 . . . . 0.0 112.763 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 42.4 -136.92 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 66.15 34.37 6.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.945 1.298 . . . . 0.0 111.997 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.565 ' H ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -136.4 -40.17 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 175.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 231' ' ' ASN . 7.6 Cg_exo -74.51 -176.88 2.98 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.362 2.041 . . . . 0.0 115.228 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.11 162.38 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 125.336 1.454 . . . . 0.0 108.868 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.454 ' CG ' HG11 ' A' ' 292' ' ' VAL . 14.1 m-85 -109.75 138.78 45.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.962 1.705 . . . . 0.0 107.811 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.9 t -152.04 2.34 0.36 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -171.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.632 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 71.2 m -148.63 63.58 1.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.48 -1.387 . . . . 0.0 114.44 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.23 162.3 0.2 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.356 0.662 . . . . 0.0 112.296 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.54 142.38 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -81.99 127.97 33.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.273 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.455 ' C ' HD13 ' A' ' 240' ' ' LEU . 2.1 tm? -136.53 108.33 7.07 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -159.24 160.52 31.34 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-O 122.703 1.168 . . . . 0.0 110.252 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.48 -3.16 3.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.28 122.75 88.27 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 120.604 -1.527 . . . . 0.0 109.629 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -87.2 -4.67 7.72 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 124.232 3.288 . . . . 0.0 109.45 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -134.42 176.26 8.77 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.285 1.434 . . . . 0.0 110.415 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.99 145.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.582 0.753 . . . . 0.0 109.874 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.14 -50.83 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.405 0 C-N-CA 122.601 0.36 . . . . 0.0 110.803 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -164.78 130.43 2.76 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.721 2.008 . . . . 0.0 105.753 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -70.97 -13.33 61.97 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 120.421 1.464 . . . . 0.0 111.965 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.04 65.78 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 125.347 1.459 . . . . 0.0 109.278 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.99 -35.68 84.66 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.83 -45.73 41.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.685 1.231 . . . . 0.0 108.63 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.9 t -62.93 -53.61 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 120.509 -1.37 . . . . 0.0 110.485 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -79.89 -13.71 59.18 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.8 t -81.52 -26.22 35.3 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.525 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -126.44 32.11 5.25 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.276 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 28.6 tpt85 -96.09 -18.2 20.34 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.436 1.094 . . . . 0.0 109.822 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 258' ' ' VAL . 4.7 t -70.35 20.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -128.12 0.4 5.84 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.466 -0.771 . . . . 0.0 112.888 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.56 -95.38 0.1 Allowed Glycine 0 N--CA 1.471 1.004 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.675 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.0 t -144.9 147.38 32.7 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.292 1.046 . . . . 0.0 109.408 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 151.67 24.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.0 m -149.71 175.72 11.32 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.34 150.25 18.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 121.072 -1.017 . . . . 0.0 113.468 -172.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.33 154.09 46.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.582 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.27 138.79 20.97 Favored Pre-proline 0 C--N 1.345 0.385 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.91 -170.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.98 -29.1 4.47 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 125.01 3.806 . . . . 0.0 109.769 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.56 -28.36 6.05 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.164 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 44.34 50.7 7.84 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.342 1.071 . . . . 0.0 110.371 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -118.89 -8.02 10.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.02 8.83 58.89 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.004 -0.887 . . . . 0.0 113.155 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.88 -36.33 76.68 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 118.642 1.221 . . . . 0.0 110.742 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -143.33 126.69 9.11 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.34 -12.41 12.8 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 125.06 3.84 . . . . 0.0 109.731 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -72.46 -72.28 0.25 Allowed 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 123.134 0.573 . . . . 0.0 111.014 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -158.24 143.7 12.22 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 124.592 1.183 . . . . 0.0 109.675 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.97 160.34 34.21 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.222 1.948 . . . . 0.0 111.16 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.37 27.19 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 125.234 3.956 . . . . 0.0 111.018 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.46 158.12 27.91 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -82.8 10.68 56.25 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.581 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.33 170.91 19.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.787 -177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 283' ' ' TYR . 11.7 p -156.85 176.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 125.217 1.573 . . . . 0.0 107.197 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 282' ' ' VAL . 10.6 m-85 -118.17 155.19 30.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 119.763 1.165 . . . . 0.0 111.374 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.02 135.25 55.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.86 120.31 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 125.577 1.551 . . . . 0.0 107.419 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -156.3 0.63 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.232 -174.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.62 18.87 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.187 0.449 . . . . 0.0 110.714 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 86.6 mt 48.99 -141.19 0.65 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 119.831 -1.793 . . . . 0.0 111.362 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 13.39 -74.42 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 127.593 2.357 . . . . 0.0 116.443 168.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -81.77 -29.12 32.92 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.813 0.845 . . . . 0.0 112.962 -170.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.7 m -78.56 -30.63 46.96 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.299 1.04 . . . . 0.0 108.705 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.454 HG11 ' CG ' ' A' ' 234' ' ' TYR . 62.4 t -68.19 -57.3 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -72.56 -20.4 61.32 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.8 t -71.77 -42.92 66.59 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.93 -0.482 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.86 -45.91 33.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.382 0.992 . . . . 0.0 111.497 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -16.32 61.84 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.468 1.031 . . . . 0.0 113.38 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -95.29 -17.03 21.99 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.69 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -78.16 -19.46 53.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 119.957 1.253 . . . . 0.0 112.307 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 5.1 t -115.26 -108.19 0.37 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.341 1.026 . . . . 0.0 113.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.2 t -142.64 163.56 32.48 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -168.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -146.94 156.23 42.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.314 1.846 . . . . 0.0 106.844 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -142.86 125.78 9.09 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.18 13.02 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 1 C-N-CA 127.521 5.481 . . . . 0.0 112.478 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.698 HD12 ' H ' ' A' ' 305' ' ' SER . 0.3 OUTLIER -38.75 -45.34 1.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.581 1.553 . . . . 0.0 112.766 -177.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.698 ' H ' HD12 ' A' ' 304' ' ' LEU . 66.2 m 42.07 51.35 5.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.09 -10.78 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.927 1.751 . . . . 0.0 112.883 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -134.62 16.58 3.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.209 0.528 . . . . 0.0 110.267 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 88.62 5.98 74.01 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.68 142.09 51.13 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 121.949 -0.736 . . . . 0.0 112.395 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 63.5 m -80.04 166.15 21.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.151 0.907 . . . . 0.0 109.702 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -136.18 142.15 44.12 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.44 145.04 35.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.78 151.18 40.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 123.211 1.481 . . . . 0.0 109.324 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -147.85 159.98 43.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.964 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 44.9 mtmt -132.53 131.27 41.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 -3.49 0.91 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 116.115 -1.898 . . . . 0.0 114.344 -167.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 m -144.63 33.71 1.16 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.563 1.529 . . . . 0.0 111.436 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.1 m -61.84 -9.7 7.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.239 1.816 . . . . 0.0 113.5 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -138.37 5.08 2.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.595 0.758 . . . . 0.0 110.221 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -113.51 -28.91 7.36 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.539 0.736 . . . . 0.0 111.464 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.578 ' C ' ' H ' ' A' ' 323' ' ' CYS . 85.7 mmm -131.28 7.52 4.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.383 -0.818 . . . . 0.0 113.167 -172.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 60.85 -16.13 0.03 OUTLIER 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.222 2.209 . . . . 0.0 110.567 -172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.578 ' H ' ' C ' ' A' ' 321' ' ' MET . 80.4 m -110.58 167.75 9.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.789 0.835 . . . . 0.0 110.346 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -159.25 -162.66 1.09 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 122.871 0.468 . . . . 0.0 111.519 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 62.69 137.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.696 1.599 . . . . 0.0 112.868 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 12.6 p -156.58 162.92 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -109.09 155.6 20.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.422 0.555 . . . . 0.0 111.989 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.84 137.72 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 8.5 pt -146.17 94.92 4.83 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.95 169.72 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.888 1 C-N-CA 125.781 4.321 . . . . 0.0 111.257 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.632 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.6 t-105 -86.53 115.35 23.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.254 175.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 18.0 t -99.48 145.09 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 123.298 1.523 . . . . 0.0 108.791 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.25 -31.97 69.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.039 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -84.58 -7.99 59.06 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.68 -1.77 57.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.721 0.692 . . . . 0.0 111.312 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 88.5 p -130.2 -2.11 4.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.725 -0.609 . . . . 0.0 112.37 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -149.58 140.24 22.61 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.202 0.314 . . . . 0.0 110.186 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -156.14 106.67 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.414 0.686 . . . . 0.0 109.331 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -89.2 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.157 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.24 28.64 8.59 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.455 1.121 . . . . 0.0 110.303 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.515 ' H ' HG22 ' A' ' 339' ' ' VAL . 26.5 t -141.63 149.11 52.68 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.06 -3.29 13.58 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.265 3.31 . . . . 0.0 110.592 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -137.85 165.72 25.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -115.14 127.64 55.7 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.756 0.788 . . . . 0.0 111.188 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -142.01 -41.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.127 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 379' ' ' TYR . 4.2 mm? 50.64 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 O-C-N 124.722 1.264 . . . . 0.0 111.948 -171.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.21 140.71 19.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.25 -5.06 14.95 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.718 1.612 . . . . 0.0 114.98 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.4 t -152.51 -169.66 3.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 48.47 99.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.889 2.075 . . . . 0.0 113.742 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.7 t -158.27 155.72 29.4 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 149.76 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 124.132 0.895 . . . . 0.0 110.326 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -85.47 152.91 22.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.796 -169.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 133.27 66.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -167.58 -168.07 29.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.476 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 58.07 19.57 6.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 19.2 mt -67.09 154.66 40.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.657 -1.277 . . . . 0.0 109.839 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.69 16.36 1.13 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 87.36 9.32 72.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.824 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 8.9 ptp -159.01 12.17 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 31.8 tp -64.62 140.06 58.83 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.154 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.4 161.05 15.38 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.682 0.793 . . . . 0.0 109.199 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -70.09 -8.63 51.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 364' ' ' GLU . 1.6 pp20? -67.16 -35.14 79.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.36 34.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.615 0.721 . . . . 0.0 110.567 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.9 -31.44 64.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.665 -0.647 . . . . 0.0 110.021 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.75 -50.17 70.13 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.427 ' HB2' ' CD ' ' A' ' 225' ' ' PRO . . . -57.84 -39.14 76.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.879 -0.513 . . . . 0.0 111.576 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 90.2 mt -71.06 -41.8 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 122.034 -0.416 . . . . 0.0 110.109 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.22 -2.94 58.9 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -171.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -127.99 1.41 5.93 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.571 -1.331 . . . . 0.0 112.528 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -119.78 -20.63 7.54 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.962 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.85 -22.76 24.26 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.21 -16.22 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.456 1.026 . . . . 0.0 111.994 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 55.32 84.15 0.04 OUTLIER Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -151.84 3.86 0.43 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 118.195 0.998 . . . . 0.0 113.136 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.8 m -96.0 166.67 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 122.402 1.096 . . . . 0.0 113.179 -173.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.08 -27.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.171 170.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.424 ' CD2' HD21 ' A' ' 346' ' ' LEU . 24.9 t80 -155.18 147.83 24.24 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.12 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 119.235 0.925 . . . . 0.0 108.608 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -153.37 168.58 32.08 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.322 0.889 . . . . 0.0 115.322 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.7 mt -116.65 140.44 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.49 146.96 24.9 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.663 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.3 p -140.52 171.62 13.87 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 124.734 1.272 . . . . 0.0 111.907 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -132.76 18.59 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.435 1.494 . . . . 0.0 108.494 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . 0.274 0.5 OUTLIER 51.83 3.68 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 130.53 3.532 . . . . 0.0 114.794 -176.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -140.84 -9.8 1.03 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.681 1.192 . . . . 0.0 112.205 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -94.33 -11.09 30.75 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.86 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.0 p90 41.92 48.57 3.26 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.81 -52.01 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.389 2.726 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 391' ' ' ILE 0.286 6.9 tp 40.17 33.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 122.046 0.927 . . . . 0.0 110.674 -173.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -160.49 16.13 0.19 Allowed Glycine 0 C--N 1.345 1.078 0 CA-C-O 118.593 -1.115 . . . . 0.0 112.496 -176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.5 p -145.44 112.12 5.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.81 0.805 . . . . 0.0 109.088 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -152.01 -175.76 24.01 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -147.28 167.04 25.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.87 142.08 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 27.8 m -99.93 105.49 17.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -85.75 162.35 18.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.231 0.613 . . . . 0.0 110.477 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -147.13 19.06 1.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.581 0.705 . . . . 0.0 111.346 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -144.39 165.37 28.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.44 1.096 . . . . 0.0 108.755 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -88.16 -36.28 16.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 120.943 1.702 . . . . 0.0 113.298 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -51.35 -26.81 8.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.449 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -76.19 -30.26 57.97 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.51 -56.94 6.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.333 -1.479 . . . . 0.0 110.471 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -23.65 58.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.902 -1.124 . . . . 0.0 113.677 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -85.79 -22.91 27.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -87.58 -28.06 22.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.179 -0.325 . . . . 0.0 110.301 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.8 m -84.57 -25.0 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.2 p -85.55 -24.87 27.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.008 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -84.0 -44.59 14.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.5 -20.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.126 2.971 . . . . 0.0 115.096 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -149.99 145.88 26.69 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.23 156.14 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 O-C-N 121.41 -0.806 . . . . 0.0 110.221 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -109.38 139.54 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 124.277 0.985 . . . . 0.0 112.882 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 221' ' ' SER . 37.5 mt -118.53 126.41 75.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.452 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -131.23 14.56 5.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.496 1.123 . . . . 0.0 110.598 -170.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -60.88 157.06 15.97 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.591 1.156 . . . . 0.0 109.735 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -62.68 -0.77 0.68 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -139.47 4.72 2.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -160.32 130.29 5.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.132 0.973 . . . . 0.0 112.516 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 416' ' ' LYS . 17.3 p -140.16 102.29 4.34 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 120.263 1.392 . . . . 0.0 110.95 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.571 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 32.4 tptt -166.39 -176.1 3.49 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.813 174.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 43.1 mtpt -128.04 172.23 11.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.617 0.767 . . . . 0.0 110.625 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.21 159.47 20.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.211 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -130.0 135.92 48.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 426' ' ' ILE . 3.7 mp -110.9 145.16 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.54 151.22 63.09 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 118.956 0.798 . . . . 0.0 110.614 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.01 166.41 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.242 2.628 . . . . 0.0 113.109 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 123.955 0.902 . . . . 0.0 110.045 -177.062 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 26.5 m 42.23 66.17 0.78 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.742 1.217 . . . . 0.0 112.729 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 19.35 0.11 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.7 m 57.16 35.1 25.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.07 86.23 0.05 OUTLIER Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -79.84 -14.78 58.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.821 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 43.75 113.34 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 128.29 2.636 . . . . 0.0 115.206 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.52 169.03 19.07 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.96 3.107 . . . . 0.0 110.039 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.11 156.55 12.79 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.072 2.515 . . . . 0.0 113.435 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -141.45 179.55 6.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.14 2.176 . . . . 0.0 108.199 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 50.48 40.79 24.06 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.674 0.79 . . . . 0.0 113.088 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.64 159.51 1.54 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.73 0.812 . . . . 0.0 111.006 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -101.26 2.41 39.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.524 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.9 OUTLIER -126.39 35.69 0.3 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -177.725 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 68.7 Cg_endo -75.15 155.89 42.29 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.892 2.394 . . . . 0.0 111.394 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.71 140.71 43.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.25 121.97 38.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 95.6 p -125.93 -6.87 6.68 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.777 -170.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.35 -173.96 3.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 123.948 0.899 . . . . 0.0 108.643 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -60.23 155.89 16.58 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.244 -170.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.57 135.52 31.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -100.67 122.55 43.51 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 108.704 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.2 tt -145.46 143.33 29.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.775 -0.578 . . . . 0.0 110.512 -169.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.56 145.75 9.56 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 123.337 0.398 . . . . 0.0 112.147 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.5 17.43 0.02 OUTLIER Glycine 0 C--O 1.211 -1.329 0 CA-C-N 119.049 1.425 . . . . 0.0 113.818 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.05 95.4 39.45 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 118.147 0.973 . . . . 0.0 111.71 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.79 10.83 3.52 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 125.133 3.889 . . . . 0.0 112.533 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 246' ' ' ASP . 11.6 p-90 -128.14 -9.79 5.33 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 11.5 p-10 -60.28 116.26 4.12 Favored 'General case' 0 C--O 1.254 1.29 0 O-C-N 123.943 0.777 . . . . 0.0 113.087 -175.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.52 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -78.32 -15.81 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.4 p -153.6 148.17 26.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.249 1.023 . . . . 0.0 108.415 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -84.1 -22.56 31.09 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.772 -1.205 . . . . 0.0 108.727 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -78.31 -14.77 59.27 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.433 1.083 . . . . 0.0 113.319 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.82 -66.07 2.78 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.5 pt? -66.08 -29.37 69.69 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.73 -35.87 76.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.786 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -77.11 -18.06 58.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.705 -1.872 . . . . 0.0 110.198 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.5 p -77.85 -25.68 48.88 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.359 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.33 20.03 4.81 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 121.832 2.106 . . . . 0.0 112.545 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.1 20.92 1.46 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 119.547 -1.971 . . . . 0.0 111.913 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.5 t -71.09 -9.91 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -166.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -91.88 -2.65 56.74 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.432 1.083 . . . . 0.0 111.085 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.81 -2.7 3.44 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-O 117.698 -1.612 . . . . 0.0 116.612 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.7 m -102.54 22.3 13.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 119.183 1.492 . . . . 0.0 112.337 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 3.7 mm? -68.97 145.23 53.79 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 t -145.35 81.47 1.63 Allowed 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.1 p -75.7 141.25 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.068 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -150.94 157.82 43.38 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.368 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.49 ' HB3' HG23 ' A' ' 282' ' ' VAL . 42.4 p90 -151.66 146.67 19.02 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.05 91.91 1.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.635 2.223 . . . . 0.0 110.267 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -178.52 177.84 48.52 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -105.46 124.34 49.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.94 -0.741 . . . . 0.0 109.434 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -111.13 7.9 21.52 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.49 0.716 . . . . 0.0 110.097 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -67.05 -12.0 59.51 Favored Glycine 0 N--CA 1.47 0.951 0 CA-C-O 118.067 -1.407 . . . . 0.0 113.824 -172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -138.7 -35.5 0.58 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.561 1.681 . . . . 0.0 111.513 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -143.87 133.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.61 -13.96 6.83 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 125.059 3.839 . . . . 0.0 111.463 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -96.41 20.67 10.19 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.452 ' HB3' ' HD3' ' A' ' 277' ' ' PRO . 42.4 t -53.46 -41.27 85.94 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.892 -0.575 . . . . 0.0 112.03 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 276' ' ' CYS . 32.5 Cg_endo -98.29 95.72 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.41 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.83 4.85 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.585 4.19 . . . . 0.0 115.407 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -78.26 6.75 7.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 66.14 11.43 55.36 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.49 141.61 44.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.602 1.201 . . . . 0.0 112.739 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -150.03 170.76 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.983 0.897 . . . . 0.0 109.054 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -133.72 155.61 49.45 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.842 -1.161 . . . . 0.0 109.986 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 96.9 mt -131.16 145.76 52.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.19 0.596 . . . . 0.0 111.908 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.31 134.2 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 15.6 p90 -169.23 -163.26 0.4 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 125.007 1.442 . . . . 0.0 108.133 -174.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.16 110.21 0.46 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.582 1.153 . . . . 0.0 107.933 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 54.1 mt -89.83 -179.66 5.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.172 0.987 . . . . 0.0 110.396 -172.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 63.99 -67.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.367 1.867 . . . . 0.0 113.803 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -81.03 -43.35 19.69 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.433 -0.792 . . . . 0.0 111.261 -168.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 7.5 m -79.13 -31.4 44.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.84 -51.65 59.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -62.7 -32.22 73.27 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 70.4 m -57.23 -44.2 83.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.475 1.11 . . . . 0.0 111.884 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.7 -49.72 67.49 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.796 -1.19 . . . . 0.0 110.194 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 296' ' ' LEU . 0.1 OUTLIER -65.35 -26.63 68.11 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 119.182 -0.437 . . . . 0.0 112.018 -177.258 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -96.21 -4.25 42.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 123.855 0.722 . . . . 0.0 111.742 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.33 -12.57 19.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 314' ' ' PHE . 9.8 t -127.43 -124.05 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.0 t -116.49 163.65 15.75 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -155.8 159.6 39.55 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.724 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.19 137.73 31.47 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.26 75.52 5.02 Favored 'Trans proline' 0 C--N 1.35 0.612 1 C-N-CA 128.302 6.001 . . . . 0.0 112.867 -168.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 304' ' ' LEU . 2.8 mp 64.58 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 115.784 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 304' ' ' LEU . 20.2 m 41.47 68.89 2.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -53.02 1.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 1 C-N-CA 127.224 5.283 . . . . 0.0 116.557 -166.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.88 16.2 24.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.701 1.601 . . . . 0.0 108.739 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -166.55 -113.66 0.28 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.802 1.668 . . . . 0.0 111.699 -175.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 16.3 tp -150.15 158.58 44.31 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.421 1.11 . . . . 0.0 111.007 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 1.5 m -62.89 153.45 33.31 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.357 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -137.24 150.06 47.58 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 123.834 0.709 . . . . 0.0 110.744 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.44 146.86 44.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -140.02 155.13 47.22 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.654 -1.279 . . . . 0.0 112.17 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.493 ' HA ' ' SG ' ' A' ' 299' ' ' CYS . 32.4 t80 -145.22 174.29 11.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -125.4 132.41 52.77 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.21 0.914 . . . . 0.0 108.922 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.602 ' HE3' ' H ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -123.3 14.3 9.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.295 1.038 . . . . 0.0 109.662 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.3 p -82.01 2.1 32.49 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.115 0.566 . . . . 0.0 111.312 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 45.7 t -61.31 150.87 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 109.968 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 56.1 8.49 0.39 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.861 0.864 . . . . 0.0 112.286 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -129.5 -62.97 0.95 Allowed 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.566 -0.709 . . . . 0.0 110.761 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.5 mmt -123.59 -13.68 7.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.435 1.094 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 44.74 23.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.8 2.04 . . . . 0.0 114.993 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 3.1 t -151.56 17.45 0.71 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 121.262 1.846 . . . . 0.0 114.172 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.56 115.55 22.35 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.989 0.9 . . . . 0.0 112.713 -174.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -74.95 162.34 28.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.016 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.88 150.02 32.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.159 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -83.32 136.71 34.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.292 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.36 133.36 57.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.013 0.824 . . . . 0.0 111.017 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 62.1 mt -149.64 114.98 3.52 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.5 154.44 6.47 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 125.024 3.816 . . . . 0.0 112.765 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -76.2 120.0 20.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 334' ' ' ALA . 44.4 t -90.06 142.67 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.377 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 333' ' ' LEU . 1.7 tt -59.01 -25.96 64.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.35 0.595 . . . . 0.0 112.195 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.653 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -76.9 1.95 16.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.045 -1.659 . . . . 0.0 114.047 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -94.82 -8.63 36.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.675 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.7 m -103.91 -27.98 11.85 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.337 1.426 . . . . 0.0 114.046 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -163.03 162.79 26.07 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.146 0.278 . . . . 0.0 110.794 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.603 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 79.0 t80 -160.67 147.51 15.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.299 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.3 141.65 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 O-C-N 123.67 0.607 . . . . 0.0 110.405 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.81 20.33 18.28 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.012 0.91 . . . . 0.0 109.007 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 18.3 t -143.54 145.98 33.72 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.68 1.592 . . . . 0.0 107.341 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.56 5.42 4.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 121.716 1.611 . . . . 0.0 112.865 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 63.9 m -106.11 158.42 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.485 0.714 . . . . 0.0 109.639 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -111.03 12.64 22.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.216 0.606 . . . . 0.0 112.559 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -70.6 162.99 27.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.718 1.247 . . . . 0.0 112.263 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 346' ' ' LEU . 11.1 tp -145.8 143.62 29.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ASP . . . . . 0.544 ' H ' HG21 ' A' ' 397' ' ' THR . 12.1 m-20 -134.65 85.3 36.92 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 124.651 1.18 . . . . 0.0 110.535 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.89 -9.95 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 124.742 3.628 . . . . 0.0 114.196 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 87.9 p -72.61 -12.57 61.1 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.141 -0.974 . . . . 0.0 112.789 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -142.43 94.23 2.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.1 t -149.33 152.27 35.57 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.92 154.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.661 1.22 . . . . 0.0 108.942 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -90.34 161.96 15.37 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.328 -171.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 4.5 p -144.68 145.16 21.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 O-C-N 121.487 -0.758 . . . . 0.0 111.378 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.91 -174.88 36.55 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 47.47 34.57 3.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.699 0.4 . . . . 0.0 111.745 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.01 -176.52 3.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.867 1.267 . . . . 0.0 108.649 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.13 140.32 58.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.18 0.592 . . . . 0.0 111.075 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -67.85 5.61 3.39 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.162 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.413 ' O ' ' N ' ' A' ' 362' ' ' ASN . 40.7 mtp -138.71 28.08 2.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.857 1.329 . . . . 0.0 107.495 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.17 82.92 0.08 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.562 1.648 . . . . 0.0 108.473 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 360' ' ' MET . 5.4 p30 -64.69 156.78 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.107 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -66.92 -19.1 65.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 120.599 -1.313 . . . . 0.0 111.401 -175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -72.64 -27.77 62.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 120.943 -1.098 . . . . 0.0 109.001 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -87.49 -32.73 19.29 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.223 1.409 . . . . 0.0 111.017 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.91 -37.37 86.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -78.8 -28.99 44.63 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.835 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -67.82 -42.47 81.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.122 1.328 . . . . 0.0 108.558 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.0 -44.22 92.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.251 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 374' ' ' PHE . 45.4 mt -89.9 -7.86 53.21 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 117.784 -1.103 . . . . 0.0 112.724 -171.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.83 -28.43 15.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.742 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.7 -26.48 25.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.98 -13.02 20.1 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 370' ' ' LEU . 22.1 m-30 -119.91 -23.07 6.52 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 120.25 1.387 . . . . 0.0 111.942 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 76.4 -0.68 63.37 Favored Glycine 0 CA--C 1.552 2.381 0 O-C-N 125.048 1.468 . . . . 0.0 113.867 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.46 120.08 0.71 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 121.36 2.58 . . . . 0.0 111.807 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.36 171.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 126.171 1.788 . . . . 0.0 107.834 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.85 -30.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.913 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -163.05 136.82 5.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.085 0.402 . . . . 0.0 110.656 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.15 129.66 13.04 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -140.73 159.67 26.46 Favored Glycine 0 C--O 1.22 -0.747 0 O-C-N 121.861 -0.525 . . . . 0.0 114.128 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 23.8 mm -80.88 149.2 5.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.5 47.8 0.5 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.909 0.755 . . . . 0.0 110.386 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.4 p -64.53 158.83 23.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 123.817 1.77 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -140.94 146.99 38.1 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.389 2.676 . . . . 0.0 104.4 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -61.01 122.5 15.09 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.695 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.4 m170 67.73 42.05 2.09 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.08 -10.86 8.11 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.3 p90 38.18 50.71 2.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.15 -46.33 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.216 2.611 . . . . 0.0 113.995 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.8 tp 41.99 31.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 112.732 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -133.66 -6.37 2.63 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -172.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.0 p -156.91 160.69 39.36 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 118.626 1.213 . . . . 0.0 108.105 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -176.99 -165.26 32.11 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.182 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -156.82 161.24 39.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.554 0.741 . . . . 0.0 109.933 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.31 134.53 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 120.9 1.682 . . . . 0.0 108.477 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' THR . . . . . 0.544 HG21 ' H ' ' A' ' 347' ' ' ASP . 96.8 m -106.37 141.95 36.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 125.062 1.476 . . . . 0.0 108.323 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.58 161.44 16.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.592 1.557 . . . . 0.0 112.271 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -131.26 11.37 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -135.96 140.31 43.87 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -76.91 -29.56 55.77 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.578 0.549 . . . . 0.0 111.869 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.567 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -64.44 -18.59 64.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.382 0.537 . . . . 0.0 110.739 -175.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.1 m -79.81 -19.74 47.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 118.485 0.584 . . . . 0.0 111.187 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -76.5 -51.14 12.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.107 0.867 . . . . 0.0 110.945 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.441 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.09 -19.2 61.21 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 119.611 1.096 . . . . 0.0 111.646 177.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.81 -26.32 57.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.737 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.98 59.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.805 -0.559 . . . . 0.0 110.908 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.53 -9.07 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.567 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.2 p -105.25 -8.79 18.08 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.324 0.39 . . . . 0.0 110.26 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -100.9 -48.44 4.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.517 0.51 . . . . 0.0 110.335 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.01 -12.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 129.947 3.299 . . . . 0.0 118.858 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -162.72 138.5 7.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.255 -1.528 . . . . 0.0 107.262 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.83 157.0 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.375 -0.828 . . . . 0.0 111.031 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 423' ' ' LYS . 41.6 mt-10 -105.97 138.92 41.32 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.401 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 421' ' ' THR . 73.4 mt -103.41 116.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -134.45 110.19 9.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.632 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.0 p -132.39 -175.12 3.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.664 0.786 . . . . 0.0 110.249 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 418' ' ' THR . 88.9 m -83.19 4.49 26.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.64 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -143.27 -4.73 0.88 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.849 1.204 . . . . 0.0 113.73 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -144.65 145.53 31.8 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.681 0.613 . . . . 0.0 110.052 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 26.6 m -153.85 116.21 4.37 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.99 0.516 . . . . 0.0 109.955 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -162.16 157.12 22.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 123.804 0.69 . . . . 0.0 110.679 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 414' ' ' GLU . 0.1 OUTLIER -114.87 162.42 16.93 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.88 148.34 19.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.731 1.212 . . . . 0.0 108.316 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -132.19 129.36 39.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.937 1.351 . . . . 0.0 111.776 -170.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.13 143.83 16.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.047 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -136.64 148.5 63.86 Favored Pre-proline 0 N--CA 1.444 -0.745 0 O-C-N 123.676 0.61 . . . . 0.0 110.223 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.56 158.41 13.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.944 3.096 . . . . 0.0 112.468 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 117.448 -1.263 . . . . 0.0 109.028 178.497 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 221' ' ' SER . 2.3 m 43.99 45.7 6.67 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.339 1.056 . . . . 0.0 110.838 -170.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 15.02 0.04 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.532 ' HB2' ' H ' ' A' ' 416' ' ' LYS . 78.5 p -46.52 143.05 2.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.571 1.548 . . . . 0.0 113.944 -168.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 134.96 -2.22 3.96 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.77 -1.104 . . . . 0.0 114.072 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -134.48 22.05 3.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.394 1.097 . . . . 0.0 111.326 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.71 -57.96 3.0 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-O 116.131 -1.89 . . . . 0.0 112.918 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.26 117.19 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.6 2.867 . . . . 0.0 108.88 -170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.57 -40.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.304 3.336 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 43.52 22.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -86.42 -7.7 58.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.755 1.222 . . . . 0.0 111.796 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.98 145.64 52.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 230' ' ' LYS . 25.8 mmmt -144.39 8.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.367 -0.833 . . . . 0.0 113.142 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 61.86 50.25 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.173 -172.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.04 129.61 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.859 2.373 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.5 mm -147.72 144.81 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.468 ' CG ' HG11 ' A' ' 292' ' ' VAL . 7.8 m-85 -105.88 151.52 24.44 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.807 -172.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -152.08 3.77 0.39 Allowed 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 4.0 t -146.99 -170.37 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.313 -0.867 . . . . 0.0 108.828 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 175.94 1.19 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.91 141.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.852 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -91.05 133.92 34.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.718 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.457 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.8 tt -143.11 124.36 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -156.62 152.11 23.5 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.04 14.55 0.1 Allowed Glycine 0 CA--C 1.537 1.42 0 O-C-N 124.646 0.85 . . . . 0.0 111.656 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.29 108.66 61.91 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 118.114 0.957 . . . . 0.0 110.982 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.3 0.26 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 124.847 3.698 . . . . 0.0 113.642 171.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.437 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 4.2 p-90 -135.9 -96.86 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 25.0 t0 42.53 65.02 0.99 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.577 . . . . 0.0 111.855 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.741 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.12 -30.49 36.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -171.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 250' ' ' ALA . 16.8 m -140.18 126.65 20.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.97 -7.41 58.78 Favored 'General case' 0 C--O 1.201 -1.499 0 O-C-N 123.554 0.534 . . . . 0.0 110.735 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.52 -21.71 61.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.062 -0.399 . . . . 0.0 111.462 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.76 -48.99 6.78 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.59 -41.2 98.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 114.823 -0.688 . . . . 0.0 109.638 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.57 -50.72 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.494 -1.379 . . . . 0.0 110.641 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -69.24 -9.06 51.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.4 m -80.94 -32.32 34.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.1 68.29 1.4 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.858 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 257' ' ' ARG . 13.6 ttt180 -123.74 7.18 8.78 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.439 1.096 . . . . 0.0 111.727 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.91 7.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 119.807 -1.808 . . . . 0.0 112.362 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.72 -10.32 23.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.34 -4.07 13.8 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.878 1.511 . . . . 0.0 116.878 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.7 p -112.32 44.76 1.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 120.599 -1.53 . . . . 0.0 111.704 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -142.47 163.57 32.47 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.6 m -149.99 175.69 11.46 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.483 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.98 157.08 41.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 O-C-N 121.525 -0.734 . . . . 0.0 111.013 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -138.11 135.6 35.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.392 1.091 . . . . 0.0 111.275 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.31 148.9 36.46 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.23 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.01 -21.37 15.9 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.239 3.293 . . . . 0.0 111.756 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 178.27 -6.5 0.03 OUTLIER Glycine 0 CA--C 1.547 2.078 0 CA-C-O 118.482 -1.176 . . . . 0.0 115.859 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 278' ' ' PRO . 18.5 tptp -94.87 107.18 19.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.793 2.297 . . . . 0.0 109.872 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.69 145.02 29.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 167.88 -173.35 42.81 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -63.92 -40.52 96.66 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.82 1.648 . . . . 0.0 112.272 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -147.05 84.56 7.34 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.25 -48.65 1.16 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.528 2.152 . . . . 0.0 114.095 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 46.56 9.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.03 2.132 . . . . 0.0 114.922 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 41.9 t -164.52 111.33 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 119.255 0.934 . . . . 0.0 110.391 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.91 160.82 46.77 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.882 2.388 . . . . 0.0 110.076 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 269' ' ' LYS . 87.0 Cg_endo -78.28 -17.47 13.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.234 2.623 . . . . 0.0 112.01 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -146.9 167.35 24.17 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.146 1.379 . . . . 0.0 110.878 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.66 19.72 3.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.964 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -152.82 165.86 34.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.336 1.568 . . . . 0.0 112.631 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.6 m -154.76 -170.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 126.328 2.267 . . . . 0.0 109.391 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -118.3 153.87 33.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.418 1.087 . . . . 0.0 110.525 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.74 147.31 48.72 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.15 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.98 112.02 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 109.268 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.629 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -139.76 -179.73 6.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.53 -174.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.56 124.18 10.27 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -62.17 -13.38 26.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.67 -49.22 0.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 116.859 -1.937 . . . . 0.0 112.195 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -81.19 -36.68 29.82 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 72.7 m -76.22 -31.18 58.27 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 120.158 1.345 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.629 HG22 ' CE1' ' A' ' 286' ' ' PHE . 2.8 t -60.86 -52.33 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -74.54 -23.48 58.8 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 74.8 m -72.44 -36.42 68.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 109.924 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.9 mp -74.66 -54.14 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 4.16 36.76 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.573 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -111.19 -10.51 14.29 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 110.783 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.54 37.25 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.323 0.965 . . . . 0.0 110.773 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.41 -115.7 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.794 0.806 . . . . 0.0 112.634 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.4 m -126.01 155.97 40.62 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 111.688 -171.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -157.56 159.28 36.97 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.646 1.178 . . . . 0.0 109.049 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 304' ' ' LEU . 16.2 m-20 -146.65 89.12 5.85 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 109.684 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' ASP . 65.0 Cg_endo -67.02 22.52 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.998 1 C-N-CA 128.618 6.212 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 302' ' ' ASP . 7.2 mp -91.01 -2.36 57.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.492 1.117 . . . . 0.0 112.271 -166.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 19.9 t 44.91 44.54 1.7 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.26 -6.25 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.661 2.241 . . . . 0.0 113.096 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.99 -42.1 0.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -124.23 -118.76 2.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 310' ' ' SER . 0.9 OUTLIER -95.84 -16.06 22.09 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.448 -1.031 . . . . 0.0 110.925 173.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 309' ' ' LEU . 3.2 p 171.08 176.97 0.06 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.418 1.487 . . . . 0.0 107.963 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.27 130.76 50.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -108.48 143.81 36.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -124.78 145.27 49.82 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.847 0.832 . . . . 0.0 110.725 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -151.71 155.98 39.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.315 -1.311 . . . . 0.0 107.77 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 11.0 ptpt -129.34 143.61 50.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.015 0.825 . . . . 0.0 110.177 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.49 -7.65 5.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.676 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.7 t -140.34 133.34 29.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.653 1.115 . . . . 0.0 109.685 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 60.4 m -140.85 -13.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.1 -8.77 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.941 1.246 . . . . 0.0 110.849 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -86.24 -29.11 23.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.769 0.827 . . . . 0.0 111.479 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.437 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 97.2 mmm -142.08 164.89 28.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.24 0.616 . . . . 0.0 109.748 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 322' ' ' ARG . 70.6 mtt-85 -92.07 45.94 1.24 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.147 1.379 . . . . 0.0 111.172 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.25 -166.13 1.53 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.798 0.839 . . . . 0.0 109.642 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -143.27 -173.2 3.87 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -54.36 158.65 2.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.571 1.548 . . . . 0.0 113.173 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 240' ' ' LEU . 11.4 p -121.38 153.4 25.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -172.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.65 150.31 21.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 120.181 1.355 . . . . 0.0 110.253 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.86 145.65 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.865 0.466 . . . . 0.0 110.281 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -144.12 99.73 5.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 123.775 0.672 . . . . 0.0 111.803 172.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.22 168.11 15.28 Favored 'Trans proline' 0 N--CA 1.46 -0.454 1 C-N-CA 125.306 4.004 . . . . 0.0 110.849 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 2.8 t-105 -88.0 125.42 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.3 t -105.84 145.12 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.394 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 333' ' ' LEU . 13.1 mt -55.79 -21.33 18.78 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.729 0.643 . . . . 0.0 111.071 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.6 -4.42 30.73 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.72 3.61 15.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.192 1.397 . . . . 0.0 111.073 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 46.6 m -107.13 -49.29 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 120.694 -1.254 . . . . 0.0 111.841 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -155.04 153.88 31.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.544 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -153.8 145.72 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.571 0.748 . . . . 0.0 109.446 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.86 138.52 41.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 18.17 4.12 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.0 t -150.6 141.44 14.72 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.29 1.836 . . . . 0.0 107.29 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -66.23 -15.99 50.25 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.901 3.067 . . . . 0.0 111.069 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 37.8 p -163.22 90.91 0.68 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.439 1.018 . . . . 0.0 111.758 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -154.29 168.59 26.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -131.95 -179.28 5.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.325 1.45 . . . . 0.0 110.235 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 346' ' ' LEU . 3.8 mm? -74.63 171.76 13.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -175.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -116.36 155.27 48.64 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.681 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -68.72 104.1 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.701 2.267 . . . . 0.0 113.205 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 74.4 m 57.31 46.15 18.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.131 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 350' ' ' ARG . 4.6 tpm_? -138.03 87.99 2.28 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.102 -0.999 . . . . 0.0 112.439 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.0 p -144.08 166.95 23.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.72 163.32 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.009 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -86.78 160.83 18.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.726 0.694 . . . . 0.0 110.487 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.7 t -146.32 131.89 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.75 -175.85 37.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 49.39 29.14 2.67 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.423 1.089 . . . . 0.0 112.273 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.813 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -93.54 -175.73 3.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.668 -0.645 . . . . 0.0 110.175 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -59.13 154.03 16.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.155 0.582 . . . . 0.0 111.904 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.08 1.1 9.04 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.256 -0.746 . . . . 0.0 113.665 -172.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 13.3 ptp -158.18 30.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.466 2.133 . . . . 0.0 111.839 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.1 126.99 29.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.23 167.49 13.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.038 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.59 -25.54 61.37 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 121.469 -0.769 . . . . 0.0 112.167 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -82.99 -18.93 38.14 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 118.481 0.582 . . . . 0.0 111.994 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.88 -36.48 18.39 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.59 -46.59 89.2 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.23 68.08 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.613 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.97 84.52 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.916 0.78 . . . . 0.0 109.695 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 35.8 mt -71.12 -36.51 63.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 119.633 -0.222 . . . . 0.0 110.56 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.0 -0.9 55.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.404 ' HA ' ' HA2' ' A' ' 375' ' ' GLY . 0.5 OUTLIER -116.79 -15.3 10.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 120.837 -1.165 . . . . 0.0 112.269 174.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.29 -26.83 13.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.852 0.751 . . . . 0.0 109.212 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.0 tp -80.87 -17.42 50.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 123.424 0.453 . . . . 0.0 110.428 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 403' ' ' SER . 29.0 p90 -166.74 -13.53 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 371' ' ' ASN . . . 68.1 20.1 72.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 171.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -90.1 9.23 78.06 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 120.808 -1.407 . . . . 0.0 114.613 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.5 163.43 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.236 1.018 . . . . 0.0 113.516 -170.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.25 -33.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.232 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -159.46 147.55 17.48 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 396' ' ' VAL . . . -150.43 149.04 29.5 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.457 0.646 . . . . 0.0 110.455 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.71 160.97 29.3 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.64 -0.662 . . . . 0.0 113.493 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.4 mm -96.37 144.28 10.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 124.383 0.696 . . . . 0.0 110.564 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -82.52 60.92 5.4 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 121.231 0.539 . . . . 0.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.464 ' HA ' ' HG2' ' A' ' 390' ' ' PRO . 2.9 p -61.15 154.53 22.96 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 124.068 1.89 . . . . 0.0 111.903 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.49 129.58 20.84 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.0 130.75 45.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.226 -170.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 8.4 m170 68.53 29.09 5.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.145 -2.298 . . . . 0.0 112.398 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.71 -0.53 13.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.2 t80 47.41 41.55 0.94 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.129 1.772 . . . . 0.0 113.645 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 392' ' ' GLY . 36.1 Cg_endo -81.34 37.91 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.523 2.148 . . . . 0.0 109.025 -170.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.454 ' HB ' ' CH2' ' A' ' 331' ' ' TRP . 10.8 tp -69.83 25.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.984 0 C-N-CA 123.637 0.775 . . . . 0.0 111.448 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 390' ' ' PRO . . . -123.04 1.55 9.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 118.543 -1.143 . . . . 0.0 111.142 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.3 p -155.47 151.61 27.94 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.264 1.032 . . . . 0.0 110.794 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.81 -174.73 42.62 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.882 1.268 . . . . 0.0 113.958 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.07 166.8 20.93 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 121.324 -1.103 . . . . 0.0 111.227 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 380' ' ' ALA . 7.4 p -146.18 144.12 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 23.1 m -103.76 119.15 38.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.6 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -106.39 156.3 18.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.656 0.782 . . . . 0.0 108.945 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -136.16 21.99 3.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -141.4 159.22 42.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -83.14 -47.24 11.83 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.444 ' H ' ' HD2' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.38 -21.86 62.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 374' ' ' PHE . 34.2 p -72.51 -21.75 61.14 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.926 -1.109 . . . . 0.0 111.163 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.58 -62.73 1.48 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.28 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.631 ' H ' HD13 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -67.95 -17.08 64.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 119.317 0.962 . . . . 0.0 113.124 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.17 -29.34 28.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.586 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -18.25 58.0 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.31 -1.494 . . . . 0.0 110.411 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.14 -27.4 7.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.4 t -85.79 -9.56 56.87 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 0.0 111.299 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -112.22 -59.66 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.247 172.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.68 -16.33 0.03 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 127.921 2.488 . . . . 0.0 114.055 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -162.8 136.99 6.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.9 m -139.54 164.29 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -105.11 145.56 30.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.957 1.411 . . . . 0.0 110.824 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.9 mt -123.89 126.52 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.411 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 221' ' ' SER . 57.0 mmtt -137.65 114.37 10.5 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.704 1.253 . . . . 0.0 110.243 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 92.7 m -151.01 159.51 44.51 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -54.67 139.95 37.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.566 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? 59.32 13.43 3.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.12 1.368 . . . . 0.0 114.675 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.54 116.18 4.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.897 -1.127 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 17.2 p -145.84 112.43 5.91 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.2 tptm -166.64 -173.11 2.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.011 0.823 . . . . 0.0 110.022 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.655 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.5 mttp -125.66 172.18 9.99 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 123.604 0.762 . . . . 0.0 109.562 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -144.25 151.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.853 1.346 . . . . 0.0 109.881 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.0 158.57 36.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.235 -0.915 . . . . 0.0 110.274 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 23.8 mt -142.69 146.02 22.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -147.56 141.62 15.91 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.653 0.661 . . . . 0.0 110.669 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -82.76 174.62 9.43 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 124.243 3.295 . . . . 0.0 111.192 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.19 171.883 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.761 0.791 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 98.1 m -139.52 147.48 41.3 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 171.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.7 -25.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.1 m 50.39 119.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.426 2.29 . . . . 0.0 114.445 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.45 -3.92 0.05 OUTLIER Glycine 0 N--CA 1.469 0.84 0 O-C-N 120.394 -1.441 . . . . 0.0 115.598 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.06 -9.39 55.24 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.374 -1.663 . . . . 0.0 114.604 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.617 ' H ' HD22 ' A' ' 224' ' ' LEU . 3.8 mm? -16.5 88.05 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 128.954 2.902 . . . . 0.0 111.281 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.83 158.43 3.41 Favored 'Trans proline' 0 N--CA 1.449 -1.11 1 C-N-CA 127.581 5.521 . . . . 0.0 111.496 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 147.74 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.949 1.766 . . . . 0.0 110.484 172.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -139.83 18.33 2.49 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.867 0.73 . . . . 0.0 109.066 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -122.39 32.13 5.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.922 0.889 . . . . 0.0 112.647 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -64.33 162.26 15.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.196 1.398 . . . . 0.0 112.762 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -77.19 -19.37 56.84 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 58.74 73.35 0.72 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.96 -44.08 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.505 2.137 . . . . 0.0 115.419 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.9 mt -147.8 153.88 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.578 1.081 . . . . 0.0 108.274 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -112.53 150.9 30.65 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.6 t -150.06 17.75 0.86 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.387 0.994 . . . . 0.0 113.409 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' CYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 331' ' ' TRP . 0.9 OUTLIER -156.77 -175.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -61.54 171.25 1.55 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.469 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 286' ' ' PHE . 2.7 p -136.25 150.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.456 -170.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -92.6 133.42 35.98 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.457 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.4 tm? -142.13 124.44 15.59 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.754 1.161 . . . . 0.0 110.564 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 167.56 -172.5 42.46 Favored Glycine 0 N--CA 1.473 1.142 0 O-C-N 124.061 0.851 . . . . 0.0 112.635 172.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.47 7.12 3.2 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.273 0.94 . . . . 0.0 112.764 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 6.5 m -102.62 135.89 19.43 Favored Pre-proline 0 C--O 1.219 -0.51 0 C-N-CA 123.722 0.809 . . . . 0.0 111.203 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 243' ' ' VAL . 33.4 Cg_exo -70.23 -5.08 15.65 Favored 'Trans proline' 0 N--CA 1.439 -1.722 1 C-N-CA 126.33 4.687 . . . . 0.0 115.574 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 323' ' ' CYS . 22.3 p-90 -142.13 -60.9 0.46 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 120.216 1.371 . . . . 0.0 113.803 -174.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.48 -60.13 0.13 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.133 1.373 . . . . 0.0 112.996 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 248' ' ' THR 0.5 0.0 OUTLIER 63.34 -41.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.832 1.958 . . . . 0.0 115.232 -179.461 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 247' ' ' ILE . 25.9 p -157.86 134.95 10.08 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 124.901 1.281 . . . . 0.0 109.078 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.1 pm0 -89.51 -22.85 22.23 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 119.632 -1.918 . . . . 0.0 111.745 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.03 64.42 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.165 0.915 . . . . 0.0 111.32 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.19 15.69 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 255' ' ' THR . 46.6 mt -70.74 -36.97 73.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.66 -37.68 80.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.582 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.431 ' HA ' ' CD ' ' A' ' 257' ' ' ARG . 62.9 m-20 -64.14 -21.96 66.75 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.243 1.383 . . . . 0.0 109.735 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 252' ' ' LEU . 84.2 m -79.16 -27.62 42.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.784 0.72 . . . . 0.0 110.669 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -131.28 23.19 4.81 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.442 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 16.6 ptm180 -86.96 33.92 0.67 Allowed 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.052 0.941 . . . . 0.0 113.391 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.54 2.26 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.14 -2.27 15.02 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 64.01 3.56 8.87 Favored Glycine 0 C--O 1.214 -1.144 0 CA-C-O 118.113 -1.381 . . . . 0.0 113.189 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.52 2.39 28.4 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.891 0.995 . . . . 0.0 113.001 -167.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 257' ' ' ARG . 6.1 mt -68.52 141.72 55.46 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 122.931 1.348 . . . . 0.0 114.551 -167.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.5 t -152.23 96.12 2.14 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 124.677 2.179 . . . . 0.0 106.976 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.06 144.31 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 O-C-N 119.423 -2.048 . . . . 0.0 109.41 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.52 135.27 42.24 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 120.758 -1.214 . . . . 0.0 111.396 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 8.9 p90 -150.88 143.83 16.66 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 121.497 0.665 . . . . 0.0 112.018 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -86.0 169.37 8.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.492 3.461 . . . . 0.0 111.633 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.41 -8.06 7.58 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 126.465 1.983 . . . . 0.0 114.756 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.82 55.22 1.79 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.471 1.136 . . . . 0.0 111.869 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.14 5.45 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.832 0.453 . . . . 0.0 111.487 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.28 149.37 9.04 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 121.124 -0.985 . . . . 0.0 112.416 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 67.89 159.72 0.16 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.627 1.571 . . . . 0.0 110.696 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 16.9 m170 34.14 76.71 0.4 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.762 1.625 . . . . 0.0 115.138 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.35 111.9 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.588 2.192 . . . . 0.0 112.056 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -157.29 169.32 25.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 12.8 t -121.62 143.02 37.04 Favored Pre-proline 0 CA--C 1.513 -0.456 0 C-N-CA 124.436 1.095 . . . . 0.0 109.853 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' PRO . . . . . 0.609 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 84.3 Cg_endo -70.7 151.07 63.44 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.626 2.884 . . . . 0.0 109.631 -174.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.58 -6.19 16.01 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.612 2.875 . . . . 0.0 111.714 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -78.08 1.42 21.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.862 -0.59 . . . . 0.0 111.909 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.27 48.25 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.462 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 8.6 p90 -152.47 157.0 40.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.287 1.543 . . . . 0.0 112.034 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.3 m -152.48 -154.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 127.491 2.316 . . . . 0.0 108.827 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -114.98 164.28 14.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.646 0.779 . . . . 0.0 112.078 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.5 138.36 14.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.865 -0.522 . . . . 0.0 111.364 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.89 125.31 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 168.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.535 ' CE1' HG11 ' A' ' 238' ' ' VAL . 0.1 OUTLIER -146.71 92.27 2.13 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.973 -173.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 286' ' ' PHE . 11.5 tp10 37.88 61.69 1.02 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -48.64 9.87 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 128.306 2.642 . . . . 0.0 117.683 -167.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.02 -72.53 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.992 1.724 . . . . 0.0 111.166 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -78.39 -34.44 48.18 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 22.8 t -73.62 -32.58 64.14 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 286' ' ' PHE . 89.0 t -63.87 -52.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -61.33 -34.92 76.06 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.668 0.605 . . . . 0.0 112.237 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.1 m -74.29 -34.15 63.44 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.773 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -45.8 65.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.469 0.652 . . . . 0.0 110.169 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -13.54 57.96 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.105 -0.997 . . . . 0.0 113.441 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.24 -4.58 35.0 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.288 -0.883 . . . . 0.0 111.54 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -104.58 -15.05 15.43 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.679 1.237 . . . . 0.0 108.841 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 60.6 m -107.68 -142.61 0.38 Allowed 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.744 -0.597 . . . . 0.0 109.829 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.2 m -110.54 172.51 6.83 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 120.474 -1.391 . . . . 0.0 113.388 -171.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.407 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 85.3 t60 -149.87 165.19 33.32 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.69 -0.631 . . . . 0.0 110.992 -172.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 33.3 t0 -134.45 112.2 11.83 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.92 51.65 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 1 C-N-CA 127.384 5.389 . . . . 0.0 110.187 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.25 5.8 mp 63.64 42.2 6.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.491 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 47.5 m -64.78 -34.38 10.45 Favored Pre-proline 0 CA--C 1.552 1.043 0 O-C-N 121.366 -0.834 . . . . 0.0 110.639 168.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 305' ' ' SER . 24.1 Cg_exo -70.16 0.6 5.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.101 2.534 . . . . 0.0 114.383 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.9 t70 57.1 16.8 3.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.222 -0.924 . . . . 0.0 111.066 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -102.8 -129.17 6.58 Favored Glycine 0 CA--C 1.525 0.675 0 O-C-N 121.795 -0.566 . . . . 0.0 112.495 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.6 pp -101.97 173.5 6.36 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.413 1.085 . . . . 0.0 111.718 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 29.9 m -66.52 132.69 48.78 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.218 0.607 . . . . 0.0 110.5 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.53 144.26 49.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 119.253 0.933 . . . . 0.0 110.882 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -110.74 152.66 26.32 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.254 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 37.1 m-85 -140.36 148.33 41.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.743 1.258 . . . . 0.0 113.061 -170.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -158.89 163.73 36.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -135.31 133.05 38.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.698 0.761 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.2 OUTLIER -134.98 13.66 3.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.659 -171.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.7 p -58.5 153.73 15.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.8 m -111.88 163.05 14.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.219 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -70.84 -9.77 58.24 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 321' ' ' MET . 17.1 ptp180 -82.36 -18.09 43.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.416 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 320' ' ' ARG . 4.0 mpp? -135.93 -48.82 0.68 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 44.33 43.08 5.78 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' CYS . . . . . 0.475 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 71.1 m -93.23 -60.49 1.78 Allowed 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.326 -1.484 . . . . 0.0 113.842 -173.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -158.52 152.39 23.61 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 118.856 -1.138 . . . . 0.0 113.164 -170.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.51 173.42 4.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.842 2.057 . . . . 0.0 113.936 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 3.7 p -118.66 158.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.168 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 5.4 pp0? -115.69 163.28 16.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.198 0.908 . . . . 0.0 112.047 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.95 130.21 13.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.689 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 pt -136.68 88.59 19.08 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.16 0.584 . . . . 0.0 110.89 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -76.99 177.85 8.38 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.903 3.735 . . . . 0.0 116.604 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' TRP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 236' ' ' CYS . 7.3 t-105 -82.24 140.89 33.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.915 0.886 . . . . 0.0 110.169 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.5 t -115.0 151.66 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.558 1.171 . . . . 0.0 111.913 -176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 333' ' ' LEU . 6.6 tt -57.25 -36.96 71.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.269 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -70.44 -5.64 29.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.261 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -105.24 -7.01 19.24 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.701 -0.624 . . . . 0.0 111.667 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.8 m -83.83 -37.91 21.9 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -154.57 165.52 36.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.071 0.548 . . . . 0.0 111.872 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' PHE . . . . . 0.425 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 44.1 t80 -146.03 133.9 21.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.8 m -120.39 148.3 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -5.07 24.89 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.869 -0.519 . . . . 0.0 110.254 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.9 m -131.11 148.46 70.32 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.07 108.4 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.669 1.579 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 8.3 t 54.58 38.57 30.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.248 1.419 . . . . 0.0 113.492 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -75.2 160.25 30.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.379 0.609 . . . . 0.0 111.061 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -92.92 179.33 5.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.13 167.06 13.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 123.966 0.791 . . . . 0.0 109.675 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.06 102.55 15.86 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.02 -1.45 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 114.568 -171.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 81.5 p -130.42 8.8 5.06 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.679 -1.263 . . . . 0.0 114.133 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -144.48 102.37 3.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.082 0.944 . . . . 0.0 108.753 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -160.46 149.5 17.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.27 0.628 . . . . 0.0 110.229 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.02 154.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -81.07 136.68 35.98 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.151 0.907 . . . . 0.0 109.753 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 84.7 t -128.61 133.13 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.761 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -175.8 -165.9 32.44 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 121.638 0.576 . . . . 0.0 114.104 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.07 28.71 5.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.6 -160.27 0.71 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.635 1.174 . . . . 0.0 111.86 -175.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -36.22 -24.64 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.949 2.1 . . . . 0.0 115.31 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.63 78.31 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 119.351 0.978 . . . . 0.0 113.644 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.419 ' HA ' HG13 ' A' ' 391' ' ' ILE . 28.0 ptm -156.76 30.29 0.31 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 113.115 174.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 361' ' ' LEU . 13.7 tp -76.84 156.24 32.37 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 121.284 0.564 . . . . 0.0 110.973 -171.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.73 170.28 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.509 1.123 . . . . 0.0 110.48 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -72.1 -25.62 61.82 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -175.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -74.68 -26.27 59.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.818 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.55 -32.59 36.66 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.23 -34.46 68.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.855 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.07 80.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.131 0.972 . . . . 0.0 111.187 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.53 -34.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 370' ' ' LEU . 4.2 mm? -94.48 -6.19 44.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.118 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -16.6 14.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.546 1.521 . . . . 0.0 111.338 172.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -97.3 -28.69 13.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.722 0.692 . . . . 0.0 110.744 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.0 tp -83.02 -26.71 30.95 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.26 -59.02 1.6 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.261 -0.899 . . . . 0.0 113.005 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 163.5 -139.66 6.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -70.33 148.16 45.23 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 123.555 1.642 . . . . 0.0 113.881 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.07 152.93 8.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 127.736 2.414 . . . . 0.0 109.893 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.58 -30.64 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.228 -0.892 . . . . 0.0 112.183 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.8 OUTLIER -150.46 147.91 28.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.177 0.899 . . . . 0.0 112.116 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -142.96 139.01 30.5 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -135.17 151.81 20.61 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.67 0.594 . . . . 0.0 114.095 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.85 148.46 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -103.5 147.78 26.74 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 125.281 1.613 . . . . 0.0 108.016 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 47.5 p -140.81 163.06 33.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.5 -0.75 . . . . 0.0 112.118 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.66 34.13 4.7 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.706 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.32 28.02 0.41 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.616 1.566 . . . . 0.0 113.498 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -136.04 23.77 3.29 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp 62.75 -15.66 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.458 ' N ' ' HD2' ' A' ' 390' ' ' PRO . 22.2 p90 -78.73 -22.0 0.37 Allowed Pre-proline 0 CA--C 1.515 -0.371 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -170.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 389' ' ' TYR . 18.5 Cg_endo -61.71 -67.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.475 HD13 ' CZ3' ' A' ' 331' ' ' TRP . 10.9 tp 32.44 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.811 1.644 . . . . 0.0 110.885 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 177.24 27.97 0.04 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.69 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 70.5 m -143.16 146.84 34.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 167.11 -159.08 32.35 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.618 -1.101 . . . . 0.0 112.095 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -154.37 166.82 32.02 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 125.299 1.234 . . . . 0.0 109.594 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.42 126.35 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 42.1 p -95.59 118.67 32.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 69.8 m-85 -90.15 162.63 15.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.145 0.974 . . . . 0.0 111.049 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -122.93 -0.51 8.99 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -124.88 153.04 43.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.628 0.371 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -80.76 -30.57 36.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.443 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -39.1 64.86 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.282 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' SER . . . . . 0.633 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 21.5 m -65.95 -25.59 67.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.536 0.607 . . . . 0.0 111.276 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.67 -57.15 3.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.338 0.589 . . . . 0.0 111.417 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' LEU . . . . . 0.47 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -74.26 -20.76 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.496 -0.752 . . . . 0.0 111.792 -177.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -81.13 -26.66 35.95 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.912 1.233 . . . . 0.0 109.626 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -71.02 -43.39 68.02 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.89 -21.84 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.233 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.4 p -81.18 -26.33 36.08 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 118.352 -0.833 . . . . 0.0 112.83 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.38 -33.15 14.68 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.232 0.469 . . . . 0.0 111.757 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 51.16 -22.54 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 26.1 t80 -163.69 130.53 3.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.891 -1.755 . . . . 0.0 107.506 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.57 174.69 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.884 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -116.46 153.85 31.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.516 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 28.6 mt -127.35 123.48 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.421 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -125.44 140.59 52.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.307 1.004 . . . . 0.0 108.815 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 m -148.8 167.76 24.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.4 t -60.95 -18.83 59.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 15.94 0.75 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -139.42 128.88 24.29 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.634 -0.666 . . . . 0.0 110.622 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 52.5 p -146.86 124.18 11.59 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.063 -0.398 . . . . 0.0 110.148 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' LYS . . . . . 0.612 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 29.4 tptt -165.6 -161.33 0.51 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.631 0.582 . . . . 0.0 110.476 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.612 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 92.8 mttt -141.45 168.48 19.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.39 139.21 29.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -122.3 160.76 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 60.2 mt -139.28 137.3 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.254 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -128.06 145.29 54.8 Favored Pre-proline 0 C--N 1.324 -0.543 0 O-C-N 123.911 0.757 . . . . 0.0 111.211 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 145.67 94.82 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.332 3.354 . . . . 0.0 111.644 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 79.0 t80 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.428 1.091 . . . . 0.0 112.967 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 93.7 m -152.86 146.4 25.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.46 -169.27 3.25 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.659 1.118 . . . . 0.0 111.529 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.1 p -130.11 19.93 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.959 1.703 . . . . 0.0 109.786 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.48 12.23 65.69 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.14 1.352 . . . . 0.0 116.386 -168.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -51.85 156.0 1.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 224' ' ' LEU . 4.1 mm? -100.48 139.46 20.65 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.346 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -44.21 109.63 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.512 3.475 . . . . 0.0 112.371 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.04 17.35 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.907 3.071 . . . . 0.0 111.138 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -133.63 19.51 3.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.539 0.336 . . . . 0.0 111.091 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -134.68 39.33 3.02 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 121.855 0.836 . . . . 0.0 110.845 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -76.13 161.7 28.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.165 0.986 . . . . 0.0 109.087 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -79.21 -10.18 59.75 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.419 ' HA ' HG11 ' A' ' 332' ' ' VAL . 73.2 m-20 42.7 62.34 8.38 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 333' ' ' LEU . 37.7 Cg_endo -63.33 -76.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.0 1.8 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.9 pt -141.17 -178.83 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 124.909 1.284 . . . . 0.0 110.061 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -111.72 153.43 26.48 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.9 p -146.22 -9.95 0.5 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 16.8 t -143.85 171.14 14.63 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.033 0.533 . . . . 0.0 109.576 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -53.66 174.13 0.05 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.824 1.649 . . . . 0.0 114.309 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.7 146.92 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.32 140.17 32.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.012 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.407 ' CD1' HG22 ' A' ' 328' ' ' VAL . 20.1 tp -141.47 143.2 33.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 111.123 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.5 156.55 28.57 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.537 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.95 14.28 1.47 Allowed Glycine 0 N--CA 1.475 1.235 0 O-C-N 122.005 -0.703 . . . . 0.0 112.616 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.96 72.98 18.04 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.342 -1.093 . . . . 0.0 110.905 -174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.8 7.72 2.27 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.532 2.154 . . . . 0.0 113.655 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 17.6 p-90 -141.42 -4.94 1.1 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.52 109.15 1.55 Allowed 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 124.69 1.196 . . . . 0.0 112.593 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -72.48 -30.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.351 -172.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.9 p -142.4 126.05 16.91 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 119.734 1.152 . . . . 0.0 112.977 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -71.0 -16.22 62.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.458 -172.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.12 -16.48 61.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 120.215 1.371 . . . . 0.0 108.472 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.33 99.23 Favored Glycine 0 N--CA 1.435 -1.424 0 O-C-N 120.88 -1.137 . . . . 0.0 112.704 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 48.6 mt -69.68 -31.84 70.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.504 1.122 . . . . 0.0 108.27 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.74 -36.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.608 -0.682 . . . . 0.0 110.179 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -80.29 -9.97 59.74 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.955 0.798 . . . . 0.0 111.179 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.0 m -96.49 -21.72 17.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -103.54 -24.32 13.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -74.3 -0.17 16.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.014 0.825 . . . . 0.0 111.81 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.23 -20.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.186 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -101.05 -7.09 23.56 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 156.23 -166.18 33.04 Favored Glycine 0 N--CA 1.432 -1.577 0 O-C-N 124.499 1.124 . . . . 0.0 114.684 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 58.5 m -51.02 124.11 10.69 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.456 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 152.95 42.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.497 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -146.99 168.84 20.52 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.598 1.559 . . . . 0.0 108.711 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.6 152.2 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 121.489 -0.757 . . . . 0.0 112.26 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.21 135.86 32.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 124.497 1.123 . . . . 0.0 110.792 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.487 ' CE2' ' HG2' ' A' ' 269' ' ' LYS . 20.0 p90 -148.11 154.07 42.33 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.93 136.33 24.85 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.162 1.908 . . . . 0.0 107.365 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.2 32.97 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.487 ' HG2' ' CE2' ' A' ' 266' ' ' TRP . 35.8 mtmt -64.28 -6.43 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.449 1.124 . . . . 0.0 111.387 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.67 5.43 43.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.919 1.288 . . . . 0.0 110.696 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -69.68 -160.75 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.435 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -77.43 -17.62 57.94 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 276' ' ' CYS . 3.7 p80 -166.04 154.43 9.96 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.81 -1.39 11.1 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.397 2.732 . . . . 0.0 114.124 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -90.77 31.11 1.09 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 110.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 17.2 t -125.61 40.16 0.52 Allowed Pre-proline 0 C--N 1.34 0.159 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 89.3 Cg_endo -75.07 170.37 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 107.117 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.96 161.56 6.28 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.07 1.846 . . . . 0.0 115.269 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -54.25 -14.82 1.27 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.501 1.12 . . . . 0.0 112.432 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -179.84 16.38 0.03 OUTLIER Glycine 0 CA--C 1.533 1.156 0 CA-C-N 120.488 1.494 . . . . 0.0 112.873 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -130.15 155.85 45.54 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.272 1.536 . . . . 0.0 112.732 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.14 158.43 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 124.176 0.99 . . . . 0.0 109.819 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -118.45 150.06 40.21 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.18 140.62 52.35 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.1 129.79 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -168.03 -167.21 0.8 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -44.6 122.54 3.17 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 124.499 1.124 . . . . 0.0 109.189 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.16 -18.39 35.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.105 2.562 . . . . 0.0 115.852 -166.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -140.32 -54.1 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 120.082 1.31 . . . . 0.0 113.675 -167.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -73.96 -45.34 50.78 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.102 -0.374 . . . . 0.0 110.909 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 71.1 m -70.13 -26.78 64.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.75 -53.58 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -67.6 -26.76 66.42 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.991 -0.443 . . . . 0.0 111.904 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.6 t -67.94 -46.25 72.01 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.207 0.317 . . . . 0.0 110.44 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 291' ' ' SER . 5.4 mt -63.8 -42.25 97.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.03 0.377 . . . . 0.0 110.513 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.66 -25.94 61.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.424 0.69 . . . . 0.0 110.042 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -104.99 2.32 29.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.142 0.902 . . . . 0.0 110.077 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.1 -10.8 14.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.594 0.634 . . . . 0.0 110.03 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 16.6 p -107.25 -148.32 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.196 0.31 . . . . 0.0 110.743 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 67.0 m -106.78 145.27 32.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.236 0.541 . . . . 0.0 110.627 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -142.89 155.06 44.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.122 0.969 . . . . 0.0 108.849 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -145.92 137.58 13.07 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 304' ' ' LEU . 96.8 Cg_endo -71.72 -103.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 122.376 2.05 . . . . 0.0 109.338 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 303' ' ' PRO . 9.8 mp . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 124.374 1.07 . . . . 0.0 109.855 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 N--CA 1.465 0.292 0 N-CA-C 111.349 0.129 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 4.1 m -79.17 148.2 32.38 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.5 151.47 31.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.4 153.77 32.49 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 124.33 1.019 . . . . 0.0 109.978 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -147.62 152.66 38.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.915 -1.116 . . . . 0.0 110.017 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 5.4 t80 -153.28 178.05 10.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 30.0 ttmt -152.47 124.95 8.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -169.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 12.67 6.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.868 0.867 . . . . 0.0 110.046 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.6 p -87.48 159.74 18.54 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.416 1.086 . . . . 0.0 111.511 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.3 m -149.27 38.0 0.78 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.768 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 52.51 33.53 13.55 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 121.238 0.542 . . . . 0.0 111.725 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -80.5 -30.65 37.29 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.75 -41.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.093 0.86 . . . . 0.0 111.176 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -147.5 166.65 26.64 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.749 1.219 . . . . 0.0 109.632 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 90.7 m -140.54 123.44 16.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.927 1.346 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -159.0 152.56 22.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -89.88 156.5 18.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 110.679 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.38 152.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.244 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -117.83 131.69 56.53 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.764 0.711 . . . . 0.0 111.77 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 240' ' ' LEU . 2.6 t -115.15 143.35 25.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.302 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.99 98.08 4.45 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 124.19 0.931 . . . . 0.0 109.904 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -83.98 162.14 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.904 4.403 . . . . 0.0 111.99 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.614 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 1.8 t90 -88.34 123.65 33.13 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.777 0.799 . . . . 0.0 109.293 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 231' ' ' ASN . 17.2 t -103.75 154.68 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.056 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 333' ' ' LEU . 7.9 tt -54.26 -26.45 29.07 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.587 -0.696 . . . . 0.0 112.173 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.09 16.95 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.558 -0.714 . . . . 0.0 112.264 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.07 -5.3 18.15 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.782 0.833 . . . . 0.0 108.894 173.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 66.8 m -100.6 -34.82 9.73 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.016 -1.677 . . . . 0.0 113.906 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -167.18 171.93 10.41 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 124.196 0.935 . . . . 0.0 113.418 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -156.51 155.07 31.35 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.081 1.352 . . . . 0.0 108.294 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.67 148.17 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.481 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -88.83 -16.45 32.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 35.8 t -151.34 113.75 3.05 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.69 -15.03 30.36 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.598 2.865 . . . . 0.0 112.02 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.2 t -86.21 4.65 37.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.428 1.091 . . . . 0.0 112.402 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -114.37 -175.11 2.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.454 1.501 . . . . 0.0 110.936 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -141.7 -179.81 6.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 122.198 0.199 . . . . 0.0 110.892 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -83.5 120.41 25.89 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 10.3 m-20 -81.1 150.69 68.89 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 124.752 1.283 . . . . 0.0 111.121 -171.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 77.5 Cg_exo -54.63 108.69 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.648 3.565 . . . . 0.0 109.885 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 86.2 p 52.79 23.51 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.52 73.98 0.99 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 119.453 1.024 . . . . 0.0 108.786 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 t -155.75 144.14 20.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.38 159.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 118.294 0.497 . . . . 0.0 110.238 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -83.53 146.92 28.08 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.382 1.051 . . . . 0.0 113.561 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 67.5 t -131.07 136.09 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.962 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.48 -176.96 31.13 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 51.0 22.94 1.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.575 1.55 . . . . 0.0 113.365 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.986 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.65 171.94 14.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.686 0.794 . . . . 0.0 111.171 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -48.7 150.19 1.5 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.546 1.138 . . . . 0.0 109.28 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -66.39 10.6 0.64 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.945 1.259 . . . . 0.0 113.135 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.0 mmt -145.43 -53.21 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.191 0.596 . . . . 0.0 109.805 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 41.73 60.01 2.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.718 0.77 . . . . 0.0 109.639 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -72.43 173.92 8.11 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 121.986 -0.447 . . . . 0.0 111.835 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -57.12 -18.01 13.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -80.55 -35.51 34.29 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.547 -0.721 . . . . 0.0 110.807 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.64 -27.22 27.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 366' ' ' LEU . 2.3 tt -78.68 -31.22 46.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.38 -28.59 56.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.91 -0.494 . . . . 0.0 111.993 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.9 -42.04 61.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 77.5 mt -79.09 -35.48 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 118.808 0.731 . . . . 0.0 109.067 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.31 -22.96 38.16 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.621 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.88 -23.61 21.59 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 120.561 1.528 . . . . 0.0 109.91 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.07 -36.48 58.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.527 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.452 HD11 HG11 ' A' ' 413' ' ' VAL . 2.9 mp -66.86 -34.44 77.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.313 -177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 403' ' ' SER . 0.2 OUTLIER -158.67 -17.38 0.07 Allowed 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.21 -7.6 5.84 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 121.979 0.766 . . . . 0.0 113.679 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -94.05 78.94 0.98 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 122.045 -0.679 . . . . 0.0 113.135 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.42 159.44 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 118.654 1.227 . . . . 0.0 112.378 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.01 -33.06 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -158.28 147.04 18.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.81 146.35 23.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.51 38.16 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 123.058 1.366 . . . . 0.0 114.304 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.56 141.4 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 122.188 0.994 . . . . 0.0 109.2 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.41 148.73 26.44 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.557 -171.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.4 p -131.39 159.6 37.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.87 -175.28 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.72 88.14 2.23 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 119.728 -1.858 . . . . 0.0 112.658 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 57.9 m170 70.49 38.58 1.32 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.18 -5.02 15.44 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.889 0.876 . . . . 0.0 110.384 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.1 p90 37.87 54.52 3.85 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 127.097 2.159 . . . . 0.0 114.364 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.18 -48.45 1.76 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.774 2.316 . . . . 0.0 111.169 -174.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.75 37.73 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 111.633 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.88 10.65 0.79 Allowed Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.5 p -155.17 126.66 7.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.265 0.555 . . . . 0.0 110.093 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -156.42 -164.94 13.95 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.468 1.038 . . . . 0.0 114.91 -171.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -151.76 162.6 40.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.551 -0.824 . . . . 0.0 108.899 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.13 134.15 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.153 -0.967 . . . . 0.0 108.881 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 346' ' ' LEU . 60.7 m -111.28 142.93 42.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.304 1.05 . . . . 0.0 109.549 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 73.8 m-85 -131.44 162.35 30.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.431 -0.793 . . . . 0.0 110.619 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.85 20.83 10.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.504 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -140.12 155.65 46.9 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.157 0.983 . . . . 0.0 109.183 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.08 -24.61 28.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.67 0.668 . . . . 0.0 110.196 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.649 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 3.8 mpt_? -52.89 -31.31 39.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.556 -0.715 . . . . 0.0 111.576 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.501 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 14.3 m -80.46 -29.21 37.48 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.577 0.751 . . . . 0.0 110.864 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.42 -54.37 10.91 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.942 0.337 . . . . 0.0 111.866 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.64 -17.86 55.36 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.005 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -86.41 -31.63 21.33 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 120.45 1.477 . . . . 0.0 112.665 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -72.6 -33.32 66.63 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 120.875 -1.141 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.7 -30.7 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 14.0 t -78.41 -32.21 48.62 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.379 1.049 . . . . 0.0 110.498 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.47 -44.55 35.04 Favored 'General case' 0 C--O 1.227 -0.095 0 O-C-N 121.735 -0.603 . . . . 0.0 110.914 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.17 -17.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.124 2.569 . . . . 0.0 116.331 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 423' ' ' LYS . 0.1 OUTLIER -164.95 136.87 4.31 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.106 -1.621 . . . . 0.0 108.664 178.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.452 HG11 HD11 ' A' ' 373' ' ' LEU . 34.0 m -135.58 154.5 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.698 0.681 . . . . 0.0 110.728 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -112.8 141.48 46.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.559 0.743 . . . . 0.0 111.438 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.0 mt -100.54 122.72 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.44 52.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 418' ' ' THR . 0.3 OUTLIER -72.53 178.51 4.02 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.55 ' H ' HG22 ' A' ' 417' ' ' THR . 10.8 m -75.46 -27.36 58.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -144.32 16.32 1.68 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.963 0.887 . . . . 0.0 110.479 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.59 113.17 4.1 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.7 p -136.27 131.86 35.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.918 0.487 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -148.91 177.74 9.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 412' ' ' PHE . 32.3 mtmm -144.45 160.93 40.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.06 133.56 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -106.98 157.44 17.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.34 0.59 . . . . 0.0 111.413 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 24.8 mt -140.87 149.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.42 149.95 56.27 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 124.196 0.935 . . . . 0.0 109.387 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.5 161.61 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.413 3.409 . . . . 0.0 109.941 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 116.797 -1.573 . . . . 0.0 111.226 178.441 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.6 m -155.03 158.94 39.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.383 1.073 . . . . 0.0 111.009 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.76 -16.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.062 -0.971 . . . . 0.0 113.472 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.1 m 43.61 52.27 6.22 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.433 1.015 . . . . 0.0 112.383 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 224' ' ' LEU . . . -71.27 -22.32 78.54 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.555 -173.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 59.67 27.33 16.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.727 0.811 . . . . 0.0 113.078 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.414 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.1 mm? -81.45 -22.55 0.34 Allowed Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 57.2 Cg_endo -67.76 121.43 8.48 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 CA-C-N 123.529 2.296 . . . . 0.0 111.619 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.14 166.98 4.57 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 125.232 3.955 . . . . 0.0 111.875 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -143.05 6.07 1.53 Allowed 'General case' 0 C--O 1.219 -0.541 0 O-C-N 122.003 -0.435 . . . . 0.0 112.128 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -115.88 30.15 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.976 1.71 . . . . 0.0 108.016 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -60.13 159.33 9.78 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -66.93 7.75 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -170.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 36.8 71.17 0.98 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.191 0.996 . . . . 0.0 112.183 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.31 -89.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.538 1 C-N-CA 126.072 4.515 . . . . 0.0 114.748 -173.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 234' ' ' TYR . 11.6 mm -127.37 178.15 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.326 1.45 . . . . 0.0 107.465 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 233' ' ' ILE . 14.8 m-85 -118.39 157.45 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.369 -0.825 . . . . 0.0 110.108 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 77.9 p -155.39 13.24 0.36 Allowed 'General case' 0 C--N 1.341 0.208 0 CA-C-N 121.242 1.837 . . . . 0.0 115.741 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 9.1 t -151.96 -177.37 6.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.115 1.325 . . . . 0.0 108.67 172.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.89 -172.77 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.541 1.162 . . . . 0.0 113.327 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.74 144.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.185 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.48 150.86 22.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.483 0.658 . . . . 0.0 111.954 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 240' ' ' LEU . 3.4 tm? -140.52 126.08 19.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.674 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.42 38.15 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.205 -0.934 . . . . 0.0 112.911 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.47 3.23 2.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -99.69 134.93 20.72 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.475 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.89 -3.19 12.64 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.332 2.688 . . . . 0.0 110.97 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -128.07 -177.11 4.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.88 1.324 . . . . 0.0 111.151 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -166.47 149.42 6.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.427 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -174.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 168.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 250' ' ' ALA . 18.8 m -42.15 129.35 3.7 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.178 -0.951 . . . . 0.0 110.527 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.2 -25.03 65.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 121.694 -0.629 . . . . 0.0 112.242 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.4 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.78 -22.93 64.25 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.397 0.999 . . . . 0.0 112.263 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.95 -30.47 67.89 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.582 1.657 . . . . 0.0 110.601 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.59 -36.17 60.4 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.731 -1.453 . . . . 0.0 108.829 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 262' ' ' LEU . 92.7 t -67.48 -36.21 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 123.172 0.589 . . . . 0.0 110.066 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.4 -18.74 61.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.488 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 87.0 m -73.1 -33.63 65.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 118.722 0.692 . . . . 0.0 110.067 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -140.43 80.09 1.74 Allowed 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.704 ' HA ' HD11 ' A' ' 262' ' ' LEU . 12.9 ptm180 -133.59 1.35 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.257 0.623 . . . . 0.0 111.493 171.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.31 -1.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.136 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -100.43 -15.44 17.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.409 0.55 . . . . 0.0 110.416 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 262' ' ' LEU . . . 158.37 170.94 23.63 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.0 t -64.08 131.18 46.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.704 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -152.1 165.35 35.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.709 0.766 . . . . 0.0 110.957 169.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -141.01 171.65 13.77 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.602 0.715 . . . . 0.0 110.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.84 147.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.564 0.746 . . . . 0.0 110.996 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -139.58 134.09 31.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.025 0.828 . . . . 0.0 109.936 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -155.23 151.0 21.79 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.011 1.324 . . . . 0.0 110.227 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.66 154.42 34.81 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.415 3.41 . . . . 0.0 111.126 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.49 11.22 75.37 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.181 -0.95 . . . . 0.0 112.783 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -79.44 9.26 4.99 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -118.56 148.2 42.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.202 1.401 . . . . 0.0 110.047 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.77 43.97 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.66 -0.65 . . . . 0.0 112.532 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -72.46 155.77 39.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 121.462 -1.022 . . . . 0.0 111.014 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 26.8 m170 46.37 61.04 13.67 Favored Pre-proline 0 N--CA 1.447 -0.613 0 O-C-N 124.537 1.148 . . . . 0.0 111.647 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.05 -20.05 57.26 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.599 2.199 . . . . 0.0 108.945 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 275' ' ' ARG . 5.7 ppt_? -80.18 10.23 4.68 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.408 1.083 . . . . 0.0 113.615 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 44.4 t -133.84 110.41 12.11 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 120.591 -1.318 . . . . 0.0 111.592 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.62 157.95 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.548 2.165 . . . . 0.0 109.785 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.55 -11.81 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -143.15 -178.15 5.7 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 127.67 2.388 . . . . 0.0 110.286 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.88 4.02 59.02 Favored Glycine 0 CA--C 1.547 2.038 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.1 116.51 32.64 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.928 -1.51 . . . . 0.0 111.879 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.4 m -145.01 163.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.795 1.31 . . . . 0.0 108.59 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -87.85 157.22 19.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 284' ' ' LEU . 18.5 mt -128.08 140.87 51.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.77 156.19 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.761 0.824 . . . . 0.0 109.94 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.575 ' CZ ' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -171.22 176.27 3.99 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -60.36 88.29 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.9 pt? -56.56 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 129.411 3.084 . . . . 0.0 117.075 -167.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -131.67 -41.73 1.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.998 1.272 . . . . 0.0 111.372 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -95.18 -32.91 12.83 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.646 -0.659 . . . . 0.0 111.437 -173.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.8 t -83.51 -17.8 40.64 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 1.8 t -82.41 -33.58 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 O-C-N 121.216 -0.927 . . . . 0.0 109.976 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -62.96 -47.44 83.17 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 123.97 0.794 . . . . 0.0 110.329 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 77.6 p -76.79 -31.52 57.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.23 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.32 -40.64 58.22 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.38 -16.8 60.34 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.122 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.08 1.64 31.14 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.007 1.442 . . . . 0.0 111.846 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -113.42 -25.08 8.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.148 0.885 . . . . 0.0 110.956 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 300' ' ' SER . 98.4 m -79.1 -157.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 299' ' ' CYS . 16.5 m -116.67 161.27 19.47 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.346 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -141.68 151.4 42.97 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -140.85 118.8 8.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.49 33.04 0.44 Allowed 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 124.563 3.509 . . . . 0.0 109.931 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.828 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.342 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 309' ' ' LEU . 1.5 pp . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.393 0.616 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 16.2 m -143.01 157.08 44.88 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.544 -1.347 . . . . 0.0 112.16 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.7 149.7 51.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.185 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.19 148.68 23.34 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.768 1.227 . . . . 0.0 112.076 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -149.03 156.57 42.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.864 -0.522 . . . . 0.0 110.418 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -158.47 161.16 37.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 11.6 ptpt -120.23 135.54 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 9.17 4.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.7 t -105.96 145.67 31.02 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.4 p -147.85 -32.62 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -138.47 -0.93 1.93 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -105.09 -30.54 9.67 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.574 -0.704 . . . . 0.0 110.716 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.7 mmt -135.03 -163.1 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.643 1.577 . . . . 0.0 106.744 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -69.89 -95.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.674 0.75 . . . . 0.0 109.775 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 98.7 m -156.33 29.8 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.678 0.791 . . . . 0.0 110.768 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.96 121.31 17.12 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 119.942 1.246 . . . . 0.0 113.231 -169.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 0.1 OUTLIER -77.22 164.01 26.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.115 0.566 . . . . 0.0 111.722 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.34 164.03 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.458 0.703 . . . . 0.0 109.522 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -109.94 153.36 24.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.669 0.668 . . . . 0.0 110.55 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.36 149.09 18.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-O 122.493 1.14 . . . . 0.0 111.358 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 119.06 3.65 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.848 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -99.11 172.59 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 124.429 3.42 . . . . 0.0 113.828 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.56 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 7.9 t-105 -85.46 124.67 32.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.837 0.855 . . . . 0.0 110.596 170.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.63 151.78 3.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-O 121.021 0.438 . . . . 0.0 110.118 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 337' ' ' ASN . 7.4 tt -61.04 -27.04 68.05 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.635 0.774 . . . . 0.0 110.156 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.2 -6.52 35.07 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 111.474 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.61 7.9 35.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.819 0.848 . . . . 0.0 109.101 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 62.6 m -111.44 -33.12 6.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.909 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . 0.478 HD21 HD21 ' A' ' 333' ' ' LEU . 1.7 p30 -155.26 158.29 38.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.233 0.924 . . . . 0.0 111.827 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -154.36 140.51 18.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.491 169.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.38 148.37 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.911 0.884 . . . . 0.0 113.121 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -111.63 -7.81 14.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.003 1.383 . . . . 0.0 108.807 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 31.1 t -123.82 132.63 24.3 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.49 -1.45 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.975 2.45 . . . . 0.0 112.072 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 43.2 t -87.3 -14.69 40.15 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.734 1.152 . . . . 0.0 114.035 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 52.02 48.95 21.71 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' A' ' 346' ' ' LEU . 40.1 ttt180 -98.25 -178.17 3.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.214 1.405 . . . . 0.0 111.379 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.493 ' H ' ' HG2' ' A' ' 345' ' ' ARG . 11.8 tp -149.16 163.84 36.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -119.23 164.67 20.15 Favored Pre-proline 0 C--N 1.351 0.666 0 CA-C-N 118.435 0.561 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.86 63.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 126.964 5.109 . . . . 0.0 115.362 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 18.8 m 59.21 21.25 9.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.32 58.09 4.32 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.545 1.164 . . . . 0.0 109.324 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.5 t -117.47 166.7 12.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.57 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.3 m -133.67 150.38 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 123.995 0.809 . . . . 0.0 110.507 171.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -78.3 142.54 37.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 124.254 0.971 . . . . 0.0 110.041 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.29 142.44 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.01 29.11 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 124.004 0.815 . . . . 0.0 112.704 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 61.18 -2.41 0.22 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 357' ' ' LEU . 2.3 pt? -69.46 159.15 33.81 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.205 0.602 . . . . 0.0 111.567 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -92.75 173.92 7.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.711 -0.618 . . . . 0.0 111.432 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -64.24 8.69 0.42 Allowed Glycine 0 CA--C 1.532 1.144 0 N-CA-C 118.232 2.053 . . . . 0.0 118.232 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 38.4 mtt -142.65 6.02 1.62 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.976 1.888 . . . . 0.0 111.319 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.7 68.13 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 124.008 1.861 . . . . 0.0 109.586 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -62.19 176.4 0.6 Allowed 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.417 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.23 62.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.04 -26.4 36.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -85.22 -32.83 22.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.232 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.89 -31.72 64.87 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.271 0.487 . . . . 0.0 110.817 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.36 42.69 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.064 1.302 . . . . 0.0 110.597 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.76 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 123.89 0.744 . . . . 0.0 110.263 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.41 -44.46 80.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 O-C-N 124.174 0.921 . . . . 0.0 109.571 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.39 -17.42 34.47 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 112.722 -168.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.03 -23.89 18.51 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.167 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -93.41 -23.73 18.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.43 0.559 . . . . 0.0 112.446 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.8 -11.51 16.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -115.12 -36.18 4.48 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 141.28 -45.76 0.94 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.899 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.95 150.92 10.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.521 -1.8 . . . . 0.0 111.187 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.53 170.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.326 1.851 . . . . 0.0 107.001 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.81 -29.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 118.101 0.41 . . . . 0.0 110.613 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.441 ' CD1' ' CD1' ' A' ' 346' ' ' LEU . 4.0 t80 -165.61 157.13 14.31 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.803 0.811 . . . . 0.0 111.464 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.55 150.61 35.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.954 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.89 29.94 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 121.248 -0.907 . . . . 0.0 113.071 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 20.7 mm -118.93 141.41 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.153 1.381 . . . . 0.0 107.349 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -90.81 139.97 30.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.4 p -132.78 168.44 18.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.197 0.999 . . . . 0.0 109.561 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -137.81 158.37 44.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.082 2.153 . . . . 0.0 105.528 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -58.66 112.81 1.75 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 18.7 m170 62.99 26.06 15.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.588 -1.32 . . . . 0.0 114.113 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -94.33 -24.48 17.39 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.9 t80 41.35 59.41 8.82 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 125.398 1.479 . . . . 0.0 111.237 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.21 -35.16 3.16 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.595 1.53 . . . . 0.0 110.992 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.56 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 6.5 tp 31.7 48.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 125.166 1.387 . . . . 0.0 110.839 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.14 12.89 0.45 Allowed Glycine 0 C--N 1.349 1.259 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.037 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.0 m -147.86 154.53 40.54 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 118.685 1.242 . . . . 0.0 110.318 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.41 -168.3 40.85 Favored Glycine 0 C--O 1.247 0.951 0 CA-C-N 119.531 1.06 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -152.22 161.23 42.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.02 145.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 123.13 0.269 . . . . 0.0 110.332 -173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.8 p -123.11 142.18 51.16 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.792 0.806 . . . . 0.0 110.563 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.44 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 26.0 m-85 -118.41 -24.81 6.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.153 -169.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.55 17.52 3.08 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.47 156.0 38.6 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.776 -0.577 . . . . 0.0 110.753 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -89.72 -18.33 26.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -55.77 -42.11 75.03 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.478 -1.389 . . . . 0.0 109.675 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.44 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 57.2 m -82.55 -13.37 56.71 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.455 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.36 -50.1 15.12 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 119.195 0.907 . . . . 0.0 110.93 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.47 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.59 -29.43 51.99 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.386 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 405' ' ' LEU . 23.6 ttmm -70.39 -28.88 65.43 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.898 0.856 . . . . 0.0 111.296 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.23 19.74 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.276 -0.89 . . . . 0.0 113.291 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.56 -27.29 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.887 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 73.3 p -82.35 -26.28 33.1 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.22 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -81.58 -40.67 22.71 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.29 -12.54 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.71 143.64 3.31 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 123.815 0.846 . . . . 0.0 109.239 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.21 162.44 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 O-C-N 123.688 0.618 . . . . 0.0 110.828 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -106.77 143.72 34.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 123.986 0.803 . . . . 0.0 111.888 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.8 mt -125.7 119.04 53.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -143.59 130.71 20.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.9 p -136.55 -161.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.5 m -88.84 -2.37 58.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.997 0.519 . . . . 0.0 111.98 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -145.57 -4.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 422' ' ' LYS . 51.2 t80 -138.39 141.07 39.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.341 -1.474 . . . . 0.0 111.1 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 45.4 m -147.2 102.01 3.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.198 0.999 . . . . 0.0 110.904 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 420' ' ' PHE . 0.6 OUTLIER -153.26 173.77 15.14 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.575 0.625 . . . . 0.0 110.502 178.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -131.43 163.15 28.57 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.39 133.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -100.5 149.91 23.21 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 72.0 mt -133.68 138.2 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.088 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -135.3 150.33 72.3 Favored Pre-proline 0 CA--C 1.53 0.18 0 O-C-N 123.977 0.798 . . . . 0.0 111.333 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.45 150.92 75.97 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.615 1.543 . . . . 0.0 111.344 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 124.852 1.261 . . . . 0.0 112.077 -177.39 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.1 m 60.03 159.68 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.879 2.072 . . . . 0.0 111.957 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.473 ' CZ3' ' CA ' ' A' ' 222' ' ' GLY . 87.8 t90 -161.51 158.6 26.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.931 0.493 . . . . 0.0 109.741 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 70.7 p -143.18 104.62 4.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.288 0.566 . . . . 0.0 110.735 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.473 ' CA ' ' CZ3' ' A' ' 220' ' ' TRP . . . -73.08 111.8 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.26 -17.38 13.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.027 -1.087 . . . . 0.0 110.165 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -130.14 14.09 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 118.202 2.668 . . . . 0.0 118.202 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 72.6 Cg_exo -49.88 124.05 11.83 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 CA-C-N 120.989 1.389 . . . . 0.0 112.995 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.75 140.96 55.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.879 3.052 . . . . 0.0 110.992 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -142.78 -1.81 1.09 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -130.41 59.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.548 0.689 . . . . 0.0 112.829 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.32 163.75 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.445 1.098 . . . . 0.0 110.391 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -157.46 146.16 19.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.23 153.94 81.83 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -85.88 28.04 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.892 2.395 . . . . 0.0 113.397 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 74.6 mt -137.45 154.75 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 121.953 -0.467 . . . . 0.0 110.596 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.45 170.77 11.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.806 1.643 . . . . 0.0 108.484 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 54.0 p -152.52 -155.44 0.61 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 122.81 0.444 . . . . 0.0 110.375 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 94.3 m -54.33 137.59 41.34 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.488 1.515 . . . . 0.0 114.416 -168.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 56.26 143.85 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.18 149.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -107.73 156.33 19.21 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 117.885 0.312 . . . . 0.0 111.468 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.29 134.26 16.9 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 125.041 1.463 . . . . 0.0 107.261 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.82 155.92 23.89 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 120.658 -1.277 . . . . 0.0 112.391 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.97 7.35 1.57 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.729 -1.039 . . . . 0.0 112.99 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.96 70.47 10.14 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.697 1.599 . . . . 0.0 109.998 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.92 9.78 1.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 1 C-N-CA 125.726 4.284 . . . . 0.0 112.267 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.42 ' CE3' ' CE ' ' A' ' 321' ' ' MET . 12.5 p-90 -136.15 -8.94 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.94 116.98 8.38 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -174.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.533 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.59 -30.45 34.01 Favored 'Isoleucine or valine' 0 C--O 1.274 2.35 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.4 m -146.85 127.1 13.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.861 -1.15 . . . . 0.0 112.197 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -56.82 -27.04 59.38 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 125.677 1.861 . . . . 0.0 113.202 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.4 -16.49 47.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.34 -57.07 3.04 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-O 121.65 0.583 . . . . 0.0 111.657 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 252' ' ' LEU . 6.8 tt -66.14 -48.99 68.99 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.46 -33.12 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.335 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -77.99 -8.75 58.56 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.369 0.531 . . . . 0.0 111.685 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.5 m -83.24 -22.96 32.93 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.309 -1.494 . . . . 0.0 112.329 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -141.56 29.85 1.74 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.391 1.451 . . . . 0.0 114.315 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -90.94 13.06 17.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.532 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.53 27.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -168.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.03 -1.32 8.3 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.002 -0.436 . . . . 0.0 111.156 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.34 1.28 88.22 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.006 -0.886 . . . . 0.0 113.869 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.8 m -126.55 30.08 5.61 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.2 OUTLIER -100.53 146.0 27.62 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -148.79 160.89 42.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 122.174 0.988 . . . . 0.0 109.551 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.8 148.07 22.18 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.76 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.32 149.77 44.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.547 0.612 . . . . 0.0 110.645 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -117.4 143.77 32.69 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.657 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.76 -25.69 7.56 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.826 2.351 . . . . 0.0 110.232 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 174.13 17.2 0.02 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-N 119.944 1.247 . . . . 0.0 114.858 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -112.96 22.03 14.83 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.968 1.884 . . . . 0.0 112.246 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.76 149.78 43.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.544 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -118.07 173.75 14.97 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-O 121.179 0.321 . . . . 0.0 112.32 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -92.06 5.78 48.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 23.8 m170 -98.26 164.09 17.92 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.852 1.661 . . . . 0.0 111.346 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 273' ' ' HIS . 71.7 Cg_endo -69.69 5.06 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.757 2.972 . . . . 0.0 110.707 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 248' ' ' THR . 7.3 ptm180 -140.57 147.54 39.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.871 1.269 . . . . 0.0 110.71 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.93 146.2 15.11 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -93.34 149.84 2.44 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 124.399 3.399 . . . . 0.0 110.447 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.81 163.79 28.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.32 2.68 . . . . 0.0 107.215 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -96.77 23.78 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.65 82.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -165.15 129.4 2.42 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.793 -0.828 . . . . 0.0 109.842 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 160.28 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.498 1.749 . . . . 0.0 108.719 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -92.25 159.18 15.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 43.3 mt -122.94 143.47 49.88 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 123.371 0.669 . . . . 0.0 109.834 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.53 132.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 30.0 p90 -171.05 -163.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.72 1.263 . . . . 0.0 108.16 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.9 107.81 0.2 Allowed 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -91.04 19.18 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -167.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.62 -72.23 0.64 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.052 -1.03 . . . . 0.0 109.918 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -25.68 29.96 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.26 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 48.9 m -83.83 -23.2 31.47 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.63 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -45.32 39.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.026 -1.046 . . . . 0.0 109.34 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -73.71 -17.2 61.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.896 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.8 t -75.3 -46.08 35.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.08 1.309 . . . . 0.0 108.572 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -61.07 -47.61 85.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.94 -24.61 67.57 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.158 -0.964 . . . . 0.0 110.12 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -101.66 -3.04 28.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.174 0.921 . . . . 0.0 113.088 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -107.24 -10.57 15.79 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.676 0.61 . . . . 0.0 110.489 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.2 m -105.79 -141.83 0.37 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.3 t -125.53 163.6 22.35 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.316 -0.865 . . . . 0.0 111.294 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -148.76 153.58 38.37 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.393 0.433 . . . . 0.0 110.036 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -135.17 122.78 15.24 Favored Pre-proline 0 N--CA 1.435 -1.182 0 O-C-N 125.761 1.913 . . . . 0.0 106.498 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.0 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.039 1.826 . . . . 0.0 113.461 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.223 -0.293 0 C-N-CA 123.856 0.862 . . . . 0.0 110.381 -170.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 12.3 m -109.62 144.77 37.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.092 0.245 . . . . 0.0 110.956 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -142.92 140.35 31.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 111.497 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.67 154.47 18.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.811 0.845 . . . . 0.0 110.026 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.38 158.17 44.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.042 -1.036 . . . . 0.0 112.387 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 2.0 t80 -148.37 177.89 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.153 0.501 . . . . 0.0 110.559 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.4 ' N ' ' CD1' ' A' ' 314' ' ' PHE . 23.5 ttmt -147.53 122.71 10.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.04 7.45 1.19 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.743 -167.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.0 p -70.68 157.99 37.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.628 1.171 . . . . 0.0 110.935 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 42.3 t -115.68 173.08 6.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -69.92 -15.87 63.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.646 1.178 . . . . 0.0 111.424 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -68.2 -20.95 64.88 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.42 ' CE ' ' CE3' ' A' ' 245' ' ' TRP . 22.7 ptm -160.95 -165.18 1.31 Allowed 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.724 1.21 . . . . 0.0 111.563 -172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 71.4 mtm-85 -55.76 157.64 4.1 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 110.151 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.3 m -140.48 145.01 36.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 125.068 1.48 . . . . 0.0 110.223 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.93 144.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.28 156.93 36.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.348 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.77 154.81 11.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.34 158.81 23.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 110.413 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.46 145.88 31.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.758 0.789 . . . . 0.0 109.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 60.4 mt -143.16 97.41 5.71 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.23 158.53 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.058 2.506 . . . . 0.0 112.368 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.45 122.27 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.3 t -96.38 146.97 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.02 -24.42 58.22 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.827 1.251 . . . . 0.0 108.43 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.524 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.49 -19.62 64.91 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.859 -1.151 . . . . 0.0 112.472 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -101.3 9.54 41.6 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.237 0.215 . . . . 0.0 111.252 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 74.0 m -102.78 -27.16 12.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.523 -1.361 . . . . 0.0 112.503 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.03 165.69 15.64 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.582 -0.699 . . . . 0.0 110.059 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -158.01 148.4 20.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.16 150.07 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.911 0.862 . . . . 0.0 108.855 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -94.46 -10.56 31.99 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.848 -0.533 . . . . 0.0 111.695 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 m -143.83 150.63 50.62 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.086 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.83 119.87 5.58 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.338 2.025 . . . . 0.0 110.239 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 23.3 t -145.84 161.61 39.6 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.596 0.236 . . . . 0.0 110.545 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -79.9 -27.34 39.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.274 0.63 . . . . 0.0 112.187 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -164.23 171.51 14.86 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.916 1.286 . . . . 0.0 108.905 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 60.5 mt -97.99 -178.31 4.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.958 1.303 . . . . 0.0 111.099 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -101.74 103.62 29.6 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.44 -6.09 12.68 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.253 1.968 . . . . 0.0 113.202 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 21.2 t -91.16 -22.32 20.73 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.621 -0.228 . . . . 0.0 111.072 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -131.82 103.87 6.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 t -154.31 156.56 37.17 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 120.966 -1.084 . . . . 0.0 110.531 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 154.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -86.83 144.36 27.05 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.279 0.987 . . . . 0.0 108.97 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.63 140.35 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.735 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -160.2 176.82 36.85 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 122.061 -0.4 . . . . 0.0 112.689 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.62 7.36 1.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.051 2.14 . . . . 0.0 114.843 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.788 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -78.02 -172.57 2.78 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 175.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -45.57 146.76 0.99 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.792 2.837 . . . . 0.0 115.182 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -71.75 -2.96 53.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.201 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.2 ptm -151.19 32.44 0.59 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.814 1.807 . . . . 0.0 111.022 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.3 OUTLIER -43.77 140.63 1.82 Allowed 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 361' ' ' LEU . 34.3 m-80 -134.03 -177.85 4.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.822 0.82 . . . . 0.0 109.78 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.4 8.63 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.963 0.887 . . . . 0.0 111.489 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -44.19 -63.73 0.82 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.479 1.912 . . . . 0.0 110.906 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.3 -28.95 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.235 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.07 -35.34 80.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.231 0.923 . . . . 0.0 109.914 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.6 63.85 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.384 -0.927 . . . . 0.0 112.008 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.52 61.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.339 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.66 -42.51 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.47 -32.27 54.26 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.819 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.75 -16.91 46.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 118.17 -1.412 . . . . 0.0 111.294 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.11 -25.09 13.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.267 -0.896 . . . . 0.0 112.58 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.8 tp -92.42 -22.51 19.6 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 121.787 -0.571 . . . . 0.0 111.217 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 7.4 m-85 -136.26 -47.01 0.63 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 111.281 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.29 -16.21 30.28 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.928 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 400' ' ' ASN . . . -99.37 22.26 41.57 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.334 1.067 . . . . 0.0 113.877 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.77 166.06 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 120.911 -1.347 . . . . 0.0 111.857 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.26 -30.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.505 ' CG ' ' N ' ' A' ' 380' ' ' ALA . 0.3 OUTLIER -156.02 162.85 40.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.15 0.886 . . . . 0.0 112.369 -174.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -153.63 146.38 24.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.67 150.19 22.39 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.57 1.077 . . . . 0.0 112.77 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 26.3 mm -85.92 136.89 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 125.641 1.576 . . . . 0.0 109.724 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.45 60.09 6.03 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.542 -0.724 . . . . 0.0 111.441 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.7 158.88 9.44 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.717 1.722 . . . . 0.0 112.683 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -140.12 157.78 45.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.968 1.707 . . . . 0.0 107.069 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -57.28 113.92 1.95 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.824 0.821 . . . . 0.0 110.494 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 28.6 m170 53.92 16.62 1.12 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -85.71 -9.67 56.82 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.356 0.98 . . . . 0.0 113.112 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 32.8 p90 39.93 54.13 5.81 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.845 1.658 . . . . 0.0 115.383 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.0 -48.86 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.868 2.379 . . . . 0.0 113.213 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.3 25.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.084 1.754 . . . . 0.0 114.243 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -145.35 19.58 1.89 Allowed Glycine 0 C--O 1.223 -0.567 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.2 p -151.34 159.77 44.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.969 0.885 . . . . 0.0 110.12 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.81 -157.31 20.76 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 115.924 1.13 . . . . 0.0 115.924 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -158.77 164.32 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.232 0.613 . . . . 0.0 109.477 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.13 143.03 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.2 p -112.05 148.77 33.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 403' ' ' SER . 71.2 m-85 -121.07 162.09 20.6 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.9 -171.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.13 0.95 15.11 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.005 0.816 . . . . 0.0 111.199 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.435 HD21 ' HA3' ' A' ' 376' ' ' GLY . 0.3 OUTLIER -150.39 164.74 35.09 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 173.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -80.67 -14.47 58.12 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 117.971 0.351 . . . . 0.0 111.103 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -58.98 -35.53 73.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.949 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 398' ' ' PHE . 8.8 m -78.36 -19.95 52.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.715 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.93 -64.29 0.91 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.444 0.64 . . . . 0.0 109.344 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.463 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.05 -19.6 62.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.983 -175.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -79.5 -25.49 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.053 0.221 . . . . 0.0 110.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -78.81 -39.29 36.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.383 0.611 . . . . 0.0 111.425 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.2 m -78.54 -21.74 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.424 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 51.8 p -87.93 -26.7 22.57 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.59 56.26 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.95 -26.22 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.299 1.839 . . . . 0.0 115.242 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.26 148.67 22.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.019 1.281 . . . . 0.0 111.843 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.75 148.04 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -107.64 94.99 5.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.2 128.98 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 136.67 49.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.754 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.64 174.94 14.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.153 1.381 . . . . 0.0 108.378 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 75.6 m -75.08 -20.88 59.29 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.146 0.885 . . . . 0.0 111.533 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -139.71 24.29 2.43 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.946 -0.471 . . . . 0.0 111.963 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -156.25 118.69 4.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.878 0.871 . . . . 0.0 111.159 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.0 p -146.85 112.13 5.51 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.805 0.729 . . . . 0.0 112.109 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -165.05 173.58 11.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.779 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -100.59 168.13 9.91 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.5 0.667 . . . . 0.0 109.339 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 357' ' ' LEU . 90.3 t -151.05 136.1 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -117.71 153.09 33.96 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 119.119 0.872 . . . . 0.0 112.898 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 78.8 mt -125.84 135.78 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -131.37 139.83 36.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.936 -0.478 . . . . 0.0 109.863 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.31 150.8 31.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.652 2.902 . . . . 0.0 116.544 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.39 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.625 0.25 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m 50.92 119.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.971 1.709 . . . . 0.0 113.475 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.493 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -128.85 -13.01 4.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 111.065 178.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.3 m 43.63 61.5 2.23 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.35 -19.14 78.65 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.726 -0.609 . . . . 0.0 114.205 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.22 32.37 21.61 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.042 -1.858 . . . . 0.0 114.245 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 151.76 86.06 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 86.5 Cg_endo -69.38 118.75 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.007 2.472 . . . . 0.0 110.364 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 8.1 Cg_endo -97.83 5.22 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 126.117 4.545 . . . . 0.0 114.802 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -137.85 11.37 2.89 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.047 0.939 . . . . 0.0 113.104 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -82.86 39.09 0.61 Allowed 'General case' 0 C--N 1.348 0.522 0 O-C-N 121.03 -1.044 . . . . 0.0 111.883 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.0 153.86 35.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -88.59 -13.51 39.83 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.327 1.017 . . . . 0.0 111.79 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.423 ' HA ' HG11 ' A' ' 332' ' ' VAL . 2.5 t-20 50.27 43.53 1.71 Allowed Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.68 -43.49 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.838 1.692 . . . . 0.0 113.867 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 51.7 mt -152.45 157.15 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.94 1.696 . . . . 0.0 107.183 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.09 144.39 31.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.113 0.565 . . . . 0.0 109.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.1 m -128.43 3.07 5.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.726 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.2 t -153.05 179.53 8.62 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 283' ' ' TYR . 12.0 ptmm? -49.5 166.44 0.05 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.308 1.043 . . . . 0.0 109.819 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.86 149.24 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -93.84 132.08 38.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 240' ' ' LEU . 3.0 tm? -134.99 119.94 18.57 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 125.198 1.562 . . . . 0.0 109.602 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.82 170.22 36.97 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 111.866 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.03 1.74 3.97 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.074 0.845 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.92 132.23 74.68 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 119.085 1.443 . . . . 0.0 108.556 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -88.86 -13.49 3.15 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 124.07 3.18 . . . . 0.0 110.921 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -105.65 -54.5 2.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.2 t0 57.48 151.41 0.01 OUTLIER 'General case' 0 C--N 1.374 1.655 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -170.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.26 -40.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.418 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.1 m -164.48 120.15 1.5 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -74.62 -23.08 58.64 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 120.926 1.694 . . . . 0.0 111.187 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -81.11 -12.58 59.23 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.003 0.921 . . . . 0.0 111.012 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.86 -41.01 29.37 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 124.94 1.4 . . . . 0.0 109.93 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.58 -42.57 78.08 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.447 1.118 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.15 -37.07 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -73.68 -15.49 61.23 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.613 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 62.2 m -80.34 -24.47 39.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.804 0.729 . . . . 0.0 109.545 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -139.9 32.04 2.0 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -103.37 12.77 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.503 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.46 23.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.7 -1.3 19.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.273 0.559 . . . . 0.0 111.651 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 110.82 -80.22 0.27 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 122.502 1.057 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.0 t -88.99 109.37 20.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.061 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 138.7 17.51 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.048 -1.032 . . . . 0.0 110.411 168.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.6 m -138.57 172.97 12.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.366 1.067 . . . . 0.0 109.311 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.95 147.61 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.876 -168.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -155.3 151.25 27.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.321 1.058 . . . . 0.0 110.726 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -160.28 138.57 7.45 Favored Pre-proline 0 C--N 1.352 0.691 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.566 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 85.1 Cg_endo -79.41 164.5 23.91 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.552 2.168 . . . . 0.0 110.772 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.61 -128.24 9.47 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -83.53 109.06 17.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.694 0.759 . . . . 0.0 109.485 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -125.75 141.22 52.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.278 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -175.85 -148.52 6.94 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 121.945 0.747 . . . . 0.0 112.325 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -80.97 1.78 29.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.242 1.417 . . . . 0.0 111.22 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -125.87 102.76 28.05 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.25 0.62 . . . . 0.0 110.264 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.8 28.29 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 125.273 3.982 . . . . 0.0 112.169 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -133.29 11.91 4.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 6.5 t -81.75 -33.41 0.65 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 116.884 -1.531 . . . . 0.0 112.203 -174.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 74.0 Cg_exo -55.72 122.5 11.86 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.293 2.662 . . . . 0.0 111.925 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.2 5.71 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.246 3.297 . . . . 0.0 112.177 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -121.95 6.16 9.84 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.87 36.73 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.944 -1.475 . . . . 0.0 113.659 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -112.6 146.87 37.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.178 1.489 . . . . 0.0 110.753 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.6 p -154.67 157.18 4.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.566 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 12.1 m-85 -109.0 154.84 21.62 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.07 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -116.02 134.37 55.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.428 1.108 . . . . 0.0 110.872 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.19 109.56 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -166.52 -166.58 0.88 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.55 -0.719 . . . . 0.0 111.261 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.63 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.235 1.814 . . . . 0.0 107.578 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 288' ' ' LEU . 2.0 pt? -73.9 -3.61 29.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -167.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -111.13 -66.13 1.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -87.29 -31.72 20.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.504 -0.748 . . . . 0.0 109.602 -171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 295' ' ' LEU . 67.4 m -83.24 -26.29 30.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 121.031 1.741 . . . . 0.0 110.381 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 288' ' ' LEU . 64.5 t -69.25 -55.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -58.11 -31.53 67.24 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.999 -1.063 . . . . 0.0 112.194 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.3 m -68.2 -39.14 82.52 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.01 0.434 . . . . 0.0 112.144 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 291' ' ' SER . 1.8 mp -71.03 -41.47 70.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.97 -19.75 61.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.361 -0.536 . . . . 0.0 112.339 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -98.06 -3.68 37.52 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.653 0.596 . . . . 0.0 110.187 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -101.66 -5.97 24.35 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 124.314 1.009 . . . . 0.0 110.277 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 33.9 m -90.59 -157.27 0.47 Allowed 'General case' 0 C--O 1.221 -0.418 0 O-C-N 125.846 1.967 . . . . 0.0 109.509 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 m -136.95 -178.23 5.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -138.4 143.79 39.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.086 0.954 . . . . 0.0 111.788 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.83 127.49 26.22 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -83.43 37.19 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.125 4.55 . . . . 0.0 110.158 176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.465 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 112.595 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.557 0.694 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.2 m -66.61 167.0 11.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.442 1.097 . . . . 0.0 108.858 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -138.58 154.05 48.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.249 0.931 . . . . 0.0 110.0 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -110.91 151.77 27.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 47.0 m-85 -147.4 159.75 43.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -162.99 151.58 14.34 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -114.57 131.48 56.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.11 0.868 . . . . 0.0 110.238 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.62 16.22 19.77 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.488 0.715 . . . . 0.0 110.376 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 322' ' ' ARG . 65.6 p -132.8 132.24 41.97 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.769 -0.582 . . . . 0.0 112.562 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 95.9 p -138.38 -18.53 1.12 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.225 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -137.2 -16.39 1.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -90.16 -25.38 20.7 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.411 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mmm -148.38 -47.15 0.15 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.613 1.565 . . . . 0.0 109.676 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.422 ' H ' ' HB2' ' A' ' 317' ' ' SER . 21.8 ptt180 47.72 39.63 10.59 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.147 1.779 . . . . 0.0 114.7 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 21.8 m -132.35 -19.11 2.48 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.552 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -148.48 168.22 23.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 158.29 30.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.057 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.35 165.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.473 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 2.8 pp0? -118.2 166.89 12.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.99 140.91 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 111.644 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -143.1 98.09 5.63 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -83.49 155.54 14.1 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.094 1.863 . . . . 0.0 112.243 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -80.21 119.87 23.55 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.145 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 334' ' ' ALA . 18.0 t -97.25 157.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.109 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -54.34 -30.96 53.31 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.687 0.756 . . . . 0.0 110.549 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.512 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -74.93 6.76 3.75 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.491 1.116 . . . . 0.0 112.413 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -112.79 6.28 17.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 109.982 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 42.9 m -123.96 -29.14 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.21 165.76 35.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 110.387 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -152.45 136.65 16.56 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 125.631 1.572 . . . . 0.0 111.903 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.03 147.55 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 122.731 1.253 . . . . 0.0 110.844 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -113.34 3.95 16.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.489 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.7 m -133.58 150.33 74.59 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 125.439 1.496 . . . . 0.0 110.087 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -85.68 -7.29 8.61 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.524 3.483 . . . . 0.0 113.799 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.5 t -149.46 -16.01 0.28 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.666 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -97.89 166.46 11.44 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 109.994 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -151.25 -169.07 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.034 -0.416 . . . . 0.0 110.457 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.533 HD11 ' CE1' ' A' ' 379' ' ' TYR . 9.4 mp -37.27 152.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.42 2.288 . . . . 0.0 114.183 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 397' ' ' THR . 8.5 t70 -131.99 134.9 25.75 Favored Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 126.331 1.852 . . . . 0.0 108.136 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -82.29 4.78 6.8 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.27 1.98 . . . . 0.0 113.811 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 6.2 t -139.24 -5.96 1.41 Allowed 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.117 1.326 . . . . 0.0 114.238 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -125.58 69.65 1.17 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.187 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 397' ' ' THR . 8.8 t -150.84 153.4 35.31 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.413 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.89 165.19 29.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 124.056 0.847 . . . . 0.0 111.131 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -83.32 151.4 25.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.331 0.586 . . . . 0.0 112.257 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.3 t -132.54 142.88 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.791 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.27 -163.8 18.08 Favored Glycine 0 C--O 1.246 0.863 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.174 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.72 37.37 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.001 1.721 . . . . 0.0 113.582 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.57 167.06 20.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.428 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 17.2 p-80 -83.57 4.86 26.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.23 34.89 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.732 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.428 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 5.0 ptp -164.13 21.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.094 0.947 . . . . 0.0 110.289 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.81 140.45 58.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.896 1.225 . . . . 0.0 110.608 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.04 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.23 66.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -73.63 -31.92 63.78 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.819 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.62 60.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.838 -1.164 . . . . 0.0 108.551 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . 0.488 HD11 HD11 ' A' ' 382' ' ' ILE . 93.3 mt -60.95 -53.45 57.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.25 59.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.95 -41.65 42.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.913 0.863 . . . . 0.0 110.36 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.3 -26.99 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.197 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 366' ' ' LEU . 51.7 mt -96.08 -20.74 18.43 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.274 -0.891 . . . . 0.0 112.882 -168.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 -7.53 18.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 116.211 -1.852 . . . . 0.0 110.543 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 -13.05 8.64 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.247 1.385 . . . . 0.0 114.684 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.412 HD21 ' CG ' ' A' ' 220' ' ' TRP . 60.5 mt -117.12 -4.01 11.48 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.61 0.641 . . . . 0.0 111.313 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 22.9 m-85 -133.08 -32.84 1.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.903 0.881 . . . . 0.0 111.857 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 79.29 -9.64 39.74 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.7 128.03 1.66 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 120.411 2.105 . . . . 0.0 110.661 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.41 171.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.04 -30.12 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.533 ' CE1' HD11 ' A' ' 346' ' ' LEU . 1.1 t80 -171.11 159.67 6.06 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -148.99 145.6 27.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -151.78 -173.97 22.03 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 122.955 1.308 . . . . 0.0 114.865 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 366' ' ' LEU . 42.2 mm -116.47 144.37 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 112.093 -2.053 . . . . 0.0 109.834 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -76.3 44.81 0.35 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.799 0.439 . . . . 0.0 111.916 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.56 155.79 5.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.271 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -145.35 144.69 30.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -48.96 114.97 1.11 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 111.099 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 14.3 m170 57.99 28.53 16.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.045 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -105.65 -1.32 24.73 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.0 p90 33.21 59.44 1.63 Allowed Pre-proline 0 C--N 1.353 0.751 0 C-N-CA 126.497 1.919 . . . . 0.0 112.962 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.06 -49.02 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 391' ' ' ILE . 8.3 tp 31.41 41.49 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.518 1.527 . . . . 0.0 112.473 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -141.3 11.72 2.77 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 117.975 -1.458 . . . . 0.0 112.155 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 45.6 m -151.95 153.44 34.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.068 0.934 . . . . 0.0 109.04 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.4 -166.5 32.5 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.707 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.08 167.68 29.55 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.34 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.89 135.47 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 119.303 0.956 . . . . 0.0 110.332 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.446 HG22 ' HB ' ' A' ' 351' ' ' THR . 21.1 p -105.5 129.13 53.85 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 121.704 -0.623 . . . . 0.0 110.868 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.449 ' CD1' ' CB ' ' A' ' 403' ' ' SER . 95.0 m-85 -96.62 -45.14 6.83 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 53.9 t30 56.64 17.47 3.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.702 0.401 . . . . 0.0 111.01 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -141.66 155.78 45.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.664 1.986 . . . . 0.0 107.91 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -103.24 -37.47 7.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 117.718 -1.134 . . . . 0.0 112.499 -171.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.521 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -61.05 -22.92 65.04 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.518 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.449 ' CB ' ' CD1' ' A' ' 398' ' ' PHE . 7.3 m -74.02 -26.51 60.47 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.155 -0.966 . . . . 0.0 111.24 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -73.71 -56.03 5.51 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.234 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -78.16 -30.54 49.22 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.827 -0.546 . . . . 0.0 111.522 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -73.08 -40.64 64.86 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.94 -30.82 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 123.392 0.432 . . . . 0.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 25.6 p -77.55 -14.52 59.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.81 1.319 . . . . 0.0 112.993 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -88.93 -46.31 9.0 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.681 0.613 . . . . 0.0 110.197 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.73 -16.6 0.01 OUTLIER 'General case' 0 C--O 1.242 0.692 0 C-N-CA 126.86 2.064 . . . . 0.0 115.099 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -163.88 145.87 9.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.4 160.81 41.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 33.5 mt-10 -118.76 128.14 54.21 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 125.354 1.659 . . . . 0.0 108.851 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.6 mt -99.29 125.25 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 40.09 3.46 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.092 0.87 . . . . 0.0 111.436 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.9 p -76.4 172.17 13.37 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.965 1.365 . . . . 0.0 110.162 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.9 t -73.62 -1.29 18.25 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 120.275 -1.516 . . . . 0.0 112.713 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -128.43 -9.69 5.17 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 422' ' ' LYS . 15.0 t80 -149.71 124.09 9.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.937 0.79 . . . . 0.0 109.175 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 14.1 p -131.43 72.14 1.49 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.668 0.787 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 420' ' ' PHE . 98.0 mttt -152.42 177.91 10.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.001 0.92 . . . . 0.0 111.156 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 93.7 mttt -122.28 -179.54 4.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.7 m -152.15 161.25 3.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.81 1.244 . . . . 0.0 107.824 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -116.26 155.08 28.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 123.413 1.578 . . . . 0.0 110.267 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.9 mt -143.37 138.35 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.341 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -139.04 153.64 71.78 Favored Pre-proline 0 C--O 1.246 0.915 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.72 149.99 88.86 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 123.468 2.779 . . . . 0.0 110.886 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.86 1.664 . . . . 0.0 111.646 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 60.0 m -162.2 152.97 17.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -18.96 1.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.96 1.709 . . . . 0.0 112.422 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m 43.65 56.43 4.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.905 0.86 . . . . 0.0 112.745 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.85 -17.71 80.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.784 -1.098 . . . . 0.0 114.964 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.534 ' HA ' HG22 ' A' ' 417' ' ' THR . 29.6 mt-30 46.91 44.56 14.68 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 1.3 pt? -137.0 6.28 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 116.068 -1.92 . . . . 0.0 115.302 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 84.3 Cg_endo -68.25 128.66 17.82 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 CA-C-N 123.091 2.14 . . . . 0.0 108.709 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.12 152.5 24.3 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.236 2.624 . . . . 0.0 111.829 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -140.44 3.52 1.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.5 1.52 . . . . 0.0 110.718 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -106.04 64.7 0.68 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.404 ' HA ' HD21 ' A' ' 231' ' ' ASN . 26.1 p90 -115.52 -99.01 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.344 1.458 . . . . 0.0 109.865 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.75 27.82 14.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.11 1.364 . . . . 0.0 112.277 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.404 HD21 ' HA ' ' A' ' 229' ' ' TYR . 8.1 m-80 -91.09 -43.89 0.38 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.64 -170.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.483 2.122 . . . . 0.0 114.653 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -105.41 178.67 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.823 1.249 . . . . 0.0 108.228 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.34 151.33 19.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.34 -1.475 . . . . 0.0 108.91 -174.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -147.4 -2.11 0.6 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.029 0.442 . . . . 0.0 111.677 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 -169.58 2.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.344 -1.472 . . . . 0.0 113.092 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.41 170.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.677 0.751 . . . . 0.0 112.603 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.37 141.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.143 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -83.62 134.14 34.81 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.92 118.7 9.24 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 169.73 -162.25 35.68 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.03 7.18 3.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.115 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.34 131.59 41.9 Favored Pre-proline 0 C--O 1.216 -0.68 0 CA-C-N 117.798 0.799 . . . . 0.0 110.406 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -86.95 -4.3 7.99 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 124.341 3.361 . . . . 0.0 109.862 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 1.3 p-90 -118.62 -43.13 2.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.464 -1.398 . . . . 0.0 114.327 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER 54.04 154.87 0.0 OUTLIER 'General case' 0 C--O 1.271 2.221 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -171.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -143.72 178.32 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.058 175.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 274' ' ' PRO . 18.0 m -44.02 123.14 3.18 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.37 -25.75 68.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.84 -14.53 62.44 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 118.218 0.463 . . . . 0.0 111.846 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.14 -44.22 36.49 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.866 0.703 . . . . 0.0 112.833 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.7 -35.83 57.61 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.433 1.111 . . . . 0.0 109.608 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.55 -35.84 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.881 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -80.9 -14.82 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 47.1 m -79.81 -28.75 40.17 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.947 -0.471 . . . . 0.0 112.002 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -130.87 26.81 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 262' ' ' LEU . 10.9 ptm85 -101.8 1.85 37.67 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 113.275 169.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 99.1 t -76.22 -14.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 122.483 1.135 . . . . 0.0 111.708 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -87.61 -16.03 35.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.892 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 163.97 172.0 30.9 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.614 1.097 . . . . 0.0 112.569 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 52.8 m -58.13 130.89 48.72 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -160.25 173.92 14.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.492 167.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.408 ' HB2' HG23 ' A' ' 285' ' ' VAL . 50.2 m -138.96 174.84 10.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.531 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 146.65 25.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 125.235 1.414 . . . . 0.0 111.334 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -146.72 141.69 27.04 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.896 0.855 . . . . 0.0 112.928 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.415 ' HB3' HG23 ' A' ' 282' ' ' VAL . 32.8 p90 -151.08 140.1 13.46 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.475 1.11 . . . . 0.0 111.325 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.08 10.27 3.02 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.691 3.594 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.32 -168.89 24.5 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -80.5 54.51 2.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.315 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.406 ' HB3' ' NE1' ' A' ' 266' ' ' TRP . 5.2 p-10 -69.43 -15.93 63.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -78.63 -11.8 84.89 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 121.221 -0.925 . . . . 0.0 113.413 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.61 -45.98 4.28 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.267 1.534 . . . . 0.0 110.274 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.47 ' CG ' ' HE ' ' A' ' 275' ' ' ARG . 2.4 p80 -163.1 145.42 8.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 123.462 0.476 . . . . 0.0 109.837 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.407 ' HG2' HG23 ' A' ' 248' ' ' THR . 35.5 Cg_endo -78.26 41.11 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 126.586 4.857 . . . . 0.0 113.097 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.47 ' HE ' ' CG ' ' A' ' 273' ' ' HIS . 28.4 ptt180 -132.28 10.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.622 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.41 56.54 14.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.781 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.63 149.36 48.95 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 N-CA-C 108.429 -1.412 . . . . 0.0 108.429 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.55 -30.82 86.78 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.65 1.567 . . . . 0.0 113.415 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -146.84 176.13 10.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.85 0.86 . . . . 0.0 110.631 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -81.62 25.66 3.85 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.487 -1.383 . . . . 0.0 116.096 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.485 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 51.3 p90 -142.63 174.18 10.87 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.373 0.69 . . . . 0.0 109.534 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 266' ' ' TRP . 9.1 p -155.45 157.1 4.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.85 140.03 30.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.779 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.3 mt -119.86 148.37 43.56 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.014 0.825 . . . . 0.0 109.676 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 263' ' ' SER . 2.8 m -131.8 98.48 3.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.469 ' C ' ' H ' ' A' ' 288' ' ' LEU . 67.2 m-85 -85.09 -171.58 3.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.176 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.96 43.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.796 1.284 . . . . 0.0 110.703 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 286' ' ' PHE . 4.1 mm? 54.12 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 131.107 3.763 . . . . 0.0 116.575 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.95 -42.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.118 0.872 . . . . 0.0 111.906 -170.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.1 -74.37 0.06 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-O 122.152 0.977 . . . . 0.0 113.026 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 37.9 m -70.33 -11.82 61.17 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.425 0.69 . . . . 0.0 109.537 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.83 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 O-C-N 119.837 -1.789 . . . . 0.0 111.452 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.11 -29.54 64.18 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.97 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.5 m -66.19 -36.68 83.69 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 121.794 -0.566 . . . . 0.0 111.368 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 295' ' ' LEU . 0.1 OUTLIER -70.59 -52.38 21.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.723 -0.611 . . . . 0.0 111.449 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.07 -29.97 70.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.731 0.696 . . . . 0.0 111.707 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -80.74 -10.77 59.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.158 0.435 . . . . 0.0 110.969 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -109.99 -2.7 16.94 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.395 -0.816 . . . . 0.0 110.862 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 90.4 m -102.99 -156.11 0.55 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.895 1.278 . . . . 0.0 109.039 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 59.0 m -124.42 166.86 15.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.076 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -140.0 161.49 37.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.655 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -147.37 124.04 5.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -85.4 22.56 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.093 3.862 . . . . 0.0 112.593 173.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.343 0.315 0 C-N-CA 124.052 0.941 . . . . 0.0 113.506 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--O 1.218 -0.6 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 21.8 m -102.68 165.05 11.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.969 0.908 . . . . 0.0 110.1 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -142.51 154.98 44.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -111.56 154.5 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 110.996 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -144.96 149.26 34.88 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.455 -0.778 . . . . 0.0 112.059 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -161.84 160.6 28.32 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.129 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -124.69 147.38 48.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.23 -0.919 . . . . 0.0 110.68 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.84 9.39 3.58 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.179 -168.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 319' ' ' ARG . 66.9 p -121.75 -97.11 0.46 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.199 0.937 . . . . 0.0 109.724 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . 0.471 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 6.2 m 65.67 -3.85 0.66 Allowed 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.232 1.013 . . . . 0.0 111.867 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 317' ' ' SER . 5.5 mpt_? -140.4 170.63 15.46 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.471 2.308 . . . . 0.0 106.624 170.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 321' ' ' MET . 17.5 ptt180 50.21 6.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.308 2.243 . . . . 0.0 115.115 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 11.7 mmt -156.68 -176.03 5.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.728 -0.607 . . . . 0.0 109.701 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -83.74 20.3 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.679 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 318' ' ' SER . 55.9 m 54.15 68.72 0.81 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.478 0.711 . . . . 0.0 112.554 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -124.55 108.11 11.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.26 169.01 2.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.039 1.336 . . . . 0.0 112.661 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.65 178.1 3.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.87 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.411 ' C ' HE21 ' A' ' 327' ' ' GLN . 0.0 OUTLIER -134.34 161.23 35.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.358 0.599 . . . . 0.0 109.851 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.33 135.69 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 24.1 mt -144.21 98.16 5.13 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 125.028 1.455 . . . . 0.0 109.837 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.75 160.47 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.13 1 C-N-CA 125.48 4.12 . . . . 0.0 112.969 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -89.19 125.16 34.95 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.133 0.895 . . . . 0.0 109.941 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 334' ' ' ALA . 63.4 t -109.86 147.85 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.94 -22.11 47.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 117.744 -1.582 . . . . 0.0 111.934 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.544 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -59.23 -14.34 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.706 1.139 . . . . 0.0 113.148 174.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -99.28 6.91 46.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.369 1.067 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.2 m -132.81 -33.73 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.518 0.727 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -146.76 152.83 39.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.988 0.899 . . . . 0.0 110.725 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -164.64 140.78 5.94 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.549 -1.66 . . . . 0.0 109.473 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 379' ' ' TYR . 5.5 m -118.85 150.6 21.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.668 -0.645 . . . . 0.0 112.112 -175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -125.1 28.52 6.36 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.655 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.4 t -148.23 143.0 16.98 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.756 0.823 . . . . 0.0 110.532 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.11 -10.69 26.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.717 2.944 . . . . 0.0 110.186 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.7 m -90.24 -9.48 47.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.355 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 43.11 17.3 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 345' ' ' ARG . 0.0 OUTLIER -117.6 174.34 6.22 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 379' ' ' TYR . 1.7 mm? -86.57 169.67 12.57 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 125.019 1.45 . . . . 0.0 111.685 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -110.44 154.15 43.14 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.26 110.16 0.51 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.043 1.829 . . . . 0.0 112.003 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 35.8 m 50.82 35.65 12.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.121 0.968 . . . . 0.0 112.41 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -115.61 64.76 0.69 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.425 0.631 . . . . 0.0 112.251 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.1 t -148.61 159.26 44.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.653 0.381 . . . . 0.0 111.556 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.05 165.44 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.139 -0.976 . . . . 0.0 111.852 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -87.62 162.2 17.27 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.93 132.91 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.904 0.753 . . . . 0.0 109.345 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -136.4 -176.7 14.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 123.222 1.457 . . . . 0.0 111.414 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 63.0 -57.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.796 1.238 . . . . 0.0 113.056 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 47.8 -158.57 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.784 1.233 . . . . 0.0 111.74 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.88 163.71 35.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.517 1.927 . . . . 0.0 107.487 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -63.25 4.18 0.95 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 120.142 -0.255 . . . . 0.0 113.272 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.8 ptp -164.4 32.2 0.07 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.848 1.324 . . . . 0.0 108.756 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.4 111.89 2.21 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.537 0.735 . . . . 0.0 110.743 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.21 159.36 17.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -71.66 -20.32 61.97 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 121.479 -0.763 . . . . 0.0 112.497 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.09 -23.24 59.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -72.12 -35.25 69.08 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.223 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.14 -29.35 63.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.0 -1.08 . . . . 0.0 109.737 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -86.5 -15.87 38.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.172 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -85.93 -43.37 13.26 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 119.483 1.038 . . . . 0.0 110.958 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.73 -52.27 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.66 -38.86 70.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -21.2 60.45 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 118.35 -1.34 . . . . 0.0 110.376 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.6 -12.83 35.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.968 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.7 tp -75.53 -20.68 58.54 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 121.777 -0.577 . . . . 0.0 110.436 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 403' ' ' SER . 27.7 p90 -156.34 -43.31 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 374' ' ' PHE . . . -177.37 -66.67 0.06 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 119.174 0.897 . . . . 0.0 114.182 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 176.46 149.95 7.91 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 119.087 1.444 . . . . 0.0 114.644 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 1.1 m -118.75 172.52 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.618 0.767 . . . . 0.0 110.914 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.8 -30.87 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' A' ' 339' ' ' VAL . 23.0 t80 -163.93 156.04 17.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.36 154.13 40.51 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.11 166.27 36.27 Favored Glycine 0 C--O 1.22 -0.739 0 CA-C-O 122.683 1.157 . . . . 0.0 114.951 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 336' ' ' SER . 11.4 mm -116.0 154.42 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.27 1.828 . . . . 0.0 107.071 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.64 134.09 42.05 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.375 -0.828 . . . . 0.0 110.758 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 4.3 p -135.2 154.05 51.73 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 125.26 1.6 . . . . 0.0 110.071 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.33 159.31 42.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' A' ' 386' ' ' LYS . 1.7 tpmt? -46.82 103.18 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.315 0.646 . . . . 0.0 112.378 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.2 m170 45.07 45.77 9.15 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.886 2.475 . . . . 0.0 114.04 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -102.55 4.08 38.11 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.403 -0.81 . . . . 0.0 110.964 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.3 p90 42.26 54.0 8.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.276 1.43 . . . . 0.0 112.746 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 85.7 Cg_endo -70.08 -66.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.3 2.667 . . . . 0.0 112.426 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.47 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 4.0 tp 42.63 28.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 124.061 0.85 . . . . 0.0 111.854 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -123.11 10.69 8.76 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.904 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 69.1 p -158.08 158.81 35.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -168.96 -169.24 32.1 Favored Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.071 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -150.53 165.51 33.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 122.1 0.952 . . . . 0.0 109.051 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.49 136.14 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 120.755 -1.215 . . . . 0.0 108.719 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 43.8 m -115.74 142.83 46.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.524 -170.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.02 164.69 15.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.56 0.695 . . . . 0.0 112.007 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -116.37 7.21 13.84 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.107 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -129.1 164.86 22.4 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -107.54 -29.26 9.29 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.912 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.581 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -56.44 -28.79 60.52 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.753 1.16 . . . . 0.0 113.398 -173.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.481 ' HB2' ' CD2' ' A' ' 374' ' ' PHE . 32.6 t -78.38 -33.99 48.52 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.617 -1.302 . . . . 0.0 113.159 175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -51.87 -50.73 60.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 123.845 0.716 . . . . 0.0 111.494 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 405' ' ' LEU 0.282 0.0 OUTLIER -83.39 -26.55 30.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.618 176.9 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.407 ' N ' HD22 ' A' ' 405' ' ' LEU . 28.9 ttpp -74.3 -19.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.465 1.029 . . . . 0.0 110.86 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -89.34 -36.75 15.35 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.201 -0.937 . . . . 0.0 112.364 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.4 m -71.61 -22.16 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.841 1.2 . . . . 0.0 108.961 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.7 p -84.01 -29.66 26.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 124.499 1.124 . . . . 0.0 112.706 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.99 -41.33 64.43 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.493 0.717 . . . . 0.0 110.667 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.21 -9.78 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.93 148.51 10.33 Favored 'General case' 0 C--O 1.219 -0.522 0 O-C-N 120.766 -1.209 . . . . 0.0 110.7 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.38 163.51 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.233 0.469 . . . . 0.0 110.528 171.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.68 139.2 47.33 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.173 0.511 . . . . 0.0 110.782 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 29.6 mt -103.74 125.78 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 29.12 5.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 223' ' ' GLN . 34.9 p -68.74 178.8 1.97 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.344 1.545 . . . . 0.0 111.638 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.3 p -73.94 -8.51 56.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -138.69 3.54 2.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.715 0.806 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.97 142.36 26.33 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.315 -1.491 . . . . 0.0 112.914 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.0 p -146.03 104.72 3.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.056 0.943 . . . . 0.0 110.091 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 41.4 tptt -165.87 176.55 7.79 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.528 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 56.2 mtpt -118.94 162.6 18.25 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.29 138.63 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -100.07 152.11 20.6 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 59.5 mt -135.38 135.11 52.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.89 150.94 29.02 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 119.395 0.998 . . . . 0.0 109.118 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.34 156.06 27.37 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.878 2.385 . . . . 0.0 111.464 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.642 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.9 m -58.61 153.74 15.76 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.826 0.85 . . . . 0.0 110.654 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -116.79 -59.18 1.99 Allowed 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.127 -0.983 . . . . 0.0 109.534 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.9 m 39.21 51.64 2.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.089 1.355 . . . . 0.0 111.917 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.04 -17.97 79.71 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.65 1.119 . . . . 0.0 111.643 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 63.53 32.4 14.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.21 93.18 17.47 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 125.15 1.38 . . . . 0.0 108.614 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.23 147.49 26.15 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 113.641 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.23 -149.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 125.054 3.836 . . . . 0.0 109.745 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 68.29 28.22 6.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.954 0.901 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -90.91 -4.96 56.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.47 147.77 52.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 112.792 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -153.5 33.65 0.46 Allowed 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.48 1.512 . . . . 0.0 109.378 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' A' ' 334' ' ' ALA . 2.5 p30 -129.42 80.08 72.76 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.95 105.83 2.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.467 2.111 . . . . 0.0 111.414 -172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 333' ' ' LEU . 14.2 pt -149.58 148.32 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.055 . . . . 0.0 107.1 173.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -125.94 157.46 37.7 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.197 -0.94 . . . . 0.0 113.072 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 99.2 p -152.4 -1.38 0.28 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 12.1 t -144.46 179.84 7.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.247 1.022 . . . . 0.0 110.837 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.82 161.43 0.76 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.76 150.45 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.205 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -94.01 140.37 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 109.691 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.77 108.93 4.43 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.68 163.9 34.89 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.668 1.122 . . . . 0.0 112.884 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.94 3.17 1.53 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.74 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 m -103.77 108.69 60.42 Favored Pre-proline 0 N--CA 1.435 -1.216 0 C-N-CA 122.514 0.326 . . . . 0.0 110.522 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.98 -20.99 11.23 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.081 1.854 . . . . 0.0 113.017 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.403 ' CD2' ' HG3' ' A' ' 321' ' ' MET . 35.7 p-90 -100.08 -26.33 14.0 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -43.56 104.34 0.04 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.106 1.362 . . . . 0.0 112.33 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -74.92 -27.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.2 m -146.12 136.07 23.5 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.749 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -9.92 59.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.33 64.03 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.8 -58.07 10.84 Favored Glycine 0 C--N 1.359 1.859 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.2 pt? -70.75 -23.31 62.39 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 119.671 -2.076 . . . . 0.0 112.085 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.08 -27.21 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 122.993 0.517 . . . . 0.0 109.79 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.46 -13.85 24.24 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.555 0.342 . . . . 0.0 111.826 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.6 m -82.46 -26.82 32.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.35 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -131.96 64.49 1.59 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.109 -1.62 . . . . 0.0 113.221 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -140.12 2.23 1.89 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.794 0.838 . . . . 0.0 111.484 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.47 -10.43 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.408 0.683 . . . . 0.0 109.529 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.08 28.69 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.834 1.253 . . . . 0.0 111.275 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.26 8.25 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.813 -0.437 . . . . 0.0 114.157 -171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 38.8 m -156.3 51.65 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 125.127 1.134 . . . . 0.0 109.886 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.587 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -115.34 175.0 5.71 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.5 t -143.89 177.92 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.846 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.87 147.57 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -157.97 153.18 25.72 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 126.419 2.324 . . . . 0.0 110.101 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -155.89 149.7 19.24 Favored Pre-proline 0 N--CA 1.432 -1.374 0 O-C-N 124.21 0.944 . . . . 0.0 113.097 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.44 153.51 50.09 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.785 1.657 . . . . 0.0 107.929 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.32 21.4 45.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 119.275 -1.441 . . . . 0.0 110.474 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -61.29 -3.86 1.03 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 126.599 1.96 . . . . 0.0 114.65 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -118.77 131.2 56.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.953 1.301 . . . . 0.0 109.464 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.47 -165.52 38.92 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -94.47 149.66 21.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.856 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 274' ' ' PRO . 20.1 m80 42.7 49.96 5.03 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 113.015 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 273' ' ' HIS . 32.6 Cg_exo -61.55 124.59 14.94 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.823 1.682 . . . . 0.0 110.893 -171.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -155.86 -32.98 0.09 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.877 0.471 . . . . 0.0 110.435 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 37.9 t -155.22 141.17 12.85 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.664 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 88.9 Cg_endo -75.26 157.96 41.41 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.058 3.172 . . . . 0.0 115.096 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 277' ' ' PRO . 70.7 Cg_exo -58.29 155.37 35.53 Favored 'Trans proline' 0 C--O 1.223 -0.245 0 C-N-CA 125.278 3.985 . . . . 0.0 112.979 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.3 tttt 49.58 24.75 1.22 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.216 1.407 . . . . 0.0 112.59 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.08 2.04 0.5 Allowed Glycine 0 C--O 1.215 -1.092 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.29 126.71 30.35 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.979 1.39 . . . . 0.0 113.344 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.01 163.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -118.88 149.07 42.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.8 mt -114.97 137.52 51.9 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.017 1.448 . . . . 0.0 110.493 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.31 116.52 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.514 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.42 -166.17 2.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.88 0.848 . . . . 0.0 112.876 -168.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -48.61 139.29 9.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 24.4 mt -74.52 -39.06 62.62 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.745 0.702 . . . . 0.0 112.714 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -121.89 -45.54 2.26 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.733 -1.229 . . . . 0.0 113.516 -170.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -69.96 -70.96 0.26 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.8 t -58.95 -29.47 67.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.145 0.498 . . . . 0.0 111.591 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -57.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.125 -174.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -66.82 -29.54 69.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.609 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.2 m -61.47 -59.96 4.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.896 1.372 . . . . 0.0 111.823 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 298' ' ' ALA . 4.0 pp -79.46 -26.74 41.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.84 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.17 -34.24 76.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.632 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.03 -2.78 57.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.814 0.696 . . . . 0.0 112.359 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 295' ' ' LEU . . . -97.43 -15.84 20.46 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.7 m -85.09 -159.3 0.42 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.9 m -96.41 158.36 15.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.539 1.162 . . . . 0.0 109.804 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.421 ' HE1' ' HB2' ' A' ' 310' ' ' SER . 85.9 t60 -158.04 153.41 25.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.6 147.08 34.68 Favored Pre-proline 0 C--N 1.349 0.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.95 5.0 4.21 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 123.06 2.507 . . . . 0.0 112.172 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER . . . . . 0 C--O 1.237 0.446 0 C-N-CA 129.352 3.061 . . . . 0.0 114.629 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.421 ' HB2' ' HE1' ' A' ' 301' ' ' HIS . 30.2 p -115.03 155.74 26.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -139.75 137.88 35.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 21.1 m-85 -116.87 144.83 44.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.075 0.95 . . . . 0.0 111.182 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -144.05 158.2 43.86 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -159.6 169.51 23.62 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 146.55 32.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.386 0.136 . . . . 0.0 110.925 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.6 162.95 36.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.527 1.531 . . . . 0.0 109.506 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -167.59 178.05 5.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.569 -0.707 . . . . 0.0 111.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.8 t -125.4 40.18 3.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.656 0.782 . . . . 0.0 109.779 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 57.42 24.29 10.01 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 111.939 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HG3' ' HE3' ' A' ' 321' ' ' MET . 17.4 ptp180 -140.98 -4.1 1.2 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 118.127 2.639 . . . . 0.0 118.127 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.464 ' HE3' ' HG3' ' A' ' 320' ' ' ARG . 1.1 pmm? -150.6 24.17 0.79 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.617 1.099 . . . . 0.0 113.877 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -48.61 110.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.747 0.419 . . . . 0.0 111.187 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 47.6 t -164.72 -49.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -110.68 132.61 54.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.844 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.91 156.18 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.256 1.422 . . . . 0.0 112.555 173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.76 168.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -127.03 150.42 49.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 3.1 t -130.98 143.31 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 124.708 1.255 . . . . 0.0 112.522 -173.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.4 mt -148.62 96.93 3.78 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.764 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -85.18 169.41 9.99 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 124.38 3.387 . . . . 0.0 113.286 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 2.0 t90 -91.51 121.04 32.85 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.249 1.42 . . . . 0.0 110.557 171.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 334' ' ' ALA . 83.3 t -101.82 145.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 233' ' ' ILE . 6.8 mp -62.54 -26.59 68.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.231 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.533 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.31 -3.57 2.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.483 0.489 . . . . 0.0 112.306 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -103.7 -10.56 18.25 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 122.126 -0.359 . . . . 0.0 110.541 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.1 m -104.95 -24.16 12.88 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.483 0.713 . . . . 0.0 110.637 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.4 143.92 31.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -153.67 134.94 14.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 22.2 m -118.69 147.6 22.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.523 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -96.31 -14.42 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.3 t -146.48 125.66 6.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.674 1.99 . . . . 0.0 109.324 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.92 -8.8 15.62 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.36 2.706 . . . . 0.0 113.059 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -103.97 7.26 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.581 -170.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.4 166.07 14.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.857 0.753 . . . . 0.0 109.177 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -115.74 179.28 4.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.912 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.4 mm? -72.89 155.68 39.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.466 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.06 118.61 64.6 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.25 -5.97 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.293 1.995 . . . . 0.0 113.02 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 42.1 m -123.78 -12.58 7.57 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.151 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -122.33 100.31 6.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.381 0.991 . . . . 0.0 112.358 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -150.75 161.42 42.67 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.26 150.33 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 121.964 0.888 . . . . 0.0 110.713 171.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -79.71 121.85 25.84 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.569 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.96 137.53 24.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 O-C-N 125.182 1.551 . . . . 0.0 110.121 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -126.23 64.95 0.57 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.619 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -114.2 123.08 48.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.875 0.87 . . . . 0.0 111.401 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -157.52 157.16 33.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 122.524 1.154 . . . . 0.0 113.325 -176.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.26 3.73 0.31 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.895 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.56 -29.49 3.8 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.546 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.5 ptp -160.19 43.86 0.21 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.873 0.836 . . . . 0.0 111.139 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 357' ' ' LEU . 2.9 tm? -63.6 133.4 53.66 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.754 -0.591 . . . . 0.0 109.748 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -130.88 -176.21 3.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.628 1.204 . . . . 0.0 111.541 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.5 -13.63 61.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.724 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.17 -20.6 40.89 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.869 -1.144 . . . . 0.0 109.419 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.76 -35.0 22.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 76.9 mt -73.6 -26.02 60.6 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.19 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -74.65 -40.72 61.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.644 0.378 . . . . 0.0 111.1 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.57 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.789 0.836 . . . . 0.0 110.261 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.03 -38.62 80.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.75 -27.88 19.74 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -15.18 58.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.812 0.733 . . . . 0.0 110.293 173.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.62 -19.03 19.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.93 0.787 . . . . 0.0 112.366 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.6 tp -96.64 -26.69 15.12 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 124.529 1.143 . . . . 0.0 114.004 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 -24.36 0.47 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.751 0.705 . . . . 0.0 112.367 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.47 -6.24 8.7 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.979 -0.9 . . . . 0.0 114.757 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -85.14 11.27 60.95 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.467 1.634 . . . . 0.0 113.907 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.5 p -91.35 162.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 124.836 1.254 . . . . 0.0 111.569 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.9 -27.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.847 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.9 OUTLIER -153.9 145.44 23.21 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -134.99 140.79 45.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.33 25.33 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.906 0.725 . . . . 0.0 112.428 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.58 138.0 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.08 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -81.63 135.86 35.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.8 p -125.27 162.24 25.16 Favored 'General case' 0 C--O 1.215 -0.732 0 O-C-N 121.499 -0.751 . . . . 0.0 112.184 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -127.88 157.61 40.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.281 1.433 . . . . 0.0 107.688 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.04 100.44 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.063 -1.023 . . . . 0.0 111.232 -169.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.8 m170 53.47 39.4 29.93 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.022 1.329 . . . . 0.0 114.139 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -104.85 -4.26 22.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.408 -2.058 . . . . 0.0 114.493 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 49.7 51.76 11.37 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-N 119.557 1.071 . . . . 0.0 113.619 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -51.08 2.74 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.792 2.995 . . . . 0.0 110.252 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 9.0 tp 39.83 39.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.942 1.697 . . . . 0.0 110.181 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.07 29.8 1.37 Allowed Glycine 0 CA--C 1.508 -0.355 0 O-C-N 121.596 -0.69 . . . . 0.0 111.927 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 25.0 p -168.89 158.45 8.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.74 -170.62 32.76 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.65 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -150.0 157.88 43.6 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.35 130.79 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.6 p -96.57 138.52 34.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.104 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -113.44 155.44 25.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.044 0.84 . . . . 0.0 111.866 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -124.89 -10.34 7.2 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.042 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -119.5 150.65 39.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.158 0.983 . . . . 0.0 108.383 171.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.33 -16.45 61.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.003 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -65.83 -37.0 85.06 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.682 0.793 . . . . 0.0 111.144 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 43.7 m -71.5 -21.59 61.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.418 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.3 -63.47 1.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.038 0.923 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.521 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -75.55 -20.87 58.37 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.832 -1.167 . . . . 0.0 112.116 -173.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -84.56 -21.94 30.26 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 120.154 -1.591 . . . . 0.0 110.603 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' A' ' 426' ' ' ILE . . . -81.39 -37.27 28.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.649 0.593 . . . . 0.0 111.095 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.18 -24.01 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.691 -0.631 . . . . 0.0 111.116 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.0 p -90.2 -16.02 30.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -90.61 -35.88 14.74 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 56.71 -41.24 0.03 OUTLIER 'General case' 0 C--N 1.344 0.36 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -157.3 124.75 5.26 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.191 -1.568 . . . . 0.0 107.963 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.46 157.2 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 423' ' ' LYS . 36.1 mt-10 -94.98 139.51 31.25 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 124.885 1.366 . . . . 0.0 110.104 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 15.3 mt -121.35 125.98 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 123.908 1.813 . . . . 0.0 112.541 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -124.59 52.28 1.54 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.944 -177.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -77.96 179.72 6.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 123.397 1.57 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 17.0 p -91.32 3.59 54.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.4 -29.83 7.64 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.52 164.27 27.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 59.1 m -123.37 113.3 18.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -162.07 178.88 8.42 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 111.786 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 414' ' ' GLU . 34.8 mtmm -124.04 166.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.25 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.28 152.73 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 O-C-N 124.747 1.279 . . . . 0.0 109.365 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -127.08 160.39 31.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.982 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.476 HD13 ' HB1' ' A' ' 407' ' ' ALA . 46.9 mt -139.12 141.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 O-C-N 125.573 1.796 . . . . 0.0 109.343 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -138.31 158.19 71.22 Favored Pre-proline 0 C--O 1.219 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.22 156.77 61.21 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 123.607 2.871 . . . . 0.0 111.259 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 8.5 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.144 -1.408 . . . . 0.0 112.348 -178.242 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.6 m -148.83 151.2 34.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.75 2.02 . . . . 0.0 109.382 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -3.47 1.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 m 38.02 60.05 1.27 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 123.903 0.881 . . . . 0.0 112.461 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.13 -28.84 74.03 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.555 -172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 53.54 46.43 26.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.146 0.473 . . . . 0.0 112.167 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.95 26.52 0.09 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.69 122.33 9.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 CA-C-N 123.316 2.22 . . . . 0.0 110.383 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 139.07 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.254 3.302 . . . . 0.0 111.951 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -153.31 170.4 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.286 1.034 . . . . 0.0 109.856 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.39 48.84 16.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 110.593 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.4 153.4 2.17 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.732 1.213 . . . . 0.0 111.111 -172.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.4 18.01 19.6 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.661 1.185 . . . . 0.0 111.602 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.72 48.13 2.94 Favored Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 123.874 0.87 . . . . 0.0 110.759 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.49 103.74 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.664 1.576 . . . . 0.0 114.487 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 mm -139.35 142.66 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -111.31 148.49 32.83 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -135.98 -8.24 2.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 84.5 m -135.85 -173.15 3.29 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.984 0.803 . . . . 0.0 110.038 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 389' ' ' TYR . 60.0 pttt -65.83 161.59 20.68 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.906 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.43 148.98 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.536 -173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -93.23 137.21 32.77 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.151 0.58 . . . . 0.0 110.727 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.456 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.8 tm? -146.62 124.6 12.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.2 -170.27 36.97 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.939 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.76 12.63 1.31 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.9 m -61.19 124.28 79.67 Favored Pre-proline 0 C--O 1.217 -0.607 0 CA-C-N 120.016 1.908 . . . . 0.0 111.589 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -83.61 0.94 9.2 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.721 1.614 . . . . 0.0 115.072 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.51 -14.17 2.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.952 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 42.81 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.93 2.492 . . . . 0.0 115.142 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 248' ' ' THR . 5.9 pt -104.53 -96.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.879 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.5 m -141.68 132.72 26.14 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 122.508 1.147 . . . . 0.0 108.838 173.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -59.61 -22.8 62.33 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.596 ' H ' HG22 ' A' ' 248' ' ' THR . . . -66.83 -39.86 87.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.356 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.68 -47.97 84.8 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 123.582 0.552 . . . . 0.0 112.374 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 252' ' ' LEU . 6.4 mp -64.11 -38.27 90.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.508 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.458 HG12 ' HD3' ' A' ' 257' ' ' ARG . 16.0 t -73.92 -41.57 53.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.409 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -78.57 -3.65 44.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.304 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.8 m -89.12 -34.86 16.58 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.857 171.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -136.08 75.82 1.57 Allowed 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 120.771 1.623 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.48 ' HA ' HD21 ' A' ' 262' ' ' LEU . 39.0 ptt180 -142.38 14.47 2.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.579 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.07 -9.75 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 122.969 0.507 . . . . 0.0 111.754 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.31 -4.39 58.4 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.422 -1.424 . . . . 0.0 109.078 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 62.18 5.13 7.26 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 125.75 1.906 . . . . 0.0 115.6 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 287' ' ' GLU . 55.2 p -103.39 7.15 38.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -129.57 163.56 25.74 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.357 0.98 . . . . 0.0 112.655 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.8 t -152.54 168.6 25.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.895 1.278 . . . . 0.0 108.419 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.7 p -118.22 144.58 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.134 1.773 . . . . 0.0 113.716 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -143.12 131.2 21.8 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -157.93 146.8 14.55 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.111 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -88.2 165.72 6.88 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 121.646 1.564 . . . . 0.0 111.141 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.72 14.67 82.16 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 118.796 -1.002 . . . . 0.0 110.943 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -69.76 17.74 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.771 1.628 . . . . 0.0 112.735 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -76.56 151.66 36.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.923 0.889 . . . . 0.0 111.224 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.54 167.85 12.73 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.221 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.66 8.28 5.58 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.42 1.488 . . . . 0.0 112.625 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 275' ' ' ARG . 81.1 m-70 -135.74 152.14 75.49 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.12 9.41 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.625 2.216 . . . . 0.0 109.326 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' HIS . 59.5 ttp85 -117.68 117.01 28.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.69 1.196 . . . . 0.0 109.239 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.743 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 17.3 t -160.51 -30.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.743 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 86.3 Cg_endo -76.48 142.49 23.58 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.346 2.698 . . . . 0.0 111.829 -170.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.68 -4.36 15.12 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.386 3.39 . . . . 0.0 113.787 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.54 150.77 25.06 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.62 0.768 . . . . 0.0 109.087 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -99.79 21.72 43.65 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.985 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -154.87 166.06 34.69 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 119.959 1.88 . . . . 0.0 113.021 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.4 m -151.72 -170.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -126.12 148.94 49.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.635 1.207 . . . . 0.0 112.306 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.98 151.51 46.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.883 -1.136 . . . . 0.0 111.785 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.33 158.04 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.364 1.466 . . . . 0.0 110.11 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 288' ' ' LEU . 62.7 m-85 -158.68 -178.22 7.1 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 123.626 1.679 . . . . 0.0 111.154 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 261' ' ' SER . 9.3 tp10 -75.43 19.44 0.18 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.803 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 286' ' ' PHE . 57.3 mt 55.51 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 128.877 2.871 . . . . 0.0 116.628 172.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.0 -51.75 3.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.872 0.869 . . . . 0.0 110.559 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.22 -74.2 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.685 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 38.7 t -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.263 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.47 -52.19 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 O-C-N 123.666 0.604 . . . . 0.0 112.618 -168.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -68.11 -26.16 65.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.495 0.497 . . . . 0.0 110.094 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.2 m -69.45 -44.32 71.47 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.992 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 291' ' ' SER . 10.2 mt -68.53 -52.89 27.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.916 1.234 . . . . 0.0 110.868 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 9.47 23.15 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -115.05 -7.33 12.51 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.124 0.964 . . . . 0.0 110.617 168.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.32 -25.1 18.71 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 13.8 t -101.78 -118.28 0.18 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.909 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.7 m -123.91 157.09 35.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.588 1.185 . . . . 0.0 113.194 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -154.07 161.27 42.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.716 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -148.25 133.86 9.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.38 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 125.514 4.142 . . . . 0.0 110.289 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.476 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.565 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.181 -174.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.2 m -60.85 170.33 1.56 Allowed 'General case' 0 C--N 1.344 0.338 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.532 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -129.08 134.8 48.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.351 0.596 . . . . 0.0 109.562 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -102.16 135.76 43.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.79 145.61 47.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -149.08 152.04 35.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.332 0.587 . . . . 0.0 111.003 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -123.77 116.33 22.82 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.966 1.365 . . . . 0.0 110.988 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.402 ' HE2' ' HB ' ' A' ' 326' ' ' VAL . 25.8 ptt? -133.19 1.34 3.49 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.748 -168.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 58.8 p -119.97 2.43 10.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 21.4 t -62.67 -3.16 1.37 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.549 -1.344 . . . . 0.0 111.732 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -88.26 -8.71 54.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.339 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -152.33 -9.65 0.19 Allowed 'General case' 0 C--N 1.347 0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 30.5 mmm -124.99 -178.4 4.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.937 2.095 . . . . 0.0 108.841 174.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -95.97 -37.03 10.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.703 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.8 t -176.52 146.6 0.61 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.953 0.901 . . . . 0.0 109.555 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -152.42 -56.0 0.13 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 62.79 100.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 124.144 0.903 . . . . 0.0 109.469 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.402 ' HB ' ' HE2' ' A' ' 316' ' ' MET . 4.6 p -84.44 155.7 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.597 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 147.77 24.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.036 0.922 . . . . 0.0 109.285 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 129.95 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.895 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.79 96.08 11.99 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.718 1.247 . . . . 0.0 108.37 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -88.29 160.22 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.392 1.395 . . . . 0.0 111.522 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 5.3 t-105 -74.7 124.31 26.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 334' ' ' ALA . 16.6 t -96.76 149.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.749 1.262 . . . . 0.0 110.382 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -59.41 -31.66 69.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.443 1.097 . . . . 0.0 108.602 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.421 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -73.62 -7.28 51.35 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.61 1.164 . . . . 0.0 113.741 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.28 0.02 33.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.842 0.857 . . . . 0.0 111.058 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 73.2 m -91.69 -54.78 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -157.33 154.71 29.44 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.864 0.865 . . . . 0.0 112.308 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.454 ' CB ' ' HB1' ' A' ' 363' ' ' ALA . 60.7 t80 -154.94 148.49 25.28 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 123.535 0.522 . . . . 0.0 111.021 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.52 155.3 29.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 122.796 0.438 . . . . 0.0 111.51 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -113.89 32.72 5.66 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 121.782 0.801 . . . . 0.0 109.157 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.0 t -152.17 141.36 14.19 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.143 0.977 . . . . 0.0 110.148 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.65 -6.57 17.03 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.22 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -115.77 149.22 38.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -99.2 138.87 35.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -158.53 152.56 23.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.79 0.805 . . . . 0.0 110.435 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.439 ' HA ' HG21 ' A' ' 397' ' ' THR . 3.4 mm? -128.78 174.74 9.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.068 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -141.4 110.45 6.34 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.04 0.79 4.61 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.766 2.977 . . . . 0.0 114.925 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 66.2 m -134.44 0.73 3.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 117.992 -1.004 . . . . 0.0 112.813 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -147.01 81.72 1.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.799 1.761 . . . . 0.0 109.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.1 p -136.9 173.33 11.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.7 143.4 37.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 O-C-N 121.506 -0.746 . . . . 0.0 109.398 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -77.83 145.47 36.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.668 1.223 . . . . 0.0 112.77 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.2 t -132.01 148.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -177.93 -161.99 27.1 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.671 -0.643 . . . . 0.0 112.853 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.5 0.54 Allowed 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 114.186 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -79.05 172.81 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.18 9.2 0.34 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -168.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.698 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 100.91 15.17 29.42 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.8 mmt -147.11 -88.68 0.09 Allowed 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.933 1.366 . . . . 0.0 109.945 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 12.3 tp 44.39 70.78 0.3 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 111.299 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -55.58 170.25 0.27 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.104 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 338' ' ' PHE . . . -64.28 -26.35 68.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -80.56 -21.4 41.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.29 -26.15 42.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.813 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.61 -44.95 63.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.9 72.85 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.774 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.45 -53.55 50.36 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.957 -1.09 . . . . 0.0 110.728 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.37 -42.48 96.48 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 370' ' ' LEU . 4.4 mm? -80.61 -38.52 29.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.295 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -12.76 46.57 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 120.261 1.391 . . . . 0.0 112.726 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.7 -22.86 13.5 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.531 -0.73 . . . . 0.0 110.477 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.3 tp -98.73 -16.52 18.93 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -105.99 -81.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 164.13 -19.36 0.13 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 119.662 1.119 . . . . 0.0 111.925 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -174.86 142.52 6.35 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 118.727 1.263 . . . . 0.0 112.925 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.17 176.93 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.414 1.102 . . . . 0.0 109.824 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.83 -31.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.889 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -155.37 146.23 22.37 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -151.05 135.29 16.84 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 125.17 1.388 . . . . 0.0 108.086 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.65 173.45 38.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.1 mm -91.3 140.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.56 -1.32 . . . . 0.0 109.32 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.27 115.86 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.7 p -111.38 163.35 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.094 0.95 . . . . 0.0 111.773 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -133.41 159.91 38.94 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.98 103.1 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.337 -0.852 . . . . 0.0 112.056 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.26 46.66 20.8 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -108.95 -20.72 12.94 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.627 1.571 . . . . 0.0 115.021 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.414 ' HB2' ' HE2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER 46.36 57.89 16.53 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 124.834 1.334 . . . . 0.0 111.479 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.53 -41.02 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.245 1.297 . . . . 0.0 113.242 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 391' ' ' ILE . 11.0 tp 31.82 38.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 127.846 2.458 . . . . 0.0 112.368 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -140.27 11.97 3.03 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 124.474 1.035 . . . . 0.0 110.749 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 93.0 p -151.15 158.33 43.84 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.896 0.409 . . . . 0.0 111.648 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 177.24 -178.45 48.26 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -150.85 166.91 29.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.31 140.36 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 346' ' ' LEU . 75.6 m -107.92 132.46 53.45 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.408 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -128.84 166.3 19.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.769 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.14 9.25 2.09 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.691 0.619 . . . . 0.0 110.656 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -124.15 144.39 49.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.28 -24.86 64.92 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -51.77 -38.8 57.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.036 0.835 . . . . 0.0 112.186 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.0 m -78.8 -19.26 52.57 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 112.367 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -74.47 -57.09 4.16 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 120.61 -1.306 . . . . 0.0 110.308 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.92 -24.32 59.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.508 -1.277 . . . . 0.0 113.795 -175.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.07 -27.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.804 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.34 -27.54 42.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.6 m -93.3 -24.48 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 O-C-N 121.378 -0.826 . . . . 0.0 112.02 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.4 p -86.18 -16.09 38.89 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.317 0.508 . . . . 0.0 112.02 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.25 -43.37 8.09 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.456 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.05 -10.93 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -170.66 152.44 3.81 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.985 -1.072 . . . . 0.0 110.764 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.54 162.16 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -100.84 123.74 45.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.63 0.729 . . . . 0.0 109.89 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.26 90.43 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 32.3 ttmt -117.42 106.01 12.75 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.287 0.992 . . . . 0.0 110.344 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 73.0 p -138.55 -177.45 4.86 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.767 1.227 . . . . 0.0 110.583 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 24.1 m -79.93 -9.95 59.73 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.689 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.24 -19.48 13.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.833 1.253 . . . . 0.0 112.89 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -153.83 140.41 18.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.637 0.732 . . . . 0.0 109.244 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 89.5 m -144.09 89.03 2.0 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.318 0.647 . . . . 0.0 109.866 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -148.33 -171.37 3.83 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 122.671 1.224 . . . . 0.0 109.912 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 423' ' ' LYS . 42.0 mtmt -130.39 168.61 16.69 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.322 1.058 . . . . 0.0 110.179 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.58 138.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.258 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.65 154.85 25.44 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 124.806 1.316 . . . . 0.0 113.707 -168.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.72 134.47 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.448 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -137.56 156.72 74.7 Favored Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.884 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.33 163.51 37.65 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.856 3.037 . . . . 0.0 110.47 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 52.2 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.995 -176.178 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 59.8 mmm . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.517 0.198 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.7 m 36.21 59.3 0.94 Allowed 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 111.746 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -4.55 36.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.7 m 44.01 52.72 6.7 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.511 1.05 . . . . 0.0 111.959 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.76 72.81 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.354 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 57.01 32.48 21.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.45 146.02 95.96 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.214 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.09 124.57 9.17 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 124.731 3.621 . . . . 0.0 112.713 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.26 5.26 6.03 Favored 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 127.278 5.318 . . . . 0.0 114.325 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -127.93 26.22 5.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 118.916 0.78 . . . . 0.0 112.573 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.63 34.1 1.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.275 1.03 . . . . 0.0 108.67 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.58 176.3 9.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -169.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -67.14 150.58 48.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.223 1.809 . . . . 0.0 106.719 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -71.92 156.71 90.66 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 120.029 1.286 . . . . 0.0 112.264 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.49 140.16 21.86 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 124.232 3.288 . . . . 0.0 115.323 -170.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.3 mm -155.3 152.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.444 ' CG ' HG11 ' A' ' 292' ' ' VAL . 4.3 m-85 -125.18 149.83 47.54 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.604 1.093 . . . . 0.0 110.938 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.7 p -148.25 11.66 0.92 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -170.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.4 t -152.48 -167.33 2.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.636 1.107 . . . . 0.0 109.057 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -59.09 171.51 0.71 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 152.88 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 21.9 m-30 -90.25 145.11 25.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.777 -0.577 . . . . 0.0 109.794 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.48 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.5 tm? -149.13 126.51 11.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.436 ' N ' HD13 ' A' ' 240' ' ' LEU . . . 173.21 165.93 30.85 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 119.276 0.944 . . . . 0.0 112.194 -176.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.56 3.27 1.0 Allowed Glycine 0 CA--C 1.547 2.034 0 O-C-N 124.699 0.882 . . . . 0.0 112.27 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.9 m -107.87 121.79 42.88 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.417 0.609 . . . . 0.0 112.597 -170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.07 -13.93 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 123.281 2.654 . . . . 0.0 112.059 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.445 ' HE1' ' HB2' ' A' ' 324' ' ' LYS . 30.0 p-90 -124.03 -17.52 6.21 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -50.48 104.66 0.08 Allowed 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 118.928 0.786 . . . . 0.0 110.593 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -18.77 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 O-C-N 126.02 2.075 . . . . 0.0 115.781 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.0 m -152.48 126.91 9.31 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 124.486 1.116 . . . . 0.0 110.328 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.03 -34.16 68.59 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.77 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.21 66.04 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 120.051 1.296 . . . . 0.0 110.718 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.64 -55.9 27.96 Favored Glycine 0 C--N 1.368 2.32 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.92 -37.9 72.11 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.673 0.867 . . . . 0.0 111.124 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.44 -22.55 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 123.383 0.673 . . . . 0.0 110.284 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -94.34 -4.94 47.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.77 -0.581 . . . . 0.0 110.867 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -82.38 -24.43 34.47 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.548 -1.345 . . . . 0.0 111.046 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.35 26.58 1.62 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.641 ' HA ' HD11 ' A' ' 262' ' ' LEU . 53.6 ptt85 -94.46 -0.23 54.88 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.585 1.993 . . . . 0.0 113.466 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 -21.41 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.257 0.623 . . . . 0.0 111.243 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.09 -4.25 54.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.653 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.42 -125.61 0.77 Allowed Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.129 -0.982 . . . . 0.0 115.276 -170.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.5 t -153.69 110.83 3.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 124.562 0.801 . . . . 0.0 109.888 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.641 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -151.61 162.28 41.25 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 176.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 64.0 m -146.62 170.73 16.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.208 1.803 . . . . 0.0 109.763 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.78 143.06 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 123.878 0.871 . . . . 0.0 111.864 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -145.94 135.74 23.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.86 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 277' ' ' PRO . 21.9 p90 -161.23 149.03 12.34 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 125.69 1.596 . . . . 0.0 110.893 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.83 152.54 14.77 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 112.893 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.78 28.72 23.06 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.288 -0.729 . . . . 0.0 111.669 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -59.3 -36.28 75.31 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 120.127 1.964 . . . . 0.0 110.953 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 25.7 t0 33.41 89.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.471 2.308 . . . . 0.0 113.31 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.71 172.06 24.43 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 122.328 0.96 . . . . 0.0 111.604 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -60.62 -25.64 66.42 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.699 -0.883 . . . . 0.0 111.686 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -134.12 155.23 80.22 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.754 1.222 . . . . 0.0 108.016 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.57 107.1 2.38 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.676 1.584 . . . . 0.0 108.237 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -119.28 -166.61 1.28 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.328 0.651 . . . . 0.0 111.139 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.6 135.05 34.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.421 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 266' ' ' TRP . 44.3 Cg_endo -83.44 148.58 12.87 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 124.516 3.478 . . . . 0.0 112.024 170.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.27 -6.6 17.35 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.794 2.329 . . . . 0.0 111.367 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 279' ' ' LYS . 7.9 ptpp? -95.77 -6.23 40.14 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.992 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.68 17.47 41.78 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-O 118.786 -1.008 . . . . 0.0 115.405 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -128.68 154.57 46.16 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 117.696 0.748 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.7 t -152.34 165.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -122.56 148.72 44.87 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.4 mt -108.23 143.86 36.48 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.49 1.138 . . . . 0.0 110.622 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.79 109.94 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -158.72 -165.42 1.65 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.695 -171.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.31 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.7 pt? -69.41 14.48 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.873 2.469 . . . . 0.0 114.802 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.74 -59.2 1.08 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.172 0.92 . . . . 0.0 111.242 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -90.31 -34.01 15.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 46.9 m -74.05 -17.1 61.01 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 119.391 0.996 . . . . 0.0 108.657 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 234' ' ' TYR . 46.6 t -76.14 -57.76 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.42 -32.57 73.43 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.741 -1.225 . . . . 0.0 112.818 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 25.0 m -68.37 -42.59 78.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.036 0.834 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.12 -39.45 49.37 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.76 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.7 mt -60.51 -25.6 66.22 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.555 1.071 . . . . 0.0 111.789 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.04 -6.82 23.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.99 22.21 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 123.796 0.685 . . . . 0.0 109.784 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 314' ' ' PHE . 24.2 p -97.85 -153.86 0.44 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.4 t -117.09 174.88 5.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.628 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -149.84 150.7 32.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -135.15 124.87 16.66 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.308 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -81.03 37.53 0.69 Allowed 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 124.416 3.411 . . . . 0.0 108.262 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.886 0 CA-C-N 119.421 1.01 . . . . 0.0 111.941 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 121.356 0.598 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 58.8 m -132.56 151.69 51.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -144.65 139.02 27.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.419 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.87 144.67 42.02 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.161 0.984 . . . . 0.0 110.961 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 327' ' ' GLN . 59.8 m-85 -136.93 159.16 42.71 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.742 0.817 . . . . 0.0 110.524 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 299' ' ' CYS . 10.4 t80 -156.86 170.68 21.93 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.2 0.938 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.68 124.9 24.56 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -141.6 28.42 1.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.413 -168.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.1 p -43.99 138.56 2.79 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.801 1.182 . . . . 0.0 112.908 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 18.2 t -116.43 -51.15 2.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -73.56 -26.21 60.73 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 108.925 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 55.24 26.07 8.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.935 1.694 . . . . 0.0 113.4 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -78.37 -20.01 52.19 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -159.57 177.3 11.06 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.67 134.5 44.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.277 1.431 . . . . 0.0 108.624 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 59.2 tptt -136.76 -7.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.43 175.43 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.811 1.291 . . . . 0.0 113.75 -171.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -151.03 153.76 9.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.843 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.471 ' HB3' ' CE1' ' A' ' 313' ' ' TYR . 3.0 pp0? -117.79 156.04 29.02 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.32 139.89 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.694 -175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.53 119.36 4.26 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 124.153 0.908 . . . . 0.0 109.819 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -95.82 161.74 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.365 4.043 . . . . 0.0 111.751 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 3.3 t-105 -70.38 118.58 13.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.56 149.65 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 110.497 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.06 -39.26 81.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.833 0.853 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.67 2.91 10.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 122.918 0.487 . . . . 0.0 112.235 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -93.27 -9.82 37.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.172 -0.955 . . . . 0.0 110.95 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 51.4 m -90.96 -58.44 2.47 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -160.9 173.49 15.24 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.892 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.65 161.52 41.54 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.783 0.833 . . . . 0.0 111.412 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.52 166.88 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 122.545 1.164 . . . . 0.0 110.837 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -126.33 27.51 6.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.694 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 342' ' ' PRO . 85.9 p -147.87 167.93 12.32 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 117.22 -1.371 . . . . 0.0 110.061 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 341' ' ' SER . 74.4 Cg_endo -69.71 56.91 1.41 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 124.821 3.681 . . . . 0.0 109.982 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.6 t 55.67 38.91 30.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.383 0.673 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -71.91 151.32 43.42 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -65.03 157.15 29.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.98 160.48 4.73 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.871 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.88 139.0 87.93 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.2 94.44 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.866 2.377 . . . . 0.0 111.891 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 63.4 m 62.83 49.83 3.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.761 -1.563 . . . . 0.0 114.334 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -140.99 43.3 1.81 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 109.332 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.444 ' HB ' HG22 ' A' ' 397' ' ' THR . 1.8 t -117.38 159.06 23.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 159.08 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.16 147.67 36.37 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.008 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 83.3 t -130.75 136.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.395 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -172.44 -157.72 14.95 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.589 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 425' ' ' GLN . . . 60.66 29.54 19.08 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.377 1.071 . . . . 0.0 111.981 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.484 HD22 HD22 ' A' ' 361' ' ' LEU . 24.6 mt -76.72 164.45 25.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.432 1.083 . . . . 0.0 110.293 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.517 ' CE1' ' H ' ' A' ' 361' ' ' LEU . 8.7 p-80 -77.62 12.7 1.53 Allowed 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.468 -0.77 . . . . 0.0 112.573 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 97.0 2.49 59.37 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 119.028 -0.873 . . . . 0.0 112.362 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 mmt -145.23 -71.32 0.26 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.039 0.92 . . . . 0.0 111.643 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.517 ' H ' ' CE1' ' A' ' 358' ' ' HIS . 12.8 tp 38.0 69.36 0.25 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.789 0.804 . . . . 0.0 111.094 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -67.33 179.3 1.28 Allowed 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.158 -0.964 . . . . 0.0 113.041 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.21 -27.07 65.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -170.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.96 -15.2 57.76 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 119.34 0.973 . . . . 0.0 112.289 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -92.63 -27.1 17.53 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.389 0.43 . . . . 0.0 111.186 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.4 mt -76.22 -37.03 58.26 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 124.74 1.275 . . . . 0.0 110.426 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.0 56.14 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.33 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.23 -50.52 73.34 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.8 -32.07 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 123.914 0.759 . . . . 0.0 111.632 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.96 -28.96 18.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.608 -1.307 . . . . 0.0 113.774 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.63 -19.86 27.15 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.682 1.128 . . . . 0.0 113.742 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -113.86 -17.3 12.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 120.051 1.296 . . . . 0.0 111.083 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 373' ' ' LEU . 10.3 tp -97.6 -3.99 38.49 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 118.873 0.76 . . . . 0.0 111.286 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -152.03 -48.05 0.11 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.47 -1.73 88.29 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.442 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.35 111.37 2.24 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.97 166.28 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 123.865 0.866 . . . . 0.0 110.396 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 -29.03 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.21 153.64 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 109.645 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -155.12 132.23 10.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.68 158.3 27.79 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 121.163 -0.96 . . . . 0.0 113.575 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.02 138.91 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.242 1.817 . . . . 0.0 108.037 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.89 153.5 23.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.081 0.467 . . . . 0.0 112.128 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 5.3 p -137.47 165.79 25.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.064 0.459 . . . . 0.0 110.233 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.21 -178.83 5.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.47 100.36 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.045 0.384 . . . . 0.0 111.107 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.2 m170 50.41 40.86 23.95 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.93 1.292 . . . . 0.0 110.848 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -88.72 -20.62 24.58 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.344 0.658 . . . . 0.0 109.72 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.0 p90 38.8 53.56 4.25 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 0.0 112.954 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.65 -48.24 0.42 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.716 3.61 . . . . 0.0 111.271 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 8.6 tp 41.05 41.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.277 1.431 . . . . 0.0 111.49 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -162.11 14.43 0.13 Allowed Glycine 0 C--N 1.349 1.299 0 C-N-CA 121.077 -0.582 . . . . 0.0 114.132 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.2 p -156.33 132.07 9.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.11 0.955 . . . . 0.0 110.796 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.08 -164.83 25.45 Favored Glycine 0 C--O 1.209 -1.415 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.349 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -142.09 166.82 23.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.505 -0.848 . . . . 0.0 110.624 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.23 146.42 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.627 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.444 HG22 ' HB ' ' A' ' 351' ' ' THR . 26.2 p -125.99 122.61 36.4 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 122.252 1.025 . . . . 0.0 108.362 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.12 -28.45 25.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.721 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.4 t30 54.07 17.09 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.301 1.048 . . . . 0.0 112.585 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -141.4 164.23 30.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.234 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -99.68 -45.31 5.81 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.56 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.82 -25.64 66.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.617 1.098 . . . . 0.0 112.921 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.0 p -84.99 -18.48 34.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -72.92 -56.09 5.67 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.583 0.629 . . . . 0.0 109.964 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.27 63.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.753 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -77.08 -24.89 51.84 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.88 1.218 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.98 -29.43 35.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.565 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.1 m -78.92 -18.29 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 123.798 0.686 . . . . 0.0 112.203 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 91.3 p -88.9 -22.16 23.27 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -85.76 -44.56 12.4 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.299 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.48 -2.24 0.0 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 128.551 2.74 . . . . 0.0 116.627 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.4 141.15 14.58 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.73 163.36 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 119.103 0.865 . . . . 0.0 109.229 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.459 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 28.2 mt-10 -119.83 131.99 55.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.993 1.378 . . . . 0.0 112.552 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.443 ' HB ' ' H ' ' A' ' 422' ' ' LYS . 6.4 mm -93.95 117.09 36.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -117.61 25.71 10.22 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.909 0.777 . . . . 0.0 109.838 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 419' ' ' LYS . 86.2 m -63.74 158.12 22.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.021 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -86.17 -2.54 58.45 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 123.455 0.702 . . . . 0.0 112.149 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 417' ' ' THR . 39.4 pttt -128.22 -1.6 5.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.498 1.119 . . . . 0.0 111.523 174.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -150.26 127.52 11.34 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.6 m -142.08 109.1 5.47 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.195 -0.94 . . . . 0.0 111.105 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 33.6 tptt -167.22 -156.46 0.21 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 117.899 0.318 . . . . 0.0 111.416 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.657 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 98.7 mttt -141.11 176.21 9.01 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.601 0.76 . . . . 0.0 109.674 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.62 154.11 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 356' ' ' ALA . 49.1 tt0 -117.03 151.75 36.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.887 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.99 139.46 47.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -142.81 113.12 5.87 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.98 161.77 40.48 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.701 3.6 . . . . 0.0 112.33 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.606 -1.664 . . . . 0.0 111.51 178.291 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.035 0.445 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 221' ' ' SER . 9.7 m 45.45 55.97 6.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.409 1.099 . . . . 0.0 113.101 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.41 18.72 0.07 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.191 0.997 . . . . 0.0 113.245 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 219' ' ' THR . 66.4 m -37.21 121.02 0.8 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.04 1.336 . . . . 0.0 113.288 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.8 0.91 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-O 118.266 -1.296 . . . . 0.0 114.035 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -89.51 -29.75 18.74 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.387 1.593 . . . . 0.0 109.564 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 10.8 mt 61.7 148.42 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 115.064 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 48.8 Cg_exo -63.01 131.14 31.49 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.641 2.227 . . . . 0.0 111.769 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 1.7 Cg_endo -82.15 147.32 14.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.208 2.606 . . . . 0.0 109.209 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -144.88 22.42 1.59 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.34 30.68 3.74 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.555 0.742 . . . . 0.0 111.627 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -71.11 161.17 31.57 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 111.384 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -135.27 -143.34 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.357 1.063 . . . . 0.0 108.594 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.4 p30 36.17 51.51 1.68 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.536 1.534 . . . . 0.0 113.655 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.83 119.28 6.28 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.936 1.757 . . . . 0.0 112.131 -173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.1 mm -129.75 140.65 48.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -104.27 155.02 19.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.987 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.3 t -137.58 -34.97 0.67 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 90.8 m -147.07 78.79 1.5 Allowed 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.67 0.748 . . . . 0.0 112.746 -168.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 19.5 pttm 52.23 -169.07 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.64 145.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -87.77 149.58 24.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.489 1.116 . . . . 0.0 110.504 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 241' ' ' GLY . 0.6 OUTLIER -149.63 117.61 6.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.121 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . -179.89 -178.23 48.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 122.192 0.884 . . . . 0.0 112.722 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.02 15.93 1.46 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 124.31 0.957 . . . . 0.0 114.792 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.51 130.27 26.02 Favored Pre-proline 0 N--CA 1.473 0.719 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 13.3 Cg_endo -87.91 -8.69 5.77 Favored 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 124.156 3.237 . . . . 0.0 112.57 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.478 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 11.5 p-90 -147.34 -7.8 0.45 Allowed 'General case' 0 C--O 1.251 1.172 0 CA-C-N 120.585 1.539 . . . . 0.0 114.876 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.33 110.55 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.486 -1.383 . . . . 0.0 108.931 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -20.25 25.68 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.152 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.3 p -153.31 154.49 34.68 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 119.416 -2.053 . . . . 0.0 111.451 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -16.89 39.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.56 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.44 -17.6 60.11 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.84 -62.28 2.86 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.75 -31.18 68.99 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 118.593 -1.243 . . . . 0.0 111.448 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.89 -50.91 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.657 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.51 -5.19 31.3 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.6 m -79.83 -21.58 44.02 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.899 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -131.59 -1.31 3.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 257' ' ' ARG . 26.4 ttt-85 -81.13 -21.39 39.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.304 1.442 . . . . 0.0 111.287 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 258' ' ' VAL . 1.2 m -61.13 -16.86 15.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 O-C-N 125.262 1.601 . . . . 0.0 115.291 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -133.48 -5.76 2.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.783 1.233 . . . . 0.0 110.649 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -94.24 -166.42 36.8 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.589 ' H ' HD11 ' A' ' 295' ' ' LEU . 73.0 m -146.47 65.82 1.19 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.492 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -147.75 171.16 16.11 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.752 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 61.5 m -138.88 174.9 10.03 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -131.24 139.41 50.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 CA-C-O 122.62 1.2 . . . . 0.0 110.949 -174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.23 142.02 24.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.237 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -163.81 142.04 5.98 Favored Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.95 -177.34 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.77 3.647 . . . . 0.0 111.787 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 67.74 -5.15 3.57 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -142.58 44.55 1.62 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 119.911 1.856 . . . . 0.0 110.619 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.12 153.03 40.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.469 0.652 . . . . 0.0 110.128 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.39 -6.27 38.93 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.015 0.817 . . . . 0.0 111.69 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -157.91 -27.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.427 1.113 . . . . 0.0 113.244 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.36 76.11 9.34 Favored Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.29 112.32 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.091 3.194 . . . . 0.0 111.203 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -170.86 -166.83 0.51 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.43 146.59 77.72 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.58 166.2 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.854 3.036 . . . . 0.0 109.18 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.74 4.16 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.632 2.888 . . . . 0.0 111.964 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -120.48 167.93 11.86 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.73 10.22 68.49 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.552 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 16.0 p90 -146.24 162.62 37.68 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.4 m -156.96 -166.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 129.069 2.948 . . . . 0.0 108.032 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -132.58 152.24 51.68 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.234 -0.916 . . . . 0.0 111.887 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.401 HD22 HD23 ' A' ' 262' ' ' LEU . 77.5 mt -110.16 140.35 44.35 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.24 0.962 . . . . 0.0 109.979 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.0 -153.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.04 0.536 . . . . 0.0 110.45 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . 0.315 33.0 t80 78.62 -107.01 0.02 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.805 -173.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.02 128.54 34.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 120.574 1.534 . . . . 0.0 107.544 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.76 17.19 3.31 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.491 1.119 . . . . 0.0 112.651 -167.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.9 -71.12 0.71 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.577 1.151 . . . . 0.0 111.833 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -79.26 -19.3 50.92 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.669 -1.27 . . . . 0.0 112.585 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 24.5 m -101.26 -8.33 22.24 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.79 0.723 . . . . 0.0 111.556 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 5.6 m -85.24 -40.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.0 -59.61 4.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.34 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.0 p -76.57 -39.58 52.31 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 120.069 1.304 . . . . 0.0 112.12 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.589 HD11 ' H ' ' A' ' 261' ' ' SER . 65.3 mt -68.57 -34.01 75.07 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -171.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -94.23 -12.89 27.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.317 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.05 0.87 54.53 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.652 0.66 . . . . 0.0 111.096 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.49 -24.63 14.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 96.7 m -78.86 -152.96 0.06 Allowed 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.767 170.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.4 m -118.81 166.89 12.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 120.675 -1.265 . . . . 0.0 111.997 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -144.99 151.74 39.06 Favored 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 122.414 0.286 . . . . 0.0 110.982 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.28 138.68 16.82 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -87.07 20.72 1.17 Allowed 'Trans proline' 0 N--CA 1.431 -2.197 0 C-N-CA 122.293 1.996 . . . . 0.0 111.478 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 17.9 tp . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.9 m -67.91 168.85 10.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -139.18 154.51 48.07 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.09 156.66 18.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -152.69 155.69 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.354 0.409 . . . . 0.0 111.097 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -153.47 152.73 31.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -111.89 146.28 38.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.407 ' HE2' ' CG1' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -148.49 -1.98 0.51 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.903 1.377 . . . . 0.0 110.541 -169.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 69.8 m -71.68 145.84 48.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.638 0.586 . . . . 0.0 112.503 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.8 m -85.2 149.79 25.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 124.358 1.036 . . . . 0.0 110.747 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -62.21 -15.53 47.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.754 -170.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.79 -23.34 67.32 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.598 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -159.65 15.04 0.15 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -44.21 142.59 1.43 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.043 0.925 . . . . 0.0 112.116 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 48.3 t -164.44 -35.64 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.031 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -137.1 163.81 29.92 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.575 0.75 . . . . 0.0 111.849 -173.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.57 167.05 10.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.443 2.697 . . . . 0.0 112.092 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.407 ' CG1' ' HE2' ' A' ' 316' ' ' MET . 12.5 m -104.15 160.42 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.88 0.848 . . . . 0.0 112.269 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 153.24 17.76 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.134 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 16.9 t -137.87 130.51 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.363 1.04 . . . . 0.0 109.946 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.5 mt -138.65 119.28 9.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.979 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.22 168.69 7.55 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.246 2.631 . . . . 0.0 110.221 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.527 ' CH2' ' HB ' ' A' ' 391' ' ' ILE . 2.9 t-105 -104.52 123.95 48.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.495 0.664 . . . . 0.0 111.68 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.21 143.67 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.558 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 333' ' ' LEU . 4.3 tt -52.53 -40.64 62.69 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 125.109 1.364 . . . . 0.0 109.851 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.59 57.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 122.277 -0.265 . . . . 0.0 110.847 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.88 -18.09 38.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.494 -1.378 . . . . 0.0 110.766 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 p -111.79 -25.97 9.2 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.844 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -141.1 142.34 34.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.883 0.765 . . . . 0.0 110.612 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -157.33 153.47 27.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.433 -1.417 . . . . 0.0 111.144 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.57 147.37 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.65 31.55 5.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.689 0.796 . . . . 0.0 109.636 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.8 t -145.72 145.94 27.33 Favored Pre-proline 0 CA--C 1.52 -0.208 0 C-N-CA 124.16 0.984 . . . . 0.0 108.396 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.21 -7.11 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.175 2.584 . . . . 0.0 111.45 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.9 p -135.1 164.58 27.33 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.693 0.797 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.93 132.97 34.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.411 0.624 . . . . 0.0 112.059 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -154.9 162.56 41.06 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.083 1.353 . . . . 0.0 110.411 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 17.8 tp -151.59 175.43 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.837 1.336 . . . . 0.0 107.76 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.425 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 9.0 t70 -145.95 129.07 8.21 Favored Pre-proline 0 N--CA 1.446 -0.674 0 O-C-N 120.931 -1.106 . . . . 0.0 109.679 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.18 0.87 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.962 1 C-N-CA 126.507 4.805 . . . . 0.0 114.996 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 14.6 t -131.67 -7.3 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.677 -0.677 . . . . 0.0 111.935 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -135.91 77.3 1.65 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.42 1.009 . . . . 0.0 110.112 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.1 p -135.54 84.67 2.11 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.328 1.643 . . . . 0.0 108.647 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.74 145.55 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.048 0.451 . . . . 0.0 111.239 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -73.08 150.39 42.33 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.122 0.963 . . . . 0.0 112.405 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.8 140.83 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.073 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.47 -166.56 23.59 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 122.25 0.917 . . . . 0.0 114.108 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.46 38.69 30.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.543 0.687 . . . . 0.0 110.248 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.26 -179.65 7.25 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.174 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -56.71 -11.87 1.58 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.231 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.59 88.15 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.192 0.906 . . . . 0.0 113.78 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.6 ptm -165.85 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.161 0.584 . . . . 0.0 110.814 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.68 144.06 52.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -94.88 159.3 15.1 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.75 60.29 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.144 -0.973 . . . . 0.0 112.524 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.66 -29.02 61.1 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.75 -26.23 24.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.22 0.95 . . . . 0.0 109.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 tt -72.42 -46.95 52.81 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -71.64 -24.28 61.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 110.224 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.04 -45.56 66.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.535 0.683 . . . . 0.0 109.799 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.39 -44.24 94.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.4 -15.04 51.29 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.829 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.95 -16.46 21.71 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 120.283 1.402 . . . . 0.0 112.169 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.48 -25.78 14.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 373' ' ' LEU . 13.2 tp -72.75 -24.81 61.01 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.203 0.94 . . . . 0.0 110.803 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 403' ' ' SER . 3.9 p90 -163.41 -24.71 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.459 0.572 . . . . 0.0 112.159 174.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 72.67 157.93 4.0 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.724 -0.61 . . . . 0.0 112.37 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 126.12 15.68 2.77 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 121.871 0.706 . . . . 0.0 111.58 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.81 173.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.053 -0.573 . . . . 0.0 112.132 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.97 -26.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.416 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -157.82 157.68 33.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.37 0.987 . . . . 0.0 110.079 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.04 141.48 28.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.79 133.64 4.76 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.512 1.062 . . . . 0.0 113.523 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.67 145.9 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.5 70.38 7.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.82 150.27 48.82 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.127 0.571 . . . . 0.0 112.097 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.83 164.19 29.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -56.68 103.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.307 0.643 . . . . 0.0 112.128 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 m170 53.05 26.65 4.99 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.788 1.635 . . . . 0.0 113.613 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -85.58 -8.39 58.31 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.157 -0.964 . . . . 0.0 111.672 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.441 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 41.9 p90 54.3 45.57 2.38 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.875 1.67 . . . . 0.0 113.053 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 86.0 Cg_endo -73.97 -66.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.034 2.489 . . . . 0.0 110.738 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.54 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 8.9 tp 38.79 35.14 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.9 0.88 . . . . 0.0 113.338 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.66 15.12 0.45 Allowed Glycine 0 CA--C 1.524 0.649 0 O-C-N 121.321 -0.862 . . . . 0.0 113.53 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 62.7 p -151.68 154.29 36.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 166.77 -146.86 11.26 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.615 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -149.29 171.36 16.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.34 136.67 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 122.077 0.942 . . . . 0.0 110.332 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.8 m -99.15 133.08 43.95 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.403 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -115.33 179.32 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -144.25 5.84 1.29 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.15 166.62 24.17 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -83.94 -29.65 26.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.114 0.566 . . . . 0.0 110.516 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.662 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -66.42 -27.72 68.05 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.143 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.431 ' HA ' ' CE1' ' A' ' 374' ' ' PHE . 51.0 m -73.12 -27.4 61.66 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.013 0.824 . . . . 0.0 110.536 174.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.78 -56.0 6.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.821 0.82 . . . . 0.0 110.201 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -8.83 56.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.884 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -100.77 -21.19 15.25 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.914 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.05 -34.16 44.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 43.2 t -83.58 -33.93 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 122.808 0.443 . . . . 0.0 110.769 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.0 t -70.44 -32.64 70.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 119.724 1.147 . . . . 0.0 109.051 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.04 -52.66 13.52 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.865 0.84 . . . . 0.0 110.175 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.24 -17.5 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 126.678 1.991 . . . . 0.0 115.672 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.91 142.78 16.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.34 0.518 . . . . 0.0 110.354 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.94 154.26 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 122.254 -0.279 . . . . 0.0 110.537 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -101.54 140.66 35.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 415' ' ' ILE . 2.8 mp -105.06 126.88 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -131.1 121.79 25.58 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.3 m -150.64 162.75 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -172.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.7 t -65.67 -5.16 7.65 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -145.58 4.43 1.02 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.346 1.058 . . . . 0.0 113.368 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -150.63 129.45 12.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.784 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.8 p -147.9 102.17 3.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -147.88 173.31 12.97 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -118.87 179.08 4.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.3 145.88 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -122.12 144.65 48.81 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 122.931 0.144 . . . . 0.0 110.766 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.94 145.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -138.44 138.94 23.43 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.1 155.68 63.42 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.168 2.579 . . . . 0.0 110.15 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.066 -170.727 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . 0.461 ' CG ' HG12 ' A' ' 413' ' ' VAL . 11.0 tpt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.8 m -153.11 159.22 42.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.241 1.417 . . . . 0.0 109.754 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 17.61 0.65 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.247 0.619 . . . . 0.0 112.479 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.6 m 61.06 26.65 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.078 1.751 . . . . 0.0 115.205 172.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 51.59 68.09 1.69 Allowed Glycine 0 CA--C 1.536 1.395 0 CA-C-O 121.117 0.287 . . . . 0.0 113.202 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.48 -17.19 63.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.375 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.7 mm? -105.62 151.82 39.92 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-O 121.365 0.602 . . . . 0.0 110.499 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.5 110.89 2.5 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.55 4.69 6.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.347 3.365 . . . . 0.0 111.989 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -143.46 -171.29 3.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.819 1.248 . . . . 0.0 109.195 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 25.8 m120 57.73 22.74 8.74 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.296 1.839 . . . . 0.0 114.078 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -62.55 -36.74 83.62 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.145 -0.347 . . . . 0.0 110.224 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 39.84 54.41 2.58 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.9 59.47 39.0 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 332' ' ' VAL . 83.5 Cg_endo -70.83 127.39 13.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.308 3.338 . . . . 0.0 114.43 -171.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.8 mm -146.14 131.54 12.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 102.604 -3.109 . . . . 0.0 102.604 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 292' ' ' VAL . 12.0 m-85 -98.45 143.03 29.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.768 -1.173 . . . . 0.0 109.231 -169.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.9 p -137.14 -1.24 2.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 14.7 t -158.97 -166.28 1.82 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.026 1.285 . . . . 0.0 108.317 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 176.91 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.535 1.134 . . . . 0.0 112.564 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.1 142.35 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.49 1.138 . . . . 0.0 109.01 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.25 130.12 38.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.512 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -137.07 113.57 10.14 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.94 173.98 38.35 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-O 121.418 0.454 . . . . 0.0 113.73 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 115.05 18.83 6.16 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.357 -1.421 . . . . 0.0 114.009 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.3 m -92.0 126.09 54.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.501 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -82.03 -17.03 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.991 3.128 . . . . 0.0 111.483 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.443 ' CH2' ' HG3' ' A' ' 321' ' ' MET . 30.1 p-90 -130.54 -70.06 0.63 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.146 0.884 . . . . 0.0 109.709 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 245' ' ' TRP . 26.7 t70 10.97 90.72 0.01 OUTLIER 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.768 1.627 . . . . 0.0 113.225 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.434 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -63.96 -22.0 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 250' ' ' ALA . 11.7 m -150.33 143.15 24.7 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-N 121.029 1.74 . . . . 0.0 108.916 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.19 -24.93 64.11 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.197 0.999 . . . . 0.0 109.52 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.54 -13.94 62.59 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.54 1.136 . . . . 0.0 110.689 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.83 -58.16 5.94 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 54.8 mt -50.49 -47.21 57.32 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 122.199 0.999 . . . . 0.0 109.437 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 264' ' ' VAL . 77.3 t -57.42 -45.59 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.916 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -73.92 -8.03 54.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.904 0.32 . . . . 0.0 110.853 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 84.6 m -90.49 -20.56 22.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.99 32.58 1.12 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.441 1.019 . . . . 0.0 112.468 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -88.25 14.98 8.25 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.14 12.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 O-C-N 120.541 -1.349 . . . . 0.0 112.37 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -93.36 -1.69 55.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.114 0.87 . . . . 0.0 111.56 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 70.12 -0.26 24.33 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.5 t -124.89 18.31 8.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.704 -0.88 . . . . 0.0 112.076 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.53 143.42 28.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.366 -0.533 . . . . 0.0 112.25 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.6 m -150.71 153.15 35.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 253' ' ' VAL . 93.5 t -138.17 138.76 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 124.012 0.82 . . . . 0.0 111.29 -169.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -143.45 156.19 44.58 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.488 1.118 . . . . 0.0 113.651 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -151.18 167.32 13.23 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.56 -19.28 22.8 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 124.087 3.191 . . . . 0.0 115.681 -168.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 170.46 157.53 12.77 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.085 1.311 . . . . 0.0 111.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -102.16 15.3 29.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.761 0.824 . . . . 0.0 112.766 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.86 144.41 47.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.639 1.176 . . . . 0.0 108.936 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.24 177.37 15.33 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.285 0.936 . . . . 0.0 110.775 -176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.74 173.36 8.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.553 -0.969 . . . . 0.0 108.494 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 60.66 142.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.539 1.135 . . . . 0.0 112.223 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.9 -11.87 11.1 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 123.852 3.034 . . . . 0.0 111.415 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -101.06 33.0 2.99 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.822 0.849 . . . . 0.0 111.991 -171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 48.9 t 64.98 144.58 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 124.685 1.194 . . . . 0.0 110.342 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.617 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 71.2 Cg_endo -66.55 166.08 23.09 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.068 1.846 . . . . 0.0 112.972 171.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.7 113.3 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 CA-C-O 122.643 1.018 . . . . 0.0 111.396 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -143.52 145.79 32.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.247 1.419 . . . . 0.0 109.977 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -92.8 4.11 75.07 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.236 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.93 165.79 35.57 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.62 161.66 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.863 1.265 . . . . 0.0 109.74 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -97.39 149.37 22.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.579 1.081 . . . . 0.0 109.752 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.509 HD23 HG22 ' A' ' 264' ' ' VAL . 81.6 mt -117.79 137.09 52.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.16 107.52 11.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -153.51 -161.68 1.31 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 124.445 1.091 . . . . 0.0 111.058 -168.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.19 92.48 0.04 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.8 pt? -67.03 17.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.792 2.437 . . . . 0.0 117.011 -168.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.86 -60.12 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.102 1.319 . . . . 0.0 109.98 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -86.19 -23.71 26.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.264 -0.897 . . . . 0.0 112.862 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 12.2 t -84.12 -22.73 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 286' ' ' PHE . 24.1 t -72.66 -48.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.561 0.696 . . . . 0.0 109.577 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.3 ptp180 -74.95 -25.67 59.04 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.551 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 48.0 m -78.18 -37.23 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 0.0 112.672 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.95 -35.96 67.08 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.34 -24.21 62.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.087 0.858 . . . . 0.0 110.006 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -92.11 -2.35 56.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.76 -18.14 18.97 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.125 -1.609 . . . . 0.0 110.226 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.84 -151.32 0.44 Allowed 'General case' 0 C--O 1.24 0.554 0 O-C-N 125.925 2.016 . . . . 0.0 110.411 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -126.46 177.94 6.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.191 0.932 . . . . 0.0 113.125 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 310' ' ' SER . 83.3 t60 -145.8 162.03 38.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.45 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -144.12 131.78 10.66 Favored Pre-proline 0 C--N 1.351 0.648 0 O-C-N 124.026 0.829 . . . . 0.0 110.102 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -86.75 23.87 0.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 1 C-N-CA 125.807 4.338 . . . . 0.0 111.174 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 C-N-CA 123.517 0.727 . . . . 0.0 111.736 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 29.0 m -108.61 158.18 17.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.312 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -138.06 135.56 35.97 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.004 -171.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.2 148.88 25.87 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.24 149.42 51.98 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.177 -0.952 . . . . 0.0 111.141 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -151.88 168.03 26.44 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 123.313 1.53 . . . . 0.0 109.785 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.7 ptpt -130.46 116.74 18.64 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.921 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.5 OUTLIER -110.99 28.46 8.7 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -176.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 86.1 p -79.61 164.31 23.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.029 0.932 . . . . 0.0 111.401 -174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 66.6 m -117.05 176.13 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 15.7 ptp180 -79.1 23.71 0.35 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -128.79 15.16 6.42 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.63 0.772 . . . . 0.0 110.778 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.443 ' HG3' ' CH2' ' A' ' 245' ' ' TRP . 16.6 mmt -137.52 179.65 6.28 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -130.8 103.41 6.56 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.678 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.7 m 64.88 166.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 111.419 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -155.34 -64.6 0.12 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.749 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 44.05 69.61 0.4 Allowed 'General case' 0 C--N 1.343 0.318 0 O-C-N 123.84 0.713 . . . . 0.0 112.652 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.7 p -83.99 160.0 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 121.902 -0.499 . . . . 0.0 109.987 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -102.8 153.59 20.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.509 0.595 . . . . 0.0 110.114 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.3 139.15 49.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 329' ' ' ILE . 19.7 tt -155.83 88.1 3.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 122.854 1.311 . . . . 0.0 108.123 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.16 164.75 26.67 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.868 2.379 . . . . 0.0 113.062 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -78.28 122.49 25.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.104 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 334' ' ' ALA . 86.8 t -103.84 148.6 8.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 122.463 1.125 . . . . 0.0 110.161 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.44 -38.62 59.65 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.554 1.142 . . . . 0.0 110.775 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -64.32 -3.09 2.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.706 0.403 . . . . 0.0 111.892 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -102.96 7.24 39.2 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 120.823 -1.173 . . . . 0.0 111.202 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.9 m -119.85 -49.37 2.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -151.13 157.41 42.7 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 119.122 0.873 . . . . 0.0 111.609 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.452 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 54.2 t80 -156.08 143.33 19.15 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.901 1.375 . . . . 0.0 109.342 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.27 154.57 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.999 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -117.87 41.18 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.8 t -137.61 147.15 56.24 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.548 1.139 . . . . 0.0 110.074 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.66 -3.36 13.76 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.564 2.176 . . . . 0.0 111.022 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.8 m -130.19 -176.85 4.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -105.86 135.95 46.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.728 -1.233 . . . . 0.0 110.243 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -159.59 165.75 32.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.083 -1.011 . . . . 0.0 109.321 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.37 150.7 25.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.057 1.343 . . . . 0.0 110.04 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.1 110.78 8.51 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.13 -2.09 11.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.864 3.043 . . . . 0.0 111.348 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 67.8 m -84.45 -14.35 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -140.42 94.72 2.77 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 109.942 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 396' ' ' VAL . 10.5 t -149.27 152.24 35.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.702 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.0 m -135.11 153.06 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 118.822 0.737 . . . . 0.0 109.375 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -75.04 145.71 42.17 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.923 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 66.9 t -132.0 140.75 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 125.089 1.493 . . . . 0.0 111.168 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -165.76 -162.15 16.39 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.523 -0.736 . . . . 0.0 111.945 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.66 31.9 18.25 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.15 0.975 . . . . 0.0 111.291 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.67 25.74 0.63 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . 0.295 0.0 OUTLIER 58.31 9.23 0.97 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.96 1.704 . . . . 0.0 114.739 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.16 63.98 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 167.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.5 ptm -165.48 21.7 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.19 1.495 . . . . 0.0 112.339 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.501 HD13 ' HZ2' ' A' ' 422' ' ' LYS . 18.4 tp -69.38 151.37 46.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.881 0.848 . . . . 0.0 111.496 -175.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -114.26 174.26 6.04 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -75.53 -14.93 60.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -71.94 -25.26 61.81 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.031 -1.043 . . . . 0.0 109.247 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -90.24 -31.84 16.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.91 1.381 . . . . 0.0 110.74 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.545 0.612 . . . . 0.0 110.557 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.53 67.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.86 -45.09 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.701 -0.624 . . . . 0.0 110.745 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 424' ' ' VAL . 81.4 mt -64.65 -43.45 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.701 0.8 . . . . 0.0 110.488 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.533 HD13 ' CE2' ' A' ' 374' ' ' PHE . 3.7 mm? -81.0 -28.04 35.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.146 -0.971 . . . . 0.0 113.293 -173.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.24 -13.73 27.92 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -108.31 -22.04 12.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.743 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.23 -16.97 21.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.2 0.909 . . . . 0.0 111.535 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 370' ' ' LEU . 16.2 m-30 -113.26 -12.29 13.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.763 1.165 . . . . 0.0 113.694 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 69.25 4.13 41.95 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.98 -0.45 . . . . 0.0 113.226 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -164.73 115.92 0.67 Allowed Glycine 0 C--N 1.357 1.717 0 CA-C-N 118.456 1.128 . . . . 0.0 115.177 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.44 179.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.237 0.615 . . . . 0.0 111.66 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.12 -39.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 O-C-N 122.028 -0.42 . . . . 0.0 110.936 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.77 152.75 30.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.653 0.66 . . . . 0.0 111.187 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.96 37.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.416 1.486 . . . . 0.0 109.036 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -168.41 169.56 41.64 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 120.83 -1.168 . . . . 0.0 115.371 175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.2 mm -90.16 150.4 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 125.994 1.718 . . . . 0.0 109.711 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.53 71.73 5.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 156.7 34.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.691 -0.63 . . . . 0.0 111.241 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.18 161.61 40.56 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.47 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 24.1 tptm -45.77 102.49 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.616 0.766 . . . . 0.0 112.201 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.47 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 24.3 m170 48.39 42.12 17.73 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.692 1.997 . . . . 0.0 112.338 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -97.25 -11.42 24.18 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 124.312 1.007 . . . . 0.0 109.835 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 26.8 p90 44.58 45.49 2.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.1 -58.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.88 3.72 . . . . 0.0 109.779 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.5 tp 42.72 32.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.421 0 C-N-CA 125.172 1.389 . . . . 0.0 113.838 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.6 16.81 0.97 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 54.0 m -152.37 157.74 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 117.833 0.816 . . . . 0.0 110.06 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 176.1 -163.84 33.49 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 123.66 0.6 . . . . 0.0 113.489 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -146.42 173.8 11.96 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.717 0.892 . . . . 0.0 111.213 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 351' ' ' THR . 2.5 p -139.17 144.03 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 34.9 p -119.1 152.27 36.8 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.623 1.201 . . . . 0.0 111.218 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 403' ' ' SER . 35.0 m-85 -129.82 179.37 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 123.611 1.672 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -126.64 1.78 6.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.314 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.35 164.03 24.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.761 1.225 . . . . 0.0 109.593 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -96.91 -13.38 22.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.19 -38.12 87.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.795 1.18 . . . . 0.0 107.928 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 398' ' ' PHE . 8.3 p -79.15 -17.99 53.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -72.75 -61.08 1.93 Allowed 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.798 -0.563 . . . . 0.0 111.944 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.523 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -72.11 -25.58 61.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.206 -1.397 . . . . 0.0 113.028 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -77.92 -20.6 52.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.073 0.851 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.71 61.15 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.725 -0.609 . . . . 0.0 111.155 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.5 m -82.71 -11.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.648 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.8 p -106.89 -8.23 16.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.068 0.855 . . . . 0.0 112.507 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -93.44 -49.83 5.73 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.36 -15.26 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.56 138.77 12.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.461 HG12 ' CG ' ' A' ' 218' ' ' MET . 10.6 m -143.94 158.98 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.972 0.351 . . . . 0.0 111.43 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.99 137.18 42.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.866 1.354 . . . . 0.0 109.713 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.21 128.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.61 50.16 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 418' ' ' THR . 28.4 m -73.9 166.5 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 417' ' ' THR . 6.7 t -71.6 -1.87 15.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -148.36 5.58 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.804 -1.185 . . . . 0.0 111.23 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -146.98 125.46 12.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.327 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 54.5 p -138.58 111.2 7.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 125.332 1.645 . . . . 0.0 112.822 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.501 ' HZ2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -159.55 -176.68 5.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.466 -1.396 . . . . 0.0 112.323 177.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.61 163.42 24.25 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.762 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 369' ' ' ILE . 25.9 m -143.98 156.88 15.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 123.68 0.613 . . . . 0.0 109.653 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -130.26 153.47 48.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.258 0.348 . . . . 0.0 111.216 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 79.2 mt -131.53 142.38 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.896 1.372 . . . . 0.0 108.115 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -139.23 155.97 72.2 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.558 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.9 158.08 35.37 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 C-N-CA 124.28 3.32 . . . . 0.0 115.22 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 75.8 t80 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.15 177.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -169.86 175.67 5.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.642 1.214 . . . . 0.0 111.199 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.486 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -129.17 16.04 6.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 174.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.1 m 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.65 84.42 0.45 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.328 -1.483 . . . . 0.0 111.602 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.47 ' C ' HD22 ' A' ' 224' ' ' LEU . 78.1 mm-40 -99.24 -5.33 30.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 223' ' ' GLN . 3.1 mm? -131.65 125.07 20.32 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.405 1.082 . . . . 0.0 109.258 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 3.4 Cg_exo -81.6 116.81 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 125.01 3.807 . . . . 0.0 111.169 172.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 225' ' ' PRO . 44.1 Cg_endo -81.8 -179.28 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.044 3.829 . . . . 0.0 111.86 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 37.93 66.21 0.5 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.923 1.689 . . . . 0.0 114.21 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -143.65 27.18 1.53 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.113 0.965 . . . . 0.0 110.186 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -66.23 0.93 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 112.561 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 55.97 45.88 22.99 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.877 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.413 ' H ' ' HD3' ' A' ' 232' ' ' PRO . 17.2 m-80 -117.61 -50.17 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 334' ' ' ALA . 24.2 Cg_exo -73.64 -170.78 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.419 3.413 . . . . 0.0 114.063 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.2 OUTLIER -102.83 -171.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 125.388 1.475 . . . . 0.0 108.717 -178.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -106.37 148.74 27.72 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.7 m -141.99 11.56 2.0 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.6 t -158.48 -145.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.317 -1.49 . . . . 0.0 110.414 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 170.05 6.76 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.978 0.911 . . . . 0.0 110.616 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 m -144.53 155.12 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 122.32 1.057 . . . . 0.0 109.59 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.78 135.93 34.58 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.62 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.5 tm? -146.09 122.66 11.1 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.336 0.588 . . . . 0.0 111.088 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.27 -170.99 33.41 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.113 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.74 6.96 0.91 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 124.689 1.138 . . . . 0.0 112.109 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.57 145.8 30.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 122.707 1.241 . . . . 0.0 113.616 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.16 -13.02 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 125.0 3.8 . . . . 0.0 110.219 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -101.2 -104.09 0.25 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.631 1.105 . . . . 0.0 110.111 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.9 t70 46.38 59.5 3.81 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 124.278 1.031 . . . . 0.0 111.294 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -70.31 -17.24 20.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 O-C-N 121.069 -1.019 . . . . 0.0 110.903 -170.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 4.8 m -149.29 133.51 17.34 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 127.053 2.141 . . . . 0.0 105.357 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.19 -10.23 59.5 Favored 'General case' 0 CA--C 1.485 -1.554 0 O-C-N 117.508 -3.245 . . . . 0.0 115.66 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.12 -18.24 58.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.3 -43.83 30.35 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.52 -45.4 68.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.061 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.2 t -64.7 -39.06 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 123.761 0.663 . . . . 0.0 110.272 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.47 -16.79 64.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.651 -1.281 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 74.7 m -77.53 -33.55 54.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.727 -0.608 . . . . 0.0 111.513 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -142.53 80.6 1.7 Allowed 'General case' 0 C--O 1.218 -0.602 0 O-C-N 118.978 -2.326 . . . . 0.0 109.934 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.424 ' HA ' HD11 ' A' ' 262' ' ' LEU . 8.6 ptm180 -139.7 5.27 2.18 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.945 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.35 -4.91 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.452 1.024 . . . . 0.0 110.744 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -77.2 -12.27 59.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.21 3.26 6.33 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.6 m -114.06 16.41 18.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.165 1.482 . . . . 0.0 110.335 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -134.88 155.71 50.2 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -148.88 -172.49 4.12 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.383 2.273 . . . . 0.0 108.03 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.45 150.55 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -170.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 129.29 23.69 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.534 -0.729 . . . . 0.0 109.847 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -156.29 152.79 23.92 Favored Pre-proline 0 N--CA 1.439 -1.004 0 O-C-N 121.025 -1.047 . . . . 0.0 113.041 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.69 148.82 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.676 4.25 . . . . 0.0 105.969 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.86 -8.7 70.72 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.792 1.187 . . . . 0.0 110.307 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -66.67 -18.37 65.33 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.912 1.356 . . . . 0.0 110.419 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -81.35 -5.25 57.64 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 112.365 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -110.97 -176.85 20.52 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -74.92 163.56 27.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.315 0.646 . . . . 0.0 112.287 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.2 m80 64.43 145.54 0.09 OUTLIER Pre-proline 0 N--CA 1.444 -0.771 0 C-N-CA 125.426 1.491 . . . . 0.0 111.697 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.52 17.29 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.239 3.293 . . . . 0.0 111.712 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -145.16 140.27 27.84 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.619 1.168 . . . . 0.0 111.563 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 49.4 t -161.72 -43.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.667 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 45.1 Cg_endo -83.11 136.58 8.01 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.941 1.761 . . . . 0.0 111.748 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -93.71 6.71 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.236 2.624 . . . . 0.0 111.118 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -106.49 5.7 29.51 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.249 1.42 . . . . 0.0 111.294 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.45 29.98 0.15 Allowed Glycine 0 N--CA 1.467 0.704 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.7 121.54 40.37 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 118.858 1.329 . . . . 0.0 110.054 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.01 174.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 122.916 1.341 . . . . 0.0 112.034 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -98.54 169.0 9.83 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.937 -1.102 . . . . 0.0 112.019 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.0 mt -124.37 145.24 49.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.206 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.21 114.39 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.96 -161.82 0.58 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.266 1.032 . . . . 0.0 111.766 -172.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.43 ' HG2' ' HE3' ' A' ' 290' ' ' LYS . 10.8 tp10 -56.84 113.11 1.52 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 288' ' ' LEU . 0.9 OUTLIER -85.37 12.47 8.21 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -168.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -135.45 -67.13 0.55 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.172 1.806 . . . . 0.0 112.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.43 ' HE3' ' HG2' ' A' ' 287' ' ' GLU . 0.0 OUTLIER -80.19 -31.34 38.76 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.908 -1.12 . . . . 0.0 112.184 -168.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.5 m -78.95 -30.85 44.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.195 0.907 . . . . 0.0 109.165 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.77 -56.49 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.57 -28.8 67.27 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.037 -1.04 . . . . 0.0 112.347 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.9 m -65.81 -32.67 74.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.36 -51.42 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.784 0.72 . . . . 0.0 109.817 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 ' C ' ' A' ' 296' ' ' LEU . 3.7 pp -74.3 -4.82 38.51 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.38 -8.06 11.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.375 0.422 . . . . 0.0 110.994 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.03 65.68 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.292 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . 0.454 ' SG ' ' HE3' ' A' ' 315' ' ' LYS . 50.3 t -112.26 -91.76 0.48 Allowed 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 123.596 0.56 . . . . 0.0 111.734 -174.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 72.3 m -142.06 158.25 43.97 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -154.9 156.12 35.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.267 1.427 . . . . 0.0 108.704 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.64 104.75 4.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.404 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.57 12.55 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 125.604 4.203 . . . . 0.0 111.783 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 49.5 m -103.19 177.88 4.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.949 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -129.39 131.61 46.85 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.596 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -109.55 151.94 26.12 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -138.27 154.49 49.04 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 122.006 0.907 . . . . 0.0 112.105 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.45 178.81 7.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.408 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.489 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 9.1 ptpt -150.11 147.04 27.28 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.22 -14.92 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.583 -1.323 . . . . 0.0 110.557 -169.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.5 t -94.96 157.31 15.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.672 1.124 . . . . 0.0 112.528 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 43.4 p -131.58 -38.61 1.16 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -152.13 -13.3 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -99.15 -21.22 16.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 69.2 mmm -130.01 -179.36 5.17 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.625 0.77 . . . . 0.0 111.697 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -123.85 31.66 5.79 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 66.7 m -104.66 -45.46 4.6 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -173.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? 53.63 17.51 1.22 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -166.97 147.63 5.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.589 -1.319 . . . . 0.0 112.317 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.75 159.93 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 117.517 -1.23 . . . . 0.0 109.695 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -109.53 157.11 19.33 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 120.089 1.313 . . . . 0.0 113.198 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.4 t -140.81 141.93 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.937 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 328' ' ' VAL . 3.9 pt -151.6 131.2 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 329' ' ' ILE . 1.5 Cg_endo -104.29 174.22 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.353 2.702 . . . . 0.0 114.344 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -82.4 125.0 30.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 334' ' ' ALA . 93.9 t -99.33 151.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.73 -26.37 68.02 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.543 -0.723 . . . . 0.0 111.523 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.553 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -71.16 -22.45 62.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.14 -10.3 59.63 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.341 0.401 . . . . 0.0 110.242 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 17.3 m -98.04 -31.79 11.96 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.1 162.06 40.3 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.728 -0.608 . . . . 0.0 111.462 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.631 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 30.2 t80 -147.55 127.67 13.76 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 341' ' ' SER . 55.2 t -104.59 140.43 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -103.86 -8.09 20.0 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.437 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 69.0 m -137.01 93.17 13.57 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.33 -9.98 27.1 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.301 2.667 . . . . 0.0 113.584 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 71.0 m -115.26 19.07 15.83 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.878 0.871 . . . . 0.0 112.845 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -140.65 172.43 12.71 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.056 1.343 . . . . 0.0 109.708 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -127.18 -83.8 0.61 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.643 -1.286 . . . . 0.0 111.083 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 3.8 tp -151.35 173.24 14.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.957 0.785 . . . . 0.0 111.065 -170.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 1.4 m-20 -124.7 151.31 67.6 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 123.609 0.764 . . . . 0.0 110.187 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.57 -15.58 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.864 3.042 . . . . 0.0 113.611 -167.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 56.6 p -150.17 8.25 0.63 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -123.88 88.74 2.96 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 121.008 -1.058 . . . . 0.0 110.094 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.0 t -151.52 155.3 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.21 150.33 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.04 0.448 . . . . 0.0 110.961 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -90.58 141.35 28.86 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 122.265 1.031 . . . . 0.0 110.283 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 78.8 t -130.94 140.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.811 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.27 -164.19 21.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 56.64 29.2 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.0 mt -74.98 170.15 16.57 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.071 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -74.79 -27.94 60.53 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 147.48 -11.45 1.33 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.714 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 18.4 ptm -156.78 22.55 0.33 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.024 1.412 . . . . 0.0 112.109 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.5 OUTLIER -42.03 129.29 3.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.442 -175.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.559 ' N ' HD13 ' A' ' 361' ' ' LEU . 10.0 p30 -104.44 164.26 11.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.954 0.901 . . . . 0.0 111.352 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -74.0 -12.16 60.55 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -168.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -81.2 -28.58 34.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.211 0.914 . . . . 0.0 109.053 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.07 77.44 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.05 -37.71 75.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.06 73.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.84 85.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.244 0.545 . . . . 0.0 110.285 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.6 mt -78.69 -33.31 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.145 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.08 1.05 47.24 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -171.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -22.56 5.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.662 0.665 . . . . 0.0 111.777 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.35 -8.93 13.43 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.08 -1.84 9.24 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 170.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.88 -24.59 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.968 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.59 34.62 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 124.032 0.825 . . . . 0.0 115.155 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.21 128.09 1.03 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.589 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 398' ' ' PHE . 33.4 m -138.02 174.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 O-C-N 121.632 -0.922 . . . . 0.0 111.533 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.17 -28.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 O-C-N 122.212 -0.305 . . . . 0.0 111.679 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.26 151.9 21.62 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.229 0.612 . . . . 0.0 110.584 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.82 149.81 34.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.362 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -176.99 175.76 47.8 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 120.58 -0.819 . . . . 0.0 115.036 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.07 147.26 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 109.082 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.46 130.04 34.64 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.262 -0.899 . . . . 0.0 111.913 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 2.5 p -111.2 169.92 8.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.861 0.838 . . . . 0.0 111.622 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.75 167.19 25.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.866 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.68 101.54 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.41 0.444 . . . . 0.0 112.099 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.0 m170 53.8 30.89 12.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -97.39 -4.25 38.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.415 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 55.6 t80 45.9 56.11 15.61 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 125.292 1.437 . . . . 0.0 113.396 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.35 -60.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.179 1.253 . . . . 0.0 109.362 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.251 9.7 tp 41.45 36.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.739 2.016 . . . . 0.0 113.85 175.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -153.71 5.92 0.36 Allowed Glycine 0 N--CA 1.474 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 115.122 -171.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 43.9 m -148.6 122.08 9.11 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 117.913 0.856 . . . . 0.0 110.296 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -158.89 -169.0 21.74 Favored Glycine 0 CA--C 1.542 1.757 0 O-C-N 120.705 -1.247 . . . . 0.0 111.848 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -152.45 171.31 18.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.034 0.534 . . . . 0.0 109.986 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.72 143.8 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 89.7 m -115.43 140.32 49.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 377' ' ' VAL . 8.3 p90 -163.25 158.15 21.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.194 1.397 . . . . 0.0 110.414 173.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -128.77 20.55 6.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.03 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -100.87 144.35 29.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.91 -27.06 21.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.594 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -68.45 -25.07 64.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 119.593 1.088 . . . . 0.0 109.784 -174.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 73.8 p -81.35 -21.6 39.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -69.73 -62.6 1.32 Allowed 'General case' 0 C--N 1.349 0.583 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.496 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -69.76 -17.48 63.44 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 178.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -76.19 -34.88 59.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.983 0.81 . . . . 0.0 110.644 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.68 -26.35 37.62 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.227 -1.546 . . . . 0.0 111.192 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 37.6 t -79.77 -32.03 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.621 1.169 . . . . 0.0 108.635 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 29.0 t -75.09 -30.26 60.86 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 117.902 -1.046 . . . . 0.0 112.111 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.26 -48.74 6.53 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.572 1.078 . . . . 0.0 110.239 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 65.2 -14.04 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.999 2.12 . . . . 0.0 116.137 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 148.18 17.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.71 157.55 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.9 117.66 33.37 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 124.991 1.432 . . . . 0.0 110.489 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.25 127.99 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 416' ' ' LYS . 8.6 mmpt? -118.95 34.07 5.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.49 1.119 . . . . 0.0 111.16 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.4 m -59.83 154.83 17.52 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.233 0.924 . . . . 0.0 109.752 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 14.0 t -73.3 0.81 10.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -145.09 15.43 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 112.244 173.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -151.03 120.41 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.309 -1.495 . . . . 0.0 108.384 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 32.4 p -132.28 110.08 10.35 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.938 -0.476 . . . . 0.0 110.265 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.545 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 26.6 tptt -162.47 -175.91 4.76 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 124.118 0.886 . . . . 0.0 109.132 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.7 mttm -121.2 173.05 7.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.631 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.75 150.04 15.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -114.79 152.27 32.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.6 mt -130.79 142.49 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 125.299 1.624 . . . . 0.0 108.283 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 24.9 t70 -138.2 140.2 27.93 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 119.839 1.199 . . . . 0.0 112.731 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 40.0 Cg_exo -57.77 153.85 41.02 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.692 2.261 . . . . 0.0 109.879 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.258 1.546 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.928 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . 0.425 ' O ' HG12 ' A' ' 413' ' ' VAL . 16.3 ptt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.3 t -130.32 -178.36 4.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.497 1.142 . . . . 0.0 111.543 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.445 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -130.6 18.3 5.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.543 0.737 . . . . 0.0 111.654 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.4 m 56.31 29.04 14.31 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.762 1.625 . . . . 0.0 114.623 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.37 1.13 Allowed Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.535 -0.728 . . . . 0.0 112.191 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -80.83 -18.94 45.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.912 0.856 . . . . 0.0 112.765 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.8 127.63 25.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -84.67 132.08 4.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.003 3.135 . . . . 0.0 108.676 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.77 -5.53 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.1 1.867 . . . . 0.0 112.486 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.61 -168.6 1.62 Allowed 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 121.326 -0.859 . . . . 0.0 109.255 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.7 m120 58.4 27.97 16.17 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 122.066 -0.396 . . . . 0.0 111.128 -172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.07 145.65 0.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.25 0.62 . . . . 0.0 112.103 168.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -141.21 14.03 2.22 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.931 0.892 . . . . 0.0 111.713 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.546 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 8.0 p30 -141.76 28.21 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.322 0.51 . . . . 0.0 112.279 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 87.8 Cg_endo -66.53 116.99 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.529 1.486 . . . . 0.0 112.047 -169.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.3 mm -144.87 153.42 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.467 ' CE1' ' HG2' ' A' ' 330' ' ' PRO . 18.8 m-85 -112.35 146.34 38.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -171.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -148.3 7.63 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 85.2 m -137.98 -74.2 0.4 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.838 0.745 . . . . 0.0 111.2 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 389' ' ' TYR . 20.7 pttp -156.18 -169.73 3.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.302 0.641 . . . . 0.0 109.575 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.2 152.31 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 122.25 1.024 . . . . 0.0 108.685 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -98.95 146.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.857 1.263 . . . . 0.0 110.071 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.19 136.44 16.65 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.798 1.311 . . . . 0.0 108.102 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.87 -173.46 33.88 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 121.638 -0.664 . . . . 0.0 113.601 170.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.73 1.61 8.21 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.344 -1.253 . . . . 0.0 110.123 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -78.44 126.61 82.76 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 118.734 1.267 . . . . 0.0 110.521 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 66.1 Cg_endo -81.45 4.78 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.969 3.779 . . . . 0.0 114.07 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.469 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 2.8 p-90 -139.99 -48.72 0.46 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 23.7 t70 56.32 -41.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.194 2.598 . . . . 0.0 115.205 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 248' ' ' THR 0.337 2.8 pp 55.38 -50.69 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -175.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.418 ' H ' HD12 ' A' ' 247' ' ' ILE . 29.9 m -150.19 135.64 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 122.113 2.233 . . . . 0.0 108.421 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -76.48 -22.08 54.99 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.51 -13.33 62.28 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.559 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.94 -74.73 0.68 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 120.956 -1.09 . . . . 0.0 113.021 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.57 -36.91 84.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.879 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.83 -50.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.533 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 257' ' ' ARG . 19.8 m-20 -71.68 -8.77 56.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 94.8 m -76.82 -26.89 54.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 124.256 0.972 . . . . 0.0 111.617 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -129.03 16.74 6.2 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 124.002 0.814 . . . . 0.0 112.863 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 254' ' ' ASN . 35.3 ttt85 -97.59 -17.16 19.69 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 258' ' ' VAL . 2.3 m -69.91 -10.79 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 121.654 0.74 . . . . 0.0 112.61 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -136.92 3.4 2.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.021 -1.05 . . . . 0.0 110.082 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.59 149.76 16.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 124.032 1.907 . . . . 0.0 111.54 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.3 m -105.17 83.4 1.97 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 112.063 -2.069 . . . . 0.0 107.235 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.57 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -149.67 171.29 16.92 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 113.596 -178.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 t -144.71 165.82 26.98 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.84 150.8 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 121.298 -0.876 . . . . 0.0 113.207 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -141.23 142.92 33.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.014 1.387 . . . . 0.0 108.412 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.65 153.15 91.58 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.808 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.38 -17.41 16.63 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.7 2.267 . . . . 0.0 113.059 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -166.99 -5.36 0.03 OUTLIER Glycine 0 C--N 1.346 1.122 0 CA-C-O 117.346 -1.808 . . . . 0.0 116.429 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 60.0 tttm 58.95 86.28 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.216 2.008 . . . . 0.0 109.646 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.39 165.48 23.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.442 -0.786 . . . . 0.0 109.712 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -72.1 -55.12 7.33 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 123.101 0.382 . . . . 0.0 112.838 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -87.08 156.69 19.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.232 0.516 . . . . 0.0 111.289 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.7 m170 44.31 61.74 10.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.63 2.04 0.17 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.62 3.546 . . . . 0.0 112.444 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -90.27 -9.55 47.53 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.604 1.093 . . . . 0.0 111.647 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 48.8 t -142.06 129.27 11.37 Favored Pre-proline 0 C--N 1.352 0.686 0 C-N-CA 125.685 1.594 . . . . 0.0 110.462 -172.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.76 156.15 67.12 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.783 3.655 . . . . 0.0 110.961 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.58 -3.5 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.549 3.499 . . . . 0.0 110.656 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 281' ' ' TYR . 5.5 ptpp? -149.84 179.34 8.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.552 1.141 . . . . 0.0 111.301 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.43 8.81 73.06 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.572 -1.127 . . . . 0.0 114.121 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.429 ' H ' ' HG3' ' A' ' 279' ' ' LYS . 1.8 m-85 -116.4 152.05 34.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.838 1.319 . . . . 0.0 113.565 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.69 167.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.22 1.808 . . . . 0.0 108.946 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -121.88 149.36 43.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.961 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.4 mp -121.45 148.47 44.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 286' ' ' PHE . 27.0 m -137.85 -154.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 O-C-N 125.223 1.577 . . . . 0.0 110.043 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 285' ' ' VAL 0.264 79.7 t80 77.55 -124.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 115.468 -2.206 . . . . 0.0 108.471 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.88 140.05 58.83 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 123.086 2.676 . . . . 0.0 108.993 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.2 pt? -135.34 8.44 3.4 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.247 1.419 . . . . 0.0 114.204 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -128.9 -86.31 0.55 Allowed 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.545 1.153 . . . . 0.0 112.499 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -61.07 -30.33 70.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 52.6 m -100.2 -25.76 14.16 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.057 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.85 -28.62 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 121.684 2.038 . . . . 0.0 108.133 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -83.66 -32.02 25.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.115 0.884 . . . . 0.0 112.953 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 297' ' ' GLN . 27.8 m -87.75 -35.93 17.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.283 0.99 . . . . 0.0 112.232 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 tt -68.85 -40.86 79.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.875 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 3.8 mp -67.2 -40.58 86.52 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.704 -1.247 . . . . 0.0 111.749 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 294' ' ' SER . 17.8 pt20 -77.35 -7.48 56.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -87.44 -27.92 22.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.64 -174.15 4.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.041 -1.891 . . . . 0.0 106.379 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 151.48 28.54 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 124.029 1.871 . . . . 0.0 111.865 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -143.19 152.97 42.36 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.659 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -126.27 110.79 23.77 Favored Pre-proline 0 N--CA 1.434 -1.251 0 O-C-N 124.13 0.894 . . . . 0.0 109.433 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.85 46.04 2.07 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.781 2.988 . . . . 0.0 109.73 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.345 0.409 0 C-N-CA 123.725 0.81 . . . . 0.0 111.015 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 309' ' ' LEU . 19.3 tp . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 121.549 0.69 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 43.0 m -106.98 178.8 4.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.613 1.196 . . . . 0.0 111.659 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -126.91 147.88 50.06 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.214 -0.929 . . . . 0.0 111.148 -171.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 32.1 m-85 -117.23 156.6 27.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.682 1.229 . . . . 0.0 110.196 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -151.5 173.85 14.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.486 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -153.69 165.66 35.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.661 0.664 . . . . 0.0 110.717 170.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -128.59 57.33 1.6 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.1 0.56 . . . . 0.0 111.663 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -55.24 -12.61 1.03 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.207 2.203 . . . . 0.0 113.899 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.8 p -89.18 138.64 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.156 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.3 t -160.11 -30.29 0.06 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-N 119.308 0.958 . . . . 0.0 112.606 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -143.64 -30.29 0.5 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.934 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -86.33 -34.52 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.481 1.037 . . . . 0.0 111.26 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 mmt -147.3 166.19 27.83 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -162.82 83.43 0.51 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 125.519 1.762 . . . . 0.0 109.047 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.9 m -133.87 -63.11 0.75 Allowed 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -149.16 139.84 22.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.082 0.944 . . . . 0.0 110.797 -174.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.87 162.6 21.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.263 1.425 . . . . 0.0 112.697 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.5 p -107.6 155.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.04 156.35 19.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.409 0.283 . . . . 0.0 111.575 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 2.4 t -142.71 134.0 24.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 122.897 0.479 . . . . 0.0 112.02 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.06 132.15 9.01 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.829 0.824 . . . . 0.0 109.917 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.467 ' HG2' ' CE1' ' A' ' 234' ' ' TYR . 30.1 Cg_endo -83.06 165.39 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.367 2.044 . . . . 0.0 110.814 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.403 ' CH2' HD13 ' A' ' 391' ' ' ILE . 6.8 t-105 -83.92 113.56 21.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 109.639 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 334' ' ' ALA . 4.2 t -83.1 150.21 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 123.058 1.408 . . . . 0.0 110.299 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.34 -20.89 65.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.429 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.475 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -77.54 1.83 18.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.721 1.208 . . . . 0.0 113.612 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.64 -0.74 21.72 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.699 0.681 . . . . 0.0 110.954 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.0 m -103.79 -36.37 7.86 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.614 0.766 . . . . 0.0 112.25 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -162.45 153.43 17.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.884 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -146.7 148.81 32.39 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.506 -0.746 . . . . 0.0 111.704 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.86 144.3 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.159 0.98 . . . . 0.0 111.671 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.98 -24.42 30.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.297 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 74.8 m -146.44 137.89 13.06 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 123.546 0.738 . . . . 0.0 110.6 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -88.39 -2.7 6.82 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.705 2.27 . . . . 0.0 111.892 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.7 m -83.23 -1.47 53.18 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.673 0.789 . . . . 0.0 112.373 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -131.76 174.74 9.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.917 1.342 . . . . 0.0 111.216 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -128.57 166.19 19.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.837 0.855 . . . . 0.0 112.319 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.7 mm? -70.65 157.75 37.42 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.904 1.282 . . . . 0.0 110.235 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -109.24 133.68 20.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.35 -7.7 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 124.227 3.284 . . . . 0.0 112.076 -174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.0 m -142.14 2.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 350' ' ' ARG . 34.5 mmt180 -126.67 71.75 1.31 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.902 0.881 . . . . 0.0 110.518 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.0 p -143.59 164.91 29.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 27.5 m -129.12 159.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.457 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -93.04 136.35 33.38 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.588 1.18 . . . . 0.0 111.681 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.93 144.91 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 121.531 0.681 . . . . 0.0 110.311 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -161.86 -160.62 11.1 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.44 34.0 15.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.999 0.92 . . . . 0.0 112.334 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 52.8 mt -89.51 169.14 11.61 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -95.0 14.9 20.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.11 66.23 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.688 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 6.8 ptp -161.14 15.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.702 1.751 . . . . 0.0 111.0 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.56 141.65 57.78 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.575 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.04 175.82 5.47 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 124.714 1.259 . . . . 0.0 111.242 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.86 -17.33 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -75.89 -30.17 58.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -76.43 -35.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.223 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.11 -41.75 76.99 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 122.692 1.234 . . . . 0.0 109.974 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.22 -0.925 . . . . 0.0 111.395 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.72 98.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 124.029 0.831 . . . . 0.0 110.241 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.98 -46.11 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.487 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.14 -29.73 21.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.533 -0.729 . . . . 0.0 112.939 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -12.03 36.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.747 -1.221 . . . . 0.0 112.088 -175.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.438 ' HB3' ' HE1' ' A' ' 220' ' ' TRP . 25.1 t70 -109.93 -23.14 11.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.664 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.18 -19.25 32.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.037 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -118.61 -22.29 7.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.318 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 75.25 -23.75 1.43 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.57 47.99 1.14 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.251 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 32.6 t -131.56 142.28 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 120.301 2.05 . . . . 0.0 113.261 -173.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.62 -24.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.424 0.63 . . . . 0.0 112.601 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 346' ' ' LEU . 1.0 OUTLIER -152.17 150.95 30.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.42 23.25 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.008 1.323 . . . . 0.0 109.481 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.8 156.42 27.94 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.99 144.22 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -92.4 148.66 21.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 118.537 0.608 . . . . 0.0 110.717 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 22.8 p -126.38 169.57 12.83 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.664 -0.647 . . . . 0.0 110.849 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.47 -178.43 5.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -72.81 90.29 1.42 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.248 1.023 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 20.5 m170 65.68 28.48 11.11 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 125.102 1.361 . . . . 0.0 111.783 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -89.55 4.08 50.42 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.497 ' HB3' ' HE2' ' A' ' 237' ' ' LYS . 8.0 p90 45.23 48.14 4.64 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 88.4 Cg_endo -69.14 -70.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.336 2.024 . . . . 0.0 112.304 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.474 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 7.2 tp 40.44 26.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 127.777 2.431 . . . . 0.0 112.285 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -135.11 4.37 4.18 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 120.533 -1.354 . . . . 0.0 112.504 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.5 p -148.77 130.56 15.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.273 0.558 . . . . 0.0 110.413 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.48 16.11 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.085 -1.009 . . . . 0.0 112.271 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 15.0 ptp180 -148.83 -178.12 6.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.165 0.986 . . . . 0.0 110.384 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.38 137.67 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.1 m -105.64 120.55 41.94 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -96.36 -33.6 11.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 60.5 t30 66.05 -2.76 0.88 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.71 179.65 8.22 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 120.962 -1.086 . . . . 0.0 110.106 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -92.28 -26.08 18.3 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.59 -41.13 80.54 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 120.252 -1.53 . . . . 0.0 112.441 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 53.7 m -80.15 -10.25 59.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -76.05 -55.37 5.66 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.799 0.727 . . . . 0.0 109.619 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.473 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.1 -23.32 60.5 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 118.615 0.643 . . . . 0.0 111.022 -175.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -79.14 -34.86 42.88 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.768 -0.583 . . . . 0.0 111.795 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.71 70.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 119.316 0.962 . . . . 0.0 110.583 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.85 -24.75 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 118.398 0.544 . . . . 0.0 111.661 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 t -74.83 -25.9 59.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.302 1.001 . . . . 0.0 108.691 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -84.87 -51.36 6.79 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 61.64 -23.33 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.321 2.248 . . . . 0.0 116.044 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.71 144.52 15.19 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 111.065 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 218' ' ' MET . 22.0 m -142.74 158.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-O 122.067 0.937 . . . . 0.0 111.289 173.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -112.59 131.81 55.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.75 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.76 124.29 39.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -121.3 31.9 6.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.015 -1.053 . . . . 0.0 110.228 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.7 m -62.26 154.83 26.48 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.4 p -61.38 -12.06 12.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.73 7.65 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -146.44 137.13 24.08 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.374 1.07 . . . . 0.0 109.054 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.43 125.55 13.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.527 0.731 . . . . 0.0 111.382 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -167.4 -170.74 1.52 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.02 165.27 23.57 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.225 1.01 . . . . 0.0 108.454 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.74 158.57 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 124.422 1.076 . . . . 0.0 108.599 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -126.87 148.29 50.0 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.193 0.933 . . . . 0.0 112.643 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.84 139.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.02 125.64 5.78 Favored Pre-proline 0 C--N 1.349 0.547 0 CA-C-O 121.742 0.782 . . . . 0.0 110.245 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.39 171.54 16.74 Favored 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 111.259 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.881 177.706 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 91.7 m -69.89 151.63 45.45 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -10.26 0.18 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m 46.89 52.33 11.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.589 1.185 . . . . 0.0 111.499 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.22 -24.24 70.39 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.002 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 54.59 33.5 19.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.172 0.986 . . . . 0.0 113.416 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.473 ' C ' ' HD3' ' A' ' 226' ' ' PRO . 4.6 mm? -63.68 157.25 67.68 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 123.002 0.521 . . . . 0.0 109.986 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.29 68.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 1 C-N-CA 125.997 4.464 . . . . 0.0 114.731 176.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 224' ' ' LEU . 71.6 Cg_exo -55.72 166.37 2.88 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.535 2.824 . . . . 0.0 110.814 169.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 60.08 23.63 12.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.631 1.572 . . . . 0.0 114.461 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -78.37 7.44 6.52 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.474 0.71 . . . . 0.0 111.399 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -73.4 155.93 38.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.227 1.011 . . . . 0.0 111.569 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -143.05 18.68 1.94 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.474 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -133.9 43.56 1.03 Allowed Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 123.947 0.899 . . . . 0.0 109.493 -170.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 93.8 Cg_endo -71.93 157.2 55.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.638 2.892 . . . . 0.0 113.094 -170.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.4 mm -147.5 153.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.02 150.53 31.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.649 1.113 . . . . 0.0 109.654 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 70.4 p -155.11 6.5 0.24 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.873 1.358 . . . . 0.0 114.612 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 4.9 t -154.7 -169.29 3.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.26 1.845 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -43.23 146.07 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 112.378 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 284' ' ' LEU . 3.5 p -122.47 139.56 49.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 125.529 1.768 . . . . 0.0 109.401 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.08 138.63 31.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.821 -1.174 . . . . 0.0 108.904 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.61 126.27 41.73 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 125.053 1.47 . . . . 0.0 108.453 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.72 154.94 21.04 Favored Glycine 0 N--CA 1.449 -0.49 0 O-C-N 120.583 -1.323 . . . . 0.0 111.234 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.73 10.28 0.92 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.2 m -120.49 73.25 21.76 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 118.446 1.123 . . . . 0.0 110.301 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.41 5.15 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 109.985 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.435 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 34.7 p-90 -116.54 -10.53 11.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.18 133.07 55.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.575 -1.328 . . . . 0.0 110.258 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.835 HD13 ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -109.14 -26.04 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 124.654 1.221 . . . . 0.0 112.822 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 m -138.54 118.84 13.65 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.026 0.53 . . . . 0.0 111.041 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.18 -24.05 67.27 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.378 0.608 . . . . 0.0 112.534 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.1 75.87 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.849 -1.782 . . . . 0.0 111.924 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.87 -63.42 4.43 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.249 0.343 . . . . 0.0 112.576 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -68.49 -21.68 64.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.662 -1.493 . . . . 0.0 113.555 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.4 HG22 HG21 ' A' ' 264' ' ' VAL . 3.3 t -71.54 -52.13 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -71.06 -12.73 61.68 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 125.435 1.709 . . . . 0.0 110.736 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m -79.6 -22.26 43.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.522 -1.361 . . . . 0.0 112.483 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.97 26.6 4.6 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -113.67 -27.32 7.87 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 123.383 0.427 . . . . 0.0 110.845 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.27 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.566 -0.709 . . . . 0.0 110.979 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.49 17.11 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.991 -1.068 . . . . 0.0 113.064 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.21 153.82 25.19 Favored Glycine 0 C--O 1.249 1.085 0 O-C-N 121.322 -0.861 . . . . 0.0 113.074 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.9 m -76.88 28.58 0.13 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 123.86 0.864 . . . . 0.0 113.3 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -109.35 164.38 12.54 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.147 -0.971 . . . . 0.0 112.092 -173.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 p -141.68 168.46 19.72 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 284' ' ' LEU . 6.6 t -125.44 154.01 33.55 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.544 -168.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -130.6 129.34 42.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.5 50.79 5.32 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 124.532 1.145 . . . . 0.0 113.979 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.19 31.48 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 125.894 4.396 . . . . 0.0 111.827 -172.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.29 -43.01 4.45 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -155.94 130.93 9.25 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.436 1.494 . . . . 0.0 111.346 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -125.54 154.8 41.61 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.75 -152.22 10.25 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.66 -16.41 58.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.343 -1.313 . . . . 0.0 109.283 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -152.55 135.11 9.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 118.798 0.726 . . . . 0.0 110.8 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.99 42.06 1.27 Allowed 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.396 4.064 . . . . 0.0 113.555 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.0 13.96 23.18 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.26 -0.9 . . . . 0.0 112.95 -171.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 63.7 m -141.31 36.51 0.24 Allowed Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.899 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.23 147.44 93.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 107.933 -1.603 . . . . 0.0 107.933 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.89 -15.12 13.43 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.138 3.226 . . . . 0.0 113.529 -175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 175.75 12.8 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.286 -0.884 . . . . 0.0 110.751 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -100.24 -9.58 47.54 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.373 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -73.3 121.84 21.04 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 118.598 1.199 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.34 -174.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 O-C-N 125.626 1.829 . . . . 0.0 109.008 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -132.21 165.73 23.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -169.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 238' ' ' VAL . 55.0 mt -117.77 148.42 42.07 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.731 171.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 143.37 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -171.64 178.2 3.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -168.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.4 136.04 56.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 166.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.35 -10.65 59.65 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.53 -43.59 0.68 Allowed 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -83.93 -49.57 8.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.207 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.9 t -71.13 -26.33 62.96 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.218 0.949 . . . . 0.0 111.583 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 3.3 t -67.57 -58.52 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 O-C-N 124.216 0.948 . . . . 0.0 111.047 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.45 -23.27 65.5 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.695 1.247 . . . . 0.0 110.571 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.6 t -71.27 -45.61 62.77 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.023 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.34 -57.54 9.07 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.297 2.1 pp -80.7 -2.01 44.99 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -170.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -100.43 -6.86 24.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 121.054 1.752 . . . . 0.0 108.202 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -94.97 -23.68 17.28 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.479 1.112 . . . . 0.0 110.585 170.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 -133.11 0.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 29.8 t -129.58 164.98 22.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.073 -2.267 . . . . 0.0 110.03 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -146.38 155.78 42.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.886 0.874 . . . . 0.0 110.206 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -136.43 126.19 15.96 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.68 47.36 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.635 3.557 . . . . 0.0 105.579 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.706 0 CA-C-O 115.911 -1.995 . . . . 0.0 113.339 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 44.0 tp . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 122.015 0.912 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.7 m -152.73 145.39 24.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -143.73 143.96 31.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.725 0.774 . . . . 0.0 111.349 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.53 153.96 33.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.199 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.38 158.66 43.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.457 0.571 . . . . 0.0 111.331 -172.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 6.3 t80 -156.08 171.24 20.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 23.8 ttmt -128.55 51.93 1.96 Allowed 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 122.884 1.326 . . . . 0.0 108.132 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -0.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.434 -1.712 . . . . 0.0 113.388 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 23.1 t -89.49 125.91 35.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 118.918 0.781 . . . . 0.0 110.245 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 13.5 t -145.98 142.44 28.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.145 0.498 . . . . 0.0 109.936 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 49.97 24.48 1.36 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.19 1.396 . . . . 0.0 113.447 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.403 ' HG3' ' HG2' ' A' ' 321' ' ' MET . 16.3 ptp180 -147.51 -41.18 0.18 Allowed 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.121 -1.612 . . . . 0.0 111.852 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.435 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 23.5 mmm -119.83 -26.88 5.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.834 1.197 . . . . 0.0 111.224 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 57.7 2.1 0.15 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.032 1.733 . . . . 0.0 113.961 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.2 m -137.98 170.35 16.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 118.117 0.417 . . . . 0.0 112.022 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 63.15 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.961 2.104 . . . . 0.0 112.556 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 1.7 pm0 -91.84 161.67 14.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.117 1.767 . . . . 0.0 111.095 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.28 143.47 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -90.27 154.71 19.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.273 -0.892 . . . . 0.0 111.861 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 45.9 t -138.75 139.84 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.369 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.0 pt -147.16 117.46 4.5 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.536 0.734 . . . . 0.0 110.515 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -85.7 162.37 10.71 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.035 2.49 . . . . 0.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -79.11 121.48 25.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.99 145.42 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.049 1.34 . . . . 0.0 110.222 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -55.83 -22.86 27.23 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.9 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.32 60.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.55 -23.95 25.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.345 0.658 . . . . 0.0 111.427 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 47.3 m -69.93 -39.7 75.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -163.32 154.84 17.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.592 1.187 . . . . 0.0 110.754 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.479 ' HB3' ' HB1' ' A' ' 363' ' ' ALA . 70.8 t80 -141.69 99.57 3.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.85 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -90.47 -17.82 26.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.589 -0.694 . . . . 0.0 112.808 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.9 m -142.18 136.32 14.85 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.711 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.03 3.82 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.172 1.915 . . . . 0.0 114.119 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.8 m -109.63 12.15 24.38 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -148.62 163.31 37.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.429 1.092 . . . . 0.0 113.4 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.697 ' HG3' ' H ' ' A' ' 346' ' ' LEU . 10.6 tpp85 -125.99 -175.71 3.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.869 1.268 . . . . 0.0 109.504 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.697 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.1 tp -56.55 164.89 1.27 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.927 2.091 . . . . 0.0 113.521 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -135.89 145.52 53.05 Favored Pre-proline 0 CA--C 1.514 -0.412 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.48 123.54 7.11 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.434 2.09 . . . . 0.0 112.812 -172.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 36.6 m 59.9 26.19 15.39 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.288 1.435 . . . . 0.0 113.18 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -114.41 43.01 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.172 0.589 . . . . 0.0 109.98 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 p -135.78 163.84 29.28 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 122.476 1.131 . . . . 0.0 109.424 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.79 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.505 172.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -82.32 149.26 27.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.568 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.23 136.27 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -169.91 -170.44 34.34 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.547 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.72 18.08 0.95 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.335 1.454 . . . . 0.0 113.367 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.725 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.21 176.27 9.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.113 0.965 . . . . 0.0 110.267 172.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.7 32.44 0.16 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.537 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 76.1 18.23 79.52 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 120.564 -1.335 . . . . 0.0 112.596 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.404 ' HA ' HG13 ' A' ' 391' ' ' ILE . 17.2 mmt -140.3 -94.32 0.15 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.175 1.488 . . . . 0.0 111.718 171.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.7 tp 40.53 68.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.497 0.719 . . . . 0.0 110.863 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -55.62 168.16 0.44 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.726 0.239 . . . . 0.0 111.045 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 338' ' ' PHE . . . -65.29 -16.64 63.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.66 -26.63 25.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.733 -1.229 . . . . 0.0 109.256 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.85 -26.91 40.24 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.542 -0.724 . . . . 0.0 110.317 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.7 -51.72 25.73 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.42 67.23 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.822 -0.549 . . . . 0.0 110.885 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.24 73.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.707 0.23 . . . . 0.0 111.298 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.8 mt -66.46 -42.6 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 119.03 -0.509 . . . . 0.0 109.836 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.24 -34.89 18.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -22.87 44.51 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.4 -1.438 . . . . 0.0 111.554 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -87.66 -27.34 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.614 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.15 -18.87 26.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.553 ' CZ ' ' HA3' ' A' ' 376' ' ' GLY . 4.1 t80 -136.16 -61.45 0.7 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.843 174.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 100.59 -16.07 58.05 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 374' ' ' PHE . . . -85.38 59.52 4.82 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 118.089 0.944 . . . . 0.0 112.514 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.67 164.58 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 118.071 -1.452 . . . . 0.0 112.478 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.69 -40.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -150.79 148.0 27.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.163 0.506 . . . . 0.0 109.852 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.75 153.11 50.94 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.77 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.74 155.43 26.75 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 118.645 0.657 . . . . 0.0 112.501 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.11 147.19 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.5 126.48 29.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.584 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.6 p -138.99 157.49 45.9 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.962 0.789 . . . . 0.0 108.976 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -145.16 166.44 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.705 1.202 . . . . 0.0 108.755 173.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -53.05 102.32 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.443 -0.786 . . . . 0.0 111.784 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 65.8 m170 60.72 30.01 19.4 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -94.5 -8.2 39.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.577 -0.702 . . . . 0.0 110.759 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 15.6 p90 37.82 52.2 2.83 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 127.173 2.189 . . . . 0.0 113.213 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.77 -55.71 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.815 1.677 . . . . 0.0 112.585 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 360' ' ' MET . 10.2 tp 37.28 34.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 124.286 1.035 . . . . 0.0 112.504 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -136.5 5.32 3.79 Favored Glycine 0 N--CA 1.442 -0.958 0 O-C-N 124.104 0.878 . . . . 0.0 114.336 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.5 m -151.57 144.06 24.19 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.16 -172.87 36.32 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 170.34 22.44 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 124.233 0.608 . . . . 0.0 109.894 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.29 135.79 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 22.1 m -103.72 144.58 31.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.089 0.868 . . . . 0.0 111.37 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.43 179.55 6.14 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.342 1.057 . . . . 0.0 111.762 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.36 16.57 2.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.09 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -136.63 157.85 45.82 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -70.67 -26.42 63.43 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.001 0.92 . . . . 0.0 112.181 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . 79.8 mmt-85 -52.92 -31.7 41.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.35 1.06 . . . . 0.0 111.818 -171.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.4 p -80.88 -34.66 33.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.663 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -62.17 -52.29 64.39 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 117.919 0.327 . . . . 0.0 110.499 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 405' ' ' LEU 0.299 0.0 OUTLIER -78.38 -19.19 53.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.417 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -85.67 -30.07 23.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 120.466 1.484 . . . . 0.0 110.69 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.3 -29.19 47.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.335 0.97 . . . . 0.0 109.423 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.17 -33.24 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 O-C-N 121.555 -0.716 . . . . 0.0 112.723 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.5 t -82.22 -11.92 58.39 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -83.79 -50.66 7.9 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.35 -50.5 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 16.4 t80 -154.61 132.8 11.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.41 160.2 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.575 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 20.3 mt-10 -111.5 99.42 8.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.74 140.67 17.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.825 0.821 . . . . 0.0 108.932 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -132.61 40.95 3.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.996 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.2 p -71.43 170.24 13.65 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.322 1.014 . . . . 0.0 108.908 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 t -79.24 -3.42 45.78 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.23 -0.919 . . . . 0.0 112.922 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 226' ' ' PRO . 67.5 mttm -93.51 -41.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.028 -0.42 . . . . 0.0 110.474 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -157.86 166.14 33.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.982 0.801 . . . . 0.0 111.071 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.5 p -127.53 104.34 7.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.296 1.838 . . . . 0.0 107.539 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -159.36 170.5 21.67 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.798 -0.564 . . . . 0.0 110.631 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.575 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 90.6 mttt -108.75 164.19 12.59 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.277 1.037 . . . . 0.0 112.139 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.46 153.9 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.347 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -119.7 156.45 30.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.135 0.897 . . . . 0.0 109.879 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.92 138.67 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 13.4 m-20 -135.75 156.1 77.63 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.165 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 37.3 Cg_exo -65.8 165.6 22.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.561 2.174 . . . . 0.0 113.922 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 116.029 -1.938 . . . . 0.0 110.896 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.6 m 49.05 42.62 21.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.193 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.47 -8.47 59.56 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.145 1.378 . . . . 0.0 112.544 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.6 t 42.6 74.41 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.355 1.862 . . . . 0.0 111.693 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.88 -23.18 78.36 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 122.03 -0.419 . . . . 0.0 112.496 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 54.99 24.74 6.19 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' A' ' 226' ' ' PRO . 4.4 mm? -62.45 141.67 96.51 Favored Pre-proline 0 C--N 1.342 0.247 0 CA-C-N 119.181 0.9 . . . . 0.0 110.489 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.7 100.73 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.618 2.212 . . . . 0.0 110.129 171.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 224' ' ' LEU . 51.0 Cg_endo -80.77 14.61 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.682 3.588 . . . . 0.0 113.077 -175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -133.79 26.72 3.99 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 121.05 -1.031 . . . . 0.0 113.684 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -125.3 39.15 4.03 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.978 0.511 . . . . 0.0 110.663 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -72.05 154.9 40.85 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.641 0.734 . . . . 0.0 110.468 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -131.65 29.4 4.5 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.771 1.228 . . . . 0.0 112.56 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.95 47.44 0.58 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.203 0.601 . . . . 0.0 110.973 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.84 138.38 31.41 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.482 2.121 . . . . 0.0 112.759 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.4 mt -150.62 144.31 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 105.352 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -96.91 148.63 22.75 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 111.513 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.0 m -141.25 -16.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 63.9 m -143.67 -174.92 4.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.483 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.472 ' HE2' ' CD1' ' A' ' 283' ' ' TYR . 58.1 mtpt -43.22 153.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.336 1.065 . . . . 0.0 112.662 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.14 133.76 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.84 145.45 31.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.83 1.3 . . . . 0.0 110.727 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.4 tm? -135.23 116.7 14.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.218 -171.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 178.31 -179.6 48.53 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.17 22.19 0.92 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 28.1 m -91.09 128.55 47.15 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.801 0.841 . . . . 0.0 112.989 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.84 -15.56 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.944 2.429 . . . . 0.0 113.655 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -140.58 0.24 1.62 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.98 1.263 . . . . 0.0 113.985 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.43 122.79 18.32 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.856 1.662 . . . . 0.0 115.426 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -87.87 -0.86 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -173.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.7 p -158.68 167.71 28.82 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 122.455 1.121 . . . . 0.0 108.488 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.469 ' HA ' HD21 ' A' ' 252' ' ' LEU . 0.0 OUTLIER -107.53 -15.6 14.56 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.056 174.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -76.78 -31.38 56.98 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 121.088 0.471 . . . . 0.0 111.246 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.37 -52.6 45.53 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 120.658 -1.277 . . . . 0.0 113.787 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 252' ' ' LEU . 1.7 pt? -71.78 -32.49 67.71 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.514 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.48 -36.16 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.385 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -74.28 -17.77 60.81 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.809 0.693 . . . . 0.0 110.381 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.0 m -80.55 -26.99 37.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 111.807 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -129.34 19.07 5.85 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -101.73 -0.77 33.89 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.045 -1.034 . . . . 0.0 111.767 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.47 -21.14 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -127.61 3.24 6.15 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.27 1.028 . . . . 0.0 108.805 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -104.52 173.6 21.27 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 121.699 0.61 . . . . 0.0 112.836 -171.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . 0.733 ' H ' HD11 ' A' ' 295' ' ' LEU . 61.2 m -135.54 77.0 1.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.56 167.96 22.44 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.702 1.201 . . . . 0.0 111.725 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 284' ' ' LEU . 22.7 t -148.56 169.54 20.09 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 170.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.44 137.91 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -145.83 136.17 23.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -166.22 154.18 9.52 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.67 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.43 161.27 28.58 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.076 3.184 . . . . 0.0 110.987 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 83.03 3.66 90.33 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -75.84 -19.13 59.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.823 0.849 . . . . 0.0 110.572 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.24 142.24 58.49 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.14 -167.61 34.54 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.423 1.011 . . . . 0.0 111.738 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -80.07 170.34 16.59 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.198 0.599 . . . . 0.0 111.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 30.8 m80 53.03 99.35 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 125.364 1.466 . . . . 0.0 112.019 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -58.01 -3.53 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 1 C-N-CA 125.522 4.148 . . . . 0.0 115.816 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -99.36 9.99 42.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.223 1.809 . . . . 0.0 111.863 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 277' ' ' PRO . 40.7 t -53.43 -45.26 98.59 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.53 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 276' ' ' CYS . 96.5 Cg_endo -72.38 148.85 49.55 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.911 1.741 . . . . 0.0 111.405 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.63 1.17 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.521 2.814 . . . . 0.0 111.501 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.41 143.97 36.31 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 118.933 0.788 . . . . 0.0 109.93 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.42 22.05 42.88 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.429 0.537 . . . . 0.0 113.014 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.418 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 37.5 p90 -152.95 164.58 37.68 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.71 -178.49 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.472 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 55.0 m-85 -110.91 157.27 20.05 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.208 0.913 . . . . 0.0 111.223 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 263' ' ' SER . 83.4 mt -126.13 136.0 52.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.671 1.188 . . . . 0.0 111.529 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.86 137.18 14.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.685 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 84.9 t80 -175.62 -76.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.614 0.366 . . . . 0.0 110.317 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -93.8 -36.8 12.09 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.685 ' CD2' ' H ' ' A' ' 286' ' ' PHE . 4.4 mm? 60.81 -3.39 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -136.12 -75.3 0.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 122.196 2.271 . . . . 0.0 112.643 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -84.28 -33.89 23.89 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . 0.502 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 44.8 m -82.61 -45.34 14.68 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 116.509 -1.71 . . . . 0.0 108.527 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.16 -36.81 16.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-N 121.506 1.957 . . . . 0.0 107.878 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 30.3 ttt-85 -62.55 -45.48 92.75 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.875 0.845 . . . . 0.0 110.806 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -70.81 -35.3 72.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 118.15 -0.928 . . . . 0.0 113.148 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.733 HD11 ' H ' ' A' ' 261' ' ' SER . 55.6 mt -66.5 -47.09 74.08 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -7.0 59.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.523 -1.36 . . . . 0.0 111.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -97.47 -3.81 39.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.473 1.033 . . . . 0.0 111.709 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -105.49 -18.55 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.0 m -81.89 -158.3 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 61.4 m -84.44 146.05 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.013 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -137.34 149.53 47.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.052 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -137.93 127.3 14.92 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 122.049 -0.407 . . . . 0.0 110.703 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -82.87 35.55 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.754 4.303 . . . . 0.0 109.566 169.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.612 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -173.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 171.59 10.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.851 0.86 . . . . 0.0 109.342 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.62 154.53 50.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -113.07 148.63 34.82 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.15 162.42 39.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -163.4 176.01 10.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.9 ptpt -135.4 132.47 37.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.42 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 0.0 OUTLIER -135.49 9.47 3.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -165.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.0 t -66.13 150.98 47.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 11.0 m -85.36 15.36 4.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.556 0.743 . . . . 0.0 110.133 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.57 24.74 3.23 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.479 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -75.01 -23.44 58.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.848 0.749 . . . . 0.0 112.308 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -148.76 -26.83 0.31 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -152.53 168.18 26.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.105 0.562 . . . . 0.0 110.642 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 74.1 m -118.22 134.63 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.818 1.247 . . . . 0.0 107.722 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 17.0 tppt? -152.93 129.68 10.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 122.542 1.163 . . . . 0.0 114.029 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.91 137.57 36.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.01 1.724 . . . . 0.0 111.972 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 327' ' ' GLN . 9.1 p -123.89 157.58 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.416 ' N ' HG22 ' A' ' 326' ' ' VAL . 5.1 pp0? -107.46 154.72 20.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.117 0.261 . . . . 0.0 110.62 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.58 136.5 46.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.276 0.56 . . . . 0.0 111.788 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 73.0 mt -142.17 109.4 5.86 Favored Pre-proline 0 C--O 1.232 0.165 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 164.96 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.089 1 C-N-CA 125.337 4.025 . . . . 0.0 112.085 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.605 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 1.7 t90 -83.66 133.3 34.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.46 152.33 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 123.605 0.762 . . . . 0.0 110.251 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.8 tt -54.46 -27.1 35.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.28 4.11 2.46 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.694 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.94 7.41 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.035 0.934 . . . . 0.0 109.567 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.3 m -129.24 -22.0 3.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 150.72 34.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.71 132.6 15.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.362 -1.745 . . . . 0.0 107.928 170.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -141.96 146.23 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.187 0.994 . . . . 0.0 111.816 177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -103.32 -15.72 15.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.575 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 339' ' ' VAL . 42.3 t -94.52 140.22 22.6 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.426 1.09 . . . . 0.0 110.444 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.4 16.2 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.204 3.269 . . . . 0.0 110.427 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 15.6 t -122.74 161.27 24.24 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.813 -1.179 . . . . 0.0 110.447 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' A' ' 344' ' ' GLN . 5.0 pm0 -79.8 22.47 0.48 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 122.33 1.062 . . . . 0.0 113.43 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -65.59 155.26 36.35 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.59 1.156 . . . . 0.0 109.342 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 22.4 tp -154.92 155.43 34.26 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.059 0.391 . . . . 0.0 111.222 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.452 ' H ' HG21 ' A' ' 397' ' ' THR . 42.4 t0 -136.58 73.35 55.37 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.016 0.926 . . . . 0.0 110.065 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.71 5.08 4.57 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.079 2.519 . . . . 0.0 111.946 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.5 t -78.29 -13.42 59.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.847 -1.158 . . . . 0.0 111.602 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -147.26 85.74 1.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.8 p -133.8 154.0 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.049 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.02 158.76 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 119.086 0.857 . . . . 0.0 110.045 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -95.19 146.46 24.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 123.837 0.711 . . . . 0.0 111.352 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.22 140.4 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.12 -178.41 32.13 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.41 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.26 47.26 21.94 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 124.469 1.107 . . . . 0.0 110.595 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 36.5 mt -84.67 -174.83 5.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 360' ' ' MET . 0.2 OUTLIER -61.92 -25.35 67.52 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.764 176.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 78.22 5.54 87.39 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 120.364 -1.46 . . . . 0.0 109.939 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.413 ' HB3' ' CE1' ' A' ' 358' ' ' HIS . 16.5 ttt -152.93 29.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.11 95.43 0.73 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.849 1.309 . . . . 0.0 110.464 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -81.12 162.23 23.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.18 -7.75 50.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.134 -171.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -90.12 -26.59 20.13 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.97 -29.63 24.92 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.08 -49.1 63.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.201 0.6 . . . . 0.0 109.458 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.96 -31.38 71.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.264 -0.273 . . . . 0.0 111.538 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.4 87.1 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.2 mt -65.46 -45.02 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.2 mt -85.57 -29.76 23.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -21.56 30.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.778 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -107.71 -20.47 13.21 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.54 -14.96 23.19 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.399 -1.438 . . . . 0.0 110.521 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.05 -41.64 2.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 112.812 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 73.38 -1.6 42.18 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.442 ' C ' HD21 ' A' ' 400' ' ' ASN . . . -143.65 117.61 1.1 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.107 0.953 . . . . 0.0 111.03 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 11.9 t -152.44 168.58 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.25 -29.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -159.75 158.56 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -165.94 146.66 6.68 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -159.46 151.97 22.86 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 121.42 0.456 . . . . 0.0 114.054 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.32 150.33 4.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -97.39 74.75 2.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.9 p -61.23 146.37 48.03 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.62 17.48 14.42 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.733 1.213 . . . . 0.0 111.705 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.0 tptm 51.53 124.31 0.0 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 128.022 2.529 . . . . 0.0 114.878 -170.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 58.2 m170 61.13 27.79 17.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -133.47 -0.91 3.19 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 6.1 p90 25.98 66.97 0.47 Allowed Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.033 1.333 . . . . 0.0 112.282 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.53 -49.84 0.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 124.262 3.308 . . . . 0.0 110.783 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.91 35.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 111.635 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.34 15.6 1.29 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.131 0.872 . . . . 0.0 114.659 -172.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 77.3 p -163.45 145.45 9.69 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.355 0.662 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.79 -161.95 28.71 Favored Glycine 0 N--CA 1.427 -1.907 0 O-C-N 120.685 -1.259 . . . . 0.0 112.725 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.54 166.88 25.15 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.719 -0.871 . . . . 0.0 111.946 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 144.07 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.662 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.452 HG21 ' H ' ' A' ' 347' ' ' ASP . 44.3 m -116.72 131.64 56.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 123.533 0.521 . . . . 0.0 110.693 -172.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -118.99 155.75 30.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.515 1.135 . . . . 0.0 111.909 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.11 7.01 10.77 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.442 HD21 ' C ' ' A' ' 376' ' ' GLY . 12.0 p30 -136.89 166.61 23.21 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.041 1.337 . . . . 0.0 109.648 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -98.08 -28.34 13.8 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.575 ' H ' ' HD3' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -62.9 -26.1 68.64 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.878 0.763 . . . . 0.0 112.987 -175.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 71.7 p -73.45 -33.04 64.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -68.62 -55.13 12.56 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 119.237 0.926 . . . . 0.0 110.645 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -24.02 58.46 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.136 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -78.4 -23.2 46.87 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 118.238 -1.385 . . . . 0.0 111.221 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.91 -26.2 36.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.247 -0.908 . . . . 0.0 111.497 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.85 -27.95 5.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.059 0.457 . . . . 0.0 111.049 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.6 p -83.39 -18.86 37.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.744 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -90.69 -45.69 8.71 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.033 0.444 . . . . 0.0 110.456 171.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.91 -10.39 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.855 2.062 . . . . 0.0 114.31 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -161.07 144.65 13.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.32 156.31 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 O-C-N 120.868 -1.145 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 414' ' ' GLU . 17.1 mp0 -120.18 137.94 53.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.594 0.711 . . . . 0.0 112.396 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.45 124.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 46.91 1.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.247 1.022 . . . . 0.0 111.786 -175.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.9 p -66.47 169.7 7.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.67 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.8 t -69.78 1.53 4.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.305 0.642 . . . . 0.0 110.749 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.45 0.88 0.44 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -171.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -154.37 139.35 17.29 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.419 -0.801 . . . . 0.0 112.512 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 50.6 p -139.08 124.05 18.83 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.205 -0.934 . . . . 0.0 110.766 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 0.8 OUTLIER -168.82 -179.33 3.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.429 176.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 55.6 mtmt -140.99 172.15 13.08 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.18 152.32 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 124.346 1.028 . . . . 0.0 109.353 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -117.09 152.16 35.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 111.623 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.92 141.79 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.288 0.566 . . . . 0.0 111.61 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.92 124.85 8.64 Favored Pre-proline 0 C--O 1.246 0.874 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.85 158.47 18.53 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 124.082 3.188 . . . . 0.0 114.001 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 C--O 1.263 1.775 0 CA-C-O 117.285 -1.34 . . . . 0.0 111.115 171.329 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.355 0.598 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.2 t -167.06 173.28 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . 0.461 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -126.37 7.37 7.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.8 m 46.56 37.75 4.81 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.356 -0.84 . . . . 0.0 112.464 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -168.96 77.92 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.244 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 164.92 25.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.939 0.435 . . . . 0.0 110.839 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.3 mm? -78.93 152.85 77.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.28 114.45 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.915 2.41 . . . . 0.0 112.314 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 364' ' ' GLU . 34.8 Cg_endo -82.12 -165.07 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.413 4.075 . . . . 0.0 111.43 175.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 58.51 32.67 22.38 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.797 0.439 . . . . 0.0 111.801 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -99.48 -1.06 39.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -74.12 153.55 39.52 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.854 0.861 . . . . 0.0 110.446 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -148.84 25.39 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.264 1.026 . . . . 0.0 110.809 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -131.99 62.2 62.43 Favored Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 120.632 -1.293 . . . . 0.0 112.084 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -68.91 117.46 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.328 3.352 . . . . 0.0 112.928 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.1 mm -140.82 151.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -109.38 141.25 42.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.925 1.239 . . . . 0.0 110.643 -173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.5 t -133.48 3.65 3.61 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.397 0.544 . . . . 0.0 112.449 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 3.6 t -153.21 177.6 10.66 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.053 0.541 . . . . 0.0 110.257 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.87 166.32 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.062 1.345 . . . . 0.0 113.924 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.01 138.14 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.89 133.01 33.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.481 HD11 HG13 ' A' ' 326' ' ' VAL . 23.0 tp -139.5 112.72 8.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.145 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.86 155.81 26.47 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.114 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.74 13.73 1.39 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 124.153 0.56 . . . . 0.0 113.081 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.17 117.14 58.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.674 -0.898 . . . . 0.0 111.826 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.7 -4.4 8.2 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.754 2.969 . . . . 0.0 113.368 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -105.71 -109.57 0.29 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.26 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 38.7 t70 43.87 74.8 0.11 Allowed 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 119.859 1.209 . . . . 0.0 111.372 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.407 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -83.77 -10.37 11.73 Favored 'Isoleucine or valine' 0 C--O 1.273 2.291 0 CA-C-N 118.551 0.614 . . . . 0.0 110.692 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.4 p -146.18 129.03 16.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.3 -22.11 66.67 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.648 0.737 . . . . 0.0 109.917 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -74.14 -21.92 59.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.298 -1.501 . . . . 0.0 110.9 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.69 -57.3 5.48 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.47 -42.69 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.079 0.952 . . . . 0.0 112.52 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.1 t -73.51 -32.83 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.474 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.62 -20.16 57.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.693 0.679 . . . . 0.0 111.294 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -73.1 -30.03 63.36 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.905 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -129.88 16.87 5.73 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -89.63 -21.83 22.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 120.018 1.281 . . . . 0.0 112.181 171.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.18 24.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -143.29 7.88 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.782 0.719 . . . . 0.0 112.659 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -167.44 169.98 41.39 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-O 121.935 0.742 . . . . 0.0 113.04 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.9 t -82.31 77.92 9.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.385 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.05 166.85 24.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 52.7 m -147.88 -175.08 4.74 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.898 1.333 . . . . 0.0 110.836 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.67 154.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 123.813 0.845 . . . . 0.0 111.689 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -142.29 131.69 23.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 124.951 1.407 . . . . 0.0 110.929 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -93.07 133.67 28.42 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.578 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 282' ' ' VAL . 66.8 Cg_endo -76.71 -23.19 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 O-C-N 123.962 1.506 . . . . 0.0 112.189 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.06 -66.99 1.57 Allowed Glycine 0 C--O 1.218 -0.866 0 C-N-CA 123.074 0.368 . . . . 0.0 112.379 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? 48.39 49.09 18.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.954 0.502 . . . . 0.0 110.253 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.87 35.31 3.95 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.259 1.824 . . . . 0.0 114.453 -170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.88 163.06 35.1 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.521 0.512 . . . . 0.0 111.951 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -92.17 169.13 10.86 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 122.467 -0.431 . . . . 0.0 110.505 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB3' ' CD ' ' A' ' 274' ' ' PRO . 14.0 m80 60.67 173.33 0.06 OUTLIER Pre-proline 0 C--O 1.219 -0.525 0 C-N-CA 125.766 1.626 . . . . 0.0 112.846 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 273' ' ' HIS . 32.4 Cg_exo -60.59 40.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 1 C-N-CA 126.723 4.948 . . . . 0.0 114.687 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -147.7 41.47 1.03 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.842 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.51 129.3 25.92 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.976 0.51 . . . . 0.0 109.671 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.42 134.04 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.456 1.438 . . . . 0.0 111.146 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.14 158.7 5.73 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 124.277 3.318 . . . . 0.0 109.545 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -100.95 12.87 36.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 0.0 108.858 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 112.95 -9.76 25.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -171.64 169.15 6.1 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.855 0.827 . . . . 0.0 110.606 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 267' ' ' PRO . 32.7 m -148.79 -174.09 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.104 1.762 . . . . 0.0 108.978 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -123.08 153.39 39.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 111.466 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.76 139.06 42.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.728 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.9 131.25 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.498 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 35.6 p90 -167.35 -151.15 0.11 Allowed 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 123.509 0.505 . . . . 0.0 110.378 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.34 -8.53 0.78 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.453 ' HA ' HG23 ' A' ' 292' ' ' VAL . 90.8 mt 50.75 -163.58 0.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 111.461 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.9 -78.59 0.0 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.276 2.63 . . . . 0.0 114.952 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -84.18 -32.8 24.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.741 1.275 . . . . 0.0 111.213 -172.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 75.6 m -85.23 -15.69 42.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.643 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 288' ' ' LEU . 79.0 t -68.32 -51.48 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -66.53 -26.4 67.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.2 t -65.19 -46.45 80.69 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 118.537 0.608 . . . . 0.0 110.786 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.39 -44.16 83.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 119.805 -1.809 . . . . 0.0 110.351 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.56 -26.96 67.37 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 124.341 1.025 . . . . 0.0 109.441 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -92.96 -10.0 37.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 120.14 1.336 . . . . 0.0 111.389 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -102.91 -19.78 14.51 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.08 178.39 7.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.013 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.2 t -77.91 163.81 25.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.369 1.668 . . . . 0.0 111.544 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -151.2 160.23 43.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.679 1.192 . . . . 0.0 111.079 -175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.18 124.76 7.67 Favored Pre-proline 0 CA--C 1.517 -0.312 0 O-C-N 121.473 -0.767 . . . . 0.0 110.02 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.43 51.29 3.24 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 124.556 3.504 . . . . 0.0 108.324 169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.494 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 310' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 122.236 1.017 . . . . 0.0 109.857 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.676 ' H ' HD13 ' A' ' 309' ' ' LEU . 32.3 m -143.35 149.36 37.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.747 1.619 . . . . 0.0 109.304 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -132.71 136.32 46.33 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 122.223 -0.298 . . . . 0.0 110.768 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 328' ' ' VAL . 64.9 m-85 -118.44 159.16 23.97 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -153.35 159.37 42.45 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 122.077 -0.389 . . . . 0.0 111.978 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -145.25 159.43 43.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.706 -0.621 . . . . 0.0 111.007 172.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -110.35 118.53 36.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.25 21.23 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.63 0.195 . . . . 0.0 111.429 -169.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.5 t -137.11 162.67 32.76 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.185 -0.947 . . . . 0.0 111.122 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 32.4 p -145.3 -10.95 0.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.875 0.87 . . . . 0.0 111.112 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 4.59 0.13 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -107.81 -38.92 5.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.877 -1.139 . . . . 0.0 110.576 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 15.8 mmt -133.91 -31.96 1.13 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.513 0.725 . . . . 0.0 109.205 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 46.12 27.48 0.54 Allowed 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.541 0.686 . . . . 0.0 110.92 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.5 -173.68 4.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 324' ' ' LYS . 0.4 OUTLIER 57.5 68.8 0.8 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.743 1.217 . . . . 0.0 114.001 176.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . 0.655 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 3.6 mp0 -46.7 156.73 0.18 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.327 173.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.481 HG13 HD11 ' A' ' 240' ' ' LEU . 7.6 p -119.4 142.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -86.53 137.46 32.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.829 0.74 . . . . 0.0 110.086 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.5 p -132.57 137.05 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 123.936 0.772 . . . . 0.0 111.924 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 328' ' ' VAL . 7.8 pt -156.76 130.76 4.84 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.67 168.6 8.29 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.544 4.162 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.409 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 1.7 t90 -82.14 124.17 29.63 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 169.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 334' ' ' ALA . 21.3 t -100.76 137.31 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.85 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.69 -35.12 60.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.933 1.293 . . . . 0.0 110.994 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.495 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -79.82 11.44 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 118.392 -0.814 . . . . 0.0 112.807 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.11 6.28 10.79 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.671 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.1 p -139.45 -2.45 1.6 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -147.91 153.58 39.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -155.02 139.1 16.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.77 0.828 . . . . 0.0 111.82 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.93 155.5 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 118.867 0.758 . . . . 0.0 111.593 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -102.68 -6.86 22.24 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 108.789 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 342' ' ' PRO . 60.6 m -131.2 166.15 29.92 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 123.703 0.801 . . . . 0.0 112.818 -171.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 57.2 Cg_endo -66.15 -9.06 22.15 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.354 2.036 . . . . 0.0 112.169 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 58.4 p -85.14 168.94 14.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.897 0.879 . . . . 0.0 109.911 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -136.32 24.22 3.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.164 0.507 . . . . 0.0 110.938 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -112.57 164.45 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.016 0.927 . . . . 0.0 111.691 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -111.84 -171.58 1.87 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.426 1.49 . . . . 0.0 110.499 -173.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.86 93.3 31.61 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.919 1.288 . . . . 0.0 107.923 171.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.71 -0.22 0.36 Allowed 'Trans proline' 0 C--O 1.24 0.579 1 C-N-CA 126.063 4.508 . . . . 0.0 115.933 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.7 m -117.66 3.93 12.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.18 0.592 . . . . 0.0 111.653 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -141.71 55.64 1.5 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.945 0.793 . . . . 0.0 109.981 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.5 t -143.34 154.02 43.32 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.88 159.89 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 124.18 0.925 . . . . 0.0 110.432 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -84.92 138.65 32.38 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.296 0.998 . . . . 0.0 113.306 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.48 149.04 24.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.095 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 178.15 -168.05 39.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.97 22.99 2.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.209 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 357' ' ' LEU . 0.6 OUTLIER -92.13 137.43 32.37 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.659 -175.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 29.02 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.885 1.274 . . . . 0.0 112.98 169.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.64 -12.65 0.05 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-O 118.132 -1.371 . . . . 0.0 111.008 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.7 mmt -133.93 -52.41 0.85 Allowed 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 125.232 1.195 . . . . 0.0 108.389 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 357' ' ' LEU . 16.0 tp 27.67 77.56 0.02 OUTLIER 'General case' 0 C--N 1.347 0.468 0 O-C-N 124.585 1.178 . . . . 0.0 111.992 -171.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -61.64 164.25 6.23 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 123.972 0.909 . . . . 0.0 111.761 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.74 -22.7 62.43 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 226' ' ' PRO . 71.1 mm-40 -83.2 -32.54 26.5 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 119.508 1.049 . . . . 0.0 110.086 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -73.82 -40.78 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 122.117 -0.365 . . . . 0.0 110.135 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.09 -46.76 82.84 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.34 65.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.712 -1.242 . . . . 0.0 111.58 -173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.05 80.35 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.403 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 89.3 mt -71.66 -41.42 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 -16.31 49.71 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.35 -1.309 . . . . 0.0 114.2 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -16.55 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 120.316 1.417 . . . . 0.0 114.367 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.45 -20.62 13.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.105 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.77 -14.36 18.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.572 1.078 . . . . 0.0 111.091 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -117.3 -64.64 1.28 Allowed 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.206 -0.934 . . . . 0.0 110.766 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 161.73 -151.23 21.31 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.324 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -66.08 130.13 32.59 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 126.248 1.88 . . . . 0.0 110.376 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.23 164.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 126.177 1.791 . . . . 0.0 107.844 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.65 -28.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.444 0.565 . . . . 0.0 112.111 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.3 OUTLIER -157.32 156.78 32.96 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -149.67 143.03 25.22 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -154.24 171.85 32.81 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 122.09 0.828 . . . . 0.0 114.181 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.487 ' HA ' ' HA3' ' A' ' 394' ' ' GLY . 26.7 mt -127.39 144.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 128.635 2.774 . . . . 0.0 108.478 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.86 149.01 24.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.337 -0.852 . . . . 0.0 111.882 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.2 p -108.91 161.41 15.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.192 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -130.02 34.56 4.23 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.519 1.152 . . . . 0.0 111.973 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 tptm 61.99 95.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.454 1.902 . . . . 0.0 111.397 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 m170 48.48 28.04 1.6 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -104.12 11.73 34.79 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.522 1.056 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 52.4 p90 44.82 49.25 5.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 126.576 1.951 . . . . 0.0 114.144 173.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.62 -52.62 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 119.338 0.799 . . . . 0.0 112.082 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.409 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 37.62 47.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 123.57 0.748 . . . . 0.0 109.826 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -158.86 6.71 0.15 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.9 p -153.8 138.61 17.09 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 382' ' ' ILE . . . -169.15 -149.17 6.1 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -154.94 172.85 17.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.974 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.2 132.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 52.2 m -101.59 110.68 22.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.848 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.1 157.17 16.01 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.708 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.76 -0.06 6.06 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.965 0.791 . . . . 0.0 109.604 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -120.82 135.86 55.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.058 1.343 . . . . 0.0 108.126 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.01 -25.69 67.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.662 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.94 -31.33 72.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.01 0.823 . . . . 0.0 110.965 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 m -80.43 -12.27 59.58 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.869 -1.144 . . . . 0.0 111.257 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.37 -60.72 2.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.536 -0.727 . . . . 0.0 109.174 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.65 63.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.495 -176.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.25 -26.32 35.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.965 0.802 . . . . 0.0 111.457 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 426' ' ' ILE . . . -75.27 -31.03 60.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.373 -0.829 . . . . 0.0 111.036 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.31 -26.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.963 0.905 . . . . 0.0 111.223 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.2 p -84.27 -26.09 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.28 -40.82 10.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.517 0.327 . . . . 0.0 110.273 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.2 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.73 141.16 10.0 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 120.297 1.408 . . . . 0.0 108.89 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -141.38 159.3 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.548 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -113.64 110.15 19.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.172 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.1 mm -77.2 129.58 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 173.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 30.3 ttmt -153.99 98.12 2.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.302 0.572 . . . . 0.0 109.487 -170.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 418' ' ' THR . 3.9 m -143.79 179.65 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 417' ' ' THR . 2.0 m -78.52 2.11 20.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.9 -0.5 . . . . 0.0 110.781 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -129.98 -8.45 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.63 131.93 11.13 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.416 -0.802 . . . . 0.0 111.395 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 7.1 p -143.64 86.81 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.829 0.741 . . . . 0.0 110.871 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -150.55 172.32 15.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.95 0.9 . . . . 0.0 109.951 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -128.56 167.72 16.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.695 0.398 . . . . 0.0 111.17 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.93 145.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 CA-C-N 118.748 0.704 . . . . 0.0 109.296 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -122.69 150.2 43.04 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.026 0.917 . . . . 0.0 112.702 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 407' ' ' ALA . 4.4 mp -133.2 145.96 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.226 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -150.74 128.38 5.68 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -83.66 166.83 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 2.78 . . . . 0.0 111.538 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.359 1.064 . . . . 0.0 111.057 176.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 C--O 1.218 -0.603 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.9 m 57.65 164.77 0.03 OUTLIER 'General case' 0 C--O 1.246 0.888 0 CA-C-O 122.68 1.229 . . . . 0.0 110.407 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -157.59 -40.58 0.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.887 -1.133 . . . . 0.0 112.143 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 m 47.81 22.89 0.39 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 57.41 69.25 1.33 Allowed Glycine 0 N--CA 1.447 -0.613 0 O-C-N 120.845 -1.159 . . . . 0.0 112.803 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -71.8 -21.58 61.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.794 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.513 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 1.0 OUTLIER -155.55 9.15 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -176.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 224' ' ' LEU . 42.6 Cg_endo -64.61 119.49 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 122.331 1.868 . . . . 0.0 111.605 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.2 142.28 41.35 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 124.4 3.4 . . . . 0.0 111.254 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -138.32 170.19 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.171 0.989 . . . . 0.0 110.772 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.35 38.11 29.44 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.816 0.817 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -54.58 30.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.989 1.316 . . . . 0.0 110.41 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 71.0 tttt 55.25 45.33 25.97 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -114.56 -46.91 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.11 -174.25 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.442 1 C-N-CA 125.304 4.002 . . . . 0.0 114.649 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 234' ' ' TYR . 4.2 mp -109.2 -179.09 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.709 ' H ' HG22 ' A' ' 233' ' ' ILE . 30.9 m-85 -93.74 158.25 15.76 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 51.0 m -145.08 -0.78 0.87 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.72 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.609 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 12.0 m -149.46 -164.55 2.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.875 1.216 . . . . 0.0 110.996 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 236' ' ' CYS . 0.1 OUTLIER -59.93 172.09 0.82 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.503 1.144 . . . . 0.0 111.542 -177.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.29 138.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.413 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -81.64 143.4 31.95 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 122.162 0.982 . . . . 0.0 109.444 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.479 HD13 ' C ' ' A' ' 240' ' ' LEU . 1.0 OUTLIER -141.02 108.22 5.49 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.65 164.53 29.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.75 12.16 5.62 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.853 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.02 116.48 65.58 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 119.097 1.449 . . . . 0.0 111.431 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.24 1.83 5.23 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 124.644 3.562 . . . . 0.0 110.406 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -141.49 175.82 9.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.3 1.04 . . . . 0.0 109.956 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.52 155.16 10.61 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.221 0.534 . . . . 0.0 110.584 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -133.67 -44.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.281 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.014 170.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 250' ' ' ALA . 7.4 m -168.48 148.72 4.63 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.809 1.943 . . . . 0.0 108.18 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -70.08 -26.73 64.13 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 119.749 -1.845 . . . . 0.0 111.722 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.454 ' H ' HG22 ' A' ' 248' ' ' THR . . . -80.91 -19.35 44.49 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.464 0.706 . . . . 0.0 110.358 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.18 -58.04 6.42 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.34 -40.06 70.76 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.178 0.575 . . . . 0.0 110.216 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.702 ' CG2' HG21 ' A' ' 264' ' ' VAL . 54.6 t -70.39 -41.32 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 118.836 -2.415 . . . . 0.0 110.414 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.22 0.09 10.71 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.854 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 48.1 m -87.8 -28.04 21.92 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.036 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -137.98 16.15 2.85 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.6 20.6 0.22 Allowed 'General case' 0 C--O 1.24 0.592 0 O-C-N 120.45 -1.406 . . . . 0.0 112.789 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.89 6.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 120.208 1.367 . . . . 0.0 110.611 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.98 -11.35 58.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.916 -1.115 . . . . 0.0 112.151 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.16 -4.08 59.76 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.828 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 10.7 t -127.3 22.6 6.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.26 1.03 . . . . 0.0 111.817 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.4 OUTLIER -92.76 144.26 25.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.928 -1.107 . . . . 0.0 109.988 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.3 m -152.68 172.05 17.26 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 125.788 1.93 . . . . 0.0 107.893 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.702 HG21 ' CG2' ' A' ' 253' ' ' VAL . 61.3 t -148.29 144.0 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.293 -169.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -109.21 131.71 54.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.955 0.784 . . . . 0.0 109.939 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.419 ' CE3' HG21 ' A' ' 282' ' ' VAL . 2.0 t-105 -145.28 81.99 10.04 Favored Pre-proline 0 C--O 1.242 0.691 0 CA-C-O 122.048 0.927 . . . . 0.0 110.979 -167.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 164.22 31.99 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 123.786 2.991 . . . . 0.0 109.747 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.01 -4.36 85.61 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -66.56 65.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.403 1.481 . . . . 0.0 111.308 174.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -142.95 2.25 1.33 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.512 0.725 . . . . 0.0 111.817 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.3 -154.08 8.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.264 0.935 . . . . 0.0 111.548 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.89 168.27 12.18 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 24.0 m170 67.47 150.84 0.12 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.066 2.147 . . . . 0.0 114.445 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.32 -4.27 14.55 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.823 2.349 . . . . 0.0 109.661 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -95.9 11.93 32.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.878 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 277' ' ' PRO . 1.8 p 63.26 155.67 0.12 Allowed Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 129.012 2.925 . . . . 0.0 111.208 -173.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 276' ' ' CYS . 84.7 Cg_endo -77.79 159.21 31.43 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.402 3.401 . . . . 0.0 111.814 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.94 136.36 18.46 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.037 3.158 . . . . 0.0 111.714 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -144.76 155.51 43.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -76.45 -21.08 76.0 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-O 117.998 -1.446 . . . . 0.0 113.334 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -166.56 168.66 14.43 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.419 HG21 ' CE3' ' A' ' 266' ' ' TRP . 21.8 m -156.84 -163.69 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.941 2.096 . . . . 0.0 108.71 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -148.09 150.7 34.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.532 1.06 . . . . 0.0 111.652 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 284' ' ' LEU . 5.3 mp -101.97 156.35 17.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.89 122.73 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 31.5 p90 -165.66 -157.54 0.32 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 117.499 -1.239 . . . . 0.0 109.915 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 93.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -69.78 14.0 0.12 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.65 2.38 . . . . 0.0 115.75 -167.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -136.09 -53.96 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.571 1.532 . . . . 0.0 111.111 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -88.05 -41.16 13.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.83 -170.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 73.9 m -74.77 -32.99 62.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.86 -47.81 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 122.105 -0.372 . . . . 0.0 110.896 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -73.3 -20.34 60.83 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.82 -0.55 . . . . 0.0 112.109 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.5 m -79.78 -35.53 38.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.606 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -46.34 87.05 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.713 172.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.07 -17.08 61.46 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.066 0.848 . . . . 0.0 110.467 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -87.97 -9.7 52.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 122.727 0.411 . . . . 0.0 111.743 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.04 -3.22 15.6 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.03 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.4 m -109.68 -154.67 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.939 1.399 . . . . 0.0 110.858 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.6 m -136.06 160.49 38.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.028 1.394 . . . . 0.0 109.641 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 74.1 t60 -142.44 165.56 27.08 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.86 -1.775 . . . . 0.0 111.343 -173.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 13.3 m-20 -147.01 115.97 4.39 Favored Pre-proline 0 C--O 1.212 -0.913 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -85.39 25.75 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 126.178 4.586 . . . . 0.0 111.538 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.352 0.69 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.027 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.216 -0.685 0 CA-C-O 121.374 0.607 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.2 m -107.62 169.91 8.3 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.614 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -141.91 149.03 39.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 1.064 . . . . 0.0 109.154 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . 0.404 ' HB2' HG23 ' A' ' 328' ' ' VAL . 5.9 m-85 -122.47 149.09 44.35 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -138.61 153.62 48.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 122.808 1.289 . . . . 0.0 112.104 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -146.61 169.63 18.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.426 -0.797 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -128.6 74.85 1.59 Allowed 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -76.72 1.37 17.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.373 177.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 67.9 m -57.66 137.27 56.61 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 25.1 t -108.77 175.2 5.55 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.816 -1.178 . . . . 0.0 109.257 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -60.65 0.5 0.2 Allowed 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 124.838 1.255 . . . . 0.0 113.822 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 ptm85 -105.12 8.21 34.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.35 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 74.1 mmm -128.78 169.91 13.97 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 46.4 mtt85 -119.49 0.06 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.342 0.657 . . . . 0.0 111.371 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 93.8 m -124.01 -174.94 3.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.677 0.791 . . . . 0.0 109.712 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -150.71 166.31 30.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 66.13 147.3 0.04 OUTLIER 'General case' 0 C--N 1.342 0.279 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.58 165.03 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.293 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 143.82 35.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.622 0.769 . . . . 0.0 110.249 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 312' ' ' TYR . 28.2 m -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.903 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 34.9 mt -144.84 107.8 4.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.52 171.8 15.33 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.257 2.638 . . . . 0.0 111.892 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.609 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.2 t-105 -101.41 112.32 24.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 169.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.29 157.61 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.04 -0.412 . . . . 0.0 110.5 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.64 -28.0 63.32 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.355 1.062 . . . . 0.0 109.859 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.21 -4.98 8.75 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 124.687 1.242 . . . . 0.0 110.176 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.68 8.66 15.04 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.57 1.148 . . . . 0.0 110.274 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.8 m -115.5 -47.13 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.642 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -155.67 166.27 34.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.908 0.861 . . . . 0.0 110.125 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -153.86 144.53 22.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 110.451 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.22 145.06 18.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -106.66 -16.54 14.48 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.803 1.314 . . . . 0.0 111.427 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 60.1 m -96.73 147.36 32.82 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.294 -0.879 . . . . 0.0 111.351 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.09 -26.43 7.74 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.244 2.629 . . . . 0.0 112.707 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.1 m -143.51 2.92 1.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.2 154.26 22.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.912 1.339 . . . . 0.0 110.062 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.23 177.37 6.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.391 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 346' ' ' LEU . 1.3 mm? -58.33 151.64 19.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.234 -0.916 . . . . 0.0 111.303 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -89.88 137.49 28.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.08 -2.8 13.01 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.003 2.468 . . . . 0.0 115.869 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 41.5 p -142.26 -0.6 1.25 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.552 1.141 . . . . 0.0 112.98 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -123.24 60.66 1.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 397' ' ' THR . 18.6 p -138.27 147.72 43.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 428' ' ' PRO . 22.3 m -123.68 169.72 14.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 122.508 -0.12 . . . . 0.0 110.921 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -97.91 125.45 42.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.68 131.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -120.44 97.28 0.64 Allowed Glycine 0 C--O 1.213 -1.181 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.599 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -145.72 132.89 20.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.498 0.666 . . . . 0.0 110.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -160.98 155.76 23.78 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.6 1.16 . . . . 0.0 113.32 -169.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.468 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 14.7 p80 -159.98 6.51 0.09 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 169.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 116.94 -17.97 12.74 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.315 1.912 . . . . 0.0 112.388 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.6 ptm -166.05 43.27 0.07 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.552 0.676 . . . . 0.0 109.783 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.495 HD13 ' C ' ' A' ' 361' ' ' LEU . 3.0 tm? -57.79 132.23 52.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.37 166.0 12.83 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.758 -173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.36 -17.26 64.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 118.467 -0.778 . . . . 0.0 111.453 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -77.72 -30.4 51.72 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.919 0.781 . . . . 0.0 109.431 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.39 74.49 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.19 -43.92 55.38 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.665 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.68 69.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.41 70.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.577 1.173 . . . . 0.0 114.053 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.57 -32.29 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 O-C-N 123.612 0.57 . . . . 0.0 110.403 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.86 -30.89 18.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.14 -14.18 31.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.918 -0.563 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.36 -33.36 13.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.503 0.668 . . . . 0.0 111.593 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.41 -11.89 19.85 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.09 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 403' ' ' SER . 23.7 m-85 -128.19 -42.36 1.53 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 173.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.75 87.19 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.415 1.007 . . . . 0.0 113.451 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -134.03 103.04 0.48 Allowed Glycine 0 C--N 1.352 1.428 0 CA-C-N 119.007 1.403 . . . . 0.0 110.352 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.44 159.02 15.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 117.587 0.694 . . . . 0.0 111.056 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.49 -58.0 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 123.829 0.852 . . . . 0.0 111.257 174.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' ' 346' ' ' LEU . 1.9 t80 -147.2 152.38 38.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.742 1.258 . . . . 0.0 110.737 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.32 137.76 29.03 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -136.0 151.61 20.78 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 122.212 0.896 . . . . 0.0 112.19 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.41 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -98.46 123.87 42.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 56.1 p -126.92 158.97 35.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.765 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.12 159.77 40.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 113.03 -1.896 . . . . 0.0 107.358 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.401 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 23.1 tptm -50.2 102.21 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.401 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 26.5 m80 54.99 22.31 4.29 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -12.45 59.99 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 111.731 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.8 p90 41.37 51.78 5.6 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.44 -30.31 8.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.112 2.541 . . . . 0.0 113.233 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.46 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 28.14 75.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 127.83 2.452 . . . . 0.0 114.143 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.53 -88.84 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 114.185 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.4 p -57.04 154.15 10.23 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.193 0.996 . . . . 0.0 108.809 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -162.77 -173.12 31.08 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.204 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -140.47 157.68 45.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.959 0.504 . . . . 0.0 110.234 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.16 151.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 351' ' ' THR . 9.9 t -129.59 146.22 51.42 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.518 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 61.4 m-85 -121.83 -30.09 4.19 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 123.947 0.779 . . . . 0.0 111.409 -172.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.93 16.48 5.79 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.472 0.483 . . . . 0.0 109.851 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -139.96 140.05 36.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.193 0.997 . . . . 0.0 109.735 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -80.53 -20.49 43.4 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.631 0.372 . . . . 0.0 111.692 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 402' ' ' ARG . 0.6 OUTLIER -58.6 -36.34 73.85 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.528 -177.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.518 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 12.1 m -82.71 -14.53 54.41 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.475 -0.766 . . . . 0.0 110.371 -172.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -76.91 -63.14 1.43 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.511 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.443 ' C ' HD22 ' A' ' 405' ' ' LEU 0.25 0.0 OUTLIER -71.09 -17.5 62.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 118.861 -1.136 . . . . 0.0 113.298 -176.246 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -84.45 -31.16 24.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.484 -0.76 . . . . 0.0 112.37 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.17 30.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.618 1.099 . . . . 0.0 108.197 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.51 -31.39 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.469 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.1 t -77.38 -27.36 52.5 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 124.868 1.355 . . . . 0.0 111.473 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.69 3.62 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.133 -176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.96 -14.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 425' ' ' GLN . 1.9 m-85 -157.71 148.29 20.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.678 0.672 . . . . 0.0 110.352 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.19 149.87 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.875 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.38 151.05 20.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 110.78 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.8 mt -124.01 117.4 50.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.542 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -127.57 64.25 1.35 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.307 1.051 . . . . 0.0 109.044 -178.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -76.93 159.92 29.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.007 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -63.18 -23.09 67.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.723 0.692 . . . . 0.0 110.998 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -142.69 33.14 1.43 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -167.25 125.41 1.29 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.144 0.973 . . . . 0.0 109.0 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 15.2 p -136.4 121.88 19.47 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.784 -1.198 . . . . 0.0 112.017 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.8 tptp -164.77 176.52 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.604 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 47.7 tttt -124.66 156.75 37.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.41 148.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.366 0.984 . . . . 0.0 110.32 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 40.3 tt0 -118.33 161.0 20.66 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 21.6 mt -142.29 137.63 29.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 124.46 1.1 . . . . 0.0 110.702 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.6 129.01 6.77 Favored Pre-proline 0 C--O 1.235 0.334 0 O-C-N 123.546 0.528 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' A' ' 352' ' ' VAL . 23.2 Cg_endo -83.79 174.02 8.87 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.447 1.431 . . . . 0.0 113.846 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 116.458 -1.734 . . . . 0.0 112.651 171.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 122.538 1.161 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 40.8 m -143.92 75.79 1.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.78 1.276 . . . . 0.0 107.946 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.13 2.57 55.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.702 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 415' ' ' ILE . 94.6 p -38.99 141.86 0.26 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -169.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 164.86 -17.41 0.1 Allowed Glycine 0 CA--C 1.537 1.447 0 O-C-N 124.356 1.035 . . . . 0.0 111.966 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 57.7 128.6 0.0 OUTLIER 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.985 2.514 . . . . 0.0 111.664 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.421 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 2.8 mm? -107.04 -49.23 0.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 117.514 -1.232 . . . . 0.0 112.994 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 368' ' ' ALA . 52.4 Cg_exo -60.55 161.31 21.22 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 125.337 4.024 . . . . 0.0 113.888 -174.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.94 160.46 45.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.796 2.997 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -151.63 32.0 0.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.648 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -99.32 -18.86 17.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.14 0.976 . . . . 0.0 112.763 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 42.4 -136.92 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 66.15 34.37 6.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.945 1.298 . . . . 0.0 111.997 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.565 ' H ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -136.4 -40.17 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 175.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 231' ' ' ASN . 7.6 Cg_exo -74.51 -176.88 2.98 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.362 2.041 . . . . 0.0 115.228 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.11 162.38 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 125.336 1.454 . . . . 0.0 108.868 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.454 ' CG ' HG11 ' A' ' 292' ' ' VAL . 14.1 m-85 -109.75 138.78 45.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.962 1.705 . . . . 0.0 107.811 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.9 t -152.04 2.34 0.36 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -171.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.632 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 71.2 m -148.63 63.58 1.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.48 -1.387 . . . . 0.0 114.44 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.23 162.3 0.2 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.356 0.662 . . . . 0.0 112.296 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.54 142.38 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -81.99 127.97 33.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.273 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.1 tm? -136.53 108.33 7.07 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -159.24 160.52 31.34 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-O 122.703 1.168 . . . . 0.0 110.252 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.48 -3.16 3.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.28 122.75 88.27 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 120.604 -1.527 . . . . 0.0 109.629 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -87.2 -4.67 7.72 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 124.232 3.288 . . . . 0.0 109.45 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -134.42 176.26 8.77 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.285 1.434 . . . . 0.0 110.415 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.99 145.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.582 0.753 . . . . 0.0 109.874 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.14 -50.83 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.405 0 C-N-CA 122.601 0.36 . . . . 0.0 110.803 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -164.78 130.43 2.76 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.721 2.008 . . . . 0.0 105.753 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -70.97 -13.33 61.97 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 120.421 1.464 . . . . 0.0 111.965 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.04 65.78 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 125.347 1.459 . . . . 0.0 109.278 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.99 -35.68 84.66 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.83 -45.73 41.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.685 1.231 . . . . 0.0 108.63 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.9 t -62.93 -53.61 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 120.509 -1.37 . . . . 0.0 110.485 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -79.89 -13.71 59.18 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.8 t -81.52 -26.22 35.3 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.525 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -126.44 32.11 5.25 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.276 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 28.6 tpt85 -96.09 -18.2 20.34 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.436 1.094 . . . . 0.0 109.822 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 258' ' ' VAL . 4.7 t -70.35 20.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -128.12 0.4 5.84 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.466 -0.771 . . . . 0.0 112.888 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.56 -95.38 0.1 Allowed Glycine 0 N--CA 1.471 1.004 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.675 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.0 t -144.9 147.38 32.7 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.292 1.046 . . . . 0.0 109.408 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 151.67 24.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.0 m -149.71 175.72 11.32 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.34 150.25 18.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 121.072 -1.017 . . . . 0.0 113.468 -172.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.33 154.09 46.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.582 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.27 138.79 20.97 Favored Pre-proline 0 C--N 1.345 0.385 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.91 -170.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.98 -29.1 4.47 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 125.01 3.806 . . . . 0.0 109.769 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.56 -28.36 6.05 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.164 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 44.34 50.7 7.84 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.342 1.071 . . . . 0.0 110.371 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -118.89 -8.02 10.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.02 8.83 58.89 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.004 -0.887 . . . . 0.0 113.155 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.88 -36.33 76.68 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 118.642 1.221 . . . . 0.0 110.742 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -143.33 126.69 9.11 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.34 -12.41 12.8 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 125.06 3.84 . . . . 0.0 109.731 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -72.46 -72.28 0.25 Allowed 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 123.134 0.573 . . . . 0.0 111.014 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -158.24 143.7 12.22 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 124.592 1.183 . . . . 0.0 109.675 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.97 160.34 34.21 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.222 1.948 . . . . 0.0 111.16 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.37 27.19 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 125.234 3.956 . . . . 0.0 111.018 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.46 158.12 27.91 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -82.8 10.68 56.25 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.581 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.33 170.91 19.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.787 -177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 283' ' ' TYR . 11.7 p -156.85 176.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 125.217 1.573 . . . . 0.0 107.197 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 282' ' ' VAL . 10.6 m-85 -118.17 155.19 30.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 119.763 1.165 . . . . 0.0 111.374 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.02 135.25 55.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.86 120.31 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 125.577 1.551 . . . . 0.0 107.419 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -156.3 0.63 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.232 -174.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.62 18.87 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.187 0.449 . . . . 0.0 110.714 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 86.6 mt 48.99 -141.19 0.65 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 119.831 -1.793 . . . . 0.0 111.362 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 13.39 -74.42 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 127.593 2.357 . . . . 0.0 116.443 168.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -81.77 -29.12 32.92 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.813 0.845 . . . . 0.0 112.962 -170.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.7 m -78.56 -30.63 46.96 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.299 1.04 . . . . 0.0 108.705 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.454 HG11 ' CG ' ' A' ' 234' ' ' TYR . 62.4 t -68.19 -57.3 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -72.56 -20.4 61.32 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.8 t -71.77 -42.92 66.59 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.93 -0.482 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.86 -45.91 33.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.382 0.992 . . . . 0.0 111.497 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -16.32 61.84 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.468 1.031 . . . . 0.0 113.38 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -95.29 -17.03 21.99 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.69 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -78.16 -19.46 53.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 119.957 1.253 . . . . 0.0 112.307 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 5.1 t -115.26 -108.19 0.37 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.341 1.026 . . . . 0.0 113.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.2 t -142.64 163.56 32.48 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -168.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -146.94 156.23 42.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.314 1.846 . . . . 0.0 106.844 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -142.86 125.78 9.09 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.18 13.02 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 1 C-N-CA 127.521 5.481 . . . . 0.0 112.478 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 125.581 1.553 . . . . 0.0 112.766 -177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 19.5 tp . . . . . 0 C--O 1.239 0.519 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 63.5 m -80.04 166.15 21.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.151 0.907 . . . . 0.0 109.702 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -136.18 142.15 44.12 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.44 145.04 35.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.78 151.18 40.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 123.211 1.481 . . . . 0.0 109.324 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -147.85 159.98 43.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.964 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 44.9 mtmt -132.53 131.27 41.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 -3.49 0.91 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 116.115 -1.898 . . . . 0.0 114.344 -167.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 m -144.63 33.71 1.16 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.563 1.529 . . . . 0.0 111.436 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.1 m -61.84 -9.7 7.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.239 1.816 . . . . 0.0 113.5 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -138.37 5.08 2.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.595 0.758 . . . . 0.0 110.221 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -113.51 -28.91 7.36 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.539 0.736 . . . . 0.0 111.464 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.578 ' C ' ' H ' ' A' ' 323' ' ' CYS . 85.7 mmm -131.28 7.52 4.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.383 -0.818 . . . . 0.0 113.167 -172.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 60.85 -16.13 0.03 OUTLIER 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.222 2.209 . . . . 0.0 110.567 -172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.578 ' H ' ' C ' ' A' ' 321' ' ' MET . 80.4 m -110.58 167.75 9.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.789 0.835 . . . . 0.0 110.346 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -159.25 -162.66 1.09 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 122.871 0.468 . . . . 0.0 111.519 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 62.69 137.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.696 1.599 . . . . 0.0 112.868 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 12.6 p -156.58 162.92 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -109.09 155.6 20.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.422 0.555 . . . . 0.0 111.989 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.84 137.72 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 8.5 pt -146.17 94.92 4.83 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.95 169.72 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.888 1 C-N-CA 125.781 4.321 . . . . 0.0 111.257 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.632 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.6 t-105 -86.53 115.35 23.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.254 175.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 18.0 t -99.48 145.09 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 123.298 1.523 . . . . 0.0 108.791 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.25 -31.97 69.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.039 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -84.58 -7.99 59.06 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.68 -1.77 57.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.721 0.692 . . . . 0.0 111.312 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 88.5 p -130.2 -2.11 4.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.725 -0.609 . . . . 0.0 112.37 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -149.58 140.24 22.61 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.202 0.314 . . . . 0.0 110.186 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -156.14 106.67 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.414 0.686 . . . . 0.0 109.331 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -89.2 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.157 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.24 28.64 8.59 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.455 1.121 . . . . 0.0 110.303 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . 0.515 ' H ' HG22 ' A' ' 339' ' ' VAL . 26.5 t -141.63 149.11 52.68 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.06 -3.29 13.58 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.265 3.31 . . . . 0.0 110.592 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -137.85 165.72 25.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -115.14 127.64 55.7 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.756 0.788 . . . . 0.0 111.188 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -142.01 -41.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.127 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 379' ' ' TYR . 4.2 mm? 50.64 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 O-C-N 124.722 1.264 . . . . 0.0 111.948 -171.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.21 140.71 19.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.25 -5.06 14.95 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.718 1.612 . . . . 0.0 114.98 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.4 t -152.51 -169.66 3.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 48.47 99.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.889 2.075 . . . . 0.0 113.742 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.7 t -158.27 155.72 29.4 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 149.76 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 124.132 0.895 . . . . 0.0 110.326 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -85.47 152.91 22.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.796 -169.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 133.27 66.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -167.58 -168.07 29.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.476 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 58.07 19.57 6.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 19.2 mt -67.09 154.66 40.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.657 -1.277 . . . . 0.0 109.839 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.479 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 3.6 p-80 -79.69 16.36 1.13 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 87.36 9.32 72.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.824 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.479 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 8.9 ptp -159.01 12.17 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 173.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 31.8 tp -64.62 140.06 58.83 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.154 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.4 161.05 15.38 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.682 0.793 . . . . 0.0 109.199 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -70.09 -8.63 51.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 364' ' ' GLU . 1.6 pp20? -67.16 -35.14 79.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.36 34.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.615 0.721 . . . . 0.0 110.567 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.9 -31.44 64.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.665 -0.647 . . . . 0.0 110.021 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.75 -50.17 70.13 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.427 ' HB2' ' CD ' ' A' ' 225' ' ' PRO . . . -57.84 -39.14 76.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.879 -0.513 . . . . 0.0 111.576 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 90.2 mt -71.06 -41.8 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 122.034 -0.416 . . . . 0.0 110.109 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.22 -2.94 58.9 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -171.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.49 HD22 ' C ' ' A' ' 371' ' ' ASN . 0.2 OUTLIER -127.99 1.41 5.93 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.571 -1.331 . . . . 0.0 112.528 175.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -119.78 -20.63 7.54 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.962 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.85 -22.76 24.26 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.21 -16.22 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.456 1.026 . . . . 0.0 111.994 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 55.32 84.15 0.04 OUTLIER Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -151.84 3.86 0.43 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 118.195 0.998 . . . . 0.0 113.136 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.8 m -96.0 166.67 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 122.402 1.096 . . . . 0.0 113.179 -173.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.08 -27.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.171 170.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.424 ' CD2' HD21 ' A' ' 346' ' ' LEU . 24.9 t80 -155.18 147.83 24.24 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.12 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 119.235 0.925 . . . . 0.0 108.608 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -153.37 168.58 32.08 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.322 0.889 . . . . 0.0 115.322 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.7 mt -116.65 140.44 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.49 146.96 24.9 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.663 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.3 p -140.52 171.62 13.87 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 124.734 1.272 . . . . 0.0 111.907 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -132.76 18.59 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.435 1.494 . . . . 0.0 108.494 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 387' ' ' HIS 0.274 0.5 OUTLIER 51.83 3.68 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 130.53 3.532 . . . . 0.0 114.794 -176.674 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.512 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 38.7 m170 -140.84 -9.8 1.03 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.681 1.192 . . . . 0.0 112.205 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -94.33 -11.09 30.75 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.86 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.0 p90 41.92 48.57 3.26 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.81 -52.01 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.389 2.726 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 391' ' ' ILE 0.286 6.9 tp 40.17 33.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 122.046 0.927 . . . . 0.0 110.674 -173.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -160.49 16.13 0.19 Allowed Glycine 0 C--N 1.345 1.078 0 CA-C-O 118.593 -1.115 . . . . 0.0 112.496 -176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.5 p -145.44 112.12 5.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.81 0.805 . . . . 0.0 109.088 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -152.01 -175.76 24.01 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -147.28 167.04 25.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.87 142.08 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 27.8 m -99.93 105.49 17.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -85.75 162.35 18.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.231 0.613 . . . . 0.0 110.477 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -147.13 19.06 1.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.581 0.705 . . . . 0.0 111.346 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -144.39 165.37 28.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.44 1.096 . . . . 0.0 108.755 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -88.16 -36.28 16.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 120.943 1.702 . . . . 0.0 113.298 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -51.35 -26.81 8.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -76.19 -30.26 57.97 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.51 -56.94 6.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.333 -1.479 . . . . 0.0 110.471 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -23.65 58.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.902 -1.124 . . . . 0.0 113.677 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -85.79 -22.91 27.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -87.58 -28.06 22.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.179 -0.325 . . . . 0.0 110.301 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.8 m -84.57 -25.0 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.2 p -85.55 -24.87 27.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.008 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -84.0 -44.59 14.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.5 -20.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.126 2.971 . . . . 0.0 115.096 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -149.99 145.88 26.69 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.23 156.14 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 O-C-N 121.41 -0.806 . . . . 0.0 110.221 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -109.38 139.54 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 124.277 0.985 . . . . 0.0 112.882 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 221' ' ' SER . 37.5 mt -118.53 126.41 75.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.452 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -131.23 14.56 5.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.496 1.123 . . . . 0.0 110.598 -170.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -60.88 157.06 15.97 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.591 1.156 . . . . 0.0 109.735 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -62.68 -0.77 0.68 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -139.47 4.72 2.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -160.32 130.29 5.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.132 0.973 . . . . 0.0 112.516 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 416' ' ' LYS . 17.3 p -140.16 102.29 4.34 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 120.263 1.392 . . . . 0.0 110.95 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.571 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 32.4 tptt -166.39 -176.1 3.49 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.813 174.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 43.1 mtpt -128.04 172.23 11.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.617 0.767 . . . . 0.0 110.625 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.21 159.47 20.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.211 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -130.0 135.92 48.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 426' ' ' ILE . 3.7 mp -110.9 145.16 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.54 151.22 63.09 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 118.956 0.798 . . . . 0.0 110.614 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.01 166.41 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.242 2.628 . . . . 0.0 113.109 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 123.955 0.902 . . . . 0.0 110.045 -177.062 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 26.5 m 42.23 66.17 0.78 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.742 1.217 . . . . 0.0 112.729 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 19.35 0.11 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.7 m 57.16 35.1 25.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.07 86.23 0.05 OUTLIER Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -79.84 -14.78 58.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.821 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 43.75 113.34 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 128.29 2.636 . . . . 0.0 115.206 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.52 169.03 19.07 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.96 3.107 . . . . 0.0 110.039 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.11 156.55 12.79 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.072 2.515 . . . . 0.0 113.435 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -141.45 179.55 6.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.14 2.176 . . . . 0.0 108.199 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 50.48 40.79 24.06 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.674 0.79 . . . . 0.0 113.088 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.64 159.51 1.54 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.73 0.812 . . . . 0.0 111.006 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -101.26 2.41 39.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.524 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.9 OUTLIER -126.39 35.69 0.3 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -177.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 68.7 Cg_endo -75.15 155.89 42.29 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.892 2.394 . . . . 0.0 111.394 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.71 140.71 43.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.25 121.97 38.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 95.6 p -125.93 -6.87 6.68 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.777 -170.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.35 -173.96 3.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 123.948 0.899 . . . . 0.0 108.643 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -60.23 155.89 16.58 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.244 -170.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.57 135.52 31.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -100.67 122.55 43.51 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 108.704 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.2 tt -145.46 143.33 29.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.775 -0.578 . . . . 0.0 110.512 -169.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.56 145.75 9.56 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 123.337 0.398 . . . . 0.0 112.147 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.5 17.43 0.02 OUTLIER Glycine 0 C--O 1.211 -1.329 0 CA-C-N 119.049 1.425 . . . . 0.0 113.818 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.05 95.4 39.45 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 118.147 0.973 . . . . 0.0 111.71 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.79 10.83 3.52 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 125.133 3.889 . . . . 0.0 112.533 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 246' ' ' ASP . 11.6 p-90 -128.14 -9.79 5.33 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 11.5 p-10 -60.28 116.26 4.12 Favored 'General case' 0 C--O 1.254 1.29 0 O-C-N 123.943 0.777 . . . . 0.0 113.087 -175.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.52 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -78.32 -15.81 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.4 p -153.6 148.17 26.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.249 1.023 . . . . 0.0 108.415 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -84.1 -22.56 31.09 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.772 -1.205 . . . . 0.0 108.727 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -78.31 -14.77 59.27 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.433 1.083 . . . . 0.0 113.319 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.82 -66.07 2.78 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.5 pt? -66.08 -29.37 69.69 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.73 -35.87 76.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.786 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -77.11 -18.06 58.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.705 -1.872 . . . . 0.0 110.198 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.5 p -77.85 -25.68 48.88 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.359 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.33 20.03 4.81 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 121.832 2.106 . . . . 0.0 112.545 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.1 20.92 1.46 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 119.547 -1.971 . . . . 0.0 111.913 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.5 t -71.09 -9.91 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -166.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -91.88 -2.65 56.74 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.432 1.083 . . . . 0.0 111.085 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.81 -2.7 3.44 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-O 117.698 -1.612 . . . . 0.0 116.612 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.7 m -102.54 22.3 13.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 119.183 1.492 . . . . 0.0 112.337 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 3.7 mm? -68.97 145.23 53.79 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 t -145.35 81.47 1.63 Allowed 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.1 p -75.7 141.25 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.068 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -150.94 157.82 43.38 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.368 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.49 ' HB3' HG23 ' A' ' 282' ' ' VAL . 42.4 p90 -151.66 146.67 19.02 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.05 91.91 1.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.635 2.223 . . . . 0.0 110.267 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -178.52 177.84 48.52 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -105.46 124.34 49.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.94 -0.741 . . . . 0.0 109.434 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -111.13 7.9 21.52 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.49 0.716 . . . . 0.0 110.097 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -67.05 -12.0 59.51 Favored Glycine 0 N--CA 1.47 0.951 0 CA-C-O 118.067 -1.407 . . . . 0.0 113.824 -172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -138.7 -35.5 0.58 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.561 1.681 . . . . 0.0 111.513 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -143.87 133.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.61 -13.96 6.83 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 125.059 3.839 . . . . 0.0 111.463 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -96.41 20.67 10.19 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.452 ' HB3' ' HD3' ' A' ' 277' ' ' PRO . 42.4 t -53.46 -41.27 85.94 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.892 -0.575 . . . . 0.0 112.03 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 276' ' ' CYS . 32.5 Cg_endo -98.29 95.72 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.41 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.83 4.85 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.585 4.19 . . . . 0.0 115.407 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -78.26 6.75 7.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 66.14 11.43 55.36 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.49 141.61 44.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.602 1.201 . . . . 0.0 112.739 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -150.03 170.76 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.983 0.897 . . . . 0.0 109.054 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -133.72 155.61 49.45 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.842 -1.161 . . . . 0.0 109.986 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 96.9 mt -131.16 145.76 52.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.19 0.596 . . . . 0.0 111.908 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.31 134.2 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 15.6 p90 -169.23 -163.26 0.4 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 125.007 1.442 . . . . 0.0 108.133 -174.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.16 110.21 0.46 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.582 1.153 . . . . 0.0 107.933 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 54.1 mt -89.83 -179.66 5.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.172 0.987 . . . . 0.0 110.396 -172.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 63.99 -67.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.367 1.867 . . . . 0.0 113.803 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -81.03 -43.35 19.69 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.433 -0.792 . . . . 0.0 111.261 -168.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 7.5 m -79.13 -31.4 44.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.84 -51.65 59.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -62.7 -32.22 73.27 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 70.4 m -57.23 -44.2 83.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.475 1.11 . . . . 0.0 111.884 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.7 -49.72 67.49 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.796 -1.19 . . . . 0.0 110.194 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 296' ' ' LEU . 0.1 OUTLIER -65.35 -26.63 68.11 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 119.182 -0.437 . . . . 0.0 112.018 -177.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -96.21 -4.25 42.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 123.855 0.722 . . . . 0.0 111.742 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.33 -12.57 19.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 314' ' ' PHE . 9.8 t -127.43 -124.05 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.0 t -116.49 163.65 15.75 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -155.8 159.6 39.55 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.724 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.19 137.73 31.47 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.26 75.52 5.02 Favored 'Trans proline' 0 C--N 1.35 0.612 1 C-N-CA 128.302 6.001 . . . . 0.0 112.867 -168.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 304' ' ' LEU . 2.8 mp . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 115.784 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.422 0.154 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 1.5 m -62.89 153.45 33.31 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.357 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -137.24 150.06 47.58 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 123.834 0.709 . . . . 0.0 110.744 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.44 146.86 44.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -140.02 155.13 47.22 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.654 -1.279 . . . . 0.0 112.17 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.493 ' HA ' ' SG ' ' A' ' 299' ' ' CYS . 32.4 t80 -145.22 174.29 11.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -125.4 132.41 52.77 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.21 0.914 . . . . 0.0 108.922 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.602 ' H ' ' HE3' ' A' ' 316' ' ' MET . 0.0 OUTLIER -123.3 14.3 9.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.295 1.038 . . . . 0.0 109.662 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.3 p -82.01 2.1 32.49 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.115 0.566 . . . . 0.0 111.312 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 45.7 t -61.31 150.87 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 109.968 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 56.1 8.49 0.39 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.861 0.864 . . . . 0.0 112.286 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -129.5 -62.97 0.95 Allowed 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.566 -0.709 . . . . 0.0 110.761 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.5 mmt -123.59 -13.68 7.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.435 1.094 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 44.74 23.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.8 2.04 . . . . 0.0 114.993 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 3.1 t -151.56 17.45 0.71 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 121.262 1.846 . . . . 0.0 114.172 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.56 115.55 22.35 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.989 0.9 . . . . 0.0 112.713 -174.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -74.95 162.34 28.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.016 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.88 150.02 32.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.159 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -83.32 136.71 34.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.292 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.36 133.36 57.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.013 0.824 . . . . 0.0 111.017 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 62.1 mt -149.64 114.98 3.52 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.5 154.44 6.47 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 125.024 3.816 . . . . 0.0 112.765 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -76.2 120.0 20.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 334' ' ' ALA . 44.4 t -90.06 142.67 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.377 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 333' ' ' LEU . 1.7 tt -59.01 -25.96 64.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.35 0.595 . . . . 0.0 112.195 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.653 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -76.9 1.95 16.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.045 -1.659 . . . . 0.0 114.047 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -94.82 -8.63 36.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.675 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.7 m -103.91 -27.98 11.85 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.337 1.426 . . . . 0.0 114.046 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -163.03 162.79 26.07 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.146 0.278 . . . . 0.0 110.794 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.603 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 79.0 t80 -160.67 147.51 15.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.299 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.3 141.65 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 O-C-N 123.67 0.607 . . . . 0.0 110.405 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.81 20.33 18.28 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.012 0.91 . . . . 0.0 109.007 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 18.3 t -143.54 145.98 33.72 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.68 1.592 . . . . 0.0 107.341 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.56 5.42 4.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 121.716 1.611 . . . . 0.0 112.865 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 63.9 m -106.11 158.42 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.485 0.714 . . . . 0.0 109.639 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -111.03 12.64 22.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.216 0.606 . . . . 0.0 112.559 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -70.6 162.99 27.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.718 1.247 . . . . 0.0 112.263 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 346' ' ' LEU . 11.1 tp -145.8 143.62 29.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . 0.544 ' H ' HG21 ' A' ' 397' ' ' THR . 12.1 m-20 -134.65 85.3 36.92 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 124.651 1.18 . . . . 0.0 110.535 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.89 -9.95 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 124.742 3.628 . . . . 0.0 114.196 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 87.9 p -72.61 -12.57 61.1 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.141 -0.974 . . . . 0.0 112.789 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -142.43 94.23 2.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.1 t -149.33 152.27 35.57 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.92 154.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.661 1.22 . . . . 0.0 108.942 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -90.34 161.96 15.37 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.328 -171.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 4.5 p -144.68 145.16 21.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 O-C-N 121.487 -0.758 . . . . 0.0 111.378 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.91 -174.88 36.55 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 47.47 34.57 3.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.699 0.4 . . . . 0.0 111.745 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.01 -176.52 3.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.867 1.267 . . . . 0.0 108.649 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' A' ' 360' ' ' MET . 22.6 t-160 -65.13 140.32 58.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.18 0.592 . . . . 0.0 111.075 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -67.85 5.61 3.39 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.162 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.416 ' HB2' ' CE1' ' A' ' 358' ' ' HIS . 40.7 mtp -138.71 28.08 2.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.857 1.329 . . . . 0.0 107.495 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.17 82.92 0.08 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.562 1.648 . . . . 0.0 108.473 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 360' ' ' MET . 5.4 p30 -64.69 156.78 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.107 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -66.92 -19.1 65.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 120.599 -1.313 . . . . 0.0 111.401 -175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -72.64 -27.77 62.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 120.943 -1.098 . . . . 0.0 109.001 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -87.49 -32.73 19.29 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.223 1.409 . . . . 0.0 111.017 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.91 -37.37 86.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -78.8 -28.99 44.63 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.835 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -67.82 -42.47 81.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.122 1.328 . . . . 0.0 108.558 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.0 -44.22 92.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.251 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 374' ' ' PHE . 45.4 mt -89.9 -7.86 53.21 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 117.784 -1.103 . . . . 0.0 112.724 -171.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.83 -28.43 15.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.742 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.7 -26.48 25.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.98 -13.02 20.1 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 370' ' ' LEU . 22.1 m-30 -119.91 -23.07 6.52 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 120.25 1.387 . . . . 0.0 111.942 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 76.4 -0.68 63.37 Favored Glycine 0 CA--C 1.552 2.381 0 O-C-N 125.048 1.468 . . . . 0.0 113.867 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.46 120.08 0.71 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 121.36 2.58 . . . . 0.0 111.807 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.36 171.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 126.171 1.788 . . . . 0.0 107.834 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.85 -30.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.913 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -163.05 136.82 5.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.085 0.402 . . . . 0.0 110.656 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.15 129.66 13.04 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -140.73 159.67 26.46 Favored Glycine 0 C--O 1.22 -0.747 0 O-C-N 121.861 -0.525 . . . . 0.0 114.128 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 23.8 mm -80.88 149.2 5.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.5 47.8 0.5 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.909 0.755 . . . . 0.0 110.386 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.4 p -64.53 158.83 23.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 123.817 1.77 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -140.94 146.99 38.1 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.389 2.676 . . . . 0.0 104.4 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -61.01 122.5 15.09 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.695 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.4 m170 67.73 42.05 2.09 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.08 -10.86 8.11 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.3 p90 38.18 50.71 2.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.15 -46.33 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.216 2.611 . . . . 0.0 113.995 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.8 tp 41.99 31.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 112.732 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -133.66 -6.37 2.63 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -172.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.0 p -156.91 160.69 39.36 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 118.626 1.213 . . . . 0.0 108.105 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -176.99 -165.26 32.11 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.182 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -156.82 161.24 39.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.554 0.741 . . . . 0.0 109.933 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.31 134.53 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 120.9 1.682 . . . . 0.0 108.477 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . 0.544 HG21 ' H ' ' A' ' 347' ' ' ASP . 96.8 m -106.37 141.95 36.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 125.062 1.476 . . . . 0.0 108.323 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.58 161.44 16.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.592 1.557 . . . . 0.0 112.271 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -131.26 11.37 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -135.96 140.31 43.87 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -76.91 -29.56 55.77 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.578 0.549 . . . . 0.0 111.869 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.567 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -64.44 -18.59 64.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.382 0.537 . . . . 0.0 110.739 -175.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.1 m -79.81 -19.74 47.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 118.485 0.584 . . . . 0.0 111.187 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -76.5 -51.14 12.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.107 0.867 . . . . 0.0 110.945 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.441 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.09 -19.2 61.21 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 119.611 1.096 . . . . 0.0 111.646 177.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.81 -26.32 57.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.737 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.98 59.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.805 -0.559 . . . . 0.0 110.908 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.53 -9.07 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.567 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.2 p -105.25 -8.79 18.08 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.324 0.39 . . . . 0.0 110.26 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -100.9 -48.44 4.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.517 0.51 . . . . 0.0 110.335 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.01 -12.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 129.947 3.299 . . . . 0.0 118.858 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -162.72 138.5 7.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.255 -1.528 . . . . 0.0 107.262 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.83 157.0 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.375 -0.828 . . . . 0.0 111.031 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 423' ' ' LYS . 41.6 mt-10 -105.97 138.92 41.32 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.401 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 421' ' ' THR . 73.4 mt -103.41 116.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -134.45 110.19 9.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.632 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.0 p -132.39 -175.12 3.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.664 0.786 . . . . 0.0 110.249 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 418' ' ' THR . 88.9 m -83.19 4.49 26.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.64 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -143.27 -4.73 0.88 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.849 1.204 . . . . 0.0 113.73 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -144.65 145.53 31.8 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.681 0.613 . . . . 0.0 110.052 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 26.6 m -153.85 116.21 4.37 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.99 0.516 . . . . 0.0 109.955 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -162.16 157.12 22.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 123.804 0.69 . . . . 0.0 110.679 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 414' ' ' GLU . 0.1 OUTLIER -114.87 162.42 16.93 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.88 148.34 19.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.731 1.212 . . . . 0.0 108.316 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -132.19 129.36 39.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.937 1.351 . . . . 0.0 111.776 -170.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.13 143.83 16.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.047 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -136.64 148.5 63.86 Favored Pre-proline 0 N--CA 1.444 -0.745 0 O-C-N 123.676 0.61 . . . . 0.0 110.223 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.56 158.41 13.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.944 3.096 . . . . 0.0 112.468 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 117.448 -1.263 . . . . 0.0 109.028 178.497 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 221' ' ' SER . 2.3 m 43.99 45.7 6.67 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.339 1.056 . . . . 0.0 110.838 -170.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 15.02 0.04 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.532 ' HB2' ' H ' ' A' ' 416' ' ' LYS . 78.5 p -46.52 143.05 2.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.571 1.548 . . . . 0.0 113.944 -168.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 134.96 -2.22 3.96 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.77 -1.104 . . . . 0.0 114.072 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -134.48 22.05 3.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.394 1.097 . . . . 0.0 111.326 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.71 -57.96 3.0 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-O 116.131 -1.89 . . . . 0.0 112.918 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.26 117.19 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.6 2.867 . . . . 0.0 108.88 -170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.57 -40.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.304 3.336 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 43.52 22.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -86.42 -7.7 58.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.755 1.222 . . . . 0.0 111.796 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.98 145.64 52.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 230' ' ' LYS . 25.8 mmmt -144.39 8.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.367 -0.833 . . . . 0.0 113.142 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 61.86 50.25 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.173 -172.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.04 129.61 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.859 2.373 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.5 mm -147.72 144.81 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.468 ' CG ' HG11 ' A' ' 292' ' ' VAL . 7.8 m-85 -105.88 151.52 24.44 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.807 -172.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -152.08 3.77 0.39 Allowed 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 4.0 t -146.99 -170.37 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.313 -0.867 . . . . 0.0 108.828 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 175.94 1.19 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.91 141.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.852 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -91.05 133.92 34.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.718 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.457 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.8 tt -143.11 124.36 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -156.62 152.11 23.5 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.04 14.55 0.1 Allowed Glycine 0 CA--C 1.537 1.42 0 O-C-N 124.646 0.85 . . . . 0.0 111.656 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.29 108.66 61.91 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 118.114 0.957 . . . . 0.0 110.982 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.3 0.26 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 124.847 3.698 . . . . 0.0 113.642 171.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.437 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 4.2 p-90 -135.9 -96.86 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 25.0 t0 42.53 65.02 0.99 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.577 . . . . 0.0 111.855 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.741 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.12 -30.49 36.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -171.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 250' ' ' ALA . 16.8 m -140.18 126.65 20.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.97 -7.41 58.78 Favored 'General case' 0 C--O 1.201 -1.499 0 O-C-N 123.554 0.534 . . . . 0.0 110.735 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.52 -21.71 61.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.062 -0.399 . . . . 0.0 111.462 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.76 -48.99 6.78 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.59 -41.2 98.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 114.823 -0.688 . . . . 0.0 109.638 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.57 -50.72 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.494 -1.379 . . . . 0.0 110.641 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -69.24 -9.06 51.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.4 m -80.94 -32.32 34.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.1 68.29 1.4 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.858 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 257' ' ' ARG . 13.6 ttt180 -123.74 7.18 8.78 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.439 1.096 . . . . 0.0 111.727 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.91 7.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 119.807 -1.808 . . . . 0.0 112.362 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.72 -10.32 23.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.34 -4.07 13.8 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.878 1.511 . . . . 0.0 116.878 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.7 p -112.32 44.76 1.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 120.599 -1.53 . . . . 0.0 111.704 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -142.47 163.57 32.47 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.6 m -149.99 175.69 11.46 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.483 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.98 157.08 41.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 O-C-N 121.525 -0.734 . . . . 0.0 111.013 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -138.11 135.6 35.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.392 1.091 . . . . 0.0 111.275 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.31 148.9 36.46 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.23 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.01 -21.37 15.9 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.239 3.293 . . . . 0.0 111.756 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 178.27 -6.5 0.03 OUTLIER Glycine 0 CA--C 1.547 2.078 0 CA-C-O 118.482 -1.176 . . . . 0.0 115.859 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 278' ' ' PRO . 18.5 tptp -94.87 107.18 19.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.793 2.297 . . . . 0.0 109.872 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.69 145.02 29.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 167.88 -173.35 42.81 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -63.92 -40.52 96.66 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.82 1.648 . . . . 0.0 112.272 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -147.05 84.56 7.34 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.25 -48.65 1.16 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.528 2.152 . . . . 0.0 114.095 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 46.56 9.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.03 2.132 . . . . 0.0 114.922 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 41.9 t -164.52 111.33 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 119.255 0.934 . . . . 0.0 110.391 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.91 160.82 46.77 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.882 2.388 . . . . 0.0 110.076 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 269' ' ' LYS . 87.0 Cg_endo -78.28 -17.47 13.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.234 2.623 . . . . 0.0 112.01 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -146.9 167.35 24.17 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.146 1.379 . . . . 0.0 110.878 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.66 19.72 3.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.964 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -152.82 165.86 34.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.336 1.568 . . . . 0.0 112.631 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.6 m -154.76 -170.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 126.328 2.267 . . . . 0.0 109.391 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -118.3 153.87 33.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.418 1.087 . . . . 0.0 110.525 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.74 147.31 48.72 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.15 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.98 112.02 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 109.268 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.629 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -139.76 -179.73 6.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.53 -174.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.56 124.18 10.27 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -62.17 -13.38 26.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.67 -49.22 0.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 116.859 -1.937 . . . . 0.0 112.195 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -81.19 -36.68 29.82 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 72.7 m -76.22 -31.18 58.27 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 120.158 1.345 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.629 HG22 ' CE1' ' A' ' 286' ' ' PHE . 2.8 t -60.86 -52.33 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -74.54 -23.48 58.8 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 74.8 m -72.44 -36.42 68.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 109.924 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.9 mp -74.66 -54.14 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 4.16 36.76 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.573 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -111.19 -10.51 14.29 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 110.783 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.54 37.25 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.323 0.965 . . . . 0.0 110.773 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.41 -115.7 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.794 0.806 . . . . 0.0 112.634 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.4 m -126.01 155.97 40.62 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 111.688 -171.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -157.56 159.28 36.97 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.646 1.178 . . . . 0.0 109.049 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 304' ' ' LEU . 16.2 m-20 -146.65 89.12 5.85 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 109.684 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' ASP . 65.0 Cg_endo -67.02 22.52 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.998 1 C-N-CA 128.618 6.212 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 302' ' ' ASP . 7.2 mp . . . . . 0 C--O 1.238 0.464 0 C-N-CA 124.492 1.117 . . . . 0.0 112.271 -166.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 310' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 121.104 0.478 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 309' ' ' LEU . 3.2 p 171.08 176.97 0.06 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.418 1.487 . . . . 0.0 107.963 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.27 130.76 50.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -108.48 143.81 36.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -124.78 145.27 49.82 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.847 0.832 . . . . 0.0 110.725 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -151.71 155.98 39.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.315 -1.311 . . . . 0.0 107.77 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 11.0 ptpt -129.34 143.61 50.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.015 0.825 . . . . 0.0 110.177 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.49 -7.65 5.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.676 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.7 t -140.34 133.34 29.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.653 1.115 . . . . 0.0 109.685 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 60.4 m -140.85 -13.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.1 -8.77 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.941 1.246 . . . . 0.0 110.849 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -86.24 -29.11 23.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.769 0.827 . . . . 0.0 111.479 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.437 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 97.2 mmm -142.08 164.89 28.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.24 0.616 . . . . 0.0 109.748 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 322' ' ' ARG . 70.6 mtt-85 -92.07 45.94 1.24 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.147 1.379 . . . . 0.0 111.172 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.25 -166.13 1.53 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.798 0.839 . . . . 0.0 109.642 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -143.27 -173.2 3.87 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -54.36 158.65 2.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.571 1.548 . . . . 0.0 113.173 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 240' ' ' LEU . 11.4 p -121.38 153.4 25.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -172.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.65 150.31 21.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 120.181 1.355 . . . . 0.0 110.253 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.86 145.65 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.865 0.466 . . . . 0.0 110.281 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -144.12 99.73 5.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 123.775 0.672 . . . . 0.0 111.803 172.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.22 168.11 15.28 Favored 'Trans proline' 0 N--CA 1.46 -0.454 1 C-N-CA 125.306 4.004 . . . . 0.0 110.849 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 2.8 t-105 -88.0 125.42 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.3 t -105.84 145.12 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.394 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 333' ' ' LEU . 13.1 mt -55.79 -21.33 18.78 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.729 0.643 . . . . 0.0 111.071 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.6 -4.42 30.73 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.72 3.61 15.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.192 1.397 . . . . 0.0 111.073 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 46.6 m -107.13 -49.29 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 120.694 -1.254 . . . . 0.0 111.841 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -155.04 153.88 31.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.544 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -153.8 145.72 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.571 0.748 . . . . 0.0 109.446 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.86 138.52 41.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 18.17 4.12 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.0 t -150.6 141.44 14.72 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.29 1.836 . . . . 0.0 107.29 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -66.23 -15.99 50.25 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.901 3.067 . . . . 0.0 111.069 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 37.8 p -163.22 90.91 0.68 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.439 1.018 . . . . 0.0 111.758 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -154.29 168.59 26.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -131.95 -179.28 5.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.325 1.45 . . . . 0.0 110.235 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 346' ' ' LEU . 3.8 mm? -74.63 171.76 13.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -175.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -116.36 155.27 48.64 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.681 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -68.72 104.1 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.701 2.267 . . . . 0.0 113.205 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 74.4 m 57.31 46.15 18.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.131 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 350' ' ' ARG . 4.6 tpm_? -138.03 87.99 2.28 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.102 -0.999 . . . . 0.0 112.439 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.0 p -144.08 166.95 23.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.72 163.32 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.009 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -86.78 160.83 18.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.726 0.694 . . . . 0.0 110.487 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.7 t -146.32 131.89 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.75 -175.85 37.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 49.39 29.14 2.67 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.423 1.089 . . . . 0.0 112.273 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.813 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -93.54 -175.73 3.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.668 -0.645 . . . . 0.0 110.175 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -59.13 154.03 16.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.155 0.582 . . . . 0.0 111.904 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.08 1.1 9.04 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.256 -0.746 . . . . 0.0 113.665 -172.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 13.3 ptp -158.18 30.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.466 2.133 . . . . 0.0 111.839 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.1 126.99 29.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.23 167.49 13.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.038 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.59 -25.54 61.37 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 121.469 -0.769 . . . . 0.0 112.167 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -82.99 -18.93 38.14 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 118.481 0.582 . . . . 0.0 111.994 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.88 -36.48 18.39 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.59 -46.59 89.2 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.23 68.08 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.613 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.97 84.52 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.916 0.78 . . . . 0.0 109.695 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 35.8 mt -71.12 -36.51 63.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 119.633 -0.222 . . . . 0.0 110.56 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.0 -0.9 55.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.404 ' HA ' ' HA2' ' A' ' 375' ' ' GLY . 0.5 OUTLIER -116.79 -15.3 10.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 120.837 -1.165 . . . . 0.0 112.269 174.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.29 -26.83 13.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.852 0.751 . . . . 0.0 109.212 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.0 tp -80.87 -17.42 50.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 123.424 0.453 . . . . 0.0 110.428 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 403' ' ' SER . 29.0 p90 -166.74 -13.53 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 371' ' ' ASN . . . 68.1 20.1 72.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 171.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -90.1 9.23 78.06 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 120.808 -1.407 . . . . 0.0 114.613 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.5 163.43 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.236 1.018 . . . . 0.0 113.516 -170.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.25 -33.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.232 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -159.46 147.55 17.48 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 396' ' ' VAL . . . -150.43 149.04 29.5 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.457 0.646 . . . . 0.0 110.455 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.71 160.97 29.3 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.64 -0.662 . . . . 0.0 113.493 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.4 mm -96.37 144.28 10.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 124.383 0.696 . . . . 0.0 110.564 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -82.52 60.92 5.4 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 121.231 0.539 . . . . 0.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . 0.464 ' HA ' ' HG2' ' A' ' 390' ' ' PRO . 2.9 p -61.15 154.53 22.96 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 124.068 1.89 . . . . 0.0 111.903 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.49 129.58 20.84 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.0 130.75 45.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.226 -170.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 8.4 m170 68.53 29.09 5.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.145 -2.298 . . . . 0.0 112.398 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.71 -0.53 13.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.2 t80 47.41 41.55 0.94 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.129 1.772 . . . . 0.0 113.645 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 392' ' ' GLY . 36.1 Cg_endo -81.34 37.91 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.523 2.148 . . . . 0.0 109.025 -170.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.454 ' HB ' ' CH2' ' A' ' 331' ' ' TRP . 10.8 tp -69.83 25.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.984 0 C-N-CA 123.637 0.775 . . . . 0.0 111.448 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 390' ' ' PRO . . . -123.04 1.55 9.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 118.543 -1.143 . . . . 0.0 111.142 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.3 p -155.47 151.61 27.94 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.264 1.032 . . . . 0.0 110.794 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.81 -174.73 42.62 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.882 1.268 . . . . 0.0 113.958 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.07 166.8 20.93 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 121.324 -1.103 . . . . 0.0 111.227 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 380' ' ' ALA . 7.4 p -146.18 144.12 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 23.1 m -103.76 119.15 38.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.6 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -106.39 156.3 18.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.656 0.782 . . . . 0.0 108.945 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -136.16 21.99 3.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -141.4 159.22 42.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -83.14 -47.24 11.83 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . 0.444 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.38 -21.86 62.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 374' ' ' PHE . 34.2 p -72.51 -21.75 61.14 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.926 -1.109 . . . . 0.0 111.163 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.58 -62.73 1.48 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.28 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.631 ' H ' HD13 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -67.95 -17.08 64.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 119.317 0.962 . . . . 0.0 113.124 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.17 -29.34 28.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.586 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -18.25 58.0 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.31 -1.494 . . . . 0.0 110.411 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.14 -27.4 7.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.4 t -85.79 -9.56 56.87 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 0.0 111.299 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -112.22 -59.66 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.247 172.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.68 -16.33 0.03 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 127.921 2.488 . . . . 0.0 114.055 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -162.8 136.99 6.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.9 m -139.54 164.29 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -105.11 145.56 30.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.957 1.411 . . . . 0.0 110.824 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.9 mt -123.89 126.52 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.411 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 221' ' ' SER . 57.0 mmtt -137.65 114.37 10.5 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.704 1.253 . . . . 0.0 110.243 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 92.7 m -151.01 159.51 44.51 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -54.67 139.95 37.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.566 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? 59.32 13.43 3.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.12 1.368 . . . . 0.0 114.675 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.54 116.18 4.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.897 -1.127 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 17.2 p -145.84 112.43 5.91 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.2 tptm -166.64 -173.11 2.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.011 0.823 . . . . 0.0 110.022 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.655 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.5 mttp -125.66 172.18 9.99 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 123.604 0.762 . . . . 0.0 109.562 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -144.25 151.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.853 1.346 . . . . 0.0 109.881 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.0 158.57 36.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.235 -0.915 . . . . 0.0 110.274 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 23.8 mt -142.69 146.02 22.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -147.56 141.62 15.91 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.653 0.661 . . . . 0.0 110.669 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -82.76 174.62 9.43 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 124.243 3.295 . . . . 0.0 111.192 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.19 171.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.761 0.791 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 98.1 m -139.52 147.48 41.3 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 171.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.7 -25.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.1 m 50.39 119.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.426 2.29 . . . . 0.0 114.445 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.45 -3.92 0.05 OUTLIER Glycine 0 N--CA 1.469 0.84 0 O-C-N 120.394 -1.441 . . . . 0.0 115.598 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.06 -9.39 55.24 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.374 -1.663 . . . . 0.0 114.604 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 224' ' ' LEU . 3.8 mm? -16.5 88.05 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 128.954 2.902 . . . . 0.0 111.281 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.83 158.43 3.41 Favored 'Trans proline' 0 N--CA 1.449 -1.11 1 C-N-CA 127.581 5.521 . . . . 0.0 111.496 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 147.74 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.949 1.766 . . . . 0.0 110.484 172.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -139.83 18.33 2.49 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.867 0.73 . . . . 0.0 109.066 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -122.39 32.13 5.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.922 0.889 . . . . 0.0 112.647 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -64.33 162.26 15.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.196 1.398 . . . . 0.0 112.762 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -77.19 -19.37 56.84 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 58.74 73.35 0.72 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.96 -44.08 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.505 2.137 . . . . 0.0 115.419 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.9 mt -147.8 153.88 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.578 1.081 . . . . 0.0 108.274 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -112.53 150.9 30.65 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.6 t -150.06 17.75 0.86 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.387 0.994 . . . . 0.0 113.409 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' CYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 331' ' ' TRP . 0.9 OUTLIER -156.77 -175.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -61.54 171.25 1.55 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.469 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 286' ' ' PHE . 2.7 p -136.25 150.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.456 -170.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -92.6 133.42 35.98 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 240' ' ' LEU . 3.4 tm? -142.13 124.44 15.59 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.754 1.161 . . . . 0.0 110.564 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 167.56 -172.5 42.46 Favored Glycine 0 N--CA 1.473 1.142 0 O-C-N 124.061 0.851 . . . . 0.0 112.635 172.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.47 7.12 3.2 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.273 0.94 . . . . 0.0 112.764 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 6.5 m -102.62 135.89 19.43 Favored Pre-proline 0 C--O 1.219 -0.51 0 C-N-CA 123.722 0.809 . . . . 0.0 111.203 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 243' ' ' VAL . 33.4 Cg_exo -70.23 -5.08 15.65 Favored 'Trans proline' 0 N--CA 1.439 -1.722 1 C-N-CA 126.33 4.687 . . . . 0.0 115.574 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 323' ' ' CYS . 22.3 p-90 -142.13 -60.9 0.46 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 120.216 1.371 . . . . 0.0 113.803 -174.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.48 -60.13 0.13 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.133 1.373 . . . . 0.0 112.996 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 248' ' ' THR 0.5 0.0 OUTLIER 63.34 -41.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.832 1.958 . . . . 0.0 115.232 -179.461 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 247' ' ' ILE . 25.9 p -157.86 134.95 10.08 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 124.901 1.281 . . . . 0.0 109.078 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.1 pm0 -89.51 -22.85 22.23 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 119.632 -1.918 . . . . 0.0 111.745 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.03 64.42 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.165 0.915 . . . . 0.0 111.32 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.19 15.69 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 255' ' ' THR . 46.6 mt -70.74 -36.97 73.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.66 -37.68 80.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.582 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.431 ' HA ' ' CD ' ' A' ' 257' ' ' ARG . 62.9 m-20 -64.14 -21.96 66.75 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.243 1.383 . . . . 0.0 109.735 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 252' ' ' LEU . 84.2 m -79.16 -27.62 42.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.784 0.72 . . . . 0.0 110.669 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -131.28 23.19 4.81 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.442 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 16.6 ptm180 -86.96 33.92 0.67 Allowed 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.052 0.941 . . . . 0.0 113.391 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.54 2.26 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.14 -2.27 15.02 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 64.01 3.56 8.87 Favored Glycine 0 C--O 1.214 -1.144 0 CA-C-O 118.113 -1.381 . . . . 0.0 113.189 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.52 2.39 28.4 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.891 0.995 . . . . 0.0 113.001 -167.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 257' ' ' ARG . 6.1 mt -68.52 141.72 55.46 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 122.931 1.348 . . . . 0.0 114.551 -167.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.5 t -152.23 96.12 2.14 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 124.677 2.179 . . . . 0.0 106.976 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.06 144.31 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 O-C-N 119.423 -2.048 . . . . 0.0 109.41 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.52 135.27 42.24 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 120.758 -1.214 . . . . 0.0 111.396 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 8.9 p90 -150.88 143.83 16.66 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 121.497 0.665 . . . . 0.0 112.018 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -86.0 169.37 8.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.492 3.461 . . . . 0.0 111.633 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.41 -8.06 7.58 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 126.465 1.983 . . . . 0.0 114.756 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.82 55.22 1.79 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.471 1.136 . . . . 0.0 111.869 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.14 5.45 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.832 0.453 . . . . 0.0 111.487 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.28 149.37 9.04 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 121.124 -0.985 . . . . 0.0 112.416 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 67.89 159.72 0.16 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.627 1.571 . . . . 0.0 110.696 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 16.9 m170 34.14 76.71 0.4 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.762 1.625 . . . . 0.0 115.138 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.35 111.9 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.588 2.192 . . . . 0.0 112.056 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -157.29 169.32 25.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 12.8 t -121.62 143.02 37.04 Favored Pre-proline 0 CA--C 1.513 -0.456 0 C-N-CA 124.436 1.095 . . . . 0.0 109.853 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' PRO . . . . . 0.609 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 84.3 Cg_endo -70.7 151.07 63.44 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.626 2.884 . . . . 0.0 109.631 -174.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.58 -6.19 16.01 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.612 2.875 . . . . 0.0 111.714 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -78.08 1.42 21.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.862 -0.59 . . . . 0.0 111.909 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.27 48.25 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.462 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 8.6 p90 -152.47 157.0 40.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.287 1.543 . . . . 0.0 112.034 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.3 m -152.48 -154.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 127.491 2.316 . . . . 0.0 108.827 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -114.98 164.28 14.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.646 0.779 . . . . 0.0 112.078 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.5 138.36 14.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.865 -0.522 . . . . 0.0 111.364 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.89 125.31 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 168.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.535 ' CE1' HG11 ' A' ' 238' ' ' VAL . 0.1 OUTLIER -146.71 92.27 2.13 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.973 -173.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 286' ' ' PHE . 11.5 tp10 37.88 61.69 1.02 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -48.64 9.87 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 128.306 2.642 . . . . 0.0 117.683 -167.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.02 -72.53 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.992 1.724 . . . . 0.0 111.166 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -78.39 -34.44 48.18 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 22.8 t -73.62 -32.58 64.14 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 286' ' ' PHE . 89.0 t -63.87 -52.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -61.33 -34.92 76.06 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.668 0.605 . . . . 0.0 112.237 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.1 m -74.29 -34.15 63.44 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.773 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -45.8 65.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.469 0.652 . . . . 0.0 110.169 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -13.54 57.96 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.105 -0.997 . . . . 0.0 113.441 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.24 -4.58 35.0 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.288 -0.883 . . . . 0.0 111.54 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -104.58 -15.05 15.43 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.679 1.237 . . . . 0.0 108.841 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 60.6 m -107.68 -142.61 0.38 Allowed 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.744 -0.597 . . . . 0.0 109.829 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.2 m -110.54 172.51 6.83 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 120.474 -1.391 . . . . 0.0 113.388 -171.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.407 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 85.3 t60 -149.87 165.19 33.32 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.69 -0.631 . . . . 0.0 110.992 -172.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 33.3 t0 -134.45 112.2 11.83 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.92 51.65 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 1 C-N-CA 127.384 5.389 . . . . 0.0 110.187 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.25 5.8 mp . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.224 -0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 29.9 m -66.52 132.69 48.78 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.218 0.607 . . . . 0.0 110.5 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.53 144.26 49.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 119.253 0.933 . . . . 0.0 110.882 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -110.74 152.66 26.32 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.254 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 37.1 m-85 -140.36 148.33 41.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.743 1.258 . . . . 0.0 113.061 -170.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -158.89 163.73 36.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -135.31 133.05 38.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.698 0.761 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.2 OUTLIER -134.98 13.66 3.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.659 -171.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.7 p -58.5 153.73 15.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.8 m -111.88 163.05 14.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.219 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -70.84 -9.77 58.24 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 321' ' ' MET . 17.1 ptp180 -82.36 -18.09 43.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.416 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 320' ' ' ARG . 4.0 mpp? -135.93 -48.82 0.68 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 44.33 43.08 5.78 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' CYS . . . . . 0.475 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 71.1 m -93.23 -60.49 1.78 Allowed 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.326 -1.484 . . . . 0.0 113.842 -173.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -158.52 152.39 23.61 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 118.856 -1.138 . . . . 0.0 113.164 -170.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.51 173.42 4.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.842 2.057 . . . . 0.0 113.936 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 3.7 p -118.66 158.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.168 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 5.4 pp0? -115.69 163.28 16.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.198 0.908 . . . . 0.0 112.047 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.95 130.21 13.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.689 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 pt -136.68 88.59 19.08 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.16 0.584 . . . . 0.0 110.89 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -76.99 177.85 8.38 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.903 3.735 . . . . 0.0 116.604 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' TRP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 236' ' ' CYS . 7.3 t-105 -82.24 140.89 33.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.915 0.886 . . . . 0.0 110.169 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.5 t -115.0 151.66 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.558 1.171 . . . . 0.0 111.913 -176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 333' ' ' LEU . 6.6 tt -57.25 -36.96 71.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.269 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -70.44 -5.64 29.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.261 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -105.24 -7.01 19.24 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.701 -0.624 . . . . 0.0 111.667 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.8 m -83.83 -37.91 21.9 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -154.57 165.52 36.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.071 0.548 . . . . 0.0 111.872 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' PHE . . . . . 0.425 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 44.1 t80 -146.03 133.9 21.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.8 m -120.39 148.3 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -5.07 24.89 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.869 -0.519 . . . . 0.0 110.254 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.9 m -131.11 148.46 70.32 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.07 108.4 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.669 1.579 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 8.3 t 54.58 38.57 30.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.248 1.419 . . . . 0.0 113.492 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -75.2 160.25 30.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.379 0.609 . . . . 0.0 111.061 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -92.92 179.33 5.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.13 167.06 13.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 123.966 0.791 . . . . 0.0 109.675 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.06 102.55 15.86 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.02 -1.45 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 114.568 -171.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 81.5 p -130.42 8.8 5.06 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.679 -1.263 . . . . 0.0 114.133 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -144.48 102.37 3.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.082 0.944 . . . . 0.0 108.753 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -160.46 149.5 17.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.27 0.628 . . . . 0.0 110.229 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.02 154.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -81.07 136.68 35.98 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.151 0.907 . . . . 0.0 109.753 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 84.7 t -128.61 133.13 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.761 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -175.8 -165.9 32.44 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 121.638 0.576 . . . . 0.0 114.104 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.07 28.71 5.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.692 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.6 -160.27 0.71 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.635 1.174 . . . . 0.0 111.86 -175.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -36.22 -24.64 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.949 2.1 . . . . 0.0 115.31 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.63 78.31 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 119.351 0.978 . . . . 0.0 113.644 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.419 ' HA ' HG13 ' A' ' 391' ' ' ILE . 28.0 ptm -156.76 30.29 0.31 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 113.115 174.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 361' ' ' LEU . 13.7 tp -76.84 156.24 32.37 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 121.284 0.564 . . . . 0.0 110.973 -171.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.73 170.28 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.509 1.123 . . . . 0.0 110.48 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -72.1 -25.62 61.82 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -175.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -74.68 -26.27 59.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.818 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.55 -32.59 36.66 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.23 -34.46 68.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.855 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.07 80.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.131 0.972 . . . . 0.0 111.187 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.53 -34.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 370' ' ' LEU . 4.2 mm? -94.48 -6.19 44.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.118 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -16.6 14.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.546 1.521 . . . . 0.0 111.338 172.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -97.3 -28.69 13.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.722 0.692 . . . . 0.0 110.744 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.0 tp -83.02 -26.71 30.95 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.26 -59.02 1.6 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.261 -0.899 . . . . 0.0 113.005 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 163.5 -139.66 6.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -70.33 148.16 45.23 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 123.555 1.642 . . . . 0.0 113.881 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.07 152.93 8.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 127.736 2.414 . . . . 0.0 109.893 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.58 -30.64 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.228 -0.892 . . . . 0.0 112.183 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.8 OUTLIER -150.46 147.91 28.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.177 0.899 . . . . 0.0 112.116 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -142.96 139.01 30.5 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -135.17 151.81 20.61 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.67 0.594 . . . . 0.0 114.095 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.85 148.46 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -103.5 147.78 26.74 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 125.281 1.613 . . . . 0.0 108.016 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 47.5 p -140.81 163.06 33.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.5 -0.75 . . . . 0.0 112.118 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.66 34.13 4.7 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.706 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.32 28.02 0.41 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.616 1.566 . . . . 0.0 113.498 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -136.04 23.77 3.29 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp 62.75 -15.66 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.458 ' N ' ' HD2' ' A' ' 390' ' ' PRO . 22.2 p90 -78.73 -22.0 0.37 Allowed Pre-proline 0 CA--C 1.515 -0.371 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -170.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 389' ' ' TYR . 18.5 Cg_endo -61.71 -67.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.475 HD13 ' CZ3' ' A' ' 331' ' ' TRP . 10.9 tp 32.44 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.811 1.644 . . . . 0.0 110.885 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 177.24 27.97 0.04 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.69 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 70.5 m -143.16 146.84 34.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 167.11 -159.08 32.35 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.618 -1.101 . . . . 0.0 112.095 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -154.37 166.82 32.02 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 125.299 1.234 . . . . 0.0 109.594 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.42 126.35 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 42.1 p -95.59 118.67 32.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 69.8 m-85 -90.15 162.63 15.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.145 0.974 . . . . 0.0 111.049 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -122.93 -0.51 8.99 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -124.88 153.04 43.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.628 0.371 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -80.76 -30.57 36.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.443 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -39.1 64.86 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.282 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' SER . . . . . 0.633 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 21.5 m -65.95 -25.59 67.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.536 0.607 . . . . 0.0 111.276 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.67 -57.15 3.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.338 0.589 . . . . 0.0 111.417 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' LEU . . . . . 0.47 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -74.26 -20.76 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.496 -0.752 . . . . 0.0 111.792 -177.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -81.13 -26.66 35.95 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.912 1.233 . . . . 0.0 109.626 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -71.02 -43.39 68.02 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.89 -21.84 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.233 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.4 p -81.18 -26.33 36.08 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 118.352 -0.833 . . . . 0.0 112.83 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.38 -33.15 14.68 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.232 0.469 . . . . 0.0 111.757 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 51.16 -22.54 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 26.1 t80 -163.69 130.53 3.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.891 -1.755 . . . . 0.0 107.506 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.57 174.69 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.884 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -116.46 153.85 31.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.516 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 28.6 mt -127.35 123.48 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.421 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -125.44 140.59 52.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.307 1.004 . . . . 0.0 108.815 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 m -148.8 167.76 24.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.4 t -60.95 -18.83 59.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 15.94 0.75 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -139.42 128.88 24.29 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.634 -0.666 . . . . 0.0 110.622 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 52.5 p -146.86 124.18 11.59 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.063 -0.398 . . . . 0.0 110.148 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' LYS . . . . . 0.612 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 29.4 tptt -165.6 -161.33 0.51 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.631 0.582 . . . . 0.0 110.476 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.612 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 92.8 mttt -141.45 168.48 19.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.39 139.21 29.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -122.3 160.76 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 60.2 mt -139.28 137.3 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.254 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -128.06 145.29 54.8 Favored Pre-proline 0 C--N 1.324 -0.543 0 O-C-N 123.911 0.757 . . . . 0.0 111.211 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 145.67 94.82 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.332 3.354 . . . . 0.0 111.644 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 79.0 t80 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.428 1.091 . . . . 0.0 112.967 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 93.7 m -152.86 146.4 25.0 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.46 -169.27 3.25 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.659 1.118 . . . . 0.0 111.529 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.1 p -130.11 19.93 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.959 1.703 . . . . 0.0 109.786 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.48 12.23 65.69 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 125.14 1.352 . . . . 0.0 116.386 -168.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -51.85 156.0 1.59 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 224' ' ' LEU . 4.1 mm? -100.48 139.46 20.65 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.68 -1.146 . . . . 0.0 108.346 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -44.21 109.63 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.512 3.475 . . . . 0.0 112.371 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -79.04 17.35 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.907 3.071 . . . . 0.0 111.138 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -133.63 19.51 3.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.539 0.336 . . . . 0.0 111.091 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -134.68 39.33 3.02 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 121.855 0.836 . . . . 0.0 110.845 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -76.13 161.7 28.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.165 0.986 . . . . 0.0 109.087 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -79.21 -10.18 59.75 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -168.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.419 ' HA ' HG11 ' A' ' 332' ' ' VAL . 73.2 m-20 42.7 62.34 8.38 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.894 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 333' ' ' LEU . 37.7 Cg_endo -63.33 -76.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.0 1.8 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.9 pt -141.17 -178.83 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 124.909 1.284 . . . . 0.0 110.061 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -111.72 153.43 26.48 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 57.9 p -146.22 -9.95 0.5 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.614 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 16.8 t -143.85 171.14 14.63 Favored 'General case' 0 C--O 1.215 -0.737 0 C-N-CA 123.033 0.533 . . . . 0.0 109.576 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -53.66 174.13 0.05 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.824 1.649 . . . . 0.0 114.309 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.7 146.92 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.32 140.17 32.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.012 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.407 ' CD1' HG22 ' A' ' 328' ' ' VAL . 20.1 tp -141.47 143.2 33.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 111.123 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -165.5 156.55 28.57 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.537 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.95 14.28 1.47 Allowed Glycine 0 N--CA 1.475 1.235 0 O-C-N 122.005 -0.703 . . . . 0.0 112.616 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.1 m -119.96 72.98 18.04 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.342 -1.093 . . . . 0.0 110.905 -174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.8 7.72 2.27 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.532 2.154 . . . . 0.0 113.655 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 17.6 p-90 -141.42 -4.94 1.1 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -63.52 109.15 1.55 Allowed 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 124.69 1.196 . . . . 0.0 112.593 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -72.48 -30.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-O 116.84 -1.552 . . . . 0.0 111.351 -172.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.9 p -142.4 126.05 16.91 Favored 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 119.734 1.152 . . . . 0.0 112.977 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -71.0 -16.22 62.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.458 -172.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -73.12 -16.48 61.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 120.215 1.371 . . . . 0.0 108.472 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.33 99.23 Favored Glycine 0 N--CA 1.435 -1.424 0 O-C-N 120.88 -1.137 . . . . 0.0 112.704 170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 48.6 mt -69.68 -31.84 70.11 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.504 1.122 . . . . 0.0 108.27 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.4 t -69.74 -36.51 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.608 -0.682 . . . . 0.0 110.179 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -80.29 -9.97 59.74 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.955 0.798 . . . . 0.0 111.179 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.0 m -96.49 -21.72 17.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -103.54 -24.32 13.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -74.3 -0.17 16.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.014 0.825 . . . . 0.0 111.81 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.23 -20.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.482 -0.761 . . . . 0.0 109.186 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -101.05 -7.09 23.56 Favored 'General case' 0 C--N 1.334 -0.074 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 156.23 -166.18 33.04 Favored Glycine 0 N--CA 1.432 -1.577 0 O-C-N 124.499 1.124 . . . . 0.0 114.684 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 58.5 m -51.02 124.11 10.69 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.456 175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 152.95 42.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.953 -1.022 . . . . 0.0 111.497 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -146.99 168.84 20.52 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.598 1.559 . . . . 0.0 108.711 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.6 152.2 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 121.489 -0.757 . . . . 0.0 112.26 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.21 135.86 32.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 124.497 1.123 . . . . 0.0 110.792 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.487 ' CE2' ' HG2' ' A' ' 269' ' ' LYS . 20.0 p90 -148.11 154.07 42.33 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.93 136.33 24.85 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 122.162 1.908 . . . . 0.0 107.365 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.2 32.97 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 116.38 1.312 . . . . 0.0 116.38 172.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.487 ' HG2' ' CE2' ' A' ' 266' ' ' TRP . 35.8 mtmt -64.28 -6.43 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.449 1.124 . . . . 0.0 111.387 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.67 5.43 43.78 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.919 1.288 . . . . 0.0 110.696 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -69.68 -160.75 2.74 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.502 -0.772 . . . . 0.0 113.435 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -77.43 -17.62 57.94 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 276' ' ' CYS . 3.7 p80 -166.04 154.43 9.96 Favored Pre-proline 0 C--O 1.223 -0.305 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.81 -1.39 11.1 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.397 2.732 . . . . 0.0 114.124 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -90.77 31.11 1.09 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.873 1.269 . . . . 0.0 110.391 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 17.2 t -125.61 40.16 0.52 Allowed Pre-proline 0 C--N 1.34 0.159 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 89.3 Cg_endo -75.07 170.37 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.924 2.416 . . . . 0.0 107.117 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -54.96 161.56 6.28 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.07 1.846 . . . . 0.0 115.269 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -54.25 -14.82 1.27 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.501 1.12 . . . . 0.0 112.432 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -179.84 16.38 0.03 OUTLIER Glycine 0 CA--C 1.533 1.156 0 CA-C-N 120.488 1.494 . . . . 0.0 112.873 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -130.15 155.85 45.54 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.272 1.536 . . . . 0.0 112.732 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.14 158.43 2.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 124.176 0.99 . . . . 0.0 109.819 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -118.45 150.06 40.21 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.6 mt -122.18 140.62 52.35 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.9 m -135.1 129.79 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -168.03 -167.21 0.8 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -44.6 122.54 3.17 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 124.499 1.124 . . . . 0.0 109.189 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.16 -18.39 35.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 128.105 2.562 . . . . 0.0 115.852 -166.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -140.32 -54.1 0.52 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 120.082 1.31 . . . . 0.0 113.675 -167.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -73.96 -45.34 50.78 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 122.102 -0.374 . . . . 0.0 110.909 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . 0.415 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 71.1 m -70.13 -26.78 64.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.75 -53.58 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -67.6 -26.76 66.42 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.991 -0.443 . . . . 0.0 111.904 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 27.6 t -67.94 -46.25 72.01 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.207 0.317 . . . . 0.0 110.44 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 291' ' ' SER . 5.4 mt -63.8 -42.25 97.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.03 0.377 . . . . 0.0 110.513 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.66 -25.94 61.45 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.424 0.69 . . . . 0.0 110.042 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -104.99 2.32 29.51 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 124.142 0.902 . . . . 0.0 110.077 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.1 -10.8 14.32 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.594 0.634 . . . . 0.0 110.03 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 16.6 p -107.25 -148.32 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.196 0.31 . . . . 0.0 110.743 177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 67.0 m -106.78 145.27 32.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.236 0.541 . . . . 0.0 110.627 -175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -142.89 155.06 44.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.122 0.969 . . . . 0.0 108.849 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -145.92 137.58 13.07 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 304' ' ' LEU . 96.8 Cg_endo -71.72 -103.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 122.376 2.05 . . . . 0.0 109.338 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 303' ' ' PRO . 9.8 mp -115.47 15.02 16.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.374 1.07 . . . . 0.0 109.855 -170.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.537 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 70.4 m -66.67 -26.19 1.43 Allowed Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 125.799 1.64 . . . . 0.0 112.055 176.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 305' ' ' SER . 63.0 Cg_exo -61.67 -6.97 8.16 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.135 2.557 . . . . 0.0 111.842 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.87 34.46 21.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -172.17 -40.59 0.04 OUTLIER Glycine 0 C--O 1.243 0.662 0 O-C-N 120.949 -1.094 . . . . 0.0 113.974 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 26.9 tp -153.71 165.23 36.63 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.598 1.199 . . . . 0.0 111.349 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 4.1 m -79.17 148.2 32.38 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.5 151.47 31.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -117.4 153.77 32.49 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 124.33 1.019 . . . . 0.0 109.978 173.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -147.62 152.66 38.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.915 -1.116 . . . . 0.0 110.017 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 315' ' ' LYS . 5.4 t80 -153.28 178.05 10.19 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 314' ' ' PHE . 30.0 ttmt -152.47 124.95 8.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -169.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 12.67 6.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.868 0.867 . . . . 0.0 110.046 -170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.6 p -87.48 159.74 18.54 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.416 1.086 . . . . 0.0 111.511 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.3 m -149.27 38.0 0.78 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.297 0.57 . . . . 0.0 110.768 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 52.51 33.53 13.55 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 121.238 0.542 . . . . 0.0 111.725 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -80.5 -30.65 37.29 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -157.75 -41.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.093 0.86 . . . . 0.0 111.176 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -147.5 166.65 26.64 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.749 1.219 . . . . 0.0 109.632 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 90.7 m -140.54 123.44 16.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.927 1.346 . . . . 0.0 111.228 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -159.0 152.56 22.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -89.88 156.5 18.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 110.679 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.38 152.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.244 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -117.83 131.69 56.53 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.764 0.711 . . . . 0.0 111.77 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 240' ' ' LEU . 2.6 t -115.15 143.35 25.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.302 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.99 98.08 4.45 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 124.19 0.931 . . . . 0.0 109.904 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -83.98 162.14 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 1 C-N-CA 125.904 4.403 . . . . 0.0 111.99 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.614 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 1.8 t90 -88.34 123.65 33.13 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.777 0.799 . . . . 0.0 109.293 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 231' ' ' ASN . 17.2 t -103.75 154.68 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.056 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 333' ' ' LEU . 7.9 tt -54.26 -26.45 29.07 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.587 -0.696 . . . . 0.0 112.173 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.09 16.95 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.558 -0.714 . . . . 0.0 112.264 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.07 -5.3 18.15 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.782 0.833 . . . . 0.0 108.894 173.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 66.8 m -100.6 -34.82 9.73 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.016 -1.677 . . . . 0.0 113.906 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -167.18 171.93 10.41 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 124.196 0.935 . . . . 0.0 113.418 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -156.51 155.07 31.35 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.081 1.352 . . . . 0.0 108.294 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 11.2 m -130.67 148.17 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.481 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -88.83 -16.45 32.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 35.8 t -151.34 113.75 3.05 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.69 -15.03 30.36 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.598 2.865 . . . . 0.0 112.02 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.2 t -86.21 4.65 37.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.428 1.091 . . . . 0.0 112.402 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -114.37 -175.11 2.61 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.454 1.501 . . . . 0.0 110.936 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -141.7 -179.81 6.39 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 122.198 0.199 . . . . 0.0 110.892 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -83.5 120.41 25.89 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 348' ' ' PRO . 10.3 m-20 -81.1 150.69 68.89 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 124.752 1.283 . . . . 0.0 111.121 -171.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 347' ' ' ASP . 77.5 Cg_exo -54.63 108.69 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.648 3.565 . . . . 0.0 109.885 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 86.2 p 52.79 23.51 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.52 73.98 0.99 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 119.453 1.024 . . . . 0.0 108.786 173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 t -155.75 144.14 20.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.38 159.35 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 118.294 0.497 . . . . 0.0 110.238 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -83.53 146.92 28.08 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 124.382 1.051 . . . . 0.0 113.561 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 67.5 t -131.07 136.09 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.962 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.48 -176.96 31.13 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 51.0 22.94 1.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.575 1.55 . . . . 0.0 113.365 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.986 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.65 171.94 14.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.686 0.794 . . . . 0.0 111.171 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -48.7 150.19 1.5 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.546 1.138 . . . . 0.0 109.28 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -66.39 10.6 0.64 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 124.945 1.259 . . . . 0.0 113.135 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.0 mmt -145.43 -53.21 0.28 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.191 0.596 . . . . 0.0 109.805 172.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 41.73 60.01 2.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.718 0.77 . . . . 0.0 109.639 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -72.43 173.92 8.11 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 121.986 -0.447 . . . . 0.0 111.835 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -57.12 -18.01 13.1 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -80.55 -35.51 34.29 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.547 -0.721 . . . . 0.0 110.807 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.64 -27.22 27.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 366' ' ' LEU . 2.3 tt -78.68 -31.22 46.57 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.38 -28.59 56.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.91 -0.494 . . . . 0.0 111.993 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.9 -42.04 61.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 77.5 mt -79.09 -35.48 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 118.808 0.731 . . . . 0.0 109.067 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.31 -22.96 38.16 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.621 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.88 -23.61 21.59 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 120.561 1.528 . . . . 0.0 109.91 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.07 -36.48 58.96 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.527 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.452 HD11 HG11 ' A' ' 413' ' ' VAL . 2.9 mp -66.86 -34.44 77.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.313 -177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 403' ' ' SER . 0.2 OUTLIER -158.67 -17.38 0.07 Allowed 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.21 -7.6 5.84 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 121.979 0.766 . . . . 0.0 113.679 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -94.05 78.94 0.98 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 122.045 -0.679 . . . . 0.0 113.135 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.42 159.44 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 118.654 1.227 . . . . 0.0 112.378 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.01 -33.06 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -158.28 147.04 18.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -154.81 146.35 23.16 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.68 176.51 38.16 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 123.058 1.366 . . . . 0.0 114.304 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mt -122.56 141.4 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 122.188 0.994 . . . . 0.0 109.2 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.41 148.73 26.44 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.557 -171.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 51.4 p -131.39 159.6 37.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -124.87 -175.28 3.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -74.72 88.14 2.23 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 119.728 -1.858 . . . . 0.0 112.658 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 57.9 m170 70.49 38.58 1.32 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.18 -5.02 15.44 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 123.889 0.876 . . . . 0.0 110.384 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.1 p90 37.87 54.52 3.85 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 127.097 2.159 . . . . 0.0 114.364 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.18 -48.45 1.76 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.774 2.316 . . . . 0.0 111.169 -174.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.75 37.73 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 111.633 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.88 10.65 0.79 Allowed Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.5 p -155.17 126.66 7.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.265 0.555 . . . . 0.0 110.093 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -156.42 -164.94 13.95 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.468 1.038 . . . . 0.0 114.91 -171.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -151.76 162.6 40.75 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.551 -0.824 . . . . 0.0 108.899 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.13 134.15 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 O-C-N 121.153 -0.967 . . . . 0.0 108.881 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 346' ' ' LEU . 60.7 m -111.28 142.93 42.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.304 1.05 . . . . 0.0 109.549 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 73.8 m-85 -131.44 162.35 30.41 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 121.431 -0.793 . . . . 0.0 110.619 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.85 20.83 10.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.504 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -140.12 155.65 46.9 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.157 0.983 . . . . 0.0 109.183 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.08 -24.61 28.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.67 0.668 . . . . 0.0 110.196 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.649 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 3.8 mpt_? -52.89 -31.31 39.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.556 -0.715 . . . . 0.0 111.576 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.501 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 14.3 m -80.46 -29.21 37.48 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.577 0.751 . . . . 0.0 110.864 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -71.42 -54.37 10.91 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.942 0.337 . . . . 0.0 111.866 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.502 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -78.64 -17.86 55.36 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 117.994 -1.003 . . . . 0.0 112.005 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -86.41 -31.63 21.33 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 120.45 1.477 . . . . 0.0 112.665 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -72.6 -33.32 66.63 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 120.875 -1.141 . . . . 0.0 110.023 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.7 -30.7 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 14.0 t -78.41 -32.21 48.62 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.379 1.049 . . . . 0.0 110.498 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -76.47 -44.55 35.04 Favored 'General case' 0 C--O 1.227 -0.095 0 O-C-N 121.735 -0.603 . . . . 0.0 110.914 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.17 -17.97 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.124 2.569 . . . . 0.0 116.331 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 423' ' ' LYS . 0.1 OUTLIER -164.95 136.87 4.31 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.106 -1.621 . . . . 0.0 108.664 178.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.452 HG11 HD11 ' A' ' 373' ' ' LEU . 34.0 m -135.58 154.5 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.698 0.681 . . . . 0.0 110.728 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -112.8 141.48 46.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.559 0.743 . . . . 0.0 111.438 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 68.0 mt -100.54 122.72 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.44 52.01 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 418' ' ' THR . 0.3 OUTLIER -72.53 178.51 4.02 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.55 ' H ' HG22 ' A' ' 417' ' ' THR . 10.8 m -75.46 -27.36 58.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -144.32 16.32 1.68 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.963 0.887 . . . . 0.0 110.479 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.59 113.17 4.1 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 47.7 p -136.27 131.86 35.01 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.918 0.487 . . . . 0.0 110.567 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -148.91 177.74 9.29 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 412' ' ' PHE . 32.3 mtmm -144.45 160.93 40.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.3 m -139.06 133.56 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -106.98 157.44 17.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.34 0.59 . . . . 0.0 111.413 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 24.8 mt -140.87 149.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.42 149.95 56.27 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 124.196 0.935 . . . . 0.0 109.387 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.5 161.61 44.91 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.413 3.409 . . . . 0.0 109.941 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 116.797 -1.573 . . . . 0.0 111.226 178.441 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 11.6 m -155.03 158.94 39.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.383 1.073 . . . . 0.0 111.009 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.76 -16.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.062 -0.971 . . . . 0.0 113.472 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 17.1 m 43.61 52.27 6.22 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.433 1.015 . . . . 0.0 112.383 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.403 ' C ' HD22 ' A' ' 224' ' ' LEU . . . -71.27 -22.32 78.54 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.555 -173.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 59.67 27.33 16.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.727 0.811 . . . . 0.0 113.078 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.414 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 2.1 mm? -81.45 -22.55 0.34 Allowed Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 57.2 Cg_endo -67.76 121.43 8.48 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 CA-C-N 123.529 2.296 . . . . 0.0 111.619 -170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.14 166.98 4.57 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 125.232 3.955 . . . . 0.0 111.875 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -143.05 6.07 1.53 Allowed 'General case' 0 C--O 1.219 -0.541 0 O-C-N 122.003 -0.435 . . . . 0.0 112.128 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -115.88 30.15 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.976 1.71 . . . . 0.0 108.016 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -60.13 159.33 9.78 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -66.93 7.75 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -170.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 36.8 71.17 0.98 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.191 0.996 . . . . 0.0 112.183 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.31 -89.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.538 1 C-N-CA 126.072 4.515 . . . . 0.0 114.748 -173.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 234' ' ' TYR . 11.6 mm -127.37 178.15 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.326 1.45 . . . . 0.0 107.465 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.549 ' H ' HG22 ' A' ' 233' ' ' ILE . 14.8 m-85 -118.39 157.45 27.13 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.369 -0.825 . . . . 0.0 110.108 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 77.9 p -155.39 13.24 0.36 Allowed 'General case' 0 C--N 1.341 0.208 0 CA-C-N 121.242 1.837 . . . . 0.0 115.741 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 9.1 t -151.96 -177.37 6.11 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.115 1.325 . . . . 0.0 108.67 172.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.89 -172.77 0.2 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.541 1.162 . . . . 0.0 113.327 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.74 144.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.185 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.48 150.86 22.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.483 0.658 . . . . 0.0 111.954 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 240' ' ' LEU . 3.4 tm? -140.52 126.08 19.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.674 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.42 38.15 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.205 -0.934 . . . . 0.0 112.911 174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.47 3.23 2.44 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -99.69 134.93 20.72 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.475 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.89 -3.19 12.64 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.332 2.688 . . . . 0.0 110.97 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -128.07 -177.11 4.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 122.88 1.324 . . . . 0.0 111.151 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -166.47 149.42 6.96 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.427 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -174.93 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 168.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 250' ' ' ALA . 18.8 m -42.15 129.35 3.7 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.178 -0.951 . . . . 0.0 110.527 173.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -67.2 -25.03 65.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 121.694 -0.629 . . . . 0.0 112.242 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.4 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.78 -22.93 64.25 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 119.397 0.999 . . . . 0.0 112.263 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.95 -30.47 67.89 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 123.582 1.657 . . . . 0.0 110.601 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.4 tt -75.59 -36.17 60.4 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.731 -1.453 . . . . 0.0 108.829 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 262' ' ' LEU . 92.7 t -67.48 -36.21 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 C-N-CA 123.172 0.589 . . . . 0.0 110.066 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.4 -18.74 61.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.488 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 87.0 m -73.1 -33.63 65.7 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 118.722 0.692 . . . . 0.0 110.067 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -140.43 80.09 1.74 Allowed 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.704 ' HA ' HD11 ' A' ' 262' ' ' LEU . 12.9 ptm180 -133.59 1.35 3.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.257 0.623 . . . . 0.0 111.493 171.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 5.7 t -78.31 -1.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.136 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -100.43 -15.44 17.93 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.409 0.55 . . . . 0.0 110.416 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 262' ' ' LEU . . . 158.37 170.94 23.63 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.0 t -64.08 131.18 46.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.704 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -152.1 165.35 35.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.709 0.766 . . . . 0.0 110.957 169.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -141.01 171.65 13.77 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.602 0.715 . . . . 0.0 110.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.84 147.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.564 0.746 . . . . 0.0 110.996 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -139.58 134.09 31.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.025 0.828 . . . . 0.0 109.936 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -155.23 151.0 21.79 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.011 1.324 . . . . 0.0 110.227 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.66 154.42 34.81 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 124.415 3.41 . . . . 0.0 111.126 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.49 11.22 75.37 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.181 -0.95 . . . . 0.0 112.783 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -79.44 9.26 4.99 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -118.56 148.2 42.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.202 1.401 . . . . 0.0 110.047 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.53 -160.77 43.97 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.66 -0.65 . . . . 0.0 112.532 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -72.46 155.77 39.75 Favored 'General case' 0 N--CA 1.44 -0.963 0 O-C-N 121.462 -1.022 . . . . 0.0 111.014 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 26.8 m170 46.37 61.04 13.67 Favored Pre-proline 0 N--CA 1.447 -0.613 0 O-C-N 124.537 1.148 . . . . 0.0 111.647 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.05 -20.05 57.26 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.599 2.199 . . . . 0.0 108.945 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.4 ' HG3' ' H ' ' A' ' 275' ' ' ARG . 5.7 ppt_? -80.18 10.23 4.68 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.408 1.083 . . . . 0.0 113.615 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 44.4 t -133.84 110.41 12.11 Favored Pre-proline 0 N--CA 1.446 -0.635 0 O-C-N 120.591 -1.318 . . . . 0.0 111.592 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.62 157.95 28.45 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.548 2.165 . . . . 0.0 109.785 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.55 -11.81 20.49 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -143.15 -178.15 5.7 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 127.67 2.388 . . . . 0.0 110.286 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.88 4.02 59.02 Favored Glycine 0 CA--C 1.547 2.038 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -103.1 116.51 32.64 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.928 -1.51 . . . . 0.0 111.879 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 26.4 m -145.01 163.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.795 1.31 . . . . 0.0 108.59 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -87.85 157.22 19.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 284' ' ' LEU . 18.5 mt -128.08 140.87 51.7 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 171.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 33.9 m -128.77 156.19 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 123.761 0.824 . . . . 0.0 109.94 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.575 ' CZ ' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -171.22 176.27 3.99 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -170.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -60.36 88.29 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.9 pt? -56.56 5.18 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 129.411 3.084 . . . . 0.0 117.075 -167.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -131.67 -41.73 1.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.998 1.272 . . . . 0.0 111.372 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -95.18 -32.91 12.83 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.646 -0.659 . . . . 0.0 111.437 -173.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.8 t -83.51 -17.8 40.64 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 1.8 t -82.41 -33.58 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 O-C-N 121.216 -0.927 . . . . 0.0 109.976 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -62.96 -47.44 83.17 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 123.97 0.794 . . . . 0.0 110.329 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 77.6 p -76.79 -31.52 57.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.23 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.32 -40.64 58.22 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.38 -16.8 60.34 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.122 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -104.08 1.64 31.14 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.007 1.442 . . . . 0.0 111.846 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -113.42 -25.08 8.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.148 0.885 . . . . 0.0 110.956 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . 0.401 ' HB3' ' H ' ' A' ' 300' ' ' SER . 98.4 m -79.1 -157.15 0.11 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 299' ' ' CYS . 16.5 m -116.67 161.27 19.47 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.346 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -141.68 151.4 42.97 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -140.85 118.8 8.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.49 33.04 0.44 Allowed 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 124.563 3.509 . . . . 0.0 109.931 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -26.61 16.47 Favored 'General case' 0 C--O 1.245 0.828 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.342 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 7.6 t 41.96 70.91 1.5 Allowed Pre-proline 0 N--CA 1.469 0.479 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.93 -1.5 10.93 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 125.063 3.842 . . . . 0.0 110.978 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -160.33 28.59 0.17 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 119.505 1.048 . . . . 0.0 113.484 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.67 12.41 83.65 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 120.768 -1.208 . . . . 0.0 112.792 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 309' ' ' LEU . 1.5 pp -131.16 -166.15 1.66 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.642 1.177 . . . . 0.0 109.531 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 16.2 m -143.01 157.08 44.88 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.544 -1.347 . . . . 0.0 112.16 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -133.7 149.7 51.52 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.185 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.19 148.68 23.34 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.768 1.227 . . . . 0.0 112.076 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -149.03 156.57 42.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.864 -0.522 . . . . 0.0 110.418 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -158.47 161.16 37.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 11.6 ptpt -120.23 135.54 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 9.17 4.27 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -169.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.7 t -105.96 145.67 31.02 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.4 p -147.85 -32.62 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -138.47 -0.93 1.93 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -105.09 -30.54 9.67 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.574 -0.704 . . . . 0.0 110.716 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.7 mmt -135.03 -163.1 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.643 1.577 . . . . 0.0 106.744 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -69.89 -95.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.674 0.75 . . . . 0.0 109.775 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 98.7 m -156.33 29.8 0.34 Allowed 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.678 0.791 . . . . 0.0 110.768 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -69.96 121.31 17.12 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 119.942 1.246 . . . . 0.0 113.231 -169.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 0.1 OUTLIER -77.22 164.01 26.0 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.115 0.566 . . . . 0.0 111.722 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.34 164.03 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.458 0.703 . . . . 0.0 109.522 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -109.94 153.36 24.62 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.669 0.668 . . . . 0.0 110.55 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.36 149.09 18.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 CA-C-O 122.493 1.14 . . . . 0.0 111.358 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.8 pt -150.29 119.06 3.65 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.848 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -99.11 172.59 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 124.429 3.42 . . . . 0.0 113.828 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.56 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 7.9 t-105 -85.46 124.67 32.3 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.837 0.855 . . . . 0.0 110.596 170.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.63 151.78 3.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 CA-C-O 121.021 0.438 . . . . 0.0 110.118 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 337' ' ' ASN . 7.4 tt -61.04 -27.04 68.05 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.635 0.774 . . . . 0.0 110.156 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.2 -6.52 35.07 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 111.474 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.61 7.9 35.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.819 0.848 . . . . 0.0 109.101 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 62.6 m -111.44 -33.12 6.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.909 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . 0.478 HD21 HD21 ' A' ' 333' ' ' LEU . 1.7 p30 -155.26 158.29 38.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.233 0.924 . . . . 0.0 111.827 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -154.36 140.51 18.47 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.491 169.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.1 m -109.38 148.37 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.911 0.884 . . . . 0.0 113.121 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -111.63 -7.81 14.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 123.003 1.383 . . . . 0.0 108.807 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 31.1 t -123.82 132.63 24.3 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.49 -1.45 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.975 2.45 . . . . 0.0 112.072 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 43.2 t -87.3 -14.69 40.15 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.734 1.152 . . . . 0.0 114.035 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 52.02 48.95 21.71 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' A' ' 346' ' ' LEU . 40.1 ttt180 -98.25 -178.17 3.95 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.214 1.405 . . . . 0.0 111.379 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.493 ' H ' ' HG2' ' A' ' 345' ' ' ARG . 11.8 tp -149.16 163.84 36.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -119.23 164.67 20.15 Favored Pre-proline 0 C--N 1.351 0.666 0 CA-C-N 118.435 0.561 . . . . 0.0 110.661 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.86 63.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 126.964 5.109 . . . . 0.0 115.362 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 18.8 m 59.21 21.25 9.36 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -83.32 58.09 4.32 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.545 1.164 . . . . 0.0 109.324 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.5 t -117.47 166.7 12.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.405 -1.725 . . . . 0.0 112.57 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 13.3 m -133.67 150.38 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 123.995 0.809 . . . . 0.0 110.507 171.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -78.3 142.54 37.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 124.254 0.971 . . . . 0.0 110.041 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.29 142.44 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.74 -170.01 29.11 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 124.004 0.815 . . . . 0.0 112.704 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 61.18 -2.41 0.22 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 357' ' ' LEU . 2.3 pt? -69.46 159.15 33.81 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.205 0.602 . . . . 0.0 111.567 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -92.75 173.92 7.52 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.711 -0.618 . . . . 0.0 111.432 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -64.24 8.69 0.42 Allowed Glycine 0 CA--C 1.532 1.144 0 N-CA-C 118.232 2.053 . . . . 0.0 118.232 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 38.4 mtt -142.65 6.02 1.62 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.976 1.888 . . . . 0.0 111.319 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.7 68.13 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 124.008 1.861 . . . . 0.0 109.586 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -62.19 176.4 0.6 Allowed 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.417 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.74 -14.23 62.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.04 -26.4 36.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -85.22 -32.83 22.42 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.232 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 67.7 mt -72.89 -31.72 64.87 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.271 0.487 . . . . 0.0 110.817 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -79.21 -25.36 42.69 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.064 1.302 . . . . 0.0 110.597 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.76 94.12 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 123.89 0.744 . . . . 0.0 110.263 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 76.4 mt -69.41 -44.46 80.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 O-C-N 124.174 0.921 . . . . 0.0 109.571 -174.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.39 -17.42 34.47 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 112.722 -168.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.03 -23.89 18.51 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.167 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -93.41 -23.73 18.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.43 0.559 . . . . 0.0 112.446 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.8 -11.51 16.22 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -115.12 -36.18 4.48 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 141.28 -45.76 0.94 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.899 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.95 150.92 10.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.521 -1.8 . . . . 0.0 111.187 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.53 170.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 126.326 1.851 . . . . 0.0 107.001 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.81 -29.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 118.101 0.41 . . . . 0.0 110.613 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.441 ' CD1' ' CD1' ' A' ' 346' ' ' LEU . 4.0 t80 -165.61 157.13 14.31 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.803 0.811 . . . . 0.0 111.464 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.55 150.61 35.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.954 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.57 164.89 29.94 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 121.248 -0.907 . . . . 0.0 113.071 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 20.7 mm -118.93 141.41 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.153 1.381 . . . . 0.0 107.349 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -90.81 139.97 30.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 29.4 p -132.78 168.44 18.35 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.197 0.999 . . . . 0.0 109.561 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -137.81 158.37 44.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.082 2.153 . . . . 0.0 105.528 169.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -58.66 112.81 1.75 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 18.7 m170 62.99 26.06 15.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 120.588 -1.32 . . . . 0.0 114.113 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -94.33 -24.48 17.39 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.9 t80 41.35 59.41 8.82 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 125.398 1.479 . . . . 0.0 111.237 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.21 -35.16 3.16 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.595 1.53 . . . . 0.0 110.992 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.56 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 6.5 tp 31.7 48.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 125.166 1.387 . . . . 0.0 110.839 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.14 12.89 0.45 Allowed Glycine 0 C--N 1.349 1.259 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.037 -176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 49.0 m -147.86 154.53 40.54 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 118.685 1.242 . . . . 0.0 110.318 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 168.41 -168.3 40.85 Favored Glycine 0 C--O 1.247 0.951 0 CA-C-N 119.531 1.06 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -152.22 161.23 42.93 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.02 145.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 123.13 0.269 . . . . 0.0 110.332 -173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.8 p -123.11 142.18 51.16 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.792 0.806 . . . . 0.0 110.563 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.44 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 26.0 m-85 -118.41 -24.81 6.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.153 -169.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.55 17.52 3.08 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.47 156.0 38.6 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.776 -0.577 . . . . 0.0 110.753 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -89.72 -18.33 26.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -55.77 -42.11 75.03 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.478 -1.389 . . . . 0.0 109.675 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.44 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 57.2 m -82.55 -13.37 56.71 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.455 -172.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.36 -50.1 15.12 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 119.195 0.907 . . . . 0.0 110.93 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.47 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -77.59 -29.43 51.99 Favored 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.386 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.418 ' N ' HD22 ' A' ' 405' ' ' LEU . 23.6 ttmm -70.39 -28.88 65.43 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.898 0.856 . . . . 0.0 111.296 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.39 -44.23 19.74 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 121.276 -0.89 . . . . 0.0 113.291 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.9 m -69.56 -27.29 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 C-N-CA 119.615 -0.834 . . . . 0.0 108.887 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 73.3 p -82.35 -26.28 33.1 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.22 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -81.58 -40.67 22.71 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.29 -12.54 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.71 143.64 3.31 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 123.815 0.846 . . . . 0.0 109.239 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.2 m -137.21 162.44 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 O-C-N 123.688 0.618 . . . . 0.0 110.828 170.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -106.77 143.72 34.46 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 123.986 0.803 . . . . 0.0 111.888 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.8 mt -125.7 119.04 53.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -143.59 130.71 20.69 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.9 p -136.55 -161.41 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.5 m -88.84 -2.37 58.55 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.997 0.519 . . . . 0.0 111.98 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -145.57 -4.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 422' ' ' LYS . 51.2 t80 -138.39 141.07 39.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.341 -1.474 . . . . 0.0 111.1 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 45.4 m -147.2 102.01 3.45 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.198 0.999 . . . . 0.0 110.904 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.504 ' HD3' ' CZ ' ' A' ' 420' ' ' PHE . 0.6 OUTLIER -153.26 173.77 15.14 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.575 0.625 . . . . 0.0 110.502 178.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -131.43 163.15 28.57 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.3 m -140.39 133.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -100.5 149.91 23.21 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 72.0 mt -133.68 138.2 51.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.088 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -135.3 150.33 72.3 Favored Pre-proline 0 CA--C 1.53 0.18 0 O-C-N 123.977 0.798 . . . . 0.0 111.333 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.45 150.92 75.97 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 121.615 1.543 . . . . 0.0 111.344 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.4 t80 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 124.852 1.261 . . . . 0.0 112.077 -177.39 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 CA--C 1.513 -0.481 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 19.1 m 60.03 159.68 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.879 2.072 . . . . 0.0 111.957 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.473 ' CZ3' ' CA ' ' A' ' 222' ' ' GLY . 87.8 t90 -161.51 158.6 26.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.931 0.493 . . . . 0.0 109.741 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 70.7 p -143.18 104.62 4.3 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.288 0.566 . . . . 0.0 110.735 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.473 ' CA ' ' CZ3' ' A' ' 220' ' ' TRP . . . -73.08 111.8 3.65 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.26 -17.38 13.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.027 -1.087 . . . . 0.0 110.165 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 224' ' ' LEU . 0.0 OUTLIER -130.14 14.09 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.678 0 N-CA-C 118.202 2.668 . . . . 0.0 118.202 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 72.6 Cg_exo -49.88 124.05 11.83 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 CA-C-N 120.989 1.389 . . . . 0.0 112.995 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.75 140.96 55.82 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.879 3.052 . . . . 0.0 110.992 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -142.78 -1.81 1.09 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -130.41 59.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.548 0.689 . . . . 0.0 112.829 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.32 163.75 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.445 1.098 . . . . 0.0 110.391 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -157.46 146.16 19.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -131.23 153.94 81.83 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -85.88 28.04 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.892 2.395 . . . . 0.0 113.397 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 74.6 mt -137.45 154.75 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 O-C-N 121.953 -0.467 . . . . 0.0 110.596 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.45 170.77 11.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.806 1.643 . . . . 0.0 108.484 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 54.0 p -152.52 -155.44 0.61 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 122.81 0.444 . . . . 0.0 110.375 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 94.3 m -54.33 137.59 41.34 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.488 1.515 . . . . 0.0 114.416 -168.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 56.26 143.85 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.18 149.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -107.73 156.33 19.21 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-N 117.885 0.312 . . . . 0.0 111.468 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.29 134.26 16.9 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 125.041 1.463 . . . . 0.0 107.261 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.82 155.92 23.89 Favored Glycine 0 N--CA 1.483 1.827 0 O-C-N 120.658 -1.277 . . . . 0.0 112.391 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.97 7.35 1.57 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.729 -1.039 . . . . 0.0 112.99 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.96 70.47 10.14 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.697 1.599 . . . . 0.0 109.998 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.92 9.78 1.57 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 1 C-N-CA 125.726 4.284 . . . . 0.0 112.267 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.42 ' CE3' ' CE ' ' A' ' 321' ' ' MET . 12.5 p-90 -136.15 -8.94 2.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -66.94 116.98 8.38 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -174.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.533 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.59 -30.45 34.01 Favored 'Isoleucine or valine' 0 C--O 1.274 2.35 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -176.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.4 m -146.85 127.1 13.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.861 -1.15 . . . . 0.0 112.197 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -56.82 -27.04 59.38 Favored 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 125.677 1.861 . . . . 0.0 113.202 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.4 -16.49 47.16 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.34 -57.07 3.04 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-O 121.65 0.583 . . . . 0.0 111.657 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.406 ' C ' HD23 ' A' ' 252' ' ' LEU . 6.8 tt -66.14 -48.99 68.99 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.46 -33.12 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 118.883 -0.579 . . . . 0.0 111.335 -176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 -77.99 -8.75 58.56 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.369 0.531 . . . . 0.0 111.685 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.5 m -83.24 -22.96 32.93 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.309 -1.494 . . . . 0.0 112.329 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -141.56 29.85 1.74 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 120.391 1.451 . . . . 0.0 114.315 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -90.94 13.06 17.63 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.532 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.53 27.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -168.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.03 -1.32 8.3 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.002 -0.436 . . . . 0.0 111.156 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.34 1.28 88.22 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.006 -0.886 . . . . 0.0 113.869 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 50.8 m -126.55 30.08 5.61 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.2 OUTLIER -100.53 146.0 27.62 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -148.79 160.89 42.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 122.174 0.988 . . . . 0.0 109.551 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.8 148.07 22.18 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.76 -168.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -139.32 149.77 44.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.547 0.612 . . . . 0.0 110.645 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -117.4 143.77 32.69 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.657 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.76 -25.69 7.56 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.826 2.351 . . . . 0.0 110.232 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 174.13 17.2 0.02 OUTLIER Glycine 0 CA--C 1.539 1.561 0 CA-C-N 119.944 1.247 . . . . 0.0 114.858 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -112.96 22.03 14.83 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.968 1.884 . . . . 0.0 112.246 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.76 149.78 43.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.544 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -118.07 173.75 14.97 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-O 121.179 0.321 . . . . 0.0 112.32 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -92.06 5.78 48.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 274' ' ' PRO . 23.8 m170 -98.26 164.09 17.92 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.852 1.661 . . . . 0.0 111.346 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 273' ' ' HIS . 71.7 Cg_endo -69.69 5.06 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.757 2.972 . . . . 0.0 110.707 175.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.497 ' HB2' HG23 ' A' ' 248' ' ' THR . 7.3 ptm180 -140.57 147.54 39.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.871 1.269 . . . . 0.0 110.71 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.93 146.2 15.11 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-O 119.392 -0.337 . . . . 0.0 111.586 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -93.34 149.84 2.44 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 124.399 3.399 . . . . 0.0 110.447 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.81 163.79 28.45 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.32 2.68 . . . . 0.0 107.215 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -96.77 23.78 6.72 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.65 82.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 -173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -165.15 129.4 2.42 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 121.793 -0.828 . . . . 0.0 109.842 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 160.28 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 O-C-N 125.498 1.749 . . . . 0.0 108.719 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -92.25 159.18 15.74 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 43.3 mt -122.94 143.47 49.88 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 123.371 0.669 . . . . 0.0 109.834 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.53 132.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 30.0 p90 -171.05 -163.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.72 1.263 . . . . 0.0 108.16 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -50.9 107.81 0.2 Allowed 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -91.04 19.18 5.91 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -167.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.62 -72.23 0.64 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.052 -1.03 . . . . 0.0 109.918 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -25.68 29.96 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-O 118.358 -0.83 . . . . 0.0 111.26 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 48.9 m -83.83 -23.2 31.47 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.63 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.51 -45.32 39.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.026 -1.046 . . . . 0.0 109.34 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -73.71 -17.2 61.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.896 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.8 t -75.3 -46.08 35.7 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.08 1.309 . . . . 0.0 108.572 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -61.07 -47.61 85.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.94 -24.61 67.57 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.158 -0.964 . . . . 0.0 110.12 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -101.66 -3.04 28.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.174 0.921 . . . . 0.0 113.088 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -107.24 -10.57 15.79 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 123.676 0.61 . . . . 0.0 110.489 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 62.2 m -105.79 -141.83 0.37 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 23.3 t -125.53 163.6 22.35 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.316 -0.865 . . . . 0.0 111.294 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -148.76 153.58 38.37 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.393 0.433 . . . . 0.0 110.036 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -135.17 122.78 15.24 Favored Pre-proline 0 N--CA 1.435 -1.182 0 O-C-N 125.761 1.913 . . . . 0.0 106.498 174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.0 -80.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.039 1.826 . . . . 0.0 113.461 -172.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.83 29.48 7.54 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 123.856 0.862 . . . . 0.0 110.381 -170.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.508 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 39.7 m -64.4 -31.04 5.31 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.471 1.508 . . . . 0.0 113.784 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 305' ' ' SER . 22.8 Cg_exo -69.4 -3.65 12.2 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 124.201 3.267 . . . . 0.0 111.748 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.4 t70 57.95 26.3 13.24 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.409 1.484 . . . . 0.0 112.641 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -176.17 -2.52 0.03 OUTLIER Glycine 0 CA--C 1.543 1.814 0 CA-C-N 118.518 0.599 . . . . 0.0 113.555 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 22.1 tp -157.03 172.58 18.42 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.442 1.621 . . . . 0.0 110.163 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 12.3 m -109.62 144.77 37.5 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.092 0.245 . . . . 0.0 110.956 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -142.92 140.35 31.11 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 111.497 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.67 154.47 18.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.811 0.845 . . . . 0.0 110.026 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.38 158.17 44.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.042 -1.036 . . . . 0.0 112.387 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 2.0 t80 -148.37 177.89 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.153 0.501 . . . . 0.0 110.559 170.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.4 ' N ' ' CD1' ' A' ' 314' ' ' PHE . 23.5 ttmt -147.53 122.71 10.19 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.04 7.45 1.19 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.743 -167.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.0 p -70.68 157.99 37.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.628 1.171 . . . . 0.0 110.935 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 42.3 t -115.68 173.08 6.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -69.92 -15.87 63.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.646 1.178 . . . . 0.0 111.424 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -68.2 -20.95 64.88 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -170.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.42 ' CE ' ' CE3' ' A' ' 245' ' ' TRP . 22.7 ptm -160.95 -165.18 1.31 Allowed 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.724 1.21 . . . . 0.0 111.563 -172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 71.4 mtm-85 -55.76 157.64 4.1 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 110.151 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.3 m -140.48 145.01 36.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 125.068 1.48 . . . . 0.0 110.223 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -168.93 144.82 3.42 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.28 156.93 36.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.348 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.77 154.81 11.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.34 158.81 23.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 118.931 0.787 . . . . 0.0 110.413 -178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.46 145.88 31.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-O 121.758 0.789 . . . . 0.0 109.882 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 60.4 mt -143.16 97.41 5.71 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.23 158.53 15.1 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.058 2.506 . . . . 0.0 112.368 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.45 122.27 28.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.3 t -96.38 146.97 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.02 -24.42 58.22 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.827 1.251 . . . . 0.0 108.43 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.524 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.49 -19.62 64.91 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.859 -1.151 . . . . 0.0 112.472 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -101.3 9.54 41.6 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.237 0.215 . . . . 0.0 111.252 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 74.0 m -102.78 -27.16 12.85 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.523 -1.361 . . . . 0.0 112.503 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.03 165.69 15.64 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.582 -0.699 . . . . 0.0 110.059 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -158.01 148.4 20.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.16 150.07 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.911 0.862 . . . . 0.0 108.855 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -94.46 -10.56 31.99 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.848 -0.533 . . . . 0.0 111.695 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 m -143.83 150.63 50.62 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.086 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.83 119.87 5.58 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.338 2.025 . . . . 0.0 110.239 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 23.3 t -145.84 161.61 39.6 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.596 0.236 . . . . 0.0 110.545 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -79.9 -27.34 39.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.274 0.63 . . . . 0.0 112.187 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -164.23 171.51 14.86 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.916 1.286 . . . . 0.0 108.905 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 60.5 mt -97.99 -178.31 4.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.958 1.303 . . . . 0.0 111.099 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -101.74 103.62 29.6 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.44 -6.09 12.68 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.253 1.968 . . . . 0.0 113.202 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 21.2 t -91.16 -22.32 20.73 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 119.621 -0.228 . . . . 0.0 111.072 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -131.82 103.87 6.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 t -154.31 156.56 37.17 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 120.966 -1.084 . . . . 0.0 110.531 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.14 154.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 O-C-N 121.236 -0.915 . . . . 0.0 110.618 176.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -86.83 144.36 27.05 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 124.279 0.987 . . . . 0.0 108.97 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.63 140.35 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.735 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -160.2 176.82 36.85 Favored Glycine 0 C--N 1.343 0.943 0 O-C-N 122.061 -0.4 . . . . 0.0 112.689 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 60.62 7.36 1.36 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.051 2.14 . . . . 0.0 114.843 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.788 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -78.02 -172.57 2.78 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 175.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -45.57 146.76 0.99 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.792 2.837 . . . . 0.0 115.182 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -71.75 -2.96 53.51 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.201 -172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.2 ptm -151.19 32.44 0.59 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.814 1.807 . . . . 0.0 111.022 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.3 OUTLIER -43.77 140.63 1.82 Allowed 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 361' ' ' LEU . 34.3 m-80 -134.03 -177.85 4.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.822 0.82 . . . . 0.0 109.78 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.4 8.63 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.963 0.887 . . . . 0.0 111.489 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -44.19 -63.73 0.82 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.479 1.912 . . . . 0.0 110.906 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -81.3 -28.95 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.235 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.07 -35.34 80.25 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.231 0.923 . . . . 0.0 109.914 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.55 -40.6 63.85 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 119.384 -0.927 . . . . 0.0 112.008 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.52 61.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.339 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.66 -42.51 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.47 -32.27 54.26 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.819 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -82.75 -16.91 46.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 118.17 -1.412 . . . . 0.0 111.294 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.11 -25.09 13.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.267 -0.896 . . . . 0.0 112.58 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.8 tp -92.42 -22.51 19.6 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 121.787 -0.571 . . . . 0.0 111.217 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 7.4 m-85 -136.26 -47.01 0.63 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 111.281 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.29 -16.21 30.28 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.928 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 400' ' ' ASN . . . -99.37 22.26 41.57 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 118.334 1.067 . . . . 0.0 113.877 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.77 166.06 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 O-C-N 120.911 -1.347 . . . . 0.0 111.857 -172.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.26 -30.71 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.505 ' CG ' ' N ' ' A' ' 380' ' ' ALA . 0.3 OUTLIER -156.02 162.85 40.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.15 0.886 . . . . 0.0 112.369 -174.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . 0.505 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -153.63 146.38 24.29 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.67 150.19 22.39 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.57 1.077 . . . . 0.0 112.77 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 26.3 mm -85.92 136.89 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 125.641 1.576 . . . . 0.0 109.724 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.45 60.09 6.03 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.542 -0.724 . . . . 0.0 111.441 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.7 158.88 9.44 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 123.717 1.722 . . . . 0.0 112.683 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -140.12 157.78 45.08 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.968 1.707 . . . . 0.0 107.069 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -57.28 113.92 1.95 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.824 0.821 . . . . 0.0 110.494 -174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 28.6 m170 53.92 16.62 1.12 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -85.71 -9.67 56.82 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.356 0.98 . . . . 0.0 113.112 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 32.8 p90 39.93 54.13 5.81 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.845 1.658 . . . . 0.0 115.383 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.0 -48.86 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.868 2.379 . . . . 0.0 113.213 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 9.0 tp 39.3 25.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.084 1.754 . . . . 0.0 114.243 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -145.35 19.58 1.89 Allowed Glycine 0 C--O 1.223 -0.567 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.2 p -151.34 159.77 44.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.969 0.885 . . . . 0.0 110.12 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.81 -157.31 20.76 Favored Glycine 0 N--CA 1.471 1.01 0 N-CA-C 115.924 1.13 . . . . 0.0 115.924 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -158.77 164.32 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.232 0.613 . . . . 0.0 109.477 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.13 143.03 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.2 p -112.05 148.77 33.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 403' ' ' SER . 71.2 m-85 -121.07 162.09 20.6 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.9 -171.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.13 0.95 15.11 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.005 0.816 . . . . 0.0 111.199 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.435 HD21 ' HA3' ' A' ' 376' ' ' GLY . 0.3 OUTLIER -150.39 164.74 35.09 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 173.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -80.67 -14.47 58.12 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 117.971 0.351 . . . . 0.0 111.103 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -58.98 -35.53 73.35 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.949 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 398' ' ' PHE . 8.8 m -78.36 -19.95 52.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 119.187 -0.435 . . . . 0.0 111.715 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.93 -64.29 0.91 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.444 0.64 . . . . 0.0 109.344 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.463 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.05 -19.6 62.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.983 -175.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -79.5 -25.49 41.79 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.053 0.221 . . . . 0.0 110.702 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -78.81 -39.29 36.03 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.383 0.611 . . . . 0.0 111.425 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 12.2 m -78.54 -21.74 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.424 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 51.8 p -87.93 -26.7 22.57 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.59 56.26 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.95 -26.22 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.299 1.839 . . . . 0.0 115.242 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.26 148.67 22.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.019 1.281 . . . . 0.0 111.843 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.75 148.04 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -107.64 94.99 5.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.2 128.98 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 136.67 49.54 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.754 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.64 174.94 14.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.153 1.381 . . . . 0.0 108.378 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 75.6 m -75.08 -20.88 59.29 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.146 0.885 . . . . 0.0 111.533 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -139.71 24.29 2.43 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.946 -0.471 . . . . 0.0 111.963 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -156.25 118.69 4.07 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.878 0.871 . . . . 0.0 111.159 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.0 p -146.85 112.13 5.51 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.805 0.729 . . . . 0.0 112.109 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -165.05 173.58 11.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.779 171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -100.59 168.13 9.91 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.5 0.667 . . . . 0.0 109.339 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 357' ' ' LEU . 90.3 t -151.05 136.1 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -117.71 153.09 33.96 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 119.119 0.872 . . . . 0.0 112.898 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 78.8 mt -125.84 135.78 62.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -131.37 139.83 36.61 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.936 -0.478 . . . . 0.0 109.863 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.31 150.8 31.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.652 2.902 . . . . 0.0 116.544 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.343 -1.313 . . . . 0.0 113.39 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.625 0.25 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.5 m 50.92 119.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.971 1.709 . . . . 0.0 113.475 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.493 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -128.85 -13.01 4.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 111.065 178.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 66.3 m 43.63 61.5 2.23 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.35 -19.14 78.65 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.726 -0.609 . . . . 0.0 114.205 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.22 32.37 21.61 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.042 -1.858 . . . . 0.0 114.245 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 151.76 86.06 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 86.5 Cg_endo -69.38 118.75 5.87 Favored 'Trans proline' 0 CA--C 1.552 1.38 0 C-N-CA 123.007 2.472 . . . . 0.0 110.364 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 8.1 Cg_endo -97.83 5.22 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 126.117 4.545 . . . . 0.0 114.802 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -137.85 11.37 2.89 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.047 0.939 . . . . 0.0 113.104 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -82.86 39.09 0.61 Allowed 'General case' 0 C--N 1.348 0.522 0 O-C-N 121.03 -1.044 . . . . 0.0 111.883 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -64.0 153.86 35.95 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -88.59 -13.51 39.83 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.327 1.017 . . . . 0.0 111.79 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.423 ' HA ' HG11 ' A' ' 332' ' ' VAL . 2.5 t-20 50.27 43.53 1.71 Allowed Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.68 -43.49 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 121.838 1.692 . . . . 0.0 113.867 -174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 51.7 mt -152.45 157.15 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.94 1.696 . . . . 0.0 107.183 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -103.09 144.39 31.35 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.113 0.565 . . . . 0.0 109.666 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.1 m -128.43 3.07 5.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.726 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.2 t -153.05 179.53 8.62 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 283' ' ' TYR . 12.0 ptmm? -49.5 166.44 0.05 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.308 1.043 . . . . 0.0 109.819 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.86 149.24 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -93.84 132.08 38.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.402 HD13 ' C ' ' A' ' 240' ' ' LEU . 3.0 tm? -134.99 119.94 18.57 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 125.198 1.562 . . . . 0.0 109.602 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 173.82 170.22 36.97 Favored Glycine 0 CA--C 1.543 1.806 0 O-C-N 120.821 -1.174 . . . . 0.0 111.866 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.03 1.74 3.97 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.074 0.845 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.92 132.23 74.68 Favored Pre-proline 0 N--CA 1.443 -0.825 0 CA-C-N 119.085 1.443 . . . . 0.0 108.556 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -88.86 -13.49 3.15 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 124.07 3.18 . . . . 0.0 110.921 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -105.65 -54.5 2.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.2 t0 57.48 151.41 0.01 OUTLIER 'General case' 0 C--N 1.374 1.655 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -170.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.26 -40.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.418 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.1 m -164.48 120.15 1.5 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -74.62 -23.08 58.64 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-N 120.926 1.694 . . . . 0.0 111.187 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -81.11 -12.58 59.23 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.003 0.921 . . . . 0.0 111.012 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.86 -41.01 29.37 Favored Glycine 0 CA--C 1.534 1.27 0 O-C-N 124.94 1.4 . . . . 0.0 109.93 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 28.9 mt -68.58 -42.57 78.08 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.447 1.118 . . . . 0.0 109.744 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.15 -37.07 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -73.68 -15.49 61.23 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.613 176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 62.2 m -80.34 -24.47 39.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 118.804 0.729 . . . . 0.0 109.545 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -139.9 32.04 2.0 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -103.37 12.77 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.503 171.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.46 23.16 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.7 -1.3 19.55 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.273 0.559 . . . . 0.0 111.651 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 110.82 -80.22 0.27 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 122.502 1.057 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.0 t -88.99 109.37 20.21 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 114.61 -0.795 . . . . 0.0 111.061 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.41 138.7 17.51 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.048 -1.032 . . . . 0.0 110.411 168.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.6 m -138.57 172.97 12.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.366 1.067 . . . . 0.0 109.311 171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.95 147.61 19.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.876 -168.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -155.3 151.25 27.77 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.321 1.058 . . . . 0.0 110.726 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -160.28 138.57 7.45 Favored Pre-proline 0 C--N 1.352 0.691 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.566 ' HD3' ' CE2' ' A' ' 283' ' ' TYR . 85.1 Cg_endo -79.41 164.5 23.91 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.552 2.168 . . . . 0.0 110.772 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 96.61 -128.24 9.47 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -83.53 109.06 17.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.694 0.759 . . . . 0.0 109.485 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -125.75 141.22 52.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.278 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -175.85 -148.52 6.94 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 121.945 0.747 . . . . 0.0 112.325 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -80.97 1.78 29.7 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.242 1.417 . . . . 0.0 111.22 -176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -125.87 102.76 28.05 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.25 0.62 . . . . 0.0 110.264 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.8 28.29 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 125.273 3.982 . . . . 0.0 112.169 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -133.29 11.91 4.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 277' ' ' PRO . 6.5 t -81.75 -33.41 0.65 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 116.884 -1.531 . . . . 0.0 112.203 -174.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 276' ' ' CYS . 74.0 Cg_exo -55.72 122.5 11.86 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.293 2.662 . . . . 0.0 111.925 176.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.2 5.71 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 124.246 3.297 . . . . 0.0 112.177 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -121.95 6.16 9.84 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.87 36.73 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.944 -1.475 . . . . 0.0 113.659 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -112.6 146.87 37.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.178 1.489 . . . . 0.0 110.753 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 3.6 p -154.67 157.18 4.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.566 ' CE2' ' HD3' ' A' ' 267' ' ' PRO . 12.1 m-85 -109.0 154.84 21.62 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.07 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.6 mt -116.02 134.37 55.03 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.428 1.108 . . . . 0.0 110.872 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.19 109.56 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -166.52 -166.58 0.88 Allowed 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.55 -0.719 . . . . 0.0 111.261 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.63 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.235 1.814 . . . . 0.0 107.578 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 288' ' ' LEU . 2.0 pt? -73.9 -3.61 29.97 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -167.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -111.13 -66.13 1.11 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -87.29 -31.72 20.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.504 -0.748 . . . . 0.0 109.602 -171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . 0.46 ' O ' HD13 ' A' ' 295' ' ' LEU . 67.4 m -83.24 -26.29 30.89 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 121.031 1.741 . . . . 0.0 110.381 177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 288' ' ' LEU . 64.5 t -69.25 -55.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -58.11 -31.53 67.24 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.999 -1.063 . . . . 0.0 112.194 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.3 m -68.2 -39.14 82.52 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.01 0.434 . . . . 0.0 112.144 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 291' ' ' SER . 1.8 mp -71.03 -41.47 70.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.97 -19.75 61.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.361 -0.536 . . . . 0.0 112.339 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -98.06 -3.68 37.52 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.653 0.596 . . . . 0.0 110.187 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -101.66 -5.97 24.35 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 124.314 1.009 . . . . 0.0 110.277 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 33.9 m -90.59 -157.27 0.47 Allowed 'General case' 0 C--O 1.221 -0.418 0 O-C-N 125.846 1.967 . . . . 0.0 109.509 175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.8 m -136.95 -178.23 5.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.74 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -138.4 143.79 39.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.086 0.954 . . . . 0.0 111.788 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.83 127.49 26.22 Favored Pre-proline 0 C--O 1.245 0.821 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -83.43 37.19 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 1 C-N-CA 126.125 4.55 . . . . 0.0 110.158 176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.465 ' CD1' ' H ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -71.01 -20.23 62.43 Favored 'General case' 0 C--O 1.244 0.795 0 O-C-N 121.222 -0.924 . . . . 0.0 112.595 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.441 ' H ' HD13 ' A' ' 304' ' ' LEU . 47.5 t -162.92 74.92 1.99 Allowed Pre-proline 0 C--N 1.346 0.45 0 CA-C-O 122.427 1.108 . . . . 0.0 108.581 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.13 -5.88 10.32 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.024 2.483 . . . . 0.0 114.36 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.18 -13.55 61.97 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.183 -0.948 . . . . 0.0 111.004 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 154.44 -25.24 0.67 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.273 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.5 tp -96.11 38.3 1.19 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 111.898 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 5.2 m -66.61 167.0 11.75 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.442 1.097 . . . . 0.0 108.858 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -138.58 154.05 48.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 119.249 0.931 . . . . 0.0 110.0 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -110.91 151.77 27.51 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 47.0 m-85 -147.4 159.75 43.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -162.99 151.58 14.34 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -114.57 131.48 56.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.11 0.868 . . . . 0.0 110.238 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.62 16.22 19.77 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.488 0.715 . . . . 0.0 110.376 -173.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 322' ' ' ARG . 65.6 p -132.8 132.24 41.97 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.769 -0.582 . . . . 0.0 112.562 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 95.9 p -138.38 -18.53 1.12 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.225 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -137.2 -16.39 1.42 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -90.16 -25.38 20.7 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.411 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mmm -148.38 -47.15 0.15 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.613 1.565 . . . . 0.0 109.676 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.422 ' H ' ' HB2' ' A' ' 317' ' ' SER . 21.8 ptt180 47.72 39.63 10.59 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.147 1.779 . . . . 0.0 114.7 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 21.8 m -132.35 -19.11 2.48 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.552 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -148.48 168.22 23.27 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.96 158.29 30.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.057 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.35 165.22 4.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.473 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 2.8 pp0? -118.2 166.89 12.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.99 140.91 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 111.644 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -143.1 98.09 5.63 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -83.49 155.54 14.1 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.094 1.863 . . . . 0.0 112.243 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -80.21 119.87 23.55 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.145 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 334' ' ' ALA . 18.0 t -97.25 157.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.109 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -54.34 -30.96 53.31 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.687 0.756 . . . . 0.0 110.549 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.512 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -74.93 6.76 3.75 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.491 1.116 . . . . 0.0 112.413 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -112.79 6.28 17.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 109.982 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 42.9 m -123.96 -29.14 3.68 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.21 165.76 35.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.799 1.181 . . . . 0.0 110.387 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -152.45 136.65 16.56 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 125.631 1.572 . . . . 0.0 111.903 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.03 147.55 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 122.731 1.253 . . . . 0.0 110.844 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 -113.34 3.95 16.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.489 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.7 m -133.58 150.33 74.59 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 125.439 1.496 . . . . 0.0 110.087 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -85.68 -7.29 8.61 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.524 3.483 . . . . 0.0 113.799 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.5 t -149.46 -16.01 0.28 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.666 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -97.89 166.46 11.44 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.565 1.146 . . . . 0.0 109.994 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -151.25 -169.07 3.28 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.034 -0.416 . . . . 0.0 110.457 -174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.533 HD11 ' CE1' ' A' ' 379' ' ' TYR . 9.4 mp -37.27 152.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.42 2.288 . . . . 0.0 114.183 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 397' ' ' THR . 8.5 t70 -131.99 134.9 25.75 Favored Pre-proline 0 N--CA 1.467 0.395 0 C-N-CA 126.331 1.852 . . . . 0.0 108.136 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -82.29 4.78 6.8 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.27 1.98 . . . . 0.0 113.811 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 6.2 t -139.24 -5.96 1.41 Allowed 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.117 1.326 . . . . 0.0 114.238 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -125.58 69.65 1.17 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.187 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 397' ' ' THR . 8.8 t -150.84 153.4 35.31 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.413 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.89 165.19 29.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 124.056 0.847 . . . . 0.0 111.131 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -83.32 151.4 25.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.331 0.586 . . . . 0.0 112.257 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.3 t -132.54 142.88 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.791 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.27 -163.8 18.08 Favored Glycine 0 C--O 1.246 0.863 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.174 175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.72 37.37 28.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.001 1.721 . . . . 0.0 113.582 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.57 167.06 20.52 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.428 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 17.2 p-80 -83.57 4.86 26.38 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -174.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 107.47 0.23 34.89 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.732 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.428 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 5.0 ptp -164.13 21.65 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.094 0.947 . . . . 0.0 110.289 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.6 tp -62.81 140.45 58.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.896 1.225 . . . . 0.0 110.608 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.04 -177.07 3.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.44 -28.23 66.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.7 1.2 . . . . 0.0 111.532 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -73.63 -31.92 63.78 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.819 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.62 60.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.838 -1.164 . . . . 0.0 108.551 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.488 HD11 HD11 ' A' ' 382' ' ' ILE . 93.3 mt -60.95 -53.45 57.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.25 59.16 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -76.95 -41.65 42.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.913 0.863 . . . . 0.0 110.36 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.3 -26.99 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.218 -1.355 . . . . 0.0 109.197 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 366' ' ' LEU . 51.7 mt -96.08 -20.74 18.43 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.274 -0.891 . . . . 0.0 112.882 -168.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 -7.53 18.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 116.211 -1.852 . . . . 0.0 110.543 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 -13.05 8.64 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 120.247 1.385 . . . . 0.0 114.684 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.412 HD21 ' CG ' ' A' ' 220' ' ' TRP . 60.5 mt -117.12 -4.01 11.48 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.61 0.641 . . . . 0.0 111.313 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 407' ' ' ALA . 22.9 m-85 -133.08 -32.84 1.18 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.903 0.881 . . . . 0.0 111.857 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 79.29 -9.64 39.74 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.278 0.871 . . . . 0.0 115.278 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -167.7 128.03 1.66 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 120.411 2.105 . . . . 0.0 110.661 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.41 171.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.9 p -119.04 -30.12 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.533 ' CE1' HD11 ' A' ' 346' ' ' LEU . 1.1 t80 -171.11 159.67 6.06 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 379' ' ' TYR . . . -148.99 145.6 27.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -151.78 -173.97 22.03 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-O 122.955 1.308 . . . . 0.0 114.865 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 366' ' ' LEU . 42.2 mm -116.47 144.37 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 112.093 -2.053 . . . . 0.0 109.834 -171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -76.3 44.81 0.35 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.799 0.439 . . . . 0.0 111.916 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.56 155.79 5.24 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.271 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -145.35 144.69 30.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -48.96 114.97 1.11 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.548 1.139 . . . . 0.0 111.099 -172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 14.3 m170 57.99 28.53 16.35 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.045 172.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -105.65 -1.32 24.73 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 4.0 p90 33.21 59.44 1.63 Allowed Pre-proline 0 C--N 1.353 0.751 0 C-N-CA 126.497 1.919 . . . . 0.0 112.962 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.06 -49.02 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.424 2.083 . . . . 0.0 113.507 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 391' ' ' ILE . 8.3 tp 31.41 41.49 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.518 1.527 . . . . 0.0 112.473 -175.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -141.3 11.72 2.77 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 117.975 -1.458 . . . . 0.0 112.155 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 45.6 m -151.95 153.44 34.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 118.068 0.934 . . . . 0.0 109.04 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -174.4 -166.5 32.5 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 119.729 -1.224 . . . . 0.0 113.707 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.08 167.68 29.55 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.34 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.89 135.47 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 119.303 0.956 . . . . 0.0 110.332 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.446 HG22 ' HB ' ' A' ' 351' ' ' THR . 21.1 p -105.5 129.13 53.85 Favored 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 121.704 -0.623 . . . . 0.0 110.868 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.449 ' CD1' ' CB ' ' A' ' 403' ' ' SER . 95.0 m-85 -96.62 -45.14 6.83 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 53.9 t30 56.64 17.47 3.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.702 0.401 . . . . 0.0 111.01 -170.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -141.66 155.78 45.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.664 1.986 . . . . 0.0 107.91 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -103.24 -37.47 7.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 117.718 -1.134 . . . . 0.0 112.499 -171.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.521 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -61.05 -22.92 65.04 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 118.058 -1.457 . . . . 0.0 110.518 -178.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.449 ' CB ' ' CD1' ' A' ' 398' ' ' PHE . 7.3 m -74.02 -26.51 60.47 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.155 -0.966 . . . . 0.0 111.24 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -73.71 -56.03 5.51 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.442 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.234 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -78.16 -30.54 49.22 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.827 -0.546 . . . . 0.0 111.522 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . . . -73.08 -40.64 64.86 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.94 -30.82 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 123.392 0.432 . . . . 0.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 25.6 p -77.55 -14.52 59.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.81 1.319 . . . . 0.0 112.993 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -88.93 -46.31 9.0 Favored 'General case' 0 C--O 1.22 -0.484 0 O-C-N 123.681 0.613 . . . . 0.0 110.197 170.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.73 -16.6 0.01 OUTLIER 'General case' 0 C--O 1.242 0.692 0 C-N-CA 126.86 2.064 . . . . 0.0 115.099 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -163.88 145.87 9.22 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.4 160.81 41.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 33.5 mt-10 -118.76 128.14 54.21 Favored 'General case' 0 C--N 1.356 0.872 0 O-C-N 125.354 1.659 . . . . 0.0 108.851 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.6 mt -99.29 125.25 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 40.09 3.46 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.092 0.87 . . . . 0.0 111.436 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 41.9 p -76.4 172.17 13.37 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.965 1.365 . . . . 0.0 110.162 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.9 t -73.62 -1.29 18.25 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 120.275 -1.516 . . . . 0.0 112.713 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -128.43 -9.69 5.17 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 422' ' ' LYS . 15.0 t80 -149.71 124.09 9.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.937 0.79 . . . . 0.0 109.175 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 14.1 p -131.43 72.14 1.49 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.668 0.787 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 420' ' ' PHE . 98.0 mttt -152.42 177.91 10.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.001 0.92 . . . . 0.0 111.156 -171.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 93.7 mttt -122.28 -179.54 4.21 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.7 m -152.15 161.25 3.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.81 1.244 . . . . 0.0 107.824 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -116.26 155.08 28.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 123.413 1.578 . . . . 0.0 110.267 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.9 mt -143.37 138.35 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.341 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -139.04 153.64 71.78 Favored Pre-proline 0 C--O 1.246 0.915 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.72 149.99 88.86 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 123.468 2.779 . . . . 0.0 110.886 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.86 1.664 . . . . 0.0 111.646 -176.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 60.0 m -162.2 152.97 17.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -18.96 1.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.96 1.709 . . . . 0.0 112.422 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 45.5 m 43.65 56.43 4.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.905 0.86 . . . . 0.0 112.745 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.85 -17.71 80.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.784 -1.098 . . . . 0.0 114.964 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.534 ' HA ' HG22 ' A' ' 417' ' ' THR . 29.6 mt-30 46.91 44.56 14.68 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.456 ' N ' ' CD ' ' A' ' 225' ' ' PRO . 1.3 pt? -137.0 6.28 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 116.068 -1.92 . . . . 0.0 115.302 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 224' ' ' LEU . 84.3 Cg_endo -68.25 128.66 17.82 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 CA-C-N 123.091 2.14 . . . . 0.0 108.709 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.12 152.5 24.3 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.236 2.624 . . . . 0.0 111.829 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -140.44 3.52 1.92 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 125.5 1.52 . . . . 0.0 110.718 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -106.04 64.7 0.68 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.404 ' HA ' HD21 ' A' ' 231' ' ' ASN . 26.1 p90 -115.52 -99.01 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.344 1.458 . . . . 0.0 109.865 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 57.75 27.82 14.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.11 1.364 . . . . 0.0 112.277 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.404 HD21 ' HA ' ' A' ' 229' ' ' TYR . 8.1 m-80 -91.09 -43.89 0.38 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.64 -170.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.483 2.122 . . . . 0.0 114.653 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 29.6 pt -105.41 178.67 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.823 1.249 . . . . 0.0 108.228 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.34 151.33 19.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.34 -1.475 . . . . 0.0 108.91 -174.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 28.1 t -147.4 -2.11 0.6 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.029 0.442 . . . . 0.0 111.677 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 -169.58 2.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 120.344 -1.472 . . . . 0.0 113.092 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -64.41 170.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.677 0.751 . . . . 0.0 112.603 178.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.37 141.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.143 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -83.62 134.14 34.81 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -144.92 118.7 9.24 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.485 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 169.73 -162.25 35.68 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.03 7.18 3.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.115 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 27.2 m -88.34 131.59 41.9 Favored Pre-proline 0 C--O 1.216 -0.68 0 CA-C-N 117.798 0.799 . . . . 0.0 110.406 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -86.95 -4.3 7.99 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 124.341 3.361 . . . . 0.0 109.862 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 1.3 p-90 -118.62 -43.13 2.7 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 120.464 -1.398 . . . . 0.0 114.327 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . 0.285 0.3 OUTLIER 54.04 154.87 0.0 OUTLIER 'General case' 0 C--O 1.271 2.221 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -171.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -143.72 178.32 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.058 175.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 274' ' ' PRO . 18.0 m -44.02 123.14 3.18 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.37 -25.75 68.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.84 -14.53 62.44 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 118.218 0.463 . . . . 0.0 111.846 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.14 -44.22 36.49 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-O 121.866 0.703 . . . . 0.0 112.833 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.7 -35.83 57.61 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.433 1.111 . . . . 0.0 109.608 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.55 -35.84 72.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.881 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -80.9 -14.82 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.388 . . . . 0.0 110.91 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 47.1 m -79.81 -28.75 40.17 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.947 -0.471 . . . . 0.0 112.002 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -130.87 26.81 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 262' ' ' LEU . 10.9 ptm85 -101.8 1.85 37.67 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.29 -0.881 . . . . 0.0 113.275 169.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 99.1 t -76.22 -14.89 15.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 122.483 1.135 . . . . 0.0 111.708 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -87.61 -16.03 35.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.892 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 163.97 172.0 30.9 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.614 1.097 . . . . 0.0 112.569 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 52.8 m -58.13 130.89 48.72 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -160.25 173.92 14.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.492 167.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.408 ' HB2' HG23 ' A' ' 285' ' ' VAL . 50.2 m -138.96 174.84 10.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.531 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 146.65 25.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 C-N-CA 125.235 1.414 . . . . 0.0 111.334 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -146.72 141.69 27.04 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.896 0.855 . . . . 0.0 112.928 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.415 ' HB3' HG23 ' A' ' 282' ' ' VAL . 32.8 p90 -151.08 140.1 13.46 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.475 1.11 . . . . 0.0 111.325 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -79.08 10.27 3.02 Favored 'Trans proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.691 3.594 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -75.32 -168.89 24.5 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -80.5 54.51 2.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.315 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.406 ' HB3' ' NE1' ' A' ' 266' ' ' TRP . 5.2 p-10 -69.43 -15.93 63.38 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -78.63 -11.8 84.89 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 121.221 -0.925 . . . . 0.0 113.413 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.61 -45.98 4.28 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.267 1.534 . . . . 0.0 110.274 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.47 ' CG ' ' HE ' ' A' ' 275' ' ' ARG . 2.4 p80 -163.1 145.42 8.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 123.462 0.476 . . . . 0.0 109.837 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.407 ' HG2' HG23 ' A' ' 248' ' ' THR . 35.5 Cg_endo -78.26 41.11 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 126.586 4.857 . . . . 0.0 113.097 -177.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.47 ' HE ' ' CG ' ' A' ' 273' ' ' HIS . 28.4 ptt180 -132.28 10.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.622 -177.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 99.4 m -125.41 56.54 14.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.781 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.63 149.36 48.95 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 N-CA-C 108.429 -1.412 . . . . 0.0 108.429 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.55 -30.82 86.78 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 121.65 1.567 . . . . 0.0 113.415 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -146.84 176.13 10.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.85 0.86 . . . . 0.0 110.631 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -81.62 25.66 3.85 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.487 -1.383 . . . . 0.0 116.096 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.485 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 51.3 p90 -142.63 174.18 10.87 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.373 0.69 . . . . 0.0 109.534 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 266' ' ' TRP . 9.1 p -155.45 157.1 4.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -89.85 140.03 30.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.779 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.3 mt -119.86 148.37 43.56 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.014 0.825 . . . . 0.0 109.676 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 263' ' ' SER . 2.8 m -131.8 98.48 3.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.469 ' C ' ' H ' ' A' ' 288' ' ' LEU . 67.2 m-85 -85.09 -171.58 3.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.176 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -76.96 43.86 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.796 1.284 . . . . 0.0 110.703 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 286' ' ' PHE . 4.1 mm? 54.12 -27.62 0.01 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 131.107 3.763 . . . . 0.0 116.575 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -148.95 -42.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.118 0.872 . . . . 0.0 111.906 -170.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -58.1 -74.37 0.06 Allowed 'General case' 0 C--O 1.244 0.806 0 CA-C-O 122.152 0.977 . . . . 0.0 113.026 -174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 37.9 m -70.33 -11.82 61.17 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.425 0.69 . . . . 0.0 109.537 -174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 17.1 t -73.83 -46.69 46.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 O-C-N 119.837 -1.789 . . . . 0.0 111.452 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.11 -29.54 64.18 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.97 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 49.5 m -66.19 -36.68 83.69 Favored 'General case' 0 C--O 1.244 0.796 0 O-C-N 121.794 -0.566 . . . . 0.0 111.368 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 295' ' ' LEU . 0.1 OUTLIER -70.59 -52.38 21.9 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.723 -0.611 . . . . 0.0 111.449 -175.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.07 -29.97 70.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.731 0.696 . . . . 0.0 111.707 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -80.74 -10.77 59.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.158 0.435 . . . . 0.0 110.969 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -109.99 -2.7 16.94 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.395 -0.816 . . . . 0.0 110.862 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 90.4 m -102.99 -156.11 0.55 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.895 1.278 . . . . 0.0 109.039 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 59.0 m -124.42 166.86 15.24 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.076 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -140.0 161.49 37.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.655 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -147.37 124.04 5.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -85.4 22.56 0.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.093 3.862 . . . . 0.0 112.593 173.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.59 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -42.02 -36.41 1.11 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.052 0.941 . . . . 0.0 113.506 -177.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.59 ' H ' HD12 ' A' ' 304' ' ' LEU . 16.9 t 47.12 50.36 8.59 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 124.979 1.312 . . . . 0.0 114.382 171.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.428 ' HD3' HD13 ' A' ' 304' ' ' LEU . 90.0 Cg_endo -71.58 -10.79 27.29 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -143.85 9.51 1.53 Allowed 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.035 0.834 . . . . 0.0 109.907 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 99.36 -0.02 56.98 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.537 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 77.9 mt -128.86 156.24 43.96 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 118.704 1.252 . . . . 0.0 110.162 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 21.8 m -102.68 165.05 11.29 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.969 0.908 . . . . 0.0 110.1 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -142.51 154.98 44.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.601 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -111.56 154.5 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 110.996 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -144.96 149.26 34.88 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.455 -0.778 . . . . 0.0 112.059 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -161.84 160.6 28.32 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.129 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -124.69 147.38 48.61 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.23 -0.919 . . . . 0.0 110.68 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.84 9.39 3.58 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.179 -168.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 319' ' ' ARG . 66.9 p -121.75 -97.11 0.46 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 124.199 0.937 . . . . 0.0 109.724 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.471 ' HA ' ' SG ' ' A' ' 323' ' ' CYS . 6.2 m 65.67 -3.85 0.66 Allowed 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.232 1.013 . . . . 0.0 111.867 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 317' ' ' SER . 5.5 mpt_? -140.4 170.63 15.46 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.471 2.308 . . . . 0.0 106.624 170.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 321' ' ' MET . 17.5 ptt180 50.21 6.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.308 2.243 . . . . 0.0 115.115 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 11.7 mmt -156.68 -176.03 5.75 Favored 'General case' 0 CA--C 1.508 -0.638 0 O-C-N 121.728 -0.607 . . . . 0.0 109.701 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -83.74 20.3 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.679 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 318' ' ' SER . 55.9 m 54.15 68.72 0.81 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.478 0.711 . . . . 0.0 112.554 175.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -124.55 108.11 11.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.354 -0.841 . . . . 0.0 109.28 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.26 169.01 2.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.039 1.336 . . . . 0.0 112.661 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.65 178.1 3.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.87 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.411 ' C ' HE21 ' A' ' 327' ' ' GLN . 0.0 OUTLIER -134.34 161.23 35.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.358 0.599 . . . . 0.0 109.851 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.33 135.69 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 24.1 mt -144.21 98.16 5.13 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 125.028 1.455 . . . . 0.0 109.837 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.75 160.47 16.37 Favored 'Trans proline' 0 N--CA 1.449 -1.13 1 C-N-CA 125.48 4.12 . . . . 0.0 112.969 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -89.19 125.16 34.95 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.133 0.895 . . . . 0.0 109.941 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 334' ' ' ALA . 63.4 t -109.86 147.85 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.94 -22.11 47.32 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 117.744 -1.582 . . . . 0.0 111.934 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.544 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -59.23 -14.34 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.706 1.139 . . . . 0.0 113.148 174.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -99.28 6.91 46.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.369 1.067 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.2 m -132.81 -33.73 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.518 0.727 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -146.76 152.83 39.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.988 0.899 . . . . 0.0 110.725 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -164.64 140.78 5.94 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.549 -1.66 . . . . 0.0 109.473 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 379' ' ' TYR . 5.5 m -118.85 150.6 21.11 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.668 -0.645 . . . . 0.0 112.112 -175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -125.1 28.52 6.36 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.99 0.916 . . . . 0.0 109.655 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.4 t -148.23 143.0 16.98 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 123.756 0.823 . . . . 0.0 110.532 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.11 -10.69 26.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.717 2.944 . . . . 0.0 110.186 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.7 m -90.24 -9.48 47.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.355 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 43.11 17.3 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 345' ' ' ARG . 0.0 OUTLIER -117.6 174.34 6.22 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 178.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.418 HD11 ' CD1' ' A' ' 379' ' ' TYR . 1.7 mm? -86.57 169.67 12.57 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 125.019 1.45 . . . . 0.0 111.685 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -110.44 154.15 43.14 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.26 110.16 0.51 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.043 1.829 . . . . 0.0 112.003 -171.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 35.8 m 50.82 35.65 12.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.121 0.968 . . . . 0.0 112.41 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -115.61 64.76 0.69 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.425 0.631 . . . . 0.0 112.251 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.1 t -148.61 159.26 44.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.653 0.381 . . . . 0.0 111.556 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.05 165.44 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 O-C-N 121.139 -0.976 . . . . 0.0 111.852 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -87.62 162.2 17.27 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.93 132.91 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.904 0.753 . . . . 0.0 109.345 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -136.4 -176.7 14.5 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 123.222 1.457 . . . . 0.0 111.414 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 63.0 -57.11 0.16 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.796 1.238 . . . . 0.0 113.056 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 47.8 -158.57 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.784 1.233 . . . . 0.0 111.74 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -147.88 163.71 35.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.517 1.927 . . . . 0.0 107.487 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -63.25 4.18 0.95 Allowed Glycine 0 CA--C 1.528 0.892 0 CA-C-O 120.142 -0.255 . . . . 0.0 113.272 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.8 ptp -164.4 32.2 0.07 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-N 118.848 1.324 . . . . 0.0 108.756 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.4 111.89 2.21 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.537 0.735 . . . . 0.0 110.743 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.21 159.36 17.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -71.66 -20.32 61.97 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 121.479 -0.763 . . . . 0.0 112.497 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.09 -23.24 59.31 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.342 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -72.12 -35.25 69.08 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.223 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.14 -29.35 63.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 119.0 -1.08 . . . . 0.0 109.737 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -86.5 -15.87 38.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.172 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -85.93 -43.37 13.26 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-N 119.483 1.038 . . . . 0.0 110.958 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.73 -52.27 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.66 -38.86 70.62 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -21.2 60.45 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 118.35 -1.34 . . . . 0.0 110.376 -175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.6 -12.83 35.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.461 -0.774 . . . . 0.0 109.968 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 13.7 tp -75.53 -20.68 58.54 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 121.777 -0.577 . . . . 0.0 110.436 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 403' ' ' SER . 27.7 p90 -156.34 -43.31 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 374' ' ' PHE . . . -177.37 -66.67 0.06 OUTLIER Glycine 0 CA--C 1.523 0.569 0 CA-C-N 119.174 0.897 . . . . 0.0 114.182 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 176.46 149.95 7.91 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 119.087 1.444 . . . . 0.0 114.644 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 1.1 m -118.75 172.52 5.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.618 0.767 . . . . 0.0 110.914 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.8 -30.87 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' A' ' 339' ' ' VAL . 23.0 t80 -163.93 156.04 17.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.36 154.13 40.51 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.11 166.27 36.27 Favored Glycine 0 C--O 1.22 -0.739 0 CA-C-O 122.683 1.157 . . . . 0.0 114.951 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 336' ' ' SER . 11.4 mm -116.0 154.42 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.27 1.828 . . . . 0.0 107.071 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.64 134.09 42.05 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.375 -0.828 . . . . 0.0 110.758 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 4.3 p -135.2 154.05 51.73 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 125.26 1.6 . . . . 0.0 110.071 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -138.33 159.31 42.4 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' A' ' 386' ' ' LYS . 1.7 tpmt? -46.82 103.18 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.315 0.646 . . . . 0.0 112.378 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.2 m170 45.07 45.77 9.15 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 127.886 2.475 . . . . 0.0 114.04 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -102.55 4.08 38.11 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.403 -0.81 . . . . 0.0 110.964 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.3 p90 42.26 54.0 8.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.276 1.43 . . . . 0.0 112.746 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 85.7 Cg_endo -70.08 -66.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.3 2.667 . . . . 0.0 112.426 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.47 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 4.0 tp 42.63 28.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 124.061 0.85 . . . . 0.0 111.854 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -123.11 10.69 8.76 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 118.188 -1.34 . . . . 0.0 113.904 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 69.1 p -158.08 158.81 35.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -168.96 -169.24 32.1 Favored Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.071 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -150.53 165.51 33.04 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 122.1 0.952 . . . . 0.0 109.051 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.49 136.14 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 120.755 -1.215 . . . . 0.0 108.719 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 43.8 m -115.74 142.83 46.23 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.524 -170.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.02 164.69 15.74 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.56 0.695 . . . . 0.0 112.007 -174.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -116.37 7.21 13.84 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.107 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -129.1 164.86 22.4 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -107.54 -29.26 9.29 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 118.056 -0.973 . . . . 0.0 112.912 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.581 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -56.44 -28.79 60.52 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.753 1.16 . . . . 0.0 113.398 -173.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.481 ' HB2' ' CD2' ' A' ' 374' ' ' PHE . 32.6 t -78.38 -33.99 48.52 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.617 -1.302 . . . . 0.0 113.159 175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -51.87 -50.73 60.41 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 123.845 0.716 . . . . 0.0 111.494 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 405' ' ' LEU 0.282 0.0 OUTLIER -83.39 -26.55 30.34 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.618 176.9 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.407 ' N ' HD22 ' A' ' 405' ' ' LEU . 28.9 ttpp -74.3 -19.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.465 1.029 . . . . 0.0 110.86 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -89.34 -36.75 15.35 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.201 -0.937 . . . . 0.0 112.364 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.4 m -71.61 -22.16 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 119.841 1.2 . . . . 0.0 108.961 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.7 p -84.01 -29.66 26.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 124.499 1.124 . . . . 0.0 112.706 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -72.99 -41.33 64.43 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.493 0.717 . . . . 0.0 110.667 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.21 -9.78 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.93 148.51 10.33 Favored 'General case' 0 C--O 1.219 -0.522 0 O-C-N 120.766 -1.209 . . . . 0.0 110.7 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 25.9 m -141.38 163.51 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.233 0.469 . . . . 0.0 110.528 171.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.68 139.2 47.33 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.173 0.511 . . . . 0.0 110.782 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 29.6 mt -103.74 125.78 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 29.12 5.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 223' ' ' GLN . 34.9 p -68.74 178.8 1.97 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.344 1.545 . . . . 0.0 111.638 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 40.3 p -73.94 -8.51 56.36 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -138.69 3.54 2.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.715 0.806 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -147.97 142.36 26.33 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.315 -1.491 . . . . 0.0 112.914 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 11.0 p -146.03 104.72 3.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.056 0.943 . . . . 0.0 110.091 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 41.4 tptt -165.87 176.55 7.79 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.528 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 56.2 mtpt -118.94 162.6 18.25 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.29 138.63 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -100.07 152.11 20.6 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 59.5 mt -135.38 135.11 52.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -150.89 150.94 29.02 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 119.395 0.998 . . . . 0.0 109.118 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.34 156.06 27.37 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.878 2.385 . . . . 0.0 111.464 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.996 -1.478 . . . . 0.0 109.642 -177.077 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 121.228 0.537 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 28.9 m -58.61 153.74 15.76 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.826 0.85 . . . . 0.0 110.654 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 55.6 t90 -116.79 -59.18 1.99 Allowed 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.127 -0.983 . . . . 0.0 109.534 -173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.9 m 39.21 51.64 2.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.089 1.355 . . . . 0.0 111.917 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -76.04 -17.97 79.71 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.65 1.119 . . . . 0.0 111.643 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 63.53 32.4 14.19 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.9 mt -111.21 93.18 17.47 Favored Pre-proline 0 N--CA 1.437 -1.083 0 C-N-CA 125.15 1.38 . . . . 0.0 108.614 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.23 147.49 26.15 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 113.641 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.23 -149.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 125.054 3.836 . . . . 0.0 109.745 170.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 68.29 28.22 6.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.954 0.901 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -90.91 -4.96 56.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.47 147.77 52.82 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 112.792 -176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -153.5 33.65 0.46 Allowed 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.48 1.512 . . . . 0.0 109.378 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.432 HD21 ' HB2' ' A' ' 334' ' ' ALA . 2.5 p30 -129.42 80.08 72.76 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.95 105.83 2.14 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.467 2.111 . . . . 0.0 111.414 -172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 333' ' ' LEU . 14.2 pt -149.58 148.32 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 126.836 2.055 . . . . 0.0 107.1 173.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -125.94 157.46 37.7 Favored 'General case' 0 CA--C 1.504 -0.8 0 O-C-N 121.197 -0.94 . . . . 0.0 113.072 -167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 99.2 p -152.4 -1.38 0.28 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 12.1 t -144.46 179.84 7.01 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.247 1.022 . . . . 0.0 110.837 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.82 161.43 0.76 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.76 150.45 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.205 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -94.01 140.37 29.8 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.906 0.882 . . . . 0.0 109.691 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -146.77 108.93 4.43 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.68 163.9 34.89 Favored Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.668 1.122 . . . . 0.0 112.884 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.94 3.17 1.53 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.74 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 9.9 m -103.77 108.69 60.42 Favored Pre-proline 0 N--CA 1.435 -1.216 0 C-N-CA 122.514 0.326 . . . . 0.0 110.522 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.98 -20.99 11.23 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.081 1.854 . . . . 0.0 113.017 175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.403 ' CD2' ' HG3' ' A' ' 321' ' ' MET . 35.7 p-90 -100.08 -26.33 14.0 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -43.56 104.34 0.04 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.106 1.362 . . . . 0.0 112.33 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.513 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -74.92 -27.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.2 m -146.12 136.07 23.5 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.749 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -9.92 59.0 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.33 64.03 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.056 -1.028 . . . . 0.0 110.722 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.8 -58.07 10.84 Favored Glycine 0 C--N 1.359 1.859 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.2 pt? -70.75 -23.31 62.39 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 119.671 -2.076 . . . . 0.0 112.085 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.0 t -68.08 -27.21 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 122.993 0.517 . . . . 0.0 109.79 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -95.46 -13.85 24.24 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 122.555 0.342 . . . . 0.0 111.826 -176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 54.6 m -82.46 -26.82 32.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.35 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -131.96 64.49 1.59 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.109 -1.62 . . . . 0.0 113.221 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -140.12 2.23 1.89 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.794 0.838 . . . . 0.0 111.484 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.47 -10.43 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.408 0.683 . . . . 0.0 109.529 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.08 28.69 4.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.834 1.253 . . . . 0.0 111.275 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.37 -160.26 8.25 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.813 -0.437 . . . . 0.0 114.157 -171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 38.8 m -156.3 51.65 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 125.127 1.134 . . . . 0.0 109.886 -174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.587 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -115.34 175.0 5.71 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -172.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.5 t -143.89 177.92 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.846 172.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.87 147.57 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -157.97 153.18 25.72 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 126.419 2.324 . . . . 0.0 110.101 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -155.89 149.7 19.24 Favored Pre-proline 0 N--CA 1.432 -1.374 0 O-C-N 124.21 0.944 . . . . 0.0 113.097 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.44 153.51 50.09 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 121.785 1.657 . . . . 0.0 107.929 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 88.32 21.4 45.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 119.275 -1.441 . . . . 0.0 110.474 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -61.29 -3.86 1.03 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 126.599 1.96 . . . . 0.0 114.65 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -118.77 131.2 56.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.953 1.301 . . . . 0.0 109.464 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 169.47 -165.52 38.92 Favored Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -94.47 149.66 21.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.856 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 274' ' ' PRO . 20.1 m80 42.7 49.96 5.03 Favored Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 124.357 1.063 . . . . 0.0 113.015 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 273' ' ' HIS . 32.6 Cg_exo -61.55 124.59 14.94 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.823 1.682 . . . . 0.0 110.893 -171.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -155.86 -32.98 0.09 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.877 0.471 . . . . 0.0 110.435 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 37.9 t -155.22 141.17 12.85 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.664 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 88.9 Cg_endo -75.26 157.96 41.41 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.058 3.172 . . . . 0.0 115.096 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 277' ' ' PRO . 70.7 Cg_exo -58.29 155.37 35.53 Favored 'Trans proline' 0 C--O 1.223 -0.245 0 C-N-CA 125.278 3.985 . . . . 0.0 112.979 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.3 tttt 49.58 24.75 1.22 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.216 1.407 . . . . 0.0 112.59 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.08 2.04 0.5 Allowed Glycine 0 C--O 1.215 -1.092 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.29 126.71 30.35 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.979 1.39 . . . . 0.0 113.344 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.01 163.62 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -118.88 149.07 42.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 63.8 mt -114.97 137.52 51.9 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.017 1.448 . . . . 0.0 110.493 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.31 116.52 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.514 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.42 -166.17 2.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.88 0.848 . . . . 0.0 112.876 -168.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -48.61 139.29 9.61 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 167.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 24.4 mt -74.52 -39.06 62.62 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.745 0.702 . . . . 0.0 112.714 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -121.89 -45.54 2.26 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.733 -1.229 . . . . 0.0 113.516 -170.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -69.96 -70.96 0.26 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 36.8 t -58.95 -29.47 67.16 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.145 0.498 . . . . 0.0 111.591 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.6 t -64.42 -57.33 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.125 -174.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -66.82 -29.54 69.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.609 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 73.2 m -61.47 -59.96 4.45 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.896 1.372 . . . . 0.0 111.823 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 298' ' ' ALA . 4.0 pp -79.46 -26.74 41.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.84 -173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.17 -34.24 76.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.632 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -91.03 -2.78 57.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.814 0.696 . . . . 0.0 112.359 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 295' ' ' LEU . . . -97.43 -15.84 20.46 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 98.7 m -85.09 -159.3 0.42 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 14.9 m -96.41 158.36 15.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.539 1.162 . . . . 0.0 109.804 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.421 ' HE1' ' HB2' ' A' ' 310' ' ' SER . 85.9 t60 -158.04 153.41 25.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.6 147.08 34.68 Favored Pre-proline 0 C--N 1.349 0.576 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.95 5.0 4.21 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 123.06 2.507 . . . . 0.0 112.172 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.466 ' C ' ' HD2' ' A' ' 306' ' ' PRO 0.276 0.0 OUTLIER 16.16 99.96 0.0 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.352 3.061 . . . . 0.0 114.629 -179.582 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 7.5 m -49.63 -29.55 2.21 Favored Pre-proline 0 C--O 1.235 0.291 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.466 ' HD2' ' C ' ' A' ' 304' ' ' LEU . 31.9 Cg_exo -60.18 -22.17 69.06 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 123.95 3.1 . . . . 0.0 113.926 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -146.21 145.96 30.63 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -67.71 3.65 4.84 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.689 -1.257 . . . . 0.0 113.832 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -170.09 2.04 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.085 0.942 . . . . 0.0 112.309 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.421 ' HB2' ' HE1' ' A' ' 301' ' ' HIS . 30.2 p -115.03 155.74 26.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -139.75 137.88 35.46 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 21.1 m-85 -116.87 144.83 44.06 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.075 0.95 . . . . 0.0 111.182 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -144.05 158.2 43.86 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -159.6 169.51 23.62 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 146.55 32.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.386 0.136 . . . . 0.0 110.925 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.6 162.95 36.27 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.527 1.531 . . . . 0.0 109.506 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -167.59 178.05 5.58 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.569 -0.707 . . . . 0.0 111.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.8 t -125.4 40.18 3.8 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.656 0.782 . . . . 0.0 109.779 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.0 mtm-85 57.42 24.29 10.01 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.668 1.187 . . . . 0.0 111.939 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.464 ' HG3' ' HE3' ' A' ' 321' ' ' MET . 17.4 ptp180 -140.98 -4.1 1.2 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 118.127 2.639 . . . . 0.0 118.127 -176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.464 ' HE3' ' HG3' ' A' ' 320' ' ' ARG . 1.1 pmm? -150.6 24.17 0.79 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.617 1.099 . . . . 0.0 113.877 173.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -48.61 110.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.747 0.419 . . . . 0.0 111.187 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 47.6 t -164.72 -49.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -110.68 132.61 54.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.844 -169.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.91 156.18 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.256 1.422 . . . . 0.0 112.555 173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.76 168.33 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -127.03 150.42 49.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 3.1 t -130.98 143.31 41.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 124.708 1.255 . . . . 0.0 112.522 -173.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 76.4 mt -148.62 96.93 3.78 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.764 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -85.18 169.41 9.99 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 124.38 3.387 . . . . 0.0 113.286 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 2.0 t90 -91.51 121.04 32.85 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.249 1.42 . . . . 0.0 110.557 171.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 334' ' ' ALA . 83.3 t -101.82 145.29 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.925 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 233' ' ' ILE . 6.8 mp -62.54 -26.59 68.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.231 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.533 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -63.31 -3.57 2.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.483 0.489 . . . . 0.0 112.306 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -103.7 -10.56 18.25 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 122.126 -0.359 . . . . 0.0 110.541 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 69.1 m -104.95 -24.16 12.88 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.483 0.713 . . . . 0.0 110.637 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.4 143.92 31.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -153.67 134.94 14.11 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 22.2 m -118.69 147.6 22.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.523 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -96.31 -14.42 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.3 t -146.48 125.66 6.56 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.674 1.99 . . . . 0.0 109.324 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.92 -8.8 15.62 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.36 2.706 . . . . 0.0 113.059 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -103.97 7.26 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.581 -170.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.4 166.07 14.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.857 0.753 . . . . 0.0 109.177 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -115.74 179.28 4.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 109.912 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.4 mm? -72.89 155.68 39.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.466 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.06 118.61 64.6 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.25 -5.97 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.293 1.995 . . . . 0.0 113.02 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 42.1 m -123.78 -12.58 7.57 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 118.257 -0.878 . . . . 0.0 113.151 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -122.33 100.31 6.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.381 0.991 . . . . 0.0 112.358 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.9 t -150.75 161.42 42.67 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.26 150.33 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-O 121.964 0.888 . . . . 0.0 110.713 171.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -79.71 121.85 25.84 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.569 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.96 137.53 24.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 O-C-N 125.182 1.551 . . . . 0.0 110.121 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -126.23 64.95 0.57 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.619 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -114.2 123.08 48.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.875 0.87 . . . . 0.0 111.401 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -157.52 157.16 33.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 122.524 1.154 . . . . 0.0 113.325 -176.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.26 3.73 0.31 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.08 -1.873 . . . . 0.0 111.895 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.56 -29.49 3.8 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.546 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.5 ptp -160.19 43.86 0.21 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.873 0.836 . . . . 0.0 111.139 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 357' ' ' LEU . 2.9 tm? -63.6 133.4 53.66 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.754 -0.591 . . . . 0.0 109.748 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -130.88 -176.21 3.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.628 1.204 . . . . 0.0 111.541 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -66.5 -13.63 61.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.724 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -81.17 -20.6 40.89 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 120.869 -1.144 . . . . 0.0 109.419 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.76 -35.0 22.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 76.9 mt -73.6 -26.02 60.6 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.19 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -74.65 -40.72 61.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.644 0.378 . . . . 0.0 111.1 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.57 36.43 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.789 0.836 . . . . 0.0 110.261 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 72.9 mt -68.03 -38.62 80.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 62.1 mt -89.75 -27.88 19.74 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -15.18 58.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.812 0.733 . . . . 0.0 110.293 173.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.62 -19.03 19.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.93 0.787 . . . . 0.0 112.366 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.6 tp -96.64 -26.69 15.12 Favored 'General case' 0 C--O 1.241 0.643 0 O-C-N 124.529 1.143 . . . . 0.0 114.004 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.49 -24.36 0.47 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.751 0.705 . . . . 0.0 112.367 172.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 71.47 -6.24 8.7 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.979 -0.9 . . . . 0.0 114.757 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -85.14 11.27 60.95 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.467 1.634 . . . . 0.0 113.907 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.5 p -91.35 162.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 124.836 1.254 . . . . 0.0 111.569 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.9 -27.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.847 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 379' ' ' TYR . 0.9 OUTLIER -153.9 145.44 23.21 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -134.99 140.79 45.95 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.33 25.33 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 121.906 0.725 . . . . 0.0 112.428 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.58 138.0 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.08 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -81.63 135.86 35.54 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.8 p -125.27 162.24 25.16 Favored 'General case' 0 C--O 1.215 -0.732 0 O-C-N 121.499 -0.751 . . . . 0.0 112.184 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -127.88 157.61 40.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.281 1.433 . . . . 0.0 107.688 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -59.04 100.44 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.063 -1.023 . . . . 0.0 111.232 -169.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.8 m170 53.47 39.4 29.93 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.022 1.329 . . . . 0.0 114.139 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -104.85 -4.26 22.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 119.408 -2.058 . . . . 0.0 114.493 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 49.7 51.76 11.37 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-N 119.557 1.071 . . . . 0.0 113.619 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -51.08 2.74 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.792 2.995 . . . . 0.0 110.252 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 9.0 tp 39.83 39.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.942 1.697 . . . . 0.0 110.181 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.07 29.8 1.37 Allowed Glycine 0 CA--C 1.508 -0.355 0 O-C-N 121.596 -0.69 . . . . 0.0 111.927 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 25.0 p -168.89 158.45 8.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -167.74 -170.62 32.76 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.65 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -150.0 157.88 43.6 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.35 130.79 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.6 p -96.57 138.52 34.03 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.104 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -113.44 155.44 25.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.044 0.84 . . . . 0.0 111.866 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -124.89 -10.34 7.2 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.042 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -119.5 150.65 39.9 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.158 0.983 . . . . 0.0 108.383 171.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.33 -16.45 61.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 118.786 -1.165 . . . . 0.0 112.003 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -65.83 -37.0 85.06 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 123.682 0.793 . . . . 0.0 111.144 -171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 43.7 m -71.5 -21.59 61.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.418 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -69.3 -63.47 1.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.038 0.923 . . . . 0.0 110.851 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.521 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -75.55 -20.87 58.37 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.832 -1.167 . . . . 0.0 112.116 -173.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -84.56 -21.94 30.26 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 120.154 -1.591 . . . . 0.0 110.603 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' A' ' 426' ' ' ILE . . . -81.39 -37.27 28.46 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 123.649 0.593 . . . . 0.0 111.095 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.18 -24.01 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 O-C-N 121.691 -0.631 . . . . 0.0 111.116 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.0 p -90.2 -16.02 30.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -90.61 -35.88 14.74 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 56.71 -41.24 0.03 OUTLIER 'General case' 0 C--N 1.344 0.36 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -157.3 124.75 5.26 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 120.191 -1.568 . . . . 0.0 107.963 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.46 157.2 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 423' ' ' LYS . 36.1 mt-10 -94.98 139.51 31.25 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 124.885 1.366 . . . . 0.0 110.104 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 15.3 mt -121.35 125.98 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 123.908 1.813 . . . . 0.0 112.541 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -124.59 52.28 1.54 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.944 -177.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 22.4 p -77.96 179.72 6.59 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 123.397 1.57 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 17.0 p -91.32 3.59 54.49 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -111.4 -29.83 7.64 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -162.52 164.27 27.01 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 59.1 m -123.37 113.3 18.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 23.1 tptt -162.07 178.88 8.42 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.74 0.305 . . . . 0.0 111.786 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 414' ' ' GLU . 34.8 mtmm -124.04 166.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.25 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.4 m -142.28 152.73 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 O-C-N 124.747 1.279 . . . . 0.0 109.365 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -127.08 160.39 31.31 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.982 -169.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.476 HD13 ' HB1' ' A' ' 407' ' ' ALA . 46.9 mt -139.12 141.88 35.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 O-C-N 125.573 1.796 . . . . 0.0 109.343 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -138.31 158.19 71.22 Favored Pre-proline 0 C--O 1.219 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.22 156.77 61.21 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 123.607 2.871 . . . . 0.0 111.259 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 8.5 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.144 -1.408 . . . . 0.0 112.348 -178.242 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.39 0.145 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 89.6 m -148.83 151.2 34.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.75 2.02 . . . . 0.0 109.382 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -3.47 1.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 32.0 m 38.02 60.05 1.27 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 123.903 0.881 . . . . 0.0 112.461 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.13 -28.84 74.03 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.067 -0.852 . . . . 0.0 112.555 -172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 53.54 46.43 26.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.146 0.473 . . . . 0.0 112.167 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.95 26.52 0.09 OUTLIER Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -65.69 122.33 9.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 CA-C-N 123.316 2.22 . . . . 0.0 110.383 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.87 139.07 21.73 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.254 3.302 . . . . 0.0 111.951 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -153.31 170.4 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.286 1.034 . . . . 0.0 109.856 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.3 t30 47.39 48.84 16.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.811 0.444 . . . . 0.0 110.593 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.4 153.4 2.17 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.732 1.213 . . . . 0.0 111.111 -172.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.4 18.01 19.6 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.661 1.185 . . . . 0.0 111.602 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.72 48.13 2.94 Favored Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 123.874 0.87 . . . . 0.0 110.759 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -69.49 103.74 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.664 1.576 . . . . 0.0 114.487 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 31.1 mm -139.35 142.66 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -111.31 148.49 32.83 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -135.98 -8.24 2.08 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 84.5 m -135.85 -173.15 3.29 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 123.984 0.803 . . . . 0.0 110.038 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 389' ' ' TYR . 60.0 pttt -65.83 161.59 20.68 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.906 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.43 148.98 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.536 -173.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -93.23 137.21 32.77 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.151 0.58 . . . . 0.0 110.727 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.456 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.8 tm? -146.62 124.6 12.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.2 -170.27 36.97 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.939 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.76 12.63 1.31 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 12.9 m -61.19 124.28 79.67 Favored Pre-proline 0 C--O 1.217 -0.607 0 CA-C-N 120.016 1.908 . . . . 0.0 111.589 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -83.61 0.94 9.2 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 121.721 1.614 . . . . 0.0 115.072 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.51 -14.17 2.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.952 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 42.81 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 127.93 2.492 . . . . 0.0 115.142 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 248' ' ' THR . 5.9 pt -104.53 -96.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.879 -174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 250' ' ' ALA . 17.5 m -141.68 132.72 26.14 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 122.508 1.147 . . . . 0.0 108.838 173.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -59.61 -22.8 62.33 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.596 ' H ' HG22 ' A' ' 248' ' ' THR . . . -66.83 -39.86 87.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.356 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.68 -47.97 84.8 Favored Glycine 0 CA--C 1.531 1.065 0 O-C-N 123.582 0.552 . . . . 0.0 112.374 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 252' ' ' LEU . 6.4 mp -64.11 -38.27 90.47 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.508 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.458 HG12 ' HD3' ' A' ' 257' ' ' ARG . 16.0 t -73.92 -41.57 53.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.409 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -78.57 -3.65 44.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.304 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.8 m -89.12 -34.86 16.58 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.857 171.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -136.08 75.82 1.57 Allowed 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 120.771 1.623 . . . . 0.0 110.717 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.48 ' HA ' HD21 ' A' ' 262' ' ' LEU . 39.0 ptt180 -142.38 14.47 2.0 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.579 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.07 -9.75 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 122.969 0.507 . . . . 0.0 111.754 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.31 -4.39 58.4 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 120.422 -1.424 . . . . 0.0 109.078 173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 62.18 5.13 7.26 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 125.75 1.906 . . . . 0.0 115.6 172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 287' ' ' GLU . 55.2 p -103.39 7.15 38.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -129.57 163.56 25.74 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 119.357 0.98 . . . . 0.0 112.655 -172.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 10.8 t -152.54 168.6 25.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.895 1.278 . . . . 0.0 108.419 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.7 p -118.22 144.58 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.134 1.773 . . . . 0.0 113.716 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -143.12 131.2 21.8 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -157.93 146.8 14.55 Favored Pre-proline 0 C--N 1.349 0.578 0 CA-C-O 121.564 0.697 . . . . 0.0 112.111 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -88.2 165.72 6.88 Favored 'Trans proline' 0 C--O 1.24 0.575 0 C-N-CA 121.646 1.564 . . . . 0.0 111.141 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 77.72 14.67 82.16 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 118.796 -1.002 . . . . 0.0 110.943 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -69.76 17.74 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.771 1.628 . . . . 0.0 112.735 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -76.56 151.66 36.24 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.923 0.889 . . . . 0.0 111.224 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 124.54 167.85 12.73 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.221 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -78.66 8.28 5.58 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.42 1.488 . . . . 0.0 112.625 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 275' ' ' ARG . 81.1 m-70 -135.74 152.14 75.49 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.12 9.41 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.625 2.216 . . . . 0.0 109.326 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 273' ' ' HIS . 59.5 ttp85 -117.68 117.01 28.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.69 1.196 . . . . 0.0 109.239 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.743 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 17.3 t -160.51 -30.89 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.743 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 86.3 Cg_endo -76.48 142.49 23.58 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.346 2.698 . . . . 0.0 111.829 -170.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.68 -4.36 15.12 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.386 3.39 . . . . 0.0 113.787 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -105.54 150.77 25.06 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 123.62 0.768 . . . . 0.0 109.087 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -99.79 21.72 43.65 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.568 -1.129 . . . . 0.0 113.985 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -154.87 166.06 34.69 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 119.959 1.88 . . . . 0.0 113.021 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.4 m -151.72 -170.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -126.12 148.94 49.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.635 1.207 . . . . 0.0 112.306 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.98 151.51 46.93 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.883 -1.136 . . . . 0.0 111.785 -171.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.33 158.04 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.364 1.466 . . . . 0.0 110.11 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.503 ' C ' ' H ' ' A' ' 288' ' ' LEU . 62.7 m-85 -158.68 -178.22 7.1 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 123.626 1.679 . . . . 0.0 111.154 -170.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 261' ' ' SER . 9.3 tp10 -75.43 19.44 0.18 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.803 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 286' ' ' PHE . 57.3 mt 55.51 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.346 0.439 0 C-N-CA 128.877 2.871 . . . . 0.0 116.628 172.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.0 -51.75 3.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.872 0.869 . . . . 0.0 110.559 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -65.22 -74.2 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.685 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 38.7 t -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.263 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -69.47 -52.19 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 O-C-N 123.666 0.604 . . . . 0.0 112.618 -168.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -68.11 -26.16 65.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 123.495 0.497 . . . . 0.0 110.094 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 34.2 m -69.45 -44.32 71.47 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.992 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 291' ' ' SER . 10.2 mt -68.53 -52.89 27.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.916 1.234 . . . . 0.0 110.868 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.32 9.47 23.15 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -115.05 -7.33 12.51 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.124 0.964 . . . . 0.0 110.617 168.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.32 -25.1 18.71 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.784 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 13.8 t -101.78 -118.28 0.18 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.909 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 63.7 m -123.91 157.09 35.07 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.588 1.185 . . . . 0.0 113.194 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -154.07 161.27 42.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.716 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -148.25 133.86 9.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -82.38 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.353 0.786 1 C-N-CA 125.514 4.142 . . . . 0.0 110.289 174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.476 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -70.21 -14.12 62.48 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.181 -174.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 16.5 m 37.16 78.98 0.33 Allowed Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.167 1.787 . . . . 0.0 113.829 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.42 -22.98 24.27 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.19 1.927 . . . . 0.0 111.63 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -144.86 3.08 1.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.671 0.748 . . . . 0.0 109.728 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.59 -11.69 15.94 Favored Glycine 0 CA--C 1.545 1.907 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.81 108.13 19.31 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 70.2 m -60.85 170.33 1.56 Allowed 'General case' 0 C--N 1.344 0.338 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.532 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -129.08 134.8 48.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.351 0.596 . . . . 0.0 109.562 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -102.16 135.76 43.18 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.79 145.61 47.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -149.08 152.04 35.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.332 0.587 . . . . 0.0 111.003 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -123.77 116.33 22.82 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.966 1.365 . . . . 0.0 110.988 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.402 ' HE2' ' HB ' ' A' ' 326' ' ' VAL . 25.8 ptt? -133.19 1.34 3.49 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.748 -168.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 58.8 p -119.97 2.43 10.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 21.4 t -62.67 -3.16 1.37 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.549 -1.344 . . . . 0.0 111.732 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -88.26 -8.71 54.8 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.339 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -152.33 -9.65 0.19 Allowed 'General case' 0 C--N 1.347 0.499 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 30.5 mmm -124.99 -178.4 4.17 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.937 2.095 . . . . 0.0 108.841 174.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -95.97 -37.03 10.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 118.334 -0.841 . . . . 0.0 112.703 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 42.8 t -176.52 146.6 0.61 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.953 0.901 . . . . 0.0 109.555 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -152.42 -56.0 0.13 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 62.79 100.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 O-C-N 124.144 0.903 . . . . 0.0 109.469 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.402 ' HB ' ' HE2' ' A' ' 316' ' ' MET . 4.6 p -84.44 155.7 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.597 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.51 147.77 24.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 122.036 0.922 . . . . 0.0 109.285 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 129.95 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.895 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 7.0 pt -136.79 96.08 11.99 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.718 1.247 . . . . 0.0 108.37 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -88.29 160.22 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.392 1.395 . . . . 0.0 111.522 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 5.3 t-105 -74.7 124.31 26.51 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 334' ' ' ALA . 16.6 t -96.76 149.29 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 122.749 1.262 . . . . 0.0 110.382 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.0 tt -59.41 -31.66 69.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.443 1.097 . . . . 0.0 108.602 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.421 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -73.62 -7.28 51.35 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.61 1.164 . . . . 0.0 113.741 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.28 0.02 33.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.842 0.857 . . . . 0.0 111.058 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 73.2 m -91.69 -54.78 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -157.33 154.71 29.44 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.864 0.865 . . . . 0.0 112.308 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.454 ' CB ' ' HB1' ' A' ' 363' ' ' ALA . 60.7 t80 -154.94 148.49 25.28 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 123.535 0.522 . . . . 0.0 111.021 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 20.4 m -123.52 155.3 29.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 122.796 0.438 . . . . 0.0 111.51 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -113.89 32.72 5.66 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-O 121.782 0.801 . . . . 0.0 109.157 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.0 t -152.17 141.36 14.19 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.143 0.977 . . . . 0.0 110.148 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.65 -6.57 17.03 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.22 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -115.77 149.22 38.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -99.2 138.87 35.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -158.53 152.56 23.79 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.79 0.805 . . . . 0.0 110.435 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.439 ' HA ' HG21 ' A' ' 397' ' ' THR . 3.4 mm? -128.78 174.74 9.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.068 171.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -141.4 110.45 6.34 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.04 0.79 4.61 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.766 2.977 . . . . 0.0 114.925 -171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 66.2 m -134.44 0.73 3.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 117.992 -1.004 . . . . 0.0 112.813 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -147.01 81.72 1.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.799 1.761 . . . . 0.0 109.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.1 p -136.9 173.33 11.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.7 143.4 37.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 O-C-N 121.506 -0.746 . . . . 0.0 109.398 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -77.83 145.47 36.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.668 1.223 . . . . 0.0 112.77 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 99.2 t -132.01 148.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -177.93 -161.99 27.1 Favored Glycine 0 C--N 1.338 0.639 0 O-C-N 121.671 -0.643 . . . . 0.0 112.853 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.5 0.54 Allowed 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.734 1.214 . . . . 0.0 114.186 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -79.05 172.81 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.18 9.2 0.34 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -168.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.698 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 100.91 15.17 29.42 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 12.8 mmt -147.11 -88.68 0.09 Allowed 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.933 1.366 . . . . 0.0 109.945 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 12.3 tp 44.39 70.78 0.3 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 111.299 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -55.58 170.25 0.27 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.104 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 338' ' ' PHE . . . -64.28 -26.35 68.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -80.56 -21.4 41.77 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.29 -26.15 42.32 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.813 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.61 -44.95 63.5 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 169.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.76 -31.9 72.85 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.774 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.45 -53.55 50.36 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 120.957 -1.09 . . . . 0.0 110.728 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.37 -42.48 96.48 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 370' ' ' LEU . 4.4 mm? -80.61 -38.52 29.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.295 -171.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -12.76 46.57 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 120.261 1.391 . . . . 0.0 112.726 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -103.7 -22.86 13.5 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.531 -0.73 . . . . 0.0 110.477 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.3 tp -98.73 -16.52 18.93 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -105.99 -81.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 164.13 -19.36 0.13 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 119.662 1.119 . . . . 0.0 111.925 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -174.86 142.52 6.35 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 118.727 1.263 . . . . 0.0 112.925 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 9.3 m -146.17 176.93 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 122.414 1.102 . . . . 0.0 109.824 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.0 p -139.83 -31.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.889 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -155.37 146.23 22.37 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -151.05 135.29 16.84 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 125.17 1.388 . . . . 0.0 108.086 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.65 173.45 38.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 29.1 mm -91.3 140.53 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.56 -1.32 . . . . 0.0 109.32 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.27 115.86 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.7 p -111.38 163.35 14.09 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.094 0.95 . . . . 0.0 111.773 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -133.41 159.91 38.94 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.98 103.1 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 O-C-N 121.337 -0.852 . . . . 0.0 112.056 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.26 46.66 20.8 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -108.95 -20.72 12.94 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.627 1.571 . . . . 0.0 115.021 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.414 ' HB2' ' HE2' ' A' ' 237' ' ' LYS . 0.3 OUTLIER 46.36 57.89 16.53 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 124.834 1.334 . . . . 0.0 111.479 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.53 -41.02 1.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.245 1.297 . . . . 0.0 113.242 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 391' ' ' ILE . 11.0 tp 31.82 38.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 127.846 2.458 . . . . 0.0 112.368 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -140.27 11.97 3.03 Favored Glycine 0 CA--C 1.545 1.913 0 C-N-CA 124.474 1.035 . . . . 0.0 110.749 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 93.0 p -151.15 158.33 43.84 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.896 0.409 . . . . 0.0 111.648 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 177.24 -178.45 48.26 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -150.85 166.91 29.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.7 p -132.31 140.36 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 346' ' ' LEU . 75.6 m -107.92 132.46 53.45 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.408 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -128.84 166.3 19.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.769 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -141.14 9.25 2.09 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.691 0.619 . . . . 0.0 110.656 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -124.15 144.39 49.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -68.28 -24.86 64.92 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -51.77 -38.8 57.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.036 0.835 . . . . 0.0 112.186 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.0 m -78.8 -19.26 52.57 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 124.292 1.037 . . . . 0.0 112.367 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -74.47 -57.09 4.16 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 120.61 -1.306 . . . . 0.0 110.308 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.454 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.92 -24.32 59.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 118.508 -1.277 . . . . 0.0 113.795 -175.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -83.07 -27.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.804 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.34 -27.54 42.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.6 m -93.3 -24.48 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 O-C-N 121.378 -0.826 . . . . 0.0 112.02 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.4 p -86.18 -16.09 38.89 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 118.317 0.508 . . . . 0.0 112.02 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -95.25 -43.37 8.09 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.456 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.05 -10.93 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -170.66 152.44 3.81 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.985 -1.072 . . . . 0.0 110.764 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.54 162.16 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -100.84 123.74 45.47 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.63 0.729 . . . . 0.0 109.89 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.26 90.43 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 32.3 ttmt -117.42 106.01 12.75 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.287 0.992 . . . . 0.0 110.344 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 73.0 p -138.55 -177.45 4.86 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.767 1.227 . . . . 0.0 110.583 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 24.1 m -79.93 -9.95 59.73 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.689 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -109.24 -19.48 13.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.833 1.253 . . . . 0.0 112.89 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -153.83 140.41 18.87 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 121.637 0.732 . . . . 0.0 109.244 -173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 89.5 m -144.09 89.03 2.0 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.318 0.647 . . . . 0.0 109.866 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -148.33 -171.37 3.83 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 122.671 1.224 . . . . 0.0 109.912 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 423' ' ' LYS . 42.0 mtmt -130.39 168.61 16.69 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.322 1.058 . . . . 0.0 110.179 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.58 138.04 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.258 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.65 154.85 25.44 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 124.806 1.316 . . . . 0.0 113.707 -168.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 36.2 mt -133.72 134.47 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.448 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -137.56 156.72 74.7 Favored Pre-proline 0 C--O 1.22 -0.47 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.884 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -69.33 163.51 37.65 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.856 3.037 . . . . 0.0 110.47 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 52.2 t80 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.995 -176.178 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 59.8 mmm . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.517 0.198 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 6.7 m 36.21 59.3 0.94 Allowed 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 111.746 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -4.55 36.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.7 m 44.01 52.72 6.7 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.511 1.05 . . . . 0.0 111.959 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.33 -26.76 72.81 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.354 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 57.01 32.48 21.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.45 146.02 95.96 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.214 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.09 124.57 9.17 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 124.731 3.621 . . . . 0.0 112.713 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.26 5.26 6.03 Favored 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 127.278 5.318 . . . . 0.0 114.325 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -127.93 26.22 5.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 118.916 0.78 . . . . 0.0 112.573 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -92.63 34.1 1.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.275 1.03 . . . . 0.0 108.67 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.58 176.3 9.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -169.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -67.14 150.58 48.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.223 1.809 . . . . 0.0 106.719 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -71.92 156.71 90.66 Favored Pre-proline 0 C--N 1.343 0.288 0 CA-C-N 120.029 1.286 . . . . 0.0 112.264 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.49 140.16 21.86 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 124.232 3.288 . . . . 0.0 115.323 -170.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 26.3 mm -155.3 152.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.444 ' CG ' HG11 ' A' ' 292' ' ' VAL . 4.3 m-85 -125.18 149.83 47.54 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 119.604 1.093 . . . . 0.0 110.938 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.7 p -148.25 11.66 0.92 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -170.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.4 t -152.48 -167.33 2.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 119.636 1.107 . . . . 0.0 109.057 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -59.09 171.51 0.71 Allowed 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 152.88 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 21.9 m-30 -90.25 145.11 25.25 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 121.777 -0.577 . . . . 0.0 109.794 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.48 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.5 tm? -149.13 126.51 11.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.436 ' N ' HD13 ' A' ' 240' ' ' LEU . . . 173.21 165.93 30.85 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 119.276 0.944 . . . . 0.0 112.194 -176.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.56 3.27 1.0 Allowed Glycine 0 CA--C 1.547 2.034 0 O-C-N 124.699 0.882 . . . . 0.0 112.27 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.9 m -107.87 121.79 42.88 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.417 0.609 . . . . 0.0 112.597 -170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -96.07 -13.93 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 123.281 2.654 . . . . 0.0 112.059 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.445 ' HE1' ' HB2' ' A' ' 324' ' ' LYS . 30.0 p-90 -124.03 -17.52 6.21 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -50.48 104.66 0.08 Allowed 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 118.928 0.786 . . . . 0.0 110.593 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -18.77 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 O-C-N 126.02 2.075 . . . . 0.0 115.781 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.0 m -152.48 126.91 9.31 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 124.486 1.116 . . . . 0.0 110.328 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -72.03 -34.16 68.59 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.77 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -66.27 -20.21 66.04 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 120.051 1.296 . . . . 0.0 110.718 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.64 -55.9 27.96 Favored Glycine 0 C--N 1.368 2.32 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.92 -37.9 72.11 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.673 0.867 . . . . 0.0 111.124 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.44 -22.55 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 123.383 0.673 . . . . 0.0 110.284 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -94.34 -4.94 47.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 121.77 -0.581 . . . . 0.0 110.867 173.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.0 m -82.38 -24.43 34.47 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.548 -1.345 . . . . 0.0 111.046 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.35 26.58 1.62 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.641 ' HA ' HD11 ' A' ' 262' ' ' LEU . 53.6 ptt85 -94.46 -0.23 54.88 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 121.585 1.993 . . . . 0.0 113.466 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.65 -21.41 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.257 0.623 . . . . 0.0 111.243 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.09 -4.25 54.61 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.93 -1.108 . . . . 0.0 112.653 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -163.42 -125.61 0.77 Allowed Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.129 -0.982 . . . . 0.0 115.276 -170.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 33.5 t -153.69 110.83 3.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 124.562 0.801 . . . . 0.0 109.888 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.641 HD11 ' HA ' ' A' ' 257' ' ' ARG . 0.0 OUTLIER -151.61 162.28 41.25 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 176.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 64.0 m -146.62 170.73 16.32 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.208 1.803 . . . . 0.0 109.763 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.78 143.06 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 123.878 0.871 . . . . 0.0 111.864 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -145.94 135.74 23.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.86 -176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 277' ' ' PRO . 21.9 p90 -161.23 149.03 12.34 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 125.69 1.596 . . . . 0.0 110.893 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.83 152.54 14.77 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.442 2.761 . . . . 0.0 112.893 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.78 28.72 23.06 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.288 -0.729 . . . . 0.0 111.669 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -59.3 -36.28 75.31 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 120.127 1.964 . . . . 0.0 110.953 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 25.7 t0 33.41 89.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.471 2.308 . . . . 0.0 113.31 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.71 172.06 24.43 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 122.328 0.96 . . . . 0.0 111.604 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -60.62 -25.64 66.42 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.699 -0.883 . . . . 0.0 111.686 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -134.12 155.23 80.22 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 124.754 1.222 . . . . 0.0 108.016 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.57 107.1 2.38 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.676 1.584 . . . . 0.0 108.237 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -119.28 -166.61 1.28 Allowed 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.328 0.651 . . . . 0.0 111.139 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 45.5 t -51.6 135.05 34.77 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.421 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 266' ' ' TRP . 44.3 Cg_endo -83.44 148.58 12.87 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 124.516 3.478 . . . . 0.0 112.024 170.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.27 -6.6 17.35 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.794 2.329 . . . . 0.0 111.367 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 279' ' ' LYS . 7.9 ptpp? -95.77 -6.23 40.14 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.992 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 59.68 17.47 41.78 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-O 118.786 -1.008 . . . . 0.0 115.405 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -128.68 154.57 46.16 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 117.696 0.748 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 51.7 t -152.34 165.35 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -122.56 148.72 44.87 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.912 0.485 . . . . 0.0 111.794 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.4 mt -108.23 143.86 36.48 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.49 1.138 . . . . 0.0 110.622 175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -134.79 109.94 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -158.72 -165.42 1.65 Allowed 'General case' 0 C--O 1.241 0.643 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.695 -171.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -57.31 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.7 pt? -69.41 14.48 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.873 2.469 . . . . 0.0 114.802 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.74 -59.2 1.08 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.172 0.92 . . . . 0.0 111.242 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -90.31 -34.01 15.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -170.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 46.9 m -74.05 -17.1 61.01 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 119.391 0.996 . . . . 0.0 108.657 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 234' ' ' TYR . 46.6 t -76.14 -57.76 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.42 -32.57 73.43 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.741 -1.225 . . . . 0.0 112.818 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 25.0 m -68.37 -42.59 78.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.036 0.834 . . . . 0.0 110.176 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.12 -39.45 49.37 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.76 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.7 mt -60.51 -25.6 66.22 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.555 1.071 . . . . 0.0 111.789 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.04 -6.82 23.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -96.81 -13.99 22.21 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 123.796 0.685 . . . . 0.0 109.784 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 314' ' ' PHE . 24.2 p -97.85 -153.86 0.44 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 169.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 7.4 t -117.09 174.88 5.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.628 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -149.84 150.7 32.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -135.15 124.87 16.66 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.308 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -81.03 37.53 0.69 Allowed 'Trans proline' 0 N--CA 1.438 -1.786 0 C-N-CA 124.416 3.411 . . . . 0.0 108.262 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -48.86 -36.57 17.29 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.421 1.01 . . . . 0.0 111.941 -177.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.606 ' H ' HD12 ' A' ' 304' ' ' LEU . 50.5 m 31.78 69.77 0.74 Allowed Pre-proline 0 C--N 1.32 -0.708 0 C-N-CA 126.6 1.96 . . . . 0.0 113.094 177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -76.04 -7.99 18.57 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.666 2.244 . . . . 0.0 110.909 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -160.07 -5.99 0.06 Allowed 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 124.214 0.946 . . . . 0.0 111.062 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 130.71 -10.62 5.75 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.429 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.26 164.7 25.83 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.253 1.421 . . . . 0.0 111.679 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 58.8 m -132.56 151.69 51.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -144.65 139.02 27.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.419 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.87 144.67 42.02 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.161 0.984 . . . . 0.0 110.961 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 327' ' ' GLN . 59.8 m-85 -136.93 159.16 42.71 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.742 0.817 . . . . 0.0 110.524 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 299' ' ' CYS . 10.4 t80 -156.86 170.68 21.93 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.2 0.938 . . . . 0.0 111.074 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.68 124.9 24.56 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -141.6 28.42 1.8 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.413 -168.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.1 p -43.99 138.56 2.79 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.801 1.182 . . . . 0.0 112.908 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 18.2 t -116.43 -51.15 2.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -73.56 -26.21 60.73 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 108.925 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 55.24 26.07 8.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.935 1.694 . . . . 0.0 113.4 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -78.37 -20.01 52.19 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -159.57 177.3 11.06 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 37.2 m -132.67 134.5 44.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.277 1.431 . . . . 0.0 108.624 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 59.2 tptt -136.76 -7.93 1.88 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -173.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.43 175.43 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.811 1.291 . . . . 0.0 113.75 -171.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 11.4 p -151.03 153.76 9.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.843 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.471 ' HB3' ' CE1' ' A' ' 313' ' ' TYR . 3.0 pp0? -117.79 156.04 29.02 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.32 139.89 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.694 -175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.53 119.36 4.26 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 124.153 0.908 . . . . 0.0 109.819 170.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -95.82 161.74 1.42 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 125.365 4.043 . . . . 0.0 111.751 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.434 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 3.3 t-105 -70.38 118.58 13.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.56 149.65 4.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 CA-C-N 119.586 1.085 . . . . 0.0 110.497 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.1 tt -59.06 -39.26 81.54 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.833 0.853 . . . . 0.0 109.984 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.67 2.91 10.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 122.918 0.487 . . . . 0.0 112.235 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -93.27 -9.82 37.68 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.172 -0.955 . . . . 0.0 110.95 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 51.4 m -90.96 -58.44 2.47 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -160.9 173.49 15.24 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.892 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -154.65 161.52 41.54 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.783 0.833 . . . . 0.0 111.412 170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.52 166.88 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 122.545 1.164 . . . . 0.0 110.837 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -126.33 27.51 6.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.694 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.479 ' HB2' ' HD2' ' A' ' 342' ' ' PRO . 85.9 p -147.87 167.93 12.32 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-O 117.22 -1.371 . . . . 0.0 110.061 -173.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 341' ' ' SER . 74.4 Cg_endo -69.71 56.91 1.41 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 124.821 3.681 . . . . 0.0 109.982 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.6 t 55.67 38.91 30.75 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.383 0.673 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -71.91 151.32 43.42 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -65.03 157.15 29.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.413 0.685 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.98 160.48 4.73 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.61 1.164 . . . . 0.0 111.871 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -69.88 139.0 87.93 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.2 94.44 0.24 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 122.866 2.377 . . . . 0.0 111.891 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 63.4 m 62.83 49.83 3.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 113.761 -1.563 . . . . 0.0 114.334 170.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.0 tpp85 -140.99 43.3 1.81 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 109.332 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.444 ' HB ' HG22 ' A' ' 397' ' ' THR . 1.8 t -117.38 159.06 23.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.09 159.08 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -77.16 147.67 36.37 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.008 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 83.3 t -130.75 136.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.395 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -172.44 -157.72 14.95 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.589 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 425' ' ' GLN . . . 60.66 29.54 19.08 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.377 1.071 . . . . 0.0 111.981 -174.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.484 HD22 HD22 ' A' ' 361' ' ' LEU . 24.6 mt -76.72 164.45 25.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 124.432 1.083 . . . . 0.0 110.293 -174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.517 ' CE1' ' H ' ' A' ' 361' ' ' LEU . 8.7 p-80 -77.62 12.7 1.53 Allowed 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.468 -0.77 . . . . 0.0 112.573 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 97.0 2.49 59.37 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-O 119.028 -0.873 . . . . 0.0 112.362 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 23.5 mmt -145.23 -71.32 0.26 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.039 0.92 . . . . 0.0 111.643 174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.517 ' H ' ' CE1' ' A' ' 358' ' ' HIS . 12.8 tp 38.0 69.36 0.25 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-O 121.789 0.804 . . . . 0.0 111.094 -176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -67.33 179.3 1.28 Allowed 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.158 -0.964 . . . . 0.0 113.041 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.21 -27.07 65.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -170.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.96 -15.2 57.76 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 119.34 0.973 . . . . 0.0 112.289 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -92.63 -27.1 17.53 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.389 0.43 . . . . 0.0 111.186 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.4 mt -76.22 -37.03 58.26 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 124.74 1.275 . . . . 0.0 110.426 171.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -76.68 -29.0 56.14 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.33 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.23 -50.52 73.34 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.8 -32.07 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 123.914 0.759 . . . . 0.0 111.632 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.96 -28.96 18.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.608 -1.307 . . . . 0.0 113.774 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.63 -19.86 27.15 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.682 1.128 . . . . 0.0 113.742 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -113.86 -17.3 12.07 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 120.051 1.296 . . . . 0.0 111.083 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 373' ' ' LEU . 10.3 tp -97.6 -3.99 38.49 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 118.873 0.76 . . . . 0.0 111.286 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -152.03 -48.05 0.11 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 83.47 -1.73 88.29 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.442 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.35 111.37 2.24 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.97 166.28 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 123.865 0.866 . . . . 0.0 110.396 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.71 -29.03 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.21 153.64 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.666 -0.646 . . . . 0.0 109.645 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -155.12 132.23 10.92 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.68 158.3 27.79 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 121.163 -0.96 . . . . 0.0 113.575 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.02 138.91 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.242 1.817 . . . . 0.0 108.037 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.89 153.5 23.95 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.081 0.467 . . . . 0.0 112.128 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 5.3 p -137.47 165.79 25.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.064 0.459 . . . . 0.0 110.233 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.21 -178.83 5.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.47 100.36 0.1 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.045 0.384 . . . . 0.0 111.107 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.2 m170 50.41 40.86 23.95 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.93 1.292 . . . . 0.0 110.848 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -88.72 -20.62 24.58 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 123.344 0.658 . . . . 0.0 109.72 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 38.0 p90 38.8 53.56 4.25 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.083 1.353 . . . . 0.0 112.954 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.65 -48.24 0.42 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.716 3.61 . . . . 0.0 111.271 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.434 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 8.6 tp 41.05 41.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.277 1.431 . . . . 0.0 111.49 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -162.11 14.43 0.13 Allowed Glycine 0 C--N 1.349 1.299 0 C-N-CA 121.077 -0.582 . . . . 0.0 114.132 -175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 97.2 p -156.33 132.07 9.64 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.11 0.955 . . . . 0.0 110.796 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.08 -164.83 25.45 Favored Glycine 0 C--O 1.209 -1.415 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.349 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -142.09 166.82 23.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.505 -0.848 . . . . 0.0 110.624 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.23 146.42 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.627 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.444 HG22 ' HB ' ' A' ' 351' ' ' THR . 26.2 p -125.99 122.61 36.4 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 122.252 1.025 . . . . 0.0 108.362 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -85.12 -28.45 25.55 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.417 -1.72 . . . . 0.0 111.721 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 64.4 t30 54.07 17.09 1.3 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.301 1.048 . . . . 0.0 112.585 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -141.4 164.23 30.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.234 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -99.68 -45.31 5.81 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.56 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.82 -25.64 66.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.617 1.098 . . . . 0.0 112.921 -173.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 39.0 p -84.99 -18.48 34.36 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.628 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -72.92 -56.09 5.67 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.583 0.629 . . . . 0.0 109.964 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.27 63.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.753 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -77.08 -24.89 51.84 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.88 1.218 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.98 -29.43 35.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.565 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.1 m -78.92 -18.29 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 O-C-N 123.798 0.686 . . . . 0.0 112.203 172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 91.3 p -88.9 -22.16 23.27 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -85.76 -44.56 12.4 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 119.742 -0.171 . . . . 0.0 111.299 171.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.48 -2.24 0.0 OUTLIER 'General case' 0 C--N 1.349 0.573 0 C-N-CA 128.551 2.74 . . . . 0.0 116.627 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.4 141.15 14.58 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.73 163.36 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 119.103 0.865 . . . . 0.0 109.229 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.459 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 28.2 mt-10 -119.83 131.99 55.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.993 1.378 . . . . 0.0 112.552 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.443 ' HB ' ' H ' ' A' ' 422' ' ' LYS . 6.4 mm -93.95 117.09 36.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.458 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -117.61 25.71 10.22 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.909 0.777 . . . . 0.0 109.838 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 419' ' ' LYS . 86.2 m -63.74 158.12 22.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.021 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -86.17 -2.54 58.45 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 123.455 0.702 . . . . 0.0 112.149 -172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 417' ' ' THR . 39.4 pttt -128.22 -1.6 5.72 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.498 1.119 . . . . 0.0 111.523 174.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -150.26 127.52 11.34 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 13.6 m -142.08 109.1 5.47 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.195 -0.94 . . . . 0.0 111.105 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.657 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 33.6 tptt -167.22 -156.46 0.21 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 117.899 0.318 . . . . 0.0 111.416 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.657 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 98.7 mttt -141.11 176.21 9.01 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.601 0.76 . . . . 0.0 109.674 175.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 27.6 m -147.62 154.11 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 356' ' ' ALA . 49.1 tt0 -117.03 151.75 36.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.887 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 53.9 mt -134.99 139.46 47.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -142.81 113.12 5.87 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.98 161.77 40.48 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.701 3.6 . . . . 0.0 112.33 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.606 -1.664 . . . . 0.0 111.51 178.291 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 121.035 0.445 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 221' ' ' SER . 9.7 m 45.45 55.97 6.1 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.409 1.099 . . . . 0.0 113.101 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.41 18.72 0.07 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.191 0.997 . . . . 0.0 113.245 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 219' ' ' THR . 66.4 m -37.21 121.02 0.8 Allowed 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.04 1.336 . . . . 0.0 113.288 -173.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 151.51 -19.8 0.91 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-O 118.266 -1.296 . . . . 0.0 114.035 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -89.51 -29.75 18.74 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.387 1.593 . . . . 0.0 109.564 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 225' ' ' PRO . 10.8 mt 61.7 148.42 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.725 1.61 . . . . 0.0 115.064 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 226' ' ' PRO . 48.8 Cg_exo -63.01 131.14 31.49 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.641 2.227 . . . . 0.0 111.769 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 225' ' ' PRO . 1.7 Cg_endo -82.15 147.32 14.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.208 2.606 . . . . 0.0 109.209 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -144.88 22.42 1.59 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.34 30.68 3.74 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 123.555 0.742 . . . . 0.0 111.627 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -71.11 161.17 31.57 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.023 0.929 . . . . 0.0 111.384 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -135.27 -143.34 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.357 1.063 . . . . 0.0 108.594 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.4 p30 36.17 51.51 1.68 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.536 1.534 . . . . 0.0 113.655 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.83 119.28 6.28 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 121.936 1.757 . . . . 0.0 112.131 -173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.1 mm -129.75 140.65 48.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -104.27 155.02 19.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.987 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.3 t -137.58 -34.97 0.67 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 90.8 m -147.07 78.79 1.5 Allowed 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.67 0.748 . . . . 0.0 112.746 -168.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 19.5 pttm 52.23 -169.07 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.64 145.05 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.8 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -87.77 149.58 24.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.489 1.116 . . . . 0.0 110.504 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 241' ' ' GLY . 0.6 OUTLIER -149.63 117.61 6.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.121 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . -179.89 -178.23 48.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 122.192 0.884 . . . . 0.0 112.722 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.02 15.93 1.46 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 124.31 0.957 . . . . 0.0 114.792 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.51 130.27 26.02 Favored Pre-proline 0 N--CA 1.473 0.719 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 13.3 Cg_endo -87.91 -8.69 5.77 Favored 'Trans proline' 0 N--CA 1.436 -1.866 0 C-N-CA 124.156 3.237 . . . . 0.0 112.57 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.478 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 11.5 p-90 -147.34 -7.8 0.45 Allowed 'General case' 0 C--O 1.251 1.172 0 CA-C-N 120.585 1.539 . . . . 0.0 114.876 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.33 110.55 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.486 -1.383 . . . . 0.0 108.931 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -20.25 25.68 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.152 -173.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 11.3 p -153.31 154.49 34.68 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 119.416 -2.053 . . . . 0.0 111.451 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -16.89 39.41 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.56 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -75.44 -17.6 60.11 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.84 -62.28 2.86 Favored Glycine 0 C--O 1.238 0.38 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -69.75 -31.18 68.99 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 118.593 -1.243 . . . . 0.0 111.448 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 39.0 t -57.89 -50.91 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.657 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.51 -5.19 31.3 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 53.6 m -79.83 -21.58 44.02 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.899 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -131.59 -1.31 3.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 257' ' ' ARG . 26.4 ttt-85 -81.13 -21.39 39.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.304 1.442 . . . . 0.0 111.287 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 258' ' ' VAL . 1.2 m -61.13 -16.86 15.04 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 O-C-N 125.262 1.601 . . . . 0.0 115.291 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -133.48 -5.76 2.93 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.783 1.233 . . . . 0.0 110.649 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -94.24 -166.42 36.8 Favored Glycine 0 CA--C 1.545 1.921 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.589 ' H ' HD11 ' A' ' 295' ' ' LEU . 73.0 m -146.47 65.82 1.19 Allowed 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -171.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.492 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -147.75 171.16 16.11 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.752 179.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 61.5 m -138.88 174.9 10.03 Favored 'General case' 0 C--O 1.203 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -131.24 139.41 50.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.776 0 CA-C-O 122.62 1.2 . . . . 0.0 110.949 -174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -149.23 142.02 24.62 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.237 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -163.81 142.04 5.98 Favored Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -90.95 -177.34 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.77 3.647 . . . . 0.0 111.787 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 67.74 -5.15 3.57 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -142.58 44.55 1.62 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 119.911 1.856 . . . . 0.0 110.619 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.12 153.03 40.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.469 0.652 . . . . 0.0 110.128 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.39 -6.27 38.93 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.015 0.817 . . . . 0.0 111.69 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -157.91 -27.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.427 1.113 . . . . 0.0 113.244 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.36 76.11 9.34 Favored Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.29 112.32 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.091 3.194 . . . . 0.0 111.203 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -170.86 -166.83 0.51 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.8 p -76.43 146.59 77.72 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.58 166.2 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.854 3.036 . . . . 0.0 109.18 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.74 4.16 1.92 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.632 2.888 . . . . 0.0 111.964 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -120.48 167.93 11.86 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.73 10.22 68.49 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 117.241 1.656 . . . . 0.0 117.241 -171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.552 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 16.0 p90 -146.24 162.62 37.68 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 15.4 m -156.96 -166.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 129.069 2.948 . . . . 0.0 108.032 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -132.58 152.24 51.68 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.234 -0.916 . . . . 0.0 111.887 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.401 HD22 HD23 ' A' ' 262' ' ' LEU . 77.5 mt -110.16 140.35 44.35 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 124.24 0.962 . . . . 0.0 109.979 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.0 -153.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.04 0.536 . . . . 0.0 110.45 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . 0.315 33.0 t80 78.62 -107.01 0.02 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-O 116.981 -1.485 . . . . 0.0 110.805 -173.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -85.02 128.54 34.67 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 120.574 1.534 . . . . 0.0 107.544 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.76 17.19 3.31 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.491 1.119 . . . . 0.0 112.651 -167.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.9 -71.12 0.71 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.577 1.151 . . . . 0.0 111.833 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -79.26 -19.3 50.92 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.669 -1.27 . . . . 0.0 112.585 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 24.5 m -101.26 -8.33 22.24 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.79 0.723 . . . . 0.0 111.556 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 5.6 m -85.24 -40.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 103.938 -2.616 . . . . 0.0 103.938 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -54.0 -59.61 4.41 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.34 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 87.0 p -76.57 -39.58 52.31 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 120.069 1.304 . . . . 0.0 112.12 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.589 HD11 ' H ' ' A' ' 261' ' ' SER . 65.3 mt -68.57 -34.01 75.07 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -171.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -94.23 -12.89 27.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 118.63 -1.228 . . . . 0.0 112.317 175.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -87.05 0.87 54.53 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.652 0.66 . . . . 0.0 111.096 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.49 -24.63 14.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 96.7 m -78.86 -152.96 0.06 Allowed 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.767 170.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 20.4 m -118.81 166.89 12.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 120.675 -1.265 . . . . 0.0 111.997 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -144.99 151.74 39.06 Favored 'General case' 0 N--CA 1.425 -1.682 0 C-N-CA 122.414 0.286 . . . . 0.0 110.982 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.28 138.68 16.82 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -87.07 20.72 1.17 Allowed 'Trans proline' 0 N--CA 1.431 -2.197 0 C-N-CA 122.293 1.996 . . . . 0.0 111.478 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.502 HD13 ' HD3' ' A' ' 306' ' ' PRO . 0.2 OUTLIER -60.16 -19.38 53.66 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.3 t 38.24 60.61 4.79 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.789 2.036 . . . . 0.0 112.646 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.502 ' HD3' HD13 ' A' ' 304' ' ' LEU . 71.9 Cg_endo -76.18 1.07 8.68 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.678 2.919 . . . . 0.0 111.941 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.52 -7.26 0.88 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.565 -1.334 . . . . 0.0 112.922 -178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.42 -9.81 17.15 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 17.9 tp -132.89 143.2 49.35 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.14 1.776 . . . . 0.0 109.029 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 30.9 m -67.91 168.85 10.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -139.18 154.51 48.07 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.09 156.66 18.2 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -152.69 155.69 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.354 0.409 . . . . 0.0 111.097 -173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -153.47 152.73 31.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -111.89 146.28 38.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.407 ' HE2' ' CG1' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -148.49 -1.98 0.51 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.903 1.377 . . . . 0.0 110.541 -169.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 69.8 m -71.68 145.84 48.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.638 0.586 . . . . 0.0 112.503 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 59.8 m -85.2 149.79 25.26 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 124.358 1.036 . . . . 0.0 110.747 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -62.21 -15.53 47.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.754 -170.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -63.79 -23.34 67.32 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.598 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -159.65 15.04 0.15 Allowed 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -44.21 142.59 1.43 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 122.043 0.925 . . . . 0.0 112.116 173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 48.3 t -164.44 -35.64 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.031 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -137.1 163.81 29.92 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.575 0.75 . . . . 0.0 111.849 -173.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.57 167.05 10.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.443 2.697 . . . . 0.0 112.092 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.407 ' CG1' ' HE2' ' A' ' 316' ' ' MET . 12.5 m -104.15 160.42 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.88 0.848 . . . . 0.0 112.269 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 153.24 17.76 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.134 176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 16.9 t -137.87 130.51 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 124.363 1.04 . . . . 0.0 109.946 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 68.5 mt -138.65 119.28 9.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.979 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -87.22 168.69 7.55 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.246 2.631 . . . . 0.0 110.221 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.527 ' CH2' ' HB ' ' A' ' 391' ' ' ILE . 2.9 t-105 -104.52 123.95 48.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.495 0.664 . . . . 0.0 111.68 170.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 25.9 t -104.21 143.67 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.558 -176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 333' ' ' LEU . 4.3 tt -52.53 -40.64 62.69 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 125.109 1.364 . . . . 0.0 109.851 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.59 57.99 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 122.277 -0.265 . . . . 0.0 110.847 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.88 -18.09 38.64 Favored 'General case' 0 CA--C 1.505 -0.778 0 O-C-N 120.494 -1.378 . . . . 0.0 110.766 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.7 p -111.79 -25.97 9.2 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.844 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -141.1 142.34 34.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.883 0.765 . . . . 0.0 110.612 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -157.33 153.47 27.41 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 120.433 -1.417 . . . . 0.0 111.144 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 9.4 m -123.57 147.37 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.65 31.55 5.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.689 0.796 . . . . 0.0 109.636 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.8 t -145.72 145.94 27.33 Favored Pre-proline 0 CA--C 1.52 -0.208 0 C-N-CA 124.16 0.984 . . . . 0.0 108.396 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.21 -7.11 19.03 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.175 2.584 . . . . 0.0 111.45 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 74.9 p -135.1 164.58 27.33 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.693 0.797 . . . . 0.0 110.674 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.93 132.97 34.3 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.411 0.624 . . . . 0.0 112.059 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -154.9 162.56 41.06 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.083 1.353 . . . . 0.0 110.411 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 17.8 tp -151.59 175.43 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.837 1.336 . . . . 0.0 107.76 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.425 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 9.0 t70 -145.95 129.07 8.21 Favored Pre-proline 0 N--CA 1.446 -0.674 0 O-C-N 120.931 -1.106 . . . . 0.0 109.679 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -89.18 0.87 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.962 1 C-N-CA 126.507 4.805 . . . . 0.0 114.996 -171.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 14.6 t -131.67 -7.3 3.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.677 -0.677 . . . . 0.0 111.935 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -135.91 77.3 1.65 Allowed 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 119.42 1.009 . . . . 0.0 110.112 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.1 p -135.54 84.67 2.11 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 125.328 1.643 . . . . 0.0 108.647 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.74 145.55 10.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.048 0.451 . . . . 0.0 111.239 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -73.08 150.39 42.33 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.122 0.963 . . . . 0.0 112.405 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.8 140.83 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.073 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -164.47 -166.56 23.59 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 122.25 0.917 . . . . 0.0 114.108 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.46 38.69 30.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.543 0.687 . . . . 0.0 110.248 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.26 -179.65 7.25 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.174 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -56.71 -11.87 1.58 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.231 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.02 6.59 88.15 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.192 0.906 . . . . 0.0 113.78 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.6 ptm -165.85 26.4 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.161 0.584 . . . . 0.0 110.814 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.68 144.06 52.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -94.88 159.3 15.1 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.75 60.29 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.144 -0.973 . . . . 0.0 112.524 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -74.66 -29.02 61.1 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.75 -26.23 24.29 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 124.22 0.95 . . . . 0.0 109.72 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 tt -72.42 -46.95 52.81 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -71.64 -24.28 61.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.49 -0.756 . . . . 0.0 110.224 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.04 -45.56 66.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.535 0.683 . . . . 0.0 109.799 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 84.7 mt -65.39 -44.24 94.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.4 mt -83.4 -15.04 51.29 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.829 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.95 -16.46 21.71 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 120.283 1.402 . . . . 0.0 112.169 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -99.48 -25.78 14.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 373' ' ' LEU . 13.2 tp -72.75 -24.81 61.01 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.203 0.94 . . . . 0.0 110.803 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 403' ' ' SER . 3.9 p90 -163.41 -24.71 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.459 0.572 . . . . 0.0 112.159 174.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 72.67 157.93 4.0 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 121.724 -0.61 . . . . 0.0 112.37 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 126.12 15.68 2.77 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 121.871 0.706 . . . . 0.0 111.58 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.81 173.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.053 -0.573 . . . . 0.0 112.132 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.97 -26.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 117.966 -1.016 . . . . 0.0 111.416 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -157.82 157.68 33.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.37 0.987 . . . . 0.0 110.079 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.04 141.48 28.93 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.79 133.64 4.76 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.512 1.062 . . . . 0.0 113.523 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 47.3 mm -85.67 145.9 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.5 70.38 7.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.82 150.27 48.82 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 123.127 0.571 . . . . 0.0 112.097 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -137.83 164.19 29.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -56.68 103.56 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.307 0.643 . . . . 0.0 112.128 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 m170 53.05 26.65 4.99 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.788 1.635 . . . . 0.0 113.613 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -85.58 -8.39 58.31 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.157 -0.964 . . . . 0.0 111.672 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.441 ' N ' ' CD ' ' A' ' 390' ' ' PRO . 41.9 p90 54.3 45.57 2.38 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.875 1.67 . . . . 0.0 113.053 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.54 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 86.0 Cg_endo -73.97 -66.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.034 2.489 . . . . 0.0 110.738 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.54 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 8.9 tp 38.79 35.14 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.9 0.88 . . . . 0.0 113.338 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -155.66 15.12 0.45 Allowed Glycine 0 CA--C 1.524 0.649 0 O-C-N 121.321 -0.862 . . . . 0.0 113.53 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 62.7 p -151.68 154.29 36.06 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 166.77 -146.86 11.26 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.615 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -149.29 171.36 16.63 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.34 136.67 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 122.077 0.942 . . . . 0.0 110.332 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 45.8 m -99.15 133.08 43.95 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.403 -173.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -115.33 179.32 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -144.25 5.84 1.29 Allowed 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -143.15 166.62 24.17 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -83.94 -29.65 26.91 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.114 0.566 . . . . 0.0 110.516 -174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.662 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -66.42 -27.72 68.05 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 118.907 -1.117 . . . . 0.0 113.143 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.431 ' HA ' ' CE1' ' A' ' 374' ' ' PHE . 51.0 m -73.12 -27.4 61.66 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.013 0.824 . . . . 0.0 110.536 174.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.78 -56.0 6.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.821 0.82 . . . . 0.0 110.201 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.19 -8.83 56.48 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.884 -173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -100.77 -21.19 15.25 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.914 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -79.05 -34.16 44.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 43.2 t -83.58 -33.93 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 122.808 0.443 . . . . 0.0 110.769 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.0 t -70.44 -32.64 70.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 119.724 1.147 . . . . 0.0 109.051 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -73.04 -52.66 13.52 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.865 0.84 . . . . 0.0 110.175 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.24 -17.5 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 126.678 1.991 . . . . 0.0 115.672 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.91 142.78 16.53 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.34 0.518 . . . . 0.0 110.354 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.94 154.26 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 O-C-N 122.254 -0.279 . . . . 0.0 110.537 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -101.54 140.66 35.53 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 415' ' ' ILE . 2.8 mp -105.06 126.88 59.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 166.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -131.1 121.79 25.58 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.3 m -150.64 162.75 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -172.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.7 t -65.67 -5.16 7.65 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -145.58 4.43 1.02 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.346 1.058 . . . . 0.0 113.368 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -150.63 129.45 12.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.631 0.253 . . . . 0.0 110.784 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 36.8 p -147.9 102.17 3.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -147.88 173.31 12.97 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -118.87 179.08 4.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 26.9 m -147.3 145.88 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -122.12 144.65 48.81 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 122.931 0.144 . . . . 0.0 110.766 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.94 145.89 27.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -138.44 138.94 23.43 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.1 155.68 63.42 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 123.168 2.579 . . . . 0.0 110.15 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.066 -170.727 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . 0.461 ' CG ' HG12 ' A' ' 413' ' ' VAL . 11.0 tpt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.8 m -153.11 159.22 42.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.241 1.417 . . . . 0.0 109.754 -175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 17.61 0.65 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.247 0.619 . . . . 0.0 112.479 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 53.6 m 61.06 26.65 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.078 1.751 . . . . 0.0 115.205 172.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 51.59 68.09 1.69 Allowed Glycine 0 CA--C 1.536 1.395 0 CA-C-O 121.117 0.287 . . . . 0.0 113.202 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -69.48 -17.19 63.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.375 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 224' ' ' LEU . 2.7 mm? -105.62 151.82 39.92 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-O 121.365 0.602 . . . . 0.0 110.499 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.5 110.89 2.5 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.011 2.474 . . . . 0.0 113.456 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.55 4.69 6.43 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.347 3.365 . . . . 0.0 111.989 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -143.46 -171.29 3.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.819 1.248 . . . . 0.0 109.195 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 25.8 m120 57.73 22.74 8.74 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.296 1.839 . . . . 0.0 114.078 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -62.55 -36.74 83.62 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.145 -0.347 . . . . 0.0 110.224 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 69.1 tttt 39.84 54.41 2.58 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.9 59.47 39.0 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 332' ' ' VAL . 83.5 Cg_endo -70.83 127.39 13.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.308 3.338 . . . . 0.0 114.43 -171.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.8 mm -146.14 131.54 12.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 102.604 -3.109 . . . . 0.0 102.604 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.413 ' CG ' HG11 ' A' ' 292' ' ' VAL . 12.0 m-85 -98.45 143.03 29.33 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.768 -1.173 . . . . 0.0 109.231 -169.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 84.9 p -137.14 -1.24 2.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 14.7 t -158.97 -166.28 1.82 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.026 1.285 . . . . 0.0 108.317 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 176.91 0.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.535 1.134 . . . . 0.0 112.564 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.1 142.35 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 122.49 1.138 . . . . 0.0 109.01 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -92.25 130.12 38.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.512 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -137.07 113.57 10.14 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -161.94 173.98 38.35 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-O 121.418 0.454 . . . . 0.0 113.73 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 115.05 18.83 6.16 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.357 -1.421 . . . . 0.0 114.009 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.3 m -92.0 126.09 54.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.501 -172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -82.03 -17.03 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 123.991 3.128 . . . . 0.0 111.483 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.443 ' CH2' ' HG3' ' A' ' 321' ' ' MET . 30.1 p-90 -130.54 -70.06 0.63 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.146 0.884 . . . . 0.0 109.709 -177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 245' ' ' TRP . 26.7 t70 10.97 90.72 0.01 OUTLIER 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.768 1.627 . . . . 0.0 113.225 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.434 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -63.96 -22.0 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 250' ' ' ALA . 11.7 m -150.33 143.15 24.7 Favored 'General case' 0 CA--C 1.495 -1.161 0 CA-C-N 121.029 1.74 . . . . 0.0 108.916 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.19 -24.93 64.11 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.197 0.999 . . . . 0.0 109.52 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.54 -13.94 62.59 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.54 1.136 . . . . 0.0 110.689 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.83 -58.16 5.94 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 54.8 mt -50.49 -47.21 57.32 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 122.199 0.999 . . . . 0.0 109.437 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 264' ' ' VAL . 77.3 t -57.42 -45.59 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.916 -177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -73.92 -8.03 54.56 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.904 0.32 . . . . 0.0 110.853 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 84.6 m -90.49 -20.56 22.56 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.99 32.58 1.12 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.441 1.019 . . . . 0.0 112.468 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -88.25 14.98 8.25 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.14 12.0 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 O-C-N 120.541 -1.349 . . . . 0.0 112.37 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -93.36 -1.69 55.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.114 0.87 . . . . 0.0 111.56 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 70.12 -0.26 24.33 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 14.5 t -124.89 18.31 8.56 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.704 -0.88 . . . . 0.0 112.076 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.53 143.42 28.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.366 -0.533 . . . . 0.0 112.25 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.6 m -150.71 153.15 35.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 171.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 253' ' ' VAL . 93.5 t -138.17 138.76 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 O-C-N 124.012 0.82 . . . . 0.0 111.29 -169.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -143.45 156.19 44.58 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 124.488 1.118 . . . . 0.0 113.651 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 44.4 p90 -151.18 167.32 13.23 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.56 -19.28 22.8 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 124.087 3.191 . . . . 0.0 115.681 -168.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 170.46 157.53 12.77 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.085 1.311 . . . . 0.0 111.783 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -102.16 15.3 29.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.761 0.824 . . . . 0.0 112.766 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.86 144.41 47.44 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.639 1.176 . . . . 0.0 108.936 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 122.24 177.37 15.33 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 122.285 0.936 . . . . 0.0 110.775 -176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.74 173.36 8.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 121.553 -0.969 . . . . 0.0 108.494 176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 60.66 142.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.539 1.135 . . . . 0.0 112.223 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -81.9 -11.87 11.1 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 123.852 3.034 . . . . 0.0 111.415 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -101.06 33.0 2.99 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.822 0.849 . . . . 0.0 111.991 -171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 48.9 t 64.98 144.58 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 124.685 1.194 . . . . 0.0 110.342 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.617 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 71.2 Cg_endo -66.55 166.08 23.09 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.068 1.846 . . . . 0.0 112.972 171.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.7 113.3 1.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 CA-C-O 122.643 1.018 . . . . 0.0 111.396 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -143.52 145.79 32.85 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.247 1.419 . . . . 0.0 109.977 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -92.8 4.11 75.07 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 113.251 -1.795 . . . . 0.0 114.236 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -154.93 165.79 35.57 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.3 p -157.62 161.66 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.863 1.265 . . . . 0.0 109.74 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -97.39 149.37 22.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.579 1.081 . . . . 0.0 109.752 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.509 HD23 HG22 ' A' ' 264' ' ' VAL . 81.6 mt -117.79 137.09 52.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.16 107.52 11.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.501 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -153.51 -161.68 1.31 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 124.445 1.091 . . . . 0.0 111.058 -168.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -62.19 92.48 0.04 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.8 pt? -67.03 17.89 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.792 2.437 . . . . 0.0 117.011 -168.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.86 -60.12 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.102 1.319 . . . . 0.0 109.98 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -86.19 -23.71 26.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.264 -0.897 . . . . 0.0 112.862 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 12.2 t -84.12 -22.73 31.0 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.501 HG22 ' CE1' ' A' ' 286' ' ' PHE . 24.1 t -72.66 -48.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.561 0.696 . . . . 0.0 109.577 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 21.3 ptp180 -74.95 -25.67 59.04 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.551 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 48.0 m -78.18 -37.23 46.21 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 0.0 112.672 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.95 -35.96 67.08 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.34 -24.21 62.06 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.087 0.858 . . . . 0.0 110.006 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -92.11 -2.35 56.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.32 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -97.76 -18.14 18.97 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 120.125 -1.609 . . . . 0.0 110.226 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 31.2 p -104.84 -151.32 0.44 Allowed 'General case' 0 C--O 1.24 0.554 0 O-C-N 125.925 2.016 . . . . 0.0 110.411 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 74.8 m -126.46 177.94 6.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.191 0.932 . . . . 0.0 113.125 -173.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 310' ' ' SER . 83.3 t60 -145.8 162.03 38.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.45 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -144.12 131.78 10.66 Favored Pre-proline 0 C--N 1.351 0.648 0 O-C-N 124.026 0.829 . . . . 0.0 110.102 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -86.75 23.87 0.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 1 C-N-CA 125.807 4.338 . . . . 0.0 111.174 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.655 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -50.55 -40.53 52.27 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.517 0.727 . . . . 0.0 111.736 -172.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.655 ' H ' HD12 ' A' ' 304' ' ' LEU . 6.2 t 49.47 52.82 13.39 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 172.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -80.23 -9.66 13.87 Favored 'Trans proline' 0 N--CA 1.441 -1.587 0 C-N-CA 122.242 1.961 . . . . 0.0 111.494 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 7.44 7.47 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.454 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 86.6 -0.17 86.6 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 119.072 -0.849 . . . . 0.0 111.965 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.29 158.53 27.96 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 29.0 m -108.61 158.18 17.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.312 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -138.06 135.56 35.97 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.004 -171.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -85.2 148.88 25.87 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.24 149.42 51.98 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.177 -0.952 . . . . 0.0 111.141 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -151.88 168.03 26.44 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 123.313 1.53 . . . . 0.0 109.785 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.7 ptpt -130.46 116.74 18.64 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.921 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.5 OUTLIER -110.99 28.46 8.7 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -176.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 86.1 p -79.61 164.31 23.92 Favored 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 124.029 0.932 . . . . 0.0 111.401 -174.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 66.6 m -117.05 176.13 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 319' ' ' ARG . 15.7 ptp180 -79.1 23.71 0.35 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -128.79 15.16 6.42 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 123.63 0.772 . . . . 0.0 110.778 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.443 ' HG3' ' CH2' ' A' ' 245' ' ' TRP . 16.6 mmt -137.52 179.65 6.28 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -130.8 103.41 6.56 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.678 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 72.7 m 64.88 166.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.915 1.286 . . . . 0.0 111.419 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -155.34 -64.6 0.12 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.749 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 44.05 69.61 0.4 Allowed 'General case' 0 C--N 1.343 0.318 0 O-C-N 123.84 0.713 . . . . 0.0 112.652 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.7 p -83.99 160.0 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 121.902 -0.499 . . . . 0.0 109.987 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -102.8 153.59 20.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.509 0.595 . . . . 0.0 110.114 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.3 139.15 49.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 329' ' ' ILE . 19.7 tt -155.83 88.1 3.0 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 122.854 1.311 . . . . 0.0 108.123 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.16 164.75 26.67 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.868 2.379 . . . . 0.0 113.062 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -78.28 122.49 25.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.104 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 334' ' ' ALA . 86.8 t -103.84 148.6 8.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 122.463 1.125 . . . . 0.0 110.161 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.44 -38.62 59.65 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.554 1.142 . . . . 0.0 110.775 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -64.32 -3.09 2.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.706 0.403 . . . . 0.0 111.892 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -102.96 7.24 39.2 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 120.823 -1.173 . . . . 0.0 111.202 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 49.9 m -119.85 -49.37 2.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -151.13 157.41 42.7 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 119.122 0.873 . . . . 0.0 111.609 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.452 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 54.2 t80 -156.08 143.33 19.15 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.901 1.375 . . . . 0.0 109.342 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.27 154.57 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.999 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -117.87 41.18 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.8 t -137.61 147.15 56.24 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.548 1.139 . . . . 0.0 110.074 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.66 -3.36 13.76 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.564 2.176 . . . . 0.0 111.022 174.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 38.8 m -130.19 -176.85 4.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -105.86 135.95 46.37 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.728 -1.233 . . . . 0.0 110.243 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -159.59 165.75 32.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.083 -1.011 . . . . 0.0 109.321 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.37 150.7 25.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.057 1.343 . . . . 0.0 110.04 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -138.1 110.78 8.51 Favored Pre-proline 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.13 -2.09 11.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.864 3.043 . . . . 0.0 111.348 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 67.8 m -84.45 -14.35 49.5 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -140.42 94.72 2.77 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 109.942 176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 396' ' ' VAL . 10.5 t -149.27 152.24 35.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.702 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.0 m -135.11 153.06 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 CA-C-N 118.822 0.737 . . . . 0.0 109.375 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -75.04 145.71 42.17 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.923 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 66.9 t -132.0 140.75 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 125.089 1.493 . . . . 0.0 111.168 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -165.76 -162.15 16.39 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 121.523 -0.736 . . . . 0.0 111.945 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.66 31.9 18.25 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.15 0.975 . . . . 0.0 111.291 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.67 25.74 0.63 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . 0.295 0.0 OUTLIER 58.31 9.23 0.97 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.96 1.704 . . . . 0.0 114.739 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 84.84 17.16 63.98 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 167.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 27.5 ptm -165.48 21.7 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 119.19 1.495 . . . . 0.0 112.339 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.501 HD13 ' HZ2' ' A' ' 422' ' ' LYS . 18.4 tp -69.38 151.37 46.23 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.881 0.848 . . . . 0.0 111.496 -175.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -114.26 174.26 6.04 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -75.53 -14.93 60.43 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -71.94 -25.26 61.81 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.031 -1.043 . . . . 0.0 109.247 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -90.24 -31.84 16.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 124.91 1.381 . . . . 0.0 110.74 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.18 -33.82 61.49 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.545 0.612 . . . . 0.0 110.557 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.53 67.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.86 -45.09 71.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.701 -0.624 . . . . 0.0 110.745 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 424' ' ' VAL . 81.4 mt -64.65 -43.45 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.701 0.8 . . . . 0.0 110.488 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.533 HD13 ' CE2' ' A' ' 374' ' ' PHE . 3.7 mm? -81.0 -28.04 35.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.146 -0.971 . . . . 0.0 113.293 -173.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.24 -13.73 27.92 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -108.31 -22.04 12.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.743 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.23 -16.97 21.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.2 0.909 . . . . 0.0 111.535 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.533 ' CE2' HD13 ' A' ' 370' ' ' LEU . 16.2 m-30 -113.26 -12.29 13.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.763 1.165 . . . . 0.0 113.694 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 69.25 4.13 41.95 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.98 -0.45 . . . . 0.0 113.226 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -164.73 115.92 0.67 Allowed Glycine 0 C--N 1.357 1.717 0 CA-C-N 118.456 1.128 . . . . 0.0 115.177 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.9 m -147.44 179.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.693 0 C-N-CA 123.237 0.615 . . . . 0.0 111.66 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.12 -39.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 O-C-N 122.028 -0.42 . . . . 0.0 110.936 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -154.77 152.75 30.24 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.653 0.66 . . . . 0.0 111.187 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -145.73 150.96 37.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.416 1.486 . . . . 0.0 109.036 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -168.41 169.56 41.64 Favored Glycine 0 C--N 1.339 0.715 0 O-C-N 120.83 -1.168 . . . . 0.0 115.371 175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 15.2 mm -90.16 150.4 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 125.994 1.718 . . . . 0.0 109.711 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -91.53 71.73 5.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.3 p -75.86 156.7 34.12 Favored 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 121.691 -0.63 . . . . 0.0 111.241 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -147.18 161.61 40.56 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.47 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 24.1 tptm -45.77 102.49 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.616 0.766 . . . . 0.0 112.201 -175.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.47 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 24.3 m170 48.39 42.12 17.73 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.692 1.997 . . . . 0.0 112.338 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -97.25 -11.42 24.18 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 124.312 1.007 . . . . 0.0 109.835 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 26.8 p90 44.58 45.49 2.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.1 -58.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.88 3.72 . . . . 0.0 109.779 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.5 tp 42.72 32.73 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.421 0 C-N-CA 125.172 1.389 . . . . 0.0 113.838 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -150.6 16.81 0.97 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 54.0 m -152.37 157.74 41.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 117.833 0.816 . . . . 0.0 110.06 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 176.1 -163.84 33.49 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 123.66 0.6 . . . . 0.0 113.489 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -146.42 173.8 11.96 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 124.717 0.892 . . . . 0.0 111.213 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 351' ' ' THR . 2.5 p -139.17 144.03 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 34.9 p -119.1 152.27 36.8 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 122.623 1.201 . . . . 0.0 111.218 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 403' ' ' SER . 35.0 m-85 -129.82 179.37 5.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 123.611 1.672 . . . . 0.0 110.849 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -126.64 1.78 6.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.314 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -129.35 164.03 24.46 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 124.761 1.225 . . . . 0.0 109.593 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -96.91 -13.38 22.47 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.19 -38.12 87.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.795 1.18 . . . . 0.0 107.928 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.536 ' HB2' ' CE1' ' A' ' 398' ' ' PHE . 8.3 p -79.15 -17.99 53.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.17 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -72.75 -61.08 1.93 Allowed 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.798 -0.563 . . . . 0.0 111.944 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.523 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -72.11 -25.58 61.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 118.206 -1.397 . . . . 0.0 113.028 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -77.92 -20.6 52.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.073 0.851 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.71 61.15 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 121.725 -0.609 . . . . 0.0 111.155 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.5 m -82.71 -11.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.648 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.8 p -106.89 -8.23 16.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.068 0.855 . . . . 0.0 112.507 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -93.44 -49.83 5.73 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 169.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.36 -15.26 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.56 138.77 12.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.461 HG12 ' CG ' ' A' ' 218' ' ' MET . 10.6 m -143.94 158.98 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.972 0.351 . . . . 0.0 111.43 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -103.99 137.18 42.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.866 1.354 . . . . 0.0 109.713 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.21 128.66 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.61 50.16 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -173.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 418' ' ' THR . 28.4 m -73.9 166.5 23.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 417' ' ' THR . 6.7 t -71.6 -1.87 15.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -148.36 5.58 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.804 -1.185 . . . . 0.0 111.23 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -146.98 125.46 12.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.327 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 54.5 p -138.58 111.2 7.6 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 125.332 1.645 . . . . 0.0 112.822 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.501 ' HZ2' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -159.55 -176.68 5.9 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.466 -1.396 . . . . 0.0 112.323 177.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -127.61 163.42 24.25 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.704 -0.665 . . . . 0.0 109.762 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.407 HG21 HD13 ' A' ' 369' ' ' ILE . 25.9 m -143.98 156.88 15.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 O-C-N 123.68 0.613 . . . . 0.0 109.653 -176.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -130.26 153.47 48.59 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 123.258 0.348 . . . . 0.0 111.216 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 79.2 mt -131.53 142.38 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 124.896 1.372 . . . . 0.0 108.115 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -139.23 155.97 72.2 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.558 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.9 158.08 35.37 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 C-N-CA 124.28 3.32 . . . . 0.0 115.22 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 75.8 t80 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.15 177.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -169.86 175.67 5.1 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.642 1.214 . . . . 0.0 111.199 172.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.486 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -129.17 16.04 6.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 174.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.1 m 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 76.65 84.42 0.45 Allowed Glycine 0 C--N 1.339 0.735 0 O-C-N 120.328 -1.483 . . . . 0.0 111.602 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.47 ' C ' HD22 ' A' ' 224' ' ' LEU . 78.1 mm-40 -99.24 -5.33 30.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.19 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 223' ' ' GLN . 3.1 mm? -131.65 125.07 20.32 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.405 1.082 . . . . 0.0 109.258 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 224' ' ' LEU . 3.4 Cg_exo -81.6 116.81 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 125.01 3.807 . . . . 0.0 111.169 172.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 225' ' ' PRO . 44.1 Cg_endo -81.8 -179.28 4.72 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 125.044 3.829 . . . . 0.0 111.86 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 37.93 66.21 0.5 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.923 1.689 . . . . 0.0 114.21 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -143.65 27.18 1.53 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.113 0.965 . . . . 0.0 110.186 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -66.23 0.93 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 112.561 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 55.97 45.88 22.99 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.877 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.413 ' H ' ' HD3' ' A' ' 232' ' ' PRO . 17.2 m-80 -117.61 -50.17 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' A' ' 334' ' ' ALA . 24.2 Cg_exo -73.64 -170.78 0.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.419 3.413 . . . . 0.0 114.063 -175.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.2 OUTLIER -102.83 -171.67 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 C-N-CA 125.388 1.475 . . . . 0.0 108.717 -178.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -106.37 148.74 27.72 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.7 m -141.99 11.56 2.0 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 10.6 t -158.48 -145.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.317 -1.49 . . . . 0.0 110.414 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 170.05 6.76 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.978 0.911 . . . . 0.0 110.616 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.9 m -144.53 155.12 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 122.32 1.057 . . . . 0.0 109.59 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.78 135.93 34.58 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.62 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 240' ' ' LEU . 3.5 tm? -146.09 122.66 11.1 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 121.336 0.588 . . . . 0.0 111.088 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.27 -170.99 33.41 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.113 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.74 6.96 0.91 Allowed Glycine 0 N--CA 1.474 1.179 0 C-N-CA 124.689 1.138 . . . . 0.0 112.109 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.57 145.8 30.52 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 122.707 1.241 . . . . 0.0 113.616 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.16 -13.02 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 125.0 3.8 . . . . 0.0 110.219 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -101.2 -104.09 0.25 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.631 1.105 . . . . 0.0 110.111 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.9 t70 46.38 59.5 3.81 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 124.278 1.031 . . . . 0.0 111.294 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.627 HD13 ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -70.31 -17.24 20.63 Favored 'Isoleucine or valine' 0 C--O 1.25 1.119 0 O-C-N 121.069 -1.019 . . . . 0.0 110.903 -170.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 4.8 m -149.29 133.51 17.34 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 127.053 2.141 . . . . 0.0 105.357 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.19 -10.23 59.5 Favored 'General case' 0 CA--C 1.485 -1.554 0 O-C-N 117.508 -3.245 . . . . 0.0 115.66 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.12 -18.24 58.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -74.3 -43.83 30.35 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 64.1 mt -69.52 -45.4 68.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.061 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.2 t -64.7 -39.06 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 O-C-N 123.761 0.663 . . . . 0.0 110.272 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.47 -16.79 64.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.651 -1.281 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 74.7 m -77.53 -33.55 54.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.727 -0.608 . . . . 0.0 111.513 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -142.53 80.6 1.7 Allowed 'General case' 0 C--O 1.218 -0.602 0 O-C-N 118.978 -2.326 . . . . 0.0 109.934 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.424 ' HA ' HD11 ' A' ' 262' ' ' LEU . 8.6 ptm180 -139.7 5.27 2.18 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.945 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.35 -4.91 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 119.452 1.024 . . . . 0.0 110.744 -171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -77.2 -12.27 59.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.21 3.26 6.33 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 116.313 1.285 . . . . 0.0 116.313 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.6 m -114.06 16.41 18.18 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.165 1.482 . . . . 0.0 110.335 -176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -134.88 155.71 50.2 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -148.88 -172.49 4.12 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.383 2.273 . . . . 0.0 108.03 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.45 150.55 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -170.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.14 129.29 23.69 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.534 -0.729 . . . . 0.0 109.847 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -156.29 152.79 23.92 Favored Pre-proline 0 N--CA 1.439 -1.004 0 O-C-N 121.025 -1.047 . . . . 0.0 113.041 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.69 148.82 47.61 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.676 4.25 . . . . 0.0 105.969 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.86 -8.7 70.72 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.792 1.187 . . . . 0.0 110.307 -173.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -66.67 -18.37 65.33 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 118.912 1.356 . . . . 0.0 110.419 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -81.35 -5.25 57.64 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 112.365 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -110.97 -176.85 20.52 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -74.92 163.56 27.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.315 0.646 . . . . 0.0 112.287 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 13.2 m80 64.43 145.54 0.09 OUTLIER Pre-proline 0 N--CA 1.444 -0.771 0 C-N-CA 125.426 1.491 . . . . 0.0 111.697 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.52 17.29 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 124.239 3.293 . . . . 0.0 111.712 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -145.16 140.27 27.84 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.619 1.168 . . . . 0.0 111.563 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.667 ' H ' ' HD2' ' A' ' 277' ' ' PRO . 49.4 t -161.72 -43.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.667 ' HD2' ' H ' ' A' ' 276' ' ' CYS . 45.1 Cg_endo -83.11 136.58 8.01 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.941 1.761 . . . . 0.0 111.748 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -93.71 6.71 2.7 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.236 2.624 . . . . 0.0 111.118 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -106.49 5.7 29.51 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 125.249 1.42 . . . . 0.0 111.294 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.45 29.98 0.15 Allowed Glycine 0 N--CA 1.467 0.704 0 N-CA-C 116.476 1.35 . . . . 0.0 116.476 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.7 121.54 40.37 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 118.858 1.329 . . . . 0.0 110.054 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.01 174.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 122.916 1.341 . . . . 0.0 112.034 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -98.54 169.0 9.83 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.937 -1.102 . . . . 0.0 112.019 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.0 mt -124.37 145.24 49.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.206 170.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.21 114.39 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.96 -161.82 0.58 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.266 1.032 . . . . 0.0 111.766 -172.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.43 ' HG2' ' HE3' ' A' ' 290' ' ' LYS . 10.8 tp10 -56.84 113.11 1.52 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 288' ' ' LEU . 0.9 OUTLIER -85.37 12.47 8.21 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -168.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -135.45 -67.13 0.55 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 121.172 1.806 . . . . 0.0 112.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.43 ' HE3' ' HG2' ' A' ' 287' ' ' GLU . 0.0 OUTLIER -80.19 -31.34 38.76 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.908 -1.12 . . . . 0.0 112.184 -168.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 44.5 m -78.95 -30.85 44.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 119.195 0.907 . . . . 0.0 109.165 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.77 -56.49 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.574 -0.704 . . . . 0.0 109.537 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.57 -28.8 67.27 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.037 -1.04 . . . . 0.0 112.347 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.9 m -65.81 -32.67 74.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.36 -51.42 36.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.784 0.72 . . . . 0.0 109.817 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 ' C ' ' A' ' 296' ' ' LEU . 3.7 pp -74.3 -4.82 38.51 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -116.38 -8.06 11.66 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.375 0.422 . . . . 0.0 110.994 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.03 65.68 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.292 171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . 0.454 ' SG ' ' HE3' ' A' ' 315' ' ' LYS . 50.3 t -112.26 -91.76 0.48 Allowed 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 123.596 0.56 . . . . 0.0 111.734 -174.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 72.3 m -142.06 158.25 43.97 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -167.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -154.9 156.12 35.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.267 1.427 . . . . 0.0 108.704 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.64 104.75 4.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.404 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.57 12.55 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 125.604 4.203 . . . . 0.0 111.783 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.523 HD13 ' HD3' ' A' ' 306' ' ' PRO . 0.2 OUTLIER -58.92 -25.05 63.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 13.5 t 43.72 67.6 3.68 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.422 0.689 . . . . 0.0 111.912 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.523 ' HD3' HD13 ' A' ' 304' ' ' LEU . 27.1 Cg_endo -84.4 -4.26 10.15 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 124.275 3.316 . . . . 0.0 113.327 -173.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -142.29 -19.79 0.7 Allowed 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.642 0.589 . . . . 0.0 112.494 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 150.56 -20.76 1.04 Allowed Glycine 0 C--N 1.34 0.758 0 O-C-N 120.616 -1.302 . . . . 0.0 113.669 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.48 165.61 19.52 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.6 0.76 . . . . 0.0 109.34 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 49.5 m -103.19 177.88 4.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.949 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -129.39 131.61 46.85 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.596 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -109.55 151.94 26.12 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -138.27 154.49 49.04 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 122.006 0.907 . . . . 0.0 112.105 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.45 178.81 7.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 112.953 -1.93 . . . . 0.0 109.408 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.489 ' HB3' ' HE2' ' A' ' 315' ' ' LYS . 9.1 ptpt -150.11 147.04 27.28 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.22 -14.92 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.583 -1.323 . . . . 0.0 110.557 -169.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.5 t -94.96 157.31 15.96 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 119.672 1.124 . . . . 0.0 112.528 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 43.4 p -131.58 -38.61 1.16 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -152.13 -13.3 0.18 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -99.15 -21.22 16.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -172.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 69.2 mmm -130.01 -179.36 5.17 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.625 0.77 . . . . 0.0 111.697 175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -123.85 31.66 5.79 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 66.7 m -104.66 -45.46 4.6 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -173.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? 53.63 17.51 1.22 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -166.97 147.63 5.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 120.589 -1.319 . . . . 0.0 112.317 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.75 159.93 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 117.517 -1.23 . . . . 0.0 109.695 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -109.53 157.11 19.33 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 120.089 1.313 . . . . 0.0 113.198 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.4 t -140.81 141.93 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.937 -175.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 328' ' ' VAL . 3.9 pt -151.6 131.2 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 329' ' ' ILE . 1.5 Cg_endo -104.29 174.22 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 123.353 2.702 . . . . 0.0 114.344 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -82.4 125.0 30.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 334' ' ' ALA . 93.9 t -99.33 151.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.73 -26.37 68.02 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.543 -0.723 . . . . 0.0 111.523 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.553 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -71.16 -22.45 62.05 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.14 -10.3 59.63 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.341 0.401 . . . . 0.0 110.242 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 17.3 m -98.04 -31.79 11.96 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.1 162.06 40.3 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 121.728 -0.608 . . . . 0.0 111.462 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.631 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 30.2 t80 -147.55 127.67 13.76 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 341' ' ' SER . 55.2 t -104.59 140.43 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -176.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -103.86 -8.09 20.0 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.766 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.437 ' H ' ' CG1' ' A' ' 339' ' ' VAL . 69.0 m -137.01 93.17 13.57 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.33 -9.98 27.1 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.301 2.667 . . . . 0.0 113.584 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 71.0 m -115.26 19.07 15.83 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.878 0.871 . . . . 0.0 112.845 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -140.65 172.43 12.71 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.056 1.343 . . . . 0.0 109.708 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -127.18 -83.8 0.61 Allowed 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.643 -1.286 . . . . 0.0 111.083 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 347' ' ' ASP . 3.8 tp -151.35 173.24 14.75 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 123.957 0.785 . . . . 0.0 111.065 -170.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.42 ' H ' ' HG ' ' A' ' 346' ' ' LEU . 1.4 m-20 -124.7 151.31 67.6 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 123.609 0.764 . . . . 0.0 110.187 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.57 -15.58 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.864 3.042 . . . . 0.0 113.611 -167.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 56.6 p -150.17 8.25 0.63 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -123.88 88.74 2.96 Favored 'General case' 0 C--O 1.219 -0.526 0 O-C-N 121.008 -1.058 . . . . 0.0 110.094 -175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.0 t -151.52 155.3 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.21 150.33 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.04 0.448 . . . . 0.0 110.961 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -90.58 141.35 28.86 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 122.265 1.031 . . . . 0.0 110.283 -172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 78.8 t -130.94 140.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.811 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.27 -164.19 21.33 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 56.64 29.2 15.28 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 62.0 mt -74.98 170.15 16.57 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.071 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -74.79 -27.94 60.53 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -168.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 147.48 -11.45 1.33 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.714 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 18.4 ptm -156.78 22.55 0.33 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.024 1.412 . . . . 0.0 112.109 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 362' ' ' ASN . 0.5 OUTLIER -42.03 129.29 3.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.442 -175.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.559 ' N ' HD13 ' A' ' 361' ' ' LEU . 10.0 p30 -104.44 164.26 11.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.954 0.901 . . . . 0.0 111.352 -175.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -74.0 -12.16 60.55 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -168.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -81.2 -28.58 34.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.211 0.914 . . . . 0.0 109.053 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.07 77.44 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.05 -37.71 75.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.06 73.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.84 85.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.244 0.545 . . . . 0.0 110.285 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 36.6 mt -78.69 -33.31 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.145 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.08 1.05 47.24 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -171.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -22.56 5.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.662 0.665 . . . . 0.0 111.777 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.35 -8.93 13.43 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.08 -1.84 9.24 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 170.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.88 -24.59 9.46 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.968 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.59 34.62 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 124.032 0.825 . . . . 0.0 115.155 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.21 128.09 1.03 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.105 -1.045 . . . . 0.0 114.589 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 398' ' ' PHE . 33.4 m -138.02 174.17 11.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 O-C-N 121.632 -0.922 . . . . 0.0 111.533 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.17 -28.82 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 O-C-N 122.212 -0.305 . . . . 0.0 111.679 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.26 151.9 21.62 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.229 0.612 . . . . 0.0 110.584 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -146.82 149.81 34.04 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 118.777 -0.63 . . . . 0.0 110.362 170.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -176.99 175.76 47.8 Favored Glycine 0 C--N 1.348 1.195 0 C-N-CA 120.58 -0.819 . . . . 0.0 115.036 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.07 147.26 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.587 0.755 . . . . 0.0 109.082 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.46 130.04 34.64 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.262 -0.899 . . . . 0.0 111.913 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 2.5 p -111.2 169.92 8.46 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.861 0.838 . . . . 0.0 111.622 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -147.75 167.19 25.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.866 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.68 101.54 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 123.41 0.444 . . . . 0.0 112.099 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 24.0 m170 53.8 30.89 12.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -97.39 -4.25 38.72 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.415 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 55.6 t80 45.9 56.11 15.61 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 125.292 1.437 . . . . 0.0 113.396 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.35 -60.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.743 0 C-N-CA 121.179 1.253 . . . . 0.0 109.362 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . 0.251 9.7 tp 41.45 36.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.739 2.016 . . . . 0.0 113.85 175.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -153.71 5.92 0.36 Allowed Glycine 0 N--CA 1.474 1.184 0 CA-C-O 118.44 -1.2 . . . . 0.0 115.122 -171.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 43.9 m -148.6 122.08 9.11 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 117.913 0.856 . . . . 0.0 110.296 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -158.89 -169.0 21.74 Favored Glycine 0 CA--C 1.542 1.757 0 O-C-N 120.705 -1.247 . . . . 0.0 111.848 -172.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -152.45 171.31 18.26 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.034 0.534 . . . . 0.0 109.986 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.72 143.8 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 89.7 m -115.43 140.32 49.24 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 377' ' ' VAL . 8.3 p90 -163.25 158.15 21.19 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.194 1.397 . . . . 0.0 110.414 173.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -128.77 20.55 6.01 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.03 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -100.87 144.35 29.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -88.91 -27.06 21.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.594 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -68.45 -25.07 64.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 119.593 1.088 . . . . 0.0 109.784 -174.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 73.8 p -81.35 -21.6 39.03 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -69.73 -62.6 1.32 Allowed 'General case' 0 C--N 1.349 0.583 0 CA-C-O 117.67 -1.157 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.496 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -69.76 -17.48 63.44 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 178.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -76.19 -34.88 59.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.983 0.81 . . . . 0.0 110.644 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.68 -26.35 37.62 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.227 -1.546 . . . . 0.0 111.192 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 37.6 t -79.77 -32.03 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.621 1.169 . . . . 0.0 108.635 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 29.0 t -75.09 -30.26 60.86 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 117.902 -1.046 . . . . 0.0 112.111 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.26 -48.74 6.53 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 119.572 1.078 . . . . 0.0 110.239 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 65.2 -14.04 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.999 2.12 . . . . 0.0 116.137 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 148.18 17.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.71 157.55 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.9 117.66 33.37 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 124.991 1.432 . . . . 0.0 110.489 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.25 127.99 39.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 416' ' ' LYS . 8.6 mmpt? -118.95 34.07 5.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.49 1.119 . . . . 0.0 111.16 -176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 17.4 m -59.83 154.83 17.52 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.233 0.924 . . . . 0.0 109.752 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 14.0 t -73.3 0.81 10.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -145.09 15.43 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 112.244 173.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -151.03 120.41 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.309 -1.495 . . . . 0.0 108.384 175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 32.4 p -132.28 110.08 10.35 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 121.938 -0.476 . . . . 0.0 110.265 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.545 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 26.6 tptt -162.47 -175.91 4.76 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 124.118 0.886 . . . . 0.0 109.132 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.545 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.7 mttm -121.2 173.05 7.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.631 176.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 35.9 m -145.75 150.04 15.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -114.79 152.27 32.4 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 15.6 mt -130.79 142.49 43.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 125.299 1.624 . . . . 0.0 108.283 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 24.9 t70 -138.2 140.2 27.93 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 119.839 1.199 . . . . 0.0 112.731 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 40.0 Cg_exo -57.77 153.85 41.02 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.692 2.261 . . . . 0.0 109.879 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.258 1.546 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.928 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . 0.425 ' O ' HG12 ' A' ' 413' ' ' VAL . 16.3 ptt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.65 -0.214 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.3 t -130.32 -178.36 4.72 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.497 1.142 . . . . 0.0 111.543 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.445 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -130.6 18.3 5.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.543 0.737 . . . . 0.0 111.654 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.4 m 56.31 29.04 14.31 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.762 1.625 . . . . 0.0 114.623 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 79.28 73.37 1.13 Allowed Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.535 -0.728 . . . . 0.0 112.191 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -80.83 -18.94 45.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 117.912 0.856 . . . . 0.0 112.765 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.8 127.63 25.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -84.67 132.08 4.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.003 3.135 . . . . 0.0 108.676 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.77 -5.53 15.42 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.1 1.867 . . . . 0.0 112.486 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.61 -168.6 1.62 Allowed 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 121.326 -0.859 . . . . 0.0 109.255 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 10.7 m120 58.4 27.97 16.17 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 122.066 -0.396 . . . . 0.0 111.128 -172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -40.07 145.65 0.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.25 0.62 . . . . 0.0 112.103 168.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -141.21 14.03 2.22 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.931 0.892 . . . . 0.0 111.713 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.546 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 8.0 p30 -141.76 28.21 0.09 OUTLIER Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.322 0.51 . . . . 0.0 112.279 -176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 87.8 Cg_endo -66.53 116.99 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.529 1.486 . . . . 0.0 112.047 -169.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 24.3 mm -144.87 153.42 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.467 ' CE1' ' HG2' ' A' ' 330' ' ' PRO . 18.8 m-85 -112.35 146.34 38.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -171.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 8.1 t -148.3 7.63 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -170.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 85.2 m -137.98 -74.2 0.4 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.838 0.745 . . . . 0.0 111.2 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 389' ' ' TYR . 20.7 pttp -156.18 -169.73 3.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.302 0.641 . . . . 0.0 109.575 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.2 152.31 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 122.25 1.024 . . . . 0.0 108.685 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -98.95 146.93 25.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.857 1.263 . . . . 0.0 110.071 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.19 136.44 16.65 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.798 1.311 . . . . 0.0 108.102 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 155.87 -173.46 33.88 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 121.638 -0.664 . . . . 0.0 113.601 170.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.73 1.61 8.21 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.344 -1.253 . . . . 0.0 110.123 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 5.9 m -78.44 126.61 82.76 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 118.734 1.267 . . . . 0.0 110.521 176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 245' ' ' TRP . 66.1 Cg_endo -81.45 4.78 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.969 3.779 . . . . 0.0 114.07 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.469 ' CD1' ' HG2' ' A' ' 244' ' ' PRO . 2.8 p-90 -139.99 -48.72 0.46 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 23.7 t70 56.32 -41.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.194 2.598 . . . . 0.0 115.205 -170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 248' ' ' THR 0.337 2.8 pp 55.38 -50.69 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -175.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.418 ' H ' HD12 ' A' ' 247' ' ' ILE . 29.9 m -150.19 135.64 18.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 122.113 2.233 . . . . 0.0 108.421 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -76.48 -22.08 54.99 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -69.51 -13.33 62.28 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.559 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.94 -74.73 0.68 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 120.956 -1.09 . . . . 0.0 113.021 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.57 -36.91 84.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.76 -0.72 . . . . 0.0 109.879 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.83 -50.67 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.533 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 257' ' ' ARG . 19.8 m-20 -71.68 -8.77 56.21 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 94.8 m -76.82 -26.89 54.89 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 124.256 0.972 . . . . 0.0 111.617 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -129.03 16.74 6.2 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 124.002 0.814 . . . . 0.0 112.863 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 254' ' ' ASN . 35.3 ttt85 -97.59 -17.16 19.69 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 258' ' ' VAL . 2.3 m -69.91 -10.79 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-O 121.654 0.74 . . . . 0.0 112.61 177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -136.92 3.4 2.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.021 -1.05 . . . . 0.0 110.082 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.59 149.76 16.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 124.032 1.907 . . . . 0.0 111.54 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 23.3 m -105.17 83.4 1.97 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 112.063 -2.069 . . . . 0.0 107.235 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.57 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -149.67 171.29 16.92 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 113.596 -178.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 t -144.71 165.82 26.98 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.537 -2.024 . . . . 0.0 105.537 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -128.84 150.8 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 121.298 -0.876 . . . . 0.0 113.207 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -141.23 142.92 33.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.014 1.387 . . . . 0.0 108.412 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -72.65 153.15 91.58 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.808 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.38 -17.41 16.63 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.7 2.267 . . . . 0.0 113.059 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -166.99 -5.36 0.03 OUTLIER Glycine 0 C--N 1.346 1.122 0 CA-C-O 117.346 -1.808 . . . . 0.0 116.429 173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 60.0 tttm 58.95 86.28 0.09 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.216 2.008 . . . . 0.0 109.646 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.39 165.48 23.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.442 -0.786 . . . . 0.0 109.712 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -72.1 -55.12 7.33 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 123.101 0.382 . . . . 0.0 112.838 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -87.08 156.69 19.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.232 0.516 . . . . 0.0 111.289 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.7 m170 44.31 61.74 10.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -57.63 2.04 0.17 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.62 3.546 . . . . 0.0 112.444 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -90.27 -9.55 47.53 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.604 1.093 . . . . 0.0 111.647 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 48.8 t -142.06 129.27 11.37 Favored Pre-proline 0 C--N 1.352 0.686 0 C-N-CA 125.685 1.594 . . . . 0.0 110.462 -172.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.76 156.15 67.12 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 124.783 3.655 . . . . 0.0 110.961 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.58 -3.5 13.88 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.549 3.499 . . . . 0.0 110.656 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 281' ' ' TYR . 5.5 ptpp? -149.84 179.34 8.11 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.552 1.141 . . . . 0.0 111.301 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -86.43 8.81 73.06 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 118.572 -1.127 . . . . 0.0 114.121 -177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.429 ' H ' ' HG3' ' A' ' 279' ' ' LYS . 1.8 m-85 -116.4 152.05 34.73 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.838 1.319 . . . . 0.0 113.565 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.69 167.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 126.22 1.808 . . . . 0.0 108.946 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -121.88 149.36 43.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.961 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 7.4 mp -121.45 148.47 44.39 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 286' ' ' PHE . 27.0 m -137.85 -154.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 O-C-N 125.223 1.577 . . . . 0.0 110.043 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.432 ' HB3' ' O ' ' A' ' 285' ' ' VAL 0.264 79.7 t80 77.55 -124.51 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 115.468 -2.206 . . . . 0.0 108.471 -174.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.88 140.05 58.83 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 123.086 2.676 . . . . 0.0 108.993 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.2 pt? -135.34 8.44 3.4 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.247 1.419 . . . . 0.0 114.204 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -128.9 -86.31 0.55 Allowed 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 124.545 1.153 . . . . 0.0 112.499 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -61.07 -30.33 70.27 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 52.6 m -100.2 -25.76 14.16 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.057 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.85 -28.62 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 121.684 2.038 . . . . 0.0 108.133 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -83.66 -32.02 25.84 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.115 0.884 . . . . 0.0 112.953 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 297' ' ' GLN . 27.8 m -87.75 -35.93 17.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.283 0.99 . . . . 0.0 112.232 -177.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 tt -68.85 -40.86 79.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.875 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 312' ' ' TYR . 3.8 mp -67.2 -40.58 86.52 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.704 -1.247 . . . . 0.0 111.749 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 294' ' ' SER . 17.8 pt20 -77.35 -7.48 56.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -87.44 -27.92 22.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.64 -174.15 4.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.041 -1.891 . . . . 0.0 106.379 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.2 t -80.92 151.48 28.54 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 124.029 1.871 . . . . 0.0 111.865 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -143.19 152.97 42.36 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.659 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -126.27 110.79 23.77 Favored Pre-proline 0 N--CA 1.434 -1.251 0 O-C-N 124.13 0.894 . . . . 0.0 109.433 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.85 46.04 2.07 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.781 2.988 . . . . 0.0 109.73 172.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.459 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -70.63 -18.7 62.86 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 123.725 0.81 . . . . 0.0 111.015 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.459 ' H ' HD12 ' A' ' 304' ' ' LEU . 22.6 t -157.93 69.0 3.95 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 121.56 0.695 . . . . 0.0 109.82 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 305' ' ' SER . 23.8 Cg_exo -63.14 -6.21 9.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.867 3.044 . . . . 0.0 115.577 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -120.71 0.53 10.41 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 121.279 -0.888 . . . . 0.0 108.786 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -128.15 25.9 4.81 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.035 1.302 . . . . 0.0 111.247 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 309' ' ' LEU . 19.3 tp 65.33 134.02 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.467 1.107 . . . . 0.0 111.521 -170.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 43.0 m -106.98 178.8 4.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.613 1.196 . . . . 0.0 111.659 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -126.91 147.88 50.06 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.214 -0.929 . . . . 0.0 111.148 -171.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 328' ' ' VAL . 32.1 m-85 -117.23 156.6 27.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.682 1.229 . . . . 0.0 110.196 176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -151.5 173.85 14.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.486 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -153.69 165.66 35.28 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.661 0.664 . . . . 0.0 110.717 170.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -128.59 57.33 1.6 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.1 0.56 . . . . 0.0 111.663 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -55.24 -12.61 1.03 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.207 2.203 . . . . 0.0 113.899 -178.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 72.8 p -89.18 138.64 31.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.156 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 22.3 t -160.11 -30.29 0.06 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-N 119.308 0.958 . . . . 0.0 112.606 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -143.64 -30.29 0.5 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.934 -176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -86.33 -34.52 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.481 1.037 . . . . 0.0 111.26 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 6.8 mmt -147.3 166.19 27.83 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -162.82 83.43 0.51 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 125.519 1.762 . . . . 0.0 109.047 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.9 m -133.87 -63.11 0.75 Allowed 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -149.16 139.84 22.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.082 0.944 . . . . 0.0 110.797 -174.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.87 162.6 21.35 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.263 1.425 . . . . 0.0 112.697 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 6.5 p -107.6 155.06 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -108.04 156.35 19.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.409 0.283 . . . . 0.0 111.575 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 312' ' ' TYR . 2.4 t -142.71 134.0 24.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 122.897 0.479 . . . . 0.0 112.02 -175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.06 132.15 9.01 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 121.829 0.824 . . . . 0.0 109.917 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.467 ' HG2' ' CE1' ' A' ' 234' ' ' TYR . 30.1 Cg_endo -83.06 165.39 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.367 2.044 . . . . 0.0 110.814 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.403 ' CH2' HD13 ' A' ' 391' ' ' ILE . 6.8 t-105 -83.92 113.56 21.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.297 0.57 . . . . 0.0 109.639 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 334' ' ' ALA . 4.2 t -83.1 150.21 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 123.058 1.408 . . . . 0.0 110.299 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.34 -20.89 65.9 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.429 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.475 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -77.54 1.83 18.25 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.721 1.208 . . . . 0.0 113.612 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -107.64 -0.74 21.72 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 118.699 0.681 . . . . 0.0 110.954 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.0 m -103.79 -36.37 7.86 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.614 0.766 . . . . 0.0 112.25 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -162.45 153.43 17.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.884 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -146.7 148.81 32.39 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.506 -0.746 . . . . 0.0 111.704 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 29.8 m -124.86 144.3 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 122.159 0.98 . . . . 0.0 111.671 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.98 -24.42 30.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.297 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 74.8 m -146.44 137.89 13.06 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 123.546 0.738 . . . . 0.0 110.6 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -88.39 -2.7 6.82 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.705 2.27 . . . . 0.0 111.892 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 9.7 m -83.23 -1.47 53.18 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.673 0.789 . . . . 0.0 112.373 -171.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -131.76 174.74 9.83 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.917 1.342 . . . . 0.0 111.216 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -128.57 166.19 19.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.837 0.855 . . . . 0.0 112.319 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.7 mm? -70.65 157.75 37.42 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.904 1.282 . . . . 0.0 110.235 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -109.24 133.68 20.7 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.35 -7.7 15.01 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 124.227 3.284 . . . . 0.0 112.076 -174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 37.0 m -142.14 2.26 1.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 350' ' ' ARG . 34.5 mmt180 -126.67 71.75 1.31 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.902 0.881 . . . . 0.0 110.518 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.0 p -143.59 164.91 29.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 395' ' ' ARG . 27.5 m -129.12 159.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.457 173.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -93.04 136.35 33.38 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.588 1.18 . . . . 0.0 111.681 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.93 144.91 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 121.531 0.681 . . . . 0.0 110.311 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -161.86 -160.62 11.1 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.44 34.0 15.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.999 0.92 . . . . 0.0 112.334 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 52.8 mt -89.51 169.14 11.61 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -95.0 14.9 20.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.6 14.11 66.23 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.688 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 6.8 ptp -161.14 15.31 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.702 1.751 . . . . 0.0 111.0 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.56 141.65 57.78 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.575 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.04 175.82 5.47 Favored 'General case' 0 N--CA 1.44 -0.938 0 O-C-N 124.714 1.259 . . . . 0.0 111.242 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -84.86 -17.33 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -75.89 -30.17 58.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -76.43 -35.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.223 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 16.1 tp -69.11 -41.75 76.99 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 122.692 1.234 . . . . 0.0 109.974 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.22 -0.925 . . . . 0.0 111.395 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.72 98.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 124.029 0.831 . . . . 0.0 110.241 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.98 -46.11 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.487 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.14 -29.73 21.59 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.533 -0.729 . . . . 0.0 112.939 -170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -12.03 36.7 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.747 -1.221 . . . . 0.0 112.088 -175.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.438 ' HB3' ' HE1' ' A' ' 220' ' ' TRP . 25.1 t70 -109.93 -23.14 11.51 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.664 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.18 -19.25 32.01 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.037 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -118.61 -22.29 7.56 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.318 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 75.25 -23.75 1.43 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.57 47.99 1.14 Allowed Glycine 0 C--N 1.344 1.005 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.251 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 32.6 t -131.56 142.28 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 120.301 2.05 . . . . 0.0 113.261 -173.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.62 -24.07 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.424 0.63 . . . . 0.0 112.601 -174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 346' ' ' LEU . 1.0 OUTLIER -152.17 150.95 30.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.42 23.25 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.008 1.323 . . . . 0.0 109.481 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -161.8 156.42 27.94 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 115.474 0.95 . . . . 0.0 115.474 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.99 144.22 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -92.4 148.66 21.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 118.537 0.608 . . . . 0.0 110.717 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 22.8 p -126.38 169.57 12.83 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.664 -0.647 . . . . 0.0 110.849 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -136.47 -178.43 5.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -72.81 90.29 1.42 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.248 1.023 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 20.5 m170 65.68 28.48 11.11 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 125.102 1.361 . . . . 0.0 111.783 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -89.55 4.08 50.42 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.497 ' HB3' ' HE2' ' A' ' 237' ' ' LYS . 8.0 p90 45.23 48.14 4.64 Favored Pre-proline 0 N--CA 1.468 0.472 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 391' ' ' ILE . 88.4 Cg_endo -69.14 -70.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.336 2.024 . . . . 0.0 112.304 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.474 ' H ' ' HG2' ' A' ' 390' ' ' PRO . 7.2 tp 40.44 26.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 127.777 2.431 . . . . 0.0 112.285 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -135.11 4.37 4.18 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 120.533 -1.354 . . . . 0.0 112.504 -172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 23.5 p -148.77 130.56 15.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.273 0.558 . . . . 0.0 110.413 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.48 16.11 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.085 -1.009 . . . . 0.0 112.271 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 352' ' ' VAL . 15.0 ptp180 -148.83 -178.12 6.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.165 0.986 . . . . 0.0 110.384 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.38 137.67 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.1 m -105.64 120.55 41.94 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -96.36 -33.6 11.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 60.5 t30 66.05 -2.76 0.88 Allowed 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -151.71 179.65 8.22 Favored 'General case' 0 N--CA 1.436 -1.16 0 O-C-N 120.962 -1.086 . . . . 0.0 110.106 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -92.28 -26.08 18.3 Favored 'General case' 0 C--O 1.222 -0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -169.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.59 -41.13 80.54 Favored 'General case' 0 C--N 1.341 0.234 0 O-C-N 120.252 -1.53 . . . . 0.0 112.441 -172.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 53.7 m -80.15 -10.25 59.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -76.05 -55.37 5.66 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.799 0.727 . . . . 0.0 109.619 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.473 ' C ' HD22 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.1 -23.32 60.5 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 118.615 0.643 . . . . 0.0 111.022 -175.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -79.14 -34.86 42.88 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.768 -0.583 . . . . 0.0 111.795 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.71 70.43 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 119.316 0.962 . . . . 0.0 110.583 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.85 -24.75 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 118.398 0.544 . . . . 0.0 111.661 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 t -74.83 -25.9 59.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.302 1.001 . . . . 0.0 108.691 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -84.87 -51.36 6.79 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 61.64 -23.33 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 127.321 2.248 . . . . 0.0 116.044 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.71 144.52 15.19 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 111.065 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 218' ' ' MET . 22.0 m -142.74 158.65 18.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-O 122.067 0.937 . . . . 0.0 111.289 173.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -112.59 131.81 55.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.75 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.76 124.29 39.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -121.3 31.9 6.14 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.015 -1.053 . . . . 0.0 110.228 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.7 m -62.26 154.83 26.48 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.4 p -61.38 -12.06 12.69 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.73 7.65 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -146.44 137.13 24.08 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.374 1.07 . . . . 0.0 109.054 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.43 125.55 13.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.527 0.731 . . . . 0.0 111.382 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 18.3 tptt -167.4 -170.74 1.52 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.02 165.27 23.57 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.225 1.01 . . . . 0.0 108.454 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.74 158.57 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 124.422 1.076 . . . . 0.0 108.599 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -126.87 148.29 50.0 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.193 0.933 . . . . 0.0 112.643 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.84 139.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.02 125.64 5.78 Favored Pre-proline 0 C--N 1.349 0.547 0 CA-C-O 121.742 0.782 . . . . 0.0 110.245 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.39 171.54 16.74 Favored 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.603 2.202 . . . . 0.0 111.259 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.881 177.706 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 91.7 m -69.89 151.63 45.45 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 -10.26 0.18 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m 46.89 52.33 11.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.589 1.185 . . . . 0.0 111.499 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -65.22 -24.24 70.39 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.002 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 54.59 33.5 19.26 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.172 0.986 . . . . 0.0 113.416 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.473 ' C ' ' HD3' ' A' ' 226' ' ' PRO . 4.6 mm? -63.68 157.25 67.68 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 123.002 0.521 . . . . 0.0 109.986 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.29 68.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 1 C-N-CA 125.997 4.464 . . . . 0.0 114.731 176.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 224' ' ' LEU . 71.6 Cg_exo -55.72 166.37 2.88 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.535 2.824 . . . . 0.0 110.814 169.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 60.08 23.63 12.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.631 1.572 . . . . 0.0 114.461 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -78.37 7.44 6.52 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.474 0.71 . . . . 0.0 111.399 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -73.4 155.93 38.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.227 1.011 . . . . 0.0 111.569 -174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -143.05 18.68 1.94 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.474 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -133.9 43.56 1.03 Allowed Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 123.947 0.899 . . . . 0.0 109.493 -170.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 93.8 Cg_endo -71.93 157.2 55.27 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.638 2.892 . . . . 0.0 113.094 -170.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 17.4 mm -147.5 153.32 12.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.02 150.53 31.83 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.649 1.113 . . . . 0.0 109.654 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 70.4 p -155.11 6.5 0.24 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 124.873 1.358 . . . . 0.0 114.612 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 4.9 t -154.7 -169.29 3.16 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 121.26 1.845 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -43.23 146.07 0.48 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 112.378 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.506 ' CG1' ' HB2' ' A' ' 284' ' ' LEU . 3.5 p -122.47 139.56 49.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 125.529 1.768 . . . . 0.0 109.401 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.08 138.63 31.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 120.821 -1.174 . . . . 0.0 108.904 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -127.61 126.27 41.73 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 125.053 1.47 . . . . 0.0 108.453 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.72 154.94 21.04 Favored Glycine 0 N--CA 1.449 -0.49 0 O-C-N 120.583 -1.323 . . . . 0.0 111.234 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.73 10.28 0.92 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.2 m -120.49 73.25 21.76 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 118.446 1.123 . . . . 0.0 110.301 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.41 5.15 3.86 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 109.985 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.435 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 34.7 p-90 -116.54 -10.53 11.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.18 133.07 55.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.575 -1.328 . . . . 0.0 110.258 -176.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.835 HD13 ' H ' ' A' ' 247' ' ' ILE . 0.2 OUTLIER -109.14 -26.04 3.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 124.654 1.221 . . . . 0.0 112.822 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 16.8 m -138.54 118.84 13.65 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.026 0.53 . . . . 0.0 111.041 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.18 -24.05 67.27 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 121.378 0.608 . . . . 0.0 112.534 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.1 75.87 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 119.849 -1.782 . . . . 0.0 111.924 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.87 -63.42 4.43 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 123.249 0.343 . . . . 0.0 112.576 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -68.49 -21.68 64.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 120.662 -1.493 . . . . 0.0 113.555 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.4 HG22 HG21 ' A' ' 264' ' ' VAL . 3.3 t -71.54 -52.13 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -71.06 -12.73 61.68 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 125.435 1.709 . . . . 0.0 110.736 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.7 m -79.6 -22.26 43.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.522 -1.361 . . . . 0.0 112.483 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.97 26.6 4.6 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -113.67 -27.32 7.87 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 123.383 0.427 . . . . 0.0 110.845 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 94.1 t -75.27 -8.29 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.566 -0.709 . . . . 0.0 110.979 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.49 17.11 11.3 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.991 -1.068 . . . . 0.0 113.064 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.21 153.82 25.19 Favored Glycine 0 C--O 1.249 1.085 0 O-C-N 121.322 -0.861 . . . . 0.0 113.074 -174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.9 m -76.88 28.58 0.13 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 123.86 0.864 . . . . 0.0 113.3 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -109.35 164.38 12.54 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.147 -0.971 . . . . 0.0 112.092 -173.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 p -141.68 168.46 19.72 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 284' ' ' LEU . 6.6 t -125.44 154.01 33.55 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.544 -168.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -130.6 129.34 42.6 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.5 50.79 5.32 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 124.532 1.145 . . . . 0.0 113.979 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.19 31.48 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 1 C-N-CA 125.894 4.396 . . . . 0.0 111.827 -172.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.29 -43.01 4.45 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -155.94 130.93 9.25 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.436 1.494 . . . . 0.0 111.346 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -125.54 154.8 41.61 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.75 -152.22 10.25 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.66 -16.41 58.54 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.343 -1.313 . . . . 0.0 109.283 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -152.55 135.11 9.05 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 118.798 0.726 . . . . 0.0 110.8 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.99 42.06 1.27 Allowed 'Trans proline' 0 CA--C 1.548 1.181 1 C-N-CA 125.396 4.064 . . . . 0.0 113.555 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -110.0 13.96 23.18 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.26 -0.9 . . . . 0.0 112.95 -171.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 63.7 m -141.31 36.51 0.24 Allowed Pre-proline 0 CA--C 1.569 1.683 0 CA-C-O 116.866 -1.54 . . . . 0.0 114.899 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.23 147.44 93.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 107.933 -1.603 . . . . 0.0 107.933 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.89 -15.12 13.43 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.138 3.226 . . . . 0.0 113.529 -175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 175.75 12.8 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.286 -0.884 . . . . 0.0 110.751 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -100.24 -9.58 47.54 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.373 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -73.3 121.84 21.04 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 118.598 1.199 . . . . 0.0 112.184 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 22.0 m -155.34 -174.9 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 O-C-N 125.626 1.829 . . . . 0.0 109.008 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -132.21 165.73 23.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -169.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HB2' ' CG1' ' A' ' 238' ' ' VAL . 55.0 mt -117.77 148.42 42.07 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.731 171.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 143.37 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -171.64 178.2 3.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -168.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.4 136.04 56.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 166.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.35 -10.65 59.65 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.53 -43.59 0.68 Allowed 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -83.93 -49.57 8.87 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.76 -1.114 . . . . 0.0 112.207 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.9 t -71.13 -26.33 62.96 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.218 0.949 . . . . 0.0 111.583 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 286' ' ' PHE . 3.3 t -67.57 -58.52 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 O-C-N 124.216 0.948 . . . . 0.0 111.047 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -67.45 -23.27 65.5 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.695 1.247 . . . . 0.0 110.571 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.6 t -71.27 -45.61 62.77 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.023 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.34 -57.54 9.07 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . 0.297 2.1 pp -80.7 -2.01 44.99 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -170.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -100.43 -6.86 24.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 121.054 1.752 . . . . 0.0 108.202 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -94.97 -23.68 17.28 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.479 1.112 . . . . 0.0 110.585 170.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 -133.11 0.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 29.8 t -129.58 164.98 22.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.073 -2.267 . . . . 0.0 110.03 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -146.38 155.78 42.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.886 0.874 . . . . 0.0 110.206 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -136.43 126.19 15.96 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.68 47.36 2.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.635 3.557 . . . . 0.0 105.579 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 304' ' ' LEU . 0.1 OUTLIER -67.22 -24.24 65.81 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 115.911 -1.995 . . . . 0.0 113.339 -174.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.42 ' H ' HD12 ' A' ' 304' ' ' LEU . 11.4 t -155.37 67.98 5.15 Favored Pre-proline 0 C--N 1.348 0.54 0 CA-C-N 120.873 1.67 . . . . 0.0 107.677 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.88 6.55 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 124.722 3.615 . . . . 0.0 114.441 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.2 0.71 20.85 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.919 0.866 . . . . 0.0 110.405 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 153.84 8.09 0.09 OUTLIER Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 44.0 tp -138.14 155.2 48.96 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 122.015 0.912 . . . . 0.0 109.699 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.7 m -152.73 145.39 24.26 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -143.73 143.96 31.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.725 0.774 . . . . 0.0 111.349 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -118.53 153.96 33.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.199 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -145.38 158.66 43.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 118.457 0.571 . . . . 0.0 111.331 -172.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 315' ' ' LYS . 6.3 t80 -156.08 171.24 20.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 23.8 ttmt -128.55 51.93 1.96 Allowed 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 122.884 1.326 . . . . 0.0 108.132 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -0.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.434 -1.712 . . . . 0.0 113.388 -175.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 23.1 t -89.49 125.91 35.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 118.918 0.781 . . . . 0.0 110.245 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 13.5 t -145.98 142.44 28.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.145 0.498 . . . . 0.0 109.936 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 49.97 24.48 1.36 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.19 1.396 . . . . 0.0 113.447 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.403 ' HG3' ' HG2' ' A' ' 321' ' ' MET . 16.3 ptp180 -147.51 -41.18 0.18 Allowed 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.121 -1.612 . . . . 0.0 111.852 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.435 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 23.5 mmm -119.83 -26.88 5.54 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.834 1.197 . . . . 0.0 111.224 170.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 57.7 2.1 0.15 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.032 1.733 . . . . 0.0 113.961 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 97.2 m -137.98 170.35 16.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 118.117 0.417 . . . . 0.0 112.022 -173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 63.15 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.961 2.104 . . . . 0.0 112.556 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 1.7 pm0 -91.84 161.67 14.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.117 1.767 . . . . 0.0 111.095 170.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 13.6 p -116.28 143.47 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -90.27 154.71 19.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.273 -0.892 . . . . 0.0 111.861 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 45.9 t -138.75 139.84 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.369 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.0 pt -147.16 117.46 4.5 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.536 0.734 . . . . 0.0 110.515 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -85.7 162.37 10.71 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 123.035 2.49 . . . . 0.0 113.765 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -79.11 121.48 25.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.99 145.42 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 125.049 1.34 . . . . 0.0 110.222 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -55.83 -22.86 27.23 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.9 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -75.82 -16.32 60.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.55 -23.95 25.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.345 0.658 . . . . 0.0 111.427 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 47.3 m -69.93 -39.7 75.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -163.32 154.84 17.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.592 1.187 . . . . 0.0 110.754 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.479 ' HB3' ' HB1' ' A' ' 363' ' ' ALA . 70.8 t80 -141.69 99.57 3.57 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.85 143.77 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -90.47 -17.82 26.46 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.589 -0.694 . . . . 0.0 112.808 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.9 m -142.18 136.32 14.85 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.711 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.03 3.82 7.07 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.172 1.915 . . . . 0.0 114.119 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.8 m -109.63 12.15 24.38 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -148.62 163.31 37.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.429 1.092 . . . . 0.0 113.4 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.697 ' HG3' ' H ' ' A' ' 346' ' ' LEU . 10.6 tpp85 -125.99 -175.71 3.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.869 1.268 . . . . 0.0 109.504 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.697 ' H ' ' HG3' ' A' ' 345' ' ' ARG . 1.1 tp -56.55 164.89 1.27 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.927 2.091 . . . . 0.0 113.521 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -135.89 145.52 53.05 Favored Pre-proline 0 CA--C 1.514 -0.412 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.48 123.54 7.11 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.434 2.09 . . . . 0.0 112.812 -172.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 36.6 m 59.9 26.19 15.39 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.288 1.435 . . . . 0.0 113.18 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpp85 -114.41 43.01 1.98 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.172 0.589 . . . . 0.0 109.98 -174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 p -135.78 163.84 29.28 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 122.476 1.131 . . . . 0.0 109.424 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.79 152.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.505 172.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -82.32 149.26 27.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.568 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.23 136.27 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -169.91 -170.44 34.34 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.547 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.72 18.08 0.95 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.335 1.454 . . . . 0.0 113.367 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.725 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -80.21 176.27 9.91 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.113 0.965 . . . . 0.0 110.267 172.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.7 32.44 0.16 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.537 ' H ' HD22 ' A' ' 357' ' ' LEU . . . 76.1 18.23 79.52 Favored Glycine 0 C--O 1.22 -0.767 0 O-C-N 120.564 -1.335 . . . . 0.0 112.596 176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.404 ' HA ' HG13 ' A' ' 391' ' ' ILE . 17.2 mmt -140.3 -94.32 0.15 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.175 1.488 . . . . 0.0 111.718 171.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 16.7 tp 40.53 68.63 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.497 0.719 . . . . 0.0 110.863 -171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -55.62 168.16 0.44 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.726 0.239 . . . . 0.0 111.045 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 338' ' ' PHE . . . -65.29 -16.64 63.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -85.66 -26.63 25.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.733 -1.229 . . . . 0.0 109.256 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -79.85 -26.91 40.24 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 121.542 -0.724 . . . . 0.0 110.317 174.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.7 -51.72 25.73 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.42 67.23 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.822 -0.549 . . . . 0.0 110.885 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.24 73.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.707 0.23 . . . . 0.0 111.298 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.8 mt -66.46 -42.6 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 119.03 -0.509 . . . . 0.0 109.836 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.24 -34.89 18.8 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -22.87 44.51 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.4 -1.438 . . . . 0.0 111.554 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -87.66 -27.34 22.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 118.484 -1.286 . . . . 0.0 111.614 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.15 -18.87 26.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.553 ' CZ ' ' HA3' ' A' ' 376' ' ' GLY . 4.1 t80 -136.16 -61.45 0.7 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.843 174.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 100.59 -16.07 58.05 Favored Glycine 0 N--CA 1.472 1.053 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.553 ' HA3' ' CZ ' ' A' ' 374' ' ' PHE . . . -85.38 59.52 4.82 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 118.089 0.944 . . . . 0.0 112.514 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.67 164.58 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 118.071 -1.452 . . . . 0.0 112.478 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.69 -40.67 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -150.79 148.0 27.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.163 0.506 . . . . 0.0 109.852 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -136.75 153.11 50.94 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 121.173 -0.954 . . . . 0.0 110.77 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -162.74 155.43 26.75 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 118.645 0.657 . . . . 0.0 112.501 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.11 147.19 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.5 126.48 29.79 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.584 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.6 p -138.99 157.49 45.9 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.962 0.789 . . . . 0.0 108.976 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -145.16 166.44 25.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.705 1.202 . . . . 0.0 108.755 173.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -53.05 102.32 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.443 -0.786 . . . . 0.0 111.784 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 65.8 m170 60.72 30.01 19.4 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 171.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -94.5 -8.2 39.08 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.577 -0.702 . . . . 0.0 110.759 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 15.6 p90 37.82 52.2 2.83 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 127.173 2.189 . . . . 0.0 113.213 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.77 -55.71 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.815 1.677 . . . . 0.0 112.585 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 360' ' ' MET . 10.2 tp 37.28 34.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 C-N-CA 124.286 1.035 . . . . 0.0 112.504 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -136.5 5.32 3.79 Favored Glycine 0 N--CA 1.442 -0.958 0 O-C-N 124.104 0.878 . . . . 0.0 114.336 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 74.5 m -151.57 144.06 24.19 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -169.16 -172.87 36.32 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 170.34 22.44 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 124.233 0.608 . . . . 0.0 109.894 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -146.29 135.79 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 22.1 m -103.72 144.58 31.28 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.089 0.868 . . . . 0.0 111.37 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.43 179.55 6.14 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.342 1.057 . . . . 0.0 111.762 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.36 16.57 2.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.09 174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -136.63 157.85 45.82 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -70.67 -26.42 63.43 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.001 0.92 . . . . 0.0 112.181 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 374' ' ' PHE . 79.8 mmt-85 -52.92 -31.7 41.47 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 124.35 1.06 . . . . 0.0 111.818 -171.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 16.4 p -80.88 -34.66 33.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.663 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -62.17 -52.29 64.39 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 117.919 0.327 . . . . 0.0 110.499 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 405' ' ' LEU 0.299 0.0 OUTLIER -78.38 -19.19 53.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.417 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -85.67 -30.07 23.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 120.466 1.484 . . . . 0.0 110.69 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -78.3 -29.19 47.66 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.335 0.97 . . . . 0.0 109.423 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.6 t -77.17 -33.24 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 O-C-N 121.555 -0.716 . . . . 0.0 112.723 173.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.5 t -82.22 -11.92 58.39 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -83.79 -50.66 7.9 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 58.35 -50.5 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 16.4 t80 -154.61 132.8 11.77 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 20.4 m -137.41 160.2 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.575 ' HG2' ' HE2' ' A' ' 423' ' ' LYS . 20.3 mt-10 -111.5 99.42 8.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 21.0 mt -72.74 140.67 17.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.825 0.821 . . . . 0.0 108.932 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -132.61 40.95 3.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.996 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 21.2 p -71.43 170.24 13.65 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.322 1.014 . . . . 0.0 108.908 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 6.2 t -79.24 -3.42 45.78 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.23 -0.919 . . . . 0.0 112.922 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 226' ' ' PRO . 67.5 mttm -93.51 -41.51 9.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 122.028 -0.42 . . . . 0.0 110.474 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -157.86 166.14 33.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.982 0.801 . . . . 0.0 111.071 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 22.5 p -127.53 104.34 7.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.296 1.838 . . . . 0.0 107.539 176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -159.36 170.5 21.67 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.798 -0.564 . . . . 0.0 110.631 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.575 ' HE2' ' HG2' ' A' ' 414' ' ' GLU . 90.6 mttt -108.75 164.19 12.59 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 122.277 1.037 . . . . 0.0 112.139 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 16.2 m -144.46 153.9 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.347 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -119.7 156.45 30.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.135 0.897 . . . . 0.0 109.879 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.92 138.67 48.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 428' ' ' PRO . 13.4 m-20 -135.75 156.1 77.63 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.165 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 427' ' ' ASP . 37.3 Cg_exo -65.8 165.6 22.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.561 2.174 . . . . 0.0 113.922 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 60.3 t80 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 116.029 -1.938 . . . . 0.0 110.896 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.6 m 49.05 42.62 21.29 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.193 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.47 -8.47 59.56 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.145 1.378 . . . . 0.0 112.544 -171.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.6 t 42.6 74.41 0.11 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.355 1.862 . . . . 0.0 111.693 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.88 -23.18 78.36 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 122.03 -0.419 . . . . 0.0 112.496 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 54.99 24.74 6.19 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' A' ' 226' ' ' PRO . 4.4 mm? -62.45 141.67 96.51 Favored Pre-proline 0 C--N 1.342 0.247 0 CA-C-N 119.181 0.9 . . . . 0.0 110.489 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.7 100.73 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.618 2.212 . . . . 0.0 110.129 171.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 224' ' ' LEU . 51.0 Cg_endo -80.77 14.61 2.0 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.682 3.588 . . . . 0.0 113.077 -175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -133.79 26.72 3.99 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 121.05 -1.031 . . . . 0.0 113.684 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -125.3 39.15 4.03 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.978 0.511 . . . . 0.0 110.663 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -72.05 154.9 40.85 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.641 0.734 . . . . 0.0 110.468 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -131.65 29.4 4.5 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.771 1.228 . . . . 0.0 112.56 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.95 47.44 0.58 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 123.203 0.601 . . . . 0.0 110.973 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.84 138.38 31.41 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.482 2.121 . . . . 0.0 112.759 -174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.4 mt -150.62 144.31 17.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 127.007 2.123 . . . . 0.0 105.352 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -96.91 148.63 22.75 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.021 0.828 . . . . 0.0 111.513 -172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.0 m -141.25 -16.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 63.9 m -143.67 -174.92 4.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.483 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.472 ' HE2' ' CD1' ' A' ' 283' ' ' TYR . 58.1 mtpt -43.22 153.38 0.1 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.336 1.065 . . . . 0.0 112.662 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.14 133.76 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -105.84 145.45 31.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.83 1.3 . . . . 0.0 110.727 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.4 tm? -135.23 116.7 14.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.218 -171.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 178.31 -179.6 48.53 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 116.056 1.182 . . . . 0.0 116.056 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.17 22.19 0.92 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 28.1 m -91.09 128.55 47.15 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.801 0.841 . . . . 0.0 112.989 -175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.84 -15.56 6.97 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.944 2.429 . . . . 0.0 113.655 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -140.58 0.24 1.62 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.98 1.263 . . . . 0.0 113.985 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -66.43 122.79 18.32 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.856 1.662 . . . . 0.0 115.426 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.0 OUTLIER -87.87 -0.86 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -173.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.7 p -158.68 167.71 28.82 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 122.455 1.121 . . . . 0.0 108.488 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.469 ' HA ' HD21 ' A' ' 252' ' ' LEU . 0.0 OUTLIER -107.53 -15.6 14.56 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.056 174.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -76.78 -31.38 56.98 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 121.088 0.471 . . . . 0.0 111.246 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.37 -52.6 45.53 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 120.658 -1.277 . . . . 0.0 113.787 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 252' ' ' LEU . 1.7 pt? -71.78 -32.49 67.71 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.514 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.1 t -67.48 -36.16 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.385 176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -74.28 -17.77 60.81 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.809 0.693 . . . . 0.0 110.381 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.0 m -80.55 -26.99 37.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.97 . . . . 0.0 111.807 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -129.34 19.07 5.85 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -101.73 -0.77 33.89 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.045 -1.034 . . . . 0.0 111.767 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.47 -21.14 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -127.61 3.24 6.15 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.27 1.028 . . . . 0.0 108.805 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -104.52 173.6 21.27 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 121.699 0.61 . . . . 0.0 112.836 -171.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.733 ' H ' HD11 ' A' ' 295' ' ' LEU . 61.2 m -135.54 77.0 1.65 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -146.56 167.96 22.44 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.702 1.201 . . . . 0.0 111.725 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 284' ' ' LEU . 22.7 t -148.56 169.54 20.09 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 170.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.44 137.91 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -145.83 136.17 23.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -166.22 154.18 9.52 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-O 119.393 -0.337 . . . . 0.0 111.67 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.43 161.27 28.58 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.076 3.184 . . . . 0.0 110.987 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 83.03 3.66 90.33 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -75.84 -19.13 59.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 123.823 0.849 . . . . 0.0 110.572 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.24 142.24 58.49 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 89.14 -167.61 34.54 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.423 1.011 . . . . 0.0 111.738 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -80.07 170.34 16.59 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.198 0.599 . . . . 0.0 111.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 30.8 m80 53.03 99.35 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 125.364 1.466 . . . . 0.0 112.019 174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -58.01 -3.53 1.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 1 C-N-CA 125.522 4.148 . . . . 0.0 115.816 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -99.36 9.99 42.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.223 1.809 . . . . 0.0 111.863 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 277' ' ' PRO . 40.7 t -53.43 -45.26 98.59 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 116.492 -1.718 . . . . 0.0 114.53 -175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 276' ' ' CYS . 96.5 Cg_endo -72.38 148.85 49.55 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.911 1.741 . . . . 0.0 111.405 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.63 1.17 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.521 2.814 . . . . 0.0 111.501 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.41 143.97 36.31 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 118.933 0.788 . . . . 0.0 109.93 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -98.42 22.05 42.88 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.429 0.537 . . . . 0.0 113.014 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.418 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 37.5 p90 -152.95 164.58 37.68 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 120.862 0.363 . . . . 0.0 110.787 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.71 -178.49 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.472 ' CD1' ' HE2' ' A' ' 237' ' ' LYS . 55.0 m-85 -110.91 157.27 20.05 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.208 0.913 . . . . 0.0 111.223 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 263' ' ' SER . 83.4 mt -126.13 136.0 52.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.671 1.188 . . . . 0.0 111.529 173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.86 137.18 14.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.685 ' H ' ' CD2' ' A' ' 288' ' ' LEU . 84.9 t80 -175.62 -76.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.614 0.366 . . . . 0.0 110.317 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -93.8 -36.8 12.09 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.685 ' CD2' ' H ' ' A' ' 286' ' ' PHE . 4.4 mm? 60.81 -3.39 0.15 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 170.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -136.12 -75.3 0.44 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 122.196 2.271 . . . . 0.0 112.643 177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -84.28 -33.89 23.89 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . 0.502 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 44.8 m -82.61 -45.34 14.68 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 116.509 -1.71 . . . . 0.0 108.527 176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.16 -36.81 16.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 CA-C-N 121.506 1.957 . . . . 0.0 107.878 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 30.3 ttt-85 -62.55 -45.48 92.75 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.875 0.845 . . . . 0.0 110.806 176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -70.81 -35.3 72.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 118.15 -0.928 . . . . 0.0 113.148 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.733 HD11 ' H ' ' A' ' 261' ' ' SER . 55.6 mt -66.5 -47.09 74.08 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.2 -7.0 59.48 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.523 -1.36 . . . . 0.0 111.597 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -97.47 -3.81 39.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.473 1.033 . . . . 0.0 111.709 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -105.49 -18.55 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 87.0 m -81.89 -158.3 0.23 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 61.4 m -84.44 146.05 27.84 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.013 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -137.34 149.53 47.08 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.052 176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -137.93 127.3 14.92 Favored Pre-proline 0 CA--C 1.533 0.303 0 O-C-N 122.049 -0.407 . . . . 0.0 110.703 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -82.87 35.55 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 1 C-N-CA 125.754 4.303 . . . . 0.0 109.566 169.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.612 ' C ' HD22 ' A' ' 304' ' ' LEU . 0.0 OUTLIER -61.26 -10.82 7.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -173.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.427 ' N ' HD22 ' A' ' 304' ' ' LEU . 22.9 t 20.65 94.87 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 168.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -81.96 -10.1 11.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.652 2.901 . . . . 0.0 113.628 169.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -160.5 -24.58 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.668 0.787 . . . . 0.0 111.962 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 164.87 -26.89 0.19 Allowed Glycine 0 C--O 1.223 -0.573 0 CA-C-O 118.394 -1.226 . . . . 0.0 111.815 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 309' ' ' LEU . 1.4 pt? -89.74 169.94 10.85 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 171.59 10.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.851 0.86 . . . . 0.0 109.342 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.62 154.53 50.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -113.07 148.63 34.82 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.415 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -148.15 162.42 39.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -163.4 176.01 10.24 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 12.9 ptpt -135.4 132.47 37.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 168.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.42 ' HB2' ' HB2' ' A' ' 252' ' ' LEU . 0.0 OUTLIER -135.49 9.47 3.41 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -165.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 41.0 t -66.13 150.98 47.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 11.0 m -85.36 15.36 4.44 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.556 0.743 . . . . 0.0 110.133 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 52.57 24.74 3.23 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.479 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -75.01 -23.44 58.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.848 0.749 . . . . 0.0 112.308 -177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -148.76 -26.83 0.31 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 171.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -152.53 168.18 26.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.105 0.562 . . . . 0.0 110.642 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 74.1 m -118.22 134.63 54.85 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.818 1.247 . . . . 0.0 107.722 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 324' ' ' LYS . 17.0 tppt? -152.93 129.68 10.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 122.542 1.163 . . . . 0.0 114.029 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.91 137.57 36.14 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.01 1.724 . . . . 0.0 111.972 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 327' ' ' GLN . 9.1 p -123.89 157.58 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.416 ' N ' HG22 ' A' ' 326' ' ' VAL . 5.1 pp0? -107.46 154.72 20.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.117 0.261 . . . . 0.0 110.62 -175.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 1.5 t -137.58 136.5 46.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.276 0.56 . . . . 0.0 111.788 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 73.0 mt -142.17 109.4 5.86 Favored Pre-proline 0 C--O 1.232 0.165 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.26 164.96 8.32 Favored 'Trans proline' 0 N--CA 1.449 -1.089 1 C-N-CA 125.337 4.025 . . . . 0.0 112.085 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.605 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 1.7 t90 -83.66 133.3 34.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 170.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.46 152.33 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 123.605 0.762 . . . . 0.0 110.251 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.8 tt -54.46 -27.1 35.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -70.28 4.11 2.46 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.694 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.94 7.41 13.2 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.035 0.934 . . . . 0.0 109.567 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 22.3 m -129.24 -22.0 3.17 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 150.72 34.52 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.71 132.6 15.09 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 113.362 -1.745 . . . . 0.0 107.928 170.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -141.96 146.23 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.187 0.994 . . . . 0.0 111.816 177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -103.32 -15.72 15.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.575 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 339' ' ' VAL . 42.3 t -94.52 140.22 22.6 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.426 1.09 . . . . 0.0 110.444 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.4 16.2 1.27 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.204 3.269 . . . . 0.0 110.427 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 15.6 t -122.74 161.27 24.24 Favored 'General case' 0 C--N 1.342 0.25 0 O-C-N 120.813 -1.179 . . . . 0.0 110.447 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' A' ' 344' ' ' GLN . 5.0 pm0 -79.8 22.47 0.48 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 122.33 1.062 . . . . 0.0 113.43 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -65.59 155.26 36.35 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.59 1.156 . . . . 0.0 109.342 -174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 22.4 tp -154.92 155.43 34.26 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.059 0.391 . . . . 0.0 111.222 174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.452 ' H ' HG21 ' A' ' 397' ' ' THR . 42.4 t0 -136.58 73.35 55.37 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.016 0.926 . . . . 0.0 110.065 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.71 5.08 4.57 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.079 2.519 . . . . 0.0 111.946 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.5 t -78.29 -13.42 59.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.847 -1.158 . . . . 0.0 111.602 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -147.26 85.74 1.6 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.8 p -133.8 154.0 51.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.049 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.02 158.76 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 119.086 0.857 . . . . 0.0 110.045 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -95.19 146.46 24.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 O-C-N 123.837 0.711 . . . . 0.0 111.352 -172.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 1.9 p -125.22 140.4 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -158.12 -178.41 32.13 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.41 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 55.26 47.26 21.94 Favored 'General case' 0 C--O 1.208 -1.112 0 C-N-CA 124.469 1.107 . . . . 0.0 110.595 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 36.5 mt -84.67 -174.83 5.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -171.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 360' ' ' MET . 0.2 OUTLIER -61.92 -25.35 67.52 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.764 176.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 78.22 5.54 87.39 Favored Glycine 0 CA--C 1.536 1.348 0 O-C-N 120.364 -1.46 . . . . 0.0 109.939 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.413 ' HB3' ' CE1' ' A' ' 358' ' ' HIS . 16.5 ttt -152.93 29.62 0.51 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -69.11 95.43 0.73 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.849 1.309 . . . . 0.0 110.464 -172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -81.12 162.23 23.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.462 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.18 -7.75 50.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.134 -171.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -90.12 -26.59 20.13 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -84.97 -29.63 24.92 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.08 -49.1 63.37 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.201 0.6 . . . . 0.0 109.458 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.96 -31.38 71.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.264 -0.273 . . . . 0.0 111.538 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.4 87.1 Favored 'General case' 0 C--O 1.226 -0.132 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 86.2 mt -65.46 -45.02 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.2 mt -85.57 -29.76 23.88 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -21.56 30.89 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.778 -177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -107.71 -20.47 13.21 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.54 -14.96 23.19 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.399 -1.438 . . . . 0.0 110.521 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.05 -41.64 2.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 112.812 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 73.38 -1.6 42.18 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.442 ' C ' HD21 ' A' ' 400' ' ' ASN . . . -143.65 117.61 1.1 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 118.107 0.953 . . . . 0.0 111.03 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 11.9 t -152.44 168.58 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 4.6 p -138.25 -29.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -159.75 158.56 31.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -165.94 146.66 6.68 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -159.46 151.97 22.86 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 121.42 0.456 . . . . 0.0 114.054 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.32 150.33 4.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -97.39 74.75 2.49 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.9 p -61.23 146.37 48.03 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -117.62 17.48 14.42 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.733 1.213 . . . . 0.0 111.705 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.0 tptm 51.53 124.31 0.0 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 128.022 2.529 . . . . 0.0 114.878 -170.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 58.2 m170 61.13 27.79 17.54 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -133.47 -0.91 3.19 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 6.1 p90 25.98 66.97 0.47 Allowed Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 125.033 1.333 . . . . 0.0 112.282 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.53 -49.84 0.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 124.262 3.308 . . . . 0.0 110.783 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.0 tp 39.91 35.53 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 124.428 1.091 . . . . 0.0 111.635 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -148.34 15.6 1.29 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.131 0.872 . . . . 0.0 114.659 -172.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 77.3 p -163.45 145.45 9.69 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.355 0.662 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 178.79 -161.95 28.71 Favored Glycine 0 N--CA 1.427 -1.907 0 O-C-N 120.685 -1.259 . . . . 0.0 112.725 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.54 166.88 25.15 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.719 -0.871 . . . . 0.0 111.946 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 144.07 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.662 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.452 HG21 ' H ' ' A' ' 347' ' ' ASP . 44.3 m -116.72 131.64 56.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 123.533 0.521 . . . . 0.0 110.693 -172.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -118.99 155.75 30.81 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.515 1.135 . . . . 0.0 111.909 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.11 7.01 10.77 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.442 HD21 ' C ' ' A' ' 376' ' ' GLY . 12.0 p30 -136.89 166.61 23.21 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.041 1.337 . . . . 0.0 109.648 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -98.08 -28.34 13.8 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.575 ' H ' ' HD3' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -62.9 -26.1 68.64 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 118.878 0.763 . . . . 0.0 112.987 -175.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 71.7 p -73.45 -33.04 64.69 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -68.62 -55.13 12.56 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 119.237 0.926 . . . . 0.0 110.645 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -24.02 58.46 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.136 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -78.4 -23.2 46.87 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 118.238 -1.385 . . . . 0.0 111.221 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -80.91 -26.2 36.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.247 -0.908 . . . . 0.0 111.497 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.85 -27.95 5.84 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 121.059 0.457 . . . . 0.0 111.049 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.6 p -83.39 -18.86 37.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.744 -176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.493 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -90.69 -45.69 8.71 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.033 0.444 . . . . 0.0 110.456 171.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.91 -10.39 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.855 2.062 . . . . 0.0 114.31 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -161.07 144.65 13.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.32 156.31 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 O-C-N 120.868 -1.145 . . . . 0.0 110.322 175.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 414' ' ' GLU . 17.1 mp0 -120.18 137.94 53.9 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.594 0.711 . . . . 0.0 112.396 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.45 124.84 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.97 46.91 1.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.247 1.022 . . . . 0.0 111.786 -175.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 30.9 p -66.47 169.7 7.16 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.67 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.8 t -69.78 1.53 4.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.305 0.642 . . . . 0.0 110.749 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.45 0.88 0.44 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -171.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -154.37 139.35 17.29 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.419 -0.801 . . . . 0.0 112.512 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 50.6 p -139.08 124.05 18.83 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.205 -0.934 . . . . 0.0 110.766 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 0.8 OUTLIER -168.82 -179.33 3.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.429 176.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 55.6 mtmt -140.99 172.15 13.08 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.18 152.32 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 124.346 1.028 . . . . 0.0 109.353 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -117.09 152.16 35.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.723 0.297 . . . . 0.0 111.623 -173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.92 141.79 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.288 0.566 . . . . 0.0 111.61 -176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.92 124.85 8.64 Favored Pre-proline 0 C--O 1.246 0.874 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.85 158.47 18.53 Favored 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 124.082 3.188 . . . . 0.0 114.001 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 37.1 p90 . . . . . 0 C--O 1.263 1.775 0 CA-C-O 117.285 -1.34 . . . . 0.0 111.115 171.329 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 121.355 0.598 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.2 t -167.06 173.28 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . 0.461 ' H ' ' HE3' ' A' ' 220' ' ' TRP . 0.0 OUTLIER -126.37 7.37 7.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 48.8 m 46.56 37.75 4.81 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.356 -0.84 . . . . 0.0 112.464 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -168.96 77.92 0.1 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 119.963 -1.113 . . . . 0.0 113.244 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 164.92 25.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.939 0.435 . . . . 0.0 110.839 176.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 224' ' ' LEU . 3.3 mm? -78.93 152.85 77.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.28 114.45 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 122.915 2.41 . . . . 0.0 112.314 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 364' ' ' GLU . 34.8 Cg_endo -82.12 -165.07 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.413 4.075 . . . . 0.0 111.43 175.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 58.51 32.67 22.38 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.797 0.439 . . . . 0.0 111.801 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -99.48 -1.06 39.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -74.12 153.55 39.52 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.854 0.861 . . . . 0.0 110.446 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -148.84 25.39 0.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.264 1.026 . . . . 0.0 110.809 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -131.99 62.2 62.43 Favored Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 120.632 -1.293 . . . . 0.0 112.084 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -68.91 117.46 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 124.328 3.352 . . . . 0.0 112.928 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 34.1 mm -140.82 151.0 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -109.38 141.25 42.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.925 1.239 . . . . 0.0 110.643 -173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 5.5 t -133.48 3.65 3.61 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.397 0.544 . . . . 0.0 112.449 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 3.6 t -153.21 177.6 10.66 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 123.053 0.541 . . . . 0.0 110.257 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.87 166.32 0.09 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.062 1.345 . . . . 0.0 113.924 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.01 138.14 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.89 133.01 33.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.481 HD11 HG13 ' A' ' 326' ' ' VAL . 23.0 tp -139.5 112.72 8.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.559 0.695 . . . . 0.0 111.145 174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -154.86 155.81 26.47 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.114 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.74 13.73 1.39 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 124.153 0.56 . . . . 0.0 113.081 175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 29.4 m -106.17 117.14 58.14 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.674 -0.898 . . . . 0.0 111.826 -174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -86.7 -4.4 8.2 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.754 2.969 . . . . 0.0 113.368 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -105.71 -109.57 0.29 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 117.701 -1.143 . . . . 0.0 110.26 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 38.7 t70 43.87 74.8 0.11 Allowed 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 119.859 1.209 . . . . 0.0 111.372 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.407 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -83.77 -10.37 11.73 Favored 'Isoleucine or valine' 0 C--O 1.273 2.291 0 CA-C-N 118.551 0.614 . . . . 0.0 110.692 -178.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.4 p -146.18 129.03 16.33 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -63.3 -22.11 66.67 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.648 0.737 . . . . 0.0 109.917 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -74.14 -21.92 59.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 120.298 -1.501 . . . . 0.0 110.9 -175.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.69 -57.3 5.48 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.47 -42.69 74.52 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.079 0.952 . . . . 0.0 112.52 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 50.1 t -73.51 -32.83 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 117.591 -1.195 . . . . 0.0 110.474 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -76.62 -20.16 57.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.693 0.679 . . . . 0.0 111.294 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 m -73.1 -30.03 63.36 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.905 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -129.88 16.87 5.73 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -89.63 -21.83 22.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 120.018 1.281 . . . . 0.0 112.181 171.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.18 24.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -143.29 7.88 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.782 0.719 . . . . 0.0 112.659 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -167.44 169.98 41.39 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-O 121.935 0.742 . . . . 0.0 113.04 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 25.9 t -82.31 77.92 9.04 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.385 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -146.05 166.85 24.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 178.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 52.7 m -147.88 -175.08 4.74 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.898 1.333 . . . . 0.0 110.836 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.67 154.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 123.813 0.845 . . . . 0.0 111.689 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -142.29 131.69 23.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 124.951 1.407 . . . . 0.0 110.929 171.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -93.07 133.67 28.42 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 118.684 -0.674 . . . . 0.0 109.578 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 282' ' ' VAL . 66.8 Cg_endo -76.71 -23.19 11.29 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 O-C-N 123.962 1.506 . . . . 0.0 112.189 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -81.06 -66.99 1.57 Allowed Glycine 0 C--O 1.218 -0.866 0 C-N-CA 123.074 0.368 . . . . 0.0 112.379 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? 48.39 49.09 18.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.954 0.502 . . . . 0.0 110.253 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.87 35.31 3.95 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.259 1.824 . . . . 0.0 114.453 -170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.88 163.06 35.1 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.521 0.512 . . . . 0.0 111.951 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -92.17 169.13 10.86 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 122.467 -0.431 . . . . 0.0 110.505 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.419 ' HB3' ' CD ' ' A' ' 274' ' ' PRO . 14.0 m80 60.67 173.33 0.06 OUTLIER Pre-proline 0 C--O 1.219 -0.525 0 C-N-CA 125.766 1.626 . . . . 0.0 112.846 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 273' ' ' HIS . 32.4 Cg_exo -60.59 40.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.592 1 C-N-CA 126.723 4.948 . . . . 0.0 114.687 175.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -147.7 41.47 1.03 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.842 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 68.7 m -50.51 129.3 25.92 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.976 0.51 . . . . 0.0 109.671 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.42 134.04 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.456 1.438 . . . . 0.0 111.146 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -89.14 158.7 5.73 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 C-N-CA 124.277 3.318 . . . . 0.0 109.545 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -100.95 12.87 36.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.289 1.036 . . . . 0.0 108.858 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 112.95 -9.76 25.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -171.64 169.15 6.1 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.855 0.827 . . . . 0.0 110.606 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 267' ' ' PRO . 32.7 m -148.79 -174.09 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 126.104 1.762 . . . . 0.0 108.978 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -123.08 153.39 39.98 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 111.466 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -107.76 139.06 42.9 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.728 172.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.9 131.25 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.498 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 35.6 p90 -167.35 -151.15 0.11 Allowed 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 123.509 0.505 . . . . 0.0 110.378 -175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.34 -8.53 0.78 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.453 ' HA ' HG23 ' A' ' 292' ' ' VAL . 90.8 mt 50.75 -163.58 0.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.854 0.862 . . . . 0.0 111.461 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.9 -78.59 0.0 OUTLIER 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.276 2.63 . . . . 0.0 114.952 172.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -84.18 -32.8 24.4 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.741 1.275 . . . . 0.0 111.213 -172.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 75.6 m -85.23 -15.69 42.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 118.12 -0.943 . . . . 0.0 108.643 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 288' ' ' LEU . 79.0 t -68.32 -51.48 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -66.53 -26.4 67.13 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.2 t -65.19 -46.45 80.69 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 118.537 0.608 . . . . 0.0 110.786 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.39 -44.16 83.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 119.805 -1.809 . . . . 0.0 110.351 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.56 -26.96 67.37 Favored 'General case' 0 N--CA 1.434 -1.239 0 O-C-N 124.341 1.025 . . . . 0.0 109.441 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -92.96 -10.0 37.97 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 120.14 1.336 . . . . 0.0 111.389 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -102.91 -19.78 14.51 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 83.7 m -86.08 178.39 7.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.013 168.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.2 t -77.91 163.81 25.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.369 1.668 . . . . 0.0 111.544 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -151.2 160.23 43.96 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.679 1.192 . . . . 0.0 111.079 -175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -144.18 124.76 7.67 Favored Pre-proline 0 CA--C 1.517 -0.312 0 O-C-N 121.473 -0.767 . . . . 0.0 110.02 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.426 ' C ' ' HD3' ' A' ' 306' ' ' PRO . 35.8 Cg_endo -84.43 51.29 3.24 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 124.556 3.504 . . . . 0.0 108.324 169.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.5 HD13 ' H ' ' A' ' 305' ' ' SER . 0.0 OUTLIER -70.73 -27.57 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.9 -173.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.5 ' H ' HD13 ' A' ' 304' ' ' LEU . 23.2 t -159.78 57.51 1.01 Allowed Pre-proline 0 N--CA 1.467 0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 111.236 177.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 303' ' ' PRO . 61.5 Cg_endo -67.94 6.62 0.76 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.695 2.93 . . . . 0.0 112.399 -174.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.0 -18.35 64.69 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 124.203 0.939 . . . . 0.0 109.29 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -174.32 -1.98 0.03 OUTLIER Glycine 0 C--N 1.341 0.836 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.85 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 310' ' ' SER . 0.1 OUTLIER -142.97 154.33 43.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.677 1.238 . . . . 0.0 109.857 -177.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.676 ' H ' HD13 ' A' ' 309' ' ' LEU . 32.3 m -143.35 149.36 37.63 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.747 1.619 . . . . 0.0 109.304 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -132.71 136.32 46.33 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 122.223 -0.298 . . . . 0.0 110.768 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 328' ' ' VAL . 64.9 m-85 -118.44 159.16 23.97 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -153.35 159.37 42.45 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 122.077 -0.389 . . . . 0.0 111.978 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -145.25 159.43 43.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.706 -0.621 . . . . 0.0 111.007 172.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -110.35 118.53 36.56 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.25 21.23 3.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.63 0.195 . . . . 0.0 111.429 -169.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 13.5 t -137.11 162.67 32.76 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.185 -0.947 . . . . 0.0 111.122 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 32.4 p -145.3 -10.95 0.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.875 0.87 . . . . 0.0 111.112 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 4.59 0.13 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -107.81 -38.92 5.71 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.877 -1.139 . . . . 0.0 110.576 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 15.8 mmt -133.91 -31.96 1.13 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.513 0.725 . . . . 0.0 109.205 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 46.12 27.48 0.54 Allowed 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 121.541 0.686 . . . . 0.0 110.92 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 1.7 t -160.5 -173.68 4.1 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 324' ' ' LYS . 0.4 OUTLIER 57.5 68.8 0.8 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.743 1.217 . . . . 0.0 114.001 176.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . 0.655 ' CD ' ' H ' ' A' ' 325' ' ' GLU . 3.6 mp0 -46.7 156.73 0.18 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.327 173.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.481 HG13 HD11 ' A' ' 240' ' ' LEU . 7.6 p -119.4 142.27 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -86.53 137.46 32.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.829 0.74 . . . . 0.0 110.086 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 329' ' ' ILE . 2.5 p -132.57 137.05 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 123.936 0.772 . . . . 0.0 111.924 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 328' ' ' VAL . 7.8 pt -156.76 130.76 4.84 Favored Pre-proline 0 N--CA 1.463 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.67 168.6 8.29 Favored 'Trans proline' 0 N--CA 1.457 -0.668 1 C-N-CA 125.544 4.162 . . . . 0.0 111.419 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.409 ' CZ3' ' HB ' ' A' ' 391' ' ' ILE . 1.7 t90 -82.14 124.17 29.63 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 169.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 334' ' ' ALA . 21.3 t -100.76 137.31 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.85 -175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.69 -35.12 60.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.933 1.293 . . . . 0.0 110.994 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.495 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -79.82 11.44 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 118.392 -0.814 . . . . 0.0 112.807 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -120.11 6.28 10.79 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.671 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 53.1 p -139.45 -2.45 1.6 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -147.91 153.58 39.26 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -155.02 139.1 16.46 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.77 0.828 . . . . 0.0 111.82 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.93 155.5 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 118.867 0.758 . . . . 0.0 111.593 171.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -102.68 -6.86 22.24 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 124.854 1.262 . . . . 0.0 108.789 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 342' ' ' PRO . 60.6 m -131.2 166.15 29.92 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 123.703 0.801 . . . . 0.0 112.818 -171.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 341' ' ' SER . 57.2 Cg_endo -66.15 -9.06 22.15 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.354 2.036 . . . . 0.0 112.169 172.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 58.4 p -85.14 168.94 14.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 123.897 0.879 . . . . 0.0 109.911 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -136.32 24.22 3.22 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.164 0.507 . . . . 0.0 110.938 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -112.57 164.45 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.016 0.927 . . . . 0.0 111.691 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -111.84 -171.58 1.87 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.426 1.49 . . . . 0.0 110.499 -173.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.86 93.3 31.61 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.919 1.288 . . . . 0.0 107.923 171.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.71 -0.22 0.36 Allowed 'Trans proline' 0 C--O 1.24 0.579 1 C-N-CA 126.063 4.508 . . . . 0.0 115.933 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 48.7 m -117.66 3.93 12.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 123.18 0.592 . . . . 0.0 111.653 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -141.71 55.64 1.5 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.945 0.793 . . . . 0.0 109.981 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.5 t -143.34 154.02 43.32 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.88 159.89 33.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 124.18 0.925 . . . . 0.0 110.432 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -84.92 138.65 32.38 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.296 0.998 . . . . 0.0 113.306 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.48 149.04 24.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.095 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 178.15 -168.05 39.11 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.97 22.99 2.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.244 1.018 . . . . 0.0 112.209 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 357' ' ' LEU . 0.6 OUTLIER -92.13 137.43 32.37 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.659 -175.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 29.02 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.353 0.725 0 C-N-CA 124.885 1.274 . . . . 0.0 112.98 169.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 169.64 -12.65 0.05 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-O 118.132 -1.371 . . . . 0.0 111.008 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 20.7 mmt -133.93 -52.41 0.85 Allowed 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 125.232 1.195 . . . . 0.0 108.389 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 357' ' ' LEU . 16.0 tp 27.67 77.56 0.02 OUTLIER 'General case' 0 C--N 1.347 0.468 0 O-C-N 124.585 1.178 . . . . 0.0 111.992 -171.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -61.64 164.25 6.23 Favored 'General case' 0 C--N 1.348 0.525 0 C-N-CA 123.972 0.909 . . . . 0.0 111.761 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -59.74 -22.7 62.43 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 226' ' ' PRO . 71.1 mm-40 -83.2 -32.54 26.5 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 119.508 1.049 . . . . 0.0 110.086 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -73.82 -40.78 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 122.117 -0.365 . . . . 0.0 110.135 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.09 -46.76 82.84 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.34 65.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.712 -1.242 . . . . 0.0 111.58 -173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.05 80.35 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.403 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 89.3 mt -71.66 -41.42 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 -16.31 49.71 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.35 -1.309 . . . . 0.0 114.2 -171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -16.55 14.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 120.316 1.417 . . . . 0.0 114.367 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -103.45 -20.62 13.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.105 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.77 -14.36 18.88 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.572 1.078 . . . . 0.0 111.091 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -117.3 -64.64 1.28 Allowed 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.206 -0.934 . . . . 0.0 110.766 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 161.73 -151.23 21.31 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.324 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -66.08 130.13 32.59 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 126.248 1.88 . . . . 0.0 110.376 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.23 164.4 20.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 126.177 1.791 . . . . 0.0 107.844 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.65 -28.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.444 0.565 . . . . 0.0 112.111 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.3 OUTLIER -157.32 156.78 32.96 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -149.67 143.03 25.22 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -154.24 171.85 32.81 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 122.09 0.828 . . . . 0.0 114.181 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.487 ' HA ' ' HA3' ' A' ' 394' ' ' GLY . 26.7 mt -127.39 144.02 38.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 128.635 2.774 . . . . 0.0 108.478 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -101.86 149.01 24.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 121.337 -0.852 . . . . 0.0 111.882 -174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 16.2 p -108.91 161.41 15.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.192 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -130.02 34.56 4.23 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 122.519 1.152 . . . . 0.0 111.973 -176.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.2 tptm 61.99 95.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.454 1.902 . . . . 0.0 111.397 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 m170 48.48 28.04 1.6 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -104.12 11.73 34.79 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 119.522 1.056 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 52.4 p90 44.82 49.25 5.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 126.576 1.951 . . . . 0.0 114.144 173.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.62 -52.62 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 119.338 0.799 . . . . 0.0 112.082 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.409 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 37.62 47.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 123.57 0.748 . . . . 0.0 109.826 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -158.86 6.71 0.15 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 116.18 1.232 . . . . 0.0 116.18 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.9 p -153.8 138.61 17.09 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 382' ' ' ILE . . . -169.15 -149.17 6.1 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -154.94 172.85 17.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.974 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 3.0 p -138.2 132.44 42.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 52.2 m -101.59 110.68 22.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.697 -2.047 . . . . 0.0 107.848 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.1 157.17 16.01 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.708 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.76 -0.06 6.06 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.965 0.791 . . . . 0.0 109.604 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -120.82 135.86 55.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.058 1.343 . . . . 0.0 108.126 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.01 -25.69 67.79 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.662 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.94 -31.33 72.39 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.01 0.823 . . . . 0.0 110.965 -172.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 m -80.43 -12.27 59.58 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 120.869 -1.144 . . . . 0.0 111.257 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -80.37 -60.72 2.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.536 -0.727 . . . . 0.0 109.174 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.65 63.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.495 -176.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.25 -26.32 35.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 118.965 0.802 . . . . 0.0 111.457 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 426' ' ' ILE . . . -75.27 -31.03 60.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.373 -0.829 . . . . 0.0 111.036 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.31 -26.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 C-N-CA 123.963 0.905 . . . . 0.0 111.223 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.2 p -84.27 -26.09 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.28 -40.82 10.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.517 0.327 . . . . 0.0 110.273 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 53.2 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.73 141.16 10.0 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 120.297 1.408 . . . . 0.0 108.89 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -141.38 159.3 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.079 0.466 . . . . 0.0 110.548 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -113.64 110.15 19.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.172 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.1 mm -77.2 129.58 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 173.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 416' ' ' LYS . 30.3 ttmt -153.99 98.12 2.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.302 0.572 . . . . 0.0 109.487 -170.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 418' ' ' THR . 3.9 m -143.79 179.65 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 417' ' ' THR . 2.0 m -78.52 2.11 20.21 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.9 -0.5 . . . . 0.0 110.781 -178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -129.98 -8.45 4.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -154.63 131.93 11.13 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.416 -0.802 . . . . 0.0 111.395 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 7.1 p -143.64 86.81 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.829 0.741 . . . . 0.0 110.871 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -150.55 172.32 15.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.95 0.9 . . . . 0.0 109.951 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -128.56 167.72 16.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.695 0.398 . . . . 0.0 111.17 -173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 33.8 m -147.93 145.7 18.52 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 CA-C-N 118.748 0.704 . . . . 0.0 109.296 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -122.69 150.2 43.04 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.026 0.917 . . . . 0.0 112.702 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 407' ' ' ALA . 4.4 mp -133.2 145.96 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.226 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -150.74 128.38 5.68 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -83.66 166.83 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.47 2.78 . . . . 0.0 111.538 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.359 1.064 . . . . 0.0 111.057 176.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 C--O 1.218 -0.603 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 3.9 m 57.65 164.77 0.03 OUTLIER 'General case' 0 C--O 1.246 0.888 0 CA-C-O 122.68 1.229 . . . . 0.0 110.407 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 82.4 t90 -157.59 -40.58 0.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.887 -1.133 . . . . 0.0 112.143 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 m 47.81 22.89 0.39 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 170.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 57.41 69.25 1.33 Allowed Glycine 0 N--CA 1.447 -0.613 0 O-C-N 120.845 -1.159 . . . . 0.0 112.803 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -71.8 -21.58 61.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.794 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.513 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 1.0 OUTLIER -155.55 9.15 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -176.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 224' ' ' LEU . 42.6 Cg_endo -64.61 119.49 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 122.331 1.868 . . . . 0.0 111.605 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.2 142.28 41.35 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 124.4 3.4 . . . . 0.0 111.254 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -138.32 170.19 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.171 0.989 . . . . 0.0 110.772 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.7 t30 56.35 38.11 29.44 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.816 0.817 . . . . 0.0 111.208 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.38 -54.58 30.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.989 1.316 . . . . 0.0 110.41 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 71.0 tttt 55.25 45.33 25.97 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -114.56 -46.91 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.11 -174.25 1.32 Allowed 'Trans proline' 0 C--N 1.346 0.442 1 C-N-CA 125.304 4.002 . . . . 0.0 114.649 -176.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 234' ' ' TYR . 4.2 mp -109.2 -179.09 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.709 ' H ' HG22 ' A' ' 233' ' ' ILE . 30.9 m-85 -93.74 158.25 15.76 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 51.0 m -145.08 -0.78 0.87 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.72 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.609 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 12.0 m -149.46 -164.55 2.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.875 1.216 . . . . 0.0 110.996 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 236' ' ' CYS . 0.1 OUTLIER -59.93 172.09 0.82 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.503 1.144 . . . . 0.0 111.542 -177.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.29 138.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.413 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -81.64 143.4 31.95 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 122.162 0.982 . . . . 0.0 109.444 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.479 HD13 ' C ' ' A' ' 240' ' ' LEU . 1.0 OUTLIER -141.02 108.22 5.49 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -149.65 164.53 29.48 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.098 0.399 . . . . 0.0 114.098 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.75 12.16 5.62 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.853 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 26.2 m -85.02 116.48 65.58 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 119.097 1.449 . . . . 0.0 111.431 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -90.24 1.83 5.23 Favored 'Trans proline' 0 N--CA 1.43 -2.223 0 C-N-CA 124.644 3.562 . . . . 0.0 110.406 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -141.49 175.82 9.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.3 1.04 . . . . 0.0 109.956 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -166.52 155.16 10.61 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.221 0.534 . . . . 0.0 110.584 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 247' ' ' ILE . 0.2 OUTLIER -133.67 -44.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.281 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.014 170.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 250' ' ' ALA . 7.4 m -168.48 148.72 4.63 Favored 'General case' 0 C--N 1.364 1.222 0 O-C-N 125.809 1.943 . . . . 0.0 108.18 175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -70.08 -26.73 64.13 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 119.749 -1.845 . . . . 0.0 111.722 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.454 ' H ' HG22 ' A' ' 248' ' ' THR . . . -80.91 -19.35 44.49 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 123.464 0.706 . . . . 0.0 110.358 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -70.18 -58.04 6.42 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.34 -40.06 70.76 Favored 'General case' 0 C--O 1.247 0.925 0 O-C-N 124.178 0.575 . . . . 0.0 110.216 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.702 ' CG2' HG21 ' A' ' 264' ' ' VAL . 54.6 t -70.39 -41.32 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 118.836 -2.415 . . . . 0.0 110.414 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -72.22 0.09 10.71 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.854 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 48.1 m -87.8 -28.04 21.92 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.036 173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -137.98 16.15 2.85 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.6 20.6 0.22 Allowed 'General case' 0 C--O 1.24 0.592 0 O-C-N 120.45 -1.406 . . . . 0.0 112.789 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 1.8 t -75.89 6.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 120.208 1.367 . . . . 0.0 110.611 -169.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.98 -11.35 58.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.916 -1.115 . . . . 0.0 112.151 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.16 -4.08 59.76 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.828 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 10.7 t -127.3 22.6 6.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.26 1.03 . . . . 0.0 111.817 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HA ' ' CB ' ' A' ' 286' ' ' PHE . 0.4 OUTLIER -92.76 144.26 25.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.928 -1.107 . . . . 0.0 109.988 -174.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.3 m -152.68 172.05 17.26 Favored 'General case' 0 C--O 1.216 -0.661 0 O-C-N 125.788 1.93 . . . . 0.0 107.893 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.702 HG21 ' CG2' ' A' ' 253' ' ' VAL . 61.3 t -148.29 144.0 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.293 -169.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -109.21 131.71 54.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 123.955 0.784 . . . . 0.0 109.939 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.419 ' CE3' HG21 ' A' ' 282' ' ' VAL . 2.0 t-105 -145.28 81.99 10.04 Favored Pre-proline 0 C--O 1.242 0.691 0 CA-C-O 122.048 0.927 . . . . 0.0 110.979 -167.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 164.22 31.99 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 123.786 2.991 . . . . 0.0 109.747 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 85.01 -4.36 85.61 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.68 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -66.56 65.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.403 1.481 . . . . 0.0 111.308 174.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -142.95 2.25 1.33 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.512 0.725 . . . . 0.0 111.817 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.3 -154.08 8.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.264 0.935 . . . . 0.0 111.548 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.89 168.27 12.18 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.396 1.078 . . . . 0.0 111.87 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 24.0 m170 67.47 150.84 0.12 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 127.066 2.147 . . . . 0.0 114.445 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.32 -4.27 14.55 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 122.823 2.349 . . . . 0.0 109.661 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -95.9 11.93 32.06 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.878 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 277' ' ' PRO . 1.8 p 63.26 155.67 0.12 Allowed Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 129.012 2.925 . . . . 0.0 111.208 -173.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 276' ' ' CYS . 84.7 Cg_endo -77.79 159.21 31.43 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.402 3.401 . . . . 0.0 111.814 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.94 136.36 18.46 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.037 3.158 . . . . 0.0 111.714 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -144.76 155.51 43.57 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -76.45 -21.08 76.0 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-O 117.998 -1.446 . . . . 0.0 113.334 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -166.56 168.66 14.43 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.419 HG21 ' CE3' ' A' ' 266' ' ' TRP . 21.8 m -156.84 -163.69 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.941 2.096 . . . . 0.0 108.71 178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -148.09 150.7 34.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.532 1.06 . . . . 0.0 111.652 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 284' ' ' LEU . 5.3 mp -101.97 156.35 17.59 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 34.2 m -138.89 122.73 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 262' ' ' LEU . 31.5 p90 -165.66 -157.54 0.32 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 117.499 -1.239 . . . . 0.0 109.915 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 93.32 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.81 HD23 ' H ' ' A' ' 288' ' ' LEU . 0.8 OUTLIER -69.78 14.0 0.12 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.65 2.38 . . . . 0.0 115.75 -167.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -136.09 -53.96 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 120.571 1.532 . . . . 0.0 111.111 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -88.05 -41.16 13.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.83 -170.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 73.9 m -74.77 -32.99 62.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.86 -47.81 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 122.105 -0.372 . . . . 0.0 110.896 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -73.3 -20.34 60.83 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.82 -0.55 . . . . 0.0 112.109 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.5 m -79.78 -35.53 38.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.606 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -46.34 87.05 Favored 'General case' 0 C--O 1.209 -1.069 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.713 172.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.07 -17.08 61.46 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 119.066 0.848 . . . . 0.0 110.467 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -87.97 -9.7 52.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 122.727 0.411 . . . . 0.0 111.743 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -111.04 -3.22 15.6 Favored 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.03 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 71.4 m -109.68 -154.67 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.939 1.399 . . . . 0.0 110.858 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 42.6 m -136.06 160.49 38.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.028 1.394 . . . . 0.0 109.641 -173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 74.1 t60 -142.44 165.56 27.08 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 119.86 -1.775 . . . . 0.0 111.343 -173.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 13.3 m-20 -147.01 115.97 4.39 Favored Pre-proline 0 C--O 1.212 -0.913 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -85.39 25.75 0.68 Allowed 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 126.178 4.586 . . . . 0.0 111.538 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 305' ' ' SER . 0.2 OUTLIER -47.98 -36.23 12.26 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.027 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.419 ' H ' HD12 ' A' ' 304' ' ' LEU . 7.5 t 39.35 47.97 1.71 Allowed Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 126.173 1.789 . . . . 0.0 113.741 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -81.31 -19.68 7.68 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 124.279 3.319 . . . . 0.0 113.009 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -124.42 24.63 7.9 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 83.66 -2.56 87.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.23 150.08 43.89 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.374 0.607 . . . . 0.0 110.24 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 50.2 m -107.62 169.91 8.3 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.614 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -141.91 149.03 39.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.403 1.064 . . . . 0.0 109.154 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . 0.404 ' HB2' HG23 ' A' ' 328' ' ' VAL . 5.9 m-85 -122.47 149.09 44.35 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -138.61 153.62 48.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 122.808 1.289 . . . . 0.0 112.104 -175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -146.61 169.63 18.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.426 -0.797 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -128.6 74.85 1.59 Allowed 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' A' ' 316' ' ' MET . 0.0 OUTLIER -76.72 1.37 17.35 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.373 177.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 67.9 m -57.66 137.27 56.61 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 25.1 t -108.77 175.2 5.55 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 120.816 -1.178 . . . . 0.0 109.257 176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 48.9 mmt-85 -60.65 0.5 0.2 Allowed 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 124.838 1.255 . . . . 0.0 113.822 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 ptm85 -105.12 8.21 34.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.35 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 74.1 mmm -128.78 169.91 13.97 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 46.4 mtt85 -119.49 0.06 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.342 0.657 . . . . 0.0 111.371 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 93.8 m -124.01 -174.94 3.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.677 0.791 . . . . 0.0 109.712 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -150.71 166.31 30.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -172.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 66.13 147.3 0.04 OUTLIER 'General case' 0 C--N 1.342 0.279 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.58 165.03 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.293 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.35 143.82 35.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.622 0.769 . . . . 0.0 110.249 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 312' ' ' TYR . 28.2 m -133.52 143.7 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.903 176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 34.9 mt -144.84 107.8 4.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.52 171.8 15.33 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.257 2.638 . . . . 0.0 111.892 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.609 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.2 t-105 -101.41 112.32 24.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 169.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.5 t -87.29 157.61 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 122.04 -0.412 . . . . 0.0 110.5 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.64 -28.0 63.32 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.355 1.062 . . . . 0.0 109.859 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -66.21 -4.98 8.75 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 124.687 1.242 . . . . 0.0 110.176 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.68 8.66 15.04 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.57 1.148 . . . . 0.0 110.274 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.8 m -115.5 -47.13 2.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 119.093 -0.48 . . . . 0.0 111.642 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -155.67 166.27 34.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.908 0.861 . . . . 0.0 110.125 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -153.86 144.53 22.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 110.451 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.22 145.06 18.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 121.223 -0.923 . . . . 0.0 110.216 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -106.66 -16.54 14.48 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.803 1.314 . . . . 0.0 111.427 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 60.1 m -96.73 147.36 32.82 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.294 -0.879 . . . . 0.0 111.351 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.09 -26.43 7.74 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.244 2.629 . . . . 0.0 112.707 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.1 m -143.51 2.92 1.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.2 154.26 22.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.912 1.339 . . . . 0.0 110.062 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.23 177.37 6.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.98 -1.918 . . . . 0.0 109.391 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 346' ' ' LEU . 1.3 mm? -58.33 151.64 19.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.234 -0.916 . . . . 0.0 111.303 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -89.88 137.49 28.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 171.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.08 -2.8 13.01 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.003 2.468 . . . . 0.0 115.869 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 41.5 p -142.26 -0.6 1.25 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.552 1.141 . . . . 0.0 112.98 -175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -123.24 60.66 1.05 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.47 HG22 ' HB ' ' A' ' 397' ' ' THR . 18.6 p -138.27 147.72 43.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 428' ' ' PRO . 22.3 m -123.68 169.72 14.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 122.508 -0.12 . . . . 0.0 110.921 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -97.91 125.45 42.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 42.8 t -107.68 131.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -120.44 97.28 0.64 Allowed Glycine 0 C--O 1.213 -1.181 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.599 ' C ' HD13 ' A' ' 357' ' ' LEU . . . -145.72 132.89 20.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.498 0.666 . . . . 0.0 110.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -160.98 155.76 23.78 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.6 1.16 . . . . 0.0 113.32 -169.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.468 ' HA ' ' HE3' ' A' ' 422' ' ' LYS . 14.7 p80 -159.98 6.51 0.09 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 169.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 116.94 -17.97 12.74 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.315 1.912 . . . . 0.0 112.388 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 16.6 ptm -166.05 43.27 0.07 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.552 0.676 . . . . 0.0 109.783 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.495 HD13 ' C ' ' A' ' 361' ' ' LEU . 3.0 tm? -57.79 132.23 52.69 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -117.37 166.0 12.83 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.758 -173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -68.36 -17.26 64.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 118.467 -0.778 . . . . 0.0 111.453 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -77.72 -30.4 51.72 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.919 0.781 . . . . 0.0 109.431 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.39 74.49 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 172.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 27.6 mt -74.19 -43.92 55.38 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 118.875 -0.583 . . . . 0.0 109.665 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -54.8 -40.68 69.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -70.37 -32.41 70.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.577 1.173 . . . . 0.0 114.053 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.57 -32.29 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 O-C-N 123.612 0.57 . . . . 0.0 110.403 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 19.4 mt -88.86 -30.89 18.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.14 -14.18 31.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.918 -0.563 . . . . 0.0 112.259 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.36 -33.36 13.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.503 0.668 . . . . 0.0 111.593 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.41 -11.89 19.85 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.09 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 403' ' ' SER . 23.7 m-85 -128.19 -42.36 1.53 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 173.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.75 87.19 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.415 1.007 . . . . 0.0 113.451 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -134.03 103.04 0.48 Allowed Glycine 0 C--N 1.352 1.428 0 CA-C-N 119.007 1.403 . . . . 0.0 110.352 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 2.7 t -144.44 159.02 15.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 117.587 0.694 . . . . 0.0 111.056 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.1 t -118.49 -58.0 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 C-N-CA 123.829 0.852 . . . . 0.0 111.257 174.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.509 ' CD1' HD11 ' A' ' 346' ' ' LEU . 1.9 t80 -147.2 152.38 38.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.742 1.258 . . . . 0.0 110.737 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -143.32 137.76 29.03 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -136.0 151.61 20.78 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 122.212 0.896 . . . . 0.0 112.19 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.41 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -98.46 123.87 42.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 56.1 p -126.92 158.97 35.39 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.765 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -136.12 159.77 40.7 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 113.03 -1.896 . . . . 0.0 107.358 170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.401 ' HE2' ' CE1' ' A' ' 387' ' ' HIS . 23.1 tptm -50.2 102.21 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.401 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 26.5 m80 54.99 22.31 4.29 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -78.13 -12.45 59.99 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 111.731 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.8 p90 41.37 51.78 5.6 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.44 -30.31 8.33 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.112 2.541 . . . . 0.0 113.233 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.46 ' HB ' ' CZ3' ' A' ' 331' ' ' TRP . 10.6 tp 28.14 75.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 127.83 2.452 . . . . 0.0 114.143 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -168.53 -88.84 0.07 OUTLIER Glycine 0 C--N 1.332 0.34 0 O-C-N 120.938 -1.101 . . . . 0.0 114.185 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.4 p -57.04 154.15 10.23 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.193 0.996 . . . . 0.0 108.809 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -162.77 -173.12 31.08 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.204 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -140.47 157.68 45.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 122.959 0.504 . . . . 0.0 110.234 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 2.3 p -145.16 151.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.47 ' HB ' HG22 ' A' ' 351' ' ' THR . 9.9 t -129.59 146.22 51.42 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.518 ' CD2' ' CB ' ' A' ' 403' ' ' SER . 61.4 m-85 -121.83 -30.09 4.19 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 123.947 0.779 . . . . 0.0 111.409 -172.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 59.93 16.48 5.79 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.472 0.483 . . . . 0.0 109.851 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -139.96 140.05 36.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.193 0.997 . . . . 0.0 109.735 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -80.53 -20.49 43.4 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.631 0.372 . . . . 0.0 111.692 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 402' ' ' ARG . 0.6 OUTLIER -58.6 -36.34 73.85 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.528 -177.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.518 ' CB ' ' CD2' ' A' ' 398' ' ' PHE . 12.1 m -82.71 -14.53 54.41 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.475 -0.766 . . . . 0.0 110.371 -172.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -76.91 -63.14 1.43 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.511 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.443 ' C ' HD22 ' A' ' 405' ' ' LEU 0.25 0.0 OUTLIER -71.09 -17.5 62.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 118.861 -1.136 . . . . 0.0 113.298 -176.246 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -84.45 -31.16 24.73 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.484 -0.76 . . . . 0.0 112.37 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -82.03 -32.17 30.6 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.618 1.099 . . . . 0.0 108.197 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.51 -31.39 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.469 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.1 t -77.38 -27.36 52.5 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 124.868 1.355 . . . . 0.0 111.473 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -95.73 -53.69 3.62 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.133 -176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 57.96 -14.98 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 425' ' ' GLN . 1.9 m-85 -157.71 148.29 20.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.678 0.672 . . . . 0.0 110.352 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.19 149.87 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.875 168.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.38 151.05 20.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.003 0.43 . . . . 0.0 110.78 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 10.8 mt -124.01 117.4 50.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.542 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 416' ' ' LYS . 0.0 OUTLIER -127.57 64.25 1.35 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.307 1.051 . . . . 0.0 109.044 -178.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -76.93 159.92 29.59 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 114.11 -1.404 . . . . 0.0 111.007 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -63.18 -23.09 67.27 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.723 0.692 . . . . 0.0 110.998 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -142.69 33.14 1.43 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -167.25 125.41 1.29 Allowed 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.144 0.973 . . . . 0.0 109.0 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 15.2 p -136.4 121.88 19.47 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.784 -1.198 . . . . 0.0 112.017 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.8 tptp -164.77 176.52 8.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.604 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 47.7 tttt -124.66 156.75 37.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.41 148.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.366 0.984 . . . . 0.0 110.32 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.464 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 40.3 tt0 -118.33 161.0 20.66 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -168.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 21.6 mt -142.29 137.63 29.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 O-C-N 124.46 1.1 . . . . 0.0 110.702 175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.6 129.01 6.77 Favored Pre-proline 0 C--O 1.235 0.334 0 O-C-N 123.546 0.528 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' A' ' 352' ' ' VAL . 23.2 Cg_endo -83.79 174.02 8.87 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.447 1.431 . . . . 0.0 113.846 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 23.5 p90 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 116.458 -1.734 . . . . 0.0 112.651 171.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 122.538 1.161 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 40.8 m -143.92 75.79 1.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 122.78 1.276 . . . . 0.0 107.946 -174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.13 2.57 55.16 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.702 -178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 415' ' ' ILE . 94.6 p -38.99 141.86 0.26 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 -169.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 164.86 -17.41 0.1 Allowed Glycine 0 CA--C 1.537 1.447 0 O-C-N 124.356 1.035 . . . . 0.0 111.966 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 57.7 128.6 0.0 OUTLIER 'General case' 0 C--N 1.351 0.647 0 C-N-CA 127.985 2.514 . . . . 0.0 111.664 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.421 ' H ' ' CD ' ' A' ' 225' ' ' PRO . 2.8 mm? -107.04 -49.23 0.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 117.514 -1.232 . . . . 0.0 112.994 175.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 368' ' ' ALA . 52.4 Cg_exo -60.55 161.31 21.22 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 125.337 4.024 . . . . 0.0 113.888 -174.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.94 160.46 45.87 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.796 2.997 . . . . 0.0 110.538 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -151.63 32.0 0.57 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 111.648 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -99.32 -18.86 17.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.14 0.976 . . . . 0.0 112.763 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 42.4 -136.92 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt 66.15 34.37 6.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.945 1.298 . . . . 0.0 111.997 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.565 ' H ' ' CD ' ' A' ' 232' ' ' PRO . 0.5 OUTLIER -136.4 -40.17 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 175.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 231' ' ' ASN . 7.6 Cg_exo -74.51 -176.88 2.98 Favored 'Trans proline' 0 N--CA 1.442 -1.548 0 C-N-CA 122.362 2.041 . . . . 0.0 115.228 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.11 162.38 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 125.336 1.454 . . . . 0.0 108.868 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.454 ' CG ' HG11 ' A' ' 292' ' ' VAL . 14.1 m-85 -109.75 138.78 45.63 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 125.962 1.705 . . . . 0.0 107.811 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.9 t -152.04 2.34 0.36 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -171.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.632 ' HB2' ' CG ' ' A' ' 331' ' ' TRP . 71.2 m -148.63 63.58 1.07 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.48 -1.387 . . . . 0.0 114.44 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.23 162.3 0.2 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.356 0.662 . . . . 0.0 112.296 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.54 142.38 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -81.99 127.97 33.61 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.69 1.196 . . . . 0.0 109.273 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 240' ' ' LEU . 2.1 tm? -136.53 108.33 7.07 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -159.24 160.52 31.34 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-O 122.703 1.168 . . . . 0.0 110.252 -174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.48 -3.16 3.91 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 m -74.28 122.75 88.27 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 120.604 -1.527 . . . . 0.0 109.629 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -87.2 -4.67 7.72 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 124.232 3.288 . . . . 0.0 109.45 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -134.42 176.26 8.77 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.285 1.434 . . . . 0.0 110.415 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.99 145.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.582 0.753 . . . . 0.0 109.874 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.14 -50.83 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.405 0 C-N-CA 122.601 0.36 . . . . 0.0 110.803 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -164.78 130.43 2.76 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.721 2.008 . . . . 0.0 105.753 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -70.97 -13.33 61.97 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 120.421 1.464 . . . . 0.0 111.965 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -67.21 -21.04 65.78 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 125.347 1.459 . . . . 0.0 109.278 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.99 -35.68 84.66 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.83 -45.73 41.31 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.685 1.231 . . . . 0.0 108.63 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 77.9 t -62.93 -53.61 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 120.509 -1.37 . . . . 0.0 110.485 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -79.89 -13.71 59.18 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -171.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.8 t -81.52 -26.22 35.3 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.525 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -126.44 32.11 5.25 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.276 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 28.6 tpt85 -96.09 -18.2 20.34 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 124.436 1.094 . . . . 0.0 109.822 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 258' ' ' VAL . 4.7 t -70.35 20.02 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -168.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -128.12 0.4 5.84 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 121.466 -0.771 . . . . 0.0 112.888 -178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 174.56 -95.38 0.1 Allowed Glycine 0 N--CA 1.471 1.004 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.675 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.0 t -144.9 147.38 32.7 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 118.292 1.046 . . . . 0.0 109.408 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 151.67 24.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.0 m -149.71 175.72 11.32 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.34 150.25 18.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 O-C-N 121.072 -1.017 . . . . 0.0 113.468 -172.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -128.33 154.09 46.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.582 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.27 138.79 20.97 Favored Pre-proline 0 C--N 1.345 0.385 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.91 -170.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.98 -29.1 4.47 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 125.01 3.806 . . . . 0.0 109.769 -175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.56 -28.36 6.05 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.164 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 44.34 50.7 7.84 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.342 1.071 . . . . 0.0 110.371 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -118.89 -8.02 10.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.02 8.83 58.89 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.004 -0.887 . . . . 0.0 113.155 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.88 -36.33 76.68 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 118.642 1.221 . . . . 0.0 110.742 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -143.33 126.69 9.11 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.34 -12.41 12.8 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 125.06 3.84 . . . . 0.0 109.731 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -72.46 -72.28 0.25 Allowed 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 123.134 0.573 . . . . 0.0 111.014 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 42.5 t -158.24 143.7 12.22 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 124.592 1.183 . . . . 0.0 109.675 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.97 160.34 34.21 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.222 1.948 . . . . 0.0 111.16 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.37 27.19 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 125.234 3.956 . . . . 0.0 111.018 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.46 158.12 27.91 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -173.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -82.8 10.68 56.25 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.581 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -153.33 170.91 19.49 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.787 -177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 283' ' ' TYR . 11.7 p -156.85 176.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 125.217 1.573 . . . . 0.0 107.197 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 282' ' ' VAL . 10.6 m-85 -118.17 155.19 30.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 119.763 1.165 . . . . 0.0 111.374 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 70.1 mt -121.02 135.25 55.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.86 120.31 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 C-N-CA 125.577 1.551 . . . . 0.0 107.419 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.86 -156.3 0.63 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.232 -174.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.62 18.87 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.187 0.449 . . . . 0.0 110.714 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 86.6 mt 48.99 -141.19 0.65 Allowed 'General case' 0 C--O 1.238 0.45 0 O-C-N 119.831 -1.793 . . . . 0.0 111.362 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 13.39 -74.42 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 127.593 2.357 . . . . 0.0 116.443 168.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -81.77 -29.12 32.92 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 123.813 0.845 . . . . 0.0 112.962 -170.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 25.7 m -78.56 -30.63 46.96 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.299 1.04 . . . . 0.0 108.705 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.454 HG11 ' CG ' ' A' ' 234' ' ' TYR . 62.4 t -68.19 -57.3 9.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -72.56 -20.4 61.32 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 35.8 t -71.77 -42.92 66.59 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.93 -0.482 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.86 -45.91 33.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.382 0.992 . . . . 0.0 111.497 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.41 -16.32 61.84 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.468 1.031 . . . . 0.0 113.38 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -95.29 -17.03 21.99 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.69 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -78.16 -19.46 53.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 119.957 1.253 . . . . 0.0 112.307 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 5.1 t -115.26 -108.19 0.37 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.341 1.026 . . . . 0.0 113.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 5.2 t -142.64 163.56 32.48 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -168.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -146.94 156.23 42.9 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.314 1.846 . . . . 0.0 106.844 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -142.86 125.78 9.09 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.18 13.02 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 1 C-N-CA 127.521 5.481 . . . . 0.0 112.478 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.698 HD12 ' H ' ' A' ' 305' ' ' SER . 0.3 OUTLIER -38.75 -45.34 1.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.581 1.553 . . . . 0.0 112.766 -177.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.698 ' H ' HD12 ' A' ' 304' ' ' LEU . 66.2 m 42.07 51.35 5.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 176.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.09 -10.78 17.92 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.927 1.751 . . . . 0.0 112.883 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -134.62 16.58 3.63 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.209 0.528 . . . . 0.0 110.267 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 88.62 5.98 74.01 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.68 142.09 51.13 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 121.949 -0.736 . . . . 0.0 112.395 176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 63.5 m -80.04 166.15 21.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 124.151 0.907 . . . . 0.0 109.702 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -136.18 142.15 44.12 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -108.44 145.04 35.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -121.78 151.18 40.86 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 123.211 1.481 . . . . 0.0 109.324 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -147.85 159.98 43.26 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.964 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 315' ' ' LYS . 44.9 mtmt -132.53 131.27 41.39 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.54 -3.49 0.91 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 116.115 -1.898 . . . . 0.0 114.344 -167.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 m -144.63 33.71 1.16 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.563 1.529 . . . . 0.0 111.436 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.1 m -61.84 -9.7 7.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.239 1.816 . . . . 0.0 113.5 -177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -138.37 5.08 2.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.595 0.758 . . . . 0.0 110.221 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -113.51 -28.91 7.36 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.539 0.736 . . . . 0.0 111.464 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.578 ' C ' ' H ' ' A' ' 323' ' ' CYS . 85.7 mmm -131.28 7.52 4.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.383 -0.818 . . . . 0.0 113.167 -172.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 60.85 -16.13 0.03 OUTLIER 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.222 2.209 . . . . 0.0 110.567 -172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.578 ' H ' ' C ' ' A' ' 321' ' ' MET . 80.4 m -110.58 167.75 9.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.789 0.835 . . . . 0.0 110.346 177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -159.25 -162.66 1.09 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 122.871 0.468 . . . . 0.0 111.519 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 62.69 137.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.696 1.599 . . . . 0.0 112.868 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 12.6 p -156.58 162.92 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -109.09 155.6 20.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.422 0.555 . . . . 0.0 111.989 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.84 137.72 38.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.947 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 8.5 pt -146.17 94.92 4.83 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.95 169.72 16.06 Favored 'Trans proline' 0 N--CA 1.453 -0.888 1 C-N-CA 125.781 4.321 . . . . 0.0 111.257 -173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.632 ' CG ' ' HB2' ' A' ' 236' ' ' CYS . 3.6 t-105 -86.53 115.35 23.96 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.254 175.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 18.0 t -99.48 145.09 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 123.298 1.523 . . . . 0.0 108.791 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.25 -31.97 69.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.039 -175.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -84.58 -7.99 59.06 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.68 -1.77 57.29 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.721 0.692 . . . . 0.0 111.312 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 88.5 p -130.2 -2.11 4.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 121.725 -0.609 . . . . 0.0 112.37 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -149.58 140.24 22.61 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.202 0.314 . . . . 0.0 110.186 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -156.14 106.67 2.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.414 0.686 . . . . 0.0 109.331 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 341' ' ' SER . 12.2 p -89.2 150.59 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.157 174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.24 28.64 8.59 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.455 1.121 . . . . 0.0 110.303 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.515 ' H ' HG22 ' A' ' 339' ' ' VAL . 26.5 t -141.63 149.11 52.68 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.06 -3.29 13.58 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.265 3.31 . . . . 0.0 110.592 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -137.85 165.72 25.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -115.14 127.64 55.7 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.756 0.788 . . . . 0.0 111.188 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -142.01 -41.36 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.127 -173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' A' ' 379' ' ' TYR . 4.2 mm? 50.64 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 O-C-N 124.722 1.264 . . . . 0.0 111.948 -171.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -142.21 140.71 19.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.25 -5.06 14.95 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 121.718 1.612 . . . . 0.0 114.98 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 8.4 t -152.51 -169.66 3.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 48.47 99.87 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.889 2.075 . . . . 0.0 113.742 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.7 t -158.27 155.72 29.4 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 31.0 m -125.41 149.76 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 124.132 0.895 . . . . 0.0 110.326 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -85.47 152.91 22.83 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.796 -169.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 133.27 66.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -167.58 -168.07 29.18 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.476 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 58.07 19.57 6.12 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 19.2 mt -67.09 154.66 40.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 120.657 -1.277 . . . . 0.0 109.839 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.479 ' CE1' ' HG3' ' A' ' 360' ' ' MET . 3.6 p-80 -79.69 16.36 1.13 Allowed 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 87.36 9.32 72.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.824 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.479 ' HG3' ' CE1' ' A' ' 358' ' ' HIS . 8.9 ptp -159.01 12.17 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 173.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 31.8 tp -64.62 140.06 58.83 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.154 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -108.4 161.05 15.38 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 123.682 0.793 . . . . 0.0 109.199 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -70.09 -8.63 51.01 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 364' ' ' GLU . 1.6 pp20? -67.16 -35.14 79.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -78.25 -41.36 34.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.615 0.721 . . . . 0.0 110.567 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 82.3 mt -72.9 -31.44 64.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.665 -0.647 . . . . 0.0 110.021 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.75 -50.17 70.13 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.427 ' HB2' ' CD ' ' A' ' 225' ' ' PRO . . . -57.84 -39.14 76.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.879 -0.513 . . . . 0.0 111.576 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 90.2 mt -71.06 -41.8 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 O-C-N 122.034 -0.416 . . . . 0.0 110.109 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 mt -88.22 -2.94 58.9 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -171.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.49 HD22 ' C ' ' A' ' 371' ' ' ASN . 0.2 OUTLIER -127.99 1.41 5.93 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.571 -1.331 . . . . 0.0 112.528 175.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -119.78 -20.63 7.54 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.486 -0.759 . . . . 0.0 112.962 176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.85 -22.76 24.26 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.21 -16.22 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.456 1.026 . . . . 0.0 111.994 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 55.32 84.15 0.04 OUTLIER Glycine 0 C--N 1.342 0.894 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -151.84 3.86 0.43 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 118.195 0.998 . . . . 0.0 113.136 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.8 m -96.0 166.67 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-O 122.402 1.096 . . . . 0.0 113.179 -173.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.08 -27.22 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 112.952 -1.931 . . . . 0.0 108.171 170.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.424 ' CD2' HD21 ' A' ' 346' ' ' LEU . 24.9 t80 -155.18 147.83 24.24 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.12 34.9 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 119.235 0.925 . . . . 0.0 108.608 175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -153.37 168.58 32.08 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.322 0.889 . . . . 0.0 115.322 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 24.7 mt -116.65 140.44 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.49 146.96 24.9 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.663 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.3 p -140.52 171.62 13.87 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 124.734 1.272 . . . . 0.0 111.907 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -132.76 18.59 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.435 1.494 . . . . 0.0 108.494 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 387' ' ' HIS 0.274 0.5 OUTLIER 51.83 3.68 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 C-N-CA 130.53 3.532 . . . . 0.0 114.794 -176.674 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.512 ' CE1' ' HE2' ' A' ' 386' ' ' LYS . 38.7 m170 -140.84 -9.8 1.03 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.681 1.192 . . . . 0.0 112.205 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -94.33 -11.09 30.75 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.86 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.0 p90 41.92 48.57 3.26 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -64.81 -52.01 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.389 2.726 . . . . 0.0 110.972 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 391' ' ' ILE 0.286 6.9 tp 40.17 33.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 122.046 0.927 . . . . 0.0 110.674 -173.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -160.49 16.13 0.19 Allowed Glycine 0 C--N 1.345 1.078 0 CA-C-O 118.593 -1.115 . . . . 0.0 112.496 -176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 64.5 p -145.44 112.12 5.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.81 0.805 . . . . 0.0 109.088 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -152.01 -175.76 24.01 Favored Glycine 0 CA--C 1.549 2.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -147.28 167.04 25.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 6.9 p -137.87 142.08 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 27.8 m -99.93 105.49 17.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.107 -174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -85.75 162.35 18.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 123.231 0.613 . . . . 0.0 110.477 173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -147.13 19.06 1.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.581 0.705 . . . . 0.0 111.346 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -144.39 165.37 28.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.44 1.096 . . . . 0.0 108.755 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -88.16 -36.28 16.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 120.943 1.702 . . . . 0.0 113.298 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -51.35 -26.81 8.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -76.19 -30.26 57.97 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -68.51 -56.94 6.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.333 -1.479 . . . . 0.0 110.471 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 -23.65 58.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.902 -1.124 . . . . 0.0 113.677 -173.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -85.79 -22.91 27.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -87.58 -28.06 22.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.179 -0.325 . . . . 0.0 110.301 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.8 m -84.57 -25.0 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 60.2 p -85.55 -24.87 27.07 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.008 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -84.0 -44.59 14.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 55.5 -20.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 129.126 2.971 . . . . 0.0 115.096 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.2 OUTLIER -149.99 145.88 26.69 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.23 156.14 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 O-C-N 121.41 -0.806 . . . . 0.0 110.221 169.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -109.38 139.54 44.2 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 124.277 0.985 . . . . 0.0 112.882 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.477 ' HA ' ' HB3' ' A' ' 221' ' ' SER . 37.5 mt -118.53 126.41 75.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.452 172.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -131.23 14.56 5.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.496 1.123 . . . . 0.0 110.598 -170.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.6 m -60.88 157.06 15.97 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.591 1.156 . . . . 0.0 109.735 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -62.68 -0.77 0.68 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -139.47 4.72 2.19 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -160.32 130.29 5.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.132 0.973 . . . . 0.0 112.516 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 416' ' ' LYS . 17.3 p -140.16 102.29 4.34 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 120.263 1.392 . . . . 0.0 110.95 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.571 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 32.4 tptt -166.39 -176.1 3.49 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.813 174.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 43.1 mtpt -128.04 172.23 11.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.617 0.767 . . . . 0.0 110.625 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 13.5 m -142.21 159.47 20.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.211 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -130.0 135.92 48.83 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 426' ' ' ILE . 3.7 mp -110.9 145.16 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -140.54 151.22 63.09 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 118.956 0.798 . . . . 0.0 110.614 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.01 166.41 1.55 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.242 2.628 . . . . 0.0 113.109 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 123.955 0.902 . . . . 0.0 110.045 -177.062 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.8 mmt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 26.5 m 42.23 66.17 0.78 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.742 1.217 . . . . 0.0 112.729 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 19.35 0.11 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.7 m 57.16 35.1 25.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 63.07 86.23 0.05 OUTLIER Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -79.84 -14.78 58.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.989 -0.606 . . . . 0.0 110.821 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 43.75 113.34 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.256 0 C-N-CA 128.29 2.636 . . . . 0.0 115.206 174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.52 169.03 19.07 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.96 3.107 . . . . 0.0 110.039 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.11 156.55 12.79 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.072 2.515 . . . . 0.0 113.435 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -141.45 179.55 6.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.14 2.176 . . . . 0.0 108.199 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 50.48 40.79 24.06 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.674 0.79 . . . . 0.0 113.088 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -53.64 159.51 1.54 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.73 0.812 . . . . 0.0 111.006 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -101.26 2.41 39.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.524 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.432 ' N ' ' CD ' ' A' ' 232' ' ' PRO . 0.9 OUTLIER -126.39 35.69 0.3 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -177.725 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 231' ' ' ASN . 68.7 Cg_endo -75.15 155.89 42.29 Favored 'Trans proline' 0 N--CA 1.441 -1.598 0 C-N-CA 122.892 2.394 . . . . 0.0 111.394 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.71 140.71 43.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.25 121.97 38.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 95.6 p -125.93 -6.87 6.68 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.777 -170.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.35 -173.96 3.99 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 123.948 0.899 . . . . 0.0 108.643 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -60.23 155.89 16.58 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.244 -170.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.57 135.52 31.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -100.67 122.55 43.51 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 125.171 1.388 . . . . 0.0 108.704 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.2 tt -145.46 143.33 29.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.775 -0.578 . . . . 0.0 110.512 -169.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.56 145.75 9.56 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 123.337 0.398 . . . . 0.0 112.147 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 165.5 17.43 0.02 OUTLIER Glycine 0 C--O 1.211 -1.329 0 CA-C-N 119.049 1.425 . . . . 0.0 113.818 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.05 95.4 39.45 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 118.147 0.973 . . . . 0.0 111.71 -174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.79 10.83 3.52 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 125.133 3.889 . . . . 0.0 112.533 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 246' ' ' ASP . 11.6 p-90 -128.14 -9.79 5.33 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.431 ' HA ' ' CE3' ' A' ' 245' ' ' TRP . 11.5 p-10 -60.28 116.26 4.12 Favored 'General case' 0 C--O 1.254 1.29 0 O-C-N 123.943 0.777 . . . . 0.0 113.087 -175.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.52 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -78.32 -15.81 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 8.4 p -153.6 148.17 26.21 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.249 1.023 . . . . 0.0 108.415 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -84.1 -22.56 31.09 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.772 -1.205 . . . . 0.0 108.727 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -78.31 -14.77 59.27 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 124.433 1.083 . . . . 0.0 113.319 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.82 -66.07 2.78 Favored Glycine 0 CA--C 1.545 1.945 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 252' ' ' LEU . 2.5 pt? -66.08 -29.37 69.69 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.73 -35.87 76.07 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.786 176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -77.11 -18.06 58.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 119.705 -1.872 . . . . 0.0 110.198 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.5 p -77.85 -25.68 48.88 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.359 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.33 20.03 4.81 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 121.832 2.106 . . . . 0.0 112.545 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.1 20.92 1.46 Allowed 'General case' 0 N--CA 1.479 0.98 0 O-C-N 119.547 -1.971 . . . . 0.0 111.913 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 22.5 t -71.09 -9.91 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -166.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -91.88 -2.65 56.74 Favored 'General case' 0 C--O 1.218 -0.56 0 O-C-N 124.432 1.083 . . . . 0.0 111.085 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.81 -2.7 3.44 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-O 117.698 -1.612 . . . . 0.0 116.612 169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 3.7 m -102.54 22.3 13.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 119.183 1.492 . . . . 0.0 112.337 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 286' ' ' PHE . 3.7 mm? -68.97 145.23 53.79 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 t -145.35 81.47 1.63 Allowed 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 1.1 p -75.7 141.25 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.067 -1.879 . . . . 0.0 110.068 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -150.94 157.82 43.38 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.368 -175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.49 ' HB3' HG23 ' A' ' 282' ' ' VAL . 42.4 p90 -151.66 146.67 19.02 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.05 91.91 1.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.635 2.223 . . . . 0.0 110.267 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -178.52 177.84 48.52 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -105.46 124.34 49.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.94 -0.741 . . . . 0.0 109.434 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -111.13 7.9 21.52 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.49 0.716 . . . . 0.0 110.097 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -67.05 -12.0 59.51 Favored Glycine 0 N--CA 1.47 0.951 0 CA-C-O 118.067 -1.407 . . . . 0.0 113.824 -172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -138.7 -35.5 0.58 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.561 1.681 . . . . 0.0 111.513 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -143.87 133.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.61 -13.96 6.83 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 125.059 3.839 . . . . 0.0 111.463 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -96.41 20.67 10.19 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.452 ' HB3' ' HD3' ' A' ' 277' ' ' PRO . 42.4 t -53.46 -41.27 85.94 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.892 -0.575 . . . . 0.0 112.03 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 276' ' ' CYS . 32.5 Cg_endo -98.29 95.72 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 123.955 3.103 . . . . 0.0 112.41 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.83 4.85 3.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.585 4.19 . . . . 0.0 115.407 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -78.26 6.75 7.56 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 66.14 11.43 55.36 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 116.777 1.471 . . . . 0.0 116.777 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -111.49 141.61 44.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.602 1.201 . . . . 0.0 112.739 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -150.03 170.76 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.983 0.897 . . . . 0.0 109.054 -179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -133.72 155.61 49.45 Favored 'General case' 0 C--N 1.345 0.405 0 O-C-N 120.842 -1.161 . . . . 0.0 109.986 173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 96.9 mt -131.16 145.76 52.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.19 0.596 . . . . 0.0 111.908 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.31 134.2 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 262' ' ' LEU . 15.6 p90 -169.23 -163.26 0.4 Allowed 'General case' 0 C--N 1.344 0.333 0 O-C-N 125.007 1.442 . . . . 0.0 108.133 -174.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.16 110.21 0.46 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.582 1.153 . . . . 0.0 107.933 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 54.1 mt -89.83 -179.66 5.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.172 0.987 . . . . 0.0 110.396 -172.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 63.99 -67.16 0.11 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.367 1.867 . . . . 0.0 113.803 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -81.03 -43.35 19.69 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.433 -0.792 . . . . 0.0 111.261 -168.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 7.5 m -79.13 -31.4 44.13 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.84 -51.65 59.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 O-C-N 121.225 -0.922 . . . . 0.0 109.955 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -62.7 -32.22 73.27 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 70.4 m -57.23 -44.2 83.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.475 1.11 . . . . 0.0 111.884 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.7 -49.72 67.49 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 120.796 -1.19 . . . . 0.0 110.194 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 296' ' ' LEU . 0.1 OUTLIER -65.35 -26.63 68.11 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-O 119.182 -0.437 . . . . 0.0 112.018 -177.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -96.21 -4.25 42.79 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 123.855 0.722 . . . . 0.0 111.742 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -100.33 -12.57 19.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 314' ' ' PHE . 9.8 t -127.43 -124.05 0.23 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 28.0 t -116.49 163.65 15.75 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -155.8 159.6 39.55 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.724 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.19 137.73 31.47 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.26 75.52 5.02 Favored 'Trans proline' 0 C--N 1.35 0.612 1 C-N-CA 128.302 6.001 . . . . 0.0 112.867 -168.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 304' ' ' LEU . 2.8 mp 64.58 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 115.784 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 304' ' ' LEU . 20.2 m 41.47 68.89 2.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -53.02 1.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 1 C-N-CA 127.224 5.283 . . . . 0.0 116.557 -166.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.88 16.2 24.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.701 1.601 . . . . 0.0 108.739 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -166.55 -113.66 0.28 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.802 1.668 . . . . 0.0 111.699 -175.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 16.3 tp -150.15 158.58 44.31 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.421 1.11 . . . . 0.0 111.007 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 1.5 m -62.89 153.45 33.31 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.357 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -137.24 150.06 47.58 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 123.834 0.709 . . . . 0.0 110.744 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.44 146.86 44.15 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -140.02 155.13 47.22 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.654 -1.279 . . . . 0.0 112.17 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.493 ' HA ' ' SG ' ' A' ' 299' ' ' CYS . 32.4 t80 -145.22 174.29 11.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -125.4 132.41 52.77 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.21 0.914 . . . . 0.0 108.922 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.602 ' H ' ' HE3' ' A' ' 316' ' ' MET . 0.0 OUTLIER -123.3 14.3 9.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.295 1.038 . . . . 0.0 109.662 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.3 p -82.01 2.1 32.49 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 123.115 0.566 . . . . 0.0 111.312 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 45.7 t -61.31 150.87 33.62 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 109.968 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 56.1 8.49 0.39 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.861 0.864 . . . . 0.0 112.286 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -129.5 -62.97 0.95 Allowed 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.566 -0.709 . . . . 0.0 110.761 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.5 mmt -123.59 -13.68 7.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.435 1.094 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 44.74 23.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.8 2.04 . . . . 0.0 114.993 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 3.1 t -151.56 17.45 0.71 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 121.262 1.846 . . . . 0.0 114.172 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.56 115.55 22.35 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.989 0.9 . . . . 0.0 112.713 -174.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -74.95 162.34 28.69 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.016 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.88 150.02 32.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.159 175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -83.32 136.71 34.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.292 -175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.36 133.36 57.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.013 0.824 . . . . 0.0 111.017 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 62.1 mt -149.64 114.98 3.52 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.5 154.44 6.47 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 125.024 3.816 . . . . 0.0 112.765 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -76.2 120.0 20.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 121.186 -0.946 . . . . 0.0 109.805 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.653 HG12 ' H ' ' A' ' 334' ' ' ALA . 44.4 t -90.06 142.67 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.377 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 333' ' ' LEU . 1.7 tt -59.01 -25.96 64.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.35 0.595 . . . . 0.0 112.195 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.653 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -76.9 1.95 16.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.045 -1.659 . . . . 0.0 114.047 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -94.82 -8.63 36.84 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.893 -1.051 . . . . 0.0 109.675 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 20.7 m -103.91 -27.98 11.85 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.337 1.426 . . . . 0.0 114.046 -169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -163.03 162.79 26.07 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.146 0.278 . . . . 0.0 110.794 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.603 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 79.0 t80 -160.67 147.51 15.46 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.299 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.3 141.65 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 O-C-N 123.67 0.607 . . . . 0.0 110.405 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.81 20.33 18.28 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.012 0.91 . . . . 0.0 109.007 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 18.3 t -143.54 145.98 33.72 Favored Pre-proline 0 N--CA 1.445 -0.695 0 C-N-CA 125.68 1.592 . . . . 0.0 107.341 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -75.56 5.42 4.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 121.716 1.611 . . . . 0.0 112.865 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 63.9 m -106.11 158.42 16.83 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.485 0.714 . . . . 0.0 109.639 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -111.03 12.64 22.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.216 0.606 . . . . 0.0 112.559 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 27.1 ptt-85 -70.6 162.99 27.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.718 1.247 . . . . 0.0 112.263 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 346' ' ' LEU . 11.1 tp -145.8 143.62 29.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . 0.544 ' H ' HG21 ' A' ' 397' ' ' THR . 12.1 m-20 -134.65 85.3 36.92 Favored Pre-proline 0 N--CA 1.445 -0.724 0 C-N-CA 124.651 1.18 . . . . 0.0 110.535 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.89 -9.95 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 124.742 3.628 . . . . 0.0 114.196 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 87.9 p -72.61 -12.57 61.1 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.141 -0.974 . . . . 0.0 112.789 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -142.43 94.23 2.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.1 t -149.33 152.27 35.57 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.92 154.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 122.661 1.22 . . . . 0.0 108.942 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -90.34 161.96 15.37 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.328 -171.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 4.5 p -144.68 145.16 21.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 O-C-N 121.487 -0.758 . . . . 0.0 111.378 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.91 -174.88 36.55 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 47.47 34.57 3.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 122.699 0.4 . . . . 0.0 111.745 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.01 -176.52 3.58 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.867 1.267 . . . . 0.0 108.649 -178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' A' ' 360' ' ' MET . 22.6 t-160 -65.13 140.32 58.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.18 0.592 . . . . 0.0 111.075 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -67.85 5.61 3.39 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.054 -0.859 . . . . 0.0 111.162 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.416 ' HB2' ' CE1' ' A' ' 358' ' ' HIS . 40.7 mtp -138.71 28.08 2.43 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.857 1.329 . . . . 0.0 107.495 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -66.17 82.92 0.08 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 123.562 1.648 . . . . 0.0 108.473 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 360' ' ' MET . 5.4 p30 -64.69 156.78 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.107 178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -66.92 -19.1 65.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 120.599 -1.313 . . . . 0.0 111.401 -175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -72.64 -27.77 62.34 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 120.943 -1.098 . . . . 0.0 109.001 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -87.49 -32.73 19.29 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.223 1.409 . . . . 0.0 111.017 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.91 -37.37 86.68 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -78.8 -28.99 44.63 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.835 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -67.82 -42.47 81.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.122 1.328 . . . . 0.0 108.558 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.0 -44.22 92.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.251 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 374' ' ' PHE . 45.4 mt -89.9 -7.86 53.21 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 117.784 -1.103 . . . . 0.0 112.724 -171.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.83 -28.43 15.88 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.742 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -85.7 -26.48 25.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 81.6 mt -98.98 -13.02 20.1 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 370' ' ' LEU . 22.1 m-30 -119.91 -23.07 6.52 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 120.25 1.387 . . . . 0.0 111.942 176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 76.4 -0.68 63.37 Favored Glycine 0 CA--C 1.552 2.381 0 O-C-N 125.048 1.468 . . . . 0.0 113.867 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -177.46 120.08 0.71 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 121.36 2.58 . . . . 0.0 111.807 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.36 171.5 13.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 126.171 1.788 . . . . 0.0 107.834 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.85 -30.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.913 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -163.05 136.82 5.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.085 0.402 . . . . 0.0 110.656 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -150.15 129.66 13.04 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -140.73 159.67 26.46 Favored Glycine 0 C--O 1.22 -0.747 0 O-C-N 121.861 -0.525 . . . . 0.0 114.128 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 23.8 mm -80.88 149.2 5.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.5 47.8 0.5 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.909 0.755 . . . . 0.0 110.386 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 3.4 p -64.53 158.83 23.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 123.817 1.77 . . . . 0.0 110.721 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -140.94 146.99 38.1 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.389 2.676 . . . . 0.0 104.4 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -61.01 122.5 15.09 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.695 -173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 40.4 m170 67.73 42.05 2.09 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -123.08 -10.86 8.11 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 10.3 p90 38.18 50.71 2.37 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.15 -46.33 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.216 2.611 . . . . 0.0 113.995 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 391' ' ' ILE . 9.8 tp 41.99 31.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 112.732 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -133.66 -6.37 2.63 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 -172.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 86.0 p -156.91 160.69 39.36 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 118.626 1.213 . . . . 0.0 108.105 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -176.99 -165.26 32.11 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.182 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -156.82 161.24 39.74 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.554 0.741 . . . . 0.0 109.933 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.31 134.53 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 120.9 1.682 . . . . 0.0 108.477 -176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . 0.544 HG21 ' H ' ' A' ' 347' ' ' ASP . 96.8 m -106.37 141.95 36.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 125.062 1.476 . . . . 0.0 108.323 -173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -112.58 161.44 16.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.592 1.557 . . . . 0.0 112.271 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -131.26 11.37 4.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -135.96 140.31 43.87 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -76.91 -29.56 55.77 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.578 0.549 . . . . 0.0 111.869 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.567 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -64.44 -18.59 64.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.382 0.537 . . . . 0.0 110.739 -175.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.1 m -79.81 -19.74 47.78 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 118.485 0.584 . . . . 0.0 111.187 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -76.5 -51.14 12.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.107 0.867 . . . . 0.0 110.945 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.441 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -73.09 -19.2 61.21 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 119.611 1.096 . . . . 0.0 111.646 177.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.81 -26.32 57.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.737 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -75.96 -34.98 59.83 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.805 -0.559 . . . . 0.0 110.908 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 28.4 m -91.53 -9.07 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 119.838 -0.745 . . . . 0.0 112.567 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.2 p -105.25 -8.79 18.08 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.324 0.39 . . . . 0.0 110.26 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -100.9 -48.44 4.46 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 123.517 0.51 . . . . 0.0 110.335 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 47.01 -12.69 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 129.947 3.299 . . . . 0.0 118.858 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -162.72 138.5 7.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.255 -1.528 . . . . 0.0 107.262 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.83 157.0 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.375 -0.828 . . . . 0.0 111.031 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 423' ' ' LYS . 41.6 mt-10 -105.97 138.92 41.32 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.401 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 421' ' ' THR . 73.4 mt -103.41 116.79 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -134.45 110.19 9.23 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.632 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.0 p -132.39 -175.12 3.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.664 0.786 . . . . 0.0 110.249 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 418' ' ' THR . 88.9 m -83.19 4.49 26.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.64 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -143.27 -4.73 0.88 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.849 1.204 . . . . 0.0 113.73 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -144.65 145.53 31.8 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.681 0.613 . . . . 0.0 110.052 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 415' ' ' ILE . 26.6 m -153.85 116.21 4.37 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.99 0.516 . . . . 0.0 109.955 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -162.16 157.12 22.72 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 123.804 0.69 . . . . 0.0 110.679 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 414' ' ' GLU . 0.1 OUTLIER -114.87 162.42 16.93 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 175.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 12.3 m -142.88 148.34 19.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.731 1.212 . . . . 0.0 108.316 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -132.19 129.36 39.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.937 1.351 . . . . 0.0 111.776 -170.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.13 143.83 16.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.047 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -136.64 148.5 63.86 Favored Pre-proline 0 N--CA 1.444 -0.745 0 O-C-N 123.676 0.61 . . . . 0.0 110.223 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.56 158.41 13.13 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.944 3.096 . . . . 0.0 112.468 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 117.448 -1.263 . . . . 0.0 109.028 178.497 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 221' ' ' SER . 2.3 m 43.99 45.7 6.67 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.339 1.056 . . . . 0.0 110.838 -170.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.9 15.02 0.04 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.532 ' HB2' ' H ' ' A' ' 416' ' ' LYS . 78.5 p -46.52 143.05 2.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.571 1.548 . . . . 0.0 113.944 -168.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 134.96 -2.22 3.96 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 114.77 -1.104 . . . . 0.0 114.072 173.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -134.48 22.05 3.68 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.394 1.097 . . . . 0.0 111.326 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.71 -57.96 3.0 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-O 116.131 -1.89 . . . . 0.0 112.918 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.26 117.19 4.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.6 2.867 . . . . 0.0 108.88 -170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.57 -40.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.304 3.336 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 43.52 22.3 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -86.42 -7.7 58.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.755 1.222 . . . . 0.0 111.796 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.98 145.64 52.42 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 230' ' ' LYS . 25.8 mmmt -144.39 8.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.367 -0.833 . . . . 0.0 113.142 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.21 61.86 50.25 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.173 -172.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.04 129.61 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.859 2.373 . . . . 0.0 112.208 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 37.5 mm -147.72 144.81 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.468 ' CG ' HG11 ' A' ' 292' ' ' VAL . 7.8 m-85 -105.88 151.52 24.44 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.807 -172.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.2 t -152.08 3.77 0.39 Allowed 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 331' ' ' TRP . 4.0 t -146.99 -170.37 3.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.313 -0.867 . . . . 0.0 108.828 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 175.94 1.19 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.91 141.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.852 -177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -91.05 133.92 34.93 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.718 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.457 HD23 ' C ' ' A' ' 240' ' ' LEU . 8.8 tt -143.11 124.36 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -156.62 152.11 23.5 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.04 14.55 0.1 Allowed Glycine 0 CA--C 1.537 1.42 0 O-C-N 124.646 0.85 . . . . 0.0 111.656 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.29 108.66 61.91 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 118.114 0.957 . . . . 0.0 110.982 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.3 0.26 1.06 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 124.847 3.698 . . . . 0.0 113.642 171.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.437 ' CZ3' ' HG3' ' A' ' 321' ' ' MET . 4.2 p-90 -135.9 -96.86 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 25.0 t0 42.53 65.02 0.99 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.577 . . . . 0.0 111.855 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.741 ' H ' ' CD1' ' A' ' 247' ' ' ILE . 0.1 OUTLIER -72.12 -30.49 36.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -171.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 250' ' ' ALA . 16.8 m -140.18 126.65 20.19 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.97 -7.41 58.78 Favored 'General case' 0 C--O 1.201 -1.499 0 O-C-N 123.554 0.534 . . . . 0.0 110.735 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.52 -21.71 61.88 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.062 -0.399 . . . . 0.0 111.462 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.76 -48.99 6.78 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 7.9 tt -63.59 -41.2 98.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 114.823 -0.688 . . . . 0.0 109.638 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.57 -50.72 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 120.494 -1.379 . . . . 0.0 110.641 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -69.24 -9.06 51.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 19.4 m -80.94 -32.32 34.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.1 68.29 1.4 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.858 171.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 257' ' ' ARG . 13.6 ttt180 -123.74 7.18 8.78 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.439 1.096 . . . . 0.0 111.727 175.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.91 7.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 119.807 -1.808 . . . . 0.0 112.362 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -98.72 -10.32 23.32 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.101 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 71.34 -4.07 13.8 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 116.878 1.511 . . . . 0.0 116.878 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 17.7 p -112.32 44.76 1.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 O-C-N 120.599 -1.53 . . . . 0.0 111.704 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -142.47 163.57 32.47 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 57.6 m -149.99 175.69 11.46 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.483 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.98 157.08 41.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 O-C-N 121.525 -0.734 . . . . 0.0 111.013 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -138.11 135.6 35.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 122.392 1.091 . . . . 0.0 111.275 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.31 148.9 36.46 Favored Pre-proline 0 C--O 1.242 0.701 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.23 173.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.01 -21.37 15.9 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 124.239 3.293 . . . . 0.0 111.756 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 178.27 -6.5 0.03 OUTLIER Glycine 0 CA--C 1.547 2.078 0 CA-C-O 118.482 -1.176 . . . . 0.0 115.859 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 278' ' ' PRO . 18.5 tptp -94.87 107.18 19.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.793 2.297 . . . . 0.0 109.872 175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.69 145.02 29.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 167.88 -173.35 42.81 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -63.92 -40.52 96.66 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.82 1.648 . . . . 0.0 112.272 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -147.05 84.56 7.34 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.25 -48.65 1.16 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.528 2.152 . . . . 0.0 114.095 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 53.2 mmm-85 46.56 9.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.03 2.132 . . . . 0.0 114.922 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 41.9 t -164.52 111.33 0.88 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 119.255 0.934 . . . . 0.0 110.391 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.91 160.82 46.77 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.882 2.388 . . . . 0.0 110.076 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 269' ' ' LYS . 87.0 Cg_endo -78.28 -17.47 13.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.234 2.623 . . . . 0.0 112.01 -177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -146.9 167.35 24.17 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.146 1.379 . . . . 0.0 110.878 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -77.66 19.72 3.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.964 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -152.82 165.86 34.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.336 1.568 . . . . 0.0 112.631 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 33.6 m -154.76 -170.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 126.328 2.267 . . . . 0.0 109.391 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -118.3 153.87 33.26 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.418 1.087 . . . . 0.0 110.525 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.74 147.31 48.72 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.15 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.98 112.02 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 109.268 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.629 ' CE1' HG22 ' A' ' 292' ' ' VAL . 0.0 OUTLIER -139.76 -179.73 6.1 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.53 -174.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.56 124.18 10.27 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 288' ' ' LEU . 3.2 mm? -62.17 -13.38 26.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -136.67 -49.22 0.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 116.859 -1.937 . . . . 0.0 112.195 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -81.19 -36.68 29.82 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 72.7 m -76.22 -31.18 58.27 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 120.158 1.345 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.629 HG22 ' CE1' ' A' ' 286' ' ' PHE . 2.8 t -60.86 -52.33 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -74.54 -23.48 58.8 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 74.8 m -72.44 -36.42 68.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 109.924 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.9 mp -74.66 -54.14 7.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.42 4.16 36.76 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.159 -1.016 . . . . 0.0 113.573 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -111.19 -10.51 14.29 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 110.783 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -92.55 -10.54 37.25 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.323 0.965 . . . . 0.0 110.773 172.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 11.5 t -118.41 -115.7 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.794 0.806 . . . . 0.0 112.634 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 4.4 m -126.01 155.97 40.62 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.625 -1.297 . . . . 0.0 111.688 -171.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -157.56 159.28 36.97 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 124.646 1.178 . . . . 0.0 109.049 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 304' ' ' LEU . 16.2 m-20 -146.65 89.12 5.85 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 123.588 0.755 . . . . 0.0 109.684 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 302' ' ' ASP . 65.0 Cg_endo -67.02 22.52 0.11 Allowed 'Trans proline' 0 CA--C 1.544 0.998 1 C-N-CA 128.618 6.212 . . . . 0.0 110.194 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 302' ' ' ASP . 7.2 mp -91.01 -2.36 57.69 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.492 1.117 . . . . 0.0 112.271 -166.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 19.9 t 44.91 44.54 1.7 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -77.26 -6.25 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.661 2.241 . . . . 0.0 113.096 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.99 -42.1 0.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -124.23 -118.76 2.38 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 176.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 310' ' ' SER . 0.9 OUTLIER -95.84 -16.06 22.09 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.448 -1.031 . . . . 0.0 110.925 173.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.538 ' N ' HD12 ' A' ' 309' ' ' LEU . 3.2 p 171.08 176.97 0.06 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.418 1.487 . . . . 0.0 107.963 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -127.27 130.76 50.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -108.48 143.81 36.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -124.78 145.27 49.82 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.847 0.832 . . . . 0.0 110.725 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -151.71 155.98 39.41 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 114.315 -1.311 . . . . 0.0 107.77 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 315' ' ' LYS . 11.0 ptpt -129.34 143.61 50.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.015 0.825 . . . . 0.0 110.177 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.49 -7.65 5.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.676 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 47.7 t -140.34 133.34 29.34 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 119.653 1.115 . . . . 0.0 109.685 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 60.4 m -140.85 -13.4 0.95 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -136.1 -8.77 2.04 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 119.941 1.246 . . . . 0.0 110.849 173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -86.24 -29.11 23.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.769 0.827 . . . . 0.0 111.479 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.437 ' HG3' ' CZ3' ' A' ' 245' ' ' TRP . 97.2 mmm -142.08 164.89 28.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.24 0.616 . . . . 0.0 109.748 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 322' ' ' ARG . 70.6 mtt-85 -92.07 45.94 1.24 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.147 1.379 . . . . 0.0 111.172 175.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.25 -166.13 1.53 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.798 0.839 . . . . 0.0 109.642 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -143.27 -173.2 3.87 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -54.36 158.65 2.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.571 1.548 . . . . 0.0 113.173 -177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 240' ' ' LEU . 11.4 p -121.38 153.4 25.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -172.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.65 150.31 21.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 120.181 1.355 . . . . 0.0 110.253 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 5.8 t -131.86 145.65 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 122.865 0.466 . . . . 0.0 110.281 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 72.7 mt -144.12 99.73 5.0 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 123.775 0.672 . . . . 0.0 111.803 172.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.22 168.11 15.28 Favored 'Trans proline' 0 N--CA 1.46 -0.454 1 C-N-CA 125.306 4.004 . . . . 0.0 110.849 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 236' ' ' CYS . 2.8 t-105 -88.0 125.42 34.53 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.011 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.3 t -105.84 145.12 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.394 -175.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 333' ' ' LEU . 13.1 mt -55.79 -21.33 18.78 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 123.729 0.643 . . . . 0.0 111.071 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -72.6 -4.42 30.73 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.72 3.61 15.65 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.192 1.397 . . . . 0.0 111.073 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 46.6 m -107.13 -49.29 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 120.694 -1.254 . . . . 0.0 111.841 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -155.04 153.88 31.61 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.544 177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -153.8 145.72 23.54 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.571 0.748 . . . . 0.0 109.446 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.86 138.52 41.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 18.17 4.12 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.0 t -150.6 141.44 14.72 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.29 1.836 . . . . 0.0 107.29 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -66.23 -15.99 50.25 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.901 3.067 . . . . 0.0 111.069 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 37.8 p -163.22 90.91 0.68 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.439 1.018 . . . . 0.0 111.758 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -154.29 168.59 26.09 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -131.95 -179.28 5.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.325 1.45 . . . . 0.0 110.235 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 346' ' ' LEU . 3.8 mm? -74.63 171.76 13.28 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -175.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -116.36 155.27 48.64 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.681 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -68.72 104.1 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.701 2.267 . . . . 0.0 113.205 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 74.4 m 57.31 46.15 18.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.131 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 350' ' ' ARG . 4.6 tpm_? -138.03 87.99 2.28 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.102 -0.999 . . . . 0.0 112.439 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.0 p -144.08 166.95 23.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.72 163.32 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 CA-C-O 117.466 -1.254 . . . . 0.0 110.009 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -86.78 160.83 18.67 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.726 0.694 . . . . 0.0 110.487 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.7 t -146.32 131.89 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -166.75 -175.85 37.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 49.39 29.14 2.67 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.423 1.089 . . . . 0.0 112.273 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.813 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -93.54 -175.73 3.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.668 -0.645 . . . . 0.0 110.175 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -59.13 154.03 16.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.155 0.582 . . . . 0.0 111.904 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.08 1.1 9.04 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.256 -0.746 . . . . 0.0 113.665 -172.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 13.3 ptp -158.18 30.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 120.466 2.133 . . . . 0.0 111.839 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 33.1 tp -59.1 126.99 29.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -89.23 167.49 13.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.038 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . . . . . . . . . . . -72.59 -25.54 61.37 Favored 'General case' 0 C--N 1.343 0.306 0 O-C-N 121.469 -0.769 . . . . 0.0 112.167 -173.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -82.99 -18.93 38.14 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 118.481 0.582 . . . . 0.0 111.994 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -86.88 -36.48 18.39 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 173.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.4 tt -61.59 -46.59 89.2 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -66.99 -28.23 68.08 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.613 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -66.14 -36.97 84.52 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.916 0.78 . . . . 0.0 109.695 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 35.8 mt -71.12 -36.51 63.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 119.633 -0.222 . . . . 0.0 110.56 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.0 -0.9 55.25 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.404 ' HA ' ' HA2' ' A' ' 375' ' ' GLY . 0.5 OUTLIER -116.79 -15.3 10.72 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 120.837 -1.165 . . . . 0.0 112.269 174.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.29 -26.83 13.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.852 0.751 . . . . 0.0 109.212 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 373' ' ' LEU . 16.0 tp -80.87 -17.42 50.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 123.424 0.453 . . . . 0.0 110.428 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 403' ' ' SER . 29.0 p90 -166.74 -13.53 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 371' ' ' ASN . . . 68.1 20.1 72.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 171.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -90.1 9.23 78.06 Favored Glycine 0 C--N 1.336 0.563 0 O-C-N 120.808 -1.407 . . . . 0.0 114.613 -173.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.5 163.43 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.236 1.018 . . . . 0.0 113.516 -170.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.25 -33.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.232 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -159.46 147.55 17.48 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . 0.406 ' HB2' HG23 ' A' ' 396' ' ' VAL . . . -150.43 149.04 29.5 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.457 0.646 . . . . 0.0 110.455 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -152.71 160.97 29.3 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.64 -0.662 . . . . 0.0 113.493 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 40.4 mm -96.37 144.28 10.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 O-C-N 124.383 0.696 . . . . 0.0 110.564 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -82.52 60.92 5.4 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 121.231 0.539 . . . . 0.0 109.784 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.464 ' HA ' ' HG2' ' A' ' 390' ' ' PRO . 2.9 p -61.15 154.53 22.96 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 124.068 1.89 . . . . 0.0 111.903 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -142.49 129.58 20.84 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.0 130.75 45.3 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.226 -170.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 8.4 m170 68.53 29.09 5.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 112.145 -2.298 . . . . 0.0 112.398 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.71 -0.53 13.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 14.2 t80 47.41 41.55 0.94 Allowed Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 126.129 1.772 . . . . 0.0 113.645 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 392' ' ' GLY . 36.1 Cg_endo -81.34 37.91 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.523 2.148 . . . . 0.0 109.025 -170.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.454 ' HB ' ' CH2' ' A' ' 331' ' ' TRP . 10.8 tp -69.83 25.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 0.984 0 C-N-CA 123.637 0.775 . . . . 0.0 111.448 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 390' ' ' PRO . . . -123.04 1.55 9.84 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-O 118.543 -1.143 . . . . 0.0 111.142 -168.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 80.3 p -155.47 151.61 27.94 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 118.264 1.032 . . . . 0.0 110.794 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -175.81 -174.73 42.62 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.882 1.268 . . . . 0.0 113.958 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -132.07 166.8 20.93 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 121.324 -1.103 . . . . 0.0 111.227 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 380' ' ' ALA . 7.4 p -146.18 144.12 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 23.1 m -103.76 119.15 38.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.6 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -106.39 156.3 18.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.656 0.782 . . . . 0.0 108.945 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -136.16 21.99 3.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -141.4 159.22 42.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.888 0.375 . . . . 0.0 110.268 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -83.14 -47.24 11.83 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.444 ' HD2' ' H ' ' A' ' 402' ' ' ARG . 0.0 OUTLIER -60.38 -21.86 62.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 374' ' ' PHE . 34.2 p -72.51 -21.75 61.14 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.926 -1.109 . . . . 0.0 111.163 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.58 -62.73 1.48 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.28 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.631 ' H ' HD13 ' A' ' 405' ' ' LEU . 0.0 OUTLIER -67.95 -17.08 64.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 119.317 0.962 . . . . 0.0 113.124 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.17 -29.34 28.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.144 -1.022 . . . . 0.0 111.586 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -77.15 -18.25 58.0 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.31 -1.494 . . . . 0.0 110.411 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.14 -27.4 7.18 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 42.4 t -85.79 -9.56 56.87 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 0.0 111.299 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 412' ' ' PHE . . . -112.22 -59.66 1.97 Allowed 'General case' 0 C--O 1.242 0.673 0 O-C-N 120.927 -1.108 . . . . 0.0 112.247 172.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 59.68 -16.33 0.03 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 127.921 2.488 . . . . 0.0 114.055 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 410' ' ' ALA . 0.1 OUTLIER -162.8 136.99 6.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 7.9 m -139.54 164.29 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -105.11 145.56 30.36 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.957 1.411 . . . . 0.0 110.824 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 13.9 mt -123.89 126.52 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.411 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 221' ' ' SER . 57.0 mmtt -137.65 114.37 10.5 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.704 1.253 . . . . 0.0 110.243 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 92.7 m -151.01 159.51 44.51 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -54.67 139.95 37.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.566 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? 59.32 13.43 3.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.12 1.368 . . . . 0.0 114.675 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -152.54 116.18 4.78 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.897 -1.127 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 17.2 p -145.84 112.43 5.91 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.655 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 16.2 tptm -166.64 -173.11 2.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.011 0.823 . . . . 0.0 110.022 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.655 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 59.5 mttp -125.66 172.18 9.99 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 123.604 0.762 . . . . 0.0 109.562 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -144.25 151.53 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.853 1.346 . . . . 0.0 109.881 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.0 158.57 36.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.235 -0.915 . . . . 0.0 110.274 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 23.8 mt -142.69 146.02 22.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -147.56 141.62 15.91 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.653 0.661 . . . . 0.0 110.669 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -82.76 174.62 9.43 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 124.243 3.295 . . . . 0.0 111.192 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 116.779 -1.581 . . . . 0.0 110.19 171.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 121.761 0.791 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 98.1 m -139.52 147.48 41.3 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 171.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.7 -25.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -173.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.1 m 50.39 119.63 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.426 2.29 . . . . 0.0 114.445 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 166.45 -3.92 0.05 OUTLIER Glycine 0 N--CA 1.469 0.84 0 O-C-N 120.394 -1.441 . . . . 0.0 115.598 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -70.06 -9.39 55.24 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.374 -1.663 . . . . 0.0 114.604 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 224' ' ' LEU . 3.8 mm? -16.5 88.05 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 C-N-CA 128.954 2.902 . . . . 0.0 111.281 174.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -91.83 158.43 3.41 Favored 'Trans proline' 0 N--CA 1.449 -1.11 1 C-N-CA 127.581 5.521 . . . . 0.0 111.496 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.44 147.74 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.949 1.766 . . . . 0.0 110.484 172.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -139.83 18.33 2.49 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.867 0.73 . . . . 0.0 109.066 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -122.39 32.13 5.89 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.922 0.889 . . . . 0.0 112.647 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -64.33 162.26 15.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.196 1.398 . . . . 0.0 112.762 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -77.19 -19.37 56.84 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 58.74 73.35 0.72 Allowed Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.96 -44.08 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.505 2.137 . . . . 0.0 115.419 -174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 39.9 mt -147.8 153.88 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 119.578 1.081 . . . . 0.0 108.274 -172.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -112.53 150.9 30.65 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 22.6 t -150.06 17.75 0.86 Allowed 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.387 0.994 . . . . 0.0 113.409 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' CYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 331' ' ' TRP . 0.9 OUTLIER -156.77 -175.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -61.54 171.25 1.55 Allowed 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.469 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 286' ' ' PHE . 2.7 p -136.25 150.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.456 -170.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -92.6 133.42 35.98 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 240' ' ' LEU . 3.4 tm? -142.13 124.44 15.59 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.754 1.161 . . . . 0.0 110.564 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.462 ' HA3' ' CB ' ' A' ' 281' ' ' TYR . . . 167.56 -172.5 42.46 Favored Glycine 0 N--CA 1.473 1.142 0 O-C-N 124.061 0.851 . . . . 0.0 112.635 172.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.47 7.12 3.2 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.273 0.94 . . . . 0.0 112.764 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 6.5 m -102.62 135.89 19.43 Favored Pre-proline 0 C--O 1.219 -0.51 0 C-N-CA 123.722 0.809 . . . . 0.0 111.203 -174.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 243' ' ' VAL . 33.4 Cg_exo -70.23 -5.08 15.65 Favored 'Trans proline' 0 N--CA 1.439 -1.722 1 C-N-CA 126.33 4.687 . . . . 0.0 115.574 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 323' ' ' CYS . 22.3 p-90 -142.13 -60.9 0.46 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 120.216 1.371 . . . . 0.0 113.803 -174.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 16.6 t70 62.48 -60.13 0.13 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.133 1.373 . . . . 0.0 112.996 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 248' ' ' THR 0.5 0.0 OUTLIER 63.34 -41.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.832 1.958 . . . . 0.0 115.232 -179.461 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 247' ' ' ILE . 25.9 p -157.86 134.95 10.08 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 124.901 1.281 . . . . 0.0 109.078 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.1 pm0 -89.51 -22.85 22.23 Favored 'General case' 0 C--N 1.348 0.535 0 O-C-N 119.632 -1.918 . . . . 0.0 111.745 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.03 64.42 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.165 0.915 . . . . 0.0 111.32 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.19 15.69 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 255' ' ' THR . 46.6 mt -70.74 -36.97 73.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.66 -37.68 80.53 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.582 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.431 ' HA ' ' CD ' ' A' ' 257' ' ' ARG . 62.9 m-20 -64.14 -21.96 66.75 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 120.243 1.383 . . . . 0.0 109.735 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 252' ' ' LEU . 84.2 m -79.16 -27.62 42.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.784 0.72 . . . . 0.0 110.669 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -131.28 23.19 4.81 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.442 ' HA ' ' CD1' ' A' ' 262' ' ' LEU . 16.6 ptm180 -86.96 33.92 0.67 Allowed 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.052 0.941 . . . . 0.0 113.391 174.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.54 2.26 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.14 -2.27 15.02 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 64.01 3.56 8.87 Favored Glycine 0 C--O 1.214 -1.144 0 CA-C-O 118.113 -1.381 . . . . 0.0 113.189 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.52 2.39 28.4 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 124.891 0.995 . . . . 0.0 113.001 -167.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 257' ' ' ARG . 6.1 mt -68.52 141.72 55.46 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 122.931 1.348 . . . . 0.0 114.551 -167.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.5 t -152.23 96.12 2.14 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 124.677 2.179 . . . . 0.0 106.976 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.06 144.31 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 O-C-N 119.423 -2.048 . . . . 0.0 109.41 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -134.52 135.27 42.24 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 120.758 -1.214 . . . . 0.0 111.396 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . . . . . . . . . 8.9 p90 -150.88 143.83 16.66 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-O 121.497 0.665 . . . . 0.0 112.018 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -86.0 169.37 8.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.492 3.461 . . . . 0.0 111.633 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 72.41 -8.06 7.58 Favored Glycine 0 C--O 1.245 0.842 0 C-N-CA 126.465 1.983 . . . . 0.0 114.756 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -129.82 55.22 1.79 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.471 1.136 . . . . 0.0 111.869 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.14 5.45 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.832 0.453 . . . . 0.0 111.487 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -178.28 149.37 9.04 Favored Glycine 0 C--N 1.338 0.646 0 O-C-N 121.124 -0.985 . . . . 0.0 112.416 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 67.89 159.72 0.16 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.627 1.571 . . . . 0.0 110.696 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 16.9 m170 34.14 76.71 0.4 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 125.762 1.625 . . . . 0.0 115.138 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.35 111.9 1.07 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.588 2.192 . . . . 0.0 112.056 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -157.29 169.32 25.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.659 1.584 . . . . 0.0 107.813 -171.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 277' ' ' PRO . 12.8 t -121.62 143.02 37.04 Favored Pre-proline 0 CA--C 1.513 -0.456 0 C-N-CA 124.436 1.095 . . . . 0.0 109.853 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' PRO . . . . . 0.609 ' HD2' ' SG ' ' A' ' 276' ' ' CYS . 84.3 Cg_endo -70.7 151.07 63.44 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.626 2.884 . . . . 0.0 109.631 -174.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.58 -6.19 16.01 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.612 2.875 . . . . 0.0 111.714 -173.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -78.08 1.42 21.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.862 -0.59 . . . . 0.0 111.909 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 70.05 4.27 48.25 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.462 ' CB ' ' HA3' ' A' ' 241' ' ' GLY . 8.6 p90 -152.47 157.0 40.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.287 1.543 . . . . 0.0 112.034 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 34.3 m -152.48 -154.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 127.491 2.316 . . . . 0.0 108.827 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -114.98 164.28 14.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.646 0.779 . . . . 0.0 112.078 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.5 138.36 14.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.865 -0.522 . . . . 0.0 111.364 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.5 m -120.89 125.31 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 168.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.535 ' CE1' HG11 ' A' ' 238' ' ' VAL . 0.1 OUTLIER -146.71 92.27 2.13 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.973 -173.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 286' ' ' PHE . 11.5 tp10 37.88 61.69 1.02 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -48.64 9.87 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 128.306 2.642 . . . . 0.0 117.683 -167.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.02 -72.53 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.992 1.724 . . . . 0.0 111.166 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -78.39 -34.44 48.18 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' SER . . . . . . . . . . . . . 22.8 t -73.62 -32.58 64.14 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 286' ' ' PHE . 89.0 t -63.87 -52.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -61.33 -34.92 76.06 Favored 'General case' 0 CA--C 1.505 -0.773 0 O-C-N 123.668 0.605 . . . . 0.0 112.237 -175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 71.1 m -74.29 -34.15 63.44 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.773 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.46 -45.8 65.07 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.469 0.652 . . . . 0.0 110.169 -176.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -13.54 57.96 Favored 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.105 -0.997 . . . . 0.0 113.441 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.24 -4.58 35.0 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.288 -0.883 . . . . 0.0 111.54 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -104.58 -15.05 15.43 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.679 1.237 . . . . 0.0 108.841 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' CYS . . . . . . . . . . . . . 60.6 m -107.68 -142.61 0.38 Allowed 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.744 -0.597 . . . . 0.0 109.829 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 50.2 m -110.54 172.51 6.83 Favored 'General case' 0 C--O 1.241 0.606 0 O-C-N 120.474 -1.391 . . . . 0.0 113.388 -171.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.407 ' CG ' ' N ' ' A' ' 302' ' ' ASP . 85.3 t60 -149.87 165.19 33.32 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.69 -0.631 . . . . 0.0 110.992 -172.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 301' ' ' HIS . 33.3 t0 -134.45 112.2 11.83 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -84.92 51.65 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 1 C-N-CA 127.384 5.389 . . . . 0.0 110.187 -175.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . 0.25 5.8 mp 63.64 42.2 6.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.491 ' N ' ' CD ' ' A' ' 306' ' ' PRO . 47.5 m -64.78 -34.38 10.45 Favored Pre-proline 0 CA--C 1.552 1.043 0 O-C-N 121.366 -0.834 . . . . 0.0 110.639 168.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 305' ' ' SER . 24.1 Cg_exo -70.16 0.6 5.71 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.101 2.534 . . . . 0.0 114.383 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.9 t70 57.1 16.8 3.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.222 -0.924 . . . . 0.0 111.066 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . -102.8 -129.17 6.58 Favored Glycine 0 CA--C 1.525 0.675 0 O-C-N 121.795 -0.566 . . . . 0.0 112.495 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.6 pp -101.97 173.5 6.36 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.413 1.085 . . . . 0.0 111.718 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . . . . . . . . . 29.9 m -66.52 132.69 48.78 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.218 0.607 . . . . 0.0 110.5 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -133.53 144.26 49.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 119.253 0.933 . . . . 0.0 110.882 175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -110.74 152.66 26.32 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.254 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 327' ' ' GLN . 37.1 m-85 -140.36 148.33 41.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.743 1.258 . . . . 0.0 113.061 -170.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -158.89 163.73 36.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -135.31 133.05 38.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.698 0.761 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 316' ' ' MET . 0.2 OUTLIER -134.98 13.66 3.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.659 -171.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 61.7 p -58.5 153.73 15.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.8 m -111.88 163.05 14.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.219 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -70.84 -9.77 58.24 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.409 ' HG3' ' SD ' ' A' ' 321' ' ' MET . 17.1 ptp180 -82.36 -18.09 43.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.416 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 320' ' ' ARG . 4.0 mpp? -135.93 -48.82 0.68 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 44.33 43.08 5.78 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' CYS . . . . . 0.475 ' HB2' ' HE1' ' A' ' 245' ' ' TRP . 71.1 m -93.23 -60.49 1.78 Allowed 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.326 -1.484 . . . . 0.0 113.842 -173.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -158.52 152.39 23.61 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 118.856 -1.138 . . . . 0.0 113.164 -170.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -67.51 173.42 4.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.842 2.057 . . . . 0.0 113.936 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 3.7 p -118.66 158.29 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.168 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 313' ' ' TYR . 5.4 pp0? -115.69 163.28 16.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.198 0.908 . . . . 0.0 112.047 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.95 130.21 13.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.689 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.3 pt -136.68 88.59 19.08 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 123.16 0.584 . . . . 0.0 110.89 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -76.99 177.85 8.38 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.903 3.735 . . . . 0.0 116.604 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' TRP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 236' ' ' CYS . 7.3 t-105 -82.24 140.89 33.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.915 0.886 . . . . 0.0 110.169 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 334' ' ' ALA . 9.5 t -115.0 151.66 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 122.558 1.171 . . . . 0.0 111.913 -176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 333' ' ' LEU . 6.6 tt -57.25 -36.96 71.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.269 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.637 ' H ' HG12 ' A' ' 332' ' ' VAL . . . -70.44 -5.64 29.97 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.261 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -105.24 -7.01 19.24 Favored 'General case' 0 C--O 1.223 -0.331 0 O-C-N 121.701 -0.624 . . . . 0.0 111.667 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.8 m -83.83 -37.91 21.9 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -154.57 165.52 36.23 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.071 0.548 . . . . 0.0 111.872 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' PHE . . . . . 0.425 ' HB2' ' HB1' ' A' ' 363' ' ' ALA . 44.1 t80 -146.03 133.9 21.28 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 17.8 m -120.39 148.3 23.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.12 -5.07 24.89 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.869 -0.519 . . . . 0.0 110.254 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.9 m -131.11 148.46 70.32 Favored Pre-proline 0 N--CA 1.438 -1.028 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.07 108.4 1.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.669 1.579 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 8.3 t 54.58 38.57 30.09 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.248 1.419 . . . . 0.0 113.492 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -75.2 160.25 30.62 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.379 0.609 . . . . 0.0 111.061 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -92.92 179.33 5.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.13 167.06 13.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 123.966 0.791 . . . . 0.0 109.675 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.06 102.55 15.86 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.02 -1.45 2.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 114.568 -171.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' SER . . . . . . . . . . . . . 81.5 p -130.42 8.8 5.06 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.679 -1.263 . . . . 0.0 114.133 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -144.48 102.37 3.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.082 0.944 . . . . 0.0 108.753 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -160.46 149.5 17.11 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.27 0.628 . . . . 0.0 110.229 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.5 m -125.02 154.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -81.07 136.68 35.98 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.151 0.907 . . . . 0.0 109.753 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 84.7 t -128.61 133.13 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.761 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . -175.8 -165.9 32.44 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 121.638 0.576 . . . . 0.0 114.104 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . 52.07 28.71 5.58 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.692 HD13 ' H ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.6 -160.27 0.71 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.635 1.174 . . . . 0.0 111.86 -175.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -36.22 -24.64 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.949 2.1 . . . . 0.0 115.31 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 91.72 -3.63 78.31 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 119.351 0.978 . . . . 0.0 113.644 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.419 ' HA ' HG13 ' A' ' 391' ' ' ILE . 28.0 ptm -156.76 30.29 0.31 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 113.115 174.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 361' ' ' LEU . 13.7 tp -76.84 156.24 32.37 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 121.284 0.564 . . . . 0.0 110.973 -171.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.73 170.28 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.509 1.123 . . . . 0.0 110.48 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 338' ' ' PHE . . . -72.1 -25.62 61.82 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -175.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -74.68 -26.27 59.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.818 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ALA . . . . . . . . . . . . . . . -80.55 -32.59 36.66 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 45.2 mt -72.23 -34.46 68.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.855 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -68.68 -38.07 80.06 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.131 0.972 . . . . 0.0 111.187 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.53 -34.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 370' ' ' LEU . 4.2 mm? -94.48 -6.19 44.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.118 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -16.6 14.55 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.546 1.521 . . . . 0.0 111.338 172.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -97.3 -28.69 13.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.722 0.692 . . . . 0.0 110.744 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' LEU . . . . . . . . . . . . . 10.0 tp -83.02 -26.71 30.95 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -123.26 -59.02 1.6 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.261 -0.899 . . . . 0.0 113.005 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . 163.5 -139.66 6.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -70.33 148.16 45.23 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 123.555 1.642 . . . . 0.0 113.881 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.07 152.93 8.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 127.736 2.414 . . . . 0.0 109.893 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.58 -30.64 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 118.228 -0.892 . . . . 0.0 112.183 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.449 ' C ' ' CD1' ' A' ' 379' ' ' TYR . 0.8 OUTLIER -150.46 147.91 28.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.177 0.899 . . . . 0.0 112.116 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ALA . . . . . . . . . . . . . . . -142.96 139.01 30.5 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -135.17 151.81 20.61 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.67 0.594 . . . . 0.0 114.095 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.85 148.46 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -103.5 147.78 26.74 Favored 'General case' 0 N--CA 1.428 -1.562 0 O-C-N 125.281 1.613 . . . . 0.0 108.016 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 47.5 p -140.81 163.06 33.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.5 -0.75 . . . . 0.0 112.118 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -127.66 34.13 4.7 Favored 'General case' 0 C--O 1.212 -0.912 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.706 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.32 28.02 0.41 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 125.616 1.566 . . . . 0.0 113.498 -177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -136.04 23.77 3.29 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp 62.75 -15.66 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.458 ' N ' ' HD2' ' A' ' 390' ' ' PRO . 22.2 p90 -78.73 -22.0 0.37 Allowed Pre-proline 0 CA--C 1.515 -0.371 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -170.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 389' ' ' TYR . 18.5 Cg_endo -61.71 -67.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.475 HD13 ' CZ3' ' A' ' 331' ' ' TRP . 10.9 tp 32.44 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.811 1.644 . . . . 0.0 110.885 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 177.24 27.97 0.04 OUTLIER Glycine 0 CA--C 1.531 1.039 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.69 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 70.5 m -143.16 146.84 34.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 167.11 -159.08 32.35 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-O 118.618 -1.101 . . . . 0.0 112.095 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -154.37 166.82 32.02 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 125.299 1.234 . . . . 0.0 109.594 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 5.4 p -140.42 126.35 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 42.1 p -95.59 118.67 32.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 403' ' ' SER . 69.8 m-85 -90.15 162.63 15.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.145 0.974 . . . . 0.0 111.049 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -122.93 -0.51 8.99 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -124.88 153.04 43.23 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 122.628 0.371 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -80.76 -30.57 36.07 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.443 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.69 -39.1 64.86 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.282 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . 0.633 ' HB3' ' CE1' ' A' ' 398' ' ' PHE . 21.5 m -65.95 -25.59 67.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.536 0.607 . . . . 0.0 111.276 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -78.67 -57.15 3.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.338 0.589 . . . . 0.0 111.417 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' LEU . . . . . 0.47 ' H ' ' CD1' ' A' ' 405' ' ' LEU . 0.0 OUTLIER -74.26 -20.76 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.496 -0.752 . . . . 0.0 111.792 -177.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -81.13 -26.66 35.95 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.912 1.233 . . . . 0.0 109.626 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -71.02 -43.39 68.02 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 33.0 m -75.89 -21.84 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.233 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.4 p -81.18 -26.33 36.08 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 118.352 -0.833 . . . . 0.0 112.83 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -92.38 -33.15 14.68 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.232 0.469 . . . . 0.0 111.757 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . 51.16 -22.54 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 118.41 2.744 . . . . 0.0 118.41 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CE2' ' HD3' ' A' ' 423' ' ' LYS . 26.1 t80 -163.69 130.53 3.3 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.891 -1.755 . . . . 0.0 107.506 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.57 174.69 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.884 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -116.46 153.85 31.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.516 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 28.6 mt -127.35 123.48 61.93 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.421 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -125.44 140.59 52.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.307 1.004 . . . . 0.0 108.815 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 m -148.8 167.76 24.75 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.4 t -60.95 -18.83 59.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 15.94 0.75 Allowed 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -139.42 128.88 24.29 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 121.634 -0.666 . . . . 0.0 110.622 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 52.5 p -146.86 124.18 11.59 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 122.063 -0.398 . . . . 0.0 110.148 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' LYS . . . . . 0.612 ' HG3' ' H ' ' A' ' 423' ' ' LYS . 29.4 tptt -165.6 -161.33 0.51 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.631 0.582 . . . . 0.0 110.476 175.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.612 ' H ' ' HG3' ' A' ' 422' ' ' LYS . 92.8 mttt -141.45 168.48 19.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.39 139.21 29.4 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -122.3 160.76 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 60.2 mt -139.28 137.3 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.254 -171.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -128.06 145.29 54.8 Favored Pre-proline 0 C--N 1.324 -0.543 0 O-C-N 123.911 0.757 . . . . 0.0 111.211 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 145.67 94.82 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.332 3.354 . . . . 0.0 111.644 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . . . . . . . . . 79.0 t80 . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.428 1.091 . . . . 0.0 112.967 -179.703 . . . . . . . . 0 0 . 1 stop_ save_